Citrus Sinensis ID: 042902

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------60
Protein Sequence
LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP
Secondary Structure (PSIPRED)
cccccccccccccHHHHHccccccccccccEEcccccccccccccccEEEccccccccccccccccccccccccccEEEcccccccccccHHHHHccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccHHHHcccccccEEccccEEEEccccccccccccccEEcccccccccHHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccHHHHcccccccccccccccEEccccccccccccHHHHcccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEccccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccEEcccccccEEcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccccccccccccHHHHccccccEEEcccccccccccHHHHccHHHccEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHcccHHHHHHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccHHHHHHHcHHHHEcccccccccEEEccccccccc
Coil and Loop (DISEMBL)
lllwgnnfsgtipsfiFNASKLSRLELEMNSFygfipntfgnlrnlkRLSLNYNyltsstpklnflsslsnckylkylsfsnnsldgilpraignlSQSMEVFFMFNcnisgsipeeISNLtnlttiylggnklngsiPIALDKLQKLQLLslednqlegsipdDLCRLAALFLLDlggnklsgfvpacfgnltslrnlylgsnqltsipstlWNLKYILYLNlssnsftgplpleiGNLRVLVQIDLsmnnfsgfipttigdlkdLQYLFLEYNrlqgsipdsigglidlksldlsnnnisgaiPISLEKLLDLKYINVSFNklegeipregpfrnfsaesfkgnellcgtpnlqvppcrtrihhtsrkNDLLLGIVLPLSTIFMMAVILLILRYRKRGksqladanmpLVANLRRFTHLELFqatngfsennligrggVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEymphgslekclyssnYILDIFQRLNIMIDVASALEYLhfgysvpiihcdlkpnnvllddnmvahlsdfgmakpllkedqslTQTQTLATIGYMAP
Flexible Loop (DISEMBL)
lllwgnnfsgtipSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLegeipregpFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQAtngfsennliGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPllkedqsltqtqtlatigymap
Low Complexity Region (SEG)
LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIAldklqklqllslEDNQLEGSIPddlcrlaalflldlGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP
Disordered region (IsUnstruct)
*LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL*********************
Disordered Region (DISOPRED)
LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPN********************LGIVLPLSTIFMMAVILLIL********************LRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED***TQTQTLATIGYMAP
Disordered Region (DISEMBL)
LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP
Disordered Region (DISPRO)
*LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	599	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.986	0.585	0.416	1e-118
C0LGT6	1031	LRR receptor-like serine/	no	no	0.986	0.573	0.378	1e-106
Q9SD62	1025	Putative receptor-like pr	no	no	0.998	0.583	0.387	1e-100
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.986	0.603	0.362	6e-97
Q9FL28	1173	LRR receptor-like serine/	no	no	0.974	0.497	0.354	1e-91
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.986	0.473	0.333	6e-85
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.981	0.469	0.318	1e-80
Q42371	976	LRR receptor-like serine/	no	no	0.973	0.597	0.341	3e-80
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.984	0.494	0.320	2e-79
C0LGW6	966	LRR receptor-like serine/	no	no	0.981	0.608	0.334	2e-79

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  426 bits (1095), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 263/631 (41%), Positives = 376/631 (59%), Gaps = 40/631 (6%)

Query: 3   LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS-STP 61
           + GN F+G+IP+ + N S L RL +  N+  G IP TFGN+ NLK L L+ N L S S+ 
Sbjct: 266 MGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR 324

Query: 62  KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
            L FL+SL+NC  L+ L    N L G LP +I NLS  +    +    ISGSIP +I NL
Sbjct: 325 DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNL 384

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
            NL  + L  N L+G +P +L KL  L+ LSL  N+L G IP  +  +  L  LDL  N 
Sbjct: 385 INLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNG 444

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
             G VP   GN + L  L++G N+L  +IP  +  ++ +L L++S NS  G LP +IG L
Sbjct: 445 FEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGAL 504

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
           + L  + L  N  SG +P T+G+   ++ LFLE N   G IPD + GL+ +K +DLSNN+
Sbjct: 505 QNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNND 563

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLC-GTPNLQVPP 359
           +SG+IP        L+Y+N+SFN LEG++P +G F N +  S  GN  LC G    Q+ P
Sbjct: 564 LSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKP 623

Query: 360 CRTRI-----HHTSRKNDLLLGIVLPLS---TIFMMAVILLILRYRKRGKSQLADANMPL 411
           C ++       H+SR   +++G+ + ++    +FM +V L+ LR RK+ K    + N P 
Sbjct: 624 CLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK----ETNNPT 679

Query: 412 VANL----RRFTHLELFQATNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG 466
            + L     + ++ +L  ATNGFS +N++G G   +VYKA  + +   VAVKV ++Q  G
Sbjct: 680 PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRG 739

Query: 467 AFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKALVLEYMPHGSLEKCLYSS--- 518
           A KSF  EC+ +K IRHRNL+K++++CS+ D     F+AL+ E+MP+GSL+  L+     
Sbjct: 740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE 799

Query: 519 -----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG 573
                +  L + +RLNI IDVAS L+YLH     PI HCDLKP+NVLLDD++ AH+SDFG
Sbjct: 800 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859

Query: 574 MAKPLLKEDQS-----LTQTQTLATIGYMAP 599
           +A+ LLK D+      L+      TIGY AP
Sbjct: 860 LARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 238/628 (37%), Positives = 349/628 (55%), Gaps = 37/628 (5%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL-N 64
           N F+G IP  + N S L R ++  N   G IP +FG LRNL  L +  N L +++     
Sbjct: 276 NQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE 335

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
           F+ +++NC  L+YL    N L G LP +I NLS ++   F+    ISG+IP +I NL +L
Sbjct: 336 FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSL 395

Query: 125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSG 184
             + L  N L+G +P++  KL  LQ++ L  N + G IP     +  L  L L  N   G
Sbjct: 396 QELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHG 455

Query: 185 FVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL 243
            +P   G    L +L++ +N+L  +IP  +  +  + Y++LS+N  TG  P E+G L +L
Sbjct: 456 RIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELL 515

Query: 244 VQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG 303
           V +  S N  SG +P  IG    +++LF++ N   G+IPD I  L+ LK++D SNNN+SG
Sbjct: 516 VGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSG 574

Query: 304 AIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLC-GTPNLQVPPCRT 362
            IP  L  L  L+ +N+S NK EG +P  G FRN +A S  GN  +C G   +Q+ PC  
Sbjct: 575 RIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIV 634

Query: 363 RIHHTSRK-----NDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANL-- 415
           +     RK       ++ GI + ++++ ++ ++  +  + KR K   A    P  +    
Sbjct: 635 QASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLG 694

Query: 416 ---RRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIE---VAVKVFDLQYEGAFK 469
               + ++ EL  AT+ FS  NLIG G   +V+K  +  G E   VAVKV +L   GA K
Sbjct: 695 MFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLL--GPENKLVAVKVLNLLKHGATK 752

Query: 470 SFDIECDMMKRIRHRNLIKIISSCSN-----DDFKALVLEYMPHGSLEKCLY-------- 516
           SF  EC+  K IRHRNL+K+I+ CS+     +DF+ALV E+MP GSL+  L         
Sbjct: 753 SFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVN 812

Query: 517 SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
             +  L   ++LNI IDVASALEYLH     P+ HCD+KP+N+LLDD++ AH+SDFG+A+
Sbjct: 813 DHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQ 872

Query: 577 PLLKEDQS-----LTQTQTLATIGYMAP 599
            L K D+       +      TIGY AP
Sbjct: 873 LLYKYDRESFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  365 bits (938), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 254/655 (38%), Positives = 362/655 (55%), Gaps = 57/655 (8%)

Query: 1   LLLWGNNFSGTI-PSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L + GN+FSGT+ P F      L  L + +NSF G IP T  N+ +L++L +  N+LT  
Sbjct: 254 LSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGK 313

Query: 60  TP-------------------------KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIG 94
            P                          L+FL +L+NC  L+YL+   N L G LP  I 
Sbjct: 314 IPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIA 373

Query: 95  NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLE 154
           NLS  +    +    ISGSIP  I NL +L T+ LG N L G +P +L +L +L+ + L 
Sbjct: 374 NLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLY 433

Query: 155 DNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTL 213
            N L G IP  L  ++ L  L L  N   G +P+  G+ + L +L LG+N+L  SIP  L
Sbjct: 434 SNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHEL 493

Query: 214 WNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE 273
             L  ++ LN+S N   GPL  +IG L+ L+ +D+S N  SG IP T+ +   L++L L+
Sbjct: 494 MELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQ 553

Query: 274 YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREG 333
            N   G IPD I GL  L+ LDLS NN+SG IP  +     L+ +N+S N  +G +P EG
Sbjct: 554 GNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEG 612

Query: 334 PFRNFSAESFKGNELLC-GTPNLQVPPCRT---RIHHTSRKNDLLLGIVLPLSTIFMMAV 389
            FRN SA S  GN  LC G P+LQ+ PC     R H + RK   +    +  + + +   
Sbjct: 613 VFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLC 672

Query: 390 ILLILRYRKRGKSQLADAN------MPLVANLRRFTHLELFQATNGFSENNLIGRGGVAS 443
           ++ +  Y+ R KS  A+ N       P+ +   + ++ EL++ T GFS +NLIG G   +
Sbjct: 673 VVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGA 732

Query: 444 VYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN-----DD 497
           V+K  +      VA+KV +L   GA KSF  EC+ +  IRHRNL+K+++ CS+     +D
Sbjct: 733 VFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGND 792

Query: 498 FKALVLEYMPHGSLEKCLY--------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           F+ALV E+MP+G+L+  L+        + +  L +F RLNI IDVASAL YLH     PI
Sbjct: 793 FRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPI 852

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ-----TLATIGYMAP 599
            HCD+KP+N+LLD ++ AH+SDFG+A+ LLK D+     Q        TIGY AP
Sbjct: 853 AHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  355 bits (911), Expect = 6e-97,   Method: Compositional matrix adjust.
 Identities = 238/657 (36%), Positives = 352/657 (53%), Gaps = 66/657 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPN-TFGNLRNLKRLSLNYNYLTSS 59
           LLLW N  +GT+PS + N++ L  ++LE N   G +P+     +  L+ L L+YN+  S 
Sbjct: 196 LLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSH 255

Query: 60  TPKLN---FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPE 116
               N   F +SL+N   L+ L  + NSL G +  ++ +LS ++    +    I GSIP 
Sbjct: 256 NNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPP 315

Query: 117 EIS------------------------NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLS 152
           EIS                         L+ L  +YL  N L G IP+ L  + +L LL 
Sbjct: 316 EISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLD 375

Query: 153 LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIP- 210
           +  N L GSIPD    L+ L  L L GN LSG VP   G   +L  L L  N LT +IP 
Sbjct: 376 VSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPV 435

Query: 211 ---STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDL 267
              S L NLK  LYLNLSSN  +GP+PLE+  + +++ +DLS N  SG IP  +G    L
Sbjct: 436 EVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIAL 493

Query: 268 QYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG 327
           ++L L  N    ++P S+G L  LK LD+S N ++GAIP S ++   LK++N SFN L G
Sbjct: 494 EHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSG 553

Query: 328 EIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMM 387
            +  +G F   + ESF G+ LLCG+        +   + +     LL  I  P+  +F  
Sbjct: 554 NVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGY 613

Query: 388 AVI--------LLILRYRKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRG 439
            ++        L +    +    +  + N P      R ++ +L  AT GF+ ++LIG G
Sbjct: 614 PLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP---KYPRISYQQLIAATGGFNASSLIGSG 670

Query: 440 GVASVYKARIQDGIEVAVKVFD----LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
               VYK  +++  +VAVKV D    L++ G+FK    EC ++KR RHRNLI+II++CS 
Sbjct: 671 RFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIRIITTCSK 727

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             F ALVL  MP+GSLE+ LY   Y    LD+ Q +NI  DVA  + YLH    V ++HC
Sbjct: 728 PGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHC 787

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA----------TIGYMAP 599
           DLKP+N+LLDD M A ++DFG+++ +   +++++   +++          ++GY+AP
Sbjct: 788 DLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  338 bits (866), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 235/663 (35%), Positives = 349/663 (52%), Gaps = 79/663 (11%)

Query: 6    NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
            N  +G IPS I N + L  L+L  N   G IP  FG + NL  +S+  N+ T   P   F
Sbjct: 394  NLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPDDIF 452

Query: 66   LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
                 NC  L+ LS ++N+L G L   IG L Q + +  +   +++G IP EI NL +L 
Sbjct: 453  -----NCSNLETLSVADNNLTGTLKPLIGKL-QKLRILQVSYNSLTGPIPREIGNLKDLN 506

Query: 126  TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
             +YL  N   G IP  +  L  LQ L +  N LEG IP+++  +  L +LDL  NK SG 
Sbjct: 507  ILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQ 566

Query: 186  VPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYI------------------------- 219
            +PA F  L SL  L L  N+   SIP++L +L  +                         
Sbjct: 567  IPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNM 626

Query: 220  -LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
             LYLN S+N  TG +P E+G L ++ +IDLS N FSG IP ++   K++  L    N L 
Sbjct: 627  QLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLS 686

Query: 279  GSIPD-------------------------SIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
            G IPD                         S G +  L SLDLS+NN++G IP SL  L 
Sbjct: 687  GHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLS 746

Query: 314  DLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPC--RTRIHHTSRKN 371
             LK++ ++ N L+G +P  G F+N +A    GN  LCG+    + PC  + +  H S++ 
Sbjct: 747  TLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRT 805

Query: 372  DLLLGIV--------LPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTHLEL 423
             ++L I+        + L  + +        +     +S L D +  L   L+RF   EL
Sbjct: 806  RVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSAL--KLKRFEPKEL 863

Query: 424  FQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRI 481
             QAT+ F+  N+IG   +++VYK +++DG  +AVKV +L+   A   K F  E   + ++
Sbjct: 864  EQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923

Query: 482  RHRNLIKIIS-SCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALE 539
            +HRNL+KI+  +  +   KALVL +M +G+LE  ++ S   I  + +++++ + +AS ++
Sbjct: 924  KHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGID 983

Query: 540  YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTL--ATIGY 596
            YLH GY  PI+HCDLKP N+LLD + VAH+SDFG A+ L  +ED S T + +    TIGY
Sbjct: 984  YLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGY 1043

Query: 597  MAP 599
            +AP
Sbjct: 1044 LAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  315 bits (807), Expect = 6e-85,   Method: Compositional matrix adjust.
 Identities = 235/704 (33%), Positives = 346/704 (49%), Gaps = 113/704 (16%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            L L+ N FSG IP  I N + L  +++  N F G IP + G L+ L  L L  N L    
Sbjct: 437  LFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGL 496

Query: 61   PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
            P     +SL NC  L  L  ++N L G +P + G L + +E   ++N ++ G++P+ + +
Sbjct: 497  P-----ASLGNCHQLNILDLADNQLSGSIPSSFGFL-KGLEQLMLYNNSLQGNLPDSLIS 550

Query: 121  LTNLTTI-----------------------------------------------YLGGNK 133
            L NLT I                                                LG N+
Sbjct: 551  LRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQ 610

Query: 134  LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
            L G IP  L K+++L LL +  N L G+IP  L     L  +DL  N LSG +P   G L
Sbjct: 611  LTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKL 670

Query: 194  TSLRNLYLGSNQ-LTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
            + L  L L SNQ + S+P+ L+N   +L L+L  NS  G +P EIGNL  L  ++L  N 
Sbjct: 671  SQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQ 730

Query: 253  FSGF------------------------IPTTIGDLKDLQ-YLFLEYNRLQGSIPDSIGG 287
            FSG                         IP  IG L+DLQ  L L YN   G IP +IG 
Sbjct: 731  FSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGT 790

Query: 288  LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNE 347
            L  L++LDLS+N ++G +P S+  +  L Y+NVSFN L G++ ++  F  + A+SF GN 
Sbjct: 791  LSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNT 848

Query: 348  LLCGTPNLQVPPCRT--RIHHTSRKNDLLLGIVLPLSTI-FMMAVILLILR-----YRKR 399
             LCG+P  +    R+  +    S ++ +++  +  L+ I  M+ VI L  +     ++K 
Sbjct: 849  GLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKV 908

Query: 400  GKSQLA---------DANMPLVANLRRFTHL---ELFQATNGFSENNLIGRGGVASVYKA 447
            G    A           + PL  N    + +   ++ +AT+  SE  +IG GG   VYKA
Sbjct: 909  GHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKA 968

Query: 448  RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVLE 504
             +++G  VAVK    + +  + KSF  E   + RIRHR+L+K++  CS+  +    L+ E
Sbjct: 969  ELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYE 1028

Query: 505  YMPHGSLEKCLYSSNYIL-------DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN 557
            YM +GS+   L+    +L       D   RL I + +A  +EYLH     PI+H D+K +
Sbjct: 1029 YMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSS 1088

Query: 558  NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL--ATIGYMAP 599
            NVLLD NM AHL DFG+AK L +   + T + T    + GY+AP
Sbjct: 1089 NVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  301 bits (770), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 223/701 (31%), Positives = 349/701 (49%), Gaps = 113/701 (16%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            + L+ N FSG +P  I N ++L  ++   N   G IP++ G L++L RL L  N L  + 
Sbjct: 438  MYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNI 497

Query: 61   PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
            P     +SL NC  +  +  ++N L G +P + G L+ ++E+F ++N ++ G++P+ + N
Sbjct: 498  P-----ASLGNCHQMTVIDLADNQLSGSIPSSFGFLT-ALELFMIYNNSLQGNLPDSLIN 551

Query: 121  LTNLTTIYLGGNKLNGSI-----------------------PIALDKLQKLQLLSLEDNQ 157
            L NLT I    NK NGSI                       P+ L K   L  L L  NQ
Sbjct: 552  LKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQ 611

Query: 158  LEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNL 216
              G IP    +++ L LLD+  N LSG +P   G    L ++ L +N L+  IP+ L  L
Sbjct: 612  FTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKL 671

Query: 217  KYILYLNLSSNSF----------------------------------------------- 229
              +  L LSSN F                                               
Sbjct: 672  PLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQ 731

Query: 230  -TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ-YLFLEYNRLQGSIPDSIGG 287
             +GPLP  IG L  L ++ LS N  +G IP  IG L+DLQ  L L YN   G IP +I  
Sbjct: 732  LSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIST 791

Query: 288  LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNE 347
            L  L+SLDLS+N + G +P  +  +  L Y+N+S+N LEG++ ++  F  + A++F GN 
Sbjct: 792  LPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNA 849

Query: 348  LLCGTPNLQVPPCRTRIHHT-SRKNDLLLGIVLPLSTIFMMAVILLI-------LRYRKR 399
             LCG+P        ++   + S K  +++  +  L+ I +M +++++       L  + R
Sbjct: 850  GLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR 909

Query: 400  G-----KSQLADANMPLVANLRRFTHL---ELFQATNGFSENNLIGRGGVASVYKARIQD 451
            G      S  + +  PL +N    + +   ++ +AT+  +E  +IG GG   VYKA +++
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969

Query: 452  GIEVAVKVF----DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVLEY 505
            G  +AVK      DL    + KSF+ E   +  IRHR+L+K++  CS+  D    L+ EY
Sbjct: 970  GETIAVKKILWKDDLM---SNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEY 1026

Query: 506  MPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL 560
            M +GS+   L+++       +L    RL I + +A  +EYLH+    PI+H D+K +NVL
Sbjct: 1027 MANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVL 1086

Query: 561  LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL--ATIGYMAP 599
            LD N+ AHL DFG+AK L     + T++ T+   + GY+AP
Sbjct: 1087 LDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  300 bits (767), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 218/638 (34%), Positives = 313/638 (49%), Gaps = 55/638 (8%)

Query: 3   LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTP- 61
           L GNN  G I   +   + L   ++  NS  G IP T GN    + L L+YN LT   P 
Sbjct: 195 LRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPF 254

Query: 62  KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
            + FL        +  LS   N L G +P  IG L Q++ V  +    +SGSIP  + NL
Sbjct: 255 DIGFLQ-------VATLSLQGNQLSGKIPSVIG-LMQALAVLDLSGNLLSGSIPPILGNL 306

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
           T    +YL  NKL GSIP  L  + KL  L L DN L G IP +L +L  LF L++  N 
Sbjct: 307 TFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANND 366

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           L G +P    + T+L +L +  N+ + +IP     L+ + YLNLSSN+  GP+P+E+  +
Sbjct: 367 LEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRI 426

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L  +DLS N  +G IP+++GDL+ L  + L  N + G +P   G L  +  +DLSNN+
Sbjct: 427 GNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNND 486

Query: 301 ISGAIPISLEKL-----------------------LDLKYINVSFNKLEGEIPREGPFRN 337
           ISG IP  L +L                       L L  +NVS N L G+IP+   F  
Sbjct: 487 ISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSR 546

Query: 338 FSAESFKGNELLCGTPNLQVPPCRT--RIHHTSRKNDLLLGIVLPLSTIFMMAVILLILR 395
           FS +SF GN  LCG+      PC    R    S     +LGI +    I +M   +LI  
Sbjct: 547 FSPDSFIGNPGLCGS--WLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLM---VLIAA 601

Query: 396 YRKRGKSQLADANMP------------LVANLRRFTHLELFQATNGFSENNLIGRGGVAS 443
            R        D ++             L  N+    + ++ + T   SE  +IG G  ++
Sbjct: 602 CRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASST 661

Query: 444 VYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL 503
           VYK  +++   VA+K        + K F+ E +M+  I+HRNL+ + +   +     L  
Sbjct: 662 VYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFY 721

Query: 504 EYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL 561
           +Y+ +GSL   L+  +    LD   RL I    A  L YLH   S  IIH D+K +N+LL
Sbjct: 722 DYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILL 781

Query: 562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           D ++ A L+DFG+AK L    +S T T  + TIGY+ P
Sbjct: 782 DKDLEARLTDFGIAKSLCVS-KSHTSTYVMGTIGYIDP 818

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  297 bits (760), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 211/659 (32%), Positives = 328/659 (49%), Gaps = 69/659 (10%)

Query: 6    NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPK-LN 64
            NNF+G IP  ++ ++ L       N   G++P   GN  +LKRL L+ N LT   P+ + 
Sbjct: 434  NNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIG 493

Query: 65   FLSSLS------------------NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF 106
             L+SLS                  +C  L  L   +N+L G +P  I  L+Q   +   +
Sbjct: 494  KLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSY 553

Query: 107  NCNISGSIPE------------EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLE 154
            N N+SGSIP             ++S L +     L  N+L+G IP  L +   L  +SL 
Sbjct: 554  N-NLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLS 612

Query: 155  DNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTL 213
            +N L G IP  L RL  L +LDL GN L+G +P   GN   L+ L L +NQL   IP + 
Sbjct: 613  NNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESF 672

Query: 214  WNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE 273
              L  ++ LNL+ N   GP+P  +GNL+ L  +DLS NN SG + + +  ++ L  L++E
Sbjct: 673  GLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIE 732

Query: 274  YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREG 333
             N+  G IP  +G L  L+ LD+S N +SG IP  +  L +L+++N++ N L GE+P +G
Sbjct: 733  QNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDG 792

Query: 334  PFRNFSAESFKGNELLCGTPNLQVPPCR---TRIHHTSRKNDLLLG-IVLPLSTIFMMAV 389
              ++ S     GN+ LCG   +    C+   T++        L+LG  ++    +F +  
Sbjct: 793  VCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRR 850

Query: 390  ILLILRYRKRGKSQ---------LADANM----------PLVANLRRFTHL-------EL 423
              +  R ++R   +           D N+          PL  N+  F          ++
Sbjct: 851  WAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDI 910

Query: 424  FQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH 483
             +AT+ FS+ N+IG GG  +VYKA +     VAVK          + F  E + + +++H
Sbjct: 911  VEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKH 970

Query: 484  RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEY 540
             NL+ ++  CS  + K LV EYM +GSL+  L +      +LD  +RL I +  A  L +
Sbjct: 971  PNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAF 1030

Query: 541  LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            LH G+   IIH D+K +N+LLD +    ++DFG+A+ L+   +S   T    T GY+ P
Sbjct: 1031 LHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLAR-LISACESHVSTVIAGTFGYIPP 1088

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  297 bits (760), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 211/630 (33%), Positives = 320/630 (50%), Gaps = 42/630 (6%)

Query: 3   LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTP- 61
           L GN  +GT+ S +   + L   ++  N+  G IP + GN  + + L ++YN +T   P 
Sbjct: 198 LRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPY 257

Query: 62  KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
            + FL        +  LS   N L G +P  IG L Q++ V  + +  + G IP  + NL
Sbjct: 258 NIGFLQ-------VATLSLQGNRLTGRIPEVIG-LMQALAVLDLSDNELVGPIPPILGNL 309

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
           +    +YL GN L G IP  L  + +L  L L DN+L G+IP +L +L  LF L+L  N+
Sbjct: 310 SFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNR 369

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           L G +P+   +  +L    +  N L+ SIP    NL  + YLNLSSN+F G +P+E+G++
Sbjct: 370 LVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHI 429

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L ++DLS NNFSG IP T+GDL+ L  L L  N L G +P   G L  ++ +D+S N 
Sbjct: 430 INLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNL 489

Query: 301 ISGAIPISLEKL------------------------LDLKYINVSFNKLEGEIPREGPFR 336
           +SG IP  L +L                          L  +NVSFN L G +P    F 
Sbjct: 490 LSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFS 549

Query: 337 NFSAESFKGNELLCG--TPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLIL 394
            F+  SF GN  LCG    ++  P  ++R+        ++LG++  L  IF+     +  
Sbjct: 550 RFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQ 609

Query: 395 RYRKRGKSQLADANMPLV---ANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQD 451
           +   +G S+ A+    LV    ++   T  ++ + T   +E  +IG G  ++VYK  ++ 
Sbjct: 610 KKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKS 669

Query: 452 GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL 511
              +A+K    QY    + F+ E + +  IRHRN++ +     +     L  +YM +GSL
Sbjct: 670 SRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSL 729

Query: 512 EKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL 569
              L+ S     LD   RL I +  A  L YLH   +  IIH D+K +N+LLD+N  AHL
Sbjct: 730 WDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHL 789

Query: 570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           SDFG+AK  +   ++   T  L TIGY+ P
Sbjct: 790 SDFGIAKS-IPASKTHASTYVLGTIGYIDP 818

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	599
255585401	843	serine-threonine protein kinase, plant-t	0.981	0.697	0.567	1e-172
255572272	1089	serine-threonine protein kinase, plant-t	0.988	0.543	0.541	1e-171
224116832	1061	predicted protein [Populus trichocarpa]	0.998	0.563	0.531	1e-170
359485453	1202	PREDICTED: probable LRR receptor-like se	0.988	0.492	0.550	1e-170
359483198	1087	PREDICTED: probable LRR receptor-like se	0.998	0.550	0.554	1e-170
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.993	0.484	0.525	1e-167
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.993	0.521	0.527	1e-167
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.996	0.495	0.527	1e-167
224139658	1019	predicted protein [Populus trichocarpa]	0.989	0.581	0.527	1e-167
359483688	1197	PREDICTED: LRR receptor-like serine/thre	0.989	0.495	0.530	1e-165

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  612 bits (1577), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 338/596 (56%), Positives = 423/596 (70%), Gaps = 8/596 (1%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
           N F GT+P  I NASKL+ LE   NS  G IP+T  NL+NLKRL+L  N   S T +L F
Sbjct: 134 NQFIGTLPPSISNASKLTILESSSNSLSGPIPDTLCNLKNLKRLNLADN---SFTDELGF 190

Query: 66  LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
           L+SL+ CK L+ L    N L+  LP +IGNLS S+E F + +CNI G+IP EI  L+NL 
Sbjct: 191 LASLARCKELRRLVLIGNPLNSTLPTSIGNLS-SIEYFNVQSCNIKGNIPSEIGVLSNLI 249

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
           T++L  N+L GSIP+ +  LQKLQ L L  N L GSIP D+C L+ L  L L  N L G 
Sbjct: 250 TLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNSLFGP 309

Query: 186 VPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV 244
           +PACFG+L SLR L+L SN  TS IP +LW+LK +L LNLSSNS +G +PL IGNL+VL 
Sbjct: 310 LPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNLKVLT 369

Query: 245 QIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGA 304
           Q+D S N+ SG IP  IG L++L  L L +NR +G IP+  G LI L+SLDLS+NN+SG 
Sbjct: 370 QVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGK 429

Query: 305 IPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRI 364
           IP SLE+L  LKY+NVSFN L+GE+P +G F NFSA SF GN  LCG+  L + PC+   
Sbjct: 430 IPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNT 489

Query: 365 HHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADA-NMPLVANLRRFTHLEL 423
           H  S+ +  LL I +  ++I  +A IL+ LR +K  K +L +  ++  V   RR +  EL
Sbjct: 490 HGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKV-KLELENVMDIITVGTWRRISFQEL 548

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH 483
            QAT+GF  +NL+G GG  SVYK R++DG  VA+KVF+L  EGAFK FD EC++M  IRH
Sbjct: 549 EQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRH 608

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           RNL+KIIS CSN DFKA+VLEYMP+GSLEK LYS NY L+I QRL +MIDVASALEYLH 
Sbjct: 609 RNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYLHH 668

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           G+S PI+HCDLKP+NVLLD +MV H++DFGMAK LL E   +TQT+TLATIGYMAP
Sbjct: 669 GFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAK-LLGEGDLITQTKTLATIGYMAP 723

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  607 bits (1564), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 326/602 (54%), Positives = 423/602 (70%), Gaps = 10/602 (1%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS--STPKL 63
           N  SG IPS+I NASKL+ LEL  NSF GFIP++ G+LRNL+ L L  N L+S  ++ +L
Sbjct: 371 NKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQEL 430

Query: 64  NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
              SSL NC+ LKYL  S N LDG LP ++GNLS S+E F   +  I GS+ E I NL++
Sbjct: 431 TIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSS 490

Query: 124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS 183
           LT + LG N L G IP  +  L+ LQ L L  N L+GSIP +LC L  L+ L+L GNKLS
Sbjct: 491 LTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLS 550

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
           G +P CF NLTSLRNL+L SN+  S I STLW LK IL +NL+SN  TG LP EI NLR 
Sbjct: 551 GSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRA 610

Query: 243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS 302
           +  I++S N  SG IP +IG L+DL  L+L  N+LQG IP S+G +  L+ LDLS+NN+S
Sbjct: 611 VYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLS 670

Query: 303 GAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCR- 361
           G IP SL+ LL LKY NVSFN L+GEIP  G F NFSA+SF GNE LCG+  LQV PC+ 
Sbjct: 671 GMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKD 730

Query: 362 --TRIHHTSRKNDLLLGIVLP--LSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRR 417
             +R   T   + ++L  VLP  +  +F++A ++++ RY +R      + +   +  +RR
Sbjct: 731 DNSRATETP-GSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRR 789

Query: 418 FTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDM 477
            ++ EL  ATNGF E+N +G G   SVYK  + DG  +A KVF+LQ E AFKSFD EC++
Sbjct: 790 ISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEV 849

Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           ++ +RHRNL+KII+SCS  +FKALVLE+MP+ SLEK LYS +Y L+  QRLNIM+DVAS 
Sbjct: 850 LRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASV 909

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LEYLH GY++P+ HCD+KP+NVLL+++MVA L+DFG++K LL E+ S+ QT TLATIGYM
Sbjct: 910 LEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISK-LLGEEGSVMQTMTLATIGYM 968

Query: 598 AP 599
           AP
Sbjct: 969 AP 970

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  606 bits (1562), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 321/604 (53%), Positives = 419/604 (69%), Gaps = 6/604 (0%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  SG IP  I NASKL  L+L  NSF G IP+  GNLRNL++L+L  N LTS +
Sbjct: 337 LYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKS 396

Query: 61  PKLNFLSSLS--NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
            +       S  NC+ L YL F+ N L G LP +IGNLS S+E  + F+C I G+IP  I
Sbjct: 397 LRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGI 456

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
            NL+NL  + L  N+L G+IP  + +L+ LQ  SL  N+L+G IP+++C L  L  L L 
Sbjct: 457 GNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLL 516

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
            N  SG +PAC  N+TSLR LYLGSN+ TSIP+T W+LK +L +NLS NS TG LPLEIG
Sbjct: 517 ENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIG 576

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
           NL+V+  ID S N  SG IPT+I DL++L +  L  NR+QG IP S G L+ L+ LDLS 
Sbjct: 577 NLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSR 636

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVP 358
           N++SGAIP SLEKL+ LK  NVSFN+L+GEI   GPF NFS  SF  NE LCG   +QVP
Sbjct: 637 NSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVP 696

Query: 359 PCRTRIHH--TSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPL-VANL 415
           PC++   H  + R  + ++  ++P     ++ + L ++ +R+  K +L+    PL  A  
Sbjct: 697 PCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATW 756

Query: 416 RRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIEC 475
           R+ ++ EL++AT GF+E NL+G G   SVYK  + DG+ +AVKVF LQ EG    FD EC
Sbjct: 757 RKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSEC 816

Query: 476 DMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 535
           ++++ +RHRNL+KIISSC N DFKAL+LE++PHGSLEK LYS NY LDI QRLNIMIDVA
Sbjct: 817 EVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVA 876

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
           SALEYLH G + P++HCDLKP+NVL++++MVAH+SDFG+++ LL E  ++TQT TLATIG
Sbjct: 877 SALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISR-LLGEGDAVTQTLTLATIG 935

Query: 596 YMAP 599
           YMAP
Sbjct: 936 YMAP 939

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 335/609 (55%), Positives = 427/609 (70%), Gaps = 17/609 (2%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS-- 58
            LL+ GN FSG IP  I N S L  L++  N F G +P   GNLR L+ L L++N LT+  
Sbjct: 485  LLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEH 544

Query: 59   STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
            S  +L FL+SL+NC +L+ LS S+N L G++P ++GNLS S+E+ +  +C + G+IP  I
Sbjct: 545  SASELAFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGI 604

Query: 119  SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
            SNLTNL  + L  N L G IP    +LQKLQ+LS+  N++ GSIP  LC L  L  LDL 
Sbjct: 605  SNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLS 664

Query: 179  GNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             NKLSG +P+C GNLT LRN+YL SN L S IPS+L NL+ +L LNLSSN     LPL++
Sbjct: 665  SNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQV 724

Query: 238  GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            GN++ LV +DLS N FSG IP+TI  L++L  L+L +N+LQG IP + G L+ L+SLDLS
Sbjct: 725  GNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLS 784

Query: 298  NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
             NN+SG IP SLE L  L+Y+NVSFNKL+GEIP  GPF NF+AESF  N  LCG P  QV
Sbjct: 785  GNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQV 844

Query: 358  PPCRTRIHHTSRKN--DLLLGIVLPLSTIF--MMAVILLILRYRKRGKSQL---ADANMP 410
              C       SRKN   LLL  ++PLS     ++ V+L +   R++ KS+     D ++P
Sbjct: 845  MACE----KDSRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLP 900

Query: 411  LVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS 470
             +   R   H EL  ATN F E+NLIG+G +  VYK  + DG+ VAVKVF+L+ +GAFKS
Sbjct: 901  RMH--RMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKS 958

Query: 471  FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI 530
            F++EC++M+ IRHRNL KIISSCSN DFKALVLEYMP+GSLEK LYS NY LD  QRL I
Sbjct: 959  FEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKI 1018

Query: 531  MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
            MIDVAS LEYLH  YS P++HCDLKP+NVLLDD+MVAH+SDFG+AK LL   + + +T+T
Sbjct: 1019 MIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAK-LLMGSEFMKRTKT 1077

Query: 591  LATIGYMAP 599
            L T+GYMAP
Sbjct: 1078 LGTVGYMAP 1086

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  604 bits (1558), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 336/606 (55%), Positives = 429/606 (70%), Gaps = 8/606 (1%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L+L  N  SG IPS I NASKL  L+   N   G IP+  G+LR L+RL+L  N L   +
Sbjct: 370 LILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGES 429

Query: 61  --PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
              +L+FL+SL+NCK L+ L  S N L GILP +IGNLS S++ F    C + G+IP EI
Sbjct: 430 YIQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEI 489

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
            NL+NL  + L  N L G+IP ++ +LQKLQ L L  N+L+GSIP+D+C+L  L  L L 
Sbjct: 490 GNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLT 549

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
            N+LSG +PAC G LT LR+LYLGSN+L S IPSTLW+L +IL L++SSN   G LP ++
Sbjct: 550 NNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDM 609

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
           GNL+VLV+IDLS N  SG IP+ IG L+DL  L L +NR +G I  S   L  L+ +DLS
Sbjct: 610 GNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLS 669

Query: 298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
           +N + G IP SLE L+ LKY++VSFN L GEIP EGPF NFSAESF  N+ LCG+P L++
Sbjct: 670 DNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKL 729

Query: 358 PPCRTRIHHTSRKNDLLLGIVLP--LSTIFMMAVILLILRYRKRGKSQLADANMPLVANL 415
           PPCRT    ++  + LLL  +LP  LST+  +A+I +  R RKR       +   L A  
Sbjct: 730 PPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATW 789

Query: 416 RRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIEC 475
           RR ++ E+FQATNGFS  NL+GRG + SVY+  + DG   A+KVF+LQ E AFKSFD EC
Sbjct: 790 RRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAEC 849

Query: 476 DMMKRIRHRNLIKIISSCSND--DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           ++M  IRHRNLIKI+SSCSN   DFKALVLEY+P+GSLE+ LYS NY LDI QRLNIMID
Sbjct: 850 EVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMID 909

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           VA A+EYLH G S P++HCDLKP+N+LLD++   H+ DFG+AK LL+E++S+ +TQTLAT
Sbjct: 910 VALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAK-LLREEESIRETQTLAT 968

Query: 594 IGYMAP 599
           IGYMAP
Sbjct: 969 IGYMAP 974

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 319/607 (52%), Positives = 414/607 (68%), Gaps = 12/607 (1%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS- 59
            L + GN FSG IP  I N SKL+ L L  NSF G +P   GNL  LK L L  N LT   
Sbjct: 515  LFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEH 574

Query: 60   -TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
               ++ FL+SL+NCK+LK L   NN   G LP ++GNL  ++E F    C   G+IP  I
Sbjct: 575  VASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRI 634

Query: 119  SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
             NLTNL  + LG N L GSIP  L +L+KLQ L +  N+L GSIP+DLC L  L  L L 
Sbjct: 635  GNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLS 694

Query: 179  GNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             NKLSG +P+CFG+L +L+ L+L SN L  +IP++LW+L+ +L LNLSSN  TG LP E+
Sbjct: 695  SNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEV 754

Query: 238  GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            GN++ +  +DLS N  SG IP  +G+ ++L  L L  N+LQG IP   G L+ L+SLDLS
Sbjct: 755  GNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLS 814

Query: 298  NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
             NN+SG IP SLE L+ LKY+NVS NKL+GEIP  GPF NF+AESF  NE LCG P+ QV
Sbjct: 815  QNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQV 874

Query: 358  PPC--RTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLA---DANMPLV 412
              C    R      K+ +L  I+LP+ +I  + V+ ++L  R+R   ++    D+ +P  
Sbjct: 875  MACDKNNRTQSWKTKSFILKYILLPVGSIVTL-VVFIVLWIRRRDNMEIPTPIDSWLP-- 931

Query: 413  ANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFD 472
                + +H +L  ATN F E+NLIG+G    VYK  + +G+ VA+KVF+L+++GA +SFD
Sbjct: 932  GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFD 991

Query: 473  IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
             EC++M+ IRHRNL++II+ CSN DFKALVLEYMP+GSLEK LYS NY LD+ QRLNIMI
Sbjct: 992  SECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMI 1051

Query: 533  DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
            DVASALEYLH   S  ++HCDLKPNNVLLDD+MVAH++DFG+ K LL + +S+ QT+TL 
Sbjct: 1052 DVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLG 1110

Query: 593  TIGYMAP 599
            TIGYMAP
Sbjct: 1111 TIGYMAP 1117

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 320/607 (52%), Positives = 414/607 (68%), Gaps = 12/607 (1%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS- 59
            L + GN FSG IP  I N SKL+ L L  NSF G +P   GNL  LK L L  N LT   
Sbjct: 426  LFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEH 485

Query: 60   -TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
               ++ FL+SL+NCK+LK L   N    G LP ++GNL  ++E F    C   G+IP  I
Sbjct: 486  VASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGI 545

Query: 119  SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
             NLTNL  + LG N L GSIP  L +LQKLQ L +  N++ GSIP+DLC L  L  L L 
Sbjct: 546  GNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLS 605

Query: 179  GNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             NKLSG +P+CFG+L +L+ L+L SN L  +IP++LW+L+ +L LNLSSN  TG LP E+
Sbjct: 606  SNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEV 665

Query: 238  GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            GN++ +  +DLS N  SG+IP+ +G L+ L  L L  NRLQG IP   G L+ L+SLDLS
Sbjct: 666  GNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLS 725

Query: 298  NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
             NN+SG IP SLE L+ LKY+NVS NKL+GEIP  GPF NF+AESF  NE LCG P+ QV
Sbjct: 726  QNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQV 785

Query: 358  PPC--RTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLA---DANMPLV 412
              C    R      K+ +L  I+LP+ +I  + V+ ++L  R+R   ++    D+ +P  
Sbjct: 786  MACDKNNRTQSWKTKSFILKYILLPVGSIVTL-VVFIVLWIRRRDNMEIPTPIDSWLP-- 842

Query: 413  ANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFD 472
                + +H +L  ATN F E+NLIG+G    VYK  + +G+ VA+KVF+L+++GA +SFD
Sbjct: 843  GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFD 902

Query: 473  IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
             EC++M+ IRHRNL++II+ CSN DFKALVLEYMP+GSLEK LYS NY LD+ QRLNIMI
Sbjct: 903  SECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMI 962

Query: 533  DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
            DVASALEYLH   S  ++HCDLKPNNVLLDD+MVAH++DFG+ K LL + +S+ QT+TL 
Sbjct: 963  DVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLG 1021

Query: 593  TIGYMAP 599
            TIGYMAP
Sbjct: 1022 TIGYMAP 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 319/605 (52%), Positives = 415/605 (68%), Gaps = 8/605 (1%)

Query: 1    LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS- 59
            L +  N FSGTIP  I N SKL+ L L  NSF G +P    NL  LK L+L +N LT   
Sbjct: 491  LYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEH 550

Query: 60   -TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
                + FL+SL+NCK+L+YL    N L G LP ++GNL  ++E F  + C   G+IP  I
Sbjct: 551  LASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGI 610

Query: 119  SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
             NLTNL  + LG N L GSIP  L +LQKLQ L +  N++ GSIP+DLC L  L  L L 
Sbjct: 611  GNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLS 670

Query: 179  GNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             NKLSG  P+CFG+L +LR L+L SN L  +IP++LW+L+ +L LNLSSN  TG LP E+
Sbjct: 671  SNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEV 730

Query: 238  GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            GN++ +  +DLS N  SG+IP+ +G L+ L  L L  NRLQG I    G L+ L+SLDLS
Sbjct: 731  GNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLS 790

Query: 298  NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
            +NN+SG IP SLE L+ LKY+NVSFNKL+GEIP  GPF  F+AESF  NE LCG P+ QV
Sbjct: 791  HNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQV 850

Query: 358  PPC--RTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADA-NMPLVAN 414
              C    R      K+ +L  I+LP+ +   + V+ ++L  R+R   ++    +  L+  
Sbjct: 851  MACDKNNRTQSWKTKSFILKYILLPVGSTVTL-VVFIVLWIRRRDNMEIPTPIDSWLLGT 909

Query: 415  LRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIE 474
              + +H +L  ATN F E+NLIG+G    VYK  + +G+ VA+KVF+L+++GA +SFD E
Sbjct: 910  HEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSE 969

Query: 475  CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
            C++M+ IRHRNL++II+ CSN DFKALVLEYMP+GSLEK LYS NY LD+ QRLNIMIDV
Sbjct: 970  CEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDV 1029

Query: 535  ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
            ASALEYLH   S  ++HCDLKP+NVLLDD+MVAH++DFG+AK LL E +S+ QT+TL TI
Sbjct: 1030 ASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAK-LLTETESMQQTKTLGTI 1088

Query: 595  GYMAP 599
            GYMAP
Sbjct: 1089 GYMAP 1093

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  593 bits (1529), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 316/599 (52%), Positives = 408/599 (68%), Gaps = 6/599 (1%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS--STPKL 63
           N  +G++P F+ N S+L  L+L  N   G +   FGNLR L+ LSL  N  T+  S+  L
Sbjct: 302 NGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTL 361

Query: 64  NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
           NF++SL+N + LK L   +N LDG+LP ++GNLS  +  F+++   + G+IP EI NL+N
Sbjct: 362 NFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSN 421

Query: 124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS 183
           L  + L  N L G IP  +  L+K+Q+L L  N L GSIP D+C    L  + L  N LS
Sbjct: 422 LIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLS 481

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
           G +P+C GNLTSLRNLYL  N L+S IP  LW+LK +L LNL SN   G LP ++G +  
Sbjct: 482 GEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEA 541

Query: 243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS 302
            + I LS N  SG IP+TIG L++L    L  N  QGSIP++ GGL+ L+ LDLS NN+S
Sbjct: 542 AIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLS 601

Query: 303 GAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRT 362
           G IP SLE L  L++ +VSFN L+GEIPR GPF NF+A SF  N+ LCG   LQVPPC  
Sbjct: 602 GEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSI 661

Query: 363 RIHHTSRKNDLLLGIVLPL--STIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFTH 420
                S+    LL   LP   S + ++A I L++  R+R +       +P+ A  RR ++
Sbjct: 662 ESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISY 721

Query: 421 LELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR 480
           LEL  ATN F E+NL+G G   SVY+ R++DG+ VAVK+F+LQ + AF+SFD EC++M+ 
Sbjct: 722 LELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRN 781

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           IRHRNL+KII SCSN DFKALVLEYMP GSLEK LYS NY LDI QR+NIMIDVASALEY
Sbjct: 782 IRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEY 841

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LH GY  P++HCDLKP+NVLLD++MVAH+ DFG+AK LL E++S  QT+TLATIGYMAP
Sbjct: 842 LHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAK-LLGENESFAQTRTLATIGYMAP 899

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera]

 Score =  589 bits (1518), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 319/601 (53%), Positives = 416/601 (69%), Gaps = 8/601 (1%)

Query: 5    GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS--TPK 62
            GN FSG IP  I N SKL +L++  NSF G +P   GNL  L+ L+L  N LT       
Sbjct: 487  GNEFSGIIPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLANNQLTDEHLASG 546

Query: 63   LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
            ++FL+SL+NCK+L+ L    N L G LP ++GNL  ++E F  + C   G+IP  I NLT
Sbjct: 547  VSFLTSLTNCKFLRTLWIGYNPLKGTLPNSLGNLPIALESFNAYACQFRGTIPTGIGNLT 606

Query: 123  NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
            NL  ++LG N L GSIP  L +LQKLQ LS+  N++ GSIP+DLC L  L  L L  NKL
Sbjct: 607  NLIMLHLGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLCHLKNLGYLGLSSNKL 666

Query: 183  SGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
            SG  P+CFG+L +LR L+L SN L  +IP++LW+L+ +L LNLSSN  TG LP E+GN++
Sbjct: 667  SGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMK 726

Query: 242  VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
             ++ +DLS N  SG+IP+ +G L++L  L L  N+LQG IP   G L+ L+SLDLS NN+
Sbjct: 727  YIITLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESLDLSQNNL 786

Query: 302  SGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPC- 360
            S  IP SLE L+ LKY+NVSFNKL+GEIP  GPF NF+AESF  NE LCG P+ QV  C 
Sbjct: 787  SRIIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPHFQVMACD 846

Query: 361  -RTRIHHTSRKNDLLLGIVLPL-STIFMMAVILLILRYRKRGKSQLADANMPLVANLRRF 418
               R      K+ +L  I+LP+ ST+ ++  I+L +R R   +     A+  L     + 
Sbjct: 847  KNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIASW-LPGTHEKI 905

Query: 419  THLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMM 478
            +H +L  ATN F E+NLIG+G    VYK  + +G+ VA+KVF+L+++ A +SFD EC++M
Sbjct: 906  SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVM 965

Query: 479  KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            + IRHRNL++II+ CSN DFKALVLEYMP+GSLEK LYS NY LD+ QRLNIMI VASAL
Sbjct: 966  QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIYVASAL 1025

Query: 539  EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            EYLH   S  ++HCDLKP+NVLLDDNMVAH++DFG+AK LL E +S+ QT+TL TIGYMA
Sbjct: 1026 EYLHHDCSSLVVHCDLKPSNVLLDDNMVAHVADFGIAK-LLTETESMQQTKTLGTIGYMA 1084

Query: 599  P 599
            P
Sbjct: 1085 P 1085

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	599
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.974	0.569	0.393	1.4e-105
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.976	0.498	0.344	4.6e-89
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.859	0.502	0.377	3.9e-83
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.964	0.589	0.361	1.3e-82
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.854	0.629	0.364	2.5e-81
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.859	0.509	0.328	3.9e-76
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.979	0.607	0.334	1e-77
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.828	0.481	0.358	9e-77
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.696	0.333	0.316	5.9e-75
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.792	0.379	0.322	5.4e-54

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 244/620 (39%), Positives = 363/620 (58%)

Query:     6 NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYN-YLTSSTPKLN 64
             N F G IP+ + NAS L+ +++  N F G I + FG LRNL  L L  N + T       
Sbjct:   283 NRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWG 342

Query:    65 FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN-ISGSIPEEISNLTN 123
             F+S L+NC  L+ L+   N+L G+LP +  NLS S+  F     N I+GSIP++I NL  
Sbjct:   343 FISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLS-FLALELNKITGSIPKDIGNLIG 401

Query:   124 LTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLS 183
             L  +YL  N   GS+P +             +N L GSIP              G NK S
Sbjct:   402 LQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFS 461

Query:   184 GFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYI-LYLNLSSNSFTGPLPLEIGNLR 241
             G++P    NLT+L +L L +N L+  IPS L+N++ + + +N+S N+  G +P EIG+L+
Sbjct:   462 GWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLK 521

Query:   242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
              LV+     N  SG IP T+GD + L+YL+L+ N L GSIP ++G L  L++LDLS+NN+
Sbjct:   522 NLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNL 581

Query:   302 SGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCG-TPNLQVPPC 360
             SG IP SL  +  L  +N+SFN   GE+P  G F   S  S +GN  LCG  P+L +P C
Sbjct:   582 SGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRC 641

Query:   361 RTRIHHTSRKNDLLLGIVLPLST-IFMMAVILLILRYRKRGK----SQLADANMPLVANL 415
                + +  RK+  +L I + L+  + +++ + L++ + KR K    S+ +    PLV+  
Sbjct:   642 CPLLEN--RKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLVS-- 697

Query:   416 RRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIEC 475
                 + +L +AT+GF+  NL+G G   SVYK ++     VAVKV  L+   A KSF  EC
Sbjct:   698 ----YSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAEC 753

Query:   476 DMMKRIRHRNLIKIISSCSN-----DDFKALVLEYMPHGSLEKCLY------SSNYILDI 524
             + ++ +RHRNL+KI++ CS+     +DFKA+V ++MP+GSLE  ++      +    L++
Sbjct:   754 EALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNL 813

Query:   525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
              +R+ I++DVA AL+YLH     P++HCD+K +NVLLD +MVAH+ DFG+A+ +L +  S
Sbjct:   814 HRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR-ILVDGTS 872

Query:   585 LTQTQT-----LATIGYMAP 599
             L Q  T     + TIGY AP
Sbjct:   873 LIQQSTSSMGFIGTIGYAAP 892

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 889 (318.0 bits), Expect = 4.6e-89, P = 4.6e-89
 Identities = 212/615 (34%), Positives = 341/615 (55%)

Query:     6 NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
             N+F+G IP  IFN S L  L +  N+  G +    G L+ L+ L ++YN LT   P+   
Sbjct:   441 NHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR--- 497

Query:    66 LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
                + N K L  L   +N   G +PR + NL+  ++   M++ ++ G IPEE+ ++  L+
Sbjct:   498 --EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLS 554

Query:   126 TIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLSGF 185
              + L  NK +G IP              + N+  GSIP                N L+G 
Sbjct:   555 VLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGT 614

Query:   186 VPACFGNLTSLRN--LYLG--SNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
             +P     L SL+N  LYL   +N LT +IP  L  L+ +  ++LS+N F+G +P  +   
Sbjct:   615 IPGEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQAC 672

Query:   241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQY-LFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
             + +  +D S NN SG IP  +    D+   L L  N   G IP S G +  L SLDLS+N
Sbjct:   673 KNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSN 732

Query:   300 NISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPP 359
             N++G IP SL  L  LK++ ++ N L+G +P  G F+N +A    GN  LCG+    + P
Sbjct:   733 NLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKP 791

Query:   360 C--RTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQL---ADANMP---L 411
             C  + +  H S++  ++L I+   + + ++ +++LIL   K+ + ++   +++++P    
Sbjct:   792 CTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDS 851

Query:   412 VANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--K 469
                L+RF   EL QAT+ F+  N+IG   +++VYK +++DG  +AVKV +L+   A   K
Sbjct:   852 ALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDK 911

Query:   470 SFDIECDMMKRIRHRNLIKIIS-SCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQR 527
              F  E   + +++HRNL+KI+  +  +   KALVL +M +G+LE  ++ S   I  + ++
Sbjct:   912 WFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEK 971

Query:   528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLT 586
             +++ + +AS ++YLH GY  PI+HCDLKP N+LLD + VAH+SDFG A+ L  +ED S T
Sbjct:   972 IDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTT 1031

Query:   587 QTQTL--ATIGYMAP 599
              + +    TIGY+AP
Sbjct:  1032 ASTSAFEGTIGYLAP 1046

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 202/535 (37%), Positives = 297/535 (55%)

Query:     1 LLLWG-NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS- 58
             +L  G N+F+GTIP  + N S L +L++  N   G IP +FG L+NL  L LN N L + 
Sbjct:   278 ILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNY 337

Query:    59 STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
             S+  L+FL +L+NC  L+YL+   N L G LP  I NLS  +    +    ISGSIP  I
Sbjct:   338 SSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGI 397

Query:   119 SNLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXG 178
              NL +L T+ LG N L G +P +              N L G IP               
Sbjct:   398 GNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLL 457

Query:   179 GNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
              N   G +P+  G+ + L +L LG+N+L  SIP  L  L  ++ LN+S N   GPL  +I
Sbjct:   458 NNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDI 517

Query:   238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
             G L+ L+ +D+S N  SG IP T+ +   L++L L+ N   G IPD I GL  L+ LDLS
Sbjct:   518 GKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLS 576

Query:   298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCG-TPNLQ 356
              NN+SG IP  +     L+ +N+S N  +G +P EG FRN SA S  GN  LCG  P+LQ
Sbjct:   577 KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQ 636

Query:   357 VPPCRTRI--HHTSRKNDLLLGIVLPLSTIFMMAVILLILR-YRKRGKSQLADAN----- 408
             + PC   +   H+S +  + + +   ++ + ++ + ++ L  Y+ R KS  A+ N     
Sbjct:   637 LQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRS 696

Query:   409 -MPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEG 466
               P+ +   + ++ EL++ T GFS +NLIG G   +V+K  +      VA+KV +L   G
Sbjct:   697 FSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRG 756

Query:   467 AFKSFDIECDMMKRIRHRNLIKIISSCSN-----DDFKALVLEYMPHGSLEKCLY 516
             A KSF  EC+ +  IRHRNL+K+++ CS+     +DF+ALV E+MP+G+L+  L+
Sbjct:   757 AAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 225/623 (36%), Positives = 325/623 (52%)

Query:     3 LWGNNFSGTIPSFIFNAS-KLSRLELEMNSFYGFIPNT-----FGNLRN---LKRLSLNY 53
             L  N  SG +PS + +   +L  L L  N F     NT     F +L N   L+ L L  
Sbjct:   222 LESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAG 281

Query:    54 NYLTSS-TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISG 112
             N L    T  +  LS   N   L  +    N + G +P  I NL  ++ +  + +  +SG
Sbjct:   282 NSLGGEITSSVRHLSV--N---LVQIHLDQNRIHGSIPPEISNLL-NLTLLNLSSNLLSG 335

Query:   113 SIPEEISNLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXX 172
              IP E+  L+ L  +YL  N L G IP+               N L GSIP         
Sbjct:   336 PIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQL 395

Query:   173 XXXXXGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIP----STLWNLKYILYLNLSSN 227
                   GN LSG VP   G   +L  L L  N LT +IP    S L NLK  LYLNLSSN
Sbjct:   396 RRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLK--LYLNLSSN 453

Query:   228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG 287
               +GP+PLE+  + +++ +DLS N  SG IP  +G    L++L L  N    ++P S+G 
Sbjct:   454 HLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQ 513

Query:   288 LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNE 347
             L  LK LD+S N ++GAIP S ++   LK++N SFN L G +  +G F   + ESF G+ 
Sbjct:   514 LPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDS 573

Query:   348 LLCGT-PNLQVPPCRTRIHHTSRKNDLLLGIVL-PLSTIFMMAVILLILRYRKR----GK 401
             LLCG+   +Q   C+ +  + S    +LL ++  P+  +F   ++    R+ K      K
Sbjct:   574 LLCGSIKGMQA--CKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRS-RFGKNLTVYAK 630

Query:   402 SQLADANMPLVANLR--RFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKV 459
              ++ D       + +  R ++ +L  AT GF+ ++LIG G    VYK  +++  +VAVKV
Sbjct:   631 EEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKV 690

Query:   460 FD----LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL 515
              D    L++ G+FK    EC ++KR RHRNLI+II++CS   F ALVL  MP+GSLE+ L
Sbjct:   691 LDPKTALEFSGSFKR---ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHL 747

Query:   516 YSSNYI---LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF 572
             Y   Y    LD+ Q +NI  DVA  + YLH    V ++HCDLKP+N+LLDD M A ++DF
Sbjct:   748 YPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDF 807

Query:   573 GMAKPLLKEDQSLTQTQTLATIG 595
             G+++ L++  +    T    + G
Sbjct:   808 GISR-LVQGVEETVSTDDSVSFG 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
 Identities = 193/529 (36%), Positives = 294/529 (55%)

Query:     3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS-TP 61
             ++ N F G IP+ I NAS +S   + +NSF G +P   G +RNL+RL L      +  T 
Sbjct:   254 MYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETN 313

Query:    62 KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
                F+++L+NC  L+ +        G+LP ++ NLS S+    + +  ISGS+P +I NL
Sbjct:   314 DWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNL 373

Query:   122 TNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNK 181
              NL  + L  N L GS+P +            ++N+L GS+P                N 
Sbjct:   374 VNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNA 433

Query:   182 LSGFVPACFGNLTSLRNLYLGSNQ-LTSIPSTLWNLKYIL-YLNLSSNSFTGPLPLEIGN 239
               G +P+  GNLT L  + LG N  +  IP  ++++  +   L++S N+  G +P EIG 
Sbjct:   434 FGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGK 493

Query:   240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
             L+ +V+     N  SG  P+TIG+ + LQ+LFL+ N L GSIP ++  L  L +LDLS N
Sbjct:   494 LKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGN 553

Query:   300 NISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCG-TPNLQVP 358
             N+SG IP+SL  +  L  +N+SFN   GE+P  G F N S    +GN  +CG  P L +P
Sbjct:   554 NLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLP 613

Query:   359 PCRTRIHHTSRKNDLLLGIVLPL-STIFMMAVILLILRYRKRGKSQLADANMPLVANLRR 417
              C  +     +   LLL +V+ L ST+ + +++ ++L   KR K ++  A   +  +   
Sbjct:   614 TCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVP-ATTSMQGH-PM 671

Query:   418 FTHLELFQATNGFSENNLIGRGGVASVYKARI--QDG-IE--VAVKVFDLQYEGAFKSFD 472
              T+ +L +AT+GFS ++L+G G   SVYK     QDG I   VAV+V  L+   A KSF 
Sbjct:   672 ITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFT 731

Query:   473 IECDMMKRIRHRNLIKIISSCSN-----DDFKALVLEYMPHGSLEKCLY 516
              EC+ ++  RHRNL+KI++ CS+     +DFKA+V ++MP+GSLE  L+
Sbjct:   732 AECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
 Identities = 175/533 (32%), Positives = 293/533 (54%)

Query:     1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
             L L  N+  G IP+ + N S L +  +  N   G I   FG + +L+ L L+ N L S T
Sbjct:   264 LNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYT 323

Query:    61 -PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                L F+ SL+NC +L+ LS     L G LP +I N+S  +    +   +  GSIP++I 
Sbjct:   324 FGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIG 383

Query:   120 NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGG 179
             NL  L  + LG N L G +P +              N++ G IP                
Sbjct:   384 NLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSN 443

Query:   180 NKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
             N   G VP   G  + + +L +G N+L  +IP  +  +  ++ L++  NS +G LP +IG
Sbjct:   444 NSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIG 503

Query:   239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
             +L+ LV++ L  N FSG +P T+G+   ++ LFL+ N   G+IP+ I GL+ ++ +DLSN
Sbjct:   504 SLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN-IRGLMGVRRVDLSN 562

Query:   299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCG-TPNLQV 357
             N++SG+IP        L+Y+N+S N   G++P +G F+N +     GN+ LCG   +L++
Sbjct:   563 NDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKL 622

Query:   358 PPCRTR-----IHHTSRKNDLLLGIVLPLSTIFMMAVILLILR-YRKRGKSQLADANMPL 411
              PC  +       H+S    + + + + ++ + ++ +  ++L  +RKR K+Q  +  +P 
Sbjct:   623 KPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPS 682

Query:   412 VANL--RRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIE-VAVKVFDLQYEGAF 468
                +   + ++ +L  ATNGFS +N++G G   +V+KA +    + VAVKV ++Q  GA 
Sbjct:   683 KLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAM 742

Query:   469 KSFDIECDMMKRIRHRNLIKIISSCSNDDF-----KALVLEYMPHGSLEKCLY 516
             KSF  EC+ +K  RHRNL+K++++C++ DF     +AL+ EY+P+GS++  L+
Sbjct:   743 KSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 782 (280.3 bits), Expect = 1.0e-77, P = 1.0e-77
 Identities = 202/603 (33%), Positives = 307/603 (50%)

Query:     5 GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
             GNN +GTIP  I N +    L++  N   G IP   G L+ +  LSL  N LT   P++ 
Sbjct:   224 GNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQ-VATLSLQGNRLTGRIPEV- 281

Query:    65 FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
                 +   + L  L  S+N L G +P  +GNLS + +++   N  ++G IP E+ N++ L
Sbjct:   282 ----IGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNM-LTGPIPSELGNMSRL 336

Query:   125 TTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLSG 184
             + + L  NKL G+IP               +N+L G IP               GN LSG
Sbjct:   337 SYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSG 396

Query:   185 FVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL 243
              +P  F NL SL  L L SN     IP  L ++  +  L+LS N+F+G +PL +G+L  L
Sbjct:   397 SIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHL 456

Query:   244 VQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG 303
             + ++LS N+ SG +P   G+L+ +Q + + +N L G IP  +G L +L SL L+NN + G
Sbjct:   457 LILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHG 516

Query:   304 AIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGT--PNLQVPPCR 361
              IP  L     L  +NVSFN L G +P    F  F+  SF GN  LCG    ++  P  +
Sbjct:   517 KIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPK 576

Query:   362 TRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVA---NLRRF 418
             +R+        ++LG++  L  IF+     +  +   +G S+ A+    LV    ++   
Sbjct:   577 SRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIH 636

Query:   419 THLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMM 478
             T  ++ + T   +E  +IG G  ++VYK  ++    +A+K    QY    + F+ E + +
Sbjct:   637 TFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETI 696

Query:   479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVAS 536
               IRHRN++ +     +     L  +YM +GSL   L+ S     LD   RL I +  A 
Sbjct:   697 GSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQ 756

Query:   537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
              L YLH   +  IIH D+K +N+LLD+N  AHLSDFG+AK +    ++   T  L TIGY
Sbjct:   757 GLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSI-PASKTHASTYVLGTIGY 815

Query:   597 MAP 599
             + P
Sbjct:   816 IDP 818

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
 Identities = 183/511 (35%), Positives = 271/511 (53%)

Query:     1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYL-TSS 59
             LLL  N F+G IP  + N S L R ++  N   G IP +FG LRNL  L +  N L  +S
Sbjct:   271 LLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNS 330

Query:    60 TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
             +  L F+ +++NC  L+YL    N L G LP +I NLS ++   F+    ISG+IP +I 
Sbjct:   331 SSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIG 390

Query:   120 NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGG 179
             NL +L  + L  N L+G +P++              N + G IP                
Sbjct:   391 NLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNS 450

Query:   180 NKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
             N   G +P   G    L +L++ +N+L  +IP  +  +  + Y++LS+N  TG  P E+G
Sbjct:   451 NSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVG 510

Query:   239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
              L +LV +  S N  SG +P  IG    +++LF++ N   G+IPD I  L+ LK++D SN
Sbjct:   511 KLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSN 569

Query:   299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCG-TPNLQV 357
             NN+SG IP  L  L  L+ +N+S NK EG +P  G FRN +A S  GN  +CG    +Q+
Sbjct:   570 NNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQL 629

Query:   358 PPCRTRIHHTSRK-----NDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLA-DANMPL 411
              PC  +     RK       ++ GI + ++++ ++ ++  +  + KR K   A D N   
Sbjct:   630 KPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSD 689

Query:   412 VANLRRF----THLELFQATNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEG 466
                L  F    ++ EL  AT+ FS  NLIG G   +V+K  +  +   VAVKV +L   G
Sbjct:   690 STTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHG 749

Query:   467 AFKSFDIECDMMKRIRHRNLIKIISSCSNDD 497
             A KSF  EC+  K IRHRNL+K+I+ CS+ D
Sbjct:   750 ATKSFMAECETFKGIRHRNLVKLITVCSSLD 780

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 490 (177.5 bits), Expect = 5.9e-75, Sum P(2) = 5.9e-75
 Identities = 139/439 (31%), Positives = 219/439 (49%)

Query:     6 NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
             N  SG+IPS       L +L L  NS  G +P++  +LRNL R++L++N L  +   L  
Sbjct:   514 NQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPL-- 571

Query:    66 LSSLSNCKYLKYLSF--SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
                   C    YLSF  +NN  +  +P  +GN SQ+++   +    ++G IP  +  +  
Sbjct:   572 ------CGSSSYLSFDVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRE 624

Query:   124 LTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLS 183
             L+ + +  N L G+IP+              +N L G IP                N+  
Sbjct:   625 LSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFV 684

Query:   184 GFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
               +P    N T L  L L  N L  SIP  + NL  +  LNL  N F+G LP  +G L  
Sbjct:   685 ESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSK 744

Query:   243 LVQIDLSMNNFSGFIPTTIGDLKDLQY-LFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
             L ++ LS N+ +G IP  IG L+DLQ  L L YN   G IP +IG L  L++LDLS+N +
Sbjct:   745 LYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQL 804

Query:   302 SGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCR 361
             +G +P S+  +  L Y+NVSFN L G++ ++  F  + A+SF GN  LCG+P  +    R
Sbjct:   805 TGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVR 862

Query:   362 T--RIHHTSRKNDLLLGIVLPLSTI-FMMAVILLILRYRKRGKSQLADANMPLVANLR-- 416
             +  +    S ++ +++  +  L+ I  M+ VI L  + R     ++   +    ++    
Sbjct:   863 SNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSS 922

Query:   417 RFTHLELFQATNGFSENNL 435
             + TH  LF+  NG S++++
Sbjct:   923 QATHKPLFR--NGASKSDI 939

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 569 (205.4 bits), Expect = 5.4e-54, P = 5.4e-54
 Identities = 166/515 (32%), Positives = 262/515 (50%)

Query:     6 NNFSGTIPS-FIFNASKLSRLELEM---NSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTP 61
             N  SG+IPS F F    L+ LEL M   NS  G +P++  NL+NL R++ + N    S  
Sbjct:   515 NQLSGSIPSSFGF----LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS-- 568

Query:    62 KLNFLSSLSNCKYLKYLSF--SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                 +S L  C    YLSF  + N  +G +P  +G  S +++   +     +G IP    
Sbjct:   569 ----ISPL--CGSSSYLSFDVTENGFEGDIPLELGK-STNLDRLRLGKNQFTGRIPRTFG 621

Query:   120 NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGG 179
              ++ L+ + +  N L+G IP+              +N L G IP                
Sbjct:   622 KISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSS 681

Query:   180 NKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
             NK  G +P    +LT++  L+L  N L  SIP  + NL+ +  LNL  N  +GPLP  IG
Sbjct:   682 NKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIG 741

Query:   239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQY-LFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
              L  L ++ LS N  +G IP  IG L+DLQ  L L YN   G IP +I  L  L+SLDLS
Sbjct:   742 KLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLS 801

Query:   298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
             +N + G +P  +  +  L Y+N+S+N LEG++ ++  F  + A++F GN  LCG+P    
Sbjct:   802 HNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHC 859

Query:   358 PPCRTRIHHT-SRKNDLLLGIVLPLSTIFMMA-VILLILR-----YRK-RG-----KSQL 404
                 ++   + S K  +++  +  L+ I +M  VI+L  +     ++K RG      S  
Sbjct:   860 NRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNS 919

Query:   405 ADANMPLVANLRRFTHL---ELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFD 461
             + +  PL +N    + +   ++ +AT+  +E  +IG GG   VYKA +++G  +AVK   
Sbjct:   920 SSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL 979

Query:   462 LQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
              + +  + KSF+ E   +  IRHR+L+K++  CS+
Sbjct:   980 WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS 1014

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	599
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-60
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-52
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-50
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-48
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-35
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-15
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	7e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.001
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.001
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.002
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.003
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.003
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.004
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  215 bits (550), Expect = 3e-60
 Identities = 176/612 (28%), Positives = 286/612 (46%), Gaps = 42/612 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L+ N  SG IP  IF+  KL  L+L  NS  G IP     L+NL+ L L  N  T   
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
           P      +L++   L+ L   +N   G +P+ +G    ++ V  +   N++G IPE + +
Sbjct: 325 PV-----ALTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGLCS 378

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
             NL  + L  N L G IP +L   + L+ + L+DN   G +P +  +L  ++ LD+  N
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
            L G + +   ++ SL+ L L  N+        +  K +  L+LS N F+G +P ++G+L
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L+Q+ LS N  SG IP  +   K L  L L +N+L G IP S   +  L  LDLS N 
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQ-VPP 359
           +SG IP +L  +  L  +N+S N L G +P  G F   +A +  GN  LCG      +PP
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618

Query: 360 CRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKRGKSQLADANMPLVANLRRFT 419
           C+ R+  T      +   +     + ++A   + +R R        +  +  V N     
Sbjct: 619 CK-RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN-------NLELKRVENEDGTW 670

Query: 420 HLELFQAT-----------NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGA 467
            L+ F +            +   E N+I RG   + YK + I++G++  VK  +      
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSI 729

Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR 527
             S   +   M +++H N++K+I  C ++    L+ EY+   +L + L +    L   +R
Sbjct: 730 PSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERR 782

Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
             I I +A AL +LH   S  ++  +L P  +++D     HL    +   L       T 
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTD 835

Query: 588 TQTLATIGYMAP 599
           T+   +  Y+AP
Sbjct: 836 TKCFISSAYVAP 847

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  194 bits (494), Expect = 1e-52
 Identities = 131/352 (37%), Positives = 181/352 (51%), Gaps = 22/352 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L GN   G IP+ + N + L  L L  N   G IP   G +++LK + L YN L+   
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 61  PK-------LNFL------------SSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
           P        LN L            SSL N K L+YL    N L G +P +I +L + + 
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
           +    N ++SG IPE +  L NL  ++L  N   G IP+AL  L +LQ+L L  N+  G 
Sbjct: 289 LDLSDN-SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYIL 220
           IP +L +   L +LDL  N L+G +P    +  +L  L L SN L   IP +L   + + 
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407

Query: 221 YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
            + L  NSF+G LP E   L ++  +D+S NN  G I +   D+  LQ L L  N+  G 
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           +PDS G    L++LDLS N  SGA+P  L  L +L  + +S NKL GEIP E
Sbjct: 468 LPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  186 bits (474), Expect = 4e-50
 Identities = 121/314 (38%), Positives = 182/314 (57%), Gaps = 8/314 (2%)

Query: 18  NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY 77
           N+S++  ++L   +  G I +    L  ++ ++L+ N L+   P   F +S S    L+Y
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS----LRY 122

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS 137
           L+ SNN+  G +PR  G++  ++E   + N  +SG IP +I + ++L  + LGGN L G 
Sbjct: 123 LNLSNNNFTGSIPR--GSIP-NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
           IP +L  L  L+ L+L  NQL G IP +L ++ +L  + LG N LSG +P   G LTSL 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 198 NLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF 256
           +L L  N LT  IPS+L NLK + YL L  N  +GP+P  I +L+ L+ +DLS N+ SG 
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 257 IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK 316
           IP  +  L++L+ L L  N   G IP ++  L  L+ L L +N  SG IP +L K  +L 
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359

Query: 317 YINVSFNKLEGEIP 330
            +++S N L GEIP
Sbjct: 360 VLDLSTNNLTGEIP 373

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  181 bits (462), Expect = 1e-48
 Identities = 126/331 (38%), Positives = 176/331 (53%), Gaps = 11/331 (3%)

Query: 1   LLLWGNNFSGTIPS-FIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L  NNF+G+IP   I N   L  L+L  N   G IPN  G+  +LK L L  N L   
Sbjct: 123 LNLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
            P     +SL+N   L++L+ ++N L G +PR +G +     ++  +N N+SG IP EI 
Sbjct: 180 IP-----NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN-NLSGEIPYEIG 233

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
            LT+L  + L  N L G IP +L  L+ LQ L L  N+L G IP  +  L  L  LDL  
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
           N LSG +P     L +L  L+L SN  T  IP  L +L  +  L L SN F+G +P  +G
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
               L  +DLS NN +G IP  +    +L  L L  N L+G IP S+G    L+ + L +
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLEGEI 329
           N+ SG +P    KL  + ++++S N L+G I
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  173 bits (440), Expect = 1e-45
 Identities = 104/259 (40%), Positives = 146/259 (56%), Gaps = 27/259 (10%)

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
           Y++ ++ SNN L G +P  I   S S+    + N N +GSIP                  
Sbjct: 94  YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP------------------ 135

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
             GSIP        L+ L L +N L G IP+D+   ++L +LDLGGN L G +P    NL
Sbjct: 136 -RGSIPN-------LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187

Query: 194 TSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
           TSL  L L SNQL   IP  L  +K + ++ L  N+ +G +P EIG L  L  +DL  NN
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247

Query: 253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKL 312
            +G IP+++G+LK+LQYLFL  N+L G IP SI  L  L SLDLS+N++SG IP  + +L
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307

Query: 313 LDLKYINVSFNKLEGEIPR 331
            +L+ +++  N   G+IP 
Sbjct: 308 QNLEILHLFSNNFTGKIPV 326

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  141 bits (357), Expect = 1e-38
 Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 8/167 (4%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFK-SFDIECDMMKRIRHRNLIKIISSC 493
           +G GG  +VY AR  + G +VA+K+   +   +       E +++K++ H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +++   LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 554 LKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+LLD DN    L+DFG++K L            + T  YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  134 bits (339), Expect = 1e-35
 Identities = 62/167 (37%), Positives = 88/167 (52%), Gaps = 9/167 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G   +VYKA+    G  VAVK+   +       ++   E  +++R+ H N++++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             + D   LV+EY   G L     S    L   +   I + +   LEYLH   S  IIH 
Sbjct: 67  FEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LLD+N V  ++DFG+AK LLK   SLT T    T  YMAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  133 bits (336), Expect = 3e-35
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 9/168 (5%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIIS 491
             +G G    VY AR  + G  VA+KV   +  +   +    E  ++K+++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              ++D   LV+EY   G L   L      L   +    +  + SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLKP N+LLD++    L+DFG+A+   + D     T  + T  YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  137 bits (347), Expect = 7e-34
 Identities = 90/236 (38%), Positives = 127/236 (53%), Gaps = 24/236 (10%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAA------- 171
           +N + + +I L G  ++G I  A+ +L  +Q ++L +NQL G IPDD+   ++       
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 172 ----------------LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLW 214
                           L  LDL  N LSG +P   G+ +SL+ L LG N L   IP++L 
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185

Query: 215 NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEY 274
           NL  + +L L+SN   G +P E+G ++ L  I L  NN SG IP  IG L  L +L L Y
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245

Query: 275 NRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
           N L G IP S+G L +L+ L L  N +SG IP S+  L  L  +++S N L GEIP
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  116 bits (293), Expect = 3e-29
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 9/170 (5%)

Query: 436 IGRGGVASVYKARI-----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    VYK  +         +VAVK       E   + F  E  +MK++ H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           +  C+  +   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DL   N L+ +N+V  +SDFG+++ + ++D    +      I +MAP
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (286), Expect = 2e-28
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 10/173 (5%)

Query: 433 NNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNL 486
              +G G    VYK +++       +EVAVK       E   + F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++  C+ ++   +V+EYM  G L   L  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IH DL   N L+ +N+V  +SDFG+++  L +D    +      I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (276), Expect = 4e-27
 Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 11/174 (6%)

Query: 433 NNLIGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNL 486
              +G G    VYK  ++       +EVAVK       E   + F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           +K++  C+ ++   +V+EYMP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH DL   N L+ +N+V  +SDFG+++  L +D           I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (276), Expect = 5e-27
 Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 23/178 (12%)

Query: 434 NLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKII 490
            L+GRG   SVY A  +D G  +AVK  +L  +     ++ + E  ++  ++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 491 SSCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNI------MIDVASALEYLH 542
            S  +++   L   LEY+  GSL         +L  F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
              S  I+H D+K  N+L+D + V  L+DFG AK  L + ++   T ++  T  +MAP
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)

Query: 434 NLIGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIK 488
             +G G    VYK +++       EVAVK       E   K F  E  +MK++ H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCL--------YSSNYILDIFQRLNIMIDVASALEY 540
           ++  C+ ++   LVLEYM  G L   L              L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L    S   +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 57/166 (34%), Positives = 84/166 (50%), Gaps = 9/166 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+GG   VYKAR  + G EVA+KV  L+ +   +    E  ++K+ +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           K  N+LL  +    L DFG++  L           T+  T  +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 88.7 bits (221), Expect = 1e-19
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 19/176 (10%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDL------QYEGAFKSFDIECDMMKRIRHRNL 486
             IG+G    VY  R   DG    +K  DL      + E A      E  ++K++ H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHF 543
           IK   S        +V+EY   G L + +         F   Q L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S  I+H D+KP N+ L  N +  L DFG++K +L     L +T  + T  Y++P
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTV-VGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 58/175 (33%), Positives = 83/175 (47%), Gaps = 21/175 (12%)

Query: 434 NLIGRGGVASVYKA-RIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKII 490
           +LIGRG    VYK   ++ G  VA+K   L+   E A KS   E D++K ++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 544
            S    D   ++LEY  +GSL +       I+  F           +  V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +IH D+K  N+L   + V  L+DFG+A  L   D S      + T  +MAP
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 56/169 (33%), Positives = 82/169 (48%), Gaps = 12/169 (7%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFD---IECDMMKRIRHRNLIKIIS 491
           +G+G    V   R +D G   A+KV   +     K  +    E +++ RI H  ++K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +   ++   LVLEY P G L   L       +   R     ++  ALEYLH   S+ II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
            DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+AP
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    V+           D   VAVK   +     A K F+ E +++   +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVA 535
               C+  D   +V EYM HG L K L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 536 SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           S + YL   HF      +H DL   N L+  ++V  + DFGM++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 593 TIGYMAP 599
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 11/166 (6%)

Query: 435 LIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
            IG+G    V     + G +VAVK        A ++F  E  +M  +RH NL++++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 495 NDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
             +   +V EYM  GSL   L S    ++ + Q+L   +DV   +EYL        +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ +++VA +SDFG+AK     + S  Q      + + AP
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 56/166 (33%), Positives = 85/166 (51%), Gaps = 14/166 (8%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKI 489
           +IG G  ++V  A+  +   E A+K+ D +    E   K   IE +++ R+  H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 490 ISSCSNDDFKALVLEYMPHGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
             +  +++    VLEY P+G L +    Y S   LD         ++  ALEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
            IIH DLKP N+LLD +M   ++DFG AK +L  + S    +  AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 85.6 bits (210), Expect = 7e-18
 Identities = 61/176 (34%), Positives = 84/176 (47%), Gaps = 16/176 (9%)

Query: 435 LIGRGGVASVYKARIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRH-RNLIKII 490
            +G G    VY AR  D   VA+KV   + E      + F  E  ++  + H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 491 SSCSNDDFKALVLEYMPHGSLEK--CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
               ++    LV+EY+  GSLE           L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 549 IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLA----TIGYMAP 599
           IIH D+KP N+LLD D  V  L DFG+AK L     + +     +    T GYMAP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 5/154 (3%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           F+    +G G    V++   ++ + VA+K+         + F  E   +KR+RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVP 548
            + CS  +   ++ E M  GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
            IH DL   N+L+ +++V  ++DFG+A+ L+KED
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR-LIKED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 14/174 (8%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           I +G    V+ A+    G   A+KV    D+  +        E D++ + +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           S        LV+EY+P G L   L +    LD       + ++  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ------TQTLATIGYMAP 599
            DLKP+N+L+D N    L+DFG++K  L   Q           + + T  Y+AP
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 6/144 (4%)

Query: 435 LIGRGGVASVYKARIQDGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
            IG+G    VYK  ++   EVAVK     L  +   K F  E +++K+  H N++K+I  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           C       +V+E +P GSL   L      L + + L + +D A+ +EYL    S   IH 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAK 576
           DL   N L+ +N V  +SDFGM++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 80.7 bits (200), Expect = 9e-17
 Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 13/168 (7%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           IG G    VYKA     G EVA+K   L+    E        E  +MK  +H N++    
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           S    D   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  +IH
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            D+K +N+LL  +    L+DFG A  L KE     +   + T  +MAP
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 80.6 bits (200), Expect = 9e-17
 Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 9/167 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    VYKAR  + G  VA+K    D + EG   +   E  ++K ++H N++K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV EY     L+K L      L      +IM  +   L Y H   S  I+H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y AP
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAP 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 22/163 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDI----ECDMMKRIRHRNLIK 488
           IG G    VYKAR  + G  VA+K   ++   EG    F I    E  +++++RH N+++
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVR 62

Query: 489 II----SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +     S      +  +V EYM H  L   L S        Q    M  +   L+YLH  
Sbjct: 63  LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-DQSLT 586
            S  I+H D+K +N+L++++ V  L+DFG+A+P  K      T
Sbjct: 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.8 bits (202), Expect = 3e-16
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 29/178 (16%)

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI 281
           L L +    G +P +I  LR L  I+LS N+  G IP ++G +  L+ L L YN   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAE 341
           P+S+G L  L+ L+L+ N++SG +P +L                 G         NF+  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT-- 523

Query: 342 SFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYRKR 399
               N  LCG P L    C   +   ++     +GI   +S  F+  VI  +  +++R
Sbjct: 524 ---DNAGLCGIPGL--RACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 31/178 (17%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G+G    VYK R    G   A+K             D + +  K++     +K + SC 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI---------HVDGDEEFRKQLL--RELKTLRSCE 57

Query: 495 NDD--------FK----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           +          +K    ++VLEYM  GSL   L     I +      I   +   L+YLH
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH 116

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
                 IIH D+KP+N+L++      ++DFG++K L   + +L Q  T + T+ YM+P
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDI----ECDMMKRIRHRNLI 487
             +G G  A VYKAR  + G  VA+K +   + + A    +     E  +++ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            ++    +     LV E+M    LEK +   + +L      + M+     LEYLH  +  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            I+H DLKPNN+L+  + V  L+DFG+A+
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 9/170 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G  A VY A  + +  +VA+K  DL + + +      E   M +  H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              D   LV+ Y+  GSL   + SS     LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLK--EDQSLTQTQTLATIGYMAP 599
            D+K  N+LL ++    ++DFG++  L    +     +   + T  +MAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 34/184 (18%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F     +G G   SVYKA   + G  VA+KV  +  E   +    E  ++K+     ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN----------IMIDVASAL 538
              S   +    +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--- 595
           EYLH   S   IH D+K  N+LL++   A L+DFG++  L     ++ +  T+  IG   
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTV--IGTPF 164

Query: 596 YMAP 599
           +MAP
Sbjct: 165 WMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 77.3 bits (190), Expect = 3e-15
 Identities = 88/257 (34%), Positives = 127/257 (49%), Gaps = 9/257 (3%)

Query: 57  TSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPE 116
            SS   L   SSLS    L  LS S  S        + NL     +    N N   S   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLDL--NLNRLRSNIS 110

Query: 117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
           E+  LTNLT++ L  N +    P+       L+ L L DN++E S+P  L  L  L  LD
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLE 236
           L  N LS        NL++L NL L  N+++ +P  +  L  +  L+LS+NS    L   
Sbjct: 170 LSFNDLSDLPKL-LSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSS 227

Query: 237 IGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDL 296
           + NL+ L  ++LS NN    +P +IG+L +L+ L L  N++  S   S+G L +L+ LDL
Sbjct: 228 LSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDL 284

Query: 297 SNNNISGAIPISLEKLL 313
           S N++S A+P+    LL
Sbjct: 285 SGNSLSNALPLIALLLL 301

Length = 394

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 11/172 (6%)

Query: 434 NLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKII 490
           N IG G    VY A  +  G  +AVK   +Q       K    E  +++ ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 491 SSCSNDDFKALVLEYMPHGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
               + +   + +EY   G+LE+   +       + +   + +     L YLH   S  I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQTQTLA-TIGYMAP 599
           +H D+KP N+ LD N V  L DFG A  L     ++  + Q+LA T  YMAP
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD + VAVK      E A + F  E +++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN---YILD-----------IFQRLNIMIDVA 535
              C+      +V EYM HG L + L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
           S + YL    S+  +H DL   N L+   +V  + DFGM++ +   D      +T+  I 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 596 YMAP 599
           +M P
Sbjct: 190 WMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 16/170 (9%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFK--SFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+        +VAVK       G     +F  E  +MK++RH  L+++ + C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----VASALEYLHFGYSVPI 549
           S ++   +V EYM  GSL   L S         RL  ++D    +A  + YL    S   
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH DL   N+L+ +N+V  ++DFG+A+ L+++D+   +      I + AP
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 11/151 (7%)

Query: 434 NLIGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLI 487
             +G G    V   R        G +VAVK  +   E   +S F+ E ++++ + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 488 KIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           K    C     ++  L++EY+P GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           S   IH DL   N+L++   +  +SDFG+AK
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 31/185 (16%)

Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--------EGAFKSFDIECDMMKR 480
            F    +IG+G    V   + +D      K+F ++Y        +G+ ++   E  +++ 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRD----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDV 534
           + H  L+ +  S  +++   LV++ +  G L        Y L    + +       + ++
Sbjct: 57  LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEI 109

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
             ALEYLH   S  IIH D+KP+N+LLD+    H++DF +A  +  +  +   T T  T 
Sbjct: 110 VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163

Query: 595 GYMAP 599
           GYMAP
Sbjct: 164 GYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 9/162 (5%)

Query: 435 LIGRGGVASVYKARIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           L+G+G    V+K  ++D   VAVK    DL  E   K F  E  ++K+  H N++K+I  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           C+      +V+E +P G     L      L   Q +   +D A+ + YL    S   IH 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           DL   N L+ +N V  +SDFGM++   +ED  +  +  L  I
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQI 156

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 48/167 (28%), Positives = 71/167 (42%), Gaps = 9/167 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDI-ECDMMKRIRHRNLIKIISS 492
           IG G    VYKAR    G  VA+K   L           + E  ++K + H N+IK++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             +     LV E+M    L K +      L      + +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L++   V  L+DFG+A+           T  + T  Y AP
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 4e-14
 Identities = 38/85 (44%), Positives = 53/85 (62%)

Query: 107 NCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL 166
           N  + G IP +IS L +L +I L GN + G+IP +L  +  L++L L  N   GSIP+ L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 167 CRLAALFLLDLGGNKLSGFVPACFG 191
            +L +L +L+L GN LSG VPA  G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 9/166 (5%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA   + F  E  +M ++ H  L+++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      LV E+M HG L   L +          L + +DV   + YL    S  +IH D
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 9/166 (5%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           +G G    V+  + +  I+VA+K+     EGA    D   E  +M ++ H NL+++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      +V EYM +G L   L      L     L++  DV  A+EYL    S   IH D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ ++ V  +SDFG+A+ +L +DQ  +   T   + +  P
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 30/188 (15%)

Query: 436 IGRGGVASVYKAR------IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        +D + VAVK        A K F  E +++  ++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYS---------------SNYILDIFQRLNIMIDV 534
              C + D   +V EYM HG L K L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 535 ASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 592 ATIGYMAP 599
             I +M P
Sbjct: 187 LPIRWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 27/185 (14%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD I VAVK      + A K F  E +++  ++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 537
              C   D   +V EYM HG L K L +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 538 LEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           + YL   HF      +H DL   N L+ +N++  + DFGM++ +   D       T+  I
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 595 GYMAP 599
            +M P
Sbjct: 187 RWMPP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.1 bits (182), Expect = 9e-14
 Identities = 34/92 (36%), Positives = 57/92 (61%), Gaps = 1/92 (1%)

Query: 209 IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ 268
           IP+ +  L+++  +NLS NS  G +P  +G++  L  +DLS N+F+G IP ++G L  L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 269 YLFLEYNRLQGSIPDSIGG-LIDLKSLDLSNN 299
            L L  N L G +P ++GG L+   S + ++N
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 19/174 (10%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDL-----QYEGAFKSFDIECDMMKRIRHRNLIK 488
           L+G G   SVY+   + DG   AVK   L       + A K  + E  ++ +++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
            + +   +D   + LE +P GSL K L                  +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
            +H D+K  N+L+D N V  L+DFGMAK      Q +  +   +  G   +MAP
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 10/167 (5%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V++    +   VAVK       G    K F  E  +MK++RH  LI++ + C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           + ++   +V E M +GSL + L       L + Q +++   VAS + YL    +   IH 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL   NVL+ +N +  ++DFG+A+ ++KED    +      I + AP
Sbjct: 128 DLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 20/178 (11%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDI-ECDMMKRIRHRNLIKII 490
           IG+G   +V K  R  DG  +  K  ++ Y       K   + E ++++ ++H N+++  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 491 SSCSNDDFKAL--VLEYMPHGSL----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
               +   + L  V+EY   G L    +KC     YI + F    I+  +  AL   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLALYECHNR 124

Query: 545 YSVP---IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            S P   ++H DLKP N+ LD N    L DFG+AK +L  D S  +T  + T  YM+P
Sbjct: 125 -SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKT-YVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 6/165 (3%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+  + G+  A K+  ++ E   + F +E D++   +H N++ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            ++   +++E+   G+L+  +      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  N+LL  +    L+DFG++       Q   +   + T  +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)

Query: 430 FSENN---LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN 485
           + EN    ++G+G    VY AR +   + +A+K    +     +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYILDIFQRLNIMIDVASALE 539
           +++ + S S + F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           YLH      I+H D+K +NVL++  + V  +SDFG +K L   +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 599 P 599
           P
Sbjct: 178 P 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 25/186 (13%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIK 488
           +G G    VYK  +           VA+K      E   +  F  E ++M  ++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMID 533
           ++  C+ +    ++ EY+ HG L + L  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 594 IGYMAP 599
           + +M P
Sbjct: 190 VRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 22/179 (12%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVK----VFDLQYEG--AFKSFDIECDMMKRIRHRNL 486
             IG G    V  A   + G +VA+K    VFD   +     +    E  +++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 487 IK---IISSCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           I    I+   S +DF  +  V E M    L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-TQTLATIGYMAP 599
           H   S  +IH DLKP+N+L++ N    + DFG+A+ +  ++      T+ + T  Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)

Query: 435 LIGRGGVASVYKARI--QDGIEVAVKVFDLQYEGAFKS----FDIECDMMKRIRHRNLIK 488
           ++G G   SV + ++   DG ++ V V  ++ +    S    F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 489 IISSC----SNDDFKA--LVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASA 537
           +I  C    S        ++L +M HG L   L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 12/180 (6%)

Query: 427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVA---VKVFDLQYEGAFKSFDIECDMMKRIR 482
              F     IG+G  + VYKA  + DG  VA   V++F++    A +    E D++K++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLE---KCLYSSNYILDIFQRLNIMIDVASALE 539
           H N+IK ++S   ++   +VLE    G L    K       ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           ++H   S  I+H D+KP NV +    V  L D G+ +      ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 54/178 (30%), Positives = 79/178 (44%), Gaps = 32/178 (17%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    VYKAR I  G  VA+KV  L+    F+    E  M+K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN----------IMIDVASALEYLHFG 544
             D   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
                IH D+K  N+LL ++    L+DFG++  L     ++ + ++   IG   +MAP
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 15/172 (8%)

Query: 434 NLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIIS 491
           + +G G    VY+   +   + VAVK   L+ +    + F  E  +MK I+H NL++++ 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYL---HFGYSV 547
            C+ +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL   +F    
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---- 125

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 126 --IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 8/168 (4%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
           ++G G    V K R +  G  VA+K F      E   K+   E  +++++RH N++ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +        LV EY+    LE  L +S   L      + +  +  A+ Y H   S  IIH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            D+KP N+L+ ++ V  L DFG A+  L+   +   T  +AT  Y AP
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVATRWYRAP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 8/166 (4%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V K   +  G  +AVK   L+   A  K    E D++ +     ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            N+   ++ +EYM  GSL+K L      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +KP+N+L++      L DFG++  L+    SL +T    T  YMAP
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 8/167 (4%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G    V+KA+  + G  VA+K   L+    G       E   ++  +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             +     LV+EYMP   L + L      L   Q  + M  +   + Y+H   +  I+H 
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L+  + V  ++DFG+A+   +E+  L   Q +AT  Y AP
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 13/166 (7%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 496 DDFKA-LVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 46/181 (25%), Positives = 89/181 (49%), Gaps = 16/181 (8%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ------YEGAFKSFDIECDMMKRIRH 483
           +++  ++G+G   +VY      G  +AVK  +L        E  ++    E D++K ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI-FQRLNIMIDVASALEYLH 542
            N+++ + +C +D+  ++ +E++P GS+   L     + +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG----YMA 598
              +  ++H D+K NNV+L  N +  L DFG A+ L       T +  L ++     +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 599 P 599
           P
Sbjct: 177 P 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 23/163 (14%)

Query: 434 NLIGRGGVASVYKARIQ-DGIEV--AVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           ++IG G    V +A I+ DG+++  A+K+  +   E   + F  E +++ ++  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMID 533
           ++ +C N  +  + +EY P+G+L   L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           VA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 34/191 (17%)

Query: 434 NLIGRGGVASVYKARIQD-------GIEVAVKVFDLQYEGA----FKSFDIECDMMKRIR 482
           N +G G    VY+    D        I VAVK      +GA     K F  E  +M    
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY------ILDIFQRLNIMIDVAS 536
           H N++K++  C  ++ + +++E M  G L   L  +        +L + + L+I +DVA 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 537 ALEYL---HFGYSVPIIHCDLKPNNVLL-----DDNMVAHLSDFGMAKPLLKEDQSLTQT 588
              YL   HF      IH DL   N L+     D + V  + DFG+A+ + K D    + 
Sbjct: 118 GCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 589 QTLATIGYMAP 599
           + L  + +MAP
Sbjct: 172 EGLLPVRWMAP 182

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 1/81 (1%)

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
           L G IP  + KL+ LQ ++L  N + G+IP  L  + +L +LDL  N  +G +P   G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 194 TSLRNLYLGSNQLTS-IPSTL 213
           TSLR L L  N L+  +P+ L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 23/163 (14%)

Query: 434 NLIGRGGVASVYKARI-QDGI--EVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           ++IG G    V KARI +DG+  + A+K + +   +   + F  E +++ ++  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMID 533
           ++ +C +  +  L +EY PHG+L   L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 6/165 (3%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++ G   A KV + + E   + + +E +++    H  ++K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            D    +++E+ P G+++  +   +  L       I +     LE L + +S+ IIH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  NVLL  +    L+DFG++   +K  Q   +   + T  +MAP
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 21/179 (11%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI----ECDMMKRIRHRNLIKII 490
           IG+G    V+KAR  +    VA+K   +  E   + F I    E  +++ ++H N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 491 SSCSN-----DDFKA---LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
             C       + +K    LV E+  H  L   L + N    + +   +M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGYMAP 599
                 I+H D+K  N+L+  + +  L+DFG+A+   L K  +    T  + T+ Y  P
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 20/170 (11%)

Query: 430 FSENNLIGRGGVASVYKARIQ----DGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRH 483
           F+   ++G+G   SV +A+++       +VAVK+   D+      + F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 484 RNLIKIISSCSNDDFKA------LVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMI 532
            N+IK+I        K       ++L +M HG L   L  S      + L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           D+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 13/177 (7%)

Query: 429 GFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRN 485
            F     +G+G   SVYK  R+ D    A+K  DL      +  D   E  ++  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---LNIMIDVASALEYLH 542
           +I    +  + +   +V+EY P G L K +        +        I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                 I+H DLK  N+LL  N +  + D G++K +LK  +++ +TQ   T  YMAP
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISK-VLK--KNMAKTQI-GTPHYMAP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 10/172 (5%)

Query: 433 NNLIGRGGVASVYKA----RIQDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLI 487
              IG G    VY+        + I VAVK        + +  F  E  +M++  H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           K+I   + ++   +V+E  P G L   L  + Y LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +H D+   NVL+       L DFG+++  L+++     ++    I +MAP
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 40/168 (23%), Positives = 85/168 (50%), Gaps = 9/168 (5%)

Query: 428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR 482
           +  ++  +IG G    V++  ++      + VA+K     Y E   + F  E  +M +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           H N+I++    +      ++ EYM +G+L+K L   +     +Q + ++  +A+ ++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
               +  +H DL   N+L++ N+   +SDFG+++ +L++D   T T +
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTS 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 32/184 (17%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------ECDMMKRIRHRNLI 487
            +G G  +S Y+AR ++ G  +AVK        + +  ++      E  +M R+ H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLY---------SSNYILDIFQRLNIMIDVASAL 538
           +++ +   D    L +E+M  GS+   L            NY   + +           L
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPLLKE--DQSLTQTQTLATIG 595
            YLH      IIH D+K  N+L+D       ++DFG A  L  +       Q Q L TI 
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 596 YMAP 599
           +MAP
Sbjct: 174 FMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 23/175 (13%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEG---------AFKSFDIECDMMKRIRHR 484
           L+G G    V K + ++ G  VA+K F    E          A +    E  M+K++RH 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           NL+ +I          LV E++ H  L+      N  LD  +    +  +   +E+ H  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH-- 117

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            S  IIH D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y AP
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 11/162 (6%)

Query: 435 LIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
           +IG G    V   R++      I VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVP 548
               +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
            +H DL   N+L++ N+V  +SDFG+++ +L++D     T  
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 42/142 (29%), Positives = 79/142 (55%), Gaps = 8/142 (5%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG G   +V +     G +VAVK  +++ +   ++F  E  +M ++ H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 496 DDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    +V+E M  G+L   L +    ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 555 KPNNVLLDDNMVAHLSDFGMAK 576
              N+L+ ++ VA +SDFG+A+
Sbjct: 127 AARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA+K  +LQ +   +    E  +M+  +H N++  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 21/179 (11%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDL-QYE---------GAFKSFDIECDMMKRIRH 483
           LIG+G    VY A  +  G  +AVK  +L                K+   E + +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N+++ +   + +++ ++ LEY+P GS+  CL +     +   R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
             S  I+H DLK +N+L+D + +  +SDFG++K   K D      Q ++   ++ +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 7/105 (6%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           E +++K + H N++K    CS    K   L++EY+P GSL   L      L++ Q L   
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFA 113

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
             +   + YLH   S   IH DL   NVLLD++ +  + DFG+AK
Sbjct: 114 QQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 436 IGRGGVASVYKA--RIQDG--IEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKII 490
           +G G   SV K    ++ G  +EVAVK    ++  A K  F  E  +M ++ H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
             C  +    LV+E  P G L K L       + D+     +   VA  + YL    S  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLE---SKH 115

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
            +H DL   NVLL +   A +SDFGM++ L
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 10/150 (6%)

Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V + R++      I+VA+K       +     F  E  +M +  H N+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 546
           ++    +      ++ EYM +GSL+K L  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
              +H DL   N+L++ N+V  +SDFG+++
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 7e-11
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 23/184 (12%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVK--VFDLQYEGAFKSFDIECDMMKRIR---H 483
           + E   IG G   +VYKAR +  G  VA+K     L  EG   S   E  ++K++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 484 RNLIKIISSCSNDDFK-----ALVLEYMP---HGSLEKCLYSSNYILDIFQRLNIMIDVA 535
            N+++++  C            LV E++       L KC       L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
             +++LH   S  I+H DLKP N+L+  +    ++DFG+A+ +   + +L  T  + T+ 
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMAL--TSVVVTLW 171

Query: 596 YMAP 599
           Y AP
Sbjct: 172 YRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 12/177 (6%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVK---VFDLQYEGAFKSFDIECDMMKRIRHRN 485
           F     IGRG  + VY+A  + DG+ VA+K   +FDL    A      E D++K++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI---MIDVASALEYLH 542
           +IK  +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              S  ++H D+KP NV +    V  L D G+ +      ++      + T  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 8e-11
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 10/148 (6%)

Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M ++ H  L+++   C+
Sbjct: 15  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 +V EYM +G L   L          Q L +  DV   + YL    S   IH DL
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L+DD     +SDFG+++ +L ++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)

Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 41  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 100

Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    VA  +EYL    S  
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQK 157

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 9e-11
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 1/89 (1%)

Query: 151 LSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SI 209
           L L++  L G IP+D+ +L  L  ++L GN + G +P   G++TSL  L L  N    SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 210 PSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
           P +L  L  +  LNL+ NS +G +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 11/170 (6%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           ++GRG    V+   R  D   V +K   ++   +    +   EC ++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
           +   D    +V+EY P G+L + +    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 551 HCDLKPNNVLLDDN-MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLK  N+LLD + MV  + DFG++K L  + ++ T    + T  Y++P
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 12/157 (7%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 26/188 (13%)

Query: 435 LIGRGGVASVYKARIQD------GIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNL 486
            +G G    V KA             VAVK+  D   E        E +MMK I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILDIFQRL------NIM 531
           I ++  C+ +    +V+EY  HG+L   L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
             VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 592 ATIGYMAP 599
             + +MAP
Sbjct: 196 LPVKWMAP 203

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 54/186 (29%), Positives = 80/186 (43%), Gaps = 37/186 (19%)

Query: 430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F+    IG+G    VYKA  +     VA+KV DL  E A    +IE D+ + I      +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEA--EDEIE-DIQQEI------Q 51

Query: 489 IISSCSN-----------DDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
            +S C +              K  +++EY   GS    L      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG- 595
            LEYLH       IH D+K  N+LL +     L+DFG++  L     + T ++    +G 
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGT 161

Query: 596 --YMAP 599
             +MAP
Sbjct: 162 PFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 14/143 (9%)

Query: 467 AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL-----YS---- 517
           A   F  E  +M R+++ N+I+++  C +DD   ++ EYM +G L + L      S    
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 518 SNYI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +N I  + I   L + + +AS ++YL    S+  +H DL   N L+ ++    ++DFGM+
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 576 KPLLKEDQSLTQTQTLATIGYMA 598
           + L   D    Q + +  I +MA
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 31/193 (16%)

Query: 429 GFSENNLIGRGGVASVYKARIQ---DGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIR 482
            +     IGRG    VYKA+ +   DG E A+K F     QY G  +S   E  +++ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 483 HRNLIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVASA 537
           H N++ ++        K+  L+ +Y  H   +   +               +++  + + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA-------KPLLKEDQSLT 586
           + YLH   S  ++H DLKP N+L+     +  V  + D G+A       KPL   D    
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---- 173

Query: 587 QTQTLATIGYMAP 599
               + TI Y AP
Sbjct: 174 --PVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 5/143 (3%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSC 493
           IGRG    V+  R++ D   VAVK          K+ F  E  ++K+  H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      +V+E +  G     L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 554 LKPNNVLLDDNMVAHLSDFGMAK 576
           L   N L+ +  V  +SDFGM++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 17/299 (5%)

Query: 13  PSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNC 72
            S +   + L+ L+L+ N+     P       NLK L L+ N + S        S L N 
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES------LPSPLRNL 162

Query: 73  KYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGN 132
             LK L  S N L   LP+ + NLS    +  +    IS  +P EI  L+ L  + L  N
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD-LSGNKIS-DLPPEIELLSALEELDLSNN 219

Query: 133 KLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGN 192
            +   +  +L  L+ L  L L +N+LE  +P+ +  L+ L  LDL  N++S       G+
Sbjct: 220 SII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGS 275

Query: 193 LTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
           LT+LR L L  N L++    L  L  +L   L +   T    LE+    +L+  ++  N 
Sbjct: 276 LTNLRELDLSGNSLSNAL-PLIALLLLLLELLLNLLLTL-KALELKLNSILLNNNILSNG 333

Query: 253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEK 311
                P  +  L+ L  L+   N L  S  +    + +  ++    + +   +   LEK
Sbjct: 334 E-TSSPEALSILESLNNLWTLDNALDESNLNRY-IVKNPNAIGSLLDLVKKHVNQLLEK 390

Length = 394

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 22/185 (11%)

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRI 481
           F   + + +   +G G  A+VYK + + +G  VA+KV  LQ E       I E  ++K +
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKC-------LYSSNYILDIFQRLNIMIDV 534
           +H N++ +       +   LV EY+ H  L +        L+  N  L +FQ L      
Sbjct: 61  KHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR----- 114

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              L Y+H  Y   I+H DLKP N+L+ D     L+DFG+A+   K   S T +  + T+
Sbjct: 115 --GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTL 167

Query: 595 GYMAP 599
            Y  P
Sbjct: 168 WYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 56/171 (32%), Positives = 80/171 (46%), Gaps = 15/171 (8%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR------IRHRNLIK 488
           IG+G    V  A+   DG   AVKV  LQ +   K  + +  M +R      ++H  L+ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +  S    D    VL+Y+  G L   L       +   R     ++ASAL YLH   S+ 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           II+ DLKP N+LLD      L+DFG+ K  +  + S T +    T  Y+AP
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 11/173 (6%)

Query: 435 LIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
           +IG G    V + R++      I VA+K     Y E   + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
               +      ++ E+M +G+L+  L  ++    + Q + ++  +A+ ++YL     +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
           +H DL   N+L++ N+V  +SDFG+++ L  +    T T +L     I + AP
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 14/155 (9%)

Query: 455 VAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVKV      + A + F  E  ++ R+   N+ +++  C+ D    +++EYM +G L +
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 514 CLY--------SSNYILDIFQR--LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD 563
            L          +     +     L +   +AS + YL    S+  +H DL   N L+  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 564 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           N    ++DFGM++ L   D    Q +    I +MA
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 22/181 (12%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA---------FKSFDIECDMMKRIRHR 484
           LIG G   SVY       G  +AVK  +L    A           +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           N+++ + S  + D   + LEY+P GS+   L +     +   R N +  +   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMA 598
            +  IIH D+K  N+L+D+     +SDFG++K L  E  SL+     A      ++ +MA
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWMA 180

Query: 599 P 599
           P
Sbjct: 181 P 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 32/186 (17%)

Query: 434 NLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI----ECDMMKRIRHRNLIK 488
             IG G    VYKAR +D G  VA+K   L  E   + F I    E  +++++ HRN++ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70

Query: 489 IISSCSND----DFKA------LVLEYMPH---GSLEKCL--YSSNYILDIFQRLNIMID 533
           +    ++     DFK       LV EYM H   G LE  L  +S ++I    ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
               LE L++ +    +H D+K +N+LL++     L+DFG+A+    E+     T  + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVIT 180

Query: 594 IGYMAP 599
           + Y  P
Sbjct: 181 LWYRPP 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 55/189 (29%)

Query: 436 IGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDI-----------ECDMMKRIRH 483
           +G G    V   R +   +  A+K+             I           E  +++ IRH
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--------KIVKLKQVEHVLNEKRILQSIRH 60

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM----IDVA---- 535
             L+ +  S  +D    LV+EY+P G             ++F  L         VA    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYA 107

Query: 536 ----SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
                ALEYLH   S+ I++ DLKP N+LLD +    ++DFG AK +        +T TL
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158

Query: 592 -ATIGYMAP 599
             T  Y+AP
Sbjct: 159 CGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 23/163 (14%)

Query: 434 NLIGRGGVASVYKARIQ-DGIEV--AVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           ++IG G    V KARI+ DG+ +  A+K   +   +   + F  E +++ ++  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMID 533
           ++ +C +  +  L +EY PHG+L   L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 11/172 (6%)

Query: 435 LIGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
            +G G    V    +       I VAVK     +       F  E  +M  + H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVP 548
                      +V E  P GSL   L         I    +  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT-IGYMAP 599
            IH DL   N+LL  +    + DFG+ + L + +      + L     + AP
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 50/172 (29%), Positives = 85/172 (49%), Gaps = 16/172 (9%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRH---RNLIK 488
           LIGRG   +VY+ + +  G  VA+K+ +L         DI  E  ++ ++R     N+ K
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              S        +++EY   GS+ + L  +  I + +  + I+ +V  AL+Y+H    V 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVG 121

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAP 599
           +IH D+K  N+L+ +     L DFG+A  L   +Q+ ++  T     Y MAP
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+        +VAVK       G    +SF  E  +MK++RH  L+++ +  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           DL+  N+L+ D +V  ++DFG+A+  L ED   T  Q
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 13/152 (8%)

Query: 436 IGRG--GVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIIS 491
           +G G  GV  + K R Q  I+VA+K  +   EGA    D   E  +M ++ H  L+++  
Sbjct: 12  LGSGQFGVVHLGKWRAQ--IKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
            C+      +V E+M +G L   L      L     L++  DV   +EYL        IH
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
            DL   N L+    V  +SDFGM + +L +D+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVL-DDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 10/170 (5%)

Query: 436 IGRGGVASVYKAR-IQDG----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G   +VYK   I +G    I VA+KV  +     A K    E  +M  + H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           +  C +     L+ + MP G L   + +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DL   NVL+       ++DFG+AK L  +++          I +MA 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 22/151 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAF---KSFDI--ECDMMKRIRHRNLIKI 489
           IG G   +VY AR ++    VA+K   + Y G     K  DI  E   ++++RH N I+ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 490 ISSCSNDDFKA-LVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFG 544
              C   +  A LV+EY        CL S++ IL++     Q + I      AL+ L + 
Sbjct: 81  -KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL 131

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +S   IH D+K  N+LL +     L+DFG A
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 52/168 (30%), Positives = 76/168 (45%), Gaps = 13/168 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    VYKAR +  G   A+KV  L+    F     E  MMK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           K  N+LL DN    L+DFG++  +     + T  +  + IG   +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 6/228 (2%)

Query: 138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
               L+ +   +L     +     +P  L RL +L LL   G            NL  L 
Sbjct: 38  PDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLP 96

Query: 198 NLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV-LVQIDLSMNNFSGF 256
           +L L  N+L S  S L  L  +  L+L +N+ T  +P  IG L+  L ++DLS N     
Sbjct: 97  SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-S 154

Query: 257 IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK 316
           +P+ + +L +L+ L L +N L   +P  +  L +L +LDLS N IS  +P  +E L  L+
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 317 YINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTRI 364
            +++S N +   +      +N S      N+L     ++        +
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETL 260

Length = 394

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 27/140 (19%)

Query: 474 ECDMMKRIRHRNLIKI--ISSCSNDDFKA--LVLEYMPHGSLEKCLYSS--------NYI 521
           E  +++  +H N+I I  I      DFK   +V++ M    L   ++S          Y 
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF 112

Query: 522 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK- 580
           L  +Q L         L+Y+H   S  +IH DLKP+N+L++++    + DFGMA+ L   
Sbjct: 113 L--YQLLR-------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 581 -EDQSLTQTQTLATIGYMAP 599
             +     T+ +AT  Y AP
Sbjct: 161 PTEHKYFMTEYVATRWYRAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 20/159 (12%)

Query: 433 NNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDIECDM------------- 477
              +G G    V KA     G  VA+K V  ++             M             
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           M  I+H N++ ++      DF  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           L  LH  Y    +H DL P N+ ++   +  ++DFG+A+
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 26/176 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G    VYKAR    G  VA+K    D + EG   +   E  ++K + H N++K++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-----LEYLHFGYSV 547
              ++   LV E++ H  L+K        +D      I + +  +     L+ L F +S 
Sbjct: 68  IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
            ++H DLKP N+L++      L+DFG+A+    P+       T T  + T+ Y AP
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 11/175 (6%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIE-VAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F + N IG G    VY+AR     E VA+K    D + +G   S   E  ++  +RH N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 487 IKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +++          +  LV+EY     L   L +        Q   +M+ +   L+YLH  
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +   IIH DLK +N+LL D     ++DFG+A+      + +  T  + T+ Y AP
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +V+ A  +  G EVA+K  +LQ +   +    E  +MK +++ N++  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   +  +IH D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +NVLL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V+  R    G   A+KV    D+           E D++       ++K+ 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPI 549
            S  +++   LV+EYMP G L   L   +   +   R  I  ++  AL+ +H  G+    
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF---- 122

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
           IH D+KP+N+L+D +    L+DFG+ K + K    
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 13/168 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKAR +  G   AVK+  L+    F     E  M+K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           + +   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           K  N+LL DN    L+DFG+A  +     + T  +  + IG   +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKI-----TATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 21/173 (12%)

Query: 435 LIGRGGVASVYKARIQDGIE-VAVK------VFDLQYEGAFKSFDIECDMMKRIRHRNLI 487
            +G G    V+  R +      A+K      V  L+ E    +   E  ++K + H  +I
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFII 64

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++  +  +  F  +++EY+P G L   L +S    +         ++  ALEYLH   S 
Sbjct: 65  RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SK 120

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
            I++ DLKP N+LLD      L+DFG AK L        +T TL  T  Y+AP
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVK------VFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G GG   V   +++      A+K      + +   +    S   E ++++   H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +  +  +  +  +++EY   G L   L       D +     +  V  A EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRG 113

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
           II+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+AP
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 15/169 (8%)

Query: 436 IGRGGVASVYKARIQDGIE-VAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+GG   V+ A+ +D  E VA+K      L      +    E D++   +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPII 550
           +  +D++  L +EY+P G   + L ++  +L        M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLKP N L+D +    L+DFG++K ++    S+     + +  YMAP
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 15/161 (9%)

Query: 435 LIGR----GGVASVYKARIQDGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIK 488
           LIG+      +  + K +  + + VAVK  +L    +   K    E    ++++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVASALEYLHFGY 545
            ++S   D    +V   M +GS E  L    +  +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
           S   IH  +K +++LL  +    LS    +  ++K  +   
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 19/176 (10%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGA-----FKSFDIECDMMKRIRHRNLIK 488
           L+G+G    VY     D G E+AVK      +         + + E  ++K ++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
                 +D+  ++ +EYMP GS++  L +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 599
           I+H D+K  N+L D      L DFG +K L    Q++  + T       T  +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)

Query: 436 IGRGGVASVYKARI-QDG--IEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKII 490
           +G G   SV + ++ QD   ++VAVK   +        + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 491 SSC----SNDDFKA--LVLEYMPHGSLEKCLYSSNY-----ILDIFQRLNIMIDVASALE 539
             C     ++ + +  ++L +M HG L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           YL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  I  G EVA+K  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 4e-09
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 32/159 (20%)

Query: 436 IGRGGVASVYKARIQDGIE-VAVKVFDLQYEGAFKSFDIECDMMKRIR-------HRNLI 487
           +G G   SVY AR ++  E VA+K      +  F S++ EC  ++ ++       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-------NIMIDVASALEY 540
           K+      +D    V EYM     E  LY    + D   +        +I+  +   L +
Sbjct: 62  KLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 541 LH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
           +H  G+     H DLKP N+L+    V  ++DFG+A+ +
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI 149

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 35/149 (23%), Positives = 72/149 (48%), Gaps = 26/149 (17%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS-----NYILDIFQRL 528
           E +++K++ H ++IK+  +CS D    L++EY  +GSL   L  S     +Y+     R 
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 529 NIMID------------------VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
           +  +D                  ++  ++YL     + ++H DL   NVL+ +     +S
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DFG+++ + +ED  + +++    + +MA 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 43/198 (21%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAF----KSFDIECDMMKRIRHRN 485
           IG+G    V++AR       +    VAVK+     E A       F  E  +M    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCL--------------------YSSNYI-LDI 524
           ++K++  C+      L+ EYM +G L + L                       N + L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 525 FQRLNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
            ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 582 DQSLTQTQTLATIGYMAP 599
           D           I +M P
Sbjct: 184 DYYKASENDAIPIRWMPP 201

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 46/169 (27%), Positives = 87/169 (51%), Gaps = 11/169 (6%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+GG   V   ++++ G   A K  D   L+ +   K   +E ++++++    ++ +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPII 550
           +  +     LV+  M  G L+  +Y+     L++ + ++    +   + +LH   S+ I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           + D+KP NVLLDD     LSD G+A   LK+ +++TQ     T GYMAP
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVE-LKDGKTITQRA--GTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 10/166 (6%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A     G +VAVK  DL+ +   +    E  +M+  +H N++++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  +IH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAP 599
           K +++LL  +    LSDFG    + KE   + + ++L    Y MAP
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 11/169 (6%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+GG   V   +++  G   A K  D   L+     +    E  +++++  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPII 550
           +    D   LV+  M  G L+  +Y+         + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           + DLKP NVLLDD+    +SD G+A  L              T GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 52/192 (27%)

Query: 435 LIGRGGVASVYKARIQDGIE----VAVKVF----------DLQYEGAFKSFDIECDMMKR 480
           ++G+GG   V++ R   G +     A+KV           D  +  A      E ++++ 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA------ERNILEA 56

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSL----EK---------CLYSSNYILDIFQR 527
           ++H  ++ +I +        L+LEY+  G L    E+         C Y S   L     
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----- 111

Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
                    ALE+LH      II+ DLKP N+LLD      L+DFG+ K  + E  ++T 
Sbjct: 112 ---------ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158

Query: 588 TQTLATIGYMAP 599
           T    TI YMAP
Sbjct: 159 T-FCGTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 12/171 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVK---VFDLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           IGRG  + VY+A  + D   VA+K   +F++    A +    E D++K++ H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 492 SCSNDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRL--NIMIDVASALEYLHFGYSVP 548
           S   D+   +VLE    G L + + Y       I +R      + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           ++H D+KP NV +    V  L D G+ +      ++      + T  YM+P
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 8/166 (4%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++ G+  A KV D + E   + + +E D++    H N++K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAP
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 20/171 (11%)

Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K +    + VAVK+  D   +        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 38  KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV 97

Query: 504 EYMPHGSLEKCLYSS-----NYILD---------IFQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +      +Y  D          F+ L +    VA  +EYL    S  
Sbjct: 98  EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQK 154

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ ++ V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 12/157 (7%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+        +VA+K       G    ++F  E  +MK++RH  L+ + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V E+M  GSL   L   +   L + Q +++   +A  + Y+     +  IH 
Sbjct: 71  SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           DL+  N+L+ DN+V  ++DFG+A+  L ED   T  Q
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 15/169 (8%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIE-CDMMKRIRHRNLIKII 490
           I +G   SVY A+    G   A+KV    D+  +    +   E   MM +     + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
            S  + D+  LV+EY+  G     + +   + + + +   + +V   +E LH      II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+KP N+L+D      L+DFG+++        L   + + T  Y+AP
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 7/145 (4%)

Query: 436 IGRGGVASVYKARIQDGIE-VAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G   +V+KA+ ++  E VA+K   L    EG   S   E  ++K ++H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             +D    LV EY     L+K   S N  +D     + M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKP 577
           DLKP N+L++ N    L+DFG+A+ 
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 14/172 (8%)

Query: 435 LIGRGGVASVYKA-RIQDG----IEVAVKVFDLQYEGAFKSFDIECDMMKRI---RHRNL 486
           L+G G   +V+K   I +G    I VA+K   +Q     ++F    D M  +    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           ++++  C     + LV +  P GSL   +      LD  + LN  + +A  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
             ++H +L   N+LL  + +  ++DFG+A  L  +D+    ++    I +MA
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 29/188 (15%)

Query: 436 IGRGGVASVYKARIQ-DGIE----VAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G      +YK  +   G++    VA+K   D+     +  F  E  +M  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLY----------SSN------YILDIFQRLNIMID 533
           +   + +    ++ EY+  G L + L           SS+        LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 534 VASALEYL--HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ +   D    Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 592 ATIGYMAP 599
             I +M P
Sbjct: 188 LPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 14/155 (9%)

Query: 455 VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+      + A   F  E  +M R++  N+I++++ C   D   ++ EYM +G L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 514 CL---------YSSNYILDIFQRLNIM-IDVASALEYLHFGYSVPIIHCDLKPNNVLLDD 563
            L           ++ +   +  L  M   +AS ++YL    S+  +H DL   N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165

Query: 564 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           N    ++DFGM++ L   D    Q + +  I +M+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 15/152 (9%)

Query: 434 NLIGRGGVASVYKARI--QDGIEV--AVK----VFDLQYEGAFKSFDIECDMMKRIRHRN 485
            +IG+G    VY   +   DG ++  AVK    + DL+    F     E  +MK   H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLK---EGIIMKDFSHPN 57

Query: 486 LIKIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           ++ ++  C   +   LV L YM HG L   + S  +   +   +   + VA  +EYL   
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-- 115

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            S   +H DL   N +LD++    ++DFG+A+
Sbjct: 116 -SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 25/184 (13%)

Query: 426 ATNGFSE---NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFK-SFDIECDMMKR 480
           A    SE    N IG G   +VYK   +  G   A+KV    +E   +     E ++++ 
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           + H N++K      ++    ++LE+M  GSLE       +I D     ++   + S + Y
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAY 183

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT-----QTLATIG 595
           LH      I+H D+KP+N+L++      ++DFG+++        L QT      ++ TI 
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR-------ILAQTMDPCNSSVGTIA 233

Query: 596 YMAP 599
           YM+P
Sbjct: 234 YMSP 237

Length = 353

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 19/142 (13%)

Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSN---- 519
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         Y  N    
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 520 --YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 24/186 (12%)

Query: 424 FQATNGFSENNLIGRGGVASVYK--ARIQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKR 480
           F A   +     +G G  A+VYK  +RI +G  VA+KV  ++ E       I E  ++K 
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKG 59

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKC-------LYSSNYILDIFQRLNIMID 533
           ++H N++ +       +    V EYM H  L +        L+  N  L +FQ L     
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR---- 114

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
               L Y+H  +   I+H DLKP N+L+       L+DFG+A+   K   S T +  + T
Sbjct: 115 ---GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVT 166

Query: 594 IGYMAP 599
           + Y  P
Sbjct: 167 LWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)

Query: 435 LIGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLI 487
            +G+G   SV   R   +QD  G  VAVK   LQ+  A   + F+ E +++K ++H N++
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 488 KIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           K    C +   +   LV+EY+P+GSL   L      LD  + L     +   +EYL    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK--PLLKE 581
           S   +H DL   N+L++      + DFG+ K  P  KE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDM------MKRIRHRNLI 487
           +IG+G    V  A R  DG   AVKV  LQ +   K  +    M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +  S    +    VL+Y+  G L   L      L+   R     +VASA+ YLH   S+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            II+ DLKP N+LLD      L+DFG+ K  ++ ++  T +    T  Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 11/169 (6%)

Query: 436 IGRG--GVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIIS 491
           +G+G  G A++Y+ R +D   V  K  +L      +  D   E  ++  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 492 SCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              +D+   + +EY   G+L +K +     + +    L  +  + SA+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+K  N+ L    +  L DFG++K +L  + S+ +T  + T  YM+P
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 9/167 (5%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVF-DLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISS 492
           IG G    V+K R ++ G  VA+K F + + +   K   + E  M+K+++H NL+ +I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
                   LV EY  H  L + L  +   +       I+     A+ + H       IH 
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           D+KP N+L+       L DFG A+ L         T  +AT  Y AP
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 6/140 (4%)

Query: 444 VYKARIQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSCSNDDFKALV 502
           VYK R +  I+VA+KV   + E + +   + E ++M ++ +  ++++I  C  +    LV
Sbjct: 15  VYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLV 72

Query: 503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD 562
           +E    G L K L      + +   + +M  V+  ++YL        +H DL   NVLL 
Sbjct: 73  MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLV 129

Query: 563 DNMVAHLSDFGMAKPLLKED 582
           +   A +SDFG++K L  +D
Sbjct: 130 NQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 23/179 (12%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKII-- 490
           +IG G    VYKAR  + G  VA+K+ D+  +   +    E +++++   H N+      
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71

Query: 491 ----SSCSNDDFKALVLEYMPHGS---LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
               +   NDD   LV+E    GS   L K L      L       I+ +    L YLH 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH- 130

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
                +IH D+K  N+LL  N    L DFG++  L   D +L +  T   IG   +MAP
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 8/145 (5%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSC 493
           +G G  A+VYK R +  G  VA+K   L  E    S  I E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 494 SNDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             ++   LV EYM    L+K +  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAK 576
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.5 bits (132), Expect = 5e-08
 Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 33/182 (18%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAF-------KSFDIECDMMKRIR-HRN 485
           +G+G    V+KA   +    VA+K +FD     AF       ++F  E   ++ +  H N
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFD-----AFRNATDAQRTFR-EIMFLQELGDHPN 68

Query: 486 LIKIIS--SCSNDDFKALVLEYMP---HGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           ++K+++     ND    LV EYM    H  +       N + D+ +R  IM  +  AL+Y
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQLLKALKY 122

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---TQTLATIGYM 597
           +H   S  +IH DLKP+N+LL+ +    L+DFG+A+ L + +++      T  +AT  Y 
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 598 AP 599
           AP
Sbjct: 180 AP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)

Query: 436 IGRGGVASVYKAR--IQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G  A+V+K R  + + + VA+K   L++E GA  +   E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              D    LV EY+    L++ +     I+ +    N+ I +   L  L + +   ++H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 173

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 11/172 (6%)

Query: 436 IGRGGVASVYKARIQDGIEVA-VKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIKIIS 491
           IG G    V    +  G   A V V +L+   + +    F  E    + ++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 492 SCSNDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            C+      LV+E+ P G     L  C  +     D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IH DL   N LL  ++   + D+G++    KED  +T  Q    + ++AP
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 27/76 (35%), Positives = 50/76 (65%), Gaps = 1/76 (1%)

Query: 67  SSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTT 126
           + +S  ++L+ ++ S NS+ G +P ++G+++ S+EV  +   + +GSIPE +  LT+L  
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRI 494

Query: 127 IYLGGNKLNGSIPIAL 142
           + L GN L+G +P AL
Sbjct: 495 LNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 24/164 (14%)

Query: 455 VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+      + A   F  E  ++ R++  N+I+++  C ++D   ++ EYM +G L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 514 CLYSSNYILDIFQR-------------------LNIMIDVASALEYLHFGYSVPIIHCDL 554
            L SS+++ D  +                    L++ + +AS ++YL    S+  +H DL
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDL 164

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
              N L+ +N+   ++DFGM++ L   D    Q + +  I +MA
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 8/166 (4%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G  A+V+K R +     VA+K   L++ EGA  +   E  ++K ++H N++ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
             +    LV EY+    L++ L +   ++ +      M  +   L Y H      I+H D
Sbjct: 73  HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P
Sbjct: 129 LKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 15/173 (8%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI----ECDMMKRIRHRNLIK 488
           N I  G    VY+AR  + G  VA+K   L+ E   + F I    E +++ +++H N++ 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 489 I--ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +  +   SN D   +V+EY+ H  L+  + +        +   +M+ + S + +LH  + 
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             I+H DLK +N+LL++  +  + DFG+A+           TQ + T+ Y AP
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 37/180 (20%), Positives = 74/180 (41%), Gaps = 19/180 (10%)

Query: 436 IGRGGVASVYK---ARIQDG---IEVAVK-VFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G+G    VY+     +  G     VA+K V +         F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS--------SNY-ILDIFQRLNIMIDVASALE 539
           ++   S      +V+E M  G L+  L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL    +   +H DL   N ++ +++   + DFGM + + + D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL 560
           L+L+Y+  G L   LY   +  +   R+ I  ++  AL++LH    + II+ D+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 561 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LD      L+DFG++K  L E++    +    TI YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 19/161 (11%)

Query: 455 VAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VA+K    + EG  +  F  E  M  R++H N++ ++   + +   +++  Y  H  L +
Sbjct: 38  VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97

Query: 514 CLY---------------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN 558
            L                +    L+    ++I+  +A+ +E+L    S  ++H DL   N
Sbjct: 98  FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRN 154

Query: 559 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           VL+ D +   +SD G+ + +   D       +L  I +M+P
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 29/181 (16%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKII-- 490
           ++G G    VYK R ++ G   A+KV D+  E   +   +E +M+K+   HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 491 ----SSCSNDDFKALVLEYMPHGSLEKCL-------YSSNYILDIFQRLNIMIDVASALE 539
               S   +DD   LV+E+   GS+   +          ++I  I +      ++   L 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR------EILRGLA 135

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMA 598
           +LH      +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MA
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMA 189

Query: 599 P 599
           P
Sbjct: 190 P 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 13/174 (7%)

Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+  E   +    E  ++ +     
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S        +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL +     L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 15/174 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVA-VKVFDLQYEGAFK---SFDIECDMMKRIRHRNLIKIIS 491
           IG G    V       G+  A V V +L+          F  E    + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYIL------DIFQRLNIMIDVASALEYLHFGY 545
            C       LVLE+ P G L+  L S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               IH DL   N  L  ++   + D+G+A     ED  +T+      + ++AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 19/155 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI----ECDMMKRIRHRNLIKII 490
           +G G    VYKAR I+ G  VA+K   +  E     F I    E  ++K+++H N++ +I
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73

Query: 491 ------SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
                    S     +  +V  YM H  L   L + +  L   Q    M+ +   + YLH
Sbjct: 74  DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
                 I+H D+K  N+L+D+  +  ++DFG+A+P
Sbjct: 133 ---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDM------MKRIRHRNLI 487
           +IG+G    V  AR + +    AVKV  LQ +   K  + +  M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +  S    D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S+
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+AP
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 10/167 (5%)

Query: 436 IGRGGVASVYKAR--IQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G  A+VYK R  + D + VA+K   L++E GA  +   E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV EY+    L++ L      +++    N+ + +   L  L++ +   ++H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L+++     L+DFG+A+   K   + T +  + T+ Y  P
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPP 173

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 5/85 (5%)

Query: 10  GTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSL 69
           G IP+ I     L  + L  NS  G IP + G++ +L+ L L+YN    S P+     SL
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-----SL 486

Query: 70  SNCKYLKYLSFSNNSLDGILPRAIG 94
                L+ L+ + NSL G +P A+G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 36/201 (17%)

Query: 418 FTHLELFQAT----NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAF--KS 470
           F   EL +      + +   + +G G    V  A     G +VA+K     ++ A   K 
Sbjct: 1   FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60

Query: 471 FDIECDMMKRIRHRNLIKIIS----SCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDI 524
              E  ++K + H N+I ++     + S +DF+   LV   M    L   +         
Sbjct: 61  TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC------- 112

Query: 525 FQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
            Q+L+      ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+  
Sbjct: 113 -QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Query: 579 LKEDQSLTQTQTLATIGYMAP 599
             E      T  +AT  Y AP
Sbjct: 169 DDE-----MTGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 21/180 (11%)

Query: 430 FSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNL 486
           F   N IG+G    V+K  R  D    A+K  DL      +  +   E  ++ ++    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYS-------SNYILDIFQRLNIMIDVASALE 539
           I+   S  +     +V+EY  +G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +LH   S  I+H D+K  N+ LD      + D G+AK L   D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 13/174 (7%)

Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+  E   +    E  ++ +     
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 28/107 (26%), Positives = 57/107 (53%), Gaps = 5/107 (4%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           E ++++ + H N++K    C+ D      L++E++P GSL++ L  +   +++ Q+L   
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
           + +   ++YL    S   +H DL   NVL++      + DFG+ K +
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 50/170 (29%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKRIR----------H 483
           L+G+G V  V+  R++   ++ A+KV D       K   I+ + +KR+           H
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLD-------KKEMIKRNKVKRVLTEQEILATLDH 60

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSL--------EKCL-------YSSNYILDIFQRL 528
             L  + +S   + +  LV++Y P G L         KCL       Y++          
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---------- 110

Query: 529 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
               +V  ALEYLH    + I++ DLKP N+LL ++    LSDF ++K  
Sbjct: 111 ----EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 38/165 (23%), Positives = 82/165 (49%), Gaps = 6/165 (3%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+     +  +VAVK        + ++F  E ++MK ++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCDL 554
           ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  NVL+ ++++  ++DFG+A+ ++++++   +      I + AP
Sbjct: 130 RAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 19/142 (13%)

Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS-----NYILDI--- 524
           E ++MK I +H+N+I ++  C+ +    +++EY   G+L + L +      +Y  DI   
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 525 ------FQRL-NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
                 F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     +     + +MAP
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 38/167 (22%), Positives = 85/167 (50%), Gaps = 11/167 (6%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+        +VA+K      +G+   ++F  E ++MK+++H  L+++ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           + +    ++ EYM +GSL   L +   I L I + +++   +A  + ++        IH 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL+  N+L+ + +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 127 DLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 52/184 (28%), Positives = 78/184 (42%), Gaps = 24/184 (13%)

Query: 428 NGFSENNLIGRGGVASVYKARIQDGIEV-AVKVF------DLQYEGAFKSFDIECDMMKR 480
               E + +G G   SV K R+++   + A+K        DLQ     K    E ++ K 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-----KQILRELEINKS 55

Query: 481 IRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLE---KCLYSSNYILDIFQRLNIMIDVA 535
            +   ++K   +  ++      + +EY   GSL+   K +      +       I   V 
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
             L YLH   S  IIH D+KP+N+LL       L DFG++  L+    SL  T T  T  
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSF 168

Query: 596 YMAP 599
           YMAP
Sbjct: 169 YMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 48/185 (25%), Positives = 76/185 (41%), Gaps = 25/185 (13%)

Query: 434 NLIGRGGVASVYKA----RIQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNL 486
             +G G    VY+     R  D +E+ V V  L     E     F +E  +M +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEY 540
           +++I        + ++LE M  G L+  L  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 541 L---HFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           L   HF      IH D+   N LL       VA ++DFGMA+ + +        + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 595 GYMAP 599
            +M P
Sbjct: 186 KWMPP 190

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL 560
           L+L+Y+  G +   LY  +   +   R     ++  ALE+LH    + I++ D+K  N+L
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH---KLGIVYRDIKLENIL 137

Query: 561 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LD      L+DFG++K  L E++  T +    TI YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 16/162 (9%)

Query: 450 QDGIEVAVKVF-DLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS-CSNDDFKALVLEY 505
             G EVA+K+      E       F  E  +  R+ H N++ ++ S  +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---D 562
           +P  +L + L +++  L   +   +M+ V  AL   H   +  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IG---YMAP 599
               A + DFG+   L     +   T T  T  +G   Y AP
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 22/137 (16%)

Query: 474 ECDMMKRIRHRNLIKI---ISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILD----- 523
           E  +++R +H N+I I   I   S + F    +V E M    L K + + +   D     
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYF 111

Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-D 582
           ++Q L         L+Y+H   S  ++H DLKP+N+LL+ N    + DFG+A+    E D
Sbjct: 112 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 583 QSLTQTQTLATIGYMAP 599
            +   T+ +AT  Y AP
Sbjct: 162 HTGFLTEYVATRWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 13/174 (7%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKV--FDLQYEGAFKSFD-IECD--MMKRIRHRNLIK 488
           L+GRG    VY     D G E+AVK   FD   +   K  + +EC+  ++K +RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 489 IISSCSNDDFKALVL--EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
                 + + K L +  EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAP 599
             I+H D+K  N+L D      L DFG +K +     S T  +++    Y M+P
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 46/150 (30%), Positives = 70/150 (46%), Gaps = 20/150 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G  A+VYK R    G  VA+K   L++ EGA  +   E  ++K ++H N++ +    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 494 SNDDFKALVLEYMPHGSL----EKC---LYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
                  LV EY+    L    + C   L   N  L +FQ L         L Y H    
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQRR- 123

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
             ++H DLKP N+L+ +     L+DFG+A+
Sbjct: 124 --VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  A ++   EV A+KV  L+ +   +  D++C M  KRI     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +       D    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +I+ DLK +N+LLD      L+DFGM K  +     +T T    T  Y+AP
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 10/166 (6%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  AR +  G +VAVK+ DL+ +   +    E  +M+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAP 599
           K +++LL  +    LSDFG    + K+   + + ++L    Y MAP
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 17/173 (9%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  A ++   E+ AVKV  L+ +   +  D+EC M  KR+     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++ S     D    V+EY+  G L   +  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
            II+ DLK +NVLLD      ++DFGM K  +    +   T T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 15/151 (9%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKV---FDL--QYEGAFKSFDIECDMMKRIRH 483
           F    +IGRG    V   R +   +V A+K+   F++  + + AF  F  E D+M     
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANS 102

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLH 542
             ++++  +  +D +  +V+EYMP G L   +  SNY I + + R     +V  AL+ +H
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVLALDAIH 159

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG 573
              S+  IH D+KP+N+LLD +    L+DFG
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 24/59 (40%), Positives = 34/59 (57%)

Query: 3   LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTP 61
           L GN+  G IP  + + + L  L+L  NSF G IP + G L +L+ L+LN N L+   P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 6e-07
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 19/182 (10%)

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAF--KSFDIECDMMKR 480
           F+ TN + +   +G G    V  AR Q  G  VA+K     +      K    E  ++K 
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 481 IRHRNLI---KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           +RH N+I    I  S   D +   V E +  G+    L +S  +   F +   +  +   
Sbjct: 66  LRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQILRG 120

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           L+Y+H   S  ++H DLKP+N+L+++N    + DFG+A+      Q    T  ++T  Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172

Query: 598 AP 599
           AP
Sbjct: 173 AP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 18/172 (10%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEG-AFKSFDI-ECDMMKRIRHRNLIKIISS 492
           IG G    VYKAR    G  VA+K   L+ E     S  I E  ++K + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             +++   LV E++    L+K + S     LD     + +  +   + Y H   S  ++H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
            DLKP N+L+D      L+DFG+A+    P+       T T  + T+ Y AP
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPV------RTYTHEVVTLWYRAP 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 40/187 (21%), Positives = 80/187 (42%), Gaps = 21/187 (11%)

Query: 429 GFSENNLIGRGGVASVYKARIQDGIE-------VAVKVFD-LQYEGAFKSFDIECDMMKR 480
              E   +GRG    V+ A+ + GIE       V VK     + E     F  E DM ++
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAK-GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI--------LDIFQRLNIMI 532
           + H+N+++++  C   +   ++LEY   G L++ L ++           L   Q++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
            +A  +++L    +   +H DL   N L+       +S   ++K +   +    +   L 
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALI 180

Query: 593 TIGYMAP 599
            + ++AP
Sbjct: 181 PLRWLAP 187

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 29/70 (41%), Positives = 40/70 (57%), Gaps = 5/70 (7%)

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           I + +  ALEYLH   SV  IH D+KP+NVL++ N    L DFG++  L+    S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 590 TLATIGYMAP 599
                 YMAP
Sbjct: 163 DAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDM------MKRIRHRNLI 487
           +IG+G    V  A R  DG   AVKV  LQ +      + +  M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +  S    +    VL+++  G L   L       +   R     ++ASAL YLH   S+
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I++ DLKP N+LLD      L+DFG+ K  +   QS T T    T  Y+AP
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 19/173 (10%)

Query: 436 IGRGGVASVYKARIQDGIE-VAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G    VYKAR +   E +A+K   L+ E  G   +   E  ++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             ++    LV EY+    L+K + SS ++  +       +  +   + Y H   S  ++H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 552 CDLKPNNVLLDDNMVA-HLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
            DLKP N+L+D    A  L+DFG+A+    P+       T T  + T+ Y AP
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPV------RTFTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 21/181 (11%)

Query: 435 LIGRGGVASVYKARIQDG---------IEVAVKVFDLQYEGAFKSFD---IECDMMK-RI 481
            +G G    VYK R ++          I V    F        KS      E  ++K ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF--QRL-NIMIDVASAL 538
           RH N+++   +   +D   +V++ +    L +   S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            YLH      I+H DL PNN++L ++    ++DFG+AK   ++      T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 599 P 599
           P
Sbjct: 182 P 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.9 bits (121), Expect = 7e-07
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 18/155 (11%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-----FKSFDIECDMMKRIRHR 484
           F++   IG G   +VY AR     EV V +  + Y G      ++    E   ++RI+H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEY 540
           N I+       +    LV+EY        CL S++ +L++ ++    +++A+    AL+ 
Sbjct: 86  NSIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           L + +S  +IH D+K  N+LL +     L+DFG A
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A     G +VAVK  DL+ +   +    E  +M+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G   SVYK   +  G+ +A+K   L+ + + F    +E D++ +     ++    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 494 SNDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
             +    + +EYM  GSL+K LY    +   +       I   V   L++L   ++  II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           H D+KP NVL++ N    L DFG++  L+    SL +T     IG   YMAP
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTN----IGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 19/151 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G    VYK R  + G  VA+K   L+ E  G   +   E  ++K ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-------FGY 545
              +    L+ E++    L+K L S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           S  ++H DLKP N+L+D+  V  L+DFG+A+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 17/169 (10%)

Query: 439 GGVASVYKARIQDGIEVAVK----VFDLQYEGAFKSFDIECDMMKRIRHRN---LIKIIS 491
           G V SV   R  DG  VA+K    VF        + F  E  M+   +H N    + I+ 
Sbjct: 14  GVVWSVTDPR--DGKRVALKKMPNVFQ-NLVSCKRVFR-ELKMLCFFKHDNVLSALDILQ 69

Query: 492 SCSNDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
               D F+ + V+  +    L K + S   +     ++  +  +   L+YLH   S  I+
Sbjct: 70  PPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH---SAGIL 125

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+KP N+L++ N V  + DFG+A+ + + D+S   TQ + T  Y AP
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 28/178 (15%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDL-----QYEGAFKSFDIECDMMKRIRHRNLIKI 489
           IG G    +Y A+ + D     +K  DL     + + A K    E  ++ +++H N++  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64

Query: 490 ISSCSNDDFKALVLEYMPHGSLEK-------CLYSSNYILDIFQRLNIMIDVASALEYLH 542
            +S   +    +V+EY   G L K        L+S + IL  F      + ++  L+++H
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH 118

Query: 543 FGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                 I+H D+K  N+ L  N MVA L DFG+A+  L +   L  T  + T  Y++P
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYT-CVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 549
            +  +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 163

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP+N+LLD +    L+DFG    + KE      T  + T  Y++P
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 12/139 (8%)

Query: 464 YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS---SNY 520
           YEGA     +E  ++ ++  R ++ +  +        LV+  M  G L   +Y+    N 
Sbjct: 37  YEGAM----VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92

Query: 521 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK 580
                +       + S LE+LH      II+ DLKP NVLLD++    +SD G+A   LK
Sbjct: 93  GFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE-LK 148

Query: 581 EDQSLTQTQTLATIGYMAP 599
           + QS T+     T G+MAP
Sbjct: 149 DGQSKTKGYA-GTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 11/175 (6%)

Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRHRN 485
           F +  ++G+GG   V   +++  G   A K  + +     K   +   E  +++++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFG 544
           ++ +  +    D   LVL  M  G L+  +Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               I++ DLKP N+LLDD+    +SD G+A   + E Q++     + T+GYMAP
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVH-VPEGQTI--KGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 20/156 (12%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGA-----FKSFDIECDMMKRIRH 483
           FS+   IG G   +VY AR +++   VA+K   + Y G      ++    E   ++++RH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALE 539
            N I+       +    LV+EY        CL S++ +L++     Q + I      AL+
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            L + +S  +IH D+K  N+LL +  +  L DFG A
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 31/142 (21%), Positives = 67/142 (47%), Gaps = 15/142 (10%)

Query: 435 LIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI--KIISS 492
           L+  G    VY    +D  +  +K+   + +GA    + E  +++ +  + L   K+++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPIIH 551
             +D +  L++E++   +L++        +   ++ +I   +A  L  LH     V + H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLV-LCH 112

Query: 552 CDLKPNNVLLDDNMVAHLSDFG 573
            DL P N+L+DD  +  + D+ 
Sbjct: 113 GDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 50/173 (28%), Positives = 89/173 (51%), Gaps = 18/173 (10%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN--IMIDVASALEYLHFGYSVP 548
            +  +D +  +V+EYMP G L   +  SNY  D+ ++       +V  AL+ +H   S+ 
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---SMG 162

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS-LTQTQT-LATIGYMAP 599
           +IH D+KP+N+LLD +    L+DFG     +K D++ + +  T + T  Y++P
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  AR+ + G   AVKV  L+ +   +  D+EC M  KRI      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++       D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            II+ DLK +NVLLD      L+DFGM K  +      T +    T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 8/176 (4%)

Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRH 483
             F   +L+GRG    V   R    G   A+KV     L  +     F+ E D++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             + ++  +  + D   LV+EY P G L   L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + +  +H D+KP NVL+D      L+DFG A   L  ++ +     + T  Y+AP
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 17/89 (19%)

Query: 523 DIFQRLN--IMI----------DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
           D+F RL+  +M           ++A AL++LH   S+ II+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DFG++K  +  D          T+ YMAP
Sbjct: 141 DFGLSKESI--DHEKKAYSFCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 13/174 (7%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDI---ECD--MMKRIRHRNLIK 488
           L+G+G    VY    +  G E+A K      E    S ++   EC+  ++K ++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 489 IISSCSNDDFKALV--LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
                 +   K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY-MAP 599
             I+H D+K  N+L D      L DFG +K L     S T  +++    Y M+P
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 23/187 (12%)

Query: 430 FSENNL-----IGRGGVASVYKA------RIQDGIEVAVKVF----DLQYEGAFKSFDIE 474
           F  NNL     +G G    V +A      +    ++VAVK+           A  S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 475 CDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMI 532
             +M  +  H N++ ++ +C+      ++ EY  +G L   L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
            VA  + +L    S   IH DL   NVLL    +  + DFG+A+ ++ +   + +     
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 593 TIGYMAP 599
            + +MAP
Sbjct: 206 PVKWMAP 212

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 37/188 (19%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKII---- 490
           +G G    V+ A   D    VAVK   L    + K    E  +++R+ H N++K+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 491 --SSCSNDDFKAL--------VLEYMP---HGSLEKCLYSSNYI-LDIFQRLNIMIDVAS 536
              S   +D  +L        V EYM       LE+   S  +  L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQ----TQTL 591
            L+Y+H   S  ++H DLKP NV ++ +++V  + DFG+A+ +   D   +     ++ L
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGL 179

Query: 592 ATIGYMAP 599
            T  Y +P
Sbjct: 180 VTKWYRSP 187

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 23/167 (13%)

Query: 434 NLIGRGGVASVYKARIQDGIE-VAVK--VFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           N+IG G    VY+A   D  E VA+K  + D QY+      + E  +MK + H N+I + 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLK 125

Query: 491 SSCSNDDFKA--------LVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEY 540
                + FK         +V+E++P    +   + +  N+ L +F        +  AL Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKEDQSLT 586
           +H  +   I H DLKP N+L+D N     L DFG AK LL   +S++
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Length = 440

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 12/171 (7%)

Query: 435 LIGRGGVASVYKA-RIQDG----IEVAVKVFDLQYEG--AFKSFDIECDMMKRIRHRNLI 487
           ++G G   +VYK   + +G    I VA+K+ + +  G  A   F  E  +M  + H +L+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           +++  C +   + LV + MPHG L   ++     +     LN  + +A  + YL      
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 128

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            ++H DL   NVL+       ++DFG+A+ L  +++          I +MA
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 12/170 (7%)

Query: 436 IGRG--GVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS 491
           +G+G  G  S+ + R  DG +  +K  +L+       K+ + E  ++ +++H N++    
Sbjct: 8   VGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 492 SCSNDD-FKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           S   +D    +V+ +   G L  K       +L   Q +   + +A AL+YLH  +   I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---I 123

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DLK  NV L    +  + D G+A+ L  E+Q    +  + T  YM+P
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 43/188 (22%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR---HRNLIKI 489
           IG G   +VYKAR    G  VA+K   +Q   +G   S   E  ++KR+    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 490 ISSCS-----------------NDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIM 531
           +  C+                 + D +  + +  P G   E        I D+ ++    
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-------IKDLMRQF--- 117

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
                 L++LH      I+H DLKP N+L+       L+DFG+A+        +  T  +
Sbjct: 118 ---LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVV 168

Query: 592 ATIGYMAP 599
            T+ Y AP
Sbjct: 169 VTLWYRAP 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 30/82 (36%), Positives = 47/82 (57%), Gaps = 4/82 (4%)

Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL 560
           LV+EY+  G ++  L+   Y  D    +  + +VA AL+YLH      IIH DLKP+N+L
Sbjct: 81  LVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNML 136

Query: 561 LDDNMVAHLSDFGMAKPLLKED 582
           + +     L+DFG++K  L  +
Sbjct: 137 ISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 19/176 (10%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISS 492
           L+G G    VYK R ++ G   A+KV D+  +   +    E +M+K+   HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71

Query: 493 C------SNDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFG 544
                    DD   LV+E+   GS+   + ++  N + + +    I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH-- 128

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
               +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 27/181 (14%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIE------VAVKVFDLQ-YEGAFKSFDIECDMMKRIR 482
           F++   IG+G    VYK     GI+      VA+K+ DL+  E   +    E  ++ +  
Sbjct: 6   FTKLERIGKGSFGEVYK-----GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASAL 538
              + +   S        +++EY+  GS    L+       YI  I +      ++   L
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGL 114

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +YLH   S   IH D+K  NVLL +     L+DFG+A  L   D  + +   + T  +MA
Sbjct: 115 DYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMA 169

Query: 599 P 599
           P
Sbjct: 170 P 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 24/185 (12%)

Query: 430 FSENNL-----IGRGGVASVYKARIQD-GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIR 482
           F+  +L     IGRG   +V K   +  G  +AVK      +    K   ++ D++ R  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 483 H-RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA--- 535
               ++K   +   +    + +E M   SL+K      Y+ ++ + +    I+  +A   
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKF---YKYVYEVLKSVIPEEILGKIAVAT 116

Query: 536 -SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
             AL YL     + IIH D+KP+N+LLD N    L DFG++  L+    S+ +T+     
Sbjct: 117 VKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCR 171

Query: 595 GYMAP 599
            YMAP
Sbjct: 172 PYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 11/175 (6%)

Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRHRN 485
           F +  ++G+GG   V   +++  G   A K  + +     K   +   E  +++++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFG 544
           ++ +  +    D   LVL  M  G L+  +Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                ++ DLKP N+LLDD     +SD G+A   +K  +  +    + T+GYMAP
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 5/70 (7%)

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           + + +  AL YL   + V  IH D+KP+N+LLD +    L DFG++  L+    S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 590 TLATIGYMAP 599
           +     YMAP
Sbjct: 174 SAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 7/127 (5%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMI 532
           E  +++++  R ++ +  +    D   LVL  M  G L+  +Y+  N   D  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           ++   LE LH      I++ DLKP N+LLDD     +SD G+A   + E +++     + 
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE-IPEGETI--RGRVG 163

Query: 593 TIGYMAP 599
           T+GYMAP
Sbjct: 164 TVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 22/59 (37%), Positives = 32/59 (54%)

Query: 267 LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           L+ L L  NRL      +  GL +LK LDLS NN++   P +   L  L+ +++S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 9/124 (7%)

Query: 469 KSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL 528
           + F  E   + +  H N++++    +  +   +V EYM +G+L+  L      L   Q +
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM 110

Query: 529 NIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
            ++  +AS ++YL   GY    +H  L  + VL++ ++V  +S F      L+ED+S   
Sbjct: 111 GMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAI 162

Query: 588 TQTL 591
             T+
Sbjct: 163 YTTM 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 8/175 (4%)

Query: 428 NGFSENNLIGRGGVASVYKARIQDGIE-VAVKVF-DLQYEGAFKSFDI-ECDMMKRIRHR 484
           N F    ++G G    V K R ++  E VA+K F D +     K   + E  M++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           N++++  +        LV EY+    LE      N +     R  I       ++ +H+ 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +   I+H D+KP N+L+  N V  L DFG A+  L E  +   T+ +AT  Y +P
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 24/174 (13%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECD--MMKRIRHRNLIK 488
           L+G+G    VY     D G E+AVK      E    S ++   EC+  ++K + H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 489 IISSCSNDDFK---ALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 544
               C  D  +   ++ +E+MP GS++  L S   + + + ++    I     LE + + 
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +S  I+H D+K  N+L D      L DFG +K L        QT  L+  G  +
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--------QTICLSGTGMKS 168

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 48/183 (26%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G   +VYKA  +     +AVKV  L         DI  ++ K+I     ++I+  C 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57

Query: 495 N------------DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------NIMIDVAS 536
           +            ++  ++  E+M  GSL           D+++++       I + V  
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVK 106

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
            L YL   +S+ I+H D+KP+N+L++      L DFG++  L+    S+ +T  + T  Y
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAY 159

Query: 597 MAP 599
           MAP
Sbjct: 160 MAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 17/108 (15%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKC-LYSSNYI-----LDIFQR 527
           E D++K I HR +I +I +      K+ V   MP     KC L++  Y+     L + Q 
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPK---YKCDLFT--YVDRSGPLPLEQA 187

Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           + I   +  AL YLH      IIH D+K  N+ LD+   A L DFG A
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 3e-05
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
           NL+ L   DLS N  +         L +L+ L L  N L    P++  GL  L+SLDLS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 299 NNI 301
           NN+
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYLHFGYSVPIIHCDLKPNNV 559
           L+L+Y+  G L   L       +  Q + I   ++  ALE+LH    + II+ D+K  N+
Sbjct: 82  LILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH---KLGIIYRDIKLENI 136

Query: 560 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LLD N    L+DFG++K    ED+         TI YMAP
Sbjct: 137 LLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 11/134 (8%)

Query: 436 IGRGGVASVYKA---RIQDG-----IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI 487
           +G+G    ++K     + D       EV +KV D  +    +SF     MM ++ H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
                C   D   +V EY+  GSL+  L  +  +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 548 PIIHCDLKPNNVLL 561
            + H ++   NVLL
Sbjct: 120 GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 18/149 (12%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF---KSFDI--ECDMMKRIRHRNLIKII 490
           IG G   +VY A      EV V V  + Y G     K  DI  E   +++++H N I+  
Sbjct: 29  IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI----FQRLNIMIDVASALEYLHFGYS 546
                +    LV+EY        CL S++ +L++     Q + I      AL+ L + +S
Sbjct: 88  GCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
             +IH D+K  N+LL +     L+DFG A
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 29/173 (16%)

Query: 439 GGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIIS----S 492
           G V S Y  R++   +VAVK     ++    +     E  ++K ++H N+I ++     +
Sbjct: 29  GSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86

Query: 493 CSNDDFKALVLEYMPHGS----LEKC--LYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            S ++F  + L     G+    + KC  L   +    I+Q L         L+Y+H   S
Sbjct: 87  TSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------GLKYIH---S 136

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+NV ++++    + DFG+A+   + D  +  T  +AT  Y AP
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 4e-05
 Identities = 26/61 (42%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 147 KLQLLSLEDNQLEGSIPDDLCR-LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQ 205
            L+ L L +N+L   IPD   + L  L +LDL GN L+   P  F  L SLR+L L  N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 206 L 206
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 7/127 (5%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMI 532
           E  +++++  R ++ +  +    D   LVL  M  G L+  +Y+  N   D  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           ++   LE L       I++ DLKP N+LLDD     +SD G+A  +    +  T    + 
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVRGRVG 163

Query: 593 TIGYMAP 599
           T+GYMAP
Sbjct: 164 TVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 8/106 (7%)

Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNI 530
           IE  +++ + H ++I++  +  +     +VL   PH S +   Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
              +   L YLH   +  IIH D+K  N+ ++D     + D G A+
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 27/178 (15%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS- 492
           +IGRGG   VY  R  D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 493 ------CSNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                 C    F        +L+ M  G L   L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T GYMAP
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 7/64 (10%)

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIG 595
           ALE+LH      I++ DLKP N+LLD      L DFG++K  L ++++   T T   T  
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTE 161

Query: 596 YMAP 599
           Y+AP
Sbjct: 162 YLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 19/131 (14%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS----NYILDIFQRLN 529
           E  ++  + H  ++ ++ S  +++    +LE++  G L   L  +    N +   +    
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH--- 124

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
              ++  A EYLH   S  II+ DLKP N+LLD+     ++DFG AK +        +T 
Sbjct: 125 --AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTF 173

Query: 590 TL-ATIGYMAP 599
           TL  T  Y+AP
Sbjct: 174 TLCGTPEYLAP 184

Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 31/180 (17%)

Query: 436 IGRGGVASVYKARIQD-GIEVAVK----VFDLQYEGAFKSFDIECDMMKRIRHRNLIK-- 488
           IGRG    V  A+  +   +VA+K     FD + +   K    E  +++ + H N+I   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA--KRTLREIKLLRHLDHENVIAIK 70

Query: 489 -IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILD------IFQRLNIMIDVASALE 539
            I+     + F    +V E M    L + + SS  + D      ++Q L         L+
Sbjct: 71  DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GLK 122

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           Y+H   S  ++H DLKP+N+LL+ N    + DFG+A+   ++   +  T+ + T  Y AP
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRAP 177

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 7/165 (4%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+ A      +VAVK        + ++F  E ++MK ++H  L+K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 554
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+  ++V  ++DFG+A+ ++++++   +      I + AP
Sbjct: 129 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 10/175 (5%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDG----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRH 483
           F +  ++G G   +VYK   I +G    I VA+K   +     A K    E  +M  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
                ++H DL   NVL+       ++DFG+AK L  +++          I +MA
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 1e-04
 Identities = 21/60 (35%), Positives = 28/60 (46%)

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           NL ++ L  N+L      A   L  L++L L  N L    P+    L +L  LDL GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 40/166 (24%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKR-----IR-HRNL- 486
           +IGRG    V   + +D G   A+K               + +M+++     +R  R++ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR------------KSEMLEKEQVAHVRAERDIL 55

Query: 487 --------IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVA 535
                   +K+  S  ++++  L++EY+P G +   L       D F   +    + +  
Sbjct: 56  AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETI 111

Query: 536 SALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK 580
            A++ +H  GY    IH D+KP+N+LLD      LSDFG+   L K
Sbjct: 112 LAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 14/130 (10%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E  ++K  RH  L  +  S    D    V+EY+  G L   L       +   R     +
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAE 103

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           + SAL+YLH G    I++ DLK  N++LD +    ++DFG+ K      + +T   T+ T
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKT 154

Query: 594 I----GYMAP 599
                 Y+AP
Sbjct: 155 FCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 28/117 (23%), Positives = 53/117 (45%), Gaps = 11/117 (9%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLE-YMPHGSLEKCLYSSNYI-------LDIF 525
           E  ++  + H+N++ I+  C  D     VL  YM  G+L+  L             L   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           Q +++ I +A  + YLH      +IH D+   N ++D+ +   ++D  +++ L   D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 25/74 (33%), Positives = 42/74 (56%), Gaps = 15/74 (20%)

Query: 511 LEKCLYSSNYILDIFQRL---------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL 561
           LEK + ++    +IF+R+         NIM D+ + LEY+H      I H D+KP N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159

Query: 562 DDNMVAHLSDFGMA 575
           D N   ++ D+G+A
Sbjct: 160 DGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)

Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAF-KSFDIECDMMKRIRHRNLIKIISSCSN 495
           G GG  S  K  I  G  +A KV  +  + +  K    E  +M   R   ++    +  N
Sbjct: 16  GNGGSVSKVK-HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           ++   + +E+M  GSL++       I ++I  +  I + V   L YL+      I+H D+
Sbjct: 75  ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHRDI 130

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           KP+N+L++      L DFG++  L+    S+  T  + T  YM+P
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 2e-04
 Identities = 20/56 (35%), Positives = 27/56 (48%), Gaps = 1/56 (1%)

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSF 229
           LDL  N+L+      F  L +L+ L L  N LTSI       L  +  L+LS N+ 
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 21/164 (12%)

Query: 436 IGRGGVASVYKARIQD---------GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRN 485
           +G+G   ++YK  ++          G EV+V +  L  +     +F     +M ++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           L+K+   C  D+   +V EY+  G L+  L+     + +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 546 SVPIIHCDLKPNNVLL---DDNM----VAHLSDFGMAKPLLKED 582
              ++H ++   N+L+     N        LSD G+   +L  +
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)

Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS- 492
           +IGRGG   VY  R  D G   A+K  D       K   ++      +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 493 ------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                 C +  F      + +L+ M  G L   L S + +    +      ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T GYMAP
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 34/160 (21%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVFD--LQYEGAFKSFDIECDMMKRIRHRNLIKII- 490
            +G G   SV  A   + G +VA+K      Q E   K    E  ++K ++H N+I ++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 491 ---SSCSNDDFKA--LVLEYM---------PHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
              S+ S D+F+   LV+ YM            S +K  Y       ++Q L        
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML-------C 128

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            L+Y+H   S  IIH DLKP N+ ++++    + DFG+A+
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 12/93 (12%)

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQ----RLNIMIDVASALEYL 541
           ++K+  S  + D    V++Y+P G +   L      L IF+    R  I  ++  A+E +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESV 117

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 574
           H    +  IH D+KP+N+L+D +    L+DFG+
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 18/133 (13%)

Query: 474 ECDMMKRIRHRNLIKIIS----SCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQR 527
           E  +MK + H+N+I +++      S ++F+   LV+E M   +L + +      LD  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI---QMDLD-HER 119

Query: 528 LNIMI-DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
           ++ ++  +   +++LH   S  IIH DLKP+N+++  +    + DFG+A+       S  
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 173

Query: 587 QTQTLATIGYMAP 599
            T  + T  Y AP
Sbjct: 174 MTPYVVTRYYRAP 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 21/158 (13%)

Query: 435 LIGRGGVASV-YKARIQDGIEVAVKVFDLQ-YEGAFKSFD-------IECDMMKRIR-HR 484
           ++G G   +V    R+ DG   AVKV D++    A K+         + CD    ++ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 485 NLIKIISSCSNDD---FKALVLEYMPHGSLEKCLYSSNYILDIFQRLN---IMIDVASAL 538
           +  K      N +     ALVL+Y   G L + + S       F+      + I V  A+
Sbjct: 99  DFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            ++H   S  +IH D+K  N+LL  N +  L DFG +K
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191

Length = 496

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 30/182 (16%)

Query: 436 IGRGGVASVYKAR-IQDGIE-VAVKVFDLQY--EGAFKSFDIECDMMKRIR---HRNLIK 488
           IG G    V+KAR +++G   VA+K   +Q   EG   S   E  +++ +    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 489 IISSC--SNDDFKA---LVLEYMPHG---SLEKCL---YSSNYILDIFQRLNIMIDVASA 537
           +   C  S  D +    LV E++       L+K       +  I D+      M  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM------MFQLLRG 122

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           L++LH   S  ++H DLKP N+L+  +    L+DFG+A+  +   Q    T  + T+ Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMAL-TSVVVTLWYR 176

Query: 598 AP 599
           AP
Sbjct: 177 AP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)

Query: 439 GGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS----S 492
           G V + +  +   G+ VAVK     ++     K    E  ++K ++H N+I ++     +
Sbjct: 31  GSVCAAFDTKT--GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88

Query: 493 CSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
            S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S  IIH
Sbjct: 89  RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIH 143

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 8/159 (5%)

Query: 430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRN 485
           F    +IGRG    V   + +D G   A+K+    D+  +        E D++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++K+  S  +     L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
            +  IH D+KP+N+LLD      LSDFG+   L K  ++
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 17/173 (9%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR------IRHRNLI 487
           ++G+G    V  A ++   E  A+K   L+ +   +  D+EC M++R        H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +  +    +    V+EY+  G L   + SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
            II+ DLK +NVLLD +    ++DFGM K  +  +    +  T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 22/177 (12%)

Query: 436 IGRGGVASVYK-ARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSC 493
           IG+G    VYK    +DG   AVK+ D       +  + E ++++ +  H N++K     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 494 SNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLH 542
              D        LVLE    GS+ + +     +L   QRL+      I+      L++LH
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +  IIH D+K NN+LL       L DFG++  L      L +  ++ T  +MAP
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 39/172 (22%), Positives = 83/172 (48%), Gaps = 14/172 (8%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   ++++  +V A+K+   +++        F  E D++    ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSV 547
            +  +++   LV++Y   G L   L    + + +   R  +  M+    ++  LH+    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +H D+KP+N+L+D N    L+DFG    L+ ED ++  +  + T  Y++P
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNV 559
           L++E++P G L   L   +   +   R   M +   A+E +H  G+    IH D+KP+N+
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHKLGF----IHRDIKPDNI 132

Query: 560 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           L+D      LSDFG++    K+  S    + L
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 11/165 (6%)

Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSCSN 495
           G GGV +  + +   G+ +A K+  L+ + A ++  I E  ++       ++    +  +
Sbjct: 16  GNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           D   ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   +   I+H D+
Sbjct: 75  DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDV 130

Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           KP+N+L++      L DFG++  L+           + T  YM+P
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 11/156 (7%)

Query: 435 LIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           ++G G   +VYK   I DG    I VA+KV  +     A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           ++  C     + LV + MP+G L   +  +   +     LN  + +A  + YL     V 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
           ++H DL   NVL+       ++DFG+A+ LL  D++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.4 bits (98), Expect = 6e-04
 Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 7/102 (6%)

Query: 476 DMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 535
            +MK   + N IK+  S +      L+++Y+  G L   L      L   +   I+  + 
Sbjct: 63  QLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLV 119

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-AHLSDFGMAK 576
            AL  LH      IIH D+K  NVL D      +L D+G+ K
Sbjct: 120 EALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 13/166 (7%)

Query: 437 GRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSCS 494
           G GGV  V+K   +  G+ +A K+  L+ + A ++  I E  ++       ++    +  
Sbjct: 16  GNGGV--VFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +D   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   +   I+H D
Sbjct: 74  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRD 129

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +KP+N+L++      L DFG++  L+           + T  YM+P
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 39.1 bits (92), Expect = 7e-04
 Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 3/46 (6%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI 481
           I    +A V++A ++DG EVAVKV   Q  G  K    +  ++K +
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLKFL 61

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 38/128 (29%), Positives = 55/128 (42%), Gaps = 10/128 (7%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E  +++  RH  L  +  S    D    V+EY   G L   L       +   R     +
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAE 103

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-- 591
           + SAL YLH   S  +++ DLK  N++LD +    ++DFG    L KE  S   T     
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC 156

Query: 592 ATIGYMAP 599
            T  Y+AP
Sbjct: 157 GTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 8e-04
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 443 SVYKARIQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRHRNLIKI----ISSCSN 495
           S+YK  I +  EV ++ F   ++G     DI   E   ++RI   N++KI    I    +
Sbjct: 35  SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 555
               +L+LEY   G L + L      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 556 PNNVLLDDNMVAHLSDFGMAKPL 578
             + L+ +N    +   G+ K L
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL 173

Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 4/101 (3%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E D++    +  ++K+  S  + D    V++Y+P G +   L       ++  R  I  +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-E 109

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 574
           +  A+E +H    +  IH D+KP+N+L+D +    L+DFG+
Sbjct: 110 LTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.6 bits (97), Expect = 9e-04
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 594 IGYMAP 599
           + +MAP
Sbjct: 245 LKWMAP 250

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 17/224 (7%)

Query: 5   GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
            +N   ++PS + N   L  L+L  N     +P    NL NL  L L+ N ++   P++ 
Sbjct: 148 SDNKIESLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSGNKISDLPPEIE 206

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
            LS+L        L  SNNS+  +L  ++ NL          + N    +PE I NL+NL
Sbjct: 207 LLSALEE------LDLSNNSIIELLS-SLSNLKNL--SGLELSNNKLEDLPESIGNLSNL 257

Query: 125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLS 183
            T+ L  N++  S   +L  L  L+ L L  N L  ++P   L  L    LL+L     +
Sbjct: 258 ETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
             +      L    N  + SN  TS P  L  L+ +  L    N
Sbjct: 316 LELKLNSILL----NNNILSNGETSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 21/65 (32%), Positives = 36/65 (55%), Gaps = 5/65 (7%)

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATI 594
            L+Y+H   S  ++H DLKP N+L++ +    + DFG+A+       + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 595 GYMAP 599
            Y AP
Sbjct: 174 WYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 42/183 (22%)

Query: 436 IGRGGVASVYKARIQDG--IEVAVKVFDLQYEGAFKSFD---IECDMMKRIRHRNLIKII 490
           +G G    V  A  ++     VA+K F+       K  D    E  ++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 491 SSCSNDDFKALVLEYMPHGSLEK-------------CLYSSNYILDIFQRLNIMIDVASA 537
            S  ++ +  LVLE++  G                 C Y++  +L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGY 596
            EYL    S+ I++ DLKP N+LLD +    ++DFG AK +       T+T TL  T  Y
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEY 194

Query: 597 MAP 599
           +AP
Sbjct: 195 IAP 197

Length = 340

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 16/76 (21%)

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL-------------KEDQ 583
           ALEYLH   +  I+H DLKP+N+L+       L+DFG++K  L             K+ +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 584 SLTQTQTLATIGYMAP 599
                Q   T  Y+AP
Sbjct: 170 EFLDKQVCGTPEYIAP 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 8/159 (5%)

Query: 430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRN 485
           F    +IGRG    V   + +D G   A+K+    D+  +        E D++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++K+  S  +     L++E++P G +   L   + + +   +  I  +   A++ +H   
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH--- 118

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
            +  IH D+KP+N+LLD      LSDFG+   L K  ++
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 17/173 (9%)

Query: 435 LIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V+ A ++      A+K   L+ +      D+EC M+ KR+      H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
            I++ DLK +N+LLD +    ++DFGM K  +  D    +T T   T  Y+AP
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 594 IGYMAP 599
           + +MAP
Sbjct: 239 LKWMAP 244

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 30/117 (25%), Positives = 60/117 (51%), Gaps = 6/117 (5%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ +      ++  
Sbjct: 46  EANVMQQLDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQ 103

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L  D++  + +T
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 19/180 (10%)

Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 539
           ++   S      +V+E M HG L+  L S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD 562
           +E+M  GSL++ L  +  I +      I I V   L YL   +   I+H D+KP+N+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                 L DFG++  L+    S+  +  + T  YM+P
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 41/175 (23%), Positives = 78/175 (44%), Gaps = 25/175 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECD-------MMKRIR-HRNL 486
           IG G  + V KA+  + G   A+K     ++       +E          ++R+  H N+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK------SLEQVNNLREIQALRRLSPHPNI 60

Query: 487 IKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +++I    +      ALV E M   +L + +      L   +  + M  +  +L+++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               I H D+KP N+L+ D+++  L+DFG  + +         T+ ++T  Y AP
Sbjct: 118 -RNGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRAP 167

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 22/65 (33%), Positives = 29/65 (44%), Gaps = 5/65 (7%)

Query: 21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF 80
           L  L+L  N         F  L NLK L L+ N LTS +P+     + S    L+ L  
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 81 SNNSL 85
          S N+L
Sbjct: 56 SGNNL 60

Length = 60

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 18/156 (11%)

Query: 452 GIEVAVKVFD--LQYEGAFKSFDIECDMMKRIRHRNLIKIIS----SCSNDDFKA--LVL 503
           GI VAVK      Q +   K    E  ++K + H+N+I +++      S ++F+   LV+
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD 563
           E M   +L + ++     LD  +   ++  +   +++LH   S  IIH DLKP+N+++  
Sbjct: 106 ELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158

Query: 564 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +    + DFG+A+       +   T  + T  Y AP
Sbjct: 159 DCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAP 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 22/78 (28%), Positives = 38/78 (48%), Gaps = 3/78 (3%)

Query: 522 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 582 DQSLTQTQTLATIGYMAP 599
              +++  T   + +MAP
Sbjct: 291 SNYVSKGSTFLPVKWMAP 308

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 16/112 (14%)

Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD--------IFQRLN 529
           + R+ H N++KI     ++        YM     +  LYS  Y           + Q   
Sbjct: 217 LGRLNHENILKIEEILRSEANT-----YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           IM  +  A+EY+H      +IH D+K  N+ L+ +    L DFG A P  KE
Sbjct: 272 IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Length = 501

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 26/101 (25%), Positives = 51/101 (50%), Gaps = 4/101 (3%)

Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E D++    +  ++++  S  + D    V++Y+P G +   L       +   R  I  +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-E 109

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 574
           +  A+E +H    +  IH D+KP+N+L+D +    L+DFG+
Sbjct: 110 LTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 22/177 (12%)

Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSC 493
           IG+G    V+K    ++G + AVK+ D  ++   +  + E +++K +  H N++K     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 494 SNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLH 542
              D K      LVLE    GS+   +      L   +R+       I+ +    L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +   IH D+K NN+LL       L DFG++  L      L +  ++ T  +MAP
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)

Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMI----DVASALE 539
           ++   S      +++E M  G L+  L S      N  +     L  MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + K+   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 594 IGYMAP 599
           + +MAP
Sbjct: 240 LKWMAP 245

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 7/68 (10%)

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL- 591
           ++A  L +LH   S  II+ DLK +NV+LD      ++DFGM K  +   ++   T+T  
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFC 162

Query: 592 ATIGYMAP 599
            T  Y+AP
Sbjct: 163 GTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 11/170 (6%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFD---IECDMMKRIRHRNLIKII 490
           +IGRG  A V   R++    + A+KV   +     +  D    E  + ++  +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 491 SSCSNDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
            SC   + +   V+EY+  G L   +     + +   R     +++ AL YLH      I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           I+ DLK +NVLLD      L+D+GM K  L+     T +    T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 568
            S ++     ++ LD+   L     VA  +++L    S   IH D+   NVLL D  VA 
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAK 252

Query: 569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           + DFG+A+ ++ +   + +      + +MAP
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAP 283

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 30/139 (21%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 436 IGRGGVASVYKARIQDG-------------IEVAVKVFDLQYEGAFKSFDIECDMMKRIR 482
           +GRG    +Y   +                I+V +KV D  +     +F     MM+++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           H++++ +   C  D    +V E++  G L+  ++  + +L    +  +   +ASAL YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 543 FGYSVPIIHCDLKPNNVLL 561
                 ++H ++   N+LL
Sbjct: 123 ---DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 38/189 (20%)

Query: 436 IGRGGVASVYKARIQDG---IEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKII 490
           +GRG    VYKA+ +DG    E A+K    Q EG   S     E  +++ ++H N+I + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 491 SS-CSNDDFKA-LVLEYMPHG-----SLEKCLYSSNYILDIFQRL--NIMIDVASALEYL 541
               S+ D K  L+ +Y  H         +   ++   + + + +  +++  +   + YL
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 542 HFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA-------KPLLKEDQSLTQTQT 590
           H  +   ++H DLKP N+L+     +     ++D G A       KPL   D        
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD------PV 175

Query: 591 LATIGYMAP 599
           + T  Y AP
Sbjct: 176 VVTFWYRAP 184

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 15/150 (10%)

Query: 436 IGRGGVASV-YKARIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKII-- 490
           +G G   +V      + G +VA+K      Q E   K    E  ++K ++H N+I ++  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 491 --SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
                S D F    LV+ +M    L K +       D  Q L  +  +   L+Y+H   +
Sbjct: 83  FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIH---A 136

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
             IIH DLKP N+ ++++    + DFG+A+
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	599
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
KOG0589	426	consensus Serine/threonine protein kinase [General	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.93
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.93
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
PTZ00283	496	serine/threonine protein kinase; Provisional	99.93
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.93
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.92
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.92
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.92
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.92
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
PHA03209	357	serine/threonine kinase US3; Provisional	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.92
PHA03207	392	serine/threonine kinase US3; Provisional	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
PTZ00036	440	glycogen synthase kinase; Provisional	99.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.92
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.92
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.92
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.92
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.92
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.91
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.91
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.91
KOG0610	459	consensus Putative serine/threonine protein kinase	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.91
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.91
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.91
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.91
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.91
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.91
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.91
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.91
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.91
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.9
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.9
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.9
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.9
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.9
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.9
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.9
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.9
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.9
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.9
PTZ00284	467	protein kinase; Provisional	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.9
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.9
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.89
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.89
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.89
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.89
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.89
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.88
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.88
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.88
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.88
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.88
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.88
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.88
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.88
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.88
PHA02882	294	putative serine/threonine kinase; Provisional	99.87
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.87
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.87
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.87
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.87
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.87
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.86
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.86
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.84
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.84
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.82
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.82
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.82
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
smart00090	237	RIO RIO-like kinase.	99.79
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.79
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.78
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.76
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.64
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.55
PLN03150	623	hypothetical protein; Provisional	99.54
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.53
PLN00181	793	protein SPA1-RELATED; Provisional	99.52
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.5
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.39
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.38
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.37
PLN03150	623	hypothetical protein; Provisional	99.36
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.36
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.33
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.33
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.33
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.32
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.29
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.19
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.13
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.12
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.94
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.88
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.87
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.86
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.84
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.79
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.75
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.74
KOG1243	690	consensus Protein kinase [General function predict	98.72
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.68
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.66
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.57
PRK09902	216	hypothetical protein; Provisional	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.49
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.47

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-73  Score=662.61  Aligned_cols=574  Identities=29%  Similarity=0.461  Sum_probs=408.4

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++.+|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++...+.     .+.++++|++|++
T Consensus       241 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~l  315 (968)
T PLN00113        241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-----LVIQLQNLEILHL  315 (968)
T ss_pred             EECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh-----hHcCCCCCcEEEC
Confidence            46677777777777777777777777777777776777777777777777777776654432     2445555555555


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEc------------------------cCCcCCc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYL------------------------GGNKLNG  136 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L------------------------~~N~l~~  136 (599)
                      ++|.+.+..|..+..++ .|+.|++++|.+.+..|..++.+++|+.|+|                        ++|.+.+
T Consensus       316 ~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~  394 (968)
T PLN00113        316 FSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG  394 (968)
T ss_pred             CCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence            55555555555555544 2455555555555444544444455555555                        4455544


Q ss_pred             ccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCC
Q 042902          137 SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNL  216 (599)
Q Consensus       137 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l  216 (599)
                      ..|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+..........
T Consensus       395 ~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~  474 (968)
T PLN00113        395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS  474 (968)
T ss_pred             cCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccccc
Confidence            55555555666666666666666666666666666666666666666666666666677777777777766332223355


Q ss_pred             CcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccC
Q 042902          217 KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDL  296 (599)
Q Consensus       217 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  296 (599)
                      ++|+.|++++|++++..|..|.++++|+.|+|++|.+.+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            78889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCCC-CCCCCCCcccccccccCcccee
Q 042902          297 SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP-NLQVPPCRTRIHHTSRKNDLLL  375 (599)
Q Consensus       297 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~-~~~~~~~~~~~~~~~~~~~~~~  375 (599)
                      ++|++++.+|..+..++.|+.+++++|+++|.+|..+.+..+...++.+|+..|+.+ ....++|.....   ...+ ++
T Consensus       555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~~-~~  630 (968)
T PLN00113        555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSW-WF  630 (968)
T ss_pred             CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---ccee-ee
Confidence            999999999999999999999999999999999999999999999999999999854 334566753211   1111 12


Q ss_pred             eehhhhhHHH-HHHHHHHhhhhhhcCcccc---ccCCccccc---ccccccHHHHHHHhCCCCcCceecccccceEEEEE
Q 042902          376 GIVLPLSTIF-MMAVILLILRYRKRGKSQL---ADANMPLVA---NLRRFTHLELFQATNGFSENNLIGRGGVASVYKAR  448 (599)
Q Consensus       376 ~~~i~~~~~~-~~~~~~~~~~~r~r~k~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~  448 (599)
                      .+++++.+++ +++++++++++|+|++.+.   +........   ................|...+.||+|+||.||+|+
T Consensus       631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~  710 (968)
T PLN00113        631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGK  710 (968)
T ss_pred             ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEE
Confidence            1221111111 1222222222222221111   100000000   00000111222233567788999999999999999


Q ss_pred             e-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHH
Q 042902          449 I-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR  527 (599)
Q Consensus       449 ~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  527 (599)
                      . .+|..||||.++.....    ...|++++++++|||||+++|+|.+.+..++|||||++|+|.++++.    ++|..+
T Consensus       711 ~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~  782 (968)
T PLN00113        711 SIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERR  782 (968)
T ss_pred             ECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHH
Confidence            7 47899999998643321    23468899999999999999999999999999999999999999964    789999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       528 ~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+|+.|||+||+|+|+.++++|+|||+||+||+++.++.+++. ||.+......      ....+|++||||
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aP  847 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAP  847 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCc
Confidence            9999999999999997778899999999999999999888876 6765533211      223688999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-42  Score=404.29  Aligned_cols=347  Identities=36%  Similarity=0.576  Sum_probs=292.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++.+|..+.++++|++|+|++|++++..|..|+++++|++|+|++|+++...+.     .+.++++|++|+|
T Consensus       217 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-----~l~~l~~L~~L~L  291 (968)
T PLN00113        217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP-----SIFSLQKLISLDL  291 (968)
T ss_pred             EECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCch-----hHhhccCcCEEEC
Confidence            57899999999999999999999999999999999999999999999999999999875543     5889999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.+.+.+|..+.+++ .|+.|++++|.+.+..|..+.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|++.+
T Consensus       292 s~n~l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~  370 (968)
T PLN00113        292 SDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG  370 (968)
T ss_pred             cCCeeccCCChhHcCCC-CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence            99999999999999987 59999999999999999999999999999999999999999999999999999999999988


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCccccCCCcccEEeecCCCccccCccccc-
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG-  238 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-  238 (599)
                      ..|..++.+++|+.|++++|.+.+..|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+++..+..+. 
T Consensus       371 ~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  450 (968)
T PLN00113        371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD  450 (968)
T ss_pred             eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc
Confidence            88887777777777777777776666666666666666666666665 3444555555555555555555444433322 


Q ss_pred             ----------------------ccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccC
Q 042902          239 ----------------------NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDL  296 (599)
Q Consensus       239 ----------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  296 (599)
                                            ..++|+.|++++|++++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|
T Consensus       451 l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  530 (968)
T PLN00113        451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL  530 (968)
T ss_pred             CCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEEC
Confidence                                  2356777788888888888888899999999999999999999999999999999999


Q ss_pred             CCCcccccCCchhhccccceEEEcccccCcccCCCC-CCCCCcccccccCCCCCcCCC
Q 042902          297 SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE-GPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       297 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      ++|.+++.+|..|..+++|+.|++++|++++.+|.. ..+..+...++.+|+..+..|
T Consensus       531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            999999999999999999999999999999998864 446667788888998776555

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=349.39  Aligned_cols=351  Identities=22%  Similarity=0.239  Sum_probs=240.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCc-cc--------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL-NF--------------   65 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~--------------   65 (599)
                      |||++|.++...+..|.++++|++++|.+|.++. +|.......+|+.|+|.+|.|+++..+. .+              
T Consensus        83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i  161 (873)
T KOG4194|consen   83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI  161 (873)
T ss_pred             eeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence            5677777777766666666666666666666654 3443333334555555555555444320 00              


Q ss_pred             ----ccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCcc
Q 042902           66 ----LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIA  141 (599)
Q Consensus        66 ----~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  141 (599)
                          ..+|..-.++++|+|++|+|+.+..+.|.++. +|.+|.|++|+|+.+.+..|.+|++|+.|+|..|+|.-..--+
T Consensus       162 s~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  162 SEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             hcccCCCCCCCCCceEEeeccccccccccccccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence                01344445566666666666666666666665 4666666666666666666666666666666666666443445


Q ss_pred             ccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCC-CccccCCCccc
Q 042902          142 LDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYIL  220 (599)
Q Consensus       142 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~  220 (599)
                      |.+|++|+.|.|..|.|.....+.|..+.++++|+|+.|+++..-.+++-+++.|++|+||+|.|..| ++++...++|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            66666666666666666666666777777777888888887777777777788888888888888866 45666677788


Q ss_pred             EEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcc---cccCCCCcccccCC
Q 042902          221 YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD---SIGGLIDLKSLDLS  297 (599)
Q Consensus       221 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~  297 (599)
                      +|+|++|+|+...++.|..+..|++|+|++|.++.+....|.++++|+.|||++|.|++.+.+   .|.+|++|+.|+|.
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~  400 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT  400 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence            888888888877777888888888888888888777777788888888888888888765543   47778888888888


Q ss_pred             CCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCCC
Q 042902          298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       298 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      +|+|..+.-.+|.++..|+.|||.+|.+...-|....-..+...-+.....+|+|.
T Consensus       401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             CceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence            88888777778888888888888888887766654222255555566666777775

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=344.48  Aligned_cols=322  Identities=24%  Similarity=0.225  Sum_probs=215.9

Q ss_pred             CccCCCcCccCCCCCCcC--CCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCC-CCcE
Q 042902            1 LLLWGNNFSGTIPSFIFN--ASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK-YLKY   77 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~--l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~-~L~~   77 (599)
                      ||.+++.+....-..+.+  .+.-+.||+++|++..+.+..|.++++|+.++|.+|.++.+|.       |++.. +|+.
T Consensus        57 ldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~-------f~~~sghl~~  129 (873)
T KOG4194|consen   57 LDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPR-------FGHESGHLEK  129 (873)
T ss_pred             eecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhccc-------ccccccceeE
Confidence            456667766432223333  2456789999999999999999999999999999999999885       44433 4777


Q ss_pred             EEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccc
Q 042902           78 LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQ  157 (599)
Q Consensus        78 L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  157 (599)
                      |+|.+|.|+.+...++..++ .++.|+|+.|.|+.+.-..|..-.++++|+|++|+|+.+..+.|.++.+|..|.|++|+
T Consensus       130 L~L~~N~I~sv~se~L~~l~-alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr  208 (873)
T KOG4194|consen  130 LDLRHNLISSVTSEELSALP-ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR  208 (873)
T ss_pred             EeeeccccccccHHHHHhHh-hhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCc
Confidence            77777777777666666665 47777777777776666666666677777777777776666677777777777777777


Q ss_pred             ccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCccc
Q 042902          158 LEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLE  236 (599)
Q Consensus       158 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~  236 (599)
                      |+...+..|.++++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|..+.+ .|+.+.++++|+|+.|+++..-.++
T Consensus       209 ittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~  288 (873)
T KOG4194|consen  209 ITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW  288 (873)
T ss_pred             ccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc
Confidence            776666667767777777777777664434556666666666666666666543 4555666666666666666555555


Q ss_pred             ccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccce
Q 042902          237 IGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK  316 (599)
Q Consensus       237 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  316 (599)
                      +.+++.|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+...+.+|..+..|+.|+|++|.++..-...|..+.+|+
T Consensus       289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~  368 (873)
T KOG4194|consen  289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH  368 (873)
T ss_pred             ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence            56666666666666666655566666666666666666666655556666666666666666666555555555556666


Q ss_pred             EEEcccccCcccCC
Q 042902          317 YINVSFNKLEGEIP  330 (599)
Q Consensus       317 ~l~l~~N~l~~~~p  330 (599)
                      .|||++|.+++.|.
T Consensus       369 ~LdLr~N~ls~~IE  382 (873)
T KOG4194|consen  369 KLDLRSNELSWCIE  382 (873)
T ss_pred             hhcCcCCeEEEEEe
Confidence            66666666555544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=330.48  Aligned_cols=185  Identities=45%  Similarity=0.687  Sum_probs=163.9

Q ss_pred             ccccccHHHHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEE
Q 042902          414 NLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC  493 (599)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  493 (599)
                      ..+.|++.++..||++|...+.||+|+||.||+|.+++|+.||||++........++|.+|++++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988655432145699999999999999999999999


Q ss_pred             EcCC-eeeEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcc
Q 042902          494 SNDD-FKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       494 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                      .+.+ +.+||||||++|+|+++++.... .++|..|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 789999999999999999999998888999999999999999999999999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|+.......... +...||.+|+||
T Consensus       221 FGLa~~~~~~~~~~~-~~~~gt~gY~~P  247 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVS-TTVMGTFGYLAP  247 (361)
T ss_pred             ccCcccCCcccccee-eecCCCCccCCh
Confidence            999975543122111 111799999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=294.96  Aligned_cols=166  Identities=33%  Similarity=0.509  Sum_probs=148.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  .....+-...|+++|+.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888889999999999999976 5899999999766  4455677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC------CcEEEccccCCcc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN------MVAHLSDFGMAKP  577 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~------~~~kl~DFGla~~  577 (599)
                      |||.||||.++++.++ .+++..+..++.|+|.||++||   +++||||||||.|||++..      -.+||+|||+||.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999876 4788889999999999999999   9999999999999999854      4689999999998


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.+..   .....+|+|-||||
T Consensus       165 L~~~~---~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  165 LQPGS---MAETLCGSPLYMAP  183 (429)
T ss_pred             CCchh---HHHHhhCCccccCH
Confidence            86443   23457899999999

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=284.77  Aligned_cols=163  Identities=33%  Similarity=0.532  Sum_probs=141.4

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEecccccc--cHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-eeeEEEEccCC
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG--AFKSFDIECDMMKRIRHRNLIKIISSCSNDD-FKALVLEYMPH  508 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  508 (599)
                      ..+.+|+|+||+||+|.++....||||++......  ..++|..|+.+|++++|||||+++|+|.... ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            34569999999999999984444999999765322  2569999999999999999999999999887 79999999999


Q ss_pred             CChhhhhhc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEccCCCCCeeecCCC-cEEEccccCCccCCcCCCce
Q 042902          509 GSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       509 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~~~~  585 (599)
                      |+|.++++. .+..+++..++++|.|||+||.|||   +.+ ||||||||+|||++.++ .+||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999988 4667999999999999999999999   777 99999999999999997 99999999998653221  2


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ..+...||+.||||
T Consensus       200 ~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAP  213 (362)
T ss_pred             cccCCCCCccccCh
Confidence            34457899999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-33  Score=271.46  Aligned_cols=166  Identities=27%  Similarity=0.417  Sum_probs=142.0

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEG-------AFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      .+.|-..+.+|+|+||.|-+|.. ++|+.||||+++++...       ......+|+++|+++.|||||++++++..+++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            35577789999999999999975 47999999999765311       12235799999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC---CcEEEccccCC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMA  575 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DFGla  575 (599)
                      .|||||||+||+|.+.+-..+. +.+.....+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            9999999999999999887664 556666789999999999999   9999999999999999755   78999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +...   +...+...+|||.|.||
T Consensus       327 K~~g---~~sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  327 KVSG---EGSFMKTLCGTPSYVAP  347 (475)
T ss_pred             hccc---cceehhhhcCCccccCh
Confidence            9654   22345668999999999

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=274.70  Aligned_cols=165  Identities=32%  Similarity=0.429  Sum_probs=142.9

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCcceeEEEEEEcCC----eeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR--IRHRNLIKIISSCSNDD----FKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  502 (599)
                      .....+.||+|+||.||||++. ++.||||++..+   ..+.|.+|.++.+.  ++|+||++++++-....    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3445578999999999999997 699999999654   45678899988875  58999999999876555    89999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      +||.+.|+|.++|...-  ++|....+|+..+++||+|||+.      ++++|+|||||++||||..|+++.|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999998764  89999999999999999999954      57899999999999999999999999999999


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+.........-..+||.+||||
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCH
Confidence            88655443344557899999999

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.9e-35  Score=298.15  Aligned_cols=339  Identities=26%  Similarity=0.414  Sum_probs=243.4

Q ss_pred             ccCCCcCc-cCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            2 LLWGNNFS-GTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         2 ~L~~n~~~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+++|.++ +.+|.....|++++.|.|.+.++.. +|..++.+.+|+.|.+++|++.++..+      ++.|+.|+.+++
T Consensus        13 DfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~-vPeEL~~lqkLEHLs~~HN~L~~vhGE------Ls~Lp~LRsv~~   85 (1255)
T KOG0444|consen   13 DFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQ-VPEELSRLQKLEHLSMAHNQLISVHGE------LSDLPRLRSVIV   85 (1255)
T ss_pred             cccCCcCCCCcCchhHHHhhheeEEEechhhhhh-ChHHHHHHhhhhhhhhhhhhhHhhhhh------hccchhhHHHhh
Confidence            78999999 6789999999999999999999986 788999999999999999999887654      677777888888


Q ss_pred             ccCcccc-cCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccc
Q 042902           81 SNNSLDG-ILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE  159 (599)
Q Consensus        81 s~N~i~~-~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  159 (599)
                      .+|++.. -+|..+..+. -|++|+|++|++. ..|..+..-+++-.|+||+|+|..++...|.+|..|-.||||+|++.
T Consensus        86 R~N~LKnsGiP~diF~l~-dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLK-DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             hccccccCCCCchhcccc-cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence            8777763 2455555565 3777778887777 56777777777777788887777665566777777777778777777


Q ss_pred             ccCChhhhcCCCCcEEEeeCCccCCC-------------------------CCcccCCCCCCcEeecCCCCCCCCCcccc
Q 042902          160 GSIPDDLCRLAALFLLDLGGNKLSGF-------------------------VPACFGNLTSLRNLYLGSNQLTSIPSTLW  214 (599)
Q Consensus       160 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~l~~ip~~~~  214 (599)
                       .+|.....+..|++|+|++|.+...                         +|..+..+.+|..+++|.|.+..+|+.+.
T Consensus       164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly  242 (1255)
T KOG0444|consen  164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLY  242 (1255)
T ss_pred             -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHh
Confidence             5566677777777777777765422                         34455556666667777777777777777


Q ss_pred             CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccc-cCcccccCCCCccc
Q 042902          215 NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG-SIPDSIGGLIDLKS  293 (599)
Q Consensus       215 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~  293 (599)
                      ++++|+.|+||+|+|+. .....+...+|++|+||.|+++ ..|+++..++.|+.|++.+|+++- -+|..++.+.+|+.
T Consensus       243 ~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev  320 (1255)
T KOG0444|consen  243 KLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV  320 (1255)
T ss_pred             hhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence            77777777777777763 3334445566677777777776 467777777777777777777652 35666777777777


Q ss_pred             ccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCCC
Q 042902          294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       294 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      +..++|.+. .+|..+..+.+|+.|.|+.|.|-..+...--+..+..+++..||.+.-+|
T Consensus       321 f~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  321 FHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             HHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence            777777776 67777777777778888888776444333445566667777777655443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=267.23  Aligned_cols=163  Identities=26%  Similarity=0.379  Sum_probs=143.6

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-eeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-FKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  506 (599)
                      .+..+.||+|..|+||+++++ +++.+|+|.+.... ....+++.+|++++++.+||+||.++|.|...+ ..+|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            345678999999999999987 68899999996553 345678999999999999999999999999888 599999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|+..+...+ .+++...-+|+.+|++||.|||+  ..+||||||||+|||+...|++||+|||.++.+...    .
T Consensus       161 DgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~  233 (364)
T KOG0581|consen  161 DGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I  233 (364)
T ss_pred             CCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence            9999999988764 47888888999999999999993  279999999999999999999999999999876533    3


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+||..||||
T Consensus       234 a~tfvGT~~YMsP  246 (364)
T KOG0581|consen  234 ANTFVGTSAYMSP  246 (364)
T ss_pred             cccccccccccCh
Confidence            4567899999999

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-32  Score=280.51  Aligned_cols=166  Identities=29%  Similarity=0.442  Sum_probs=149.5

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ..|...+.||+|||+.+|+++. ..|+.||+|++.+.   .....+...+||++.+.++|||||++++++++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999997 78999999999754   3445677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+|+.|+|.++++++ ..+++.++..+++||+.||.|||   +.+|+|||||..|++++++.++||+|||+|..+..+++
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999854 45899999999999999999999   99999999999999999999999999999998764432


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+|||.|+||
T Consensus       174 --rk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAP  187 (592)
T ss_pred             --ccceecCCCcccCh
Confidence              23447899999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-33  Score=266.57  Aligned_cols=167  Identities=31%  Similarity=0.456  Sum_probs=146.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..++||+|+||+||.++.+ +++.+|+|+++++.   ....+....|..++.+++||.||+++..+++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467899999999999999999865 58999999997652   34567788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +||+.||+|..+|.+.+ .+++..+.-++.+|+.||.|||   +.+||||||||+|||+|.+|.++|+|||+|+.-...+
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999999998655 4778877889999999999999   9999999999999999999999999999999543322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  .....+||+.||||
T Consensus       180 ~--~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  180 D--ATRTFCGTPEYMAP  194 (357)
T ss_pred             C--ccccccCCccccCh
Confidence            1  23447999999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.6e-32  Score=272.25  Aligned_cols=167  Identities=32%  Similarity=0.434  Sum_probs=147.4

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  502 (599)
                      +.|+..+.||+|.||.||+|+. .+|+.||+|+++...  +....-..+||.+|++++||||+++.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4566778999999999999984 579999999997653  44556678899999999999999999988766  689999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +|||++ ||.-++...+-.++..++..|+.|+++||.|+|   ..+|+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999987 998888887778999999999999999999999   9999999999999999999999999999999775443


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                       ....+..+-|.+|.||
T Consensus       273 -~~~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  273 -SAPYTSRVVTLWYRPP  288 (560)
T ss_pred             -CcccccceEEeeccCh
Confidence             3446778899999998

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=1.4e-34  Score=291.94  Aligned_cols=317  Identities=27%  Similarity=0.366  Sum_probs=257.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCcccc--ccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEE
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFY--GFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYL   78 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L   78 (599)
                      |.+++|+++ .+...+..++.|+.++++.|++.  | +|..+-.|..|+.||||+|++++.|..      +..-+++-.|
T Consensus        60 Ls~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsG-iP~diF~l~dLt~lDLShNqL~EvP~~------LE~AKn~iVL  131 (1255)
T KOG0444|consen   60 LSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSG-IPTDIFRLKDLTILDLSHNQLREVPTN------LEYAKNSIVL  131 (1255)
T ss_pred             hhhhhhhhH-hhhhhhccchhhHHHhhhccccccCC-CCchhcccccceeeecchhhhhhcchh------hhhhcCcEEE
Confidence            346677776 45666777777777777777765  4 344555777788888888888777764      5666777778


Q ss_pred             EcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccc
Q 042902           79 SFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL  158 (599)
Q Consensus        79 ~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  158 (599)
                      +||+|+|..++...|.++.. |-.|+|++|++. ..|..+..|.+|++|.|++|.+...--..+..+++|+.|.+++.+=
T Consensus       132 NLS~N~IetIPn~lfinLtD-LLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR  209 (1255)
T KOG0444|consen  132 NLSYNNIETIPNSLFINLTD-LLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR  209 (1255)
T ss_pred             EcccCccccCCchHHHhhHh-Hhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence            88888887666666777764 667777777776 4455667777778888888776643333445566777777777653


Q ss_pred             c-ccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccc
Q 042902          159 E-GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI  237 (599)
Q Consensus       159 ~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~  237 (599)
                      + .-+|.++..+.+|..+|||.|.+. ..|+++-.+++|+.|+||+|+|+++......+.+|++|+||+|+++ ..|.++
T Consensus       210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~av  287 (1255)
T KOG0444|consen  210 TLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAV  287 (1255)
T ss_pred             hhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHH
Confidence            2 357888999999999999999998 7899999999999999999999999877778899999999999999 789999


Q ss_pred             cccccccEEEccCCccCC-CCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccce
Q 042902          238 GNLRVLVQIDLSMNNFSG-FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK  316 (599)
Q Consensus       238 ~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  316 (599)
                      ++++.|+.|.+.+|+++- -+|..++.+.+|+.+..++|.+. ..|+.+..+..|+.|.|+.|++- ..|..+.-++.|+
T Consensus       288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~  365 (1255)
T KOG0444|consen  288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK  365 (1255)
T ss_pred             hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc
Confidence            999999999999999862 36889999999999999999998 89999999999999999999998 7899999999999


Q ss_pred             EEEcccccCcccCCC
Q 042902          317 YINVSFNKLEGEIPR  331 (599)
Q Consensus       317 ~l~l~~N~l~~~~p~  331 (599)
                      +||+..|+=--.+|.
T Consensus       366 vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  366 VLDLRENPNLVMPPK  380 (1255)
T ss_pred             eeeccCCcCccCCCC
Confidence            999999985545554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=9.9e-33  Score=257.03  Aligned_cols=166  Identities=28%  Similarity=0.360  Sum_probs=142.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.|+...++|+|+||+||+|+.+ +|+.||||++....+  ...+--++|+++++.++|||+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777789999999999999976 599999999965533  234557899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||+. ++-+-+.+.....+.....+|.+|+++|+.|+|   +.+||||||||+|||++.+|.+|+||||+||.+...+. 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9987 444555555556888889999999999999999   99999999999999999999999999999998863322 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ..+..+.|.+|.||
T Consensus       157 -~YTDYVATRWYRaP  170 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAP  170 (396)
T ss_pred             -hhhhhhhhhhccCh
Confidence             34667899999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=5e-32  Score=248.28  Aligned_cols=166  Identities=31%  Similarity=0.471  Sum_probs=148.0

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .+|...+.+|+|.||.||+|++ ++|+.||||+++...  ++......+||+.++.++||||+.+++++...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577889999999999999985 479999999997653  2334567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||+. +|+..+++....++..++..++.++++|++|+|   ++.|+|||+||.|+|++++|.+||+|||+|+.+.+.+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9966 999999999889999999999999999999999   899999999999999999999999999999988766543


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .  +..+.|.+|.||
T Consensus       158 ~--~~~V~TRWYRAP  170 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAP  170 (318)
T ss_pred             c--ccceeeeeccCh
Confidence            3  334789999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-32  Score=271.61  Aligned_cols=165  Identities=30%  Similarity=0.511  Sum_probs=146.5

Q ss_pred             CCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +...+.||+|.||.||.|.++....||||.++.. ....++|.+|+++|++++|++||+++|+|..++.+|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4456899999999999999987779999999765 334578999999999999999999999999988999999999999


Q ss_pred             Chhhhhhc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          510 SLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       510 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      +|.++|+. .+..+...+.+.++.|||+||+||+   ++.+|||||.++||||+++..+||+|||+|| ...++++....
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr-~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLAR-LIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccc-ccCCCceeecC
Confidence            99999997 4557888889999999999999999   9999999999999999999999999999999 44445555556


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      +..-+..|.||
T Consensus       363 ~~kfPIkWtAP  373 (468)
T KOG0197|consen  363 GGKFPIKWTAP  373 (468)
T ss_pred             CCCCCceecCH
Confidence            66678899998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.8e-33  Score=256.57  Aligned_cols=168  Identities=26%  Similarity=0.384  Sum_probs=141.8

Q ss_pred             CCCcCceecccccceEEEEE-ecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEE-EEEcCCe-eeEEE
Q 042902          429 GFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIIS-SCSNDDF-KALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~  503 (599)
                      .|.+.++||+|.||.|||+. ..+|..||.|.+.-.  ......+...|+.+|+.++|||||++++ -+.++.+ .+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46677899999999999997 458999999998633  3345667899999999999999999998 4445554 89999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      |||++|+|..+++.   .+..+++..++++..|+++||.++|.-+ +.  |+||||||.||+++.+|.||++|||+++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999998853   4457899999999999999999999322 45  999999999999999999999999999987


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ....+.+|||.||+|
T Consensus       179 ~s~~--tfA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSP  197 (375)
T ss_pred             cchh--HHHHhhcCCCcccCH
Confidence            5432  234568999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=270.37  Aligned_cols=165  Identities=27%  Similarity=0.435  Sum_probs=146.8

Q ss_pred             hCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHH--HHHHHHHhcCC-CCcceeEEEEEEcCC-eeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSF--DIECDMMKRIR-HRNLIKIISSCSNDD-FKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l  501 (599)
                      .++|...+.+|.|.||.||+|+ .++|..||||+++.+... +++.  ++|++.|+++. |||||++.+++.+.+ ..|+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3568888999999999999998 457999999999876543 3332  66999999998 999999999999888 9999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |||||+. +|+++++++...+++..+..|+.||++||+|+|   .+|++|||+||+|||+.....+||+|||+||.+...
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999966 999999999889999999999999999999999   999999999999999998889999999999977543


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .   ..+..+.|.+|.||
T Consensus       164 p---PYTeYVSTRWYRAP  178 (538)
T KOG0661|consen  164 P---PYTEYVSTRWYRAP  178 (538)
T ss_pred             C---Ccchhhhcccccch
Confidence            3   44678899999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-31  Score=243.62  Aligned_cols=163  Identities=31%  Similarity=0.415  Sum_probs=145.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.+|.|+||+|..++.+ +|..+|+|+++++..   ...+...+|..+++.+.||+++++++.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45778899999999999999866 588999999976642   34556788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||++||.|..+++..++ ++...+.-+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.....  
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            99999999999987654 788888889999999999999   999999999999999999999999999999976422  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .-..+|||.|+||
T Consensus       198 ---T~TlCGTPeYLAP  210 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAP  210 (355)
T ss_pred             ---EEEecCCccccCh
Confidence               2347899999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=268.61  Aligned_cols=173  Identities=27%  Similarity=0.460  Sum_probs=150.0

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      .++....+.+.....||+|+||+||+|+|.  ..||||++....  .+..++|.+|+.++++-+|.||+-+.|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444455556677889999999999999996  579999997653  4467899999999999999999999999998877


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                       .||+.+|+|.+|+.++|..+..++......||+|||+||.|||   .++|||||||+.||++++++.|||+|||+|..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             9999999999999999998888999999999999999999999   999999999999999999999999999999754


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .............|..-||||
T Consensus       539 ~~w~g~~q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAP  559 (678)
T ss_pred             eeeccccccCCCccchhhhcH
Confidence            333323333455688889998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=253.31  Aligned_cols=169  Identities=34%  Similarity=0.498  Sum_probs=144.9

Q ss_pred             CCCCcCceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--eeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--FKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  504 (599)
                      .+|...+.||+|+||.||.+...+ |...|||..........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            346677899999999999998764 8999999987653333677899999999999999999999855544  6899999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCccCCc-CC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLK-ED  582 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~~~~~-~~  582 (599)
                      |+++|+|.+++...+..+++..+..+++||++||+|||   +++||||||||+|||++. ++.+||+|||+|+.... ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999887656899999999999999999999   999999999999999999 79999999999987653 11


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .........||+.||||
T Consensus       174 ~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAP  190 (313)
T ss_pred             cccccccccCCccccCc
Confidence            12233467899999999

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=8.8e-31  Score=247.23  Aligned_cols=166  Identities=26%  Similarity=0.346  Sum_probs=144.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  502 (599)
                      +.|+..+.|++|.||.||+|+++ +++.||+|+++...  .+..-.-.+||.++.+++|||||.+-.+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777889999999999999976 68899999997543  3334456889999999999999999887754  4589999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||||+. +|...++..+..+...++..++.|+++|++|||   ...|+|||||++|+|+...|.+||+|||+||.+...-
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999987 999999988878999999999999999999999   8889999999999999999999999999999886543


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      +  ..+..+-|.+|.||
T Consensus       232 k--~~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  232 K--PYTPLVVTLWYRAP  246 (419)
T ss_pred             c--cCcceEEEeeecCH
Confidence            2  45677889999998

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.2e-30  Score=275.50  Aligned_cols=168  Identities=30%  Similarity=0.515  Sum_probs=148.0

Q ss_pred             CCCcCceecccccceEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      +....+.||+|+||+||+|+..      +.+.||||.++..... ..++|++|+++++.++|||||+++|+|..++..|+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4455688999999999999743      4567999999876554 77899999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC-------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          502 VLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                      |+|||..|||.++|+...             ..++..+.+.||.|||.||+||-   +..+|||||.++|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999997432             12778889999999999999999   88999999999999999999999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||++|.+...+.+.......-+.+||||
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCH
Confidence            9999999998877776655455668899998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=4.3e-33  Score=268.34  Aligned_cols=337  Identities=30%  Similarity=0.462  Sum_probs=189.3

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCccccc--------------
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLS--------------   67 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~--------------   67 (599)
                      +.++|+++ .+|+.+.++.++..|+.+.|.+.. .|+.++.+-.|+.|+..+|++++++++..+..              
T Consensus        97 ~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~  174 (565)
T KOG0472|consen   97 NVSHNKLS-ELPEQIGSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKA  174 (565)
T ss_pred             hcccchHh-hccHHHhhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhh
Confidence            44555555 445555566666666666666654 34445555566666666666665555311000              


Q ss_pred             ---ccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccC
Q 042902           68 ---SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDK  144 (599)
Q Consensus        68 ---~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  144 (599)
                         ..-+++.|++||.-.|.++ .+|..++.+. +++.|++..|.|.. .| .|.++..|.+|+++.|+|+.++.+..++
T Consensus       175 l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~-~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~  250 (565)
T KOG0472|consen  175 LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLE-SLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKH  250 (565)
T ss_pred             CCHHHHHHHHHHhcccchhhhh-cCChhhcchh-hhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcc
Confidence               0112344444444444443 3444444444 35555555555552 23 4555555555555555555333333446


Q ss_pred             CCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCC----------------
Q 042902          145 LQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS----------------  208 (599)
Q Consensus       145 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------------  208 (599)
                      +++|..|||.+|+++ ..|+.++-+.+|+.||+|+|.|++ .|..++++ .|+.|-+.+|.+.+                
T Consensus       251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY  327 (565)
T ss_pred             cccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence            666666666666666 456666666666666666666664 34445555 55555555554221                


Q ss_pred             -------------------------------------------------CCccccCCCc---ccEEeecCCCcc------
Q 042902          209 -------------------------------------------------IPSTLWNLKY---ILYLNLSSNSFT------  230 (599)
Q Consensus       209 -------------------------------------------------ip~~~~~l~~---L~~L~Ls~N~l~------  230 (599)
                                                                       +|+..|....   ....+++.|++.      
T Consensus       328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L  407 (565)
T KOG0472|consen  328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRL  407 (565)
T ss_pred             HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhh
Confidence                                                             1111110000   122333333332      


Q ss_pred             -----------------ccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCccc
Q 042902          231 -----------------GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKS  293 (599)
Q Consensus       231 -----------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  293 (599)
                                       +.+|..++.+++|..|+|++|.+. .+|..++.+..|+.|++|.|++. ..|.....+..|+.
T Consensus       408 ~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEt  485 (565)
T KOG0472|consen  408 VELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLET  485 (565)
T ss_pred             HHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHH
Confidence                             123334445566666666666665 34556666666666666666665 45555555555555


Q ss_pred             ccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCC
Q 042902          294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELL  349 (599)
Q Consensus       294 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  349 (599)
                      +-.++|++....|..+.+|.+|+.|||.+|.+...+|..+...++....+.|||..
T Consensus       486 llas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  486 LLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            55566666656666688899999999999999888888888888888888898754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=258.90  Aligned_cols=170  Identities=32%  Similarity=0.496  Sum_probs=148.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  500 (599)
                      ...+|...+.||+|+|++||+|+.. +++++|||++.++.   +...+....|..+|.++ .||.|++|+..++++...|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            4467888999999999999999854 69999999997653   44566778899999999 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +|+||+++|+|.++++..+. +++..+..++.+|+.|++|||   +.|||||||||+|||+|+||.+||+|||.|+.+.+
T Consensus       151 FvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            99999999999999988754 788888889999999999999   99999999999999999999999999999998754


Q ss_pred             CCCc---------ee--eecccCCccccCC
Q 042902          581 EDQS---------LT--QTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~---------~~--~~~~~gt~~y~AP  599 (599)
                      ....         ..  ..+.+||..|.+|
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCH
Confidence            3221         11  1458999999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=8e-33  Score=266.49  Aligned_cols=309  Identities=29%  Similarity=0.455  Sum_probs=259.3

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+..+|+++ ..|+.++++.++..|++.+|+++...|..+. ++.|++||..+|-++.+|++      ++++.+|.-|||
T Consensus       142 l~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~------lg~l~~L~~LyL  213 (565)
T KOG0472|consen  142 LDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPE------LGGLESLELLYL  213 (565)
T ss_pred             hhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChh------hcchhhhHHHHh
Confidence            356678888 6688888999999999999999986666555 99999999999999999986      899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      .+|+|. ..| .|.+.+ .+..+++..|.|+....+...++++|..|||..|+++ ..|+...-+.+|+.||+|+|.|+ 
T Consensus       214 ~~Nki~-~lP-ef~gcs-~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-  288 (565)
T KOG0472|consen  214 RRNKIR-FLP-EFPGCS-LLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-  288 (565)
T ss_pred             hhcccc-cCC-CCCccH-HHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-
Confidence            999998 455 788886 6999999999998555555669999999999999999 56778899999999999999999 


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCC--------------------------------------CCcccCC----------
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGF--------------------------------------VPACFGN----------  192 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~--------------------------------------~~~~~~~----------  192 (599)
                      ..|..++++ +|+.|-+.+|.+..+                                      .+..|..          
T Consensus       289 ~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL  367 (565)
T KOG0472|consen  289 SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKIL  367 (565)
T ss_pred             cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhh
Confidence            567788888 899999988876421                                      0000100          


Q ss_pred             ------C----------C---CCcEeecCCCCCCCCC------------------------ccccCCCcccEEeecCCCc
Q 042902          193 ------L----------T---SLRNLYLGSNQLTSIP------------------------STLWNLKYILYLNLSSNSF  229 (599)
Q Consensus       193 ------l----------~---~L~~L~L~~N~l~~ip------------------------~~~~~l~~L~~L~Ls~N~l  229 (599)
                            +          .   -....+++.|++.++|                        ..++.+++|..|+|++|-+
T Consensus       368 ~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~L  447 (565)
T KOG0472|consen  368 DVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLL  447 (565)
T ss_pred             cccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchh
Confidence                  0          0   0234555666655554                        4456788999999999999


Q ss_pred             cccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchh
Q 042902          230 TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISL  309 (599)
Q Consensus       230 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  309 (599)
                      . .+|.+++.+..|+.||+|.|++. ..|.....+..|+.+-.++|++..+.|+.+.+|.+|..|||.+|.+. .+|..+
T Consensus       448 n-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~L  524 (565)
T KOG0472|consen  448 N-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPIL  524 (565)
T ss_pred             h-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhh
Confidence            8 68899999999999999999998 67888888888999999999999888888999999999999999998 788999


Q ss_pred             hccccceEEEcccccCc
Q 042902          310 EKLLDLKYINVSFNKLE  326 (599)
Q Consensus       310 ~~l~~L~~l~l~~N~l~  326 (599)
                      +++++|+.|++++|++.
T Consensus       525 gnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  525 GNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccceeEEEecCCccC
Confidence            99999999999999997

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-30  Score=249.61  Aligned_cols=166  Identities=30%  Similarity=0.472  Sum_probs=140.2

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCcceeEEEEEEcCC----eeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR--IRHRNLIKIISSCSNDD----FKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l  501 (599)
                      .+....+.||+|+||.||+|+|+ |..||||++....+   +.+.+|.++++.  ++|+||..+++.-..++    ..||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            45667789999999999999998 99999999976544   456678888776  59999999998865443    6899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-----GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-----~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      |++|.|.|||+++|.+.  .++....++++..+|.||+|||.     ..++.|.|||||+.||||..++.+.|+|+|+|.
T Consensus       287 vTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             eeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999999874  48888999999999999999993     247899999999999999999999999999998


Q ss_pred             cCCcCCC--ceeeecccCCccccCC
Q 042902          577 PLLKEDQ--SLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~--~~~~~~~~gt~~y~AP  599 (599)
                      .......  .......+||-+||||
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAP  389 (513)
T ss_pred             EecccCCcccCCCCCccceeeccCh
Confidence            6643321  1233567899999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=1.7e-30  Score=260.12  Aligned_cols=165  Identities=32%  Similarity=0.444  Sum_probs=147.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|...+.||+|.||.||||+.+ +.+.||+|.+.+..  +...+...+|++++++++|||||.++++|++..+.|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778889999999999999865 68999999997553  4456779999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+.| +|..++...+ .+++..+..|+.+++.||.|||   +.+|+|||+||.|||++..|.+|++|||+||.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 9999997755 4888899999999999999999   99999999999999999999999999999997643  23


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      ...+...|||-||||
T Consensus       155 ~vltsikGtPlYmAP  169 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAP  169 (808)
T ss_pred             eeeeeccCcccccCH
Confidence            455788999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-30  Score=259.37  Aligned_cols=165  Identities=30%  Similarity=0.446  Sum_probs=148.8

Q ss_pred             CCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ..|+....||+|+.|.||.|+ ..+++.||||++..+.....+-..+|+.+|+..+|+|||.++..|...++.|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457778899999999999997 4578999999998887777788999999999999999999999998889999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +||+|.+.+....  +++.++..|++++++||+|||   ..+|+|||||++|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999886654  889999999999999999999   99999999999999999999999999999997754432  3


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+|||.||||
T Consensus       426 R~TmVGTPYWMAP  438 (550)
T KOG0578|consen  426 RSTMVGTPYWMAP  438 (550)
T ss_pred             cccccCCCCccch
Confidence            4567899999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=257.44  Aligned_cols=168  Identities=27%  Similarity=0.381  Sum_probs=145.6

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc----cc-ccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ----YE-GAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  498 (599)
                      ....|...+.||+|+||+||.|... +|..||||++..+    .. ...+...+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4567889999999999999999865 6899999987653    11 23445667999999999 9999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCcc
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKP  577 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~  577 (599)
                      .++||||+.||+|.+++.. ...+.+..+..+++|+++|++|+|   +.+|+||||||+|||+|.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 445788899999999999999999   9999999999999999999 9999999999996


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..  .........+||+.|+||
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCH
Confidence            63  111233457899999999

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=3.9e-30  Score=247.86  Aligned_cols=165  Identities=25%  Similarity=0.375  Sum_probs=146.4

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .+|+..+.+|+|.||.|-+|.. ..|+.||||.+++.   .+++.-.+.+||++|+.++||||++++.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3566778999999999999985 57999999998654   4556677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||..+|.|++++.+++. +++.++..+++||.+|+.|+|   ..+++|||||.+|||+|.++++||+|||++-.+.... 
T Consensus       133 EYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-  207 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-  207 (668)
T ss_pred             EecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence            99999999999988765 788889999999999999999   9999999999999999999999999999998765332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        -....+|+|-|.+|
T Consensus       208 --fLqTFCGSPLYASP  221 (668)
T KOG0611|consen  208 --FLQTFCGSPLYASP  221 (668)
T ss_pred             --HHHHhcCCcccCCc
Confidence              23457899999887

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=248.46  Aligned_cols=172  Identities=30%  Similarity=0.416  Sum_probs=141.3

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---------c-----cHHHHHHHHHHHhcCCCCccee
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---------G-----AFKSFDIECDMMKRIRHRNLIK  488 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~-----~~~~~~~e~~~l~~l~h~niv~  488 (599)
                      ....++|+..+.||+|.||.|-+|+.. +++.||||++.+...         .     -.+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344578999999999999999999865 799999999964311         1     1347888999999999999999


Q ss_pred             EEEEEEcC--CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc
Q 042902          489 IISSCSND--DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  566 (599)
Q Consensus       489 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~  566 (599)
                      |+.+..+.  +..|||+|||..|.+...=.. +..++..++.+|.++++.||+|||   ..+||||||||+|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            99998765  588999999999988643222 223788899999999999999999   999999999999999999999


Q ss_pred             EEEccccCCccCCcC---CCceeeecccCCccccCC
Q 042902          567 AHLSDFGMAKPLLKE---DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       567 ~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~AP  599 (599)
                      +||+|||.+......   +........+|||.||||
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            999999998755222   112223457899999999

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=265.66  Aligned_cols=166  Identities=27%  Similarity=0.480  Sum_probs=145.3

Q ss_pred             CcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          431 SENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .+.++||.|.||.||+|+++-    ...||||.++..+ ++...+|+.|+.||.+++||||++|.|+.......+||+||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            456899999999999999762    4579999998775 45677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC-Cc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED-QS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~-~~  584 (599)
                      |++|+|+.+|+...+.+.+.+.+.+.++||.||.||.   ..++|||||.++|||++.+..+|++|||++|.+.++. ..
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            9999999999998888999999999999999999999   8899999999999999999999999999999765433 22


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .+..+..-+.+|.||
T Consensus       789 ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAP  803 (996)
T ss_pred             ccccCCccceeecCh
Confidence            222333346789998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-29  Score=243.32  Aligned_cols=170  Identities=29%  Similarity=0.423  Sum_probs=147.8

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .+.|+....||.|..++||+|+. ..+..||||++.... ......+.+|+..|+.++||||++++..|..++..|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45688889999999999999985 468999999997653 3346889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||.+|++.+.++..-. .+++..+..|.+++++||.|||   ..|.||||||+.|||++++|.+||+|||.+..+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999876432 4888889999999999999999   99999999999999999999999999998876655442


Q ss_pred             -ceee-ecccCCccccCC
Q 042902          584 -SLTQ-TQTLATIGYMAP  599 (599)
Q Consensus       584 -~~~~-~~~~gt~~y~AP  599 (599)
                       .... ...+|||.||||
T Consensus       182 R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             eeeEeeccccCcccccCh
Confidence             1122 456899999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=6.9e-29  Score=248.80  Aligned_cols=148  Identities=25%  Similarity=0.414  Sum_probs=135.0

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..++|+....||+|+||.||.|+.+ +|..+|+|++++..   ....+....|-.+|...++|.||+++..+++.++.||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3578999999999999999999865 69999999997652   4456788899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ||||++||++..+|...+ .+++..+..++.+++-|+..+|   ..|+|||||||+|+|||..|.+|++|||++.-
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999998766 4778888889999999999999   99999999999999999999999999999853

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=256.79  Aligned_cols=171  Identities=27%  Similarity=0.414  Sum_probs=144.5

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEecC--C--cE-EEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQD--G--IE-VAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCS  494 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  494 (599)
                      ++-..++....+.||+|+||.||+|++..  +  .. ||||..+..   .....++|++|+++|+.++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33345555666899999999999998763  2  23 899998752   3556789999999999999999999999999


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      .....++|||+|+||+|.++|+..+..++..++..++.+.|+||+|||   +.++|||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999999999988777999999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCcCCCceeee-cccCCccccCC
Q 042902          575 AKPLLKEDQSLTQT-QTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~-~~~gt~~y~AP  599 (599)
                      ++.-.   .+.... .-.-+.+|+||
T Consensus       309 s~~~~---~~~~~~~~~klPirWLAP  331 (474)
T KOG0194|consen  309 SRAGS---QYVMKKFLKKLPIRWLAP  331 (474)
T ss_pred             ccCCc---ceeeccccccCcceecCh
Confidence            88432   111111 22356789998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=252.11  Aligned_cols=168  Identities=27%  Similarity=0.466  Sum_probs=149.9

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .....++||+|.||.|..|....+..||||.++.... ....+|..|+++|.+++|||||+++|+|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            3456689999999999999998889999999987654 345899999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCc-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|+|.+++...... .+.....+|+.|||+||+||.   +..+||||+.++|+|+|.++++||+|||++|.+..++.+..
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999999876432 344556789999999999999   89999999999999999999999999999998888887777


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+-+.+||||
T Consensus       696 qgr~vlpiRwmaw  708 (807)
T KOG1094|consen  696 QGRAVLPIRWMAW  708 (807)
T ss_pred             ecceeeeeeehhH
Confidence            7777888999996

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=8e-29  Score=238.69  Aligned_cols=166  Identities=31%  Similarity=0.439  Sum_probs=141.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCc-ceeEEEEEEcCC------
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRN-LIKIISSCSNDD------  497 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  497 (599)
                      ..|+..+.||+|+||+||+|+.. +|+.||+|+++...+  +....-.+|+.++++++|+| ||.+++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666778999999999999855 799999999976643  34456688999999999999 999999998877      


Q ss_pred             eeeEEEEccCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ..++|+||++. +|.+++....   ...+...+..+++||++||+|||   +.+|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            78999999965 9999998755   34777788999999999999999   99999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+.+.-...  ..+..++|.+|.||
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaP  189 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAP  189 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCH
Confidence            996653322  24567889999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=3.4e-29  Score=240.69  Aligned_cols=160  Identities=31%  Similarity=0.489  Sum_probs=131.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----eeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  502 (599)
                      .|...+++|.|+||.||+|... +++.||||+.....+-    -..|.++|++++|||||++..++....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5677799999999999999965 5799999998644321    235899999999999999998876432     34589


Q ss_pred             EEccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCccC
Q 042902          503 LEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPL  578 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~~  578 (599)
                      |||||. +|.+.++..   +..++...+.-+++||.+||.|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 999888742   334666677789999999999999   8999999999999999955 99999999999987


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..++.   ..+...|..|.||
T Consensus       177 ~~~ep---niSYicSRyYRaP  194 (364)
T KOG0658|consen  177 VKGEP---NISYICSRYYRAP  194 (364)
T ss_pred             ccCCC---ceeEEEeccccCH
Confidence            65443   2456788899998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=4e-28  Score=249.63  Aligned_cols=170  Identities=24%  Similarity=0.419  Sum_probs=139.1

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC-
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD-  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  497 (599)
                      .++|...+.||+|+||.||+|.+      .++..||||++.... ....+.+..|++++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788899999999999999974      235689999986543 23356799999999999 8999999999887654 


Q ss_pred             eeeEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  519 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  519 (599)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999999886431                                                          


Q ss_pred             ---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccc
Q 042902          520 ---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY  596 (599)
Q Consensus       520 ---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  596 (599)
                         ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               13667788899999999999999   899999999999999999999999999999865433322222334567889


Q ss_pred             cCC
Q 042902          597 MAP  599 (599)
Q Consensus       597 ~AP  599 (599)
                      |||
T Consensus       243 ~aP  245 (338)
T cd05102         243 MAP  245 (338)
T ss_pred             cCc
Confidence            998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-29  Score=252.05  Aligned_cols=161  Identities=29%  Similarity=0.374  Sum_probs=142.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      -|...+.||.|+||.||-|+.. +.+.||||++.-.   ....+.++..|++.+.+++|||+|.+-|+|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4677789999999999999854 6789999999643   34457789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      || -|+..+++.-.+..+.+..+..|+.+.++||+|||   +.+.||||||+.|||+++.|.||++|||.|..+.+    
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            99 56888888776667888888999999999999999   89999999999999999999999999999986543    


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        ..+.+|||.||||
T Consensus       179 --AnsFvGTPywMAP  191 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAP  191 (948)
T ss_pred             --hhcccCCccccch
Confidence              3457899999999

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.95  E-value=7.5e-28  Score=249.91  Aligned_cols=147  Identities=24%  Similarity=0.386  Sum_probs=132.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++...   ......+..|+.++.+++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 58999999996532   233457888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999987654 4788899999999999999999   899999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=9.2e-28  Score=243.18  Aligned_cols=169  Identities=26%  Similarity=0.459  Sum_probs=140.9

Q ss_pred             CCCCcCceecccccceEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-----------------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI  489 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  489 (599)
                      ++|...+.||+|+||.||+|.+++                 +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999997532                 3479999987543 3345679999999999999999999


Q ss_pred             EEEEEcCCeeeEEEEccCCCChhhhhhcCC------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 042902          490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIH  551 (599)
Q Consensus       490 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH  551 (599)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++..+.+++.||+.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999885421                  13677788999999999999999   889999


Q ss_pred             ccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       552 ~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||||+||+++.++.+||+|||+++.+.............+++.||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            999999999999999999999999866443332222334567889998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=268.07  Aligned_cols=169  Identities=29%  Similarity=0.498  Sum_probs=148.2

Q ss_pred             CCCCcCceecccccceEEEEEecC--Cc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD--GI----EVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ...+..+.||+|+||.||+|...+  |.    .||||.++.. ..+...+|.+|..+|++++|||||+++|+|.+...++
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            344566889999999999998653  43    4899998755 4556789999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcC------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          501 LVLEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      |++|||+||+|..+|++.      ...+...+.+.++.|||+|+.||+   ++++|||||.++|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999987      557888999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||.+...+.+.......-+.+||||
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCH
Confidence            9987766665554444567899998

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=249.67  Aligned_cols=166  Identities=23%  Similarity=0.338  Sum_probs=145.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|...+++|+|.||+|+.+..+ +++.+|||++++.   ..+..+..+.|.+++.... ||.+++++.++++.++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467889999999999999999976 5889999999876   3567788999999988775 9999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+.||++..+.+.  ..+++..+.-||..|+.||.|||   .++||+||||.+|||+|.+|.+||+|||+++.-...
T Consensus       447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999996554443  35888889999999999999999   999999999999999999999999999999965422


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                        .......+|||.||||
T Consensus       522 --g~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  522 --GDRTSTFCGTPEFLAP  537 (694)
T ss_pred             --CCccccccCChhhcCh
Confidence              2244668999999999

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=6.6e-28  Score=250.31  Aligned_cols=168  Identities=24%  Similarity=0.349  Sum_probs=144.3

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999976 5889999998643   22334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998754  3788888899999999999999   899999999999999999999999999999865432


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .. .......||+.||||
T Consensus       196 ~~-~~~~~~~gt~~Y~aP  212 (370)
T cd05621         196 GM-VRCDTAVGTPDYISP  212 (370)
T ss_pred             Cc-eecccCCCCcccCCH
Confidence            21 122356799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.2e-28  Score=249.57  Aligned_cols=147  Identities=24%  Similarity=0.411  Sum_probs=132.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999976 68999999996432   234456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654 4788899999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.2e-28  Score=222.92  Aligned_cols=166  Identities=27%  Similarity=0.391  Sum_probs=144.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..+.+|+|.||.||.|+.+ ++-.||+|++.+.   ..+...++.+|+++-+.++||||.++++++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            457889999999999999999865 5788999998543   234456889999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          503 LEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      +||.+.|++...|++... .++......++.|+|.|+.|+|   .+.||||||||+|+|++..+..||+|||-+..-.. 
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence            999999999999985443 4788888899999999999999   99999999999999999999999999999875431 


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                         ......+||.-|.||
T Consensus       177 ---~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPP  191 (281)
T ss_pred             ---CCceeeecccccCCH
Confidence               123446899999998

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-30  Score=270.58  Aligned_cols=331  Identities=31%  Similarity=0.415  Sum_probs=226.4

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |||++|+++ ..|..+..+.+|+.|++++|.|.. .|.+..++.+|++|.|.+|++..+|.      .+..+++|++||+
T Consensus        50 l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~~lP~------~~~~lknl~~Ldl  121 (1081)
T KOG0618|consen   50 LDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYLNLKNNRLQSLPA------SISELKNLQYLDL  121 (1081)
T ss_pred             eeccccccc-cCCchhhhHHHHhhcccchhhHhh-CchhhhhhhcchhheeccchhhcCch------hHHhhhccccccc
Confidence            567766666 667777777777777777777775 45677777777777777777777665      3667777777777


Q ss_pred             ccCcccccCChhhhcccc---------------------------------------cce-EEEccCCcccccCCccccC
Q 042902           81 SNNSLDGILPRAIGNLSQ---------------------------------------SME-VFFMFNCNISGSIPEEISN  120 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~---------------------------------------~l~-~l~l~~n~i~~~~~~~~~~  120 (599)
                      |.|++.. .|..+..+..                                       .++ .+++.+|.+...   .+.+
T Consensus       122 S~N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~---dls~  197 (1081)
T KOG0618|consen  122 SFNHFGP-IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVL---DLSN  197 (1081)
T ss_pred             chhccCC-CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhh---hhhh
Confidence            7777653 2222211110                                       011 244455544411   1112


Q ss_pred             CCCC--------------------CEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCC
Q 042902          121 LTNL--------------------TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN  180 (599)
Q Consensus       121 l~~L--------------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  180 (599)
                      +++|                    +.|+.++|.+....+ . .--.+|+++++++|+++. .|++++.+.+|+.++..+|
T Consensus       198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N  274 (1081)
T KOG0618|consen  198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHN  274 (1081)
T ss_pred             ccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-c-cccccceeeecchhhhhc-chHHHHhcccceEecccch
Confidence            2222                    222222222221100 0 011345555555555552 3355555566665555555


Q ss_pred             ccCC----------------------CCCcccCCCCCCcEeecCCCCCCCCCcccc------------------------
Q 042902          181 KLSG----------------------FVPACFGNLTSLRNLYLGSNQLTSIPSTLW------------------------  214 (599)
Q Consensus       181 ~l~~----------------------~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~------------------------  214 (599)
                      .++.                      -+|....++++|++|+|..|+|.++|+.+.                        
T Consensus       275 ~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~  354 (1081)
T KOG0618|consen  275 RLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE  354 (1081)
T ss_pred             hHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc
Confidence            5532                      234555667888888888888888775431                        


Q ss_pred             --CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcc
Q 042902          215 --NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK  292 (599)
Q Consensus       215 --~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  292 (599)
                        ..+.|+.|++.+|.+++..-..+.+..+|+.|+|++|+|..++...+.+++.|++|+||+|+|+ .+|+.+..+..|+
T Consensus       355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~  433 (1081)
T KOG0618|consen  355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH  433 (1081)
T ss_pred             chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence              1334677888888888887788889999999999999999887788999999999999999999 7789999999999


Q ss_pred             cccCCCCcccccCCchhhccccceEEEcccccCccc-CCCCCCCCCcccccccCCCCC
Q 042902          293 SLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGE-IPREGPFRNFSAESFKGNELL  349 (599)
Q Consensus       293 ~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~~~~~~~~~~~~n~~~  349 (599)
                      +|...+|++. ..| .+.+++.|+++|+|.|+|+.. +|...+++++...++.||.+.
T Consensus       434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            9999999999 778 899999999999999999754 355567788889999999863

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=1.7e-27  Score=243.12  Aligned_cols=160  Identities=26%  Similarity=0.357  Sum_probs=137.8

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|+.. +|+.||||+++...   ......+..|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999987542   234467888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeec
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                      +|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.......  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence            9999887644 4788888999999999999999   89999999999999999999999999999985432221  2234


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05571         155 FCGTPEYLAP  164 (323)
T ss_pred             eecCccccCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-27  Score=248.70  Aligned_cols=147  Identities=23%  Similarity=0.373  Sum_probs=130.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +|+.||||++....   ....+.+..|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999865 68999999986432   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999987643 4778888889999999999999   899999999999999999999999999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=243.65  Aligned_cols=168  Identities=24%  Similarity=0.358  Sum_probs=144.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||++...   .....+.|..|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999965 5899999998643   2234466889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999765556888889999999999999999   99999999999999999999999999999976543322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05597         158 -VQSNVAVGTPDYISP  172 (331)
T ss_pred             -ccccceeccccccCH
Confidence             122234699999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=2.1e-27  Score=248.13  Aligned_cols=145  Identities=22%  Similarity=0.336  Sum_probs=130.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|...+.||+|+||+||+|+.. +++.||||++....   ....+.+..|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999865 68899999996542   2345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      |+++|+|.+++.... .+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999987654 4778888889999999999999   89999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=2.3e-27  Score=243.05  Aligned_cols=168  Identities=21%  Similarity=0.322  Sum_probs=144.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+++.. +++.||+|++...   .......+..|+.++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999876 5889999998643   2233456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++......+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875556888888999999999999999   99999999999999999999999999999986643322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05624         158 -VQSSVAVGTPDYISP  172 (331)
T ss_pred             -eeeccccCCcccCCH
Confidence             122335799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=1.6e-27  Score=244.72  Aligned_cols=164  Identities=25%  Similarity=0.330  Sum_probs=142.0

Q ss_pred             hCCCCcCceecccccceEEEEEecC--CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD--GIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|.+..  +..||+|.+...   .....+.+..|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3468889999999999999998653  368999998643   23345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 4788888999999999999999   899999999999999999999999999999865321


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                           .....||+.||||
T Consensus       185 -----~~~~~gt~~y~aP  197 (340)
T PTZ00426        185 -----TYTLCGTPEYIAP  197 (340)
T ss_pred             -----cceecCChhhcCH
Confidence                 1235799999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=2.9e-27  Score=237.15  Aligned_cols=165  Identities=26%  Similarity=0.397  Sum_probs=141.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||.||+|... +|+.||||.+....   ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999864 79999999986432   2233567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|+...... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999988876433 35788899999999999999999   8999999999999999999999999999998653222 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       157 --~~~~~~g~~~y~aP  170 (285)
T cd05631         157 --TVRGRVGTVGYMAP  170 (285)
T ss_pred             --eecCCCCCCCccCH
Confidence              22345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2e-27  Score=243.95  Aligned_cols=163  Identities=27%  Similarity=0.456  Sum_probs=143.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|++++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 58999999996542   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 4788888999999999999999   89999999999999999999999999999986532   


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       154 --~~~~~~gt~~y~aP  167 (333)
T cd05600         154 --YANSVVGSPDYMAP  167 (333)
T ss_pred             --ccCCcccCccccCh
Confidence              22345799999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=1.6e-27  Score=243.95  Aligned_cols=163  Identities=25%  Similarity=0.354  Sum_probs=142.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++...   ....+.+..|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999976 58999999986542   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999987654 4678888889999999999999   8999999999999999999999999999998653221 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                          ....||+.||||
T Consensus       173 ----~~~~gt~~y~aP  184 (329)
T PTZ00263        173 ----FTLCGTPEYLAP  184 (329)
T ss_pred             ----ceecCChhhcCH
Confidence                235689999998

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=2.6e-27  Score=242.80  Aligned_cols=168  Identities=26%  Similarity=0.363  Sum_probs=146.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999865 68999999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++......+++..+..++.||++||.|+|   +.+|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876556889999999999999999999   89999999999999999999999999999986643322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (330)
T cd05601         158 -VNSKLPVGTPDYIAP  172 (330)
T ss_pred             -eeeecccCCccccCH
Confidence             222345789999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=2.9e-27  Score=241.46  Aligned_cols=160  Identities=26%  Similarity=0.357  Sum_probs=137.5

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999996542   234567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeec
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                      +|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            9998886654 4788899999999999999999   89999999999999999999999999999875432221  2234


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05595         155 FCGTPEYLAP  164 (323)
T ss_pred             ccCCcCcCCc
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=3.1e-27  Score=237.33  Aligned_cols=166  Identities=27%  Similarity=0.442  Sum_probs=142.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999875 68999999986543 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++ +|.+++......+++..+..++.||++||+|||   +.+|+||||||+||++++++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            975 999988766656788889999999999999999   89999999999999999999999999999975432221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+|+.||||
T Consensus       159 ~~~~~~~~~~y~aP  172 (288)
T cd07871         159 TYSNEVVTLWYRPP  172 (288)
T ss_pred             cccCceecccccCh
Confidence            22345688999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=4e-27  Score=240.82  Aligned_cols=160  Identities=28%  Similarity=0.366  Sum_probs=137.9

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|+.. +|+.||||++...   .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 6899999999654   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeec
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                      +|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9998886643 4788899999999999999999   8999999999999999999999999999998543221  12234


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..||+.||||
T Consensus       155 ~~gt~~y~aP  164 (328)
T cd05593         155 FCGTPEYLAP  164 (328)
T ss_pred             ccCCcCccCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=240.01  Aligned_cols=163  Identities=29%  Similarity=0.393  Sum_probs=142.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999876 68999999986432   234467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999987654 4788888999999999999999   899999999999999999999999999999865322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....||+.|+||
T Consensus       155 ---~~~~~gt~~y~aP  167 (291)
T cd05612         155 ---TWTLCGTPEYLAP  167 (291)
T ss_pred             ---cccccCChhhcCH
Confidence               1234689999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=2.6e-27  Score=246.11  Aligned_cols=170  Identities=25%  Similarity=0.350  Sum_probs=145.3

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      ....++|+..+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            334578999999999999999999976 5889999998643   223345688899999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++|+|.+++....  ++...+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            99999999999999987643  677888889999999999999   9999999999999999999999999999998664


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .... .......||+.||||
T Consensus       194 ~~~~-~~~~~~~gt~~y~aP  212 (371)
T cd05622         194 KEGM-VRCDTAVGTPDYISP  212 (371)
T ss_pred             cCCc-ccccCcccCccccCH
Confidence            3221 122346799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=3.7e-27  Score=246.07  Aligned_cols=145  Identities=23%  Similarity=0.354  Sum_probs=129.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||.||+|+.. +++.||||++....   ......+..|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999865 58999999986432   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|..
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999987654 4677788889999999999999   89999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=227.51  Aligned_cols=167  Identities=24%  Similarity=0.448  Sum_probs=143.0

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++.|+..+.||+|+|+.||++.+. +|+.+|+|++...  ...+.+...+|+++.+.++|||||++...+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3467788889999999999999754 7999999998644  344678899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCccCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLL  579 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~~~~  579 (599)
                      +|+|+||+|..-+-.+ ...++..+-.+++||++||.|+|   ..+|||||+||+|+++.+   ..-+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999997665544 34677888899999999999999   999999999999999953   3369999999999876


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +   ...-.+.+|||+||||
T Consensus       165 ~---g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  165 D---GEAWHGFAGTPGYLSP  181 (355)
T ss_pred             C---ccccccccCCCcccCH
Confidence            2   2234678999999998

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=2.6e-27  Score=246.11  Aligned_cols=167  Identities=25%  Similarity=0.365  Sum_probs=142.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457888999999999999999876 6889999998643   223345678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++....  ++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       122 ~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999987643  677778889999999999999   8999999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      . .......||+.||||
T Consensus       197 ~-~~~~~~~gt~~y~aP  212 (370)
T cd05596         197 M-VRCDTAVGTPDYISP  212 (370)
T ss_pred             c-ccCCCCCCCcCeECH
Confidence            1 122345799999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=3.3e-27  Score=246.95  Aligned_cols=145  Identities=23%  Similarity=0.353  Sum_probs=129.9

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|++++++++|||||++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999865 68899999986542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ||++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987654 4677888889999999999999   88999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-27  Score=238.87  Aligned_cols=158  Identities=26%  Similarity=0.326  Sum_probs=136.6

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+..|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 5889999998643   233456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                      .+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987654 4788899999999999999999   8999999999999999999999999999998543222  1223457


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      ||+.||||
T Consensus       155 gt~~y~aP  162 (312)
T cd05585         155 GTPEYLAP  162 (312)
T ss_pred             CCcccCCH
Confidence            99999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=8.2e-27  Score=238.45  Aligned_cols=160  Identities=26%  Similarity=0.355  Sum_probs=136.7

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542   234567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      +|..++.... .+++..+..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+|+.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9998886544 4788899999999999999999   6 6999999999999999999999999999975432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05594         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCcccCCH
Confidence            45699999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=229.86  Aligned_cols=171  Identities=29%  Similarity=0.357  Sum_probs=144.8

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEec--ccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc-----
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFD--LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN-----  495 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----  495 (599)
                      +.....|...+.||+|+||.|+.|... +|+.||||++.  -+.....++-.+|+++++.++|+||+.+...+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344556666789999999999999865 79999999986  3344566788999999999999999999998865     


Q ss_pred             CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      -+..|+|+|+| +.+|.+.++.++. ++......++.|+++||.|+|   +.+|+|||+||+|++++.++..||+|||+|
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            24789999999 5599999987653 777788889999999999999   999999999999999999999999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |...........+..+.|.+|.||
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAP  196 (359)
T ss_pred             eeccccCcccchhcceeeeeecCH
Confidence            977543333345778899999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-27  Score=240.04  Aligned_cols=165  Identities=27%  Similarity=0.400  Sum_probs=145.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  501 (599)
                      ...|+..+.||+|.||.||+|+.. +|+.+|+|.+.+...   ...+...+|+.+|+++. |||||++.+++++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456778899999999999999977 499999999976643   24568999999999998 9999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC----CcEEEccccCCcc
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKP  577 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~----~~~kl~DFGla~~  577 (599)
                      |||+++||.|.+.+...  .+++.++..++.||+.|+.|+|   +.+|+|||+||+|+|+...    +.+|++|||+|..
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999998776  3889999999999999999999   8999999999999999633    4799999999997


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...   .......+|||.|+||
T Consensus       189 ~~~---~~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAP  207 (382)
T ss_pred             ccC---CceEeeecCCccccCc
Confidence            754   2345668999999999

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=6e-27  Score=240.13  Aligned_cols=168  Identities=21%  Similarity=0.333  Sum_probs=144.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+++.. +++.||+|++...   .......|..|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888899999999999999976 4788999998643   1223455888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++......+++..+..++.||+.||+|+|   +.+|+||||||+||+++.++.+||+|||+|+.......
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999875556888888999999999999999   89999999999999999999999999999976543322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (332)
T cd05623         158 -VQSSVAVGTPDYISP  172 (332)
T ss_pred             -ceecccccCccccCH
Confidence             222345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=3.8e-27  Score=245.34  Aligned_cols=170  Identities=24%  Similarity=0.389  Sum_probs=140.4

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|++      .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688889999999999999974      246689999986442 33456789999999999 89999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-----------------------------------------------------------
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-----------------------------------------------------------  519 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  519 (599)
                      .++||||+++|+|.++++...                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          520 ---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       520 ---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                                     ..+++..+.+++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           13677888999999999999999   899999999999999999999999999999866433322


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......++..||||
T Consensus       271 ~~~~~~~~~~~y~aP  285 (375)
T cd05104         271 VVKGNARLPVKWMAP  285 (375)
T ss_pred             cccCCCCCCcceeCh
Confidence            222233456789998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=7.6e-27  Score=236.33  Aligned_cols=167  Identities=28%  Similarity=0.410  Sum_probs=142.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 689999999875432 234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++ +++.+++......+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||+|+......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6888887766556888889999999999999999   8999999999999999999999999999997543221  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.||||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (303)
T cd07869         158 HTYSNEVVTLWYRPP  172 (303)
T ss_pred             ccCCCCcccCCCCCh
Confidence            122345689999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.7e-27  Score=243.49  Aligned_cols=164  Identities=27%  Similarity=0.392  Sum_probs=143.5

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      -|...+.+|.|+.|.|..|++. +|+.+|||++.+..   ......+..|+.+|+-+.||||++++++|++..+.|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            4566789999999999999865 79999999997652   2334568889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++||.|.+++..++. +.+.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-. ++. 
T Consensus        93 yv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gk-  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGK-  166 (786)
T ss_pred             ecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc-CCc-
Confidence            9999999999988765 677788899999999999999   9999999999999999999999999999998533 222 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       .....||+|+|.||
T Consensus       167 -lLeTSCGSPHYA~P  180 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAP  180 (786)
T ss_pred             -cccccCCCcccCCc
Confidence             33456899999998

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=6.9e-27  Score=242.46  Aligned_cols=147  Identities=24%  Similarity=0.392  Sum_probs=131.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++...   ......+..|+.++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999875 68999999996432   334567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999987654 4788888999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=6.1e-27  Score=251.21  Aligned_cols=168  Identities=23%  Similarity=0.294  Sum_probs=143.2

Q ss_pred             CCCcCceecccccceEEEEEec-C-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-D-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .|...+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.++|||||++++++...+..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3788899999999999999754 3 6789999876555555567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          507 PHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       507 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ++|+|.++++..   ...+++..+..++.||+.||.|+|   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887642   235788888999999999999999   89999999999999999999999999999987643322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      .......+||++||||
T Consensus       225 ~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        225 LDVASSFCGTPYYLAP  240 (478)
T ss_pred             cccccccCCCccccCH
Confidence            2223456799999998

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.94  E-value=6.7e-28  Score=221.51  Aligned_cols=167  Identities=32%  Similarity=0.492  Sum_probs=145.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcC-CCCcceeEEEEEEc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--------EGAFKSFDIECDMMKRI-RHRNLIKIISSCSN  495 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  495 (599)
                      .-+.|...+.+|.|..++|.++.++ +|+++|+|++....        ....++-..|+.+++++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456788899999999999998765 68999999985321        12345667799999987 69999999999999


Q ss_pred             CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      +...++|+|.|+.|.|.+++.+.- .+++....+|++|+.+|+.|||   ...||||||||+|||+|++.++||+|||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence            999999999999999999997653 4788888999999999999999   999999999999999999999999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..+.++.+   ....+|||+|.||
T Consensus       171 ~~l~~Gek---LrelCGTPgYLAP  191 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGTPGYLAP  191 (411)
T ss_pred             eccCCchh---HHHhcCCCcccCh
Confidence            98866543   3567899999999

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.7e-27  Score=242.34  Aligned_cols=149  Identities=28%  Similarity=0.436  Sum_probs=134.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++...   ......+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 68999999996542   234567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999876 35788889999999999999999   89999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=1.1e-26  Score=238.40  Aligned_cols=166  Identities=26%  Similarity=0.380  Sum_probs=141.0

Q ss_pred             CCCcCceecccccceEEEEEe----cCCcEEEEEEeccc----ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCee
Q 042902          429 GFSENNLIGRGGVASVYKARI----QDGIEVAVKVFDLQ----YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFK  499 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  499 (599)
                      +|+..+.||+|+||.||+|+.    .+++.||+|++...    .....+.+..|++++..++ ||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999875    35889999998643    2233456888999999994 99999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 4788888999999999999999   8999999999999999999999999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... ......||+.||||
T Consensus       157 ~~~~~-~~~~~~gt~~y~aP  175 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAP  175 (332)
T ss_pred             ccCCC-ccccccCCccccCH
Confidence            33222 22345799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.5e-27  Score=239.94  Aligned_cols=167  Identities=27%  Similarity=0.416  Sum_probs=147.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe-eeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF-KALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  503 (599)
                      ++|...+++|+|+||.++.++++ +++.+|+|.+...  .....+.-..|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999998866 6789999998644  34444577889999999999999999999988887 99999


Q ss_pred             EccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +||+||++.+.+.+.+ ..+++.....++.|++.|+.|||   +..|+|||||++||+++.++.|||+|||+|+.+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998766 57899999999999999999999   8999999999999999999999999999999886654


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ...+.+|||.||.|
T Consensus       161 ~--~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  161 S--LASTVVGTPYYMCP  175 (426)
T ss_pred             h--hhheecCCCcccCH
Confidence            2  23457899999998

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.2e-26  Score=236.81  Aligned_cols=160  Identities=29%  Similarity=0.436  Sum_probs=135.8

Q ss_pred             ceecccccceEEEEEe----cCCcEEEEEEeccc----ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARI----QDGIEVAVKVFDLQ----YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +.||+|+||.||+|+.    .+++.||||+++..    .......+..|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    35789999998643    123345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++|+|.+++...+ .+.+..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987654 4677788889999999999999   89999999999999999999999999999875432221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.||||
T Consensus       156 ~~~~~~gt~~y~aP  169 (323)
T cd05584         156 VTHTFCGTIEYMAP  169 (323)
T ss_pred             cccccCCCccccCh
Confidence            22345799999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=6.8e-27  Score=243.21  Aligned_cols=170  Identities=24%  Similarity=0.439  Sum_probs=139.7

Q ss_pred             hCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|...      ++..||||+++... ....+.+..|+++++.+ +|||||+++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346888899999999999998742      34589999997543 33456788999999999 89999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-----------------------------------------------------------
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-----------------------------------------------------------  519 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  519 (599)
                      .++||||+++|+|.++++...                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999875421                                                           


Q ss_pred             ----------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeec
Q 042902          520 ----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       520 ----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                                ..+++..+.+|+.||++||+|||   +.+|+||||||+||++++++.+||+|||+|+.+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      13677788999999999999999   89999999999999999999999999999986543322222223


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..+++.||||
T Consensus       274 ~~~~~~y~aP  283 (374)
T cd05106         274 ARLPVKWMAP  283 (374)
T ss_pred             CCCccceeCH
Confidence            3456789998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=1.5e-26  Score=235.66  Aligned_cols=168  Identities=24%  Similarity=0.365  Sum_probs=141.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|+..+.||+|+||.||+|++. +|+    .||||.++... ....++|..|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888999999999999999864 333    48999986543 33456799999999999999999999999764 5789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |+||+++|+|.+++......+++.....++.||++||+|||   +.+|+||||||+||++++++.+||+|||+|+.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999876666888899999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         163 EKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             CcceeccCCccceeecCh
Confidence            332222334456789998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-27  Score=244.65  Aligned_cols=164  Identities=31%  Similarity=0.488  Sum_probs=139.7

Q ss_pred             CCcCceecccccceEEEEEe-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------eeeE
Q 042902          430 FSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------FKAL  501 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  501 (599)
                      |...+.+|+|+||.||+|+. .+|..||||.++.. ...-.+....|+++|++++|||||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34457899999999999995 47999999999754 3344677899999999999999999999765543      5689


Q ss_pred             EEEccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec--CCC--cEEEccccCC
Q 042902          502 VLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNM--VAHLSDFGMA  575 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~--~~~--~~kl~DFGla  575 (599)
                      |||||.||||+..+.+...  .+++.+.+.+..+++.||.|||   ..+|+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999986543  6899999999999999999999   89999999999999984  445  4799999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |.+.+..   ..++.+||+.|.||
T Consensus       172 rel~d~s---~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHP  192 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcCh
Confidence            9775433   56789999999998

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=1.7e-26  Score=236.35  Aligned_cols=160  Identities=26%  Similarity=0.344  Sum_probs=136.6

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 68999999997542   23345688899999988 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++...+ .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence            99998886543 4889999999999999999999   89999999999999999999999999999975322211  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05588         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=1.6e-26  Score=241.50  Aligned_cols=171  Identities=23%  Similarity=0.429  Sum_probs=141.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  497 (599)
                      ..++|...+.||+|+||.||+|...      .+..||||+++... ....+.|..|+++++++. |||||+++++|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888899999999999999853      23479999996543 334567999999999996 999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  519 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  519 (599)
                      ..|+|||||++|+|.++++...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998876421                                                          


Q ss_pred             -------------------------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec
Q 042902          520 -------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  562 (599)
Q Consensus       520 -------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~  562 (599)
                                                           ..+++..+..++.||++||.|||   ..+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13667778899999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.+||+|||+++...............+++.||||
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            9999999999999865433322223344577889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=2.3e-26  Score=235.03  Aligned_cols=165  Identities=24%  Similarity=0.285  Sum_probs=139.4

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCC-cceeEEEEEEcCCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHR-NLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  503 (599)
                      +|+..+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|++++..++|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999876 5789999998654   233456788899999999765 5888999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999887644 4788889999999999999999   89999999999999999999999999999875332221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       157 --~~~~~~gt~~y~aP  170 (324)
T cd05587         157 --TTRTFCGTPDYIAP  170 (324)
T ss_pred             --ceeeecCCccccCh
Confidence              22345799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=1.7e-26  Score=235.92  Aligned_cols=163  Identities=25%  Similarity=0.348  Sum_probs=136.6

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH---hcCCCCcceeEEEEEEcCCeeeEE
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMM---KRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      |...+.||+|+||.||+|... +|+.||||+++...   ....+.+..|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999865 68999999996442   22345666676654   567899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|...+...  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999887653  4889999999999999999999   8999999999999999999999999999987543221


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                        .......||+.||||
T Consensus       156 --~~~~~~~g~~~y~aP  170 (324)
T cd05589         156 --DRTSTFCGTPEFLAP  170 (324)
T ss_pred             --CcccccccCccccCH
Confidence              122346799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=1.9e-26  Score=228.76  Aligned_cols=168  Identities=19%  Similarity=0.331  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45788899999999999999764    36789999987553 23346799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876556889999999999999999999   8999999999999999999999999999876432221


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      . .......+++.|+||
T Consensus       162 ~-~~~~~~~~~~~y~aP  177 (266)
T cd05064         162 I-YTTMSGKSPVLWAAP  177 (266)
T ss_pred             h-hcccCCCCceeecCH
Confidence            1 111223456789998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=2.2e-26  Score=234.18  Aligned_cols=160  Identities=24%  Similarity=0.359  Sum_probs=134.2

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhc-CCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKR-IRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999986542   2334556667777765 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887654 4788888999999999999999   8999999999999999999999999999998543222  1223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05592         155 TFCGTPDYIAP  165 (316)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=1.9e-26  Score=235.28  Aligned_cols=160  Identities=27%  Similarity=0.334  Sum_probs=136.0

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||+++..   .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999876 5789999998654   233456678899988866 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99998887544 4788888999999999999999   89999999999999999999999999999985432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05591         155 TFCGTPDYIAP  165 (321)
T ss_pred             ccccCccccCH
Confidence            45689999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=2e-26  Score=234.88  Aligned_cols=160  Identities=29%  Similarity=0.372  Sum_probs=136.2

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||++...   .....+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 5889999998643   233456778888888876 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence            99998887654 4788889999999999999999   89999999999999999999999999999885432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (320)
T cd05590         155 TFCGTPDYIAP  165 (320)
T ss_pred             ccccCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=2.3e-26  Score=234.35  Aligned_cols=160  Identities=27%  Similarity=0.408  Sum_probs=137.1

Q ss_pred             ceecccccceEEEEEe----cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          434 NLIGRGGVASVYKARI----QDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      +.||+|+||.||+++.    .+|+.||+|+++...  ......+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    358999999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            999999886543 4789999999999999999999   89999999999999999999999999999986533221  22


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||+.||||
T Consensus       156 ~~~~g~~~y~aP  167 (318)
T cd05582         156 YSFCGTVEYMAP  167 (318)
T ss_pred             ecccCChhhcCH
Confidence            346789999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=2.6e-26  Score=234.94  Aligned_cols=160  Identities=29%  Similarity=0.368  Sum_probs=135.7

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999875 58899999997542   23345678898888776 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99998886543 4788899999999999999999   89999999999999999999999999999975432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05618         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=2e-28  Score=227.60  Aligned_cols=163  Identities=26%  Similarity=0.382  Sum_probs=145.3

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      |++...+|+|+||.||+|.++ .|+.||||.+...  .+.+++..|+.+|+.++.|+||+++|.|......|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            556789999999999999876 6999999998654  3568899999999999999999999998888889999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+..+.++.+...+++.++..+.+..++||+|||   ...-||||||+.|||+..+|.+|++|||.|-.+.+.  -....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence            9999999988888999999999999999999999   667799999999999999999999999999866432  22345


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      .++|||.||||
T Consensus       188 TVIGTPFWMAP  198 (502)
T KOG0574|consen  188 TVIGTPFWMAP  198 (502)
T ss_pred             ccccCcccccH
Confidence            68999999998

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=3.3e-26  Score=225.73  Aligned_cols=167  Identities=24%  Similarity=0.371  Sum_probs=142.6

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      +.|+..+.||+|+||.||+|++.++..+|+|.+... ....++|..|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            357778899999999999999988889999987633 2334678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.++++.....+++..+..++.|++.||.|+|   ..+|+||||||+||++++++.+|++|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            99999998765556889999999999999999999   8999999999999999999999999999998653322 1122


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (256)
T cd05114         159 SGAKFPVKWSPP  170 (256)
T ss_pred             CCCCCchhhCCh
Confidence            233456689988

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=4.6e-26  Score=226.05  Aligned_cols=169  Identities=26%  Similarity=0.449  Sum_probs=144.0

Q ss_pred             CCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|++..    ...||||.++... .....+|..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998752    4579999987543 33456799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+.+++.|++.|++|||   +.+|+||||||+||++++++.+|++|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999998765222


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .........+++.|+||
T Consensus       161 ~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         161 ATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             cceeccCCCCCccccCh
Confidence            22222234456789998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=3.2e-26  Score=234.02  Aligned_cols=160  Identities=31%  Similarity=0.423  Sum_probs=133.5

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECD-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +|+.||||++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68999999986542   223345556654 56779999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            99998886543 4788889999999999999999   89999999999999999999999999999975422221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05604         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCChhhCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=3.2e-26  Score=228.99  Aligned_cols=159  Identities=26%  Similarity=0.385  Sum_probs=135.6

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||+||+|... +|+.||||.+....   ....+.+..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 68999999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          512 EKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       512 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      ..++..   ....+++..+..++.||+.||.|||   +.+|+||||||+||++++++.+||+|||+++.+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887753   2335889999999999999999999   89999999999999999999999999999986543322  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       156 ~~~g~~~y~aP  166 (280)
T cd05608         156 GYAGTPGFMAP  166 (280)
T ss_pred             ccCCCcCccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=3.7e-26  Score=233.41  Aligned_cols=165  Identities=24%  Similarity=0.291  Sum_probs=138.9

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      +|...+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++... +||+|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999876 57899999987542   23345677788888777 5899999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999998887654 4788899999999999999999   89999999999999999999999999999985432221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       157 --~~~~~~gt~~y~aP  170 (323)
T cd05616         157 --TTKTFCGTPDYIAP  170 (323)
T ss_pred             --ccccCCCChhhcCH
Confidence              22346799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=3.9e-26  Score=233.19  Aligned_cols=160  Identities=33%  Similarity=0.420  Sum_probs=133.3

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECD-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||+||+|+.. +|+.||||++....   ....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986432   223344555554 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999887644 4788888899999999999999   8999999999999999999999999999997543222  1223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (323)
T cd05575         155 TFCGTPEYLAP  165 (323)
T ss_pred             cccCChhhcCh
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=5.7e-26  Score=232.78  Aligned_cols=165  Identities=23%  Similarity=0.349  Sum_probs=143.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|+.. +|..||+|.+.... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367889999999999999999976 68899999987543 2345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999987654 4788888999999999999999   54 69999999999999999999999999998653321 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....||+.|+||
T Consensus       159 ---~~~~~g~~~y~aP  171 (331)
T cd06649         159 ---ANSFVGTRSYMSP  171 (331)
T ss_pred             ---cccCCCCcCcCCH
Confidence               2345689999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=238.78  Aligned_cols=154  Identities=27%  Similarity=0.459  Sum_probs=135.8

Q ss_pred             CcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          431 SENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      ...+-+|.|+.|.||.|+++ ++.||||+++..       -..+|+-|++++||||+.+.|+|.....+|||||||+.|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34578999999999999997 899999998533       2458889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecc
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  590 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  590 (599)
                      |++.|+.... +.....+.+..+||.||.|||   .+.|||||||+-||||..+..+||+|||-++.....   .+..+.
T Consensus       199 L~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  199 LYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            9999987654 666677889999999999999   899999999999999999999999999999865432   344678


Q ss_pred             cCCccccCC
Q 042902          591 LATIGYMAP  599 (599)
Q Consensus       591 ~gt~~y~AP  599 (599)
                      +||..||||
T Consensus       272 aGTVaWMAP  280 (904)
T KOG4721|consen  272 AGTVAWMAP  280 (904)
T ss_pred             hhhHhhhCH
Confidence            999999998

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=4.1e-26  Score=232.87  Aligned_cols=160  Identities=31%  Similarity=0.413  Sum_probs=132.3

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECD-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999986432   222344555554 67889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence            99998886543 4677788889999999999999   89999999999999999999999999999875322211  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05603         155 TFCGTPEYLAP  165 (321)
T ss_pred             cccCCcccCCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=3.1e-26  Score=229.94  Aligned_cols=167  Identities=26%  Similarity=0.339  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++...  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999976 58899999986542  3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++++.+..+.. ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+....... 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            999887765543 3345788889999999999999999   89999999999999999999999999999986543221 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (287)
T cd07848         156 ANYTEYVATRWYRSP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            122345789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=5.1e-26  Score=231.41  Aligned_cols=160  Identities=24%  Similarity=0.376  Sum_probs=135.1

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhc-CCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKR-IRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57899999997542   2344567778888876 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+.......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999887643 4788888999999999999999   89999999999999999999999999999975322221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05619         155 TFCGTPDYIAP  165 (316)
T ss_pred             eecCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=4.6e-26  Score=231.80  Aligned_cols=160  Identities=24%  Similarity=0.383  Sum_probs=135.0

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhc-CCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKR-IRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|.+++.. .+||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 58899999997542   2344566778888775 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence            99999887643 4788888999999999999999   89999999999999999999999999999875322221  224


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05620         155 TFCGTPDYIAP  165 (316)
T ss_pred             ccCCCcCccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-29  Score=238.46  Aligned_cols=228  Identities=24%  Similarity=0.331  Sum_probs=140.4

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEccc-CcccccCChhhhccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSN-NSLDGILPRAIGNLSQS   99 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~~   99 (599)
                      .-+.++|..|+|+.+.+++|+.+++|++||||+|.|+.+.++     +|.++++|..|-+-+ |+|+.+..++|.++. .
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~-----AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~-s  141 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPD-----AFKGLASLLSLVLYGNNKITDLPKGAFGGLS-S  141 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChH-----hhhhhHhhhHHHhhcCCchhhhhhhHhhhHH-H
Confidence            344455555555555555555555555555555555555443     445544444333322 555544444555544 2


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccc---------------------
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL---------------------  158 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l---------------------  158 (599)
                      ++.|.+.-|++.-+..++|..|++|..|.|.+|.+..+...+|..+..++.+.+..|.+                     
T Consensus       142 lqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iets  221 (498)
T KOG4237|consen  142 LQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETS  221 (498)
T ss_pred             HHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcc
Confidence            44455555555544445555555555555555555433333455555555555444441                     


Q ss_pred             ---------------c-------------------------cc-CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          159 ---------------E-------------------------GS-IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       159 ---------------~-------------------------~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                                     .                         ++ ....|..+++|++|+|++|+|+.+.+.+|.++..++
T Consensus       222 garc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~  301 (498)
T KOG4237|consen  222 GARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQ  301 (498)
T ss_pred             cceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhh
Confidence                           0                         01 112467788888888888888888888888888888


Q ss_pred             EeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          198 NLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       198 ~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +|.|..|+|..+.. .|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.
T Consensus       302 eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  302 ELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            88888888888765 5667888888888888888888888888888888888877553

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=3.4e-26  Score=236.65  Aligned_cols=161  Identities=27%  Similarity=0.429  Sum_probs=135.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +|+..+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3556688999999999999865 68999999986543 234567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|....     ..++.....++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+.....  .
T Consensus       155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  224 (353)
T PLN00034        155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P  224 (353)
T ss_pred             CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence            999986532     2456677889999999999999   89999999999999999999999999999986542211  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....||+.|+||
T Consensus       225 ~~~~~gt~~y~aP  237 (353)
T PLN00034        225 CNSSVGTIAYMSP  237 (353)
T ss_pred             ccccccCccccCc
Confidence            2345789999998

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=4.8e-26  Score=251.29  Aligned_cols=169  Identities=27%  Similarity=0.346  Sum_probs=141.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +|+.||||+++...   ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888999999999999999875 58999999986542   223567999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcC----------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcccc
Q 042902          504 EYMPHGSLEKCLYSS----------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       504 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      ||++||+|.+++...          ....++..+++++.||++||+|+|   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988632          123456778899999999999999   8999999999999999999999999999


Q ss_pred             CCccCCcCCCc----------------eeeecccCCccccCC
Q 042902          574 MAKPLLKEDQS----------------LTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~----------------~~~~~~~gt~~y~AP  599 (599)
                      +|+........                ......+||+.||||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            99865211100                011235699999998

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.9e-26  Score=227.70  Aligned_cols=165  Identities=27%  Similarity=0.404  Sum_probs=141.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||.||++... +++.||||++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3777899999999999999865 68999999986432   2233567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 35889999999999999999999   8899999999999999999999999999998653222 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......|++.||||
T Consensus       157 --~~~~~~~~~~y~aP  170 (285)
T cd05605         157 --TIRGRVGTVGYMAP  170 (285)
T ss_pred             --ccccccCCCCccCc
Confidence              12345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=4.8e-26  Score=232.44  Aligned_cols=165  Identities=24%  Similarity=0.289  Sum_probs=139.0

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .|+..+.||+|+||.||+|+.. +|+.||+|+++..   .....+.+..|.+++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677789999999999999865 6899999998643   2334566888999988886 577888999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999887644 4888999999999999999999   89999999999999999999999999999985432221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       157 --~~~~~~gt~~y~aP  170 (323)
T cd05615         157 --TTRTFCGTPDYIAP  170 (323)
T ss_pred             --cccCccCCccccCH
Confidence              22345689999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=5.7e-26  Score=232.19  Aligned_cols=160  Identities=31%  Similarity=0.392  Sum_probs=131.7

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHH-HHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIEC-DMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57889999986432   12233444444 456789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+.+..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.......  ...
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999887654 3667777889999999999999   89999999999999999999999999999985432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05602         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=6.2e-26  Score=232.06  Aligned_cols=160  Identities=28%  Similarity=0.352  Sum_probs=136.4

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999875 57899999997542   23455688899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence            99998876543 4889999999999999999999   89999999999999999999999999999975322221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (327)
T cd05617         155 TFCGTPNYIAP  165 (327)
T ss_pred             cccCCcccCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.94  E-value=5.7e-26  Score=247.74  Aligned_cols=180  Identities=29%  Similarity=0.345  Sum_probs=77.6

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecC
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLG  202 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  202 (599)
                      +|+.|+|++|+++.+ |.   .+++|+.|+|++|+|+++ |..   ..+|+.|++++|+|+++ |..   ..+|+.|+|+
T Consensus       283 ~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~L-P~l---p~~Lq~LdLS  350 (788)
T PRK15387        283 GLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSL-PTL---PSGLQELSVS  350 (788)
T ss_pred             hcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCccccc-ccc---ccccceEecC
Confidence            344444555544432 21   123445555555544432 211   12344444555554432 211   1244555555


Q ss_pred             CCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCc
Q 042902          203 SNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP  282 (599)
Q Consensus       203 ~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  282 (599)
                      +|+|+.+|..   .++|+.|++++|.|+. +|..   ..+|+.|+|++|.|++ +|..   .++|+.|++++|+|++ +|
T Consensus       351 ~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP  418 (788)
T PRK15387        351 DNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LP  418 (788)
T ss_pred             CCccCCCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CC
Confidence            5555544432   1234444555555542 2221   1234555555555543 2221   1344555555555542 23


Q ss_pred             ccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          283 DSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       283 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      ..+   .+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus       419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~  462 (788)
T PRK15387        419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL  462 (788)
T ss_pred             cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence            221   23445555555554 345555555555555555555554433

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=232.95  Aligned_cols=166  Identities=31%  Similarity=0.427  Sum_probs=145.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..|+..+.||+|.||.||+|... +++.||+|++.... +...++.+.|+.+++.++++||.+++|.+..+...|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999865 68999999998764 45578899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      |.||++.+.++.... +++....-|++++..|+.|+|   ..+.+|||||+.||++..+|.+|++|||.|..+.....  
T Consensus        93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            999999999876542 466677778999999999999   88999999999999999999999999999987653322  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      .....+|||.||||
T Consensus       167 rr~tfvGTPfwMAP  180 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAP  180 (467)
T ss_pred             ccccccccccccch
Confidence            22567899999999

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=7.5e-26  Score=231.96  Aligned_cols=165  Identities=23%  Similarity=0.367  Sum_probs=142.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367899999999999999999976 68899999887542 3345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++...+ .+++..+..++.|++.||.|||   . .+|+||||||+||+++.++.+||+|||+++.+...  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999987644 4788888899999999999999   5 37999999999999999999999999999755322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       158 --~~~~~~~~~~y~aP  171 (333)
T cd06650         158 --MANSFVGTRSYMSP  171 (333)
T ss_pred             --ccccCCCCccccCH
Confidence              12335689999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=5.8e-29  Score=239.71  Aligned_cols=297  Identities=22%  Similarity=0.257  Sum_probs=244.1

Q ss_pred             EccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEc
Q 042902           26 ELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFM  105 (599)
Q Consensus        26 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l  105 (599)
                      +-++-.++. +|..+-  +.-..++|..|+|+.+|+.     +|+.+++|+.||||+|+|+.|-|++|.++...++.++.
T Consensus        52 dCr~~GL~e-VP~~LP--~~tveirLdqN~I~~iP~~-----aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly  123 (498)
T KOG4237|consen   52 DCRGKGLTE-VPANLP--PETVEIRLDQNQISSIPPG-----AFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLY  123 (498)
T ss_pred             EccCCCccc-CcccCC--CcceEEEeccCCcccCChh-----hccchhhhceecccccchhhcChHhhhhhHhhhHHHhh
Confidence            344445554 343332  3468899999999999986     79999999999999999999999999999988888888


Q ss_pred             cCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccC--
Q 042902          106 FNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS--  183 (599)
Q Consensus       106 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--  183 (599)
                      .+|+|+.+..++|.+|..|+.|.+.-|++..+..++|..|++|..|.+-+|.++.+-...|..+.+++.+.+..|.+-  
T Consensus       124 g~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  124 GNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             cCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            889999988899999999999999999999999999999999999999999999665568999999999999988832  


Q ss_pred             ----------CCCCcccCCCCCCcEeecCCCCCCCCCccccC--CCcccEEeecCCCccccCc-ccccccccccEEEccC
Q 042902          184 ----------GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWN--LKYILYLNLSSNSFTGPLP-LEIGNLRVLVQIDLSM  250 (599)
Q Consensus       184 ----------~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~--l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~  250 (599)
                                ...|..+++..-.....+.++++..+++.-+.  +..+..=-.+.+...+..| ..|.++++|+.|+|++
T Consensus       204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn  283 (498)
T KOG4237|consen  204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN  283 (498)
T ss_pred             cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence                      22445566666666667777777776543222  2233222233333433444 4699999999999999


Q ss_pred             CccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      |.|+++.+.+|.++..+++|+|..|+|..+....|.++..|+.|+|.+|+|+...|..|..+..|..|+|-.|++.|..-
T Consensus       284 N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  284 NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence            99999999999999999999999999998888899999999999999999999999999999999999999999988764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=7.7e-26  Score=229.62  Aligned_cols=166  Identities=26%  Similarity=0.434  Sum_probs=141.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999876 58889999987543 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++ ++.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 888888776666888889999999999999999   89999999999999999999999999999975432221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+|+.|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (309)
T cd07872         160 TYSNEVVTLWYRPP  173 (309)
T ss_pred             ccccccccccccCC
Confidence            12334678899998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=4.7e-26  Score=225.02  Aligned_cols=165  Identities=36%  Similarity=0.583  Sum_probs=137.4

Q ss_pred             cCceecccccceEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          432 ENNLIGRGGVASVYKARIQ-----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+.||.|+||.||+|.+.     .+..||||.++... ....+.|.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3478999999999999977     35789999996543 33468899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++... ...+++..+..|+.||++||.|||   +.+++|+||+++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 556899999999999999999999   889999999999999999999999999999876333333


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+...|+||
T Consensus       160 ~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAP  174 (259)
T ss_dssp             EESTTSESGGGGS-H
T ss_pred             ccccccccccccccc
Confidence            333445577789987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=5.6e-26  Score=240.24  Aligned_cols=163  Identities=23%  Similarity=0.254  Sum_probs=140.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+|...+.||+|+||.||+|.+. +++.||||...      ...+.+|++++++++|||||++++++...+..++||||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457899999999999999999976 57899999642      23467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +. ++|.+++......+++..+..|+.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6898888765556899999999999999999999   8999999999999999999999999999998654332222


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.||||
T Consensus       318 ~~~~~~GT~~Y~AP  331 (461)
T PHA03211        318 FHYGIAGTVDTNAP  331 (461)
T ss_pred             cccccCCCcCCcCH
Confidence            22346799999998

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=4.7e-26  Score=227.44  Aligned_cols=171  Identities=20%  Similarity=0.367  Sum_probs=141.3

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ..++|+..+.||+|+||.||+|.+.      ++..||||.+.... .....+|.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998753      35679999986432 2334578999999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC---------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          499 KALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                      .++||||+++|+|.+++....         ...++..+..++.|+++|+.|||   +.+++||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         13567788899999999999999   889999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+|+...............+++.||||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            999999865433322222234567889998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=6.8e-26  Score=236.60  Aligned_cols=161  Identities=24%  Similarity=0.281  Sum_probs=137.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+|+..+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++|||||++++++...+..++|+||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999865 68999999753      23567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +. ++|.+++.... .+++..+..++.||+.||+|+|   +.+|+||||||+||+++.++.+||+|||+|+...... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68888876644 4788899999999999999999   8899999999999999999999999999997543221 11


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.|+||
T Consensus       239 ~~~~~~gt~~y~aP  252 (391)
T PHA03212        239 KYYGWAGTIATNAP  252 (391)
T ss_pred             ccccccCccCCCCh
Confidence            22346799999998

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=1e-25  Score=221.61  Aligned_cols=163  Identities=26%  Similarity=0.415  Sum_probs=136.4

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      +.||+|+||.||+|... +++.||+|...... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999875 68999999886443 33456799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                      .+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+|++|||+++...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999766656889999999999999999999   8999999999999999999999999999998543221111111122


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      ++..|+||
T Consensus       158 ~~~~y~aP  165 (252)
T cd05084         158 IPVKWTAP  165 (252)
T ss_pred             CceeecCc
Confidence            34568888

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=6.3e-26  Score=233.31  Aligned_cols=166  Identities=23%  Similarity=0.370  Sum_probs=137.6

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----eee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  500 (599)
                      +|+..+.||+|+||.||+|... +|+.||||++....  .....++.+|++++++++||||+++++++...+     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999865 68999999986432  233457889999999999999999999886432     479


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||++ ++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68988887544 4788999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCc-eeeecccCCccccCC
Q 042902          581 EDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-~~~~~~~gt~~y~AP  599 (599)
                      .... .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             ccCccccccCCCCCCCcCCH
Confidence            2211 122345799999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=1e-25  Score=222.28  Aligned_cols=167  Identities=24%  Similarity=0.381  Sum_probs=142.2

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||.|++.++..||||.+.... ...++|.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577788999999999999998877789999986432 234679999999999999999999999998889999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++......+++..+..++.||+.|++|||   +.+++|+||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999998765556899999999999999999999   8999999999999999999999999999998654322 1222


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~~p  170 (256)
T cd05113         159 VGSKFPVRWSPP  170 (256)
T ss_pred             CCCccChhhCCH
Confidence            233456678887

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=4.4e-26  Score=232.53  Aligned_cols=167  Identities=31%  Similarity=0.415  Sum_probs=146.7

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ....|.....||+|.|++|..|++. +|..||||.+++..  ....+.+.+|+++|..+.|||||+++.+...+...|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567888899999999999999876 69999999997653  22335588999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+.+|.+++++...+...+ ..+..++.|+.+|++|+|   ++.|||||||++|||++.+.++||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence            999999999999988776444 777889999999999999   9999999999999999999999999999998775332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         .....+|++.|.||
T Consensus       210 ---~lqt~cgsppyAaP  223 (596)
T KOG0586|consen  210 ---MLQTFCGSPPYAAP  223 (596)
T ss_pred             ---cccccCCCCCccCh
Confidence               34567899999998

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=9.4e-26  Score=224.21  Aligned_cols=163  Identities=25%  Similarity=0.352  Sum_probs=133.2

Q ss_pred             ceecccccceEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQD---GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......|.+|++.++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   4568888875442 333467899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC----cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          510 SLEKCLYSSNY----ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       510 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +|.+++.....    ..++.....++.||+.|++|+|   +.+|+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999876432    2456777899999999999999   8999999999999999999999999999997543332222


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05042         158 TKDCHAVPLRWLAP  171 (269)
T ss_pred             ccCCCCCcccccCH
Confidence            22334567789998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=1.1e-25  Score=226.15  Aligned_cols=169  Identities=30%  Similarity=0.489  Sum_probs=143.3

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|...+.||+|+||.||++...      ++..||+|.+..........+..|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999742      356799999876655556789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          502 VLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                      ||||+++|+|.+++...+            ..+++..+..++.|++.||+|+|   ..+++||||||+||++++++.+|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            24788999999999999999999   899999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+++...............+++.|+||
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCH
Confidence            999999866433322222334467789998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=1.2e-25  Score=225.29  Aligned_cols=169  Identities=24%  Similarity=0.434  Sum_probs=140.7

Q ss_pred             CCCCcCceecccccceEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|+..+.||+|+||.||+|..     .+++.||+|.+.... .....+|.+|++++++++||||+++++++...+..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577778999999999999974     246789999986443 3344678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC----------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC
Q 042902          502 VLEYMPHGSLEKCLYSSN----------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  565 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~  565 (599)
                      ||||+++|+|.+++....                ..+++.....++.|++.||.|+|   +.+|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999885321                24678888999999999999999   88999999999999999999


Q ss_pred             cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+|++|||+++...............++..|+||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecCh
Confidence            9999999999866443332233344567789988

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=1.3e-25  Score=224.80  Aligned_cols=158  Identities=22%  Similarity=0.277  Sum_probs=134.9

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEeccccccc---HHHHHHHHHHHhcCCCCcceeEEEEEEc----CCeeeEEEE
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA---FKSFDIECDMMKRIRHRNLIKIISSCSN----DDFKALVLE  504 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  504 (599)
                      ....||+|++|.||+|.+ +|+.||||.++......   .+.|.+|+++|++++|||||+++|++.+    ....++|||
T Consensus        24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            346899999999999998 58999999997543322   5678899999999999999999999876    347889999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++...+ .+++..+.+++.+++.|+.|+|   . .+++||||||+||++++++.+||+|||+++.+.... 
T Consensus       103 y~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        103 YCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             eCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999997654 5788899999999999999999   5 378899999999999999999999999998653221 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                          ....||+.||||
T Consensus       178 ----~~~~~~~~y~aP  189 (283)
T PHA02988        178 ----FKNVNFMVYFSY  189 (283)
T ss_pred             ----ccccCcccccCH
Confidence                234688899998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.93  E-value=5.4e-26  Score=225.87  Aligned_cols=160  Identities=27%  Similarity=0.414  Sum_probs=135.4

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      .+++|.|.||+||-|+++ +|+.||||++++-  ......+..+|+.+++.++||.||.+...|++.+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            478999999999999865 7999999999654  233457889999999999999999999999999999999999955 


Q ss_pred             Chhhh-hhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCccCCcCCCce
Q 042902          510 SLEKC-LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       510 ~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +..++ +...++.+++....-+..||+.||.|||   .++|+|+||||+|||+.+   .-++||+|||+||.+....   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            55554 4555567888888888999999999999   899999999999999963   3489999999999774322   


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      -..+++|||.|.||
T Consensus       722 FRrsVVGTPAYLaP  735 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAP  735 (888)
T ss_pred             hhhhhcCCccccCH
Confidence            23568999999998

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=226.86  Aligned_cols=166  Identities=27%  Similarity=0.391  Sum_probs=146.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      +.|..-++||+||||.||.++.+ +|+-+|.|.+.++.   .....--++|..++.++..+.||.+-.+|++.+..|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56888899999999999999866 69999999986442   333445688999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ..|.||+|.-++...+ ..+++..+.-++.+|+.||++||   +.+||.||+||+|||+|+.|.++|+|.|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999998887655 36899999999999999999999   9999999999999999999999999999999875433


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ...+.+||.+||||
T Consensus       342 ---~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  342 ---PIRGRVGTVGYMAP  355 (591)
T ss_pred             ---ccccccCcccccCH
Confidence               34566999999999

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-27  Score=240.52  Aligned_cols=165  Identities=25%  Similarity=0.368  Sum_probs=146.3

Q ss_pred             CCcCceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      |.+...+|.|+||.||+|..++ +...|.|++..+.....++|+-||++|+.++||+||++++.|..++..||+.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            3345678999999999998664 556788999888888889999999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |-.+..+-+-+..+...++.-+++|++.||.|||   +..|||||||+.|||++-+|.++++|||.+.....  +-....
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence            9999998888888999999999999999999999   99999999999999999999999999998764322  222346


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      +.+|||.||||
T Consensus       189 sFIGTPYWMAP  199 (1187)
T KOG0579|consen  189 SFIGTPYWMAP  199 (1187)
T ss_pred             cccCCcccccc
Confidence            78999999999

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.6e-25  Score=221.41  Aligned_cols=168  Identities=27%  Similarity=0.403  Sum_probs=143.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|+..+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998888899999986543 23567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++++|.+++.... ..+++..+..++.|++.|+.|+|   ..+|+||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999987654 45889999999999999999999   89999999999999999999999999999987642211 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      .......+..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05068         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCcCceeccCc
Confidence            11222334579988

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7.5e-26  Score=242.92  Aligned_cols=171  Identities=26%  Similarity=0.327  Sum_probs=142.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  497 (599)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++...  .......+..|+..+..++|+|+++++..+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            4568999999999999999999854 6999999998654  2334567889999999999999999988765332     


Q ss_pred             ---eeeEEEEccCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcc
Q 042902          498 ---FKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       498 ---~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                         ..++||||+++|+|.++++...   ..+++..+..++.|++.||+|+|   +.+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               3689999999999999886532   35788889999999999999999   89999999999999999999999999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+++.+.............||+.||||
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCH
Confidence            9999866433222223446799999998

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.1e-25  Score=226.93  Aligned_cols=169  Identities=27%  Similarity=0.448  Sum_probs=140.0

Q ss_pred             CCCCcCceecccccceEEEEEecC---------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD---------------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIIS  491 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  491 (599)
                      ++|...+.||+|+||.||+|+...               ...||+|.++... .....+|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987542               2358999987543 334567999999999999999999999


Q ss_pred             EEEcCCeeeEEEEccCCCChhhhhhcCC-----------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCee
Q 042902          492 SCSNDDFKALVLEYMPHGSLEKCLYSSN-----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  560 (599)
Q Consensus       492 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nil  560 (599)
                      ++...+..++||||+++++|.+++....           ...++..++.++.|+++|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999886532           13678888999999999999999   899999999999999


Q ss_pred             ecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          561 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       561 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++++.+|++|||+++...............+++.|+||
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            999999999999999865433322222334557789998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=2e-25  Score=221.88  Aligned_cols=163  Identities=26%  Similarity=0.387  Sum_probs=134.8

Q ss_pred             ceecccccceEEEEEecC---CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQD---GIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998865532 23457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          510 SLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       510 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +|.+++....    ...++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    23566777889999999999999   8999999999999999999999999999997554333222


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05087         158 TPDQLWVPLRWIAP  171 (269)
T ss_pred             cCCCcCCcccccCH
Confidence            22345578889998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.3e-25  Score=230.21  Aligned_cols=158  Identities=28%  Similarity=0.349  Sum_probs=132.0

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC---CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI---RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      ||+|+||+||+|+.. +|+.||||++....   ......+..|..++.+.   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 58999999986432   22334556677777665   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            99998887644 4788899999999999999999   89999999999999999999999999999975432221  223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (330)
T cd05586         155 TFCGTTEYLAP  165 (330)
T ss_pred             CccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=1.4e-25  Score=228.52  Aligned_cols=160  Identities=27%  Similarity=0.339  Sum_probs=136.0

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999997542   33456678899998887 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++.... .+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99998887654 4889999999999999999999   89999999999999999999999999999975322221  123


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus       155 ~~~g~~~y~aP  165 (318)
T cd05570         155 TFCGTPDYIAP  165 (318)
T ss_pred             ceecCccccCH
Confidence            35689999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=2e-25  Score=221.61  Aligned_cols=166  Identities=29%  Similarity=0.380  Sum_probs=143.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|+..+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888999999999999999964 68899999997655455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.++++... .+++..+..++.|++.|+.|+|   +.+|+|||+||+||++++++.+||+|||+++.+.....  .
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            9999999887543 4788889999999999999999   88999999999999999999999999999986532211  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~~P  175 (267)
T cd06646         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cCccccCccccCH
Confidence            2334688889998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.93  E-value=1.9e-25  Score=223.31  Aligned_cols=168  Identities=24%  Similarity=0.378  Sum_probs=138.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|...+.||+|+||.||+|.+. +|+    .||+|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35777889999999999999864 344    47778775432 2334678889989999999999999998754 45789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ++||+++|+|.+++......+++..+..++.||+.||.|+|   +.+++||||||+||++++++.+|++|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999866443


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         163 DKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             CcccccCCCCCcccccCH
Confidence            332233345577789998

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=215.46  Aligned_cols=172  Identities=27%  Similarity=0.401  Sum_probs=144.5

Q ss_pred             cHHHHHHHhCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcC
Q 042902          419 THLELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSND  496 (599)
Q Consensus       419 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  496 (599)
                      .+.++.+.|+     +.+|+|+||.|--|. ..+|+++|||++.++......+..+|++++...+ |+||++++.+++++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3455555554     689999999999886 6789999999998886667788999999999985 99999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEcccc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFG  573 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DFG  573 (599)
                      ...|||||-|.||+|..++..+.. +++.++.++..+|+.||.|||   .+||.|||+||+|||-.+..   -+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999887654 788889999999999999999   99999999999999986443   48999998


Q ss_pred             CCccCCc-----CCCceeeecccCCccccCC
Q 042902          574 MAKPLLK-----EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~-----~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++.-+..     ..........+|+..||||
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcch
Confidence            8754321     1122233567899999999

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.8e-25  Score=220.51  Aligned_cols=166  Identities=27%  Similarity=0.394  Sum_probs=140.8

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +|+..+.||+|+||.||+|.++++..+|+|.+.... ....+|..|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            477788999999999999998877889999986432 2345788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      ++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||+++....... ....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~  159 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ  159 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence            9999999876556899999999999999999999   88999999999999999999999999999986542211 1112


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~~P  170 (256)
T cd05059         160 GTKFPVKWAPP  170 (256)
T ss_pred             CCCCCccccCH
Confidence            22344578887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=199.28  Aligned_cols=165  Identities=29%  Similarity=0.393  Sum_probs=143.1

Q ss_pred             CCCcCceecccccceEEEEEe-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .|+..++||+|.||+||+|+. ++++.||+|.++..  .++....-.+|+.+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456678999999999999984 46889999998755  344566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      |. .+|.++...-.+.++...+..++.|+++|+.|+|   +..+.|||+||.|.++..+|+.|++|||+|+.+.-..  .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            94 5999988887778999999999999999999999   8999999999999999999999999999999764322  2


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      .....+.|.+|.+|
T Consensus       157 cysaevvtlwyrpp  170 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPP  170 (292)
T ss_pred             eeeceeeeeeccCc
Confidence            34556778888887

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.93  E-value=1.6e-25  Score=224.25  Aligned_cols=169  Identities=26%  Similarity=0.519  Sum_probs=142.0

Q ss_pred             CCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|....      .+.||+|.+.... .....+|.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357788999999999999998643      2579999986543 234567899999999999999999999999989999


Q ss_pred             EEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC
Q 042902          501 LVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  565 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~  565 (599)
                      ++|||+++|+|.+++....               ..+++..+..++.|++.||.|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986532               34678888999999999999999   89999999999999999999


Q ss_pred             cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+||+|||+++.....+.........+++.||||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCH
Confidence            9999999999865443333333445678899998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.6e-25  Score=222.88  Aligned_cols=169  Identities=27%  Similarity=0.422  Sum_probs=140.8

Q ss_pred             CCCCcCceecccccceEEEEEec-----CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Ceee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-----DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  500 (599)
                      .+|...+.||+|+||.||+|...     ++..||+|.++.......+.|..|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999743     5789999998766555667899999999999999999999987543  4688


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||   ..+|+||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999766556899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcee-eecccCCccccCC
Q 042902          581 EDQSLT-QTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~-~~~~~gt~~y~AP  599 (599)
                      ...... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             CCcceeecCCCCCceEeeCH
Confidence            332211 1122334468887

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=1.9e-25  Score=243.57  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=213.6

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|+++ .+|..+.  ++|+.|++.+|+|+.+ |.   .+++|++|+|++|+|+.++..         .++|+.|++
T Consensus       206 LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~LtsLP~l---------p~sL~~L~L  269 (788)
T PRK15387        206 LNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSLPVL---------PPGLLELSI  269 (788)
T ss_pred             EEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccCcccCc---------ccccceeec
Confidence            578999998 6788776  4899999999999974 43   358999999999999988642         368999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.|+.+ |.    ++..|+.|++++|+++.+ |.   .+++|+.|+|++|+|+++ |..   ..+|+.|++++|+|++
T Consensus       270 s~N~L~~L-p~----lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~  336 (788)
T PRK15387        270 FSNPLTHL-PA----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS  336 (788)
T ss_pred             cCCchhhh-hh----chhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCcccc
Confidence            99999853 33    334688999999999854 43   357899999999999965 432   2468899999999985


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                       +|..   ..+|+.|+|++|+|+++ |..   .++|+.|++++|+|+.+|...   .+|+.|++++|+|++ +|..   .
T Consensus       337 -LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~-LP~l---~  401 (788)
T PRK15387        337 -LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTS-LPVL---P  401 (788)
T ss_pred             -cccc---ccccceEecCCCccCCC-CCC---CcccceehhhccccccCcccc---cccceEEecCCcccC-CCCc---c
Confidence             4532   25899999999999964 432   357899999999999998643   579999999999995 4433   3


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhcc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKL  312 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  312 (599)
                      ++|+.|++++|.|++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..|..+..+
T Consensus       402 s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            679999999999996 4543   357899999999999 678899999999999999999999888877544

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=1.2e-25  Score=225.72  Aligned_cols=171  Identities=22%  Similarity=0.375  Sum_probs=139.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ..++|+..+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999999753      24589999886443 2234568899999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC---------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          499 KALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                      .++||||+++|+|.+++....         ...++..+..++.|++.||.|||   +++|+||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996532         23456678889999999999999   899999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+|+...............++..||||
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  190 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCH
Confidence            999999865433222222233456789988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=1.1e-25  Score=235.16  Aligned_cols=171  Identities=22%  Similarity=0.429  Sum_probs=140.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  497 (599)
                      ..++|...+.||+|+||.||+|++.      .+..||||+++... ....+.+..|++++.++. |||||+++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456778899999999999999864      24689999997543 233457899999999997 999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  519 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  519 (599)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886431                                                          


Q ss_pred             ---------------------------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCee
Q 042902          520 ---------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  560 (599)
Q Consensus       520 ---------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nil  560 (599)
                                                             ..+++....+++.|++.||.|||   ..+|+||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                   13566778889999999999999   899999999999999


Q ss_pred             ecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          561 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       561 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++++.+|++|||+++.+.............+++.||||
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            999999999999999865432222222334577889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=8.2e-26  Score=223.50  Aligned_cols=168  Identities=25%  Similarity=0.445  Sum_probs=145.7

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ..+|+..+.||+|+||.||+|...+++.||+|.+.........++..|+.+++.++||||+++++++.+.+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688889999999999999998889999999997665555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++.... ..+++..+..++.|++.|+.|||   ..+|+||||||+||++++++.+||+|||.+........  
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence            9999999997643 35789999999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~~~~P  173 (261)
T cd05148         160 LSSDKKIPYKWTAP  173 (261)
T ss_pred             cccCCCCceEecCH
Confidence            12234456778887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.93  E-value=2.3e-25  Score=223.91  Aligned_cols=164  Identities=28%  Similarity=0.404  Sum_probs=133.9

Q ss_pred             CCCcCceecccccceEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCcceeEEEEEEc-----C
Q 042902          429 GFSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNLIKIISSCSN-----D  496 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  496 (599)
                      +|+..+.||+|+||.||+|+..  +|+.||||.++...  ......+.+|+.+++.+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888899999999999999863  46889999986542  22345566777777665   69999999998852     3


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      ...++||||++ ++|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            46899999996 68988886543 34788899999999999999999   899999999999999999999999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.....   .......||+.|+||
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aP  178 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAP  178 (290)
T ss_pred             EeccCC---cccccccccccccCh
Confidence            865332   122345689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=2.4e-25  Score=220.31  Aligned_cols=157  Identities=24%  Similarity=0.431  Sum_probs=134.1

Q ss_pred             ceecccccceEEEEEecC-------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          434 NLIGRGGVASVYKARIQD-------------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      +.||+|+||.||+|.+.+             ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358999887665555678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc-------EEEcccc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-------AHLSDFG  573 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~-------~kl~DFG  573 (599)
                      +||||+++|+|..++......+++..+.+++.||++||+|+|   +.+|+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988776666899999999999999999999   899999999999999986654       8999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++......      ....++..||||
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aP  177 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAP  177 (262)
T ss_pred             CCccccCc------ccccccccccCh
Confidence            98754321      234578889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.93  E-value=1.7e-25  Score=223.63  Aligned_cols=169  Identities=30%  Similarity=0.482  Sum_probs=142.3

Q ss_pred             CCCCcCceecccccceEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|...+.||+|+||.||+|...+      ++.||||.++..... ..+.|.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999998643      478999998765443 4578999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC-------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          501 LVLEYMPHGSLEKCLYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      +||||+++|+|.+++...+             ..+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999987542             24678888999999999999999   8999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |++|||+++...............+++.|+||
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecCh
Confidence            99999999865433222222334567889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.93  E-value=2.1e-25  Score=220.56  Aligned_cols=168  Identities=22%  Similarity=0.398  Sum_probs=143.2

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+..|+.++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35688889999999999999998888999999986433 23578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.++++.. ....++..+..++.|+++|++|||   ..+++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998754 335788888999999999999999   88999999999999999999999999999986543221 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05072         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCccceecCCH
Confidence            22233456789998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.93  E-value=2.6e-25  Score=222.30  Aligned_cols=168  Identities=25%  Similarity=0.368  Sum_probs=139.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|+..+.||+|+||.||+|++. +|.    .||+|.+.... ....+.+..|+.+++.+.||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            46788899999999999999854 444    48999986543 33456788999999999999999999998754 5789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      +|||+++|+|.++++.....+++..++.++.||++||+|+|   +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999876666899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........+++.||||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         163 ETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             cceeecCCCccchhhCCH
Confidence            222222233456789998

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.6e-25  Score=224.01  Aligned_cols=168  Identities=25%  Similarity=0.378  Sum_probs=146.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|+..+.||+|+||.||+|... +++.||+|..+.......+.|..|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888899999999999999875 6899999999766656667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++|+|.+++...+..+++..+..++.|++.||.|+|   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            9999999998776666899999999999999999999   88999999999999999999999999999875432221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (280)
T cd06611         159 KRDTFIGTPYWMAP  172 (280)
T ss_pred             ccceeecchhhcCH
Confidence            22345688889988

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=3e-25  Score=220.33  Aligned_cols=169  Identities=27%  Similarity=0.464  Sum_probs=141.3

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .+|...+.||+|+||.||+|++.    .+..||+|.++... ....+.|..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45778899999999999999864    23479999986543 33456899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876666899999999999999999999   8999999999999999999999999999998764332


Q ss_pred             Ccee-eecccCCccccCC
Q 042902          583 QSLT-QTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~-~~~~~gt~~y~AP  599 (599)
                      .... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             ceeeecCCCccceeecCH
Confidence            2111 1222345678887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.8e-27  Score=250.36  Aligned_cols=173  Identities=26%  Similarity=0.359  Sum_probs=153.2

Q ss_pred             HHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC
Q 042902          422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD  497 (599)
Q Consensus       422 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  497 (599)
                      ++....++|.+.++||+|+||.|..++++ +++.+|.|++++.   ......-|..|-.+|..-+.+=||+++.+|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445678999999999999999999976 5889999999763   2445678999999999999999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      +.|+|||||+||+|-.++.... .+++..+.-|+..|+-||.-+|   +.|+|||||||+|||+|.+|.+|++|||.+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998777 6888888889999999999999   99999999999999999999999999999987


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +..++ .......+|||-|++|
T Consensus       225 m~~dG-~V~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  225 MDADG-TVRSSVAVGTPDYISP  245 (1317)
T ss_pred             cCCCC-cEEeccccCCCCccCH
Confidence            76544 3455678999999998

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=2.8e-25  Score=220.68  Aligned_cols=171  Identities=27%  Similarity=0.388  Sum_probs=144.7

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..+++.+.....||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345667777789999999999999865 5788999998766655667899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCccCC
Q 042902          503 LEYMPHGSLEKCLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLL  579 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~~~~  579 (599)
                      +||+++++|.+++......+  ++..+..++.||++|++|||   +.+|+||||||+||+++. ++.+||+|||.+..+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999998654434  77788889999999999999   899999999999999986 6799999999987653


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ......|++.|+||
T Consensus       161 ~~~~--~~~~~~~~~~~~aP  178 (268)
T cd06624         161 GINP--CTETFTGTLQYMAP  178 (268)
T ss_pred             cCCC--ccccCCCCccccCh
Confidence            2221  12234578899998

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=3.4e-25  Score=222.14  Aligned_cols=164  Identities=25%  Similarity=0.390  Sum_probs=140.3

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      |+..+.||+|+||+||+|... +++.||+|.+....   ....+.+..|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 68999999986442   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 35899999999999999999999   8999999999999999999999999999997543221  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......|++.|+||
T Consensus       157 -~~~~~~g~~~~~aP  170 (285)
T cd05632         157 -SIRGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCcCccCh
Confidence             12345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=1.2e-25  Score=230.78  Aligned_cols=170  Identities=26%  Similarity=0.443  Sum_probs=138.9

Q ss_pred             hCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC-C
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND-D  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  497 (599)
                      .++|...+.||+|+||.||+|...      +++.||+|+++... ....+.+..|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            346888999999999999999642      35789999986432 23345678899999999 799999999988654 5


Q ss_pred             eeeEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  519 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  519 (599)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999998885421                                                          


Q ss_pred             --CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCcccc
Q 042902          520 --YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM  597 (599)
Q Consensus       520 --~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  597 (599)
                        ..+++..+..++.||++||+|+|   +.+|+||||||+||++++++.+||+|||+|+.+.............++..||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              14688889999999999999999   8999999999999999999999999999998764433333333445677899


Q ss_pred             CC
Q 042902          598 AP  599 (599)
Q Consensus       598 AP  599 (599)
                      ||
T Consensus       243 aP  244 (337)
T cd05054         243 AP  244 (337)
T ss_pred             Cc
Confidence            98

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=2e-25  Score=222.40  Aligned_cols=156  Identities=24%  Similarity=0.423  Sum_probs=131.2

Q ss_pred             eecccccceEEEEEecC-------------------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeE
Q 042902          435 LIGRGGVASVYKARIQD-------------------------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI  489 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  489 (599)
                      .||+|+||.||+|.+..                         ...||+|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997521                         13589999876554455678999999999999999999


Q ss_pred             EEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----
Q 042902          490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----  565 (599)
Q Consensus       490 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----  565 (599)
                      +++|...+..++||||+++|+|..++......+++..++.++.||++||+|||   +.+|+||||||+||+++.++    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998766566889999999999999999999   89999999999999997543    


Q ss_pred             ---cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 ---VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                         .+|++|||.+......      ....+++.|+||
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aP  189 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAP  189 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCc
Confidence               4899999998643221      123567789988

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.93  E-value=5e-25  Score=219.98  Aligned_cols=158  Identities=28%  Similarity=0.440  Sum_probs=134.1

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||.||+++.. +|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 58999999986432   22234566799999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecc
Q 042902          512 EKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  590 (599)
Q Consensus       512 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  590 (599)
                      .+++.... ..+++..+..++.||+.||+|+|   +.+|+||||||+||++++++.+||+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98876543 25788888999999999999999   8999999999999999999999999999998654322   22345


Q ss_pred             cCCccccCC
Q 042902          591 LATIGYMAP  599 (599)
Q Consensus       591 ~gt~~y~AP  599 (599)
                      .|++.|+||
T Consensus       155 ~~~~~y~aP  163 (277)
T cd05607         155 AGTNGYMAP  163 (277)
T ss_pred             CCCCCccCH
Confidence            689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=4e-25  Score=221.33  Aligned_cols=165  Identities=25%  Similarity=0.390  Sum_probs=143.0

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      |+..+.||+|+||.||+|... ++..+|+|.+........+.+..|+++++.++||||+++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456688999999999999976 4788999998766555667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|..++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+|++|||+++......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988765556899999999999999999999   8899999999999999999999999999997543221  1223


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...+++.||||
T Consensus       162 ~~~~~~~y~aP  172 (282)
T cd06643         162 SFIGTPYWMAP  172 (282)
T ss_pred             cccccccccCH
Confidence            45688899998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=2.8e-25  Score=224.97  Aligned_cols=170  Identities=28%  Similarity=0.454  Sum_probs=141.3

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|+..        ++..||+|..+... ....+++..|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456788899999999999999741        34579999986442 33456789999999999 899999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++||||+++|+|.+++....               ..+++..+..++.||++||.|||   +.+|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999987532               24677888999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++++.+||+|||+|+.+.............+++.|+||
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            99999999999999876443322222334567789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=3.6e-25  Score=222.70  Aligned_cols=168  Identities=30%  Similarity=0.485  Sum_probs=142.2

Q ss_pred             CCCcCceecccccceEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|...+.||+|+||.||+|+..      ++..||+|.++.......+.+.+|++++++++||||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            4677789999999999999743      3567999998765555557899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          503 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      |||+++++|.+++....               ..+++..++.++.||+.|++|||   +.+|+||||||+||++++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence            99999999999986532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |++|||+|+...............+++.||||
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            99999999865443322223345567889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=2e-25  Score=229.78  Aligned_cols=170  Identities=25%  Similarity=0.436  Sum_probs=137.2

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC-C
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND-D  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  497 (599)
                      .++|...+.||+|+||.||+|.+      .+++.||||+++... ......+..|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999973      357889999997543 23346788999999999 689999999988654 4


Q ss_pred             eeeEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN----------------------------------------------------------  519 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  519 (599)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             --------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          520 --------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       520 --------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                              ..+++..+..++.||++||+|+|   +.+|+||||||+||+++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13577788899999999999999   8999999999999999999999999999998654332222222334


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      +++.||||
T Consensus       243 ~~~~y~aP  250 (343)
T cd05103         243 LPLKWMAP  250 (343)
T ss_pred             CCcceECc
Confidence            56779998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.93  E-value=3.7e-25  Score=223.13  Aligned_cols=170  Identities=26%  Similarity=0.404  Sum_probs=143.7

Q ss_pred             hCCCCcCceecccccceEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCccee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-----------------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIK  488 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  488 (599)
                      ..+|...+.||+|+||.||+|...+                 +..||+|.+.... ....++|..|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3568889999999999999987542                 2468999987553 334578999999999999999999


Q ss_pred             EEEEEEcCCeeeEEEEccCCCChhhhhhcCC----------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 042902          489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  558 (599)
Q Consensus       489 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~N  558 (599)
                      +++++..++..++||||+++++|.+++....          ..+++..+..++.|++.||+|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987644          25788899999999999999999   8899999999999


Q ss_pred             eeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          559 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       559 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++.++.+|++|||+++.....+.........+++.||||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            99999999999999999865444333333445567889998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-26  Score=240.46  Aligned_cols=170  Identities=31%  Similarity=0.395  Sum_probs=139.0

Q ss_pred             CCCcCceecccccceEEEEEecCC-cEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEE-EEEcC------Cee
Q 042902          429 GFSENNLIGRGGVASVYKARIQDG-IEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIIS-SCSND------DFK  499 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~~------~~~  499 (599)
                      ++++.+.|.+|||+.||.|+...+ ..||+|++-...+...+...+||++|+.+. |+|||.+++ .....      -+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            456778999999999999998765 999999987777778889999999999997 999999999 32211      267


Q ss_pred             eEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          500 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      +|.||||+||.|-+++..+. ..+++.++++|+.|+++|+++|| ...++|||||||.+|||++.++..||||||.|.-.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            89999999999999987432 24899999999999999999999 44788999999999999999999999999998743


Q ss_pred             CcCCCcee-------eecccCCccccCC
Q 042902          579 LKEDQSLT-------QTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~-------~~~~~gt~~y~AP  599 (599)
                      ....+...       .-...-|+.|.||
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            22211100       0123458889998

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=6e-25  Score=215.82  Aligned_cols=162  Identities=28%  Similarity=0.430  Sum_probs=137.4

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChh
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLE  512 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  512 (599)
                      +.||+|+||.||+|...+++.||+|.++... ......|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998889999999986553 233457899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccC
Q 042902          513 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  592 (599)
Q Consensus       513 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  592 (599)
                      +++......+++..+..++.|++.||.|+|   +.+++||||||+||++++++.+|++|||+++....... .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            998766556889999999999999999999   89999999999999999999999999999975432211 11112234


Q ss_pred             CccccCC
Q 042902          593 TIGYMAP  599 (599)
Q Consensus       593 t~~y~AP  599 (599)
                      ++.|+||
T Consensus       157 ~~~y~aP  163 (250)
T cd05085         157 PIKWTAP  163 (250)
T ss_pred             cccccCH
Confidence            5679888

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.93  E-value=7.5e-26  Score=229.02  Aligned_cols=166  Identities=28%  Similarity=0.440  Sum_probs=143.1

Q ss_pred             CCCcCceecccccceEEEEEecC---C--cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD---G--IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..+..+.||+|-||.||+|.+.+   |  -.||||.-+.. ..+..+.|+.|..+|+.++|||||+++|+|.+. ..|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34456789999999999998542   3  35889988764 445678899999999999999999999999764 68999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||.++-|.|.+++...+..++......++.||+.||+|||   +..+|||||.++|||+....-+|++|||++|.+.++.
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999999998888999998999999999999999   9999999999999999999999999999999876554


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .+ ..+...-+..||||
T Consensus       546 yY-kaS~~kLPIKWmaP  561 (974)
T KOG4257|consen  546 YY-KASRGKLPIKWMAP  561 (974)
T ss_pred             hh-hccccccceeecCc
Confidence            43 33445567789998

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=5.5e-25  Score=220.57  Aligned_cols=168  Identities=23%  Similarity=0.439  Sum_probs=140.8

Q ss_pred             CCCcCceecccccceEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Ceee
Q 042902          429 GFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  500 (599)
                      -|+..+.||+|+||.||.|++     .++..||+|.++... ....+.+.+|++++++++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467789999999999999974     257889999986543 33456799999999999999999999998775  5688


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++++|.+++......+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998765556899999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCce-eeecccCCccccCC
Q 042902          581 EDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ..... ......++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             CccceeecCCCCCCccccCH
Confidence            33221 11234566779987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=6.6e-25  Score=220.92  Aligned_cols=167  Identities=28%  Similarity=0.393  Sum_probs=145.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+........+.+..|+++++.++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888899999999999999876 58999999997766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +++++..++......+++..+..++.|+++|+.|||   +.+++||||||+||+++.++.+||+|||++.......  ..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence            999999888765556899999999999999999999   8899999999999999999999999999987542221  12


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       167 ~~~~~~~~~y~aP  179 (292)
T cd06644         167 RDSFIGTPYWMAP  179 (292)
T ss_pred             cceecCCccccCc
Confidence            2344678889998

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=5.6e-25  Score=220.57  Aligned_cols=164  Identities=26%  Similarity=0.404  Sum_probs=139.8

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      |+..+.||+|+||.||+|... +++.||||.+....   ....+.+..|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999866 68999999986442   22235678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++.... ..+++..+..++.|++.||.|+|   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886433 25788889999999999999999   8999999999999999999999999999997553222  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.||||
T Consensus       157 -~~~~~~g~~~y~aP  170 (285)
T cd05630         157 -TIKGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCccccCh
Confidence             12345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.4e-25  Score=219.48  Aligned_cols=168  Identities=24%  Similarity=0.383  Sum_probs=140.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|...+.||+|+||.||+|.+. +|.    .||+|...... .....++.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45778899999999999999865 233    68999886543 3345678999999999999999999999987 78899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.||++|++|||   +.+|+||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876666899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         163 EKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             ccceecCCCcccccccCH
Confidence            332222223346679988

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=3.3e-25  Score=230.99  Aligned_cols=165  Identities=28%  Similarity=0.364  Sum_probs=138.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----eee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  500 (599)
                      +|+..+.||+|+||.||+|... +|+.||||++....  ....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999864 78999999986432  234567889999999999999999999998776     789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||++ ++|.+.+.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888776543 4788899999999999999999   89999999999999999999999999999985432


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      .. ........+|+.|+||
T Consensus       156 ~~-~~~~~~~~~~~~y~aP  173 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAP  173 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCH
Confidence            22 1223345688999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=6.2e-25  Score=222.13  Aligned_cols=166  Identities=26%  Similarity=0.430  Sum_probs=141.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+..|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999875 58899999986543 33345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++ ++|.+++......+++..+..++.||++||+|||   +.+|+||||||+||++++++.+||+|||+++.......  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 5999888776656888899999999999999999   89999999999999999999999999999975432221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (301)
T cd07873         160 TYSNEVVTLWYRPP  173 (301)
T ss_pred             cccccceeecccCc
Confidence            12234578889998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.92  E-value=5.5e-25  Score=220.10  Aligned_cols=169  Identities=28%  Similarity=0.480  Sum_probs=142.3

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|...+.||+|+||.||+|...      ++..||+|.+..........|..|++++++++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35677889999999999999642      366899999876666666789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC--------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          502 VLEYMPHGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      ||||+++|+|.+++....              ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24788889999999999999999   8999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||+++.+.............+++.|+||
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCH
Confidence            99999999865433222222334457789998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.92  E-value=8.1e-25  Score=216.08  Aligned_cols=163  Identities=32%  Similarity=0.545  Sum_probs=142.0

Q ss_pred             ceecccccceEEEEEecC----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQD----GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|...+    +..||+|.++..... ..+++..|+++++.++|+|++++++++.+.+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998764    788999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          509 GSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       509 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      |+|.+++...        ...+++..+..++.|+++|+.|||   +.+++||||||+||+++.++.+|++|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        356899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...........+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccCCCcCccccCH
Confidence            4322233445678899998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=3.8e-25  Score=219.55  Aligned_cols=166  Identities=30%  Similarity=0.371  Sum_probs=143.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777789999999999999865 68999999987665555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...+ .+++..+..++.|++.|+.|+|   ..+++|+||||+||+++.++.+||+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999887554 4788899999999999999999   8899999999999999999999999999987653221  12


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~aP  175 (267)
T cd06645         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cccccCcccccCh
Confidence            2345789999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=5.3e-26  Score=232.20  Aligned_cols=161  Identities=28%  Similarity=0.445  Sum_probs=136.9

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEecc----cccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe--eeEEEEc
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDL----QYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF--KALVLEY  505 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  505 (599)
                      ..+||+|+|-+||||.+. +|.+||.-.++.    +.....++|..|+.+|+.++|||||+++.+|.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            368999999999999876 588888755432    234456899999999999999999999999987765  6789999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |..|+|..|.++.+. .+.....++++||++||.|||+. .+||||||||-+||+|+ ..|.|||+|.|+|..+...   
T Consensus       125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---  199 (632)
T ss_pred             ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence            999999999987654 78888899999999999999965 68999999999999998 5589999999999866422   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ....++|||.||||
T Consensus       200 -~aksvIGTPEFMAP  213 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAP  213 (632)
T ss_pred             -ccceeccCccccCh
Confidence             22347999999999

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=1e-24  Score=215.18  Aligned_cols=161  Identities=26%  Similarity=0.436  Sum_probs=133.3

Q ss_pred             eecccccceEEEEEec---CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          435 LIGRGGVASVYKARIQ---DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764   356799999875532 334679999999999999999999998854 57899999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce-eeec
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQTQ  589 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~  589 (599)
                      |.+++......+++..+++++.|++.||.|+|   ..+++||||||+||+++.++.+|++|||+++......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866667899999999999999999999   8899999999999999999999999999998654332211 1122


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..+++.|+||
T Consensus       158 ~~~~~~y~aP  167 (257)
T cd05115         158 GKWPLKWYAP  167 (257)
T ss_pred             CCCCcccCCH
Confidence            3346789998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.92  E-value=4.5e-25  Score=222.23  Aligned_cols=171  Identities=29%  Similarity=0.450  Sum_probs=141.7

Q ss_pred             HhCCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  497 (599)
                      ..++|+..+.||+|+||.||+|...+      ...||+|.+.... .....++.+|++++.++ +||||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888999999999999998642      3679999987542 33446788999999999 7999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcC---------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec
Q 042902          498 FKALVLEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  562 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~  562 (599)
                      ..++||||+++|+|.+++...               ...+++..++.++.|++.|+.|||   ..+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642               235788899999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.+|++|||+++.+.............++..|+||
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            9999999999999876443322222333456789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.92  E-value=6e-25  Score=218.32  Aligned_cols=163  Identities=21%  Similarity=0.349  Sum_probs=131.6

Q ss_pred             ceecccccceEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          434 NLIGRGGVASVYKARIQDG---IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +.||+|+||.||+|+..++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999986543   346677665443 234578999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          510 SLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       510 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|.+++....   ...++.....++.||++||+|+|   +.+++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999987542   23566677889999999999999   88999999999999999999999999999864322221112


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       158 ~~~~~~~~~y~aP  170 (268)
T cd05086         158 EDDKCVPLRWLAP  170 (268)
T ss_pred             ccCCcCcccccCc
Confidence            2345678889998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.92  E-value=5.9e-25  Score=222.29  Aligned_cols=169  Identities=24%  Similarity=0.408  Sum_probs=141.9

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  499 (599)
                      ++|...+.||+|+||.||+|...      ++..||||.++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888899999999999999742      35689999987543 33456799999999999 799999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ++||||+++|+|.++++.... .+++.++..++.|++.|+.|+|   +.+|+|+||||+||+++.++.+|++|||+++.+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            999999999999999876433 4799999999999999999999   899999999999999999999999999999866


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .............+++.|+||
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aP  212 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAP  212 (302)
T ss_pred             cCCCceeecCCCCcccccCCH
Confidence            443322222234467789998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.92  E-value=4.2e-25  Score=221.27  Aligned_cols=167  Identities=24%  Similarity=0.404  Sum_probs=138.8

Q ss_pred             CCcCceecccccceEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          430 FSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      |...+.||+|+||.||+|...      +++.||+|+++..... ..+.|..|+.+++.++||||+++++++.+.+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            556688999999999999863      3578999999755332 346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcC---------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          503 LEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      +||+++++|.+++...               ...+++..+..++.|++.||+|+|   +.+|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            9999999999988532               124778888999999999999999   8999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||+++...............+++.||||
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCH
Confidence            99999999865433322222334567889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=7.1e-25  Score=221.09  Aligned_cols=165  Identities=28%  Similarity=0.413  Sum_probs=143.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|+..+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46888899999999999999864 68999999997665555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...  .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||+++.......  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998654  3788899999999999999999   88999999999999999999999999999886533221  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....|++.|+||
T Consensus       173 ~~~~~~~~~y~aP  185 (296)
T cd06654         173 RSTMVGTPYWMAP  185 (296)
T ss_pred             cCcccCCccccCH
Confidence            2334688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=6.8e-25  Score=218.04  Aligned_cols=168  Identities=26%  Similarity=0.450  Sum_probs=139.5

Q ss_pred             CCCcCceecccccceEEEEEecC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD-G---IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .|...+.||+|+||.||+|.+.. +   ..||||.++.. .....++|..|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999998652 3   36999998754 2334578999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++......+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+|++|||+++.......
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999999876666899999999999999999999   89999999999999999999999999999876543221


Q ss_pred             ceeeecc---cCCccccCC
Q 042902          584 SLTQTQT---LATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~---~gt~~y~AP  599 (599)
                      .......   ..+..|+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAP  180 (269)
T ss_pred             ccccccccCCCcceeecCH
Confidence            1111111   124578887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=1.1e-24  Score=221.11  Aligned_cols=164  Identities=24%  Similarity=0.344  Sum_probs=141.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|... ++..||+|.++... .....++..|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 58889999986542 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++...+ .+++..+..++.|+++||.|||   + .+++||||||+||++++++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999987653 4788888999999999999999   5 589999999999999999999999999987553221  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....|++.|+||
T Consensus       155 --~~~~~~~~~~~aP  167 (308)
T cd06615         155 --ANSFVGTRSYMSP  167 (308)
T ss_pred             --cccCCCCcCccCh
Confidence              2335688899998

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.92  E-value=5.3e-25  Score=223.25  Aligned_cols=170  Identities=28%  Similarity=0.436  Sum_probs=140.0

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|+..        ++..||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888999999999999999753        23579999997542 33456788899999999 799999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++||||+++|+|.+++....               ..+++..+++++.|++.||+|+|   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997532               24788899999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||.|+...............+++.||||
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            99999999999999865432221122223355789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=7.7e-25  Score=220.88  Aligned_cols=169  Identities=25%  Similarity=0.421  Sum_probs=139.0

Q ss_pred             CCCCcCceecccccceEEEEEec-----------------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-----------------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI  489 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  489 (599)
                      ++|+..+.||+|+||.||+|...                 ++..||+|.++... .....+|..|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998543                 24469999987543 3345689999999999999999999


Q ss_pred             EEEEEcCCeeeEEEEccCCCChhhhhhcCC----------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCe
Q 042902          490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNV  559 (599)
Q Consensus       490 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Ni  559 (599)
                      ++++...+..++||||+++|+|.+++....          ..+++..+..++.|++.|++|+|   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999986532          13667788999999999999999   88999999999999


Q ss_pred             eecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          560 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       560 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++++++.+|++|||+++.+.............+++.||||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            9999999999999999865433222122223446678887

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=9.4e-25  Score=217.31  Aligned_cols=166  Identities=27%  Similarity=0.451  Sum_probs=133.0

Q ss_pred             CcCceecccccceEEEEEecC-Cc--EEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------Cee
Q 042902          431 SENNLIGRGGVASVYKARIQD-GI--EVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSND------DFK  499 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  499 (599)
                      ...+.||+|+||.||+|++.+ +.  .||+|.++..  .....+.|..|++++++++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999764 33  6999988654  233457789999999999999999999987532      246


Q ss_pred             eEEEEccCCCChhhhhhc-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          500 ALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ++||||+++|+|.+++..     ....+++.....++.|+++||+|||   ..+|+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988742     2234788889999999999999999   89999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+.+.............+++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCH
Confidence            9876433322222233456678887

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=7.8e-25  Score=220.88  Aligned_cols=165  Identities=28%  Similarity=0.414  Sum_probs=143.8

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788899999999999999986 479999999997665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++++|.+++...  .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            999999988654  3788889999999999999999   88999999999999999999999999999986543221  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       172 ~~~~~~~~~y~aP  184 (297)
T cd06656         172 RSTMVGTPYWMAP  184 (297)
T ss_pred             cCcccCCccccCH
Confidence            2234678889987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=8.5e-25  Score=219.86  Aligned_cols=168  Identities=25%  Similarity=0.431  Sum_probs=138.5

Q ss_pred             CCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      +|...+.||+|+||.||+|...      ....||+|.+.... .....++..|+.++++++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677789999999999999753      23579999886543 2335679999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 042902          502 VLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  558 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~N  558 (599)
                      ||||+++|+|.+++....                       ..+++..+..++.|++.|+.|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999875421                       24678888999999999999999   8999999999999


Q ss_pred             eeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          559 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       559 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |++++++.+||+|||+++...............++..|+||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            99999999999999999865433332222334567789987

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.8e-26  Score=229.44  Aligned_cols=174  Identities=25%  Similarity=0.398  Sum_probs=148.8

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      ++++....+.+..+++|-|.||.||.|.|+. ...||||.++... ...++|+.|+.+|+.++|||+|+++|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444445567778999999999999999874 6789999997543 3568999999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      |||+|||.+|+|.++|++... ..+.-..+.+|.||++||+||.   .+.+|||||.++|+|+.++-.+||+|||++|.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999987654 4555566789999999999999   999999999999999999999999999999976


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      . ++++....+..-+..|.||
T Consensus       416 t-gDTYTAHAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  416 T-GDTYTAHAGAKFPIKWTAP  435 (1157)
T ss_pred             c-CCceecccCccCcccccCc
Confidence            4 4555555555567788888

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=3.9e-25  Score=228.84  Aligned_cols=161  Identities=23%  Similarity=0.284  Sum_probs=138.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ...+|...+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999976 5788999985322      23468999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+. |+|.+++......+++..+..|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            995 6898888776667899999999999999999999   889999999999999999999999999999743221   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.||||
T Consensus       211 ~~~~~~~gt~~y~aP  225 (357)
T PHA03209        211 PAFLGLAGTVETNAP  225 (357)
T ss_pred             cccccccccccccCC
Confidence            122345689999998

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=8.4e-25  Score=215.91  Aligned_cols=155  Identities=25%  Similarity=0.449  Sum_probs=131.7

Q ss_pred             ceecccccceEEEEEecCC-----------cEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          434 NLIGRGGVASVYKARIQDG-----------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +.||+|+||.||+|.+.+.           ..||+|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999997643           25788877654433 6789999999999999999999999988 778999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-------cEEEccccCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-------VAHLSDFGMA  575 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-------~~kl~DFGla  575 (599)
                      |||+++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.++       .+|++|||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656889999999999999999999   89999999999999999887       7999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +....      .....++..|+||
T Consensus       156 ~~~~~------~~~~~~~~~y~aP  173 (259)
T cd05037         156 ITVLS------REERVERIPWIAP  173 (259)
T ss_pred             ccccc------ccccccCCCccCh
Confidence            86532      1223456678887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=9.1e-25  Score=215.25  Aligned_cols=166  Identities=27%  Similarity=0.330  Sum_probs=143.4

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|... +++.||+|.+...  .....+++..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999875 6899999998643  234567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++++|.+++... ...+++..+..++.|++.||.|||   ..+++||||||+||++++++.+|++|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998764 346888899999999999999999   88999999999999999999999999999986643322 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~aP  170 (256)
T cd08529         157 -FANTIVGTPYYLSP  170 (256)
T ss_pred             -hhhccccCccccCH
Confidence             12334688899998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.1e-24  Score=216.95  Aligned_cols=167  Identities=28%  Similarity=0.467  Sum_probs=136.2

Q ss_pred             CCcCceecccccceEEEEEecC----CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe-----
Q 042902          430 FSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF-----  498 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  498 (599)
                      |...+.||+|+||.||+|.+..    +..||||.++...  .....++..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    3679999987542  2345679999999999999999999998866554     


Q ss_pred             -eeEEEEccCCCChhhhhhcC-----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          499 -KALVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       499 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                       .++||||+++|+|..++...     ...+++..+..++.|++.||.|+|   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999887532     235788889999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|+.+.............++..|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             cceeeccccccccccccccCCccccCH
Confidence            999876544332222223456678887

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=8.8e-25  Score=216.35  Aligned_cols=166  Identities=25%  Similarity=0.428  Sum_probs=139.4

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|++.++..||+|+++.... ..++|..|++++++++||||+++++++. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            46888899999999999999987777899999875332 3467899999999999999999999874 456899999999


Q ss_pred             CCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|+|.+++.... ..+++..+..++.|+++||+|+|   +.+++||||||+||++++++.+||+|||.++.+..... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            999999997543 35788999999999999999999   89999999999999999999999999999986543322 11


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~~P  172 (262)
T cd05071         160 RQGAKFPIKWTAP  172 (262)
T ss_pred             ccCCcccceecCH
Confidence            2234466789998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=7.8e-25  Score=218.52  Aligned_cols=170  Identities=21%  Similarity=0.367  Sum_probs=142.1

Q ss_pred             hCCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .++|...+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3568888999999999999998642      4689999986543 23456788999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC---------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         23678888999999999999999   8999999999999999999999999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++.+...+.........+|..|+||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCH
Confidence            99999866443322222344567889998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=1e-24  Score=219.37  Aligned_cols=163  Identities=31%  Similarity=0.396  Sum_probs=142.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999876 58999999986432   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.|+++||.|||   ..+|+||||+|+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987654 4788889999999999999999   899999999999999999999999999999865432  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....+++.|+||
T Consensus       155 ---~~~~~~~~~y~aP  167 (290)
T cd05580         155 ---TYTLCGTPEYLAP  167 (290)
T ss_pred             ---CCCCCCCccccCh
Confidence               2234688899998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.92  E-value=9.6e-25  Score=216.62  Aligned_cols=167  Identities=28%  Similarity=0.412  Sum_probs=141.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||.++...   .....+|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999865 68999999876432   233457899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++..   ....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.++++|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2234788888999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  ......|++.|+||
T Consensus       159 ~~~--~~~~~~~~~~~~aP  175 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             hhH--HHhcCCCCccccCh
Confidence            221  12234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=4.9e-25  Score=231.00  Aligned_cols=163  Identities=25%  Similarity=0.272  Sum_probs=138.6

Q ss_pred             hCCCCcCceecccccceEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ---DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ..+|...+.||+|+||.||+|...   .++.||||.+...     ..+.+|++++++++|||||++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            356899999999999999999754   3578999987533     23567999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+. ++|.+++.. ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 688888843 345899999999999999999999   89999999999999999999999999999986654333


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      ........||+.|+||
T Consensus       241 ~~~~~~~~gt~~y~aP  256 (392)
T PHA03207        241 TPQCYGWSGTLETNSP  256 (392)
T ss_pred             cccccccccccCccCH
Confidence            3333456799999998

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=1.1e-24  Score=215.77  Aligned_cols=167  Identities=25%  Similarity=0.428  Sum_probs=140.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|+..+.||+|+||.||+|.+. .++.||+|.+.... ....++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34777889999999999999876 58899999986432 34567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++.... ..+++..+..++.|+++||+|||   ..+++||||||+||++++++.+||+|||+++....... .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999987543 35788999999999999999999   89999999999999999999999999999986543221 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++++|+||
T Consensus       161 ~~~~~~~~~~y~aP  174 (263)
T cd05052         161 AHAGAKFPIKWTAP  174 (263)
T ss_pred             ccCCCCCccccCCH
Confidence            11223346679998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.92  E-value=8.1e-25  Score=222.64  Aligned_cols=170  Identities=26%  Similarity=0.431  Sum_probs=139.4

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|+..        .+..||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356788899999999999999742        24579999987542 33456788999999999 699999999999998


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++||||+++|+|.+++....               ..+++..+.+++.|++.||.|+|   +.+|+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999986532               24788889999999999999999   8999999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++++.+|++|||+++...............+++.||||
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            99999999999999865432222112223345679998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=228.56  Aligned_cols=161  Identities=29%  Similarity=0.430  Sum_probs=142.6

Q ss_pred             ceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChh
Q 042902          434 NLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLE  512 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  512 (599)
                      -++|+|.||+||.|++.+ ...+|||-+..+..+..+...+||..-++++|.|||+++|.|...+..-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            379999999999999664 5679999998888777888999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccCCccCCcCCCceeeec
Q 042902          513 KCLYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       513 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                      +.++...+.+  .+...--+..||++||.|||   ...|||||||-+||||. -.|.+||+|||-++++..-  ......
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence            9999877765  56667789999999999999   89999999999999997 5689999999999987532  234456


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..||..||||
T Consensus       736 FTGTLQYMAP  745 (1226)
T KOG4279|consen  736 FTGTLQYMAP  745 (1226)
T ss_pred             cccchhhhCh
Confidence            7899999999

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.92  E-value=6.6e-25  Score=232.80  Aligned_cols=162  Identities=31%  Similarity=0.438  Sum_probs=131.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--------C
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND--------D  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  497 (599)
                      ..+|...+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++|||||++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999875 68999999885332    2345699999999999999998876432        2


Q ss_pred             eeeEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEcccc
Q 042902          498 FKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFG  573 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFG  573 (599)
                      ..++||||+++ ++.+++..   ....+++..+..++.||++||+|||   +.+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 77666542   3345888899999999999999999   89999999999999999664 79999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|+.+.....   .....||+.||||
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aP  239 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAP  239 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCH
Confidence            9986643322   2345789999998

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.92  E-value=3.8e-25  Score=218.39  Aligned_cols=164  Identities=35%  Similarity=0.543  Sum_probs=139.3

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEeccccccc--HHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      |+..+.||+|+||+||+|+.. +++.||+|++.......  ......|+.++++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999976 46789999997664332  223456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++++|.+++... ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.++|+|||.+.....  ....
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccc
Confidence            999999999832 34789999999999999999999   88999999999999999999999999999975421  1223


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (260)
T PF00069_consen  155 FNPFVGTPEYMAP  167 (260)
T ss_dssp             BSSSSSSGGGSCH
T ss_pred             ccccccccccccc
Confidence            4556789999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.92  E-value=9.4e-25  Score=218.04  Aligned_cols=170  Identities=26%  Similarity=0.394  Sum_probs=139.4

Q ss_pred             hCCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      +++|...+.||+|+||.||+|.+.+      +..||+|.+.... ......|..|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4568888999999999999998753      5679999886443 23345799999999999999999999999998999


Q ss_pred             eEEEEccCCCChhhhhhcCC------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLS  570 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~  570 (599)
                      ++||||+++|+|.+++....      ..+++..+.+++.||+.|++|||   +.+++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987543      24788999999999999999999   88999999999999998654   69999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++.+..............++.||||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPP  190 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCH
Confidence            99999866332221112223345679988

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.92  E-value=1.3e-24  Score=214.84  Aligned_cols=166  Identities=26%  Similarity=0.445  Sum_probs=139.9

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|...++..||+|.++.... ..++|.+|+.++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788899999999999999988888999999875433 3467999999999999999999999875 456899999999


Q ss_pred             CCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +++|.++++... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.+...... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence            999999987643 35789999999999999999999   889999999999999999999999999999865432211 1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~aP  172 (260)
T cd05070         160 RQGAKFPIKWTAP  172 (260)
T ss_pred             ccCCCCCccccCh
Confidence            1233456679998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=1e-24  Score=242.12  Aligned_cols=166  Identities=28%  Similarity=0.390  Sum_probs=143.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|.+. +++.||||+++...   ......+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 68999999986432   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..|+.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~-  158 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE-  158 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc-
Confidence            9999999999987644 4778888999999999999999   8899999999999999999999999999998654322 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......+|+.|+||
T Consensus       159 -~~~~~~~~t~~~~~p  173 (669)
T cd05610         159 -LNMMDILTTPSMAKP  173 (669)
T ss_pred             -ccccccccCccccCc
Confidence             223346788888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=8.4e-25  Score=221.41  Aligned_cols=161  Identities=20%  Similarity=0.181  Sum_probs=125.8

Q ss_pred             HHhCCCCcCceecccccceEEEEEec--CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDLQ-----YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD  497 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  497 (599)
                      ...++|...+.||+|+||+||+|.+.  +++.||||++...     .....+.|.+|++++++++|+|++..+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            45678999999999999999999865  5778899987533     122356799999999999999998533322   4


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCeeecCCCcEEEccccCCc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DFGla~  576 (599)
                      ..++||||++|++|... ...    .   ...++.++++||.|+|   +.+|+|||| ||+|||++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57999999999999632 111    1   1467889999999999   899999999 9999999999999999999999


Q ss_pred             cCCcCCCcee------eecccCCccccCC
Q 042902          577 PLLKEDQSLT------QTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~------~~~~~gt~~y~AP  599 (599)
                      .+...+....      .+...+++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            7654432111      1355678888887

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=1.9e-24  Score=216.07  Aligned_cols=159  Identities=26%  Similarity=0.375  Sum_probs=136.6

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +|+..+.||+|+||.||+|... +++.||+|.+.... ....++|..|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5777889999999999999864 68999999986542 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|++..+.     .+++..+..++.|++.||.|+|   +.+|+|+||||+||+++.++.+||+|||++..+...    .
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence            999997542     2567788899999999999999   899999999999999999999999999999865322    1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....||+.|+||
T Consensus       150 ~~~~~~~~~y~aP  162 (279)
T cd06619         150 AKTYVGTNAYMAP  162 (279)
T ss_pred             ccCCCCChhhcCc
Confidence            2335788999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=233.17  Aligned_cols=164  Identities=27%  Similarity=0.400  Sum_probs=142.1

Q ss_pred             CcCceecccccceEEEEEec-CC----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          431 SENNLIGRGGVASVYKARIQ-DG----IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ...++||+|+||+||+|.|- .|    .+||||++... ......+++.|+-+|++++|||+++++|+|..+. ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34579999999999999853 33    47999998654 3445688999999999999999999999998776 789999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||+.|+|.++++..+..+.....+.|..|||+||.|||   ..++|||||.++||||..-..+||.|||+|+....++..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999988888888899999999999999999   999999999999999999999999999999988776655


Q ss_pred             eeeecccCCccccC
Q 042902          585 LTQTQTLATIGYMA  598 (599)
Q Consensus       585 ~~~~~~~gt~~y~A  598 (599)
                      .......-.+.|||
T Consensus       855 y~~~~gK~pikwma  868 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMA  868 (1177)
T ss_pred             ccccccccCcHHHH
Confidence            55455555667776

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=9e-25  Score=219.46  Aligned_cols=170  Identities=28%  Similarity=0.457  Sum_probs=140.7

Q ss_pred             hCCCCcCceecccccceEEEEEec------CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .++|+..+.||+|+||.||+|...      ++..||+|.++.... ....+|..|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999863      467899999875432 3456799999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC---------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSN---------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNN  558 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~N  558 (599)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||.|+|   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986432                     13677888999999999999999   8999999999999


Q ss_pred             eeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          559 VLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       559 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |++++++.+|++|||+++.+..............++.|+||
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            99999999999999998865332221122223456679887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=1.5e-24  Score=218.13  Aligned_cols=168  Identities=27%  Similarity=0.414  Sum_probs=140.6

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++++|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++|+||+++.+++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 689999999865532 33356788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||++ +++.+++......+.+..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6787777655455778888899999999999999   88999999999999999999999999999985432221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......+++.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (291)
T cd07870         159 --TYSSEVVTLWYRPP  172 (291)
T ss_pred             --CCCCccccccccCC
Confidence              12334578899998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=6.4e-26  Score=212.25  Aligned_cols=170  Identities=27%  Similarity=0.361  Sum_probs=139.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec---C--CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ---D--GIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  497 (599)
                      ....|+....||+|.||.||+|.-.   +  .+.+|+|+++...  .+....-.+|+..++.++||||+.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457888899999999999999643   2  3479999997553  2334566789999999999999999998876 77


Q ss_pred             eeeEEEEccCCCChhhhhhcC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC----CcEEE
Q 042902          498 FKALVLEYMPHGSLEKCLYSS----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHL  569 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~----~~~kl  569 (599)
                      ..++++||+|. +|.+.++-.    ...++...+..|+.||+.|+.|||   +.=|+||||||+|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            89999999988 898887632    235788888999999999999999   6669999999999999877    89999


Q ss_pred             ccccCCccCCcCCCce-eeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~AP  599 (599)
                      +|||+||.+...-+.. ....++.|.+|.||
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecCh
Confidence            9999999886554433 34567789999998

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.92  E-value=1.1e-24  Score=226.07  Aligned_cols=164  Identities=27%  Similarity=0.346  Sum_probs=135.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  497 (599)
                      ..++|...+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3468999999999999999999865 5899999998643  2334567889999999999999999999886543     


Q ss_pred             -eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          498 -FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       498 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                       ..|+||||+++ ++.+.+..   .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999975 56665543   3677888899999999999999   8999999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....   .......||+.|+||
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aP  191 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAP  191 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCc
Confidence            54322   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.1e-24  Score=213.51  Aligned_cols=168  Identities=30%  Similarity=0.400  Sum_probs=146.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|...+.||+|+||.||+|... +++.+|+|.+........+.+..|++++++++||||+++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888899999999999999875 5788999999766555678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+|+|+||||+||++++++.+||+|||.+........  
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            9999999998776456888999999999999999999   88999999999999999999999999999986543211  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~y~~P  170 (262)
T cd06613         157 KRKSFIGTPYWMAP  170 (262)
T ss_pred             ccccccCCccccCc
Confidence            22335678889998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=1.8e-24  Score=214.87  Aligned_cols=169  Identities=25%  Similarity=0.489  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CC---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DG---IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|... ++   ..||+|.++... ....+.+..|++++++++|||++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999875 33   379999986553 33456799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|++.|++|+|   +.+++||||||+||++++++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999876666899999999999999999999   8899999999999999999999999999998654322


Q ss_pred             Cce-eeecccCCccccCC
Q 042902          583 QSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~-~~~~~~gt~~y~AP  599 (599)
                      ... .......++.|+||
T Consensus       162 ~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             ccceeccCCCcCceecCH
Confidence            211 11122335578887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.92  E-value=1.2e-24  Score=220.30  Aligned_cols=167  Identities=31%  Similarity=0.524  Sum_probs=136.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGI--EVAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|.++ ++.  .+|+|.++.. ......+|..|++++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            356888899999999999999875 454  4677777543 233456788999999999 89999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc
Q 042902          502 VLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  566 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~  566 (599)
                      ||||+++|+|.++++...               ..+++..+..++.|+++|++|||   +.+|+||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999987532               24788889999999999999999   899999999999999999999


Q ss_pred             EEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          567 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       567 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +||+|||+++....   ........+++.|+||
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP  192 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAI  192 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCH
Confidence            99999999863211   1111222345678887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.7e-24  Score=214.12  Aligned_cols=168  Identities=27%  Similarity=0.457  Sum_probs=143.3

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|...+.||+|+||.||+|..++++.||||.+.... ...+++..|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45788889999999999999998888999999987543 34577999999999999999999999999889999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++++|.+++.... ..+++..+..++.|++.|+.|+|   +.+++|+||||+||++++++.+|++|||+++.+.... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997654 36889999999999999999999   8899999999999999999999999999998654321 11


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (261)
T cd05034         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             hhhccCCCccccCH
Confidence            11223345678887

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.4e-24  Score=213.24  Aligned_cols=168  Identities=26%  Similarity=0.400  Sum_probs=141.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|...+.||+|++|.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 68999999986432     1234578899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887644 4778888999999999999999   899999999999999999999999999999865322


Q ss_pred             CCce-eeecccCCccccCC
Q 042902          582 DQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~-~~~~~~gt~~y~AP  599 (599)
                      .... ......+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             ccccccccCCCcCccccCc
Confidence            1111 11234678889998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.5e-24  Score=211.55  Aligned_cols=163  Identities=31%  Similarity=0.466  Sum_probs=137.2

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChh
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLE  512 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  512 (599)
                      +.||+|+||.||+|...+++.||+|.+...... ..+.|..|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998655332 4578999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccC
Q 042902          513 KCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA  592 (599)
Q Consensus       513 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  592 (599)
                      +++......+++..+..++.+++.|+.|+|   +.+++||||||+||+++.++.+||+|||.++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999765556788889999999999999999   89999999999999999999999999999985432211111112233


Q ss_pred             CccccCC
Q 042902          593 TIGYMAP  599 (599)
Q Consensus       593 t~~y~AP  599 (599)
                      +..|+||
T Consensus       158 ~~~y~~P  164 (251)
T cd05041         158 PIKWTAP  164 (251)
T ss_pred             eeccCCh
Confidence            5568887

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=2.3e-24  Score=216.05  Aligned_cols=165  Identities=28%  Similarity=0.410  Sum_probs=139.2

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|+.. +++.||||.++...  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999875 68999999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ++ +++.+++....  ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68888876432  45888999999999999999999   8999999999999999999999999999997543221 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......+++.|+||
T Consensus       156 -~~~~~~~~~~~y~aP  170 (285)
T cd07861         156 -RVYTHEVVTLWYRAP  170 (285)
T ss_pred             -ccccCCcccccccCh
Confidence             112334578889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=2.5e-24  Score=212.25  Aligned_cols=166  Identities=23%  Similarity=0.328  Sum_probs=143.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||.++.. +++.||+|.+...  ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999998854 6899999998654  234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++... ...+++..+..++.|+++|+.|+|   +.+++||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 345788999999999999999999   88999999999999999999999999999986543321 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......+++.|+||
T Consensus       157 -~~~~~~~~~~y~ap  170 (256)
T cd08221         157 -MAETVVGTPYYMSP  170 (256)
T ss_pred             -cccccCCCccccCH
Confidence             22345688899988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=1.7e-24  Score=215.37  Aligned_cols=167  Identities=27%  Similarity=0.411  Sum_probs=139.4

Q ss_pred             CCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|.+.+    ...||||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998653    3469999886554 3455689999999999999999999998875 457899


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|++.|+.|+|   +.+++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876656899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      . .......+++.|+||
T Consensus       162 ~-~~~~~~~~~~~y~aP  177 (270)
T cd05056         162 Y-YKASKGKLPIKWMAP  177 (270)
T ss_pred             c-eecCCCCccccccCh
Confidence            1 122233455679988

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=2e-24  Score=215.94  Aligned_cols=170  Identities=21%  Similarity=0.341  Sum_probs=141.8

Q ss_pred             hCCCCcCceecccccceEEEEEecC-----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  499 (599)
                      .++|...+.||+|+||.||+|.+.+     +..||+|.+.... ....+.+..|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999999765     6889999986443 3345678899999999999999999998876 4678


Q ss_pred             eEEEEccCCCChhhhhhcCC-------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                      ++++||+++|+|.+++....       ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986532       34789999999999999999999   899999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++.+.............++..|+||
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCH
Confidence            999876443322222234456779988

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=2.3e-24  Score=213.70  Aligned_cols=167  Identities=27%  Similarity=0.453  Sum_probs=141.0

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|+..+.||+|+||.||+|...+|+.+|||.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12235688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++.... .+++..+..++.|++.|++|+|   ..+|+|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997644 4678888899999999999999   8899999999999999999999999999987543211


Q ss_pred             ----CceeeecccCCccccCC
Q 042902          583 ----QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ----~~~~~~~~~gt~~y~AP  599 (599)
                          .........|++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~p  177 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAP  177 (265)
T ss_pred             ccccccccccccCCCccccCh
Confidence                11112345688899998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.92  E-value=2.9e-24  Score=211.81  Aligned_cols=166  Identities=30%  Similarity=0.543  Sum_probs=141.8

Q ss_pred             CCcCceecccccceEEEEEecC-----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          430 FSENNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      |+..+.||+|+||.||+|+..+     +..||+|.+...... ..+.+..|++++..++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456899999999999998764     388999999655433 5678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCc-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765544 899999999999999999999   8899999999999999999999999999998665442


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .... ....+++.|+||
T Consensus       158 ~~~~-~~~~~~~~y~~P  173 (258)
T smart00219      158 YYKK-KGGKLPIRWMAP  173 (258)
T ss_pred             cccc-ccCCCcccccCh
Confidence            2221 123477889998

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=1.6e-24  Score=222.37  Aligned_cols=169  Identities=28%  Similarity=0.441  Sum_probs=139.0

Q ss_pred             CCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD  497 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  497 (599)
                      .+|+..+.||+|+||.||+|+..        .+..||+|.++... ....+++..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            45888899999999999999742        12479999887543 33457899999999999 7999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  562 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~  562 (599)
                      ..++||||+++|+|.+++....               ..+++..++.++.|+++||.|||   ..+|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986532               24778888999999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.+||+|||+++...............+++.||||
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            9999999999999865432222222233446679998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.92  E-value=1.9e-24  Score=213.21  Aligned_cols=162  Identities=25%  Similarity=0.389  Sum_probs=137.7

Q ss_pred             ceecccccceEEEEEecC--C--cEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQD--G--IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...++|..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  2  3699999976654 556789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc-ee
Q 042902          509 GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS-LT  586 (599)
Q Consensus       509 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~-~~  586 (599)
                      |+|.+++.... ..+++.....++.|+++||+|+|   ..+++||||||+||+++.++.+||+|||+++.+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765 46889999999999999999999   899999999999999999999999999999876443221 11


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       157 ~~~~~~~~~y~~p  169 (257)
T cd05040         157 EEHLKVPFAWCAP  169 (257)
T ss_pred             ccCCCCCceecCH
Confidence            2234567789988

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.7e-24  Score=212.03  Aligned_cols=162  Identities=30%  Similarity=0.489  Sum_probs=140.3

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|...+.||+|+||.||+|... |+.||||.++.... ..+++..|+.++++++|+||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46788899999999999999875 89999999975543 46789999999999999999999999998899999999999


Q ss_pred             CCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +++|.+++..... .+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+||+|||.++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----  156 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence            9999999876543 5889999999999999999999   8999999999999999999999999999998653221    


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                       .....+..|+||
T Consensus       157 -~~~~~~~~~~ap  168 (256)
T cd05039         157 -DSGKLPVKWTAP  168 (256)
T ss_pred             -ccCCCcccccCc
Confidence             122345568877

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=2.1e-24  Score=213.43  Aligned_cols=167  Identities=21%  Similarity=0.399  Sum_probs=140.5

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+.|...+.||+|+||.||+|...+++.||+|.+.... ...++|..|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            45688889999999999999998889999999986543 23568999999999999999999999864 56789999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.++++|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999886543 35788899999999999999999   89999999999999999999999999999976542221 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~p  172 (260)
T cd05067         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            22334456789887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=3.3e-24  Score=211.25  Aligned_cols=166  Identities=20%  Similarity=0.317  Sum_probs=141.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +|+..+.||+|+||.||+++.. +++.||+|.++.. .....+.+..|+.++++++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999865 6899999998643 2334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|++.+++... ...+++.....++.|++.||.|+|   +.+|+|+||||+||++++++.++++|||.++.......  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 335788888999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (255)
T cd08219         156 YACTYVGTPYYVPP  169 (255)
T ss_pred             ccccccCCccccCH
Confidence            22345688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.4e-24  Score=223.87  Aligned_cols=165  Identities=26%  Similarity=0.341  Sum_probs=138.4

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC----
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND----  496 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  496 (599)
                      +...++|+..+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999864 68899999986532  22345678899999999999999999887543    


Q ss_pred             --CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          497 --DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       497 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                        ...|+++|++ +++|.+++...  .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3568999998 78998887643  4888999999999999999999   89999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+.....     .....||+.|+||
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aP  184 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             ceecCCC-----cCCccccccccCc
Confidence            9865322     2345689999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.3e-24  Score=216.11  Aligned_cols=166  Identities=28%  Similarity=0.379  Sum_probs=144.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|...+.||+|+||.||+|... +|+.||||++....  ....+.+..|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4777889999999999999975 68999999987553  33456899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      + +++|.+++......+++..+..++.||++||.|+|   +.+++|+||||+||++++++.++++|||+++....... .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999998766666899999999999999999999   88999999999999999999999999999986643321 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......|+.+|+||
T Consensus       156 ~~~~~~~~~~y~aP  169 (286)
T cd07832         156 LYSHQVATRWYRAP  169 (286)
T ss_pred             ccccccCcccccCc
Confidence            22345688899998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=1.4e-24  Score=217.78  Aligned_cols=173  Identities=25%  Similarity=0.325  Sum_probs=142.7

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEE----
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCS----  494 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~----  494 (599)
                      ..+..+.++|+..+.||+|+||.||+|... +++.||+|+++... ....++..|+.+++++ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            444557789999999999999999999875 58899999886432 2346788899999999 6999999999874    


Q ss_pred             -cCCeeeEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc
Q 042902          495 -NDDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       495 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                       .++..++||||+++|+|.+++..   ....+++..+..++.|+++|+.|||   +.+|+||||||+||++++++.+|++
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEc
Confidence             34578999999999999988753   2335788888999999999999999   8999999999999999999999999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++.+.....  ......|++.|+||
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~~y~aP  193 (286)
T cd06638         167 DFGVSAQLTSTRL--RRNTSVGTPFWMAP  193 (286)
T ss_pred             cCCceeecccCCC--ccccccCCCcccCh
Confidence            9999986543221  22334689999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=2.5e-24  Score=216.54  Aligned_cols=166  Identities=27%  Similarity=0.432  Sum_probs=140.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999876 689999999865432 2334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++ +|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 999988776656888999999999999999999   88999999999999999999999999999875422111  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       159 ~~~~~~~~~~~~aP  172 (291)
T cd07844         159 TYSNEVVTLWYRPP  172 (291)
T ss_pred             cccccccccccCCc
Confidence            11223467788888

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=1.4e-24  Score=217.72  Aligned_cols=165  Identities=27%  Similarity=0.403  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++.. .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999976 6899999988654 233456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +++++|.+++...  ...+++..+..++.|+++||.|||   . .+|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999988764  235889999999999999999999   5 589999999999999999999999999997653221


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                          .....+++.|+||
T Consensus       158 ----~~~~~~~~~y~aP  170 (286)
T cd06622         158 ----AKTNIGCQSYMAP  170 (286)
T ss_pred             ----cccCCCccCccCc
Confidence                1234578889988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.92  E-value=2.4e-24  Score=217.32  Aligned_cols=166  Identities=28%  Similarity=0.492  Sum_probs=136.0

Q ss_pred             CCCCcCceecccccceEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-GI--EVAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|...+ +.  .+|+|.++.. .....+.|..|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998753 43  4788888643 233456789999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          503 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      |||+++|+|.+++....               ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24778888999999999999999   8999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||++.....   .........+..|+||
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP  187 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAI  187 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCc
Confidence            9999999874211   1111122335578888

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=3.3e-24  Score=214.71  Aligned_cols=168  Identities=26%  Similarity=0.429  Sum_probs=140.8

Q ss_pred             CCCcCceecccccceEEEEEec-----CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-----DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  500 (599)
                      .|+..+.||+|+||.||+|++.     ++..||||.+...... ..+.|..|++++++++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4667789999999999999854     3688999999755443 46789999999999999999999999877  55789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+.....
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999876666899999999999999999999   88999999999999999999999999999987653


Q ss_pred             CCCcee-eecccCCccccCC
Q 042902          581 EDQSLT-QTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~-~~~~~gt~~y~AP  599 (599)
                      ...... .....++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             CCcceeccCCCCCcccccCc
Confidence            322111 1123345568887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.92  E-value=2.6e-24  Score=219.30  Aligned_cols=161  Identities=23%  Similarity=0.311  Sum_probs=129.3

Q ss_pred             CceecccccceEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEEEEccC
Q 042902          433 NNLIGRGGVASVYKARIQ---DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVLEYMP  507 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  507 (599)
                      .+.||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999865   46789999986432  23567889999999999999999998854  456889999995


Q ss_pred             CCChhhhhhcC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----cCCCcEEEccccCC
Q 042902          508 HGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMA  575 (599)
Q Consensus       508 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DFGla  575 (599)
                       +++.+++...        ...+++..+..++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5887776432        124788888999999999999999   8999999999999999    45678999999999


Q ss_pred             ccCCcCCCc-eeeecccCCccccCC
Q 042902          576 KPLLKEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      +.+...... .......||+.||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             eccCCCCccccccCCccccccccCC
Confidence            866433221 122356789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=2.3e-24  Score=217.25  Aligned_cols=165  Identities=29%  Similarity=0.433  Sum_probs=144.1

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|+..+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999985 468999999997665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++.......  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988654  3789999999999999999999   89999999999999999999999999999886543321  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       172 ~~~~~~~~~y~aP  184 (296)
T cd06655         172 RSTMVGTPYWMAP  184 (296)
T ss_pred             CCCcCCCccccCc
Confidence            2234688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.92  E-value=3.6e-24  Score=211.34  Aligned_cols=160  Identities=24%  Similarity=0.383  Sum_probs=132.7

Q ss_pred             eecccccceEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          435 LIGRGGVASVYKARIQ---DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      .||+|+||.||+|.++   +++.||+|+++...  ....+++..|+.++++++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57889999986443  234567999999999999999999999885 45678999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce-eee
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL-TQT  588 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~  588 (599)
                      +|.+++.... .+++..+..++.|++.|++|+|   +.+|+||||||+||++++++.+||+|||+++.+....... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987543 4788899999999999999999   8999999999999999999999999999998764433221 112


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...+++.||||
T Consensus       157 ~~~~~~~y~aP  167 (257)
T cd05116         157 HGKWPVKWYAP  167 (257)
T ss_pred             CCCCCccccCH
Confidence            23446789998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=2.3e-24  Score=217.61  Aligned_cols=165  Identities=32%  Similarity=0.470  Sum_probs=140.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-----ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-----GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|+..+.||+|+||.||+|... +|+.||||.++....     .....+..|++++++++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3777889999999999999875 689999999965432     1234677899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+ +|+|.+++......+++..+..++.||++||.|||   ..+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 89999999776546899999999999999999999   8999999999999999999999999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+++.|+||
T Consensus       157 ~--~~~~~~~~~~y~aP  171 (298)
T cd07841         157 R--KMTHQVVTRWYRAP  171 (298)
T ss_pred             c--cccccccceeeeCH
Confidence            1  11233467788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=3.2e-24  Score=214.83  Aligned_cols=164  Identities=27%  Similarity=0.434  Sum_probs=135.2

Q ss_pred             CcCceecccccceEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEE
Q 042902          431 SENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALV  502 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  502 (599)
                      ...+.||+|+||+||.+..     .+++.||+|.++... ....+.|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7789999999999988653     357899999987543 23456788999999999999999999988654  367899


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++....  +++..+..++.|+++|+.|||   +.+|+||||||+||++++++.+|++|||+++.+....
T Consensus        87 ~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            99999999999987643  899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             Ccee-eecccCCccccCC
Q 042902          583 QSLT-QTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~-~~~~~gt~~y~AP  599 (599)
                      .... .....++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         162 EYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             hhhccCCCCCCCceeeCH
Confidence            2111 1223456678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.92  E-value=3e-24  Score=212.41  Aligned_cols=163  Identities=26%  Similarity=0.445  Sum_probs=133.0

Q ss_pred             ceecccccceEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEE-cCCeeeEEEEccC
Q 042902          434 NLIGRGGVASVYKARIQ----DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCS-NDDFKALVLEYMP  507 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  507 (599)
                      +.||+|+||.||+|.+.    ++..||+|.+... .....+.+..|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998543 2334578899999999999999999999876 4556899999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc--e
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS--L  585 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~--~  585 (599)
                      +|+|.+++.......++..+..++.|+++|+.|+|   ..+++||||||+||++++++.+|++|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555778888899999999999999   889999999999999999999999999999865432211  1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (262)
T cd05058         158 NHTGAKLPVKWMAL  171 (262)
T ss_pred             ccccCcCCccccCh
Confidence            11233457789998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=8e-25  Score=216.12  Aligned_cols=157  Identities=27%  Similarity=0.409  Sum_probs=133.9

Q ss_pred             ceecccccceEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +.||+|+||.||+|....        ...||+|.+........++|..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998642        234888888655555567889999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc--------EEEccccCCcc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--------AHLSDFGMAKP  577 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~DFGla~~  577 (599)
                      +++|+|.++++..+..+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.        +|++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876666899999999999999999999   899999999999999987764        69999999875


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....      ....+++.||||
T Consensus       158 ~~~~------~~~~~~~~y~aP  173 (258)
T cd05078         158 VLPK------EILLERIPWVPP  173 (258)
T ss_pred             cCCc------hhccccCCccCc
Confidence            4321      224577889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.92  E-value=3.6e-24  Score=211.67  Aligned_cols=166  Identities=25%  Similarity=0.429  Sum_probs=138.4

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|...+.||+|+||.||+|.+.++..||+|.+.... ...+.|.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4577888999999999999998877789999886433 23467899999999999999999998875 456899999999


Q ss_pred             CCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||.++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999997643 34788899999999999999999   88999999999999999999999999999986533221 12


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~~P  172 (260)
T cd05069         160 RQGAKFPIKWTAP  172 (260)
T ss_pred             cCCCccchhhCCH
Confidence            2233466789988

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=2.1e-24  Score=218.50  Aligned_cols=168  Identities=25%  Similarity=0.400  Sum_probs=138.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|+..+.||+|+||.||+|.+. +|.    .||+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45777889999999999999864 444    578898865432 2344788999999999999999999998754 4679


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999998876656888899999999999999999   899999999999999999999999999999866433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         163 EKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             ccccccCCCccccccCCH
Confidence            322222334457789987

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=2.2e-24  Score=215.12  Aligned_cols=168  Identities=21%  Similarity=0.413  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.|..|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888899999999999999864      3467999998755443 4578999999999999999999999999989999


Q ss_pred             EEEEccCCCChhhhhhcCC--------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          501 LVLEYMPHGSLEKCLYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                      +||||+++|+|.+++....        ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        14789999999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++...... ........+++.|+||
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~P  187 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAP  187 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecCh
Confidence            9987543221 1122334567778887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.92  E-value=3.3e-24  Score=211.47  Aligned_cols=164  Identities=30%  Similarity=0.419  Sum_probs=141.6

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     ....+.+..|++++++++||||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999876 78999999986543     23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.|+++|++|+|   +.+|+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 4788888999999999999999   8899999999999999999999999999988653322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......|++.|+||
T Consensus       157 ---~~~~~~~~~~y~~p  170 (258)
T cd06632         157 ---FAKSFKGSPYWMAP  170 (258)
T ss_pred             ---cccccCCCcceeCH
Confidence               22345688889987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.92  E-value=1.6e-24  Score=215.63  Aligned_cols=168  Identities=29%  Similarity=0.375  Sum_probs=140.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC------C
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSND------D  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  497 (599)
                      +++.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +||||+++++++...      +
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999865 58899999986543 3346788899999998 699999999998653      4


Q ss_pred             eeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6799999999999999987643 35788889999999999999999   8899999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......  .......|++.|+||
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aP  180 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAP  180 (272)
T ss_pred             eccccc--ccCCcccccccccCH
Confidence            653221  122345688899998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=4.3e-24  Score=211.87  Aligned_cols=167  Identities=29%  Similarity=0.420  Sum_probs=142.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...   ....+++.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 79999999886432   233568999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++..   ....+++..+..++.++++|+.|||   +.+|+||||||+||+++.++.++++|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   2335788899999999999999999   89999999999999999999999999999886533


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  ......+++.|+||
T Consensus       159 ~~~--~~~~~~~~~~y~ap  175 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccceecCCccccCH
Confidence            221  12334678889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=1.8e-24  Score=214.60  Aligned_cols=167  Identities=29%  Similarity=0.436  Sum_probs=141.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... ++..||||.+....   .....++.+|+++++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46778899999999999999864 78999999876432   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++++|.+++..   ....+++..+..++.||++|+.|||   +.+++|+||||+||+++.++.++++|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2335788999999999999999999   89999999999999999999999999999886543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  ......|++.|+||
T Consensus       159 ~~~--~~~~~~~~~~~~ap  175 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccccccCCcCccCH
Confidence            221  12334688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=4.2e-24  Score=211.86  Aligned_cols=168  Identities=25%  Similarity=0.348  Sum_probs=138.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Cee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  499 (599)
                      .+|+..+.||+|+||.||+|... +|..||||.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999875 58999999885321     12345788899999999999999999988764  467


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++|+|.+++.... .+++..+.+++.|++.||+|+|   +.+|+|+||||+||++++++.+||+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 3678888999999999999999   8899999999999999999999999999998653


Q ss_pred             cCCCc-eeeecccCCccccCC
Q 042902          580 KEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      ..... .......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             cccccccccccCCCCccccCh
Confidence            22111 112334688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=3.8e-24  Score=213.01  Aligned_cols=167  Identities=28%  Similarity=0.449  Sum_probs=139.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc----------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY----------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD  497 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  497 (599)
                      +|...+.||+|+||.||+|... +|+.||+|.++...          ....+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677789999999999999865 68999999875321          112346888999999999999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..++||||+++|+|.+++.... .+++..+..++.||+.|+.|+|   +.+++||||+|+||+++.++.+|++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987754 5788888999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..............|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             ccccccccccccccCCccccCH
Confidence            5322222222345678889988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=4.7e-24  Score=211.67  Aligned_cols=167  Identities=29%  Similarity=0.449  Sum_probs=139.5

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      +|.....||+|+||.||+|... +++.||+|.+.....         ...+.+..|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999865 588999998864321         123568889999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+++++|.+++...+ .+++..+..++.|++.|++|+|   +.+++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 4788888899999999999999   889999999999999999999999999999866


Q ss_pred             CcCCCc----eeeecccCCccccCC
Q 042902          579 LKEDQS----LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~----~~~~~~~gt~~y~AP  599 (599)
                      ......    .......|++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             ccccccCCccccccccCCCcCccCh
Confidence            422111    111234578889998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=4.6e-24  Score=210.25  Aligned_cols=166  Identities=29%  Similarity=0.395  Sum_probs=145.6

Q ss_pred             hCCCCcCceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|+..+.||+|+||.||+|...+ ++.||+|.+.....  .+++.+|++++++++||||+++++++.+....|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3578889999999999999999875 88999999865433  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+++||||+|+||++++++.+||+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999999776667899999999999999999999   88999999999999999999999999999986543321  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       155 ~~~~~~~~~~y~~P  168 (256)
T cd06612         155 KRNTVIGTPFWMAP  168 (256)
T ss_pred             ccccccCCccccCH
Confidence            22334578889998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=4.7e-24  Score=213.89  Aligned_cols=166  Identities=28%  Similarity=0.352  Sum_probs=140.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999976 58999999986442  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++++++..+..... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765433 4889999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~~~aP  169 (286)
T cd07847         156 -DYTDYVATRWYRAP  169 (286)
T ss_pred             -cccCcccccccCCH
Confidence             12234577788887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=1.9e-24  Score=223.83  Aligned_cols=164  Identities=26%  Similarity=0.331  Sum_probs=136.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND------  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  496 (599)
                      ..++|+..+.||+|+||.||+|... .++.||||.+....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999865 58999999986542  33456788899999999999999999988643      


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ...++||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            256999999965 66666543   3678888899999999999999   8999999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....   .......||+.||||
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aP  187 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAP  187 (355)
T ss_pred             cCCCc---cccCCccccCCccCH
Confidence            54322   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=4.6e-24  Score=210.32  Aligned_cols=167  Identities=26%  Similarity=0.411  Sum_probs=141.9

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ..|+..+.||+|+||.||+|.+.++..+|+|.++... ....+|..|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3577789999999999999998778899999986442 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999876556788899999999999999999   8899999999999999999999999999988653221 1112


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++.+|+||
T Consensus       159 ~~~~~~~~~~aP  170 (256)
T cd05112         159 TGTKFPVKWSSP  170 (256)
T ss_pred             CCCccchhhcCH
Confidence            233456789988

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=5.3e-24  Score=215.70  Aligned_cols=146  Identities=26%  Similarity=0.391  Sum_probs=130.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   ......+..|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999876 57899999986543   233457889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ||+++|+|.+++.... .+++..+..++.|+++|+.|+|   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997654 4788888899999999999999   88999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-25  Score=208.56  Aligned_cols=166  Identities=27%  Similarity=0.338  Sum_probs=143.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+++|+|.||+|..++-+ +|+.+|+|++++..   .+....-..|-++++..+||.+..+-..++..+..|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56888899999999999999855 69999999997653   344566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+.||.|.-++.+.. .+++....-+..+|+.||.|||   +.+||.||+|.+|.|+|.+|.+||+|||+++.-...  
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--  321 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc--
Confidence            9999999988887644 4676666778999999999999   899999999999999999999999999999853322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      .......+|||.|.||
T Consensus       322 g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAP  337 (516)
T ss_pred             cceeccccCChhhcCc
Confidence            2344568999999999

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.91  E-value=2.1e-24  Score=216.33  Aligned_cols=165  Identities=28%  Similarity=0.405  Sum_probs=139.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|... +|+.||+|.++...  ......+..|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999975 68999999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++ +++.+++......+++..+..++.||++||.|||   ..+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 5888887765556899999999999999999999   89999999999999999999999999999986532221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~y~aP  168 (284)
T cd07839         155 CYSAEVVTLWYRPP  168 (284)
T ss_pred             CcCCCccccCCcCh
Confidence            12334678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.91  E-value=3.4e-24  Score=222.69  Aligned_cols=164  Identities=25%  Similarity=0.325  Sum_probs=136.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND------  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  496 (599)
                      ..++|...+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3567999999999999999999865 58899999986532  33456788999999999999999999987543      


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77776643   3678888899999999999999   8999999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....   .......||+.|+||
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aP  194 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAP  194 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCH
Confidence            54322   122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=6.7e-24  Score=209.22  Aligned_cols=161  Identities=30%  Similarity=0.439  Sum_probs=136.0

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEE-cCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS-NDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  506 (599)
                      ++|...+.||+|+||.||+|... |..||+|..+..  ...+.|..|+.++++++|+|++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46788899999999999999875 888999998543  23467899999999999999999999764 456789999999


Q ss_pred             CCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++..... .+++..+..++.|++.||+|+|   +.+++||||||+||++++++.+|++|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            99999999876543 4788899999999999999999   8999999999999999999999999999988543221   


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                        ....++..||||
T Consensus       157 --~~~~~~~~y~aP  168 (256)
T cd05082         157 --DTGKLPVKWTAP  168 (256)
T ss_pred             --CCCccceeecCH
Confidence              122345678887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.91  E-value=1.7e-24  Score=217.84  Aligned_cols=162  Identities=28%  Similarity=0.380  Sum_probs=139.2

Q ss_pred             CcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          431 SENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      +....||+|+||.||++... ++..||||.+........+.+..|+.+++.++||||+++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33467999999999999865 68899999987655555677899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeec
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ  589 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  589 (599)
                      +|.+++...  .+++..+..++.||+.||.|+|   +.+|+||||||+||++++++.+||+|||++........  ....
T Consensus       105 ~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  177 (292)
T cd06658         105 ALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS  177 (292)
T ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence            999988654  3788889999999999999999   88999999999999999999999999999875533221  1233


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..|++.|+||
T Consensus       178 ~~~~~~y~aP  187 (292)
T cd06658         178 LVGTPYWMAP  187 (292)
T ss_pred             eecCccccCH
Confidence            5688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=6e-24  Score=213.43  Aligned_cols=164  Identities=30%  Similarity=0.418  Sum_probs=133.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCcceeEEEEEEcC-----C
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNLIKIISSCSND-----D  497 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  497 (599)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.++...  ......+..|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999876 68999999987542  22234566777777665   699999999987642     3


Q ss_pred             eeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ..++||||+++ ++.+++.... ..+++..+..++.|++.||.|+|   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999974 8888886543 34788999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aP  176 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAP  176 (288)
T ss_pred             cccCcc---cCCCccccccccCc
Confidence            653221   12345688999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=5.1e-24  Score=214.55  Aligned_cols=166  Identities=26%  Similarity=0.363  Sum_probs=140.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...  ......+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999976 58899999986443  22334678899999999999999999998877  889999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||++ ++|.+++......+++..+..++.||++||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 4999888765556899999999999999999999   8899999999999999999999999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+++.||||
T Consensus       161 ~--~~~~~~~~~~~~aP  175 (293)
T cd07843         161 K--PYTQLVVTLWYRAP  175 (293)
T ss_pred             c--ccccccccccccCc
Confidence            1  22334578889998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.91  E-value=1.1e-23  Score=208.95  Aligned_cols=168  Identities=24%  Similarity=0.369  Sum_probs=139.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  499 (599)
                      .+|+..+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999865 58999999886432     1234578899999999999999999998875  3578


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      +++|||+++++|.+++.... .+++.....++.|+++||.|||   +.+|+||||||+||++++++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987654 3788888999999999999999   8999999999999999999999999999998653


Q ss_pred             cCCC-ceeeecccCCccccCC
Q 042902          580 KEDQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~-~~~~~~~~gt~~y~AP  599 (599)
                      .... ........++.+|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cccccCCccccCCccccccCH
Confidence            2211 1111234578899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=2.1e-24  Score=210.04  Aligned_cols=147  Identities=27%  Similarity=0.383  Sum_probs=131.0

Q ss_pred             CCCcCceecccccceEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|...+.||+|.-|+||.|++.+ +..+|+|++.+..   .....+.+.|-+||+.++||.++.|++.++.++..|+|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45566899999999999999874 6899999997653   3345677889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          505 YMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+||+|....+.+.. .+++..+.-++.+|+-||+|||   -.|||.|||||+||||.++|.+-++||.++...
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999998876543 6888888999999999999999   899999999999999999999999999987543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=4.5e-24  Score=236.69  Aligned_cols=171  Identities=22%  Similarity=0.359  Sum_probs=138.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  500 (599)
                      ..++|...+.||+|+||.||+|+.. +++.||+|.+...  .......|..|+.+++.++|||||++++++..  ....|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3467999999999999999999876 5788999998644  23345678999999999999999999998754  35789


Q ss_pred             EEEEccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEEccCCCCCeeecC----------
Q 042902          501 LVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY----SVPIIHCDLKPNNVLLDD----------  563 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~iiH~dlk~~Nill~~----------  563 (599)
                      +||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    ..+||||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999988652   235889999999999999999999321    146999999999999964          


Q ss_pred             -------CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 -------NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                             .+.+||+|||+++.+....   ......||+.||||
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAP  210 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSP  210 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCH
Confidence                   2358999999998653221   12345799999998

>PLN03210 Resistant to P

Probab=99.91  E-value=1.8e-23  Score=245.09  Aligned_cols=313  Identities=22%  Similarity=0.259  Sum_probs=188.6

Q ss_pred             CCCcCCCCCCEEEccCcc------ccccCCccccCCC-CCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902           14 SFIFNASKLSRLELEMNS------FYGFIPNTFGNLR-NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        14 ~~~~~l~~L~~L~L~~n~------i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      .+|.++.+|+.|.+..+.      +....|+.|..++ +|+.|++.+|.++.+|..      | .+++|++|+|++|+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~------f-~~~~L~~L~L~~s~l~  624 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN------F-RPENLVKLQMQGSKLE  624 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc------C-CccCCcEEECcCcccc
Confidence            345666666666664442      2223445555553 366666666666665543      2 2455666666666665


Q ss_pred             ccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhh
Q 042902           87 GILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL  166 (599)
Q Consensus        87 ~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  166 (599)
                       .++..+..++ .|+.+++++|+....+|. ++.+++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..+
T Consensus       625 -~L~~~~~~l~-~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i  701 (1153)
T PLN03210        625 -KLWDGVHSLT-GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI  701 (1153)
T ss_pred             -ccccccccCC-CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC
Confidence             2344444444 356666665543334442 5556666666666655444555556666666666666543323444433


Q ss_pred             hcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccc------------------------------cCC
Q 042902          167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTL------------------------------WNL  216 (599)
Q Consensus       167 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~------------------------------~~l  216 (599)
                       ++++|+.|++++|......|..   .++|+.|++++|.++.+|..+                              ...
T Consensus       702 -~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~  777 (1153)
T PLN03210        702 -NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLS  777 (1153)
T ss_pred             -CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhcc
Confidence             4556666666665443333322   245555666666655555322                              113


Q ss_pred             CcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccC
Q 042902          217 KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDL  296 (599)
Q Consensus       217 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  296 (599)
                      ++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|... .+++|+.|++++|.....+|..   .++|+.|+|
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            467888888887777788888888888888888875444556555 6888888888887654455543   357888999


Q ss_pred             CCCcccccCCchhhccccceEEEccc-ccCcccCCCCCCCCCcccccccC
Q 042902          297 SNNNISGAIPISLEKLLDLKYINVSF-NKLEGEIPREGPFRNFSAESFKG  345 (599)
Q Consensus       297 ~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~p~~~~~~~~~~~~~~~  345 (599)
                      ++|.++ .+|..+..+++|++|++++ |++.+.++....+..+....+.+
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCC
Confidence            999988 6788888899999999988 55665444444555555555544

syringae 6; Provisional

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=6.1e-24  Score=213.93  Aligned_cols=165  Identities=30%  Similarity=0.423  Sum_probs=143.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|...+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999854 68899999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...  .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998754  3688889999999999999999   89999999999999999999999999999876543322  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+++.|+||
T Consensus       172 ~~~~~~~~~y~~P  184 (293)
T cd06647         172 RSTMVGTPYWMAP  184 (293)
T ss_pred             cccccCChhhcCc
Confidence            2334688889998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=7.6e-24  Score=209.39  Aligned_cols=167  Identities=22%  Similarity=0.392  Sum_probs=140.5

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|...+.||+|+||.||+|...++..||+|.+.... ...+.|.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            35788889999999999999998888889999886442 235678999999999999999999999877 7789999999


Q ss_pred             CCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++... ....++..++.++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||.++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999998764 335788889999999999999999   88999999999999999999999999999986543221 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (260)
T cd05073         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            22233456778887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.91  E-value=9.9e-24  Score=209.79  Aligned_cols=160  Identities=31%  Similarity=0.542  Sum_probs=130.8

Q ss_pred             ceecccccceEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQD-GI--EVAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|++.+ +.  .+|+|.++.. .....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 43  5788888643 234456789999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcccc
Q 042902          509 GSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       509 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      |+|.+++....               ..+++..+..++.|++.|++|+|   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               24678889999999999999999   8999999999999999999999999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++....   .........++.|+||
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~ap  180 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAI  180 (270)
T ss_pred             Cccccch---hhhccCCCCccccCCh
Confidence            9863211   1111122345678887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.91  E-value=3.2e-24  Score=216.34  Aligned_cols=161  Identities=29%  Similarity=0.382  Sum_probs=138.8

Q ss_pred             cCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          432 ENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      ....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999865 689999999876555556778899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecc
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  590 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  590 (599)
                      |..++...  .+++..+..++.|++.||.|+|   +.+++||||||+||+++.++.+||+|||+++.+.....  .....
T Consensus       105 L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~  177 (297)
T cd06659         105 LTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL  177 (297)
T ss_pred             HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence            99887553  4788899999999999999999   88999999999999999999999999999875533221  22345


Q ss_pred             cCCccccCC
Q 042902          591 LATIGYMAP  599 (599)
Q Consensus       591 ~gt~~y~AP  599 (599)
                      .|++.|+||
T Consensus       178 ~~~~~y~aP  186 (297)
T cd06659         178 VGTPYWMAP  186 (297)
T ss_pred             ecCccccCH
Confidence            688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.91  E-value=9.5e-24  Score=215.07  Aligned_cols=160  Identities=24%  Similarity=0.333  Sum_probs=128.4

Q ss_pred             ceecccccceEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ---DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  508 (599)
                      ..||+|+||.||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++..  +...++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999865   35789999986432  23567889999999999999999998853  4578999999965


Q ss_pred             CChhhhhhcC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----cCCCcEEEccccCCc
Q 042902          509 GSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAK  576 (599)
Q Consensus       509 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DFGla~  576 (599)
                       ++.+++...        ...+++..+..++.||+.||.|||   +.+|+||||||+||++    +.++.+||+|||+|+
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777766421        124778888999999999999999   8999999999999999    466799999999998


Q ss_pred             cCCcCCCc-eeeecccCCccccCC
Q 042902          577 PLLKEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      ........ .......||+.||||
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             ccCCCcccccccCcceecccccCc
Confidence            66433221 122345789999999

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.91  E-value=9.3e-24  Score=212.32  Aligned_cols=166  Identities=27%  Similarity=0.345  Sum_probs=139.6

Q ss_pred             CCCcCceecccccceEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCee
Q 042902          429 GFSENNLIGRGGVASVYKARI----QDGIEVAVKVFDLQY----EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  499 (599)
                      +|+..+.||+|+||.||+|+.    .+|+.||+|+++...    ....+.+..|+++++++ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367788999999999999986    368999999986432    22346788899999999 599999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 4778888889999999999999   8999999999999999999999999999998653


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .... .......|+..|+||
T Consensus       157 ~~~~-~~~~~~~~~~~y~aP  175 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAP  175 (290)
T ss_pred             cccc-cccccccCCcccCCh
Confidence            3221 122235688899998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=8.5e-24  Score=210.73  Aligned_cols=165  Identities=30%  Similarity=0.362  Sum_probs=143.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||.|+||.||+|... +++.||+|.+.... ......+..|+++++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778889999999999999876 58999999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|   ..+++||||+|+||++++++.++++|||+++.+....  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  5788999999999999999999   8999999999999999999999999999998764332  1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       154 ~~~~~~~~~~y~~P  167 (274)
T cd06609         154 KRNTFVGTPFWMAP  167 (274)
T ss_pred             ccccccCCccccCh
Confidence            22345688889998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=2.8e-24  Score=215.57  Aligned_cols=166  Identities=31%  Similarity=0.419  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999976 58999999986442  2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++++++.++..... .+++..+..++.||++||+|||   +.+++|||++|+||++++++.+|++|||+++....... 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999999988765443 3789999999999999999999   88999999999999999999999999999986543322 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~y~aP  169 (286)
T cd07846         156 -VYTDYVATRWYRAP  169 (286)
T ss_pred             -ccCcccceeeccCc
Confidence             12334578889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-26  Score=241.53  Aligned_cols=313  Identities=30%  Similarity=0.346  Sum_probs=216.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccc-------------c
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFL-------------S   67 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------------~   67 (599)
                      ++|..|.+.+.++..+..+++  .|||++|.+..   -.+..+.+|+.|....|+++.+...-...             .
T Consensus       161 ~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~  235 (1081)
T KOG0618|consen  161 LDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLD  235 (1081)
T ss_pred             hhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeec
Confidence            356667777777777776666  68888887762   23456666666666666665443210000             0


Q ss_pred             ccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCC
Q 042902           68 SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQK  147 (599)
Q Consensus        68 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  147 (599)
                      .-..-.+|+++|+|+|++++. |+++..+. .++.+...+|++. ..|..+...++|+.|....|.++.+ |....+++.
T Consensus       236 ~~p~p~nl~~~dis~n~l~~l-p~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi-p~~le~~~s  311 (1081)
T KOG0618|consen  236 VHPVPLNLQYLDISHNNLSNL-PEWIGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI-PPFLEGLKS  311 (1081)
T ss_pred             cccccccceeeecchhhhhcc-hHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC-CCcccccce
Confidence            011224566666666666643 36666665 3666666666663 5566666666666666666666643 445566777


Q ss_pred             CCEEEcccccccccCChhhhcCCC-CcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCC-CCccccCCCcccEEeec
Q 042902          148 LQLLSLEDNQLEGSIPDDLCRLAA-LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLS  225 (599)
Q Consensus       148 L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~Ls  225 (599)
                      |++|+|..|+|....+..|..+.. |..|+.+.|+++....-.=..++.|+.|++.+|.++. .-+.+.+.++|+.|+|+
T Consensus       312 L~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLs  391 (1081)
T KOG0618|consen  312 LRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLS  391 (1081)
T ss_pred             eeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeec
Confidence            777777777776333322333332 5666666676664432222245678999999999993 33457788999999999


Q ss_pred             CCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccC
Q 042902          226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      +|++.......+.++..|+.|+||+|.++. +|.....+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...
T Consensus       392 yNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~  468 (1081)
T KOG0618|consen  392 YNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVT  468 (1081)
T ss_pred             ccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhh
Confidence            999997777788999999999999999994 6799999999999999999998 677 8999999999999999998654


Q ss_pred             CchhhccccceEEEcccccC
Q 042902          306 PISLEKLLDLKYINVSFNKL  325 (599)
Q Consensus       306 p~~~~~l~~L~~l~l~~N~l  325 (599)
                      -..-...++|++|||++|..
T Consensus       469 l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  469 LPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhCCCcccceeeccCCcc
Confidence            43333448999999999984

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.91  E-value=9.4e-24  Score=216.07  Aligned_cols=164  Identities=21%  Similarity=0.309  Sum_probs=134.3

Q ss_pred             Cceeccc--ccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          433 NNLIGRG--GVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       433 ~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .++||+|  +||+||++... +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4689999  68899999865 68999999997542  2334567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+...........
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999998653 234788999999999999999999   89999999999999999999999999987654322211110


Q ss_pred             -----eecccCCccccCC
Q 042902          587 -----QTQTLATIGYMAP  599 (599)
Q Consensus       587 -----~~~~~gt~~y~AP  599 (599)
                           .....++..||||
T Consensus       160 ~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             ccccccccccceecccCh
Confidence                 1123467779998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=214.21  Aligned_cols=166  Identities=26%  Similarity=0.347  Sum_probs=145.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .-|+..+.||+|.|++|-.|++- +|..||||++.+..  ......+..|++-|+-++|||||+++.+..+....|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34777789999999999999854 79999999997553  3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~~~~  583 (599)
                      .=++|+|++++......+.+..+.+|+.||+.|+.|+|   ...+|||||||+||++- .-|-+|+.|||++-.+.++.+
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999877777888899999999999999999   88899999999999875 668999999999988876543


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .+..+|+..|-||
T Consensus       175 ---L~TsCGSLAYSAP  187 (864)
T KOG4717|consen  175 ---LTTSCGSLAYSAP  187 (864)
T ss_pred             ---hhcccchhhccCc
Confidence               3456899999998

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=7.7e-24  Score=210.19  Aligned_cols=167  Identities=29%  Similarity=0.444  Sum_probs=140.1

Q ss_pred             CCCcCceecccccceEEEEEe-cCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      +|+..+.||+|+||.||+|.. .+++.||+|.++...      ....+.+..|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 468999999986432      1234678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCc
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLK  580 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~  580 (599)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987644 4788889999999999999999   88999999999999998776 699999999986643


Q ss_pred             CCCc--eeeecccCCccccCC
Q 042902          581 EDQS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~--~~~~~~~gt~~y~AP  599 (599)
                      ....  .......+|..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~P  177 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAP  177 (268)
T ss_pred             ccccCCccccccccccceeCH
Confidence            3211  111234678899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.91  E-value=1.4e-23  Score=206.96  Aligned_cols=166  Identities=25%  Similarity=0.425  Sum_probs=139.7

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  504 (599)
                      +|+..+.||+|++|.||++... +++.||+|.+....  ....+.+..|++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999865 57899999986542  2345678899999999999999999988764 446799999


Q ss_pred             ccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++++|.+++... ...+++.++..++.+++.|++|+|   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999998764 335789999999999999999999   89999999999999999999999999999986533221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......+++.|+||
T Consensus       158 --~~~~~~~~~~y~aP  171 (257)
T cd08223         158 --MASTLIGTPYYMSP  171 (257)
T ss_pred             --ccccccCCcCccCh
Confidence              22345688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.91  E-value=1.5e-23  Score=209.39  Aligned_cols=164  Identities=29%  Similarity=0.394  Sum_probs=139.9

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      -|+..+.||+|+||.||+|... ++..||+|...... ....+.+.+|++.+++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999865 68899999986443 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||+++.+.....  .
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999999988654  4788899999999999999999   89999999999999999999999999999876543221  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~~P  170 (277)
T cd06641         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hccccCCccccCh
Confidence            2234678889988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.91  E-value=3.9e-24  Score=213.54  Aligned_cols=163  Identities=28%  Similarity=0.386  Sum_probs=138.9

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      |+..+.||+|+||.||+|.+. +++.||+|.++... ....+.+..|++++++++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            556678999999999999865 57899999987443 3345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +++|.+++...  .+++..+..++.|+++|+.|+|   ..+++|+||+|+||++++++.+|++|||+++.+.....  ..
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06642          86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence            99999988653  4788888999999999999999   89999999999999999999999999999986543221  12


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (277)
T cd06642         159 NTFVGTPFWMAP  170 (277)
T ss_pred             hcccCcccccCH
Confidence            234578889987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.2e-23  Score=209.93  Aligned_cols=164  Identities=27%  Similarity=0.417  Sum_probs=141.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCC---CCcceeEEEEEEcCCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIR---HRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .|+..+.||+|+||.||+|.+. +++.||+|.++.. .....+++.+|++++++++   |||++++++++...+..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4677789999999999999964 6899999998654 2344567889999999986   999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++++|.+++...  .+++..+..++.|+++|+.|+|   ..+|+||||+|+||++++++.++++|||++..+.....
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999988664  4788999999999999999999   89999999999999999999999999999987644331


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......|++.|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (277)
T cd06917         157 --KRSTFVGTPYWMAP  170 (277)
T ss_pred             --ccccccCCcceeCH
Confidence              22334688899998

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.91  E-value=1.2e-23  Score=210.73  Aligned_cols=165  Identities=27%  Similarity=0.356  Sum_probs=134.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHH-HhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDM-MKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|.++.... ....++..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999876 699999999875432 233455556664 566789999999999999999999999


Q ss_pred             ccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          505 YMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       505 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      |++ |+|.+++..   ....+++..+..++.||+.||+|||   +. +++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688777653   2335889999999999999999999   75 899999999999999999999999999986532


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......++..|+||
T Consensus       157 ~~---~~~~~~~~~~y~aP  172 (283)
T cd06617         157 SV---AKTIDAGCKPYMAP  172 (283)
T ss_pred             cc---ccccccCCccccCh
Confidence            21   12234578889988

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.91  E-value=1.4e-23  Score=209.53  Aligned_cols=164  Identities=28%  Similarity=0.398  Sum_probs=141.0

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ......+..|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4677789999999999999875 58899999987543 344567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++...  .+++.....++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            999999988654  3788888999999999999999   89999999999999999999999999999976543221  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~ap  170 (277)
T cd06640         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             cccccCcccccCH
Confidence            2334678889887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.91  E-value=1.8e-23  Score=207.27  Aligned_cols=169  Identities=30%  Similarity=0.407  Sum_probs=144.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++|+|++++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999865 68899999986543 33557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987542  35788899999999999999999   89999999999999999999999999999986654332


Q ss_pred             ce--eeecccCCccccCC
Q 042902          584 SL--TQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~--~~~~~~gt~~y~AP  599 (599)
                      ..  ......|++.|+||
T Consensus       158 ~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             ccccccccccCChhhcCh
Confidence            21  12334688899998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=8.3e-24  Score=211.99  Aligned_cols=164  Identities=24%  Similarity=0.364  Sum_probs=140.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45777789999999999999865 58899999886543 33457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++...+ .+++..+..++.+++.|+.|||   + .+++||||||+||++++++.++|+|||+++......  
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            99999999887643 4788899999999999999999   5 589999999999999999999999999987543221  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....|+..|+||
T Consensus       159 --~~~~~~~~~~~aP  171 (284)
T cd06620         159 --ADTFVGTSTYMSP  171 (284)
T ss_pred             --cCccccCcccCCH
Confidence              1235688899998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=1.1e-24  Score=236.54  Aligned_cols=170  Identities=28%  Similarity=0.457  Sum_probs=134.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--------  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  496 (599)
                      ..+|+..+.+|+||||.||+++.+ ||+.+|||++.... ........+|++.+++++|||||+++..|.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356788899999999999999976 89999999997653 33445678899999999999999998533110        


Q ss_pred             --------------------------------------------------------------------------------
Q 042902          497 --------------------------------------------------------------------------------  496 (599)
Q Consensus       497 --------------------------------------------------------------------------------  496 (599)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 042902          497 -------------------------------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY  545 (599)
Q Consensus       497 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  545 (599)
                                                     -..||=||||+.-++++++++....-......+++++|++||.|+|   
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---
Confidence                                           1236777888776666666655432245567789999999999999   


Q ss_pred             CCCeEEccCCCCCeeecCCCcEEEccccCCccCC----------------cCCCceeeecccCCccccCC
Q 042902          546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL----------------KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       546 ~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..|||||||||.||++|+++.|||+|||+|....                ........++.+||.-|+||
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            8999999999999999999999999999998621                11112245778999999999

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.91  E-value=6.6e-24  Score=210.83  Aligned_cols=163  Identities=30%  Similarity=0.508  Sum_probs=134.8

Q ss_pred             ceecccccceEEEEEecC-------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARIQD-------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +.||+|+||.||+|+..+       ++.||||.+.... ......|.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886443 23466899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-----cEEEccccC
Q 042902          506 MPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-----VAHLSDFGM  574 (599)
Q Consensus       506 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~DFGl  574 (599)
                      +++|+|.+++...      ...+++..++.++.|+++|++|+|   +.+++|+||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      234788899999999999999999   88999999999999999877     899999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++...............++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccccccccccccCcccCCCccccCH
Confidence            9866433322222234557789988

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-23  Score=213.62  Aligned_cols=148  Identities=30%  Similarity=0.435  Sum_probs=132.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+..|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999876 489999999875432   24567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++++|.+++.... ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999987542 35888899999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=5.3e-24  Score=210.19  Aligned_cols=164  Identities=29%  Similarity=0.422  Sum_probs=142.5

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 58999999986442   2346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++++|.+++... ..+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++++|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 35788899999999999999999   8899999999999999999999999999988654332  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......|+..|+||
T Consensus       155 -~~~~~~~~~~y~~P  168 (258)
T cd05578         155 -LTTSTSGTPGYMAP  168 (258)
T ss_pred             -cccccCCChhhcCH
Confidence             12335578889888

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.91  E-value=1.9e-23  Score=206.85  Aligned_cols=167  Identities=32%  Similarity=0.443  Sum_probs=143.0

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|...+.||+|+||.||+|... +++.||+|.++....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999865 689999999876543  3567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++++|.+++.... ..++..+..++.++++|+.|||   +.+|+|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987653 4688888999999999999999   8999999999999999999999999999998664332211


Q ss_pred             e--eecccCCccccCC
Q 042902          586 T--QTQTLATIGYMAP  599 (599)
Q Consensus       586 ~--~~~~~gt~~y~AP  599 (599)
                      .  .....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~P  172 (264)
T cd06626         157 GEEVQSLAGTPAYMAP  172 (264)
T ss_pred             cccccCCcCCcCccCh
Confidence            1  1134678889988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=1.5e-23  Score=210.14  Aligned_cols=165  Identities=28%  Similarity=0.442  Sum_probs=139.6

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +|+..+.||+|++|.||+|+.. +|+.||||.++.... ...+.+..|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999976 689999999875532 33467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          507 PHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ++ +|.+++....  ..+++..+..++.|++.||.|+|   ..+++||||||+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888876543  35789999999999999999999   88999999999999999999999999999975432211 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~~P  169 (284)
T cd07836         156 -TFSNEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCh
Confidence             12334568889988

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.91  E-value=1.1e-23  Score=211.92  Aligned_cols=173  Identities=28%  Similarity=0.342  Sum_probs=142.7

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC--
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSND--  496 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--  496 (599)
                      .++..++++|...+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|||++++++++...  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            344456788999999999999999999875 68899999986432 2346778899999998 799999999998654  


Q ss_pred             ---CeeeEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc
Q 042902          497 ---DFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       497 ---~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                         +..++||||+++|+|.++++.   ....+++..+..++.|++.||+|+|   ..+|+||||||+||++++++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence               358999999999999988753   2345788899999999999999999   8899999999999999999999999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++.......  ......|++.|+||
T Consensus       171 dfg~~~~~~~~~~--~~~~~~~~~~y~aP  197 (291)
T cd06639         171 DFGVSAQLTSTRL--RRNTSVGTPFWMAP  197 (291)
T ss_pred             ecccchhcccccc--cccCccCCccccCh
Confidence            9999986543221  11234678889998

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.1e-23  Score=205.79  Aligned_cols=161  Identities=29%  Similarity=0.406  Sum_probs=132.8

Q ss_pred             ceecccccceEEEEEecC----CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQD----GIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|.+..    +..||+|.+..... ...+++..|+++++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997542    26899999875543 34567999999999999999999999876 4567999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee-e
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT-Q  587 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~  587 (599)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||++++++.+|++|||+++.+........ .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997655 5789999999999999999999   88999999999999999999999999999986643332211 1


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       156 ~~~~~~~~y~aP  167 (257)
T cd05060         156 TAGRWPLKWYAP  167 (257)
T ss_pred             cCccccccccCH
Confidence            122345679988

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.3e-23  Score=206.49  Aligned_cols=168  Identities=25%  Similarity=0.373  Sum_probs=139.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Cee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-----YEGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  499 (599)
                      .+|...+.||+|+||.||+|... +++.||+|.+...     .......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888899999999999999865 5899999987532     123446788999999999999999999998764  467


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++++|.+++.... .+++.....++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 3788888999999999999999   8899999999999999999999999999998653


Q ss_pred             cCCC-ceeeecccCCccccCC
Q 042902          580 KEDQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~-~~~~~~~~gt~~y~AP  599 (599)
                      .... ........++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             cccccCccccccCCcccccCH
Confidence            2111 1112335688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.90  E-value=6.7e-24  Score=210.27  Aligned_cols=164  Identities=28%  Similarity=0.373  Sum_probs=142.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +|+..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999976 68999999987553 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++++|.+++......+++.....++.|+++|+.|+|   + .+++||||||+||++++++.+||+|||.+........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999999876456888888999999999999999   7 8999999999999999999999999999876532211  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                        ....++..|+||
T Consensus       157 --~~~~~~~~y~~P  168 (265)
T cd06605         157 --KTFVGTSSYMAP  168 (265)
T ss_pred             --hcccCChhccCH
Confidence              115678889988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.90  E-value=2.2e-23  Score=207.54  Aligned_cols=167  Identities=30%  Similarity=0.496  Sum_probs=133.5

Q ss_pred             CCcCceecccccceEEEEEec----CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          430 FSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      |...+.||+|+||.||+|.+.    +++.||||++....  ....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999854    36899999986542  334567899999999999999999999886532      


Q ss_pred             eeeEEEEccCCCChhhhhhcC-----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          498 FKALVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                      ..++++||+++|+|.+++...     ...+++.....++.||+.|++|+|   +.+|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999998876432     124688888999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++...............+++.|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCH
Confidence            999866433222222233456678876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.90  E-value=1.8e-23  Score=212.94  Aligned_cols=167  Identities=26%  Similarity=0.391  Sum_probs=137.3

Q ss_pred             CCCcCceecccccceEEEEEec---CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Ceee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ---DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  500 (599)
                      +|+..+.||+|+||.||+|...   +++.||+|.+....   ....+.+..|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999975   47899999997632   44456788899999999999999999999988  7899


Q ss_pred             EEEEccCCCChhhhhhcC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC----CCcEEEccc
Q 042902          501 LVLEYMPHGSLEKCLYSS----NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD----NMVAHLSDF  572 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~----~~~~kl~DF  572 (599)
                      +||||+++ ++.+.+...    ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666655422    125788888999999999999999   899999999999999999    899999999


Q ss_pred             cCCccCCcCCC-ceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~-~~~~~~~~gt~~y~AP  599 (599)
                      |+++.+..... ........+|+.|+||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCH
Confidence            99986543322 1122345678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=2.5e-23  Score=205.86  Aligned_cols=166  Identities=26%  Similarity=0.378  Sum_probs=143.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|++|.||+|+.. +++.||||++..... ....++..|++++.+++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            35788899999999999999977 499999999876543 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++++|.+++... ..+++..+..++.|+++|+.|+|   . .+++||||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999765 34788999999999999999999   8 99999999999999999999999999999866433221


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....++..|+||
T Consensus       157 --~~~~~~~~~y~~p  169 (264)
T cd06623         157 --CNTFVGTVTYMSP  169 (264)
T ss_pred             --ccceeecccccCH
Confidence              1234577889887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=2e-23  Score=208.59  Aligned_cols=157  Identities=27%  Similarity=0.356  Sum_probs=128.5

Q ss_pred             eecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHh---cCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          435 LIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMK---RIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .||+|+||.||+|... +++.||+|.+....   ......+..|..+++   ..+||+|+.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58999999986442   122233445554443   3479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++...+ .+++..+..++.|++.||+|+|   +.+|+||||||+||++++++.+|++|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999887654 4889999999999999999999   8999999999999999999999999999997543221    1


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||+.||||
T Consensus       153 ~~~~~~~~y~aP  164 (279)
T cd05633         153 HASVGTHGYMAP  164 (279)
T ss_pred             cCcCCCcCccCH
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=5.7e-25  Score=239.83  Aligned_cols=169  Identities=30%  Similarity=0.412  Sum_probs=143.7

Q ss_pred             hCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      +-+|.....||.|.||.||-|. .++|...|+|-++.+.  ........+|+.++..++|||+|+++|+-.+++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4567778899999999999987 5579999999886553  344567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||++|+|.+.+.... ..++.....+..|++.|+.|||   +.|||||||||.||+++.+|.+|.+|||.|..+....+
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999887643 3555555668899999999999   99999999999999999999999999999998764432


Q ss_pred             c--eeeecccCCccccCC
Q 042902          584 S--LTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~--~~~~~~~gt~~y~AP  599 (599)
                      .  ......+|||-||||
T Consensus      1390 ~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             cCCHHHHhhcCCchhcCc
Confidence            1  122467899999999

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=2.8e-23  Score=210.67  Aligned_cols=163  Identities=28%  Similarity=0.351  Sum_probs=138.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ...|+..+.||+|+||.||+|... +|+.||+|.+....   ....+++.+|++++++++||||+++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            345888899999999999999875 68999999986432   23345788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||++ |++.+.+......+++..+..++.|++.||.|||   ..+|+||||+|+||++++++.+||+|||+++..... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99996 5777776654456899999999999999999999   889999999999999999999999999998754322 


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                           ....+++.|+||
T Consensus       169 -----~~~~~~~~y~aP  180 (307)
T cd06607         169 -----NSFVGTPYWMAP  180 (307)
T ss_pred             -----CCccCCccccCc
Confidence                 234578889988

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=2.1e-23  Score=205.65  Aligned_cols=166  Identities=21%  Similarity=0.363  Sum_probs=141.2

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||++... +|+.||+|.+...  .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999865 6899999998643  233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++++|.+++.... ..+++..+..++.|++.|+.|+|   +.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 35788889999999999999999   88999999999999999999999999999986533221 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (256)
T cd08218         157 -LARTCIGTPYYLSP  170 (256)
T ss_pred             -hhhhccCCccccCH
Confidence             11234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PLN03210 Resistant to P

Probab=99.90  E-value=6.1e-23  Score=240.64  Aligned_cols=294  Identities=21%  Similarity=0.272  Sum_probs=191.6

Q ss_pred             CCCCCCcCCC-CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccC
Q 042902           11 TIPSFIFNAS-KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGIL   89 (599)
Q Consensus        11 ~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~   89 (599)
                      .+|..|..++ +|+.|++.++.++. .|..| ...+|+.|+|++|++..++.      .+..+++|++|+|++|.....+
T Consensus       579 ~lp~~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~~L~~------~~~~l~~Lk~L~Ls~~~~l~~i  650 (1153)
T PLN03210        579 HLPEGFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLEKLWD------GVHSLTGLRNIDLRGSKNLKEI  650 (1153)
T ss_pred             ecCcchhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccccccc------ccccCCCCCEEECCCCCCcCcC
Confidence            4555555543 46666666666654 34444 35666666666666665543      2455666666666655432233


Q ss_pred             ChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcC
Q 042902           90 PRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRL  169 (599)
Q Consensus        90 ~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  169 (599)
                      |. +..++ .|+.|++.+|.....+|..+.++++|+.|++++|.--..+|..+ ++++|+.|++++|.....+|..   .
T Consensus       651 p~-ls~l~-~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~  724 (1153)
T PLN03210        651 PD-LSMAT-NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---S  724 (1153)
T ss_pred             Cc-cccCC-cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---c
Confidence            32 44443 36666666665555556666666666666666643222334332 4556666666665443333322   2


Q ss_pred             CCCcEEEeeCCccCCCCC-----------------------------cccCCCCCCcEeecCCCC-CCCCCccccCCCcc
Q 042902          170 AALFLLDLGGNKLSGFVP-----------------------------ACFGNLTSLRNLYLGSNQ-LTSIPSTLWNLKYI  219 (599)
Q Consensus       170 ~~L~~L~Ls~N~l~~~~~-----------------------------~~~~~l~~L~~L~L~~N~-l~~ip~~~~~l~~L  219 (599)
                      .+|+.|++++|.+..++.                             ..+...++|+.|+|++|. +..+|..+.++++|
T Consensus       725 ~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L  804 (1153)
T PLN03210        725 TNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL  804 (1153)
T ss_pred             CCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCC
Confidence            345555555555543211                             112224678999999885 55799999999999


Q ss_pred             cEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCC-
Q 042902          220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN-  298 (599)
Q Consensus       220 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-  298 (599)
                      +.|++++|..-+.+|... ++++|+.|+|++|..-...|..   ..+|+.|+|++|.++ .+|..+..+++|+.|+|++ 
T Consensus       805 ~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C  879 (1153)
T PLN03210        805 EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGC  879 (1153)
T ss_pred             CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCC
Confidence            999999986544667665 7899999999998654445543   468999999999998 6788999999999999999 


Q ss_pred             CcccccCCchhhccccceEEEccccc
Q 042902          299 NNISGAIPISLEKLLDLKYINVSFNK  324 (599)
Q Consensus       299 N~l~~~~p~~~~~l~~L~~l~l~~N~  324 (599)
                      |++. .+|..+..+++|+.++++++.
T Consensus       880 ~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        880 NNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCcC-ccCcccccccCCCeeecCCCc
Confidence            4565 577788899999999999886

syringae 6; Provisional

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=2.2e-23  Score=210.87  Aligned_cols=169  Identities=29%  Similarity=0.395  Sum_probs=139.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  497 (599)
                      ..++|+..+.||+|+||.||+|... +|+.||||.++...  ......+..|++++++++||||+++++++.+.+     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567889999999999999999976 58999999986542  233456788999999999999999999887654     


Q ss_pred             -----eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          498 -----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       498 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                           ..++|+||+++ ++...+......+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                 78999999976 777777665556899999999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++....... .......+++.|+||
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~~y~~P  186 (302)
T cd07864         161 GLARLYNSEES-RPYTNKVITLWYRPP  186 (302)
T ss_pred             cccccccCCcc-cccccceeccCccCh
Confidence            99986643321 111223457788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.90  E-value=1.6e-23  Score=209.78  Aligned_cols=165  Identities=29%  Similarity=0.441  Sum_probs=138.9

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|+.. +|+.||||.++...  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999875 68999999986442  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ++ ++|.+++.... ..+++..+..++.|+++||+|||   ..+++||||+|+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 68888876533 35788999999999999999999   88999999999999999999999999999875532221 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~aP  169 (284)
T cd07860         156 -TYTHEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCC
Confidence             12233567889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-23  Score=210.02  Aligned_cols=166  Identities=30%  Similarity=0.370  Sum_probs=140.7

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|... +++.||||.++...  ....+.+..|++++++++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5888899999999999999876 58899999986542  33457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++++.+..+... ...+++..+..++.||+.|+.|||   ..+++|||++|+||++++++.+||+|||++........ .
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~  156 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S  156 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence            998777665544 334788999999999999999999   88999999999999999999999999999986644332 1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~~~~P  170 (288)
T cd07833         157 PLTDYVATRWYRAP  170 (288)
T ss_pred             cccCcccccCCcCC
Confidence            22345678889998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.90  E-value=2.6e-23  Score=211.05  Aligned_cols=169  Identities=25%  Similarity=0.391  Sum_probs=138.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|+..+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999875 68999999986432  223345678999999999999999999987654      


Q ss_pred             --eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          498 --FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       498 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                        ..++||||++ +++.+++......+++..+..++.||++||.|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              3599999996 4888888766556899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCcCCCc--eeeecccCCccccCC
Q 042902          576 KPLLKEDQS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~--~~~~~~~gt~~y~AP  599 (599)
                      ..+......  .......+++.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCc
Confidence            865432211  112334678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=2e-23  Score=205.56  Aligned_cols=160  Identities=28%  Similarity=0.470  Sum_probs=134.1

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .+|+..+.||+|+||.||+|.. +++.||+|..+...  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3578889999999999999975 58889999986432  346789999999999999999999998654 4799999999


Q ss_pred             CCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|+|.+++..... .+++..+..++.|++.|+.|+|   +.+++||||||+||+++.++.+||+|||+++......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            9999999876543 5788899999999999999999   8999999999999999999999999999987542211    


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                       .....+..|+||
T Consensus       155 -~~~~~~~~y~~p  166 (254)
T cd05083         155 -DNSKLPVKWTAP  166 (254)
T ss_pred             -CCCCCCceecCH
Confidence             122345568877

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.90  E-value=3.4e-23  Score=207.63  Aligned_cols=164  Identities=28%  Similarity=0.372  Sum_probs=140.8

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .|...+.||+|++|.||+|... +++.||+|.++.......+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999864 689999999875554555678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +++|.+++...  .+++..+..++.|++.|++|+|   +.+|+||||+|+||+++.++.+|++|||.+........  ..
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            99999998773  4788889999999999999999   89999999999999999999999999999875432211  22


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....|++.|+||
T Consensus       173 ~~~~~~~~y~aP  184 (285)
T cd06648         173 KSLVGTPYWMAP  184 (285)
T ss_pred             ccccCCccccCH
Confidence            335688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.90  E-value=5e-23  Score=201.91  Aligned_cols=165  Identities=35%  Similarity=0.474  Sum_probs=145.2

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .|+..+.||+|++|.||+|... +++.||+|++........+.+.+|++++++++|||++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999976 689999999976655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +++|.+++......+++..+..++.|+++|+.|+|   ..+++||||+|+||++++++.+||+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999998876556899999999999999999999   89999999999999999999999999999986644321   2


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       155 ~~~~~~~~~~~P  166 (253)
T cd05122         155 NTMVGTPYWMAP  166 (253)
T ss_pred             cceecCCcccCH
Confidence            334578889887

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=3.4e-23  Score=207.82  Aligned_cols=168  Identities=32%  Similarity=0.423  Sum_probs=145.6

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++.|+..+.||+|+||.||+|.++ +++.||+|++..... ..+.+..|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999987 689999999976544 56788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++++|.+++......+++..+..++.|++.||.|+|   ..+|+|+||+|+||+++.++.+||+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876546899999999999999999999   89999999999999999999999999999875533221 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......+++.|+||
T Consensus       172 -~~~~~~~~~~y~~P  185 (286)
T cd06614         172 -KRNSVVGTPYWMAP  185 (286)
T ss_pred             -hhccccCCcccCCH
Confidence             11234577889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.90  E-value=4.1e-23  Score=205.21  Aligned_cols=165  Identities=26%  Similarity=0.439  Sum_probs=137.6

Q ss_pred             CCCcCceecccccceEEEEEecC--CcEEEEEEeccc----------ccccHHHHHHHHHHHhc-CCCCcceeEEEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQD--GIEVAVKVFDLQ----------YEGAFKSFDIECDMMKR-IRHRNLIKIISSCSN  495 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  495 (599)
                      +|+..+.||+|+||.||+|....  ++.||+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999765  688999987532          12234567788888875 799999999999999


Q ss_pred             CCeeeEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEcc
Q 042902          496 DDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.||.|+|   . .+++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3345888899999999999999999   5 5799999999999999999999999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||.+.......   ......|+..|+||
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~P  182 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCP  182 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcCh
Confidence            99998654332   23445688889998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-24  Score=196.39  Aligned_cols=173  Identities=24%  Similarity=0.319  Sum_probs=143.6

Q ss_pred             HhCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Cee
Q 042902          426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DFK  499 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  499 (599)
                      ..++|...+.+|+|||+-||.++ ..++..+|+|++.....++.+..++|++..++++||||+++++++..+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34678999999999999999998 567899999999777767778899999999999999999999876433     368


Q ss_pred             eEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          500 ALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ||+++|...|+|.+.+..   ++..+++.+.+.|+.+|++||.+||+. .++++||||||.|||+.+++.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999998764   344789999999999999999999933 4469999999999999999999999999998


Q ss_pred             cCCcCCCc-------eeeecccCCccccCC
Q 042902          577 PLLKEDQS-------LTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~-------~~~~~~~gt~~y~AP  599 (599)
                      ...-.-..       +.-.....|..|.||
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP  207 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAP  207 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence            65321111       111344578889998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.7e-23  Score=221.11  Aligned_cols=170  Identities=20%  Similarity=0.296  Sum_probs=129.8

Q ss_pred             HhCCCCcCceecccccceEEEEEe-----------------cCCcEEEEEEecccccccHHH--------------HHHH
Q 042902          426 ATNGFSENNLIGRGGVASVYKARI-----------------QDGIEVAVKVFDLQYEGAFKS--------------FDIE  474 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  474 (599)
                      ..++|...++||+|+||.||+|.+                 .+++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235689999986543322223              3457


Q ss_pred             HHHHhcCCCCcc-----eeEEEEEEc--------CCeeeEEEEccCCCChhhhhhcCC----------------------
Q 042902          475 CDMMKRIRHRNL-----IKIISSCSN--------DDFKALVLEYMPHGSLEKCLYSSN----------------------  519 (599)
Q Consensus       475 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  519 (599)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677777653        356899999999999999887431                      


Q ss_pred             -CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccC
Q 042902          520 -YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA  598 (599)
Q Consensus       520 -~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  598 (599)
                       ...++..+..++.|+++||.|+|   ..+|+||||||+||+++.++.+||+|||+|+.+..... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence             12356678889999999999999   88999999999999999999999999999976543221 11122345889999


Q ss_pred             C
Q 042902          599 P  599 (599)
Q Consensus       599 P  599 (599)
                      |
T Consensus       379 P  379 (507)
T PLN03224        379 P  379 (507)
T ss_pred             h
Confidence            8

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.90  E-value=2.8e-23  Score=207.34  Aligned_cols=158  Identities=27%  Similarity=0.374  Sum_probs=134.3

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||+||+|... +|+.||+|.+....   ....+.+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68999999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecc
Q 042902          512 EKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT  590 (599)
Q Consensus       512 ~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  590 (599)
                      .+++..... .+++..+..++.|+++|+.|+|   ..+++||||+|+||++++++.+|++|||.++.....   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            999876543 5788899999999999999999   899999999999999999999999999998765321   112334


Q ss_pred             cCCccccCC
Q 042902          591 LATIGYMAP  599 (599)
Q Consensus       591 ~gt~~y~AP  599 (599)
                      .++..|+||
T Consensus       155 ~~~~~y~~P  163 (277)
T cd05577         155 AGTPGYMAP  163 (277)
T ss_pred             cCCCCcCCH
Confidence            577889887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.7e-23  Score=206.89  Aligned_cols=168  Identities=27%  Similarity=0.361  Sum_probs=141.8

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC------
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD------  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  497 (599)
                      ++++|+..+.||+|+||.||+|... +++.||+|++..... ..++|..|+++++++ +||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999975 578999999875543 346789999999999 6999999999987644      


Q ss_pred             eeeEEEEccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          498 FKALVLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ..++||||+++++|.+++...   ...+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+|++|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999987653   246888899999999999999999   89999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.......  .......|++.|+||
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aP  182 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAP  182 (275)
T ss_pred             ceecccch--hhhcCccccccccCH
Confidence            87553222  122345688889998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.90  E-value=3.1e-23  Score=209.01  Aligned_cols=166  Identities=25%  Similarity=0.374  Sum_probs=136.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCe-----
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDF-----  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  498 (599)
                      ++|+..+.||+|+||.||+|... +|+.||||..+...  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999975 68999999986543  223467888999999995 6999999999877665     


Q ss_pred             eeEEEEccCCCChhhhhhcCC----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEcccc
Q 042902          499 KALVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFG  573 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFG  573 (599)
                      .|+||||+++ ++.+++....    ..+++..+..++.||++||.|||   ..+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8888876432    24789999999999999999999   899999999999999998 8899999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.+.....  ......+++.|+||
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aP  180 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAP  180 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCCh
Confidence            9986532211  11233567889988

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=1.6e-23  Score=207.27  Aligned_cols=160  Identities=32%  Similarity=0.437  Sum_probs=136.7

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||.||+|+.. +|+.||+|.+.....   ...+.+..|++++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 499999999865432   3456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC------ce
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ------SL  585 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~------~~  585 (599)
                      .+++.... .+++..+..++.||++||+|+|   ..+++||||+|+||++++++.+||+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987654 5789999999999999999999   89999999999999999999999999999875433211      11


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       157 ~~~~~~~~~~~~~P  170 (265)
T cd05579         157 EDKRIVGTPDYIAP  170 (265)
T ss_pred             cccCcccCccccCH
Confidence            22345678889988

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=2.4e-23  Score=209.48  Aligned_cols=160  Identities=28%  Similarity=0.371  Sum_probs=138.0

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ...||+|+||.||+|... +|+.||||.+..........+..|+.+++.++|||++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999875 6899999998655444566799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                      .+++...  .+++.....++.|++.|++|+|   +.+++||||+|+||+++.++.++|+|||++........  ......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            9987554  3788888999999999999999   88999999999999999999999999999876543221  223356


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      |++.|+||
T Consensus       178 ~~~~y~~p  185 (292)
T cd06657         178 GTPYWMAP  185 (292)
T ss_pred             cCccccCH
Confidence            88899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.90  E-value=3e-23  Score=210.64  Aligned_cols=167  Identities=31%  Similarity=0.400  Sum_probs=139.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++...  ......+.+|++++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999975 58999999986442  22234567899999999999999999998755  46899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++ +|.+++......+++..+..++.||++|+.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999964 888888765556899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..  ......+++.|+||
T Consensus       162 ~~--~~~~~~~~~~y~aP  177 (309)
T cd07845         162 AK--PMTPKVVTLWYRAP  177 (309)
T ss_pred             cC--CCCcccccccccCh
Confidence            21  12233457889998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.90  E-value=4.5e-23  Score=203.12  Aligned_cols=165  Identities=28%  Similarity=0.463  Sum_probs=140.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|... +++.||||.+...  .....+++..|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6889999998654  233456899999999999999999999999989999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~~~~~~~  583 (599)
                      +++++|.+++.... ..+++..+..++.++++|+.|+|   +.+++||||||+||+++++ +.+|++|||.++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997643 34788899999999999999999   8999999999999999855 4689999999986543221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....+++.|+||
T Consensus       158 ---~~~~~~~~~y~aP  170 (256)
T cd08220         158 ---AYTVVGTPCYISP  170 (256)
T ss_pred             ---ccccccCCcccCc
Confidence               2234678899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=3.5e-23  Score=207.58  Aligned_cols=165  Identities=31%  Similarity=0.468  Sum_probs=140.6

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEEEE
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALVLE  504 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  504 (599)
                      |+..+.||+|+||.||+|... +|+.||+|.+....  ......+..|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999876 48999999997653  33456788999999999999999999999887  79999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++ +|.+++......+++..+..++.||++|++|||   ..+++|+||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 898888776556899999999999999999999   88999999999999999999999999999986643321 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......++..|+||
T Consensus       156 ~~~~~~~~~~~y~~P  170 (287)
T cd07840         156 ADYTNRVITLWYRPP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            122334567889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=4.6e-24  Score=218.82  Aligned_cols=164  Identities=26%  Similarity=0.405  Sum_probs=138.2

Q ss_pred             cCceecccccceEEEEEec--CC--cEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          432 ENNLIGRGGVASVYKARIQ--DG--IEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ..+.||+|.||+|++|.|.  .|  ..||||+++..... ...+|..|+.+|.+++|||+++|+|...+ ....+|||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4478999999999999986  24  46999999766433 67899999999999999999999999987 6778999999


Q ss_pred             CCCChhhhhhc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +.|+|.+.|+. .+..+-......|+.|||.||.||.   .++.|||||.++|+++.....+||+|||+.|.+...+..+
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999987 3445667777899999999999999   9999999999999999999999999999999876544433


Q ss_pred             ee-ecccCCccccCC
Q 042902          586 TQ-TQTLATIGYMAP  599 (599)
Q Consensus       586 ~~-~~~~gt~~y~AP  599 (599)
                      .+ ....-...|.||
T Consensus       270 vm~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAP  284 (1039)
T ss_pred             EecCCCcCcccccCH
Confidence            33 333445568877

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.9e-23  Score=201.91  Aligned_cols=165  Identities=32%  Similarity=0.445  Sum_probs=143.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999865 588999999975543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++++|.+++... ..+++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+|||.++........ 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 35889999999999999999999   899999999999999999999999999999866433221 


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                       .....++..|+||
T Consensus       156 -~~~~~~~~~y~~p  168 (254)
T cd06627         156 -DASVVGTPYWMAP  168 (254)
T ss_pred             -ccccccchhhcCH
Confidence             2334678889988

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.90  E-value=2.5e-23  Score=208.32  Aligned_cols=175  Identities=28%  Similarity=0.376  Sum_probs=142.8

Q ss_pred             cHHHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEc-
Q 042902          419 THLELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSN-  495 (599)
Q Consensus       419 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  495 (599)
                      +..++..+.+.|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            33444456678899999999999999999875 68899999986543 2345688899999998 69999999999853 


Q ss_pred             -----CCeeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          496 -----DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       496 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                           .+..++||||+++|+|.+++.... ..+++..+..++.|+++|+.|||   +.+|+|||+||+||++++++.+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999887533 34778888899999999999999   889999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+++.......  ......|++.|+||
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  190 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAP  190 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCH
Confidence            99999875432111  12335688899998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=3e-23  Score=218.74  Aligned_cols=168  Identities=27%  Similarity=0.383  Sum_probs=142.3

Q ss_pred             HhCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEc-----CCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSN-----DDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~  498 (599)
                      .++.|.+.+.||+|.+|.||+++. ++|+.+|||++..... ..++...|.++++.. .|||++.++|++.-     ++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            466788899999999999999984 4799999999876543 346778889998877 59999999998853     468


Q ss_pred             eeEEEEccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          499 KALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      .|||||||.+|+..++++.- +..+.|.....|+++++.|+.|||   ...++|||+|-.|||++.++.||++|||++..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            99999999999999998754 346888888999999999999999   99999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +...  -......+|||.||||
T Consensus       173 ldsT--~grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  173 LDST--VGRRNTFIGTPYWMAP  192 (953)
T ss_pred             eecc--cccccCcCCCcccccc
Confidence            5322  1223456899999999

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.1e-23  Score=211.33  Aligned_cols=167  Identities=25%  Similarity=0.353  Sum_probs=146.7

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..|+..+.||+||.+.||++...+.+.+|+|++...  ..+....|.+|+..|.+++ |.+||++++|-..+++.|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            458888999999999999999988889999887533  4556778999999999995 9999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |=+ -+|.++|..+....+...+..|..|++.|+.++|   ..||||.||||.|.|+- .|.+||+|||+|..+..+.+.
T Consensus       441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            974 4999999988775553467789999999999999   89999999999999984 579999999999988877777


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      ......+||+.||||
T Consensus       516 I~kdsQvGT~NYMsP  530 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSP  530 (677)
T ss_pred             eeeccccCcccccCH
Confidence            677788999999998

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.4e-23  Score=226.06  Aligned_cols=169  Identities=21%  Similarity=0.240  Sum_probs=130.6

Q ss_pred             HhCCCCcCceecccccceEEEEEecC--CcEEEEEE--------------ecc---cccccHHHHHHHHHHHhcCCCCcc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQD--GIEVAVKV--------------FDL---QYEGAFKSFDIECDMMKRIRHRNL  486 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni  486 (599)
                      ..++|...+.||+|+||.||+|.++.  +..+++|.              +.+   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987542  22222221              111   112234568899999999999999


Q ss_pred             eeEEEEEEcCCeeeEEEEccCCCChhhhhhcCC----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec
Q 042902          487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  562 (599)
Q Consensus       487 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~  562 (599)
                      |++++++...+..|+|+|++. +++.+++....    .......+..|+.||+.||.|||   +.+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999995 57777765432    12234556789999999999999   89999999999999999


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .++.+||+|||+|+.+..... .......||+.||||
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aP  337 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSP  337 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCc
Confidence            999999999999986643322 122346799999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=4.9e-23  Score=203.76  Aligned_cols=157  Identities=28%  Similarity=0.411  Sum_probs=135.9

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||.|+||.||+|+.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 48999999986542   23446799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                      .+++.... .+++..+..++.|+++||+|+|   +.+++|+||+|+||+++.++.+|++|||+++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997654 3788888999999999999999   8999999999999999999999999999998664332   123346


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      +++.|+||
T Consensus       154 ~~~~~~~P  161 (262)
T cd05572         154 GTPEYVAP  161 (262)
T ss_pred             CCcCccCh
Confidence            78889998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.90  E-value=7e-23  Score=208.68  Aligned_cols=160  Identities=29%  Similarity=0.369  Sum_probs=137.1

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....   .....++..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999865 68999999986432   23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++ |++.+.+......+++..+..++.|++.|+.|||   ..+|+||||+|+||+++.++.+||+|||++......    
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            96 5888777655556899999999999999999999   899999999999999999999999999998754321    


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                        ....|++.|+||
T Consensus       179 --~~~~~~~~y~aP  190 (317)
T cd06635         179 --NSFVGTPYWMAP  190 (317)
T ss_pred             --ccccCCccccCh
Confidence              234578889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PTZ00284 protein kinase; Provisional

Probab=99.90  E-value=3.1e-23  Score=222.46  Aligned_cols=164  Identities=23%  Similarity=0.330  Sum_probs=131.0

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC------CcceeEEEEEEcC-
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH------RNLIKIISSCSND-  496 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~-  496 (599)
                      ...++|...+.||+|+||+||+|... +++.||||+++... .....+..|+++++.++|      ++++++++++... 
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            34678999999999999999999865 58899999986432 223445667777776654      5588999988754 


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCC----------
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNM----------  565 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~----------  565 (599)
                      +..|+|||++ +++|.+++...+ .+++..+..|+.||+.||+|||   . .+||||||||+|||++.++          
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            5789999998 778988887643 4888899999999999999999   6 5999999999999998665          


Q ss_pred             ------cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 ------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                            .+||+|||.+.....     .....+||+.||||
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSP  314 (467)
T ss_pred             cCCCCceEEECCCCccccCcc-----ccccccCCccccCc
Confidence                  499999998864321     22346799999999

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=5.9e-23  Score=206.92  Aligned_cols=166  Identities=28%  Similarity=0.414  Sum_probs=136.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|++|.||+|... +|+.||+|.+....  ....+.+..|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999876 68999999986542  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCccCCcCC
Q 042902          505 YMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~~~~~~~  582 (599)
                      |++ +++.+++..... ..++.....++.||+.||+|||   +.+++||||+|+||+++. ++.+||+|||+++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 578777755433 3577788889999999999999   889999999999999985 5679999999997543221


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+++.|+||
T Consensus       158 ~--~~~~~~~~~~y~~P  172 (294)
T PLN00009        158 R--TFTHEVVTLWYRAP  172 (294)
T ss_pred             c--ccccCceeecccCH
Confidence            1  11234567889987

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=5.8e-23  Score=203.27  Aligned_cols=169  Identities=25%  Similarity=0.374  Sum_probs=140.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  503 (599)
                      +|+..+.+|.|+||.||+|... +++.||+|.+...  .....+++..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4777889999999999999864 6889999998643  23345678899999999999999999998764  34679999


Q ss_pred             EccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++++|.+++...   ...+++..++.++.|+++|+.|+|..+  ..+++|+||||+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   346888999999999999999999543  678999999999999999999999999999866


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....  ......+++.|+||
T Consensus       161 ~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             cCCcc--cccccccCCCccCh
Confidence            43321  12335688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=7.2e-23  Score=204.51  Aligned_cols=157  Identities=26%  Similarity=0.342  Sum_probs=128.6

Q ss_pred             eecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHH---HHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          435 LIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECD---MMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 588999999865421   12223444443   3444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      ||+|.+++...+ .+++..+..++.|+++|+.|+|   +.+|+||||||+||+++.++.+||+|||+++.+....    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999998886543 5899999999999999999999   8899999999999999999999999999997553221    1


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....|+..|+||
T Consensus       153 ~~~~~~~~y~aP  164 (278)
T cd05606         153 HASVGTHGYMAP  164 (278)
T ss_pred             cCcCCCcCCcCc
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.90  E-value=2e-23  Score=215.44  Aligned_cols=161  Identities=25%  Similarity=0.388  Sum_probs=136.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-C-----CcceeEEEEEEcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-H-----RNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  501 (599)
                      +|.+.+.||+|.||.|.+|.+. +++.||||+++.+. ....+-..|+.+|..++ |     -|+|++++++...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            6888999999999999999865 69999999997543 33456678999999997 4     499999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC--CcEEEccccCCccC
Q 042902          502 VLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVAHLSDFGMAKPL  578 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DFGla~~~  578 (599)
                      |+|.++ -+|+++++.... .++...+..|+.||+.||.+||   ..+|||+||||+|||+-+-  ..+||+|||+|...
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999995 599999987543 5888899999999999999999   9999999999999999643  47999999999854


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...     ....+-+..|.||
T Consensus       342 ~q~-----vytYiQSRfYRAP  357 (586)
T KOG0667|consen  342 SQR-----VYTYIQSRFYRAP  357 (586)
T ss_pred             CCc-----ceeeeeccccccc
Confidence            221     1245677889998

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.90  E-value=7.3e-23  Score=201.59  Aligned_cols=166  Identities=29%  Similarity=0.421  Sum_probs=143.7

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|...+.||+|+||.||++... +++.||+|++.....  ...+.+..|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999976 589999999875432  4566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +++++|.+++....   ..+++..+..++.++++|+.|||   ..+++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987653   56899999999999999999999   8899999999999999999999999999998654332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                        .......|++.|+||
T Consensus       158 --~~~~~~~~~~~y~~p  172 (258)
T cd08215         158 --DLAKTVVGTPYYLSP  172 (258)
T ss_pred             --ceecceeeeecccCh
Confidence              122334678889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.90  E-value=3e-23  Score=213.30  Aligned_cols=167  Identities=29%  Similarity=0.398  Sum_probs=138.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC--Ceee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSND--DFKA  500 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~  500 (599)
                      .++|+..+.||+|+||.||+|... +|+.||||++...  .......+..|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888899999999999999876 5889999988543  223345677899999999 999999999998654  3689


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||++ ++|..++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 5999888765  5788888999999999999999   89999999999999999999999999999986643


Q ss_pred             CCCc---eeeecccCCccccCC
Q 042902          581 EDQS---LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~---~~~~~~~gt~~y~AP  599 (599)
                      ....   .......||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             ccccccCcchhcccccccccCc
Confidence            3321   122345688899998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.90  E-value=3.3e-23  Score=212.88  Aligned_cols=167  Identities=27%  Similarity=0.357  Sum_probs=137.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----ee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  499 (599)
                      .++|...+.||+|+||.||+|... +|+.||||.++... .....++..|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467899999999999999999865 68999999986432 334567888999999999999999999876543     57


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++|+||++ +++.+.+...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 4888777553  4788899999999999999999   8999999999999999999999999999998654


Q ss_pred             cCCCce-eeecccCCccccCC
Q 042902          580 KEDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ...... ......||+.||||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             ccccccCCcCCcCcCCCccCh
Confidence            322111 12335689999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7e-24  Score=206.91  Aligned_cols=170  Identities=31%  Similarity=0.464  Sum_probs=139.1

Q ss_pred             CCCCcCceecccccceEEEEE-ecCCcEEEEEEeccc--c-----cccHHHHHHHHHHHhcCCCCcceeEEEEEE-cCCe
Q 042902          428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--Y-----EGAFKSFDIECDMMKRIRHRNLIKIISSCS-NDDF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~  498 (599)
                      ++|-..+.+|+|||+.||+|. +...+.||||+-...  .     +.-.+...+|.++-+.++||.||++++|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            345667889999999999997 445788999987433  1     112345677999999999999999999986 5568


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMA  575 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla  575 (599)
                      .|-|+|||+|.+|+-+|+..+ .+++.++..|+.||+.||.||. ..+++|||-||||.|||+-   ..|.+||.|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            899999999999999998765 4788999999999999999998 4478999999999999984   4578999999999


Q ss_pred             ccCCcCCCc-----eeeecccCCccccCC
Q 042902          576 KPLLKEDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      +.+.++...     .-.....||.+|.+|
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPP  649 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCc
Confidence            977544322     123567899999988

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=5.7e-23  Score=211.62  Aligned_cols=166  Identities=26%  Similarity=0.376  Sum_probs=138.5

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--  497 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  497 (599)
                      ++...++|+..+.||+|+||.||+|... +|..||||++....  ....+.+..|++++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445678999999999999999999854 68999999985432  223456889999999999999999999887553  


Q ss_pred             ----eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcccc
Q 042902          498 ----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       498 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                          ..++||||+ +++|.+++...  .+++..+..++.|+++||+|+|   +.+|+||||||+||+++.++.+|++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 77998887643  4788899999999999999999   8999999999999999999999999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.....     .....+++.|+||
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAP  184 (343)
T ss_pred             cccccccC-----ccccccCCcccCH
Confidence            99865322     1234578889988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=8.1e-23  Score=205.16  Aligned_cols=165  Identities=27%  Similarity=0.341  Sum_probs=137.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  503 (599)
                      ++|...+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 588999999875432 3456789999999999999999999988654  4689999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++++|.+++..   ....+++.....++.|+++||.|+|   ..+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   2335788888999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...    ....++..|+||
T Consensus       158 ~~~----~~~~~~~~y~~p  172 (287)
T cd06621         158 SLA----GTFTGTSFYMAP  172 (287)
T ss_pred             ccc----ccccCCccccCH
Confidence            211    234567788887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.89  E-value=6.4e-23  Score=205.40  Aligned_cols=164  Identities=30%  Similarity=0.442  Sum_probs=138.6

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      |+..+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999865 69999999986543  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      + ++|.+++.... ..+++..+..++.|+++||.|+|   +.+++||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999887654 35789999999999999999999   88999999999999999999999999999975532211  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~~~aP  168 (283)
T cd07835         155 TYTHEVVTLWYRAP  168 (283)
T ss_pred             ccCccccccCCCCC
Confidence            11233568889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.89  E-value=9.2e-23  Score=200.90  Aligned_cols=167  Identities=29%  Similarity=0.417  Sum_probs=143.9

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALVL  503 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  503 (599)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  +..++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 689999999865542  4567899999999999999999999999988  8899999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++++|.+++.... .+++..+..++.|+++|+.|||   +.+++|+||+|+||+++.++.+||+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987765 6889999999999999999999   89999999999999999999999999999986654332


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      ........++..|+||
T Consensus       157 ~~~~~~~~~~~~y~~p  172 (260)
T cd06606         157 GEGTGSVRGTPYWMAP  172 (260)
T ss_pred             cccccCCCCCccccCH
Confidence            1112345678888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.89  E-value=8.8e-23  Score=204.19  Aligned_cols=162  Identities=25%  Similarity=0.353  Sum_probs=134.7

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcC--CeeeEEEE
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSND--DFKALVLE  504 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  504 (599)
                      |+..+.||+|+||.||+|... +++.||+|.++... .........|+.++.++. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999865 68999999986542 222234557888899885 99999999999887  88999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++ |++.+.+......+++..+..++.|+++||+|||   ..+++||||||+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 5888888765556899999999999999999999   889999999999999999 9999999999986543221 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....+++.|+||
T Consensus       155 --~~~~~~~~~y~aP  167 (282)
T cd07831         155 --YTEYISTRWYRAP  167 (282)
T ss_pred             --cCCCCCCcccCCh
Confidence              1234578889998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.89  E-value=5e-23  Score=202.97  Aligned_cols=166  Identities=25%  Similarity=0.397  Sum_probs=140.4

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999976 58999999986542  23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~~  583 (599)
                      +++++|.+++..... .+++..+..++.|+++|+.|+|   ..+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999876443 5789999999999999999999   88999999999999999875 579999999986643221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......|++.|+||
T Consensus       158 --~~~~~~~~~~~~ap  171 (257)
T cd08225         158 --LAYTCVGTPYYLSP  171 (257)
T ss_pred             --cccccCCCccccCH
Confidence              12234588889998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=6.4e-23  Score=206.02  Aligned_cols=166  Identities=27%  Similarity=0.385  Sum_probs=138.9

Q ss_pred             CCCcCceecccccceEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY----EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  499 (599)
                      +|+..+.||+|+||.||+|+..    +++.||||.++...    ....+.+..|++++.++ +||||+++++++..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677789999999999998743    57889999986431    22346788999999999 599999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++|+|.+++.... .+++..+..++.|+++||.|||   ..+++||||||+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887543 4788888999999999999999   8999999999999999999999999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... ......|++.|+||
T Consensus       157 ~~~~~-~~~~~~~~~~y~aP  175 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAP  175 (288)
T ss_pred             ccccc-ccccccCCccccCH
Confidence            33221 12335688899988

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=194.14  Aligned_cols=162  Identities=24%  Similarity=0.322  Sum_probs=135.2

Q ss_pred             cCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          432 ENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      ....+|.|..|.||+++++ +|...|||.+.... ....++++..++++.+- ++|+||+.+||+..+...++.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            4467999999999999976 58999999997553 34456777777776665 4999999999999999999999999 4


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      ...++++++-...+++...=++...+++||.||.+  .++|||||+||+|||+|+.|++|++|||++-++.+..   ..+
T Consensus       175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Aht  249 (391)
T KOG0983|consen  175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHT  249 (391)
T ss_pred             HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---ccc
Confidence            47777887776678877777899999999999985  5699999999999999999999999999998765433   234


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...|.+.||||
T Consensus       250 rsAGC~~YMaP  260 (391)
T KOG0983|consen  250 RSAGCAAYMAP  260 (391)
T ss_pred             cccCCccccCc
Confidence            56789999998

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.89  E-value=4e-23  Score=206.36  Aligned_cols=168  Identities=33%  Similarity=0.492  Sum_probs=143.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+.||+|+||.||+|... +|+.||+|++...   .....+.+..|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999875 6999999998653   2233467888999999998 99999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987654 5899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             Cc------------------eeeecccCCccccCC
Q 042902          583 QS------------------LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~------------------~~~~~~~gt~~y~AP  599 (599)
                      ..                  .......++..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  191 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP  191 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCH
Confidence            11                  112334578889987

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.89  E-value=9.7e-23  Score=210.87  Aligned_cols=164  Identities=26%  Similarity=0.327  Sum_probs=136.5

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSND------  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  496 (599)
                      ..++|+..+.||+|+||.||+|... +|+.||||.+...  .......+..|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999865 6899999998643  223445678899999999999999999988644      


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ...|+||||++ +++.+.+...   +++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35699999996 5888877543   788888899999999999999   8899999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......+++.|+||
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aP  186 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAP  186 (353)
T ss_pred             eCCCCC---CCCCCcccccccCH
Confidence            653321   12334678899998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=9.6e-23  Score=210.11  Aligned_cols=171  Identities=26%  Similarity=0.345  Sum_probs=141.7

Q ss_pred             ccHHHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 042902          418 FTHLELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCS  494 (599)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  494 (599)
                      ....++...+++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            344567778899999999999999999999854 68999999986432  223467888999999999999999999875


Q ss_pred             cC------CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          495 ND------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       495 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                      ..      ...++++|++ +++|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 78998887654  3788899999999999999999   89999999999999999999999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+++.....     .....+++.|+||
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aP  186 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAP  186 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCH
Confidence            9999999854221     1234678889998

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.89  E-value=3.2e-22  Score=198.61  Aligned_cols=163  Identities=24%  Similarity=0.268  Sum_probs=131.5

Q ss_pred             HHHHHhCCCCcCcee--cccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC
Q 042902          422 ELFQATNGFSENNLI--GRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD  497 (599)
Q Consensus       422 ~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  497 (599)
                      +.....+.|+..+.+  |+|+||.||++... +++.+|+|..........     |+.....+ +||||+++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445667776666  99999999999865 688899999865422111     22222212 6999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAK  576 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~  576 (599)
                      ..++||||+++|+|.+++.... .+++..+..++.||++|+.|+|   +.+++||||||+||+++.++ .++|+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999999987754 5899999999999999999999   88999999999999999888 99999999988


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....      ....+++.|+||
T Consensus       159 ~~~~~------~~~~~~~~y~aP  175 (267)
T PHA03390        159 IIGTP------SCYDGTLDYFSP  175 (267)
T ss_pred             ecCCC------ccCCCCCcccCh
Confidence            55322      123578899998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-23  Score=209.82  Aligned_cols=164  Identities=23%  Similarity=0.317  Sum_probs=137.6

Q ss_pred             CCCCcCceecccccceEEEEEecC-CcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---CCcceeEEEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQY--------EGAFKSFDIECDMMKRIR---HRNLIKIISSCSN  495 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  495 (599)
                      ..|+..+.+|+|+||.|+.|.++. ..+|+||.+.+..        ....-..-.||++|++++   |+||++++.++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458888999999999999999774 6789999885432        011112345999999997   9999999999999


Q ss_pred             CCeeeEEEEcc-CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          496 DDFKALVLEYM-PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       496 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ++++||+||-. ++-+|.+++..+. .+++..+..|++||+.|+++||   ..+|||||||-+||.+|.+|.+|++|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999965 5668889887655 4888899999999999999999   99999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |.....+    +....+||..|.||
T Consensus       717 aa~~ksg----pfd~f~gtv~~aap  737 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAP  737 (772)
T ss_pred             hhhhcCC----Ccceeeeeccccch
Confidence            9855332    23457899999998

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.89  E-value=6.7e-23  Score=210.41  Aligned_cols=168  Identities=26%  Similarity=0.345  Sum_probs=138.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc----CCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN----DDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  499 (599)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ......+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999865 69999999987542  2345678889999999999999999987753    3468


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||++ |+|.+++.... .+++..+..++.||++||.|||   ..+|+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68988886554 4889999999999999999999   8899999999999999999999999999997653


Q ss_pred             cCCCc--eeeecccCCccccCC
Q 042902          580 KEDQS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~--~~~~~~~gt~~y~AP  599 (599)
                      .....  .......|+..|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             ccCcCCCcccccccccccccCh
Confidence            32211  111345688889998

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=4.4e-25  Score=200.88  Aligned_cols=168  Identities=26%  Similarity=0.433  Sum_probs=138.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--------
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND--------  496 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  496 (599)
                      ..|.....||+|.||.||+|+.. +|+.||+|+.--  ..++....-.+|++++..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566678999999999999865 578899987532  2334455678899999999999999999887532        


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ...|+|+++|+. +|.-.+......++..++.+++.++..||.|+|   +..|+|||+||+|+||+.+|.+||+|||+||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            257999999987 898888887777999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCcCCC--ceeeecccCCccccCC
Q 042902          577 PLLKEDQ--SLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~--~~~~~~~~gt~~y~AP  599 (599)
                      .+...+.  ....+..+.|.+|.+|
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCH
Confidence            7653332  2233556678888876

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.1e-22  Score=198.97  Aligned_cols=156  Identities=28%  Similarity=0.386  Sum_probs=128.8

Q ss_pred             ceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH-hcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMM-KRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|... +|+.||||.++...   ......+..|..++ ...+|||++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999875 58999999986432   12223445555444 455899999999999999999999999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.+++.... .+++..+..++.|+++||.|+|   +.+++||||+|+||++++++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987644 4788888999999999999999   88999999999999999999999999999875432      12


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...+++.|+||
T Consensus       152 ~~~~~~~y~~p  162 (260)
T cd05611         152 KFVGTPDYLAP  162 (260)
T ss_pred             cCCCCcCccCh
Confidence            34578889888

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.89  E-value=2.8e-22  Score=203.76  Aligned_cols=160  Identities=28%  Similarity=0.350  Sum_probs=136.1

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      |...+.||+|+||.||+|+.. +|+.||+|.+....   ....+.+..|+++++.++|||++++++++.+.+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999865 68899999986432   23345788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +. |++.+++......+++..+..++.||+.|+.|||   ..+++||||+|+||+++.++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5888877665556889999999999999999999   88999999999999999999999999999864321     


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                       .....|+..|+||
T Consensus       174 -~~~~~~~~~y~aP  186 (313)
T cd06633         174 -ANSFVGTPYWMAP  186 (313)
T ss_pred             -CCCccccccccCh
Confidence             1234678889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=4.1e-23  Score=209.57  Aligned_cols=148  Identities=22%  Similarity=0.363  Sum_probs=129.3

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ...|...+.||-|+||.|..++. ++...+|.|.+++..   .........|..||+..+.+=||+|+..|.+.+..|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            45688889999999999999874 456779999987653   33445667799999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      |||++||++..+|.+.+ .+++..+.-++.++..|++++|   ..|+|||||||+|||||.+|.+|+.|||++.-+
T Consensus       708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999887765 4677777778889999999999   999999999999999999999999999998643

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=5.8e-23  Score=225.76  Aligned_cols=247  Identities=26%  Similarity=0.390  Sum_probs=179.7

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      .+.+.|++++++++. +|..+.  ++|+.|+|++|+|++++..      +  .++|++|++++|+|+.+ |..+   +..
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~LtsLP~~------l--~~nL~~L~Ls~N~LtsL-P~~l---~~~  242 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKSLPEN------L--QGNIKTLYANSNQLTSI-PATL---PDT  242 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCcCChh------h--ccCCCEEECCCCccccC-Chhh---hcc
Confidence            357889999999887 455443  5789999999999987764      2  24789999999998854 5443   346


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |+.|++++|++. .+|..+.  ++|++|+|++|+|+. +|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|++++
T Consensus       243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~  313 (754)
T PRK15370        243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQS  313 (754)
T ss_pred             ccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcC
Confidence            888889888888 4455543  578899999998884 454443  478899999998884 444432  4688888888


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT  259 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  259 (599)
                      |+++.+ |..+  .++|+.|++++|.++.+|..+.  ++|+.|++++|+|+ .+|..+  .++|+.|+|++|+|+.+ |.
T Consensus       314 N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~L-P~  384 (754)
T PRK15370        314 NSLTAL-PETL--PPGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTNL-PE  384 (754)
T ss_pred             CccccC-Cccc--cccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCCC-CH
Confidence            888864 3333  2678888889998888887653  67888888888887 355544  25788888888888854 44


Q ss_pred             cccCcccccccccccccccccCccc----ccCCCCcccccCCCCccc
Q 042902          260 TIGDLKDLQYLFLEYNRLQGSIPDS----IGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       260 ~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~  302 (599)
                      .+.  ..|+.|++++|+|+ .+|..    +..++.+..|++.+|+++
T Consensus       385 ~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        385 NLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            443  36888888888887 34443    344577888888888887

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=1.9e-22  Score=203.43  Aligned_cols=166  Identities=27%  Similarity=0.361  Sum_probs=136.6

Q ss_pred             hCCCCcCceecccccceEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|+..+.||+|+||.||+|.+.+ ++.||||.++... ......+..|+.++.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999999875 8999999996543 233456777887776665 999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||++ +++.++.......+++..+..++.||++||+|||   + .+|+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9995 4777776654556889999999999999999999   6 589999999999999999999999999998653322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .   .....+++.|+||
T Consensus       170 ~---~~~~~~~~~y~aP  183 (296)
T cd06618         170 A---KTRSAGCAAYMAP  183 (296)
T ss_pred             c---ccCCCCCccccCH
Confidence            1   1234577889988

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.88  E-value=2e-22  Score=204.50  Aligned_cols=161  Identities=29%  Similarity=0.378  Sum_probs=137.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+...   ......++..|+++++.++|||++++.+++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4667789999999999999975 5889999998642   22345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+. |++.+.+......+++..+..++.|++.|+.|+|   ..+++||||||+||+++.++.+|++|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 6888777655556788899999999999999999   889999999999999999999999999998754322   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                         ....+++.|+||
T Consensus       169 ---~~~~~~~~y~aP  180 (308)
T cd06634         169 ---NXFVGTPYWMAP  180 (308)
T ss_pred             ---ccccCCccccCH
Confidence               234578889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.88  E-value=4.8e-24  Score=218.10  Aligned_cols=168  Identities=29%  Similarity=0.405  Sum_probs=148.3

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..++|...+++|.|.||.||||+.. .++..|||+++....+..+-.+.|+-+++..+|||||.++|.+...+..|+.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3467888999999999999999865 689999999988877777888899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||.+|+|++..+..+ .+++.+...+++...+|+.|+|   +.+-+|||||-.||++++.|.+|++|||.+..+..  .-
T Consensus        93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            999999999877654 4777888889999999999999   88989999999999999999999999999876632  22


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      ....+..|||.||||
T Consensus       167 ~KrksfiGtpywmap  181 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAP  181 (829)
T ss_pred             hhhhcccCCccccch
Confidence            234568899999998

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.88  E-value=2.6e-22  Score=205.26  Aligned_cols=166  Identities=28%  Similarity=0.384  Sum_probs=138.1

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCe
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDF  498 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  498 (599)
                      +...+++|+..+.||+|+||.||+|... +++.||||++....  ....+.+..|++++++++||||+++.+++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999865 79999999885432  2345678899999999999999999998865 557


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+ +++|.+++...  .+++.....++.|+++||.|||   +.+|+||||+|+||++++++.+|++|||.++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999999 56898887653  3677778889999999999999   899999999999999999999999999998754


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...     .....+++.|+||
T Consensus       159 ~~~-----~~~~~~~~~y~aP  174 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAP  174 (328)
T ss_pred             CCC-----cCCCcccccccCc
Confidence            221     1234567788887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.88  E-value=3e-22  Score=205.73  Aligned_cols=167  Identities=25%  Similarity=0.360  Sum_probs=135.3

Q ss_pred             CCCCc-CceecccccceEEEEEec-CCcEEEEEEeccccccc--------------HHHHHHHHHHHhcCCCCcceeEEE
Q 042902          428 NGFSE-NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA--------------FKSFDIECDMMKRIRHRNLIKIIS  491 (599)
Q Consensus       428 ~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~  491 (599)
                      ++|.. .+.||+|+||.||+|... +++.||||.++......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 467999999999999865 68999999986432111              125778999999999999999999


Q ss_pred             EEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcc
Q 042902          492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       492 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                      ++...+..++||||++ |+|.+++.... .+++.....++.|+++||+|||   +.+|+||||||+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 68998886543 4788889999999999999999   89999999999999999999999999


Q ss_pred             ccCCccCCcCC------------CceeeecccCCccccCC
Q 042902          572 FGMAKPLLKED------------QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~------------~~~~~~~~~gt~~y~AP  599 (599)
                      ||.++......            .........+++.|+||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  202 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP  202 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCC
Confidence            99997654110            01112234567889998

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=1.7e-22  Score=198.92  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=140.1

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||+++.. +++.+|+|.+...  .......+..|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 6889999998653  233456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +++++|.+++...   ...+++..+..++.|+++||.|+|   +.+++|+||+|+||++++++.+|++|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988662   235788889999999999999999   899999999999999999999999999999865433 


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......+++.|+||
T Consensus       157 ---~~~~~~~~~~~~~P  170 (256)
T cd08530         157 ---MAKTQIGTPHYMAP  170 (256)
T ss_pred             ---CcccccCCccccCH
Confidence               11234578888887

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.88  E-value=1.8e-22  Score=205.02  Aligned_cols=169  Identities=27%  Similarity=0.390  Sum_probs=137.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468899999999999999999865 68999999986442  223356788999999999999999998775433      


Q ss_pred             --eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          498 --FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       498 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                        ..++||||+++ ++...+......+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+|++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999965 777777665556899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCcCCCc---------eeeecccCCccccCC
Q 042902          576 KPLLKEDQS---------LTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~---------~~~~~~~gt~~y~AP  599 (599)
                      +........         ...+...+++.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCCh
Confidence            865322211         111334578889998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=1.9e-22  Score=207.25  Aligned_cols=166  Identities=27%  Similarity=0.343  Sum_probs=137.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Ce
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  498 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||.++..  .......+..|+.++++++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999865 6899999998653  223345678899999999999999999987644     24


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+. ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68988886543 4888999999999999999999   899999999999999999999999999999865


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....  ......++..|+||
T Consensus       159 ~~~~~--~~~~~~~~~~y~aP  177 (337)
T cd07858         159 SEKGD--FMTEYVVTRWYRAP  177 (337)
T ss_pred             CCCcc--cccccccccCccCh
Confidence            43321  22334678889998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.88  E-value=3.3e-22  Score=205.13  Aligned_cols=166  Identities=23%  Similarity=0.288  Sum_probs=134.5

Q ss_pred             CCCcCceecccccceEEEEEec-C--CcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC----Ce
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-D--GIEVAVKVFDLQY--EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND----DF  498 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  498 (599)
                      +|+..+.||+|+||.||+|+.. +  ++.||+|.+....  ....+++..|+++++++ .||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999865 3  7889999986432  22356788899999999 599999999875432    45


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++++||++ ++|.+++.... .+++..+..++.||+.||.|||   ..+|+||||||+||++++++.+||+|||+|+.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999995 68988886543 4788999999999999999999   899999999999999999999999999999865


Q ss_pred             CcCCCc--eeeecccCCccccCC
Q 042902          579 LKEDQS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~--~~~~~~~gt~~y~AP  599 (599)
                      ......  .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             ccccccccccccCcccCccccCc
Confidence            432211  112345789999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=2.2e-22  Score=201.44  Aligned_cols=164  Identities=31%  Similarity=0.418  Sum_probs=140.0

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      |+..+.||+|++|.||+|... +++.+|+|.++....  .....+..|++++++++||||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999875 689999999865432  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++ ++.+.+......+++..+..++.|+++|+.|||   ..+|+|+||||+||++++++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 888888776556899999999999999999999   8999999999999999999999999999998664332  12


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~~P  167 (283)
T cd05118         155 YTHYVVTRWYRAP  167 (283)
T ss_pred             ccCccCcccccCc
Confidence            2334577889888

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=6.2e-23  Score=225.52  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=201.7

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|+++.++ .+|..+.  ++|+.|+|++|+|+.+ |..+.  .+|++|+|++|++++++..      +  .++|+.|+|
T Consensus       183 L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~LtsLP~~------l--~~~L~~L~L  248 (754)
T PRK15370        183 LRLKILGLT-TIPACIP--EQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLTSIPAT------L--PDTIQEMEL  248 (754)
T ss_pred             EEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCccccCChh------h--hccccEEEC
Confidence            568888888 5677664  5899999999999975 44443  5899999999999988753      2  247999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|+|. .+|..+.   ..|+.|++++|+++. +|..+.  ++|+.|+|++|+|+.+ |..+.  ++|+.|++++|.++.
T Consensus       249 s~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        249 SINRIT-ELPERLP---SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTA  318 (754)
T ss_pred             cCCccC-cCChhHh---CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCcccc
Confidence            999998 4565543   469999999999995 566553  5899999999999964 44332  479999999999995


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                       +|..+  .++|+.|++++|.++++ |..+.  ++|+.|++++|+|+.+|..+.  ++|+.|++++|+|+. +|..+.  
T Consensus       319 -LP~~l--~~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--  387 (754)
T PRK15370        319 -LPETL--PPGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTN-LPENLP--  387 (754)
T ss_pred             -CCccc--cccceeccccCCccccC-Chhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCC-CCHhHH--
Confidence             45444  36899999999999974 54443  789999999999999998663  689999999999995 455543  


Q ss_pred             ccccEEEccCCccCCCCCcc----ccCcccccccccccccccccCcccccCCCCcccccCCCCcccc
Q 042902          241 RVLVQIDLSMNNFSGFIPTT----IGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  303 (599)
                      ..|+.|++++|+|+. +|..    ++.++++..|++.+|+++.      ..+.+|+.| ++.+.+.|
T Consensus       388 ~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g  446 (754)
T PRK15370        388 AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG  446 (754)
T ss_pred             HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence            479999999999985 4543    3455889999999999972      344556666 44455443

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.88  E-value=2e-22  Score=202.35  Aligned_cols=164  Identities=29%  Similarity=0.380  Sum_probs=133.0

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +|+..+.||+|+||.||++... +++.||+|.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999865 58999999987543 234567889999999996 99999999999998899999999


Q ss_pred             cCCCChhhhh---hc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          506 MPHGSLEKCL---YS-SNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       506 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ++. ++.++.   .. ....+++..+..++.++++||+|+|   + .+|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 554432   22 2245888899999999999999999   5 4899999999999999999999999999976543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...   .....|++.|+||
T Consensus       161 ~~~---~~~~~~~~~y~aP  176 (288)
T cd06616         161 SIA---KTRDAGCRPYMAP  176 (288)
T ss_pred             CCc---cccccCccCccCH
Confidence            221   1234578889998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=2.3e-22  Score=201.12  Aligned_cols=164  Identities=32%  Similarity=0.438  Sum_probs=139.9

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+..|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556688999999999999976 48999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      + ++|.+++......+++..+..++.|+++||.|||   ..+|+||||+|+||++++++.+||+|||.++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876456899999999999999999999   88999999999999999999999999999986543322  1


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (282)
T cd07829         155 YTHEVVTLWYRAP  167 (282)
T ss_pred             cCccccCcCcCCh
Confidence            2234457778887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.88  E-value=3.4e-23  Score=193.23  Aligned_cols=162  Identities=27%  Similarity=0.327  Sum_probs=129.7

Q ss_pred             hCCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhc-CCCCcceeEEEEEEcC----Cee
Q 042902          427 TNGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKR-IRHRNLIKIISSCSND----DFK  499 (599)
Q Consensus       427 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~----~~~  499 (599)
                      +++|+.. ++||-|-.|.|..|..+ +|+.+|+|++...     ..-.+|++.--. -.|||||.++++|...    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4455443 68999999999999865 6889999998533     223456665333 3699999999987543    466


Q ss_pred             eEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMA  575 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla  575 (599)
                      .+|||.|+||.|.+.+.+++. .+++.++..|+.||+.|+.|||   +..|.||||||+|+|..   .+..+|++|||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence            799999999999999887654 6899999999999999999999   89999999999999996   4557999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.-..   .......+.||.|.||
T Consensus       212 K~t~~---~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  212 KETQE---PGDLMTPCFTPYYVAP  232 (400)
T ss_pred             cccCC---CccccCCcccccccCH
Confidence            95322   2344557889999998

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2e-22  Score=220.57  Aligned_cols=170  Identities=28%  Similarity=0.467  Sum_probs=142.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCcceeEEEEEEc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR-HRNLIKIISSCSN  495 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  495 (599)
                      ..++....+.+|+|+||.|++|...        ....||||.++... ....+.+..|+++|+.+. ||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455569999999999999743        14579999987543 345678999999999985 9999999999999


Q ss_pred             CCeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCee
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  560 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nil  560 (599)
                      ++..++|+||++.|+|.++++..+               ..+...+.+.++.|||.||+||+   +.++|||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998776               23788889999999999999999   999999999999999


Q ss_pred             ecCCCcEEEccccCCccCCcCCCceeeeccc--CCccccCC
Q 042902          561 LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL--ATIGYMAP  599 (599)
Q Consensus       561 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~AP  599 (599)
                      +..+..+||+|||+||.....+.+... ...  -+.+||||
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAP  490 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCH
Confidence            999999999999999976655544322 122  35579998

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=3e-22  Score=200.53  Aligned_cols=163  Identities=26%  Similarity=0.374  Sum_probs=137.3

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccccc-cHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      |...+.||+|+||.||+|... +++.||||.+...... ......+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999976 4789999998654322 2234567899999999 999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                       +|++.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||.++.......  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889998887654 45799999999999999999999   88999999999999999999999999999986543221  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                       .....++..|+||
T Consensus       155 -~~~~~~~~~~~aP  167 (283)
T cd07830         155 -YTDYVSTRWYRAP  167 (283)
T ss_pred             -cCCCCCcccccCc
Confidence             2234578889988

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.88  E-value=4.1e-22  Score=204.02  Aligned_cols=141  Identities=26%  Similarity=0.343  Sum_probs=123.2

Q ss_pred             ceeccc--ccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRG--GVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      ..||+|  +||+||+|++. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  89999999875 79999999986542  23457789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          509 GSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       509 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      |++.+++.... ..+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+|++|||.+..
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999887643 24788888899999999999999   89999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-23  Score=201.30  Aligned_cols=167  Identities=24%  Similarity=0.293  Sum_probs=141.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..+|....+||+|+||.|-.|..+ +.+.+|||++++.   ..++.+--+.|.++|+.- +-|.+++++.++++.+..|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346888899999999999999866 4677999999765   234455567788888766 57899999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+.||+|.-++.+-+. +.+..++-+|.+||-||-|||   +++||.||||..|||+|.+|.+||+|||+++.-..+
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999888776554 566677889999999999999   999999999999999999999999999999854433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      +.  +....+|||.||||
T Consensus       504 ~~--TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  504 GV--TTKTFCGTPDYIAP  519 (683)
T ss_pred             Cc--ceeeecCCCccccc
Confidence            32  34568999999999

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2.4e-22  Score=206.05  Aligned_cols=166  Identities=27%  Similarity=0.355  Sum_probs=140.4

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----eee
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKA  500 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  500 (599)
                      +|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+..|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999976 48999999987543  344568999999999999999999999988765     789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58988887654 5889999999999999999999   89999999999999999999999999999986644


Q ss_pred             CCCc-eeeecccCCccccCC
Q 042902          581 EDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-~~~~~~~gt~~y~AP  599 (599)
                      .... .......+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             cccccccccccccccCcCCc
Confidence            3210 112345678889998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.4e-22  Score=187.32  Aligned_cols=139  Identities=19%  Similarity=0.222  Sum_probs=107.5

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccc--c-------HHHH-----------------HHHHHHHhcCCCCcc
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG--A-------FKSF-----------------DIECDMMKRIRHRNL  486 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~~-----------------~~e~~~l~~l~h~ni  486 (599)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ..+|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999999654210  1       1122                 349999999988776


Q ss_pred             eeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEccCCCCCeeecCCC
Q 042902          487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKPNNVLLDDNM  565 (599)
Q Consensus       487 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dlk~~Nill~~~~  565 (599)
                      .....+..  ...++||||++++++...... ...+++.....++.|+++||.|+ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            44333222  224899999999877654322 23478888999999999999999 7   77999999999999998 47


Q ss_pred             cEEEccccCCccC
Q 042902          566 VAHLSDFGMAKPL  578 (599)
Q Consensus       566 ~~kl~DFGla~~~  578 (599)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=3.9e-22  Score=202.91  Aligned_cols=161  Identities=22%  Similarity=0.269  Sum_probs=129.9

Q ss_pred             eecccccceEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChh
Q 042902          435 LIGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLE  512 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  512 (599)
                      .+|.|+++.||++.. +++.||||++...  .....+.+..|++++++++||||+++++++.+.+..+++|||+++|++.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344455555555544 6999999998654  3345578999999999999999999999999999999999999999999


Q ss_pred             hhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc-----ee
Q 042902          513 KCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS-----LT  586 (599)
Q Consensus       513 ~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~-----~~  586 (599)
                      +++... ...+++.....++.|+++||.|||   +.+|+||||||+||+++.++.+|++|||.+..+...+..     ..
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            998754 234788888899999999999999   889999999999999999999999999998755332211     01


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....++..|+||
T Consensus       165 ~~~~~~~~~y~aP  177 (314)
T cd08216         165 PKSSVKNLPWLSP  177 (314)
T ss_pred             cccccccccccCH
Confidence            1234567789988

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.88  E-value=5.1e-22  Score=204.52  Aligned_cols=161  Identities=28%  Similarity=0.374  Sum_probs=133.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+..|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999865 68999999986432  233456889999999999999999999886543      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..++|+||++. ++..+..   ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776542   24788889999999999999999   88999999999999999999999999999985


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....     .....+++.||||
T Consensus       167 ~~~~-----~~~~~~~~~y~aP  183 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAP  183 (342)
T ss_pred             CCCC-----CCCceeeecccCh
Confidence            4321     1234578889998

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.87  E-value=6.9e-22  Score=199.04  Aligned_cols=167  Identities=22%  Similarity=0.311  Sum_probs=122.5

Q ss_pred             CCCCcCceecccccceEEEEEecC----CcEEEEEEeccccccc-----------HHHHHHHHHHHhcCCCCcceeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQYEGA-----------FKSFDIECDMMKRIRHRNLIKIISS  492 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~  492 (599)
                      ++|...+.||+|+||.||+|.+.+    +..+|+|+........           ......+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578899999999999999998764    3466777643322111           0112233445667789999999997


Q ss_pred             EEcCC----eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          493 CSNDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       493 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                      +....    ..++++|++.. ++.+.+.... ..++..+..|+.|+++||+|+|   +.+|+||||||+|||+++++.+|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            76543    45788888743 6666554432 2467778899999999999999   89999999999999999999999


Q ss_pred             EccccCCccCCcCCCc-----eeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      |+|||+|+.+......     .......||+.||||
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence            9999999876432211     112234699999997

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=8.3e-24  Score=209.82  Aligned_cols=164  Identities=24%  Similarity=0.338  Sum_probs=142.8

Q ss_pred             CCCcCceecccccceEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++.....+|-||||.|-.++... ...+|+|++++..   ....+....|..+|...+.|.||+++..|.++.+.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            45556789999999999988663 3348999887552   3345667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      -|-||.++..++.++. ++...+.-|+..+.+|++|||   +++||.|||||+|.++|.+|-+|+.|||+|+.+....+.
T Consensus       501 aClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            9999999999998775 777777789999999999999   999999999999999999999999999999998766654


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .   ..+|||.|.||
T Consensus       577 w---TFcGTpEYVAP  588 (732)
T KOG0614|consen  577 W---TFCGTPEYVAP  588 (732)
T ss_pred             e---eecCCcccccc
Confidence            4   37899999999

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.87  E-value=9.8e-22  Score=197.08  Aligned_cols=163  Identities=30%  Similarity=0.420  Sum_probs=133.8

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCcceeEEEEEEcCCe-----
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNLIKIISSCSNDDF-----  498 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  498 (599)
                      |+..+.||+|+||.||+|+.+ +++.||+|.++...  ......+..|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999987 48999999997442  22234567788777665   59999999999988776     


Q ss_pred             eeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      .+++|||++ +++.+++.... ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 48988886643 35889999999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.....   .....+++.|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~~~P  175 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAP  175 (287)
T ss_pred             ccCCcc---cccccccccccCh
Confidence            543321   1233478889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5e-24  Score=196.04  Aligned_cols=164  Identities=26%  Similarity=0.383  Sum_probs=135.0

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-----eeeE
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-----FKAL  501 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  501 (599)
                      .+..+.||-|+||+||.+.+. +|+.||.|++..-  .-...+++.+|++++..++|.|+...++.....+     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345578999999999999865 7999999998532  2235678899999999999999999988776554     6789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |+|.|.. +|++.+...+ .++...+.-+..||++||.|||   +.+|.||||||.|.|++++...||+|||+||.-. .
T Consensus       135 ~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q  208 (449)
T ss_pred             HHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence            9999954 8988876654 3666677778999999999999   9999999999999999999999999999999532 3


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      +....++..+-|..|.||
T Consensus       209 d~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             hhhhhhHHHHHHHHhccH
Confidence            334455667778888887

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.87  E-value=7.6e-24  Score=194.43  Aligned_cols=162  Identities=29%  Similarity=0.351  Sum_probs=130.2

Q ss_pred             cCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHH-hcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          432 ENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMM-KRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      ....||.|+||+|+|-.++ .|+..|||+++... +...++++.|.++. +.-++||||+++|.+..++..|+-||.|+ 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            4468999999999998866 69999999997553 35667888888764 44579999999999999999999999994 


Q ss_pred             CChhhhhhc----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          509 GSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       509 g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      -+++.+.+.    ++..+++.-.-.|+...+.||.||.+  ...|||||+||+|||+|..|.+|++|||++-.+..   +
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S  221 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S  221 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence            477665432    23346666666788888999999985  45799999999999999999999999999976532   2


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      ...+.-+|...||||
T Consensus       222 iAkT~daGCrpYmAP  236 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAP  236 (361)
T ss_pred             HHhhhccCCccccCh
Confidence            233456788899999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=6.1e-22  Score=214.64  Aligned_cols=166  Identities=22%  Similarity=0.262  Sum_probs=118.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-C----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEE------EE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-D----GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS------CS  494 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  494 (599)
                      ..++|...+.||+|+||.||+|++. +    +..||||++.....  .+.+..|.  +....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNER--VRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHHH--HHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999975 4    68999998754321  12222221  112222222222211      24


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcCCCc-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSSNYI-------------------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  555 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  555 (599)
                      ..+..++||||+++++|.+++......                   .....+..++.||+.||+|+|   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            556889999999999999988754311                   112234579999999999999   8999999999


Q ss_pred             CCCeeecC-CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          556 PNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       556 ~~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||++. ++.+||+|||+|+.+..... .......+|++||||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~AP  326 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAP  326 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccCh
Confidence            99999985 57999999999986543322 223456789999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=179.53  Aligned_cols=164  Identities=24%  Similarity=0.313  Sum_probs=131.3

Q ss_pred             CCcCceecccccceEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHh-cCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-YEGAFKSFDIECDMMK-RIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ......||+|++|.|-+-++. +|+..|+|.++.. ..+..++.+.|+.+.. ...+|.+|+++|.+......|+.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            334568999999999887754 6999999999755 3344567788887654 457999999999999999999999999


Q ss_pred             CCCChhhhhh---cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          507 PHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       507 ~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      + -||+.+.+   ..+...++...=+||..|..||.|||+  +..+||||+||+|||++.+|++|++|||++-.+.+.- 
T Consensus       128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-  203 (282)
T KOG0984|consen  128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-  203 (282)
T ss_pred             h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence            5 48876643   344567777778999999999999995  4589999999999999999999999999987654321 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ..+...|...||||
T Consensus       204 --Akt~daGCkpYmaP  217 (282)
T KOG0984|consen  204 --AKTMDAGCKPYMAP  217 (282)
T ss_pred             --HHHHhcCCCccCCh
Confidence              22334677889998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.87  E-value=8.1e-22  Score=193.46  Aligned_cols=158  Identities=32%  Similarity=0.436  Sum_probs=135.9

Q ss_pred             ecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      ||+|+||.||++... +++.||+|.+....   ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 58999999986543   22456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeeccc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL  591 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  591 (599)
                      .+++.... .+++.....++.|+++|+.|+|   ..+++|+||+|+||+++.++.++++|||++.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987654 4788999999999999999999   8999999999999999999999999999998654321  1223456


Q ss_pred             CCccccCC
Q 042902          592 ATIGYMAP  599 (599)
Q Consensus       592 gt~~y~AP  599 (599)
                      ++..|+||
T Consensus       155 ~~~~~~~P  162 (250)
T cd05123         155 GTPEYLAP  162 (250)
T ss_pred             CCccccCh
Confidence            78889887

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.87  E-value=5.2e-22  Score=204.42  Aligned_cols=166  Identities=26%  Similarity=0.366  Sum_probs=135.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC----------
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND----------  496 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----------  496 (599)
                      .+|...+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999865 6899999998766555667889999999999999999999776543          


Q ss_pred             ----CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEcc
Q 042902          497 ----DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSD  571 (599)
Q Consensus       497 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~D  571 (599)
                          ...++||||++ ++|.+++...  .+++..+..++.||++||.|||   ..+|+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 5898887643  4788899999999999999999   88999999999999998 456799999


Q ss_pred             ccCCccCCcCCCce-eeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ||.++......... ......++..|+||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             cccceecCCccccccccccccccccccCH
Confidence            99997653221111 11233578889998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.87  E-value=5.6e-22  Score=204.28  Aligned_cols=164  Identities=26%  Similarity=0.348  Sum_probs=138.1

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe---
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF---  498 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  498 (599)
                      ...++|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+..|+.++++++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999976 58899999986432  2234567889999999999999999988766554   


Q ss_pred             ---eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          499 ---KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       499 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                         .++|+||+ +++|.+++...  .+++..+..++.|+++|++|+|   +.+|+||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 67999888753  4889999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......     .....+++.|+||
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             cccccc-----ccCCcccccccCH
Confidence            865322     2234578889988

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.4e-21  Score=181.45  Aligned_cols=139  Identities=24%  Similarity=0.252  Sum_probs=110.2

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccc--------------------------cHHHHHHHHHHHhcCCCCcc
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG--------------------------AFKSFDIECDMMKRIRHRNL  486 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  486 (599)
                      ...||+|+||.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3689999999999999878999999998754211                          01224578999999999987


Q ss_pred             eeEEEEEEcCCeeeEEEEccCCCChhhh-hhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCC
Q 042902          487 IKIISSCSNDDFKALVLEYMPHGSLEKC-LYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       487 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~  564 (599)
                      .....+...  ..++||||++|+++... +..  ..++......++.|++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            544444332  24899999998865433 332  23677788899999999999999   7 8999999999999999 8


Q ss_pred             CcEEEccccCCccCC
Q 042902          565 MVAHLSDFGMAKPLL  579 (599)
Q Consensus       565 ~~~kl~DFGla~~~~  579 (599)
                      +.++++|||+|+...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.86  E-value=9.9e-22  Score=194.20  Aligned_cols=165  Identities=22%  Similarity=0.344  Sum_probs=133.4

Q ss_pred             CCCcCceecccccceEEEEEecC-CcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQ-----YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|...+.||+|+||.||++.... +..+++|.++..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778899999999999998653 455666665421     122344677899999999999999999999988899999


Q ss_pred             EEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          503 LEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |||+++++|.+++..   ....+++..+..++.|+++|+.|+|   +.+++|+||||+||++++ +.+|++|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   2345889999999999999999999   899999999999999975 569999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ......|++.|+||
T Consensus       157 ~~~~--~~~~~~~~~~~~~p  174 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSP  174 (260)
T ss_pred             CCcc--cccCCCCCcCccCH
Confidence            3221  22334578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.86  E-value=3.3e-21  Score=187.69  Aligned_cols=147  Identities=20%  Similarity=0.134  Sum_probs=123.0

Q ss_pred             cccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhc
Q 042902          439 GGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS  517 (599)
Q Consensus       439 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  517 (599)
                      |.||.||+++.. +++.||+|.+....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 68999999986542     233455555666799999999999999999999999999999998876


Q ss_pred             CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCcccc
Q 042902          518 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM  597 (599)
Q Consensus       518 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  597 (599)
                      .. .+++..+..++.|+++||.|+|   +.+|+||||||+||+++.++.++++|||.+......     .....++..||
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 4788999999999999999999   899999999999999999999999999988754321     12234566788


Q ss_pred             CC
Q 042902          598 AP  599 (599)
Q Consensus       598 AP  599 (599)
                      ||
T Consensus       150 aP  151 (237)
T cd05576         150 AP  151 (237)
T ss_pred             CC
Confidence            88

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.85  E-value=1.5e-20  Score=181.10  Aligned_cols=166  Identities=31%  Similarity=0.432  Sum_probs=141.5

Q ss_pred             CCcCceecccccceEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      |...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+..|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 899999999765444 56789999999999999999999999999899999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +++|.+++......+++.....++.+++.++.|+|   ..+++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999998765433788889999999999999999   88999999999999999999999999999987644320 012


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....++..|+||
T Consensus       157 ~~~~~~~~~~~p  168 (225)
T smart00221      157 KTVKGTPFYLAP  168 (225)
T ss_pred             cceeccCCcCCH
Confidence            234567778887

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.84  E-value=2.5e-21  Score=203.49  Aligned_cols=162  Identities=31%  Similarity=0.469  Sum_probs=128.6

Q ss_pred             CCcCceecccccce-EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          430 FSENNLIGRGGVAS-VYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       430 ~~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      |...+.+|.|+-|+ ||+|.++ |++||||++-..   ...-..+|+..++.- +|||||++++.-.++...||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456788998765 7999986 899999998533   223446799988877 49999999999999999999999995


Q ss_pred             CCChhhhhhcCCCc---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---C--CcEEEccccCCccCC
Q 042902          508 HGSLEKCLYSSNYI---LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---N--MVAHLSDFGMAKPLL  579 (599)
Q Consensus       508 ~g~L~~~l~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~--~~~kl~DFGla~~~~  579 (599)
                      . +|.+++......   ........+..|+++||+|||   +.+||||||||.||||+.   +  .+++|+|||+++++.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 999999874111   111234678899999999999   899999999999999975   3  479999999999887


Q ss_pred             cCCCce-eeecccCCccccCC
Q 042902          580 KEDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~-~~~~~~gt~~y~AP  599 (599)
                      .+..+. ......||-||+||
T Consensus       663 ~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             CCcchhhcccCCCCcccccCH
Confidence            554332 23567899999999

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.7e-21  Score=181.91  Aligned_cols=167  Identities=27%  Similarity=0.323  Sum_probs=140.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..+|+..++||+|+|++|..+++. +.+.+|+|++++..   .....-.+.|..+.... +||.+|.++.++.++...+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            457888999999999999999865 68899999997652   33344566777777665 69999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |.||++||+|.-++.++. .+++..+.-+..+|.-||.|||   +.|||.||+|..|||+|..|.+|+.|+|+++.-...
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999987776654 4777777789999999999999   999999999999999999999999999999854322


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      +  ......+|||.|+||
T Consensus       405 g--d~tstfcgtpnyiap  420 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAP  420 (593)
T ss_pred             C--cccccccCCCcccch
Confidence            2  133568999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.83  E-value=1e-19  Score=172.79  Aligned_cols=159  Identities=35%  Similarity=0.573  Sum_probs=135.3

Q ss_pred             ecccccceEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhh
Q 042902          436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK  513 (599)
Q Consensus       436 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  513 (599)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999999755432 35679999999999999999999999999899999999999999999


Q ss_pred             hhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCccCCcCCCceeeecccC
Q 042902          514 CLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLA  592 (599)
Q Consensus       514 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~g  592 (599)
                      ++.......++..+..++.++++++.|+|   ..+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            98876445788899999999999999999   889999999999999999 89999999999986543221  1223446


Q ss_pred             CccccCC
Q 042902          593 TIGYMAP  599 (599)
Q Consensus       593 t~~y~AP  599 (599)
                      ...|++|
T Consensus       156 ~~~~~~p  162 (215)
T cd00180         156 TPAYMAP  162 (215)
T ss_pred             CCCccCh
Confidence            6677776

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=9.8e-20  Score=171.22  Aligned_cols=138  Identities=16%  Similarity=0.258  Sum_probs=108.0

Q ss_pred             CCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-----CCCcceeEEEEEEcCC---e-ee
Q 042902          430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-----RHRNLIKIISSCSNDD---F-KA  500 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~  500 (599)
                      .+..+.||+|+||.||.  +.+....+||++........+.+.+|+++++.+     .||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567999999999996  443333479988765444567899999999999     5799999999998873   4 34


Q ss_pred             EEEEc--cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEEccCCCCCeeecC----CCcEEEcccc
Q 042902          501 LVLEY--MPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDLKPNNVLLDD----NMVAHLSDFG  573 (599)
Q Consensus       501 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~iiH~dlk~~Nill~~----~~~~kl~DFG  573 (599)
                      +|+||  +++|+|.+++.+..  +++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  66899999997642  4444  35677888777 9999   999999999999999973    3479999944


Q ss_pred             CCc
Q 042902          574 MAK  576 (599)
Q Consensus       574 la~  576 (599)
                      -++
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.82  E-value=7.1e-20  Score=178.20  Aligned_cols=153  Identities=35%  Similarity=0.454  Sum_probs=133.3

Q ss_pred             ccceEEEEEec-CCcEEEEEEeccccccc-HHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhc
Q 042902          440 GVASVYKARIQ-DGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS  517 (599)
Q Consensus       440 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  517 (599)
                      +||.||+|... +|+.||+|++....... .+.+..|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997664444 68899999999999999999999999999999999999999999999876


Q ss_pred             CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCcccc
Q 042902          518 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM  597 (599)
Q Consensus       518 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  597 (599)
                      ... +++..+..++.++++|+.|||   ..+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            544 788899999999999999999   8899999999999999999999999999998654332   223456788888


Q ss_pred             CC
Q 042902          598 AP  599 (599)
Q Consensus       598 AP  599 (599)
                      ||
T Consensus       154 ~p  155 (244)
T smart00220      154 AP  155 (244)
T ss_pred             CH
Confidence            87

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.82  E-value=6.2e-22  Score=201.89  Aligned_cols=88  Identities=20%  Similarity=0.235  Sum_probs=42.4

Q ss_pred             cccccccEEEccCCccCCCCCcccc-----Ccccccccccccccccc----cCcccccCCCCcccccCCCCccccc----
Q 042902          238 GNLRVLVQIDLSMNNFSGFIPTTIG-----DLKDLQYLFLEYNRLQG----SIPDSIGGLIDLKSLDLSNNNISGA----  304 (599)
Q Consensus       238 ~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----  304 (599)
                      ..+++|++|++++|.+++.....+.     ..+.|++|++++|.+++    .+...+..+++|+.+++++|.++..    
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~  297 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQL  297 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHH
Confidence            3344455555555555432111111     12455556666555541    1223344445666666666666633    


Q ss_pred             CCchhhcc-ccceEEEcccccC
Q 042902          305 IPISLEKL-LDLKYINVSFNKL  325 (599)
Q Consensus       305 ~p~~~~~l-~~L~~l~l~~N~l  325 (599)
                      ....+... +.|+.+++.+|++
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         298 LAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHhhcCCchhhcccCCCCC
Confidence            22223333 4566666666653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.82  E-value=6.6e-22  Score=201.70  Aligned_cols=62  Identities=26%  Similarity=0.185  Sum_probs=36.4

Q ss_pred             EEEccCcccc-ccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902           24 RLELEMNSFY-GFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        24 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      .|+|.++.++ .-....|..+.+|++|+++++.++..... .....+...++|++|+++++.+.
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-~i~~~l~~~~~l~~l~l~~~~~~   64 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK-ALASALRPQPSLKELCLSLNETG   64 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH-HHHHHHhhCCCceEEeccccccC
Confidence            4667777766 33344556667777777777776542111 11223556666777777777665

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.81  E-value=9.9e-21  Score=170.33  Aligned_cols=148  Identities=22%  Similarity=0.421  Sum_probs=124.6

Q ss_pred             HhCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCC--eeeE
Q 042902          426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDD--FKAL  501 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l  501 (599)
                      ..++|+..+.+|+|.++.||.|. ..+.+.++||++++-.   .+.+.+|+.++..++ ||||+++++...++.  .+.+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35678888999999999999997 4568899999997543   356788999999997 999999999987764  6789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCccCCc
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPLLK  580 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~~~~  580 (599)
                      |+||+.+.+......    .++..++..++.++++||.|+|   +.||+|||+||.|+++|.. ...+++|+|+|..+-+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999988765442    2566677889999999999999   9999999999999999955 5799999999987755


Q ss_pred             CCC
Q 042902          581 EDQ  583 (599)
Q Consensus       581 ~~~  583 (599)
                      ..+
T Consensus       186 ~~e  188 (338)
T KOG0668|consen  186 GKE  188 (338)
T ss_pred             Cce
Confidence            443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=4e-19  Score=168.49  Aligned_cols=164  Identities=21%  Similarity=0.307  Sum_probs=139.0

Q ss_pred             CCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          429 GFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .|.+.++||+|.||+++.|+ +-+++.||||.-..+.+  .-++..|.+..+.+ ..+.|..++.+..++-+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            68889999999999999997 55799999998754433  34677788888877 4799999998888888899999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-----cEEEccccCCccCCcC
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-----VAHLSDFGMAKPLLKE  581 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~DFGla~~~~~~  581 (599)
                       |-+|+++..-.++.++...++.+|.|+..-++|+|   ++..|.|||||+|.||..-+     .+.|+|||+|+.+.+.
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             77999998877778999999999999999999999   89999999999999997433     5899999999988766


Q ss_pred             CCc-----eeeecccCCccccC
Q 042902          582 DQS-----LTQTQTLATIGYMA  598 (599)
Q Consensus       582 ~~~-----~~~~~~~gt~~y~A  598 (599)
                      .+.     ...-+..||.+||+
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             cccccCccccccccccceeeeE
Confidence            532     23346779999996

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=3.1e-19  Score=161.98  Aligned_cols=167  Identities=23%  Similarity=0.299  Sum_probs=135.6

Q ss_pred             HhCCCCcCceecccccceEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CcceeEEEEEEcCCeeeEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-RNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  503 (599)
                      ....|...+.||.|+||.+|.|. ..+|.+||||.-+...  ...+..-|.++...++| ..|..+..|..+.++..+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34678999999999999999997 5679999999975432  22456678888888874 67888888888889999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~~~~~  580 (599)
                      |.. |-+|++...-....++...++..|-|++.-++|+|   ..++|||||||+|.|..-   ...+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 77999988766667899999999999999999999   999999999999999863   34689999999998754


Q ss_pred             CCCc-----eeeecccCCccccC
Q 042902          581 EDQS-----LTQTQTLATIGYMA  598 (599)
Q Consensus       581 ~~~~-----~~~~~~~gt~~y~A  598 (599)
                      ..+.     .......||.+|.+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             ccccccCccccCCccceeeeehh
Confidence            3321     22345678888854

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=2.7e-21  Score=166.50  Aligned_cols=180  Identities=26%  Similarity=0.415  Sum_probs=144.3

Q ss_pred             hhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccE
Q 042902          166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQ  245 (599)
Q Consensus       166 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  245 (599)
                      +..+.+++.|-||+|+++. .|..++.+.+|+.|++++|+|+++|..++.+++|+.|+++-|++. ..|..|+.++.|+.
T Consensus        29 Lf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            3445566777788888874 445577888888888888888888888888888888888888887 78888888999999


Q ss_pred             EEccCCccCC-CCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEccccc
Q 042902          246 IDLSMNNFSG-FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNK  324 (599)
Q Consensus       246 L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~  324 (599)
                      |||++|++.. ..|..|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+.+|.+- ..|..++.++.|+.|.+.+|.
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9999988863 67888888999999999999988 77888999999999999999987 788999999999999999999


Q ss_pred             CcccCCCCCCCCCc---ccccccCCCCC
Q 042902          325 LEGEIPREGPFRNF---SAESFKGNELL  349 (599)
Q Consensus       325 l~~~~p~~~~~~~~---~~~~~~~n~~~  349 (599)
                      ++-.+|..+.+.-.   .......|||.
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            98777765543322   12334556653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.3e-19  Score=186.36  Aligned_cols=160  Identities=24%  Similarity=0.326  Sum_probs=129.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++.|.....+|.|+|+.|.++... +++..|||++..+..    +-.+|+.++... .||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3556777788999999999999865 689999999976522    234466555555 6999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee-cCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL-DDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill-~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |++.||-+.+.+..... .. ..+..|+.+|+.|+.|||   +.||||||+||+|||+ ++.+.++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999988777665442 22 566789999999999999   8999999999999999 58899999999999866433 


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                          ....+-|..|.||
T Consensus       470 ----~~tp~~t~~y~AP  482 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAP  482 (612)
T ss_pred             ----hcccchhhcccCh
Confidence                2234567788888

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=4.9e-19  Score=166.74  Aligned_cols=139  Identities=14%  Similarity=0.139  Sum_probs=114.6

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccH---HH------HHHHHHHHhcCCCCcceeEEEEEEcC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF---KS------FDIECDMMKRIRHRNLIKIISSCSND  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~l~~~~~~~  496 (599)
                      ..++|...+.+|+|+||.||.+.. ++..+|||.++.......   +.      |.+|++.+.++.||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            367899999999999999999766 577899999975533222   22      68999999999999999998876533


Q ss_pred             --------CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          497 --------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       497 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                              +..++||||++|.+|.++..     .+.    ....++++++..+|   ..+++|||+||+||++++++ ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999987632     222    34669999999999   99999999999999999988 99


Q ss_pred             EccccCCccC
Q 042902          569 LSDFGMAKPL  578 (599)
Q Consensus       569 l~DFGla~~~  578 (599)
                      ++|||..+..
T Consensus       175 liDfg~~~~~  184 (232)
T PRK10359        175 IIDLSGKRCT  184 (232)
T ss_pred             EEECCCcccc
Confidence            9999988754

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=7.9e-19  Score=169.31  Aligned_cols=142  Identities=20%  Similarity=0.161  Sum_probs=110.6

Q ss_pred             CCCcCceecccccceEEEEE--ecCCcEEEEEEecccccc------------------------cHHHHHHHHHHHhcCC
Q 042902          429 GFSENNLIGRGGVASVYKAR--IQDGIEVAVKVFDLQYEG------------------------AFKSFDIECDMMKRIR  482 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  482 (599)
                      .|...+.||+|+||.||+|.  ..+|+.||||+++.....                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47778899999999999998  558999999998643210                        1123567999999997


Q ss_pred             CC--cceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEccCCCCCe
Q 042902          483 HR--NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-IIHCDLKPNNV  559 (599)
Q Consensus       483 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiH~dlk~~Ni  559 (599)
                      +.  .+++++++    ...++||||++|+++........ ..+......++.||+.++.++|   ..+ |+|||+||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34455543    23589999999988876543222 3455566789999999999999   889 99999999999


Q ss_pred             eecCCCcEEEccccCCccCC
Q 042902          560 LLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       560 ll~~~~~~kl~DFGla~~~~  579 (599)
                      +++ ++.++++|||.|....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999998543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.79  E-value=1.1e-19  Score=171.75  Aligned_cols=162  Identities=28%  Similarity=0.346  Sum_probs=132.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      ..+|...+.+|.|+- .|..|-+. .++.||+|++...  .....++-.+|...+..+.|+||++++.++....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777788898887 56555543 5899999987433  2345567788999999999999999999986543      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      +.|+|||||. ++|...+..   .++......|..|++.|++|+|   +.+|+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            6799999995 588888763   3677788899999999999999   99999999999999999999999999999985


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      -.   ..-..+..+.|..|.||
T Consensus       168 e~---~~~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  168 ED---TDFMMTPYVVTRYYRAP  186 (369)
T ss_pred             cC---cccccCchhheeeccCc
Confidence            32   22355677888899998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.5e-19  Score=167.15  Aligned_cols=135  Identities=25%  Similarity=0.307  Sum_probs=114.6

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYE--------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      +.||+|++|.||+|.+ +|..|+||+......        .....+..|++++..++|++++....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 678899998653321        1234678899999999999988877777777888999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ++|++|.+++....    + .+..++.+++.+|.++|   ..+++|||++|+||+++ ++.++++|||.++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999886532    2 67889999999999999   89999999999999999 789999999998853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.79  E-value=3.5e-19  Score=172.26  Aligned_cols=163  Identities=23%  Similarity=0.305  Sum_probs=133.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC--C----cceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH--R----NLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~  499 (599)
                      +++|.+...+|+|.||.|-++.++ .+..||||+++.-. .-.++-..|++++.++.+  |    -+|++.+|+.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999865 47899999986432 234566789999999942  2    367788889999999


Q ss_pred             eEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---------------
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---------------  563 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---------------  563 (599)
                      |||+|.+ |-|+.+++..... .++...+..|+.|+++++.|||   +.+++|-||||+|||+-+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 7799999987554 6888899999999999999999   999999999999999821               


Q ss_pred             -----CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 -----NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                           +..+|++|||.|+.-. +    .....+.|..|.||
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-e----~hs~iVsTRHYRAP  278 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-E----HHSTIVSTRHYRAP  278 (415)
T ss_pred             eccCCCcceEEEecCCcceec-c----CcceeeeccccCCc
Confidence                 2248999999998432 1    12456789999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.78  E-value=3.9e-19  Score=174.26  Aligned_cols=142  Identities=31%  Similarity=0.402  Sum_probs=124.7

Q ss_pred             HhCCCCcCceecccccceEEEEEec----CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  500 (599)
                      ..+.|..+++||+|.|++||++.+.    ....||+|.+....  ...+..+|+++|..+. +.||+++.+++...+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3467888999999999999999754    36789999986443  3467889999999995 999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~  576 (599)
                      +|+||++..+..++...    ++...+..+++.+..||.|+|   ..|||||||||+|++.+ ..+.-.|+|||+|.
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999998888765    556778889999999999999   99999999999999998 55788999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2.9e-19  Score=164.93  Aligned_cols=147  Identities=22%  Similarity=0.383  Sum_probs=122.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEE-EEEcCCeeeEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIIS-SCSNDDFKALV  502 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  502 (599)
                      ..+.|++.+.+|+|.||.+-.|+++ ..+.+|+|.+.... ...++|.+|...--.+ .|.||+.-++ .+++.+.+..+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3457889999999999999999987 46789999886443 3457899998754445 4899998776 46778888999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee-c-CCCcEEEccccCCccC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL-D-DNMVAHLSDFGMAKPL  578 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill-~-~~~~~kl~DFGla~~~  578 (599)
                      +||++.|+|.+-+...+  +-+....+++.|+++|+.|||   ++.+||||||.+|||| + +..++|++|||..+..
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999998876644  666777889999999999999   9999999999999998 3 3448999999998854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2e-18  Score=187.54  Aligned_cols=138  Identities=21%  Similarity=0.283  Sum_probs=112.9

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEe-cccc-------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVF-DLQY-------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ...|...+.||+|+||.||+|.+.+. .+++|+. ....       ....+++..|+++++.++|++++....++...+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456678999999999999987643 4444433 2111       1123568899999999999999988888877778


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+++++|.+++.         ....++.++++++.|+|   +.+++|||+||+||++ +++.++|+|||+|+..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999998775         34678999999999999   8999999999999999 6779999999999854

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=7.4e-21  Score=163.78  Aligned_cols=162  Identities=33%  Similarity=0.583  Sum_probs=124.4

Q ss_pred             ccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                      +.++++++.|.||+|+++.+ |..+..+.+|+.|++.+|+|+ ..|..+..+++|+.|+++-|++. +.|..|+.+|.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~~v-ppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVV-PPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCceeec-CCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            44667788888999998844 446788888888888888888 57778888888888888888887 6788888888888


Q ss_pred             EeecCCCCCC--CCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccc
Q 042902          198 NLYLGSNQLT--SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       198 ~L~L~~N~l~--~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      .|||.+|++.  .+|..|+.+..|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- ..|..++.+..|++|.+.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            8888888887  57888888888888888888877 66777777777777777777766 35666677777777777777


Q ss_pred             cccccCcccc
Q 042902          276 RLQGSIPDSI  285 (599)
Q Consensus       276 ~l~~~~~~~~  285 (599)
                      +++ .+|..+
T Consensus       184 rl~-vlppel  192 (264)
T KOG0617|consen  184 RLT-VLPPEL  192 (264)
T ss_pred             eee-ecChhh
Confidence            766 344333

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.8e-18  Score=163.31  Aligned_cols=137  Identities=24%  Similarity=0.187  Sum_probs=109.2

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEeccccc----------------------ccHHHHHHHHHHHhcCCCC--
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE----------------------GAFKSFDIECDMMKRIRHR--  484 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--  484 (599)
                      .|...+.||+|+||.||+|...+|+.||||+++....                      .....+..|+.++..+.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4777899999999999999988899999998754320                      0112367788899998887  


Q ss_pred             cceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC
Q 042902          485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       485 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~  564 (599)
                      .+++.++.    +..++||||++|++|.+....       .....++.++++++.++|   ..+|+||||||+||+++++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence            44444432    456899999999999765431       234568899999999999   8999999999999999999


Q ss_pred             CcEEEccccCCccCC
Q 042902          565 MVAHLSDFGMAKPLL  579 (599)
Q Consensus       565 ~~~kl~DFGla~~~~  579 (599)
                      +.++|+|||.|....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.9e-18  Score=157.92  Aligned_cols=134  Identities=15%  Similarity=0.094  Sum_probs=107.6

Q ss_pred             CCcCceecccccceEEEEEecCCcEEEEEEeccccc----ccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEE
Q 042902          430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE----GAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.....+++|+||+||.+.. ++..++.+.++....    -....|.+|+++|+++. |+++++++++    +..+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34567899999999997766 678888887754432    11235889999999995 5889999886    34699999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCeeecCCCcEEEccccCCccCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL-KPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dl-k~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |++|.+|.+....        ....++.|+++++.++|   +.||+|||| ||+|||++.++.++|+|||+|....
T Consensus        79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            9999998754321        12357889999999999   999999999 7999999999999999999998543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=2.6e-18  Score=162.49  Aligned_cols=131  Identities=22%  Similarity=0.317  Sum_probs=108.0

Q ss_pred             eecccccceEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          435 LIGRGGVASVYKARIQDGIEVAVKVFDLQYE--------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .||+|+||.||+|.+ +|..|++|.......        ...+++..|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 578999998643211        12356788999999999887665555566667789999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      +|++|.+.+.....        .++.+++++|.++|   ..+++|||++|+||+++ ++.++++|||.|+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987754321        78999999999999   99999999999999999 789999999998854

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.76  E-value=1.1e-18  Score=168.78  Aligned_cols=174  Identities=20%  Similarity=0.257  Sum_probs=142.6

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEc
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSN  495 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  495 (599)
                      +.....+++....+-+|.||.||+|.|.      +.+.|-||.++.+. +-....+..|..++..+.|||+.++.+++.+
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3334456777778899999999999654      34567788776553 3345678999999999999999999999876


Q ss_pred             C-CeeeEEEEccCCCChhhhhh-----cCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          496 D-DFKALVLEYMPHGSLEKCLY-----SSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       496 ~-~~~~lv~e~~~~g~L~~~l~-----~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      + ..++++|.++.-|+|..++.     +..  ...+..+.+.++.|++.||+|||   +.+|||.||.++|++||+..++
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence            5 57899999999999999997     222  24556677889999999999999   9999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |++|=.++|.+.+.+..--....-.+..||||
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCH
Confidence            99999999998877765555556678889986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=4.4e-18  Score=173.06  Aligned_cols=167  Identities=25%  Similarity=0.341  Sum_probs=132.9

Q ss_pred             CCCcCceecccccceEEEEEecCC--cEEEEEEecccccccHHHHHHHHHHHhcCCC----CcceeEEEEE-EcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQDG--IEVAVKVFDLQYEGAFKSFDIECDMMKRIRH----RNLIKIISSC-SNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  501 (599)
                      +|...+.||+|+||.||.|.....  ..+|+|............+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  5789998765433322367778888888863    6899999988 47778999


Q ss_pred             EEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-----CcEEEccccCC
Q 042902          502 VLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-----MVAHLSDFGMA  575 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-----~~~kl~DFGla  575 (599)
                      ||+.+ |.+|.++..... ..++...+.+|+.|++.||+++|   +.|++||||||+|+++...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 889999876554 57899999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--cCCcCCCc----e-e-eecccCCccccCC
Q 042902          576 K--PLLKEDQS----L-T-QTQTLATIGYMAP  599 (599)
Q Consensus       576 ~--~~~~~~~~----~-~-~~~~~gt~~y~AP  599 (599)
                      +  .+......    . . .....||.+|+++
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9  43322211    1 1 1235599999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.5e-16  Score=142.96  Aligned_cols=135  Identities=21%  Similarity=0.282  Sum_probs=115.0

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CcceeEEEEEEcCCeeeEEEEccCCC
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH--RNLIKIISSCSNDDFKALVLEYMPHG  509 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  509 (599)
                      ..+.||+|.++.||++...+ ..+++|.......  ...+..|+.++..++|  +.+++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35689999999999999864 7899999865433  4678999999999987  59999999888888899999999998


Q ss_pred             ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       510 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            87654        4456678899999999999944446899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.70  E-value=2.4e-16  Score=160.64  Aligned_cols=165  Identities=36%  Similarity=0.514  Sum_probs=139.5

Q ss_pred             CCcCceecccccceEEEEEecCCcEEEEEEecccccc---cHHHHHHHHHHHhcCCCC-cceeEEEEEEcCCeeeEEEEc
Q 042902          430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHR-NLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  505 (599)
                      |...+.+|.|+||.||++...  ..+|+|.+......   ....|..|+.+++.+.|+ +++++.+++......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999987  88999999765432   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhcCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~  582 (599)
                      +.++++.+++....  ...+......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766554  25788888999999999999999   88999999999999999888 79999999998554333


Q ss_pred             Cce----eeecccCCccccCC
Q 042902          583 QSL----TQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~----~~~~~~gt~~y~AP  599 (599)
                      ...    ......||..|+||
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             ccccccccccccccccccCCH
Confidence            221    23567899999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.1e-16  Score=149.67  Aligned_cols=136  Identities=24%  Similarity=0.256  Sum_probs=98.2

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccc--cHHH----------------------HHHHHHHHhcCCCCc--c
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG--AFKS----------------------FDIECDMMKRIRHRN--L  486 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  486 (599)
                      .+.||+|+||.||+|...+|+.||||+++.....  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3679999999999999888999999998643211  1111                      134666666664432  4


Q ss_pred             eeEEEEEEcCCeeeEEEEccCCCChhh-hhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCC
Q 042902          487 IKIISSCSNDDFKALVLEYMPHGSLEK-CLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       487 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~  564 (599)
                      .+.+++    ...++||||++++++.. .+....  .. .....++.+++.++.++|   . .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    24689999999965421 111111  11 456789999999999999   7 8999999999999999 8


Q ss_pred             CcEEEccccCCccCC
Q 042902          565 MVAHLSDFGMAKPLL  579 (599)
Q Consensus       565 ~~~kl~DFGla~~~~  579 (599)
                      +.++++|||.|+...
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999998553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.69  E-value=2.5e-17  Score=164.60  Aligned_cols=164  Identities=24%  Similarity=0.340  Sum_probs=133.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC------CCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR------HRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~  499 (599)
                      ..+|.+....|+|-|++|.+|... .|+.||||++.... ...+.=+.|+++|+++.      --+.++++..|...++.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            456777788899999999999976 48899999997543 33455577999999994      24788999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCc
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAK  576 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~  576 (599)
                      |||+|-+ .-+|.+.|+..+.  .+....+..|+.|+.-||..|-   ..+|+|.||||.|||+.+. ..+||||||.|.
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999988 4599999986554  4777788899999999999999   8999999999999999865 468999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....+    .+....+..|.||
T Consensus       586 ~~~ene----itPYLVSRFYRaP  604 (752)
T KOG0670|consen  586 FASENE----ITPYLVSRFYRAP  604 (752)
T ss_pred             cccccc----ccHHHHHHhccCc
Confidence            664332    2344556678777

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.2e-15  Score=147.60  Aligned_cols=136  Identities=15%  Similarity=0.202  Sum_probs=106.7

Q ss_pred             Cceec-ccccceEEEEEecCCcEEEEEEecccc-------------cccHHHHHHHHHHHhcCCCCcc--eeEEEEEEcC
Q 042902          433 NNLIG-RGGVASVYKARIQDGIEVAVKVFDLQY-------------EGAFKSFDIECDMMKRIRHRNL--IKIISSCSND  496 (599)
Q Consensus       433 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  496 (599)
                      ...|| .||.|+||.++.. +..+|||.+....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999885 7889999874311             1223567889999999998875  6777765433


Q ss_pred             C----eeeEEEEccCC-CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEcc
Q 042902          497 D----FKALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       497 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                      .    ..++||||++| .+|.+++....  ++.    ..+.+|++++.++|   ..||+||||||+|||++.++.++++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP--LSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC--CCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 68988876532  333    24678999999999   99999999999999999988999999


Q ss_pred             ccCCccC
Q 042902          572 FGMAKPL  578 (599)
Q Consensus       572 FGla~~~  578 (599)
                      ||.++..
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998854

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=7.9e-16  Score=153.20  Aligned_cols=134  Identities=26%  Similarity=0.345  Sum_probs=110.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----C---CcceeEEEEEEcC-
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-----H---RNLIKIISSCSND-  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~-  496 (599)
                      ..+|-+.++||-|.|++||.|.+. +.+.||+|+.+... .-.+.-+.||++|++++     |   ..||+|++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            367888999999999999999854 57889999986432 22456678999999884     2   4799999998754 


Q ss_pred             ---CeeeEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC
Q 042902          497 ---DFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       497 ---~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~  564 (599)
                         .+.|+|+|++ |-+|..++..... .++...+.+|++||+.||.|||..|  +|||-||||+|||+-.+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence               3889999999 7789888876543 5888899999999999999999754  99999999999999644

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.61  E-value=3.5e-17  Score=165.57  Aligned_cols=174  Identities=32%  Similarity=0.508  Sum_probs=94.9

Q ss_pred             CCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeec
Q 042902          146 QKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS  225 (599)
Q Consensus       146 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls  225 (599)
                      .--...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|..+.++..|++|+|+.|+++.+|..++.++ |+.|-++
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEe
Confidence            33344555555555 44555555555555555555555 344455555555555555555555555555544 5555555


Q ss_pred             CCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccC
Q 042902          226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      +|+++ .+|..++.+..|..||.+.|.+. ..|..++++.+|+.|++..|++. .+|..+..| .|..||+|.|+++ .+
T Consensus       152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i  226 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL  226 (722)
T ss_pred             cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence            55555 44555555555555555555555 24455555555666666555555 333344433 3555666666655 55


Q ss_pred             CchhhccccceEEEcccccCcc
Q 042902          306 PISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       306 p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      |..|..|..|++|-|.+|+|..
T Consensus       227 Pv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  227 PVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             chhhhhhhhheeeeeccCCCCC
Confidence            5556666666666666665553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=4.3e-15  Score=156.05  Aligned_cols=141  Identities=21%  Similarity=0.239  Sum_probs=101.8

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEeccccccc----------------------------------------HHHHH
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA----------------------------------------FKSFD  472 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  472 (599)
                      .+.||.|++|.||+|++++|+.||||+.++.....                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986431100                                        01355


Q ss_pred             HHHHHHhcCC----CCcceeEEEEE-EcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 042902          473 IECDMMKRIR----HRNLIKIISSC-SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS-ALEYLHFGYS  546 (599)
Q Consensus       473 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~~  546 (599)
                      .|++.+.+++    |.+-+.+-..+ ......+|||||++|+++.+.........   .+.+++..++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence            5666666552    33333333333 22346799999999999988765322112   23456766666 467888   8


Q ss_pred             CCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       547 ~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      .|++|+|+||.||++++++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            899999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.2e-15  Score=163.36  Aligned_cols=145  Identities=31%  Similarity=0.419  Sum_probs=113.0

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR---HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.|.+.+.||+|+||.||+|...+|+.||+|+-++...   -+|..=.+++.+++   -+-|..+..++.-.+.-++|+|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            45777889999999999999988899999999754421   12222233444444   2334444455555667789999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-------CCCcEEEccccCCcc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-------DNMVAHLSDFGMAKP  577 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-------~~~~~kl~DFGla~~  577 (599)
                      |.+.|+|.+++. ..+.++|.-++.++.|++.-+++||   ..+|||+||||+|.|+.       +...++|+|||-|..
T Consensus       775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999999987 3446899999999999999999999   99999999999999994       234699999999976


Q ss_pred             CC
Q 042902          578 LL  579 (599)
Q Consensus       578 ~~  579 (599)
                      +.
T Consensus       851 m~  852 (974)
T KOG1166|consen  851 MK  852 (974)
T ss_pred             ee
Confidence            53

>PLN03150 hypothetical protein; Provisional

Probab=99.54  E-value=1.2e-14  Score=159.61  Aligned_cols=118  Identities=35%  Similarity=0.611  Sum_probs=102.9

Q ss_pred             cccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcc
Q 042902          242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVS  321 (599)
Q Consensus       242 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  321 (599)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcccCCCCC--CCCCcccccccCCCCCcCCCCCCCCCCc
Q 042902          322 FNKLEGEIPREG--PFRNFSAESFKGNELLCGTPNLQVPPCR  361 (599)
Q Consensus       322 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~~~~~  361 (599)
                      +|+++|.+|..-  .+.......+.+|+..|+.|.  .+.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999999999742  123445677889999999764  35664

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.2e-15  Score=139.25  Aligned_cols=156  Identities=20%  Similarity=0.413  Sum_probs=127.2

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      ..+|.+...|..|+|+|+ |..+++|++..+.  ....++|.+|.-.++-+.||||..++|.|..+....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            456888999999999997 6777788887653  3445789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc--cccCCccCCcCCCceee
Q 042902          511 LEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS--DFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       511 L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~--DFGla~~~~~~~~~~~~  587 (599)
                      |+..+++... ..+..++++++.+||+|++|||+. .+-|..--+.++.|++|++.+++|+  |--++         ...
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs---------fqe  343 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS---------FQE  343 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee---------eec
Confidence            9999998765 578889999999999999999954 3445555789999999999988876  32221         122


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      .+..-.|.||+|
T Consensus       344 ~gr~y~pawmsp  355 (448)
T KOG0195|consen  344 VGRAYSPAWMSP  355 (448)
T ss_pred             cccccCcccCCH
Confidence            344567789987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.52  E-value=5.5e-15  Score=168.59  Aligned_cols=115  Identities=17%  Similarity=0.278  Sum_probs=85.0

Q ss_pred             CCC-CcceeEEEEE-------EcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 042902          481 IRH-RNLIKIISSC-------SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC  552 (599)
Q Consensus       481 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~  552 (599)
                      ..| +||+++++++       ...+..+.++||+ +++|.+++......+++..++.|+.||++||.|||   +.+|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            445 5788888876       2223567888988 66999999866566899999999999999999999   8999999


Q ss_pred             cCCCCCeeecC-------------------CCcEEEccccCCccCCcCCC--------------ceeeecccCCccccCC
Q 042902          553 DLKPNNVLLDD-------------------NMVAHLSDFGMAKPLLKEDQ--------------SLTQTQTLATIGYMAP  599 (599)
Q Consensus       553 dlk~~Nill~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~AP  599 (599)
                      ||||+|||++.                   ++.+|++|||+++.......              .......+||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   44567777777764211000              0011124689999999

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.50  E-value=4.8e-14  Score=148.14  Aligned_cols=202  Identities=34%  Similarity=0.426  Sum_probs=128.7

Q ss_pred             EEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCC-CCCEEEccCCcCCcccCccccCCCCCCEEEccc
Q 042902           77 YLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT-NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLED  155 (599)
Q Consensus        77 ~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  155 (599)
                      .|+++.|.+... ......+. .++.+.+.+|+++.+ +.....+. +|+.|++++|.+.. +|..+..+++|+.|++++
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~-~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELT-NLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccC-chhhhccc-ceeEEecCCcccccC-ccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence            466666665321 22222332 366666666666633 33344443 77777777777773 334567777777777777


Q ss_pred             ccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcc
Q 042902          156 NQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL  235 (599)
Q Consensus       156 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~  235 (599)
                      |++. .+|.....+++|+.|++++|+++.+ |........|++|.+++|.+..++..+..+.++..+.+++|++.. .+.
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l-~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccccC-chhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccc
Confidence            7777 3444444667777777777777754 333334455777777777666666667777777777777777763 355


Q ss_pred             cccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccC
Q 042902          236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG  287 (599)
Q Consensus       236 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  287 (599)
                      .++.+++++.|++++|.++.+.+  ++.+.+|+.|++++|.+....|.....
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence            66677777777777777775433  777777788888877777665554443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.50  E-value=9e-16  Score=155.48  Aligned_cols=177  Identities=28%  Similarity=0.466  Sum_probs=91.3

Q ss_pred             CCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCC
Q 042902          124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS  203 (599)
Q Consensus       124 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  203 (599)
                      -...||+.|++. .+|..+..+..|+.+.|.+|.|. .+|..++++..|++|||+.|+++. .|..+..++ |+.|.+++
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEec
Confidence            344555555555 34444455555555555555555 445555555555555555555553 233333333 55555555


Q ss_pred             CCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcc
Q 042902          204 NQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD  283 (599)
Q Consensus       204 N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  283 (599)
                      |+++.+|..+..+..|..||.+.|++. ..|..++++.+|+.|.+..|++.. .|..+..| .|..||+|.|+++ .+|-
T Consensus       153 Nkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis-~iPv  228 (722)
T KOG0532|consen  153 NKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS-YLPV  228 (722)
T ss_pred             CccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee-ecch
Confidence            555555555555555555555555555 344455555555555555555553 23334422 2555555555555 4555


Q ss_pred             cccCCCCcccccCCCCcccccCCchh
Q 042902          284 SIGGLIDLKSLDLSNNNISGAIPISL  309 (599)
Q Consensus       284 ~~~~l~~L~~L~L~~N~l~~~~p~~~  309 (599)
                      .|..|..|++|-|.+|.+. ..|+.+
T Consensus       229 ~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  229 DFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             hhhhhhhheeeeeccCCCC-CChHHH
Confidence            5555555555555555555 444444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.49  E-value=2.7e-14  Score=150.03  Aligned_cols=260  Identities=29%  Similarity=0.348  Sum_probs=155.0

Q ss_pred             EEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCC-CCcEEEcccCcccccCChhhhcccccceE
Q 042902           24 RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK-YLKYLSFSNNSLDGILPRAIGNLSQSMEV  102 (599)
Q Consensus        24 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~  102 (599)
                      .|++..|.+.. ....+..++.++.|++.+|.++.+++.      ...++ +|+.|++++|.|..+ |            
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~i~~~------~~~~~~nL~~L~l~~N~i~~l-~------------  156 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNITDIPPL------IGLLKSNLKELDLSDNKIESL-P------------  156 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccccCccc------cccchhhcccccccccchhhh-h------------
Confidence            68899998854 344567778999999999999999874      34453 899999999999743 2            


Q ss_pred             EEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCcc
Q 042902          103 FFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL  182 (599)
Q Consensus       103 l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  182 (599)
                                   ..+..+++|+.|++++|+++.+ |.....+++|+.|++++|++. .+|........|++|.+++|.+
T Consensus       157 -------------~~~~~l~~L~~L~l~~N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~  221 (394)
T COG4886         157 -------------SPLRNLPNLKNLDLSFNDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI  221 (394)
T ss_pred             -------------hhhhccccccccccCCchhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc
Confidence                         2345566666666666666643 223335666666666666666 3444444445566777777743


Q ss_pred             CCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCcccc
Q 042902          183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG  262 (599)
Q Consensus       183 ~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  262 (599)
                      . ..+..+..+.++..+.+++|++..++..+..++++++|++++|.++....  ++.+.+++.|++++|.+....|....
T Consensus       222 ~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         222 I-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             e-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence            3 23445666666777777777777666666666777777777777764433  66677777777777777665554433


Q ss_pred             CcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccC
Q 042902          263 DLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL  325 (599)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  325 (599)
                      .....+.+..  +.++ ..+..+.....+....+..+... ..+..+.....+..++...+..
T Consensus       299 ~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  357 (394)
T COG4886         299 LLLLLELLLN--LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNAL  357 (394)
T ss_pred             cchhHHhhhh--hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceeccccc
Confidence            3222221111  2222 12222222233334444444444 4444444444455445444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=3.6e-14  Score=153.74  Aligned_cols=163  Identities=23%  Similarity=0.291  Sum_probs=125.1

Q ss_pred             cCceecccccceEEEEEec-CCcEEEEEEecc---c--ccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          432 ENNLIGRGGVASVYKARIQ-DGIEVAVKVFDL---Q--YEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~---~--~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..+.+|.|++|.|+.+... .....+.|.++.   .  ... ....+..|..+-.++.|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999988776543 344455554431   1  111 11225667777888999999888777766665556699


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||++ +|...+.... .+...++..++.|+..|+.|+|   ..||.|||+|++|++++.+|.+||+|||.+..+.-..+.
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999887752 3677778889999999999999   999999999999999999999999999999866544333


Q ss_pred             --eeeecccCCccccCC
Q 042902          585 --LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 --~~~~~~~gt~~y~AP  599 (599)
                        ....+.+|+-.|+||
T Consensus       477 ~~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAP  493 (601)
T ss_pred             hhhhhcCcccCCcCcCc
Confidence              556778999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=6.3e-13  Score=122.15  Aligned_cols=128  Identities=22%  Similarity=0.229  Sum_probs=96.7

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcce-eEEEEEEcCCeeeEEEEccCCCCh
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI-KIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      .+.++.|.++.||+++.. +..|++|....... ....+..|+++++.+.+.+++ +++++.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999875 78899999754432 224567899999988655544 454443  2345899999999888


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ...    .     .....++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.|..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643    0     011346779999999999   555     59999999999999 66899999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=1e-12  Score=139.55  Aligned_cols=146  Identities=18%  Similarity=0.190  Sum_probs=95.4

Q ss_pred             CCCCcCceecccccceEEEEEecC-CcEEEEEEecccccc------------------------------c----H----
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEG------------------------------A----F----  468 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~----  468 (599)
                      ..|+. +.||+|++|.||+|++++ |+.||||+.++.-..                              .    .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 789999999999999987 999999998644110                              0    0    


Q ss_pred             --HHHHHHHHHHhcCC----CCcceeEEEEEEc-CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHH-HHH
Q 042902          469 --KSFDIECDMMKRIR----HRNLIKIISSCSN-DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-LEY  540 (599)
Q Consensus       469 --~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~  540 (599)
                        -+|..|+.-+.+++    +...+.+-.++.+ ....+|||||++|+.+.+.-.-.....+.   ..++...++. +.-
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~~~~Q  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEVFFTQ  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHHHHHH
Confidence              12444555555442    4444444443332 45678999999999997742211111222   1223222221 222


Q ss_pred             HhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCCccCCc
Q 042902          541 LHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAKPLLK  580 (599)
Q Consensus       541 lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla~~~~~  580 (599)
                      +.   ..|++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            23   67999999999999999888    999999999987643

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.39  E-value=4.7e-14  Score=132.42  Aligned_cols=203  Identities=27%  Similarity=0.285  Sum_probs=108.5

Q ss_pred             cCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCC-cCCcccCccccCCCC
Q 042902           69 LSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGN-KLNGSIPIALDKLQK  147 (599)
Q Consensus        69 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~  147 (599)
                      +..+++|+.+.+|.+.-..+.  .+..+.+.|+++...+..++..  +.+-....+..+.-+.- -..|...........
T Consensus       210 l~~f~~l~~~~~s~~~~~~i~--~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~  285 (490)
T KOG1259|consen  210 LNAFRNLKTLKFSALSTENIV--DIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQE  285 (490)
T ss_pred             hHHhhhhheeeeeccchhhee--ceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHhh
Confidence            344555666666666443321  1122233466666655544321  11111222221111111 111222223334456


Q ss_pred             CCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCC
Q 042902          148 LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN  227 (599)
Q Consensus       148 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N  227 (599)
                      |++||||+|.|+ .+.++..-+|.++.|++|+|.|..+  +.++.+++|+.||||+|.++++..+-..+.+++.|.|++|
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence            777777777777 4556666677777777777777644  2366677777777777777766655555666666666666


Q ss_pred             CccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccc
Q 042902          228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       228 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  303 (599)
                      .|...  ..+.++.+|..||+++|+|....                       --..++++|.|+.|.|.+|++++
T Consensus       363 ~iE~L--SGL~KLYSLvnLDl~~N~Ie~ld-----------------------eV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  363 KIETL--SGLRKLYSLVNLDLSSNQIEELD-----------------------EVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hHhhh--hhhHhhhhheeccccccchhhHH-----------------------HhcccccccHHHHHhhcCCCccc
Confidence            66532  23444555555555555554221                       11345667777777777777773

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.38  E-value=3e-14  Score=140.45  Aligned_cols=211  Identities=24%  Similarity=0.248  Sum_probs=117.8

Q ss_pred             CCCCCCEEEccCccccccCC-ccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcc
Q 042902           18 NASKLSRLELEMNSFYGFIP-NTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNL   96 (599)
Q Consensus        18 ~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l   96 (599)
                      ++++|+...|++..+..... +....+++++.||||+|-+....+-.   .-...|++|+.|+||.|++..-......  
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~---~i~eqLp~Le~LNls~Nrl~~~~~s~~~--  193 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVL---KIAEQLPSLENLNLSSNRLSNFISSNTT--  193 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHH---HHHHhcccchhcccccccccCCccccch--
Confidence            34556666666666553221 24556666666666666665443321   1234566666666666666522111111  


Q ss_pred             cccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-ccccCCCCCCEEEcccccccccCChhhhcCCCCcEE
Q 042902           97 SQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus        97 ~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                                            .-+++|+.|.|++|.++.-.- .....+|+|+.|+|..|....+.......+..|+.|
T Consensus       194 ----------------------~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L  251 (505)
T KOG3207|consen  194 ----------------------LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL  251 (505)
T ss_pred             ----------------------hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence                                  134566666666666652111 123456667777777664333334444556667777


Q ss_pred             EeeCCccCCCCC-cccCCCCCCcEeecCCCCCCCC--Ccc-----ccCCCcccEEeecCCCcccc-CcccccccccccEE
Q 042902          176 DLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLTSI--PST-----LWNLKYILYLNLSSNSFTGP-LPLEIGNLRVLVQI  246 (599)
Q Consensus       176 ~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~i--p~~-----~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L  246 (599)
                      ||++|.+-+... ...+.++.|+.|+++.+.+.++  |+.     ...+++|++|+++.|++... .-..+..+++|+.|
T Consensus       252 dLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l  331 (505)
T KOG3207|consen  252 DLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL  331 (505)
T ss_pred             cccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence            777776654431 2345667777777777777754  332     23466777888888877432 12344556677777


Q ss_pred             EccCCccCC
Q 042902          247 DLSMNNFSG  255 (599)
Q Consensus       247 ~Ls~N~l~~  255 (599)
                      ....|.++.
T Consensus       332 ~~~~n~ln~  340 (505)
T KOG3207|consen  332 RITLNYLNK  340 (505)
T ss_pred             hcccccccc
Confidence            777777764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.37  E-value=6e-14  Score=145.05  Aligned_cols=155  Identities=26%  Similarity=0.310  Sum_probs=126.6

Q ss_pred             eecccccceEEEEE----ecCCcEEEEEEecccccc--cHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEEccC
Q 042902          435 LIGRGGVASVYKAR----IQDGIEVAVKVFDLQYEG--AFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .+|+|.||.|+.++    .+.|..+|.|..++....  .......|..++..++ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36899999999764    334778899988654321  1225566888888887 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|++...+..... ++......+...++-|++++|   +.+|+|||+|++||+++.+|.+|+.|||+++.......    
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999887766543 455556667888999999999   99999999999999999999999999999986543332    


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                        .+||..||||
T Consensus       153 --~cgt~eymAp  162 (612)
T KOG0603|consen  153 --ACGTYEYRAP  162 (612)
T ss_pred             --cccchhhhhh
Confidence              2899999998

>PLN03150 hypothetical protein; Provisional

Probab=99.36  E-value=1.4e-12  Score=143.41  Aligned_cols=114  Identities=37%  Similarity=0.569  Sum_probs=105.9

Q ss_pred             cccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCC
Q 042902          218 YILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS  297 (599)
Q Consensus       218 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  297 (599)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCchhhcc-ccceEEEcccccCcccCCC
Q 042902          298 NNNISGAIPISLEKL-LDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       298 ~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p~  331 (599)
                      +|++++.+|..+..+ .++..+++++|+..|..|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999998764 4678899999997776553

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.36  E-value=1e-13  Score=145.93  Aligned_cols=268  Identities=27%  Similarity=0.267  Sum_probs=138.6

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      +.++.++...+.+....-. ...+..++.+.+..|.|.....      .+..+++|+.|++.+|.|..+...        
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~~~~------~l~~~~~l~~l~l~~n~i~~i~~~--------  113 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAKILN------HLSKLKSLEALDLYDNKIEKIENL--------  113 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhhhhc------ccccccceeeeeccccchhhcccc--------
Confidence            4566666666665543221 1566777777788888876332      367778888888888888754221        


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                                        +..+++|++|+|++|.|+.+.  .+..++.|+.|++++|.|..+  ..+..++.|+.+++++
T Consensus       114 ------------------l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~  171 (414)
T KOG0531|consen  114 ------------------LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSY  171 (414)
T ss_pred             ------------------hhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCc
Confidence                              334455555555555555432  234444455555555555422  2333355555555555


Q ss_pred             CccCCCCC-cccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC
Q 042902          180 NKLSGFVP-ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       180 N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      |++..+.+ . ...+.+++.+++.+|.+..+. .+..+..+..+++..|.++...+........|+.+++++|++... +
T Consensus       172 n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~-~  248 (414)
T KOG0531|consen  172 NRIVDIENDE-LSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRS-P  248 (414)
T ss_pred             chhhhhhhhh-hhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccc-c
Confidence            55554333 1 244555555555555555442 122233333445555555533221111111255666666666522 2


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCcccccCCCCccccc---CCch-hhccccceEEEcccccCcccC
Q 042902          259 TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGA---IPIS-LEKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~l~l~~N~l~~~~  329 (599)
                      ..+..+..+..|++.+|++...-  .+...+.+..+.++.|.+...   .... ....+.+..+.+..|+.....
T Consensus       249 ~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  249 EGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             ccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            44555566666666666655321  233444555556666655421   1111 344556666666666665443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.35  E-value=1.3e-13  Score=145.12  Aligned_cols=248  Identities=28%  Similarity=0.333  Sum_probs=142.3

Q ss_pred             CCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccc
Q 042902           18 NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS   97 (599)
Q Consensus        18 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~   97 (599)
                      .+..++.++++.|.|.. ....+..+++|+.|++.+|+|..+...      +..+++|++|++++|.|+.+.+  +..  
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~------l~~~~~L~~L~ls~N~I~~i~~--l~~--  138 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL------LSSLVNLQVLDLSFNKITKLEG--LST--  138 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc------hhhhhcchheeccccccccccc--hhh--
Confidence            46678888899999986 335578889999999999999887642      6778899999999999986532  222  


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCC-hhhhcCCCCcEEE
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFLLD  176 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  176 (599)
                                             ++.|+.|++++|.|+.+  ..+..++.|+.+++++|++..+.+ . ...+.+++.++
T Consensus       139 -----------------------l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~  192 (414)
T KOG0531|consen  139 -----------------------LTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELD  192 (414)
T ss_pred             -----------------------ccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHh
Confidence                                   23345555555555432  233345555555555555543322 1 34445555555


Q ss_pred             eeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCc--ccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKY--ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       177 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +++|.+..+  ..+..+..+..+++..|.++.+-. +..+..  |+.+++++|.+.. .+..+..+..+..|++++|++.
T Consensus       193 l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  193 LGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG-LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             ccCCchhcc--cchHHHHHHHHhhcccccceeccC-cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccc
Confidence            555555432  223333334444555555554421 111222  5556666665552 2234455556666666666665


Q ss_pred             CCCCccccCcccccccccccccccc---cCccc-ccCCCCcccccCCCCcccccCCch
Q 042902          255 GFIPTTIGDLKDLQYLFLEYNRLQG---SIPDS-IGGLIDLKSLDLSNNNISGAIPIS  308 (599)
Q Consensus       255 ~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~  308 (599)
                      ..  ..+.....+..+.++.|.+..   ..... ....+.++...+..|.+....+..
T Consensus       269 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
T KOG0531|consen  269 NL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLD  324 (414)
T ss_pred             cc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccccc
Confidence            43  224445566666666666542   11111 455667777888888777655533

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.33  E-value=1.8e-13  Score=128.53  Aligned_cols=205  Identities=25%  Similarity=0.283  Sum_probs=137.2

Q ss_pred             cCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccccc---CChhhhcccccceEEEccCCccc
Q 042902           35 FIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGI---LPRAIGNLSQSMEVFFMFNCNIS  111 (599)
Q Consensus        35 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~---~~~~~~~l~~~l~~l~l~~n~i~  111 (599)
                      ..|-.+..+++|+.+.+|++.-..+..-      -..-+.|+++...+.-++..   .|...-.-     .+.-...-..
T Consensus       205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~------~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D-----~~~~E~~t~~  273 (490)
T KOG1259|consen  205 RLSFNLNAFRNLKTLKFSALSTENIVDI------ELLKPTLQTICVHNTTIQDVPSLLPETILAD-----PSGSEPSTSN  273 (490)
T ss_pred             ccccchHHhhhhheeeeeccchhheece------eecCchhheeeeecccccccccccchhhhcC-----ccCCCCCccC
Confidence            3444455667777777777654433221      11235677887777666532   22211100     0000111122


Q ss_pred             ccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccC
Q 042902          112 GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFG  191 (599)
Q Consensus       112 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  191 (599)
                      |.......-.+-|++||||+|.|+ .+..+.+-+|+++.|++|+|.|..+  +.+..+++|+.||||+|.++. ..++-.
T Consensus       274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~  349 (490)
T KOG1259|consen  274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHL  349 (490)
T ss_pred             CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHh
Confidence            233333444577999999999999 4567888999999999999999854  458999999999999999985 456666


Q ss_pred             CCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccC-cccccccccccEEEccCCccCC
Q 042902          192 NLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL-PLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       192 ~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      .+.+.+.|.|++|.|.++. .+..+-+|..||+++|+|.... ...+++++.|+.+.|-+|.+.+
T Consensus       350 KLGNIKtL~La~N~iE~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  350 KLGNIKTLKLAQNKIETLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhcCEeeeehhhhhHhhhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            7899999999999999874 5777888999999999997532 2345555555555555555553

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.33  E-value=2e-13  Score=134.78  Aligned_cols=187  Identities=22%  Similarity=0.220  Sum_probs=116.9

Q ss_pred             cCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccC
Q 042902           41 GNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN  120 (599)
Q Consensus        41 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~  120 (599)
                      +++++|+...|.+..+...+.+    +....|++++.||||.|-+....+                       +......
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~----~~~k~~~~v~~LdLS~NL~~nw~~-----------------------v~~i~eq  170 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIE----EYSKILPNVRDLDLSRNLFHNWFP-----------------------VLKIAEQ  170 (505)
T ss_pred             hhHHhhhheeecCccccccchh----hhhhhCCcceeecchhhhHHhHHH-----------------------HHHHHHh
Confidence            5678888888888887766542    246678888888888887763311                       1122345


Q ss_pred             CCCCCEEEccCCcCCcccCcc-ccCCCCCCEEEcccccccccC-ChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcE
Q 042902          121 LTNLTTIYLGGNKLNGSIPIA-LDKLQKLQLLSLEDNQLEGSI-PDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRN  198 (599)
Q Consensus       121 l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  198 (599)
                      ||+|+.|+|+.|++....... -..+++|+.|.|+.|.++... ......+|+|+.|+|+.|............+..|++
T Consensus       171 Lp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~  250 (505)
T KOG3207|consen  171 LPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE  250 (505)
T ss_pred             cccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence            788888888888876332221 235677888888888887322 223455778888888887533333334455667777


Q ss_pred             eecCCCCCCCCC--ccccCCCcccEEeecCCCccccCcccc------cccccccEEEccCCccC
Q 042902          199 LYLGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPLPLEI------GNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       199 L~L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~Ls~N~l~  254 (599)
                      |+|++|++-..+  .....++.|..|+++.+.++++--...      ..+++|+.|+++.|+|.
T Consensus       251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            888877777766  345566777777777777664322111      23445555555555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.33  E-value=9.2e-13  Score=119.21  Aligned_cols=14  Identities=29%  Similarity=0.349  Sum_probs=3.5

Q ss_pred             CCcccEEeecCCCc
Q 042902          216 LKYILYLNLSSNSF  229 (599)
Q Consensus       216 l~~L~~L~Ls~N~l  229 (599)
                      +++|+.|+|.+|.+
T Consensus       112 l~~L~~L~L~~NPv  125 (175)
T PF14580_consen  112 LPKLRVLSLEGNPV  125 (175)
T ss_dssp             -TT--EEE-TT-GG
T ss_pred             CCCcceeeccCCcc
Confidence            33333333333333

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.32  E-value=5.1e-14  Score=135.30  Aligned_cols=247  Identities=20%  Similarity=0.239  Sum_probs=123.5

Q ss_pred             ccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccC---cccccCChhhhcccccceEEEccCCcccccCCc
Q 042902           40 FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN---SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPE  116 (599)
Q Consensus        40 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N---~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~  116 (599)
                      ...+..++.|+||+|.+..-.... .-..+.+.++|+.-++|+=   ++...+|.++.-+.                  .
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~-i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~------------------~   86 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARA-IAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS------------------K   86 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHH-HHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH------------------H
Confidence            445566777777777665422210 1123555666676666653   12222333332222                  3


Q ss_pred             cccCCCCCCEEEccCCcCCcccCcc----ccCCCCCCEEEcccccccccCChhh-------------hcCCCCcEEEeeC
Q 042902          117 EISNLTNLTTIYLGGNKLNGSIPIA----LDKLQKLQLLSLEDNQLEGSIPDDL-------------CRLAALFLLDLGG  179 (599)
Q Consensus       117 ~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~Ls~  179 (599)
                      ++...++|++|+||.|.+....+..    +.++..|++|.|.+|.+...-...+             ..-+.|+++...+
T Consensus        87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r  166 (382)
T KOG1909|consen   87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR  166 (382)
T ss_pred             HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence            4555667888888888776433333    3456778888888887763222221             1223455555555


Q ss_pred             CccCCCCC----cccCCCCCCcEeecCCCCCCC--C---CccccCCCcccEEeecCCCccccCcccccccccccEEEccC
Q 042902          180 NKLSGFVP----ACFGNLTSLRNLYLGSNQLTS--I---PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM  250 (599)
Q Consensus       180 N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~--i---p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  250 (599)
                      |++.....    ..|+..+.|+.+.++.|.|..  +   -..+..+++|+.|||..|.++.....               
T Consensus       167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~---------------  231 (382)
T KOG1909|consen  167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV---------------  231 (382)
T ss_pred             cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH---------------
Confidence            55543211    223444455555555554441  1   12333444444444444444321111               


Q ss_pred             CccCCCCCccccCcccccccccccccccccCcccc-----cCCCCcccccCCCCccccc----CCchhhccccceEEEcc
Q 042902          251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-----GGLIDLKSLDLSNNNISGA----IPISLEKLLDLKYINVS  321 (599)
Q Consensus       251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l~l~  321 (599)
                           .+...+..+++|+.|++++|.+......+|     ...++|+.|.+.+|.++..    +.......+.|..|+|+
T Consensus       232 -----~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLn  306 (382)
T KOG1909|consen  232 -----ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLN  306 (382)
T ss_pred             -----HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCC
Confidence                 122334445555555555555543322222     1245667777777766532    22334456777777777


Q ss_pred             cccC
Q 042902          322 FNKL  325 (599)
Q Consensus       322 ~N~l  325 (599)
                      +|.+
T Consensus       307 gN~l  310 (382)
T KOG1909|consen  307 GNRL  310 (382)
T ss_pred             cccc
Confidence            7777

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.32  E-value=9.4e-13  Score=119.14  Aligned_cols=102  Identities=27%  Similarity=0.259  Sum_probs=34.6

Q ss_pred             CCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCcccc-CCCcccEEeecCCCccccCc-ccccccccccEE
Q 042902          169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSFTGPLP-LEIGNLRVLVQI  246 (599)
Q Consensus       169 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L  246 (599)
                      +.+|+.|+|++|.|+.+  +.+..++.|++|++++|+|+++++.+. .+++|++|++++|+|..... ..+..+++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            34444444444444433  124445555555555555555543332 34555555555555543221 345567777777


Q ss_pred             EccCCccCCCCC---ccccCccccccccc
Q 042902          247 DLSMNNFSGFIP---TTIGDLKDLQYLFL  272 (599)
Q Consensus       247 ~Ls~N~l~~~~~---~~~~~l~~L~~L~L  272 (599)
                      +|.+|+++...-   ..+..+++|+.||-
T Consensus       119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen  119 SLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             E-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             eccCCcccchhhHHHHHHHHcChhheeCC
Confidence            777777764311   12445677777664

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=2.7e-11  Score=111.91  Aligned_cols=135  Identities=20%  Similarity=0.221  Sum_probs=97.7

Q ss_pred             ceecccccceEEEEEecC-------CcEEEEEEecccc------------c----------ccHHHHH----HHHHHHhc
Q 042902          434 NLIGRGGVASVYKARIQD-------GIEVAVKVFDLQY------------E----------GAFKSFD----IECDMMKR  480 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~e~~~l~~  480 (599)
                      ..||.|.-+.||.|...+       +..+|||+.+...            +          ...+.+.    .|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997553       4799999874310            0          0122233    68889988


Q ss_pred             CC--CCcceeEEEEEEcCCeeeEEEEccCCCChh-hhhhcCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEccCCC
Q 042902          481 IR--HRNLIKIISSCSNDDFKALVLEYMPHGSLE-KCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYSVPIIHCDLKP  556 (599)
Q Consensus       481 l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dlk~  556 (599)
                      +.  .-++++.+++    ...++||||+.++.+. ..+++.  .++..+...+..+++.+|.++ |   ..++||+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            85  3466666654    4568999999765442 223221  234445567889999999999 8   88999999999


Q ss_pred             CCeeecCCCcEEEccccCCccC
Q 042902          557 NNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       557 ~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .||+++ ++.+.++|||.|...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.29  E-value=2.2e-13  Score=131.02  Aligned_cols=229  Identities=18%  Similarity=0.230  Sum_probs=132.1

Q ss_pred             CCcCCCCCCEEEccCccccc----cCCccccCCCCCCEEeccCccCccc----CCCcc-cccccCCCCCCcEEEcccCcc
Q 042902           15 FIFNASKLSRLELEMNSFYG----FIPNTFGNLRNLKRLSLNYNYLTSS----TPKLN-FLSSLSNCKYLKYLSFSNNSL   85 (599)
Q Consensus        15 ~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~-~~~~~~~l~~L~~L~Ls~N~i   85 (599)
                      .+..+..++.++|++|.|..    .+...+...++|+.-++|+=.....    ++.+. +..++.++++|++||||+|-+
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            34557889999999999863    2445667888999999986433221    11111 123567788999999999998


Q ss_pred             cccCChhhhccc---ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc-
Q 042902           86 DGILPRAIGNLS---QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS-  161 (599)
Q Consensus        86 ~~~~~~~~~~l~---~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-  161 (599)
                      .-.-+..|..+-   ..|++|+|.||.+....-..++.  -|..|.  .       ......-++|+.+...+|++... 
T Consensus       105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~-------~kk~~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen  105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--V-------NKKAASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--H-------HhccCCCcceEEEEeecccccccc
Confidence            755555555432   13555555555544221111110  000000  0       01122335667777777776532 


Q ss_pred             ---CChhhhcCCCCcEEEeeCCccCCC----CCcccCCCCCCcEeecCCCCCCC-----CCccccCCCcccEEeecCCCc
Q 042902          162 ---IPDDLCRLAALFLLDLGGNKLSGF----VPACFGNLTSLRNLYLGSNQLTS-----IPSTLWNLKYILYLNLSSNSF  229 (599)
Q Consensus       162 ---~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~Ls~N~l  229 (599)
                         +...|...+.|+.+.++.|.|...    ....|..++.|+.|+|.+|-++.     +...++.+++|+.|++++|.+
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll  253 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL  253 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence               223455566777777777776532    12346677778888888887773     233455666777777777777


Q ss_pred             cccCccccc-----ccccccEEEccCCccC
Q 042902          230 TGPLPLEIG-----NLRVLVQIDLSMNNFS  254 (599)
Q Consensus       230 ~~~~~~~~~-----~l~~L~~L~Ls~N~l~  254 (599)
                      ......+|.     ..++|+.|.|.+|.|+
T Consensus       254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  254 ENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             ccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            654333331     2455555555555554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.29  E-value=3e-11  Score=116.15  Aligned_cols=142  Identities=17%  Similarity=0.171  Sum_probs=111.5

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCC--CcceeEEEEEEcC---CeeeEEEEccC
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRH--RNLIKIISSCSND---DFKALVLEYMP  507 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  507 (599)
                      +.++.|.++.||++...+|+.+++|....... .....+..|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999999754432 234578899999999875  4467788777654   26689999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-------------------------------------------  544 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------------------------------------------  544 (599)
                      |+++.+.+..  ...+..+...++.++++++.++|+.                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988776532  2356677778889999999999842                                           


Q ss_pred             ----------CCCCeEEccCCCCCeeecC--CCcEEEccccCCcc
Q 042902          545 ----------YSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKP  577 (599)
Q Consensus       545 ----------~~~~iiH~dlk~~Nill~~--~~~~kl~DFGla~~  577 (599)
                                ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0256799999999999998  66789999998873

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=4.5e-11  Score=106.29  Aligned_cols=131  Identities=24%  Similarity=0.347  Sum_probs=102.2

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEe-ccccc-------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVF-DLQYE-------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+++|+-+.+|.+.+. |.++++|.- ++.+.       -..++-.+|++++++++--.|..-.=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            36789999999999875 445666643 22221       1245677899999988765555555566677888999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ++|-.|.+.+...        +..++..|-.-+.-||   ..+|+|+|+.++||.+..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888888664        2467888888999999   99999999999999998775 99999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=6.1e-12  Score=122.80  Aligned_cols=89  Identities=26%  Similarity=0.413  Sum_probs=70.5

Q ss_pred             CCCcceeEEEEEEcC---------------------------CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHH
Q 042902          482 RHRNLIKIISSCSND---------------------------DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV  534 (599)
Q Consensus       482 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  534 (599)
                      +|||||++++++.++                           ...|+||.-.+. +|++++..+.  .+...+.-|..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            699999999875321                           245788887755 8999888765  3444555588899


Q ss_pred             HHHHHHHhcCCCCCeEEccCCCCCeee--cCCC--cEEEccccCCc
Q 042902          535 ASALEYLHFGYSVPIIHCDLKPNNVLL--DDNM--VAHLSDFGMAK  576 (599)
Q Consensus       535 ~~~l~~lH~~~~~~iiH~dlk~~Nill--~~~~--~~kl~DFGla~  576 (599)
                      ++|+.|||   +++|.|||+|++|||+  |+|+  ...|+|||.+-
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            99999999   9999999999999998  4554  57899999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=1.3e-10  Score=102.72  Aligned_cols=142  Identities=20%  Similarity=0.239  Sum_probs=104.5

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEE-ecccc-------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKV-FDLQY-------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ....+-+|+-+.|+++.+. |+...||. +.+.+       .-..++..+|++.+.+++--.|..-.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568899999999999986 77766664 33332       113456778999999886545544444566666778999


Q ss_pred             EccCC-CChhhhhhcCCCcCCHHHH-HHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEccccCCcc
Q 042902          504 EYMPH-GSLEKCLYSSNYILDIFQR-LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAKP  577 (599)
Q Consensus       504 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DFGla~~  577 (599)
                      ||++| .++.+++......-..... ...+..|-+.+.-||   ..+|||+||..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4777777654332222222 578999999999999   99999999999999997665   468999999863

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.19  E-value=1.4e-10  Score=113.04  Aligned_cols=144  Identities=24%  Similarity=0.352  Sum_probs=93.5

Q ss_pred             CcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCC----------CcceeEEEEE---
Q 042902          431 SENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRH----------RNLIKIISSC---  493 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~---  493 (599)
                      ...+.||.|+++.||.+++. +|+++|||++...   .....+++.+|.-....+.+          -.++-.++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34578999999999999987 4899999998533   23356677777655444322          1222222211   


Q ss_pred             ------EcC---C-----eeeEEEEccCCCChhhhhh---cCCC---cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 042902          494 ------SND---D-----FKALVLEYMPHGSLEKCLY---SSNY---ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  553 (599)
Q Consensus       494 ------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d  553 (599)
                            ...   .     ..+++|+-+ .+||.+++.   ....   ......++.+..|+++.++++|   +.|++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                  111   1     236788888 458887754   2211   2334455677899999999999   99999999


Q ss_pred             CCCCCeeecCCCcEEEccccCCccC
Q 042902          554 LKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       554 lk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      |||+|++++.+|.++++||+.....
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~  195 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRA  195 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEET
T ss_pred             cceeeEEEcCCCCEEEcChHHHeec
Confidence            9999999999999999999987643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.13  E-value=1e-11  Score=135.22  Aligned_cols=143  Identities=24%  Similarity=0.309  Sum_probs=116.7

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHH--HhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY-EGAFKSFDIECDM--MKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .+...+.+|+++|=+|.+|+++.|. |+||++-++. .-..+.|.++++-  ...++|||.+++.-+-..+...|||=+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998887 9999986553 3344555444333  4556899999998887777788899999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      +.+ +|++.+..+. .+...+.+-|+.|++.|+.-+|   ..+|+|||||.+|||++.-.=+.++||..-+.
T Consensus       103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCC
Confidence            955 9998887654 3566677789999999999999   99999999999999999888899999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.12  E-value=8.1e-11  Score=122.08  Aligned_cols=98  Identities=35%  Similarity=0.570  Sum_probs=90.6

Q ss_pred             HhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EEccCCC
Q 042902          478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI-IHCDLKP  556 (599)
Q Consensus       478 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i-iH~dlk~  556 (599)
                      |+.+.|.|+.+++|.+.++...++|.+||+.|+|.+.+......++|.-...++++|+.||+|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35688999999999999999999999999999999999987778999999999999999999999   5555 9999999


Q ss_pred             CCeeecCCCcEEEccccCCccC
Q 042902          557 NNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       557 ~Nill~~~~~~kl~DFGla~~~  578 (599)
                      +|+++|..+.+|++|||+....
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             ccceeeeeEEEEechhhhcccc
Confidence            9999999999999999998755

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=2.4e-11  Score=131.86  Aligned_cols=170  Identities=25%  Similarity=0.322  Sum_probs=135.7

Q ss_pred             CCCCcCceecccccceEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..|...+.||+|+|+.|-.+...  ....+|+|.+....  ....++...|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45777788999999999887653  34557777765442  333445555777777776 99999999999999999999


Q ss_pred             EEccCCCChhhhh-hcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCc
Q 042902          503 LEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLK  580 (599)
Q Consensus       503 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~  580 (599)
                      +||.+||++.+.+ +......+...+..+..|+..|+.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999888 4332245556677899999999999995  45899999999999999999 999999999998876


Q ss_pred             -CCCceeeecccC-CccccCC
Q 042902          581 -EDQSLTQTQTLA-TIGYMAP  599 (599)
Q Consensus       581 -~~~~~~~~~~~g-t~~y~AP  599 (599)
                       .+........+| ++.|+||
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             cCCcceeeecccCCCCCCCCc
Confidence             555555566788 9999998

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.05  E-value=1.2e-10  Score=86.68  Aligned_cols=61  Identities=43%  Similarity=0.638  Sum_probs=55.7

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSL   85 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i   85 (599)
                      ++|++|+|++|+|+.+.+++|.++++|++|++++|+|+.+++.     .|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~-----~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPD-----AFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETT-----TTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHH-----HHcCCCCCCEEeCcCCcC
Confidence            5789999999999999889999999999999999999998876     699999999999999976

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.5e-09  Score=100.11  Aligned_cols=125  Identities=27%  Similarity=0.318  Sum_probs=82.3

Q ss_pred             eEEEEEecCCcEEEEEEecccc--------------c------------ccHHHHHHHHHHHhcCCCC--cceeEEEEEE
Q 042902          443 SVYKARIQDGIEVAVKVFDLQY--------------E------------GAFKSFDIECDMMKRIRHR--NLIKIISSCS  494 (599)
Q Consensus       443 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  494 (599)
                      .||.|...+|..||||+.+...              .            .......+|.+.|.++..-  ++++.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999874310              0            0123466799999999755  566666553 


Q ss_pred             cCCeeeEEEEccC--CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEEccCCCCCeeecCCCcEEEcc
Q 042902          495 NDDFKALVLEYMP--HGSLEKCLYSSNYILDIFQRLNIMIDVASALEY-LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       495 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                         ..+|||||++  |..+.. +....  ++......+..+++..+.. +|   ..+|+|+|+.+.||+++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3579999998  545544 33222  1122345577777775555 57   8899999999999999988 999999


Q ss_pred             ccCCccC
Q 042902          572 FGMAKPL  578 (599)
Q Consensus       572 FGla~~~  578 (599)
                      ||.|...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.02  E-value=2.1e-10  Score=85.42  Aligned_cols=59  Identities=36%  Similarity=0.510  Sum_probs=27.4

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      +|++|+|++|+|+.+.+.+|.++++|++|++++|.|+.+.++.|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444444444444444444444444444444444444444444444444443

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.96  E-value=8.1e-09  Score=101.03  Aligned_cols=140  Identities=15%  Similarity=0.072  Sum_probs=98.9

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCC--cceeEEEEEEc-----
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG-----------AFKSFDIECDMMKRIRHR--NLIKIISSCSN-----  495 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--niv~l~~~~~~-----  495 (599)
                      +.+-+-....|+++.+ +|+.|.||........           ....+.+|.+.+.++..-  .+++.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455445555778776 4789999977432211           112477888888877432  33344555543     


Q ss_pred             CCeeeEEEEccCCC-ChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-------CCc
Q 042902          496 DDFKALVLEYMPHG-SLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-------NMV  566 (599)
Q Consensus       496 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-------~~~  566 (599)
                      ....++|||++++- +|.+++... ....+...+..++.++++.+.-||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999886 788887531 122445566789999999999999   999999999999999975       468


Q ss_pred             EEEccccCCcc
Q 042902          567 AHLSDFGMAKP  577 (599)
Q Consensus       567 ~kl~DFGla~~  577 (599)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998853

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.94  E-value=1.5e-09  Score=100.16  Aligned_cols=73  Identities=26%  Similarity=0.195  Sum_probs=62.5

Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |+|.++++..+..+++..+..|+.||++||.|+|   +.+      ||+||+++.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            7899999876667999999999999999999999   555      999999999999999  9999854321       


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.||||
T Consensus        63 ~~~g~~~y~aP   73 (176)
T smart00750       63 QSRVDPYFMAP   73 (176)
T ss_pred             cCCCcccccCh
Confidence            12589999999

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.93  E-value=1.8e-10  Score=117.38  Aligned_cols=96  Identities=28%  Similarity=0.477  Sum_probs=81.3

Q ss_pred             eeeEEEEccCCCChhhhhhcCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          498 FKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      +.||.|++|+.++|.+|+.++.  ...++...+.++.|++.|+.|      ++.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999996443  357788889999999999999      47899999999999999999999999998


Q ss_pred             ccCCcCC----CceeeecccCCccccCC
Q 042902          576 KPLLKED----QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~----~~~~~~~~~gt~~y~AP  599 (599)
                      .......    .....+..+||..||+|
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCH
Confidence            8665443    22345678899999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.88  E-value=1.5e-09  Score=118.67  Aligned_cols=132  Identities=30%  Similarity=0.422  Sum_probs=90.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+|..++.|..|+||.||.++++ ..+.+|.|+ .++.-     ..+.  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence            357888999999999999999887 477889844 22211     1111  33344455544                  


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC---
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED---  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~---  582 (599)
                         |+=...++..+. ++.        +++.|++|+|   +.+|+|||+||+|.+|+.-|.+|+.|||+.+......   
T Consensus       136 ---gDc~tllk~~g~-lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCCC-Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               333333443322 111        2278999999   9999999999999999999999999999987532111   


Q ss_pred             ----------CceeeecccCCccccCC
Q 042902          583 ----------QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ----------~~~~~~~~~gt~~y~AP  599 (599)
                                ......+++|||.|+||
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccCh
Confidence                      00112467899999998

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.87  E-value=2.7e-09  Score=120.22  Aligned_cols=80  Identities=28%  Similarity=0.357  Sum_probs=41.2

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |.+|++++|.=.+.+|..+++|-+|++|+|++..++ .+|..+.+|.+|.+|++..+.-...+|.....+++|++|.+..
T Consensus       573 LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~  651 (889)
T KOG4658|consen  573 LRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR  651 (889)
T ss_pred             eEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence            333333333333344555555555555555555555 3445555555555555555554444455555555555555544


Q ss_pred             C
Q 042902          180 N  180 (599)
Q Consensus       180 N  180 (599)
                      -
T Consensus       652 s  652 (889)
T KOG4658|consen  652 S  652 (889)
T ss_pred             c
Confidence            3

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.86  E-value=1.9e-09  Score=121.50  Aligned_cols=204  Identities=23%  Similarity=0.236  Sum_probs=143.3

Q ss_pred             CCCCCCEEEccCccccccCCccccCCCCCCEEeccCcc--CcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhc
Q 042902           18 NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNY--LTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN   95 (599)
Q Consensus        18 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~   95 (599)
                      +....++..+-+|++..+ +... ..++|++|-+..|.  +..++..     .|..++.|++||||+|.=-+.+|..+++
T Consensus       521 ~~~~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~~is~~-----ff~~m~~LrVLDLs~~~~l~~LP~~I~~  593 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLLEISGE-----FFRSLPLLRVLDLSGNSSLSKLPSSIGE  593 (889)
T ss_pred             chhheeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhhhcCHH-----HHhhCcceEEEECCCCCccCcCChHHhh
Confidence            346788999999998764 4443 33479999999996  6666554     4888999999999988766789999999


Q ss_pred             ccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccc--ccCChhhhcCCCCc
Q 042902           96 LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE--GSIPDDLCRLAALF  173 (599)
Q Consensus        96 l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~  173 (599)
                      +- +|+.|+++...++ .+|..+.+|..|.+|++..+.-...+|+....|++|++|.+..-...  ...-..+..+.+|+
T Consensus       594 Li-~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~  671 (889)
T KOG4658|consen  594 LV-HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE  671 (889)
T ss_pred             hh-hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence            88 4899999999998 78899999999999999988766666888888999999998876532  22223445555666


Q ss_pred             EEEeeCCccCCCCCcccCCCCCCc----EeecCCCCCCCCCccccCCCcccEEeecCCCcccc
Q 042902          174 LLDLGGNKLSGFVPACFGNLTSLR----NLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGP  232 (599)
Q Consensus       174 ~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~  232 (599)
                      .+........  .-..+..++.|.    .+.+.++...+.+..+..+.+|+.|.+.++.+...
T Consensus       672 ~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~  732 (889)
T KOG4658|consen  672 NLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEI  732 (889)
T ss_pred             hheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchh
Confidence            5555433321  111223333332    34444445555566667777788888877777643

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.84  E-value=1e-10  Score=122.20  Aligned_cols=182  Identities=29%  Similarity=0.241  Sum_probs=104.9

Q ss_pred             CccccCCCCCCEEEcccccccccCChhhhcC-CCCcEEEeeCCccC---CCCC---cccCCC---CCCcEeecCCCCCCC
Q 042902          139 PIALDKLQKLQLLSLEDNQLEGSIPDDLCRL-AALFLLDLGGNKLS---GFVP---ACFGNL---TSLRNLYLGSNQLTS  208 (599)
Q Consensus       139 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~---~~~~---~~~~~l---~~L~~L~L~~N~l~~  208 (599)
                      |-.+..+.+|+.|.|.++.|...  ..+..+ ..|+.|--. |.+.   .++.   +.+.+-   -.|...+.+.|.+..
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh
Confidence            45566778999999999988631  111111 122222211 1111   0000   001110   135666677777776


Q ss_pred             CCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCC
Q 042902          209 IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL  288 (599)
Q Consensus       209 ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  288 (599)
                      +..++.-++.|+.|||++|+++..  ..+..++.|++|||++|.++.+.--...++. |+.|++++|.++..  ..+.++
T Consensus       179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~L  253 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENL  253 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhh
Confidence            666666667777777777777654  2666677777777777777744333333444 77777777777632  245667


Q ss_pred             CCcccccCCCCcccccC-CchhhccccceEEEcccccCccc
Q 042902          289 IDLKSLDLSNNNISGAI-PISLEKLLDLKYINVSFNKLEGE  328 (599)
Q Consensus       289 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~  328 (599)
                      .+|+.||+++|-|.+.- -..+..|..|+.|+|.+|++.|-
T Consensus       254 ksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  254 KSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            77777777777776432 12344566777777777777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=3.2e-08  Score=93.67  Aligned_cols=134  Identities=24%  Similarity=0.250  Sum_probs=97.6

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEecccc----------------------cccHHHHHHHHHHHhcCCCC--cce
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY----------------------EGAFKSFDIECDMMKRIRHR--NLI  487 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--niv  487 (599)
                      ....||.|.-+.||.|..+.|.++|||.-+...                      ........+|.++|.++.-.  .|.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            447899999999999999999999999653210                      01233456789999988654  666


Q ss_pred             eEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       488 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      +.+++    +.-.+||||++|-.|...--      +....-.+...|++-+...-   ..||||+|+.+-||+++++|.+
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             Ccccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCE
Confidence            66654    45679999999977754321      12223345555555555554   5789999999999999999999


Q ss_pred             EEccccCCccC
Q 042902          568 HLSDFGMAKPL  578 (599)
Q Consensus       568 kl~DFGla~~~  578 (599)
                      .++||--+...
T Consensus       242 ~vIDwPQ~v~~  252 (304)
T COG0478         242 VVIDWPQAVPI  252 (304)
T ss_pred             EEEeCcccccC
Confidence            99999887644

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=2e-08  Score=106.32  Aligned_cols=140  Identities=22%  Similarity=0.251  Sum_probs=93.2

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEeccccc----------------------c--------cH----------HHHHH
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYE----------------------G--------AF----------KSFDI  473 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~--------~~----------~~~~~  473 (599)
                      +.|+.++-|.||+|++++|+.||||+.++.-.                      .        ..          -+|..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999999999999998754210                      0        01          12344


Q ss_pred             HHHHHhcCC-----CCcceeEEEEE-EcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHH-HHHHhcCCC
Q 042902          474 ECDMMKRIR-----HRNLIKIISSC-SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA-LEYLHFGYS  546 (599)
Q Consensus       474 e~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~lH~~~~  546 (599)
                      |+.-+.+++     .|.+ ++=..| .-.....|+|||++|-.+.+...-+....+..   .++..++++ +..+-   .
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~---~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLL---R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHH---h
Confidence            555555542     3333 333333 33567889999999998888743222335533   333333332 11111   4


Q ss_pred             CCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       547 ~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      .|++|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            5899999999999999999999999999876643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.75  E-value=8.2e-09  Score=107.39  Aligned_cols=167  Identities=25%  Similarity=0.232  Sum_probs=127.5

Q ss_pred             CCCcCceecc--cccceEEEEEe---cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeee
Q 042902          429 GFSENNLIGR--GGVASVYKARI---QDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       429 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  500 (599)
                      .|...+.+|.  |.+|.||.+..   +++..+|+|.-+..  .......=.+|+..-++++ |++.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556678999  99999999876   36889999984322  2223333345666666664 999999888999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCC
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMA  575 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla  575 (599)
                      +-+|++ +.++..+-+.....++......+..+..+    |+.++|   ...++|-|+||.||+...+ ...+.+|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            999999 46888877766555677777788888888    999999   9999999999999999999 88999999999


Q ss_pred             ccCCcCCCce---eeecccCCccccCC
Q 042902          576 KPLLKEDQSL---TQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~---~~~~~~gt~~y~AP  599 (599)
                      ..+.+..-..   ..-...|...|+||
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeCh
Confidence            8776543111   11122466678876

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.74  E-value=2.9e-10  Score=118.96  Aligned_cols=179  Identities=25%  Similarity=0.309  Sum_probs=106.6

Q ss_pred             CccccCCCCCCEEEccCCcCCcccCccccCC-CCCCEEEcccccccccCChh-------hhc---CCCCcEEEeeCCccC
Q 042902          115 PEEISNLTNLTTIYLGGNKLNGSIPIALDKL-QKLQLLSLEDNQLEGSIPDD-------LCR---LAALFLLDLGGNKLS  183 (599)
Q Consensus       115 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~-------~~~---l~~L~~L~Ls~N~l~  183 (599)
                      |-.+..+..|+.|.|.++.|...  ..+..+ ..|++|.- +|.+. .+...       +++   .-.|.+.+.++|++.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC-~~Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLIC-HNSLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhh-hccHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence            44566788999999999998731  111111 23444422 22222 11111       111   124666677777776


Q ss_pred             CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccC
Q 042902          184 GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD  263 (599)
Q Consensus       184 ~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  263 (599)
                       ....++.-++.|+.|+|++|+++++. .+..++.|++|||++|.++.+.--...++. |..|.|++|.++..  ..+.+
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~  252 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN  252 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence             34455666677777777777777664 566677777777777777644333333433 77777777777643  34567


Q ss_pred             cccccccccccccccccCc-ccccCCCCcccccCCCCccc
Q 042902          264 LKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       264 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  302 (599)
                      +++|+.||+++|-|.+--. ..++.+..|+.|+|.+|++-
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            7777777777777764221 22455667777777777775

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.72  E-value=4.6e-08  Score=102.88  Aligned_cols=123  Identities=18%  Similarity=0.230  Sum_probs=101.0

Q ss_pred             EecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHH
Q 042902          448 RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR  527 (599)
Q Consensus       448 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  527 (599)
                      +..++.+|.|...+...........+-++.|+.++||||++++..+..++..|||+|-+.  .|..++.+..    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            345789999999876655444556777889999999999999999999999999999885  5666665543    3345


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       528 ~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .-.++||+.||.|||+  ...++|++|.-+.|+|+..|.-||++|-++...
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            5678999999999985  558999999999999999999999999887543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.68  E-value=8.1e-10  Score=92.56  Aligned_cols=105  Identities=27%  Similarity=0.318  Sum_probs=48.1

Q ss_pred             CcEeecCCCCCCCCCcccc---CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccc
Q 042902          196 LRNLYLGSNQLTSIPSTLW---NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFL  272 (599)
Q Consensus       196 L~~L~L~~N~l~~ip~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  272 (599)
                      +..++|++++|-.+++...   ....|+..+|++|.+....+..-...+.++.|+|++|.|+. +|..+..++.|+.|++
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhccc
Confidence            3445555555544433222   22233444455554442222222223344555555555552 3444555555555555


Q ss_pred             ccccccccCcccccCCCCcccccCCCCccc
Q 042902          273 EYNRLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       273 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      +.|++. ..|..+..+.+|-.|+..+|.+.
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            555554 34444444555555555555554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.66  E-value=2.2e-09  Score=90.04  Aligned_cols=105  Identities=26%  Similarity=0.290  Sum_probs=54.2

Q ss_pred             CCEEEcccccccccCChh---hhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEee
Q 042902          148 LQLLSLEDNQLEGSIPDD---LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL  224 (599)
Q Consensus       148 L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  224 (599)
                      +..++|+++++. -+++.   +.....|+..+|++|.+..+.+..-...+.++.|+|++|+|+.+|..+..++.|+.|++
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhccc
Confidence            344555555543 22232   22333444555666665544333333334556666666666666655555666666666


Q ss_pred             cCCCccccCcccccccccccEEEccCCccC
Q 042902          225 SSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       225 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +.|.+. ..|..+..+.++-.||..+|.+.
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            666655 34444444555555555555554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.63  E-value=4.2e-09  Score=99.56  Aligned_cols=108  Identities=25%  Similarity=0.291  Sum_probs=68.8

Q ss_pred             ceEEEccCCcccccCC-ccc-cCCCCCCEEEccCCcCCcc--cCccccCCCCCCEEEcccccccccCChhhhcCCCCcEE
Q 042902          100 MEVFFMFNCNISGSIP-EEI-SNLTNLTTIYLGGNKLNGS--IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~-~~~-~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                      ++.+.+.++.|-.+.. ..| ...+.+++|||.+|.|+..  +...+.+||.|+.|+|+.|++...+...-..+.+|++|
T Consensus        47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l  126 (418)
T KOG2982|consen   47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL  126 (418)
T ss_pred             hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence            4455566665543322 122 2457788888888888743  22345688888888888888874433222456688888


Q ss_pred             EeeCCccCCCC-CcccCCCCCCcEeecCCCCCC
Q 042902          176 DLGGNKLSGFV-PACFGNLTSLRNLYLGSNQLT  207 (599)
Q Consensus       176 ~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~  207 (599)
                      -|.+..+...- ...+..+|.+++|++|.|.+.
T Consensus       127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r  159 (418)
T KOG2982|consen  127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR  159 (418)
T ss_pred             EEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence            88887776432 234556777788888877554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.63  E-value=1.7e-08  Score=105.13  Aligned_cols=148  Identities=24%  Similarity=0.232  Sum_probs=114.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec--CCcEEEEEEecccccccHH--HHHHHHHHHhcC-CCCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDLQYEGAFK--SFDIECDMMKRI-RHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  500 (599)
                      ...+|..+..||.|.|+.|+++..+  ++..+|+|...........  .-..|+.+...+ .|.+++.+...+......|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3557888999999999999998754  5788999987544222111  123455555555 4888888877776666777


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCcc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKP  577 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~  577 (599)
                      +--|||++++......- ...++...++++..|++.|+.++|   ++.++|+|+||+||++..+ +..+++|||.+..
T Consensus       343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            99999999988765522 224677778889999999999999   9999999999999999876 7889999999864

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=3e-07  Score=87.06  Aligned_cols=107  Identities=23%  Similarity=0.240  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHHhcCC--CCcceeEEEEEEcCC----eeeEEEEccCCC-ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHH
Q 042902          468 FKSFDIECDMMKRIR--HRNLIKIISSCSNDD----FKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEY  540 (599)
Q Consensus       468 ~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~  540 (599)
                      .....+|...+.++.  .=.+++.+++.....    ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            345677887777764  333556666665432    458999999884 78888876332 4555677899999999999


Q ss_pred             HhcCCCCCeEEccCCCCCeeecCCC---cEEEccccCCccC
Q 042902          541 LHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAKPL  578 (599)
Q Consensus       541 lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DFGla~~~  578 (599)
                      ||   ..||+|+|++++|||++.+.   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   99999999999999999876   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=3e-07  Score=97.11  Aligned_cols=139  Identities=21%  Similarity=0.252  Sum_probs=93.1

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccc-------------------------------------cHHHHHHHHH
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG-------------------------------------AFKSFDIECD  476 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~e~~  476 (599)
                      +.||.-..|.||+|++++|+.||||+-++.-+.                                     ..-+|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            689999999999999999999999987543110                                     0113444555


Q ss_pred             HHhcC----CCCc------ceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 042902          477 MMKRI----RHRN------LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS  546 (599)
Q Consensus       477 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  546 (599)
                      -..++    +|-+      |.+++..+  .....|+||||+|..+.+.-.-....++......-+.+...-+-+     .
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-----~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-----K  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----h
Confidence            44333    3544      44443322  346899999999998876543333335655544444443333333     3


Q ss_pred             CCeEEccCCCCCeeecC----CCcEEEccccCCccCC
Q 042902          547 VPIIHCDLKPNNVLLDD----NMVAHLSDFGMAKPLL  579 (599)
Q Consensus       547 ~~iiH~dlk~~Nill~~----~~~~kl~DFGla~~~~  579 (599)
                      .|++|+|=+|.||+++.    ++++.+-|||+...+.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            48999999999999983    5689999999987653

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=1.7e-06  Score=80.23  Aligned_cols=139  Identities=18%  Similarity=0.084  Sum_probs=102.4

Q ss_pred             eecccccceEEEEEecCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCC--CcceeEEEEEEcC----CeeeEE
Q 042902          435 LIGRGGVASVYKARIQDGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRH--RNLIKIISSCSND----DFKALV  502 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv  502 (599)
                      --|+||-+-|++..++ |+.+=+|.-....      .-....|.+|...+.++..  -.+.+...+....    ...+||
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            3467888899998776 5578888764111      2245689999999998853  2355555322221    246799


Q ss_pred             EEccCC-CChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc--EEEccccCCcc
Q 042902          503 LEYMPH-GSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAKP  577 (599)
Q Consensus       503 ~e~~~~-g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DFGla~~  577 (599)
                      +|-++| -+|.+++.+... ..+...+..+..+|+++++-||   ..++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998754 588888765332 3466667789999999999999   999999999999999986666  99999987764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.1e-06  Score=84.15  Aligned_cols=132  Identities=14%  Similarity=0.149  Sum_probs=86.4

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCc--ceeEEEEEEcCCeeeEEEEccCCCC-
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN--LIKIISSCSNDDFKALVLEYMPHGS-  510 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  510 (599)
                      ..||+|..+.||+.   .|..+++|..+...  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25567889886533  2345678999998886333  4677888877778889999999864 


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc----------------------------------------CCCCCeE
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF----------------------------------------GYSVPII  550 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~----------------------------------------~~~~~ii  550 (599)
                      +...+..     +......++..+++.+.-+|.                                        .....++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2211110     011111122222222222221                                        1234678


Q ss_pred             EccCCCCCeeecCCCcEEEccccCCc
Q 042902          551 HCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       551 H~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      |+|+.|.||++++++ +.++||+.|.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999886

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.49  E-value=1.2e-08  Score=95.24  Aligned_cols=197  Identities=17%  Similarity=0.200  Sum_probs=93.4

Q ss_pred             cCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhh-hcccccceEEEccCCcccccCCcccc
Q 042902           41 GNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAI-GNLSQSMEVFFMFNCNISGSIPEEIS  119 (599)
Q Consensus        41 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~-~~l~~~l~~l~l~~n~i~~~~~~~~~  119 (599)
                      ..+..++.++||+|.|.+-.... .-..+++-++|+..++|.--.. ..-+.+ .++.               ..-.++-
T Consensus        27 ~~~d~~~evdLSGNtigtEA~e~-l~~~ia~~~~L~vvnfsd~ftg-r~kde~~~~L~---------------~Ll~aLl   89 (388)
T COG5238          27 EMMDELVEVDLSGNTIGTEAMEE-LCNVIANVRNLRVVNFSDAFTG-RDKDELYSNLV---------------MLLKALL   89 (388)
T ss_pred             HhhcceeEEeccCCcccHHHHHH-HHHHHhhhcceeEeehhhhhhc-ccHHHHHHHHH---------------HHHHHHh
Confidence            34566677777777665432211 1123445556666666554222 111111 1110               1123556


Q ss_pred             CCCCCCEEEccCCcCCcccCcc----ccCCCCCCEEEcccccccccCChhhh-------------cCCCCcEEEeeCCcc
Q 042902          120 NLTNLTTIYLGGNKLNGSIPIA----LDKLQKLQLLSLEDNQLEGSIPDDLC-------------RLAALFLLDLGGNKL  182 (599)
Q Consensus       120 ~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~-------------~l~~L~~L~Ls~N~l  182 (599)
                      ++|.|+..+||.|.+....|..    +.+-+.|++|.|++|.+..+...-++             +-|.|++.+...|++
T Consensus        90 kcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRl  169 (388)
T COG5238          90 KCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRL  169 (388)
T ss_pred             cCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchh
Confidence            6777888888888776555443    34556777777777776532222221             234555555555555


Q ss_pred             CCCCCc----ccCCCCCCcEeecCCCCCCC--CC----ccccCCCcccEEeecCCCccccC----cccccccccccEEEc
Q 042902          183 SGFVPA----CFGNLTSLRNLYLGSNQLTS--IP----STLWNLKYILYLNLSSNSFTGPL----PLEIGNLRVLVQIDL  248 (599)
Q Consensus       183 ~~~~~~----~~~~l~~L~~L~L~~N~l~~--ip----~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L  248 (599)
                      ......    .|..-.+|+++.+..|.|..  +.    ..++.+.+|+.|||..|.++...    ..+++.++.|+.|.+
T Consensus       170 engs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~l  249 (388)
T COG5238         170 ENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRL  249 (388)
T ss_pred             ccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccc
Confidence            432111    12222345555555555541  10    12334445555555555554221    122333444444444


Q ss_pred             cCCccC
Q 042902          249 SMNNFS  254 (599)
Q Consensus       249 s~N~l~  254 (599)
                      ..|-++
T Consensus       250 nDClls  255 (388)
T COG5238         250 NDCLLS  255 (388)
T ss_pred             cchhhc
Confidence            444444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.47  E-value=1e-06  Score=90.10  Aligned_cols=139  Identities=19%  Similarity=0.222  Sum_probs=107.0

Q ss_pred             cceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEE----cCCeeeEEEEccCC-CChhhh
Q 042902          441 VASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS----NDDFKALVLEYMPH-GSLEKC  514 (599)
Q Consensus       441 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~  514 (599)
                      -.+.||+... ||..|+.|+++............-+++++++.|+|||++..++.    .+...++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3568898754 89999999996544333323344567889999999999998776    33478999999986 467665


Q ss_pred             hhcC--------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          515 LYSS--------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       515 l~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ....              +...++...+.++.|+..||.++|   +.|..-+-|.+++|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              123566778899999999999999   88888899999999999999999999998776554


Q ss_pred             CC
Q 042902          581 ED  582 (599)
Q Consensus       581 ~~  582 (599)
                      +.
T Consensus       446 d~  447 (655)
T KOG3741|consen  446 DP  447 (655)
T ss_pred             CC
Confidence            43

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	599
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-24
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-23
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-23
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-06
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		4e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-06
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		9e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-05
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		4e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		6e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-04
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		1e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		2e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-04
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		2e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-04
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		2e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-04
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		3e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-04
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		4e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-04
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		6e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 102/192 (53%), Gaps = 5/192 (2%)
Query: 412 VANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVF-DLQYEGAFKS 470
           +  L+RF+  EL  A++ FS  N++GRGG   VYK R+ DG  VAVK   + + +G    
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 471 FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQR 527
           F  E +M+    HRNL+++   C     + LV  YM +GS+  CL     S   LD  +R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
             I +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK +  +D  +  
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 588 TQTLATIGYMAP 599
                TIG++AP
Sbjct: 202 A-VRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/192 (35%), Positives = 100/192 (52%), Gaps = 5/192 (2%)
Query: 412 VANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVF-DLQYEGAFKS 470
           +  L+RF+  EL  A++ F   N++GRGG   VYK R+ DG  VAVK   + + +G    
Sbjct: 14  LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ 73
Query: 471 FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQR 527
           F  E +M+    HRNL+++   C     + LV  YM +GS+  CL     S   LD  +R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
             I +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK +  +D  +  
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 588 TQTLATIGYMAP 599
                 IG++AP
Sbjct: 194 A-VRGXIGHIAP 204

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 112/413 (27%), Positives = 167/413 (40%), Gaps = 58/413 (14%)
Query: 6   NNFSGTIPSFIFN-ASKLSRLELEMNSFYG-FIPNTFGNLRN-LKRLSLNYNYLTSSTPK 62
           N FSG +P  + N ++ L  L+L  N+F G  +PN   N +N L+ L L  N  T   P 
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 409
Query: 63  LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
                +LSNC  L  L  S N L G +P ++G+LS+  ++    N  + G IP+E+  + 
Sbjct: 410 -----TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM-LEGEIPQELMYVK 463
Query: 123 NLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKL 182
            L T+ L  N L G IP               +N+L G IP                N  
Sbjct: 464 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 523
Query: 183 SGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSN-------------- 227
           SG +PA  G+  SL  L L +N    +IP+ ++     +  N  +               
Sbjct: 524 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 583
Query: 228 --------SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG 279
                    F G    ++  L      +++   + G    T  +   + +L + YN L G
Sbjct: 584 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 643
Query: 280 SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE------- 332
            IP  IG +  L  L+L +N+ISG+IP  +  L  L  +++S NKL+G IP+        
Sbjct: 644 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 703
Query: 333 -----------------GPFRNFSAESFKGNELLCGTPNLQVPPCRTR--IHH 366
                            G F  F    F  N  LCG P  +  P       HH
Sbjct: 704 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 756

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 111/405 (27%), Positives = 166/405 (40%), Gaps = 59/405 (14%)
Query: 6   NNFSGTIPSFIFN-ASKLSRLELEMNSFYG-FIPNTFGNLRN-LKRLSLNYNYLTSSTPK 62
           N FSG +P  + N ++ L  L+L  N+F G  +PN   N +N L+ L L  N  T   P 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 63  LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
                +LSNC  L  L  S N L G +P ++G+LS+  ++    N  + G IP+E+  + 
Sbjct: 413 -----TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM-LEGEIPQELMYVK 466
Query: 123 NLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKL 182
            L T+ L  N L G IP               +N+L G IP                N  
Sbjct: 467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 183 SGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSN-------------- 227
           SG +PA  G+  SL  L L +N    +IP+ ++     +  N  +               
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 586
Query: 228 --------SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG 279
                    F G    ++  L      +++   + G    T  +   + +L + YN L G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 280 SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE------- 332
            IP  IG +  L  L+L +N+ISG+IP  +  L  L  +++S NKL+G IP+        
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 333 -----------------GPFRNFSAESFKGNELLCGTPNLQVPPC 360
                            G F  F    F  N  LCG P   +P C
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 748

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 127/295 (43%), Gaps = 53/295 (17%)
Query: 67  SSLSNCKYLKYLSFSN-NSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
           SSL+N  YL +L     N+L G +P AI  L+Q +   ++ + N+SG+IP+ +S +  L 
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 126 TIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLSGF 185
           T+                            N L G++P               GN++SG 
Sbjct: 129 TLDF------------------------SYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 186 VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQ 245
           +P  +G+ +                      K    + +S N  TG +P    NL  L  
Sbjct: 165 IPDSYGSFS----------------------KLFTSMTISRNRLTGKIPPTFANLN-LAF 201
Query: 246 IDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI 305
           +DLS N   G      G  K+ Q + L  N L   +   +G   +L  LDL NN I G +
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTL 260
Query: 306 PISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPC 360
           P  L +L  L  +NVSFN L GEIP+ G  + F   ++  N+ LCG+P   +P C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 100/186 (53%), Gaps = 6/186 (3%)
Query: 417 RFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECD 476
           R   ++L +ATN F    LIG G    VYK  ++DG +VA+K    +     + F+ E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 477 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMID 533
            +   RH +L+ +I  C   +   L+ +YM +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   + DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 594 IGYMAP 599
           +GY+ P
Sbjct: 205 LGYIDP 210

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 99/186 (53%), Gaps = 6/186 (3%)
Query: 417 RFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECD 476
           R   ++L +ATN F    LIG G    VYK  ++DG +VA+K    +     + F+ E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 477 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMID 533
            +   RH +L+ +I  C   +   L+ +YM +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   +  Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 594 IGYMAP 599
           +GY+ P
Sbjct: 205 LGYIDP 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 418 FTHLELFQATNGFSEN------NLIGRGGVASVYKARIQDGIEVAVK----VFDLQYEGA 467
           F+  EL   TN F E       N +G GG   VYK  + +   VAVK    + D+  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK---CLYSSNYILDI 524
            + FD E  +M + +H NL++++   S+ D   LV  YMP+GSL     CL      L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 585 LTQTQTLATIGYMAP 599
           +  ++ + T  YMAP
Sbjct: 190 VMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 96/195 (49%), Gaps = 18/195 (9%)
Query: 418 FTHLELFQATNGFSEN------NLIGRGGVASVYKARIQDGIEVAVK----VFDLQYEGA 467
           F+  EL   TN F E       N +G GG   VYK  + +   VAVK    + D+  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK---CLYSSNYILDI 524
            + FD E  +M + +H NL++++   S+ D   LV  YMP+GSL     CL      L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 585 LTQTQTLATIGYMAP 599
           +   + + T  YMAP
Sbjct: 190 VMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 418 FTHLELFQATNGFSEN------NLIGRGGVASVYKARIQDGIEVAVK----VFDLQYEGA 467
           F+  EL   TN F E       N +G GG   VYK  + +   VAVK    + D+  E  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK---CLYSSNYILDI 524
            + FD E  +M + +H NL++++   S+ D   LV  YMP+GSL     CL      L  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 126
Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 585 LTQTQTLATIGYMAP 599
           +   + + T  YMAP
Sbjct: 184 VMXXRIVGTTAYMAP 198

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 8/168 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +V++A    G +VAVK+   Q  +      F  E  +MKR+RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLK  N+L+D      + DFG+++  LK    L       T  +MAP
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAP 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 418 FTHLELFQATNGFSEN------NLIGRGGVASVYKARIQDGIEVAVK----VFDLQYEGA 467
           F+  EL   TN F E       N  G GG   VYK  + +   VAVK    + D+  E  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK---CLYSSNYILDI 524
            + FD E  +  + +H NL++++   S+ D   LV  Y P+GSL     CL      L  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSW 123
Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
             R  I    A+ + +LH  +    IH D+K  N+LLD+   A +SDFG+A+   K  Q 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 585 LTQTQTLATIGYMAP 599
           +  ++ + T  Y AP
Sbjct: 181 VXXSRIVGTTAYXAP 195

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 8/168 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +V++A    G +VAVK+   Q  +      F  E  +MKR+RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +LK  N+L+D      + DFG+++  LK    L+      T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAP 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQDGIEVAV-KVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G   +VYK +    + V + KV D   E  F++F  E  ++++ RH N++  +   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            D+  A+V ++    SL K L+       +FQ ++I    A  ++YLH   +  IIH D+
Sbjct: 103 KDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K NN+ L + +   + DFG+A    +   S    Q   ++ +MAP
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARI----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R+    Q  + VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 546
           ++    +      +V EYM +GSL+  L + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLATIGYMAP 599
              +H DL   NVL+D N+V  +SDFG+++ L  + D + T T     I + AP
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARI----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R+    Q  + VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 546
           ++    +      +V EYM +GSL+  L + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLATIGYMAP 599
              +H DL   NVL+D N+V  +SDFG+++ L  + D + T T     I + AP
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD I VAVK      + A K F  E +++  ++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASA 537
              C   D   +V EYM HG L K L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           + YL    S   +H DL   N L+ +N++  + DFGM++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 598 AP 599
            P
Sbjct: 198 PP 199

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 436 IGRGGVASVYKARIQD---GIEVAVKVFDL---QYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G GG+++VY A  +D    I+VA+K   +   + E   K F+ E     ++ H+N++ +
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           I     DD   LV+EY+   +L + +  S+  L +   +N    +   +++ H    + I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT-QTLATIGYMAP 599
           +H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 152
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 127
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 95/185 (51%), Gaps = 12/185 (6%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKARIQDGIE-VAVKVFDLQY-----EGAFKSFDIE 474
           L++      + + + +G G  A+VYKAR ++  + VA+K   L +     +G  ++   E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +++ + H N+I ++ +  +    +LV ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              LEYLH  +   I+H DLKPNN+LLD+N V  L+DFG+AK     +++      + T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTR 176
Query: 595 GYMAP 599
            Y AP
Sbjct: 177 WYRAP 181

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 124
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 126
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 125
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 131
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+A+ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 19/179 (10%)
Query: 433 NNLIGRGGVASVYKARIQDGIEVAVKVF----DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
             +IG GG   VY+A    G EVAVK      D       ++   E  +   ++H N+I 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +   C  +    LV+E+   G L + L       DI   +N  + +A  + YLH    VP
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 549 IIHCDLKPNNVLLDD--------NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IIH DLK +N+L+          N +  ++DFG+A    +E    T+        +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+     +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 154
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 30  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 149 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 8/174 (4%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++   AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 24/185 (12%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        +D + VAVK        A K F  E +++  ++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYS---------------SNYILDIFQRLNIMIDV 534
              C + D   +V EYM HG L K L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           AS + YL    S   +H DL   N L+  N++  + DFGM++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 595 GYMAP 599
            +M P
Sbjct: 200 RWMPP 204

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 132 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 34/196 (17%)
Query: 425 QATNGFSEN----NLIGRGGVASVYKARIQDGI--EVAVKVFDLQYEGAFKSFDI----- 473
            +T+GF EN     ++GRG V+SV +  I      E AVK+ D+   G+F + ++     
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 474 ----ECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILD 523
               E D+++++  H N+I++  +   + F  LV + M  G L     EK   S      
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
           I + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D 
Sbjct: 129 IMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DP 176
Query: 584 SLTQTQTLATIGYMAP 599
                +   T  Y+AP
Sbjct: 177 GEKLREVCGTPSYLAP 192

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+ + L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 40  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 159 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 431 SENNLIGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHR 484
           +   +IG G    VYK  ++       + VA+K     Y E     F  E  +M +  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           N+I++    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
            ++  +H DL   N+L++ N+V  +SDFG+++ +L++D   T T +   I
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKI 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA    D   E ++M ++ H  L+++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRD 128
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 34/196 (17%)
Query: 425 QATNGFSEN----NLIGRGGVASVYKARIQDGI--EVAVKVFDLQYEGAFKSFDI----- 473
            +T+GF EN     ++GRG V+SV +  I      E AVK+ D+   G+F + ++     
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 474 ----ECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILD 523
               E D+++++  H N+I++  +   + F  LV + M  G L     EK   S      
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
           I + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D 
Sbjct: 129 IMRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DP 176
Query: 584 SLTQTQTLATIGYMAP 599
                    T  Y+AP
Sbjct: 177 GEKLRSVCGTPSYLAP 192

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 29/187 (15%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD + VAVK      E A + F  E +++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 535
              C+      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 536 SALEY---LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           + + Y   LHF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 593 TIGYMAP 599
            I +M P
Sbjct: 223 PIRWMPP 229

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 9/171 (5%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V EYM +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL     +  +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA    D   E ++M ++ H  L+++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 131
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 176

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA    D   E ++M ++ H  L+++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 128
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA    D   E ++M ++ H  L+++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 126
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 171

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 29/187 (15%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD + VAVK      E A + F  E +++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 535
              C+      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 536 SALEY---LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           + + Y   LHF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 593 TIGYMAP 599
            I +M P
Sbjct: 194 PIRWMPP 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EGA    D   E ++M ++ H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 174

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 29/187 (15%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        QD + VAVK      E A + F  E +++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYS--------------SNYILDIFQRLNIMIDVA 535
              C+      +V EYM HG L + L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 536 SALEY---LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           + + Y   LHF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 593 TIGYMAP 599
            I +M P
Sbjct: 200 PIRWMPP 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K      EG+    D   E ++M ++ H  L+++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E+M HG L   L +   +      L + +DV   + YL       +IH D
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 193

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 596 YMAP 599
           + AP
Sbjct: 201 WYAP 204

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 200
Query: 596 YMAP 599
           + AP
Sbjct: 201 WYAP 204

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 23/188 (12%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGA------FKSFDIECDM 477
           A N       IG+GG   V+K R ++D   VA+K   L   EG       F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           M  + H N++K+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 538 LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPLLKEDQSL-TQTQTL 591
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG+++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 592 ATIGYMAP 599
               +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 429 GFSEN----NLIGRGGVASVYKARIQDGI--EVAVKVFDLQYEGAFKSFDI--------- 473
           GF EN     ++GRG V+SV +  I      E AVK+ D+   G+F + ++         
Sbjct: 1   GFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 59
Query: 474 ECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQR 527
           E D+++++  H N+I++  +   + F  LV + M  G L     EK   S      I + 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
           L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 120 L---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 167
Query: 588 TQTLATIGYMAP 599
            +   T  Y+AP
Sbjct: 168 REVCGTPSYLAP 179

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 596 YMAP 599
           + AP
Sbjct: 183 WYAP 186

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 182
Query: 596 YMAP 599
           + AP
Sbjct: 183 WYAP 186

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIF 182
Query: 596 YMAP 599
           + AP
Sbjct: 183 WYAP 186

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 596 YMAP 599
           + AP
Sbjct: 186 WYAP 189

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 213
Query: 596 YMAP 599
           + AP
Sbjct: 214 WYAP 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDL--------QYEGAFKSFDIECDMMK 479
           +   ++IGRG V+SV +  +    G E AVK+ ++        Q E   ++   E  +++
Sbjct: 96  YDPKDVIGRG-VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 480 RIR-HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           ++  H ++I +I S  +  F  LV + M  G L   L +    L   +  +IM  +  A+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAV 213
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            +LH      I+H DLKP N+LLDDNM   LSDFG +  L   +      +   T GY+A
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLA 267
Query: 599 P 599
           P
Sbjct: 268 P 268

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 134 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 189
Query: 596 YMAP 599
           + AP
Sbjct: 190 WYAP 193

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V E M +GSL+  L   +    + Q + ++  +AS +
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 132 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V E M +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYL-HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL   GY    +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 132 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 187
Query: 596 YMAP 599
           + AP
Sbjct: 188 WYAP 191

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 131 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 186
Query: 596 YMAP 599
           + AP
Sbjct: 187 WYAP 190

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 133 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 188
Query: 596 YMAP 599
           + AP
Sbjct: 189 WYAP 192

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 126 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 181
Query: 596 YMAP 599
           + AP
Sbjct: 182 WYAP 185

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 125 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 180
Query: 596 YMAP 599
           + AP
Sbjct: 181 WYAP 184

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L +    +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 596 YMAP 599
           + AP
Sbjct: 186 WYAP 189

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAP
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
             ++GRG    V KA+ +   +VA+K   ++ E   K+F +E   + R+ H N++K+  +
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPII 550
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 551 HCDLKPNNVLL-DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLKP N+LL     V  + DFG A      D     T    +  +MAP
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 173

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 23/188 (12%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGA------FKSFDIECDM 477
           A N       IG+GG   V+K R ++D   VA+K   L   EG       F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           M  + H N++K+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 538 LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPLLKEDQSL-TQTQTL 591
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG ++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLL 187
Query: 592 ATIGYMAP 599
               +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
             ++GRG    V KA+ +   +VA+K   ++ E   K+F +E   + R+ H N++K+  +
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSVPII 550
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 551 HCDLKPNNVLL-DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLKP N+LL     V  + DFG A      D     T    +  +MAP
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++E++P+GSL + L      +D  + L     +   
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT--LATIG 595
           +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I 
Sbjct: 130 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIF 185
Query: 596 YMAP 599
           + AP
Sbjct: 186 WYAP 189

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 94  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 9/171 (5%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMM 478
             ATN  S + ++G G    V   R++      I VA+K   + Y E   + F  E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
            +  H N+I++    +      +V E M +GSL+  L   +    + Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           +YL     +  +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 161 KYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 424 FQATNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVF-DLQYEGAFKSFDI-ECDMMKR 480
           FQ+   +    L+G G    V K R +D G  VA+K F +   +   K   + E  ++K+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKC-LYSSNYILDIFQRLNIMIDVASALE 539
           +RH NL+ ++  C       LV E++ H  L+   L+ +     + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + F +S  IIH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
            LIG+G    VY  R     EVA+++ D++   E   K+F  E    ++ RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 552 CDLKPNNVLLDDNMVAHLSDFGM 574
            DLK  NV  D+  V  ++DFG+
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +  ++ +   R      + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA---FKSFDIECDMMKRIRH 483
           N     ++IG G    V KARI+ DG+ +   +  ++   +    + F  E +++ ++ H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 484 R-NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQR 527
             N+I ++ +C +  +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA---FKSFDIECDMMKRIRH 483
           N     ++IG G    V KARI+ DG+ +   +  ++   +    + F  E +++ ++ H
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 484 R-NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQR 527
             N+I ++ +C +  +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 135 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVA---VKVFDLQYEGAFKSFDIECDMMKRIRHRN 485
           F     IGRG  + VY+A  + DG+ VA   V++FDL    A      E D++K++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM---IDVASALEYLH 542
           +IK  +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              S  ++H D+KP NV +    V  L D G+ +      ++      + T  YM+P
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSP 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQD--GIEVAVKVFDLQYEGAFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   +QD  G  VAVK      E   + F+ E +++K
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 480 RIRHRNLIKIISSCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            ++H N++K    C +   +   L++EY+P+GSL   L      +D  + L     +   
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
           +EYL    +   IH +L   N+L+++     + DFG+ K L ++ +
Sbjct: 128 MEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 425 QATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKR 480
           +    F   NL+G+G  A VY+A  I  G+EVA+K+ D   +   G  +    E  +  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           ++H +++++ +   + ++  LVLE   +G + + L +        +  + M  + + + Y
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
           LH   S  I+H DL  +N+LL  NM   ++DFG+A  L
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 23/188 (12%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGA------FKSFDIECDM 477
           A N       IG+GG   V+K R ++D   VA+K   L   EG       F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           M  + H N++K+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 538 LEYLHFGYSVPIIHCDLKPNNVL---LDDN--MVAHLSDFGMAKPLLKEDQSL-TQTQTL 591
           +EY+    + PI+H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 592 ATIGYMAP 599
               +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 7/162 (4%)
Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISS 492
            ++G+G      K   ++  EV V    +++ E   ++F  E  +M+ + H N++K I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              D     + EY+  G+L   + S +      QR++   D+AS + YLH   S+ IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           DL  +N L+ +N    ++DFG+A+ ++ E    TQ + L ++
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSL 171

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 129 DLRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAP 174

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSC 493
           +G G    V   + +   +VAVK+     EG+     F  E   M ++ H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           S +    +V EY+ +G L   L S    L+  Q L +  DV   + +L    S   IH D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+D ++   +SDFGM + +L +DQ ++   T   + + AP
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 433

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 433 NNLIGRGGVASVYKARIQDGIE----VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V + R++   +    VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++    +N     ++ E+M +G+L+  L  ++    + Q + ++  +AS + YL     +
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 137
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
             +H DL   N+L++ N+V  +SDFG+++ L +     T+T +L     I + AP
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 350

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +L ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 350

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAP 184

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 23/169 (13%)
Query: 428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGA---FKSFDIECDMMKRIRH 483
           N     ++IG G    V KARI+ DG+ +   +  ++   +    + F  E +++ ++ H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 484 R-NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQR 527
             N+I ++ +C +  +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           L+   DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK+IRH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V+EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 93
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 76  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 132 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 177

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR +  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  Y   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS 161

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 106
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 220

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 35  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
              N L++D  V  +SDFG+++ +L ++++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWN-LKYILYLNLSSNSFTGPLPLEIG 238
           NKLS      F  LT LR LYL  N+L ++P+ ++  LK +  L ++ N     LP+ + 
Sbjct: 47  NKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVF 105
Query: 239 NLRV-LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDL 296
           +  V L ++ L  N      P     L  L YL L YN LQ S+P  +   L  LK L L
Sbjct: 106 DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 297 SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPF 335
            NN +      + +KL +LK + +  N+L+  +P EG F
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGAF 201

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 136 DLRAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAP 181

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 73
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 187

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 70
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 184

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 68
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 182

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 350

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV+EY   G +   L +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V++ + + G EVAVK+F  + E + F+  +I   +M  +RH N++  I++ +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 67
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----- 545
            D+       LV +Y  HGSL    Y + Y + +   + + +  AS L +LH        
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA------TIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   ++ D S T T  +A      T  YMAP
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAP 181

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R++      + VA+K   + Y E   + F  E  +M +  H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 546
            +    +      +V+E+M +G+L+  L   +    + Q + ++  +A+ + YL   GY 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              +H DL   N+L++ N+V  +SDFG+++ ++++D     T T   I
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDPEAVYTTTGGKI 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R++      + VA+K   + Y E   + F  E  +M +  H N+I
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 546
            +    +      +V EYM +GSL+  L  ++    + Q + ++  +++ ++YL   GY 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY- 145
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
              +H DL   N+L++ N+V  +SDFG+++ L  + ++   T+
Sbjct: 146 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 72  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 128 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 173

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAP 228

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     +++ + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAP 185

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 494 SNDDFKALVLEYMPHGSLEKCLY-SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L   +   L + Q +++   +AS + Y+     +  +H 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 136 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 181

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 74  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 130 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 175

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 433 NNLIGRGGVASVYKARIQDGIE----VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V + R++   +    VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++    +N     ++ E+M +G+L+  L  ++    + Q + ++  +AS + YL     +
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
             +H DL   N+L++ N+V  +SDFG+++ L +     T T +L     I + AP
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 405 ADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF--- 460
           A A MP     R+FT        + F     +G+G   +VY AR  Q+   +A+KV    
Sbjct: 3   ALAEMPK----RKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS 51
Query: 461 DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY 520
            L+ EG       E ++   +RH N++++ +   +     L+LE+ P G L K L     
Sbjct: 52  QLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR 111
Query: 521 ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK 580
             D  +    M ++A AL Y H      +IH D+KP N+L+       ++DFG +     
Sbjct: 112 -FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----V 163
Query: 581 EDQSLTQTQTLATIGYMAP 599
              SL +     T+ Y+ P
Sbjct: 164 HAPSLRRRXMCGTLDYLPP 182

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V+EYM  G L   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 35  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSC 493
           IGRG    V+  R++ D   VAVK          K+ F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 554 LKPNNVLLDDNMVAHLSDFGMAK 576
           L   N L+ +  V  +SDFGM++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 50  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 109
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 110 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 166
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 167 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 48  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 107
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 108 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 164
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 165 CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 107 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 166
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 223
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSC 493
           IGRG    V+  R++ D   VAVK          K+ F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 554 LKPNNVLLDDNMVAHLSDFGMAK 576
           L   N L+ +  V  +SDFGM++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 30/184 (16%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSS-----------NYILDIFQRLNIMIDVA 535
           +K++     ++   LV E++ H  L+K + +S           +Y+  + Q L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS------ 117
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 596 YMAP 599
           Y AP
Sbjct: 169 YRAP 172

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 179

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 53  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 112
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 113 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 169
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 170 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 220

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAP 228

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 179

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 26  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++ G   A KV + + E   + + +E +++    H  ++K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAP
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAP 178

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 185

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++ G   A KV + + E   + + +E +++    H  ++K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +D    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  NVL+       L+DFG++   LK  Q   +   + T  +MAP
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAP 186

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  +   + G    F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +   LV L YM HG L   + +  +   +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMA 598
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 173

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 20  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 89/164 (54%), Gaps = 19/164 (11%)
Query: 433 NNLIGRGGVASVYKARIQD-GIEVAVKVFD-LQYEGAFKSFDI---ECDMMKRIRHRNLI 487
           ++++G+G  A+V++ R +  G   A+KVF+ + +    +  D+   E +++K++ H+N++
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIV 70
Query: 488 KI--ISSCSNDDFKALVLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHF 543
           K+  I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 544 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQ 583
                I+H ++KP N++     D   V  L+DFG A+ L  ++Q
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 186

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 20  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+G   +VY AR  Q+   +A+KV     L+ EG       E ++   +RH N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              +     L+LE+ P G L K L       D  +    M ++A AL Y H      +IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            D+KP N+L+       ++DFG +        SL +     T+ Y+ P
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPP 181

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCL-----------YSSNYILD---IFQRL-NIMIDVASALEYLHFGYSVP 548
           EY   G+L + L           Y  N + +    F+ L +    +A  +EYL    S  
Sbjct: 121 EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAP 228

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 89/164 (54%), Gaps = 19/164 (11%)
Query: 433 NNLIGRGGVASVYKARIQD-GIEVAVKVFD-LQYEGAFKSFDI---ECDMMKRIRHRNLI 487
           ++++G+G  A+V++ R +  G   A+KVF+ + +    +  D+   E +++K++ H+N++
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIV 70
Query: 488 KI--ISSCSNDDFKALVLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHF 543
           K+  I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 544 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQ 583
                I+H ++KP N++     D   V  L+DFG A+ L  ++Q
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL   N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLAAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 19  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ P
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 179

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 176

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 19/188 (10%)
Query: 425 QATNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKS-FDIECDMMKRIR 482
           Q    +     +G GG   V +   QD G +VA+K    +     +  + +E  +MK++ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 483 HRNLIKI------ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR--LNIMIDV 534
           H N++        +   + +D   L +EY   G L K L        + +     ++ D+
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 132 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 185
Query: 592 ATIGYMAP 599
            T+ Y+AP
Sbjct: 186 GTLQYLAP 193

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 19/188 (10%)
Query: 425 QATNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKS-FDIECDMMKRIR 482
           Q    +     +G GG   V +   QD G +VA+K    +     +  + +E  +MK++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 483 HRNLIKI------ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR--LNIMIDV 534
           H N++        +   + +D   L +EY   G L K L        + +     ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 184
Query: 592 ATIGYMAP 599
            T+ Y+AP
Sbjct: 185 GTLQYLAP 192

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 9/166 (5%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G+G    V+         VA+K        + ++F  E  +MK++RH  L+++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-NMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 496 DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H DL
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           +  N+L+ +N+V  ++DFG+ +  L ED   T  Q     I + AP
Sbjct: 308 RAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAP 351

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    VYKA+   G  VA+K    D + EG   +   E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            ++    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    VYKA+   G  VA+K    D + EG   +   E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            ++    LV E+M    L+K L  +   L   Q   I I +   L  +   +   I+H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCS 494
           G+ GV    K R Q   +VA+K+     EG+     F  E  +M  + H  L+++   C+
Sbjct: 15  GQFGVVKYGKWRGQ--YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
                 ++ EYM +G L   L    +     Q L +  DV  A+EYL    S   +H DL
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKED 582
              N L++D  V  +SDFG+++ +L ++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY    +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    +V EYMP+G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N V  ++DFG+++ L+  D           I + AP
Sbjct: 156 LAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 200

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +    AFK+ +++  +M+++ H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G+G    V+         VA+K       G    ++F  E  +MK++RH  L+++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  G L   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 83  SEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAP 184

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +    AFK+ +++  +M+++ H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 496 DDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 174

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 443 SVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCSND--DF 498
            ++K R Q G ++ VKV  ++     KS  F+ EC  ++   H N++ ++ +C +     
Sbjct: 25  ELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 499 KALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN 557
             L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH    +   H  L   
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNSR 142
Query: 558 NVLLDDNMVAHLS 570
           +V++D++M A +S
Sbjct: 143 SVMIDEDMTARIS 155

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 83
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 144 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 157
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 218 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 260

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 112
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLK 580
           H FG    I H D+KP N+LLD D  V  L DFG AK L++
Sbjct: 173 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 114
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 175 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 112
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 173 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 418 FTHLELFQATNGFSEN---------NLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY 464
           FT  +  QA   F++           +IG G    V   R++      I VA+K     Y
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 465 -EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD 523
            +   + F  E  +M +  H N+I +    +      ++ EYM +GSL+  L  ++    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
           + Q + ++  + S ++YL     +  +H DL   N+L++ N+V  +SDFGM++ L  + +
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 584 SLTQTQ 589
           +   T+
Sbjct: 187 AAYTTR 192

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N+++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVR 78
Query: 489 I----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           +     SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 541 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y A
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 191
Query: 599 P 599
           P
Sbjct: 192 P 192

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 116
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 177 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 430 FSENNLIGRGGVASVYKARI--QDG--IEVAVKVF--DLQYEGAFKSFDIECDMMKRIRH 483
           F+   ++G+G   SV +A++  +DG  ++VAVK+   D+      + F  E   MK   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 484 RNLIKIISSCSNDDFKA------LVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMI 532
            ++ K++        K       ++L +M HG L   L +S      + L +   +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           D+A  +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 489 I----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           +     SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 541 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 599 P 599
           P
Sbjct: 191 P 191

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +    AFK+ +++  +M+++ H N++++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 496 DDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 489 I----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           +     SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 541 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 599 P 599
           P
Sbjct: 191 P 191

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 106
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLK 580
           H FG    I H D+KP N+LLD D  V  L DFG AK L++
Sbjct: 167 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 203

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 489 I----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           +     SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 541 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 599 P 599
           P
Sbjct: 191 P 191

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 86
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 147 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 199

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 90
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 151 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 203

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 82
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 143 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 195

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 90
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 151 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 203

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 97
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 158 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T+   T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPP 175

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 88/168 (52%), Gaps = 17/168 (10%)
Query: 429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 489 I----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
           +     SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 541 LH-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           +H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAV--KV-FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +   EV    K+  D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAV--KV-FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +   EV    K+  D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 496 DDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVA+K+ D       + +    E  +MK + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    L++EY   G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS 158

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 17/167 (10%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +++  +IG G    VY+A++ D  E+ V +  +  +  FK+ +++  +M+++ H N++++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQ--IMRKLDHCNIVRL 91
Query: 490 ----ISSCSNDD--FKALVLEYMPHG--SLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
                SS    D  +  LVL+Y+P     + +    +   L +      M  +  +L Y+
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 542 H-FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLT 586
           H FG    I H D+KP N+LLD D  V  L DFG AK L++ + +++
Sbjct: 152 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 194

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMA 575
            D+KP N+LL  N    ++DFG +
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWS 159

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R++      I VA+K     Y +   + F  E  +M +  H N+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +    +      ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL     +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
             +H DL   N+L++ N+V  +SDFGM++ L  + ++   T+
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 420 HLELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECD 476
           H+E FQ          IG G    VYKAR +  G  VA+K    D + EG   +   E  
Sbjct: 2   HMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 477 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
           ++K + H N++K++     ++   LV E++ H  L+K + +S   L       I   +  
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQ 112
Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
            L+ L F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 170
Query: 597 MAP 599
            AP
Sbjct: 171 RAP 173

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 496 DDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 355

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 176

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V   R++      I VA+K     Y +   + F  E  +M +  H N+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +    +      ++ EYM +GSL+  L  ++    + Q + ++  + S ++YL     +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
             +H DL   N+L++ N+V  +SDFGM++ L  + ++   T+
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVA+K+ D       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    L++EY   G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS 161

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 145 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 188

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-FDLQYE--GAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV F  Q E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
            Y   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 AYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 179

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 144 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 187

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 171

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 12/176 (6%)
Query: 428 NGFSENNLIGRGGVASVYKARIQDG-IEVAVKVF---DLQYEGAFKSFDIECDMMKRIRH 483
           + F     +G+G   +VY AR +     VA+KV     ++ EG       E ++   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N++++ +   +     L+LEY P G L K L  S    D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH- 140
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                +IH D+KP N+LL       ++DFG +        SL +     T+ Y+ P
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPP 190

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 179

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 186

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 138 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 181

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L K    ++ +  I   L I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 185

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 137 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAP 180

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 171

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 179

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPP 175

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 174

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 446 KARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL 503
           K + ++ + VAVK+  D   E        E +MMK I +H+N+I ++ +C+ D    +++
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 504 EYMPHGSLEKCLYSS-----NYILDI---------FQRL-NIMIDVASALEYLHFGYSVP 548
            Y   G+L + L +       Y  DI         F+ L +    +A  +EYL    S  
Sbjct: 121 GYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQK 177
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   NVL+ +N V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 440 GVASVYKARIQD----GIEVAVKVFDLQYEGAFKSFDI------ECDMMKRIRHRNLIKI 489
           GV +  K +I +    G +VAVK+ + Q     +S D+      E   +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
               S      +V+EY+  G L   +     + ++  R  +   + SA++Y H      +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +H DLKP NVLLD +M A ++DFG++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 175

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    +++E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 182

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           ++G+G    VY  R + + + +A+K    +     +    E  + K ++H+N+++ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMI-DVASALEYLHFGYSVPIIH 551
           S + F  + +E +P GSL   L S    + D  Q +      +   L+YLH      I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 552 CDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            D+K +NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAP
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 65/131 (49%), Gaps = 14/131 (10%)
Query: 452 GIEVAVKVFDL----QYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL--VLEY 505
           G  VAVK        Q+   +K    E D+++ + H ++IK    C +   K+L  V+EY
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM 565
           +P GSL    Y   + + + Q L     +   + YLH   S   IH +L   NVLLD++ 
Sbjct: 100 VPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDR 154
Query: 566 VAHLSDFGMAK 576
           +  + DFG+AK
Sbjct: 155 LVKIGDFGLAK 165

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 452 GIEVAVKVFDL----QYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL--VLEY 505
           G  VAVK        Q+   +K    E D+++ + H ++IK    C +    +L  V+EY
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM 565
           +P GSL    Y   + + + Q L     +   + YLH  +    IH DL   NVLLD++ 
Sbjct: 117 VPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDR 171
Query: 566 VAHLSDFGMAK 576
           +  + DFG+AK
Sbjct: 172 LVKIGDFGLAK 182

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 84/165 (50%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++ +   +      I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAP 179

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 175

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 440 GVASVYKARIQD----GIEVAVKVFDLQYEGAFKSFDI------ECDMMKRIRHRNLIKI 489
           GV +  K +I +    G +VAVK+ + Q     +S D+      E   +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
               S      +V+EY+  G L   +     + ++  R  +   + SA++Y H      +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +H DLKP NVLLD +M A ++DFG++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 185

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 141 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 184

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 452 GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPH 508
           G +VAVK    +  G        E ++++ + H N++K    C+ D      L++E++P 
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 568
           GSL++ L  +   +++ Q+L   + +   ++YL    S   +H DL   NVL++      
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 166
Query: 569 LSDFGMAKPLLKEDQSLT 586
           + DFG+ K +  + +  T
Sbjct: 167 IGDFGLTKAIETDKEXXT 184

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 131 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 174

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 452 GIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPH 508
           G +VAVK    +  G        E ++++ + H N++K    C+ D      L++E++P 
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 568
           GSL++ L  +   +++ Q+L   + +   ++YL    S   +H DL   NVL++      
Sbjct: 98  GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 154
Query: 569 LSDFGMAKPLLKEDQSLT 586
           + DFG+ K +  + +  T
Sbjct: 155 IGDFGLTKAIETDKEXXT 172

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 146 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 189

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 172

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 176

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G   SVYKA   + G  VA+K   +  E   +    E  +M++    +++K   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            +    +V+EY   GS+   +   N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  N+LL+    A L+DFG+A  L   D    +   + T  +MAP
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAP 194

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 201

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 422 ELFQATNGFSENN---LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDM 477
           +L +    + EN    ++G+G    VY  R + + + +A+K    +     +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMI-DVA 535
            K ++H+N+++ + S S + F  + +E +P GSL   L S    + D  Q +      + 
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
             L+YLH      I+H D+K +NVL++  + V  +SDFG +K L   +   T+T T  T+
Sbjct: 133 EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTL 187
Query: 595 GYMAP 599
            YMAP
Sbjct: 188 QYMAP 192

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 180

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-FDLQYE--GAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV F  Q E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-FDLQYE--GAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV F  Q E  G       E ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 175

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    +++E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 434 NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKR------IRHRNL 486
            +IG+G    V  AR + + +  AVKV  LQ +   K  + +  M +R      ++H  L
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           + +  S    D    VL+Y+  G L   L      L+   R     ++ASAL YLH   S
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 157
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           + I++ DLKP N+LLD      L+DFG+ K  ++ +   T +    T  Y+AP
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAP 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L K    ++ +  I   L I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-FDLQYE--GAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV F  Q E  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 14/131 (10%)
Query: 452 GIEVAVKVFDL----QYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL--VLEY 505
           G  VAVK        Q+   +K    E D+++ + H ++IK    C +   K+L  V+EY
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM 565
           +P GSL    Y   + + + Q L     +   + YLH  +    IH +L   NVLLD++ 
Sbjct: 100 VPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDR 154
Query: 566 VAHLSDFGMAK 576
           +  + DFG+AK
Sbjct: 155 LVKIGDFGLAK 165

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 37/191 (19%)
Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI---RHRNLIKII 490
            LIGRG   +VYK  + D   VAVKVF       F    I    + R+    H N+ + I
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNF----INEKNIYRVPLMEHDNIARFI 73
Query: 491 SSCSNDDFKA-------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
               ++   A       LV+EY P+GSL K  Y S +  D      +   V   L YLH 
Sbjct: 74  --VGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 544 ------GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA---------KPLLKEDQSLTQT 588
                  Y   I H DL   NVL+ ++    +SDFG++         +P  +++ ++++ 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE- 188
Query: 589 QTLATIGYMAP 599
             + TI YMAP
Sbjct: 189 --VGTIRYMAP 197

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 11/175 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V    ++      I VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +    +      ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL     +
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
             +H DL   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 192

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 23/193 (11%)
Query: 430 FSENNL-----IGRGGVASVYKARI-----QDGI-EVAVKVFD-LQYEGAFKSFDIECDM 477
           F  NNL     +G G    V +A       +D + +VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 478 MKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
           M  + +H N++ ++ +C++     ++ EY  +G L   L   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 537 ALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
             + LHF   V            IH D+   NVLL +  VA + DFG+A+ ++ +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 587 QTQTLATIGYMAP 599
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 186

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAP 262

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 70/148 (47%), Gaps = 26/148 (17%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI------------ 521
           E +++K++ H ++IK+  +CS D    L++EY  +GSL   L  S  +            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 522 -----------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
                      L +   ++    ++  ++YL     + ++H DL   N+L+ +     +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 571 DFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           DFG+++ + +ED  + ++Q    + +MA
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 70/148 (47%), Gaps = 26/148 (17%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI------------ 521
           E +++K++ H ++IK+  +CS D    L++EY  +GSL   L  S  +            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 522 -----------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
                      L +   ++    ++  ++YL     + ++H DL   N+L+ +     +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKIS 192
Query: 571 DFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           DFG+++ + +ED  + ++Q    + +MA
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 86/168 (51%), Gaps = 24/168 (14%)
Query: 425 QATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHR 484
           Q    ++   +IG G    V++A++ +  EVA+K   +  +  FK+ +++  +M+ ++H 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFKNRELQ--IMRIVKHP 92
Query: 485 NLIKIIS------SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI------MI 532
           N++ + +         ++ F  LVLEY+P    E    +S +   + Q + +      M 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLL 579
            +  +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+
Sbjct: 149 QLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    +++E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 194

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIRHRNLIKI 489
            ++G GG++ V+ AR ++D  +VAVKV   DL  + +F   F  E      + H  ++ +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 490 ISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             +   +        +V+EY+   +L   +++      +  +  I + +A A + L+F +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSH 133
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
              IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKARIQDGIEV-AVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR ++   + A+KV     L+  G       E ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIRHRNLIKI 489
            ++G GG++ V+ AR ++D  +VAVKV   DL  + +F   F  E      + H  ++ +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 490 ISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             +   +        +V+EY+   +L   +++   +     +  I + +A A + L+F +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADACQALNFSH 133
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
              IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 426 ATNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRH 483
           +++ F +   +G G  A+VYK      G+ VA+K   L  E    S  I E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY----------ILDIFQRLNIMID 533
            N++++      ++   LV E+M    L+K + S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
               L+ L F +   I+H DLKP N+L++      L DFG+A+
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+        +VAVK    Q   +  +F  E ++MK+++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           +    ++ EYM +GSL   L + + I L I + L++   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 132 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 175

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 21/177 (11%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS---- 492
            RG    V+KA++ +   VAVK+F +Q + ++++ + E   +  ++H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF-------GY 545
            S D    L+  +   GSL   L ++  ++   +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
              I H D+K  NVLL +N+ A ++DFG+A   LK +   +   T   +G   YMAP
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLA---LKFEAGKSAGDTHGQVGTRRYMAP 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/148 (22%), Positives = 70/148 (47%), Gaps = 26/148 (17%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI------------ 521
           E +++K++ H ++IK+  +CS D    L++EY  +GSL   L  S  +            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 522 -----------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
                      L +   ++    ++  ++YL     + ++H DL   N+L+ +     +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 571 DFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           DFG+++ + +ED  + ++Q    + +MA
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMA 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI------ECDMMKRIRHRNLIKI 489
           +G  G   V K  +  G +VAVK+ + Q     +S D+      E   +K  RH ++IK+
Sbjct: 26  VGTFGKVKVGKHELT-GHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
               S      +V+EY+  G L   +   N  LD  +   +   + S ++Y H      +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +H DLKP NVLLD +M A ++DFG++
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLS 163

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G+G    V++   Q G  VAVK+F  + E + F+  ++   +M  +RH N++  I+S  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 101
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS- 546
                +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG   
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 547 -VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 7/143 (4%)
Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  A V  AR I  G EVAVK+ D       + +    E  + K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV EY   G +   L +     +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 553 DLKPNNVLLDDNMVAHLSDFGMA 575
           DLK  N+LLD +    ++DFG +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS 160

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++ H  L+  + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 436 IGRGGVASVYK--ARIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G  A+VYK  +++ D + VA+K   L++E GA  +   E  ++K ++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    LV EY+    L++ L     I+++    N+ + +   L  L + +   ++H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+L+++     L+DFG+A+   K   + T    + T+ Y  P
Sbjct: 125 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPP 169

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 192 IHHIDYYKKTTNGRLPVKWMAP 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 549
            +  +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP+N+LLD +    L+DFG    + KE      T  + T  Y++P
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 189 IHHIDYYKKTTNGRLPVKWMAP 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 436 IGRGGVASVYKARIQDGIE-VAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G   +V+KA+ ++  E VA+K    D   EG   S   E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             +D    LV E+     L+K   S N  LD     + +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAK 576
           DLKP N+L++ N    L+DFG+A+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 182

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 383 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 427

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 193 IHHIDYYKKTTNGRLPVKWMAP 214

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-FDLQYE--GAFKSFDIECDMMKRI 481
           A   F     +G+G   +VY AR  Q    +A+KV F  Q E  G       E ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  +IH D+KP N+LL       +++FG +        S  +T    T+ Y+ P
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPP 177

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 549
            +  +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 189
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP+N+LLD +    L+DFG    + KE      T  + T  Y++P
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI------DVASALEYLHFGYSVP 548
            +    ++ E+M +G+L   L   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 183

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G+G    V++   Q G  VAVK+F  + E + F+  ++   +M  +RH N++  I+S  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS- 546
                +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG   
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 547 -VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-----FKSFDIECDMMKRIRHR 484
           FS+   IG G   +VY AR     EV V +  + Y G      ++    E   ++++RH 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEY 540
           N I+       +    LV+EY        CL S++ +L++ ++    +++A+    AL+ 
Sbjct: 115 NTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           L + +S  +IH D+K  N+LL +  +  L DFG A
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G+G    V++   Q G  VAVK+F  + E + F+  ++   +M  +RH N++  I+S  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 495 NDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS- 546
                +    L+  Y   GSL   L  +   LD    L I++ +AS L +LH   FG   
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 547 -VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-----LATIGYMAP 599
              I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 435 LIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPI 549
            +  +D +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S+  
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP+N+LLD +    L+DFG    + KE      T  + T  Y++P
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIRHRNLIKI 489
            ++G GG++ V+ AR ++D  +VAVKV   DL  + +F   F  E      + H  ++ +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 490 ISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             +   +        +V+EY+   +L   +++      +  +  I + +A A + L+F +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSH 133
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
              IIH D+KP N+L+       + DFG+A+ +     S+ QT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 344 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VY+   +   + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAP 179

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+        +VA+K       G    +SF  E  +MK+++H  L+++ +  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L +   +++   VA+ + Y+     +  IH 
Sbjct: 74  SEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           DL+  N+L+ + ++  ++DFG+A+  L ED   T  Q     I + AP
Sbjct: 130 DLRSANILVGNGLICKIADFGLAR--LIEDNEXTARQGAKFPIKWTAP 175

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 30/191 (15%)
Query: 418 FTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFD----- 472
           F H E+ +A         IG+G    V   +  D      K++ ++Y    K  +     
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVR 60
Query: 473 ---IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN 529
               E  +M+ + H  L+ +  S  +++   +V++ +  G L   L  + +  +   +L 
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           I  ++  AL+YL    +  IIH D+KP+N+LLD++   H++DF +A  L +E    TQ  
Sbjct: 121 I-CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQIT 172
Query: 590 TLA-TIGYMAP 599
           T+A T  YMAP
Sbjct: 173 TMAGTKPYMAP 183

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVF-DLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISS 492
           IG G    V+K R +D G  VA+K F + + +   K   + E  M+K+++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---LNIMIDVA-SALEYLHFGYSVP 548
                   LV EY  H  L +        LD +QR    +++  +    L+ ++F +   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH D+KP N+L+  + V  L DFG A+  L    S      +AT  Y +P
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSP 171

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++  +  A KV D + E   + + +E D++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
           K  N+L   +    L+DFG++    K  +++ +  + + T  +MAP
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAP 204

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------------YS 517
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L               ++
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 518 SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 200 IHHIDXXKKTTNGRLPVKWMAP 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G    VYKA+   G   A+K   L+ E  G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 554 LKPNNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L++      ++DFG+A+    P+ K       T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK------YTHEIVTLWYRAP 169

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++   S++   +     L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++  +  A KV D + E   + + +E D++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAP
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAP 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++   S++   +     L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G    VYKA+   G   A+K   L+ E  G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 554 LKPNNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L++      ++DFG+A+    P+ K       T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK------YTHEVVTLWYRAP 169

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 23/193 (11%)
Query: 430 FSENNL-----IGRGGVASVYKARI-----QDGI-EVAVKVFD-LQYEGAFKSFDIECDM 477
           F  NNL     +G G    V +A       +D + +VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 478 MKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
           M  + +H N++ ++ +C++     ++ EY  +G L   L   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 537 ALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
             + LHF   V            IH D+   NVLL +  VA + DFG+A+ ++ +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 587 QTQTLATIGYMAP 599
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-----FKSFDIECDMMKRIRHR 484
           FS+   IG G   +VY AR     EV V +  + Y G      ++    E   ++++RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS----ALEY 540
           N I+       +    LV+EY        CL S++ +L++ ++    +++A+    AL+ 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           L + +S  +IH D+K  N+LL +  +  L DFG A
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G    VYKA+   G   A+K   L+ E  G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 554 LKPNNVLLDDNMVAHLSDFGMAK----PLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+L++      ++DFG+A+    P+ K       T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK------YTHEVVTLWYRAP 169

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 426 ATNGF---SENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI 481
           A N F   S+  ++G G    V+K      G+++A K+   +     +    E  +M ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
            H NLI++  +  + +   LV+EY+  G L   +   +Y L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 542 HFGYSVPIIHCDLKPNNVLL--DDNMVAHLSDFGMAK 576
           H  Y   I+H DLKP N+L    D     + DFG+A+
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    VYKA+ ++  +  A KV D + E   + + +E D++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K  N+L   +    L+DFG++    +  Q   +   + T  +MAP
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAP 204

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 452 GIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPH 508
           G  VAVK          +S +  E ++++ + H +++K    C +   K+  LV+EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 568
           GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVLLD++ +  
Sbjct: 98  GSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVK 152
Query: 569 LSDFGMAKPL 578
           + DFG+AK +
Sbjct: 153 IGDFGLAKAV 162

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++    L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 452 GIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPH 508
           G  VAVK          +S +  E ++++ + H +++K    C +   K+  LV+EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH 568
           GSL    Y   + + + Q L     +   + YLH  +    IH  L   NVLLD++ +  
Sbjct: 97  GSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVK 151
Query: 569 LSDFGMAKPL 578
           + DFG+AK +
Sbjct: 152 IGDFGLAKAV 161

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++   S++   +     L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR +  G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++   S++   +     L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 417 RFTHLELFQAT----NGFSENNLIGRGGVASVYKARIQDGIEV--------AVKVFDLQY 464
           RF   +  +A     + F +  ++GRGG   V+  +++   ++                Y
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 465 EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI 524
           +GA     +E  ++ ++  R ++ +  +        LV+  M  G +   +Y+ +     
Sbjct: 230 QGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 525 FQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           FQ    +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A   LK 
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKA 341
Query: 582 DQSLTQTQTLATIGYMAP 599
            Q+ T+     T G+MAP
Sbjct: 342 GQTKTKGYA-GTPGFMAP 358

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 11/175 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
             +IG G    V    ++      I VA+K     Y E   + F  E  +M +  H N+I
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +    +      ++ E+M +GSL+  L  ++    + Q + ++  +A+ ++YL     +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 128
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA---TIGYMAP 599
             +H  L   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 417 RFTHLELFQAT----NGFSENNLIGRGGVASVYKARIQDGIEV--------AVKVFDLQY 464
           RF   +  +A     + F +  ++GRGG   V+  +++   ++                Y
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 465 EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI 524
           +GA     +E  ++ ++  R ++ +  +        LV+  M  G +   +Y+ +     
Sbjct: 230 QGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 525 FQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           FQ    +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A   LK 
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKA 341
Query: 582 DQSLTQTQTLATIGYMAP 599
            Q+ T+     T G+MAP
Sbjct: 342 GQTKTKGYA-GTPGFMAP 358

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 417 RFTHLELFQAT----NGFSENNLIGRGGVASVYKARIQDGIEV--------AVKVFDLQY 464
           RF   +  +A     + F +  ++GRGG   V+  +++   ++                Y
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 465 EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI 524
           +GA     +E  ++ ++  R ++ +  +        LV+  M  G +   +Y+ +     
Sbjct: 230 QGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 525 FQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           FQ    +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A   LK 
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKA 341
Query: 582 DQSLTQTQTLATIGYMAP 599
            Q+ T+     T G+MAP
Sbjct: 342 GQTKTKGYA-GTPGFMAP 358

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 436 IGRGGVASVYKARIQDGIE-VAVKV--FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG G   +V+KA+ ++  E VA+K    D   EG   S   E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             +D    LV E+     L+K   S N  LD     + +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 553 DLKPNNVLLDDNMVAHLSDFGMAK 576
           DLKP N+L++ N    L++FG+A+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 423 LFQATNGFSEN----NLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIEC 475
           +  A+  FS+N      +G+G  + V +      G+E A K+ + +   A  F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 476 DMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 535
            + ++++H N++++  S   + F  LV + +  G L + + +  +    +   +    + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQ 135
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
             LE + + +S  I+H +LKP N+LL          L+DFG+A   ++ + S        
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAG 192
Query: 593 TIGYMAP 599
           T GY++P
Sbjct: 193 TPGYLSP 199

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 408 NMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFD 461
            MPL+   ++    E+  +   F E   +G      VYK  +      +    VA+K   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 462 LQYEGAFKS-FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY 520
            + EG  +  F  E  +  R++H N++ ++   + D   +++  Y  HG L + L   + 
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 521 ILDIFQR---------------LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM 565
             D+                  ++++  +A+ +EYL    S  ++H DL   NVL+ D +
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182
Query: 566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +SD G+ + +   D       +L  I +MAP
Sbjct: 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         Y  N   +
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAP 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)
Query: 474 ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILD 523
           E +MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         Y  N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 524 IFQRLN------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
             ++L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D     T     + +MAP
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 417 RFTHLELFQAT----NGFSENNLIGRGGVASVYKARIQDGIEV--------AVKVFDLQY 464
           RF   +  +A     + F +  ++GRGG   V+  +++   ++                Y
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 465 EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDI 524
           +GA     +E  ++ ++  R ++ +  +        LV+  M  G +   +Y+ +     
Sbjct: 230 QGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 525 FQRLNIMI---DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
           FQ    +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A   LK 
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKA 341
Query: 582 DQSLTQTQTLATIGYMAP 599
            Q+ T+     T G+MAP
Sbjct: 342 GQTKTKGYA-GTPGFMAP 358

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 78/194 (40%), Gaps = 33/194 (17%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIK 488
           IG G    V++AR       +    VAVK+   +     ++ F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNY-----------------------ILDIF 525
           ++  C+      L+ EYM +G L + L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
           ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 586 TQTQTLATIGYMAP 599
                   I +M P
Sbjct: 232 ADGNDAIPIRWMPP 245

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS---C 493
            RG    V+KA++ +   VAVK+F LQ + +++S + E      ++H NL++ I++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 494 SNDDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF--------G 544
           SN + +  L+  +   GSL    Y    I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +   I H D K  NVLL  ++ A L+DFG+A               + T  YMAP
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 434 NLIGRGGVASVYKARIQDGIEV-AVKV---FDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
            +IGRG    V   R +   +V A+K+   F++        F  E D+M       ++++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
             +  +D +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S+ +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGL 195
Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
           IH D+KP+N+LLD +    L+DFG    +  ++  +    T + T  Y++P
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDYISP 244

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVK----VFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V  AR +  G +VA+K     FD+      K    E  ++K  +H N+I I 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKHDNIIAIK 119
Query: 491 S----SCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
                +    +FK++  VL+ M    L + ++SS   L +      +  +   L+Y+H  
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH-- 175
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAP 599
            S  +IH DLKP+N+L+++N    + DFGMA+ L     +     T+ +AT  Y AP
Sbjct: 176 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 82/165 (49%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+     +  +VAVK        + ++F  E ++MK ++H  L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCDL 554
           ++   ++ EYM  GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  NVL+ ++++  ++DFG+A+ ++++++   +      I + AP
Sbjct: 137 RAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 180

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIRHRNLIKI 489
            ++G GG++ V+ AR ++   +VAVKV   DL  + +F   F  E      + H  ++ +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 490 ISSCSNDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            ++   +        +V+EY+   +L   +++      +  +  I + +A A + L+F +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSH 133
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
              IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 43  LRNLKRLSLNYNYLTSSTP---------------KLNFLSSLSNCKYLKYLSFSNNSLDG 87
           L NL+ L+LN N +T  +P               K+  +S+L N   L+ L  + +++  
Sbjct: 65  LTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISD 124
Query: 88  ILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIAXXXXXX 147
           I P A  NL++   +    N N+S   P  +SN T L  + +  +K+    PIA      
Sbjct: 125 ISPLA--NLTKXYSLNLGANHNLSDLSP--LSNXTGLNYLTVTESKVKDVTPIANLTDLY 180
Query: 148 XXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKLSGFVPACFGNLTSLRNLYLGSNQLT 207
                   NQ+E   P                N+++   P    N T L +L +G+N++T
Sbjct: 181 SLSLNY--NQIEDISPLASLTSLHYFTAYV--NQITDITPVA--NXTRLNSLKIGNNKIT 234
Query: 208 SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDL 267
            + S L NL  + +L + +N  +      + +L  L  +++  N  S    + + +L  L
Sbjct: 235 DL-SPLANLSQLTWLEIGTNQISDINA--VKDLTKLKXLNVGSNQISDI--SVLNNLSQL 289
Query: 268 QYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS 308
             LFL  N+L     + IGGL +L +L LS N+I+   P++
Sbjct: 290 NSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRPLA 330

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 26/200 (13%)
Query: 404 LADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKA--------RIQDGIEV 455
           LA+    L+ + R  TH            + +IG+G    VY          RIQ  I+ 
Sbjct: 8   LAEVKDVLIPHERVVTH-----------SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS 56
Query: 456 AVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIIS-SCSNDDFKALVLEYMPHGSLEKC 514
             ++ ++Q   AF     E  +M+ + H N++ +I      +    ++L YM HG L + 
Sbjct: 57  LSRITEMQQVEAFLR---EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 515 LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 574
           + S      +   ++  + VA  +EYL        +H DL   N +LD++    ++DFG+
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
Query: 575 AKPLLKEDQSLTQTQTLATI 594
           A+ +L  +    Q    A +
Sbjct: 171 ARDILDREYYSVQQHRHARL 190

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 43/202 (21%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F E  LIG GG   V+KA+ + DG    ++      E A +    E   + ++ H N++ 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 489 IISSC----------SNDDFKA--------------------LVLEYMPHGSLEKCLYSS 518
             + C          S+D  ++                    + +E+   G+LE+ +   
Sbjct: 70  Y-NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 519 N-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
               LD    L +   +   ++Y+H   S  +IH DLKP+N+ L D     + DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           L  + +   +T++  T+ YM+P
Sbjct: 186 LKNDGK---RTRSKGTLRYMSP 204

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/233 (20%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 389 VILLILRYRKRGKSQLADANMPLVANLRRFTHLELFQ------ATNGFSENNLIGRGGVA 442
           VI+L + +RKR  S+L +  +    N   F+  +++       A    + +  +G+G   
Sbjct: 2   VIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFG 61
Query: 443 SVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIKIISSCSN 495
            VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++++   S 
Sbjct: 62  MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 121
Query: 496 DDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALEYLHFGYS 546
                +++E M  G L+  L S      +N +L    + + + +  ++A  + YL+   +
Sbjct: 122 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---A 178
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 179 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVK----VFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V  AR +  G +VA+K     FD+      K    E  ++K  +H N+I I 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKHDNIIAIK 120
Query: 491 S----SCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
                +    +FK++  VL+ M    L + ++SS   L +      +  +   L+Y+H  
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH-- 176
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAP 599
            S  +IH DLKP+N+L+++N    + DFGMA+ L     +     T+ +AT  Y AP
Sbjct: 177 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 430 FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F E  LIG GG   V+KA+ + DG    +K      E A +    E   + ++ H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 489 IISSCSNDDFKA----------------LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIM 531
                   D+                  + +E+   G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
             +   ++Y+H   S  +I+ DLKP+N+ L D     + DFG+   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 592 ATIGYMAP 599
            T+ YM+P
Sbjct: 183 GTLRYMSP 190

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           F   + +GRG  + VY+ + Q G +    +  L+     K    E  ++ R+ H N+IK+
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 490 ISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
                     +LVLE +  G L     EK  YS     D  ++      +  A+ YLH  
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLH-- 165
Query: 545 YSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               I+H DLKP N+L      +    ++DFG++K  + E Q L +T    T GY AP
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT-VCGTPGYCAP 219

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 15/172 (8%)
Query: 435 LIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  AR+++ G   AVKV  L+ +   +  D+EC M  KRI      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++       D    V+E++  G L   +  S    +   R     ++ SAL +LH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            II+ DLK +NVLLD      L+DFGM K  +     +T      T  Y+AP
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAP 193

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 14/174 (8%)
Query: 434 NLIGRGGVASVYKARIQDG--------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN 485
            ++G+GG   V++ R   G        ++V  K   ++          E ++++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAP 190

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 430 FSENNLIGRGGVASVYKARIQDG--IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI 487
           ++  N IGRG    V K  +Q G  I  A K     +      F  E ++MK + H N+I
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 488 KIISSCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           ++  +  ++    LV+E    G L E+ ++   +      R  IM DV SA+ Y H    
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---K 141
Query: 547 VPIIHCDLKPNNVL-LDDNMVAHLS--DFGMA 575
           + + H DLKP N L L D+  + L   DFG+A
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIRHRNLIKI 489
            ++G GG++ V+ AR ++   +VAVKV   DL  + +F   F  E      + H  ++ +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 490 ISSCSNDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             +   +        +V+EY+   +L   +++      +  +  I + +A A + L+F +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADACQALNFSH 133
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
              IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A     G +VAVK  DL+ +   +    E  +M+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAP 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 86/168 (51%), Gaps = 19/168 (11%)
Query: 439 GGVASVYKARIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS---- 491
           G V S Y AR++   +VAVK     ++    A +++  E  ++K ++H N+I ++     
Sbjct: 42  GSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTP 98
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           + S +DF  + L     G+    +  S  + D   +  ++  +   L+Y+H   S  IIH
Sbjct: 99  ATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---SAGIIH 154
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLKP+NV ++++    + DFG+A+   + D+ +  T  +AT  Y AP
Sbjct: 155 RDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-- 483
            + F E  ++G+G    V KAR   D    A+K      E    +   E  ++  + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 484 -----------RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
                      RN +K +++        + +EY  +G+L   ++S N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+ A      +VAVK        + ++F  E ++MK ++H  L+K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 554
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+  ++V  ++DFG+A+ ++++++   +      I + AP
Sbjct: 138 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 181

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 13/182 (7%)
Query: 427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFK-SFDIECDMMKRIR 482
           ++ +    ++G GG++ V+ AR ++   +VAVKV   DL  + +F   F  E      + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 483 HRNLIKIISSCSNDD----FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           H  ++ +  +   +        +V+EY+   +L   +++      +  +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYM 597
           + L+F +   IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 598 AP 599
           +P
Sbjct: 204 SP 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 82/165 (49%), Gaps = 6/165 (3%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+     +  +VAVK        + ++F  E ++MK ++H  L+++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-NIMIDVASALEYLHFGYSVPIIHCDL 554
           ++   ++ E+M  GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  NVL+ ++++  ++DFG+A+ ++++++   +      I + AP
Sbjct: 136 RAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 179

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 430 FSENNLIGRGGVASVYKARIQDG--IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI 487
           ++  N IGRG    V K  +Q G  I  A K     +      F  E ++MK + H N+I
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 488 KIISSCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           ++  +  ++    LV+E    G L E+ ++   +      R  IM DV SA+ Y H    
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---K 124
Query: 547 VPIIHCDLKPNNVL-LDDNMVAHLS--DFGMA 575
           + + H DLKP N L L D+  + L   DFG+A
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 443 SVYKARIQDGIEVAVKVFDLQYEGAFKS--FDIECDMMKRIRHRNLIKIISSCSND--DF 498
            ++K R Q G ++ VKV  ++     KS  F+ EC  ++   H N++ ++ +C +     
Sbjct: 25  ELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 499 KALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN 557
             L+  + P+GSL   L+  +N+++D  Q +   +D A    +LH    +   H  L   
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LNSR 142
Query: 558 NVLLDDNMVAHLS 570
           +V +D++  A +S
Sbjct: 143 SVXIDEDXTARIS 155

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 31/174 (17%)
Query: 439 GGVASVYKARIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS---- 491
           G V S Y AR++   +VAVK     ++    A +++  E  ++K ++H N+I ++     
Sbjct: 42  GSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTP 98
Query: 492 SCSNDDFKALVLEYMPHGS----LEKCLYSSNYILD--IFQRLNIMIDVASALEYLHFGY 545
           + S +DF  + L     G+    + KC   S+  +   ++Q L         L+Y+H   
Sbjct: 99  ATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR-------GLKYIH--- 148
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S  IIH DLKP+NV ++++    + DFG+A+   + D+ +  T  +AT  Y AP
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+ A      +VAVK        + ++F  E ++MK ++H  L+K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 554
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  N+L+  ++V  ++DFG+A+ ++++++   +      I + AP
Sbjct: 311 RAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 354

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 434 NLIGRGGVASVYKARI--QDG--IEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLI 487
            ++G G   SV +  +  +DG  ++VAVK   L    +   + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 488 KIISSCSNDDFKAL-----VLEYMPHGSLEKCLYSSNY-----ILDIFQRLNIMIDVASA 537
           +++  C     + +     +L +M +G L   L  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 31/194 (15%)
Query: 419 THLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG---AFKSFDIEC 475
           T  E+ Q   G         G V S Y AR++   +VAVK     ++    A +++  E 
Sbjct: 14  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-EL 70
Query: 476 DMMKRIRHRNLIKIIS----SCSNDDFKALVLEYMPHGS----LEKCLYSSNYILD--IF 525
            ++K ++H N+I ++     + S +DF  + L     G+    + KC   S+  +   ++
Sbjct: 71  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVY 130
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
           Q L         L+Y+H   S  IIH DLKP+NV ++++    + DFG+A+   + D+ +
Sbjct: 131 QLLR-------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEM 177
Query: 586 TQTQTLATIGYMAP 599
             T  +AT  Y AP
Sbjct: 178 --TGYVATRWYRAP 189

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 39/313 (12%)
Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +L+  N  +   P  + N + L+ L L  N      P    NL NL RL L+ N ++   
Sbjct: 90  ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-- 143
Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                +S+LS    L+ LSFS+N +  + P A         +  +   +IS +   +IS 
Sbjct: 144 -----ISALSGLTSLQQLSFSSNQVTDLKPLA--------NLTTLERLDISSNKVSDISV 190
Query: 120 --NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLE--GSIPXXXXXXXXXXXX 175
              LTNL ++    N+++   P+               NQL+  G++             
Sbjct: 191 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTL----ASLTNLTDL 244
Query: 176 XXGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
               N++S   P     LT L  L LG+NQ+++I S L  L  +  L L+ N      P 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLEDISP- 300
Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            I NL+ L  + L  NN S   P  +  L  LQ LF   N++  S   S+  L ++  L 
Sbjct: 301 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKV--SDVSSLANLTNINWLS 355
Query: 296 LSNNNISGAIPIS 308
             +N IS   P++
Sbjct: 356 AGHNQISDLTPLA 368

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/186 (22%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIK 488
           +G      VYK  +      +    VA+K    + EG  +  F  E  +  R++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---------------LNIMID 533
           ++   + D   +++  Y  HG L + L   +   D+                  ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 594 IGYMAP 599
           I +MAP
Sbjct: 194 IRWMAP 199

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQYEGAFKSF-DIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 141
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 142 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 193

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 8/128 (6%)
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI-M 531
           +E D++  + H  ++K+  +   +    L+L+++  G L   L  S  ++   + +   +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
            ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D         
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFC 187
Query: 592 ATIGYMAP 599
            T+ YMAP
Sbjct: 188 GTVEYMAP 195

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 434 NLIGRGGVASVYKA-RIQDG--IEVAVKVFDLQYEGAFKSFDIECDMMKRI---RHRNLI 487
            ++G G   +V+K   I +G  I++ V +  ++ +   +SF    D M  I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           +++  C     + LV +Y+P GSL   +      L     LN  + +A  + YL      
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 410 PLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQ 463
           P  A LR     EL +         ++G G   +VYK   + +G    I VA+K+  +  
Sbjct: 27  PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 464 YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD 523
              A   F  E  +M  + H +L++++  C +   + LV + MPHG L + ++     + 
Sbjct: 80  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 138
Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
               LN  + +A  + YL       ++H DL   NVL+       ++DFG+A+ L  +++
Sbjct: 139 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 584 SLTQTQTLATIGYMA 598
                     I +MA
Sbjct: 196 EYNADGGKMPIKWMA 210

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 8/128 (6%)
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI-M 531
           +E D++  + H  ++K+  +   +    L+L+++  G L   L  S  ++   + +   +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
            ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D         
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFC 187
Query: 592 ATIGYMAP 599
            T+ YMAP
Sbjct: 188 GTVEYMAP 195

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 8/128 (6%)
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI-M 531
           +E D++  + H  ++K+  +   +    L+L+++  G L   L  S  ++   + +   +
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 133
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
            ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D         
Sbjct: 134 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFC 188
Query: 592 ATIGYMAP 599
            T+ YMAP
Sbjct: 189 GTVEYMAP 196

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQYEGAFKSF-DIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 173

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 434 NLIGRGGVASVYKA-RIQDG--IEVAVKVFDLQYEGAFKSFDIECDMMKRI---RHRNLI 487
            ++G G   +V+K   I +G  I++ V +  ++ +   +SF    D M  I    H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           +++  C     + LV +Y+P GSL   +      L     LN  + +A  + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQYEGAFKSF-DIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 173

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQYEGAFKSF-DIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S        +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 137
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL +     L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 189

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQDGIEVAVKVFDLQYEGA--FKSFDIECDMMK 479
           F E +L     +G+G   SV   R   + D     V V  LQ+ G    + F  E  ++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 480 RIRHRNLIKI--ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            +    ++K   +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGY 596
           +EYL    S   +H DL   N+L++      ++DFG+AK L L +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 597 MAP 599
            AP
Sbjct: 181 YAP 183

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 430 FSENNLIGRGGVASVYKA---RIQDGIEVAVKVFDLQYEGAFKSF-DIECDMMKRIRHRN 485
           F++   IG+G    V+K    R Q    VA+K+ DL+           E  ++ +     
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           + K   S   D    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 136
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S   IH D+K  NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 188

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRH 483
           ++ +     +G+G  + V +      G+E A K+ + +   A  F+  + E  + ++++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N++++  S   + F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 544 GYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 176

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 8/124 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           E  +++R+RH+N+I+++    N++ + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK---PLLKEDQSLTQT 588
             +   LEYLH   S  I+H D+KP N+LL       +S  G+A+   P   +D   T  
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 589 QTLA 592
            + A
Sbjct: 173 GSPA 176

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 410 PLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARI-QDGIEVAVKV---FDLQYE 465
           P+V  L+     E+    + F    +IGRG  + V   ++ Q G   A+K+   +D+   
Sbjct: 48  PIVVRLK-----EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 466 GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF 525
           G    F  E D++     R + ++  +  ++++  LV+EY   G L   L      +   
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162
Query: 526 QRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
                + ++  A++ +H  GY    +H D+KP+N+LLD      L+DFG     L+ D +
Sbjct: 163 MARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLK-LRADGT 217
Query: 585 LTQTQTLATIGYMAP 599
           +     + T  Y++P
Sbjct: 218 VRSLVAVGTPDYLSP 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL 486
           N FS + +IGRGG   VY  R  D G   A+K  D       K   ++      +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 241
Query: 487 IKIISS-------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
           + ++S+       C +  F      + +L+ M  G L   L       +   R     ++
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 300
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              LE++H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T 
Sbjct: 301 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 353
Query: 595 GYMAP 599
           GYMAP
Sbjct: 354 GYMAP 358

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 39/313 (12%)
Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +L+  N  +   P  + N + L+ L L  N      P    NL NL RL L+ N ++   
Sbjct: 90  ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-- 143
Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                +S+LS    L+ LSFS+N +  + P A         +  +   +IS +   +IS 
Sbjct: 144 -----ISALSGLTSLQQLSFSSNQVTDLKPLA--------NLTTLERLDISSNKVSDISV 190
Query: 120 --NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLE--GSIPXXXXXXXXXXXX 175
              LTNL ++    N+++   P+               NQL+  G++             
Sbjct: 191 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTL----ASLTNLTDL 244
Query: 176 XXGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
               N++S   P     LT L  L LG+NQ+++I S L  L  +  L L+ N      P 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLEDISP- 300
Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            I NL+ L  + L  NN S   P  +  L  LQ LF   N++  S   S+  L ++  L 
Sbjct: 301 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLS 355
Query: 296 LSNNNISGAIPIS 308
             +N IS   P++
Sbjct: 356 AGHNQISDLTPLA 368

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL 486
           N FS + +IGRGG   VY  R  D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 487 IKIISS-------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
           + ++S+       C +  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              LE++H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 595 GYMAP 599
           GYMAP
Sbjct: 355 GYMAP 359

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 409 MPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIE-VAVK-VFDLQYEG 466
           MP      R+   E  +    F   +++G G  + V  A  +   + VA+K +     EG
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 58
Query: 467 AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYI 521
              S + E  ++ +I+H N++ +     +     L+++ +  G L     EK  Y+    
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER-- 116
Query: 522 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPL 578
                   ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K  
Sbjct: 117 ----DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-- 167
Query: 579 LKEDQSLTQTQTLATIGYMAP 599
             ED     +    T GY+AP
Sbjct: 168 -MEDPGSVLSTACGTPGYVAP 187

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQDGIEVAVKVFDLQYEG--AFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   + D     V V  LQ+ G    + F  E  ++K
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 480 RIRHRNLIKI--ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            +    ++K   +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGY 596
           +EYL    S   +H DL   N+L++      ++DFG+AK L L +D  + +    + I +
Sbjct: 127 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 597 MAP 599
            AP
Sbjct: 184 YAP 186

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 410 PLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQ 463
           P  A LR     EL +         ++G G   +VYK   + +G    I VA+K+  +  
Sbjct: 4   PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 464 YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD 523
              A   F  E  +M  + H +L++++  C +   + LV + MPHG L + ++     + 
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 115
Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
               LN  + +A  + YL       ++H DL   NVL+       ++DFG+A+ L  +++
Sbjct: 116 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
Query: 584 SLTQTQTLATIGYMA 598
                     I +MA
Sbjct: 173 EYNADGGKMPIKWMA 187

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQDGIEVAVKVFDLQYEGA--FKSFDIECDMMK 479
           F E +L     +G+G   SV   R   + D     V V  LQ+ G    + F  E  ++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 480 RIRHRNLIKI--ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            +    ++K   +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGY 596
           +EYL    S   +H DL   N+L++      ++DFG+AK L L +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 597 MAP 599
            AP
Sbjct: 185 YAP 187

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 434 NLIGRGGVASVYKARIQDG--------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN 485
            ++G+GG   V++ R   G        ++V  K   ++          E ++++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAP 190

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 430 FSENNL-----IGRGGVASVYKAR---IQDGIEVAVKVFDLQYEG--AFKSFDIECDMMK 479
           F E +L     +G+G   SV   R   + D     V V  LQ+ G    + F  E  ++K
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 480 RIRHRNLIKI--ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
            +    ++K   +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATIGY 596
           +EYL    S   +H DL   N+L++      ++DFG+AK L L +D  + +    + I +
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 597 MAP 599
            AP
Sbjct: 197 YAP 199

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL 486
           N FS + +IGRGG   VY  R  D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 487 IKIISS-------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
           + ++S+       C +  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              LE++H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 595 GYMAP 599
           GYMAP
Sbjct: 355 GYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL 486
           N FS + +IGRGG   VY  R  D G   A+K  D       K   ++      +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 487 IKIISS-------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
           + ++S+       C +  F      + +L+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              LE++H  +   +++ DLKP N+LLD++    +SD G+A    K+        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 595 GYMAP 599
           GYMAP
Sbjct: 355 GYMAP 359

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 433 NNLIGRGGVASVYKA-RIQDG-------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHR 484
           N  +G+G    ++K  R + G        EV +KV D  +    +SF     MM ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +L+     C   D   LV E++  GSL+  L  +   ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 545 YSVPIIHCDLKPNNVLL---DDNMVAH-----LSDFGMAKPLLKED 582
               +IH ++   N+LL   +D    +     LSD G++  +L +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRH 483
           ++ +     +G+G  + V +      G+E A K+ + +   A  F+  + E  + ++++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N++++  S   + F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 544 GYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 176

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 6/142 (4%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +G G    V+ A      +VAVK        + ++F  E ++MK ++H  L+K+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSVPIIHCDL 554
           +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 555 KPNNVLLDDNMVAHLSDFGMAK 576
           +  N+L+  ++V  ++DFG+A+
Sbjct: 305 RAANILVSASLVCKIADFGLAR 326

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRH 483
           ++ +     +G+G  + V +      G+E A K+ + +   A  F+  + E  + ++++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N++++  S   + F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +S  I+H +LKP N+LL          L+DFG+A   ++ + S        T GY++P
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 175

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECD---MMKRIRHRNLIKIIS 491
           +G G    V+  R + +G   A+KV   +     K  +   D   M+  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +  +     ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAK 576
            DLKP N+LLD N    ++DFG AK
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAK 154

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 47/256 (18%)
Query: 66  LSSLSNCKYLKYLS---FSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
           + S+   +YL  L+   FSNN L  I P  + NL++ +++  M N  I+   P  ++NLT
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL-MNNNQIADITP--LANLT 107
Query: 123 NLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKL 182
           NLT + L  N++    P+               N+LE S                  N +
Sbjct: 108 NLTGLTLFNNQITDIDPLKNLTNL---------NRLELS-----------------SNTI 141
Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL-EIGNLR 241
           S    +    LTSL+ L  G NQ+T +   L NL  +  L++SSN  +    L ++ NL 
Sbjct: 142 SDI--SALSGLTSLQQLNFG-NQVTDLKP-LANLTTLERLDISSNKVSDISVLAKLTNLE 197
Query: 242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
            L+  +   N  S   P  +G L +L  L L  N+L+     ++  L +L  LDL+NN I
Sbjct: 198 SLIATN---NQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI 250
Query: 302 SGAIPIS-LEKLLDLK 316
           S   P+S L KL +LK
Sbjct: 251 SNLAPLSGLTKLTELK 266

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 47/256 (18%)
Query: 66  LSSLSNCKYLKYLS---FSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
           + S+   +YL  L+   FSNN L  I P  + NL++ +++  M N  I+   P  ++NLT
Sbjct: 53  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL-MNNNQIADITP--LANLT 107
Query: 123 NLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLEGSIPXXXXXXXXXXXXXXGGNKL 182
           NLT + L  N++    P+               N+LE S                  N +
Sbjct: 108 NLTGLTLFNNQITDIDPLKNLTNL---------NRLELS-----------------SNTI 141
Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL-EIGNLR 241
           S    +    LTSL+ L  G NQ+T +   L NL  +  L++SSN  +    L ++ NL 
Sbjct: 142 SDI--SALSGLTSLQQLNFG-NQVTDLKP-LANLTTLERLDISSNKVSDISVLAKLTNLE 197
Query: 242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
            L+  +   N  S   P  +G L +L  L L  N+L+     ++  L +L  LDL+NN I
Sbjct: 198 SLIATN---NQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI 250
Query: 302 SGAIPIS-LEKLLDLK 316
           S   P+S L KL +LK
Sbjct: 251 SNLAPLSGLTKLTELK 266

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 462 LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS--NDDFKALVLEYMPHGSLEKCLYSSN 519
           +Q  G  +    E  ++K++ H N++K++      N+D   +V E +  G + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 520 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL 579
              D  Q      D+   +EYLH+     IIH D+KP+N+L+ ++    ++DFG++    
Sbjct: 134 LSED--QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 580 KEDQSLTQTQTLATIGYMAP 599
             D  L  + T+ T  +MAP
Sbjct: 189 GSDALL--SNTVGTPAFMAP 206

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 8/128 (6%)
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNI-M 531
           +E D++  + H  ++K+  +   +    L+L+++  G L   L  S  ++   + +   +
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 136
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
            ++A  L++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D         
Sbjct: 137 AELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFC 191
Query: 592 ATIGYMAP 599
            T+ YMAP
Sbjct: 192 GTVEYMAP 199

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 27/171 (15%)
Query: 453 IEVAVKVFDLQYEGAFK-SFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGS 510
           I+VAVK+   + + + + +   E  MM ++  H N++ ++ +C+      L+ EY  +G 
Sbjct: 76  IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 511 L-------------EKCLYSSNYILDIFQRLNIMI---------DVASALEYLHFGYSVP 548
           L             ++  Y +   L+  + LN++           VA  +E+L F     
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S 192
Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +H DL   NVL+    V  + DFG+A+ ++ +   + +      + +MAP
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS 492
           +G+G  + V +  +I  G E A K+ + +   A   +  + E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 553 DLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSP 175

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIIS 491
            L+G G    VYK R ++ G   A+KV D+  +   +    E +M+K+   HRN+     
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYG 88
Query: 492 SCSN------DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFG 544
           +         DD   LV+E+   GS+   + ++    L       I  ++   L +LH  
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 146
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
               +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 198

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 14/177 (7%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           F   +++G G   ++    + D  +VAVK         F   D E  +++    H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              +  +  F+ + +E     +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 549 IIHCDLKPNNVLLD-----DNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
           I+H DLKP+N+L+        + A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 185

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIK---- 488
           IG G      K R + DG  +  K  D     E   +    E ++++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 489 IISSCSNDDFKALVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 543
           II   +   +  +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 544 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              G++V  +H DLKP NV LD      L DFG+A+ +L  D S  +T  + T  YM+P
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKT-FVGTPYYMSP 185

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 189

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS 492
           +G+G  + V +  +I  G E A K+ + +   A   +  + E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 553 DLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G  + V +  ++  G E A K+ + +   A   +  + E  + + ++H N++++  S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
            S + F  LV + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 553 DLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LL          L+DFG+A  +  + Q+        T GY++P
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSP 175

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 194

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     IG G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EYMP G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     IG G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EYMP G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 18/164 (10%)
Query: 427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-- 483
            + F E  ++G+G    V KAR   D    A+K      E    +   E  ++  + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 484 -----------RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
                      RN +K +++        + +EY  + +L   ++S N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 433 NNLIGRGGVASVYKARIQDGIE-VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
            +++G G  + V  A  +   + VA+K    +  EG   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 491 SSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 546 SVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+AP
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 187

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 132/313 (42%), Gaps = 39/313 (12%)
Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +L+  N  +   P  + N + L+ L L  N      P    NL NL RL L+ N ++   
Sbjct: 90  ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-- 143
Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                +S+LS    L+ L+FS+N +  + P A         +  +   +IS +   +IS 
Sbjct: 144 -----ISALSGLTSLQQLNFSSNQVTDLKPLA--------NLTTLERLDISSNKVSDISV 190
Query: 120 --NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLE--GSIPXXXXXXXXXXXX 175
              LTNL ++    N+++   P+               NQL+  G++             
Sbjct: 191 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTL----ASLTNLTDL 244
Query: 176 XXGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
               N++S   P     LT L  L LG+NQ+++I S L  L  +  L L+ N      P 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLEDISP- 300
Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            I NL+ L  + L  NN S   P  +  L  LQ LF   N++  S   S+  L ++  L 
Sbjct: 301 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLS 355
Query: 296 LSNNNISGAIPIS 308
             +N IS   P++
Sbjct: 356 AGHNQISDLTPLA 368

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 433 NNLIGRGGVASVYKARIQDGIE-VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
            +++G G  + V  A  +   + VA+K    +  EG   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 491 SSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 546 SVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+AP
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 187

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 14/169 (8%)
Query: 420 HLELFQATNGFSENNLIGRGGVASVYKARIQDG--IEVAVKVFDLQYEGAFKSFDIECDM 477
           H    Q T+G+     IG G   SV K  I     +E AVK+ D       +  +I   +
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---L 69
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           ++  +H N+I +     +  +  +V E M  G L   +    +  +  +   ++  +   
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKT 128
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPLLKED 582
           +EYLH   +  ++H DLKP+N+L  D         + DFG AK L  E+
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 433 NNLIGRGGVASVYKA-RIQDG-------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHR 484
           N  +G+G    ++K  R + G        EV +KV D  +    +SF     MM ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +L+     C   D   LV E++  GSL+  L  +   ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 545 YSVPIIHCDLKPNNVLL---DDNMVAH-----LSDFGMAKPLLKED 582
               +IH ++   N+LL   +D    +     LSD G++  +L +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 433 NNLIGRGGVASVYKARIQDGIE-VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
            +++G G  + V  A  +   + VA+K    +  EG   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 491 SSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 546 SVPIIHCDLKPNNVL---LDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+AP
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 187

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  AR +  G +VAVK+ DL+ +   +    E  +M+  +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + K+     +   + T  +MAP
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAP 210

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G    V  A ++  G  VAVK  DL+ +   +    E  +M+  +H N++++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
             D   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           K +++LL  +    LSDFG    + KE     +   + T  +MAP
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 316

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    L   L  ++ Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 208 VATRWYRAP 216

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R  +   VA  + YL    S   IH DL   N+LL    + 
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 160
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 161 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISS-- 492
           +G+G    V++  +  G  VAVK+F  + E + F+  +I   ++  +RH N++  I+S  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDM 72
Query: 493 -CSNDDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH---FGYS- 546
              N   +  L+  Y  HGSL   L      L+    L + +  A  L +LH   FG   
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 547 -VPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
              I H D K  NVL+  N+   ++D G+A
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 151
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 208 VATRWYRAP 216

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAV-KVFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+ K+   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 5/102 (4%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E   +K +RH ++IK+    +      +V+EY      +  +       D  +R      
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQ 116
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +  A+EY H      I+H DLKP N+LLDDN+   ++DFG++
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 66/154 (42%), Gaps = 29/154 (18%)
Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWN-LKYILYLNLSSNSFTGPLPLEIG 238
           N L       F  LTSL  LYLG N+L S+P+ ++N L  + YLNLS+N           
Sbjct: 38  NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS------- 90
Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDL 296
                             +P  + D L  L+ L L  N+LQ S+PD +   L  LK L L
Sbjct: 91  ------------------LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRL 131
Query: 297 SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
             N +        ++L  L+YI +  N  +   P
Sbjct: 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 192
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 193 VATRWYRAP 201

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 82
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 83  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 137
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 138 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 193
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 194 VATRWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 73
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 74  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 128
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 129 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 184
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 185 VATRWYRAP 193

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 186 VATRWYRAP 194

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R    + VA  + YL    S   IH DL   N+LL    + 
Sbjct: 96  SLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 151 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 190 VATRWYRAP 198

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEY 187
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 188 VATRWYRAP 196

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 444 VYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV 502
           VY+ R +  I+VA+KV     E A  +    E  +M ++ +  ++++I  C  +    LV
Sbjct: 30  VYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLV 87
Query: 503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD 562
           +E    G L K L      + +     ++  V+  ++YL        +H DL   NVLL 
Sbjct: 88  MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLV 144
Query: 563 DNMVAHLSDFGMAKPLLKEDQSLT 586
           +   A +SDFG++K L  +D   T
Sbjct: 145 NRHYAKISDFGLSKALGADDSYYT 168

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 186 VATRWYRAP 194

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 188 VATRWYRAP 196

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 188 VATRWYRAP 196

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T  Y+AP
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAP 193

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 28/178 (15%)
Query: 434 NLIGRGGVASVY--KARIQDGIEVAVKVFDLQYEGAFK--SFDIECDMMKRIRHRNLIKI 489
            ++G G  + V+  K R+  G   A+K   ++   AF+  S + E  ++K+I+H N++ +
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKC--IKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 490 ISSCSNDDFKALVLEYMPHGS-----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
                +     LV++ +  G      LE+ +Y+      + Q+      V SA++YLH  
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH-- 123
Query: 545 YSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               I+H DLKP N+L    ++N    ++DFG++K     +Q+   +    T GY+AP
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAP 176

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R  +   VA  + YL    S   IH DL   N+LL    + 
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 160
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS 492
           +G+G  + V +  ++  G E A K+ + +   A   +  + E  + + ++H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
            S +    L+ + +  G L + + +  Y    +   +    +   LE +   + + ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 553 DLKPNNVLLDDNM---VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LL   +      L+DFG+A  +  E Q+        T GY++P
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSP 193

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 188 VATRWYRAP 196

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAP 208

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 84
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 85  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 139
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 140 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 195
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 196 VATRWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 188 VATRWYRAP 196

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 99
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R  +   VA  + YL    S   IH DL   N+LL    + 
Sbjct: 100 SLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 154
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIK---- 488
           IG G      K R + DG  +  K  D     E   +    E ++++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 489 IISSCSNDDFKALVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 543
           II   +   +  +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 544 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              G++V  +H DLKP NV LD      L DFG+A+ +L  D+   + + + T  YM+P
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDEDFAK-EFVGTPYYMSP 185

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 99
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R    + VA  + YL    S   IH DL   N+LL    + 
Sbjct: 100 SLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 154
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 155 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWN-LKYILYLNLSSNSFTGPLPLEI 237
           GN+L       F  LT+L+ L L  NQL S+P  +++ L  + YLNL+ N     LP  +
Sbjct: 94  GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGV 152
Query: 238 -GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLD 295
              L  L ++DLS N            L  L+ L L  N+L+ S+PD +   L  L+ + 
Sbjct: 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIW 211
Query: 296 LSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI 329
           L +N      P        ++Y++   NK  G +
Sbjct: 212 LHDNPWDCTCP-------GIRYLSEWINKHSGVV 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R    + VA  + YL    S   IH DL   N+LL    + 
Sbjct: 96  SLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 432 ENNLIGRGGVASVYKARIQDGI------EVAVKVFDLQYEGAFKSFDIECDMMKRIR-HR 484
           + +++G G       AR+Q  I      E AVK+ + Q          E +M+ + + HR
Sbjct: 17  QEDVLGEGA-----HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           N++++I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH-- 128
Query: 545 YSVPIIHCDLKPNNVLLDD-NMVA--HLSDFGMAKPL-LKEDQSLTQTQTLAT----IGY 596
            +  I H DLKP N+L +  N V+   + DFG+   + L  D S   T  L T      Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 597 MAP 599
           MAP
Sbjct: 188 MAP 190

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 453 IEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHG 509
           + VAVK      L    A   F  E + M  + HRNLI++         K +V E  P G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 510 SLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA 567
           SL   L  +  +++L    R  +   VA  + YL    S   IH DL   N+LL    + 
Sbjct: 96  SLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150
Query: 568 HLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            + DFG+ + L + +D  + Q        + AP
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIK---- 488
           IG G      K R + DG  +  K  D     E   +    E ++++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 489 IISSCSNDDFKALVLEYMPHGSLE----KCLYSSNYILDIFQRLNIMIDVASALEYLHF- 543
           II   +   +  +V+EY   G L     K      Y+ + F  L +M  +  AL+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 544 ---GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              G++V  +H DLKP NV LD      L DFG+A+ +L  D S  +   + T  YM+P
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKA-FVGTPYYMSP 185

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 433 NNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKII 490
           + L+G G  A V  A  +Q+G E AVK+ + Q   +      E + + + + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
               +D    LV E +  GS+   +    +  +  +   ++ DVA+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 551 HCDLKPNNVLLD 562
           H DLKP N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     IG G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 477
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK 533
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 534 WPVKWYAP 541

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 13/178 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQYEGAFKSFDIECDMMKRIR 482
           N F +  ++G+GG   V   +++        +   K    + +G   + + E  +++++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVN 242
Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYL 541
            R ++ +  +    D   LVL  M  G L+  +Y          + +    ++   LE L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H      I++ DLKP N+LLDD+    +SD G+A   +   +  T    + T+GYMAP
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAP 354

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK 534
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 535 WPVKWYAP 542

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG+G    V+  + + G +VAVKVF    E + F+  +I   ++  +RH N++  I++  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAA-- 99
Query: 495 NDDFKA--------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY- 545
             D K         L+ +Y  +GSL   L S+   LD    L +     S L +LH    
Sbjct: 100 --DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 546 ----SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE--DQSLTQTQTLATIGYMAP 599
                  I H DLK  N+L+  N    ++D G+A   + +  +  +     + T  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 430 FSENNL-----IGRGGVASVYKARI-----QDGI-EVAVKVFD-LQYEGAFKSFDIECDM 477
           F  NNL     +G G    V +A       +D + +VAVK+     +    ++   E  +
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 478 MKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------LDIFQR 527
           M  + +H N++ ++ +C++     ++ EY  +G L   L               L++   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   + +
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 588 TQTLATIGYMAP 599
                 + +MAP
Sbjct: 212 GNARLPVKWMAP 223

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+    +  G+E  +K  +  + +   +  + E +++K + H N+IKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQR---LNIMIDVASALEYLHFGYSVPII 550
            +     +V+E    G L + + S+              +M  + +AL Y H   S  ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 551 HCDLKPNNVLLDD---NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLKP N+L  D   +    + DFG+A+ L K D+    T    T  YMAP
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEH--STNAAGTALYMAP 195

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 455 VAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+ D++      ++   E  + K + H N++K        + + L LEY   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 91
Query: 514 CLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLDDN 564
                      F R+  +I +    A  + H       + + + I H D+KP N+LLD+ 
Sbjct: 92  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 140
Query: 565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +SDFG+A      ++     +   T+ Y+AP
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLA 592
           V+  ++YL        +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 593 TIGYMAP 599
            + + AP
Sbjct: 177 PVKWYAP 183

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 455 VAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+ D++      ++   E  + K + H N++K        + + L LEY   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 92
Query: 514 CLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLDDN 564
                      F R+  +I +    A  + H       + + + I H D+KP N+LLD+ 
Sbjct: 93  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +SDFG+A      ++     +   T+ Y+AP
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 13/178 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQYEGAFKSFDIECDMMKRIR 482
           N F +  ++G+GG   V   +++        +   K    + +G   + + E  +++++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVN 242
Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYL 541
            R ++ +  +    D   LVL  M  G L+  +Y          + +    ++   LE L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H      I++ DLKP N+LLDD+    +SD G+A   +   +  T    + T+GYMAP
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAP 354

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G    V  A     G +VA+K+ +   L         + E   ++ +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 492 SCSNDDFKALVLEYMPHG----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + D   +V+EY  +      +++   S       FQ+      + SA+EY H     
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 132
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            I+H DLKP N+LLD+++   ++DFG++
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLS 160

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 38/298 (12%)
Query: 16  IFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYL 75
           + N + L+ L L  N      P    NL NL RL L+ N ++        +S+LS    L
Sbjct: 107 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-------ISALSGLTSL 157
Query: 76  KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS---NLTNLTTIYLGGN 132
           + LSF N   D    + + NL+       +   +IS +   +IS    LTNL ++    N
Sbjct: 158 QQLSFGNQVTD---LKPLANLTT------LERLDISSNKVSDISVLAKLTNLESLIATNN 208
Query: 133 KLNGSIPIAXXXXXXXXXXXXEDNQLE--GSIPXXXXXXXXXXXXXXGGNKLSGFVPACF 190
           +++   P+               NQL+  G++                 N++S   P   
Sbjct: 209 QISDITPLG--ILTNLDELSLNGNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--L 260
Query: 191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM 250
             LT L  L LG+NQ+++I S L  L  +  L L+ N      P  I NL+ L  + L  
Sbjct: 261 SGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 317
Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS 308
           NN S   P  +  L  LQ LF   N++  S   S+  L ++  L   +N IS   P++
Sbjct: 318 NNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA 371

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G    V  A     G +VA+K+ +   L         + E   ++ +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 492 SCSNDDFKALVLEYMPHG----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + D   +V+EY  +      +++   S       FQ+      + SA+EY H     
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 122
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            I+H DLKP N+LLD+++   ++DFG++
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLS 150

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G    V  A     G +VA+K+ +   L         + E   ++ +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 492 SCSNDDFKALVLEYMPHG----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + D   +V+EY  +      +++   S       FQ+      + SA+EY H     
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 131
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            I+H DLKP N+LLD+++   ++DFG++
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLS 159

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 169
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 170 WPVKWYAP 177

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 427 TNGFSENNLIGRGGVASVYK-ARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI---- 481
           T  F E   IG G   SV+K  +  DG   A+K       G+      E + ++ +    
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 61
Query: 482 ---RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA 535
              +H ++++  S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL 561
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 23/180 (12%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVK--VFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G    V+KAR +  G +VA+K  + + + EG   +   E  +++ ++H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 493 CSN-----DDFKA---LVLEYMPH---GSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           C       +  KA   LV ++  H   G L   L    + L   +R+  M+   + L Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML--LNGLYYI 141
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGYMAP 599
           H      I+H D+K  NVL+  + V  L+DFG+A+   L K  Q       + T+ Y  P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI---- 481
           T  F E   IG G   SV+K  +  DG   A+K       G+      E + ++ +    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 65
Query: 482 ---RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA 535
              +H ++++  S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL 561
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 175
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 176 WPVKWYAP 183

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 12/130 (9%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMI 532
           E  ++K + H N+IK+     +  +  LV E+   G L E+ +  + +  D     NIM 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMK 153
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQ 589
            + S + YLH      I+H D+KP N+LL++    +   + DFG++     +D  L    
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKL--RD 207
Query: 590 TLATIGYMAP 599
            L T  Y+AP
Sbjct: 208 RLGTAYYIAP 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 424 FQATNGFSENNLIGRGG---VASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR 480
           F     +++   IG G    V+S Y    +  + +  K+   +++   +    E  ++ R
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK-KISPFEHQTYCQRTLREIQILLR 97
Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMID 533
            RH N+I I      D  +A  LE M    + + L  ++ Y L   Q+L+       +  
Sbjct: 98  FRHENVIGI-----RDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQ 152
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLA 592
           +   L+Y+H   S  ++H DLKP+N+L++      + DFG+A+    E D +   T+ +A
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 593 TIGYMAP 599
           T  Y AP
Sbjct: 210 TRWYRAP 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G    V  A     G +VA+K+ +   L         + E   ++ +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 492 SCSNDDFKALVLEYMPHG----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + D   +V+EY  +      +++   S       FQ+      + SA+EY H     
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 126
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            I+H DLKP N+LLD+++   ++DFG++
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLS 154

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 171
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 172 WPVKWYAP 179

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 125
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 181
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 182 WPVKWYAP 189

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI---- 481
           T  F E   IG G   SV+K  +  DG   A+K       G+      E + ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 63
Query: 482 ---RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA 535
              +H ++++  S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL 561
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 455 VAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+ D++      ++   E  + K + H N++K        + + L LEY   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 92
Query: 514 CLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLDDN 564
                      F R+  +I +    A  + H       + + + I H D+KP N+LLD+ 
Sbjct: 93  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +SDFG+A      ++     +   T+ Y+AP
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 455 VAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+ D++      ++   E  + K + H N++K        + + L LEY   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 92
Query: 514 CLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLDDN 564
                      F R+  +I +    A  + H       + + + I H D+KP N+LLD+ 
Sbjct: 93  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +SDFG+A      ++     +   T+ Y+AP
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 455 VAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK 513
           VAVK+ D++      ++   E  + K + H N++K        + + L LEY   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 92
Query: 514 CLYSSNYILDIFQRL--NIMIDVASALEYLH-------FGYSVPIIHCDLKPNNVLLDDN 564
                      F R+  +I +    A  + H       + + + I H D+KP N+LLD+ 
Sbjct: 93  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +SDFG+A      ++     +   T+ Y+AP
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 427 TNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI---- 481
           T  F E   IG G   SV+K  +  DG   A+K       G+      E + ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 63
Query: 482 ---RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---NIMIDVA 535
              +H ++++  S+ + DD   +  EY   GSL   +  +  I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL 561
             L Y+H   S+ ++H D+KP+N+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 433 NNLIGRGGVASVYKA----RIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNL 486
           N ++G G    VY+        + I VAVK    D   +   K F  E  +MK + H ++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHI 87
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K+I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL    S
Sbjct: 88  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 195

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 18/164 (10%)
Query: 427 TNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-- 483
            + F E  ++G+G    V KAR   D    A+K      E    +   E  ++  + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQY 63
Query: 484 -----------RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
                      RN +K  ++        +  EY  + +L   ++S N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            +  AL Y+H   S  IIH +LKP N+ +D++    + DFG+AK
Sbjct: 124 QILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 430 FSENNL-----IGRGGVASVYKARI-----QDGI-EVAVKVFD-LQYEGAFKSFDIECDM 477
           F  NNL     +G G    V +A       +D + +VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 478 MKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------LDIFQR 527
           M  + +H N++ ++ +C++     ++ EY  +G L   L               L++   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   + +
Sbjct: 163 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 588 TQTLATIGYMAP 599
                 + +MAP
Sbjct: 220 GNARLPVKWMAP 231

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 133
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 189
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 190 WPVKWYAP 197

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 437 GRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSCSN 495
           G GGV +  + R   G+ +A K+  L+ + A ++  I E  ++       ++    +  +
Sbjct: 27  GNGGVVTKVQHR-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 85
Query: 496 DDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
           D   ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   +   I+H D+
Sbjct: 86  DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDV 141
Query: 555 KPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           KP+N+L++      L DFG++  L+    S+  +  + T  YMAP
Sbjct: 142 KPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAP 182

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNL 486
           N ++G G    VY+        + I VAVK    D   +   K F  E  +MK + H ++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHI 75
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K+I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL    S
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 183

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVK--VFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G    V+KAR +  G +VA+K  + + + EG   +   E  +++ ++H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 493 CSNDDFKA-----------LVLEYMPH---GSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           C     KA           LV ++  H   G L   L    + L   +R+  M+     L
Sbjct: 86  CRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML-----L 135
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGY 596
             L++ +   I+H D+K  NVL+  + V  L+DFG+A+   L K  Q       + T+ Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 597 MAP 599
             P
Sbjct: 196 RPP 198

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T    + 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEX 191
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 192 VATRWYRAP 200

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
           R RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T    + 
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEX 192
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 193 VATRWYRAP 201

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 72  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 19/174 (10%)
Query: 417 RFTHLELFQATNGFSENNLIGRGGVAS----VYKARIQDGIEVAVKVFDLQYEGAFKSFD 472
           R +H+ L   ++G+     IG G  +     V+KA     +E AVKV D       +  +
Sbjct: 17  RGSHMNLV-FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIE 72
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
           I   +++  +H N+I +     +     LV E M  G L   +    +  +      ++ 
Sbjct: 73  I---LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLH 128
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPLLKED 582
            +   +EYLH   S  ++H DLKP+N+L  D         + DFG AK L  E+
Sbjct: 129 TIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 131/313 (41%), Gaps = 40/313 (12%)
Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +L+  N  +   P  + N + L+ L L  N      P    NL NL RL L+ N ++   
Sbjct: 95  ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-- 148
Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                +S+LS    L+ LSF N   D    + + NL+       +   +IS +   +IS 
Sbjct: 149 -----ISALSGLTSLQQLSFGNQVTD---LKPLANLTT------LERLDISSNKVSDISV 194
Query: 120 --NLTNLTTIYLGGNKLNGSIPIAXXXXXXXXXXXXEDNQLE--GSIPXXXXXXXXXXXX 175
              LTNL ++    N+++   P+               NQL+  G++             
Sbjct: 195 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTL----ASLTNLTDL 248
Query: 176 XXGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
               N++S   P     LT L  L LG+NQ+++I S L  L  +  L L+ N      P 
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQLEDISP- 304
Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            I NL+ L  + L  NN S   P  +  L  LQ LF   N++  S   S+  L ++  L 
Sbjct: 305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLS 359
Query: 296 LSNNNISGAIPIS 308
             +N IS   P++
Sbjct: 360 AGHNQISDLTPLA 372

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISS 492
           +G+G  + V +  +     E A K+ + +   A   +  + E  + + ++H N++++  S
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
            S + F  LV + +  G L + + +  Y    +   +    +   LE ++  +   I+H 
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIHQILESVNHIHQHDIVHR 154
Query: 553 DLKPNNVLLDDN---MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLKP N+LL          L+DFG+A  +  E Q+        T GY++P
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FGFAGTPGYLSP 202

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 11/131 (8%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           + E +++K++ H  +IKI +    +D+  +VLE M  G L   +  +  + +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQT 588
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   + SL +T
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 314
Query: 589 QTLATIGYMAP 599
               T  Y+AP
Sbjct: 315 -LCGTPTYLAP 324

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 191
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 192 WPVKWYAP 199

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E ++M+++ +  ++++I  C  + +  LV+E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           V+  ++YL        +H DL   NVLL     A +SDFG++K  L+ D++  + QT   
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGK 191
Query: 594 --IGYMAP 599
             + + AP
Sbjct: 192 WPVKWYAP 199

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 433 NNLIGRGGVASVYKARIQ----DGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNL 486
           N ++G G    VY+        + I VAVK    D   +   K F  E  +MK + H ++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHI 71
Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K+I     +    +++E  P+G L   L  +   L +   +   + +  A+ YL    S
Sbjct: 72  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 127
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 179

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----R 482
           F  + ++G+G    V+ A  +   +  A+K   L+ +      D+EC M+ KR+      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           H  L  +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 136
Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              S  I++ DLK +N+LLD +    ++DFGM K  +  D      +   T  Y+AP
Sbjct: 137 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAP 188

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 73/188 (38%), Gaps = 13/188 (6%)
Query: 180 NKLSGFVPACFGNLTSLRNLYLGSN-QLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEI 237
           N L+G   A F  LT L  L L  N QL  + P+T   L ++  L+L         P   
Sbjct: 65  NALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLF 124
Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
             L  L  + L  NN       T  DL +L +LFL  NR+      +  GL  L  L L 
Sbjct: 125 RGLAALQYLYLQDNNLQALPDNTFRDLGNLTHLFLHGNRIPSVPEHAFRGLHSLDRLLLH 184
Query: 298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE--GPFRNFSAESFKGNELLCGTPNL 355
            N+++   P +   L  L  + +  N L   +P E   P R+        N  +C     
Sbjct: 185 QNHVARVHPHAFRDLGRLMTLYLFANNLS-MLPAEVLVPLRSLQYLRLNDNPWVCD---- 239
Query: 356 QVPPCRTR 363
               CR R
Sbjct: 240 ----CRAR 243

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRN 485
           + F + + +G G    V+K   +  G+ +A K+  L+ + A ++  I E  ++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLNIMIDVASALEYLHFG 544
           ++    +  +D   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +   I+H D+KP+N+L++      L DFG++  L+ E       + + T  YM+P
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 424 FQATNGFSENNLIGRG--GVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMK 479
           FQ+   +     IG G  G A + K+  +DG +  +K  ++    + +  +   E  ++ 
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKS-TEDGRQYVIKEINISRMSSKEREESRREVAVLA 78
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEK-------CLYSSNYILDIFQRLNIMI 532
            ++H N+++   S   +    +V++Y   G L K        L+  + ILD F      +
Sbjct: 79  NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------V 132
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
            +  AL+++H      I+H D+K  N+ L  +    L DFG+A+ L
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/128 (24%), Positives = 60/128 (46%), Gaps = 8/128 (6%)
Query: 474 ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID 533
           E  +M ++ H  LI +  +  +     L+LE++  G L   + + +Y +   + +N M  
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS--DFGMAKPLLKEDQSLTQTQTL 591
               L+++H      I+H D+KP N++ +    + +   DFG+A  L  ++       T 
Sbjct: 158 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTT 211
Query: 592 ATIGYMAP 599
           AT  + AP
Sbjct: 212 ATAEFAAP 219

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 1/107 (0%)
Query: 219 ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           +  L L  N FT  +P E+ N + L  IDLS N  S     +  ++  L  L L YNRL+
Sbjct: 33  VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
              P +  GL  L+ L L  N+IS     +   L  L ++ +  N L
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR 482
           AT+ +     IG G   +VYKAR    G  VA+K   +    EG   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 483 ---HRNLIKIISSCS----NDDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
              H N+++++  C+    + + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              L++LH      I+H DLKP N+L+       L+DFG+A+        +     + T+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVVVTL 175
Query: 595 GYMAP 599
            Y AP
Sbjct: 176 WYRAP 180

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    V  A  R+ +   VAVK+ D++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH-------F 543
               + + L LEY   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR 482
           AT+ +     IG G   +VYKAR    G  VA+K   +    EG   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 483 ---HRNLIKIISSCS----NDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
              H N+++++  C+    + + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
              L++LH      I+H DLKP N+L+       L+DFG+A+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 444 VYKARIQDGIEVAVKVFDLQYEGA-FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV 502
           VY+ R +  I+VA+KV     E A  +    E  +M ++ +  ++++I  C  +    LV
Sbjct: 356 VYRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLV 413
Query: 503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD 562
           +E    G L K L      + +     ++  V+  ++YL        +H +L   NVLL 
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLV 470
Query: 563 DNMVAHLSDFGMAKPLLKEDQSLT 586
           +   A +SDFG++K L  +D   T
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYT 494

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 598 AP 599
            P
Sbjct: 177 PP 178

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 5/129 (3%)
Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEI-G 238
           K+   + + F + T L  L L  N++  I  +  W L ++L LNLS N F G +   +  
Sbjct: 286 KIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN-FLGSIDSRMFE 344
Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLS 297
           NL  L  +DLS N+       +   L +L+ L L+ N+L+ S+PD I   L  L+ + L 
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 403
Query: 298 NNNISGAIP 306
            N    + P
Sbjct: 404 TNPWDCSCP 412

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 426 ATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR 482
           AT+ +     IG G   +VYKAR    G  VA+K   +    EG   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 483 ---HRNLIKIISSCS----NDDFK-ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
              H N+++++  C+    + + K  LV E++          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
              L++LH      I+H DLKP N+L+       L+DFG+A+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 11/131 (8%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           + E +++K++ H  +IKI +    +D+  +VLE M  G L   +  +  + +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQT 588
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   + SL +T
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 300
Query: 589 QTLATIGYMAP 599
               T  Y+AP
Sbjct: 301 -LCGTPTYLAP 310

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 433 NNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKII 490
             ++  GG A VY+A+ +  G E A+K      E   ++   E   MK++  H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 491 SSCS-----NDDFKA--LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYL 541
           S+ S     +D  +A  L+L  +  G L + L    S   L     L I      A++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H     PIIH DLK  N+LL +     L DFG A
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 14/169 (8%)
Query: 420 HLELFQATNGFSENNLIGRGGVASVYKARIQDGI--EVAVKVFDLQYEGAFKSFDIECDM 477
           H    Q T+G+     IG G   SV K  I      E AVK+ D       +  +I   +
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---L 69
Query: 478 MKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           ++  +H N+I +     +  +  +V E    G L   +    +  +  +   ++  +   
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKT 128
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPLLKED 582
           +EYLH   +  ++H DLKP+N+L  D         + DFG AK L  E+
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 598 AP 599
            P
Sbjct: 224 PP 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVK--VFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G    V+KAR +  G +VA+K  + + + EG   +   E  +++ ++H N++ +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 493 CSNDDFKA-----------LVLEYMPH---GSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           C     KA           LV ++  H   G L   L    + L   +R+  M+   + L
Sbjct: 86  CRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML--LNGL 138
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGY 596
            Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L K  Q       + T+ Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 597 MAP 599
             P
Sbjct: 196 RPP 198

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 36/181 (19%)
Query: 436 IGRGGVASVYKA--RIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI------RHRNLI 487
           +G G    V  A  R+ +   VAVK+ D++     ++ D   ++ K I       H N++
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMK-----RAVDCPENIKKEICINAMLNHENVV 68
Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLH--- 542
           K        + + L LEY   G L             F R+  +I +    A  + H   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 543 ----FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
               + + + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 599 P 599
           P
Sbjct: 176 P 176

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIF 525
           + E +++K++ H  +IKI +    +D+  +VLE M  G L       K L  +   L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED 582
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   +
Sbjct: 121 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 168
Query: 583 QSLTQTQTLATIGYMAP 599
            SL +T    T  Y+AP
Sbjct: 169 TSLMRT-LCGTPTYLAP 184

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 20/143 (13%)
Query: 465 EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSN 519
           +G   S + E  ++++I+H N++ +     + +   LV++ +  G L     EK  Y+  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK 120
Query: 520 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAK 576
               + ++      V  A+ YLH    + I+H DLKP N+L    D+     +SDFG++K
Sbjct: 121 DASTLIRQ------VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 577 PLLKEDQSLTQTQTLATIGYMAP 599
              K D     +    T GY+AP
Sbjct: 172 MEGKGD---VMSTACGTPGYVAP 191

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 598 AP 599
            P
Sbjct: 180 PP 181

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 17/152 (11%)
Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY-----------LNLSS 226
             N++  F P CF  +  L  L+L + QL   PS    L   L              LS+
Sbjct: 184 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLG--PSLTEKLCLELANTSIRNLSLSNSQLST 241
Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
            S T  L L+  NL +L   DLS NN +     +   L  L+Y FLEYN +Q     S+ 
Sbjct: 242 TSNTTFLGLKWTNLTML---DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 298
Query: 287 GLIDLKSLDLSNNNISGAIPI-SLEKLLDLKY 317
           GL +++ L+L  +    +I + SL K+ D  +
Sbjct: 299 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 330

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIF 525
           + E +++K++ H  +IKI +    +D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED 582
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   +
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 169
Query: 583 QSLTQTQTLATIGYMAP 599
            SL +T    T  Y+AP
Sbjct: 170 TSLMRT-LCGTPTYLAP 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIF 525
           + E +++K++ H  +IKI +    +D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED 582
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   +
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 169
Query: 583 QSLTQTQTLATIGYMAP 599
            SL +T    T  Y+AP
Sbjct: 170 TSLMRT-LCGTPTYLAP 185

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 598 AP 599
            P
Sbjct: 196 PP 197

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIF 525
           + E +++K++ H  +IKI +    +D+  +VLE M  G L       K L  +   L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED 582
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   +
Sbjct: 128 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 175
Query: 583 QSLTQTQTLATIGYMAP 599
            SL +T    T  Y+AP
Sbjct: 176 TSLMRT-LCGTPTYLAP 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 436 IGRGGVASVYKARIQD-GIEVAVK--VFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           IG+G    V+KAR +  G +VA+K  + + + EG   +   E  +++ ++H N++ +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 493 CSNDDFKA-----------LVLEYMPH---GSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           C     KA           LV ++  H   G L   L    + L   +R+  M+   + L
Sbjct: 85  CRT---KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML--LNGL 137
Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP--LLKEDQSLTQTQTLATIGY 596
            Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L K  Q       + T+ Y
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 597 MAP 599
             P
Sbjct: 195 RPP 197

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 598 AP 599
            P
Sbjct: 176 PP 177

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 472 DIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIF 525
           + E +++K++ H  +IKI +    +D+  +VLE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED 582
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K L   +
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GE 169
Query: 583 QSLTQTQTLATIGYMAP 599
            SL +T    T  Y+AP
Sbjct: 170 TSLMRT-LCGTPTYLAP 185

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 17/176 (9%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSF-DIECDMMKRIRHRNLI 487
           F++ + IG+G    VYK       EV A+K+ DL+           E  ++ +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 488 KIISSCSNDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           +   S        +++EY+  GS    L+       YI  I +      ++   L+YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 133
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S   IH D+K  NVLL +     L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 134 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 185

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 17/152 (11%)
Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY-----------LNLSS 226
             N++  F P CF  +  L  L+L + QL   PS    L   L              LS+
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLG--PSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
            S T  L L+  NL +L   DLS NN +     +   L  L+Y FLEYN +Q     S+ 
Sbjct: 237 TSNTTFLGLKWTNLTML---DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 287 GLIDLKSLDLSNNNISGAIPI-SLEKLLDLKY 317
           GL +++ L+L  +    +I + SL K+ D  +
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 598 AP 599
            P
Sbjct: 224 PP 225

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY-----------LNLSS 226
             N++  F P CF  +  L  L+L + QL   PS    L   L              LS+
Sbjct: 189 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLG--PSLTEKLCLELANTSIRNLSLSNSQLST 246
Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
            S T  L L+  NL +L   DLS NN +     +   L  L+Y FLEYN +Q     S+ 
Sbjct: 247 TSNTTFLGLKWTNLTML---DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 303
Query: 287 GLIDLKSLDLSNNNISGAIPI-SLEKLLD--------LKYINVSFNKLEG 327
           GL +++ L+L  +    +I + SL K+ D        L+++N+  N + G
Sbjct: 304 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 353

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 434 NLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAFKSFDIE--------CDMMKRIRHR 484
            +IG+G  + V +    + G + AVK+ D+    +      E        C M+K   H 
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK---HP 86
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCL-----YSSNYILDIFQRLNIMIDVASALE 539
           ++++++ + S+D    +V E+M    L  C        + ++       + M  +  AL 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
           Y H      IIH D+KP NVLL   +++    L DFG+A  L   +  L     + T  +
Sbjct: 145 YCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHF 199
Query: 597 MAP 599
           MAP
Sbjct: 200 MAP 202

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 430 FSENNL-----IGRGGVASVYKARI-----QDGI-EVAVKVFD-LQYEGAFKSFDIECDM 477
           F  NNL     +G G    V +A       +D + +VAVK+     +    ++   E  +
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 478 MKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------YSSNYILDIFQR 527
           M  + +H N++ ++ +C++     ++ EY  +G L   L         YS N   +  ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 528 LNIMIDVASALEYLHFGYSVP----------IIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
           L       S+ + LHF   V            IH D+   NVLL +  VA + DFG+A+ 
Sbjct: 163 L-------SSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           ++ +   + +      + +MAP
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAP 237

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/180 (20%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 138 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H +L   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 402 SQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVA 456
           S +A    P  A LR     E       F +  ++G G   +VYK   I +G    I VA
Sbjct: 2   SHMASGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 54
Query: 457 VKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCL 515
           +K   +     A K    E  +M  + + ++ +++  C     + L+ + MP G L   +
Sbjct: 55  IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 113
Query: 516 YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
                 +     LN  + +A  + YL       ++H DL   NVL+       ++DFG+A
Sbjct: 114 REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 170
Query: 576 KPLLKEDQSLTQTQTLATIGYMA 598
           K L  E++          I +MA
Sbjct: 171 KLLGAEEKEYHAEGGKVPIKWMA 193

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H +L   N ++  +    + DFGM + + + D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/180 (20%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
             RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 190 VATRWYRAP 198

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 427 TNGFSENNLIGRGGVAS----VYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR 482
           ++G+     IG G  +     V+KA     +E AVKV D       +  +I   +++  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           H N+I +     +     LV E M  G L   +    +  +      ++  +   +EYLH
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH 138
Query: 543 FGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPLLKED 582
              S  ++H DLKP+N+L  D         + DFG AK L  E+
Sbjct: 139 ---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 53/125 (42%), Gaps = 6/125 (4%)
Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTS--IPSTLWNLK--YILYLNLSSNSFTGPL 233
             N L  F P CF  +  L  L L + QL         W L    I  L+L++N      
Sbjct: 179 SSNPLKEFSPGCFQTIGKLFALLLNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATS 238
Query: 234 PLEIGNLRV--LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDL 291
                 L+   L Q+DLS NN       +   L  L+YL LEYN +Q   P S  GL +L
Sbjct: 239 ESTFSGLKWTNLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNL 298
Query: 292 KSLDL 296
           + L L
Sbjct: 299 RYLSL 303

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI-DVASALEYLHFGYSVPIIHCDLKPNNV 559
           L+L+Y+  G L   L       +    + I + ++  ALE+LH    + II+ D+K  N+
Sbjct: 136 LILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENI 190
Query: 560 LLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LLD N    L+DFG++K  +  D++        TI YMAP
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAP 229

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  + + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +VLEY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 436 IGRGGVASVYKARIQDGIE-VAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    VYKA      E VA+K   L++E  G   +   E  ++K ++HRN+I++ S 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
             ++    L+ EY     L+K +  +    D+  R+ I   +   +  ++F +S   +H 
Sbjct: 102 IHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRV-IKSFLYQLINGVNFCHSRRCLHR 156
Query: 553 DLKPNNVLL-----DDNMVAHLSDFGMAK 576
           DLKP N+LL      +  V  + DFG+A+
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           IG G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 148
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  +  ++ G+++AVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 172
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVK-VFDLQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K +   +++   +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLN------IMI 532
             RH N+I I     ND  +A  +E M    + + L  ++ Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ--TQT 590
            +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+ +   D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 591 LATIGYMAP 599
           +AT  Y AP
Sbjct: 190 VATRWYRAP 198

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G    I VA+K   +     A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+++ MP G L   +      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 595 GYMA 598
            +MA
Sbjct: 188 KWMA 191

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G    I VA+K   +     A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+++ MP G L   +      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 595 GYMA 598
            +MA
Sbjct: 186 KWMA 189

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAF-----KSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G +V + V  ++   A      K    E
Sbjct: 43  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDE 101
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+ + MP G L   +      +     LN  + +
Sbjct: 102 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 160
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 595 GYMA 598
            +MA
Sbjct: 218 KWMA 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G    I VA+K   +     A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+++ MP G L   +      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 595 GYMA 598
            +MA
Sbjct: 187 KWMA 190

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAP 191

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 10/175 (5%)
Query: 430 FSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRH 483
           F +  ++G G   +VYK   I +G    I VA+K   +     A K    E  +M  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
                ++H DL   NVL+       ++DFG+AK L  E++          I +MA
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G    I VA+K   +     A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+++ MP G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 595 GYMA 598
            +MA
Sbjct: 184 KWMA 187

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 432 ENNLIGRGGVASVYKARIQDGI------EVAVKVFDLQYEGAFKSFDIECDMMKRIR-HR 484
           + +++G G       AR+Q  I      E AVK+ + Q          E +M+ + + HR
Sbjct: 17  QEDVLGEGA-----HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           N++++I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH-- 128
Query: 545 YSVPIIHCDLKPNNVLLDD-NMVA--HLSDFGMAKPL-LKEDQSLTQTQTLAT----IGY 596
            +  I H DLKP N+L +  N V+   + DF +   + L  D S   T  L T      Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 597 MAP 599
           MAP
Sbjct: 188 MAP 190

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 154
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 148
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 421 LELFQATNGFSENNLIGRGGVASVYKA-RIQDG----IEVAVKVF-DLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G    I VA+K   +     A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+++ MP G L   +      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 595 GYMA 598
            +MA
Sbjct: 185 KWMA 188

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 186

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 141
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 189

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 184

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 10/174 (5%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFD---LQYEGAFKSFDIECDMMKRIRHRN 485
           +     +G+GG A  Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++       +DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 146
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 147 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 195

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 29/164 (17%)
Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
           GGNKL     +    LT+L  L L  NQL S+P+ +++                    ++
Sbjct: 71  GGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFD--------------------KL 108
Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDL 296
            NL+ LV ++   N            L +L YL+L +N+LQ S+P  +   L +L  LDL
Sbjct: 109 TNLKELVLVE---NQLQSLPDGVFDKLTNLTYLYLYHNQLQ-SLPKGVFDKLTNLTRLDL 164
Query: 297 SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSA 340
            NN +        +KL  LK ++++ N+L+  +P +G F   ++
Sbjct: 165 DNNQLQSLPEGVFDKLTQLKQLSLNDNQLKS-VP-DGVFDRLTS 206

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 15/174 (8%)
Query: 433 NNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRN 485
           + ++G+G    V+ A  +   +  A+K   L+ +      D+EC M+ KR+      H  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           L  +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH   
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--- 135
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S  I++ DLK +N+LLD +    ++DFGM K  +  D          T  Y+AP
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAP 187

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/180 (20%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 139
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   + S     D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+ +    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAP 191

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 181

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS- 491
           +G G   SV  A   + G+ VAVK     ++     K    E  ++K ++H N+I ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 492 ---SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS- 491
           +G G   SV  A   + G+ VAVK     ++     K    E  ++K ++H N+I ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 492 ---SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 210

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 155
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 155
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 20/134 (14%)
Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS-LEKCLYSSNYILDIFQRLN-- 529
           +E  ++ R+ H N+IK++    N  F  LV+E   HGS L+  L++    +D   RL+  
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLD--LFA---FIDRHPRLDEP 130
Query: 530 ----IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
               I   + SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L
Sbjct: 131 LASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKL 185
Query: 586 TQTQTLATIGYMAP 599
             T    TI Y AP
Sbjct: 186 FYT-FCGTIEYCAP 198

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 145
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 181

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS- 491
           +G G   SV  A   + G+ VAVK     ++     K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 492 ---SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 211

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 145
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 183

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 145
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 166
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 214

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 154
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 202

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 75/180 (41%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVYKARIQDGI----EVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +D I    E  V V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD---------IFQRLNIMIDVASALE 539
           ++   S      +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++  +    + DFGM + + +        + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 140
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 148
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 142
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 190

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 145
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 149
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/198 (19%), Positives = 84/198 (42%), Gaps = 19/198 (9%)
Query: 418 FTHLELFQATNGFSENNLIGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS--- 470
           F   E   A    + +  +G+G    VY    K  ++D  E  V +  +    + +    
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 471 FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL-- 522
           F  E  +MK     ++++++   S      +++E M  G L+  L S      +N +L  
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 523 -DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
             + + + +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + + 
Sbjct: 126 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 582 DQSLTQTQTLATIGYMAP 599
           D      + L  + +M+P
Sbjct: 183 DYYRKGGKGLLPVRWMSP 200

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 155
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 149
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +  S+ +   +  + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 598 AP 599
            P
Sbjct: 224 PP 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEGAF--KSFDIECDMMKRIRHRNLIKIIS- 491
           +G G   SV  A   + G+ VAVK     ++     K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 492 ---SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 1/62 (1%)
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           LE +H  +   I+H DLKP N L+ D M+  L DFG+A  +  +   + +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 598 AP 599
            P
Sbjct: 196 PP 197

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 150
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 198

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 436 IGRGGVASVYKA-RIQDGIEVAVKVFDLQYEG---AFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV  A   + G+ VAVK     ++    A +++  E  ++K ++H N+I ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 492 ----SCSNDDFKALVL-EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
               + S ++F  + L  ++    L   +       D  Q L  +  +   L+Y+H   S
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---S 143
Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH DLKP+N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 10/169 (5%)
Query: 436 IGRGGVASV----YKARIQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V    Y +     + VA+K   +   +   + F  E   M++  H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
              + +    +++E    G L   L    Y LD+   +     +++AL YL    S   +
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 178

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D+     ++DFG AK +      L       T  Y+AP
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 194

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/180 (20%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 10/174 (5%)
Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFD---LQYEGAFKSFDIECDMMKRIRHRN 485
           +     +G+GG A  Y+    D  EV A KV     L      +    E  + K + + +
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           ++       +DDF  +VLE     SL +       + +   R   M      ++YLH   
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR 162
Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 19/186 (10%)
Query: 428 NGFSENNLIGRGGVASVYKARIQDGIE-VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRN 485
           + +    +IG G  A V  A      E VA+K  +L+  + +      E   M +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 486 LIKIISSCSNDDFKALVLEYMPHGSL--------EKCLYSSNYILDIFQRLNIMIDVASA 537
           ++   +S    D   LV++ +  GS+         K  + S  +LD      I+ +V   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEG 128
Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT----LAT 593
           LEYLH       IH D+K  N+LL ++    ++DFG++   L     +T+ +     + T
Sbjct: 129 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGT 184
Query: 594 IGYMAP 599
             +MAP
Sbjct: 185 PCWMAP 190

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L+K+  S  ++    +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/180 (20%), Positives = 79/180 (43%), Gaps = 19/180 (10%)
Query: 436 IGRGGVASVY----KARIQDGIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLIK 488
           +G+G    VY    K  ++D  E  V +  +    + +    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYS------SNYIL---DIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 13/176 (7%)
Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRH 483
           + F     +G G    V   + ++ G   A+K+ D Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L K+  S  ++    +V+EY P G +   L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	599
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-109
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-90
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-83
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-82
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-66
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-49
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-66
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-60
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-59
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-48
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-41
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-62
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-62
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-51
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-50
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-57
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-57
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-57
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-50
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-49
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-49
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-54
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-49
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-46
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-46
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-43
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-43
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-44
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-40
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-40
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-14
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-36
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-31
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-30
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-38
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-08
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-36
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-36
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-12
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-29
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-29
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-28
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-14
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-26
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-09
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-25
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-25
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-25
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-25
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-10
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-04
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-24
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-09
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-06
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-18
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-18
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-05
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-18
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-18
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-17
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-17
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-16
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-16
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-16
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-13
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-14
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-12
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-14
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-14
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-09
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-09
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	7e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  344 bits (884), Expect = e-109
 Identities = 114/363 (31%), Positives = 162/363 (44%), Gaps = 16/363 (4%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N F+G IP  + N S+L  L L  N   G IP++ G+L  L+ L L  N L    
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
           P       L   K L+ L    N L G +P  + N + ++    + N  ++G IP+ I  
Sbjct: 459 P-----QELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGR 512

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           L NL  + L  N  +G+IP  L   + L  L L  N   G+IP  + +        +  N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAAN 568

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLT---SIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
            ++G       N    +  +   N L         L  L      N++S  + G      
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            N   ++ +D+S N  SG+IP  IG +  L  L L +N + GSIPD +G L  L  LDLS
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688

Query: 298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQV 357
           +N + G IP ++  L  L  I++S N L G IP  G F  F    F  N  LCG P   +
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---L 745

Query: 358 PPC 360
           P C
Sbjct: 746 PRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  293 bits (752), Expect = 6e-90
 Identities = 101/341 (29%), Positives = 152/341 (44%), Gaps = 20/341 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLE---LEMNSFYGFIPNTFGNLRNLKRLSLNYNYLT 57
           L L  N+ SG        +     L+   +  N   G +        NL+ L ++ N  +
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213

Query: 58  SSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE 117
           +  P       L +C  L++L  S N L G   RAI   +  +++  + +    G IP  
Sbjct: 214 TGIP------FLGDCSALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPP- 265

Query: 118 ISNLTNLTTIYLGGNKLNGSIPIALD-KLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
              L +L  + L  NK  G IP  L      L  L L  N   G++P      + L  L 
Sbjct: 266 -LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324

Query: 177 LGGNKLSGFVPA-CFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYIL-YLNLSSNSFTGPL 233
           L  N  SG +P      +  L+ L L  N+ +  +P +L NL   L  L+LSSN+F+GP+
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384

Query: 234 PLEIGN--LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDL 291
              +       L ++ L  N F+G IP T+ +  +L  L L +N L G+IP S+G L  L
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444

Query: 292 KSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           + L L  N + G IP  L  +  L+ + + FN L GEIP  
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  291 bits (748), Expect = 3e-89
 Identities = 108/338 (31%), Positives = 166/338 (49%), Gaps = 17/338 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L + GN  SG +   +     L  L++  N+F   IP   G+   L+ L ++ N L+   
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                  ++S C  LK L+ S+N   G +P     L  S++   +     +G IP+ +S 
Sbjct: 240 S-----RAISTCTELKLLNISSNQFVGPIPPL--PLK-SLQYLSLAENKFTGEIPDFLSG 291

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLG 178
               LT + L GN   G++P        L+ L+L  N   G +P D L ++  L +LDL 
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351

Query: 179 GNKLSGFVPACFGNLT-SLRNLYLGSNQLT-SIPSTLWN--LKYILYLNLSSNSFTGPLP 234
            N+ SG +P    NL+ SL  L L SN  +  I   L       +  L L +N FTG +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411

Query: 235 LEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSL 294
             + N   LV + LS N  SG IP+++G L  L+ L L  N L+G IP  +  +  L++L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471

Query: 295 DLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
            L  N+++G IP  L    +L +I++S N+L GEIP+ 
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  276 bits (707), Expect = 2e-83
 Identities = 104/334 (31%), Positives = 155/334 (46%), Gaps = 16/334 (4%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
           N     + S + + + L  L L  +   G +   F    +L  L L+ N L+        
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVT---T 118

Query: 66  LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI---SNLT 122
           L+SL +C  LK+L+ S+N+LD     + G    S+EV  +   +ISG+            
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
            L  + + GNK++G + ++  +   L+ L +  N     IP  L   +AL  LD+ GNKL
Sbjct: 179 ELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEI-GNL 240
           SG         T L+ L + SNQ    IP     LK + YL+L+ N FTG +P  + G  
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGAC 293

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNN 299
             L  +DLS N+F G +P   G    L+ L L  N   G +P D++  +  LK LDLS N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353

Query: 300 NISGAIPISLEKLL-DLKYINVSFNKLEGEIPRE 332
             SG +P SL  L   L  +++S N   G I   
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  271 bits (696), Expect = 8e-82
 Identities = 97/343 (28%), Positives = 155/343 (45%), Gaps = 22/343 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIP--NTFGNLRNLKRLSLNYNYLTS 58
           L L  ++ +G++  F   ++ L+ L+L  NS  G +    + G+   LK L+++ N L  
Sbjct: 82  LFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 59  STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAI---GNLSQSMEVFFMFNCNISGSIP 115
                  +S       L+ L  S NS+ G               ++   +    ISG + 
Sbjct: 141 PGK----VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG-ELKHLAISGNKISGDVD 195

Query: 116 EEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL 175
             +S   NL  + +  N  +  IP  L     LQ L +  N+L G     +     L LL
Sbjct: 196 --VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLL 252

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLW-NLKYILYLNLSSNSFTGPL 233
           ++  N+  G +P     L SL+ L L  N+ T  IP  L      +  L+LS N F G +
Sbjct: 253 NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPT-TIGDLKDLQYLFLEYNRLQGSIPDSIGGL-IDL 291
           P   G+  +L  + LS NNFSG +P  T+  ++ L+ L L +N   G +P+S+  L   L
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370

Query: 292 KSLDLSNNNISGAIPISLEK--LLDLKYINVSFNKLEGEIPRE 332
            +LDLS+NN SG I  +L +     L+ + +  N   G+IP  
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  229 bits (587), Expect = 3e-66
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 17/299 (5%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
               +  + L+   L      ++  SSL +   L+ L  SN+ ++G +       + S+ 
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVS--SSLLSLTGLESLFLSNSHINGSVS-GFKCSA-SLT 103

Query: 102 VFFMFNCNISGSIPE--EISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQL 158
              +   ++SG +     + + + L  + +  N L+    +    KL  L++L L  N +
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163

Query: 159 EGSIPDDLCR---LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLW 214
            G+             L  L + GNK+SG V        +L  L + SN  +  IP  L 
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LG 220

Query: 215 NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEY 274
           +   + +L++S N  +G     I     L  +++S N F G IP     LK LQYL L  
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAE 278

Query: 275 NRLQGSIPDSIGG-LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           N+  G IPD + G    L  LDLS N+  GA+P        L+ + +S N   GE+P +
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.5 bits (132), Expect = 8e-08
 Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 3/74 (4%)

Query: 266 DLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           DL    L  N    ++  S+  L  L+SL LSN++I+G++    +    L  +++S N L
Sbjct: 56  DLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112

Query: 326 EGEIPREGPFRNFS 339
            G +       + S
Sbjct: 113 SGPVTTLTSLGSCS 126

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  294 bits (755), Expect = 1e-95
 Identities = 95/307 (30%), Positives = 141/307 (45%), Gaps = 15/307 (4%)

Query: 63  LNFLSSLSNCKYL----KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS--IPE 116
           L     L N   L          N +  G+L          +    +   N+     IP 
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY-RVNNLDLSGLNLPKPYPIPS 70

Query: 117 EISNLTNLTTIYLGG-NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL 175
            ++NL  L  +Y+GG N L G IP A+ KL +L  L +    + G+IPD L ++  L  L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYIL-YLNLSSNSFTGPL 233
           D   N LSG +P    +L +L  +    N+++ +IP +  +   +   + +S N  TG +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKS 293
           P    NL  L  +DLS N   G      G  K+ Q + L  N L   +   +G   +L  
Sbjct: 191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248

Query: 294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP 353
           LDL NN I G +P  L +L  L  +NVSFN L GEIP+ G  + F   ++  N+ LCG+P
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

Query: 354 NLQVPPC 360
              +P C
Sbjct: 309 ---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  195 bits (499), Expect = 6e-58
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 33/248 (13%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
           NN  G IP  I   ++L  L +   +  G IP+    ++ L  L  +YN L+ + P    
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP---- 142

Query: 66  LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
             S+S+   L  ++F  N + G +P + G+ S+      +    ++G IP   +NL NL 
Sbjct: 143 -PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLA 200

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
            + L  N L G   +     +  Q + L  N L   +                       
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--------------------- 239

Query: 186 VPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV 244
                G   +L  L L +N++  ++P  L  LK++  LN+S N+  G +P + GNL+   
Sbjct: 240 ----VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD 294

Query: 245 QIDLSMNN 252
               + N 
Sbjct: 295 VSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  171 bits (437), Expect = 5e-49
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 10/205 (4%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L +   N SG IP F+     L  L+   N+  G +P +  +L NL  ++ + N ++ + 
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 61  PKLNFLSSLSNCKYL-KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
           P      S  +   L   ++ S N L G +P    NL  ++    +    + G       
Sbjct: 166 P-----DSYGSFSKLFTSMTISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFG 218

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
           +  N   I+L  N L   +   +   + L  L L +N++ G++P  L +L  L  L++  
Sbjct: 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSN 204
           N L G +P   GNL         +N
Sbjct: 278 NNLCGEIPQ-GGNLQRFDVSAYANN 301

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  226 bits (577), Expect = 7e-66
 Identities = 64/362 (17%), Positives = 121/362 (33%), Gaps = 43/362 (11%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGF--------IPNTFGNLRNLKRLSLN 52
           + ++       +P+F+    ++  + +  N                       ++ + + 
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313

Query: 53  YNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISG 112
           YN L +   +    +SL   K L  L    N L+G LP A G+    +    +    I+ 
Sbjct: 314 YNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQITE 367

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALD--KLQKLQLLSLEDNQLEG-------SIP 163
                      +  +    NKL   IP   D   +  +  +    N++          + 
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--------STLWN 215
               +   +  ++L  N++S F    F   + L ++ L  N LT IP            N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486

Query: 216 LKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE- 273
              +  ++L  N  T          L  LV IDLS N+FS   PT   +   L+   +  
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545

Query: 274 -----YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGE 328
                 NR     P+ I     L  L + +N+I   +   +    ++  +++  N     
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISI 602

Query: 329 IP 330
             
Sbjct: 603 DL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  210 bits (536), Expect = 4e-60
 Identities = 56/364 (15%), Positives = 125/364 (34%), Gaps = 30/364 (8%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYG----FIPNTFGNLRNLKRLSLNYNYL 56
           L L G   SG +P  I   ++L  L L  +        F P       + ++      + 
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 57  TSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPE 116
             +    +     S+   L     +++     + ++     +  ++  + N NI+  + +
Sbjct: 146 QKTFVDYDPREDFSD---LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN-NIT-FVSK 200

Query: 117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
            +  LT L   Y+G +             +  +  + E  Q   +       L  L  ++
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP---------STLWNLKYILYLNLSSN 227
           +        +P     L  ++ + +  N+  S           +     + I  + +  N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

Query: 228 SF-TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
           +  T P+   +  ++ L  ++   N   G +P   G    L  L L YN++     +  G
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCG 374

Query: 287 GLIDLKSLDLSNNNISGAIPISLE--KLLDLKYINVSFNKLEGEIPREGPFRNFSAESFK 344
               +++L  ++N +   IP   +   +  +  I+ S+N++         F       FK
Sbjct: 375 FTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDG--KNFDPLDPTPFK 431

Query: 345 GNEL 348
           G  +
Sbjct: 432 GINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  208 bits (531), Expect = 2e-59
 Identities = 51/346 (14%), Positives = 101/346 (29%), Gaps = 31/346 (8%)

Query: 1   LLLWGNNFSGTIPSFIFNA--SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS 58
                 ++  T   +      S L +  +  +     I  +        ++    N +T 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 59  STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
                    ++     L+     N+               S             +   + 
Sbjct: 198 ------VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE------YAQQYKTEDLKW 245

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL--------EGSIPDDLCRLA 170
            NL +LT + +        +P  L  L ++QL+++  N+         +     D     
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305

Query: 171 ALFLLDLGGNKL-SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSF 229
            + ++ +G N L +  V      +  L  L    NQL        +   +  LNL+ N  
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365

Query: 230 TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT-IGDLKDLQYLFLEYNRLQG-------SI 281
           T       G    +  +  + N             +  +  +   YN +          +
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425

Query: 282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG 327
             +    I++ S++LSNN IS            L  IN+  N L  
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  178 bits (453), Expect = 1e-48
 Identities = 43/320 (13%), Positives = 103/320 (32%), Gaps = 28/320 (8%)

Query: 28  EMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG 87
           E++ +      +  +   +  LSL     +   P      ++     L+ L+  ++    
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-----DAIGQLTELEVLALGSHGEKV 119

Query: 88  ----ILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS--NLTNLTTIYLGGNKLNGSIPIA 141
                 P+ I       E       +   +  +     + ++L    +  +    SI  +
Sbjct: 120 NERLFGPKGISANMSD-EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178

Query: 142 LDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL 201
                K   +    N +   +   + RL  L    +G +              +      
Sbjct: 179 SRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA-- 235

Query: 202 GSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF-------- 253
              Q  +      NLK +  + + +      LP  +  L  +  I+++ N          
Sbjct: 236 --QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQ-GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKL 312
                      + +Q +++ YN L+   +  S+  +  L  L+   N + G +P +    
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSE 352

Query: 313 LDLKYINVSFNKLEGEIPRE 332
           + L  +N+++N++   IP  
Sbjct: 353 IKLASLNLAYNQITE-IPAN 371

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  158 bits (402), Expect = 1e-41
 Identities = 45/268 (16%), Positives = 74/268 (27%), Gaps = 19/268 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTF-GNLRNLKRLSLNYNYLTSS 59
           L L  N  +    +F     ++  L    N            ++  +  +  +YN + S 
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSV 417

Query: 60  TPKL--NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNC------NIS 111
             K       +      +  ++ SNN +           S    +  M N       N  
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477

Query: 112 GSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSIPDDLCRLA 170
               E   N   LT+I L  NKL           L  L  + L  N      P      +
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536

Query: 171 ALFLLDLG------GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL 224
            L    +       GN+     P       SL  L +GSN +  +   +     I  L++
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDI 594

Query: 225 SSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
             N         +          L  + 
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 16/117 (13%), Positives = 36/117 (30%), Gaps = 7/117 (5%)

Query: 247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG--- 303
           +  ++ +      ++     +  L LE     G +PD+IG L +L+ L L ++       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 304 -AIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFS---AESFKGNELLCGTPNLQ 356
              P  +   +  +         +       P  +FS    +    +          
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  217 bits (554), Expect = 3e-62
 Identities = 82/362 (22%), Positives = 124/362 (34%), Gaps = 26/362 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
             +   +              L  L +E N   G   N F  L NLK LSL+ ++ +  T
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIP-EEIS 119
                  SL++   L  L+ + N +  I   A   L   +EV  +    I   +  +E  
Sbjct: 370 LTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWR 427

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG--SIPDDLCRLAALFLLDL 177
            L N+  IYL  NK       +   +  LQ L L    L+   S P     L  L +LDL
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             N ++         L  L  L L  N L  +                 ++  G     +
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWK---------------HANPGGPIYFL 532

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
             L  L  ++L  N F         DL +L+ + L  N L           + LKSL+L 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 298 NNNISGAIPISLEKLLD-LKYINVSFNKLEGEIPREGPFRNFSAESFK-----GNELLCG 351
            N I+             L  +++ FN  +        F N+  E+        +  LC 
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN 652

Query: 352 TP 353
           TP
Sbjct: 653 TP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  216 bits (552), Expect = 5e-62
 Identities = 74/347 (21%), Positives = 138/347 (39%), Gaps = 26/347 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
                   +  +P  +   + ++ L L  N         F     L  L + +N ++   
Sbjct: 9   ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
           P             LK L+  +N L  +  +     + ++    + + +I          
Sbjct: 66  P-----ELCQKLPMLKVLNLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVK 119

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL--CRLAALFLLDLG 178
             NL T+ L  N L+ +      +L+ LQ L L +N+++    ++L     ++L  L+L 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTL---WNLKYILYLNLSSNSFTGPLP 234
            N++  F P CF  +  L  L+L + QL  S+   L        I  L+LS++  +    
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 235 LEIGNLRV--LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK 292
                L+   L  +DLS NN +     +   L  L+Y FLEYN +Q     S+ GL +++
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299

Query: 293 SLDLSNN---------NISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
            L+L  +         ++      S + L  L+++N+  N + G   
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  204 bits (520), Expect = 2e-57
 Identities = 78/351 (22%), Positives = 126/351 (35%), Gaps = 27/351 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L +  N  S   P        L  L L+ N        TF    NL  L L  N +    
Sbjct: 54  LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS- 119
                 +     K L  L  S+N L          L  +++   + N  I     EE+  
Sbjct: 114 N-----NPFVKQKNLITLDLSHNGLSSTKLGTQVQLE-NLQELLLSNNKIQALKSEELDI 167

Query: 120 -NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC---RLAALFLL 175
              ++L  + L  N++    P     + +L  L L + QL  S+ + LC      ++  L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227

Query: 176 DLGGNKLSGFVPACFGNL--TSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGP 232
            L  ++LS      F  L  T+L  L L  N L  +   +   L  + Y  L  N+    
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287

Query: 233 LPLEIGNLRVLVQIDL---------SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD 283
               +  L  +  ++L         S+ +       +   LK L++L +E N + G   +
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347

Query: 284 SIGGLIDLKSLDLSNNNISGAIPISLE----KLLDLKYINVSFNKLEGEIP 330
              GLI+LK L LSN+  S     +          L  +N++ NK+     
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  187 bits (477), Expect = 1e-51
 Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 17/295 (5%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
           + +    ++  LT      +  ++      +  L+ ++N L  +        SQ +    
Sbjct: 5   SHEVADCSHLKLTQVPD--DLPTN------ITVLNLTHNQLRRLPAANFTRYSQ-LTSLD 55

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
           +    IS   PE    L  L  + L  N+L+            L  L L  N ++    +
Sbjct: 56  VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS---TLWNLKYILY 221
              +   L  LDL  N LS         L +L+ L L +N++ ++ S    ++    +  
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD---LKDLQYLFLEYNRLQ 278
           L LSSN      P     +  L  + L+       +   +        ++ L L  ++L 
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 279 GSIPDSIGGLID--LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR 331
            +   +  GL    L  LDLS NN++     S   L  L+Y  + +N ++     
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  174 bits (443), Expect = 6e-47
 Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 12/267 (4%)

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
             +    S+  L  +      +L  ++ V  + +  +        +  + LT++ +G N 
Sbjct: 5   SHEVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
           ++   P    KL  L++L+L+ N+L             L  L L  N +       F   
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 194 TSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTG--PLPLEIGNLRVLVQIDLSM 250
            +L  L L  N L+S    T   L+ +  L LS+N         L+I     L +++LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG---GLIDLKSLDLSNNNISGAIPI 307
           N    F P     +  L  LFL   +L  S+ + +        +++L LSN+ +S     
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 308 SLE--KLLDLKYINVSFNKLEGEIPRE 332
           +    K  +L  +++S+N L       
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDS 267

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  147 bits (373), Expect = 1e-37
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 6/214 (2%)

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
            +         KL   +P  L     + +L+L  NQL      +  R + L  LD+G N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           +S   P     L  L+ L L  N+L+ +   T      +  L+L SNS            
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD--SIGGLIDLKSLDLSN 298
           + L+ +DLS N  S     T   L++LQ L L  N++Q    +   I     LK L+LS+
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           N I    P     +  L  + ++  +L   +  +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  207 bits (528), Expect = 9e-58
 Identities = 65/393 (16%), Positives = 127/393 (32%), Gaps = 48/393 (12%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGF---------IPNTFGNLRNLKRLSL 51
           + L+       +P F+++  +L  L +  N              + +       ++   +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 52  NYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS 111
            YN L          +SL     L  L   +N +  +   A G     +    +    I 
Sbjct: 556 GYNNLEEFPAS----ASLQKMVKLGLLDCVHNKVRHL--EAFGTNV-KLTDLKLDYNQIE 608

Query: 112 GSIPEEI-SNLTNLTTIYLGGNKLNGSIP--IALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
             IPE+  +    +  +    NKL   IP       +  +  +    N++     +  C 
Sbjct: 609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666

Query: 169 LAALFL-----LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS--------TLWN 215
           +          + L  N++  F    F   + +  + L +N +TSIP            N
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726

Query: 216 LKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYL---- 270
              +  ++L  N  T          L  L  +D+S N FS   PT   +   L+      
Sbjct: 727 TYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785

Query: 271 --FLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL-EG 327
               E NR+    P  I     L  L + +N+I     +  +    L  ++++ N     
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYILDIADNPNISI 842

Query: 328 EIPREGPFRNFSAESFKGN--ELLCGTPNLQVP 358
           ++    P+          +  + + G   L + 
Sbjct: 843 DVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  186 bits (474), Expect = 2e-50
 Identities = 58/369 (15%), Positives = 110/369 (29%), Gaps = 46/369 (12%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL-- 63
           + +       + N  +++ L L      G +P+  G L  LK LS   +  T S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 64  ---------------------NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEV 102
                                 FL           L  + N    + P    +     + 
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 103 FFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSI 162
                 N    I + I  LT L  IY   +                +  + +  +   + 
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENE 483

Query: 163 PDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS----------IPST 212
                 L  L  ++L        +P    +L  L++L +  N+  S          +   
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

Query: 213 LWNLKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLF 271
                 I    +  N+    P    +  +  L  +D   N          G    L  L 
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLK 601

Query: 272 LEYNRLQGSIPDSIG-GLIDLKSLDLSNNNISGAIP--ISLEKLLDLKYINVSFNKLEGE 328
           L+YN+++  IP+        ++ L  S+N +   IP   + + +  +  ++ S+NK+  E
Sbjct: 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 329 IPREGPFRN 337
                   +
Sbjct: 660 GRNISCSMD 668

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  133 bits (335), Expect = 1e-32
 Identities = 37/248 (14%), Positives = 84/248 (33%), Gaps = 13/248 (5%)

Query: 108 CNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC 167
                    ++ N   +T + L G    G +P A+ +L +L++LS   +    S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 168 RLAALFLLDLGGNKLSGFVPACFGN-------LTSLRNLYLGSNQLTSIPSTLWNLKYIL 220
                 + +   +++       F +          L++    + ++  I           
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 221 YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
            +   +N  T  +   I  L  L  I  + + F+           D +    +Y +   +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSA 340
              S   L DL  ++L N      +P  L  L +L+ +N++ N+       +  +   + 
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542

Query: 341 ESFKGNEL 348
           +   G ++
Sbjct: 543 DEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 13/111 (11%), Positives = 39/111 (35%), Gaps = 1/111 (0%)

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI 281
           L+  +  +         +       +  ++ +       + +   +  L L     +G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           PD+IG L +LK L    ++ + +  +  ++ L         +++     + 
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  195 bits (498), Expect = 1e-57
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 6/195 (3%)

Query: 408 NMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA 467
           +  +     R   ++L +ATN F    LIG G    VYK  ++DG +VA+K    +    
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78

Query: 468 FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN---YILDI 524
            + F+ E + +   RH +L+ +I  C   +   L+ +YM +G+L++ LY S+     +  
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
            QRL I I  A  L YLH      IIH D+K  N+LLD+N V  ++DFG++K   + DQ+
Sbjct: 139 EQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195

Query: 585 LTQTQTLATIGYMAP 599
              T    T+GY+ P
Sbjct: 196 HLSTVVKGTLGYIDP 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  195 bits (498), Expect = 1e-57
 Identities = 72/190 (37%), Positives = 100/190 (52%), Gaps = 5/190 (2%)

Query: 414 NLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ-YEGAFKSFD 472
            L+RF+  EL  A++ FS  N++GRGG   VYK R+ DG  VAVK    +  +G    F 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 473 IECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLY---SSNYILDIFQRLN 529
            E +M+    HRNL+++   C     + LV  YM +GS+  CL     S   LD  +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           I +  A  L YLH      IIH D+K  N+LLD+   A + DFG+AK L+    +   T 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTA 194

Query: 590 TLATIGYMAP 599
              TIG++AP
Sbjct: 195 VRGTIGHIAP 204

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  200 bits (511), Expect = 8e-57
 Identities = 71/346 (20%), Positives = 133/346 (38%), Gaps = 13/346 (3%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L+L  N       + +     L  L                N + L+ L L  N+++S  
Sbjct: 86  LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                       + LK L F NN++  +    + +L Q+  +    N N    I     +
Sbjct: 146 L-----PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD 200

Query: 121 LTNLTTIYLGGNKLNGSIPIALD--KLQKLQLLSLEDNQLEGSIPDDLCRLAALFL--LD 176
                ++  GG +    I   L    +Q L L + ED   E   P     L  + +  ++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLE 236
           L  +         F   + L+ L L +  L+ +PS L  L  +  L LS+N F     + 
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQIS 320

Query: 237 IGNLRVLVQIDLSMNNFSGFIPT-TIGDLKDLQYLFLEYNRLQGS--IPDSIGGLIDLKS 293
             N   L  + +  N     + T  + +L++L+ L L ++ ++ S      +  L  L+S
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380

Query: 294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFS 339
           L+LS N        + ++   L+ ++++F +L+     + PF+N  
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  181 bits (461), Expect = 8e-50
 Identities = 69/342 (20%), Positives = 126/342 (36%), Gaps = 20/342 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNAS--KLSRLELEMNSFYGFIPNTFGNLR--NLKRLSLNYNYL 56
           L   G      I   + N++   L     E        P  F  L   +++ ++L  +Y 
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266

Query: 57  TSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPE 116
            + +      ++      L+ L  +   L  + P  +  LS +++   +           
Sbjct: 267 FNISS-----NTFHCFSGLQELDLTATHLSEL-PSGLVGLS-TLKKLVLSANKFENLCQI 319

Query: 117 EISNLTNLTTIYLGGNKLNGSI-PIALDKLQKLQLLSLEDNQLEGS--IPDDLCRLAALF 173
             SN  +LT + + GN     +    L+ L+ L+ L L  + +E S      L  L+ L 
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379

Query: 174 LLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI--PSTLWNLKYILYLNLSSNSFTG 231
            L+L  N+        F     L  L L   +L      S   NL  +  LNLS +    
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439

Query: 232 PLPLEIGNLRVLVQIDLSMNNFSGFI---PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL 288
                   L  L  ++L  N+F         ++  L  L+ L L +  L      +   L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499

Query: 289 IDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
             +  +DLS+N ++ +   +L  L  + Y+N++ N +   +P
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  180 bits (459), Expect = 2e-49
 Identities = 68/340 (20%), Positives = 119/340 (35%), Gaps = 20/340 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
                   +  IP  +   +    LE   N        TF  L NL  L L    +    
Sbjct: 17  YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                  +  +   L  L  + N L  +   A+     +++  F     IS      + N
Sbjct: 74  E-----DTFQSQHRLDTLVLTANPLIFMAETALSGPK-ALKHLFFIQTGISSIDFIPLHN 127

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFL--LDLG 178
              L ++YLG N ++          +KL++L  ++N +     +D+  L       L+L 
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP------STLWNLKYILYLNLSSNSFTGP 232
           GN ++G  P  F +    ++L  G  Q   +       ST+ +L    + ++     +  
Sbjct: 188 GNDIAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246

Query: 233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK 292
           +   +  +  +  I+L  + F      T      LQ L L    L   +P  + GL  LK
Sbjct: 247 VFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
            L LS N       IS      L ++++  N    E+   
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  178 bits (454), Expect = 8e-49
 Identities = 68/341 (19%), Positives = 114/341 (33%), Gaps = 14/341 (4%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNS-FYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L    N         + +  + + L L +N      I     +    + L+         
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ-SMEVFFMFNCNISGSIPEEI 118
             K    S++ +   L   +F +   + I P     L + S+E   +             
Sbjct: 218 IFKGLKNSTIQS---LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
              + L  + L    L+  +P  L  L  L+ L L  N+ E           +L  L + 
Sbjct: 275 HCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333

Query: 179 GNKLSGFV-PACFGNLTSLRNLYLGSNQLTSIPS---TLWNLKYILYLNLSSNSFTGPLP 234
           GN     +   C  NL +LR L L  + + +       L NL ++  LNLS N       
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393

Query: 235 LEIGNLRVLVQIDLSMNNFSGFIP-TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKS 293
                   L  +DL+          +   +L  L+ L L ++ L  S      GL  L+ 
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453

Query: 294 LDLSNNNISGAIPI---SLEKLLDLKYINVSFNKLEGEIPR 331
           L+L  N+          SL+ L  L+ + +SF  L      
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  159 bits (405), Expect = 3e-42
 Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 15/308 (4%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFI-PNTFGNLRNLKRLSLNYNYLTSS 59
           L+L  N F         N   L+ L ++ N+    +      NL NL+ L L+++ + +S
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
                 L +LS+   L+ L+ S N    +   A       +E+  +    +     +   
Sbjct: 366 DCCNLQLRNLSH---LQSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPF 421

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSI---PDDLCRLAALFLL 175
            NL  L  + L  + L+ S     D L  LQ L+L+ N          + L  L  L +L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
            L    LS      F +L  + ++ L  N+LTS      +    +YLNL+SN  +  LP 
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPS 541

Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDL-QYLFLEYNRLQGSIPDSIGGLIDLKSL 294
            +  L     I+L  N                 ++      +L+ +          L+ +
Sbjct: 542 LLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGV 596

Query: 295 DLSNNNIS 302
            LS+  +S
Sbjct: 597 RLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  140 bits (355), Expect = 1e-35
 Identities = 54/270 (20%), Positives = 89/270 (32%), Gaps = 12/270 (4%)

Query: 76  KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN 135
           K  +  N  L+ I     G L  S E        +        S L NLT + L   ++ 
Sbjct: 15  KTYNCENLGLNEI----PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 136 GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTS 195
                      +L  L L  N L       L    AL  L      +S        N  +
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 196 LRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMN-NF 253
           L +LYLGSN ++SI     +  + +  L+  +N+       ++ +L+    + L++N N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG--LIDLKSLDLSNNNISGAIPISLEK 311
              I     D    Q L     +    I   +    +  L      + +     P   E 
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 312 L--LDLKYINVSFNKLEGEIPREGPFRNFS 339
           L  + ++ IN+  +           F  FS
Sbjct: 251 LCEMSVESINLQKHYFFNISS--NTFHCFS 278

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  193 bits (493), Expect = 3e-54
 Identities = 64/334 (19%), Positives = 106/334 (31%), Gaps = 23/334 (6%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNS---FYGFIPNTFGNLRNLKRLSLNYNYLTSSTPK 62
            N      S +     L+  E  +     +   I + F  L N+   SL           
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV-------T 293

Query: 63  LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
           +  +   S     ++L   N          + +L +          +  G       +L 
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT------FTSNKGGNAFSEVDLP 347

Query: 123 NLTTIYLGGNKLN--GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           +L  + L  N L+  G    +      L+ L L  N +   +  +   L  L  LD   +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406

Query: 181 KLSGFVPA-CFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEI- 237
            L        F +L +L  L +               L  +  L ++ NSF      +I 
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
             LR L  +DLS        PT    L  LQ L + +N            L  L+ LD S
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526

Query: 298 NNNISGAIPISLEKLLD-LKYINVSFNKLEGEIP 330
            N+I  +    L+     L ++N++ N       
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (434), Expect = 4e-46
 Identities = 60/341 (17%), Positives = 111/341 (32%), Gaps = 28/341 (8%)

Query: 5   GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
             NF   IP  +        L+L  N        +F +   L+ L L+   + +      
Sbjct: 16  ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--- 69

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
              +  +  +L  L  + N +  +   A   LS S++       N++      I +L  L
Sbjct: 70  --GAYQSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTL 126

Query: 125 TTIYLGGNKLNG-SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL----FLLDLGG 179
             + +  N +    +P     L  L+ L L  N+++     DL  L  +      LDL  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLT--SIPSTLWNLKYILYLNLSSNSFTGPLPLE- 236
           N ++   P  F  +  L  L L +N  +   + + +  L  +    L    F     LE 
Sbjct: 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 237 --IGNLRVLVQIDLSMNNFS------GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL 288
                L  L  + +     +        I      L ++    L    ++     S    
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YN 303

Query: 289 IDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI 329
              + L+L N        + L+ L  L + +        E+
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (434), Expect = 4e-46
 Identities = 71/367 (19%), Positives = 126/367 (34%), Gaps = 42/367 (11%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGF-IPNTFGNLRNLKRLSLNYNYLTSS 59
           L+    N +      I +   L  L +  N    F +P  F NL NL+ L L+ N + S 
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 60  TPK-LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE- 117
               L  L  +        L  S N ++ I P A   +   +    + N   S ++ +  
Sbjct: 165 YCTDLRVLHQMPLL--NLSLDLSLNPMNFIQPGAFKEI--RLHKLTLRNNFDSLNVMKTC 220

Query: 118 ISNLTNLTTIYLGGNKLNGSIPI------ALDKLQKLQLLSLEDNQLEGS---IPDDLCR 168
           I  L  L    L   +      +      AL+ L  L +       L+     I D    
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280

Query: 169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS----------------- 211
           L  +    L    +       F      ++L L + +    P+                 
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338

Query: 212 ---TLWNLKYILYLNLSSN--SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKD 266
              +  +L  + +L+LS N  SF G           L  +DLS N     + +    L+ 
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ 397

Query: 267 LQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           L++L  +++ L+     S+   L +L  LD+S+ +   A       L  L+ + ++ N  
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457

Query: 326 EGEIPRE 332
           +     +
Sbjct: 458 QENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (432), Expect = 8e-46
 Identities = 58/317 (18%), Positives = 100/317 (31%), Gaps = 22/317 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
             L        +  F +N      LEL    F  F      +L+ L   S          
Sbjct: 287 FSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN--------- 335

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLD--GILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
            K     S  +   L++L  S N L   G   ++    + S++   +    +   +    
Sbjct: 336 -KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVIT-MSSNF 392

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
             L  L  +    + L           L+ L  L +       +       L++L +L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 178 GGNKLSGFVPAC-FGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPL 235
            GN          F  L +L  L L   QL  + P+   +L  +  LN+S N+F      
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDL-KDLQYLFLEYNRLQGSIP--DSIGGLIDLK 292
               L  L  +D S+N+        +      L +L L  N    +      +  + D +
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 293 SLDLSNNNISGAIPISL 309
            L +    +  A P   
Sbjct: 573 QLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (382), Expect = 4e-39
 Identities = 48/255 (18%), Positives = 87/255 (34%), Gaps = 15/255 (5%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
              +   I      NL  S +   +    +         +   L  + L   ++      
Sbjct: 15  MELNFYKI----PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLY 200
           A   L  L  L L  N ++         L++L  L      L+       G+L +L+ L 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 201 LGSNQLTS--IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR----VLVQIDLSMNNFS 254
           +  N + S  +P    NL  + +L+LSSN        ++  L     + + +DLS+N  +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 255 GFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNNNISGAIPI---SLE 310
              P    +++ L  L L  N    ++    I GL  L+   L          +      
Sbjct: 191 FIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 311 KLLDLKYINVSFNKL 325
            L  L  + +   +L
Sbjct: 250 ALEGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  116 bits (293), Expect = 1e-27
 Identities = 47/254 (18%), Positives = 84/254 (33%), Gaps = 36/254 (14%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIP-NTFGNLRNLKRLSLNYNYLTSS 59
           L L  N       +F     +L  L+ + ++       + F +LRNL  L +++ +   +
Sbjct: 378 LDLSFNGVITMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                     +    L+ L  + NS                              P+  +
Sbjct: 437 FN-----GIFNGLSSLEVLKMAGNSFQENFL------------------------PDIFT 467

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
            L NLT + L   +L    P A + L  LQ+L++  N            L +L +LD   
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 180 NKLSGFVPACFGNL-TSLRNLYLGSNQLT---SIPSTLWNLKYILYLNLSSNSFTGPLPL 235
           N +         +  +SL  L L  N         S L  +K    L +         P 
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587

Query: 236 EIGNLRVLVQIDLS 249
           +   + VL  ++++
Sbjct: 588 DKQGMPVL-SLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (257), Expect = 3e-23
 Identities = 29/139 (20%), Positives = 45/139 (32%), Gaps = 3/139 (2%)

Query: 189 CFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDL 248
           C   + ++            IP  L        L+LS N           +   L  +DL
Sbjct: 3   CVEVVPNIT-YQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS 308
           S              L  L  L L  N +Q     +  GL  L+ L     N++      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 309 LEKLLDLKYINVSFNKLEG 327
           +  L  LK +NV+ N ++ 
Sbjct: 120 IGHLKTLKELNVAHNLIQS 138

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  174 bits (444), Expect = 1e-49
 Identities = 81/313 (25%), Positives = 139/313 (44%), Gaps = 26/313 (8%)

Query: 14  SFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK 73
             I   + L  L L  N      P    NL  L  L +  N +T        +S+L N  
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISALQNLT 110

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
            L+ L  + +++  I P  + NL++   +    N N+S      +SN+T L  + +  +K
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS--DLSPLSNMTGLNYLTVTESK 166

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
           +    PIA   L  L  LSL  NQ+E   P  L  L +L       N+++   P    N+
Sbjct: 167 VKDVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 194 TSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF 253
           T L +L +G+N++T +   L NL  + +L + +N  +    +   +L  L  +++  N  
Sbjct: 221 TRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNVGSNQI 277

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
           S      + +L  L  LFL  N+L     + IGGL +L +L LS N+I+   P++   L 
Sbjct: 278 SDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLS 333

Query: 314 DLKYINVSFNKLE 326
            +   + +   ++
Sbjct: 334 KMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  162 bits (412), Expect = 5e-45
 Identities = 78/330 (23%), Positives = 137/330 (41%), Gaps = 28/330 (8%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            +L   + +  +         +++L +               L NL+ L+LN N +T   
Sbjct: 27  AVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNGNQITD-- 80

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                +S LSN   L  L    N +  I    + NL+ ++   ++   NIS   P  ++N
Sbjct: 81  -----ISPLSNLVKLTNLYIGTNKITDISA--LQNLT-NLRELYLNEDNISDISP--LAN 130

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           LT + ++ LG N    S    L  +  L  L++ +++++   P  +  L  L+ L L  N
Sbjct: 131 LTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           ++    P    +LTSL       NQ+T I   + N+  +  L + +N  T   PL   NL
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSPL--ANL 242

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L  +++  N  S      + DL  L+ L +  N++  S    +  L  L SL L+NN 
Sbjct: 243 SQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQ 298

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
           +       +  L +L  + +S N +    P
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  145 bits (368), Expect = 7e-39
 Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 19/272 (6%)

Query: 56  LTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIP 115
           L +    +N +   ++            S+  ++      L   +    +    ++    
Sbjct: 5   LATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELES-ITKLVVAGEKVAS--I 59

Query: 116 EEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL 175
           + I  LTNL  + L GN++    P++   L KL  L +  N++  +    L  L  L  L
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLREL 115

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL 235
            L  + +S   P    NLT + +L LG+N   S  S L N+  + YL ++ +      P 
Sbjct: 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP- 172

Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            I NL  L  + L+ N      P  +  L  L Y     N++    P  +  +  L SL 
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227

Query: 296 LSNNNISGAIPISLEKLLDLKYINVSFNKLEG 327
           + NN I+   P  L  L  L ++ +  N++  
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  173 bits (442), Expect = 2e-49
 Identities = 55/332 (16%), Positives = 120/332 (36%), Gaps = 27/332 (8%)

Query: 15  FIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKY 74
              ++S    L  + ++      +     +       N  +        N     +    
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETR--- 63

Query: 75  LKYLSFSNNSLDGILPRAIGNLSQ-SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
                 +  +L       + + +Q       + +  +    P++   L++L  + +    
Sbjct: 64  ------TGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGN- 192
           L   +P  + +   L+ L+L  N L  ++P  +  L  L  L +        +P    + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 193 --------LTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV 244
                   L +L++L L    + S+P+++ NL+ +  L + ++  +  L   I +L  L 
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232

Query: 245 QIDLSMNNFSGFIPTTIGDLKDLQYLFL-EYNRLQGSIPDSIGGLIDLKSLDLSNNNISG 303
           ++DL         P   G    L+ L L + + L  ++P  I  L  L+ LDL       
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 304 AIPISLEKLLDLKYINVSFNKLEGEIPREGPF 335
            +P  + +L     I V  + L+ ++ +  P 
Sbjct: 292 RLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  143 bits (363), Expect = 2e-38
 Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 27/252 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L         P   F  S L  + ++       +P+T      L+ L+L  N L +  
Sbjct: 86  LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLRA-- 141

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                 +S+++   L+ LS         LP  + +                     E   
Sbjct: 142 ----LPASIASLNRLRELSIRACPELTELPEPLAST----------------DASGEHQG 181

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           L NL ++ L    +  S+P ++  LQ L+ L + ++ L  ++   +  L  L  LDL G 
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 181 KLSGFVPACFGNLTSLRNLYL-GSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN 239
                 P  FG    L+ L L   + L ++P  +  L  +  L+L        LP  I  
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299

Query: 240 LRVLVQIDLSMN 251
           L     I +  +
Sbjct: 300 LPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  125 bits (316), Expect = 5e-32
 Identities = 47/252 (18%), Positives = 88/252 (34%), Gaps = 36/252 (14%)

Query: 112 GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD------- 164
           GS      + +    +Y  G+         L + Q+                +       
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 165 --------------DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP 210
                         +         L+L    L  F P     L+ L+++ + +  L  +P
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLMELP 120

Query: 211 STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG-------- 262
            T+     +  L L+ N     LP  I +L  L ++ +        +P  +         
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 263 -DLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVS 321
             L +LQ L LE+  ++ S+P SI  L +LKSL + N+ +S A+  ++  L  L+ +++ 
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237

Query: 322 -FNKLEGEIPRE 332
               L    P  
Sbjct: 238 GCTALR-NYPPI 248

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  101 bits (253), Expect = 1e-23
 Identities = 38/192 (19%), Positives = 74/192 (38%), Gaps = 18/192 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGN---------LRNLKRLSL 51
           L L  N     +P+ I + ++L  L +        +P    +         L NL+ L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190

Query: 52  NYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS 111
            +  + S        +S++N + LK L   N+ L   L  AI +L   +E   +  C   
Sbjct: 191 EWTGIRS------LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP-KLEELDLRGCTAL 242

Query: 112 GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAA 171
            + P        L  + L       ++P+ + +L +L+ L L        +P  + +L A
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302

Query: 172 LFLLDLGGNKLS 183
             ++ +  +  +
Sbjct: 303 NCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 29/181 (16%), Positives = 62/181 (34%), Gaps = 17/181 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNAS---------KLSRLELEMNSFYGFIPNTFGNLRNLKRLSL 51
           L +        +P  + +            L  L LE       +P +  NL+NLK L +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213

Query: 52  NYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS 111
             + L++         ++ +   L+ L     +     P   G  +  ++   + +C+  
Sbjct: 214 RNSPLSA------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNL 266

Query: 112 GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAA 171
            ++P +I  LT L  + L G      +P  + +L    ++ +  +              A
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326

Query: 172 L 172
            
Sbjct: 327 E 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 57.6 bits (140), Expect = 4e-09
 Identities = 17/148 (11%), Positives = 41/148 (27%), Gaps = 24/148 (16%)

Query: 206 LTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG---------- 255
           + S      +      L    ++   P    +   +     D +  + +           
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 256 ---------FIPTTIGDLKD--LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGA 304
                         + D        L L    L    PD    L  L+ + +    +   
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118

Query: 305 IPISLEKLLDLKYINVSFNKLEGEIPRE 332
           +P ++++   L+ + ++ N L   +P  
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPAS 145

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  172 bits (438), Expect = 3e-49
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 414 NLRRFTHLELFQATNGFSE------NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGA 467
               F+  EL   TN F E       N +G GG   VYK  + +   VAVK   L     
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVD 67

Query: 468 FKS------FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY- 520
             +      FD E  +M + +H NL++++   S+ D   LV  YMP+GSL   L   +  
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 521 -ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL 579
             L    R  I    A+ + +LH       IH D+K  N+LLD+   A +SDFG+A+   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 580 KEDQSLTQTQTLATIGYMAP 599
           K  Q++  ++ + T  YMAP
Sbjct: 185 KFAQTVMTSRIVGTTAYMAP 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  164 bits (417), Expect = 3e-46
 Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 15/189 (7%)

Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI 481
            L+  +       +  RG    V+KA++     VAVK+F +Q + +++  + E   +  +
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYSLPGM 75

Query: 482 RHRNLIKIISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASA 537
           +H N+++ I +            L+  +   GSL   L     ++   +  +I   +A  
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARG 133

Query: 538 LEYLH-------FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
           L YLH        G+   I H D+K  NVLL +N+ A ++DFG+A        +      
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 591 LATIGYMAP 599
           + T  YMAP
Sbjct: 194 VGTRRYMAP 202

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  167 bits (426), Expect = 6e-46
 Identities = 92/345 (26%), Positives = 144/345 (41%), Gaps = 40/345 (11%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +    N  +   P  + N +KL  + +  N      P    NL NL  L+L  N +T   
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 128

Query: 61  P---------------KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFM 105
           P                ++ +S+LS    L+ LSF N   D    + + NL+ ++E   +
Sbjct: 129 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD---LKPLANLT-TLERLDI 184

Query: 106 FNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD 165
            +  +S      ++ LTNL ++    N+++   P  L  L  L  LSL  NQL+      
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 238

Query: 166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS 225
           L  L  L  LDL  N++S   P     LT L  L LG+NQ+++I   L  L  +  L L+
Sbjct: 239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELN 295

Query: 226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI 285
            N      P  I NL+ L  + L  NN S   P  +  L  LQ LF   N++  S   S+
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSL 349

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
             L ++  L   +N IS   P++   L  +  + ++         
Sbjct: 350 ANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  160 bits (408), Expect = 2e-43
 Identities = 89/330 (26%), Positives = 142/330 (43%), Gaps = 32/330 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            +L   N + T+     +  +++ L+ +              L NL +++ + N LT   
Sbjct: 29  TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTD-- 82

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                ++ L N   L  +  +NN +  I P  + NL+  +    +FN  I+   P  + N
Sbjct: 83  -----ITPLKNLTKLVDILMNNNQIADITP--LANLTN-LTGLTLFNNQITDIDP--LKN 132

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           LTNL  + L  N ++     AL  L  LQ LS   NQ+    P  L  L  L  LD+  N
Sbjct: 133 LTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSN 187

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           K+S         LT+L +L   +NQ++ I   L  L  +  L+L+ N       L   +L
Sbjct: 188 KVSDISV--LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIGTL--ASL 242

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L  +DL+ N  S   P  +  L  L  L L  N++    P  + GL  L +L+L+ N 
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
           +    PIS   L +L Y+ + FN +    P
Sbjct: 299 LEDISPIS--NLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  145 bits (369), Expect = 4e-38
 Identities = 72/326 (22%), Positives = 127/326 (38%), Gaps = 30/326 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  S    S +   + L +L    N      P    NL  L+RL ++ N ++   
Sbjct: 139 LELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD-- 191

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                +S L+    L+ L  +NN +  I P  +G L+ +++   +    +       +++
Sbjct: 192 -----ISVLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKD--IGTLAS 241

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           LTNLT + L  N+++   P  L  L KL  L L  NQ+    P  L  L AL  L+L  N
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 297

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
           +L    P    NL +L  L L  N ++ I   + +L  +  L   +N  +    L   NL
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDVSSL--ANL 352

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             +  +    N  S   P  + +L  +  L L       +  +    +    ++      
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLE 326
           +    P ++         ++++N   
Sbjct: 411 LI--APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  145 bits (367), Expect = 6e-38
 Identities = 76/324 (23%), Positives = 133/324 (41%), Gaps = 29/324 (8%)

Query: 2   LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTP 61
           L +GN  +   P  + N + L RL++  N       +    L NL+ L    N ++    
Sbjct: 161 LSFGNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--- 213

Query: 62  KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
               ++ L     L  LS + N L  I    + +L+  +    + N  IS   P  +S L
Sbjct: 214 ----ITPLGILTNLDELSLNGNQLKDIGT--LASLTN-LTDLDLANNQISNLAP--LSGL 264

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
           T LT + LG N+++   P+A   L  L  L L +NQLE   P  +  L  L  L L  N 
Sbjct: 265 TKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
           +S   P    +LT L+ L+  +N+++ + S L NL  I +L+   N  +   P  + NL 
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSDVSS-LANLTNINWLSAGHNQISDLTP--LANLT 375

Query: 242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
            + Q+ L+   ++        ++     +      L    P +I         D++ N  
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLP 433

Query: 302 S--GAIPISLEKLLDLKYINVSFN 323
           S    +  +  + + +     +F+
Sbjct: 434 SYTNEVSYTFSQPVTIGKGTTTFS 457

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  138 bits (351), Expect = 1e-35
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 22/281 (7%)

Query: 50  SLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN 109
            L    +T  TP +N + + +             ++   +     +L Q +         
Sbjct: 2   PLGSATITQDTP-INQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQ-VTTLQADRLG 57

Query: 110 ISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRL 169
           I     + +  L NLT I    N+L    P+    L KL  + + +NQ+    P  L  L
Sbjct: 58  IK--SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANL 111

Query: 170 AALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSF 229
             L  L L  N+++   P    NLT+L  L L SN ++ I + L  L  +  L+   N  
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA-LSGLTSLQQLSF-GNQV 167

Query: 230 TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI 289
           T   PL   NL  L ++D+S N  S    + +  L +L+ L    N++    P  +G L 
Sbjct: 168 TDLKPL--ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILT 221

Query: 290 DLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
           +L  L L+ N +      +L  L +L  ++++ N++    P
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 82.3 bits (204), Expect = 8e-17
 Identities = 42/234 (17%), Positives = 79/234 (33%), Gaps = 42/234 (17%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  S   P  +   + L+ LEL  N      P    NL+NL  L+L +N ++   
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD-- 323

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                +S +S+   L+ L F NN +  +   ++ NL+ ++      +  IS   P  ++N
Sbjct: 324 -----ISPVSSLTKLQRLFFYNNKVSDV--SSLANLT-NINWLSAGHNQISDLTP--LAN 373

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           LT +T + L       +       +     +      L                      
Sbjct: 374 LTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL---------------------- 411

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP 234
                 PA   +  S     +  N  +      +     + +   + +F+G + 
Sbjct: 412 ----IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  170 bits (433), Expect = 6e-46
 Identities = 65/332 (19%), Positives = 103/332 (31%), Gaps = 21/332 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEM--NSFYGFIPNTFGNLRNLKRLSLNYNYLTS 58
                 N     PS +     ++  E  +   + +      F  L N+  +SL       
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV---- 295

Query: 59  STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
               + +L  +      + LS     L       +  L            N  GSI  + 
Sbjct: 296 ---SIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL-----KSLTLTMN-KGSISFKK 346

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQ--KLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
             L +L+ + L  N L+ S   +   L    L+ L L  N     +  +   L  L  LD
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD 405

Query: 177 LGGNKLSGFVPA-CFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLP 234
              + L        F +L  L  L +               L  +  L ++ NSF     
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 235 LEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKS 293
             +  N   L  +DLS              L  LQ L + +N L          L  L +
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525

Query: 294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           LD S N I  +  I       L + N++ N +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (411), Expect = 6e-43
 Identities = 58/341 (17%), Positives = 107/341 (31%), Gaps = 30/341 (8%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
                   S  +P  I   S    ++L  N        +F N   L+ L L+   + +  
Sbjct: 16  YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                  +     +L  L  + N +    P +   L+ S+E        ++      I  
Sbjct: 73  D-----KAWHGLHHLSNLILTGNPIQSFSPGSFSGLT-SLENLVAVETKLASLESFPIGQ 126

Query: 121 LTNLTTIYLGGNKLNG-SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRL----AALFLL 175
           L  L  + +  N ++   +P     L  L  + L  N ++    +DL  L         L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS--IPSTLWNLKYILYLNLSSNSFTGPL 233
           D+  N +       F  +  L  L L  N  +S  + + L NL  +    L    F    
Sbjct: 187 DMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 234 PLEIGNLRVL--------VQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI 285
            LEI    ++         +  L+  N           L ++  + L    +     + +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDV 303

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
                 +SL +    +          L  LK + ++ NK  
Sbjct: 304 PKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGS 341

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (411), Expect = 6e-43
 Identities = 70/351 (19%), Positives = 121/351 (34%), Gaps = 27/351 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L+L GN      P      + L  L               G L  LK+L++ +N++ S  
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-- 142

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNC--NISGSIPEEI 118
                 +  SN   L ++  S N +  I    +  L ++ +V    +   N    I ++ 
Sbjct: 143 --CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200

Query: 119 SNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEG---------SIPDDLCR 168
                L  + L GN  + +I    L  L  L +  L   + +          SI + LC 
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260

Query: 169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNS 228
           +       L            F  L ++  + L    +  +   +        L++    
Sbjct: 261 VTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED-VPKHFKWQSLSIIRCQ 318

Query: 229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS--IG 286
                 L++  L+ L    L+MN  S  I      L  L YL L  N L  S   S    
Sbjct: 319 LKQFPTLDLPFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373

Query: 287 GLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
           G   L+ LDLS N     +  +   L +L++++   + L+  +     F +
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  135 bits (342), Expect = 6e-34
 Identities = 49/275 (17%), Positives = 87/275 (31%), Gaps = 18/275 (6%)

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS 137
               +  L  +      ++  S +   +    +        SN + L  + L   ++   
Sbjct: 16  YQCMDQKLSKVPD----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71

Query: 138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
              A   L  L  L L  N ++   P     L +L  L     KL+       G L +L+
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131

Query: 198 NLYLGSNQLTSI--PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR----VLVQIDLSMN 251
            L +  N + S   P+   NL  +++++LS N        ++  LR    V + +D+S+N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 252 NFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNNNISGAIPIS-- 308
                       +K L  L L  N    +I    +  L  L    L          +   
Sbjct: 192 PIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 309 ----LEKLLDLKYINVSFNKLEGEIPREGPFRNFS 339
               +E L D+                   F   +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  123 bits (312), Expect = 5e-30
 Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 7/214 (3%)

Query: 7   NFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFL 66
           +FSG         + L  L+L  N     +   F  L  L+ L   ++ L   T      
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE----F 417

Query: 67  SSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLT 125
           S+  + + L YL  S  +           L+ S+    M   +   +    + +N TNLT
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
            + L   +L        D L +LQLL++  N L         +L +L  LD   N++   
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 186 VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
                    SL    L +N +  I      L+++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  158 bits (402), Expect = 4e-44
 Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 8/168 (4%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +V++A    G +VAVK+   Q         F  E  +MKR+RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +LK  N+L+D      + DFG+++  LK    L+      T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAP 208

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  153 bits (388), Expect = 2e-41
 Identities = 65/355 (18%), Positives = 122/355 (34%), Gaps = 28/355 (7%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           +    +     +P+ +  +  ++  L L            F     +++L + +N +   
Sbjct: 50  VTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 108

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
            P +       N   L  L    N L  +      N    +    M N N+   I ++  
Sbjct: 109 PPHV-----FQNVPLLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTF 161

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
              T+L  + L  N+L     + L  +  L   ++  N L       L    A+  LD  
Sbjct: 162 QATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 213

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
            N ++         LT    L L  N LT     L N   ++ ++LS N     +     
Sbjct: 214 HNSINVVRGPVNVELTI---LKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFV 269

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
            ++ L ++ +S N     +      +  L+ L L +N L   +  +      L++L L +
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP 353
           N+I     + L     LK + +S N  +        FRN +  +    +  C   
Sbjct: 328 NSIV---TLKLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (347), Expect = 9e-36
 Identities = 63/324 (19%), Positives = 127/324 (39%), Gaps = 24/324 (7%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            I S +        + ++M +   +       L N K ++   + +          + L 
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA-----ALLD 66

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL 129
           + + ++ L+ ++  ++ I   A      +++  +M    I   +P  +  N+  LT + L
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124

Query: 130 GGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFLLDLGGNKLSGFVPA 188
             N L+           KL  LS+ +N LE  I DD  +   +L  L L  N+L+     
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVD-- 181

Query: 189 CFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDL 248
               + SL +  +  N L+++      ++    L+ S NS      +       L  + L
Sbjct: 182 -LSLIPSLFHANVSYNLLSTLAI-PIAVE---ELDASHNSINV---VRGPVNVELTILKL 233

Query: 249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS 308
             NN +      + +   L  + L YN L+  +      +  L+ L +SNN +  A+ + 
Sbjct: 234 QHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 309 LEKLLDLKYINVSFNKLEGEIPRE 332
            + +  LK +++S N L   + R 
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERN 313

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  130 bits (329), Expect = 2e-33
 Identities = 62/317 (19%), Positives = 113/317 (35%), Gaps = 27/317 (8%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L +  N     +P  +F N   L+ L LE N         F N   L  LS++ N L   
Sbjct: 98  LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                   +      L+ L  S+N L  +    I +L         F+ N+S ++   ++
Sbjct: 157 ED-----DTFQATTSLQNLQLSSNRLTHVDLSLIPSL---------FHANVSYNLLSTLA 202

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
               +  +    N +N  +   +    +L +L L+ N L  +    L     L  +DL  
Sbjct: 203 IPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSY 257

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN 239
           N+L   +   F  +  L  LY+ +N+L ++      +  +  L+LS N     +      
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQ 316

Query: 240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
              L  + L  N+    +   +     L+ L L +N    +         ++    + + 
Sbjct: 317 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDA 371

Query: 300 NISGAIPISLEKLLDLK 316
           +    I   LE  L  K
Sbjct: 372 DQHCKIDYQLEHGLCCK 388

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (377), Expect = 6e-41
 Identities = 37/169 (21%), Positives = 77/169 (45%), Gaps = 14/169 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +       ++K R Q G ++ VKV  ++       + F+ EC  ++   H N++ ++ +C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 494 SN--DDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
            +       L+  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH      I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              L   +V++D++M A +S   +         S      +    ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP 177

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  150 bits (381), Expect = 6e-41
 Identities = 58/201 (28%), Positives = 80/201 (39%), Gaps = 25/201 (12%)

Query: 418 FTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDM 477
               E     +      LIGRG   +VYK  + D   VAVKVF        ++F  E ++
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58

Query: 478 MK--RIRHRNLIKIISSCSNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNI 530
            +   + H N+ + I               LV+EY P+GSL K  Y S +  D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRL 116

Query: 531 MIDVASALEYLH------FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
              V   L YLH        Y   I H DL   NVL+ ++    +SDFG++  L      
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 585 LTQTQTLA------TIGYMAP 599
               +  A      TI YMAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  149 bits (377), Expect = 7e-41
 Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF-------DLQYEGAFKSFDIECDMMKRIRHRNLI 487
           IG+GG   V+K R ++D   VA+K         + +    F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 548 PIIHCDLKPNNVLLD-----DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (376), Expect = 1e-40
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 8/166 (4%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LK NN+ L ++    + DFG+A    +   S    Q   +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  148 bits (376), Expect = 2e-40
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 11/171 (6%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
            LIG+G    VY  R     EVA+++ D++   E   K+F  E    ++ RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAK---PLLKEDQSLTQTQTLATIGYMAP 599
            DLK  NV  D+  V  ++DFG+      L    +          + ++AP
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  148 bits (376), Expect = 2e-40
 Identities = 49/310 (15%), Positives = 116/310 (37%), Gaps = 21/310 (6%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
           I     N ++    ++  +S    + +   +  N+K L L+ N L+  +      + L+ 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-----ADLAP 56

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
              L+ L+ S+N L   L   + +LS       +   +++ +  +E+    ++ T++   
Sbjct: 57  FTKLELLNLSSNVLYETLD--LESLST------LRTLDLNNNYVQELLVGPSIETLHAAN 108

Query: 132 NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF-VPACF 190
           N ++    ++  + Q  + + L +N++      D    + +  LDL  N++         
Sbjct: 109 NNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM 250
            +  +L +L L  N +  +         +  L+LSSN     +  E  +   +  I L  
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRN 223

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQ-GSIPDSIGGLIDLKSLDLSNNNISGAIPISL 309
           N     I   +   ++L++  L  N    G++ D       ++++               
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282

Query: 310 EKLLDLKYIN 319
             +  L +  
Sbjct: 283 CTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  131 bits (331), Expect = 3e-34
 Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 26/239 (10%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
           +I E   N        +  + L  ++         ++ L L  N L      DL     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYIL------------ 220
            LL+L  N L   +     +L++LR L L +N +  +     +++ +             
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-VGPSIETLHAANNNISRVSCS 117

Query: 221 ------YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLE 273
                  + L++N  T    L+ G    +  +DL +N                L++L L+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 274 YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           YN +   +   +     LK+LDLS+N ++  +    +    + +I++  NKL   I + 
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  147 bits (373), Expect = 5e-40
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 13/167 (7%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           +GRG    V KA      +VA+K  + + E   K+F +E   + R+ H N++K+  +C N
Sbjct: 16  VGRGAFGVVCKA-KWRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 496 DDFKALVLEYMPHGSLEKCLYSSN--YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                LV+EY   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 554 LKPNNVLLDDNM-VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N+LL     V  + DFG A      D     T    +  +MAP
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  150 bits (381), Expect = 1e-39
 Identities = 70/355 (19%), Positives = 124/355 (34%), Gaps = 41/355 (11%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +L     F   +P  I   ++   L+L  N       + F +  +L+ L LN N +++  
Sbjct: 16  VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-S 119
           P      + +N   L+ L   +N L                            IP  + +
Sbjct: 73  PG-----AFNNLFNLRTLGLRSNRLK--------------------------LIPLGVFT 101

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLG 178
            L+NLT + +  NK+   +      L  L+ L + DN L   I       L +L  L L 
Sbjct: 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLE 160

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI 237
              L+        +L  L  L L    + +I   +   L  +  L +S   +   +    
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
                L  + ++  N +      +  L  L++L L YN +       +  L+ L+ + L 
Sbjct: 221 LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280

Query: 298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE--GPFRNFSAESFKGNELLC 350
              ++   P +   L  L+ +NVS N+L   +         N        N L C
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 6/144 (4%)

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS 254
             R +     +  ++P  +        L+L  N        E  +   L +++L+ N  S
Sbjct: 12  QDRAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPISLEKLL 313
              P    +L +L+ L L  NRL+  IP  +  GL +L  LD+S N I   +    + L 
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128

Query: 314 DLKYINVSFNKLEGEIPREGPFRN 337
           +LK + V  N L   I     F  
Sbjct: 129 NLKSLEVGDNDLV-YIS-HRAFSG 150

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  149 bits (377), Expect = 1e-38
 Identities = 65/355 (18%), Positives = 122/355 (34%), Gaps = 28/355 (7%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           +    +     +P+ +  +  ++  L L            F     +++L + +N +   
Sbjct: 56  VTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 114

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
            P +       N   L  L    N L  +      N    +    M N N+   I ++  
Sbjct: 115 PPHV-----FQNVPLLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTF 167

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
              T+L  + L  N+L     + L  +  L   ++  N L       L    A+  LD  
Sbjct: 168 QATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
            N ++         LT    L L  N LT     L N   ++ ++LS N     +     
Sbjct: 220 HNSINVVRGPVNVELTI---LKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFV 275

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
            ++ L ++ +S N     +      +  L+ L L +N L   +  +      L++L L +
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP 353
           N+I     + L     LK + +S N  +        FRN +  +    +  C   
Sbjct: 334 NSIV---TLKLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  130 bits (329), Expect = 3e-32
 Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 27/314 (8%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L +  N     +P  +F N   L+ L LE N         F N   L  LS++ N L   
Sbjct: 104 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 162

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                   +      L+ L  S+N L  +    I +L         F+ N+S ++   ++
Sbjct: 163 ED-----DTFQATTSLQNLQLSSNRLTHVDLSLIPSL---------FHANVSYNLLSTLA 208

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
               +  +    N +N    +      +L +L L+ N L  +    L     L  +DL  
Sbjct: 209 IPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSY 263

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN 239
           N+L   +   F  +  L  LY+ +N+L ++      +  +  L+LS N     +      
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQ 322

Query: 240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
              L  + L  N+    +   +     L+ L L +N    +         ++    + + 
Sbjct: 323 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDA 377

Query: 300 NISGAIPISLEKLL 313
           +    I   LE  L
Sbjct: 378 DQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  130 bits (328), Expect = 4e-32
 Identities = 61/316 (19%), Positives = 118/316 (37%), Gaps = 35/316 (11%)

Query: 39  TFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ 98
              +            ++   T  + F          K ++F N+++  +    + +  Q
Sbjct: 17  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76

Query: 99  SMEVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQ 157
            +E+  + +  I   I     +    +  +Y+G N +    P     +  L +L LE N 
Sbjct: 77  -VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 158 LEGSIPDDL-CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWN 215
           L  S+P  +      L  L +  N L       F   TSL+NL L SN+LT +  S + +
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193

Query: 216 LKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP----------------- 258
           L    + N+S N  +      +     + ++D S N+ +                     
Sbjct: 194 LF---HANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 245

Query: 259 --TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK 316
               + +   L  + L YN L+  +      +  L+ L +SNN +  A+ +  + +  LK
Sbjct: 246 DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 304

Query: 317 YINVSFNKLEGEIPRE 332
            +++S N L   + R 
Sbjct: 305 VLDLSHNHLL-HVERN 319

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (298), Expect = 2e-28
 Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 27/293 (9%)

Query: 51  LNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS----QSMEVFFMF 106
             YN      P+   +   SN +Y     F +  +D                + ++    
Sbjct: 5   QRYNVKPR-QPEYKCI--DSNLQYD--CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFK 59

Query: 107 NCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD 165
           N  +   +P  +  +   +  + L   ++      A      +Q L +  N +    P  
Sbjct: 60  NSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118

Query: 166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNL 224
              +  L +L L  N LS      F N   L  L + +N L  I   T      +  L L
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178

Query: 225 SSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS 284
           SSN  T    +++  +  L   ++S N       +T+     ++ L   +N +   +   
Sbjct: 179 SSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGP 229

Query: 285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
           +   ++L  L L +NN++      L     L  +++S+N+LE +I    PF  
Sbjct: 230 V--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIM-YHPFVK 276

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  146 bits (370), Expect = 3e-38
 Identities = 50/317 (15%), Positives = 120/317 (37%), Gaps = 23/317 (7%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
           I     N ++    ++  +S    + +   +  N+K L L+ N L+  +      + L+ 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-----ADLAP 56

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
              L+ L+ S+N L   L   + +LS       +   +++ +  +E+    ++ T++   
Sbjct: 57  FTKLELLNLSSNVLYETLD--LESLST------LRTLDLNNNYVQELLVGPSIETLHAAN 108

Query: 132 NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF-VPACF 190
           N ++    ++  + Q  + + L +N++      D    + +  LDL  N++         
Sbjct: 109 NNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM 250
            +  +L +L L  N +  +   +     +  L+LSSN     +  E  +   +  I L  
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRN 223

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQ-GSIPDSIGGLIDLKSLDLSNNNISGAIPISL 309
           N     I   +   ++L++  L  N    G++ D       ++++      +      + 
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNE 280

Query: 310 EKLLDLKYINVSFNKLE 326
           E+       +      E
Sbjct: 281 EECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  142 bits (359), Expect = 1e-36
 Identities = 49/349 (14%), Positives = 112/349 (32%), Gaps = 26/349 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
             +  ++    + S   +A  +  L+L  N               L+ L+L+ N L  + 
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74

Query: 61  P-----KL-------NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNC 108
                  L       N++  L     ++ L  +NN++  +            +  ++ N 
Sbjct: 75  DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGK----KNIYLANN 130

Query: 109 NISGSIPEEISNLTNLTTIYLGGNKLNG-SIPIALDKLQKLQLLSLEDNQLEGSIPDDLC 167
            I+     +    + +  + L  N+++  +          L+ L+L+ N +   +   + 
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189

Query: 168 RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
             A L  LDL  NKL+ F+   F +   +  + L +N+L  I   L   + + + +L  N
Sbjct: 190 -FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN 247

Query: 228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG 287
            F     L     +      ++             +              +         
Sbjct: 248 GFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 288 LIDLKSLDLS----NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           LI LK  + +      + +  +    E     + I+    +    +  +
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQ 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  134 bits (339), Expect = 5e-34
 Identities = 56/346 (16%), Positives = 100/346 (28%), Gaps = 23/346 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS-- 58
           L L GN  S    + +   +KL  L L  N  Y  +     +L  L+ L LN NY+    
Sbjct: 39  LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL 96

Query: 59  STPKLNFLS---------SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN 109
             P +  L          S S  +  K +  +NN +  +     G  S  ++   +    
Sbjct: 97  VGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRS-RVQYLDLKLNE 155

Query: 110 ISG-SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
           I   +  E  ++   L  + L  N +   +        KL+ L L  N+L   +  +   
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQS 212

Query: 169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNS 228
            A +  + L  NKL   +        +L +  L  N         +  K      ++  +
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS----IPDS 284
                        V                     L  L+         QGS    +   
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331

Query: 285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
                  + +D         I     +      +      L+ ++ 
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  127 bits (320), Expect = 2e-31
 Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 26/239 (10%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
           +I E   N        +  + L  ++         ++ L L  N L      DL     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYIL------------ 220
            LL+L  N L   +     +L++LR L L +N +  +     +++ +             
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-VGPSIETLHAANNNISRVSCS 117

Query: 221 ------YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLE 273
                  + L++N  T    L+ G    +  +DL +N                L++L L+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 274 YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           YN +   +   +     LK+LDLS+N ++  +    +    + +I++  NKL   I + 
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 31/298 (10%), Positives = 77/298 (25%), Gaps = 14/298 (4%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  +  +     +A+ ++ + L  N     I       +NL+   L  N     T
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGT 253

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNC--NISGSIPEEI 118
            +  F       K  +  + +  ++  +  +     +      +   C  ++     + +
Sbjct: 254 LRDFFS------KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 119 SNLT--NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
             L       +   G++    +    +   + + +     Q    I     R  A   L+
Sbjct: 308 IALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL-PL 235
                L   V         L      +     +         +  L      +       
Sbjct: 367 QKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQ 426

Query: 236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKS 293
           +      +   D+  +  +          K      L       ++ + +    +L S
Sbjct: 427 QSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  141 bits (357), Expect = 3e-38
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 19/176 (10%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVF----DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           IG GG   VY+A    G EVAVK      D       ++   E  +   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
            C  +    LV+E+   G L + L      +     +N  + +A  + YLH    VPIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 552 CDLKPNNVLLD--------DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLK +N+L+          N +  ++DFG+A    +E    T+        +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  147 bits (373), Expect = 4e-38
 Identities = 63/350 (18%), Positives = 120/350 (34%), Gaps = 23/350 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYG------FIPNTFGNLRNLKRLSLNY 53
           L L  N  S  +        + L    L +  F        F  +    L NL       
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 54  NYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS 113
            YL       + +   +    +   S  + +++ +   +     Q +E+           
Sbjct: 265 AYLDYYL--DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 114 IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE--GSIPDDLCRLAA 171
                  L +L  +    NK   +   +   L  L+ L L  N L   G          +
Sbjct: 323 ------KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSF 229
           L  LDL  N +   + + F  L  L +L    + L  +   S   +L+ ++YL++S    
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 230 TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTI-GDLKDLQYLFLEYNRLQGSIPDSIGGL 288
                     L  L  + ++ N+F       I  +L++L +L L   +L+   P +   L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493

Query: 289 IDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNF 338
             L+ L++++N +        ++L  L+ I +  N  +   PR      +
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  142 bits (360), Expect = 2e-36
 Identities = 69/353 (19%), Positives = 125/353 (35%), Gaps = 30/353 (8%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L+L GN             S L +L     +         G+L+ LK L++ +N + S  
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-- 138

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNC--NISGSIPEEI 118
                    SN   L++L  S+N +  I    +  L Q   +    +   N    I    
Sbjct: 139 --FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196

Query: 119 SNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLE------DNQLEGSIPDDLCRLAA 171
                L  + L  N  + ++    +  L  L++  L       +  LE      L  L  
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 172 LFLLDLGGNKLSGF---VPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSS 226
           L + +     L  +   +   F  LT++ +  L S  +  +   S  +  +++  +N   
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316

Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ--GSIPDS 284
             F          L+ L ++  + N           DL  L++L L  N L   G    S
Sbjct: 317 GQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
             G   LK LDLS N +   +  +   L  L++++   + L+ ++     F +
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  127 bits (321), Expect = 2e-31
 Identities = 80/361 (22%), Positives = 114/361 (31%), Gaps = 44/361 (12%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N          F+  +L  L+L            + +L +L  L L  N + S  
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                  + S    L+ L     +L  +    IG+L    E+    N   S  +PE  SN
Sbjct: 93  L-----GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQL----LSLEDNQLEGSIPDDLCRLAALFLLD 176
           LTNL  + L  NK+       L  L ++ L    L L  N +   I     +   L  L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206

Query: 177 LGGNKLSGFVPA-CFGNLTSLRNLYL------GSNQLTSIP-STLWNLK--YILYLNLSS 226
           L  N  S  V   C   L  L    L          L     S L  L    I    L+ 
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 227 NS-FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT-------------------TIGDLKD 266
              +   +      L  +    L                                  LK 
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

Query: 267 LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS--GAIPISLEKLLDLKYINVSFNK 324
           L+ L    N+   +  +    L  L+ LDLS N +S  G    S      LKY+++SFN 
Sbjct: 327 LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 325 L 325
           +
Sbjct: 385 V 385

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  125 bits (316), Expect = 1e-30
 Identities = 58/330 (17%), Positives = 107/330 (32%), Gaps = 30/330 (9%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
           IP  +        L+L  N        +F +   L+ L L+   + +         +  +
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED-----GAYQS 74

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
             +L  L  + N +  +   A   LS S++       N++      I +L  L  + +  
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 132 NKLN-GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL----FLLDLGGNKLSGFV 186
           N +    +P     L  L+ L L  N+++     DL  L  +      LDL  N ++   
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 187 PACFGNLTSLRNLYLGSNQLTS--IPSTLWNLKYILYLNLSSNSFTGP---LPLEIGNLR 241
           P  F  +  L  L L +N  +   + + +  L  +    L    F         +   L 
Sbjct: 194 PGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 242 VLVQIDLSMNNFSGF------IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD 295
            L  + +     +        I      L ++    L    ++     S       + L+
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLE 310

Query: 296 LSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           L N            KL  LK +  + NK 
Sbjct: 311 LVNCKFGQ---FPTLKLKSLKRLTFTSNKG 337

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  115 bits (291), Expect = 2e-27
 Identities = 52/259 (20%), Positives = 88/259 (33%), Gaps = 18/259 (6%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
              +   I      NL  S +   +    +         +   L  + L   ++      
Sbjct: 15  MELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLY 200
           A   L  L  L L  N ++         L++L  L      L+       G+L +L+ L 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 201 LGSNQLTSI--PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL----VQIDLSMNNFS 254
           +  N + S   P    NL  + +L+LSSN        ++  L  +    + +DLS+N  +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPD-SIGGLIDLKSLDL------SNNNISGAIPI 307
            FI         L  L L  N    ++    I GL  L+   L      +  N+      
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 308 SLEKLLDLKYINVSFNKLE 326
           +LE L +L         L+
Sbjct: 250 ALEGLCNLTIEEFRLAYLD 268

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (256), Expect = 4e-23
 Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 11/218 (5%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMN--SFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL 63
           +N  G   S + +   L  L+L  N  SF G    +     +LK L L++N + + +   
Sbjct: 334 SNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNF 392

Query: 64  NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
             L  L      ++L F +++L  +   ++    +++    + + +   +     + L++
Sbjct: 393 LGLEQL------EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 124 LTTIYLGGNKLNGSI-PIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           L  + + GN    +  P    +L+ L  L L   QLE   P     L++L +L++  N+L
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYI 219
                  F  LTSL+ ++L +N    S P   +  +++
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 32/152 (21%), Positives = 51/152 (33%), Gaps = 6/152 (3%)

Query: 189 CFGNLTSLRNLYLGSNQLTSIPSTL-WNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQID 247
           C   + ++            IP  L ++ K    L+LS N           +   L  +D
Sbjct: 3   CVEVVPNI-TYQCMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLD 58

Query: 248 LSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPI 307
           LS              L  L  L L  N +Q     +  GL  L+ L     N++     
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 308 SLEKLLDLKYINVSFNKLEGEIPREGPFRNFS 339
            +  L  LK +NV+ N ++        F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  141 bits (357), Expect = 5e-38
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 15/177 (8%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             +G+G    V++   Q G  VAVK+F  + E ++   + E      +RH N++  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 494 SNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 544
                 +    L+  Y   GSL   L      LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA--TIGYMAP 599
               I H DLK  N+L+  N    ++D G+A    +    L         T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  140 bits (356), Expect = 2e-37
 Identities = 60/301 (19%), Positives = 119/301 (39%), Gaps = 28/301 (9%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            +P  +      + L+L+ N         F NL+NL  L L  N ++  +P      + +
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFA 97

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL 129
               L+ L  S N L  +       + ++++   +    I+  + + + + L  +  + L
Sbjct: 98  PLVKLERLYLSKNQLKELPE----KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVEL 152

Query: 130 GGNKLNGSI--PIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVP 187
           G N L  S     A   ++KL  + + D  +  +IP  L    +L  L L GNK++    
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA 209

Query: 188 ACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQI 246
           A    L +L  L L  N ++++ + +L N  ++  L+L++N     +P  + + + +  +
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVV 268

Query: 247 DLSMNNFSGFIPTTIG------DLKDLQYLFLEYNRLQGSI--PDSIGGLIDLKSLDLSN 298
            L  NN S                     + L  N +Q     P +   +    ++ L N
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328

Query: 299 N 299
            
Sbjct: 329 Y 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  125 bits (315), Expect = 7e-32
 Identities = 54/266 (20%), Positives = 102/266 (38%), Gaps = 20/266 (7%)

Query: 95  NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLE 154
           +L     +  + N  I+     +  NL NL T+ L  NK++   P A   L KL+ L L 
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 155 DNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI---PS 211
            NQL+  +P+ +     L  L +  N+++    + F  L  +  + LG+N L S      
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 212 TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLF 271
               +K + Y+ ++  + T    +  G    L ++ L  N  +     ++  L +L  L 
Sbjct: 166 AFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 272 LEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR 331
           L +N +      S+     L+ L L+NN +   +P  L     ++ + +  N +      
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI------ 275

Query: 332 EGPFRNFSAESFKGNELLCGTPNLQV 357
                   +  F          +   
Sbjct: 276 ----SAIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 54/206 (26%), Positives = 81/206 (39%), Gaps = 10/206 (4%)

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           +L  +      L   +P  L       LL L++N++      D   L  L  L L  NK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
           S   P  F  L  L  LYL  NQL  +P  +   K +  L +  N  T         L  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146

Query: 243 LVQIDLSMNNF--SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
           ++ ++L  N    SG        +K L Y+ +    +  +IP   G    L  L L  N 
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLE 326
           I+     SL+ L +L  + +SFN + 
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSIS 229

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 29/141 (20%), Positives = 48/141 (34%), Gaps = 15/141 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L GN  +  + +      + L++L L  NS       +  N  +L+ L LN N L   
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 255

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGI------LPRAIGNLSQSMEVFFMFNCNISGS 113
                    L++ KY++ +   NN++  I       P      +    V    N      
Sbjct: 256 PG------GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 114 IPEEI-SNLTNLTTIYLGGNK 133
           I       +     + LG  K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  140 bits (355), Expect = 2e-37
 Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 15/177 (8%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             IG+G    V+  + + G +VAVKVF    E ++   + E      +RH N++  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 494 SNDDFK----ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 544
                      L+ +Y  +GSL   L   +  LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA--TIGYMAP 599
               I H DLK  N+L+  N    ++D G+A   + +   +         T  YM P
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  144 bits (366), Expect = 1e-36
 Identities = 71/350 (20%), Positives = 118/350 (33%), Gaps = 51/350 (14%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L       TI    F N   L  L+L  +  Y   P+ F  L +L  L L +  L+ +
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
             K  +  +L     L  L  S N +  +                         +     
Sbjct: 113 VLKDGYFRNLKA---LTRLDLSKNQIRSL------------------------YLHPSFG 145

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQ--KLQLLSLEDNQLEGSIPDDLCRLAALF---- 173
            L +L +I    N++       L+ LQ   L   SL  N L   +  D  +    F    
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205

Query: 174 --LLDLGGNKLSGFVPACFGN------------LTSLRNLYLGSNQLTSIP-STLWNLK- 217
             +LD+ GN  +  +   F N               +     G + +     +T   L  
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265

Query: 218 -YILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNR 276
             + +L+LS              L+ L  ++L+ N  +         L +LQ L L YN 
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325

Query: 277 LQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
           L      +  GL  +  +DL  N+I+     + + L  L+ +++  N L 
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  144 bits (364), Expect = 3e-36
 Identities = 70/347 (20%), Positives = 122/347 (35%), Gaps = 35/347 (10%)

Query: 5   GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
             N +  +P      +   RL L  N       ++F  L  L+ L L   Y   +  K  
Sbjct: 13  FCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK-- 66

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSI--PEEISNLT 122
              +  N   L+ L   ++ +  + P A   L   +    ++ C +S ++       NL 
Sbjct: 67  --EAFRNLPNLRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 123 NLTTIYLGGNKLNG-SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFL--LDLGG 179
            LT + L  N++    +  +  KL  L+ +    NQ+      +L  L    L    L  
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 180 NKLSGFVPACFGNL------TSLRNLYLGSNQLTSIPS-------------TLWNLKYIL 220
           N L   V   +G          L  L +  N  T   +             +L    +I+
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 221 YLNLSSNSFTGPLPLEIGNLRV--LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
                 ++   P       L    +  +DLS              LKDL+ L L YN++ 
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303

Query: 279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
               ++  GL +L+ L+LS N +      +   L  + YI++  N +
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  140 bits (354), Expect = 4e-35
 Identities = 80/436 (18%), Positives = 142/436 (32%), Gaps = 61/436 (13%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLR--NLKRLSLNYNYLTSSTPKL 63
           N  S +    +  A  +       ++      NTF  L   +++ L L++ ++ S     
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-- 283

Query: 64  NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
                    K LK L+ + N ++ I   A   L  +++V  +    +          L  
Sbjct: 284 ---RVFETLKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPK 339

Query: 124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS 183
           +  I L  N +          L+KLQ L L DN L       +  + ++  + L GNKL 
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394

Query: 184 GF---------------------VPACFGNLTSLRNLYLGSNQLTSIPS--TLWNLKYIL 220
                                  +      +  L+ L L  N+ +S     T      + 
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454

Query: 221 YLNLSSNSFTGPLPLEI-----GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN 275
            L L  N        E+       L  L  + L+ N  +   P     L  L+ L L  N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514

Query: 276 RLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPF 335
           RL     + +     L+ LD+S N +      + +  + L  ++++ NK   E      F
Sbjct: 515 RLTVLSHNDLPAN--LEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECE-LSTF 568

Query: 336 RNFSAESFKG-----NELLCGTP---------NLQVPPCRTRIHHTSRKNDLLLGIVLPL 381
            N+   +         ++ C  P         +L    C       S K  L +   + L
Sbjct: 569 INWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628

Query: 382 STIFMMAVILLILRYR 397
           +   M  + +   R  
Sbjct: 629 TLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  139 bits (353), Expect = 6e-35
 Identities = 75/366 (20%), Positives = 127/366 (34%), Gaps = 43/366 (11%)

Query: 1   LLLWGNNFSGTIPSFIFN---ASKLSRLELEMNSFYGFIPNTFGNLRN------LKRLSL 51
           +    N     +            LS   L  NS Y  +   +G   N      L+ L +
Sbjct: 153 IDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211

Query: 52  NYNYLTSSTPKLNF-------LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ-SMEVF 103
           + N  T                 SL    ++    F  +++          L++ S+   
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271

Query: 104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP 163
            + +  +          L +L  + L  NK+N     A   L  LQ+L+L  N L     
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYIL--- 220
            +   L  +  +DL  N ++      F  L  L+ L L  N LT+I   + ++  I    
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-IPSIPDIFLSG 390

Query: 221 --------------YLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNNFSGFIPT-TIGDL 264
                          ++LS N       L     +  L  + L+ N FS      T  + 
Sbjct: 391 NKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450

Query: 265 KDLQYLFLEYNRLQGSI-----PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYIN 319
             L+ LFL  N LQ +       D   GL  L+ L L++N ++   P     L  L+ ++
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510

Query: 320 VSFNKL 325
           ++ N+L
Sbjct: 511 LNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  121 bits (305), Expect = 7e-29
 Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 26/278 (9%)

Query: 75  LKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL 134
            + L  S N +  +   +   L Q   +             E   NL NL  + LG +K+
Sbjct: 26  TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

Query: 135 NGSIPIALDKLQKLQLLSLEDNQLEGSI--PDDLCRLAALFLLDLGGNKLSGF-VPACFG 191
               P A   L  L  L L    L  ++        L AL  LDL  N++    +   FG
Sbjct: 86  YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145

Query: 192 NLTSLRNLYLGSNQLTSIP-STLWNL--KYILYLNLSSNSFTGPLPLEIGNL------RV 242
            L SL+++   SNQ+  +    L  L  K + + +L++NS    + ++ G         V
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205

Query: 243 LVQIDLSMNNFSGFIP------------TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID 290
           L  +D+S N ++  I              ++     +      ++ ++    ++  GL  
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265

Query: 291 --LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
             ++ LDLS+  +        E L DLK +N+++NK+ 
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  104 bits (262), Expect = 1e-23
 Identities = 55/275 (20%), Positives = 101/275 (36%), Gaps = 30/275 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  +       +    L  L L  N       + F  L  +  + L  N++    
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 61  PKL--------------NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF 106
            +               N L+++     +  +  S N L       +  ++ +  +  + 
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLS 409

Query: 107 NCNISG-SIPEEISNLTNLTTIYLGGNKLNG-SIPIALDKLQKLQLLSLEDNQLEGSIPD 164
              +    I   +  + +L  + L  N+ +  S      +   L+ L L +N L+ +   
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469

Query: 165 DLCR-----LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
           +LC      L+ L +L L  N L+   P  F +LT+LR L L SN+LT +         +
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN-DLPANL 528

Query: 220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS 254
             L++S N    P P    +L     +D++ N F 
Sbjct: 529 EILDISRNQLLAPNPDVFVSLS---VLDITHNKFI 560

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  135 bits (342), Expect = 1e-35
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 15/177 (8%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             IG+G    V++ + + G EVAVK+F  + E ++   + E      +RH N++  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 494 SNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FG 544
           + D+       LV +Y  HGSL   L  + Y + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATIGYMAP 599
               I H DLK  N+L+  N    ++D G+A       +   +     + T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  134 bits (339), Expect = 2e-35
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 16/177 (9%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G+G      K    + G  + +K      E   ++F  E  +M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDL 554
            D     + EY+  G+L   + S +      QR++   D+AS + YLH   S+ IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 555 KPNNVLLDDNMVAHLSDFGMAK------------PLLKEDQSLTQTQTLATIGYMAP 599
             +N L+ +N    ++DFG+A+              LK+     +   +    +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  139 bits (351), Expect = 4e-35
 Identities = 76/307 (24%), Positives = 120/307 (39%), Gaps = 49/307 (15%)

Query: 20  SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLS 79
           +  + L +  +     +P+      ++  L +  N LTS        +       L+ L 
Sbjct: 40  NGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLTS------LPALPPE---LRTLE 87

Query: 80  FSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP 139
            S N L   LP     L +               +P   S L  L   ++ GN+L  S+P
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLT-----HLPALPSGLCKL---WIFGNQLT-SLP 137

Query: 140 IALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL 199
           +    LQ+   LS+ DNQL  S+P     L  L+  +   N+L+  +P     L     L
Sbjct: 138 VLPPGLQE---LSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQE---L 186

Query: 200 YLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT 259
            +  NQL S+P+    L     L   +N  T  LP     L+ L    +S N  +  +P 
Sbjct: 187 SVSDNQLASLPTLPSELY---KLWAYNNRLT-SLPALPSGLKEL---IVSGNRLTS-LPV 238

Query: 260 TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYIN 319
                 +L+ L +  NRL  S+P    G   L SL +  N ++  +P SL  L     +N
Sbjct: 239 LPS---ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVN 290

Query: 320 VSFNKLE 326
           +  N L 
Sbjct: 291 LEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (337), Expect = 3e-33
 Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 49/301 (16%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L++  NN + ++P+      +L  LE+  N     +P     L  L   S    +L    
Sbjct: 66  LVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP--- 117

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                 +  S    L  L    N L   LP     L    +   + +  ++ S+P   S 
Sbjct: 118 ------ALPSG---LCKLWIFGNQLTS-LPVLPPGL----QELSVSDNQLA-SLPALPSE 162

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           L  L   +   N+L  S+P+    LQ+   LS+ DNQL  S+P     L  L+  +    
Sbjct: 163 LCKL---WAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYKLWAYNNRLT 214

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
            L           + L+ L +  N+LTS+P     LK    L +S N  T  LP+    L
Sbjct: 215 SLP-------ALPSGLKELIVSGNRLTSLPVLPSELK---ELMVSGNRLTS-LPMLPSGL 263

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             L    +  N  +  +P ++  L     + LE N L            ++ S    +  
Sbjct: 264 LSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGP 316

Query: 301 I 301
           I
Sbjct: 317 I 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (321), Expect = 3e-31
 Identities = 69/290 (23%), Positives = 109/290 (37%), Gaps = 49/290 (16%)

Query: 43  LRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEV 102
                 L++  + LT+    L          ++  L   +N+L   LP     L +++EV
Sbjct: 39  NNGNAVLNVGESGLTTLPDCL--------PAHITTLVIPDNNLT-SLPALPPEL-RTLEV 88

Query: 103 FFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSI 162
               + N   S+P     L  L+        L             L  L +  NQL  S+
Sbjct: 89  ----SGNQLTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SL 136

Query: 163 PDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYL 222
           P        L  L +  N+L+   PA    L     L+  +NQLTS+P     L+    L
Sbjct: 137 PVL---PPGLQELSVSDNQLASL-PALPSELC---KLWAYNNQLTSLPMLPSGLQ---EL 186

Query: 223 NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP 282
           ++S N     LP     L  L       N  +  +P        L+ L +  NRL  S+P
Sbjct: 187 SVSDNQLAS-LPTLPSELYKL---WAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLP 237

Query: 283 DSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
                  +LK L +S N ++ ++P+    LL L   +V  N+L   +P  
Sbjct: 238 VLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPES 279

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 90.0 bits (223), Expect = 4e-19
 Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 23/166 (13%)

Query: 167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS 226
           C      +L++G + L+  +P C      +  L +  N LTS+P+    L+    L +S 
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELR---TLEVSG 90

Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
           N  T  LP+    L  L      + +              L  L++  N+L  S+P    
Sbjct: 91  NQLTS-LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPP 141

Query: 287 GLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           G   L+ L +S+N ++ ++P    +L  L       N+L   +P  
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPML 179

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  132 bits (334), Expect = 2e-34
 Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 27/300 (9%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            +P  I      + L+L+ N       + F  L++L  L L  N ++    K     + S
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK-----AFS 99

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL 129
             + L+ L  S N L  I P    NL  S+    + +  I   +P+ + S L N+  I +
Sbjct: 100 PLRKLQKLYISKNHLVEIPP----NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEM 154

Query: 130 GGNKL-NGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPA 188
           GGN L N           KL  L + + +L   IP DL     L  L L  NK+      
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELE 211

Query: 189 CFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQID 247
                + L  L LG NQ+  I + +L  L  +  L+L +N  +  +P  + +L++L  + 
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVY 270

Query: 248 LSMNNFSGFIPTTIGDLKD------LQYLFLEYNRLQGSI--PDSIGGLIDLKSLDLSNN 299
           L  NN +         +           + L  N +      P +   + D  ++   N 
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  120 bits (304), Expect = 2e-30
 Identities = 61/286 (21%), Positives = 108/286 (37%), Gaps = 25/286 (8%)

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
           +L+ +  S+  L  + P+    +S    +  + N +IS    ++   L +L  + L  NK
Sbjct: 34  HLRVVQCSDLGLKAV-PK---EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
           ++     A   L+KLQ L +  N L   IP +L   ++L  L +  N++       F  L
Sbjct: 90  ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146

Query: 194 TSLRNLYLGSNQLTSI---PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM 250
            ++  + +G N L +    P     LK + YL +S    TG   +       L ++ L  
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG---IPKDLPETLNELHLDH 202

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLE 310
           N         +     L  L L +N+++     S+  L  L+ L L NN +S  +P  L 
Sbjct: 203 NKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 311 KLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQ 356
            L  L+ + +  N +                 F             
Sbjct: 262 DLKLLQVVYLHTNNI----------TKVGVNDFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 48/235 (20%), Positives = 80/235 (34%), Gaps = 40/235 (17%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L +  N+    IP  +   S L  L +  N         F  LRN+  + +  N L +S 
Sbjct: 107 LYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ--------------------SM 100
            +      L     L YL  S   L GI       L++                     +
Sbjct: 164 FEPGAFDGLK----LNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKL 219

Query: 101 EVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
               + +  I   I     S L  L  ++L  NKL+  +P  L  L+ LQ++ L  N + 
Sbjct: 220 YRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

Query: 160 GSIPDD-------LCRLAALFLLDLGGNKLSGFV--PACFGNLTSLRNLYLGSNQ 205
             +  +         + A    + L  N +  +   PA F  +T    +  G+ +
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  136 bits (343), Expect = 3e-34
 Identities = 62/353 (17%), Positives = 121/353 (34%), Gaps = 28/353 (7%)

Query: 5   GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
             +F+ +IPS +   + +  L+L  N              NL+ L L  + + +      
Sbjct: 14  SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG--- 67

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
              +  +   L++L  S+N L  +     G LS    +  M N   +  +     NLTNL
Sbjct: 68  --DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 125 TTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS 183
            T+ +G  +    I  I    L  L  L ++   L       L  +  +  L L  ++ +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTSIP----STLWNLKYILYLNLSSNSFTGP------- 232
             +      L+S+R L L    L                +  L    +  T         
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKD--------LQYLFLEYNRLQGSIPDS 284
           L   I  L  +   D ++N    F P+    + +        ++ L +    L   +   
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
              L  +K + + N+ +        + L  L+++++S N +  E  +    + 
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  135 bits (341), Expect = 5e-34
 Identities = 53/362 (14%), Positives = 120/362 (33%), Gaps = 28/362 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  +      +   + L  L L+ +       + F +L +L+ L L+ N+L+S +
Sbjct: 31  LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE-IS 119
                 S       LKYL+   N    +   ++     +++   + N      I     +
Sbjct: 91  S-----SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
            LT+L  + +    L      +L  ++ +  L+L  ++    +      L+++  L+L  
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQ-----------LTSIPSTLWNLKYILYLNLSSNS 228
             L+ F  +          +   + +           L  +   +  L  + + + + N 
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265

Query: 229 FTGPLPLEIGNLR--------VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
                P E   +          + ++ +        + T    L+ ++ + +E +++   
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAI---PISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
                  L  L+ LDLS N +                L+ + +S N L            
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

Query: 338 FS 339
             
Sbjct: 386 LK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  125 bits (317), Expect = 6e-31
 Identities = 69/384 (17%), Positives = 129/384 (33%), Gaps = 58/384 (15%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L+L  +  + TI    F +   L  L+L  N       + FG L +LK L+L  N   + 
Sbjct: 55  LILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT- 112

Query: 60  TPKLNFLSSLSNCKYLKYLSFS-NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
              L   S   N   L+ L      +   I       L+ S+    +   ++     + +
Sbjct: 113 ---LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT-SLNELEIKALSLRNYQSQSL 168

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG------------------ 160
            ++ ++  + L  ++    + I  D L  ++ L L D  L                    
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228

Query: 161 ----------------SIPDDLCRLAALFLLDLGGNKLSGFVPA--------CFGNLTSL 196
                            +   +  L+ +   D   N L  F P+              ++
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288

Query: 197 RNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG 255
           R L++    L    S     L+ +  + + ++           +L+ L  +DLS N    
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 256 FIPTT---IGDLKDLQYLFLEYNRLQ--GSIPDSIGGLIDLKSLDLSNNNISGAIPISLE 310
                    G    LQ L L  N L+      + +  L +L SLD+S N     +P S +
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407

Query: 311 KLLDLKYINVSFNKLEGEIPREGP 334
               ++++N+S   +   +    P
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCIP 430

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  123 bits (311), Expect = 4e-30
 Identities = 59/338 (17%), Positives = 114/338 (33%), Gaps = 27/338 (7%)

Query: 6   NNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPK-- 62
            + S  +     +  S +  LEL   +   F  +          +       +  T +  
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 63  LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF----------NCNISG 112
              L  L     L  + F + +L+G+            E+  +              +  
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD---LCRL 169
            +    S L  +  I +  +K+          L+ L+ L L +N +      +       
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 170 AALFLLDLGGNKLS--GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
            +L  L L  N L            L +L +L +  N    +P +    + + +LNLSS 
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420

Query: 228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG 287
                  ++    + L  +D+S NN   F       L  LQ L++  N+L+ ++PD+   
Sbjct: 421 GIRV---VKTCIPQTLEVLDVSNNNLDSFSL----FLPRLQELYISRNKLK-TLPDA-SL 471

Query: 288 LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
              L  + +S N +        ++L  L+ I +  N  
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (276), Expect = 1e-25
 Identities = 50/281 (17%), Positives = 89/281 (31%), Gaps = 39/281 (13%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L  +  + S  +          + RL +     +  +   +  L  +KR+++  + +   
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
               +F   L +   L++L  S N +     +                            
Sbjct: 326 PC--SFSQHLKS---LEFLDLSENLMVEEYLKN----------------------SACKG 358

Query: 120 NLTNLTTIYLGGNKLN--GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
              +L T+ L  N L         L  L+ L  L +  N     +PD       +  L+L
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
               +   V  C     +L  L + +N L S    L  L+    L +S N     LP + 
Sbjct: 418 SSTGIR-VVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQE---LYISRNKLKT-LP-DA 469

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
               VL+ + +S N            L  LQ ++L  N   
Sbjct: 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  108 bits (272), Expect = 4e-25
 Identities = 44/225 (19%), Positives = 91/225 (40%), Gaps = 9/225 (4%)

Query: 108 CNISG----SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP 163
           C+       SIP  ++    + ++ L  NK+       L     LQ+L L+ +++     
Sbjct: 10  CDGRSRSFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILY 221
           D    L +L  LDL  N LS    + FG L+SL+ L L  N   ++   S   NL  +  
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 222 LNLSS-NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
           L + +  +F+    ++   L  L ++++   +   +   ++  ++D+ +L L  +     
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           +      L  ++ L+L + N++      L        +     + 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  106 bits (266), Expect = 2e-24
 Identities = 50/260 (19%), Positives = 95/260 (36%), Gaps = 9/260 (3%)

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
           +C         + S   I       L+ +M+   +    I+     ++    NL  + L 
Sbjct: 3   SCDASGVCDGRSRSFTSIPS----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58

Query: 131 GNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFLLDLGGNKLSGF-VPA 188
            +++N     A   L  L+ L L DN L  S+       L++L  L+L GN      V +
Sbjct: 59  SSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 189 CFGNLTSLRNLYLGS-NQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQI 246
            F NLT+L+ L +G+    + I       L  +  L + + S        + ++R +  +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIP 306
            L ++  +  +      L  ++YL L    L       +        +       S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 307 ISLEKLLDLKYINVSFNKLE 326
            S  +LL L    +  +++E
Sbjct: 238 ESFNELLKLLRYILELSEVE 257

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 88.6 bits (220), Expect = 1e-18
 Identities = 39/240 (16%), Positives = 83/240 (34%), Gaps = 29/240 (12%)

Query: 5   GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
                  + +      K+ R+ +E +  +    +   +L++L+ L L+ N +     K +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGI--LPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
             +       L+ L  S N L  +      +  L  ++    +        +P+      
Sbjct: 355 --ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK-NLTSLDISRNTFH-PMPDSCQWPE 410

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFL-------- 174
            +  + L    +   +   +   Q L++L + +N L+ S    L RL  L++        
Sbjct: 411 KMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTL 466

Query: 175 -----------LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLN 223
                      + +  N+L       F  LTSL+ ++L +N        +  L   L  N
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  131 bits (332), Expect = 3e-33
 Identities = 86/342 (25%), Positives = 130/342 (38%), Gaps = 52/342 (15%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L     S ++P    +   L  L    NS    +P    +L++L   + N   L+   
Sbjct: 76  LELNNLGLS-SLPELPPH---LESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLP 130

Query: 61  P----------KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNI 110
           P          +L  L  L N  +LK +   NNSL   LP    +L    E     N  +
Sbjct: 131 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSL----EFIAAGNNQL 185

Query: 111 SGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLA 170
              +PE + NL  LT IY   N L   +P   D    L+ +   +N L      +L  L 
Sbjct: 186 E-ELPE-LQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL--EELPELQNLP 237

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT 230
            L  +    N L            SL  L +  N LT +P    +L +   L++S N F+
Sbjct: 238 FLTTIYADNNLLKTL----PDLPPSLEALNVRDNYLTDLPELPQSLTF---LDVSENIFS 290

Query: 231 GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID 290
           G L     NL  L   + S N     I +       L+ L +  N+L   +P     L  
Sbjct: 291 G-LSELPPNLYYL---NASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPPRL-- 339

Query: 291 LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
            + L  S N+++  +P   + L   K ++V +N L  E P  
Sbjct: 340 -ERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR-EFPDI 375

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  131 bits (331), Expect = 4e-33
 Identities = 83/360 (23%), Positives = 130/360 (36%), Gaps = 69/360 (19%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPN---------------TFGNLRN 45
           L+   N+ +  +P    +   L      + +     P                   N   
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154

Query: 46  LKRLSLNYNYLTS-------------STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRA 92
           LK + ++ N L                  +L  L  L N  +L  +   NNSL   LP  
Sbjct: 155 LKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK-LPDL 213

Query: 93  IGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLS 152
             +L    E     N  +      E+ NL  LTTIY   N L  ++P   D    L+ L+
Sbjct: 214 PLSL----ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLP---DLPPSLEALN 263

Query: 153 LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST 212
           + DN L   +P+    L  L + +   + LS           +L  L   SN++ S+   
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLSEL-------PPNLYYLNASSNEIRSLCDL 315

Query: 213 LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFL 272
             +L+    LN+S+N     LP     L  L     S N+ +  +P    +LK    L +
Sbjct: 316 PPSLEE---LNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQNLK---QLHV 364

Query: 273 EYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
           EYN L+   PD    + DL+      N+    +P   + L   K ++V  N L  E P  
Sbjct: 365 EYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNL---KQLHVETNPLR-EFPDI 414

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  130 bits (330), Expect = 5e-33
 Identities = 64/330 (19%), Positives = 116/330 (35%), Gaps = 48/330 (14%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            L   +N +  +P    N    +      + +    P   G  R +    L         
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-- 72

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                            L  +N  L   LP    +L    E       +++  +PE   +
Sbjct: 73  --------------AHELELNNLGLS-SLPELPPHL----ESLVASCNSLT-ELPELPQS 112

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           L +L         L+   P        L+ L + +NQLE  +P +L   + L ++D+  N
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNN 163

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
            L            SL  +  G+NQL  +P  L NL ++  +   +NS    LP    +L
Sbjct: 164 SLKKL----PDLPPSLEFIAAGNNQLEELPE-LQNLPFLTAIYADNNSLKK-LPDLPLSL 217

Query: 241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNN 300
             +       N         + +L  L  ++ + N L+ ++PD       L++L++ +N 
Sbjct: 218 ESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNY 268

Query: 301 ISGAIPISLEKLLDLKYINVSFNKLEGEIP 330
           ++  +P   + L  L      F+ L    P
Sbjct: 269 LT-DLPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  124 bits (313), Expect = 9e-31
 Identities = 68/338 (20%), Positives = 113/338 (33%), Gaps = 56/338 (16%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           + +  N+    +P    +   L  +    N     +P    NL  L  +  + N L    
Sbjct: 158 IDVDNNSLK-KLPDLPPS---LEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLKKLP 211

Query: 61  P-------------KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFN 107
                          L  L  L N  +L  +   NN L   LP    +L    E   + +
Sbjct: 212 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL-KTLPDLPPSL----EALNVRD 266

Query: 108 CNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC 167
             ++  +PE   +LT L       + L+   P        L  L+   N++  S+ D   
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPP 317

Query: 168 RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
            L  L   ++  NKL    PA    L     L    N L  +P    NLK    L++  N
Sbjct: 318 SLEEL---NVSNNKLIEL-PALPPRLE---RLIASFNHLAEVPELPQNLK---QLHVEYN 367

Query: 228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG 287
                 P    ++      DL MN+    +P    +LK    L +E N L+   PD    
Sbjct: 368 PLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPES 417

Query: 288 LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
              ++ L +++  +      + E    L+      +  
Sbjct: 418 ---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  102 bits (257), Expect = 1e-23
 Identities = 53/252 (21%), Positives = 96/252 (38%), Gaps = 39/252 (15%)

Query: 88  ILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKL-- 145
           I PR + N    ++     + N++  +P E  N+ + T  Y   ++   + P    +   
Sbjct: 3   INPRNVSNTF--LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59

Query: 146 -----------QKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLT 194
                      ++   L L +  L  S+P+    L +   L    N L+  +P    +L 
Sbjct: 60  MAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLK 114

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS 254
           SL         L+ +P  L       YL +S+N     LP E+ N   L  ID+  N+  
Sbjct: 115 SLLVDNNNLKALSDLPPLL------EYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166

Query: 255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD 314
                       L+++    N+L+  +P+ +  L  L ++   NN++   +P        
Sbjct: 167 KLPDL----PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS--- 216

Query: 315 LKYINVSFNKLE 326
           L+ I    N LE
Sbjct: 217 LESIVAGNNILE 228

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 28/139 (20%), Positives = 47/139 (33%), Gaps = 16/139 (11%)

Query: 192 NLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMN 251
           + T L+     S+ LT +P    N+K       + + +    P   G  R +    L   
Sbjct: 9   SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 252 NFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEK 311
                        +    L L    L  S+P+       L+SL  S N+++  +P   + 
Sbjct: 69  L-----------DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS 112

Query: 312 LLDLKYINVSFNKLEGEIP 330
           L  L   N +   L    P
Sbjct: 113 LKSLLVDNNNLKALSDLPP 131

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  123 bits (311), Expect = 2e-31
 Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 16/260 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +       + ++P+ I   S  +RLELE N         F  L  L +LSL+ N L+   
Sbjct: 12  IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE--I 118
                    ++   LKYL  S N +   +      L   +E     + N+   + E    
Sbjct: 69  CCSQSDFGTTS---LKYLDLSFNGV-ITMSSNFLGLE-QLEHLDFQHSNLK-QMSEFSVF 122

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDL 177
            +L NL  + +       +     + L  L++L +  N  + +   D    L  L  LDL
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLE 236
              +L    P  F +L+SL+ L +  N   S+ +     L  +  L+ S N        +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQ 241

Query: 237 I--GNLRVLVQIDLSMNNFS 254
                   L  ++L+ N+F+
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  120 bits (302), Expect = 2e-30
 Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 7/237 (2%)

Query: 95  NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN--GSIPIALDKLQKLQLLS 152
            +  S     + +  +          LT LT + L  N L+  G    +      L+ L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 153 LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPAC-FGNLTSLRNLYLGSNQLTSIPS 211
           L  N +  ++  +   L  L  LD   + L        F +L +L  L +         +
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143

Query: 212 -TLWNLKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQY 269
                L  +  L ++ NSF      +I   LR L  +DLS        PT    L  LQ 
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203

Query: 270 LFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD-LKYINVSFNKL 325
           L + +N            L  L+ LD S N+I  +    L+     L ++N++ N  
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 11/192 (5%)

Query: 151 LSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI- 209
           +      L  S+P  +   ++   L+L  NKL       F  LT L  L L SN L+   
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 210 --PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTI-GDLKD 266
               + +    + YL+LS N     +      L  L  +D   +N       ++   L++
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127

Query: 267 LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI-PISLEKLLDLKYINVSFNKL 325
           L YL + +   + +      GL  L+ L ++ N+      P    +L +L ++++S  +L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187

Query: 326 EGEIPREGPFRN 337
           E ++     F +
Sbjct: 188 E-QLS-PTAFNS 197

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 6/135 (4%)

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN-- 252
           S   +   S  LTS+P+ +        L L SN            L  L ++ LS N   
Sbjct: 8   SGTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISL-EK 311
           F G    +      L+YL L +N +  ++  +  GL  L+ LD  ++N+      S+   
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124

Query: 312 LLDLKYINVSFNKLE 326
           L +L Y+++S     
Sbjct: 125 LRNLIYLDISHTHTR 139

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  126 bits (317), Expect = 2e-31
 Identities = 70/257 (27%), Positives = 112/257 (43%), Gaps = 17/257 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           ++    N    +P  I   +    L L  N       N+F +LR+L+ L L+ N++ +  
Sbjct: 48  VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-S 119
                  + +    L  L   +N L  I   A   LS  ++  ++ N  I  SIP    +
Sbjct: 105 IG-----AFNGLANLNTLELFDNRLTTIPNGAFVYLS-KLKELWLRNNPIE-SIPSYAFN 157

Query: 120 NLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
            + +L  + LG  K    I   A + L  L+ L+L    L   IP +L  L  L  LDL 
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI 237
           GN LS   P  F  L  L+ L++  +Q+  I      NL+ ++ +NL+ N+ T  LP ++
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDL 274

Query: 238 -GNLRVLVQIDLSMNNF 253
              L  L +I L  N +
Sbjct: 275 FTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  118 bits (298), Expect = 6e-29
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 10/246 (4%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
              +L  + P     +S +  +  +    I         +L +L  + L  N +      
Sbjct: 51  VRKNLREV-PD---GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL 199
           A + L  L  L L DN+L  +IP+     L+ L  L L  N +       F  + SLR L
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL 165

Query: 200 YLGS-NQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI 257
            LG   +L+ I       L  + YLNL+  +    +P  +  L  L ++DLS N+ S   
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIR 223

Query: 258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKY 317
           P +   L  LQ L++  +++Q    ++   L  L  ++L++NN++         L  L+ 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283

Query: 318 INVSFN 323
           I++  N
Sbjct: 284 IHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  116 bits (291), Expect = 6e-28
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 11/243 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAA 171
            +P+ IS  TN   + L  N++      +   L+ L++L L  N +  +I       LA 
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSFT 230
           L  L+L  N+L+      F  L+ L+ L+L +N + SIPS  +  +  +  L+L      
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173

Query: 231 GPLPLEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI 289
             +       L  L  ++L+M N    IP  +  L  L  L L  N L    P S  GL+
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231

Query: 290 DLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE--GPFRNFSAESFKGNE 347
            L+ L +  + I      + + L  L  IN++ N L   +P +   P  +        N 
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNP 290

Query: 348 LLC 350
             C
Sbjct: 291 WNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 36/138 (26%), Positives = 49/138 (35%), Gaps = 14/138 (10%)

Query: 189 CFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDL 248
           C    + +         L  +P  +        LNL  N           +LR L  + L
Sbjct: 41  CSNQFSKV---ICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPI 307
           S N+           L +L  L L  NRL  +IP+     L  LK L L NN I  +IP 
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153

Query: 308 S----LEKL--LDLKYIN 319
                +  L  LDL  + 
Sbjct: 154 YAFNRIPSLRRLDLGELK 171

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 21/87 (24%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L GN+ S  I    F     L +L +  +       N F NL++L  ++L +N LT  
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLD 86
               +  + L +   L+ +   +N  +
Sbjct: 271 PH--DLFTPLHH---LERIHLHHNPWN 292

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  126 bits (317), Expect = 3e-31
 Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 17/257 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           ++      S  +P  I   S    L L  N+      +TF +L +L+ L L  N +    
Sbjct: 59  VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-S 119
                  + +    L  L   +N L  I   A   LS  +   ++ N  I  SIP    +
Sbjct: 116 VG-----AFNGLASLNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-SIPSYAFN 168

Query: 120 NLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
            + +L  + LG  K    I   A + L  L+ L+L    ++  +P +L  L  L  L++ 
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI 237
           GN      P  F  L+SL+ L++ ++Q++ I       L  ++ LNL+ N+ +  LP ++
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDL 285

Query: 238 -GNLRVLVQIDLSMNNF 253
              LR LV++ L  N +
Sbjct: 286 FTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  118 bits (297), Expect = 9e-29
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 10/246 (4%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
           +   L  + P+    +  +     +   NI     +   +L +L  + LG N +      
Sbjct: 62  TRRGLSEV-PQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL 199
           A + L  L  L L DN L   IP      L+ L  L L  N +       F  + SL  L
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL 176

Query: 200 YLGS-NQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI 257
            LG   +L  I       L  + YLNL   +    +P  +  L  L ++++S N+F    
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIR 234

Query: 258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKY 317
           P +   L  L+ L++  +++     ++  GL  L  L+L++NN+S         L  L  
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294

Query: 318 INVSFN 323
           +++  N
Sbjct: 295 LHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  115 bits (289), Expect = 1e-27
 Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 11/243 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAA 171
            +P+ I   +N   + L  N +          L  L++L L  N +   I       LA+
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFT 230
           L  L+L  N L+      F  L+ LR L+L +N + SIPS     +  ++ L+L      
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184

Query: 231 GPLPLEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI 289
             +       L  L  ++L M N    +P  +  L  L+ L +  N      P S  GL 
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLS 242

Query: 290 DLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE--GPFRNFSAESFKGNE 347
            LK L + N+ +S     + + L  L  +N++ N L   +P +   P R         N 
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301

Query: 348 LLC 350
             C
Sbjct: 302 WNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 2e-26
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 11/221 (4%)

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
             + +      L+  +P  +      + L+L +N ++    D    L  L +L LG N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI-GNL 240
                  F  L SL  L L  N LT IPS     L  +  L L +N     +P      +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRV 170

Query: 241 RVLVQIDLSMNNFSGFIPTTI-GDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
             L+++DL       +I       L +L+YL L    ++  +P+ +  L+ L+ L++S N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGN 228

Query: 300 NISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSA 340
           +     P S   L  LK + V  +++   I     F   ++
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE-RNAFDGLAS 267

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  125 bits (316), Expect = 4e-31
 Identities = 68/336 (20%), Positives = 124/336 (36%), Gaps = 38/336 (11%)

Query: 22  LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS 81
           ++ ++L +NS       +F  L++L+ L +             F   LS+   L  L   
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-RGLSS---LIILKLD 87

Query: 82  NNSLDGILPRAIGNLSQSMEVFFMFNCNI-SGSIPEEI-SNLTNLTTIYLGGNKLNGSIP 139
            N    +   A   L+ ++EV  +  CN+    +       LT+L  + L  N +    P
Sbjct: 88  YNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146

Query: 140 -IALDKLQKLQLLSLEDNQLEGSIPDD-----------LCRLAALFLLDLGGNKLSGFVP 187
                 +++  +L L  N+++ SI ++           L RL+++ L D+    L     
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205

Query: 188 ACFGNLTSLRNLYLGSNQLTSIPS-------------TLW-NLKYILYLNLSSNSFTGPL 233
                 TS+  L L  N      +             +L  +  Y +  +    +F  P 
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265

Query: 234 PLEIGNLRV--LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLID 290
                 L    +   DLS +     + +      DL+ L L  N +   I D+   GL  
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH 324

Query: 291 LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
           L  L+LS N +        E L  L+ +++S+N + 
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  118 bits (298), Expect = 7e-29
 Identities = 68/355 (19%), Positives = 125/355 (35%), Gaps = 40/355 (11%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L +        I +  F   S L  L+L+ N F       F  L NL+ L+L    L  +
Sbjct: 59  LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
               NF   L++   L+ L   +N++  I P +     +   V  +    +  SI EE  
Sbjct: 119 VLSGNFFKPLTS---LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDL 174

Query: 119 ----------SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
                       L+++T   +    L         K   +  L L  N  + S+      
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234

Query: 169 LAALFLL-------------DLGGNKLSGFVPACFGNL--TSLRNLYLGSNQLTSIPSTL 213
             A   +               G           F  L  + ++   L  +++ ++  ++
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV 294

Query: 214 W-NLKYILYLNLSSNSFTGPLPLEIG---NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQY 269
           + +   +  L L+ N       ++      L  L++++LS N           +L  L+ 
Sbjct: 295 FSHFTDLEQLTLAQNEIN---KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351

Query: 270 LFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFN 323
           L L YN ++ ++ D    GL +LK L L  N +        ++L  L+ I +  N
Sbjct: 352 LDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  108 bits (271), Expect = 2e-25
 Identities = 50/312 (16%), Positives = 100/312 (32%), Gaps = 60/312 (19%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
           ++  + L+ N +           S S  + L++L     +   ++             F 
Sbjct: 31  HVNYVDLSLNSIAELNET-----SFSRLQDLQFLKVEQQTPGLVIRN---------NTF- 75

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGS-I 162
                           L++L  + L  N+    +   A + L  L++L+L    L+G+ +
Sbjct: 76  --------------RGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVL 120

Query: 163 PDDL-CRLAALFLLDLGGNKLSGFVPAC-FGNLTSLRNLYLGSNQLTSIPSTLW------ 214
             +    L +L +L L  N +    PA  F N+     L L  N++ SI           
Sbjct: 121 SGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK 180

Query: 215 -----NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQY 269
                 L  I   +++                 +  +DLS N F   +     D      
Sbjct: 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240

Query: 270 L-------------FLEYNRLQGSIPDSIGGLI--DLKSLDLSNNNISGAIPISLEKLLD 314
           +                +   +     +  GL    +K+ DLS + I   +        D
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD 300

Query: 315 LKYINVSFNKLE 326
           L+ + ++ N++ 
Sbjct: 301 LEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 55/253 (21%), Positives = 88/253 (34%), Gaps = 28/253 (11%)

Query: 1   LLLWGNNFSGTIPSFIF---NASKLSRLELEMN--------SFYGFIPNTFGNLRNLKRL 49
           L L  N    +I             + L L                         ++  L
Sbjct: 159 LDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217

Query: 50  SLNYNYLTSSTPK-------LNFLSSLS-NCKYLKYLSFSNNSLDGILPRAIGNLSQS-M 100
            L+ N    S  K          + SL  +  Y    SF + +           L  S +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277

Query: 101 EVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQL 158
           +   +    I  ++ + + S+ T+L  + L  N++N  I   A   L  L  L+L  N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335

Query: 159 EGSIPDDLCR-LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNL 216
            GSI   +   L  L +LDL  N +       F  L +L+ L L +NQL S+P      L
Sbjct: 336 -GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394

Query: 217 KYILYLNLSSNSF 229
             +  + L +N +
Sbjct: 395 TSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 95.6 bits (238), Expect = 4e-21
 Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 18/242 (7%)

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFLLDLGGN 180
            ++  + L  N +      +  +LQ LQ L +E       I ++  R L++L +L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSI---PSTLWNLKYILYLNLSSNSFTGPLPLEI 237
           +        F  L +L  L L    L       +    L  +  L L  N+     P   
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 238 -GNLRVLVQIDLSMNNFS----------GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
             N+R    +DL+ N                  T+  L  +    +    L      +  
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 287 GLIDLKSLDLSNNNISGAIP---ISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESF 343
               + +LDLS N    ++            ++ + +S +   G       F++    +F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 344 KG 345
           KG
Sbjct: 270 KG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.3 bits (232), Expect = 2e-20
 Identities = 56/304 (18%), Positives = 90/304 (29%), Gaps = 29/304 (9%)

Query: 1   LLLWGNNF-SGTIPSFIF-NASKLSRLELEMNSFYGFIPNT-FGNLRNLKRLSLNYNYLT 57
           L L   N     +    F   + L  L L  N+     P + F N+R    L L +N + 
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 58  SSTPK-LNFLSSLS----NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISG 112
           S   + L               +     +   L             S+    +       
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN-TSITTLDLSGNGFKE 226

Query: 113 SIPEEISNLTNLTTIY-------------LGGNKLNGSIPIALDKLQ--KLQLLSLEDNQ 157
           S+ +   +    T I               G              L+   ++   L  ++
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286

Query: 158 LEGSIPDDLCR-LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWN 215
           +  ++   +      L  L L  N+++      F  LT L  L L  N L SI S    N
Sbjct: 287 IF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345

Query: 216 LKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEY 274
           L  +  L+LS N     L  +    L  L ++ L  N            L  LQ ++L  
Sbjct: 346 LDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404

Query: 275 NRLQ 278
           N   
Sbjct: 405 NPWD 408

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  117 bits (296), Expect = 9e-30
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 14/223 (6%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            +P  I   +   R+ L  N        +F   RNL  L L+ N L          + L+
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA--AAFTGLA 80

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL 129
             + L  LS  N  L  + P     L + +    +  C +   +   +   L  L  +YL
Sbjct: 81  LLEQL-DLS-DNAQLRSVDPATFHGLGR-LHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 130 GGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLSGFVP 187
             N L  ++P      L  L  L L  N++  S+P+     L +L  L L  N+++   P
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 188 ACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSF 229
             F +L  L  LYL +N L+++P+     L+ + YL L+ N +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  111 bits (280), Expect = 2e-27
 Identities = 56/222 (25%), Positives = 83/222 (37%), Gaps = 8/222 (3%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
               L  + P     +  + +  F+    IS           NLT ++L  N L      
Sbjct: 19  PQQGLQAV-PV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL 199
           A   L  L+ L L DN    S+       L  L  L L    L    P  F  L +L+ L
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 200 YLGSNQLTSIPSTLW-NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP 258
           YL  N L ++P   + +L  + +L L  N  +         L  L ++ L  N  +   P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 259 TTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNN 299
               DL  L  L+L  N L  ++P      L  L+ L L++N
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (254), Expect = 4e-24
 Identities = 50/216 (23%), Positives = 73/216 (33%), Gaps = 28/216 (12%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
           ++P  I        I+L GN+++     +    + L +L L  N L          LA L
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 173 FLLDLGGNKLSGFVPA-CFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFT 230
             LDL  N     V    F  L  L  L+L    L  +       L  + YL L  N+  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 231 GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID 290
                            L  + F          L +L +LFL  NR+      +  GL  
Sbjct: 143 ----------------ALPDDTFRD--------LGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 291 LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
           L  L L  N ++   P +   L  L  + +  N L 
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 27/141 (19%), Positives = 47/141 (33%), Gaps = 7/141 (4%)

Query: 199 LYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP 258
                  L ++P  +        + L  N  +          R L  + L  N  +    
Sbjct: 16  TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 259 TTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPI-SLEKLLDLK 316
                L  L+ L L  N    S+  +   GL  L +L L    +   +       L  L+
Sbjct: 74  AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ 132

Query: 317 YINVSFNKLEGEIPREGPFRN 337
           Y+ +  N L+  +P +  FR+
Sbjct: 133 YLYLQDNALQ-ALP-DDTFRD 151

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  121 bits (305), Expect = 2e-29
 Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 31/296 (10%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
           N   LS N  Y T S    ++ S+    +       + N    +L      L        
Sbjct: 9   NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQFSELQ 65

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
           +   N+S S+P+ +     +T + +  N L  S+P     L+ L      DN+L  ++P+
Sbjct: 66  LNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYLDAC---DNRLS-TLPE 117

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL 224
               L  L   D+  N+L+  +P     L  +      +NQLT +P    +L+    L++
Sbjct: 118 LPASLKHL---DVDNNQLT-MLPELPALLEYI---NADNNQLTMLPELPTSLEV---LSV 167

Query: 225 SSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ----YLFLEYNRLQGS 280
            +N  T  LP    +L  L   D+S N     +P         +    +     NR+   
Sbjct: 168 RNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-H 221

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFR 336
           IP++I  L    ++ L +N +S  I  SL +       +           ++    
Sbjct: 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  100 bits (251), Expect = 1e-22
 Identities = 49/259 (18%), Positives = 88/259 (33%), Gaps = 36/259 (13%)

Query: 6   NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNF 65
           N     +   + N  + S L+L   +    +P+       +  L +  N L S       
Sbjct: 47  NEAVSLLKECLIN--QFSELQLNRLNL-SSLPDNLPP--QITVLEITQNALIS------L 95

Query: 66  LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
               ++   L+YL   +N L   LP    +L        + N  ++  +PE  + L  + 
Sbjct: 96  PELPAS---LEYLDACDNRLS-TLPELPASLKH----LDVDNNQLT-MLPELPALLEYI- 145

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
                 N+L   +P   +    L++LS+ +NQL   +P+    L AL   D+  N L   
Sbjct: 146 --NADNNQLT-MLP---ELPTSLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLES- 194

Query: 186 VPACFGNLTSLRN----LYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
           +PA                   N++T IP  + +L     + L  N  +  +   +    
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254

Query: 242 VLVQIDLSMNNFSGFIPTT 260
                      FS      
Sbjct: 255 AQPDYHGPRIYFSMSDGQQ 273

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  116 bits (293), Expect = 7e-29
 Identities = 55/294 (18%), Positives = 101/294 (34%), Gaps = 30/294 (10%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
           +IPS +     +  L+L  N       +      NL+ L L  N + +        SSL 
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS--FSSLG 100

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI--SNLTNLTTIY 128
           +   L++L  S N L  +       LS S+    +       ++ E    S+LT L  + 
Sbjct: 101 S---LEHLDLSYNYLSNLSSSWFKPLS-SLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155

Query: 129 LGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVP 187
           +G       I       L  L+ L ++ + L+   P  L  +  +  L L   +    + 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215

Query: 188 ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQID 247
                 +S+  L L    L +   +           LS+      +            + 
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFS----------ELSTGETNSLI-----KKFTFRNVK 260

Query: 248 LSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNN 300
           ++  +    +   +  +  L  L    N+L+ S+PD I   L  L+ + L  N 
Sbjct: 261 ITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNP 312

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  115 bits (290), Expect = 2e-28
 Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 20/265 (7%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L  N  +  I +        L  L L  N       ++F +L +L+ L L+YNYL++ 
Sbjct: 57  LDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNL 115

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
           +        LS+   L +L+   N    +   ++ +    +++  + N +    I  +  
Sbjct: 116 SSSW--FKPLSS---LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFLLDL 177
           + LT L  + +  + L    P +L  +Q +  L L   Q    + +      +++  L+L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229

Query: 178 GGNKLSGF--------VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSF 229
               L  F                 + RN+ +    L  +   L  +  +L L  S N  
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289

Query: 230 TGPLPLEI-GNLRVLVQIDLSMNNF 253
              +P  I   L  L +I L  N +
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (256), Expect = 6e-24
 Identities = 49/293 (16%), Positives = 102/293 (34%), Gaps = 55/293 (18%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
            +K L L+ N +T  +      S L  C  L+ L  ++N ++ I   +            
Sbjct: 53  AVKSLDLSNNRITYISN-----SDLQRCVNLQALVLTSNGINTIEEDS------------ 95

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIP 163
            F            S+L +L  + L  N L  ++       L  L  L+L  N  + ++ 
Sbjct: 96  -F------------SSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLG 140

Query: 164 DD--LCRLAALFLLDLGGNKLSGFVPA-CFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYI 219
           +      L  L +L +G       +    F  LT L  L + ++ L S    +L +++ +
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200

Query: 220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG 279
            +L L                       L              +L+D       ++ L  
Sbjct: 201 SHLILHMKQHI----------------LLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

Query: 280 SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE 332
              +S+      +++ +++ ++   +   L ++  L  +  S N+L+  +P  
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.3 bits (240), Expect = 7e-22
 Identities = 42/194 (21%), Positives = 79/194 (40%), Gaps = 5/194 (2%)

Query: 137 SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSL 196
           SIP  L   + ++ L L +N++      DL R   L  L L  N ++      F +L SL
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102

Query: 197 RNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNNFS 254
            +L L  N L+++ S     L  + +LNL  N +       +  +L  L  + +   +  
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162

Query: 255 GFIPT-TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
             I       L  L+ L ++ + LQ   P S+  + ++  L L        + I ++   
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

Query: 314 DLKYINVSFNKLEG 327
            ++ + +    L+ 
Sbjct: 223 SVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 43/248 (17%), Positives = 85/248 (34%), Gaps = 35/248 (14%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS- 58
           L+L  N  + TI    F++   L  L+L  N       + F  L +L  L+L  N   + 
Sbjct: 81  LVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTL 139

Query: 59  -------STPKLNFLSSLSN-------------CKYLKYLSFSNNSLDGILPRAIGNLSQ 98
                     KL  L   +                +L+ L    + L    P+++ ++  
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

Query: 99  SMEVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNG----SIPI----ALDKLQKLQ 149
            +    +        + E      +++  + L    L+      +      +L K    +
Sbjct: 200 -VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257

Query: 150 LLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI 209
            + + D  L   +   L +++ L  L+   N+L       F  LTSL+ ++L +N     
Sbjct: 258 NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316

Query: 210 PSTLWNLK 217
              +  L 
Sbjct: 317 CPRIDYLS 324

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 35/140 (25%), Positives = 54/140 (38%), Gaps = 6/140 (4%)

Query: 203 SNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG 262
           S  L SIPS L   + +  L+LS+N  T     ++     L  + L+ N  +     +  
Sbjct: 40  SGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97

Query: 263 DLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPISL-EKLLDLKYINV 320
            L  L++L L YN L  ++  S    L  L  L+L  N        SL   L  L+ + V
Sbjct: 98  SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156

Query: 321 SFNKLEGEIPREGPFRNFSA 340
                  +I     F   + 
Sbjct: 157 GNMDTFTKIQ-RKDFAGLTF 175

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  114 bits (287), Expect = 3e-28
 Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 18/180 (10%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            +G GG + V     + DG   A+K      +   +    E DM +   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 494 SNDDFKA----LVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYS 546
             +        L+L +   G+L   +         L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-------TIGYMAP 599
               H DLKP N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/219 (24%), Positives = 78/219 (35%), Gaps = 39/219 (17%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            +P  +      + L L  N  Y F   T      L +L+L+   LT        L    
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-------LQVDG 74

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
               L  L  S+N L                           S+P     L  LT + + 
Sbjct: 75  TLPVLGTLDLSHNQLQ--------------------------SLPLLGQTLPALTVLDVS 108

Query: 131 GNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDLGGNKLSGFVPA 188
            N+L  S+P+ AL  L +LQ L L+ N+L+ ++P  L      L  L L  N L+     
Sbjct: 109 FNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAG 166

Query: 189 CFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
               L +L  L L  N L +IP   +    + +  L  N
Sbjct: 167 LLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  100 bits (251), Expect = 1e-23
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 9/189 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
           ++P ++    + T ++L  N L       L    +L  L+L+  +L     D    L  L
Sbjct: 24  ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVL 79

Query: 173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTG 231
             LDL  N+L   +P     L +L  L +  N+LTS+P   L  L  +  L L  N    
Sbjct: 80  GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 232 PLPLEI-GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID 290
            LP  +      L ++ L+ NN +      +  L++L  L L+ N L  +IP    G   
Sbjct: 139 -LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196

Query: 291 LKSLDLSNN 299
           L    L  N
Sbjct: 197 LPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  100 bits (250), Expect = 2e-23
 Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 14/209 (6%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
           S + +   +      L  ++P  L   +   +L L +N L       L     L  L+L 
Sbjct: 7   SKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
             +L+  +    G L  L  L L  NQL S+P     L  +  L++S N  T    L +G
Sbjct: 64  RAELTK-LQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS---LPLG 118

Query: 239 ---NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSL 294
               L  L ++ L  N      P  +     L+ L L  N L   +P  +  GL +L +L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 295 DLSNNNISGAIPISLEKLLDLKYINVSFN 323
            L  N++   IP        L +  +  N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 8/141 (5%)

Query: 187 PAC-FGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQ 245
           P C    + S   +      LT++P  L   K    L+LS N         +     L Q
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 246 IDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI 305
           ++L     +  +    G L  L  L L +N+LQ S+P     L  L  LD+S N ++ ++
Sbjct: 60  LNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115

Query: 306 PISL-EKLLDLKYINVSFNKL 325
           P+     L +L+ + +  N+L
Sbjct: 116 PLGALRGLGELQELYLKGNEL 136

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  114 bits (286), Expect = 3e-27
 Identities = 42/177 (23%), Positives = 84/177 (47%), Gaps = 14/177 (7%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           F   +++G G   ++    + D  +VAVK    +    F   D E  +++    H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              +  +  F+ + +E     +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 549 IIHCDLKPNNVLL-----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           I+H DLKP+N+L+        + A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  110 bits (276), Expect = 7e-27
 Identities = 55/285 (19%), Positives = 115/285 (40%), Gaps = 25/285 (8%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
            L N  +++   + +T          + ++   +  LS     +  I    +  L+  + 
Sbjct: 17  ALANAIKIAAGKSNVTD-------TVTQADLDGITTLSAFGTGVTTI--EGVQYLNN-LI 66

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
              + +  I+      + NLT +T + L GN L  ++  A+  LQ ++ L L   Q+   
Sbjct: 67  GLELKDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV 122

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY 221
            P  L  L+ L +L L  N+++   P     LT+L+ L +G+ Q++ + + L NL  +  
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TPLANLSKLTT 177

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI 281
           L    N  +   PL   +L  L+++ L  N  S   P  + +  +L  + L    +  + 
Sbjct: 178 LKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQ 232

Query: 282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
           P      + +    +   + +   P ++         N+++N   
Sbjct: 233 PVFYNNNL-VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  108 bits (272), Expect = 2e-26
 Identities = 52/260 (20%), Positives = 100/260 (38%), Gaps = 18/260 (6%)

Query: 66  LSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT 125
           +           ++   +++   +     +L   +     F   ++ +I E +  L NL 
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVT-TI-EGVQYLNNLI 66

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
            + L  N++   +   L  L K+  L L  N L       +  L ++  LDL   +++  
Sbjct: 67  GLELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 186 VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQ 245
            P     L++L+ LYL  NQ+T+I   L  L  + YL++ +   +   PL   NL  L  
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTT 177

Query: 246 IDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI 305
           +    N  S   P  +  L +L  + L+ N++    P  +    +L  + L+N  I+   
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233

Query: 306 PISLEKLLDLKYINVSFNKL 325
                 L+    +       
Sbjct: 234 VFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 15/209 (7%)

Query: 118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
              L N   I  G + +  ++  A   L  +  LS     +  +I   +  L  L  L+L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             N+++   P    NLT +  L L  N L ++ S +  L+ I  L+L+S   T   PL  
Sbjct: 71  KDNQITDLAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVTPLA- 126

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
             L  L  + L +N  +   P  +  L +LQYL +   ++    P  +  L  L +L   
Sbjct: 127 -GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181

Query: 298 NNNISGAIPISLEKLLDLKYINVSFNKLE 326
           +N IS   P  L  L +L  +++  N++ 
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 21/236 (8%)

Query: 40  FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
              L NL  L L  N +T        L+ L N   +  L  S N L  +    I  L   
Sbjct: 59  VQYLNNLIGLELKDNQITD-------LAPLKNLTKITELELSGNPLKNVSA--IAGLQS- 108

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
           ++   + +  I+   P  ++ L+NL  +YL  N++  +I   L  L  LQ LS+ + Q+ 
Sbjct: 109 IKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS 164

Query: 160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
              P  L  L+ L  L    NK+S   P    +L +L  ++L +NQ++ +   L N   +
Sbjct: 165 DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNL 219

Query: 220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN 275
             + L++ + T        NL V   +     + +   P TI D        L +N
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVPNVVKG--PSGAPIAPATISDNGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 47/240 (19%), Positives = 90/240 (37%), Gaps = 45/240 (18%)

Query: 14  SFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK 73
           + + N +K++ LEL  N            L+++K L L    +T        ++ L+   
Sbjct: 79  APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD-------VTPLAGLS 129

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
            L+ L    N +  I                             ++ LTNL  + +G  +
Sbjct: 130 NLQVLYLDLNQITNI---------------------------SPLAGLTNLQYLSIGNAQ 162

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNL 193
           ++  +   L  L KL  L  +DN++   I   L  L  L  + L  N++S   P    N 
Sbjct: 163 VS-DLT-PLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANT 216

Query: 194 TSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL-PLEIGNLRVLVQIDLSMNN 252
           ++L  + L +  +T+ P  ++    ++  N+       P+ P  I +       +L+ N 
Sbjct: 217 SNLFIVTLTNQTITNQP--VFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNL 274

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 31/158 (19%), Positives = 56/158 (35%), Gaps = 16/158 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L     +   P  +   S L  L L++N      P     L NL+ LS+    ++   
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-- 165

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                L+ L+N   L  L   +N +  I P  + +L  ++    + N  IS      ++N
Sbjct: 166 -----LTPLANLSKLTTLKADDNKISDISP--LASLP-NLIEVHLKNNQISDV--SPLAN 215

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL 158
            +NL  + L    +        + L    ++       
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (276), Expect = 7e-27
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKARIQDGI---EVAVKVFDLQYEG--AFKS-FDIECDMMKRIRHRNLIK 488
           L+GRGG+  VY+A   D +    VA+K+          F++    E     R++  +++ 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           I      D    + +  +    L   L      L   + + I+  + SAL+  H   +  
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
             H D+KP N+L+  +  A+L DFG+A      D+ LTQ    + T+ YMAP
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  109 bits (275), Expect = 1e-26
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 10/170 (5%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNL--IKI 489
             IG GG + V++   +     A+K  +L+        S+  E   + +++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                 D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM P
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (273), Expect = 1e-26
 Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 11/170 (6%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           ++G+G    VY  R + + + +A+K    +     +    E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--NIMIDVASALEYLHFGYSVPIIH 551
           S + F  + +E +P GSL   L S    L   ++        +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 552 CDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
            D+K +NVL++  + V  +SDFG +K L   +     T+T   T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAP 192

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  108 bits (273), Expect = 2e-26
 Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 15/172 (8%)

Query: 435 LIGRGGVASVYKARIQDGI---EVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIK 488
            +G GG+++VY A   D I   +VA+K   +     E   K F+ E     ++ H+N++ 
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +I     DD   LV+EY+   +L      S+  L +   +N    +   +++ H    + 
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
           I+H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +P
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  110 bits (276), Expect = 2e-26
 Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 10/170 (5%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNL--IKI 489
             IG GG + V++   +     A+K  +L+        S+  E   + +++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                 D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DLKP N L+ D M+  L DFG+A  +  +  S+ +   +  + YM P
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (280), Expect = 6e-26
 Identities = 37/174 (21%), Positives = 74/174 (42%), Gaps = 23/174 (13%)

Query: 435 LIGRGGVASVYKAR--IQDGIEVAVKVFDLQYEGAFKS-FDIECDMMKRIRHRNLIKIIS 491
            I  GG+  +Y A     +G  V +K      +   ++    E   +  + H ++++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 492 SCSNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
              + D        +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
           + +++ DLKP N++L +  +  L D G           +        T G+ AP
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAP 246

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (270), Expect = 7e-26
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 14/207 (6%)

Query: 398 KRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVA 456
           +R   +  D    L+    +    E  +  +  +    +GRG    V++ +  Q G + A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 457 VKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLY 516
           VK   L+          E      +    ++ +  +     +  + +E +  GSL + + 
Sbjct: 88  VKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142

Query: 517 SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMA 575
                L   + L  +      LEYLH   +  I+H D+K +NVLL  +   A L DFG A
Sbjct: 143 QMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

Query: 576 KPLLKEDQSLTQTQTLATIG---YMAP 599
             L  +    +        G   +MAP
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAP 225

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  111 bits (278), Expect = 7e-26
 Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 23/284 (8%)

Query: 46  LKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFM 105
           +                +  +            +    S+   +      L  S++    
Sbjct: 1   MGETITVST-------PIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIA 50

Query: 106 FNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD 165
            N +I  S+ + I  L N+T ++L GNKL   I   L  L+ L  L L++N+++  +   
Sbjct: 51  NNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DL-SS 104

Query: 166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS 225
           L  L  L  L L  N +S        +L  L +LYLG+N++T I + L  L  +  L+L 
Sbjct: 105 LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLE 161

Query: 226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI 285
            N  +  +PL    L  L  + LS N+ S      +  LK+L  L L          +  
Sbjct: 162 DNQISDIVPLA--GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQ 217

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI 329
             L+   ++  ++ ++     IS +   +   +     +   E+
Sbjct: 218 SNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  109 bits (272), Expect = 4e-25
 Identities = 60/333 (18%), Positives = 116/333 (34%), Gaps = 25/333 (7%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
                 + +L    +T          + +    +  +  +N+ +  +    I  L   + 
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDIKSVQG--IQYLPN-VT 68

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
             F+    ++  I + ++NL NL  ++L  NK+   +  +L  L+KL+ LSLE N +   
Sbjct: 69  KLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-D 123

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY 221
           I + L  L  L  L LG NK++         LT L  L L  NQ++ I   L  L  +  
Sbjct: 124 I-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQN 179

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI 281
           L LS N  +    L    L+ L  ++L              +L     +      L    
Sbjct: 180 LYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--T 235

Query: 282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKY--INVSFNKLEGEIPREGPFRNFS 339
           P+ I    D +  ++  +       +S      +        F+    +  +E    ++ 
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYD 295

Query: 340 AESFKGNELLCGTPNLQVPPCRTRIHHTSRKND 372
            +       +     +  P   T+  +  +   
Sbjct: 296 VDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWY 328

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 61.3 bits (148), Expect = 5e-10
 Identities = 31/145 (21%), Positives = 54/145 (37%), Gaps = 14/145 (9%)

Query: 14  SFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK 73
           S + +  KL  L LE N           +L  L+ L L  N +T        ++ LS   
Sbjct: 103 SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD-------ITVLSRLT 153

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNK 133
            L  LS  +N +  I+P  +  L+  ++  ++   +IS  +   ++ L NL  + L   +
Sbjct: 154 KLDTLSLEDNQISDIVP--LAGLT-KLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQE 208

Query: 134 LNGSIPIALDKLQKLQLLSLEDNQL 158
                      L     +   D  L
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSL 233

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (270), Expect = 9e-26
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 10/170 (5%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNL--IKI 489
             IG GG + V++   +     A+K  +L+        S+  E   + +++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                 D +  +V+E   +  L   L      +D ++R +   ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DLKP N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM P
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  108 bits (271), Expect = 3e-25
 Identities = 51/288 (17%), Positives = 99/288 (34%), Gaps = 57/288 (19%)

Query: 39  TFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ 98
           +   L  L  L  + + +T        ++ +     L  L  ++N++  +          
Sbjct: 37  SEEQLATLTSLDCHNSSITD-------MTGIEKLTGLTKLICTSNNITTL---------- 79

Query: 99  SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL 158
                             ++S  TNLT +    NKL     + +  L KL  L+ + N+L
Sbjct: 80  ------------------DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL 118

Query: 159 EGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKY 218
                 D+ +   L  L+   N L+        + T L  L    N+  +    +     
Sbjct: 119 T---KLDVSQNPLLTYLNCARNTLTEID---VSHNTQLTELDCHLNKKITKL-DVTPQTQ 171

Query: 219 ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           +  L+ S N  T    L++   ++L +++   NN +      +     L +L    N+L 
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT 225

Query: 279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
             I   +  L  L   D S N ++    + +  L  L  ++     L 
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  107 bits (270), Expect = 4e-25
 Identities = 63/338 (18%), Positives = 110/338 (32%), Gaps = 46/338 (13%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLT--- 57
           L+   NN + T+   +   + L+ L  + N            L  L  L+ + N LT   
Sbjct: 69  LICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLD 122

Query: 58  -SSTPKLNFLS---------SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFN 107
            S  P L +L+          +S+   L  L    N     L   +   +Q +       
Sbjct: 123 VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQ-LTTLDCSF 179

Query: 108 CNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC 167
             I+     ++S    L  +    N +     + L++  +L  L    N+L   I  D+ 
Sbjct: 180 NKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI--DVT 230

Query: 168 RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN 227
            L  L   D   N L+         L+ L  L+     L  I   L +   ++Y      
Sbjct: 231 PLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLEID--LTHNTQLIYFQAEGC 285

Query: 228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGG 287
                L  ++ +   L  +D      +      +     L YL+L    L   +   +  
Sbjct: 286 RKIKEL--DVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSH 337

Query: 288 LIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
              LKSL   N +I      S+ K+  L     +  + 
Sbjct: 338 NTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 51/307 (16%), Positives = 103/307 (33%), Gaps = 33/307 (10%)

Query: 3   LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPK 62
           L  +         +   ++L+ L+   N             + L RL+ + N +T     
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK---- 205

Query: 63  LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT 122
           L+     +    L +L  S+N L  I    +  L+  +  F      ++  +   +S L+
Sbjct: 206 LDL----NQNIQLTFLDCSSNKLTEID---VTPLT-QLTYFDCSVNPLT-ELD--VSTLS 254

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
            LTT++     L     I L    +L     E  +    +  D+     L+LLD     +
Sbjct: 255 KLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI 309

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
           +            L  LYL + +LT +   + +   +  L+  +          +G +  
Sbjct: 310 TELD---LSQNPKLVYLYLNNTELTELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPA 362

Query: 243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG---SIPDSIGGLIDLKSLDLSNN 299
           L     +          T+ +      +  +     G   +I    GG+ D  +  ++  
Sbjct: 363 LNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWE 422

Query: 300 NISGAIP 306
           N+S   P
Sbjct: 423 NLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.0 bits (195), Expect = 9e-16
 Identities = 39/184 (21%), Positives = 62/184 (33%), Gaps = 18/184 (9%)

Query: 143 DKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLG 202
           D        + E    +        +LA L  LD   + ++         LT L  L   
Sbjct: 18  DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICT 72

Query: 203 SNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG 262
           SN +T++   L     + YL   SN  T    L++  L  L  ++   N  +      + 
Sbjct: 73  SNNITTLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVS 124

Query: 263 DLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSF 322
               L YL    N L   I   +     L  LD   N     + ++      L  ++ SF
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSF 179

Query: 323 NKLE 326
           NK+ 
Sbjct: 180 NKIT 183

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  104 bits (262), Expect = 3e-25
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 21/225 (9%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
           IP  +  ++K   L+L  N        +F +   L+ L L+   + +         SLS+
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSH 77

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYLG 130
              L  L  + N +  +   A   LS   ++      N++ S+      +L  L  + + 
Sbjct: 78  ---LSTLILTGNPIQSLALGAFSGLSSLQKL-VAVETNLA-SLENFPIGHLKTLKELNVA 132

Query: 131 GNKLNGSIPI--ALDKLQKLQLLSLEDNQLEGSIP----DDLCRLAALFL-LDLGGNKLS 183
            N +  S  +      L  L+ L L  N+++ SI       L ++  L L LDL  N ++
Sbjct: 133 HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSN 227
              P  F  +  L+ L L +NQL S+P      L  +  + L +N
Sbjct: 191 FIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  103 bits (259), Expect = 7e-25
 Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 21/194 (10%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFLLD 176
            +   L  + L   ++  +I   A   L  L  L L  N ++ S+       L++L  L 
Sbjct: 49  FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 106

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-----STLWNLKYILYLNLSSNSFTG 231
                L+       G+L +L+ L +  N + S       S L NL++   L+LSSN    
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH---LDLSSNKIQS 163

Query: 232 PLPLEI----GNLRVL-VQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI- 285
            +          + +L + +DLS+N  + FI         L+ L L+ N+L+ S+PD I 
Sbjct: 164 -IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIF 220

Query: 286 GGLIDLKSLDLSNN 299
             L  L+ + L  N
Sbjct: 221 DRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  102 bits (257), Expect = 1e-24
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 11/218 (5%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAA 171
            IP+ +    +   + L  N L      +     +LQ+L L   +++ +I D     L+ 
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSFT 230
           L  L L GN +       F  L+SL+ L      L S+ +    +LK +  LN++ N   
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 231 G-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQY----LFLEYNRLQGSIPDSI 285
              LP    NL  L  +DLS N       T +  L  +      L L  N +   I    
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFN 323
              I LK L L  N +        ++L  L+ I +  N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 14/210 (6%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L  N     + S+ F +  +L  L+L            + +L +L  L L  N + S 
Sbjct: 33  LDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
                     S    L+ L     +L  +    IG+L    E+    N   S  +PE  S
Sbjct: 92  ALGA-----FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 120 NLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQL----LSLEDNQLEGSIPDDLCRLAALFL 174
           NLTNL  + L  NK+  SI    L  L ++ L    L L  N +   I     +   L  
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLGSN 204
           L L  N+L       F  LTSL+ ++L +N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  104 bits (261), Expect = 3e-25
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G    V+     +  +VA+K        E  F     E ++M ++ H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPII 550
                  LV E+M HG L   L +   +      L + +DV   + YL           I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +P
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASP 174

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (262), Expect = 6e-25
 Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 17/176 (9%)

Query: 435 LIGRGGVASVYKARIQDGI---EVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIK 488
           ++G GG++ V+ AR  D     +VAVKV           +  F  E      + H  ++ 
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 489 IISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
           +  +   +        +V+EY+   +L + +  +   +   + + ++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT-LATIGYMAP 599
               IIH D+KP N+++       + DFG+A+ +     S+TQT   + T  Y++P
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score =  103 bits (259), Expect = 7e-25
 Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 39/221 (17%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            IPS I   +   +L+L+ N         F  L  L+ L LN N L +    + F   L 
Sbjct: 30  AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI-F-KELK 85

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL 129
           N   L+ L  ++N L                           ++P  +   L NL  + L
Sbjct: 86  N---LETLWVTDNKLQ--------------------------ALPIGVFDQLVNLAELRL 116

Query: 130 GGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDLGGNKLSGFVP 187
             N+L  S+P    D L KL  LSL  N+L+ S+P  +  +L +L  L L  N+L     
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPE 174

Query: 188 ACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSN 227
             F  LT L+ L L +NQL  +P     +L+ +  L L  N
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 59/196 (30%), Positives = 83/196 (42%), Gaps = 19/196 (9%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAA 171
           +IP  I    +   + L  NKL+     A  +L KL+LL L DN+L+ ++P  +   L  
Sbjct: 30  AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST----LWNLKYILYLNLSSN 227
           L  L +  NKL       F  L +L  L L  NQL S+P      L  L Y   L+L  N
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY---LSLGYN 143

Query: 228 SFTGPLPLEIG---NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS 284
                  L  G    L  L ++ L  N            L +L+ L L+ N+L+  +P+ 
Sbjct: 144 ELQS---LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

Query: 285 I-GGLIDLKSLDLSNN 299
               L  LK L L  N
Sbjct: 200 AFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 11/148 (7%)

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTL-WNLKYILYLNLSSNSFTGPLPLEIGN 239
           K  G V +C  N  S+      S +LT+IPS +  + K    L+L SN  +         
Sbjct: 6   KKDGGVCSCNNNKNSV---DCSSKKLTAIPSNIPADTK---KLDLQSNKLSSLPSKAFHR 59

Query: 240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSN 298
           L  L  + L+ N           +LK+L+ L++  N+LQ ++P  +   L++L  L L  
Sbjct: 60  LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDR 118

Query: 299 NNISGAIPISL-EKLLDLKYINVSFNKL 325
           N +  ++P  + + L  L Y+++ +N+L
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNEL 145

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  103 bits (259), Expect = 1e-24
 Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 20/178 (11%)

Query: 433 NNLIGRGGVASVYKAR-IQDGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +  IGRG   +VYK    +  +EVA          +   + F  E +M+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 490 ISSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             S  +         LV E M  G+L K       ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 546 SVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           + PIIH DLK +N+ +        + D G+A            +   A IG   +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAP 199

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  103 bits (259), Expect = 1e-24
 Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 434 NLIGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIK 488
            +IGRG    VY   + D     I  AVK  +     G    F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 489 IISSCSNDDFKAL-VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 544
           ++  C   +   L VL YM HG L   + +  +   +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAP 599
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (260), Expect = 2e-24
 Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 16/173 (9%)

Query: 436 IGRGGVASVYKARIQDG-----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G   +VYK           I VA+K   +     A K    E  +M  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 546
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +H DL   NVL+       ++DFG+AK L  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (255), Expect = 2e-24
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 15/169 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V   + +   +VAVK+       E  F     E   M ++ H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPII 550
           S +    +V EY+ +G L   L S    L+  Q L +  DV   + +L    F      I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DL   N L+D ++   +SDFGM +  + +DQ ++   T   + + AP
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAP 174

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  104 bits (260), Expect = 2e-24
 Identities = 63/266 (23%), Positives = 101/266 (37%), Gaps = 30/266 (11%)

Query: 358 PPCRTRIHHTSRKNDLLLGIVLPLST----IFMMAVILLILRYRKRGKSQLADANMPLVA 413
           P      HH  R+  +  GI++P  +           L    Y+K G   L       V 
Sbjct: 6   PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65

Query: 414 NLRRFTHLELFQATNGFSE---------NNLIGRGGVASVYKARIQDG----IEVAVKVF 460
                 + EL QA               N +IGRG    VY   + D     I  AVK  
Sbjct: 66  IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125

Query: 461 DLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL-VLEYMPHGSLEKCLYSS 518
           +     G    F  E  +MK   H N++ ++  C   +   L VL YM HG L   + + 
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185

Query: 519 NYILDIFQRLNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            +   +   +   + VA  +++L    F      +H DL   N +LD+     ++DFG+A
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 576 KPLLKEDQSLTQTQTLAT--IGYMAP 599
           + +  ++      +T A   + +MA 
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMAL 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (255), Expect = 3e-24
 Identities = 42/164 (25%), Positives = 60/164 (36%), Gaps = 17/164 (10%)

Query: 436 IGRGGVASVYKAR----IQDGIEVAVKVF---DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    V +          + VAVK      L    A   F  E + M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGY 545
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
               IH DL   N+LL    +  + DFG+ + L + D      +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  105 bits (263), Expect = 3e-24
 Identities = 61/357 (17%), Positives = 119/357 (33%), Gaps = 26/357 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L   +   +    I + +    L +   ++          L++    SL+  + T+  
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKE 177

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS-----QSMEVFFMFNCNISGSIP 115
                  S+     L+  +      D      +  L+       +    + N   + +  
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237

Query: 116 EEISNLTNLTTIY--------LGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC 167
             I  L   TT++        L G         +   L+ L +  +  +           
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297

Query: 168 RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST-LWNLKYILYLNLSS 226
             + + + +   +        C   ++   +L   +N LT        +L  +  L L  
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357

Query: 227 NSFTGPLPLEIG---NLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIP 282
           N     L         ++ L Q+D+S N+ S           K L  L +  N L  +I 
Sbjct: 358 NQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416

Query: 283 DSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFS 339
             +     +K LDL +N I  +IP  + KL  L+ +NV+ N+L+  +P  G F   +
Sbjct: 417 RCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  100 bits (251), Expect = 1e-22
 Identities = 63/314 (20%), Positives = 110/314 (35%), Gaps = 19/314 (6%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNL----RNLKRLSLNYNYL 56
           +      F   +   +   + L    ++              L     N K  +L  N +
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230

Query: 57  TSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS-QSMEVFFM--FNCNISGS 113
            ++      +  L     + Y S SN  L G L     + S  S++   +     ++ G 
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290

Query: 114 IPEEI-SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
               I    +N+       +       +   K+     L   +N L  ++ ++   L  L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350

Query: 173 FLLDLGGNKLS--GFVPACFGNLTSLRNLYLGSNQLTSI--PSTLWNLKYILYLNLSSNS 228
             L L  N+L     +      + SL+ L +  N ++           K +L LN+SSN 
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410

Query: 229 FT-GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-G 286
            T          ++VL   DL  N     IP  +  L+ LQ L +  N+L+ S+PD I  
Sbjct: 411 LTDTIFRCLPPRIKVL---DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465

Query: 287 GLIDLKSLDLSNNN 300
            L  L+ + L  N 
Sbjct: 466 RLTSLQKIWLHTNP 479

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 98.8 bits (246), Expect = 6e-22
 Identities = 62/348 (17%), Positives = 116/348 (33%), Gaps = 34/348 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS-- 58
           L +  N  S    S I + SKL  L +  N       + F   + L+ L L++N L    
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKIS 85

Query: 59  --STPKL-------NFLSSLSNCKY------LKYLSFSNNSLDGILPRAIGNLSQSMEVF 103
              T  L       N   +L  CK       LK+L  S   L+      I +L+ S  + 
Sbjct: 86  CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145

Query: 104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP 163
            +          E+   L +  T  L            +  +    + +LE + ++  + 
Sbjct: 146 VLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLE 202

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLN 223
           D+ C      L  L  N           +  +L N+    N    I   +W+   + Y +
Sbjct: 203 DNKCSYFLSILAKLQTN--------PKLSNLTLNNIETTWNSFIRILQLVWHTT-VWYFS 253

Query: 224 LSSNSFTGPLPLEIG-----NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           +S+    G L          +L+ L    +  + F            ++       +  +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313

Query: 279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
                    +     LD SNN ++  +  +   L +L+ + +  N+L+
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 38/209 (18%), Positives = 81/209 (38%), Gaps = 11/209 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           +    ++  G   S+I+   S ++     ++            +     L  + N LT +
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGI--LPRAIGNLSQSMEVFFMFNCNISGSIPEE 117
             +     +  +   L+ L    N L  +  +      +    ++    N         +
Sbjct: 340 VFE-----NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394

Query: 118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
            S   +L ++ +  N L  +I   L    ++++L L  N+++ SIP  + +L AL  L++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQL 206
             N+L       F  LTSL+ ++L +N  
Sbjct: 452 ASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.9 bits (223), Expect = 4e-19
 Identities = 42/266 (15%), Positives = 87/266 (32%), Gaps = 32/266 (12%)

Query: 17  FNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLK 76
              + +    +      G +     +       +L+ + + S                + 
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303

Query: 77  YLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNG 136
             +F+ +    +       +S         N  ++ ++ E   +LT L T+ L  N+L  
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISP-FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK- 361

Query: 137 SIPI---ALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDLGGNKLSGFVPACFGN 192
            +        +++ LQ L +  N +        C    +L  L++  N L+  +  C   
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419

Query: 193 LTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
              ++ L L SN++ SIP  +  L+ +  LN++SN                    +    
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK----------------SVPDGI 463

Query: 253 FSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           F          L  LQ ++L  N   
Sbjct: 464 FDR--------LTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 17/245 (6%)

Query: 109 NISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
            IS     +I +L+ L  + +  N++           Q+L+ L L  N+L   I      
Sbjct: 32  YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--P 88

Query: 169 LAALFLLDLGGNKLSGF-VPACFGNLTSLRNLYLGSNQLTSIP----STLWNLKYILYLN 223
              L  LDL  N      +   FGN++ L+ L L +  L        + L   K +L L 
Sbjct: 89  TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148

Query: 224 LSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG---- 279
            +      P  L+  N   L  +  +   F   +  ++  + +L+   ++          
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208

Query: 280 --SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD---LKYINVSFNKLEGEIPREGP 334
             SI   +     L +L L+N   +    I + +L+    + Y ++S  KL+G++     
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268

Query: 335 FRNFS 339
             + +
Sbjct: 269 DYSGT 273

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 39/205 (19%), Positives = 75/205 (36%), Gaps = 9/205 (4%)

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           +   +    N L   +P  L +  K  +L++  N +      D+  L+ L +L +  N++
Sbjct: 1   SEFLVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTG-PLPLEIGNLR 241
                + F     L  L L  N+L  I         + +L+LS N+F   P+  E GN+ 
Sbjct: 58  QYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMS 115

Query: 242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP---DSIGGLIDLKSLDLSN 298
            L  + LS  +        I  L   + L +                     L  +  +N
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175

Query: 299 NNISGAIPISLEKLLDLKYINVSFN 323
                 + +S++ + +L+  N+   
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCV 200

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 3/80 (3%)

Query: 246 IDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI 305
           +D S N     +P  +   +    L +  N +       I  L  L+ L +S+N I    
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 306 PISLEKLLDLKYINVSFNKL 325
               +   +L+Y+++S NKL
Sbjct: 62  ISVFKFNQELEYLDLSHNKL 81

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  102 bits (256), Expect = 4e-24
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 16/175 (9%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDIECDMMKRIRHRNLIKI--I 490
           ++G+G  A+V++ R  + G   A+KVF+ + +         E +++K++ H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              +    K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 549 IIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHP 184

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  101 bits (254), Expect = 4e-24
 Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 28/188 (14%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F E  LIG GG   V+KA+   DG    +K      E A +    E   + ++ H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 489 IISSCSNDDFKA----------------LVLEYMPHGSLEKCL-YSSNYILDIFQRLNIM 531
                   D+                  + +E+   G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
             +   ++Y+H   S  +I+ DLKP+N+ L D     + DFG+   L        +T++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSK 182

Query: 592 ATIGYMAP 599
            T+ YM+P
Sbjct: 183 GTLRYMSP 190

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  103 bits (259), Expect = 4e-24
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 5/166 (3%)

Query: 436 IGRGGVASVYKARIQ-DGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IGRG    V+  R++ D   VAVK   +         F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L   N L+ +  V  +SDFGM++       + +       + + AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  101 bits (254), Expect = 4e-24
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 14/154 (9%)

Query: 436 IGRGGVASVYKARIQDG---IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV +   +     I+VA+KV      +   +    E  +M ++ +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVP 548
            C  +    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
            +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  101 bits (253), Expect = 5e-24
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGA--FKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V   + +   +VA+K+     EG+     F  E  +M  + H  L+++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVPII 550
           +      ++ EYM +G L   L    +     Q L +  DV  A+EYL    F      +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  P
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPP 190

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  102 bits (256), Expect = 6e-24
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 9/169 (5%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
            IG G        +  +DG +  +K  ++        +    E  ++  ++H N+++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 492 SCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
           S   +    +V++Y   G L ++       +    Q L+  + +  AL+++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+K  N+ L  +    L DFG+A+ +L     L +     T  Y++P
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSP 194

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (260), Expect = 6e-24
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 7/167 (4%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             +G+G    V+         VA+K          ++F  E  +MK++RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+ L+++++   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 350

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 6e-24
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 13/173 (7%)

Query: 436 IGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +G+G   SV   R        G  VAVK      E   + F+ E +++K ++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 491 SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
             C +   +   L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAP 599
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + AP
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAP 217

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (253), Expect = 7e-24
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 13/173 (7%)

Query: 436 IGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +G+G   SV   R        G  VAVK      E   + F+ E +++K ++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 491 SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
             C +   +   L++EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAP 599
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + AP
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAP 186

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  104 bits (261), Expect = 8e-24
 Identities = 59/353 (16%), Positives = 116/353 (32%), Gaps = 20/353 (5%)

Query: 1   LLLWGNNF-SGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L    F    +            L+L      G    +     N   L L ++  +  
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLF 209

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF-NCNISGSIPEEI 118
           + ++N   +      L  +  ++ +   ++            +     +   +     ++
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269

Query: 119 SNL---TNLTTIYLGGNKLNGSIP-----IALDKLQKLQLLSLEDNQLEGSIPDDLCRLA 170
                   +  + +    +   I       +   L+ L +  +++     S        A
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSF 229
            + +  L  +        C  + +S   L    N  T         LK +  L L  N  
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389

Query: 230 T--GPLPLEIGNLRVLVQIDLSMNNF-SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
                + L   N+  L  +D+S+N+  S     T    + +  L L  N L GS+   + 
Sbjct: 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL- 448

Query: 287 GLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFS 339
               +K LDL NN I  +IP  +  L  L+ +NV+ N+L+  +P  G F   +
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.4 bits (206), Expect = 5e-17
 Identities = 55/367 (14%), Positives = 109/367 (29%), Gaps = 74/367 (20%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N+ S      I   S+L  L L  N       + F   ++L+ L +++N L +  
Sbjct: 57  LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-- 114

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
             ++    +++   L++L  S N  D +                         + +E  N
Sbjct: 115 --ISC-CPMAS---LRHLDLSFNDFDVL------------------------PVCKEFGN 144

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQL-LSLEDNQLEGSIPDDLCRLAALFL----- 174
           LT LT + L   K      + +  L    + L L    ++G   + L       L     
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204

Query: 175 ------------------LDLGGNKLSGFVPACFGNLT------------SLRNLYLGSN 204
                             L L   KL+                       +L+++     
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264

Query: 205 QLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN-----LRVLVQIDLSMNNFSGFIPT 259
               +    W  + + YLN+ + + T  +  E        L+ L+   +    F      
Sbjct: 265 CSVKLFQFFWP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323

Query: 260 TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYIN 319
                 ++    L  +                  L+ + N  + ++      L  L+ + 
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 320 VSFNKLE 326
           +  N L+
Sbjct: 384 LQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.9 bits (197), Expect = 6e-16
 Identities = 40/203 (19%), Positives = 77/203 (37%), Gaps = 13/203 (6%)

Query: 6   NNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLN 64
           N         +++  ++++   L ++           +  +   L+   N  T S  +  
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG- 372

Query: 65  FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN---ISGSIPEEISNL 121
             S+L     L+ L    N L     +          +  +        S +     +  
Sbjct: 373 -CSTLKR---LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
            ++  + L  N L GS+   L    K+++L L +N++  SIP D+  L AL  L++  N+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484

Query: 182 LSGFVPACFGNLTSLRNLYLGSN 204
           L       F  LTSL+ ++L  N
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.4 bits (180), Expect = 8e-14
 Identities = 42/299 (14%), Positives = 94/299 (31%), Gaps = 28/299 (9%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
             K LSL+ N ++           +S    L+ L  S+N +  +         Q +E   
Sbjct: 53  RTKALSLSQNSISELRM-----PDISFLSELRVLRLSHNRIRSLDFHVFLFN-QDLEYLD 106

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIA--LDKLQKLQLLSLEDNQLEGSI 162
           + + N   +I      + +L  + L  N  +  +P+      L KL  L L   +     
Sbjct: 107 VSH-NRLQNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 163 PDDLCRLA-ALFLLDLGGNKLSGFVPACFGNL-TSLRNLYLGSNQLTSIPSTLW----NL 216
              +  L  +  LLDL    + G          T++ +L    N L S+   +       
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222

Query: 217 KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLK-----DLQYLF 271
             +  + L+  +    +       R    +++++ +       ++   +      ++YL 
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282

Query: 272 LEYNRLQGSIPDSIGGLID-----LKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
           +    +   I        +     L    + N     +         ++    +S +  
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 7/204 (3%)

Query: 148 LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT 207
            + LSL  N +      D+  L+ L +L L  N++       F     L  L +  N+L 
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113

Query: 208 SIPSTLWNLKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLK- 265
           +I      +  + +L+LS N F   P+  E GNL  L  + LS   F       +  L  
Sbjct: 114 NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171

Query: 266 DLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
               L L    ++G   +S+  + +   L L  +  S         +  L ++ +S  KL
Sbjct: 172 SCILLDLVSYHIKGGETESL-QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230

Query: 326 EGEIPREGPFRNFSAESFKGNELL 349
             E         F +E  +G  LL
Sbjct: 231 NDE--NCQRLMTFLSELTRGPTLL 252

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  100 bits (251), Expect = 9e-24
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 12/175 (6%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
            IG G      K R   DG  +  K  D     E   +    E ++++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 492 SCSNDDFKAL--VLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLH--FG 544
              +     L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               ++H DLKP NV LD      L DFG+A+ +L  D S  +T  + T  YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTF-VGTPYYMSP 185

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  100 bits (251), Expect = 1e-23
 Identities = 61/268 (22%), Positives = 109/268 (40%), Gaps = 16/268 (5%)

Query: 62  KLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL 121
            +  + S          +    S+   +      L  S++     N +I  S+ + I  L
Sbjct: 13  PIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIK-SV-QGIQYL 67

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK 181
            N+T ++L GNKL   I   L  L+ L  L L++N+++  +   L  L  L  L L  N 
Sbjct: 68  PNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNG 123

Query: 182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
           +S        +L  L +LYLG+N++T I + L  L  +  L+L  N  +  +PL    L 
Sbjct: 124 ISDING--LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVPLA--GLT 178

Query: 242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
            L  + LS N+ S      +  LK+L  L L          +    L+   ++  ++ ++
Sbjct: 179 KLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

Query: 302 SGAIPISLEKLLDLKYINVSFNKLEGEI 329
                IS +   +   +     +   E+
Sbjct: 237 VTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 43/239 (17%)

Query: 40  FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
              L N+ +L LN N LT        +  L+N K L +L    N +  +           
Sbjct: 64  IQYLPNVTKLFLNGNKLTD-------IKPLANLKNLGWLFLDENKVKDL----------- 105

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
                             + +L  L ++ L  N ++  I   L  L +L+ L L +N++ 
Sbjct: 106 ----------------SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI- 146

Query: 160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
            +    L RL  L  L L  N++S  VP     LT L+NLYL  N ++ +   L  LK +
Sbjct: 147 -TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNL 202

Query: 220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
             L L S            NL V   +  +  +     P  I D  D +   ++++  +
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 44/210 (20%), Positives = 70/210 (33%), Gaps = 45/210 (21%)

Query: 40  FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
             +L+ LK LSL +N ++        ++ L +   L+ L   NN +  I           
Sbjct: 108 LKDLKKLKSLSLEHNGISD-------INGLVHLPQLESLYLGNNKITDI----------- 149

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
                             +S LT L T+ L  N+++  I   L  L KLQ L L  N + 
Sbjct: 150 ----------------TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 191

Query: 160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-----TLW 214
             +   L  L  L +L+L   +          NL     +      L +           
Sbjct: 192 -DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249

Query: 215 NLKYILYLNLSSN--SFTGPLPLEIGNLRV 242
                 +L   +N  SF    P+ IG  + 
Sbjct: 250 KPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 279

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  102 bits (256), Expect = 1e-23
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 16/175 (9%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDIECDMMKRIRHRNLIKI--I 490
           ++G+G  A+V++ R  + G   A+KVF+ + +         E +++K++ H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              +    K L++E+ P GSL   L    + Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 549 IIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHP 184

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (260), Expect = 1e-23
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 7/167 (4%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             +G+G    V+         VA+K          ++F  E  +MK++RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL+  N+L+ +N+V  ++DFG+A+ L+++++   +      I + AP
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (253), Expect = 1e-23
 Identities = 40/154 (25%), Positives = 63/154 (40%), Gaps = 10/154 (6%)

Query: 436 IGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +G+G   SV   R        G  VAVK          + F  E  ++K +    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 491 SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
                   ++  LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
            +H DL   N+L++      ++DFG+AK L  + 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 1e-23
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 14/174 (8%)

Query: 436 IGRGGVASVYKAR-----IQDGIEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V   R        G +VAVK                E ++++ + H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 490 ISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
              C+ D      L++E++P GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAP 599
             +H DL   NVL++      + DFG+ K  ++ D+     +      + + AP
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAP 198

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (251), Expect = 2e-23
 Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 10/170 (5%)

Query: 436 IGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G   +V+K           I V +KV + +    +F++       +  + H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           +  C     + LV +Y+P GSL   +      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (250), Expect = 2e-23
 Identities = 42/185 (22%), Positives = 80/185 (43%), Gaps = 29/185 (15%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVFDLQYEGA----FKSFDIECDMMKRIRHRNLI 487
           +G G   SV +  ++      ++VAVK   ++ + +     + F  E   MK   H N+I
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 488 KIISSCSNDDFKA-----LVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASA 537
           +++  C     +      ++L +M +G L        L +    + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 538 LEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           +EYL   +F      +H DL   N +L D+M   ++DFG++K +   D           +
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 595 GYMAP 599
            ++A 
Sbjct: 214 KWIAI 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 19/174 (10%)

Query: 436 IGRGGVASVYKARIQDG---IEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           +G G   +V K   Q       VAVK+   +            E ++M+++ +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
             C  + +  LV+E    G L K L  + + +     + ++  V+  ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAP 599
             +H DL   NVLL     A +SDFG++K  L+ D++  + QT     + + AP
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAP 189

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  102 bits (256), Expect = 3e-23
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 11/170 (6%)

Query: 434 NLIGRGGVASVYKARIQD-GIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           + +G G    VY+   +   + VAVK    D      F     E  +MK I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLL 282

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPI 549
             C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH +L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  103 bits (258), Expect = 3e-23
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 14/154 (9%)

Query: 436 IGRGGVASVYKARIQDG---IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G   SV +   +     I+VA+KV      +   +    E  +M ++ +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSVP 548
            C  +    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
            +H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 44/184 (23%), Positives = 83/184 (45%), Gaps = 26/184 (14%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G+G   SV +A+++      ++VAVK+   D+      + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 490 ISSCSNDDFKA------LVLEYMPHGSLEKCLYSS-----NYILDIFQRLNIMIDVASAL 538
           +        K       ++L +M HG L   L +S      + L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 539 EYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 596 YMAP 599
           ++A 
Sbjct: 205 WLAL 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  101 bits (254), Expect = 4e-23
 Identities = 37/167 (22%), Positives = 79/167 (47%), Gaps = 7/167 (4%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             +G G    V+ A      +VAVK          ++F  E ++MK ++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           + +    ++ E+M  GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL+  N+L+  ++V  ++DFG+A+ ++++++   +      I + AP
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 354

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 33/171 (19%), Positives = 65/171 (38%), Gaps = 13/171 (7%)

Query: 39  TFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ 98
           T   + +L  ++L    +T        L+ +     +K L+ +N       P  I  LS 
Sbjct: 39  TEAQMNSLTYITLANINVTD-------LTGIEYAHNIKDLTINNIHATNYNP--ISGLSN 89

Query: 99  SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL 158
            +E   +   +++      +S LT+LT + +  +  + SI   ++ L K+  + L  N  
Sbjct: 90  -LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148

Query: 159 EGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI 209
              I   L  L  L  L++  + +  +      +   L  LY  S  +   
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 29/189 (15%), Positives = 63/189 (33%), Gaps = 9/189 (4%)

Query: 140 IALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL 199
           I     +      L  +         +    +L  + L    ++           ++++L
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG--IEYAHNIKDL 71

Query: 200 YLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT 259
            + +   T+  + +  L  +  L +     T      +  L  L  +D+S +     I T
Sbjct: 72  TINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 260 TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYIN 319
            I  L  +  + L YN     I   +  L +LKSL++  + +       +E    L  + 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187

Query: 320 VSFNKLEGE 328
                + G+
Sbjct: 188 AFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 29/214 (13%), Positives = 61/214 (28%), Gaps = 39/214 (18%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
             +      L  +   + T         +    L Y++ +N ++  +             
Sbjct: 21  TFKAYLNGLLGQSSTANITE--------AQMNSLTYITLANINVTDL------------- 59

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
                           I    N+  + +         PI+   L  L+ L +    +   
Sbjct: 60  --------------TGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSD 103

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY 221
              +L  L +L LLD+  +     +      L  + ++ L  N   +    L  L  +  
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKS 163

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG 255
           LN+  +       +E  +   L Q+        G
Sbjct: 164 LNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 19/158 (12%), Positives = 46/158 (29%), Gaps = 35/158 (22%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L +   + +    + I   S L RL +               L +L  L ++++    S 
Sbjct: 71  LTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                L+ ++    +  +  S N         I ++                     +  
Sbjct: 129 -----LTKINTLPKVNSIDLSYNGA-------ITDIM-------------------PLKT 157

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL 158
           L  L ++ +  + ++      ++   KL  L      +
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 9/128 (7%)

Query: 203 SNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG 262
           S    +IP +    K  L   L  +S      +    +  L  I L+  N +      I 
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IE 63

Query: 263 DLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSF 322
              +++ L +         P  I GL +L+ L +   +++     +L  L  L  +++S 
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 323 NKLEGEIP 330
           +  +  I 
Sbjct: 122 SAHDDSIL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.7 bits (135), Expect = 4e-09
 Identities = 17/136 (12%), Positives = 38/136 (27%), Gaps = 33/136 (24%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L + G + +      +   + L+ L++  ++    I      L  +  + L+YN   +  
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD- 151

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                +  L     LK L+   + +                                I +
Sbjct: 152 -----IMPLKTLPELKSLNIQFDGVHDY---------------------------RGIED 179

Query: 121 LTNLTTIYLGGNKLNG 136
              L  +Y     + G
Sbjct: 180 FPKLNQLYAFSQTIGG 195

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 11/168 (6%)

Query: 436 IGRGGVASVYKARIQDG-IEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
           +G G    VY+   +   + VAVK    D      F     E  +MK I+H NL++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL        IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 12/172 (6%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVK---VFDLQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            IGRG  + VY+A  + DG+ VA+K   +FDL    A      E D++K++ H N+IK  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLHFGYSV 547
           +S   D+   +VLE    G L + +        +          + + SALE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            ++H D+KP NV +    V  L D G+ +       +   +    T  YM+P
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-GTPYYMSP 205

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 25/166 (15%)

Query: 436 IGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI 487
           +G+G    ++K   ++          EV +KV D  +    +SF     MM ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFG 544
                C   D   LV E++  GSL+  L  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 545 YSVPIIHCDLKPNNVLLD--------DNMVAHLSDFGMAKPLLKED 582
                IH ++   N+LL         +     LSD G++  +L +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 45/196 (22%), Positives = 79/196 (40%), Gaps = 30/196 (15%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F E  ++G+G    V KAR   D    A+K      E    +   E  ++  + H+ +++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66

Query: 489 IISSCSNDDFKA-------------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA 535
             ++                     + +EY  +G+L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL--------LKEDQSLTQ 587
            AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK +        L        
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 588 TQTLAT-IG---YMAP 599
           +  L + IG   Y+A 
Sbjct: 184 SDNLTSAIGTAMYVAT 199

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 17/179 (9%)

Query: 432 ENNLIGRGGVASVYKARIQDG----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNL 486
            + +IG+G    VY     D     I+ A+K    +      ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 487 IKIISSCSNDD-FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---H 542
           + +I      +    ++L YM HG L + + S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAP 599
           F      +H DL   N +LD++    ++DFG+A+ +L  +             + + A 
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  100 bits (251), Expect = 7e-23
 Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 29/192 (15%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
                ++G G   +V       G  VAVK   + +        +E  ++     H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 489 IISSCSNDDFKALVLEYMPHGSLE------KCLYSSNYILDIFQRLNIMIDVASALEYLH 542
              S + D F  + LE     +L+           +  +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 543 FGYSVPIIHCDLKPNNVLLD-------------DNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
              S+ IIH DLKP N+L+              +N+   +SDFG+ K L     S     
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 590 TLA--TIGYMAP 599
                T G+ AP
Sbjct: 190 NNPSGTSGWRAP 201

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 16/173 (9%)

Query: 436 IGRGGVASVYKARIQDG-----IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G   +VYK           I VA+K   +     A K    E  +M  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 546
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              +H DL   NVL+       ++DFG+AK L  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  102 bits (254), Expect = 8e-23
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 19/177 (10%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKII--- 490
           +G GG   V +      G +VA+K    +      + + +E  +MK++ H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 491 ---SSCSNDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHFGY 545
                 + +D   L +EY   G L K L  + +   L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 546 SVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N++L      ++  + D G AK L  +   L     + T+ Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAP 192

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 99.1 bits (247), Expect = 8e-23
 Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 22/186 (11%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISS 492
           ++  GG A VY+A+ +  G E A+K      E   ++   E   MK++  H N+++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 493 CS-------NDDFKALVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASALEYLHF 543
            S           + L+L  +  G L + L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA----------T 593
               PIIH DLK  N+LL +     L DFG A  +          Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 594 IGYMAP 599
             Y  P
Sbjct: 214 PMYRTP 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 40/167 (23%), Positives = 83/167 (49%), Gaps = 11/167 (6%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+        +VAVK          AF +   E ++MK+++H+ L+++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
           + +    ++ EYM +GSL   L + +   L I + L++   +A  + ++        IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DL+  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 98.4 bits (245), Expect = 9e-23
 Identities = 63/334 (18%), Positives = 108/334 (32%), Gaps = 52/334 (15%)

Query: 7   NFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFL 66
           NFS   P +    + L   ++E+          +G  R+L+ L    +         + +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVEL----------YGGGRSLEYLLKRVDTEADLGQFTDII 65

Query: 67  SSLSNCKYLKYLSFSNNSL-DGILPRAIGNLSQS-MEVFFMFNCNISGSIPEEISNLT-- 122
            SLS    LK L+     +   IL  A+  L  S ++   + N  ++G+ P  +   T  
Sbjct: 66  KSLS----LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121

Query: 123 NLTTIYLGGNKLNGSIPIALD----KLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
           +L  + L             +        L++LS+          + +    AL  LDL 
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 179 GNKLSGFVP----ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP 234
            N   G        C     +L+ L L +  + +       L                  
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL------------------ 223

Query: 235 LEIGNLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSIGGLIDLKS 293
                   L  +DLS N+          D    L  L L +  L+  +P  +     L  
Sbjct: 224 --AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSV 278

Query: 294 LDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG 327
           LDLS N +    P   E L  +  +++  N    
Sbjct: 279 LDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 53/286 (18%), Positives = 86/286 (30%), Gaps = 29/286 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNT---FGNLRNLKRLSLNYNYLT 57
           L            + I  +  L RL +        I         +  L+ L+L    +T
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 58  SSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE 117
            + P     ++  +   L   + S  + D  L      L   ++V  +   +      E+
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
           +     L+T+ L  N   G   +                 +    P     L  L L + 
Sbjct: 169 VRVFPALSTLDLSDNPELGERGL-----------------ISALCPLKFPTLQVLALRNA 211

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPLPL 235
           G    SG   A       L+ L L  N L       +      +  LNLS       +P 
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK 270

Query: 236 EIG-NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
            +   L VL   DLS N        +  +L  +  L L+ N    S
Sbjct: 271 GLPAKLSVL---DLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 45/255 (17%), Positives = 86/255 (33%), Gaps = 20/255 (7%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
            L   +  +  IPS +        L   +          F    +L+++ ++ N +    
Sbjct: 14  FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 61  PKLNFLSSLSNCKYLKYLSFSN-NSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
               F S+L     L  +     N+L  I P A  NL  +++   + N  I   +P+   
Sbjct: 71  EADVF-SNLPK---LHEIRIEKANNLLYINPEAFQNLP-NLQYLLISNTGIK-HLPDVHK 124

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQ-KLQLLSLEDNQLEGSIPDDLCR-LAALFLL 175
            +      + +  N    +I   +   L  +  +L L  N ++  I +          L 
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLP 234
               N L       F   +    L +   ++ S+PS  L NLK +   +  +      L 
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL- 242

Query: 235 LEIGNLRVLVQIDLS 249
                L  L++  L+
Sbjct: 243 ---EKLVALMEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 97.2 bits (242), Expect = 4e-22
 Identities = 48/233 (20%), Positives = 81/233 (34%), Gaps = 15/233 (6%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIP-NTFGNLRNLKRLSL-NYNYLT 57
           L          I    F     L ++E+  N     I  + F NL  L  + +   N L 
Sbjct: 35  LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93

Query: 58  SSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE 117
              P      +L N   L+YL  SN  +  +      +  Q + +    N NI  +I   
Sbjct: 94  YINP--EAFQNLPN---LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERN 147

Query: 118 -ISNLT-NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL 175
               L+     ++L  N +      A +  Q  +L   ++N LE    D     +   +L
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNS 228
           D+   ++         NL  LR        L  +P+ L  L  ++  +L+  S
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 39/219 (17%), Positives = 71/219 (32%), Gaps = 11/219 (5%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP----DDLCR 168
            IP ++    N   +     KL      A      L+ + +  N +   I      +L +
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSN 227
           L  + +     N L    P  F NL +L+ L + +  +  +P     +    + L++  N
Sbjct: 81  LHEIRIEK--ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138

Query: 228 SFTGPLPLEI--GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI 285
                +      G     V + L+ N       +     +  +    + N L+    D  
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNK 324
            G      LD+S   I       LE L  L+  +    K
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 50/231 (21%), Positives = 85/231 (36%), Gaps = 12/231 (5%)

Query: 75  LKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYL-GGN 132
              L F    L  I   A        ++    N ++   I  ++ SNL  L  I +   N
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN-DVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 133 KLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFLLDLGGN-KLSGFVPACF 190
            L    P A   L  LQ L + +  ++  +PD          LLD+  N  +       F
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149

Query: 191 GNLTS-LRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDL 248
             L+     L+L  N +  I ++ +N   +  LNLS N+    LP ++       V +D+
Sbjct: 150 VGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209

Query: 249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN 299
           S           + +LK L+       +    +P ++  L+ L    L+  
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 32/151 (21%), Positives = 51/151 (33%), Gaps = 7/151 (4%)

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS 254
           S R      +++T IPS L   +  + L                    L +I++S N+  
Sbjct: 10  SNRVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67

Query: 255 GFIPT-TIGDLKDLQYLFLE-YNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPISLEK 311
             I      +L  L  + +E  N L   I       L +L+ L +SN  I     +    
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126

Query: 312 LLDLKYINVSFNKLEGEIPREGPFRNFSAES 342
            L    +++  N     I     F   S ES
Sbjct: 127 SLQKVLLDIQDNINIHTIE-RNSFVGLSFES 156

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (251), Expect = 1e-22
 Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 8/143 (5%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 496 DDFKA-LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 554 LKPNNVLLDDNMVAHLSDFGMAK 576
           L   NVL+ ++ VA +SDFG+ K
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK 337

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 42/174 (24%), Positives = 65/174 (37%), Gaps = 11/174 (6%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRI-RHRN 485
           F   + +G G    V+K R  +DG   AVK     + G         E    +++ +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +++  +        L  E     SL++   +    L   Q    + D   AL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S  ++H D+KP N+ L       L DFG+   L        Q        YMAP
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAP 225

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 15/173 (8%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V   R++      + VA+K     Y E   + F  E  +M +  H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
              +      +V EYM +GSL+  L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
             +H DL   NVL+D N+V  +SDFG+++ L    D + T T     I + AP
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.7 bits (243), Expect = 4e-22
 Identities = 34/191 (17%), Positives = 67/191 (35%), Gaps = 24/191 (12%)

Query: 430 FSENNLIGRGGVASVYKAR------IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH 483
              ++L+G G  A VY+A        ++  +  +KV        F       + +K    
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSL----EKCLYSSNYILDIFQRLNIMIDVASALE 539
              +K  S+    +   LV E   +G+L         +   ++     ++  + +   +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAH-----------LSDFGMAKPLLKEDQSLTQT 588
            +H      IIH D+KP+N +L +  +             L D G +  +    +    T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 589 QTLATIGYMAP 599
               T G+   
Sbjct: 244 AKCETSGFQCV 254

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 20/176 (11%)

Query: 436 IGRGGVASVYKARIQD-----GIEVAVKVFDLQYEGAFKS---FDIECDMMKRIRHRNLI 487
           +G G    V            G  VAVK   L+ +   +    +  E D+++ + H ++I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 488 KIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           K    C +    +  LV+EY+P GSL   L   +  + + Q L     +   + YLH   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH--- 151

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT--IGYMAP 599
           +   IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + AP
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 16/172 (9%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V++          + VA+K       +   + F  E   M++  H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
              + +    +++E    G L   L    Y LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 186

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 8/145 (5%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             IG+G    V     + G +VAVK   ++ +   ++F  E  +M ++RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 494 SNDDFKA-LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAK 576
            DL   NVL+ ++ VA +SDFG+ K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK 165

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 96.7 bits (241), Expect = 7e-22
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 15/173 (8%)

Query: 436 IGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
           +G G    V   R++      I VA+K   + Y E   + F  E  +M +  H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
              +      +V EYM +GSL+  L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
             +H DL   N+L++ N+V  +SDFG+ + L    + + T       I + +P
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 37/172 (21%), Positives = 73/172 (42%), Gaps = 16/172 (9%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
           +G G    VY+    +     I VAVK           + F  E  +MK + H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
                +    +++E  P+G L   L  +   L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +H D+   N+L+       L DFG+++  ++++     + T   I +M+P
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 183

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 32/195 (16%)

Query: 425 QATNGFSEN----NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------ 473
            +T+GF EN     ++GRG  + V +        E AVK+ D+   G+F + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 474 ---ECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDI 524
              E D+++++  H N+I++  +   + F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
            +       +   +  LH    + I+H DLKP N+LLDD+M   L+DFG +   L   + 
Sbjct: 130 MR------ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEK 179

Query: 585 LTQTQTLATIGYMAP 599
           L   +   T  Y+AP
Sbjct: 180 L--REVCGTPSYLAP 192

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 11/170 (6%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
           L+G+G  A VY+A  I  G+EVA+K+ D   +   G  +    E  +  +++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
           +   + ++  LVLE   +G + + L +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
           H DL  +N+LL  NM   ++DFG+A  L    +      TL  T  Y++P
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISP 181

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 38/192 (19%), Positives = 77/192 (40%), Gaps = 31/192 (16%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISS 492
            +GRGG   V++A+   D    A+K   L   E A +    E   + ++ H  +++  ++
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 493 CSNDDFKA------------LVLEYMPHGSLEKCL--YSSNYILDIFQRLNIMIDVASAL 538
               +               + ++     +L+  +    +    +    L+I + +A A+
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG--- 595
           E+LH   S  ++H DLKP+N+    + V  + DFG+    + +D+      T        
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYARH 187

Query: 596 --------YMAP 599
                   YM+P
Sbjct: 188 TGQVGTKLYMSP 199

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 15/163 (9%)

Query: 436 IGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
           IG G    VYK  ++       + VA+K     Y E     F  E  +M +  H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 546
               S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
              +H DL   N+L++ N+V  +SDFG+++ L  + ++   T 
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 11/166 (6%)

Query: 95  NLSQSMEVFFMFNCNISGSIPEEI--SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLL 151
           +L     +  + + N+S  +  E   + LTNL ++ L  N LN  I   A   +  L+ L
Sbjct: 36  SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93

Query: 152 SLEDNQLEGSIPDD-LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP 210
            L  N L  ++ +     L AL +L L  N +       F ++  L+ LYL  NQ++  P
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152

Query: 211 ----STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN 252
                    L  ++ L+LSSN        ++  L   V+  L ++N
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 38/193 (19%), Positives = 61/193 (31%), Gaps = 31/193 (16%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIP--IALDKLQKLQLLSLEDNQLEGSIPDD-LCRL 169
           ++P+ +   +    + L  N L   +       +L  L  L L  N L   I  +    +
Sbjct: 32  NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 170 AALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNS 228
             L  LDL  N L       F +L +L  L L +N +  +      ++  +  L LS N 
Sbjct: 88  PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147

Query: 229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL 288
            +                   +             L  L  L L  N+L+      +  L
Sbjct: 148 IS----------------RFPVELIKDG-----NKLPKLMLLDLSSNKLKKLPLTDLQKL 186

Query: 289 IDLK--SLDLSNN 299
                  L L NN
Sbjct: 187 PAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 42/158 (26%), Positives = 59/158 (37%), Gaps = 31/158 (19%)

Query: 175 LDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL 233
           LDL  N LS          LT+L +L L  N L  I S                +F    
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISS---------------EAFVP-- 86

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLK 292
                 +  L  +DLS N+          DL+ L+ L L  N +   +  +    +  L+
Sbjct: 87  ------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139

Query: 293 SLDLSNNNISGAIP----ISLEKLLDLKYINVSFNKLE 326
            L LS N IS   P        KL  L  +++S NKL+
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 51/255 (20%), Positives = 74/255 (29%), Gaps = 62/255 (24%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L L  NN S     +     + L  L L  N         F  + NL+ L L+ N+L + 
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTL 103

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS 119
              L   S L     L+ L   NN +                            +     
Sbjct: 104 DEFL--FSDLQA---LEVLLLYNNHIV--------------------------VVDRN-- 130

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDD----LCRLAALFLL 175
                                A + + +LQ L L  NQ+    P +      +L  L LL
Sbjct: 131 ---------------------AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168

Query: 176 DLGGNKLSGFVPACFGNLTSL--RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL 233
           DL  NKL          L +     LYL +N L           +  Y  LSS       
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228

Query: 234 PLEIGNLRVLVQIDL 248
              + + ++     L
Sbjct: 229 LYCMHSKKLHNIFSL 243

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 5/94 (5%)

Query: 246 IDLSMNNFSGFIPTTI-GDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISG 303
           +DLS NN S          L +L  L L +N L   I       + +L+ LDLS+N++  
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT 102

Query: 304 AIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
                   L  L+ + +  N +   +     F +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVD-RNAFED 134

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 12/174 (6%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +     +G G    VYKA+  + G   A KV + + E   + + +E +++    H  ++K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           ++ +  +D    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           IIH DLK  NVL+       L+DFG++       ++L +  +   IG   +MAP
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAP 186

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 14/174 (8%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           F     +G G   SVYKA   + G  VA+K   +  E   +    E  +M++    +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
              S   +    +V+EY   GS+   +   N  L   +   I+      LEYLH    + 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
            IH D+K  N+LL+    A L+DFG+A  L     ++ +  T+  IG   +MAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAP 194

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 47/230 (20%)

Query: 397 RKRGKSQLADANMPLVANLRRFTHLELFQATNGFSEN----NLIGRGGVASVYKAR-IQD 451
           +K   +Q          ++     L  + A   F +     ++IGRG  + V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 452 GIEVAVKVFDL--------QYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALV 502
           G E AVK+ ++        Q E   ++   E  +++++  H ++I +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 503 LEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYLHFGYSVPII 550
            + M  G L             F  L            +IM  +  A+ +LH   +  I+
Sbjct: 179 FDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIV 222

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           H DLKP N+LLDDNM   LSDFG +   L+  + L     L  T GY+AP
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAP 268

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 10/172 (5%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           ++    IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
            + S    D   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           +IH D+K +N+LL  +    L+DFG    +       ++  T+  T  +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 185

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 38/172 (22%), Positives = 73/172 (42%), Gaps = 16/172 (9%)

Query: 436 IGRGGVASVYKARIQDG----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKII 490
           IG G    V++          + VA+K       +   + F  E   M++  H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL---HFGYSV 547
              + +    +++E    G L   L    + LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +H D+   NVL+  N    L DFG+++  +++      ++    I +MAP
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 561

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 31/180 (17%), Positives = 71/180 (39%), Gaps = 19/180 (10%)

Query: 436 IGRGGVASVYKARIQDGIE------VAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G+G    VY+   +  ++      VA+K   +         F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 489 IISSCSNDDFKALVLEYMPHGSL---------EKCLYSSNYILDIFQRLNIMIDVASALE 539
           ++   S      +++E M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 14/174 (8%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
                 IG G    V  AR    G +VAVK+ DL+ +   +    E  +M+  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +  S    +   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           +IH D+K +++LL  +    LSDFG    +    + + + ++L  +G   +MAP
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAP 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 36/171 (21%), Positives = 71/171 (41%), Gaps = 14/171 (8%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G+GG A  ++          A K+     L      +   +E  + + + H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
               ++DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ--TLATIGYMAP 599
           H DLK  N+ L++++   + DFG+A   ++ D    +    T     Y+AP
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP 210

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 36/171 (21%), Positives = 71/171 (41%), Gaps = 14/171 (8%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G+GG A  ++          A K+     L      +   +E  + + + H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
               ++DF  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ--TLATIGYMAP 599
           H DLK  N+ L++++   + DFG+A   ++ D    +    T     Y+AP
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP 184

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 12/170 (7%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKI 489
             +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                +     L+LEY P G++ + L   +   +       + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP N+LL       ++DFG +        S        T+ Y+ P
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGTLDYLPP 176

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 436 IGRGGVASVYKARIQDG------IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    VY+ ++         ++VAVK   ++  E     F +E  ++ +  H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 541
            I        + +++E M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 542 --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
             HF      IH D+   N LL       VA + DFGMA+ + +          +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 597 MAP 599
           M P
Sbjct: 212 MPP 214

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 38/182 (20%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           ++G G  + V+  +    G   A+K           S + E  ++K+I+H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 541
            +     LV++ +  G L             F R+             ++  V SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 542 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 597
           H      I+H DLKP N+L    ++N    ++DFG++K  ++++  ++   T   T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYV 174

Query: 598 AP 599
           AP
Sbjct: 175 AP 176

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 37/186 (19%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           IG+G  + V +    + G + AVK+ D+    +           E  +   ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 490 ISSCSNDDFKALVLEYMPHGSL---------EKCLYS----SNYILDIFQRLNIMIDVAS 536
           + + S+D    +V E+M    L            +YS    S+Y+  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           AL Y H      IIH D+KP+ VLL   +++    L  FG+A  L +          + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 594 IGYMAP 599
             +MAP
Sbjct: 197 PHFMAP 202

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 436 IGRGGVASVYKARIQDG------IEVAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    VY+ ++         ++VAVK   ++  E     F +E  ++ +  H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSS------NYILDIFQRLNIMIDVASALEYL- 541
            I        + ++LE M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 542 --HFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGY 596
             HF      IH D+   N LL       VA + DFGMA+ + +          +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 597 MAP 599
           M P
Sbjct: 253 MPP 255

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 36/189 (19%), Positives = 73/189 (38%), Gaps = 33/189 (17%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFD-----------------LQYEGAFKSFDIECDMM 478
           + +G    +     +D    A+K ++                 +  +  +  F  E  ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL-------NIM 531
             I++   +      +N D   ++ EYM + S+ K       +   +           I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
             V ++  Y+H   +  I H D+KP+N+L+D N    LSDFG ++     D+ +   +  
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKI---KGS 210

Query: 592 A-TIGYMAP 599
             T  +M P
Sbjct: 211 RGTYEFMPP 219

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 28/201 (13%), Positives = 57/201 (28%), Gaps = 40/201 (19%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGA-------------------------- 467
           ++G+    +  +A   + G    V V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 468 --FKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM-PHGSLEKCL------YSS 518
                F    D++K  + + +I++     +    +    Y     +L+          S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 519 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260

Query: 579 LKEDQSLTQTQTLATIGYMAP 599
                     +  A     A 
Sbjct: 261 DGASAVSPIGRGFAPPETTAE 281

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 30/188 (15%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A        +D + VAVK        A K F  E +++  ++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 490 ISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIMIDV 534
              C + D   +V EYM HG L               +     +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 535 ASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 592 ATIGYMAP 599
             I +M P
Sbjct: 197 LPIRWMPP 204

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 29/187 (15%)

Query: 436 IGRGGVASVYKARIQDGIE------VAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
           +G G    V+ A   + +       VAVK      E A + F  E +++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 490 ISSCSNDDFKALVLEYMPHGSL--------------EKCLYSSNYILDIFQRLNIMIDVA 535
              C+      +V EYM HG L                    +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 536 SALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 593 TIGYMAP 599
            I +M P
Sbjct: 223 PIRWMPP 229

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 32/182 (17%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDI-----ECDMMKRIRHRNL 486
           +G G    V  A   +   +VA+K+          A ++        E +++K++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 487 IKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           IKI +    +D+  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 542 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 597
           H      IIH DLKP NVLL   +++ +  ++DFG +K +L E   +    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183

Query: 598 AP 599
           AP
Sbjct: 184 AP 185

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 40/194 (20%), Positives = 81/194 (41%), Gaps = 33/194 (17%)

Query: 436 IGRGGVASVYKARIQDG------IEVAVK-VFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    V KA             VAVK + +       +    E +++K++ H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------------------EKCLYSSNYILDIF 525
           +  +CS D    L++EY  +GSL                           +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
             ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+++ + +ED  +
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 586 TQTQTLATIGYMAP 599
            ++Q    + +MA 
Sbjct: 208 KRSQGRIPVKWMAI 221

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 26/186 (13%)

Query: 434 NLIGRGGVASVYKARIQDG---IEVAVKVF-DLQYEGAFKSFDIECDMMKRI-RHRNLIK 488
           ++IG G    V KARI+     ++ A+K   +   +   + F  E +++ ++  H N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 489 IISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIMID 533
           ++ +C +  +  L +EY PHG+L                    S+   L   Q L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 594 IGYMAP 599
           + +MA 
Sbjct: 205 VRWMAI 210

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 89.2 bits (221), Expect = 3e-19
 Identities = 32/175 (18%), Positives = 72/175 (41%), Gaps = 14/175 (8%)

Query: 436 IGRG--GVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKII 490
           IG+G   + +V  AR    G  V V+  +L+         +  E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCL-YSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           ++   D+   +V  +M +GS +  +       ++      I+  V  AL+Y+H    +  
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIG---YMAP 599
           +H  +K +++L+  +   +LS       ++     Q +       ++    +++P
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 41/180 (22%), Positives = 77/180 (42%), Gaps = 32/180 (17%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISS 492
           +G+G  + V +   +  G E A  + + +   A     +  E  + + ++H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 493 CSNDDFKALVLEYMPHGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEYLHF 543
            S +    L+ + +  G L      +  YS    S+ I  I            A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127

Query: 544 GYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
              + ++H +LKP N+LL          L+DFG+A  +  E Q+       A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 15/176 (8%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           IG G  A V  A       +VA+K  +L + + +      E   M +  H N++   +S 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 494 SNDDFKALVLEYMPHGSL-------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
              D   LV++ +  GS+              + +LD      I+ +V   LEYLH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
              IH D+K  N+LL ++    ++DFG++  L               +G   +MAP
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 30/201 (14%), Positives = 63/201 (31%), Gaps = 45/201 (22%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKS----------------------- 470
           ++G+    +  +A   + G    V V          +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 471 -----FDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM-PHGSLEKCL------YSS 518
                F    D++K  + + +I++     +    +    Y     +L+          S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 519 NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE----H 252

Query: 579 LKEDQSLTQTQTLATIGYMAP 599
           L  D +   +    + G+  P
Sbjct: 253 LVRDGARVVSSV--SRGFEPP 271

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 21/173 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    V++      G     K  +  Y     +   E  +M ++ H  LI +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 495 NDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +     L+LE++  G L      E    S   +      +N M      L+++H      
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHS 169

Query: 549 IIHCDLKPNNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           I+H D+KP N++ +    + +   DFG+A   L  D+ +    T AT  + AP
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAP 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 39/197 (19%), Positives = 75/197 (38%), Gaps = 37/197 (18%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRI-RHRN 485
           F E   IG G   SV+K     DG   A+K       G+    +   E      + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF---QRLNIMIDVASALEYLH 542
           +++  S+ + DD   +  EY   GSL   +  +  I+  F   +  ++++ V   L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 543 FGYSVPIIHCDLKPNNVLLDDN-------------------MVAHLSDFGMAKPLLKEDQ 583
              S+ ++H D+KP+N+ +                      ++  + D G          
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------- 182

Query: 584 SLTQTQTLA-TIGYMAP 599
            ++  Q       ++A 
Sbjct: 183 RISSPQVEEGDSRFLAN 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 32/182 (17%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDI-----ECDMMKRIRHRNL 486
           +G G    V  A   +   +VA+++          A ++        E +++K++ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 487 IKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           IKI +    +D+  +VLE M  G L                  F        +  A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 542 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 597
           H      IIH DLKP NVLL   +++ +  ++DFG +K +L E   +    TL  T  Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 308

Query: 598 AP 599
           AP
Sbjct: 309 AP 310

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 45/197 (22%), Positives = 74/197 (37%), Gaps = 39/197 (19%)

Query: 436 IGRGGVASVYKARIQDGIE------VAVKVF-DLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           IG G    V++AR    +       VAVK+  +         F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------------------EKCLYSSNYILDIF 525
           ++  C+      L+ EYM +G L                        +        L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 526 QRLNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
           ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 583 QSLTQTQTLATIGYMAP 599
                      I +M P
Sbjct: 229 YYKADGNDAIPIRWMPP 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 39/189 (20%), Positives = 73/189 (38%), Gaps = 31/189 (16%)

Query: 436 IGRGGVASVYKARIQDG------IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIK 488
           +G      VYK  +           VA+K    +      + F  E  +  R++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 489 IISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNIMID 533
           ++   + D   +++  Y  HG L                    +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 534 VASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 591 LATIGYMAP 599
           L  I +MAP
Sbjct: 191 LLPIRWMAP 199

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 20/177 (11%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---ECDMMKRIRHRN 485
           FS+   IG G   +VY AR +++   VA+K      + + + +     E   ++++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            I+       +    LV+EY   GS    L      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
           S  +IH D+K  N+LL +  +  L DFG A         +    +   +G   +MAP
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAP 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 38/187 (20%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISS 492
           ++G G  A V     +    E AVK+ + Q          E +M+ + + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEY 540
              +D   LV E M  GS+                +             ++ DVASAL++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 541 LHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPL-LKEDQSLTQTQTLATI-- 594
           LH   +  I H DLKP N+L    +      + DF +   + L  D S   T  L T   
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 595 --GYMAP 599
              YMAP
Sbjct: 184 SAEYMAP 190

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLI 487
           F++   IG+G    V+K    +    VA+K+ DL + E   +    E  ++ +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 488 KIISSCSNDDFKALVLEYMPHGS----LEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           K   S   D    +++EY+  GS    LE        I        I+ ++   L+YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLH- 136

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
             S   IH D+K  NVLL ++    L+DFG+A  L     +  +  T   +G   +MAP
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAP 188

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 24/175 (13%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G+G   +VY AR  Q+   +A+KV     L+ EG       E ++   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFG 544
           +   +     L+LE+ P G L K L           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               +IH D+KP N+L+       ++DFG +           +T    T+ Y+ P
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRT-MCGTLDYLPP 181

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 40/182 (21%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IG G  +   +       +E AVK+ D       +  +I   +++  +H N+I +     
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYD 86

Query: 495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYLH 542
           +  +  +V E M  G L               ++             ++  +   +EYLH
Sbjct: 87  DGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 543 FGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYM 597
              +  ++H DLKP+N+L      +     + DFG AK L  E+  L    T   T  ++
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFV 187

Query: 598 AP 599
           AP
Sbjct: 188 AP 189

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 87.4 bits (217), Expect = 7e-19
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 37/182 (20%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           +G+G  + V +      G+E A K+ + +      + D      E  + ++++H N++++
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 490 ISSCSNDDFKALVLEYMPHGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEY 540
             S   + F  LV + +  G L      +  YS    S+ I  I            ++ Y
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 143

Query: 541 LHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
            H   S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 197

Query: 598 AP 599
           +P
Sbjct: 198 SP 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.1 bits (214), Expect = 8e-19
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 37/182 (20%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           +G+G  + V +      G+E A K+ + +      + D      E  + ++++H N++++
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 490 ISSCSNDDFKALVLEYMPHGSL-----EKCLYS----SNYILDIFQRLNIMIDVASALEY 540
             S   + F  LV + +  G L      +  YS    S+ I  I            ++ Y
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 120

Query: 541 LHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
            H   S  I+H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 174

Query: 598 AP 599
           +P
Sbjct: 175 SP 176

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 22/149 (14%), Positives = 48/149 (32%), Gaps = 14/149 (9%)

Query: 435 LIGRGGVASVYKARIQDGI---EVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIK 488
             G       ++A   D     +VA+   D Q    +   +        + RI    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           ++          +V E++  GSL++   +S         +  M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
           +      P+ V +  +    L+       
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPD 178

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 40/176 (22%), Positives = 77/176 (43%), Gaps = 25/176 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+G    V K +      E AVKV +    + +    +   E +++K++ H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88

Query: 492 SCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
              +     +V E    G L     ++  +S +    I +       V S + Y+H    
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---K 139

Query: 547 VPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP 192

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 24/176 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G+G    V   +    G E AVKV     ++ +   +S   E  ++K++ H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 492 SCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
              +  +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 547 VPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             I+H DLKP N+LL     +    + DFG++    +  + +     + T  Y+AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAP 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 38/181 (20%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSC 493
           +G G  +   K    +     AVK+   + E   +    E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVASALEYL 541
            +     LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 542 HFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           H    V ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 599 P 599
           P
Sbjct: 178 P 178

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 28/189 (14%)

Query: 436 IGRGGVASVYKARIQD--------GIEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRN 485
           +G G    V  A             + VAVK + D   E        E +MMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNI 530
           +I ++ +C+ D    +++EY   G+L                         +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 591 LATIGYMAP 599
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 23/175 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISS 492
           +G G    V   R     +E A+K+          +  +  E  ++K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 493 CSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
             +     LV+E    G L      +  ++      I +       V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KH 155

Query: 548 PIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I+H DLKP N+LL   + + +  + DFG++  + +  + +   + L T  Y+AP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAP 207

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 24/200 (12%), Positives = 50/200 (25%), Gaps = 44/200 (22%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +  G  + V+  R ++   + A+KVF           +          R+   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 491 SSC----------------------SNDDFKA----LVLEYM-----PHGSLEKCLYSSN 519
                                      DD+      L++           S    +Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 520 YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL 579
               I     +   +      L    S  ++H    P+N+ +  +    L D      + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV- 244

Query: 580 KEDQSLTQTQTLATIGYMAP 599
                 T+    +     AP
Sbjct: 245 -----GTRGPASSVPVTYAP 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 27/188 (14%)

Query: 436 IGRGGVASVYKARIQD------GIEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRNLI 487
           +GRG    V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 488 KIISSCSNDDFKALV-LEYMPHGSL---------------EKCLYSSNYILDIFQRLNIM 531
            ++ +C+      +V +E+   G+L                         L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 592 ATIGYMAP 599
             + +MAP
Sbjct: 212 LPLKWMAP 219

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 37/189 (19%), Positives = 72/189 (38%), Gaps = 28/189 (14%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRNLI 487
           +G G    V +A           + VAVK +    +    ++   E  ++  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------------EKCLYSSNYILDIFQRLNI 530
            ++ +C+      ++ EY  +G L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 591 LATIGYMAP 599
              + +MAP
Sbjct: 208 RLPVKWMAP 216

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 38/190 (20%), Positives = 76/190 (40%), Gaps = 30/190 (15%)

Query: 434 NLIGRGGVASVYKARIQDGIE------VAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRN 485
             +G G    V +A      +      VAVK +    +    ++   E  +M  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSL-------------EKCLYSSNYILDIFQRLNIMI 532
           ++ ++ +C++     ++ EY  +G L             +     +N        L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 533 DVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
            VA  + +L   +       IH D+   NVLL +  VA + DFG+A+ ++ +   + +  
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 590 TLATIGYMAP 599
               + +MAP
Sbjct: 226 ARLPVKWMAP 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 21/179 (11%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            S+  ++G G    V+K      G+++A K+   +     +    E  +M ++ H NLI+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 489 IISSCSNDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
           +  +  + +   LV+EY+  G L      E    +    +        M  +   + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             Y   I+H DLKP N+L  +     +   DFG+A+   K  + L       T  ++AP
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAP 257

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 40/195 (20%)

Query: 436 IGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGA----FKSFDIECDMMKRI-R 482
           +G G    V  A             + VAVK+     + A          E +MMK I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQR 527
           H+N+I ++ +C+ D    +++EY   G+L                         +     
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 528 LNIMIDVASALEYL---HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
           ++    +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D  
Sbjct: 206 VSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259

Query: 585 LTQTQTLATIGYMAP 599
              T     + +MAP
Sbjct: 260 KKTTNGRLPVKWMAP 274

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 48/263 (18%), Positives = 86/263 (32%), Gaps = 50/263 (19%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
            L N  + +L    +T        L S      ++  +  N+++  +             
Sbjct: 17  GLANAVKQNLGKQSVTD-------LVSQKELSGVQNFNGDNSNIQSL------------- 56

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
                           +   TNL  ++L  N+++  +   L  L KL+ LS+  N+L+  
Sbjct: 57  --------------AGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-- 98

Query: 162 IPDDLCRLAALFL--LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
              +L  + +  L  L L  N+L         +L +L  L + +N+L SI   L  L  +
Sbjct: 99  ---NLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVM-LGFLSKL 152

Query: 220 LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG 279
             L+L  N  T    L    L+ +  IDL+             +L     +     R   
Sbjct: 153 EVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-- 208

Query: 280 SIPDSIGGLIDLKSLDLSNNNIS 302
             P  I          +      
Sbjct: 209 ISPYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 39/188 (20%), Positives = 63/188 (33%), Gaps = 40/188 (21%)

Query: 40  FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
             +L  L+ LS+N N L +       L+ + +   L  L   NN L              
Sbjct: 81  LKDLTKLEELSVNRNRLKN-------LNGIPSAC-LSRLFLDNNELRDT----------- 121

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
                           + + +L NL  + +  NKL  SI   L  L KL++L L  N++ 
Sbjct: 122 ----------------DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163

Query: 160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI 219
            +    L RL  +  +DL G K           L     +     +  S P  + N    
Sbjct: 164 -NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-PYYISNGGSY 220

Query: 220 LYLNLSSN 227
           +   +   
Sbjct: 221 VDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 19/126 (15%), Positives = 43/126 (34%), Gaps = 10/126 (7%)

Query: 201 LGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT 260
                +  +      L   +  NL   S T  +  +   L  +   +   +N        
Sbjct: 4   QRPTPINQV-FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG-- 58

Query: 261 IGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV 320
           +    +L+ L L +N++  S    +  L  L+ L ++ N +     ++      L  + +
Sbjct: 59  MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFL 113

Query: 321 SFNKLE 326
             N+L 
Sbjct: 114 DNNELR 119

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 46/213 (21%), Positives = 72/213 (33%), Gaps = 52/213 (24%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           IG+G    V  A   Q     A+K+ +          D+     E  +MK++ H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 490 ISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRL---------------- 528
                ++ +  LV+E    G L          S+        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 529 ------------------NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL- 569
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 570 -SDFGMAK--PLLKEDQSLTQTQTLATIGYMAP 599
             DFG++K    L   +    T    T  ++AP
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 21/173 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           IGRG    V  A      I  A K     +      F  E ++MK + H N+I++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 495 NDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           ++    LV+E    G L      K ++  +    I +      DV SA+ Y H    + +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 550 IHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            H DLKP N L      +    L DFG+A    K  + +     + T  Y++P
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSP 177

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 81.6 bits (202), Expect = 7e-18
 Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 5/114 (4%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLD 176
             L  L  I    NK+   I   A +    +  + L  N+LE ++   +   L +L  L 
Sbjct: 54  KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLM 111

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSF 229
           L  N+++      F  L+S+R L L  NQ+T++       L  +  LNL +N F
Sbjct: 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 35/190 (18%), Positives = 64/190 (33%), Gaps = 54/190 (28%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIAL-DKLQKLQLLSLEDNQLEGSIPDD-LCRLA 170
            IPE I        + L  N+        +  KL +L+ ++  +N++   I +      +
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT 230
            +  + L  N+L       F  L SL+ L L SN++T +                ++SF 
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVG---------------NDSFI 126

Query: 231 GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLI 289
           G                                L  ++ L L  N++  ++       L 
Sbjct: 127 G--------------------------------LSSVRLLSLYDNQIT-TVAPGAFDTLH 153

Query: 290 DLKSLDLSNN 299
            L +L+L  N
Sbjct: 154 SLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 36/198 (18%), Positives = 63/198 (31%), Gaps = 59/198 (29%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPN-TFGNLRNLKRLSLNYNYLTSSTPKLNFLSSL 69
            IP  I      + L L  N F        F  L  L++++ + N +T            
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA--FEGA 80

Query: 70  SNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYL 129
           S    +  +  ++N L+ +  +          +F                 L +L T+ L
Sbjct: 81  SG---VNEILLTSNRLENVQHK----------MF---------------KGLESLKTLML 112

Query: 130 GGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPA 188
             N++   +   +   L  ++LLSL DNQ+  ++                          
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA---------------------- 148

Query: 189 CFGNLTSLRNLYLGSNQL 206
            F  L SL  L L +N  
Sbjct: 149 -FDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 32/151 (21%), Positives = 55/151 (36%), Gaps = 26/151 (17%)

Query: 175 LDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL 233
           L L  N+ +       F  L  LR +   +N++T I                  +F G  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE---------------GAFEG-- 79

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLK 292
                    + +I L+ N            L+ L+ L L  NR+   + +    GL  ++
Sbjct: 80  ------ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR 132

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSFN 323
            L L +N I+   P + + L  L  +N+  N
Sbjct: 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 26/134 (19%), Positives = 44/134 (32%), Gaps = 34/134 (25%)

Query: 1   LLLWGNNFSGTIPSFIFN-ASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           +    N  +  I    F  AS ++ + L  N         F  L +LK L L  N +T  
Sbjct: 62  INFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-C 119

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
               +F   LS+   ++ LS  +N +                           ++     
Sbjct: 120 VGNDSF-IGLSS---VRLLSLYDNQI--------------------------TTVAPGAF 149

Query: 119 SNLTNLTTIYLGGN 132
             L +L+T+ L  N
Sbjct: 150 DTLHSLSTLNLLAN 163

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 85.5 bits (212), Expect = 7e-18
 Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 23/175 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNLIKIISS 492
           +G+G    V K +      E AVKV +        +  I  E +++K++ H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 493 CSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
             +     +V E    G L     ++  +S +          I+  V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH---KH 140

Query: 548 PIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I+H DLKP N+LL   + +    + DFG++    +++  +     + T  Y+AP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP 192

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 28/189 (14%)

Query: 436 IGRGGVASVYKARIQD--------GIEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRN 485
           +G G    V  A              +VAVK +     E        E +MMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSL---------------EKCLYSSNYILDIFQRLNI 530
           +I ++ +C+ D    +++EY   G+L                   ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 591 LATIGYMAP 599
              + +MAP
Sbjct: 254 RLPVKWMAP 262

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 37/184 (20%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDI-----ECDMMKRIRHRNL 486
           +G G    V+ A   +   EV VK      +  +   +   +     E  ++ R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVA 535
           IK++    N  F  LV+E    G L+  L+   +I             IF++L       
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LF--AFIDRHPRLDEPLASYIFRQL------V 140

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIG 595
           SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 596 YMAP 599
           Y AP
Sbjct: 195 YCAP 198

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 82.8 bits (205), Expect = 8e-18
 Identities = 59/223 (26%), Positives = 87/223 (39%), Gaps = 49/223 (21%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
             P   F  +   +  L+  S    +      L ++ ++  N + + S       +  L 
Sbjct: 12  IFPDDAFAETI--KANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG----IQYLP 63

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
           N   ++YL+   N L              +                    LTNLT + L 
Sbjct: 64  N---VRYLALGGNKL------------HDISAL---------------KELTNLTYLILT 93

Query: 131 GNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDLGGNKLSGFVPA 188
           GN+L  S+P    DKL  L+ L L +NQL+ S+PD +  +L  L  L+L  N+L      
Sbjct: 94  GNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKG 151

Query: 189 CFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYILYLNLSSN 227
            F  LT+L  L L  NQL S+P      L  LK    L L  N
Sbjct: 152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLK---DLRLYQN 191

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 65/203 (32%), Positives = 88/203 (43%), Gaps = 46/203 (22%)

Query: 107 NCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL 166
           N +   S+   I  L N+  + LGGNKL+  I  AL +L  L  L L  NQL+ S+P+ +
Sbjct: 49  NNSDIKSVQG-IQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQ-SLPNGV 104

Query: 167 -CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYILY 221
             +L  L  L L  N+L       F  LT+L  L L  NQL S+P      L NL     
Sbjct: 105 FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE--- 161

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGS 280
           L+LS N                             +P  + D L  L+ L L  N+L+ S
Sbjct: 162 LDLSYNQLQS-------------------------LPEGVFDKLTQLKDLRLYQNQLK-S 195

Query: 281 IPDSIGGLID-LKSLD---LSNN 299
           +PD   G+ D L SL    L +N
Sbjct: 196 VPD---GVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
             L   + +    +     + + ++    +            L N++ L+L  N L    
Sbjct: 24  ANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD-- 77

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISG--SIPEEI 118
             ++ L  L+N   L YL  + N L  +       L+   E+        +   S+P+ +
Sbjct: 78  --ISALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKEL----VLVENQLQSLPDGV 128

Query: 119 SN-LTNLTTIYLGGNKLNGSIPIAL-DKLQKLQLLSLEDNQLEGSIPD---DLCRLAALF 173
            + LTNLT + L  N+L  S+P  + DKL  L  L L  NQL+ S+P+   D  +L  L 
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD--KLTQLK 184

Query: 174 LLDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQ 205
            L L  N+L   VP   F  LTSL+ ++L  N 
Sbjct: 185 DLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 65.0 bits (159), Expect = 8e-12
 Identities = 46/227 (20%), Positives = 80/227 (35%), Gaps = 69/227 (30%)

Query: 107 NCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
             +       P++           L    +        ++L  +  +   ++ ++     
Sbjct: 4   TVSTPIKQIFPDDAF--AETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGI 59

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL 224
               L  +  L LGGNKL   + A    LT+L  L L  NQL S+P+ +           
Sbjct: 60  Q--YLPNVRYLALGGNKLHD-ISA-LKELTNLTYLILTGNQLQSLPNGV----------- 104

Query: 225 SSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS 284
                                       F          L +L+ L L  N+LQ S+PD 
Sbjct: 105 ----------------------------FDK--------LTNLKELVLVENQLQ-SLPDG 127

Query: 285 I-GGLIDLKSLDLSNNNISGAIPISLE-----KLLDLKYINVSFNKL 325
           +   L +L  L+L++N +      SL      KL +L  +++S+N+L
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-----SLPKGVFDKLTNLTELDLSYNQL 169

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 21/173 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS 494
           +G G    V++      G   A K     +E   ++   E   M  +RH  L+ +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 495 NDDFKALVLEYMPHGSL------EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +D+   ++ E+M  G L      E    S +        +  M  V   L ++H      
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENN 275

Query: 549 IIHCDLKPNNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +H DLKP N++        L   DFG+    L   QS+    T  T  + AP
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAP 325

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 33/194 (17%)

Query: 436 IGRGGVASVYKARIQDG------IEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRNLI 487
           +G G    V  A           I+VAVK + +       ++   E  MM ++  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 488 KIISSCSNDDFKALVLEYMPHGSL----------------------EKCLYSSNYILDIF 525
            ++ +C+      L+ EY  +G L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 586 TQTQTLATIGYMAP 599
            +      + +MAP
Sbjct: 230 VRGNARLPVKWMAP 243

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 32/159 (20%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD----LQYEGAFKSFDIECDMMKRIRHRNLIK- 488
           L+G G    V +    +     AVK+       +      +   E  +++R+RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 489 --IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD----------IFQRLNIMIDVAS 536
             ++ +        +V+EY   G  E  +   + + +           F +L        
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQL------ID 120

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            LEYLH   S  I+H D+KP N+LL       +S  G+A
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 49/187 (26%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIK 488
            +GRG  + VY+ +        A+KV         K+ D      E  ++ R+ H N+IK
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 536
           +          +LVLE +  G L             F R+            + +  +  
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILE 159

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA- 592
           A+ YLH      I+H DLKP N+L      +    ++DFG++K +++    +    T+  
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCG 212

Query: 593 TIGYMAP 599
           T GY AP
Sbjct: 213 TPGYCAP 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 17/173 (9%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECD-MMKRIRHRNLIKIISS 492
           IGRG   SV K      G  +AVK       E   K   ++ D +M+      +++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFGYS 546
              +    + +E M   S +K          +   +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IIH D+KP+N+LLD +    L DFG++  L     S+ +T+      YMAP
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAP 194

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 39/174 (22%), Positives = 78/174 (44%), Gaps = 13/174 (7%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHRNL 486
           F + + +G G    V+K      G+ +A K+  L+ + A ++  I  E  ++       +
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYI 93

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +    +  +D   ++ +E+M  GSL++ +      +       + I V   L YL   + 
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
             I+H D+KP+N+L++      L DFG++  L+      +   +   T  YM+P
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSP 199

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 79.7 bits (197), Expect = 3e-17
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 5/114 (4%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFLLD 176
           S    L  I L  N+++  +   A   L+ L  L L  N++   +P  L   L +L LL 
Sbjct: 53  SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSF 229
           L  NK++      F +L +L  L L  N+L +I   T   L+ I  ++L+ N F
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.8 bits (179), Expect = 8e-15
 Identities = 38/172 (22%), Positives = 62/172 (36%), Gaps = 36/172 (20%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            IP+ +        + LE N+     P  F   + L+R+ L+ N ++   P       L 
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA--FQGLR 80

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
           +   L  L    N +  +             +F                 L +L  + L 
Sbjct: 81  S---LNSLVLYGNKITELPKS----------LF---------------EGLFSLQLLLLN 112

Query: 131 GNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDD-LCRLAALFLLDLGGN 180
            NK+N  + + A   L  L LLSL DN+L+ +I       L A+  + L  N
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.8 bits (179), Expect = 9e-15
 Identities = 42/188 (22%), Positives = 67/188 (35%), Gaps = 51/188 (27%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
            IP  +     +T I L  N +    P A    +KL+ + L +NQ+   +  D       
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA------ 75

Query: 173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGP 232
                            F  L SL +L L  N++T +P +L               F G 
Sbjct: 76  -----------------FQGLRSLNSLVLYGNKITELPKSL---------------FEG- 102

Query: 233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDL 291
                  L  L  + L+ N  +        DL +L  L L  N+LQ +I       L  +
Sbjct: 103 -------LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154

Query: 292 KSLDLSNN 299
           +++ L+ N
Sbjct: 155 QTMHLAQN 162

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 18/222 (8%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            IPS   +      L+L          + F NL N+ R+ ++ +         +F  +LS
Sbjct: 25  RIPSLPPS---TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF-YNLS 80

Query: 71  NCKYLKYLSFSNN-SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE--ISNLTNLTTI 127
               + ++   N  +L  I P A+  L   ++   +FN  +    P+   + +      +
Sbjct: 81  K---VTHIEIRNTRNLTYIDPDALKELPL-LKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135

Query: 128 YLGGNKLNGSIPI-ALDKLQK-LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK-LSG 184
            +  N    SIP+ A   L      L L +N    S+         L  + L  NK L+ 
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTV 194

Query: 185 FVPACFGNLTS-LRNLYLGSNQLTSIPS-TLWNLKYILYLNL 224
                FG + S    L +    +T++PS  L +LK ++  N 
Sbjct: 195 IDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 38/210 (18%), Positives = 80/210 (38%), Gaps = 11/210 (5%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAALFLLD 176
           S   +  T+ L    L  +IP  A   L  +  + +  +     +       L+ +  ++
Sbjct: 28  SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 177 LGGNK-LSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPL 233
           +   + L+   P     L  L+ L + +  L   P  + +++      L ++ N +   +
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 234 PLEI--GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLI- 289
           P+    G     + + L  N F+  +     +   L  ++L  N+    I  D+ GG+  
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

Query: 290 DLKSLDLSNNNISGAIPISLEKLLDLKYIN 319
               LD+S  +++      LE L +L   N
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 35/182 (19%), Positives = 60/182 (32%), Gaps = 10/182 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIP-NTFGNLRNLKRLSLNYNYLTS 58
           + +  +     + S  F   SK++ +E+       +I  +    L  LK L +    L  
Sbjct: 60  IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119

Query: 59  STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI 118
             P L  + S      L+     N  +  I   A   L        ++N   + S+    
Sbjct: 120 F-PDLTKVYSTDIFFILEIT--DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA 175

Query: 119 SNLTNLTTIYLGGNKLNGSIPI-ALDKL-QKLQLLSLEDNQLEGSIPDDLCR-LAALFLL 175
            N T L  +YL  NK    I   A   +     LL +    +  ++P      L  L   
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

Query: 176 DL 177
           + 
Sbjct: 235 NT 236

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 34/188 (18%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKV-------------FDLQYEGAFKSFDIECDMMK 479
             +G G    V   +      E A+KV              +   E   +    E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDV 534
            + H N+IK+     +  +  LV E+   G L      +  +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTL 591
            S + YLH      I+H D+KP N+LL   +  +   + DFG++     +D  L     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRL 209

Query: 592 ATIGYMAP 599
            T  Y+AP
Sbjct: 210 GTAYYIAP 217

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 41/178 (23%), Positives = 71/178 (39%), Gaps = 26/178 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRIRHR-NLIKIIS 491
           +GRG  A V +      G E A K    +  G     +I  E  +++  +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 492 SCSNDDFKALVLEYMPHGSL-EKCLYSSNYILDIFQRL------NIMIDVASALEYLHFG 544
              N     L+LEY   G +   C      + ++ + +       ++  +   + YLH  
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAH---LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
               I+H DLKP N+LL          + DFGM++  +     L   + + T  Y+AP
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAP 202

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 44/198 (22%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD----------------LQYEGAFKSFDIECDM 477
            IG+G    V  A    D    A+KV                       A          
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 478 ----------MKRIRHRNLIKIIS--SCSNDDFKALVLEYMPHGSL----EKCLYSSNYI 521
                     +K++ H N++K++      N+D   +V E +  G +         S +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 522 LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE 581
              FQ      D+   +EYLH      IIH D+KP+N+L+ ++    ++DFG++    K 
Sbjct: 140 RFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKG 189

Query: 582 DQSLTQTQTLATIGYMAP 599
             +L    T+ T  +MAP
Sbjct: 190 SDALLSN-TVGTPAFMAP 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 408 NMPLVANLRRFTHLELFQATN---GFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ 463
           +M   +  R    ++L    +    F    L+G G    VYK R ++ G   A+KV D+ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 464 YEGAFKSFDIECDMMKRI-RHRNLIKIISS------CSNDDFKALVLEYMPHGSLEKCLY 516
                +    E +M+K+   HRN+     +         DD   LV+E+   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 517 SSNYILDIFQRLN-----------IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM 565
                 D+ +              I  ++   L +LH      +IH D+K  NVLL +N 
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166

Query: 566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIG---YMAP 599
              L DFG++  L   D+++ +  T   IG   +MAP
Sbjct: 167 EVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAP 198

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 40/187 (21%)

Query: 24  RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN 83
           +L+L+          TF  L  L  L+L+YN L + +        L+    L  L  +NN
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA--GVFDDLTE---LGTLGLANN 93

Query: 84  SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPI-A 141
            L                           S+P  +  +LT L  +YLGGN+L  S+P   
Sbjct: 94  QLA--------------------------SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV 126

Query: 142 LDKLQKLQLLSLEDNQLEGSIPD---DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRN 198
            D+L KL+ L L  NQL+ SIP    D  +L  L  L L  N+L       F  L  L+ 
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFD--KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT 183

Query: 199 LYLGSNQ 205
           + L  NQ
Sbjct: 184 ITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 56/194 (28%), Positives = 77/194 (39%), Gaps = 39/194 (20%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL-CRLAA 171
           S+P  I    +   + L    L          L KL  L+L+ NQL+ ++   +   L  
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYILYLNLSSN 227
           L  L L  N+L+      F +LT L  LYLG NQL S+PS     L  LK    L L++N
Sbjct: 85  LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKE---LRLNTN 141

Query: 228 SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSI- 285
                                        IP    D L +LQ L L  N+LQ S+P    
Sbjct: 142 QLQS-------------------------IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAF 175

Query: 286 GGLIDLKSLDLSNN 299
             L  L+++ L  N
Sbjct: 176 DRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 34/153 (22%), Positives = 52/153 (33%), Gaps = 51/153 (33%)

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP 234
           LDL    L+    A F  LT L  L L  NQL ++ +                 F     
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA---------------GVFDD--- 81

Query: 235 LEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKS 293
                                        L +L  L L  N+L  S+P  +   L  L  
Sbjct: 82  -----------------------------LTELGTLGLANNQLA-SLPLGVFDHLTQLDK 111

Query: 294 LDLSNNNISGAIPISL-EKLLDLKYINVSFNKL 325
           L L  N +  ++P  + ++L  LK + ++ N+L
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.9 bits (198), Expect = 9e-17
 Identities = 46/187 (24%), Positives = 69/187 (36%), Gaps = 42/187 (22%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDI-----ECDMMKRIRHRNLIK 488
           +G G  A V K R    G E A K     +   + +         E ++++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 536
           +     N     L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH----LSDFGMAKPLLKEDQSLTQTQTLA 592
            + YLH   S  I H DLKP N++L D  V +    L DFG+A   ++            
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFG 173

Query: 593 TIGYMAP 599
           T  ++AP
Sbjct: 174 TPEFVAP 180

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 28/180 (15%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDI-----ECDMMKRIRHRNLIK 488
           +G G  A V K R    G+E A K     Q   + +         E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           +     N     L+LE +  G L     +K   S             +  +   + YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLH- 132

Query: 544 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +  I H DLKP N++L           L DFG+A   +++           T  ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAP 187

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 36/183 (19%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFD---IECDMMKRIRHRNLIKII 490
           ++G G  ++V  AR +    E A+K+ + ++            E D+M R+ H   +K+ 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 491 SSCSNDDFKALVLEYMPHGSL------EKCL-------YSSNYILDIFQRLNIMIDVASA 537
            +  +D+     L Y  +G L                 Y++              ++ SA
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------------EIVSA 142

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGY 596
           LEYLH      IIH DLKP N+LL+++M   ++DFG AK +L  +    +  +   T  Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQY 198

Query: 597 MAP 599
           ++P
Sbjct: 199 VSP 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 42/187 (22%), Positives = 68/187 (36%), Gaps = 42/187 (22%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDI-----ECDMMKRIRHRNLIK 488
           +G G  A V K R    G+E A K     Q   + +         E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL------------NIMIDVAS 536
           +     N     L+LE +  G L             F  L            + +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
            + YLH   +  I H DLKP N++L           L DFG+A   +++           
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFG 180

Query: 593 TIGYMAP 599
           T  ++AP
Sbjct: 181 TPEFVAP 187

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 26/178 (14%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
           +G G    V+       G+E  +K  +  + +   +  + E +++K + H N+IKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL---------NIMIDVASALEYLHFG 544
            +     +V+E    G L         I+    R           +M  + +AL Y H  
Sbjct: 90  EDYHNMYIVMETCEGGEL------LERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 545 YSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            S  ++H DLKP N+L      +    + DFG+A+ L K D+    T    T  YMAP
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAP 195

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFK-SFDI----ECDMMKRIRHRNLIKI 489
           +G G  A+VYKAR       VA+K   L +    K   +     E  +++ + H N+I +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           + +  +    +LV ++M    LE  +  ++ +L        M+     LEYLH      I
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           +H DLKPNN+LLD+N V  L+DFG+AK
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAK 160

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 42/180 (23%), Positives = 70/180 (38%), Gaps = 28/180 (15%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDI-----ECDMMKRIRHRNLIK 488
           +G G  A V K R    G++ A K     + + + +         E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----EKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           +     N     L+LE +  G L     EK   +     +       +  + + + YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131

Query: 544 GYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S+ I H DLKP N++L           + DFG+A   +             T  ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVAP 186

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 6/117 (5%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAA 171
            +P+ I    ++T +YL GN+    +P  L   + L L+ L +N++  ++ +     +  
Sbjct: 24  VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSN 227
           L  L L  N+L    P  F  L SLR L L  N ++ +P     +L  + +L + +N
Sbjct: 80  LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 38/161 (23%), Positives = 60/161 (37%), Gaps = 57/161 (35%)

Query: 47  KRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF 106
             L L+ N  T    +L+        K+L  +  SNN +  +  +           F   
Sbjct: 34  TELYLDGNQFTLVPKELSNY------KHLTLIDLSNNRISTLSNQ----------SF--- 74

Query: 107 NCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDD 165
                       SN+T L T+ L  N+L   IP    D L+ L+LLSL  N +   +P+ 
Sbjct: 75  ------------SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE- 119

Query: 166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQL 206
                             G     F +L++L +L +G+N L
Sbjct: 120 ------------------GA----FNDLSALSHLAIGANPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 34/113 (30%), Positives = 51/113 (45%), Gaps = 14/113 (12%)

Query: 194 TSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG---NLRVLVQIDLSM 250
             +  LYL  NQ T +P  L N K++  ++LS+N  +    L      N+  L+ + LS 
Sbjct: 31  RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS---TLSNQSFSNMTQLLTLILSY 87

Query: 251 NNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD---LSNN 299
           N     IP    D LK L+ L L  N +   +P+  G   DL +L    +  N
Sbjct: 88  NRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 33/133 (24%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L GN F+  +P  + N   L+ ++L  N        +F N+  L  L L+YN L    
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-S 119
           P   F   L +   L+ LS   N +                            +PE   +
Sbjct: 94  PPRTF-DGLKS---LRLLSLHGNDIS--------------------------VVPEGAFN 123

Query: 120 NLTNLTTIYLGGN 132
           +L+ L+ + +G N
Sbjct: 124 DLSALSHLAIGAN 136

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 42/187 (22%), Positives = 72/187 (38%), Gaps = 46/187 (24%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRI-RHRNLIKII 490
           ++G G    V +    + G + A+K+          S     E D   +     +++ I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 491 ----SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLN----------IMIDVA 535
               +         +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA 592
           +A+++LH   S  I H D+KP N+L    + + V  L+DFG AK       +L       
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191

Query: 593 TIGYMAP 599
           T  Y+AP
Sbjct: 192 TPYYVAP 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 28/154 (18%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
            +G G    V  A        VAVK+ D+ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALEYL 541
               + + L LEY   G L       + I              F +L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           H    + I H D+KP N+LLD+     +SDFG+A
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLA 152

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 32/182 (17%), Positives = 63/182 (34%), Gaps = 40/182 (21%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           +GRG    V++            K   +      K  D      E  ++   RHRN++ +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHL 66

Query: 490 ISSCSNDDFKALVLEYMPHGSL------EKCLYS----SNYILDIFQRLNIMIDVASALE 539
             S  + +   ++ E++    +           +     +Y+  +            AL+
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----------EALQ 116

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           +LH      I H D++P N++      + +   +FG A+  LK   +           Y 
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYY 170

Query: 598 AP 599
           AP
Sbjct: 171 AP 172

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 26/186 (13%)

Query: 397 RKRGKSQLADANMPLVANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVA 456
                      N+     + ++  LE             +G G    VYKA+   G  VA
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEK------------VGEGTYGVVYKAKDSQGRIVA 49

Query: 457 VKV--FDLQYEGAFKSFDI----ECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS 510
           +K    D + EG           E  ++K + H N++ +I    ++    LV E+M    
Sbjct: 50  LKRIRLDAEDEG----IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104

Query: 511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS 570
           L+K L  +   L   Q    +  +   + + H      I+H DLKP N+L++ +    L+
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161

Query: 571 DFGMAK 576
           DFG+A+
Sbjct: 162 DFGLAR 167

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 30/156 (19%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G G    V        G +VAVK+ +   ++          E   +K  RH ++IK+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 539
              S      +V+EY+  G L       +YI             +FQ++       SA++
Sbjct: 78  QVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LSAVD 125

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           Y H      ++H DLKP NVLLD +M A ++DFG++
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 9/167 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECD-MMKRIRHRNLIKIISS 492
           +G G    V+K R  + G  +AVK       +   K   ++ D ++K      +++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              +    + +E M     EK        +       + + +  AL YL   +   +IH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           D+KP+N+LLD+     L DFG++  L        + ++     YMAP
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAP 193

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 9/155 (5%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDI-ECDMMKRIRHRNLIKIIS 491
           IG G    V+K R    G  VA+K F          K   + E  M+K+++H NL+ ++ 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALREIRMLKQLKHPNLVNLLE 69

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
                    LV EY  H ++   L      +      +I      A+ + H       IH
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIH 125

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
            D+KP N+L+  + V  L DFG A+ L        
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 18/173 (10%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGA-FKSFDIECDM-MKRIRHRNLIKIISS 492
           +GRG    V K R +  G  +AVK           K   ++ D+ M+ +     +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALEYLHFGYS 546
              +    + +E M   SL+K       ++D  Q +       I + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             +IH D+KP+NVL++      + DFG++  L      + +        YMAP
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAP 178

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 18/180 (10%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR-----IRH 483
           F +  ++GRGG   V+  +++   ++ A K   L  +   K    +  M+++     +  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF--QRLNIMI-DVASALEY 540
           R ++ +  +        LV+  M  G +   +Y+ +     F   R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           LH      II+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 28/155 (18%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
            +G G    V  A        VAVK+ D+ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALEYL 541
               + + L LEY   G L       + I              F +L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           H    + I H D+KP N+LLD+     +SDFG+A 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLAT 153

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 41/194 (21%), Positives = 68/194 (35%), Gaps = 23/194 (11%)

Query: 422 ELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVK-VFDLQYEGAFKS-FDIECD--- 476
           EL    + ++    I  G   +V      +GI VA+K VF+   +G   +          
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 477 ------MMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIF 525
                 ++    H N++    I             LV E M    L + ++    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQ 134

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
                M  +   L  LH      ++H DL P N+LL DN    + DF +A+    +    
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK- 190

Query: 586 TQTQTLATIGYMAP 599
             T  +    Y AP
Sbjct: 191 --THYVTHRWYRAP 202

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 45/186 (24%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRI-RHRNLIKII- 490
           +G G    V +    +   + A+K+                E ++  R  +  ++++I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 491 ---SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-IFQRLN----------IMIDVAS 536
              +  +      +V+E +  G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           A++YLH   S+ I H D+KP N+L      N +  L+DFG AK       SL  T    T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSL--TTPCYT 226

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 227 PYYVAP 232

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 30/156 (19%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G G    V   +    G +VAVK+ +   ++          E   +K  RH ++IK+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASALE 539
              S      +V+EY+  G L       +YI             +FQ++       S ++
Sbjct: 83  QVISTPSDIFMVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI------LSGVD 130

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           Y H      ++H DLKP NVLLD +M A ++DFG++
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 34/175 (19%)

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQDGIEVAVK--VFDLQYEGAFKSFDIECDMMKRI 481
            Q    ++   +IG G    V++A++ +  EVA+K  + D +++        E  +M+ +
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIV 89

Query: 482 RHRNLIK----IISSCSNDDFKA--LVLEYMP--------HGSLEKCLYSSNYI-LDIFQ 526
           +H N++       S+    D     LVLEY+P        H +  K       I L ++Q
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 527 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLK 580
            L        +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+ 
Sbjct: 150 LLR-------SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 59/331 (17%), Positives = 113/331 (34%), Gaps = 46/331 (13%)

Query: 43  LRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG----ILPRAIGNLSQ 98
           L+  + + L+   LT +  K +  S+L     L  L+  +N L       + + +   S 
Sbjct: 27  LQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85

Query: 99  SMEVFFMFNCNIS----GSIPEEISNLTNLTTIYLGGNKLN--GSIPIA---LDKLQKLQ 149
            ++   + NC ++    G +   +  L  L  ++L  N L   G   +    LD   +L+
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 150 LLSLEDNQL--EG--SIPDDLCRLAALFLLDLGGNKLSG-----FVPACFGNLTSLRNLY 200
            L LE   L       +   L        L +  N ++             +   L  L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 201 LGSNQLT-----SIPSTLWNLKYILYLNLSSNSFTGP-----LPLEIGNLRVLVQIDLSM 250
           L S  +T      +   + +   +  L L SN           P  +     L  + +  
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 251 NNFS----GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG-GLID----LKSLDLSNNNI 301
              +    G +   +   + L+ L L  N L       +   L++    L+SL + + + 
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

Query: 302 S--GAIPIS--LEKLLDLKYINVSFNKLEGE 328
           +       S  L +   L  + +S N+LE  
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 64/320 (20%), Positives = 121/320 (37%), Gaps = 46/320 (14%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG----ILPRAIGNLSQSM 100
            L++L L Y  L++++ +    S L      K L+ SNN ++     +L + + +    +
Sbjct: 143 RLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 101 EVFFMFNCNIS----GSIPEEISNLTNLTTIYLGGNKLNGS-----IPIALDKLQKLQLL 151
           E   + +C ++      +   +++  +L  + LG NKL         P  L    +L+ L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 152 SLEDNQLE----GSIPDDLCRLAALFLLDLGGNKLS-----GFVPACFGNLTSLRNLYLG 202
            + +  +     G +   L    +L  L L GN+L                  L +L++ 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321

Query: 203 SNQLTS-----IPSTLWNLKYILYLNLSSNSFT--GPLPLEIG---NLRVLVQIDLSMNN 252
           S   T+       S L   +++L L +S+N     G   L  G      VL  + L+  +
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381

Query: 253 FS----GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID-----LKSLDLSNNNISG 303
            S      +  T+     L+ L L  N L  +    +   +      L+ L L +   S 
Sbjct: 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441

Query: 304 AIPISLEKLL----DLKYIN 319
            +   L+ L      L+ I+
Sbjct: 442 EMEDRLQALEKDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 46/271 (16%), Positives = 86/271 (31%), Gaps = 38/271 (14%)

Query: 96  LSQSMEVFFMFNCNIS-GSIPEEISNLTNLTTIYLGGNKLN----GSIPIALDKLQKLQL 150
           +S  ++   +    +S     E +  L     + L    L       I  AL     L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 151 LSLEDNQLEGSIPDDLCRL-----AALFLLDLGGNKLS----GFVPACFGNLTSLRNLYL 201
           L+L  N+L       + +        +  L L    L+    G + +    L +L+ L+L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 202 GSNQLTSI------PSTLWNLKYILYLNLSSNSFT----GPLPLEIGNLRVLVQIDLSMN 251
             N L            L     +  L L   S +     PL   +       ++ +S N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 252 NFSGFIPTTIGD-LKD----LQYLFLEYNRLQ----GSIPDSIGGLIDLKSLDLSNNNI- 301
           + +      +   LKD    L+ L LE   +       +   +     L+ L L +N + 
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 302 -SGAIPIS---LEKLLDLKYINVSFNKLEGE 328
             G   +    L     L+ + +    +  +
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAK 271

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.9 bits (191), Expect = 3e-15
 Identities = 40/251 (15%), Positives = 75/251 (29%), Gaps = 19/251 (7%)

Query: 52  NYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS--QSMEVFFMFNCN 109
               +        +    +  + L     S      +L   + +    Q +E    +   
Sbjct: 328 QKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLL 386

Query: 110 ISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRL 169
               +   +  L          + L    P+    L  L+   L +N +           
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KMEY 440

Query: 170 AALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSF 229
           A + +L L    L+  V      L  + +L L  N+L ++P  L  L+ +  L  S N+ 
Sbjct: 441 ADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL 498

Query: 230 TGPLPLEIGNLRVLVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL 288
              +   + NL  L ++ L  N          +     L  L L+ N L          L
Sbjct: 499 EN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERL 555

Query: 289 I----DLKSLD 295
                 + S+ 
Sbjct: 556 AEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.3 bits (148), Expect = 4e-10
 Identities = 35/218 (16%), Positives = 70/218 (32%), Gaps = 44/218 (20%)

Query: 115 PEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFL 174
             + +    L    L   K    +   L+  ++LQ L  E+     +I   +  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLG------SNQLTSIPSTLWNLKYILYLNLSSNS 228
                   S         L ++  +         S  L            +  L+L+   
Sbjct: 401 EKETLQYFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL 288
            T      + +L                       L  + +L L +NRL+ ++P ++  L
Sbjct: 453 LT-----VLCHL---------------------EQLLLVTHLDLSHNRLR-ALPPALAAL 485

Query: 289 IDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE 326
             L+ L  S+N +   +   +  L  L+ + +  N+L+
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.3 bits (122), Expect = 7e-07
 Identities = 24/134 (17%), Positives = 43/134 (32%), Gaps = 34/134 (25%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L   +   T+   +     ++ L+L  N     +P     LR L+ L  + N L +  
Sbjct: 446 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-- 500

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
                +  ++N   L+ L   NN L                           +  + + +
Sbjct: 501 -----VDGVANLPRLQELLLCNNRLQQS------------------------AAIQPLVS 531

Query: 121 LTNLTTIYLGGNKL 134
              L  + L GN L
Sbjct: 532 CPRLVLLNLQGNSL 545

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 75.6 bits (187), Expect = 3e-15
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 15/148 (10%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKV--FDLQYEGAFKSFDI----ECDMMKRIRHRNLIK 488
           IG G   +V+KA+  +    VA+K    D   EG           E  ++K ++H+N+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVR 65

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +     +D    LV E+     L+K   S N  LD     + +  +   L + H   S  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           ++H DLKP N+L++ N    L++FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 9/169 (5%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDL-QYEGAFKSFDI-ECDMMKRIRHRNLIKII 490
            L+G G    V K R    G  VA+K F     +   K   + E  ++K++RH NL+ ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
             C       LV E++ H ++   L      LD       +  + + + + H   S  II
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAP 193

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 46/185 (24%), Positives = 66/185 (35%), Gaps = 45/185 (24%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------ECDMMKRIRHRNLI 487
            IG G        R       VAVK  +       +   I      E    + +RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVAS 536
           +           A+++EY   G L         I +            FQ+L       S
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL------LS 127

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL--SDFGMAKPLLKEDQSLTQTQTLATI 594
            + Y H   S+ I H DLK  N LLD +    L   DFG +K       S  ++ T+ T 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS-TVGTP 181

Query: 595 GYMAP 599
            Y+AP
Sbjct: 182 AYIAP 186

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 14/147 (9%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKV--FDLQYEGAFKSFDI----ECDMMKRIRHRNLIKI 489
           IG G    VYKA+   G   A+K    + + EG           E  ++K ++H N++K+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKL 65

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                      LV E++    L+K L      L+     + ++ + + + Y H      +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           +H DLKP N+L++      ++DFG+A+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 30/179 (16%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
           +IGRG    V   R +   +V A+K+  L      K  D        D+M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVA--------SALEY 540
           +  +  +D +  +V+EYMP G L          +++    ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H   S+  IH D+KP+N+LLD +    L+DFG    + KE      T  + T  Y++P
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 38/143 (26%), Positives = 69/143 (48%), Gaps = 6/143 (4%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSC 493
           +G G  A+VYK +       VA+K   L++E       I E  ++K ++H N++ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
             +    LV EY+    L++ L     I+++      +  +   L Y H      ++H D
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125

Query: 554 LKPNNVLLDDNMVAHLSDFGMAK 576
           LKP N+L+++     L+DFG+A+
Sbjct: 126 LKPQNLLINERGELKLADFGLAR 148

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 35/157 (22%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-----ECDMMKRIRHRNLIKI 489
           IG+G  A V  AR I  G EVA+K+ D           +     E  +MK + H N++K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD-----------IFQRLNIMIDVASAL 538
                 +    L++EY   G +       +Y++             F+++       SA+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           +Y H      I+H DLK  N+LLD +M   ++DFG +
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 6/120 (5%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIAL-DKLQKLQLLSLEDNQLEGSIPDDLC-RLA 170
            IP +I    + T + L  N+L       L  +L  L  L L+ NQL   I  +     +
Sbjct: 22  EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSF 229
            +  L LG NK+       F  L  L+ L L  NQ++ +   +  +L  +  LNL+SN F
Sbjct: 79  HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 35/159 (22%), Positives = 49/159 (30%), Gaps = 55/159 (34%)

Query: 47  KRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMF 106
             L LN N L   +    F   L +   L  L    N L GI P            F   
Sbjct: 32  TELLLNDNELGRISSDGLF-GRLPH---LVKLELKRNQLTGIEPN----------AF--- 74

Query: 107 NCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDD 165
                          +++  + LG NK+   I       L +L+ L+L DNQ+   +   
Sbjct: 75  ------------EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMP- 119

Query: 166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSN 204
                                   F +L SL +L L SN
Sbjct: 120 ----------------------GSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 38/151 (25%), Positives = 52/151 (34%), Gaps = 50/151 (33%)

Query: 175 LDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL 233
           L L  N+L        FG L  L  L L  NQLT I                        
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA-------------------- 73

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLK 292
                              F G           +Q L L  N+++  I + +  GL  LK
Sbjct: 74  -------------------FEG--------ASHIQELQLGENKIK-EISNKMFLGLHQLK 105

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSFN 323
           +L+L +N IS  +P S E L  L  +N++ N
Sbjct: 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 28/134 (20%), Positives = 43/134 (32%), Gaps = 33/134 (24%)

Query: 1   LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           LLL  N         +F     L +LEL+ N   G  PN F    +++ L L  N +   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI- 118
                F   L     LK L+  +N +                            +     
Sbjct: 93  ISNKMF-LGLHQ---LKTLNLYDNQIS--------------------------CVMPGSF 122

Query: 119 SNLTNLTTIYLGGN 132
            +L +LT++ L  N
Sbjct: 123 EHLNSLTSLNLASN 136

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 37/162 (22%)

Query: 47  KRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME--VFF 104
           + L L+ N +T   P +    SL N   LK L   +N L             ++   VF 
Sbjct: 43  QILYLHDNQITKLEPGV--FDSLIN---LKELYLGSNQL------------GALPVGVF- 84

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIAL-DKLQKLQLLSLEDNQLEGSIP 163
                          +LT LT + LG N+L   +P A+ D+L  L+ L +  N+L   +P
Sbjct: 85  --------------DSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELP 128

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQ 205
             + RL  L  L L  N+L       F  L+SL + YL  N 
Sbjct: 129 RGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 51/191 (26%), Positives = 71/191 (37%), Gaps = 58/191 (30%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAA 171
           S+P  I   TN   +YL  N++    P   D L  L+ L L  NQL  ++P  +   L  
Sbjct: 33  SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTG 231
           L +LDLG N+L+    A F  L  L+ L++  N+LT +P                     
Sbjct: 90  LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPR-------------------- 129

Query: 232 PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDL 291
                                  G        L  L +L L+ N+L+ SIP   G    L
Sbjct: 130 -----------------------GI-----ERLTHLTHLALDQNQLK-SIPH--GAFDRL 158

Query: 292 KSLD---LSNN 299
            SL    L  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 39/134 (29%), Positives = 50/134 (37%), Gaps = 7/134 (5%)

Query: 24  RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN 83
            L L  N      P  F +L NLK L L  N L +    +    SL+    L  L    N
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV--FDSLTQ---LTVLDLGTN 98

Query: 84  SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALD 143
            L  +       L    E+F    CN    +P  I  LT+LT + L  N+L      A D
Sbjct: 99  QLTVLPSAVFDRLVHLKELFM--CCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156

Query: 144 KLQKLQLLSLEDNQ 157
           +L  L    L  N 
Sbjct: 157 RLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 26/87 (29%), Positives = 45/87 (51%), Gaps = 5/87 (5%)

Query: 247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAI 305
            L  N  +   P     L +L+ L+L  N+L  ++P  +   L  L  LDL  N ++  +
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VL 103

Query: 306 PISL-EKLLDLKYINVSFNKLEGEIPR 331
           P ++ ++L+ LK + +  NKL  E+PR
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPR 129

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 38/183 (20%), Positives = 78/183 (42%), Gaps = 36/183 (19%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
           +IGRG    V   ++++  +V A+K+  L      K  +  C     D++     + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 538
           +  +  +D+   LV++Y   G L          L +  +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTLATIGY 596
           + +H    +  +H D+KP+N+L+D N   H  L+DFG    L+++    +    + T  Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 597 MAP 599
           ++P
Sbjct: 243 ISP 245

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 11/147 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKIISSC 493
           +G G  A+VYK      G+ VA+K   L  E    S  I E  +MK ++H N++++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYI-----LDIFQRLNIMIDVASALEYLHFGYSVP 548
             ++   LV E+M +  L+K + S         L++         +   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           I+H DLKP N+L++      L DFG+A
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 36/171 (21%), Positives = 64/171 (37%), Gaps = 48/171 (28%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI--ECDMMKRI-RHRNLIKII- 490
           +G G    V +    +   + A+K+                E ++  R  +  ++++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 491 ---SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRL--------------NIMID 533
              +  +      +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKE 581
           +  A++YLH   S+ I H D+KP N+L      N +  L+DFG AK    E
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 69.6 bits (171), Expect = 4e-14
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 5/117 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAA 171
           S+P  I   ++ T + L  NKL        DKL +L  LSL  NQ++ S+PD +  +L  
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSN 227
           L +L L  NKL       F  LT L+ L L +NQL S+P  ++  L  +  + L +N
Sbjct: 78  LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 8/89 (8%)

Query: 121 LTNLTTIYLGGNKLNGSIPIAL-DKLQKLQLLSLEDNQLEGSIPD---DLCRLAALFLLD 176
           LT LT + L  N++  S+P  + DKL KL +L L +N+L+ S+P+   D  +L  L  L 
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFD--KLTQLKELA 106

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQ 205
           L  N+L       F  LTSL+ ++L +N 
Sbjct: 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 35/136 (25%), Positives = 47/136 (34%), Gaps = 34/136 (25%)

Query: 24  RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN 83
           RLELE N         F  L  L +LSL+ N + S    +     L+    L  L    N
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV--FDKLTK---LTILYLHEN 86

Query: 84  SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-SNLTNLTTIYLGGNKLNGSIPI-A 141
            L                           S+P  +   LT L  + L  N+L  S+P   
Sbjct: 87  KLQ--------------------------SLPNGVFDKLTQLKELALDTNQLK-SVPDGI 119

Query: 142 LDKLQKLQLLSLEDNQ 157
            D+L  LQ + L  N 
Sbjct: 120 FDRLTSLQKIWLHTNP 135

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVK--VFDLQYEGAFKSFDI-ECDMMKRIRHRN---LIK 488
           IG+G    V+KAR  + G +VA+K  + + + EG F    + E  +++ ++H N   LI+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIE 83

Query: 489 IISSCSNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
           I  + ++   +      LV ++  H  L   L +      + +   +M  + + L Y+H 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH- 141

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA----KPLLKEDQSLTQ 587
                I+H D+K  NVL+  + V  L+DFG+A         +    T 
Sbjct: 142 --RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 25/157 (15%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD----LQYEGAFKSFDI--ECDMMKRIRHR--N 485
           L+G GG  SVY    + D + VA+K  +      +        +  E  ++K++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLN------IMIDVASALE 539
           +I+++      D   L+LE  P    +  L+  ++I +    L           V  A+ 
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LF--DFITE-RGALQEELARSFFWQVLEAVR 163

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMA 575
           + H   +  ++H D+K  N+L+D N     L DFG  
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 21/180 (11%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR-----IRH 483
           F +  ++G+GG   V   +++   ++ A K   L+ +   K       + ++     +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI---DVASALEY 540
           R ++ +  +    D   LVL  M  G L+  +Y  +     F     +    ++   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           LH      I++ DLKP N+LLDD+    +SD G+A  + +        +    T+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 33/157 (21%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKII 490
            +G G    V  A   +   +VA+K      L+        + E   +K +RH ++IK+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 491 SSCSNDDFKALVLEY---------MPHGSL---EKCLYSSNYILDIFQRLNIMIDVASAL 538
              +      +V+EY         +    +   E   +        FQ++        A+
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--------FQQI------ICAI 121

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           EY H      I+H DLKP N+LLDDN+   ++DFG++
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 23/174 (13%)

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQD-GIEVAVK-VF-DLQYEGAFKSFDIECDMMKR 480
                 +++  +IG G    VY+A++ D G  VA+K V  D +++        E  +M++
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRK 103

Query: 481 IRHRNLIKII------SSCSNDDFKALVLEYMP---HGSLEKCLYSSNYILDIFQRLNIM 531
           + H N++++           ++ +  LVL+Y+P   +        +   +  I+ +L  M
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YM 162

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQS 584
             +  +L Y+H   S  I H D+KP N+LLD D  V  L DFG AK L++ + +
Sbjct: 163 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 43/185 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
            IG+G    V   +  D  ++ A+K   +  +   +  ++        +M+ + H  L+ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 535
           +  S  +++   +V++ +  G L           E+   L+                ++ 
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC--------------ELV 125

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TI 594
            AL+YL    +  IIH D+KP+N+LLD++   H++DF +A  L +E    TQ  T+A T 
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTK 178

Query: 595 GYMAP 599
            YMAP
Sbjct: 179 PYMAP 183

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 9e-14
 Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 21/180 (11%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI------ 481
           FS + +IGRGG   VY  R  D  ++ A+K   L  +           +  + +      
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 482 -RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
                ++ +  +    D  + +L+ M  G L   L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
           +H   +  +++ DLKP N+LLD++    +SD G+A    K+     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 43/189 (22%), Positives = 72/189 (38%), Gaps = 43/189 (22%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFD----LQYEGAFKSFDI--ECDMMKRIR----H 483
           L+G+GG  +V+    + D ++VA+KV      L +     S     E  ++ ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF------QRL------NIM 531
             +I+++      +   LVLE                  D+F        L         
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
             V +A+++ H   S  ++H D+K  N+L+D     A L DFG     L  D+  T    
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD- 199

Query: 591 LATIGYMAP 599
             T  Y  P
Sbjct: 200 -GTRVYSPP 207

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 29/152 (19%), Positives = 63/152 (41%), Gaps = 15/152 (9%)

Query: 460 FDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN 519
           + L       +  ++   M     +N +  +   S   +  + ++     +L+  +    
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 520 YI--LDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
            +   +    L+I I +A A+E+LH   S  ++H DLKP+N+    + V  + DFG+   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 578 LLKEDQSLTQTQTLA----------TIGYMAP 599
           + ++++  T    +           T  YM+P
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 2/91 (2%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLI 487
           F     +GRGG   V++A+   D    A+K   L   E A +    E   + ++ H  ++
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSS 518
           +  ++      +    E       ++     
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 16/162 (9%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKV--FDLQYEGAFKSFDI----ECDMMKRIRHRNL 486
             IG G    VYKAR    G  VA+K    D + EG           E  ++K + H N+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNI 64

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGY 545
           +K++     ++   LV E++    L+K + +S    + +    + +  +   L + H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
           S  ++H DLKP N+L++      L+DFG+A+      ++ T 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 39/183 (21%), Positives = 78/183 (42%), Gaps = 36/183 (19%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
           +IGRG  + V   +++   +V A+K+  +      K  ++ C     D++     R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMID----------VASAL 538
           +  +  ++++  LV+EY   G L          L +  +    I           +  A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTLATIGY 596
           + +H    +  +H D+KP+N+LLD     H  L+DFG    L  +    +    + T  Y
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229

Query: 597 MAP 599
           ++P
Sbjct: 230 LSP 232

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 41/186 (22%), Positives = 72/186 (38%), Gaps = 24/186 (12%)

Query: 432 ENNLIGRGGVASVYKAR---IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN--- 485
           E   +GRG    VYKA+    +D  + A+K    +  G   S   E  +++ ++H N   
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVIS 82

Query: 486 LIKIISSCSNDDFKALVLEYMPH-------GSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           L K+  S ++     L+ +Y  H                    L      +++  +   +
Sbjct: 83  LQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAH----LSDFGMAKPLLKEDQSLTQ-TQTLAT 593
            YLH   +  ++H DLKP N+L+           ++D G A+      + L      + T
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 594 IGYMAP 599
             Y AP
Sbjct: 199 FWYRAP 204

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 23/165 (13%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDI------EC 475
           +Q  + +   +LIG G    V +A    +   VA+K +        F+          E 
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-----VFEDLIDCKRILREI 103

Query: 476 DMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNI 530
            ++ R+ H +++K   I+     + F    +VLE       +K   +  Y+ ++  +  +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-L 161

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
           + ++   ++Y+H   S  I+H DLKP N L++ +    + DFG+A
Sbjct: 162 LYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 41/192 (21%), Positives = 80/192 (41%), Gaps = 26/192 (13%)

Query: 424 FQATNGFSENNLIGRG--GVASVYKARIQD-GIEVAVK-VFDLQYEGAFKSFDI-ECDMM 478
            +  + F    + G+G  G   V   + +  G+ VA+K V     +  F++ ++     +
Sbjct: 19  RKEMDRFQVERMAGQGTFGT--VQLGKEKSTGMSVAIKKVIQ---DPRFRNRELQIMQDL 73

Query: 479 KRIRHRNLIK---IISSCSNDDFK----ALVLEYMP---HGSLEKCLYSSNYILDIFQRL 528
             + H N+++      +    D +     +V+EY+P   H               I  ++
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133

Query: 529 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQ 587
             +  +  ++  LH   SV + H D+KP+NVL++  +    L DFG AK L   + +   
Sbjct: 134 -FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--- 188

Query: 588 TQTLATIGYMAP 599
              + +  Y AP
Sbjct: 189 VAYICSRYYRAP 200

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 51/195 (26%), Positives = 73/195 (37%), Gaps = 58/195 (29%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
           +P+ I   +    L+LE NS        F  L +L +L L  N L S    +   + L++
Sbjct: 22  VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV--FNKLTS 77

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
              L YL+ S N L  +             VF                 LT L  + L  
Sbjct: 78  ---LTYLNLSTNQLQSLPNG----------VF---------------DKLTQLKELALNT 109

Query: 132 NKLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACF 190
           N+L  S+P    DKL +L+ L L  NQL+ S+PD                         F
Sbjct: 110 NQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPD-----------------------GVF 144

Query: 191 GNLTSLRNLYLGSNQ 205
             LTSL+ ++L  N 
Sbjct: 145 DRLTSLQYIWLHDNP 159

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 61.2 bits (149), Expect = 6e-11
 Identities = 49/198 (24%), Positives = 73/198 (36%), Gaps = 57/198 (28%)

Query: 107 NCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
            C   G  S+P  I      T + L  N L        D+L  L  L L  N+L+ S+P+
Sbjct: 13  ECYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN 69

Query: 165 DLC-RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLN 223
            +  +L +L  L+L  N+L       F  LT L+ L L +NQL S               
Sbjct: 70  GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS--------------- 114

Query: 224 LSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIP 282
                                            +P  + D L  L+ L L  N+L+ S+P
Sbjct: 115 ---------------------------------LPDGVFDKLTQLKDLRLYQNQLK-SVP 140

Query: 283 DSI-GGLIDLKSLDLSNN 299
           D +   L  L+ + L +N
Sbjct: 141 DGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 34/159 (21%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N+            + L++L L  N         F  L +L  L+L+ N L S  
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP 92

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI-S 119
             +     L+    LK L+ + N L                           S+P+ +  
Sbjct: 93  NGV--FDKLTQ---LKELALNTNQL--------------------------QSLPDGVFD 121

Query: 120 NLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDNQ 157
            LT L  + L  N+L  S+P    D+L  LQ + L DN 
Sbjct: 122 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNP 159

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 2/80 (2%)

Query: 247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAI 305
           DL  N+          +L  L  L+L  N+LQ S+P+ +   L  L  L+LS N +    
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLP 92

Query: 306 PISLEKLLDLKYINVSFNKL 325
               +KL  LK + ++ N+L
Sbjct: 93  NGVFDKLTQLKELALNTNQL 112

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 35/194 (18%)

Query: 423 LFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDI------E 474
            F     +     IG G    V  A        VA+K +        F++         E
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRE 74

Query: 475 CDMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMP---HGSLEKCLYSSNYILDIF 525
             +MK + H+N+I +        S ++F+   +V+E M       ++  L        ++
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 134

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
           Q L         +++LH   S  IIH DLKP+N+++  +    + DFG+A+       S 
Sbjct: 135 QMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSF 181

Query: 586 TQTQTLATIGYMAP 599
             T  + T  Y AP
Sbjct: 182 MMTPYVVTRYYRAP 195

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 42/213 (19%)

Query: 408 NMPLVANLRRFTHLEL----FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFD 461
           ++ L+   + F   ++    ++    +     +G G   SV  A   + G +VA+K +  
Sbjct: 1   SLSLIRK-KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR 59

Query: 462 LQYEGAFKSFDI------ECDMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMP-- 507
                 F+S         E  ++K ++H N+I +      + S  +F    LV+ +M   
Sbjct: 60  -----PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD 114

Query: 508 -HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV 566
               +            ++Q L         L+Y+H   S  ++H DLKP N+ ++++  
Sbjct: 115 LQKIMGLKFSEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

Query: 567 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             + DFG+A+           T  + T  Y AP
Sbjct: 165 LKILDFGLARH-----ADAEMTGYVVTRWYRAP 192

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 24/190 (12%)

Query: 423 LFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------EC 475
           +F     ++  + IG G    V  A    + + VA+K         F+          E 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-----PFEHQTYCQRTLREI 76

Query: 476 DMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNI 530
            ++ R RH N+I    II + + +  K   +V + M    L K L +  ++ +       
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY-F 133

Query: 531 MIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ-TQ 589
           +  +   L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+    +       T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 590 TLATIGYMAP 599
            +AT  Y AP
Sbjct: 191 YVATRWYRAP 200

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 27/191 (14%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK----VFDLQYEGAFKSFDI----- 473
               + +   +LIGRG    VY A        VA+K    +F+          D      
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-------DLIDCKRILR 74

Query: 474 ECDMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRL 528
           E  ++ R++   +I+   +I       F    +VLE      L+K   +  ++ +   + 
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT 133

Query: 529 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 588
            I+ ++     ++H      IIH DLKP N LL+ +    + DFG+A+ +  E  +    
Sbjct: 134 -ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 589 QTLATIGYMAP 599
                      
Sbjct: 190 DLEENEEPGPH 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKV--FDLQYEGAFKSFDI----ECDMMKRIRHRNLIK 488
           +G G    VYKA        VA+K    + + EG           E  ++K ++HRN+I+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIE 97

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           + S   ++    L+ EY  +  L+K +   N  + +    + +  + + + + H   S  
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152

Query: 549 IIHCDLKPNNVLLDDNMVAH-----LSDFGMAK 576
            +H DLKP N+LL  +  +      + DFG+A+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 19/158 (12%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYE-GAFKSFDI----ECDMMKRIR---HR 484
             IG G   +VYKAR    G  VA+K   +    G      I    E  +++R+    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 485 N---LIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASAL 538
           N   L+ + ++   D      LV E++    L   L  +    L      ++M      L
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
           ++LH   +  I+H DLKP N+L+       L+DFG+A+
Sbjct: 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.0 bits (162), Expect = 5e-12
 Identities = 49/187 (26%), Positives = 76/187 (40%), Gaps = 49/187 (26%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
            +G G    V+  R +      A+KV  L+ E   +   +E       M+  + H  +I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 535
           +  +  +     ++++Y+  G L                 Y++              +V 
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--------------EVC 116

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL-A 592
            ALEYLH   S  II+ DLKP N+LLD N   H  ++DFG AK           T TL  
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCG 165

Query: 593 TIGYMAP 599
           T  Y+AP
Sbjct: 166 TPDYIAP 172

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 28/190 (14%)

Query: 423 LFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------EC 475
           +++    +   + +G G   SV  A   + G+ VAVK    +    F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79

Query: 476 DMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLN 529
            ++K ++H N+I +      + S ++F    LV   M    L   +       D  Q   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--F 136

Query: 530 IMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQ 589
           ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+       +   T 
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTG 188

Query: 590 TLATIGYMAP 599
            +AT  Y AP
Sbjct: 189 YVATRWYRAP 198

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 43/186 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  +  +   E+ AVK+  L+ +   +  D+EC M+ KR+     +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
           ++ S     D    V+EY+  G L           E     Y++              ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-T 593
           A  L +L    S  II+ DLK +NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 505

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 506 PDYIAP 511

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 42/185 (22%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR-----IRHRNLIK 488
           L+G+G    V   R +      A+K+  L+ E      ++   + +       RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 535
           +  +    D    V+EY   G L           E+    Y +              ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATI 594
           SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +  +    +T   T 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 595 GYMAP 599
            Y+AP
Sbjct: 170 EYLAP 174

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 41/185 (22%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR-----IRHRNLIK 488
           L+G+G    V   + +      A+K+  L+ E      ++   + +       RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 489 IISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDVA 535
           +  S    D    V+EY   G L           E     Y +              ++ 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIV 258

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATI 594
           SAL+YLH   +  +++ DLK  N++LD +    ++DFG+ K  +K+  +    +T   T 
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313

Query: 595 GYMAP 599
            Y+AP
Sbjct: 314 EYLAP 318

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 19/172 (11%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIEC-----DMMKRIRHRNLIK 488
            +G G    V   + ++     A+K+  L  +   K   IE       +++ +    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +  S  ++    +V+EY+  G +   L       +   R      +    EYLH   S+ 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-ATIGYMAP 599
           +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T   +AP
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAP 207

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 39/205 (19%)

Query: 416 RRFTHLEL----FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFK 469
            +F  +E+    F     +     IG G    V  A        VA+K +        F+
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQ 100

Query: 470 SFDI------ECDMMKRIRHRNLIKII----SSCSNDDFKA--LVLEYMP---HGSLEKC 514
           +         E  +MK + H+N+I ++       + ++F+   LV+E M       ++  
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 160

Query: 515 LYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM 574
           L        ++Q L         +++LH   S  IIH DLKP+N+++  +    + DFG+
Sbjct: 161 LDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 575 AKPLLKEDQSLTQTQTLATIGYMAP 599
           A+       S   T  + T  Y AP
Sbjct: 211 ARTA---GTSFMMTPYVVTRYYRAP 232

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 61/360 (16%), Positives = 112/360 (31%), Gaps = 82/360 (22%)

Query: 44  RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSL--DGILPRAIGNLSQSME 101
            +++  SL  + +T+   K +  + L     +K +  S N++  +    R +        
Sbjct: 4   FSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAA--RWLS------- 53

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN----------GSIPIALDKLQKLQLL 151
                         E I++  +L                       +  AL K  KL  +
Sbjct: 54  --------------ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 99

Query: 152 SLEDNQLEGSIPDDLCRL----AALFLLDLGGNKLS-------------GFVPACFGNLT 194
            L DN    +  + L         L  L L  N L                V     N  
Sbjct: 100 RLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP 159

Query: 195 SLRNLYLGSNQLTS-----IPSTLWNLKYILYLNLSSNSFT-----GPLPLEIGNLRVLV 244
            LR++  G N+L +        T  + + +  + +  N          L   +   + L 
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219

Query: 245 QIDLSMNNFSG----FIPTTIGDLKDLQYLFLEYNRLQG----SIPDSIGGL--IDLKSL 294
            +DL  N F+      +   +    +L+ L L    L      ++ D+   L  I L++L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279

Query: 295 DLSNNNIS--GAIPIS---LEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELL 349
            L  N I       +     EK+ DL ++ ++ N+       E    +   E F      
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR----FSEEDDVVDEIREVFSTRGRG 335

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 42/238 (17%), Positives = 84/238 (35%), Gaps = 38/238 (15%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
               L  + L+ N    +  +   +  LS    L++L   NN   G+ P+A   ++++++
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEP-LIDFLSKHTPLEHLYLHNN---GLGPQAGAKIARALQ 147

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL--NGSIPIA--LDKLQKLQLLSLEDNQ 157
                      ++ ++  N   L +I  G N+L        A      + L  + +  N 
Sbjct: 148 ---------ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198

Query: 158 L-----EGSIPDDLCRLAALFLLDLGGNKLSG----FVPACFGNLTSLRNLYLGSNQLTS 208
           +     E  + + L     L +LDL  N  +      +     +  +LR L L    L++
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258

Query: 209 -----IPSTLWNL--KYILYLNLSSNSFTGPLPLEIG-----NLRVLVQIDLSMNNFS 254
                +      L    +  L L  N         +       +  L+ ++L+ N FS
Sbjct: 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 47/188 (25%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMMKR------IRHRNLI 487
           +IG+G    V  AR +      AVKV  LQ +   K  + +  M +R      ++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
            +  S    D    VL+Y+  G L           E     Y++              ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL- 591
           ASAL YLH   S+ I++ DLKP N+LLD     H  L+DFG+ K  ++ + +   T T  
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200

Query: 592 ATIGYMAP 599
            T  Y+AP
Sbjct: 201 GTPEYLAP 208

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 53/186 (28%), Positives = 81/186 (43%), Gaps = 43/186 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  AR+++  ++ AVKV  L+ +   +  D+EC M  KRI      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
           ++       D    V+E++  G L           E     Y++              ++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 593
            SAL +LH      II+ DLK +NVLLD      L+DFGM K  +    +   T T   T
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 188 PDYIAP 193

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 4/97 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSIPDD-LCRLA 170
                +    NLT +Y+   +    +    L  L +L+ L++  + L   +  D      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT 207
            L  L+L  N L          L SL+ L L  N L 
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.1 bits (150), Expect = 1e-10
 Identities = 23/100 (23%), Positives = 31/100 (31%), Gaps = 1/100 (1%)

Query: 132 NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD-DLCRLAALFLLDLGGNKLSGFVPACF 190
                     L   + L  L +E+ Q    +   DL  L  L  L +  + L    P  F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT 230
                L  L L  N L S+         +  L LS N   
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 3e-07
 Identities = 20/97 (20%), Positives = 40/97 (41%), Gaps = 5/97 (5%)

Query: 257 IPTTIGDLKDLQYLFLEYNRLQGSIPD-SIGGLIDLKSLDLSNNNISGAIPISLEKLLDL 315
               +   ++L  L++E  +    +    + GL +L++L +  + +    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 316 KYINVSFNKLEGEIPREGPFRNFSAES--FKGNELLC 350
             +N+SFN LE  +      +  S +     GN L C
Sbjct: 83  SRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 19/87 (21%), Positives = 31/87 (35%), Gaps = 7/87 (8%)

Query: 1   LLLWGNNFSGTIPSFIF-NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSS 59
           L +        +         +L  L +  +      P+ F     L RL+L++N L S 
Sbjct: 36  LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL 95

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLD 86
           +     +  LS    L+ L  S N L 
Sbjct: 96  SW--KTVQGLS----LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 2e-06
 Identities = 17/93 (18%), Positives = 37/93 (39%), Gaps = 2/93 (2%)

Query: 234 PLEIGNLRVLVQIDLSMNNFSGFIPT-TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK 292
              +     L ++ +        +    +  L +L+ L +  + L+   PD+      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSFNKL 325
            L+LS N +  ++     + L L+ + +S N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 5/95 (5%)

Query: 90  PRAIGNLSQSMEVFFMFNCNISGSIPEE-ISNLTNLTTIYLGGNKLNGSIPI-ALDKLQK 147
              +       E++     ++   +    +  L  L  + +  + L   +   A     +
Sbjct: 24  LHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 148 LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           L  L+L  N LE S+     +  +L  L L GN L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 1e-05
 Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 6/91 (6%)

Query: 11  TIPSFIFNASKLSRLELE-MNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSL 69
                +  A  L+ L +E               L  L+ L++  + L    P      + 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AF 76

Query: 70  SNCKYLKYLSFSNNSLDGILPRAIGNLSQSM 100
                L  L+ S N+L+ +  + +  LS   
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQE 107

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 43/186 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V  +  +   E+ AVK+  L+ +   +  D+EC M+ KR+     +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
           ++ S     D    V+EY+  G L           E     Y++              ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 593
           A  L +L    S  II+ DLK +NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 185 PDYIAP 190

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 44/197 (22%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDI------EC 475
           ++    + +   +G G   +V  A   + G +VA+K ++       F+S         E 
Sbjct: 21  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-----PFQSELFAKRAYREL 75

Query: 476 DMMKRIRHRNLIKII----SSCSNDDFKA--LVLEYMPHGSLEKCLYSSN-------YIL 522
            ++K +RH N+I ++       + DDF    LV+ +M    L K +           ++ 
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL- 133

Query: 523 DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED 582
            ++Q L         L Y+H   +  IIH DLKP N+ ++++    + DFG+A+      
Sbjct: 134 -VYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ----- 177

Query: 583 QSLTQTQTLATIGYMAP 599
                T  + T  Y AP
Sbjct: 178 ADSEMTGYVVTRWYRAP 194

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI-KIISSC 493
           IG G    +   + +     VA+K+     +       +E    K++   + I ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 494 SNDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
               + A+VLE +  G SLE      +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 553 DLKPNNVLL------DDNMVAHLSDFGMAK 576
           D+KP N L+         ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 45/196 (22%), Positives = 82/196 (41%), Gaps = 31/196 (15%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI------ECD 476
           +  ++ F   +L+G G    V  A     G  VA+K  +      F           E  
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-----PFDKPLFALRTLREIK 61

Query: 477 MMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIM 531
           ++K  +H N+I    I    S ++F    ++ E M    L + + S+  + D   +   +
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FI 118

Query: 532 IDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ---- 587
                A++ LH      +IH DLKP+N+L++ N    + DFG+A+ + +     ++    
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 588 ----TQTLATIGYMAP 599
                + +AT  Y AP
Sbjct: 176 QSGMVEFVATRWYRAP 191

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 43/186 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           +IGRG  A V   R++    + A+KV  ++ E      DI+     K +      H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
            + S    +     V+EY+  G L           E+    YS+              ++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 119

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 593
           + AL YLH      II+ DLK +NVLLD      L+D+GM K  L+       T T   T
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 173

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 174 PNYIAP 179

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 43/186 (23%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           +IGRG  A V   R++    + A++V  ++ E      DI+     K +      H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
            + S    +     V+EY+  G L           E+    YS+              ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 162

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTL-AT 593
           + AL YLH      II+ DLK +NVLLD      L+D+GM K  L+       T T   T
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216

Query: 594 IGYMAP 599
             Y+AP
Sbjct: 217 PNYIAP 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 8/68 (11%)

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL 591
           +  ALE+LH    + II+ D+K  N+LLD N   H  L+DFG++K  + ++         
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-FC 221

Query: 592 ATIGYMAP 599
            TI YMAP
Sbjct: 222 GTIEYMAP 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 47/188 (25%)

Query: 435 LIGRGGVASVYKARIQDGIEV-AVKVFDLQYEGAFKSFDIECDMM-KRI-----RHRNLI 487
           ++G+G    V+ A  +   +  A+K   L+ +      D+EC M+ KR+      H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 488 KIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRLNIMIDV 534
            +  +    +    V+EY+  G L                 Y++              ++
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------------EI 127

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL- 591
              L++LH   S  I++ DLK +N+LLD +   H  ++DFGM K  +  D     T T  
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFC 179

Query: 592 ATIGYMAP 599
            T  Y+AP
Sbjct: 180 GTPDYIAP 187

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 25/160 (15%)

Query: 434 NLIGRGGVASVYKAR--IQDGIEVAVKV--FDLQYEGAFKSFDI----ECDMMKRIR--- 482
             IG G    V+KAR     G  VA+K        EG      +    E  +++ +    
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG----MPLSTIREVAVLRHLETFE 72

Query: 483 HRN---LIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVAS 536
           H N   L  + +    D      LV E++    L   L       +      ++M  +  
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK 576
            L++LH   S  ++H DLKP N+L+  +    L+DFG+A+
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 59/313 (18%), Positives = 109/313 (34%), Gaps = 63/313 (20%)

Query: 51  LNYNYLTSSTPKLNFLSS-LSNCKYLKYLSFSNNSLDGI----LPRAIGNLSQSMEVFFM 105
           +NY            +    S    +  L  S N+L  I    L +A  N   S+    +
Sbjct: 1   MNYKLTLHPGSNP--VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNL 58

Query: 106 FNCNISGSIPEEI-----SNLTNLTTIYLGGNKLN--GSIPIA---LDKLQKLQLLSLED 155
              ++     +E+     +   N+T++ L GN L+   S  +          + +L L  
Sbjct: 59  SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118

Query: 156 NQLEGSIPDDLCRL-----AALFLLDLGGNKLS-----GFVPACFGNLTSLRNLYLGSNQ 205
           N        +  +      A++  L+L GN L        +        ++ +L L  N 
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 206 LT------------SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG-----NLRVLVQIDL 248
           L             SIP+++        L+LS+N        E+          +V ++L
Sbjct: 179 LASKNCAELAKFLASIPASV------TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232

Query: 249 SMNNFSG----FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID-------LKSLDLS 297
            +N   G     +      LK LQ ++L+Y+ ++    +    L         +  +D +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292

Query: 298 NNNI--SGAIPIS 308
              I  S +IPIS
Sbjct: 293 GKEIHPSHSIPIS 305

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 52/268 (19%), Positives = 88/268 (32%), Gaps = 50/268 (18%)

Query: 105 MFNCNISGS----IPEEISNLTNLTTIYLGGNKL--NGSIPIA---LDKLQKLQLLSLED 155
           M            + E  S    +T++ L  N L    ++ +     +    +  L+L  
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 156 NQLEGSIPDDLCRL-----AALFLLDLGGNKLS-----GFVPACFGNLTSLRNLYLGSNQ 205
           N L     D+L ++     A +  L+L GN LS       V        ++  L LG N 
Sbjct: 61  NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120

Query: 206 LTS-----IPSTLWNL-KYILYLNLSSNSFTGP--------LPLEIGNLRVLVQIDLSMN 251
            +S           NL   I  LNL  N             L     N+  L   +L  N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGN 177

Query: 252 NFSGFIPTTIGDL-----KDLQYLFLEYNRLQGSIPDSIGGLI-----DLKSLDLSNNNI 301
           N +      +          +  L L  N L       +  +       + SL+L  N +
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237

Query: 302 SGAIPISLEKLLD----LKYINVSFNKL 325
            G    +L+ L D    L+ + + ++ +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIV 265

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 42/291 (14%), Positives = 92/291 (31%), Gaps = 45/291 (15%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG----ILPRAIGNLS 97
              N+  L+L+ N+L+  +      +  +    +  L    N           +A  NL 
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 98  QSMEVFFMFNCNISGSIPEEISNL-----TNLTTIYLGGNKL--NGSIPIA---LDKLQK 147
            S+    +   ++     +E+  +      N+ ++ L GN L       +A         
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 148 LQLLSLEDNQLEGSIPDDLCRL-----AALFLLDLGGNKLSG----FVPACFGNLTSLRN 198
           +  L L  N L      +L  +       +  L+L  N L G     +     +L  L+ 
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 199 LYLGSNQLTSIP--------STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM 250
           +YL  + + ++         +   N++ I+ ++ +         + I NL   +     +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI 301
            +            +         N    +IPD       L+    +   +
Sbjct: 318 PSLLNQCLIFAQKHQT--------NIEDLNIPDE------LRESIQTCKPL 354

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 27/69 (39%), Positives = 42/69 (60%), Gaps = 11/69 (15%)

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLTQTQTL 591
           +A AL++LH   S+ II+ DLKP N+LLD+    H  L+DFG++K  +  ++      + 
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186

Query: 592 -ATIGYMAP 599
             T+ YMAP
Sbjct: 187 CGTVEYMAP 195

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 48/194 (24%), Positives = 79/194 (40%), Gaps = 56/194 (28%)

Query: 435 LIGRGGVASVYKARIQDGIEV----AVKVFD----LQYEGAFKSFDIECDMMKR-----I 481
           ++G+GG   V++ R   G       A+KV      ++      + D      +R     +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNYILDIFQRL 528
           +H  ++ +I +        L+LEY+  G L           E   C Y +          
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA---------- 128

Query: 529 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMAKPLLKEDQSLT 586
               +++ AL +LH      II+ DLKP N++L+     H  L+DFG+ K  + +     
Sbjct: 129 ----EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV-- 177

Query: 587 QTQTLA-TIGYMAP 599
            T T   TI YMAP
Sbjct: 178 -THTFCGTIEYMAP 190

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 41/235 (17%), Positives = 79/235 (33%), Gaps = 71/235 (30%)

Query: 436 IGRGGVASVYKARI------QDGIEVAVK-VFDLQYEGAFKSFDIECDMMKRI-RHRNLI 487
           +GRG    V +A             VAVK + +       ++   E  ++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 488 KIISSCSNDDFKALV-LEYMPHGSLEKCL----------------------YSSNYILDI 524
            ++ +C+      +V +E+   G+L   L                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 525 FQRLNIMI------------------------------DVASALEYLHFGYSV------- 547
            +RL+ +                               D  +    + + + V       
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 548 ---PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                IH DL   N+LL +  V  + DFG+A+ + K+   + +      + +MAP
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 31/197 (15%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK--VFDLQYEG--AFKSFDIECDMM 478
           F   + + +   +G GG   V+ A        VA+K  V         A +    E  ++
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKII 62

Query: 479 KRIRHRNLIKII------------SSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDI 524
           +R+ H N++K+                S  +  +  +V EYM    L   L     + + 
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEH 121

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQ 583
            +    M  +   L+Y+H   S  ++H DLKP N+ ++ +++V  + DFG+A+ +     
Sbjct: 122 AR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 584 SLTQ-TQTLATIGYMAP 599
                ++ L T  Y +P
Sbjct: 177 HKGHLSEGLVTKWYRSP 193

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 12/124 (9%)

Query: 36  IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN 95
           +  T   L+  K L+L+ N +         +SSLS  + L+ LS   N +  I    +  
Sbjct: 40  MDATLSTLKACKHLALSTNNIEK-------ISSLSGMENLRILSLGRNLIKKIEN--LDA 90

Query: 96  LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIA-LDKLQKLQLLSLE 154
           ++ ++E  ++    I+ S+   I  L NL  +Y+  NK+     I  L  L KL+ L L 
Sbjct: 91  VADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148

Query: 155 DNQL 158
            N L
Sbjct: 149 GNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 17/146 (11%)

Query: 114 IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALF 173
           +   +S L     + L  N +   I  +L  ++ L++LSL  N ++  I +       L 
Sbjct: 40  MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 174 LLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS--TLWNLKYILYLNLSSNSFTG 231
            L +  N+++         L +LR LY+ +N++T+      L  L  +  L L+ N    
Sbjct: 97  ELWISYNQIASLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154

Query: 232 PLPLE----------IGNLRVLVQID 247
                          +  L  L ++D
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 30/152 (19%), Positives = 48/152 (31%), Gaps = 28/152 (18%)

Query: 151 LSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP 210
           L      +E  +   L  L A   L L  N +          + +LR L LG N +  I 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIKKIE 86

Query: 211 STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYL 270
           +       +  L +S N       +E   L  L  + +S N         I +  ++  L
Sbjct: 87  NLDAVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSNNK--------ITNWGEIDKL 136

Query: 271 FLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS 302
                            L  L+ L L+ N + 
Sbjct: 137 ---------------AALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 29/129 (22%), Positives = 56/129 (43%), Gaps = 31/129 (24%)

Query: 199 LYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP 258
           L+     +  + +TL  LK   +L LS+N+       +I +L                  
Sbjct: 30  LHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSL------------------ 66

Query: 259 TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS-LEKLLDLKY 317
                +++L+ L L  N ++  I +       L+ L +S N I+    +S +EKL++L+ 
Sbjct: 67  ---SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRV 119

Query: 318 INVSFNKLE 326
           + +S NK+ 
Sbjct: 120 LYMSNNKIT 128

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 1e-09
 Identities = 82/541 (15%), Positives = 159/541 (29%), Gaps = 157/541 (29%)

Query: 49  LSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPR-------------AIGN 95
           L +NY +L S         S+    Y++      N                     A+  
Sbjct: 87  LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146

Query: 96  LSQS-------M----------EV-----------FFMF-----NCNISGSIPEEISNL- 121
           L  +       +          +V           F +F     NCN   ++ E +  L 
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQ-KLQLLSLEDNQLEGS--IPDDLCRLAALFLLDLG 178
             +   +   +  + +I + +  +Q +L+ L L+    E    +  ++    A    +L 
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLS 265

Query: 179 GNKLSGFVPACFGNLTSLRNL----YLGSNQLTSIPS-------TLWNLKYIL--YLNLS 225
                     C   LT+ R      +L +   T I         T   +K +L  YL+  
Sbjct: 266 ----------CKILLTT-RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314

Query: 226 SNSFTGPLPLEI--GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD 283
                  LP E+   N R L  I  S+ +       T        +  +  ++L   I  
Sbjct: 315 PQD----LPREVLTTNPRRLSIIAESIRDG----LATWD-----NWKHVNCDKLTTIIES 361

Query: 284 SIGGL--IDLKSL--DLS--NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN 337
           S+  L   + + +   LS    +    IP     LL L + +V  + +   +  +     
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAH--IP---TILLSLIWFDVIKSDVM-VVVNK--LHK 413

Query: 338 FSAESFKGNELLCGTPNLQVPPCRTRIHHTSRKNDLLLGIVLPLSTIFMMAVILLILRYR 397
           +S        L+      Q       I        + L + + L   + +    ++  Y 
Sbjct: 414 YS--------LV----EKQPKESTISIP------SIYLELKVKLENEYALH-RSIVDHYN 454

Query: 398 KRGKSQLADANMPLVAN---------LRRFTHLELFQATN------GFSENNLI------ 436
                   D   P +           L+   H E             F E  +       
Sbjct: 455 IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514

Query: 437 -GRGGVASV------YKARIQDGIEVAVKVFDLQYEGAFKSFDIECD-MMKRIRHRNLIK 488
              G + +       YK  I D        ++ +   A   F  + +  +   ++ +L++
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDP----KYE-RLVNAILDFLPKIEENLICSKYTDLLR 569

Query: 489 I 489
           I
Sbjct: 570 I 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.7 bits (102), Expect = 2e-04
 Identities = 63/449 (14%), Positives = 129/449 (28%), Gaps = 150/449 (33%)

Query: 245 QIDLSMNN-FSGFIPTTIGDL--KDLQYLFL------EYNRLQGSIPDSIGG---LIDLK 292
           +      +  S F    + +   KD+Q +        E + +  S  D++ G   L    
Sbjct: 13  EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMS-KDAVSGTLRLFWT- 70

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSF--NKLEGE-IPREGPFRNFSAES---FKGN 346
            L      +   +   +E++L + Y    F  + ++ E        R +  +    +  N
Sbjct: 71  -LLSKQEEM---VQKFVEEVLRINY---KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 347 ELLCGTPNLQVPPCRTRIHHTSRKNDLLL----GIVLPLSTIFMMAVILLILRYRKRGKS 402
           ++        V   R + +   R+  L L     +++       +            GK+
Sbjct: 124 QVF---AKYNVS--RLQPYLKLRQALLELRPAKNVLI-----DGVLGS---------GKT 164

Query: 403 QLA---------DANMPL------VANLRRFTH-LELFQATNGFSENNLIGRGGVASVYK 446
            +A            M        + N       LE+ Q      + N   R   +S  K
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224

Query: 447 ARIQDGIEVAVKVF-------------DLQYEGAFKSFDIECDMM--------------K 479
            RI        ++              ++Q   A+ +F++ C ++               
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284

Query: 480 RIRHRNLIKIISSCSNDDFKALVLEY--MPHGSL--EKCLYS-----------------S 518
              H +L     + + D+ K+L+L+Y       L  E    +                  
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344

Query: 519 NYILDI-FQRLNIMIDVASALEYLH-------------FGYSVPIIHCDLKPNNVL---- 560
           +    +   +L  +I+  S+L  L              F  S  I      P  +L    
Sbjct: 345 DNWKHVNCDKLTTIIE--SSLNVLEPAEYRKMFDRLSVFPPSAHI------PTILLSLIW 396

Query: 561 ------LDDNMVAHLSDFGMAKPLLKEDQ 583
                     +V  L        L+++  
Sbjct: 397 FDVIKSDVMVVVNKLHK----YSLVEKQP 421

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 56.5 bits (137), Expect = 1e-09
 Identities = 35/124 (28%), Positives = 51/124 (41%), Gaps = 29/124 (23%)

Query: 107 NCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
           +C+     S+P  I   T    +YL  N++    P   D+L +L  L L++NQL   +P 
Sbjct: 15  DCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLP- 70

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLN 223
                                    F  LT L  L L  NQL SIP   + NLK + ++ 
Sbjct: 71  ----------------------AGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIW 108

Query: 224 LSSN 227
           L +N
Sbjct: 109 LLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.6 bits (101), Expect = 8e-05
 Identities = 36/123 (29%), Positives = 46/123 (37%), Gaps = 43/123 (34%)

Query: 186 VPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
           VP   G  T+ + LYL  NQ+T +       L  L     L+L +N  T           
Sbjct: 24  VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTR---LDLDNNQLTV---------- 68

Query: 242 VLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSIGGLID-LKSLD---L 296
                          +P  + D L  L  L L  N+L+ SIP    G  D LKSL    L
Sbjct: 69  ---------------LPAGVFDKLTQLTQLSLNDNQLK-SIPR---GAFDNLKSLTHIWL 109

Query: 297 SNN 299
            NN
Sbjct: 110 LNN 112

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 45/211 (21%), Positives = 81/211 (38%), Gaps = 62/211 (29%)

Query: 436 IGRG--GVASVYKARIQD-GIEVAVK-VFDLQYEGAFKSFDI-ECDMMKRIRHRNLIKII 490
           +G G  G+  V +    + G   A+K V           +   E D+MK + H N+IK++
Sbjct: 15  LGTGSFGI--VCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 491 --------------------------------------SSCSNDDFKALVLEYMP---HG 509
                                                  + S + +  +++EY+P   H 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 510 SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAH 568
            L+  + S   I      +  +  +  A+ ++H   S+ I H D+KP N+L++  +    
Sbjct: 127 VLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182

Query: 569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           L DFG AK L+  + S      + +  Y AP
Sbjct: 183 LCDFGSAKKLIPSEPS---VAYICSRFYRAP 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 28/149 (18%), Positives = 58/149 (38%), Gaps = 15/149 (10%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI-KIISSC 493
           IG G    +++   + +  +VA+K    + +        E    K +     I  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 554 LKPNNVLL------DDNMVAHLSDFGMAK 576
           +KP+N L+      + NM+ ++ DFGM K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 35/124 (28%), Positives = 45/124 (36%), Gaps = 33/124 (26%)

Query: 107 NCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
           NC      S+P  I   T+   ++L  N++    P   D L  LQ L    N+L  +IP 
Sbjct: 18  NCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIP- 73

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYI- 219
                                    F  LT L  L L  N L SIP      L +L +I 
Sbjct: 74  ----------------------TGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111

Query: 220 LYLN 223
           LY N
Sbjct: 112 LYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 7e-05
 Identities = 39/123 (31%), Positives = 48/123 (39%), Gaps = 43/123 (34%)

Query: 186 VPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLKYILYLNLSSNSFTGPLPLEIGNLR 241
           VPA  G  T  + L+L +NQ+T +       L NL+    L  +SN  T           
Sbjct: 27  VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQ---LYFNSNKLTA---------- 71

Query: 242 VLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLEYNRLQGSIPDSIGGLID-LKSLD---L 296
                          IPT + D L  L  L L  N L+ SIP    G  D LKSL    L
Sbjct: 72  ---------------IPTGVFDKLTQLTQLDLNDNHLK-SIPR---GAFDNLKSLTHIYL 112

Query: 297 SNN 299
            NN
Sbjct: 113 YNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 33/113 (29%), Positives = 44/113 (38%), Gaps = 32/113 (28%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
           + +RL LN N +T   P +     L N   L+ L F++N L  I             VF 
Sbjct: 34  DKQRLWLNNNQITKLEPGV--FDHLVN---LQQLYFNSNKLTAIPTG----------VF- 77

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI-ALDKLQKLQLLSLEDN 156
                           LT LT + L  N L  SIP  A D L+ L  + L +N
Sbjct: 78  --------------DKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI-KIISSC 493
           IG G    +Y    I  G EVA+K+  ++ +       IE  + K ++    I  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
           +  D+  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 554 LKPNNVLL---DDNMVAHLSDFGMAK 576
           +KP+N L+       + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 5/114 (4%)

Query: 120 NLTNLTTIYLGGNKLN-GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG 178
               +  + L   K N G I     +   L+ LSL +  L  S+  +L +L  L  L+L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS--TLWNLKYILYLNLSSNSFT 230
            N++ G +      L +L +L L  N+L  I +   L  L+ +  L+L +   T
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 3/103 (2%)

Query: 109 NISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
           +  G I    +   NL  + L    L  S+   L KL KL+ L L +N++ G +     +
Sbjct: 36  SNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEK 93

Query: 169 LAALFLLDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLTSIP 210
           L  L  L+L GNKL           L  L++L L + ++T++ 
Sbjct: 94  LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 36/136 (26%), Positives = 51/136 (37%), Gaps = 25/136 (18%)

Query: 168 RLAALFLLDLGGNKLS-GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS 226
             AA+  L L   K + G +        +L  L L +  L S+ S L  L  +  L LS 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSE 80

Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
           N   G L +    L  L  ++LS N         + D+  L+ L                
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPL---------------K 117

Query: 287 GLIDLKSLDLSNNNIS 302
            L  LKSLDL N  ++
Sbjct: 118 KLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 30/164 (18%), Positives = 50/164 (30%), Gaps = 39/164 (23%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
               ++ L L+                 +    L++LS  N  L  +             
Sbjct: 22  TPAAVRELVLDNCKSNDGK----IEGLTAEFVNLEFLSLINVGLISV------------- 64

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
                           +  L  L  + L  N++ G + +  +KL  L  L+L  N+L+  
Sbjct: 65  --------------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD- 109

Query: 162 IPDDLCRLAA---LFLLDLGGN---KLSGFVPACFGNLTSLRNL 199
               L  L     L  LDL       L+ +  + F  L  L  L
Sbjct: 110 -ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 38/163 (23%), Positives = 78/163 (47%), Gaps = 22/163 (13%)

Query: 424 FQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVK-VFDLQYEGAFKSFDI------EC 475
                 +     +G+G    V+K+   + G  VAVK +FD     AF++         E 
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTDAQRTFREI 59

Query: 476 DMMKRIR-HRNLIKIISSCSNDDFKA--LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMI 532
            ++  +  H N++ +++    D+ +   LV +YM    L   + ++  IL+   +  ++ 
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVY 116

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA 575
            +   ++YLH   S  ++H D+KP+N+LL+      ++DFG++
Sbjct: 117 QLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 11/147 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLI-KIISSC 493
           IG G    +Y    IQ   EVA+K      +        E  + + ++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
              D+  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 554 LKPNNVLLDDNMVAH---LSDFGMAKP 577
           +KP+N L+     A+   + DFG+AK 
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.3 bits (132), Expect = 2e-08
 Identities = 34/203 (16%), Positives = 56/203 (27%), Gaps = 54/203 (26%)

Query: 424 FQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKV--------FDLQYEGAFKSFDIEC 475
              T        IG G    V++    D   VA+K+         +  ++  F+    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 476 DMMKRI---------RHRNLIKIISSC------------------------------SND 496
            + K +         R    I + S                                  D
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 497 DFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK 555
           D   +VLE+   G  LE+       +  +    +I+  + ++L            H DL 
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189

Query: 556 PNNVLLDDNMVAHLSDFGMAKPL 578
             NVLL    +  L      K  
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSS 212

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 5/113 (4%)

Query: 192 NLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLE-IGNLRVLVQIDLSM 250
           N    R L L   ++  I +    L     ++ S N       L+    LR L  + ++ 
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNN 73

Query: 251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQG-SIPDSIGGLIDLKSLDLSNNNIS 302
           N            L DL  L L  N L      D +  L  L  L +  N ++
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 13/138 (9%)

Query: 18  NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY 77
           NA +   L+L        I N    L     +  + N +         L      + LK 
Sbjct: 17  NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRK-------LDGFPLLRRLKT 68

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISG-SIPEEISNLTNLTTIYLGGN---K 133
           L  +NN +  I       L   +    + N ++      + +++L +LT + +  N    
Sbjct: 69  LLVNNNRICRIGEGLDQAL-PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127

Query: 134 LNGSIPIALDKLQKLQLL 151
                   + K+ ++++L
Sbjct: 128 KKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 28/186 (15%), Positives = 51/186 (27%), Gaps = 60/186 (32%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
           N    + L L    +      +  L +         + FS+N +  +             
Sbjct: 17  NAVRDRELDLRGYKIP----VIENLGA--TLDQFDAIDFSDNEIRKL------------- 57

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS 161
                         +    L  L T+ +  N++          L  L  L L +N L   
Sbjct: 58  --------------DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--V 101

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS----TLWNLK 217
              DL  LA                     +L SL  L +  N +T+        ++ + 
Sbjct: 102 ELGDLDPLA---------------------SLKSLTYLCILRNPVTNKKHYRLYVIYKVP 140

Query: 218 YILYLN 223
            +  L+
Sbjct: 141 QVRVLD 146

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 32/167 (19%), Positives = 65/167 (38%), Gaps = 31/167 (18%)

Query: 435 LIGRGGVASVYKAR------IQDGIEVAVKVF-----DLQYEGAFKSFDIECDMMKRIRH 483
            IG+GG   +Y A       +       VKV       L  E  F     + + +++   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 484 RNLIKII----------SSCSNDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMI 532
              +K +             +   ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 533 DVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAK 576
            +   LEY+H       +H D+K +N+LL   + + V +L D+G+A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 36/165 (21%), Positives = 64/165 (38%), Gaps = 30/165 (18%)

Query: 435 LIGRGGVASVYKA-RIQDGIEVAVKVF--------DLQYEGAFKSFDIECDMMKRIRHRN 485
            IG GG   +Y A       + A  V          L  E  F     + D +K+   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 486 LIKII----------SSCSNDDFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDV 534
            +  +          +      ++ +V+E +  G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAK 576
              LEY+H       +H D+K  N+LL   + + V +L+D+G++ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 31/166 (18%)

Query: 436 IGRGGVASVYKAR---------IQDGIEVAVKV----FDLQYEGAFKSFDIECDMMKRIR 482
             R     +Y+A               + ++K+      L  E  F     +   + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 483 HRNLIKII-------SSCSNDDFKALVLEYMPHG-SLEKCL-YSSNYILDIFQRLNIMID 533
                 ++            D ++ LVL  +  G SL+  L  S  ++L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAK 576
           +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 35/168 (20%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
            +G G  ++V+ A+ + +   VA+K+   D  Y    ++ + E  +++R+   +  K  S
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 82

Query: 492 SCSN------DDFKA---------LVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMID 533
             +N      D F           +V E +   +L   +    +    L   ++  I   
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH------LSDFGMA 575
           +   L+Y+H      IIH D+KP NVL++            ++D G A
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 33/154 (21%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKII--- 490
           +GRG  + V++A  I +  +V VK+     +   K    E  +++ +R   N+I +    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 491 -SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS-------ALEYLH 542
               S     ALV E++ +   ++          ++Q L    D+         AL+Y H
Sbjct: 101 KDPVSRTP--ALVFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEILKALDYCH 147

Query: 543 FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMA 575
              S+ I+H D+KP+NV++D ++    L D+G+A
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 33/138 (23%), Positives = 49/138 (35%), Gaps = 26/138 (18%)

Query: 165 DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL 224
               +  L L +   N+    +         L  L   +  LTSI + L  L  +  L L
Sbjct: 15  TPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLEL 71

Query: 225 SSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS 284
           S N  +G L +       L  ++LS N         I DL  ++ L              
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPL-------------- 109

Query: 285 IGGLIDLKSLDLSNNNIS 302
              L +LKSLDL N  ++
Sbjct: 110 -KKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 29/133 (21%), Positives = 54/133 (40%), Gaps = 6/133 (4%)

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
               +K L   N+  +      + +  + +E     N  ++ SI   +  L  L  + L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 131 GNKLNGSIPIALDKLQKLQLLSLEDNQLEG-SIPDDLCRLAALFLLDLGGN---KLSGFV 186
            N+++G + +  +K   L  L+L  N+++  S  + L +L  L  LDL       L+ + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132

Query: 187 PACFGNLTSLRNL 199
              F  L  L  L
Sbjct: 133 ENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 4/88 (4%)

Query: 239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN 298
           +++ LV +D S +N  G +     + ++L++L      L  SI + +  L  LK L+LS+
Sbjct: 18  DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 299 NNISGAIPISLEKLLDLKYINVSFNKLE 326
           N +SG + +  EK  +L ++N+S NK++
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 30/146 (20%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIR-----HRNLI 487
           +G G  ++V+ +  IQ    VA+KV      Y         E  ++K +R       N  
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101

Query: 488 KIISSCSNDDFK---------ALVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMIDVA 535
            ++     DDFK          +V E + H  L K +  SNY    L   ++  I+  V 
Sbjct: 102 MVVQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVL 156

Query: 536 SALEYLHFGYSVPIIHCDLKPNNVLL 561
             L+YLH      IIH D+KP N+LL
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILL 180

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 2e-05
 Identities = 29/226 (12%), Positives = 64/226 (28%), Gaps = 39/226 (17%)

Query: 108 CNISGSIPEEISNLTNLTTIYLGGNKLN---------GSIPIALDKLQKLQLLSLEDNQL 158
            +I+  I E      +   ++ G                +   LD +  L  L ++    
Sbjct: 125 SDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN 184

Query: 159 EGSIPDDLCRLAALFLL--DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNL 216
                     L +L ++   L  + +   + +   NL  L  LY+G              
Sbjct: 185 LSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVE------------ 231

Query: 217 KYILYLNLSSNSFTGPLP--LEIGNLRVLVQIDLSMNNFSGFIPTTIGD---LKDLQYLF 271
                 +   +                 L  + +        +     +   L  L+ + 
Sbjct: 232 ------DYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 272 LEYNRLQGS----IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
           +    L       + D +  +  LK +++  N +S  +   L+K L
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 50/348 (14%), Positives = 107/348 (30%), Gaps = 52/348 (14%)

Query: 18  NASKLSRLELEMNSFYGF----IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK 73
           + + L  L   M  F       +     N R+L  + +    +      + F  + +N +
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILEL---VGFFKAAANLE 246

Query: 74  YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS-GSIPEEISNLTNLTTIYLGGN 132
                S +    D  +P    NL    ++  +    +    +P        +  + L   
Sbjct: 247 EFCGGSLNE---DIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYA 303

Query: 133 KLNGSIPI-ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFG 191
            L        + K   L++L   +   +  +         L  L +        +    G
Sbjct: 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG 363

Query: 192 NLT------------SLRNLYLGSNQLT-----SIPSTLWNLKYILYLNLSSNSFTGPLP 234
            ++             L  + +  + +T     SI + L NL     + L        LP
Sbjct: 364 LVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP 423

Query: 235 LEIG------NLRVLVQIDLSMNNFSGFIPTTIGD---------LKDLQYLFLEYNRLQ- 278
           L+ G        + L +    +          + D           +++++ L Y     
Sbjct: 424 LDNGVRSLLIGCKKLRRFAFYLR------QGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477

Query: 279 GSIPDSIGGLIDLKSLDLSNNNIS-GAIPISLEKLLDLKYINVSFNKL 325
             + +   G  +L+ L++     S  AI  ++ KL  L+Y+ V   + 
Sbjct: 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 44/289 (15%), Positives = 87/289 (30%), Gaps = 35/289 (12%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLS-NCKYLKYLSFSNNSLDGILP---RAIGNLS 97
           + R +K L +  +  +    K  +L  L+ +   L+ L+F       I P     I    
Sbjct: 162 HCRKIKTLLMEESSFSEKDGK--WLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219

Query: 98  QSMEVFFMFNCNIS--GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLED 155
           +S+    + +  I       +  +NL       L  +       + L   +KL  L L  
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279

Query: 156 NQLEGSIPDDLCRLAALFLLDLGG-NKLSGFVPACFGNLTSLRNLYLGSNQLT--SIPST 212
                 +P      A +  LDL      +           +L  L    N +    +   
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRGLEVL 337

Query: 213 LWNLKYILYLNLSSNSFTGPLPLEIG------------NLRVLVQIDLSMNNFSGFIPTT 260
               K +  L +   +    +  E G              + L  + + +++ +     +
Sbjct: 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397

Query: 261 IG----DLKDLQYLFLEYNRLQGSIPDSIG------GLIDLKSLDLSNN 299
           IG    +L D + + L+       +P   G      G   L+       
Sbjct: 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 47/316 (14%), Positives = 102/316 (32%), Gaps = 47/316 (14%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSL---DGILPRAIGNLSQ 98
           NLR LK +      ++     L+ L+  +    L+ L     S    DG+L  +I    +
Sbjct: 110 NLRQLKSVHFRRMIVSDLD--LDRLAK-ARADDLETLKLDKCSGFTTDGLL--SIVTHCR 164

Query: 99  SMEVFFMFNCNIS-------GSIPEEISNLTNLTTIYLGGNKLN-GSIPIALDKLQKLQL 150
            ++   M   + S         + +  ++L  L        K++   +       + L  
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224

Query: 151 LSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFG--------NLTSLRNLYLG 202
           + + D ++   +       AA  L +  G  L+  +              L  L   Y+G
Sbjct: 225 VKVGDFEI---LELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG 281

Query: 203 SNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLE-IGNLRVLVQIDLSMNNFSGFIPTTI 261
            N++  +      ++    L+L             I     L  ++         +    
Sbjct: 282 PNEMPILFPFAAQIR---KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLA 338

Query: 262 GDLKDLQYLFLEYNRLQGSIPDSIGGLID------------LKSLDLSNNNIS----GAI 305
              K L+ L +E    +  + D  G +              L+ + +  ++I+     +I
Sbjct: 339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI 398

Query: 306 PISLEKLLDLKYINVS 321
              L+ L D + + + 
Sbjct: 399 GTYLKNLCDFRLVLLD 414

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 27/200 (13%), Positives = 63/200 (31%), Gaps = 17/200 (8%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
           + +N K L L+     S+       +  + C+ LK L    + +D +    + +   +  
Sbjct: 128 SFKNFKVLVLSSCEGFSTDG---LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184

Query: 102 -----VFFMFNCNIS-GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLE- 154
                        +S  ++   ++   NL ++ L        +   L +  +L+ L    
Sbjct: 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG 244

Query: 155 -----DNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-- 207
                   +   +   L     L  L    + +  ++PA +   + L  L L    +   
Sbjct: 245 YTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSY 304

Query: 208 SIPSTLWNLKYILYLNLSSN 227
            +   L     +  L +   
Sbjct: 305 DLVKLLCQCPKLQRLWVLDY 324

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 35/155 (22%), Positives = 68/155 (43%), Gaps = 23/155 (14%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHR---NLIK 488
           +IG+G    V KA   +    VA+K+   + ++    +    E  +++ +R +   N + 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNTMN 160

Query: 489 IISSCSNDDFKA---LVLEYMPHGSLEKCLYSSNYI---LDIFQRLNIMIDVASALEYLH 542
           +I    N  F+    +  E +   +L + +  + +    L + ++      +   L+ LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH 217

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMA 575
                 IIHCDLKP N+LL     +   + DFG +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 37/284 (13%), Positives = 85/284 (29%), Gaps = 37/284 (13%)

Query: 73  KYLKYLSFSNNSLDGI----LPRAIGNLSQSMEVFFMFNCNISGSIPEEISN-LTNLTTI 127
             L+ L+ +   +  +    +   +G+   +++   + +C +  +    +         +
Sbjct: 72  SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131

Query: 128 YLGGNKL--NGSIPIA---LDKLQKLQLLSLEDNQLEGSIPDDLCR-LAA---LFLLDLG 178
            L  N L       +    L    ++  L L +N L  +    L   LA    +  L L 
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191

Query: 179 GNKLS----GFVPACFGNLTSLRNLYLGSNQLTS-----IPSTLWNLKYILYLNLSSNSF 229
              L       + A       L+ L +  N         +         +  L+L  N  
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251

Query: 230 TGP----LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI 285
           +      L    G      ++ +S+   +         L ++Q        L       +
Sbjct: 252 SSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQ------RNLNSWDRARV 305

Query: 286 GGLIDLKSLDLSNNNISGAIPISLEKLL----DLKYINVSFNKL 325
              ++L   DL ++  +   P    +LL    +++ +       
Sbjct: 306 QRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 17/155 (10%)

Query: 433 NNLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHR----- 484
           ++LIG+G    V KA    +   VA+K+      +        IE  +++ +        
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF---LNQAQIEVRLLELMNKHDTEMK 115

Query: 485 -NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLH 542
             ++ +       +   LV E +   +L   L ++N+  + +         + +AL +L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAH--LSDFGMA 575
               + IIHCDLKP N+LL +   +   + DFG +
Sbjct: 175 -TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 30/176 (17%), Positives = 64/176 (36%), Gaps = 42/176 (23%)

Query: 433 NNLIGRGGVASVYKARIQDGIEVAVKVFDL----------QYEGAFKSFDI--------E 474
             L+G G  ++V+    +   E  VK   +          + +     F +        E
Sbjct: 95  GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 154

Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
              +++++   + K+ +   N    A+++E +    L +        ++    +  MI  
Sbjct: 155 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVR------VENPDEVLDMI-- 202

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG--------MAKPLLKED 582
              LE +   Y   I+H DL   NVL+ +  +  + DF           + +L+ D
Sbjct: 203 ---LEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERD 254

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 40.6 bits (95), Expect = 9e-04
 Identities = 35/228 (15%), Positives = 79/228 (34%), Gaps = 15/228 (6%)

Query: 33  YGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRA 92
               P+  G L +   ++          P    L+   +   ++++  SN+ ++      
Sbjct: 57  KNLHPDVTGRLLSQGVIAFRCPRSFMDQP----LAEHFSPFRVQHMDLSNSVIEVSTLHG 112

Query: 93  IGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL--NGSIPIALDKLQKLQL 150
           I +    ++   +    +S  I   ++  +NL  + L G       ++   L    +L  
Sbjct: 113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172

Query: 151 LSL------EDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL-GS 203
           L+L       +  ++ ++      +  L L     N     +        +L +L L  S
Sbjct: 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 232

Query: 204 NQLTSIP-STLWNLKYILYLNLSS-NSFTGPLPLEIGNLRVLVQIDLS 249
             L +      + L Y+ +L+LS          LE+G +  L  + + 
Sbjct: 233 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	599
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.98
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.98
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.93
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.93
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.93
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.93
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.93
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.93
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.93
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.93
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.87
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.82
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.82
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.81
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.81
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.81
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.8
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.76
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.73
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.73
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.69
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.65
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.65
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.64
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.61
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.58
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.53
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.35
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.72
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.61
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.55
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.09
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.0
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.98
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.48
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.47
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.46
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.23
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.17
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.16
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.11
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.25
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.26
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.89
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.8
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.56
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	82.48
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	81.82

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.4e-49  Score=449.17  Aligned_cols=359  Identities=35%  Similarity=0.575  Sum_probs=316.3

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCcc-ccCCCCCCEEeccCccCccc-CCCccc-------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNT-FGNLRNLKRLSLNYNYLTSS-TPKLNF-------------   65 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~-------------   65 (599)
                      |+|++|++++.+|..|.++++|++|+|++|++++.+|.. |.++++|++|+|++|+++.. +..+..             
T Consensus       299 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N  378 (768)
T 3rgz_A          299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN  378 (768)
T ss_dssp             EECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSS
T ss_pred             EECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCC
Confidence            578888888888888888888888888888888656654 88888888888888887733 221100             


Q ss_pred             ------ccccCC--CCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcc
Q 042902           66 ------LSSLSN--CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS  137 (599)
Q Consensus        66 ------~~~~~~--l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  137 (599)
                            +..+..  +++|++|++++|.+++..|..+.+++ .|+.|++++|++++..|..|.++++|++|+|++|.+++.
T Consensus       379 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  457 (768)
T 3rgz_A          379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE  457 (768)
T ss_dssp             EEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             CcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCc
Confidence                  011222  67788888888888888899998887 599999999999999999999999999999999999999


Q ss_pred             cCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCccccCC
Q 042902          138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNL  216 (599)
Q Consensus       138 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l  216 (599)
                      +|..+..+++|++|+|++|++.+.+|..+..+++|++|+|++|++++..|.+|+.+++|++|+|++|+++ .+|..+..+
T Consensus       458 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  537 (768)
T 3rgz_A          458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC  537 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGC
T ss_pred             CCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998 788899999


Q ss_pred             CcccEEeecCCCccccCcccc-----------------------------------------------------------
Q 042902          217 KYILYLNLSSNSFTGPLPLEI-----------------------------------------------------------  237 (599)
Q Consensus       217 ~~L~~L~Ls~N~l~~~~~~~~-----------------------------------------------------------  237 (599)
                      ++|++|++++|++++.+|..+                                                           
T Consensus       538 ~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  617 (768)
T 3rgz_A          538 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS  617 (768)
T ss_dssp             TTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTS
T ss_pred             CCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccccccccc
Confidence            999999999999987766543                                                           


Q ss_pred             -----------cccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCC
Q 042902          238 -----------GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIP  306 (599)
Q Consensus       238 -----------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  306 (599)
                                 ..+++|+.|||++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|
T Consensus       618 ~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip  697 (768)
T 3rgz_A          618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP  697 (768)
T ss_dssp             CEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCC
T ss_pred             ceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCC
Confidence                       345789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCCCCCCCCCCccc
Q 042902          307 ISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCRTR  363 (599)
Q Consensus       307 ~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~  363 (599)
                      ..+..++.|++||+++|+++|.+|..+.+..++..++.||+.+||.|.   ++|...
T Consensus       698 ~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~  751 (768)
T 3rgz_A          698 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPS  751 (768)
T ss_dssp             GGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSC
T ss_pred             hHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCC
Confidence            999999999999999999999999999999999999999999999873   367644

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.3e-45  Score=416.54  Aligned_cols=344  Identities=37%  Similarity=0.571  Sum_probs=280.4

Q ss_pred             CccCCCcCccCCCCCCcCC-CCCCEEEccCccccccCCccccCCCCCCEEeccCccCc-ccCCCcccccccCCCCCCcEE
Q 042902            1 LLLWGNNFSGTIPSFIFNA-SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLT-SSTPKLNFLSSLSNCKYLKYL   78 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~~~l~~L~~L   78 (599)
                      |+|++|++++.+|..++.. ++|++|+|++|++++..|..|+++++|++|+|++|+++ .++..     .+.++++|++|
T Consensus       274 L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~-----~l~~l~~L~~L  348 (768)
T 3rgz_A          274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD-----TLLKMRGLKVL  348 (768)
T ss_dssp             EECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH-----HHTTCTTCCEE
T ss_pred             EECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH-----HHhcCCCCCEE
Confidence            5788899999999998886 99999999999999999999999999999999999998 44432     47888889999


Q ss_pred             EcccCcccccCChhhhcccc--------------------------cceEEEccCCcccccCCccccCCCCCCEEEccCC
Q 042902           79 SFSNNSLDGILPRAIGNLSQ--------------------------SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGN  132 (599)
Q Consensus        79 ~Ls~N~i~~~~~~~~~~l~~--------------------------~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N  132 (599)
                      ++++|.+++..|..+..++.                          .++.|++++|.+++..|..|.++++|++|+|++|
T Consensus       349 ~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N  428 (768)
T 3rgz_A          349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN  428 (768)
T ss_dssp             ECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSS
T ss_pred             eCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCC
Confidence            99999988888877776542                          3556666666666677777777888888888888


Q ss_pred             cCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCc
Q 042902          133 KLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPS  211 (599)
Q Consensus       133 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~  211 (599)
                      .+++.+|..|..+++|++|+|++|.+.+.+|..+..+++|++|++++|++++..|..|..+++|++|+|++|+++ .+|.
T Consensus       429 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  508 (768)
T 3rgz_A          429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK  508 (768)
T ss_dssp             EEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             cccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCCh
Confidence            887777878888888888888888888788888888888888888888888888888888888888888888888 6677


Q ss_pred             cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCcc-------------------------------
Q 042902          212 TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT-------------------------------  260 (599)
Q Consensus       212 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------  260 (599)
                      ++..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..                               
T Consensus       509 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (768)
T 3rgz_A          509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH  588 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCC
T ss_pred             HHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccc
Confidence            8888888888888888888888888888888888888888887665543                               


Q ss_pred             ---------------------------------------ccCcccccccccccccccccCcccccCCCCcccccCCCCcc
Q 042902          261 ---------------------------------------IGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI  301 (599)
Q Consensus       261 ---------------------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  301 (599)
                                                             ++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|++
T Consensus       589 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l  668 (768)
T 3rgz_A          589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI  668 (768)
T ss_dssp             SSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCcc
Confidence                                                   33356788888888888888888888888888888888888


Q ss_pred             cccCCchhhccccceEEEcccccCcccCCCC-CCCCCcccccccCCCCC
Q 042902          302 SGAIPISLEKLLDLKYINVSFNKLEGEIPRE-GPFRNFSAESFKGNELL  349 (599)
Q Consensus       302 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~  349 (599)
                      +|.+|..+..+++|+.|||++|+++|.+|.. +.+..+...++.+|+..
T Consensus       669 ~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~  717 (768)
T 3rgz_A          669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS  717 (768)
T ss_dssp             CSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred             CCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence            8888888888888888888888888888864 44566677777777653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=377.60  Aligned_cols=343  Identities=22%  Similarity=0.235  Sum_probs=309.7

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      +.++++++ .+|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.|+.+.+.     .|.++++|++|+|+
T Consensus        17 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~   88 (477)
T 2id5_A           17 LCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-----AFNNLFNLRTLGLR   88 (477)
T ss_dssp             ECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECC
T ss_pred             EeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChh-----hhhCCccCCEEECC
Confidence            34567777 6677664  5899999999999999999999999999999999999998765     69999999999999


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS  161 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  161 (599)
                      +|+|+.+.+..|.+++ .|+.|++++|.+.+..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|++++.
T Consensus        89 ~n~l~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  167 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLS-NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI  167 (477)
T ss_dssp             SSCCCSCCTTSSTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred             CCcCCccCcccccCCC-CCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence            9999988888888887 599999999999999999999999999999999999999999999999999999999999988


Q ss_pred             CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       162 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      .+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+. .+|.......+|++|++++|.+++..+..|..+
T Consensus       168 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  247 (477)
T 2id5_A          168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL  247 (477)
T ss_dssp             CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTC
T ss_pred             ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCc
Confidence            8888999999999999999999998899999999999999998765 677777777799999999999997777789999


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                      ++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++
T Consensus       248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  327 (477)
T 2id5_A          248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL  327 (477)
T ss_dssp             TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred             cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence            99999999999999998899999999999999999999999999999999999999999999888888999999999999


Q ss_pred             ccccCcccCCCCCCCCCcccccccCCCCCcCCC
Q 042902          321 SFNKLEGEIPREGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       321 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      ++|++.|.++....+.......+.++...|..|
T Consensus       328 ~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          328 DSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             cCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            999999887543222233344566777788766

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=5.8e-43  Score=387.33  Aligned_cols=347  Identities=23%  Similarity=0.216  Sum_probs=253.0

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..+..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+++.+.+.     .|+++++|++|+|
T Consensus        37 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~L  111 (606)
T 3vq2_A           37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-----SFSGLTSLENLVA  111 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT-----SSTTCTTCCEEEC
T ss_pred             EECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh-----hcCCcccCCEEEc
Confidence            46777777777777777777777777777777777777777777777777777777776554     4677777777777


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccc-cCCccccCCCCCCEEEccCCcCCcccCccc-----------------
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISG-SIPEEISNLTNLTTIYLGGNKLNGSIPIAL-----------------  142 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----------------  142 (599)
                      ++|.++++.+..|.+++ .|+.|++++|.+.+ .+|..|+++++|++|+|++|++++..+..|                 
T Consensus       112 ~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          112 VETKLASLESFPIGQLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             TTSCCCCSSSSCCTTCT-TCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             cCCccccccccccCCCC-CCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            77777766666666665 37777777777665 346667777777777776666654433221                 


Q ss_pred             --------------------------------------------------------------------------------
Q 042902          143 --------------------------------------------------------------------------------  142 (599)
Q Consensus       143 --------------------------------------------------------------------------------  142 (599)
                                                                                                      
T Consensus       191 n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  270 (606)
T 3vq2_A          191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY  270 (606)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred             CCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------cCCC
Q 042902          143 ----------------------------------------------------------------------------DKLQ  146 (599)
Q Consensus       143 ----------------------------------------------------------------------------~~l~  146 (599)
                                                                                                  ..++
T Consensus       271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~  350 (606)
T 3vq2_A          271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP  350 (606)
T ss_dssp             CTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCT
T ss_pred             cccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCC
Confidence                                                                                        1233


Q ss_pred             CCCEEEccccccccc--CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCC--ccccCCCcccEE
Q 042902          147 KLQLLSLEDNQLEGS--IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYL  222 (599)
Q Consensus       147 ~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip--~~~~~l~~L~~L  222 (599)
                      +|++|++++|.+++.  .|..+..+++|++|++++|.+++ .|..|..+++|+.|++++|.++.++  ..+..+++|++|
T Consensus       351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  429 (606)
T 3vq2_A          351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL  429 (606)
T ss_dssp             TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred             CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence            444455555555433  25566666667777777776664 3466777788888888888887664  366778888888


Q ss_pred             eecCCCccccCcccccccccccEEEccCCccCC-CCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcc
Q 042902          223 NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG-FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI  301 (599)
Q Consensus       223 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  301 (599)
                      ++++|.+++..|..|.++++|++|++++|.+++ .+|..|+.+++|++|+|++|++++..|..|..+++|+.|+|++|++
T Consensus       430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  509 (606)
T 3vq2_A          430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL  509 (606)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence            888888888888888888888888888888887 4678888888889999999988888888888888999999999998


Q ss_pred             cccCCchhhccccceEEEcccccCcccCCCCCCCC-CcccccccCCCCCcCCCC
Q 042902          302 SGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFR-NFSAESFKGNELLCGTPN  354 (599)
Q Consensus       302 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~~  354 (599)
                      ++..|..|..+++|+.|++++|+++..++....+. .+...++.+|++.|+++.
T Consensus       510 ~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             SCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            88888888888889999999999885443333343 467778889999888763

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=398.28  Aligned_cols=345  Identities=22%  Similarity=0.253  Sum_probs=211.7

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCcc--ccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEE
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNT--FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYL   78 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L   78 (599)
                      |+|++|++++..|..|.++++|++|+|++|++++..|..  |+++++|++|+|++|.+++..+.    ..|+++++|++|
T Consensus        78 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~----~~~~~L~~L~~L  153 (844)
T 3j0a_A           78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH----PSFGKLNSLKSI  153 (844)
T ss_dssp             EECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCC----GGGGTCSSCCEE
T ss_pred             EECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccc----hhHhhCCCCCEE
Confidence            355666666666666666666666666666665533333  56666666666666666554432    246667777777


Q ss_pred             EcccCcccccCChhhhccc-cc------------------------------ceEEEccCCcccccCCcccc--------
Q 042902           79 SFSNNSLDGILPRAIGNLS-QS------------------------------MEVFFMFNCNISGSIPEEIS--------  119 (599)
Q Consensus        79 ~Ls~N~i~~~~~~~~~~l~-~~------------------------------l~~l~l~~n~i~~~~~~~~~--------  119 (599)
                      +|++|.+++..+..+..+. ..                              ++.|++++|.+++..+..+.        
T Consensus       154 ~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l  233 (844)
T 3j0a_A          154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA  233 (844)
T ss_dssp             EEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCB
T ss_pred             ECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccc
Confidence            7777776665555554330 01                              33333333332222221111        


Q ss_pred             ----------------------------C--CCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcC
Q 042902          120 ----------------------------N--LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRL  169 (599)
Q Consensus       120 ----------------------------~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  169 (599)
                                                  +  .++|++|+|++|.+.+..+..|..+++|+.|+|++|.+.+..|..|..+
T Consensus       234 ~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l  313 (844)
T 3j0a_A          234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL  313 (844)
T ss_dssp             SEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTC
T ss_pred             cceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCC
Confidence                                        0  1345566666666665556666666666666666666666666666666


Q ss_pred             CCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCc--------------
Q 042902          170 AALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLP--------------  234 (599)
Q Consensus       170 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~--------------  234 (599)
                      ++|++|+|++|++++..+..|.++++|+.|++++|.++.++. .+..+++|++|+|++|.+++...              
T Consensus       314 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l  393 (844)
T 3j0a_A          314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL  393 (844)
T ss_dssp             SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCC
T ss_pred             CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCc
Confidence            666666666666666556666666666666666666665543 34455555555555555543210              


Q ss_pred             --------------------------ccccccccccEEEccCCccCC------------------------------CCC
Q 042902          235 --------------------------LEIGNLRVLVQIDLSMNNFSG------------------------------FIP  258 (599)
Q Consensus       235 --------------------------~~~~~l~~L~~L~Ls~N~l~~------------------------------~~~  258 (599)
                                                ..+.++++|+.|+|++|++++                              ..+
T Consensus       394 ~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~  473 (844)
T 3j0a_A          394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW  473 (844)
T ss_dssp             CCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS
T ss_pred             ccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccch
Confidence                                      001234455555555555542                              233


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCc
Q 042902          259 TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNF  338 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~  338 (599)
                      ..|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++..|..+.  ++|+.|++++|++++.+|..  +..+
T Consensus       474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L  549 (844)
T 3j0a_A          474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSL  549 (844)
T ss_dssp             SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSC
T ss_pred             hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCc
Confidence            4577788888888888888888888888888888888888888877666665  78888888888888877753  5677


Q ss_pred             ccccccCCCCCcCCC
Q 042902          339 SAESFKGNELLCGTP  353 (599)
Q Consensus       339 ~~~~~~~n~~~c~~~  353 (599)
                      ...++.+||+.|+|+
T Consensus       550 ~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          550 SVLDITHNKFICECE  564 (844)
T ss_dssp             CEEEEEEECCCCSSS
T ss_pred             CEEEecCCCcccccc
Confidence            888899999999876

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.1e-42  Score=371.53  Aligned_cols=342  Identities=20%  Similarity=0.244  Sum_probs=272.0

Q ss_pred             cCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCc-ccCCCcccccccCCCCCCcEEEcc
Q 042902            3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLT-SSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         3 L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      .++++++ .+|. +.  ++|++|+|++|+|+++.|..|+++++|++|+|++|.+. .+++.     .|.++++|++|+|+
T Consensus        17 c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~-----~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           17 CINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN-----TFRGLSSLIILKLD   87 (455)
T ss_dssp             CCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT-----TTTTCTTCCEEECT
T ss_pred             cCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc-----cccccccCCEEeCC
Confidence            3455555 4555 32  67888888888888888888888888888888888876 34443     57888888888888


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCCcc--ccCCCCCCEEEccCCcCCcccCcc-ccCCCCCCEEEcccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE--ISNLTNLTTIYLGGNKLNGSIPIA-LDKLQKLQLLSLEDNQL  158 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l  158 (599)
                      +|.+++..|.+|.+++ .|+.|++++|++++..+..  |.++++|++|+|++|.+++..|.. |.++++|++|+|++|++
T Consensus        88 ~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  166 (455)
T 3v47_A           88 YNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV  166 (455)
T ss_dssp             TCTTCEECTTTTTTCT-TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred             CCccCccChhhccCcc-cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence            8888888888888886 4888888888887754444  888888888888888888776765 78888888888888888


Q ss_pred             cccCChhhhcC--CCCcEEEeeCCccCCCCCccc--------CCCCCCcEeecCCCCCCC-CCcc---------------
Q 042902          159 EGSIPDDLCRL--AALFLLDLGGNKLSGFVPACF--------GNLTSLRNLYLGSNQLTS-IPST---------------  212 (599)
Q Consensus       159 ~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~--------~~l~~L~~L~L~~N~l~~-ip~~---------------  212 (599)
                      .+..+..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|.++. +|..               
T Consensus       167 ~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l  246 (455)
T 3v47_A          167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL  246 (455)
T ss_dssp             SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEEC
T ss_pred             cccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEee
Confidence            88777777766  567777777777776554432        245667777777776652 1111               


Q ss_pred             ----------------------cc--CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccc
Q 042902          213 ----------------------LW--NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ  268 (599)
Q Consensus       213 ----------------------~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  268 (599)
                                            +.  ..++|+.|++++|.+++..|..|..+++|+.|+|++|.+++..|..|.++++|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  326 (455)
T 3v47_A          247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL  326 (455)
T ss_dssp             TTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCC
Confidence                                  11  125799999999999988899999999999999999999988888999999999


Q ss_pred             ccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCC-CCCCCcccccccCCC
Q 042902          269 YLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE-GPFRNFSAESFKGNE  347 (599)
Q Consensus       269 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  347 (599)
                      +|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|++++|++++.++.. ..+..+...++.+|+
T Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             EEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            9999999999888999999999999999999999888999999999999999999999766543 456778888899999


Q ss_pred             CCcCCCC
Q 042902          348 LLCGTPN  354 (599)
Q Consensus       348 ~~c~~~~  354 (599)
                      +.|.+|.
T Consensus       407 l~~~~~~  413 (455)
T 3v47_A          407 WDCSCPR  413 (455)
T ss_dssp             BCCCTTT
T ss_pred             cccCCCc
Confidence            9998873

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7.2e-43  Score=372.83  Aligned_cols=327  Identities=21%  Similarity=0.241  Sum_probs=278.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCcccc-ccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEE
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFY-GFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLS   79 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~   79 (599)
                      |+|++|++++..|..|.++++|++|+|++|.+. .+.+.+|.++++|++|+|++|+++.+.+.     .|+++++|++|+
T Consensus        35 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~  109 (455)
T 3v47_A           35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG-----AFNGLANLEVLT  109 (455)
T ss_dssp             EECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT-----TTTTCTTCCEEE
T ss_pred             EEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh-----hccCcccCCEEe
Confidence            689999999999999999999999999999997 55678899999999999999999988765     689999999999


Q ss_pred             cccCcccccCChh--hhcccccceEEEccCCcccccCCcc-ccCCCCCCEEEccCCcCCcccCccccCC--CCCCEEEcc
Q 042902           80 FSNNSLDGILPRA--IGNLSQSMEVFFMFNCNISGSIPEE-ISNLTNLTTIYLGGNKLNGSIPIALDKL--QKLQLLSLE  154 (599)
Q Consensus        80 Ls~N~i~~~~~~~--~~~l~~~l~~l~l~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~  154 (599)
                      |++|.+++..+..  |..++ .|+.|++++|++++..|.. |.++++|++|+|++|.+++..+..+..+  .+|+.|+++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~  188 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS  188 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCT-TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECT
T ss_pred             CCCCCCCccccCcccccCcc-cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccc
Confidence            9999999755444  88887 5999999999999988876 8999999999999999999888877765  455555555


Q ss_pred             cccccccCChh--------hhcCCCCcEEEeeCCccCCCCCc-------------------------------------c
Q 042902          155 DNQLEGSIPDD--------LCRLAALFLLDLGGNKLSGFVPA-------------------------------------C  189 (599)
Q Consensus       155 ~N~l~~~~~~~--------~~~l~~L~~L~Ls~N~l~~~~~~-------------------------------------~  189 (599)
                      +|.+.+..+..        +..+++|++|++++|++++..|.                                     .
T Consensus       189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~  268 (455)
T 3v47_A          189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT  268 (455)
T ss_dssp             TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTT
T ss_pred             cCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccc
Confidence            55555433322        12334555555555554432222                                     1


Q ss_pred             cCC--CCCCcEeecCCCCCCCC-CccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccc
Q 042902          190 FGN--LTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKD  266 (599)
Q Consensus       190 ~~~--l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  266 (599)
                      +..  .++|++|++++|.++.+ |..+..+++|++|++++|.+++..|..|.++++|+.|+|++|.+++..|..|+.+++
T Consensus       269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (455)
T 3v47_A          269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK  348 (455)
T ss_dssp             TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred             cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence            222  26899999999999965 667889999999999999999999999999999999999999999998999999999


Q ss_pred             ccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCC
Q 042902          267 LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREG  333 (599)
Q Consensus       267 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  333 (599)
                      |++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|+++|.+|...
T Consensus       349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            9999999999999999999999999999999999998888888999999999999999999998643

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1e-41  Score=377.31  Aligned_cols=343  Identities=20%  Similarity=0.199  Sum_probs=306.2

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+++++.|++|+++++|++|+|++|+++.+.+.     .|+++++|++|++
T Consensus        38 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L  112 (606)
T 3t6q_A           38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-----ALSGPKALKHLFF  112 (606)
T ss_dssp             EECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-----TTSSCTTCCEEEC
T ss_pred             EEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-----hhcccccccEeec
Confidence            68999999999999999999999999999999999999999999999999999999988765     6899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCC--EEEcccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQ--LLSLEDNQL  158 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l  158 (599)
                      ++|.|+++.+..|.+++ .|+.|++++|.+.+..+..+.++++|++|+|++|.+++..+..|..+++|+  .|++++|.+
T Consensus       113 ~~n~i~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             TTSCCSCGGGSCCTTCT-TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             cccCcccCCcchhccCC-cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence            99999988888898887 499999999999987666666799999999999999988888999999999  899999999


Q ss_pred             cccCChhhhcC---------------------------------------------------CCCcEEEeeCCccCCCCC
Q 042902          159 EGSIPDDLCRL---------------------------------------------------AALFLLDLGGNKLSGFVP  187 (599)
Q Consensus       159 ~~~~~~~~~~l---------------------------------------------------~~L~~L~Ls~N~l~~~~~  187 (599)
                      .+..|..|...                                                   .+|+.|++++|.++++.+
T Consensus       192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~  271 (606)
T 3t6q_A          192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS  271 (606)
T ss_dssp             CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred             CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence            98777665431                                                   167889999999999888


Q ss_pred             cccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC-ccccCccc
Q 042902          188 ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP-TTIGDLKD  266 (599)
Q Consensus       188 ~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~  266 (599)
                      ..|+.+++|++|++++|+++.+|..+..+++|++|++++|.+++..|..+.++++|+.|++++|.+.+.+| ..+..+++
T Consensus       272 ~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  351 (606)
T 3t6q_A          272 NTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN  351 (606)
T ss_dssp             TTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred             HHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence            88999999999999999999999999999999999999999998888999999999999999999986554 45899999


Q ss_pred             ccccccccccccccC--cccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCC--CCCCCccccc
Q 042902          267 LQYLFLEYNRLQGSI--PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE--GPFRNFSAES  342 (599)
Q Consensus       267 L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~~~~~  342 (599)
                      |++|++++|++++..  +..+..+++|++|++++|.+++..|..|..+++|+.|++++|++++..|..  ..+..+....
T Consensus       352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  431 (606)
T 3t6q_A          352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN  431 (606)
T ss_dssp             CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred             CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence            999999999998776  778999999999999999999899999999999999999999998876653  4566777777


Q ss_pred             ccCCCCC
Q 042902          343 FKGNELL  349 (599)
Q Consensus       343 ~~~n~~~  349 (599)
                      +.+|...
T Consensus       432 l~~n~l~  438 (606)
T 3t6q_A          432 LSHSLLD  438 (606)
T ss_dssp             CTTCCCB
T ss_pred             CCCCccC
Confidence            8777653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=378.68  Aligned_cols=348  Identities=22%  Similarity=0.221  Sum_probs=244.4

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..+..|.++++|++|+|++|+++++.+++|+++++|++|+|++|+++.+++.     .|+++++|++|++
T Consensus        33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  107 (570)
T 2z63_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQKLVA  107 (570)
T ss_dssp             EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTT-----TTTTCTTCCEEEC
T ss_pred             EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHh-----hhcCccccccccc
Confidence            57888999888888888899999999999999888888889999999999999988888764     5788888888888


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCccccc-CCccccCCCCCCEEEccCCcCCcccCccccCCCCC----CEEEccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS-IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKL----QLLSLED  155 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~  155 (599)
                      ++|+++++.+..|++++ .|+.|++++|.+++. .|..|.++++|++|++++|.+++..+..|..+++|    +.|++++
T Consensus       108 ~~n~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          108 VETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             TTSCCCCSTTCSCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             cccccccCCCccccccc-cccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            88888877666677776 488888888888763 57788888888888888888776655555544444    4455555


Q ss_pred             ccccccCC------------------------------------------------------------------------
Q 042902          156 NQLEGSIP------------------------------------------------------------------------  163 (599)
Q Consensus       156 N~l~~~~~------------------------------------------------------------------------  163 (599)
                      |.+.+..|                                                                        
T Consensus       187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  266 (570)
T 2z63_A          187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  266 (570)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred             CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence            44433222                                                                        


Q ss_pred             ---------hhhhcCCCCcEEEeeCCccCCCC------------------------------------------------
Q 042902          164 ---------DDLCRLAALFLLDLGGNKLSGFV------------------------------------------------  186 (599)
Q Consensus       164 ---------~~~~~l~~L~~L~Ls~N~l~~~~------------------------------------------------  186 (599)
                               ..+..+++|+.|++++|.++++.                                                
T Consensus       267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~  346 (570)
T 2z63_A          267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL  346 (570)
T ss_dssp             TTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBC
T ss_pred             chhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccC
Confidence                     22222334444444444433211                                                


Q ss_pred             -------------------CcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCc-ccccccccccEE
Q 042902          187 -------------------PACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP-LEIGNLRVLVQI  246 (599)
Q Consensus       187 -------------------~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L  246 (599)
                                         +..+..+++|++|++++|.++.+|..+..+++|++|++++|.+++..+ ..|..+++|+.|
T Consensus       347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  426 (570)
T 2z63_A          347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  426 (570)
T ss_dssp             TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred             CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence                               222333444444444444444444445556666666666666665544 456777777777


Q ss_pred             EccCCccCCCCCccccCccccccccccccccc-ccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccC
Q 042902          247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ-GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKL  325 (599)
Q Consensus       247 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  325 (599)
                      ++++|.+++..|..|.++++|++|++++|+++ +.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++
T Consensus       427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  506 (570)
T 2z63_A          427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL  506 (570)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence            77777777777777777888888888888876 46777788888888888888888877788888888888888888888


Q ss_pred             cccCCCC-CCCCCcccccccCCCCCcCCCC
Q 042902          326 EGEIPRE-GPFRNFSAESFKGNELLCGTPN  354 (599)
Q Consensus       326 ~~~~p~~-~~~~~~~~~~~~~n~~~c~~~~  354 (599)
                      ++.+|.. ..+..+...++.+|++.|.+|.
T Consensus       507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            8766643 4556677777888888877663

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.4e-42  Score=381.91  Aligned_cols=343  Identities=17%  Similarity=0.240  Sum_probs=301.2

Q ss_pred             CccCCCcCccC-----------------CCCCCc--CCCCCCEEEccCccccccCCccccCCCCCCEEeccCcc-Ccc--
Q 042902            1 LLLWGNNFSGT-----------------IPSFIF--NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNY-LTS--   58 (599)
Q Consensus         1 L~L~~n~~~~~-----------------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~--   58 (599)
                      |+|++|++++.                 +|..+.  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++.  
T Consensus       211 L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~  290 (636)
T 4eco_A          211 FYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ  290 (636)
T ss_dssp             EEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHH
T ss_pred             EECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcccc
Confidence            68999999986                 999999  99999999999999999999999999999999999998 885  


Q ss_pred             cCCCcccccccCCCCCCcEEEcccCcccccCCh--hhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCc
Q 042902           59 STPKLNFLSSLSNCKYLKYLSFSNNSLDGILPR--AIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNG  136 (599)
Q Consensus        59 ~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~--~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  136 (599)
                      ++..+..+..+..+++|++|+|++|+++ .+|.  .+.+++ .|+.|++++|++++.+| .|.++++|++|+|++|+++ 
T Consensus       291 lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-  366 (636)
T 4eco_A          291 LKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-  366 (636)
T ss_dssp             HHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-
T ss_pred             chHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-
Confidence            4443211112234599999999999999 6777  899997 59999999999998899 9999999999999999999 


Q ss_pred             ccCccccCCCC-CCEEEcccccccccCChhhhcCC--CCcEEEeeCCccCCCCCcccC-------CCCCCcEeecCCCCC
Q 042902          137 SIPIALDKLQK-LQLLSLEDNQLEGSIPDDLCRLA--ALFLLDLGGNKLSGFVPACFG-------NLTSLRNLYLGSNQL  206 (599)
Q Consensus       137 ~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l  206 (599)
                      .+|..+..+++ |++|+|++|.++ .+|..+..+.  +|++|++++|++++..|..|.       .+++|++|+|++|++
T Consensus       367 ~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l  445 (636)
T 4eco_A          367 EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI  445 (636)
T ss_dssp             ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred             cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence            67788999999 999999999999 6788777755  899999999999999999888       888999999999999


Q ss_pred             CCCCcccc-CCCcccEEeecCCCccccCcccccccc-------cccEEEccCCccCCCCCcccc--Cccccccccccccc
Q 042902          207 TSIPSTLW-NLKYILYLNLSSNSFTGPLPLEIGNLR-------VLVQIDLSMNNFSGFIPTTIG--DLKDLQYLFLEYNR  276 (599)
Q Consensus       207 ~~ip~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~  276 (599)
                      +.+|..++ .+++|++|+|++|+++.+.+..+....       +|+.|+|++|+++ .+|..+.  .+++|++|+|++|+
T Consensus       446 ~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~  524 (636)
T 4eco_A          446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS  524 (636)
T ss_dssp             CSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred             CcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence            99998655 589999999999999955544554433       9999999999999 5677776  99999999999999


Q ss_pred             ccccCcccccCCCCcccccC------CCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCc
Q 042902          277 LQGSIPDSIGGLIDLKSLDL------SNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLC  350 (599)
Q Consensus       277 l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  350 (599)
                      +++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|++++|++ +.+|... ...+...++.+|++.|
T Consensus       525 l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred             CCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence            997 8899999999999999      56889999999999999999999999999 6777653 3778888999998877


Q ss_pred             CC
Q 042902          351 GT  352 (599)
Q Consensus       351 ~~  352 (599)
                      -.
T Consensus       602 ~~  603 (636)
T 4eco_A          602 ID  603 (636)
T ss_dssp             EE
T ss_pred             cc
Confidence            43

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.5e-42  Score=381.79  Aligned_cols=334  Identities=24%  Similarity=0.287  Sum_probs=264.6

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCc--------------------------------------------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMN--------------------------------------------------   30 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n--------------------------------------------------   30 (599)
                      |+|++|+++|.+|..+.++++|++|+|++|                                                  
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l  165 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC  165 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHH
Confidence            578899999999999999999999999888                                                  


Q ss_pred             ----------------------------cccccCCccccCCCCCCEEeccCccCcc------------------cCCCcc
Q 042902           31 ----------------------------SFYGFIPNTFGNLRNLKRLSLNYNYLTS------------------STPKLN   64 (599)
Q Consensus        31 ----------------------------~i~~~~~~~~~~l~~L~~L~L~~N~l~~------------------~~~~~~   64 (599)
                                                  ++++ +|.+|+++++|++|+|++|++++                  +|.   
T Consensus       166 ~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~---  241 (636)
T 4eco_A          166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE---  241 (636)
T ss_dssp             HHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS---
T ss_pred             hhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch---
Confidence                                        4445 67788999999999999999988                  554   


Q ss_pred             cccccC--CCCCCcEEEcccCcccccCChhhhcccccceEEEccCCc-ccc-cCCccccCC------CCCCEEEccCCcC
Q 042902           65 FLSSLS--NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN-ISG-SIPEEISNL------TNLTTIYLGGNKL  134 (599)
Q Consensus        65 ~~~~~~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~-i~~-~~~~~~~~l------~~L~~L~L~~N~l  134 (599)
                         .++  ++++|++|+|++|.+.+.+|..|.+++ .|+.|++++|+ +++ .+|..++++      ++|++|+|++|.+
T Consensus       242 ---~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l  317 (636)
T 4eco_A          242 ---DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP-EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL  317 (636)
T ss_dssp             ---CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS-SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCC
T ss_pred             ---hhhhcccCCCCEEEecCCcCCccChHHHhcCC-CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcC
Confidence               466  888999999999998888888888887 48899999998 887 788887776      8899999999998


Q ss_pred             CcccCc--cccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCC-CcEeecCCCCCCCCCc
Q 042902          135 NGSIPI--ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTS-LRNLYLGSNQLTSIPS  211 (599)
Q Consensus       135 ~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~ip~  211 (599)
                      + .+|.  .+..+++|++|+|++|++++.+| .|..+++|++|+|++|+++ .+|..|..+++ |++|++++|.++.+|.
T Consensus       318 ~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~  394 (636)
T 4eco_A          318 K-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPN  394 (636)
T ss_dssp             S-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCS
T ss_pred             C-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccch
Confidence            8 6676  78888999999999999887788 8888888889999998888 56777888888 8889999888888888


Q ss_pred             cccCCC--cccEEeecCCCccccCccccc-------ccccccEEEccCCccCCCCCccccCcccccccccccccccccCc
Q 042902          212 TLWNLK--YILYLNLSSNSFTGPLPLEIG-------NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP  282 (599)
Q Consensus       212 ~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  282 (599)
                      .+..++  +|++|++++|.+++..|..|.       .+++|+.|+|++|.++.+.+..+..+++|++|+|++|+++...+
T Consensus       395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~  474 (636)
T 4eco_A          395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK  474 (636)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred             hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence            776544  788888888888888887777       67788888888888886555556667888888888888874444


Q ss_pred             ccccCCC-------CcccccCCCCcccccCCchhh--ccccceEEEcccccCcccCCC-CCCCCCcccccccCCC
Q 042902          283 DSIGGLI-------DLKSLDLSNNNISGAIPISLE--KLLDLKYINVSFNKLEGEIPR-EGPFRNFSAESFKGNE  347 (599)
Q Consensus       283 ~~~~~l~-------~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~  347 (599)
                      ..+....       +|+.|+|++|+++ .+|..+.  .+++|+.|++++|++++ +|. ...+..+....+.+|+
T Consensus       475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~  547 (636)
T 4eco_A          475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR  547 (636)
T ss_dssp             SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB
T ss_pred             HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc
Confidence            4444332       7888888888887 5666665  77788888888888877 443 3445566666665443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.4e-41  Score=366.80  Aligned_cols=335  Identities=22%  Similarity=0.211  Sum_probs=251.6

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      +++++|++++ +|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+++++.     .|.++++|++|||
T Consensus        36 l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L  107 (562)
T 3a79_B           36 VDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH-----VFLFNQDLEYLDV  107 (562)
T ss_dssp             EECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT-----TTTTCTTCCEEEC
T ss_pred             EEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH-----HhCCCCCCCEEEC
Confidence            4677777774 666554  6777777777777777777777777777777777777777654     5777777777777


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCccccc-CCccccCCCCCCEEEccCCcCCcccCccccCCCCC--CEEEccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS-IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKL--QLLSLEDNQ  157 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~  157 (599)
                      ++|+|+.+.+.   .++ .|+.|++++|++++. .|..|.++++|++|+|++|.+++.   .+..+++|  ++|+|++|.
T Consensus       108 s~N~l~~lp~~---~l~-~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~  180 (562)
T 3a79_B          108 SHNRLQNISCC---PMA-SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVS  180 (562)
T ss_dssp             TTSCCCEECSC---CCT-TCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESS
T ss_pred             CCCcCCccCcc---ccc-cCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccc
Confidence            77777754333   444 477777777777764 356777777777777777777653   34444444  777777777


Q ss_pred             c--cccCChhhhcCC-----------------------------------------------------------------
Q 042902          158 L--EGSIPDDLCRLA-----------------------------------------------------------------  170 (599)
Q Consensus       158 l--~~~~~~~~~~l~-----------------------------------------------------------------  170 (599)
                      +  .+..|..+..+.                                                                 
T Consensus       181 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~  260 (562)
T 3a79_B          181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE  260 (562)
T ss_dssp             CCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEE
T ss_pred             ccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCc
Confidence            6  444444444322                                                                 


Q ss_pred             ----------------CCcEEEeeCCccCCCCCccc--------------------------------------------
Q 042902          171 ----------------ALFLLDLGGNKLSGFVPACF--------------------------------------------  190 (599)
Q Consensus       171 ----------------~L~~L~Ls~N~l~~~~~~~~--------------------------------------------  190 (599)
                                      +|++|++++|.+++..|..+                                            
T Consensus       261 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~  340 (562)
T 3a79_B          261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD  340 (562)
T ss_dssp             ECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEES
T ss_pred             CcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccC
Confidence                            56667777777765555443                                            


Q ss_pred             ---------CCCCCCcEeecCCCCCCC-CCccccCCCcccEEeecCCCccccC--cccccccccccEEEccCCccCC-CC
Q 042902          191 ---------GNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTGPL--PLEIGNLRVLVQIDLSMNNFSG-FI  257 (599)
Q Consensus       191 ---------~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~-~~  257 (599)
                               ..+++|++|++++|.++. +|..+..+++|++|++++|++++..  |..|.++++|+.|+|++|.+++ ..
T Consensus       341 n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  420 (562)
T 3a79_B          341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY  420 (562)
T ss_dssp             SCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCS
T ss_pred             CCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccC
Confidence                     677889999999999996 6778889999999999999998743  4678899999999999999998 44


Q ss_pred             CccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC-CCCCC
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR-EGPFR  336 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~  336 (599)
                      +..+..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...+.
T Consensus       421 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~  497 (562)
T 3a79_B          421 DRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLT  497 (562)
T ss_dssp             SCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCT
T ss_pred             hhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCC
Confidence            45688899999999999999877766554  68999999999999 6777777999999999999999954444 45667


Q ss_pred             CcccccccCCCCCcCCC
Q 042902          337 NFSAESFKGNELLCGTP  353 (599)
Q Consensus       337 ~~~~~~~~~n~~~c~~~  353 (599)
                      .+...++.+|++.|+++
T Consensus       498 ~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          498 SLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TCCCEECCSCCBCCCHH
T ss_pred             CCCEEEecCCCcCCCcc
Confidence            77888899999998875

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=365.68  Aligned_cols=335  Identities=20%  Similarity=0.196  Sum_probs=220.6

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |++++|+++ .+|..+.  ++|++|+|++|+|+++.|++|.++++|++|+|++|+|+++.+.     .|+++++|++|||
T Consensus         5 l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L   76 (520)
T 2z7x_B            5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-----VFKFNQELEYLDL   76 (520)
T ss_dssp             EECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-----GGTTCTTCCEEEC
T ss_pred             EecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH-----HhhcccCCCEEec
Confidence            456677776 4565554  6677777777777766666677777777777777777665443     4666777777777


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCccccc-CCccccCCCCCCEEEccCCcCCcccCccccCCCCC--CEEEccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS-IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKL--QLLSLEDNQ  157 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~  157 (599)
                      ++|+|+.+.+.   .++ .|++|++++|.+++. .|..|+++++|++|+|++|.+++   ..|..+++|  ++|++++|.
T Consensus        77 s~N~l~~lp~~---~l~-~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~  149 (520)
T 2z7x_B           77 SHNKLVKISCH---PTV-NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGE  149 (520)
T ss_dssp             CSSCCCEEECC---CCC-CCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECT
T ss_pred             CCCceeecCcc---ccC-CccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccc
Confidence            77777643332   343 466777777776653 45666677777777777666654   234444444  555555555


Q ss_pred             c--cccCChhhhcCC-----------------------------------------------------------------
Q 042902          158 L--EGSIPDDLCRLA-----------------------------------------------------------------  170 (599)
Q Consensus       158 l--~~~~~~~~~~l~-----------------------------------------------------------------  170 (599)
                      +  .+..|..+..+.                                                                 
T Consensus       150 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~  229 (520)
T 2z7x_B          150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN  229 (520)
T ss_dssp             TTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEE
T ss_pred             ccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccc
Confidence            5  333333333211                                                                 


Q ss_pred             ------------------CCcEEEeeCCccCCCCCccc------------------------------------------
Q 042902          171 ------------------ALFLLDLGGNKLSGFVPACF------------------------------------------  190 (599)
Q Consensus       171 ------------------~L~~L~Ls~N~l~~~~~~~~------------------------------------------  190 (599)
                                        +|++|++++|++++..|..+                                          
T Consensus       230 ~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l  309 (520)
T 2z7x_B          230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV  309 (520)
T ss_dssp             EEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEE
T ss_pred             cccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEc
Confidence                              45555555555554444333                                          


Q ss_pred             -----------CCCCCCcEeecCCCCCCC-CCccccCCCcccEEeecCCCccc--cCcccccccccccEEEccCCccCCC
Q 042902          191 -----------GNLTSLRNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTG--PLPLEIGNLRVLVQIDLSMNNFSGF  256 (599)
Q Consensus       191 -----------~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~  256 (599)
                                 ..+++|++|++++|+++. +|..+..+++|++|++++|++++  ..|..+..+++|+.|+|++|.+++.
T Consensus       310 ~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~  389 (520)
T 2z7x_B          310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD  389 (520)
T ss_dssp             ESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred             CCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence                       566777788888887775 56677777788888888888776  3456677778888888888888773


Q ss_pred             CC-ccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC-CCC
Q 042902          257 IP-TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR-EGP  334 (599)
Q Consensus       257 ~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~  334 (599)
                      +| ..+..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...
T Consensus       390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~  466 (520)
T 2z7x_B          390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR  466 (520)
T ss_dssp             GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence            34 3477778888888888888766666554  67888888888888 6777777888888888888888853333 344


Q ss_pred             CCCcccccccCCCCCcCCC
Q 042902          335 FRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       335 ~~~~~~~~~~~n~~~c~~~  353 (599)
                      +..+...++.+|++.|.|+
T Consensus       467 l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          467 LTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CTTCCEEECCSSCBCCCHH
T ss_pred             CCcccEEECcCCCCcccCC
Confidence            5667777788888877654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=7.5e-41  Score=375.40  Aligned_cols=353  Identities=24%  Similarity=0.265  Sum_probs=278.8

Q ss_pred             CccCCCcCccCCCCCCcCCCC--CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCc---------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASK--LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL---------------   63 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------   63 (599)
                      |+|++|++++..|..|.+++.  |++|+|++|+++++.|..|+++++|++|+|++|++++..+..               
T Consensus       227 L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~  306 (680)
T 1ziw_A          227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS  306 (680)
T ss_dssp             EECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTC
T ss_pred             EEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccch
Confidence            356667777666666666543  777777777777666666777777777777777666554321               


Q ss_pred             ---------ccc----cccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCccc--ccCCccccCC--CCCCE
Q 042902           64 ---------NFL----SSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS--GSIPEEISNL--TNLTT  126 (599)
Q Consensus        64 ---------~~~----~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~--~~~~~~~~~l--~~L~~  126 (599)
                               ...    ..|..+++|++|++++|.++++.+..|.+++ .|+.|++++|.+.  ......|..+  ++|++
T Consensus       307 ~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~  385 (680)
T 1ziw_A          307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI  385 (680)
T ss_dssp             BCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCE
T ss_pred             hhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCce
Confidence                     000    0355666677777777777766666666665 3677777766532  2223334332  46777


Q ss_pred             EEccCCcCCcccCccccCCCCCCEEEcccccccccCC-hhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCC
Q 042902          127 IYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQ  205 (599)
Q Consensus       127 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  205 (599)
                      |+|++|+++++.|.+|..+++|++|+|++|.+.+.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.
T Consensus       386 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~  465 (680)
T 1ziw_A          386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA  465 (680)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence            7778888888888899999999999999999987555 688999999999999999998889999999999999999999


Q ss_pred             CC---CCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC--------ccccCccccccccccc
Q 042902          206 LT---SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP--------TTIGDLKDLQYLFLEY  274 (599)
Q Consensus       206 l~---~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~L~~  274 (599)
                      ++   .+|..+..+++|++|++++|++++..+..|.++++|+.|+|++|.+++..+        ..|.++++|++|+|++
T Consensus       466 l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~  545 (680)
T 1ziw_A          466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES  545 (680)
T ss_dssp             CBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCS
T ss_pred             ccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCC
Confidence            86   467889999999999999999999888899999999999999999987532        2478999999999999


Q ss_pred             ccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCC--CCCCcccccccCCCCCcCC
Q 042902          275 NRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREG--PFRNFSAESFKGNELLCGT  352 (599)
Q Consensus       275 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~  352 (599)
                      |+++.+.+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++.+|...  .+..+...++.+|||.|+|
T Consensus       546 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c  625 (680)
T 1ziw_A          546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC  625 (680)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred             CCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence            99997777789999999999999999998888888999999999999999998776532  4677888899999999998


Q ss_pred             CC
Q 042902          353 PN  354 (599)
Q Consensus       353 ~~  354 (599)
                      +.
T Consensus       626 ~~  627 (680)
T 1ziw_A          626 ES  627 (680)
T ss_dssp             CC
T ss_pred             cc
Confidence            73

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.1e-40  Score=365.46  Aligned_cols=345  Identities=21%  Similarity=0.207  Sum_probs=184.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCc-----------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL-----------------   63 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----------------   63 (599)
                      |+|++|++++..|..|.++++|++|+|++|+++++.|.+|+++++|++|+|++|+++.+++..                 
T Consensus        62 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l  141 (606)
T 3t6q_A           62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI  141 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCC
T ss_pred             EECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcc
Confidence            355666666655666666666666666666666555555666666666666555555542210                 


Q ss_pred             c--cccccCCCCCCcEEEcccCcccccCChhhhcccccce--EEEccCCccccc--------------------------
Q 042902           64 N--FLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME--VFFMFNCNISGS--------------------------  113 (599)
Q Consensus        64 ~--~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~--~l~l~~n~i~~~--------------------------  113 (599)
                      .  ....+..+++|++|++++|.++++.|..|..+++ ++  .+++++|.+.+.                          
T Consensus       142 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~  220 (606)
T 3t6q_A          142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ-ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK  220 (606)
T ss_dssp             CCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTT-CCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHH
T ss_pred             cccCcccccCCcccCEEEcccCcccccChhhhhhhcc-cceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhh
Confidence            0  0012333556666666666666555555555442 33  344444444333                          


Q ss_pred             -------------------------------------------------CCccccCCCCCCEEEccCCcCCcccCccccC
Q 042902          114 -------------------------------------------------IPEEISNLTNLTTIYLGGNKLNGSIPIALDK  144 (599)
Q Consensus       114 -------------------------------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  144 (599)
                                                                       .+..|.++++|++|+|++|.++ .+|..+..
T Consensus       221 ~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~  299 (606)
T 3t6q_A          221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG  299 (606)
T ss_dssp             HTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCS
T ss_pred             hccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcc
Confidence                                                             3333444555555555555555 33444555


Q ss_pred             CCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCC-CcccCCCCCCcEeecCCCCCCCC---CccccCCCccc
Q 042902          145 LQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFV-PACFGNLTSLRNLYLGSNQLTSI---PSTLWNLKYIL  220 (599)
Q Consensus       145 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~i---p~~~~~l~~L~  220 (599)
                      +++|++|++++|.+.+..|..+..+++|++|++++|.+.+.. +..|..+++|++|++++|.++.+   |..+..+++|+
T Consensus       300 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~  379 (606)
T 3t6q_A          300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ  379 (606)
T ss_dssp             CTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCC
T ss_pred             cccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCC
Confidence            555555555555555555555555555555555555554332 23355555555555555555543   34455555566


Q ss_pred             EEeecCCCccccCcccccccccccEEEccCCccCCCCCc-cccCcccccccccccccccccCcccccCCCCcccccCCCC
Q 042902          221 YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT-TIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN  299 (599)
Q Consensus       221 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  299 (599)
                      +|++++|.+++..|..|..+++|+.|++++|.+++..+. .+..+++|++|++++|.+++..|..+..+++|++|++++|
T Consensus       380 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n  459 (606)
T 3t6q_A          380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN  459 (606)
T ss_dssp             EEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTC
T ss_pred             EEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCC
Confidence            666666665555555555556666666666665544333 2555566666666666665555555555666666666666


Q ss_pred             ccccc---CCchhhccccceEEEcccccCcccCCCC-CCCCCcccccccCCC
Q 042902          300 NISGA---IPISLEKLLDLKYINVSFNKLEGEIPRE-GPFRNFSAESFKGNE  347 (599)
Q Consensus       300 ~l~~~---~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  347 (599)
                      ++++.   .+..+..+++|+.|++++|++++.+|.. ..+..+...++.+|.
T Consensus       460 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  511 (606)
T 3t6q_A          460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR  511 (606)
T ss_dssp             BCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence            55541   2244555556666666666665554432 334444455555554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=358.45  Aligned_cols=324  Identities=21%  Similarity=0.172  Sum_probs=294.3

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+++.+++.     .|.++++|++|+|
T Consensus        37 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  111 (477)
T 2id5_A           37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG-----VFTGLSNLTKLDI  111 (477)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT-----SSTTCTTCCEEEC
T ss_pred             EECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc-----cccCCCCCCEEEC
Confidence            68999999999999999999999999999999999999999999999999999999998875     5899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.|+++.+..|..++ .|+.|++++|.+.+..+..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|.+.+
T Consensus       112 s~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          112 SENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             TTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             CCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            99999999999999997 59999999999999999999999999999999999998888889999999999999999999


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGN  239 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  239 (599)
                      ..+..|..+++|+.|++++|.+.+..+.......+|++|++++|.++.+|. .+..+++|+.|+|++|.+++..+..|.+
T Consensus       191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  270 (477)
T 2id5_A          191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE  270 (477)
T ss_dssp             ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred             eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence            988899999999999999998877777666666799999999999999985 6788999999999999999998999999


Q ss_pred             cccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEE
Q 042902          240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYIN  319 (599)
Q Consensus       240 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~  319 (599)
                      +++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++...+.. .-...+..++
T Consensus       271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~-~~~~~~~~~~  349 (477)
T 2id5_A          271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL-WVFRRRWRLN  349 (477)
T ss_dssp             CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH-HHHTTTTSSC
T ss_pred             cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH-hHHhhhhccc
Confidence            999999999999999999999999999999999999999988889999999999999999998543322 1122333455


Q ss_pred             cccccCcccCCC
Q 042902          320 VSFNKLEGEIPR  331 (599)
Q Consensus       320 l~~N~l~~~~p~  331 (599)
                      +.++...|..|.
T Consensus       350 ~~~~~~~C~~p~  361 (477)
T 2id5_A          350 FNRQQPTCATPE  361 (477)
T ss_dssp             CTTCCCBEEESG
T ss_pred             cCccCceeCCch
Confidence            667777766664

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.9e-40  Score=367.08  Aligned_cols=210  Identities=22%  Similarity=0.187  Sum_probs=190.5

Q ss_pred             CCCCCCEEEccCCcCCcc--cCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCC-cccCCCCCC
Q 042902          120 NLTNLTTIYLGGNKLNGS--IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVP-ACFGNLTSL  196 (599)
Q Consensus       120 ~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L  196 (599)
                      .+++|++|+|++|.+++.  .|..+..+++|++|++++|.+.+ +|..+..+++|+.|++++|++++..+ ..|..+++|
T Consensus       348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  426 (606)
T 3vq2_A          348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL  426 (606)
T ss_dssp             CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred             cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence            455667777777777755  37788999999999999999985 56889999999999999999998887 789999999


Q ss_pred             cEeecCCCCCCC-CCccccCCCcccEEeecCCCccc-cCcccccccccccEEEccCCccCCCCCccccCccccccccccc
Q 042902          197 RNLYLGSNQLTS-IPSTLWNLKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEY  274 (599)
Q Consensus       197 ~~L~L~~N~l~~-ip~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  274 (599)
                      ++|++++|.++. .|..+..+++|++|++++|.+++ ..|..|..+++|+.|+|++|.+++..|..|+++++|++|+|++
T Consensus       427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  506 (606)
T 3vq2_A          427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH  506 (606)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence            999999999996 46788899999999999999998 4788999999999999999999999999999999999999999


Q ss_pred             ccccccCcccccCCCCcccccCCCCcccccCCchhhccc-cceEEEcccccCcccCCC
Q 042902          275 NRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL-DLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       275 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~p~  331 (599)
                      |++++..|..|..+++|+.|+|++|+++ .+|..+..++ +|++|++++|++.|.++.
T Consensus       507 N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          507 NNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             SCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            9999999999999999999999999999 6777799997 599999999999998875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.4e-40  Score=359.93  Aligned_cols=316  Identities=21%  Similarity=0.215  Sum_probs=274.3

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+|+++.|++|.++++|++|+|++|+|+.++..        .+++|++|+|
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--------~l~~L~~L~L  128 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--------PMASLRHLDL  128 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--------CCTTCSEEEC
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--------ccccCCEEEC
Confidence            68999999988889999999999999999999999999999999999999999999987752        7899999999


Q ss_pred             ccCcccccC-ChhhhcccccceEEEccCCcccccCCccccCCCCC--CEEEccCCcC--CcccCccccCCC---------
Q 042902           81 SNNSLDGIL-PRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL--TTIYLGGNKL--NGSIPIALDKLQ---------  146 (599)
Q Consensus        81 s~N~i~~~~-~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~---------  146 (599)
                      ++|+|+++. |..|.+++ .|+.|++++|.+++.   .+.++++|  ++|+|++|.+  ++..|..|..+.         
T Consensus       129 s~N~l~~l~~p~~~~~l~-~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~  204 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH  204 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCT-TCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred             CCCCccccCchHhhcccC-cccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence            999999754 68999997 599999999999864   34555555  9999999988  666666665543         


Q ss_pred             ------------------------------------------------------------------------CCCEEEcc
Q 042902          147 ------------------------------------------------------------------------KLQLLSLE  154 (599)
Q Consensus       147 ------------------------------------------------------------------------~L~~L~L~  154 (599)
                                                                                              +|++|+++
T Consensus       205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~  284 (562)
T 3a79_B          205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY  284 (562)
T ss_dssp             SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEE
T ss_pred             CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEe
Confidence                                                                                    67788888


Q ss_pred             cccccccCChhh-----------------------------------------------------hcCCCCcEEEeeCCc
Q 042902          155 DNQLEGSIPDDL-----------------------------------------------------CRLAALFLLDLGGNK  181 (599)
Q Consensus       155 ~N~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~Ls~N~  181 (599)
                      +|.+.+.+|..+                                                     ..+++|++|++++|+
T Consensus       285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~  364 (562)
T 3a79_B          285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV  364 (562)
T ss_dssp             EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSC
T ss_pred             ccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCc
Confidence            888876666544                                                     677899999999999


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCC---ccccCCCcccEEeecCCCccc-cCcccccccccccEEEccCCccCCCC
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIP---STLWNLKYILYLNLSSNSFTG-PLPLEIGNLRVLVQIDLSMNNFSGFI  257 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip---~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~  257 (599)
                      +++..|..|..+++|++|++++|+++.++   ..+..+++|++|++++|.+++ ..+..+..+++|+.|+|++|++++..
T Consensus       365 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  444 (562)
T 3a79_B          365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV  444 (562)
T ss_dssp             CCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG
T ss_pred             cccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch
Confidence            99989999999999999999999999876   468899999999999999998 44456899999999999999999877


Q ss_pred             CccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      |..+.  ++|++|+|++|+++ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.+|.
T Consensus       445 ~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             GSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             hhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            76654  79999999999999 5666666999999999999999954444499999999999999999998764

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=365.48  Aligned_cols=325  Identities=22%  Similarity=0.268  Sum_probs=266.6

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+++++.|++|+++++|++|+|++|+++.+++.     .++++++|++|++
T Consensus        57 L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-----~~~~l~~L~~L~L  131 (570)
T 2z63_A           57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNV  131 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTC-----SCTTCTTCCEEEC
T ss_pred             EECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCc-----cccccccccEEec
Confidence            57888999888888888899999999999999888888889999999999999988887753     3677777777888


Q ss_pred             ccCccccc-CChhhhcccccceEEEccCCcccccCCccccC---------------------------------------
Q 042902           81 SNNSLDGI-LPRAIGNLSQSMEVFFMFNCNISGSIPEEISN---------------------------------------  120 (599)
Q Consensus        81 s~N~i~~~-~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~---------------------------------------  120 (599)
                      ++|.++++ .|..|.+++ .|+.|++++|.+++..+..|..                                       
T Consensus       132 ~~n~l~~~~lp~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n  210 (570)
T 2z63_A          132 AHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN  210 (570)
T ss_dssp             CSSCCCCCCCCGGGGGCT-TCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             CCCccceecChhhhcccC-CCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence            77777763 477777775 3777777777665544433333                                       


Q ss_pred             ----------------------------------------------------------------------CCCCCEEEcc
Q 042902          121 ----------------------------------------------------------------------LTNLTTIYLG  130 (599)
Q Consensus       121 ----------------------------------------------------------------------l~~L~~L~L~  130 (599)
                                                                                            +++|++|+++
T Consensus       211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~  290 (570)
T 2z63_A          211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV  290 (570)
T ss_dssp             CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred             cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence                                                                                  3444444444


Q ss_pred             CCcCCcccCccc------------------------------------------cCCCCCCEEEcccccccccC--Chhh
Q 042902          131 GNKLNGSIPIAL------------------------------------------DKLQKLQLLSLEDNQLEGSI--PDDL  166 (599)
Q Consensus       131 ~N~l~~~~~~~~------------------------------------------~~l~~L~~L~L~~N~l~~~~--~~~~  166 (599)
                      +|.+++ +|..+                                          ..+++|++|++++|.+.+..  +..+
T Consensus       291 ~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~  369 (570)
T 2z63_A          291 SVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD  369 (570)
T ss_dssp             SCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHH
T ss_pred             Cccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccc
Confidence            444442 22111                                          34566777777777776543  6778


Q ss_pred             hcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc--cccCCCcccEEeecCCCccccCccccccccccc
Q 042902          167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS--TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV  244 (599)
Q Consensus       167 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  244 (599)
                      ..+++|++|++++|.+++..+. |..+++|++|++++|.++.++.  .+..+++|++|++++|.+++..|..|.++++|+
T Consensus       370 ~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  448 (570)
T 2z63_A          370 FGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  448 (570)
T ss_dssp             HTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             cccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc
Confidence            8899999999999999876555 9999999999999999997643  678899999999999999999999999999999


Q ss_pred             EEEccCCccC-CCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccc
Q 042902          245 QIDLSMNNFS-GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFN  323 (599)
Q Consensus       245 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  323 (599)
                      .|+|++|.++ +.+|..+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|..|..+++|+.|++++|
T Consensus       449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  528 (570)
T 2z63_A          449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN  528 (570)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence            9999999998 578899999999999999999999999999999999999999999999998889999999999999999


Q ss_pred             cCcccCCCCC
Q 042902          324 KLEGEIPREG  333 (599)
Q Consensus       324 ~l~~~~p~~~  333 (599)
                      +++|.+|...
T Consensus       529 ~~~~~~~~~~  538 (570)
T 2z63_A          529 PWDCSCPRID  538 (570)
T ss_dssp             CBCCCTTTTH
T ss_pred             cccCCCcchH
Confidence            9999998753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.5e-40  Score=373.65  Aligned_cols=315  Identities=21%  Similarity=0.241  Sum_probs=217.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEc-cCcccccc--------------------------------------------
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLEL-EMNSFYGF--------------------------------------------   35 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L-~~n~i~~~--------------------------------------------   35 (599)
                      |+|++|+++|.+|..|.++++|+.|+| ++|.+.+.                                            
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~  407 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA  407 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence            578888999889988999999999999 66654333                                            


Q ss_pred             --------------------------------CCccccCCCCCCEEeccCccCcc------------------cCCCccc
Q 042902           36 --------------------------------IPNTFGNLRNLKRLSLNYNYLTS------------------STPKLNF   65 (599)
Q Consensus        36 --------------------------------~~~~~~~l~~L~~L~L~~N~l~~------------------~~~~~~~   65 (599)
                                                      +|..|+++++|++|+|++|+|++                  +|.    
T Consensus       408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~----  483 (876)
T 4ecn_A          408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE----  483 (876)
T ss_dssp             HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS----
T ss_pred             hhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh----
Confidence                                            67788888999999999998887                  554    


Q ss_pred             ccccC--CCCCCcEEEcccCcccccCChhhhcccccceEEEccCCc-ccc-cCCccccCCC-------CCCEEEccCCcC
Q 042902           66 LSSLS--NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCN-ISG-SIPEEISNLT-------NLTTIYLGGNKL  134 (599)
Q Consensus        66 ~~~~~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~-i~~-~~~~~~~~l~-------~L~~L~L~~N~l  134 (599)
                        .++  ++++|++|+|++|++.+.+|..|.+++ .|+.|++++|+ +++ .+|..+++++       +|++|+|++|.+
T Consensus       484 --~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~-~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          484 --ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP-ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             --CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCS-SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             --hhhhccCCCCCEEECcCCCCCccChHHHhCCC-CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence              345  888888888888888888888888887 48888888887 877 6776555444       888888888888


Q ss_pred             CcccCc--cccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCC-CcEeecCCCCCCCCCc
Q 042902          135 NGSIPI--ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTS-LRNLYLGSNQLTSIPS  211 (599)
Q Consensus       135 ~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~ip~  211 (599)
                      + .+|.  .|.++++|++|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++.+|.
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~  636 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN  636 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCch
Confidence            8 5666  7888888888888888888 666 7888888888888888888 56677888887 8888888888888887


Q ss_pred             cccCCCc--ccEEeecCCCccccCcccc---c--ccccccEEEccCCccCCCCCccccCcccccccccccccccccCccc
Q 042902          212 TLWNLKY--ILYLNLSSNSFTGPLPLEI---G--NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS  284 (599)
Q Consensus       212 ~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  284 (599)
                      .+..++.  |+.|+|++|++++.+|...   .  .+++|+.|+|++|.++.+.+..+..+++|+.|+|++|+++...+..
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~  716 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS  716 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence            6655443  7777777777765444221   1  2235555555555555332223334555555555555555222222


Q ss_pred             ccCC-------CCcccccCCCCcccccCCchhh--ccccceEEEcccccCcc
Q 042902          285 IGGL-------IDLKSLDLSNNNISGAIPISLE--KLLDLKYINVSFNKLEG  327 (599)
Q Consensus       285 ~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l~~  327 (599)
                      +...       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++
T Consensus       717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~  767 (876)
T 4ecn_A          717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS  767 (876)
T ss_dssp             SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred             hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc
Confidence            2211       14555555555555 4444443  45555555555555554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-40  Score=364.09  Aligned_cols=178  Identities=19%  Similarity=0.175  Sum_probs=107.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+|+++.|++|.++++|++|+|++|+++++++.     .|+++++|++|+|
T Consensus        31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L  105 (549)
T 2z81_A           31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-----WFGPLSSLKYLNL  105 (549)
T ss_dssp             EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-----HHTTCTTCCEEEC
T ss_pred             EECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-----HhccCCCCcEEEC
Confidence            46677777766666777777777777777777776666777777777777777777666543     3666677777777


Q ss_pred             ccCccccc-CChhhhcccccceEEEccCCc-ccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccc
Q 042902           81 SNNSLDGI-LPRAIGNLSQSMEVFFMFNCN-ISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL  158 (599)
Q Consensus        81 s~N~i~~~-~~~~~~~l~~~l~~l~l~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  158 (599)
                      ++|.+++. .|..|.+++ .|+.|++++|. +....+..|.++++|++|+|++|.+++..|..+..+++|++|++++|.+
T Consensus       106 s~n~l~~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~  184 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES  184 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCT-TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred             CCCcccccchhhhhhccC-CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence            77776653 345566665 36667776666 3433345666667777777777766666666655544444444444443


Q ss_pred             cccCChhhhcCCCCcEEEeeCCccCC
Q 042902          159 EGSIPDDLCRLAALFLLDLGGNKLSG  184 (599)
Q Consensus       159 ~~~~~~~~~~l~~L~~L~Ls~N~l~~  184 (599)
                      ....+..+..+++|++|++++|++++
T Consensus       185 ~~~~~~~~~~l~~L~~L~L~~n~l~~  210 (549)
T 2z81_A          185 AFLLEIFADILSSVRYLELRDTNLAR  210 (549)
T ss_dssp             TTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred             cccchhhHhhcccccEEEccCCcccc
Confidence            32111112334555555555555544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.2e-39  Score=362.31  Aligned_cols=347  Identities=23%  Similarity=0.285  Sum_probs=278.5

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |||++|+|++..|.+|.++++|++|+|++|+|+++.+++|++|++|++|+|++|+|+.+++.     .|.++++|++|+|
T Consensus        57 LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~-----~f~~L~~L~~L~L  131 (635)
T 4g8a_A           57 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQKLVA  131 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG-----GGTTCTTCCEEEC
T ss_pred             EEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH-----HhcCCCCCCEEEC
Confidence            68999999988888899999999999999999998888999999999999999999988865     5889999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCccccc-CCccccCCCCCCEEEccCCcCCcccCccccCCCC------------
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGS-IPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQK------------  147 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~------------  147 (599)
                      ++|+|+++.+.+|++++ .|+.|++++|.+++. .|..+.++++|++|+|++|+|++..+..|..+.+            
T Consensus       132 s~N~l~~l~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~  210 (635)
T 4g8a_A          132 VETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  210 (635)
T ss_dssp             TTSCCCCSTTCCCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             CCCcCCCCChhhhhcCc-ccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence            99999988888888887 499999999998764 5778888999999999999887665544432221            


Q ss_pred             --------------------------------------------------------------------------------
Q 042902          148 --------------------------------------------------------------------------------  147 (599)
Q Consensus       148 --------------------------------------------------------------------------------  147 (599)
                                                                                                      
T Consensus       211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence                                                                                            


Q ss_pred             ---------------------------------------CCEEEcccccccccCCh-------------------hhhcC
Q 042902          148 ---------------------------------------LQLLSLEDNQLEGSIPD-------------------DLCRL  169 (599)
Q Consensus       148 ---------------------------------------L~~L~L~~N~l~~~~~~-------------------~~~~l  169 (599)
                                                             |+.|++.+|.+....+.                   ....+
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l  370 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL  370 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred             hcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence                                                   22222222222211110                   11234


Q ss_pred             CCCcEEEeeCCccCCC-------------------------CCcccCCCCCCcEeecCCCCCCCCC--ccccCCCcccEE
Q 042902          170 AALFLLDLGGNKLSGF-------------------------VPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYL  222 (599)
Q Consensus       170 ~~L~~L~Ls~N~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~l~~ip--~~~~~l~~L~~L  222 (599)
                      ++|+.|++++|.+...                         .+..+..+++|+.+++++|.....+  ..+..+++++.+
T Consensus       371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l  450 (635)
T 4g8a_A          371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  450 (635)
T ss_dssp             TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred             cccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence            5677777777766421                         1234556677777777777666443  356678899999


Q ss_pred             eecCCCccccCcccccccccccEEEccCCcc-CCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcc
Q 042902          223 NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF-SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI  301 (599)
Q Consensus       223 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  301 (599)
                      +++.|.+.+..+..+..++.|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus       451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l  530 (635)
T 4g8a_A          451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  530 (635)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence            9999999999999999999999999999985 456788999999999999999999999999999999999999999999


Q ss_pred             cccCCchhhccccceEEEcccccCcccCCCC-CCC-CCcccccccCCCCCcCCC
Q 042902          302 SGAIPISLEKLLDLKYINVSFNKLEGEIPRE-GPF-RNFSAESFKGNELLCGTP  353 (599)
Q Consensus       302 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~~~  353 (599)
                      ++..|..|..+++|++|++++|++++.+|.. ..+ ..+...++.+|||.|+|.
T Consensus       531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            9999999999999999999999999988865 233 567788999999999875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7e-40  Score=369.95  Aligned_cols=340  Identities=16%  Similarity=0.206  Sum_probs=293.1

Q ss_pred             CccCCCcCcc-----------------CCCCCCc--CCCCCCEEEccCccccccCCccccCCCCCCEEeccCcc-Ccc--
Q 042902            1 LLLWGNNFSG-----------------TIPSFIF--NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNY-LTS--   58 (599)
Q Consensus         1 L~L~~n~~~~-----------------~~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~--   58 (599)
                      |+|++|++++                 .+|..+.  ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ ++.  
T Consensus       453 L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~  532 (876)
T 4ecn_A          453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ  532 (876)
T ss_dssp             EEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHH
T ss_pred             EECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCccccc
Confidence            6789999998                 4899987  99999999999999999999999999999999999998 875  


Q ss_pred             cCCCccccc-ccCCCCCCcEEEcccCcccccCCh--hhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCC
Q 042902           59 STPKLNFLS-SLSNCKYLKYLSFSNNSLDGILPR--AIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN  135 (599)
Q Consensus        59 ~~~~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~--~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~  135 (599)
                      +|..+..+. .+..+++|++|+|++|.|+ .+|.  .|.+++ .|+.|++++|+++ .+| .|.++++|++|+|++|.++
T Consensus       533 iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~  608 (876)
T 4ecn_A          533 LKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE  608 (876)
T ss_dssp             HHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS
T ss_pred             chHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc
Confidence            444322222 4567779999999999999 6677  899997 5999999999999 677 8999999999999999999


Q ss_pred             cccCccccCCCC-CCEEEcccccccccCChhhhcCCC--CcEEEeeCCccCCCCCccc---C--CCCCCcEeecCCCCCC
Q 042902          136 GSIPIALDKLQK-LQLLSLEDNQLEGSIPDDLCRLAA--LFLLDLGGNKLSGFVPACF---G--NLTSLRNLYLGSNQLT  207 (599)
Q Consensus       136 ~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~  207 (599)
                       .+|..+..+++ |++|+|++|.++ .+|..+..++.  |+.|+|++|++++.+|...   .  .+++|+.|+|++|.++
T Consensus       609 -~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~  686 (876)
T 4ecn_A          609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ  686 (876)
T ss_dssp             -CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC
T ss_pred             -cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC
Confidence             77888999999 999999999999 67888877654  9999999999998766433   2  3458999999999999


Q ss_pred             CCCcccc-CCCcccEEeecCCCccccCcccccc-------cccccEEEccCCccCCCCCcccc--Ccccccccccccccc
Q 042902          208 SIPSTLW-NLKYILYLNLSSNSFTGPLPLEIGN-------LRVLVQIDLSMNNFSGFIPTTIG--DLKDLQYLFLEYNRL  277 (599)
Q Consensus       208 ~ip~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l  277 (599)
                      .+|..++ .+++|+.|+|++|+++.+.+..+..       +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++
T Consensus       687 ~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L  765 (876)
T 4ecn_A          687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF  765 (876)
T ss_dssp             SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCC
T ss_pred             ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCC
Confidence            9998765 7899999999999999544444443       349999999999999 5677776  999999999999999


Q ss_pred             cccCcccccCCCCcccccCCC------CcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCc
Q 042902          278 QGSIPDSIGGLIDLKSLDLSN------NNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLC  350 (599)
Q Consensus       278 ~~~~~~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  350 (599)
                      ++ +|..+..+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|... ...+...++.+|++..
T Consensus       766 ~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l-~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          766 SS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL-TPQLYILDIADNPNIS  841 (876)
T ss_dssp             SS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CSSSCEEECCSCTTCE
T ss_pred             Cc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhh-cCCCCEEECCCCCCCc
Confidence            97 788899999999999976      889999999999999999999999999 6777752 3577788888887643

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=358.10  Aligned_cols=316  Identities=22%  Similarity=0.274  Sum_probs=263.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+|+++.|++|+++++|++|+|++|+|+.++.       . .+++|++|+|
T Consensus        26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-------~-~l~~L~~L~L   97 (520)
T 2z7x_B           26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC-------H-PTVNLKHLDL   97 (520)
T ss_dssp             EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEEC-------C-CCCCCSEEEC
T ss_pred             EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCc-------c-ccCCccEEec
Confidence            6899999998888899999999999999999999989999999999999999999997764       2 7889999999


Q ss_pred             ccCccccc-CChhhhcccccceEEEccCCcccccCCccccCCCCC--CEEEccCCcC--CcccCccccCCC---------
Q 042902           81 SNNSLDGI-LPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL--TTIYLGGNKL--NGSIPIALDKLQ---------  146 (599)
Q Consensus        81 s~N~i~~~-~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~---------  146 (599)
                      ++|.|+++ .|..|++++ .|+.|++++|.+++   ..+..+++|  ++|+|++|.+  .+..|..+..+.         
T Consensus        98 ~~N~l~~~~~p~~~~~l~-~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~  173 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMS-QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP  173 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCT-TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred             cCCccccccchhhhccCC-cceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence            99999874 678888887 48888888888875   345555555  6677766666  444444444322         


Q ss_pred             --------------------------------------------------------------------------CCCEEE
Q 042902          147 --------------------------------------------------------------------------KLQLLS  152 (599)
Q Consensus       147 --------------------------------------------------------------------------~L~~L~  152 (599)
                                                                                                +|++|+
T Consensus       174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~  253 (520)
T 2z7x_B          174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS  253 (520)
T ss_dssp             SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred             cCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence                                                                                      556666


Q ss_pred             cccccccccCChhh-----------------------------------------------------hcCCCCcEEEeeC
Q 042902          153 LEDNQLEGSIPDDL-----------------------------------------------------CRLAALFLLDLGG  179 (599)
Q Consensus       153 L~~N~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~Ls~  179 (599)
                      +++|++.+.+|..+                                                     ..+++|++|++++
T Consensus       254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~  333 (520)
T 2z7x_B          254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN  333 (520)
T ss_dssp             EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCS
T ss_pred             eecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeEC
Confidence            66666554444433                                                     5678999999999


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCC---CccccCCCcccEEeecCCCccccCcc-cccccccccEEEccCCccCC
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSI---PSTLWNLKYILYLNLSSNSFTGPLPL-EIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i---p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      |++++..|..+..+++|++|++++|+++.+   |..+..+++|++|++++|.+++.+|. .+..+++|+.|++++|.+++
T Consensus       334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~  413 (520)
T 2z7x_B          334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD  413 (520)
T ss_dssp             SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred             CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence            999998899999999999999999999964   46788999999999999999984554 58899999999999999998


Q ss_pred             CCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC
Q 042902          256 FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       256 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      ..|..+.  ++|++|+|++|+++ .+|..+..+++|+.|++++|+++...+..+..+++|+.|++++|+++|.++.
T Consensus       414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            8777665  79999999999999 6777777999999999999999954444589999999999999999998763

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=372.15  Aligned_cols=345  Identities=22%  Similarity=0.208  Sum_probs=232.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCcc-ccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEE
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNS-FYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLS   79 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~   79 (599)
                      |+|++|++++..|..|.++++|++|+|++|. +..+.|.+|+++++|++|+|++|.|+.+.+.     .|+++++|++|+
T Consensus        29 LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-----~~~~l~~L~~L~  103 (844)
T 3j0a_A           29 LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-----AFQGLFHLFELR  103 (844)
T ss_dssp             EEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-----SSCSCSSCCCEE
T ss_pred             EECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-----HccCCcccCEee
Confidence            4677777777666666666666666666663 3334466666666666666666666665443     456666666666


Q ss_pred             cccCcccccCChh--hhcccccceEEEccCCcccccCC-ccccCCCCCCEEEccCCcCCcccCccccC------------
Q 042902           80 FSNNSLDGILPRA--IGNLSQSMEVFFMFNCNISGSIP-EEISNLTNLTTIYLGGNKLNGSIPIALDK------------  144 (599)
Q Consensus        80 Ls~N~i~~~~~~~--~~~l~~~l~~l~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------  144 (599)
                      |++|.+++..|..  |.+++ .|+.|++++|.+++..+ ..|+++++|++|+|++|.+++..+..+..            
T Consensus       104 Ls~n~l~~~~~~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          104 LYFCGLSDAVLKDGYFRNLK-ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             CTTCCCSSCCSTTCCCSSCS-SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred             CcCCCCCcccccCccccccC-CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence            6666665543333  55554 36666666666655443 34556666666666665554433322211            


Q ss_pred             --------------------------------------------------------------------------------
Q 042902          145 --------------------------------------------------------------------------------  144 (599)
Q Consensus       145 --------------------------------------------------------------------------------  144 (599)
                                                                                                      
T Consensus       183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~  262 (844)
T 3j0a_A          183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG  262 (844)
T ss_dssp             CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred             CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence                                                                                            


Q ss_pred             --CCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCC-CccccCCCcccE
Q 042902          145 --LQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILY  221 (599)
Q Consensus       145 --l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~  221 (599)
                        .++|++|+|++|.+.+..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|.++.+ |..+..+++|+.
T Consensus       263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence              13566666666666666666777778888888888888877777888888888888888888766 557778888888


Q ss_pred             EeecCCCccccCcccccccccccEEEccCCccCCCCC----------------------------------------ccc
Q 042902          222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP----------------------------------------TTI  261 (599)
Q Consensus       222 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----------------------------------------~~~  261 (599)
                      |++++|.+++..+..|.++++|+.|+|++|.+++...                                        ..+
T Consensus       343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~  422 (844)
T 3j0a_A          343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL  422 (844)
T ss_dssp             EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHH
T ss_pred             EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhh
Confidence            8888888887777778888888888888887764311                                        012


Q ss_pred             cCcccccccccccccccc------------------------------cCcccccCCCCcccccCCCCcccccCCchhhc
Q 042902          262 GDLKDLQYLFLEYNRLQG------------------------------SIPDSIGGLIDLKSLDLSNNNISGAIPISLEK  311 (599)
Q Consensus       262 ~~l~~L~~L~L~~N~l~~------------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  311 (599)
                      ..+++|++|+|++|++++                              ..+..|..+++|+.|+|++|++++..|..|..
T Consensus       423 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  502 (844)
T 3j0a_A          423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH  502 (844)
T ss_dssp             TTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred             hcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence            245555555555555542                              22345777889999999999999988999999


Q ss_pred             cccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCC
Q 042902          312 LLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGT  352 (599)
Q Consensus       312 l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  352 (599)
                      +++|+.|+|++|++++.+|...+ ..+...++.+|......
T Consensus       503 l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~  542 (844)
T 3j0a_A          503 LTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN  542 (844)
T ss_dssp             CCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred             hhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence            99999999999999987766544 66777777777654433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9.1e-39  Score=358.48  Aligned_cols=326  Identities=21%  Similarity=0.230  Sum_probs=284.9

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccc---------------------------------cCCCCCC
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTF---------------------------------GNLRNLK   47 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---------------------------------~~l~~L~   47 (599)
                      |+|++|++++..|..|..+++|++|+|++|+++++.|.+|                                 ..+++|+
T Consensus       253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~  332 (680)
T 1ziw_A          253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE  332 (680)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCC
T ss_pred             EECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCC
Confidence            5788888888888888888888888888888887766544                                 4455666


Q ss_pred             EEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc--ccCChhhhccc-ccceEEEccCCcccccCCccccCCCCC
Q 042902           48 RLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD--GILPRAIGNLS-QSMEVFFMFNCNISGSIPEEISNLTNL  124 (599)
Q Consensus        48 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~~~~~~~l~-~~l~~l~l~~n~i~~~~~~~~~~l~~L  124 (599)
                      +|+|++|+++.+++.     .|.++++|++|++++|.++  .+.+..|..+. ..++.+++++|++++..|..|.++++|
T Consensus       333 ~L~l~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L  407 (680)
T 1ziw_A          333 HLNMEDNDIPGIKSN-----MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL  407 (680)
T ss_dssp             EEECCSCCBCCCCTT-----TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             EEECCCCccCCCChh-----HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence            666667777776654     5899999999999999853  44455565543 369999999999999999999999999


Q ss_pred             CEEEccCCcCCcccC-ccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccC--CCCCcccCCCCCCcEeec
Q 042902          125 TTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS--GFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       125 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L  201 (599)
                      ++|+|++|.+.+.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|+.|++
T Consensus       408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~L  487 (680)
T 1ziw_A          408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL  487 (680)
T ss_dssp             CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEEC
T ss_pred             CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEEC
Confidence            999999999987554 78999999999999999999999999999999999999999997  567889999999999999


Q ss_pred             CCCCCCCCCc-cccCCCcccEEeecCCCccccCc--------ccccccccccEEEccCCccCCCCCccccCccccccccc
Q 042902          202 GSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLP--------LEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFL  272 (599)
Q Consensus       202 ~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  272 (599)
                      ++|+++.+|. .+.++++|++|++++|++++..+        ..|.++++|+.|+|++|+++.+.+..|.++++|+.|+|
T Consensus       488 s~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L  567 (680)
T 1ziw_A          488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL  567 (680)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeEC
Confidence            9999999876 57889999999999999987532        23788999999999999999777778999999999999


Q ss_pred             ccccccccCcccccCCCCcccccCCCCcccccCCchhh-ccccceEEEcccccCcccCCC
Q 042902          273 EYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLE-KLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       273 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      ++|++++..+..|..+++|+.|+|++|++++..|..+. .+++|+.|++++|++.|.++.
T Consensus       568 s~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            99999988888899999999999999999998888887 799999999999999999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.3e-39  Score=334.79  Aligned_cols=313  Identities=19%  Similarity=0.229  Sum_probs=257.9

Q ss_pred             CCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccc
Q 042902           18 NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS   97 (599)
Q Consensus        18 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~   97 (599)
                      .+++++.|++++|.++.+.+..|..+++|++|+|++|.++.+++.     .|..+++|++|+|++|.|+++.|..|.+++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  117 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHVFQNVP  117 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChh-----hccCCCCcCEEECCCCCCCcCCHHHhcCCC
Confidence            458899999999999988777789999999999999999888764     588899999999999999988888888887


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEe
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL  177 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  177 (599)
                       .|+.|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|++++|++++.   .+..+++|+.|++
T Consensus       118 -~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l  193 (390)
T 3o6n_A          118 -LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV  193 (390)
T ss_dssp             -TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEEC
T ss_pred             -CCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeec
Confidence             599999999999877777788999999999999999988888899999999999999998865   3567788899999


Q ss_pred             eCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCC
Q 042902          178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI  257 (599)
Q Consensus       178 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  257 (599)
                      ++|.+++.     ...++|++|++++|.++.+|...  .++|+.|++++|.+++.  ..+..+++|+.|+|++|.+++..
T Consensus       194 ~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~  264 (390)
T 3o6n_A          194 SYNLLSTL-----AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM  264 (390)
T ss_dssp             CSSCCSEE-----ECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE
T ss_pred             cccccccc-----CCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcC
Confidence            99888753     33467888888888888776543  46788888888888864  56788888888888888888888


Q ss_pred             CccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCC
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRN  337 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~  337 (599)
                      |..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++...  ...+..
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~  340 (390)
T 3o6n_A          265 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHT  340 (390)
T ss_dssp             SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCC
T ss_pred             hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhcc
Confidence            8888888888888888888885 4556677888888888888888 56667788888888888888887553  345667


Q ss_pred             cccccccCCCCCcCC
Q 042902          338 FSAESFKGNELLCGT  352 (599)
Q Consensus       338 ~~~~~~~~n~~~c~~  352 (599)
                      +...++.+|++.|.+
T Consensus       341 L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          341 LKNLTLSHNDWDCNS  355 (390)
T ss_dssp             CSEEECCSSCEEHHH
T ss_pred             CCEEEcCCCCccchh
Confidence            777888888887754

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.1e-38  Score=348.82  Aligned_cols=338  Identities=23%  Similarity=0.260  Sum_probs=236.9

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++..|..|.++++|++|+|++|+++++.+..|+++++|++|+|++|+++.++..    ..++++++|++|++
T Consensus        55 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----~~~~~l~~L~~L~L  130 (549)
T 2z81_A           55 LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT----SLFPNLTNLQTLRI  130 (549)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSS----CSCTTCTTCCEEEE
T ss_pred             EECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchh----hhhhccCCccEEEC
Confidence            68999999999999999999999999999999998888899999999999999999875421    25889999999999


Q ss_pred             ccCc-ccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccc
Q 042902           81 SNNS-LDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE  159 (599)
Q Consensus        81 s~N~-i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  159 (599)
                      ++|. +..+.+.+|.+++ .|+.|++++|.+++..|..+.++++|++|++++|.+....+..+..+++|++|++++|++.
T Consensus       131 ~~n~~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~  209 (549)
T 2z81_A          131 GNVETFSEIRRIDFAGLT-SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA  209 (549)
T ss_dssp             EESSSCCEECTTTTTTCC-EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCT
T ss_pred             CCCccccccCHhhhhccc-ccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccc
Confidence            9998 5656567888887 5999999999999988888876655555555554443222222233444444444444433


Q ss_pred             c-------------------------------------------------------------------------------
Q 042902          160 G-------------------------------------------------------------------------------  160 (599)
Q Consensus       160 ~-------------------------------------------------------------------------------  160 (599)
                      +                                                                               
T Consensus       210 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~  289 (549)
T 2z81_A          210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR  289 (549)
T ss_dssp             TCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEE
T ss_pred             cccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccccc
Confidence            2                                                                               


Q ss_pred             ----------------------------------cCChhh-hcCCCCcEEEeeCCccCCCCC---cccCCCCCCcEeecC
Q 042902          161 ----------------------------------SIPDDL-CRLAALFLLDLGGNKLSGFVP---ACFGNLTSLRNLYLG  202 (599)
Q Consensus       161 ----------------------------------~~~~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~  202 (599)
                                                        .+|..+ ..+++|++|++++|++++..|   ..++.+++|++|+++
T Consensus       290 ~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls  369 (549)
T 2z81_A          290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS  369 (549)
T ss_dssp             SCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECT
T ss_pred             ccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEcc
Confidence                                              122222 345556666666666554332   224555566666666


Q ss_pred             CCCCCCCC---ccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccc
Q 042902          203 SNQLTSIP---STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG  279 (599)
Q Consensus       203 ~N~l~~ip---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  279 (599)
                      +|+++.+|   ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.+++. |..+  .++|++|+|++|++++
T Consensus       370 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~  445 (549)
T 2z81_A          370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDS  445 (549)
T ss_dssp             TSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSC
T ss_pred             CCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhh
Confidence            66665554   23455566666666666665 3455555566666666666665532 2222  1456666666666664


Q ss_pred             cCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC-CCCCCCcccccccCCCCCcCCC
Q 042902          280 SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR-EGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       280 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      .+    ..+++|++|+|++|+++ .+|. ...+++|++|++++|++++.+|. ...+..+...++.+|++.|.+|
T Consensus       446 ~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          446 FS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             hc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            32    47889999999999999 5665 46799999999999999988776 3567788888999999999876

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=5.3e-38  Score=328.26  Aligned_cols=329  Identities=19%  Similarity=0.191  Sum_probs=286.2

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |++++|.++...+..|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|+++.+++.     .|+++++|++|+|
T Consensus        50 l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  124 (390)
T 3o6n_A           50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLLTVLVL  124 (390)
T ss_dssp             EEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEEC
T ss_pred             EEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH-----HhcCCCCCCEEEC
Confidence            46788888866555678899999999999999999999999999999999999999998875     5899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.|+.+.+..|..++ .|+.|++++|.+++..+..|.++++|++|+|++|.+++.   .+..+++|++|++++|.+++
T Consensus       125 ~~n~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             CCCccCcCCHHHhcCCC-CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence            99999977777788887 599999999999999999999999999999999999975   36778999999999999985


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      .     ...++|+.|++++|.++.....   ..++|+.|++++|.++.+ ..+..+++|++|++++|.+++..|..|..+
T Consensus       201 ~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l  271 (390)
T 3o6n_A          201 L-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKM  271 (390)
T ss_dssp             E-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred             c-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHcccc
Confidence            3     3456899999999999876332   347899999999999987 468889999999999999999999999999


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                      ++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++.. |  +..+++|+.|++
T Consensus       272 ~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l  346 (390)
T 3o6n_A          272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTL  346 (390)
T ss_dssp             SSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEEC
T ss_pred             ccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEc
Confidence            999999999999996 4666788999999999999999 5677788999999999999999855 3  677889999999


Q ss_pred             ccccCcccCCCCCCCCCcccccccCCCCCcCCC
Q 042902          321 SFNKLEGEIPREGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       321 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      ++|++.|.... ..+..+....+.+++..|.++
T Consensus       347 ~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          347 SHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             CCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            99999986433 234455556667777788765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-38  Score=350.87  Aligned_cols=312  Identities=18%  Similarity=0.220  Sum_probs=215.5

Q ss_pred             CCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccc
Q 042902           19 ASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ   98 (599)
Q Consensus        19 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   98 (599)
                      +++++.|++++|.++.+.+..|.++++|++|+|++|.|+.+++.     .|+.+++|++|+|++|.|+++.|..|.+++ 
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-  123 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHVFQNVP-  123 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChH-----HhcCCCCCCEEECCCCcCCCCCHHHHcCCC-
Confidence            46677777777777777666777777777777777777776654     477777777777777777777777777776 


Q ss_pred             cceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEee
Q 042902           99 SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG  178 (599)
Q Consensus        99 ~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  178 (599)
                      .|+.|++++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..   +..+++|+.|+++
T Consensus       124 ~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~  200 (597)
T 3oja_B          124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVS  200 (597)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECC
T ss_pred             CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcc
Confidence            4777777777777666666777777777777777777777777777777777777777777542   4556677777777


Q ss_pred             CCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC
Q 042902          179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       179 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      +|.+++.     ...++|+.|++++|.++.+|..+.  ++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|
T Consensus       201 ~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~  271 (597)
T 3oja_B          201 YNLLSTL-----AIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY  271 (597)
T ss_dssp             SSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEES
T ss_pred             cCccccc-----cCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCH
Confidence            7776642     234567777777777766654332  467777777777765  2556667777777777777776666


Q ss_pred             ccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCc
Q 042902          259 TTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNF  338 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~  338 (599)
                      ..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..  ...+..+
T Consensus       272 ~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L  347 (597)
T 3oja_B          272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTL  347 (597)
T ss_dssp             GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCC
T ss_pred             HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCC
Confidence            677777777777777777764 3555566677777777777776 45666666777777777777766543  2344556


Q ss_pred             ccccccCCCCCcCC
Q 042902          339 SAESFKGNELLCGT  352 (599)
Q Consensus       339 ~~~~~~~n~~~c~~  352 (599)
                      ....+.+|++.|.+
T Consensus       348 ~~L~l~~N~~~~~~  361 (597)
T 3oja_B          348 KNLTLSHNDWDCNS  361 (597)
T ss_dssp             SEEECCSSCEEHHH
T ss_pred             CEEEeeCCCCCChh
Confidence            66666677666643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-39  Score=323.51  Aligned_cols=169  Identities=30%  Similarity=0.490  Sum_probs=147.2

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45777889999999999999864      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          502 VLEYMPHGSLEKCLYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                      |||||++|+|.++++..+            ..++|..+..|+.|||+||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            35899999999999999999999   889999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+|+.....+.........||++||||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCH
Confidence            999999876554443344456799999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=318.18  Aligned_cols=167  Identities=28%  Similarity=0.466  Sum_probs=140.4

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .+++...+.||+|+||+||+|+++  ..||||+++...  ....++|.+|+++|++++|||||+++|+|.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356778899999999999999875  369999986442  3456789999999999999999999999864 56899999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||++|+|.++++.....++|..+..|+.|||+||+|||   +.+||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999877777999999999999999999999   889999999999999999999999999999876543333


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      ......+||+.||||
T Consensus       189 ~~~~~~~GT~~ymAP  203 (307)
T 3omv_A          189 QQVEQPTGSVLWMAP  203 (307)
T ss_dssp             -----CCCCTTSCCH
T ss_pred             eeecccccCCCccCH
Confidence            344567899999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=323.98  Aligned_cols=168  Identities=27%  Similarity=0.477  Sum_probs=139.0

Q ss_pred             CCCcCceecccccceEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +|...+.||+|+||+||+|+++      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4566789999999999999864      4789999999876666678899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC--------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          503 LEYMPHGSLEKCLYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                      ||||++|+|.++++...              ..++|.+++.|+.|||+||+|||   +.+||||||||+|||+++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEE
Confidence            99999999999987532              35899999999999999999999   88999999999999999999999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+|+.+...+.........||+.||||
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCH
T ss_pred             EcccccceeccCCCcceecCcccccccccCh
Confidence            9999999976554444444567899999998

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.2e-37  Score=318.27  Aligned_cols=305  Identities=25%  Similarity=0.372  Sum_probs=187.9

Q ss_pred             CcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhc
Q 042902           16 IFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN   95 (599)
Q Consensus        16 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~   95 (599)
                      +..+++|++|++++|.++.+ + .|..+++|++|+|++|+++++++       +..+++|++|++++|.++.+  .++..
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~-------~~~l~~L~~L~L~~n~i~~~--~~~~~  108 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP-------LSNLVKLTNLYIGTNKITDI--SALQN  108 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh-------hhcCCcCCEEEccCCcccCc--hHHcC
Confidence            34556666666666666653 2 26666666666666666665442       55666666666666666643  24555


Q ss_pred             ccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEE
Q 042902           96 LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus        96 l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                      ++ .|+.|++++|.+.+..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|+.|
T Consensus       109 l~-~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L  182 (347)
T 4fmz_A          109 LT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL  182 (347)
T ss_dssp             CT-TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred             CC-cCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEE
Confidence            54 36666666666665433  6666666666666664443332 36666666666666666664332  6666666666


Q ss_pred             EeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCC
Q 042902          176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       176 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      ++++|.+++..+  +..+++|+.|++++|.++.++. +..+++|++|++++|.+++..+  +..+++|++|++++|.+++
T Consensus       183 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  257 (347)
T 4fmz_A          183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD  257 (347)
T ss_dssp             ECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             EccCCccccccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC
Confidence            666666665433  5666666666666666666544 5566666666666666665433  6666666666666666665


Q ss_pred             CCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCC
Q 042902          256 FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPF  335 (599)
Q Consensus       256 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~  335 (599)
                      .  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+| ...+
T Consensus       258 ~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l  332 (347)
T 4fmz_A          258 I--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASL  332 (347)
T ss_dssp             C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGC
T ss_pred             C--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhh
Confidence            3  3466666666666666666643  346666666666666666666666666666666666666666665555 3345


Q ss_pred             CCcccccccCCC
Q 042902          336 RNFSAESFKGNE  347 (599)
Q Consensus       336 ~~~~~~~~~~n~  347 (599)
                      ..+...++.+|+
T Consensus       333 ~~L~~L~l~~N~  344 (347)
T 4fmz_A          333 SKMDSADFANQV  344 (347)
T ss_dssp             TTCSEESSSCC-
T ss_pred             hccceeehhhhc
Confidence            555555555554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-38  Score=319.12  Aligned_cols=168  Identities=24%  Similarity=0.390  Sum_probs=145.1

Q ss_pred             CCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+...+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455688999999999999863      46889999997553 3446789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc
Q 042902          502 VLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV  566 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~  566 (599)
                      |||||++|+|.++++...               ..++|..+++|+.|||+||+|||   +.+||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532               25899999999999999999999   889999999999999999999


Q ss_pred             EEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          567 AHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       567 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +||+|||+|+.+...+.........||++||||
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCH
Confidence            999999999976554444444567899999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-38  Score=315.81  Aligned_cols=168  Identities=30%  Similarity=0.452  Sum_probs=150.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46899999999999999999975 6999999999754   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||+||+|.+++...+ .+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 4899999999999999999999   89999999999999999999999999999997755444


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      .......+||+.||||
T Consensus       188 ~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          188 QARANSFVGTAQYVSP  203 (311)
T ss_dssp             CCCBCCCCSCGGGCCH
T ss_pred             cccccCcccCcccCCH
Confidence            3444567899999998

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.4e-37  Score=341.02  Aligned_cols=329  Identities=19%  Similarity=0.188  Sum_probs=290.1

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |++++|.+++..+..|.++++|++|+|++|.|+++.|..|+.+++|++|+|++|.|+.+++.     .|+++++|++|+|
T Consensus        56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  130 (597)
T 3oja_B           56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLLTVLVL  130 (597)
T ss_dssp             EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEEC
T ss_pred             EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCCCCCEEEe
Confidence            46788888877666788899999999999999999999999999999999999999998875     5899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.|+++++..|.+++ .|+.|++++|.+++..|..|.++++|++|+|++|.+++..   +..+++|+.|++++|.+.+
T Consensus       131 ~~n~l~~l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred             eCCCCCCCCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence            99999988888888887 5999999999999999999999999999999999999763   5678999999999999985


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      .     ...++|+.|++++|.++.+.+..   .++|+.|+|++|.++.. ..+..+++|+.|+|++|.+++..|..|..+
T Consensus       207 l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  277 (597)
T 3oja_B          207 L-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKM  277 (597)
T ss_dssp             E-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred             c-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCc
Confidence            3     34568999999999998664443   36899999999999985 578899999999999999999999999999


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                      ++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++..   +..+++|+.|++
T Consensus       278 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l  352 (597)
T 3oja_B          278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTL  352 (597)
T ss_dssp             SSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEEC
T ss_pred             cCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEe
Confidence            999999999999997 4677788999999999999999 57778899999999999999998653   667889999999


Q ss_pred             ccccCcccCCCCCCCCCcccccccCCCCCcCCC
Q 042902          321 SFNKLEGEIPREGPFRNFSAESFKGNELLCGTP  353 (599)
Q Consensus       321 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  353 (599)
                      ++|++.|..+. ..+..+....+.+++..|+.+
T Consensus       353 ~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          353 SHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             eCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            99999987543 245566666777888888864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.6e-37  Score=327.53  Aligned_cols=319  Identities=26%  Similarity=0.393  Sum_probs=215.5

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      ++++|.++. +| .+..+++|++|+|++|+++++.+  |.++++|++|+|++|+++.+++       +.++++|++|+++
T Consensus        52 ~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------~~~l~~L~~L~L~  120 (466)
T 1o6v_A           52 QADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-------LANLTNLTGLTLF  120 (466)
T ss_dssp             ECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEECC
T ss_pred             ecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-------hcCCCCCCEEECC
Confidence            455666653 34 25666667777777777666543  6666667777777666665442       5566666666666


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCC-------------------ccccCCCCCCEEEccCCcCCcccCccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIP-------------------EEISNLTNLTTIYLGGNKLNGSIPIAL  142 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~-------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~  142 (599)
                      +|.+++..+  +..++ .|+.|++++|.+.+...                   ..+.++++|++|++++|.+++.  ..+
T Consensus       121 ~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l  195 (466)
T 1o6v_A          121 NNQITDIDP--LKNLT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVL  195 (466)
T ss_dssp             SSCCCCCGG--GTTCT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             CCCCCCChH--HcCCC-CCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhh
Confidence            666665432  55554 36666666666554211                   1256667777777777777654  246


Q ss_pred             cCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEE
Q 042902          143 DKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYL  222 (599)
Q Consensus       143 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L  222 (599)
                      ..+++|++|++++|.+.+..|  +..+++|+.|++++|++++.  ..+..+++|++|++++|.++.++. +..+++|+.|
T Consensus       196 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L  270 (466)
T 1o6v_A          196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTEL  270 (466)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred             ccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEE
Confidence            677777777777777775544  66677777777777777754  356677777777777777776654 6677777778


Q ss_pred             eecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCccc
Q 042902          223 NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       223 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      ++++|.+++..+  +..+++|+.|++++|.+++..+  ++.+++|+.|+|++|++++..|  +..+++|+.|++++|.++
T Consensus       271 ~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  344 (466)
T 1o6v_A          271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS  344 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccC
Confidence            888777776544  6777778888888887776544  6777788888888888776655  677778888888888877


Q ss_pred             ccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCc
Q 042902          303 GAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLC  350 (599)
Q Consensus       303 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  350 (599)
                      +.  ..+..+++|+.|++++|++++.+| ...+..+....+.+|++..
T Consensus       345 ~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          345 DV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred             Cc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence            54  467777888888888888877776 4556666666777776544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-38  Score=318.37  Aligned_cols=165  Identities=27%  Similarity=0.360  Sum_probs=148.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ..|+..+.||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999976 69999999997666556677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +||+|.+++...  .+++..+..|+.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999764  3899999999999999999999   89999999999999999999999999999997644322  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+||+.||||
T Consensus       227 ~~~~~GTp~YmAP  239 (346)
T 4fih_A          227 RKSLVGTPYWMAP  239 (346)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCcCcCCH
Confidence            3457899999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.8e-38  Score=318.62  Aligned_cols=167  Identities=21%  Similarity=0.351  Sum_probs=141.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++...  ....+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975 69999999997542  3346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+||+|.+++...+ ..+++..+..|+.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999997554 35788899999999999999999   8999999999999999999999999999999664321 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       ......+||+.||||
T Consensus       180 -~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          180 -ELARACIGTPYYLSP  194 (350)
T ss_dssp             -HHHHHHHSCCTTCCH
T ss_pred             -ccccccCCCccccCH
Confidence             122456899999998

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.3e-37  Score=311.97  Aligned_cols=254  Identities=34%  Similarity=0.565  Sum_probs=231.1

Q ss_pred             cceEEEccCCcccc--cCCccccCCCCCCEEEccC-CcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEE
Q 042902           99 SMEVFFMFNCNISG--SIPEEISNLTNLTTIYLGG-NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus        99 ~l~~l~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                      .++.|++++|++++  .+|..|.++++|++|+|++ |.+.+.+|..|..+++|++|+|++|.+++.+|..|..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            46667777777776  6778888889999999995 88888889899999999999999999998889999999999999


Q ss_pred             EeeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCccccCCC-cccEEeecCCCccccCcccccccccccEEEccCCcc
Q 042902          176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLK-YILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF  253 (599)
Q Consensus       176 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  253 (599)
                      +|++|.+++..|..|..+++|++|++++|+++ .+|..+..++ +|++|++++|.+++..|..|..++ |+.|+|++|.+
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            99999999888999999999999999999998 7888888887 899999999999999999999887 99999999999


Q ss_pred             CCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCC
Q 042902          254 SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREG  333 (599)
Q Consensus       254 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  333 (599)
                      ++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|..+
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            999999999999999999999999977666 8889999999999999999999999999999999999999999999988


Q ss_pred             CCCCcccccccCCCCCcCCCC
Q 042902          334 PFRNFSAESFKGNELLCGTPN  354 (599)
Q Consensus       334 ~~~~~~~~~~~~n~~~c~~~~  354 (599)
                      .+..+....+.+|++.|+.|.
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS
T ss_pred             cccccChHHhcCCCCccCCCC
Confidence            889999999999999999873

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=320.18  Aligned_cols=165  Identities=27%  Similarity=0.366  Sum_probs=148.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|+..+.||+|+||.||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46889999999999999999976 69999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +||+|.+++....  +++..+..|+.||++||+|||   +.+||||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            9999999997643  899999999999999999999   89999999999999999999999999999997644322  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+||+.||||
T Consensus       304 ~~~~~GTp~YmAP  316 (423)
T 4fie_A          304 RKSLVGTPYWMAP  316 (423)
T ss_dssp             BCCCEECTTTCCH
T ss_pred             ccccccCcCcCCH
Confidence            3457899999998

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.1e-36  Score=307.47  Aligned_cols=298  Identities=27%  Similarity=0.409  Sum_probs=264.2

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |++++|+++. +| .+..+++|++|+|++|+++++.+  |..+++|++|+|++|.++.++       .+.++++|++|++
T Consensus        49 L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~-------~~~~l~~L~~L~l  117 (347)
T 4fmz_A           49 LVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-------ALQNLTNLRELYL  117 (347)
T ss_dssp             EECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-------GGTTCTTCSEEEC
T ss_pred             EEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch-------HHcCCCcCCEEEC
Confidence            5788999985 44 48889999999999999998654  999999999999999998764       4899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.+++..+  +..++ .|+.|++++|......+ .+..+++|++|++++|.+.+..+  +..+++|++|++++|.+.+
T Consensus       118 ~~n~i~~~~~--~~~l~-~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~  191 (347)
T 4fmz_A          118 NEDNISDISP--LANLT-KMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED  191 (347)
T ss_dssp             TTSCCCCCGG--GTTCT-TCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred             cCCcccCchh--hccCC-ceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence            9999997644  77776 59999999997665444 48999999999999999987654  8899999999999999986


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      ..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|.++.++. +..+++|++|++++|.+++.  ..+..+
T Consensus       192 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l  264 (347)
T 4fmz_A          192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDL  264 (347)
T ss_dssp             CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred             ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcC
Confidence            543  8899999999999999997655  8899999999999999999887 88999999999999999975  578899


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                      ++|+.|++++|.+++.  ..+..+++|++|++++|++++..|..+..+++|+.|++++|++++..|  +..+++|+.|++
T Consensus       265 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l  340 (347)
T 4fmz_A          265 TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF  340 (347)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESS
T ss_pred             CCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeeh
Confidence            9999999999999975  468999999999999999999999999999999999999999997766  889999999999


Q ss_pred             ccccCc
Q 042902          321 SFNKLE  326 (599)
Q Consensus       321 ~~N~l~  326 (599)
                      ++|+++
T Consensus       341 ~~N~i~  346 (347)
T 4fmz_A          341 ANQVIK  346 (347)
T ss_dssp             SCC---
T ss_pred             hhhccc
Confidence            999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-35  Score=317.71  Aligned_cols=314  Identities=29%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             CCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCc
Q 042902            5 GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNS   84 (599)
Q Consensus         5 ~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~   84 (599)
                      .+++.+.++.  ..+++++.|++++|.++.+ | .+..+++|++|+|++|.++++++       +.++++|++|++++|.
T Consensus        33 ~~~~~~~i~~--~~l~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~-------~~~l~~L~~L~l~~n~  101 (466)
T 1o6v_A           33 KTNVTDTVSQ--TDLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP-------LKNLTKLVDILMNNNQ  101 (466)
T ss_dssp             CSSTTSEECH--HHHHTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEECCSSC
T ss_pred             ccccccccCh--hHhccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh-------hhccccCCEEECCCCc
Confidence            3444444432  3467899999999999975 4 48999999999999999998763       7899999999999999


Q ss_pred             ccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-------------------ccccCC
Q 042902           85 LDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-------------------IALDKL  145 (599)
Q Consensus        85 i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------------~~~~~l  145 (599)
                      +++..+  +..++ .|+.|++++|.+++..+  +.++++|++|+|++|.+++...                   ..+..+
T Consensus       102 l~~~~~--~~~l~-~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l  176 (466)
T 1o6v_A          102 IADITP--LANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL  176 (466)
T ss_dssp             CCCCGG--GTTCT-TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTC
T ss_pred             cccChh--hcCCC-CCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccC
Confidence            997765  88887 59999999999997654  9999999999999999986421                   113344


Q ss_pred             CCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeec
Q 042902          146 QKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS  225 (599)
Q Consensus       146 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls  225 (599)
                      ++|++|++++|.+.+.  ..+..+++|++|++++|.+++..+  ++.+++|++|++++|.++.++ .+..+++|+.|+++
T Consensus       177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~  251 (466)
T 1o6v_A          177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLA  251 (466)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECC
T ss_pred             CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECC
Confidence            5555555555555432  235555555555555555554433  445555566666666555543 34555566666666


Q ss_pred             CCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccC
Q 042902          226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      +|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..
T Consensus       252 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~  325 (466)
T 1o6v_A          252 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS  325 (466)
T ss_dssp             SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCG
T ss_pred             CCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCch
Confidence            666654433  5555666666666666655433  5556666666666666654433  555666666666666666544


Q ss_pred             CchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCC
Q 042902          306 PISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNEL  348 (599)
Q Consensus       306 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~  348 (599)
                      |  +..+++|+.|++++|++++. +....+..+...++.+|+.
T Consensus       326 ~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l  365 (466)
T 1o6v_A          326 P--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI  365 (466)
T ss_dssp             G--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred             h--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence            4  45566666666666666543 3333444455555555543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=9.5e-36  Score=330.91  Aligned_cols=324  Identities=23%  Similarity=0.226  Sum_probs=265.9

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|+|++..|.+|.++++|++|+|++|+|+++.+++|.++++|++|+|++|+|+++++.     .|+++++|++|+|
T Consensus        81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~-----~~~~L~~L~~L~L  155 (635)
T 4g8a_A           81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNV  155 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTC-----CCTTCTTCCEEEC
T ss_pred             EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChh-----hhhcCcccCeecc
Confidence            68999999988888999999999999999999999889999999999999999999998875     5899999999999


Q ss_pred             ccCccccc-CChhhhcccccceEEEccCCcccccCCccccCCC-------------------------------------
Q 042902           81 SNNSLDGI-LPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT-------------------------------------  122 (599)
Q Consensus        81 s~N~i~~~-~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~-------------------------------------  122 (599)
                      ++|.|++. .|..+..++ .|+.|++++|++++..+..|..++                                     
T Consensus       156 s~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n  234 (635)
T 4g8a_A          156 AHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN  234 (635)
T ss_dssp             CSSCCCCCCCCGGGGGCT-TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             ccCccccCCCchhhccch-hhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence            99999864 567777776 488999998888766554433221                                     


Q ss_pred             --------------------------------------------------------------------------------
Q 042902          123 --------------------------------------------------------------------------------  122 (599)
Q Consensus       123 --------------------------------------------------------------------------------  122 (599)
                                                                                                      
T Consensus       235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~  314 (635)
T 4g8a_A          235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV  314 (635)
T ss_dssp             CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred             cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence                                                                                            


Q ss_pred             --------------CCCEEEccCCcCCcccCc-------------------cccCCCCCCEEEcccccccc--cCC----
Q 042902          123 --------------NLTTIYLGGNKLNGSIPI-------------------ALDKLQKLQLLSLEDNQLEG--SIP----  163 (599)
Q Consensus       123 --------------~L~~L~L~~N~l~~~~~~-------------------~~~~l~~L~~L~L~~N~l~~--~~~----  163 (599)
                                    +|+.|++.+|.+....+.                   .+..+++|+.|++++|.+..  ..+    
T Consensus       315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~  394 (635)
T 4g8a_A          315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF  394 (635)
T ss_dssp             SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred             ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence                          233344444433322111                   12346788889998888753  222    


Q ss_pred             -------------------hhhhcCCCCcEEEeeCCccCCCC-CcccCCCCCCcEeecCCCCCCCC-CccccCCCcccEE
Q 042902          164 -------------------DDLCRLAALFLLDLGGNKLSGFV-PACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYL  222 (599)
Q Consensus       164 -------------------~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L  222 (599)
                                         ..+..+++|+.+++++|...... +..|..+++++.++++.|.+..+ |..+..++.|+.|
T Consensus       395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L  474 (635)
T 4g8a_A          395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  474 (635)
T ss_dssp             SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred             hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence                               23445666777777766665443 45688999999999999999976 4567789999999


Q ss_pred             eecCCCc-cccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcc
Q 042902          223 NLSSNSF-TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNI  301 (599)
Q Consensus       223 ~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  301 (599)
                      ++++|.+ .+..|..|..+++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus       475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l  554 (635)
T 4g8a_A          475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  554 (635)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred             hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence            9999985 446788999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCchhhcc-ccceEEEcccccCcccCC
Q 042902          302 SGAIPISLEKL-LDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       302 ~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p  330 (599)
                      ++..|..+..+ ++|++|++++|++.|.+.
T Consensus       555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          555 MTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999988 689999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.7e-37  Score=301.80  Aligned_cols=161  Identities=26%  Similarity=0.381  Sum_probs=137.6

Q ss_pred             CcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc----CCeeeEEE
Q 042902          431 SENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN----DDFKALVL  503 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  503 (599)
                      ...+.||+|+||+||+|.+. +++.||||++....  ....+.|.+|++++++++|||||++++++.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45568999999999999876 68999999996542  3345789999999999999999999999865    34689999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeec-CCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~  580 (599)
                      |||+||+|.+++...+ .+++..+..|+.||++||+|||   +.+  ||||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997654 4899999999999999999999   666  99999999999998 479999999999985422


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      .    .....+|||.||||
T Consensus       185 ~----~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             T----SBEESCSSCCCCCG
T ss_pred             C----ccCCcccCccccCH
Confidence            1    23456899999999

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.5e-35  Score=312.19  Aligned_cols=292  Identities=18%  Similarity=0.164  Sum_probs=193.2

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |+|++|++++. | .+..+++|++|+|++|+|+++ |  |+.+++|++|+|++|++++++        ++++++|++|++
T Consensus        47 L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~--------~~~l~~L~~L~L  113 (457)
T 3bz5_A           47 LDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD--------VTPLTKLTYLNC  113 (457)
T ss_dssp             EECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--------CTTCTTCCEEEC
T ss_pred             EEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee--------cCCCCcCCEEEC
Confidence            46677777754 4 566777777777777777764 2  677777777777777776642        566777777777


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|+++++ |  +..++ .|+.|++++|++++.   .++++++|++|++++|...+.+  .+..+++|++|++++|++++
T Consensus       114 ~~N~l~~l-~--~~~l~-~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~  184 (457)
T 3bz5_A          114 DTNKLTKL-D--VSQNP-LLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE  184 (457)
T ss_dssp             CSSCCSCC-C--CTTCT-TCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCee-c--CCCCC-cCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence            77777754 2  55554 477777777777764   2666777777777777443333  36667777777777777775


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      . |  +..+++|+.|++++|++++.   .+..+++|++|++++|+++.+|  +..+++|+.|++++|++++..+..+.++
T Consensus       185 l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L  256 (457)
T 3bz5_A          185 L-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKL  256 (457)
T ss_dssp             C-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred             e-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence            3 3  66677777777777777764   2666777777777777777776  6667777777777777776655444444


Q ss_pred             c-------cccEEEccCCccCCCCCccccCcccccccccccccccccCcc--------cccCCCCcccccCCCCcccccC
Q 042902          241 R-------VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD--------SIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       241 ~-------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      .       +|+.|++++|.+.+.+|  ++.+++|+.|++++|+..+.+|.        .++.+++|+.|++++|++++. 
T Consensus       257 ~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-  333 (457)
T 3bz5_A          257 TTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-  333 (457)
T ss_dssp             CEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-
T ss_pred             CEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-
Confidence            3       44555555555554444  45667777777777766554443        244556777777777777763 


Q ss_pred             CchhhccccceEEEcccccCcc
Q 042902          306 PISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       306 p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      +  +..+++|+.|++++|++++
T Consensus       334 ~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          334 D--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             C--CTTCTTCSEEECCSSCCCB
T ss_pred             c--cccCCcCcEEECCCCCCCC
Confidence            2  6677777777777777775

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-36  Score=297.94  Aligned_cols=164  Identities=24%  Similarity=0.410  Sum_probs=132.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999865 69999999996542   334568999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||| +|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 689999987754 4899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.||||
T Consensus       167 --~~~~~~GT~~Y~AP  180 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAP  180 (275)
T ss_dssp             ----------CTTSCH
T ss_pred             --ccCCeeECcccCCh
Confidence              23456899999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-36  Score=306.47  Aligned_cols=163  Identities=25%  Similarity=0.306  Sum_probs=138.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|...++||+|+||+||+|++. +|+.||||+++....     +.+|++++++++|||||++++++.+++..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777789999999999999975 699999999975432     246999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~~~~  585 (599)
                      +||+|.++++..+ .+++..+..|+.||+.||+|||   +.+||||||||+|||++.++ .+||+|||+|+.+.......
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999998654 4899999999999999999999   99999999999999999988 69999999999765432211


Q ss_pred             ---eeecccCCccccCC
Q 042902          586 ---TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ---~~~~~~gt~~y~AP  599 (599)
                         .....+||+.||||
T Consensus       209 ~~~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAP  225 (336)
T ss_dssp             -----CCCCCCGGGCCH
T ss_pred             ceecCCccccCccccCH
Confidence               22346799999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-36  Score=303.59  Aligned_cols=168  Identities=23%  Similarity=0.421  Sum_probs=133.5

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC---------
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD---------  497 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------  497 (599)
                      +|+..+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            4888899999999999999975 69999999997543 334567999999999999999999999987544         


Q ss_pred             ---eeeEEEEccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          498 ---FKALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       498 ---~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                         ..|+|||||++|+|.+++.....  ..++..+..|+.||++||+|||   +.+||||||||+|||++.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccC
Confidence               36899999999999999986543  3566778899999999999999   899999999999999999999999999


Q ss_pred             cCCccCCcCCCc----------eeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQS----------LTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~----------~~~~~~~gt~~y~AP  599 (599)
                      |+|+.+......          ...+..+||+.||||
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             CCC--------------------------CCCTTSCH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCH
Confidence            999876433211          112346799999999

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.5e-35  Score=301.06  Aligned_cols=287  Identities=19%  Similarity=0.254  Sum_probs=180.0

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      +++.+++++|.++.+ |..+  .++|++|+|++|.++.+++.     .|.++++|++|+|++|.|+++.|.+|.+++ .|
T Consensus        34 ~l~~l~~~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L  104 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAV-PKEI--SPDTTLLDLQNNDISELRKD-----DFKGLQHLYALVLVNNKISKIHEKAFSPLR-KL  104 (332)
T ss_dssp             ETTEEECCSSCCSSC-CSCC--CTTCCEEECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECGGGSTTCT-TC
T ss_pred             cCCEEECCCCCcccc-CCCC--CCCCeEEECCCCcCCccCHh-----HhhCCCCCcEEECCCCccCccCHhHhhCcC-CC
Confidence            577777777777653 4433  25677777777777766553     467777777777777777766666666665 36


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc--cCChhhhcCCCCcEEEee
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG--SIPDDLCRLAALFLLDLG  178 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls  178 (599)
                      +.|++++|.++.. |..+.  ++|++|++++|.+++..+..|.++++|++|++++|.++.  ..+..+..+ +|+.|+++
T Consensus       105 ~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~  180 (332)
T 2ft3_A          105 QKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS  180 (332)
T ss_dssp             CEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCC
T ss_pred             CEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECc
Confidence            6677776666633 33322  566677777777666666666666777777777776642  455556555 66666666


Q ss_pred             CCccCCCCCcccCCCCCCcEeecCCCCCCCCC-ccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCC
Q 042902          179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI  257 (599)
Q Consensus       179 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  257 (599)
                      +|+++++.. .+.  ++|++|++++|.++.++ ..+..+++|+.|++++|.+++..+..|..+++|+.|+|++|+++ .+
T Consensus       181 ~n~l~~l~~-~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l  256 (332)
T 2ft3_A          181 EAKLTGIPK-DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV  256 (332)
T ss_dssp             SSBCSSCCS-SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred             CCCCCccCc-ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ec
Confidence            666665332 222  56666666666666654 45666666666666666666666666666666666666666666 44


Q ss_pred             CccccCcccccccccccccccccCcccccCC------CCcccccCCCCccc--ccCCchhhccccceEEEccccc
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL------IDLKSLDLSNNNIS--GAIPISLEKLLDLKYINVSFNK  324 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~l~~N~  324 (599)
                      |..+..+++|++|++++|++++..+..|...      ..|+.|++++|++.  +..|..|..+++|+.+++++|+
T Consensus       257 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            5556666666666666666666555555442      45666666666665  4556666666666666666653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.5e-35  Score=298.88  Aligned_cols=289  Identities=18%  Similarity=0.245  Sum_probs=244.7

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      .+++.++++++.++.+ |..+.  ++|++|+|++|+|+++++.     .|+++++|++|+|++|.|+++.|.+|..++ .
T Consensus        31 c~l~~l~~~~~~l~~l-p~~~~--~~l~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~  101 (330)
T 1xku_A           31 CHLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDG-----DFKNLKNLHTLILINNKISKISPGAFAPLV-K  101 (330)
T ss_dssp             EETTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEECCSSCCCCBCTTTTTTCT-T
T ss_pred             CCCeEEEecCCCcccc-CccCC--CCCeEEECCCCcCCEeChh-----hhccCCCCCEEECCCCcCCeeCHHHhcCCC-C
Confidence            3789999999999874 55443  6889999999999988764     588899999999999999988889998887 4


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc--cCChhhhcCCCCcEEEe
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG--SIPDDLCRLAALFLLDL  177 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L  177 (599)
                      |+.|++++|.++.. |..+.  ++|++|++++|.+++..+..|.++++|++|++++|.+..  ..+..|..+++|++|++
T Consensus       102 L~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l  178 (330)
T 1xku_A          102 LERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  178 (330)
T ss_dssp             CCEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             CCEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEEC
Confidence            99999999998854 44443  789999999999998888889999999999999999964  67888999999999999


Q ss_pred             eCCccCCCCCcccCCCCCCcEeecCCCCCCCC-CccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCC
Q 042902          178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF  256 (599)
Q Consensus       178 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  256 (599)
                      ++|.++.+... +.  ++|++|++++|.++.+ |..+..+++|++|++++|.+++..+..|..+++|+.|+|++|.++ .
T Consensus       179 ~~n~l~~l~~~-~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~  254 (330)
T 1xku_A          179 ADTNITTIPQG-LP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K  254 (330)
T ss_dssp             CSSCCCSCCSS-CC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred             CCCccccCCcc-cc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-c
Confidence            99999865433 32  7899999999999977 567888999999999999999888888999999999999999999 5


Q ss_pred             CCccccCcccccccccccccccccCcccccCC------CCcccccCCCCcccc--cCCchhhccccceEEEccccc
Q 042902          257 IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL------IDLKSLDLSNNNISG--AIPISLEKLLDLKYINVSFNK  324 (599)
Q Consensus       257 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~l~~N~  324 (599)
                      +|..+..+++|++|++++|++++..+..|...      +.|+.|++++|++..  ..|..|..+..++.+++++|+
T Consensus       255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            67789999999999999999998887777543      788999999999864  667889999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-36  Score=304.22  Aligned_cols=167  Identities=28%  Similarity=0.390  Sum_probs=134.7

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC----eeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD----FKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  504 (599)
                      +|...+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++    ..|||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            456678999999999999998 4899999999654321 223445666677899999999999998654    5799999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ||++|+|.++++...  ++|..+.+++.|+++||+|+|+.     ..++||||||||+|||++.++.+||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            999999999998754  89999999999999999999943     13499999999999999999999999999998764


Q ss_pred             cCCCce--eeecccCCccccCC
Q 042902          580 KEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      ......  .....+||++||||
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCH
T ss_pred             CCCCceeeecccccccccccCH
Confidence            333221  22346799999999

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.6e-35  Score=300.87  Aligned_cols=283  Identities=25%  Similarity=0.301  Sum_probs=249.8

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      +++++|+++ .+|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+++.+.+.     .|+++++|++|+|
T Consensus        38 l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  109 (332)
T 2ft3_A           38 VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK-----AFSPLRKLQKLYI  109 (332)
T ss_dssp             EECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG-----GSTTCTTCCEEEC
T ss_pred             EECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh-----HhhCcCCCCEEEC
Confidence            467888887 6787764  6899999999999999999999999999999999999988664     6899999999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCC--cccCccccCCCCCCEEEcccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN--GSIPIALDKLQKLQLLSLEDNQL  158 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l  158 (599)
                      ++|.|+.+.+..+    +.|+.|++++|.+++..+..|.++++|++|++++|.++  +..+..|..+ +|++|++++|++
T Consensus       110 ~~n~l~~l~~~~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          110 SKNHLVEIPPNLP----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CSSCCCSCCSSCC----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCcCCccCcccc----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            9999995544333    46999999999999888888999999999999999996  3778888888 999999999999


Q ss_pred             cccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccc
Q 042902          159 EGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEI  237 (599)
Q Consensus       159 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~  237 (599)
                      ++ +|..+.  ++|+.|++++|++++..+..|..+++|++|++++|+++.++. .+..+++|++|++++|+++ .+|..+
T Consensus       185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence            96 455443  799999999999999988999999999999999999998875 7889999999999999999 677889


Q ss_pred             cccccccEEEccCCccCCCCCccccCc------cccccccccccccc--ccCcccccCCCCcccccCCCCc
Q 042902          238 GNLRVLVQIDLSMNNFSGFIPTTIGDL------KDLQYLFLEYNRLQ--GSIPDSIGGLIDLKSLDLSNNN  300 (599)
Q Consensus       238 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~  300 (599)
                      ..+++|+.|++++|++++..+..|...      .+|+.|++++|++.  +..|..|..+++|+.+++++|+
T Consensus       261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            999999999999999998888877654      67999999999997  6788999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-37  Score=307.05  Aligned_cols=166  Identities=25%  Similarity=0.368  Sum_probs=138.2

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++...  .....++.+|+++|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999862    47899999996542  2234578899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |||||+||+|.+++...+ .+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 4899999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..  .....+||+.||||
T Consensus       180 ~~--~~~~~~GT~~YmAP  195 (304)
T 3ubd_A          180 EK--KAYSFCGTVEYMAP  195 (304)
T ss_dssp             -C--CCCSCCCCGGGCCH
T ss_pred             Cc--cccccccCcccCCH
Confidence            22  23457899999998

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=8.5e-35  Score=296.81  Aligned_cols=270  Identities=21%  Similarity=0.273  Sum_probs=231.0

Q ss_pred             CCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCC
Q 042902           43 LRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLT  122 (599)
Q Consensus        43 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~  122 (599)
                      ..+|+.++++++.++.++..      +  .++|++|+|++|+|+++.+..|.+++ .|+.|++++|.+++..|..|.+++
T Consensus        30 ~c~l~~l~~~~~~l~~lp~~------~--~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~  100 (330)
T 1xku_A           30 QCHLRVVQCSDLGLEKVPKD------L--PPDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLV  100 (330)
T ss_dssp             EEETTEEECTTSCCCSCCCS------C--CTTCCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTTTTCT
T ss_pred             cCCCeEEEecCCCccccCcc------C--CCCCeEEECCCCcCCEeChhhhccCC-CCCEEECCCCcCCeeCHHHhcCCC
Confidence            34788999999999887764      2  26789999999999988888888887 499999999999988899999999


Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCC--CCCcccCCCCCCcEee
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSG--FVPACFGNLTSLRNLY  200 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~  200 (599)
                      +|++|+|++|.++.+.. .+.  ++|++|++++|.+++..+..|..+++|++|++++|.++.  ..+..|..+++|++|+
T Consensus       101 ~L~~L~Ls~n~l~~l~~-~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~  177 (330)
T 1xku_A          101 KLERLYLSKNQLKELPE-KMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR  177 (330)
T ss_dssp             TCCEEECCSSCCSBCCS-SCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred             CCCEEECCCCcCCccCh-hhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence            99999999999985443 332  789999999999998888889999999999999999864  6777888999999999


Q ss_pred             cCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccccc
Q 042902          201 LGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       201 L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      +++|.++.+|..+.  ++|++|++++|.+++..+..|.++++|+.|+|++|.+++..+..+..+++|++|+|++|+++ .
T Consensus       178 l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~  254 (330)
T 1xku_A          178 IADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K  254 (330)
T ss_dssp             CCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred             CCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-c
Confidence            99999999887665  78999999999999888888999999999999999999888888999999999999999998 6


Q ss_pred             CcccccCCCCcccccCCCCcccccCCchhhc------cccceEEEcccccCcc
Q 042902          281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEK------LLDLKYINVSFNKLEG  327 (599)
Q Consensus       281 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~l~l~~N~l~~  327 (599)
                      +|..+..+++|++|++++|++++..+..|..      .+.++.+++++|++..
T Consensus       255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence            7778888999999999999999777777754      3678899999999864

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.8e-35  Score=299.15  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=150.4

Q ss_pred             CCCCEEEccCccccc--cCCccccCCCCCCEEeccC-ccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcc
Q 042902           20 SKLSRLELEMNSFYG--FIPNTFGNLRNLKRLSLNY-NYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNL   96 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l   96 (599)
                      .+++.|+|++|++++  .+|..|.++++|++|+|++ |.++...+.     .|+++++|++|+|++|.|++..|..|..+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~-----~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l  124 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP-----AIAKLTQLHYLYITHTNVSGAIPDFLSQI  124 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCG-----GGGGCTTCSEEEEEEECCEEECCGGGGGC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCCh-----hHhcCCCCCEEECcCCeeCCcCCHHHhCC
Confidence            456677777777766  5666677777777777763 666644432     46666677777777777766666666666


Q ss_pred             cccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCC-CCCEEEcccccccccCChhhhcCCCCcEE
Q 042902           97 SQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQ-KLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus        97 ~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                      + .|+.|++++|.+++..|..|.++++|++|+|++|++++.+|..+..++ +|++|+|++|++++..|..+..+. |+.|
T Consensus       125 ~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L  202 (313)
T 1ogq_A          125 K-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV  202 (313)
T ss_dssp             T-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred             C-CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence            5 366666666666666666666666666666666666656666666665 666666666666666666666655 6666


Q ss_pred             EeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCC
Q 042902          176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       176 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      ++++|++++..|..|..+++|+.|+|++|.++..+..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++
T Consensus       203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  282 (313)
T 1ogq_A          203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG  282 (313)
T ss_dssp             ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred             ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence            66666666656666666666666666666665443334445555555555555555555555555555555555555554


Q ss_pred             CCCccccCccccccccccccc
Q 042902          256 FIPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       256 ~~~~~~~~l~~L~~L~L~~N~  276 (599)
                      .+|.. +.+++|+.|++++|+
T Consensus       283 ~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          283 EIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             ECCCS-TTGGGSCGGGTCSSS
T ss_pred             cCCCC-ccccccChHHhcCCC
Confidence            44443 444455555555444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-36  Score=308.48  Aligned_cols=179  Identities=23%  Similarity=0.389  Sum_probs=151.9

Q ss_pred             ccHHHHHHHhCCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCC-CcceeE
Q 042902          418 FTHLELFQATNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRH-RNLIKI  489 (599)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l  489 (599)
                      +...+++...++|+..+.||+|+||+||+|++..      ++.||||+++... ....++|.+|+++|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4445555567789999999999999999998642      3689999997553 3345789999999999975 899999


Q ss_pred             EEEEEcC-CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 042902          490 ISSCSND-DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  553 (599)
Q Consensus       490 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d  553 (599)
                      +|+|.++ +..+||||||++|+|.++++...               ..+++..+..|+.|||+||+|||   +.+|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9999764 57899999999999999997532               24789999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       554 lk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+|||+++++.+||+|||+|+.+.............||+.||||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            9999999999999999999999977655544455567899999998

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.6e-34  Score=304.36  Aligned_cols=308  Identities=20%  Similarity=0.195  Sum_probs=264.4

Q ss_pred             cCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902            7 NFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus         7 ~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      ...+..+..+.++++|++|+|++|+|+++ | .|..+++|++|+|++|++++++        ++.+++|++|++++|.|+
T Consensus        29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--------~~~l~~L~~L~Ls~N~l~   98 (457)
T 3bz5_A           29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--------LSQNTNLTYLACDSNKLT   98 (457)
T ss_dssp             TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--------CTTCTTCSEEECCSSCCS
T ss_pred             CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--------cccCCCCCEEECcCCCCc
Confidence            34455566788899999999999999986 5 6999999999999999999863        678999999999999999


Q ss_pred             ccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhh
Q 042902           87 GILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL  166 (599)
Q Consensus        87 ~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  166 (599)
                      ++ +  +..++ .|+.|++++|++++. +  ++++++|++|++++|+++++   .+..+++|++|++++|...+.+  .+
T Consensus        99 ~~-~--~~~l~-~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~  166 (457)
T 3bz5_A           99 NL-D--VTPLT-KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DV  166 (457)
T ss_dssp             CC-C--CTTCT-TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CC
T ss_pred             ee-e--cCCCC-cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--cc
Confidence            76 3  77776 599999999999985 3  89999999999999999985   3889999999999999655444  48


Q ss_pred             hcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEE
Q 042902          167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQI  246 (599)
Q Consensus       167 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  246 (599)
                      ..+++|+.|++++|+++++ |  +..+++|+.|++++|.++.++  +..+++|++|++++|++++ +|  +..+++|+.|
T Consensus       167 ~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L  238 (457)
T 3bz5_A          167 TPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF  238 (457)
T ss_dssp             TTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred             ccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence            8899999999999999985 3  889999999999999999984  7889999999999999998 44  8899999999


Q ss_pred             EccCCccCCCCCccccCcc-------cccccccccccccccCcccccCCCCcccccCCCCcccccCCch--------hhc
Q 042902          247 DLSMNNFSGFIPTTIGDLK-------DLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS--------LEK  311 (599)
Q Consensus       247 ~Ls~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~--------~~~  311 (599)
                      ++++|++++..+..+..++       +|+.|++++|++.+.+|  ++.+++|+.|++++|...+.+|..        +..
T Consensus       239 ~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~  316 (457)
T 3bz5_A          239 DCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQ  316 (457)
T ss_dssp             ECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTT
T ss_pred             EeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhh
Confidence            9999999998777777666       67888888888777776  578899999999999977766643        556


Q ss_pred             cccceEEEcccccCcccCCCCCCCCCcccccccCCCC
Q 042902          312 LLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNEL  348 (599)
Q Consensus       312 l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~  348 (599)
                      +++|+.|++++|++++. + .+.+..+...++.+|..
T Consensus       317 ~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l  351 (457)
T 3bz5_A          317 NPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHI  351 (457)
T ss_dssp             CTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCC
T ss_pred             cccCCEEECCCCccccc-c-cccCCcCcEEECCCCCC
Confidence            68999999999999984 3 45567777777888764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=6.9e-33  Score=294.25  Aligned_cols=260  Identities=28%  Similarity=0.360  Sum_probs=145.1

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      ++|++|++++|+++++. ..   .++|++|+|++|++++++       .|+++++|++|++++|++++ +|..+    ..
T Consensus       111 ~~L~~L~l~~n~l~~l~-~~---~~~L~~L~L~~n~l~~lp-------~~~~l~~L~~L~l~~N~l~~-lp~~~----~~  174 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKALS-DL---PPLLEYLGVSNNQLEKLP-------ELQNSSFLKIIDVDNNSLKK-LPDLP----PS  174 (454)
T ss_dssp             TTCCEEECCSSCCSCCC-SC---CTTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSC-CCCCC----TT
T ss_pred             CCCcEEECCCCccCccc-CC---CCCCCEEECcCCCCCCCc-------ccCCCCCCCEEECCCCcCcc-cCCCc----cc
Confidence            34455555555444421 11   145666666666665543       25666667777777776664 23222    24


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |+.|++++|++++ +| .|.++++|++|++++|+++++ |..   .++|++|++++|.++ .+| .+..+++|++|++++
T Consensus       175 L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~  246 (454)
T 1jl5_A          175 LEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADN  246 (454)
T ss_dssp             CCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCS
T ss_pred             ccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCC
Confidence            6666777776665 33 466677777777777766642 222   246667777777666 344 366677777777777


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT  259 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  259 (599)
                      |+++++ |..   +++|+.|++++|+++.+|..   +++|++|++++|.+++... .   .++|+.|++++|.+++. + 
T Consensus       247 N~l~~l-~~~---~~~L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l~~-~---~~~L~~L~l~~N~l~~i-~-  313 (454)
T 1jl5_A          247 NLLKTL-PDL---PPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGLSE-L---PPNLYYLNASSNEIRSL-C-  313 (454)
T ss_dssp             SCCSSC-CSC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEESC-C---CTTCCEEECCSSCCSEE-C-
T ss_pred             CcCCcc-ccc---ccccCEEECCCCcccccCcc---cCcCCEEECcCCccCcccC-c---CCcCCEEECcCCcCCcc-c-
Confidence            777653 222   35666777777766666653   2556666666666665211 0   13445555555544431 1 


Q ss_pred             cccCc-ccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcc
Q 042902          260 TIGDL-KDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       260 ~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                         .+ ++|++|++++|++++ +|..   +++|+.|++++|++++ +|.   .+++|++|++++|++++
T Consensus       314 ---~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          314 ---DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS
T ss_pred             ---CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCc
Confidence               12 356666666666664 3332   3556666666666663 443   34566666666666665

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.7e-33  Score=299.02  Aligned_cols=247  Identities=25%  Similarity=0.295  Sum_probs=119.0

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCC-------------CEEeccCccCcccCCCccccc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNL-------------KRLSLNYNYLTSSTPKLNFLS   67 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~~~~   67 (599)
                      |++++|++ +.+|.+++++++|++|++++|++++..|.+++++++|             ++|++++|.+++++..     
T Consensus        16 L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~-----   89 (454)
T 1jl5_A           16 PLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL-----   89 (454)
T ss_dssp             -------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC-----
T ss_pred             hhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC-----
Confidence            57889999 7899999999999999999999999899999888764             8888888888776541     


Q ss_pred             ccCCCCCCcEEEcccCcccccCChhhh----------------cccccceEEEccCCcccccCCccccCCCCCCEEEccC
Q 042902           68 SLSNCKYLKYLSFSNNSLDGILPRAIG----------------NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG  131 (599)
Q Consensus        68 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~----------------~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~  131 (599)
                          .++|++|++++|.+++ +|..+.                .++..++.|++++|++++ +| .|+++++|++|++++
T Consensus        90 ----~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~  162 (454)
T 1jl5_A           90 ----PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN  162 (454)
T ss_dssp             ----CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             ----cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence                2456666666666654 232210                111234445555554443 23 344555555555555


Q ss_pred             CcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc
Q 042902          132 NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS  211 (599)
Q Consensus       132 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~  211 (599)
                      |++++ +|..   .++|++|++++|++++ +| .+..+++|+.|++++|+++++ |..   .++|++|++++|.++.+|.
T Consensus       163 N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~~lp~  232 (454)
T 1jl5_A          163 NSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILEELPE  232 (454)
T ss_dssp             SCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSSCCC
T ss_pred             CcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCCcccc
Confidence            55443 2221   1344555555555443 22 344455555555555555432 211   1344555555555554442


Q ss_pred             cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccc
Q 042902          212 TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG  279 (599)
Q Consensus       212 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  279 (599)
                       +..+++|++|++++|++++. |..   +++|+.|++++|.+++. |..   +++|++|++++|++++
T Consensus       233 -~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l-~~~---~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          233 -LQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSG  291 (454)
T ss_dssp             -CTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSE
T ss_pred             -cCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCccccc-Ccc---cCcCCEEECcCCccCc
Confidence             44455555555555555432 211   23444455555544432 221   2445555555555543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=293.51  Aligned_cols=167  Identities=29%  Similarity=0.399  Sum_probs=141.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc------CCe
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN------DDF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  498 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999975 69999999996543  2345678999999999999999999998764      357


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|||||||+ |+|.+++...+ .+++..+..|+.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 68999987654 5899999999999999999999   899999999999999999999999999999876


Q ss_pred             CcCC--CceeeecccCCccccCC
Q 042902          579 LKED--QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~--~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ........+||+.||||
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAP  231 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCH
T ss_pred             ccCccccccccccceeChHhcCH
Confidence            4322  11233567899999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.8e-33  Score=301.41  Aligned_cols=164  Identities=26%  Similarity=0.359  Sum_probs=141.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHH---HHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDI---ECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++..   ........+   ++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56889999999999999999976 69999999996432   222233333   466777889999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +|||||+||+|.+++...+ .+++..+..|+.||+.||+|||   +.+||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999998654 4899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..    ....+||+.||||
T Consensus       345 ~~----~~t~~GTp~YmAP  359 (689)
T 3v5w_A          345 KK----PHASVGTHGYMAP  359 (689)
T ss_dssp             CC----CCSCCSCGGGCCH
T ss_pred             CC----CCCccCCcCccCH
Confidence            22    2346899999999

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-33  Score=286.26  Aligned_cols=283  Identities=18%  Similarity=0.208  Sum_probs=174.4

Q ss_pred             CCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccc
Q 042902           19 ASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ   98 (599)
Q Consensus        19 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   98 (599)
                      ++.....++++|+++.+ |..+.  ++|++|+|++|+++.+++.     .|.++++|++|+|++|.|+++.|.+|.+++ 
T Consensus        30 C~~~~~c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-  100 (353)
T 2z80_A           30 CDRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNS-----DLQRCVNLQALVLTSNGINTIEEDSFSSLG-  100 (353)
T ss_dssp             ECTTSEEECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECTTSCCCEECTTTTTTCT-
T ss_pred             CCCCeEeeCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHH-----HhccCCCCCEEECCCCccCccCHhhcCCCC-
Confidence            34455577777777764 33333  4677777777777776653     467777777777777777766666666665 


Q ss_pred             cceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-ccccCCCCCCEEEcccc-cccccCChhhhcCCCCcEEE
Q 042902           99 SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDN-QLEGSIPDDLCRLAALFLLD  176 (599)
Q Consensus        99 ~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~  176 (599)
                      .|+.|++++|++++..+..|.++++|++|+|++|+++++.+ ..|..+++|++|++++| .+....+..|..+++|++|+
T Consensus       101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~  180 (353)
T 2z80_A          101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE  180 (353)
T ss_dssp             TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence            36666666666665555556666666666666666664444 35666666666666666 35555555666666666666


Q ss_pred             eeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCcccc-CCCcccEEeecCCCccccCcccccccccccEEEccCCccCC
Q 042902          177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW-NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       177 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      +++|++++..|..|..+++|++|++++|.++.+|..+. .+++|+.|++++|.+++..+..+..                
T Consensus       181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~----------------  244 (353)
T 2z80_A          181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST----------------  244 (353)
T ss_dssp             EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--------------------
T ss_pred             CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc----------------
Confidence            66666666556666666666666666666655554322 3455555555555555433322211                


Q ss_pred             CCCccccCcccccccccccccccc----cCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCC
Q 042902          256 FIPTTIGDLKDLQYLFLEYNRLQG----SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       256 ~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                           ......++.++|++|.+++    .+|..+..+++|+.|+|++|+++...+..|..+++|++|++++|++.|.+|.
T Consensus       245 -----~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          245 -----GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             -------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             -----ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence                 1122334444444444443    4567788888888888888888844444467888888888888888887763

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-33  Score=285.53  Aligned_cols=276  Identities=18%  Similarity=0.156  Sum_probs=220.7

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      ++++|+++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+++++++.     .|.++++|++|+|+
T Consensus        37 ~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED-----SFSSLGSLEHLDLS  108 (353)
T ss_dssp             ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECC
T ss_pred             eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh-----hcCCCCCCCEEECC
Confidence            56788888 6677665  4899999999999998888999999999999999999998765     68999999999999


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCC-ccccCCCCCCEEEccCC-cCCcccCccccCCCCCCEEEccccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIP-EEISNLTNLTTIYLGGN-KLNGSIPIALDKLQKLQLLSLEDNQLE  159 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~  159 (599)
                      +|+|+++.+..|.+++ .|+.|++++|++++..+ ..|.++++|++|++++| .++...+..|.++++|++|++++|.+.
T Consensus       109 ~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          109 YNYLSNLSSSWFKPLS-SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             SSCCSSCCHHHHTTCT-TCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCcCCcCCHhHhCCCc-cCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence            9999988777788887 59999999999997665 58999999999999999 588888889999999999999999999


Q ss_pred             ccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-ccc---CCCcccEEeecCCCccccCcc
Q 042902          160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLW---NLKYILYLNLSSNSFTGPLPL  235 (599)
Q Consensus       160 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~---~l~~L~~L~Ls~N~l~~~~~~  235 (599)
                      +..|..+..+++|++|++++|+++...+..+..+++|+.|++++|.++.++. .+.   ....++.++++++.+++    
T Consensus       188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~----  263 (353)
T 2z80_A          188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD----  263 (353)
T ss_dssp             EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH----
T ss_pred             ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC----
Confidence            9999999999999999999999987665566678999999999999998753 221   23344555555554443    


Q ss_pred             cccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCC
Q 042902          236 EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIP  306 (599)
Q Consensus       236 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  306 (599)
                                     |.+. .+|..+..+++|++|+|++|+++...+..|..+++|++|+|++|++++..|
T Consensus       264 ---------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          264 ---------------ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             ---------------HHHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ---------------cchh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence                           1111 234556666666666666666664433445677777777777777775443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-33  Score=284.47  Aligned_cols=145  Identities=26%  Similarity=0.347  Sum_probs=129.5

Q ss_pred             HhCCCCcCceecccccceEEEEEec----CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  500 (599)
                      ..+.|+..+.||+|+||+||+|+.+    +++.||||++....  ...++.+|+++|+.+ +|||||++++++.+.+..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3578999999999999999999853    46889999986543  346788999999988 6999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCccCC
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAKPLL  579 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~~~~  579 (599)
                      +|||||++|+|.+++..    +++.++..++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999998843    788899999999999999999   8999999999999999876 799999999998653

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=4.6e-32  Score=273.47  Aligned_cols=275  Identities=21%  Similarity=0.251  Sum_probs=146.3

Q ss_pred             CEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccC--Chhhhcccccc
Q 042902           23 SRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGIL--PRAIGNLSQSM  100 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--~~~~~~l~~~l  100 (599)
                      +.++.+++.++.+ |..+  .++|++|+|++|+++.++..     .|.++++|++|+|++|.|+...  +..+.      
T Consensus        10 ~~l~c~~~~l~~i-p~~~--~~~l~~L~L~~n~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~~~------   75 (306)
T 2z66_A           10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHG-----VFDKLTQLTKLSLSSNGLSFKGCCSQSDF------   75 (306)
T ss_dssp             TEEECCSSCCSSC-CSCC--CTTCCEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCEEEEEEHHHH------
T ss_pred             CEEEcCCCCcccC-CCCC--CCCCCEEECCCCccCccCHh-----HhhccccCCEEECCCCccCcccCcccccc------
Confidence            4677777777764 3333  25677777777777776654     4677777777777777776321  33333      


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCC-hhhhcCCCCcEEEeeC
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFLLDLGG  179 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~  179 (599)
                                         ++++|++|+|++|.+.. +|..+..+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus        76 -------------------~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~  135 (306)
T 2z66_A           76 -------------------GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH  135 (306)
T ss_dssp             -------------------SCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTT
T ss_pred             -------------------cccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCC
Confidence                               33444444444444442 22334444444444444444443332 3344444444444444


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCC--CCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCC
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTS--IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI  257 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  257 (599)
                      |.+++..+..|..+++|++|++++|.++.  +|..+..+++|++|++++|.+++..|..|..+++|+.|+|++|.+++..
T Consensus       136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  215 (306)
T 2z66_A          136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD  215 (306)
T ss_dssp             SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred             CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence            44444444444455555555555555543  3444555555555555555555555555555555555555555555555


Q ss_pred             CccccCcccccccccccccccccCcccccCCC-CcccccCCCCcccccCCc-h-hhccccceEEEcccccCcccCCC
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI-DLKSLDLSNNNISGAIPI-S-LEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~-~-~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      +..+..+++|++|+|++|++++..|..+..++ +|+.|+|++|++++..+. . ...+...+.+.+..+.+.|..|.
T Consensus       216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            55555555666666666666555555555553 566666666666543221 1 11223333444555566665554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=2.4e-32  Score=275.63  Aligned_cols=279  Identities=23%  Similarity=0.271  Sum_probs=170.8

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      +.++++++ .+|..+.  ++|++|+|++|+++++.++.|.++++|++|+|++|+++.....   ...+..+++|++|+|+
T Consensus        13 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           13 RCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC---SQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             ECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE---EHHHHSCSCCCEEECC
T ss_pred             EcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc---ccccccccccCEEECC
Confidence            56777777 5676664  6899999999999998888899999999999999999865311   1246678999999999


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-ccccCCCCCCEEEcccccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      +|.++. +|..+.                         ++++|++|+|++|.+++..+ ..+..+++|++|++++|.+.+
T Consensus        87 ~n~i~~-l~~~~~-------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~  140 (306)
T 2z66_A           87 FNGVIT-MSSNFL-------------------------GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV  140 (306)
T ss_dssp             SCSEEE-EEEEEE-------------------------TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE
T ss_pred             CCcccc-ChhhcC-------------------------CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc
Confidence            999874 333344                         44455555555555544333 344555555555555555554


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCC-CCCcccCCCCCCcEeecCCCCCCCC-CccccCCCcccEEeecCCCccccCccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSG-FVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEIG  238 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  238 (599)
                      ..+..|..+++|++|++++|.+++ ..|..|..+++|++|++++|.++.+ |..+..+++|++|++++|.+++..+..|.
T Consensus       141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence            445555555555555555555543 3444555555555555555555544 33455555555555555555555555555


Q ss_pred             ccccccEEEccCCccCCCCCccccCcc-cccccccccccccccCc--ccccCCCCcccccCCCCcccccCCchhhcc
Q 042902          239 NLRVLVQIDLSMNNFSGFIPTTIGDLK-DLQYLFLEYNRLQGSIP--DSIGGLIDLKSLDLSNNNISGAIPISLEKL  312 (599)
Q Consensus       239 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  312 (599)
                      .+++|+.|+|++|.+++..|..+..++ +|++|+|++|++++..+  .....+...+.+.+..+.+....|..+.+.
T Consensus       221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~  297 (306)
T 2z66_A          221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM  297 (306)
T ss_dssp             TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTC
T ss_pred             CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCc
Confidence            566666666666666655555565553 56666666666654321  112223344555566666666666666554

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.98  E-value=1.5e-32  Score=298.53  Aligned_cols=166  Identities=22%  Similarity=0.333  Sum_probs=149.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57899999999999999999975 69999999997666556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC--CcEEEccccCCccCCcCCCc
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DFGla~~~~~~~~~  584 (599)
                      +||+|.+++......+++..+..|+.||++||.|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+....  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            999999999776667899999999999999999999   8999999999999999854  799999999999775432  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       .....+||+.||||
T Consensus       312 -~~~~~~GT~~y~AP  325 (573)
T 3uto_A          312 -SVKVTTGTAEFAAP  325 (573)
T ss_dssp             -EEEEECSSGGGCCH
T ss_pred             -ceeeeEECccccCH
Confidence             23456899999998

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.98  E-value=2.3e-31  Score=282.34  Aligned_cols=248  Identities=23%  Similarity=0.239  Sum_probs=177.9

Q ss_pred             CCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCC
Q 042902           45 NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL  124 (599)
Q Consensus        45 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L  124 (599)
                      +.+.++.+++.++.+|..+        .++++.|+|++|+|+.+.+.+|.+++ .|+.|++++|.|+++.+..|.++++|
T Consensus        44 ~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~L  114 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGI--------STNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLANL  114 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCC--------CTTCSEEECCSCCCCEECTTTTSSCS-SCCEEECCSSCCCEECGGGGTTCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCC--------CCCCcEEEccCCcCCeeCHHHhhCCC-CCCEEECCCCcCCccChhhccCCccC
Confidence            3556777777777666532        14677777777777766666666665 36677777777766666777777778


Q ss_pred             CEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC-CccCCCCCcccCCCCCCcEeecCC
Q 042902          125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG-NKLSGFVPACFGNLTSLRNLYLGS  203 (599)
Q Consensus       125 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~  203 (599)
                      ++|+|++|+|+.+.+..|..+++|++|+|++|.|+...+..|..+++|+.|+|++ |.+..+.+..|.++++|++|+|++
T Consensus       115 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~  194 (440)
T 3zyj_A          115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM  194 (440)
T ss_dssp             CEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTT
T ss_pred             CEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCC
Confidence            8888888887777767777778888888888887777667777777888888877 455555556777778888888888


Q ss_pred             CCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcc
Q 042902          204 NQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD  283 (599)
Q Consensus       204 N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  283 (599)
                      |.++.+|. +..+++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+.
T Consensus       195 n~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  273 (440)
T 3zyj_A          195 CNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD  273 (440)
T ss_dssp             SCCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred             CcCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence            88777763 66677777777777777777677777777777777777777776677777777777777777777766666


Q ss_pred             cccCCCCcccccCCCCccc
Q 042902          284 SIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       284 ~~~~l~~L~~L~L~~N~l~  302 (599)
                      .|..+++|+.|+|++|++.
T Consensus       274 ~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          274 LFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTSSCTTCCEEECCSSCEE
T ss_pred             HhccccCCCEEEcCCCCcc
Confidence            6666777777777777665

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=2.5e-31  Score=283.16  Aligned_cols=249  Identities=24%  Similarity=0.236  Sum_probs=179.3

Q ss_pred             CCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCC
Q 042902           45 NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL  124 (599)
Q Consensus        45 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L  124 (599)
                      +...++.+++.++.+|..+        .++|++|+|++|+|+++.+..|.+++ .|+.|++++|+|+++.+..|.++++|
T Consensus        55 ~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L  125 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGI--------PSNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASL  125 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCcEEEECCCCcCccCCCC--------CCCccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcccC
Confidence            3466777777777766532        14677777777777777777777765 37777777777777777777777777


Q ss_pred             CEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC-CccCCCCCcccCCCCCCcEeecCC
Q 042902          125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG-NKLSGFVPACFGNLTSLRNLYLGS  203 (599)
Q Consensus       125 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~  203 (599)
                      ++|+|++|+|+.+.+..|..+++|++|+|++|+|+.+.+..|..+++|+.|++++ |.+..+.+..|.++++|++|+|++
T Consensus       126 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~  205 (452)
T 3zyi_A          126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM  205 (452)
T ss_dssp             CEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTT
T ss_pred             CEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCC
Confidence            7777777777777777777777777777777777766666777777777777777 455555555677777777777777


Q ss_pred             CCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcc
Q 042902          204 NQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD  283 (599)
Q Consensus       204 N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  283 (599)
                      |+++.+| .+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..+.
T Consensus       206 n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  284 (452)
T 3zyi_A          206 CNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD  284 (452)
T ss_dssp             SCCSSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             Ccccccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH
Confidence            7777775 356677777777777777777777777777777777777777777677777777777777777777766666


Q ss_pred             cccCCCCcccccCCCCcccc
Q 042902          284 SIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       284 ~~~~l~~L~~L~L~~N~l~~  303 (599)
                      .|..+++|+.|+|++|++..
T Consensus       285 ~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          285 LFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             SSTTCTTCCEEECCSSCEEC
T ss_pred             HhccccCCCEEEccCCCcCC
Confidence            66777777777777777653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1.8e-31  Score=284.16  Aligned_cols=251  Identities=22%  Similarity=0.260  Sum_probs=232.2

Q ss_pred             CCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEc
Q 042902           74 YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSL  153 (599)
Q Consensus        74 ~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  153 (599)
                      ..+.++.+++.++.+ |..   ++..++.|++++|+|+++.+..|.++++|++|+|++|.|+++.+.+|.++++|++|+|
T Consensus        55 ~~~~v~c~~~~l~~i-P~~---~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEV-PQG---IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SSCEEECCSSCCSSC-CSC---CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEECCCCcCcc-CCC---CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence            467899999999854 443   3457999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCC-CCCCCCCc-cccCCCcccEEeecCCCccc
Q 042902          154 EDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS-NQLTSIPS-TLWNLKYILYLNLSSNSFTG  231 (599)
Q Consensus       154 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~  231 (599)
                      ++|+|+...+..|..+++|++|+|++|+++.+.+..|..+++|++|++++ |.+..+|. .+.++++|++|+|++|++++
T Consensus       131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            99999988888899999999999999999998888999999999999999 67778876 67889999999999999996


Q ss_pred             cCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhc
Q 042902          232 PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEK  311 (599)
Q Consensus       232 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  311 (599)
                      .  ..+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..
T Consensus       211 ~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  288 (452)
T 3zyi_A          211 M--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP  288 (452)
T ss_dssp             C--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred             c--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence            5  35889999999999999999999999999999999999999999999999999999999999999999888888999


Q ss_pred             cccceEEEcccccCcccCC
Q 042902          312 LLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       312 l~~L~~l~l~~N~l~~~~p  330 (599)
                      +++|+.|++++|++.|...
T Consensus       289 l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          289 LRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CTTCCEEECCSSCEECSTT
T ss_pred             ccCCCEEEccCCCcCCCCC
Confidence            9999999999999998765

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=8.7e-35  Score=310.74  Aligned_cols=322  Identities=17%  Similarity=0.149  Sum_probs=171.8

Q ss_pred             CccCCCcCccCCCCC-CcCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCccCcccCCCcccccccCCCC--
Q 042902            1 LLLWGNNFSGTIPSF-IFNASKLSRLELEMNSFYGF----IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCK--   73 (599)
Q Consensus         1 L~L~~n~~~~~~~~~-~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~--   73 (599)
                      |+|++|+++...... +..+++|++|+|++|++++.    ++..|..+++|++|+|++|.+++.....    .+..++  
T Consensus         8 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~----l~~~l~~~   83 (461)
T 1z7x_W            8 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC----VLQGLQTP   83 (461)
T ss_dssp             EEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH----HHHTTCST
T ss_pred             hhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHH----HHHHHhhC
Confidence            456666665443332 55566677777777766632    3455666666777777776665432210    112222  


Q ss_pred             --CCcEEEcccCcccc----cCChhhhcccccceEEEccCCcccccCCcccc-----CCCCCCEEEccCCcCCccc----
Q 042902           74 --YLKYLSFSNNSLDG----ILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS-----NLTNLTTIYLGGNKLNGSI----  138 (599)
Q Consensus        74 --~L~~L~Ls~N~i~~----~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----  138 (599)
                        +|++|+|++|.|+.    .++.++..++ .|+.|++++|.+++..+..+.     ..++|++|+|++|.+++..    
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCC-ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence              56666666666663    3355555555 466666666666544333322     2445666666666665422    


Q ss_pred             CccccCCCCCCEEEcccccccccCChhhhc-----CCCCcEEEeeCCccCCC----CCcccCCCCCCcEeecCCCCCCCC
Q 042902          139 PIALDKLQKLQLLSLEDNQLEGSIPDDLCR-----LAALFLLDLGGNKLSGF----VPACFGNLTSLRNLYLGSNQLTSI  209 (599)
Q Consensus       139 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~i  209 (599)
                      +..+..+++|++|+|++|.+.+..+..+..     .++|++|++++|.+++.    .+..+..+++|++|++++|.++..
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            334455566666666666665443333322     44666666666666543    244445556666666666665532


Q ss_pred             ------CccccCCCcccEEeecCCCcccc----CcccccccccccEEEccCCccCCCCCccccCc-----cccccccccc
Q 042902          210 ------PSTLWNLKYILYLNLSSNSFTGP----LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDL-----KDLQYLFLEY  274 (599)
Q Consensus       210 ------p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~  274 (599)
                            +..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+...     ++|++|+|++
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  322 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  322 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence                  11122355566666666666543    34444555666666666666554333333221     4566666666


Q ss_pred             cccccc----CcccccCCCCcccccCCCCcccccCCchhhc-----cccceEEEcccccCcc
Q 042902          275 NRLQGS----IPDSIGGLIDLKSLDLSNNNISGAIPISLEK-----LLDLKYINVSFNKLEG  327 (599)
Q Consensus       275 N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~  327 (599)
                      |.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|+.|++++|++++
T Consensus       323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  384 (461)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence            665543    3344445556666666666655444443332     3456666666665553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=281.79  Aligned_cols=251  Identities=24%  Similarity=0.279  Sum_probs=231.5

Q ss_pred             CCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEc
Q 042902           74 YLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSL  153 (599)
Q Consensus        74 ~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  153 (599)
                      ..+.++.+++.++.+ |..+   +..++.|++++|+|+++.+..|.++++|++|+|++|.|+++.+.+|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~~i-P~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLREV-PDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCSSC-CSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcCcC-CCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            467899999999854 4433   356899999999999999999999999999999999999998899999999999999


Q ss_pred             ccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCC-CCCCCCCc-cccCCCcccEEeecCCCccc
Q 042902          154 EDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS-NQLTSIPS-TLWNLKYILYLNLSSNSFTG  231 (599)
Q Consensus       154 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~  231 (599)
                      ++|+|+.+.+..|..+++|++|+|++|+++.+.+..|..+++|++|+|++ |.+..++. .+.++++|++|+|++|.++.
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            99999988888899999999999999999998888999999999999999 66777776 68889999999999999995


Q ss_pred             cCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhc
Q 042902          232 PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEK  311 (599)
Q Consensus       232 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  311 (599)
                      . | .+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..
T Consensus       200 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  277 (440)
T 3zyj_A          200 I-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP  277 (440)
T ss_dssp             C-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred             c-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence            4 4 5889999999999999999999999999999999999999999999999999999999999999999888888999


Q ss_pred             cccceEEEcccccCcccCC
Q 042902          312 LLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       312 l~~L~~l~l~~N~l~~~~p  330 (599)
                      +++|+.|++++|++.|...
T Consensus       278 l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          278 LHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CTTCCEEECCSSCEECSST
T ss_pred             ccCCCEEEcCCCCccCCCC
Confidence            9999999999999998764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=3.2e-31  Score=264.51  Aligned_cols=267  Identities=24%  Similarity=0.256  Sum_probs=196.2

Q ss_pred             CEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceE
Q 042902           23 SRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEV  102 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~  102 (599)
                      ++++.+++.++.+ |..+  .++|++|+|++|.++.+++.     .|..+++|++|+|++|.|+++.|.+|..++ .|+.
T Consensus        14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~-----~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~   84 (285)
T 1ozn_A           14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLA-LLEQ   84 (285)
T ss_dssp             CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCE
T ss_pred             eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHH-----HcccCCCCCEEECCCCccceeCHhhcCCcc-CCCE
Confidence            5667777777654 3322  35677777777777766654     466777777777777777766677777665 4777


Q ss_pred             EEccCCc-ccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          103 FFMFNCN-ISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       103 l~l~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      |++++|. +....|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus        85 L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  164 (285)
T 1ozn_A           85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (285)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence            7777775 666667778888888888888888887777788888888888888888887777778888888888888888


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCC-CccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCcc
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT  260 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  260 (599)
                      ++++.+..|..+++|++|++++|.++.+ |..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|++....+. 
T Consensus       165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-  243 (285)
T 1ozn_A          165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-  243 (285)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-
T ss_pred             ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-
Confidence            8877777788888888888888888866 66777888888888888888877777788888888888888888753222 


Q ss_pred             ccCcccccccccccccccccCcccccC--CCCcccccCCCC
Q 042902          261 IGDLKDLQYLFLEYNRLQGSIPDSIGG--LIDLKSLDLSNN  299 (599)
Q Consensus       261 ~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N  299 (599)
                      ..-...++.+..+.+.+....|..+.+  +..++..++.++
T Consensus       244 ~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C  284 (285)
T 1ozn_A          244 RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC  284 (285)
T ss_dssp             HHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred             HHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence            122345677777888888777777654  344555555443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=2.6e-31  Score=265.18  Aligned_cols=232  Identities=25%  Similarity=0.289  Sum_probs=152.9

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccc-ccccCChhhhcCCCCcEEEee
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQ-LEGSIPDDLCRLAALFLLDLG  178 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls  178 (599)
                      ++.|++++|++++..+..|.++++|++|+|++|.++++.|.+|..+++|++|+|++|. +....|..|..+++|++|+++
T Consensus        34 l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~  113 (285)
T 1ozn_A           34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD  113 (285)
T ss_dssp             CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred             ceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECC
Confidence            4444444444444444555566666666666666666656666666666666666665 555556666666666666666


Q ss_pred             CCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCC
Q 042902          179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFI  257 (599)
Q Consensus       179 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  257 (599)
                      +|++++..+..|..+++|++|++++|.++.+|. .+..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++..
T Consensus       114 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  193 (285)
T 1ozn_A          114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH  193 (285)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccC
Confidence            666666666666666777777777777766654 3556667777777777777666666777777777777777777777


Q ss_pred             CccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCC
Q 042902          258 PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE  332 (599)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  332 (599)
                      |..|..+++|++|++++|++++..+..+..+++|+.|++++|+++...+.. .-+..++.+..+.|.+.|..|..
T Consensus       194 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred             HhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence            777777777777777777777766667777777888888888777543322 22234555567777777777753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=1e-32  Score=279.57  Aligned_cols=267  Identities=18%  Similarity=0.141  Sum_probs=145.1

Q ss_pred             CEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceE
Q 042902           23 SRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEV  102 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~  102 (599)
                      +.++++.+.+.......+..+++|++|+|++|+++.+++.     .|.++++|++|+|++|.|++..+  |..++ .|+.
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~-~L~~   84 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAPFTKLELLNLSSNVLYETLD--LESLS-TLRT   84 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHH-----HHTTCTTCCEEECTTSCCEEEEE--ETTCT-TCCE
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHH-----HhhCCCcCCEEECCCCcCCcchh--hhhcC-CCCE
Confidence            3344444444443334444444444444444444444322     34444444444444444443332  33333 2444


Q ss_pred             EEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCcc
Q 042902          103 FFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL  182 (599)
Q Consensus       103 l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  182 (599)
                      |++++|.+++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..+++|++|+|++|++
T Consensus        85 L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A           85 LDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             EECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             EECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence            445444444322     2255666666666665544332   45566666666666655555566666666666666666


Q ss_pred             CCCCCccc-CCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccc
Q 042902          183 SGFVPACF-GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTI  261 (599)
Q Consensus       183 ~~~~~~~~-~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  261 (599)
                      ++..+..+ ..+++|++|+|++|.++.+|... .+++|++|++++|++++..+ .|..+++|+.|+|++|++++ +|..+
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l~~~~  233 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKAL  233 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-hhhHh
Confidence            65555444 24566666666666666554322 35666666666666664333 36666666666666666663 45556


Q ss_pred             cCccccccccccccccc-ccCcccccCCCCcccccCC-CCcccccCCch
Q 042902          262 GDLKDLQYLFLEYNRLQ-GSIPDSIGGLIDLKSLDLS-NNNISGAIPIS  308 (599)
Q Consensus       262 ~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~  308 (599)
                      ..+++|+.|++++|+++ +.+|..+..+++|+.|+++ .+.+++..|..
T Consensus       234 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             CCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             hcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            66666677777777666 5566666666677777766 33455544433

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.3e-34  Score=309.51  Aligned_cols=327  Identities=19%  Similarity=0.176  Sum_probs=233.4

Q ss_pred             CccCCCcCcc----CCCCCCcCCCCCCEEEccCccccccCCccc-cCCC----CCCEEeccCccCcccCCCcccccccCC
Q 042902            1 LLLWGNNFSG----TIPSFIFNASKLSRLELEMNSFYGFIPNTF-GNLR----NLKRLSLNYNYLTSSTPKLNFLSSLSN   71 (599)
Q Consensus         1 L~L~~n~~~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~----~L~~L~L~~N~l~~~~~~~~~~~~~~~   71 (599)
                      |+|++|++++    .++..+..+++|++|+|++|++++..+..+ ..++    +|++|+|++|+++..... .+...+..
T Consensus        33 L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~-~l~~~l~~  111 (461)
T 1z7x_W           33 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG-VLSSTLRT  111 (461)
T ss_dssp             EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH-HHHHHTTS
T ss_pred             EEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH-HHHHHHcc
Confidence            4677888774    345667777888888888888876544333 3455    688888888888753210 11235778


Q ss_pred             CCCCcEEEcccCcccccCChhhhcc----cccceEEEccCCcccccC----CccccCCCCCCEEEccCCcCCcccCcccc
Q 042902           72 CKYLKYLSFSNNSLDGILPRAIGNL----SQSMEVFFMFNCNISGSI----PEEISNLTNLTTIYLGGNKLNGSIPIALD  143 (599)
Q Consensus        72 l~~L~~L~Ls~N~i~~~~~~~~~~l----~~~l~~l~l~~n~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  143 (599)
                      +++|++|+|++|.|+...+..+...    ...|+.|++++|++++..    +..+..+++|++|+|++|.++...+..+.
T Consensus       112 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  191 (461)
T 1z7x_W          112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC  191 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred             CCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH
Confidence            8888888888888876555544431    124888888888887644    55566778888888888888754444433


Q ss_pred             -----CCCCCCEEEccccccccc----CChhhhcCCCCcEEEeeCCccCCCC-----CcccCCCCCCcEeecCCCCCCC-
Q 042902          144 -----KLQKLQLLSLEDNQLEGS----IPDDLCRLAALFLLDLGGNKLSGFV-----PACFGNLTSLRNLYLGSNQLTS-  208 (599)
Q Consensus       144 -----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~-  208 (599)
                           .+++|++|+|++|.+++.    ++..+..+++|++|++++|++++..     +..+..+++|++|++++|.++. 
T Consensus       192 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~  271 (461)
T 1z7x_W          192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK  271 (461)
T ss_dssp             HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             HHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHH
Confidence                 366888888888888753    4666777888888888888876532     3334457888888888888886 


Q ss_pred             ----CCccccCCCcccEEeecCCCccccCcccccc-----cccccEEEccCCccCCC----CCccccCcccccccccccc
Q 042902          209 ----IPSTLWNLKYILYLNLSSNSFTGPLPLEIGN-----LRVLVQIDLSMNNFSGF----IPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       209 ----ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N  275 (599)
                          ++..+..+++|++|++++|.+++..+..+..     .++|+.|+|++|.+++.    ++..+..+++|++|+|++|
T Consensus       272 ~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n  351 (461)
T 1z7x_W          272 GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN  351 (461)
T ss_dssp             HHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSS
T ss_pred             HHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCC
Confidence                5666777888888888888887654444433     25888888888888765    3555667788888888888


Q ss_pred             cccccCcccccC-----CCCcccccCCCCcccc----cCCchhhccccceEEEcccccCccc
Q 042902          276 RLQGSIPDSIGG-----LIDLKSLDLSNNNISG----AIPISLEKLLDLKYINVSFNKLEGE  328 (599)
Q Consensus       276 ~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~  328 (599)
                      ++++..+..+..     .++|++|+|++|.+++    .+|..+..+++|++|++++|++++.
T Consensus       352 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             BCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            887665554443     5688888888888886    6777778888888888888887653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=1e-31  Score=282.82  Aligned_cols=173  Identities=21%  Similarity=0.321  Sum_probs=150.2

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      +....++|+..+.||+|+||+||+|++. +++.||||+++...   ....+.+.+|+.++..++||||+++++++.+.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3344678999999999999999999977 47899999996432   2233458899999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+|||||++|+|.+++......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            99999999999999999876566899999999999999999999   899999999999999999999999999999866


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... ......+||+.||||
T Consensus       226 ~~~~~-~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          226 MEDGT-VQSSVAVGTPDYISP  245 (437)
T ss_dssp             CTTSC-EECCSCCSCGGGCCH
T ss_pred             ccCCC-cccccccCCcCeeCh
Confidence            44332 233456899999998

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.8e-30  Score=264.08  Aligned_cols=223  Identities=21%  Similarity=0.259  Sum_probs=176.4

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      ++.|++++|+++ .+|..+.++++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++
T Consensus        83 l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~  159 (328)
T 4fcg_A           83 RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA  159 (328)
T ss_dssp             CCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEE
T ss_pred             eeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCC
Confidence            445555555554 34445555667777777777776 55666677777777777777776 5566677777777777777


Q ss_pred             CccCCCCCcccC---------CCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccC
Q 042902          180 NKLSGFVPACFG---------NLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM  250 (599)
Q Consensus       180 N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  250 (599)
                      |.+.+..|..+.         ++++|++|+|++|.++.+|..+..+++|++|++++|.+++ +|..+..+++|+.|+|++
T Consensus       160 n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~  238 (328)
T 4fcg_A          160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG  238 (328)
T ss_dssp             ETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTT
T ss_pred             CCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcC
Confidence            666666665544         4888999999999999888888888999999999999985 555788899999999999


Q ss_pred             CccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCc
Q 042902          251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE  326 (599)
Q Consensus       251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  326 (599)
                      |++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       239 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            9988888989999999999999999988899988999999999999999999999999999999999999887764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.8e-30  Score=264.10  Aligned_cols=225  Identities=20%  Similarity=0.216  Sum_probs=167.9

Q ss_pred             CCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCC
Q 042902           44 RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN  123 (599)
Q Consensus        44 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~  123 (599)
                      .+++.|+|++|.++.+++.      +..+++|++|+|++|.|+ .                         +|..+.++++
T Consensus        81 ~~l~~L~L~~n~l~~lp~~------l~~l~~L~~L~L~~n~l~-~-------------------------lp~~~~~l~~  128 (328)
T 4fcg_A           81 PGRVALELRSVPLPQFPDQ------AFRLSHLQHMTIDAAGLM-E-------------------------LPDTMQQFAG  128 (328)
T ss_dssp             TTCCEEEEESSCCSSCCSC------GGGGTTCSEEEEESSCCC-C-------------------------CCSCGGGGTT
T ss_pred             cceeEEEccCCCchhcChh------hhhCCCCCEEECCCCCcc-c-------------------------hhHHHhccCC
Confidence            4556666666666555442      444555666666655555 3                         3444555566


Q ss_pred             CCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhh---------cCCCCcEEEeeCCccCCCCCcccCCCC
Q 042902          124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC---------RLAALFLLDLGGNKLSGFVPACFGNLT  194 (599)
Q Consensus       124 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l~  194 (599)
                      |++|+|++|.++ .+|..+..+++|++|+|++|++.+.+|..+.         .+++|++|+|++|+++ .+|..+..++
T Consensus       129 L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~  206 (328)
T 4fcg_A          129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ  206 (328)
T ss_dssp             CSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCT
T ss_pred             CCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCC
Confidence            666666666666 4455566666666666666655555555544         4888888888888888 5667788888


Q ss_pred             CCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccc
Q 042902          195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEY  274 (599)
Q Consensus       195 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  274 (599)
                      +|++|+|++|.++.+|..+..+++|++|++++|.+.+.+|..|.++++|+.|+|++|++.+.+|..++.+++|++|+|++
T Consensus       207 ~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~  286 (328)
T 4fcg_A          207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG  286 (328)
T ss_dssp             TCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTT
T ss_pred             CCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCC
Confidence            88888888888888888888888888888888888888888888888999999999888888888888899999999999


Q ss_pred             ccccccCcccccCCCCcccccCCCCccc
Q 042902          275 NRLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       275 N~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      |++.+.+|..++.+++|+.+++..|.+.
T Consensus       287 n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          287 CVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCchhhccHHHhhccCceEEeCCHHHHH
Confidence            8888888999999999999888877765

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=2.3e-32  Score=277.09  Aligned_cols=266  Identities=18%  Similarity=0.174  Sum_probs=181.9

Q ss_pred             CCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCC
Q 042902           46 LKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLT  125 (599)
Q Consensus        46 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~  125 (599)
                      ++.++++.+.+......     .+..+++|++|+|++|.|+++.|.+|..++ .|+.|++++|.+++..+  |..+++|+
T Consensus        12 l~i~~ls~~~l~~~~~~-----~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~--~~~l~~L~   83 (317)
T 3o53_A           12 YKIEKVTDSSLKQALAS-----LRQSAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLR   83 (317)
T ss_dssp             EEEESCCTTTHHHHHHH-----HHTTGGGCSEEECTTSCCCCCCHHHHTTCT-TCCEEECTTSCCEEEEE--ETTCTTCC
T ss_pred             eeEeeccccchhhhHHH-----HhccCCCCCEEECcCCccCcCCHHHhhCCC-cCCEEECCCCcCCcchh--hhhcCCCC
Confidence            44456666666554432     345566777777777777777777777776 47777777777776554  77777777


Q ss_pred             EEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCC
Q 042902          126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQ  205 (599)
Q Consensus       126 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  205 (599)
                      +|+|++|.+++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..|..+++|++|++++|.
T Consensus        84 ~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (317)
T 3o53_A           84 TLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (317)
T ss_dssp             EEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred             EEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence            7777777776443     2367777777777777654433   4667777777777777767677777777777777777


Q ss_pred             CCCCC-cccc-CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcc
Q 042902          206 LTSIP-STLW-NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD  283 (599)
Q Consensus       206 l~~ip-~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  283 (599)
                      ++.++ ..+. .+++|++|++++|.+++..  ....+++|+.|+|++|.+++..+ .+..+++|++|+|++|+++ .+|.
T Consensus       156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~-~l~~  231 (317)
T 3o53_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEK  231 (317)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECT
T ss_pred             CCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc-chhh
Confidence            77653 3343 5677777777777777552  22346777777777777775433 4777777777777777777 3566


Q ss_pred             cccCCCCcccccCCCCccc-ccCCchhhccccceEEEcc-cccCcccCCC
Q 042902          284 SIGGLIDLKSLDLSNNNIS-GAIPISLEKLLDLKYINVS-FNKLEGEIPR  331 (599)
Q Consensus       284 ~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~-~N~l~~~~p~  331 (599)
                      .+..+++|+.|++++|+++ +.+|..+..+++|+.++++ .+.+++..|.
T Consensus       232 ~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            6777777777777777777 6666777777777777777 3445555544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=7.4e-30  Score=279.28  Aligned_cols=259  Identities=24%  Similarity=0.228  Sum_probs=114.9

Q ss_pred             CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccce
Q 042902           22 LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME  101 (599)
Q Consensus        22 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~  101 (599)
                      ++.|++++|.++. +|..+.  ++|++|+|++|.|+.++.         .+++|++|+|++|+|+++.+    .+ ..|+
T Consensus        42 l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~~lp~---------~l~~L~~L~Ls~N~l~~lp~----~l-~~L~  104 (622)
T 3g06_A           42 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLPA---------LPPELRTLEVSGNQLTSLPV----LP-PGLL  104 (622)
T ss_dssp             CCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCSCCCC---------CCTTCCEEEECSCCCSCCCC----CC-TTCC
T ss_pred             CcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCCCCCC---------cCCCCCEEEcCCCcCCcCCC----CC-CCCC
Confidence            4444444444443 222222  444444555444444332         13444444555444443222    11 2344


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      .|++++|++++..+    .+++|++|+|++|+|+++.+    .+++|++|+|++|+++++ |.   .+++|+.|++++|+
T Consensus       105 ~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~  172 (622)
T 3g06_A          105 ELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQ  172 (622)
T ss_dssp             EEEECSCCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSC
T ss_pred             EEECcCCcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCC
Confidence            44444444443222    33445555555555543221    124455555555555432 21   22344555555555


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccc
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTI  261 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  261 (599)
                      ++++.    ..+++|+.|++++|.|+.+|..   +++|+.|++++|.++.. |.   .+++|+.|+|++|.|+++ |   
T Consensus       173 l~~l~----~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~l-p---  237 (622)
T 3g06_A          173 LTSLP----MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSL-P---  237 (622)
T ss_dssp             CSCCC----CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCC-C---
T ss_pred             CCCCc----ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcC-C---
Confidence            54322    2234455555555555544432   23445555555555422 21   124455555555555432 2   


Q ss_pred             cCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccC
Q 042902          262 GDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       262 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  329 (599)
                      ..+++|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++.+
T Consensus       238 ~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~  300 (622)
T 3g06_A          238 VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT  300 (622)
T ss_dssp             CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHH
T ss_pred             CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcC
Confidence            233445555555555542 222   3344555555555555 34444555555555555555554443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=6.6e-32  Score=273.04  Aligned_cols=248  Identities=19%  Similarity=0.234  Sum_probs=199.5

Q ss_pred             cCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCccc-ccCCcccc-------CCCCCCEEEccCCcCCcccCc
Q 042902           69 LSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS-GSIPEEIS-------NLTNLTTIYLGGNKLNGSIPI  140 (599)
Q Consensus        69 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~  140 (599)
                      ++..++|++|++++|.+  ..|..+...   ++.|++++|.+. ...|..+.       ++++|++|+|++|.+++..|.
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            34455566666777766  345444432   666677777663 34455444       789999999999999988887


Q ss_pred             cc--cCCCCCCEEEcccccccccCChhhhcC-----CCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCC---CC
Q 042902          141 AL--DKLQKLQLLSLEDNQLEGSIPDDLCRL-----AALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTS---IP  210 (599)
Q Consensus       141 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---ip  210 (599)
                      .+  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..+..|+.+++|++|+|++|++..   +|
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI  192 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred             HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence            76  8899999999999999977 7888887     899999999999999888999999999999999999764   34


Q ss_pred             ccc--cCCCcccEEeecCCCcccc---CcccccccccccEEEccCCccCCCCC-ccccCcccccccccccccccccCccc
Q 042902          211 STL--WNLKYILYLNLSSNSFTGP---LPLEIGNLRVLVQIDLSMNNFSGFIP-TTIGDLKDLQYLFLEYNRLQGSIPDS  284 (599)
Q Consensus       211 ~~~--~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~  284 (599)
                      ..+  ..+++|++|++++|++++.   ....+.++++|+.|+|++|.+++..| ..+..+++|++|+|++|+|+ .+|..
T Consensus       193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~  271 (312)
T 1wwl_A          193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG  271 (312)
T ss_dssp             HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred             HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence            444  7889999999999999842   22345678999999999999998775 55677899999999999999 66666


Q ss_pred             ccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcc
Q 042902          285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       285 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      +.  ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus       272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            65  8999999999999976 66 8899999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=6.2e-31  Score=267.11  Aligned_cols=176  Identities=36%  Similarity=0.601  Sum_probs=154.5

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      .++...+++|+..+.||+|+||.||+|++.+|+.||||++........+.+.+|++++++++||||+++++++.+.+..+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34445678999999999999999999998889999999987766666788999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          501 LVLEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      +||||+++|+|.+++....   ..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999987543   24889999999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..............||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCH
T ss_pred             cccccccccccccCCCccccCH
Confidence            5433333333445689999998

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=4.5e-31  Score=266.93  Aligned_cols=248  Identities=19%  Similarity=0.184  Sum_probs=169.5

Q ss_pred             cCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccC-------CCCCCcEEEcccCcccccC
Q 042902           17 FNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS-------NCKYLKYLSFSNNSLDGIL   89 (599)
Q Consensus        17 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~-------~l~~L~~L~Ls~N~i~~~~   89 (599)
                      ...++|++|++++|.+  .+|..+...  |+.|+|++|+++.....    ..+.       ++++|++|+|++|+|++..
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~----~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  111 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIP----SRILFGALRVLGISGLQELTLENLEVTGTA  111 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECB----HHHHHHHHHHHTTSCCCEEEEEEEBCBSCC
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcC----HHHHHHHHHhcCcCCccEEEccCCcccchh
Confidence            3455677777777777  345555443  77777777777543211    1122       5677777777777777666


Q ss_pred             Chhh--hcccccceEEEccCCcccccCCccccCC-----CCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc-
Q 042902           90 PRAI--GNLSQSMEVFFMFNCNISGSIPEEISNL-----TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS-  161 (599)
Q Consensus        90 ~~~~--~~l~~~l~~l~l~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-  161 (599)
                      |..+  ..++ .|+.|++++|++++. |..+..+     ++|++|+|++|++++..|..|..+++|++|+|++|++.+. 
T Consensus       112 ~~~~~~~~l~-~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          112 PPPLLEATGP-DLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER  189 (312)
T ss_dssp             CCCSSSCCSC-CCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH
T ss_pred             HHHHHHhcCC-CccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch
Confidence            6665  5554 477777777777766 6666665     7788888888887777777777778888888888876543 


Q ss_pred             -CChhh--hcCCCCcEEEeeCCccCCC---CCcccCCCCCCcEeecCCCCCCCCC--ccccCCCcccEEeecCCCccccC
Q 042902          162 -IPDDL--CRLAALFLLDLGGNKLSGF---VPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPL  233 (599)
Q Consensus       162 -~~~~~--~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~~~~  233 (599)
                       .+..+  ..+++|++|+|++|++++.   ....+..+++|++|++++|+++..+  ..+..+++|++|+|++|.|+ .+
T Consensus       190 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~i  268 (312)
T 1wwl_A          190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV  268 (312)
T ss_dssp             HHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SC
T ss_pred             HHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hh
Confidence             23333  6777788888888877732   2234456677888888888877654  34455677888888888877 45


Q ss_pred             cccccccccccEEEccCCccCCCCCccccCcccccccccccccccc
Q 042902          234 PLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG  279 (599)
Q Consensus       234 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  279 (599)
                      |..+.  ++|+.|||++|+|++. |. +..+++|++|+|++|++++
T Consensus       269 p~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          269 PKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            55554  7788888888888766 44 7788888888888888764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=3.2e-30  Score=260.48  Aligned_cols=169  Identities=26%  Similarity=0.407  Sum_probs=147.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|...+.||+|+||.||+|.+. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56788899999999999999975 68999999987666666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce-
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL-  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~-  585 (599)
                      ++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+....... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999999886667999999999999999999999   8899999999999999999999999999998664332211 


Q ss_pred             -----------eeecccCCccccCC
Q 042902          586 -----------TQTQTLATIGYMAP  599 (599)
Q Consensus       586 -----------~~~~~~gt~~y~AP  599 (599)
                                 ......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             -------------CCCCSCGGGCCH
T ss_pred             ccccccccccccccccCCCcceeCH
Confidence                       11145799999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=4.6e-30  Score=257.64  Aligned_cols=166  Identities=28%  Similarity=0.412  Sum_probs=148.6

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999986 46999999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++|+|.+++....  +++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.......  
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            99999999997753  788999999999999999999   88999999999999999999999999999987643322  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.|+||
T Consensus       172 ~~~~~~gt~~y~aP  185 (297)
T 3fxz_A          172 KRSTMVGTPYWMAP  185 (297)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCCccCCcCccCh
Confidence            23456799999998

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=4.8e-29  Score=272.86  Aligned_cols=264  Identities=23%  Similarity=0.255  Sum_probs=225.4

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |++++|+++ .+|..+.  ++|++|+|++|+|+.+.+    .+++|++|+|++|+|++++.         .+++|++|+|
T Consensus        45 L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~L~L  108 (622)
T 3g06_A           45 LNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV---------LPPGLLELSI  108 (622)
T ss_dssp             EECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC---------CCTTCCEEEE
T ss_pred             EEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC---------CCCCCCEEEC
Confidence            578999999 7788776  799999999999997543    57999999999999998764         5689999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|+|+++.+     ....|+.|++++|+++++ |.   .+++|++|+|++|.++++ |.   .+++|+.|++++|.|++
T Consensus       109 s~N~l~~l~~-----~l~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~  175 (622)
T 3g06_A          109 FSNPLTHLPA-----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS  175 (622)
T ss_dssp             CSCCCCCCCC-----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC
T ss_pred             cCCcCCCCCC-----CCCCcCEEECCCCCCCcC-CC---CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC
Confidence            9999997544     234699999999999964 43   359999999999999965 33   45789999999999996


Q ss_pred             cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccc
Q 042902          161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       161 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                       +|   ..+++|+.|++++|+++++.+    .+++|+.|++++|.++.+|..   +++|+.|++++|.|++ +|   ..+
T Consensus       176 -l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l  240 (622)
T 3g06_A          176 -LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLP  240 (622)
T ss_dssp             -CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCC
T ss_pred             -Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCC
Confidence             45   457899999999999997543    247899999999999999864   4789999999999996 44   456


Q ss_pred             ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL  313 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  313 (599)
                      ++|+.|+|++|.|+.+ |.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..++
T Consensus       241 ~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          241 SELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CcCcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            8999999999999964 44   6789999999999999 6788899999999999999999999998887765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=3.2e-30  Score=262.39  Aligned_cols=186  Identities=38%  Similarity=0.584  Sum_probs=159.1

Q ss_pred             cccccccHHHHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEE
Q 042902          413 ANLRRFTHLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIIS  491 (599)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  491 (599)
                      ...+.++..++....++|...+.||+|+||.||+|+..+|+.||||++.... ......+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4456788889999999999999999999999999998889999999997543 223347899999999999999999999


Q ss_pred             EEEcCCeeeEEEEccCCCChhhhhhcCCC---cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          492 SCSNDDFKALVLEYMPHGSLEKCLYSSNY---ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       492 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                      ++.+.+..++||||+++|+|.+++.....   .+++..+..++.|+++||+|||..+..+|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999986542   489999999999999999999933333999999999999999999999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+|+....... .......||+.|+||
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAP  204 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCH
T ss_pred             eccCccccccCcccc-cccccccCCcCccCH
Confidence            999999987643332 233456699999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=9.7e-30  Score=258.19  Aligned_cols=176  Identities=27%  Similarity=0.347  Sum_probs=152.8

Q ss_pred             cccHHHHHHHhCC----------CCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCc
Q 042902          417 RFTHLELFQATNG----------FSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN  485 (599)
Q Consensus       417 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  485 (599)
                      .++..++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4566666666543          566779999999999999976 79999999998766666788999999999999999


Q ss_pred             ceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC
Q 042902          486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  565 (599)
Q Consensus       486 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~  565 (599)
                      |+++++++...+..++||||+++|+|.+++...  .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999998754  4899999999999999999999   88999999999999999999


Q ss_pred             cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+||+|||+++.......  ......||+.|+||
T Consensus       179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  210 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAP  210 (321)
T ss_dssp             CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCH
T ss_pred             cEEEeeeeeeeecccCcc--ccccccCCccccCH
Confidence            999999999986643322  23456799999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.6e-30  Score=271.88  Aligned_cols=173  Identities=23%  Similarity=0.352  Sum_probs=150.0

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      .....++|+..+.||+|+||.||+|+.. +|+.||||++++..   ....+.+.+|+.++..++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            3344678999999999999999999975 69999999996432   2234568899999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||+++|+|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999999875556899999999999999999999   899999999999999999999999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... ......+||+.||||
T Consensus       213 ~~~~~-~~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          213 RADGT-VRSLVAVGTPDYLSP  232 (412)
T ss_dssp             CTTSC-EECSSCCSCGGGCCH
T ss_pred             cCCCc-cccceeccccCcCCH
Confidence            44322 223446899999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=1.1e-30  Score=279.82  Aligned_cols=235  Identities=21%  Similarity=0.212  Sum_probs=140.7

Q ss_pred             CCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccc
Q 042902           19 ASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQ   98 (599)
Q Consensus        19 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~   98 (599)
                      +++|++|+|++|+|+++.|.+|..+++|++|+|++|.+++.++       |..+++|++|+|++|.|+++.+.      +
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------l~~l~~L~~L~Ls~N~l~~l~~~------~   99 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-------LESLSTLRTLDLNNNYVQELLVG------P   99 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-------CTTCTTCCEEECCSSEEEEEEEC------T
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-------cccCCCCCEEEecCCcCCCCCCC------C
Confidence            3478888888888888877888888888888888888876543       67788888888888888754322      2


Q ss_pred             cceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhh-cCCCCcEEEe
Q 042902           99 SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDL  177 (599)
Q Consensus        99 ~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L  177 (599)
                      .|+.|++++|.+++..+.   .+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..+. .+++|+.|+|
T Consensus       100 ~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            466666666666654443   235566666666666655555556666666666666666655555554 4555666666


Q ss_pred             eCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC-CC
Q 042902          178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS-GF  256 (599)
Q Consensus       178 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~  256 (599)
                      ++|.+++..+  +..+++|+.|+|++|.|+.+|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.
T Consensus       177 s~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~  253 (487)
T 3oja_A          177 QYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT  253 (487)
T ss_dssp             TTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred             CCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence            6665554422  223555555555555555555445555555555555555553 3334444455555555555544 33


Q ss_pred             CCccccCccccccccc
Q 042902          257 IPTTIGDLKDLQYLFL  272 (599)
Q Consensus       257 ~~~~~~~l~~L~~L~L  272 (599)
                      +|..+..++.|+.+++
T Consensus       254 ~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          254 LRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             HHHHHTTCHHHHHHHH
T ss_pred             hHHHHHhCCCCcEEec
Confidence            3444444444444444

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=4.7e-30  Score=260.94  Aligned_cols=166  Identities=27%  Similarity=0.402  Sum_probs=146.7

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|++ .+|+.||||++...  .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45789999999999999999997 47999999999654  2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999987654 4888999999999999999999   8899999999999999999999999999998654332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.|+||
T Consensus       169 --~~~~~~gt~~y~aP  182 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAP  182 (328)
T ss_dssp             --GGGTTSSSGGGCCH
T ss_pred             --ccccccCCcceeCc
Confidence              23456799999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=4.9e-30  Score=265.53  Aligned_cols=170  Identities=28%  Similarity=0.453  Sum_probs=146.1

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|++.        ++..||||+++... ....+++.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357888899999999999999852        35679999997553 33457899999999999 899999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..|+||||+++|+|.+++....               ..+++..+..++.||++||+|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997643               24788999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+|+.+.............+|+.||||
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            99999999999999876544333333456678999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=2.3e-30  Score=270.53  Aligned_cols=170  Identities=25%  Similarity=0.349  Sum_probs=147.6

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      ....++|...+.||+|+||.||+|+.. +++.||+|+++..   .....+.+.+|+.+++.++|||||++++++.+.+..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            344678999999999999999999976 5899999998643   122345688999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |+|||||+||+|.+++....  +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       145 ~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            99999999999999997653  788899999999999999999   8899999999999999999999999999998764


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ... .......+||+.||||
T Consensus       220 ~~~-~~~~~~~~gt~~Y~AP  238 (410)
T 3v8s_A          220 KEG-MVRCDTAVGTPDYISP  238 (410)
T ss_dssp             TTS-EEECCSCCSCGGGCCH
T ss_pred             cCC-cccccCCcCCccccCH
Confidence            332 2233457899999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=6.5e-30  Score=260.66  Aligned_cols=166  Identities=26%  Similarity=0.354  Sum_probs=145.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++..   .....+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56888999999999999999976 6999999999654   2345678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            9999999999887643 4788899999999999999999   88999999999999999999999999999986433222


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.||||
T Consensus       161 --~~~~~~gt~~y~aP  174 (337)
T 1o6l_A          161 --TMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CBCCCEECGGGCCG
T ss_pred             --cccccccChhhCCh
Confidence              23456799999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=7e-30  Score=262.17  Aligned_cols=167  Identities=28%  Similarity=0.359  Sum_probs=141.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++..   .....+.+..|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999976 5899999999754   234556788999999988 69999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            999999999999987654 4889999999999999999999   889999999999999999999999999999854322


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+||+.||||
T Consensus       178 ~--~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          178 G--VTTATFCGTPDYIAP  193 (353)
T ss_dssp             ----------CCGGGCCH
T ss_pred             C--ccccccCCCcCeECh
Confidence            2  233456899999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=8.1e-30  Score=258.95  Aligned_cols=169  Identities=24%  Similarity=0.354  Sum_probs=145.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357889999999999999999876 78999999986543 2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987654 4889999999999999999999   899999999999999999999999999999866443333


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       162 ~~~~~~~gt~~y~aP  176 (323)
T 3tki_A          162 RLLNKMCGTLPYVAP  176 (323)
T ss_dssp             CCBCSCCSCGGGSCH
T ss_pred             cccCCCccCcCccCc
Confidence            333456899999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=257.44  Aligned_cols=169  Identities=28%  Similarity=0.480  Sum_probs=143.6

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+.||+|+||.||+|++.    .+..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46778899999999999999974    3556999999755 334457899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999877667999999999999999999999   8899999999999999999999999999998764432


Q ss_pred             C-ceeeecccCCccccCC
Q 042902          583 Q-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~-~~~~~~~~gt~~y~AP  599 (599)
                      . ........+|+.|+||
T Consensus       206 ~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             -CCEECC---CCGGGSCH
T ss_pred             cceeeccCCCCcccccCH
Confidence            2 2223445678899998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=4.9e-29  Score=251.32  Aligned_cols=181  Identities=35%  Similarity=0.535  Sum_probs=157.7

Q ss_pred             cccccHHHHHHHhCCCCcC------ceecccccceEEEEEecCCcEEEEEEeccc----ccccHHHHHHHHHHHhcCCCC
Q 042902          415 LRRFTHLELFQATNGFSEN------NLIGRGGVASVYKARIQDGIEVAVKVFDLQ----YEGAFKSFDIECDMMKRIRHR  484 (599)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~  484 (599)
                      ...|+..++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4578899999999999887      8999999999999987 5899999998643    233467899999999999999


Q ss_pred             cceeEEEEEEcCCeeeEEEEccCCCChhhhhhcC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec
Q 042902          485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS--NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD  562 (599)
Q Consensus       485 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~  562 (599)
                      ||+++++++.+.+..++||||+++|+|.+++...  ...+++..+..++.||++||.|||   +.+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998643  235889999999999999999999   88999999999999999


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .++.+||+|||+++...............||+.|+||
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            9999999999999866543333333456799999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=262.82  Aligned_cols=167  Identities=22%  Similarity=0.284  Sum_probs=143.7

Q ss_pred             hCCCCcCceecccccceEEEEE------ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCcceeEEEEEEcCC
Q 042902          427 TNGFSENNLIGRGGVASVYKAR------IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR---HRNLIKIISSCSNDD  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~  497 (599)
                      .++|...+.||+|+||.||+|.      ..+++.||||+++..   ...++..|++++++++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4678889999999999999994      446899999999654   3456778888888886   999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhc----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC----------
Q 042902          498 FKALVLEYMPHGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD----------  563 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~----------  563 (599)
                      ..++|||||++|+|.+++..    ....+++..+..|+.||++||+|||   +.+|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999974    3446899999999999999999999   899999999999999998          


Q ss_pred             -CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 -NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                       ++.+||+|||+|+.+............+||++||||
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence             899999999999865433334455667899999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=2.5e-29  Score=256.16  Aligned_cols=170  Identities=24%  Similarity=0.407  Sum_probs=141.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  497 (599)
                      .++|+..+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            346888899999999999999986 79999999997543 345678999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeeEEEEccCCCChhhhhhcCCC--cCCHH
Q 042902          498 --------------------------------------------------FKALVLEYMPHGSLEKCLYSSNY--ILDIF  525 (599)
Q Consensus       498 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  525 (599)
                                                                        ..++||||+++|+|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999987543  35666


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc----------eeeecccCCcc
Q 042902          526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS----------LTQTQTLATIG  595 (599)
Q Consensus       526 ~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  595 (599)
                      .+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78899999999999999   889999999999999999999999999999876543211          12244579999


Q ss_pred             ccCC
Q 042902          596 YMAP  599 (599)
Q Consensus       596 y~AP  599 (599)
                      |+||
T Consensus       242 y~aP  245 (332)
T 3qd2_B          242 YMSP  245 (332)
T ss_dssp             GSCH
T ss_pred             ccCh
Confidence            9998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=1.1e-29  Score=257.93  Aligned_cols=166  Identities=27%  Similarity=0.369  Sum_probs=143.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC----eeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD----FKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  502 (599)
                      .++|+..+.||+|+||.||+|++. ++.||||+++.... ....+..|+.++++++|||||++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            457888999999999999999886 89999999965432 3345667999999999999999999998754    46999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEEccCCCCCeeecCCCcEEEccc
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV----------PIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~----------~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                      |||+++|+|.+++....  +++..+..++.|+++||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997754  899999999999999999999   77          9999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|+.+.............||+.|+||
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aP  202 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAP  202 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred             CcccccccccCccccccCccCccccCH
Confidence            999876544433334456799999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=260.78  Aligned_cols=165  Identities=26%  Similarity=0.368  Sum_probs=146.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999876 5889999998643   2345678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            9999999999998654 4889999999999999999999   8999999999999999999999999999998664332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.||||
T Consensus       170 --~~~~~~gt~~Y~aP  183 (384)
T 4fr4_A          170 --QITTMAGTKPYMAP  183 (384)
T ss_dssp             --CBCCCCSCGGGCCG
T ss_pred             --ceeccCCCccccCC
Confidence              23456899999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=1.8e-29  Score=258.22  Aligned_cols=169  Identities=23%  Similarity=0.364  Sum_probs=146.0

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCee
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  499 (599)
                      ...++|...+.||+|+||.||+|+.. +|+.||||+++...   ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999976 68999999997542   34566788899999877 899999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |+||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999987643 4889999999999999999999   8899999999999999999999999999998643


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  .....+||+.||||
T Consensus       170 ~~~~--~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAP  187 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCH
T ss_pred             cCCC--cccCCCCCcccCCh
Confidence            2222  23456899999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.7e-29  Score=253.79  Aligned_cols=166  Identities=20%  Similarity=0.306  Sum_probs=146.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367889999999999999999976 58899999987543 3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC--CCcEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DFGla~~~~~~~~  583 (599)
                      +++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.  ++.+||+|||+|+.+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999876667899999999999999999999   889999999999999987  7899999999998764332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       159 --~~~~~~gt~~y~aP  172 (321)
T 1tki_A          159 --NFRLLFTAPEYYAP  172 (321)
T ss_dssp             --EEEEEESCGGGSCH
T ss_pred             --ccccccCChhhcCc
Confidence              23446799999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=2.6e-29  Score=253.83  Aligned_cols=167  Identities=28%  Similarity=0.400  Sum_probs=143.9

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|+..+|+.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36788999999999999999999889999999996542  2335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++ ++.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+....... 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9975 888888777667899999999999999999999   88999999999999999999999999999986643222 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.|+||
T Consensus       175 -~~~~~~~t~~y~aP  188 (311)
T 3niz_A          175 -SYTHEVVTLWYRAP  188 (311)
T ss_dssp             ----CCCCCCTTCCH
T ss_pred             -cccCCcccCCcCCH
Confidence             23445789999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=5.5e-30  Score=265.95  Aligned_cols=170  Identities=26%  Similarity=0.393  Sum_probs=145.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|...+.||+|+||.||+|++. +++.||||.++... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888899999999999999986 78999999987543 2334578999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++|+|.+++...+..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999876666899999999999999999999   889999999999999999999999999999864332111


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+|+.|+||
T Consensus       270 ~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAP  284 (377)
T ss_dssp             CCSSCCEEEGGGSCH
T ss_pred             ecCCCCCCCcCcCCH
Confidence            111223357789998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=3.5e-29  Score=253.31  Aligned_cols=163  Identities=28%  Similarity=0.352  Sum_probs=144.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999976 69999999996542   234677889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....  
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            9999999999998654 4788899999999999999999   899999999999999999999999999999865321  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         ....+||+.||||
T Consensus       160 ---~~~~~gt~~y~aP  172 (318)
T 1fot_A          160 ---TYTLCGTPDYIAP  172 (318)
T ss_dssp             ---BCCCCSCTTTCCH
T ss_pred             ---cccccCCccccCH
Confidence               2345799999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=1.4e-29  Score=263.09  Aligned_cols=167  Identities=28%  Similarity=0.346  Sum_probs=143.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++.++ +|||||++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357888999999999999999976 58899999997542   22345688899999887 89999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999987643 4889999999999999999999   889999999999999999999999999999864322


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+||+.||||
T Consensus       207 ~--~~~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAP  222 (396)
T ss_dssp             T--CCBCCCCBCGGGCCH
T ss_pred             C--CccccccCCcccCCc
Confidence            2  223456899999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=1.5e-29  Score=261.98  Aligned_cols=169  Identities=27%  Similarity=0.495  Sum_probs=135.3

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .+|+..+.||+|+||.||+|++.    ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47888999999999999999865    57789999997553 34457899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.++++.....+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999877667899999999999999999999   8899999999999999999999999999998764332


Q ss_pred             Cc-eeeecccCCccccCC
Q 042902          583 QS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~-~~~~~~~gt~~y~AP  599 (599)
                      .. .......+|+.|+||
T Consensus       202 ~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             ------------CTTSCH
T ss_pred             ccceeccCCCcCCCccCh
Confidence            21 122234467889998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=5.3e-29  Score=256.32  Aligned_cols=166  Identities=25%  Similarity=0.379  Sum_probs=145.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .+.|...+.||+|+||.||+|+.. +|+.||||+++....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457889999999999999999976 689999999975432      1357899999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMA  575 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla  575 (599)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||++++++    .+||+|||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997644 5889999999999999999999   88999999999999998776    7999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.+....   ......||+.|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aP  187 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAP  187 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCH
T ss_pred             eEcCCCC---ccccCCCCccEECc
Confidence            8764332   23456799999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=2.9e-29  Score=251.44  Aligned_cols=167  Identities=28%  Similarity=0.483  Sum_probs=140.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+....   ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57889999999999999999865 68999999985432   334568999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.|+++||+|+|   +.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  165 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-  165 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence            9999999999987654 4889999999999999999999   8899999999999999999999999999998654322 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      ........||+.|+||
T Consensus       166 ~~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSP  181 (294)
T ss_dssp             ---------CCSSCCH
T ss_pred             ccccCccccCccccCH
Confidence            1223446799999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=3.1e-29  Score=256.78  Aligned_cols=166  Identities=28%  Similarity=0.362  Sum_probs=144.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|+.++.++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888899999999999999976 58999999997542   23456688999999988 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999987643 4889999999999999999999   8899999999999999999999999999998643222


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  .....+||+.|+||
T Consensus       165 ~--~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          165 D--TTSTFCGTPNYIAP  179 (345)
T ss_dssp             C--CBCCCCSCGGGCCH
T ss_pred             C--cccccCCCccccCc
Confidence            1  23456899999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=5e-29  Score=250.19  Aligned_cols=166  Identities=27%  Similarity=0.413  Sum_probs=139.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--------------------------ccHHHHHHHHHHHh
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--------------------------GAFKSFDIECDMMK  479 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  479 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367889999999999999999875 689999999864421                          12356899999999


Q ss_pred             cCCCCcceeEEEEEEc--CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 042902          480 RIRHRNLIKIISSCSN--DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN  557 (599)
Q Consensus       480 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~  557 (599)
                      +++||||+++++++.+  .+..++||||+++|+|.+++...  .+++..+..++.||++||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  56889999999999998876443  4899999999999999999999   889999999999


Q ss_pred             CeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          558 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       558 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+++.++.+||+|||+|+.+.....  ......||+.|+||
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAP  206 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCG
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccCh
Confidence            99999999999999999987643322  23456799999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=5.8e-30  Score=274.35  Aligned_cols=234  Identities=21%  Similarity=0.198  Sum_probs=125.5

Q ss_pred             CCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCC
Q 042902           44 RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN  123 (599)
Q Consensus        44 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~  123 (599)
                      ++|++|+|++|.|+.+++.     .|..+++|++|+|++|.|++..|  |                         ..+++
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~--l-------------------------~~l~~   81 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAA-----DLAPFTKLELLNLSSNVLYETLD--L-------------------------ESLST   81 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGG-----GGTTCTTCCEEECTTSCCEEEEE--C-------------------------TTCTT
T ss_pred             CCccEEEeeCCcCCCCCHH-----HHhCCCCCCEEEeeCCCCCCCcc--c-------------------------ccCCC
Confidence            3677777777776665543     46666667777777776665433  4                         44444


Q ss_pred             CCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCC
Q 042902          124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS  203 (599)
Q Consensus       124 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  203 (599)
                      |++|+|++|.|+++.+     .++|++|+|++|.|.+..+.   .+++|+.|+|++|.+++..|..|..+++|+.|+|++
T Consensus        82 L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (487)
T 3oja_A           82 LRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (487)
T ss_dssp             CCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTT
T ss_pred             CCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCC
Confidence            5555555554443221     14455555555555443332   234455555555555554444455555555555555


Q ss_pred             CCCCCC-Ccccc-CCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccC
Q 042902          204 NQLTSI-PSTLW-NLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI  281 (599)
Q Consensus       204 N~l~~i-p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  281 (599)
                      |.++.+ |..+. .+++|+.|+|++|.+++..  .+..+++|+.|+|++|.|++.+| .+..+++|+.|+|++|.+++ +
T Consensus       154 N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-l  229 (487)
T 3oja_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-I  229 (487)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-E
T ss_pred             CCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-c
Confidence            555532 33333 3455555555555555431  12235555556666665554333 35556666666666666653 4


Q ss_pred             cccccCCCCcccccCCCCccc-ccCCchhhccccceEEEcc
Q 042902          282 PDSIGGLIDLKSLDLSNNNIS-GAIPISLEKLLDLKYINVS  321 (599)
Q Consensus       282 ~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~  321 (599)
                      |..+..+++|+.|++++|+++ +.+|..+..++.|+.++++
T Consensus       230 p~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             chhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            445556666666666666665 4555566666666666665

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=7.1e-29  Score=257.69  Aligned_cols=167  Identities=22%  Similarity=0.362  Sum_probs=147.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .+.|+..+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357899999999999999999876 6899999999766555566899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC--CCcEEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~--~~~~kl~DFGla~~~~~~~~  583 (599)
                      +++|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+|||++.  ++.+||+|||+|+.+.....
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999876667899999999999999999999   889999999999999974  46899999999987643322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....||+.||||
T Consensus       207 ---~~~~~gt~~y~aP  219 (387)
T 1kob_A          207 ---VKVTTATAEFAAP  219 (387)
T ss_dssp             ---EEEECSSGGGCCH
T ss_pred             ---eeeeccCCCccCc
Confidence               2345799999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=4.4e-29  Score=246.53  Aligned_cols=168  Identities=27%  Similarity=0.391  Sum_probs=148.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|+..+.||+|+||.||+|++.++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            356888899999999999999998888999999975432 3467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999876666899999999999999999999   8899999999999999999999999999998664332 223


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+|+.|+||
T Consensus       162 ~~~~~~~~~y~aP  174 (268)
T 3sxs_A          162 SVGTKFPVKWSAP  174 (268)
T ss_dssp             CCSCCCCGGGCCH
T ss_pred             ccCCCcCcccCCH
Confidence            3455677889998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.3e-29  Score=248.76  Aligned_cols=167  Identities=26%  Similarity=0.397  Sum_probs=147.1

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|++.+++.||||++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            56888899999999999999998899999999975432 34779999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+...... ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  164 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence            99999999877767899999999999999999999   8899999999999999999999999999998653321 1223


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....+|+.|+||
T Consensus       165 ~~~~~~~~y~aP  176 (269)
T 4hcu_A          165 TGTKFPVKWASP  176 (269)
T ss_dssp             TSTTCCGGGCCH
T ss_pred             cCcccccccCCH
Confidence            445678889998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=3.2e-29  Score=252.84  Aligned_cols=167  Identities=31%  Similarity=0.467  Sum_probs=136.5

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|++ +|+.||||++....  ....++|.+|++++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45788889999999999999987 58999999986553  3345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          505 YMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      |+++|+|.+++.....  .+++..+..++.||++||+|||   +.+  |+||||||+||+++.++.+||+|||+|+....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999987543  3889999999999999999999   778  99999999999999999999999999985432


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..  .......||+.|+||
T Consensus       192 ~~--~~~~~~~gt~~y~aP  208 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAP  208 (309)
T ss_dssp             ------------CCTTSCH
T ss_pred             cc--cccccCCCCccccCh
Confidence            21  223456799999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=1.3e-29  Score=261.51  Aligned_cols=180  Identities=23%  Similarity=0.390  Sum_probs=150.5

Q ss_pred             cccHHHHHHHhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCccee
Q 042902          417 RFTHLELFQATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIK  488 (599)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~  488 (599)
                      .+...++....++|...+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3445555566788999999999999999999742      46889999997543 33456799999999999 7999999


Q ss_pred             EEEEEEcCC-eeeEEEEccCCCChhhhhhcCCC-----------------------------------------------
Q 042902          489 IISSCSNDD-FKALVLEYMPHGSLEKCLYSSNY-----------------------------------------------  520 (599)
Q Consensus       489 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  520 (599)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999976432                                               


Q ss_pred             ------------------cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          521 ------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       521 ------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                                        .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              1788899999999999999999   8899999999999999999999999999998765444


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .........||+.||||
T Consensus       248 ~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TCEEC--CEECGGGCCH
T ss_pred             cchhccccCCCceeECh
Confidence            44444566789999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=4.2e-29  Score=256.25  Aligned_cols=168  Identities=23%  Similarity=0.272  Sum_probs=145.9

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  500 (599)
                      ..++|...+.||+|+||.||+|+.. +|+.||||+++..   .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999986 4889999999754   234567788999999988 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||++||+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987644 4889999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  .....+||+.||||
T Consensus       174 ~~~--~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAP  190 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCH
T ss_pred             CCc--ccccccCCccccCh
Confidence            221  23456899999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=5.9e-29  Score=257.47  Aligned_cols=162  Identities=24%  Similarity=0.433  Sum_probs=138.5

Q ss_pred             cCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          432 ENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      ..+.||+|+||.||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3568999999999999875 689999999987655566789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee--cCCCcEEEccccCCccCCcCCCceeee
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL--DDNMVAHLSDFGMAKPLLKEDQSLTQT  588 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill--~~~~~~kl~DFGla~~~~~~~~~~~~~  588 (599)
                      |.+++......+++..+..++.||++||+|||   +.+|+||||||+|||+  +.++.+||+|||+|+.+.....   ..
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence            99998876667899999999999999999999   8899999999999999  5678999999999987643322   23


Q ss_pred             cccCCccccCC
Q 042902          589 QTLATIGYMAP  599 (599)
Q Consensus       589 ~~~gt~~y~AP  599 (599)
                      ...||+.|+||
T Consensus       247 ~~~gt~~y~aP  257 (373)
T 2x4f_A          247 VNFGTPEFLAP  257 (373)
T ss_dssp             CCCSSCTTCCH
T ss_pred             cccCCCcEeCh
Confidence            45799999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=5.5e-29  Score=255.31  Aligned_cols=163  Identities=24%  Similarity=0.321  Sum_probs=144.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 69999999996542   345678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999997644 4888999999999999999999   899999999999999999999999999999865332  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         ....+||+.||||
T Consensus       195 ---~~~~~gt~~y~aP  207 (350)
T 1rdq_E          195 ---TWTLCGTPEALAP  207 (350)
T ss_dssp             ---BCCCEECGGGCCH
T ss_pred             ---cccccCCccccCH
Confidence               2345799999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=1e-28  Score=247.24  Aligned_cols=166  Identities=27%  Similarity=0.384  Sum_probs=143.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999976 68999999997543  3345778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++ ++.+.+......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 666666655556899999999999999999999   8899999999999999999999999999998654322  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~t~~y~aP  170 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccccCCccccCCcCh
Confidence            223456789999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=3e-29  Score=250.58  Aligned_cols=166  Identities=26%  Similarity=0.392  Sum_probs=141.8

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||.||+|+..+|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688889999999999999999889999999986543  23357789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++ +|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999998876667899999999999999999999   8899999999999999999999999999998653221  1


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (288)
T 1ob3_A          156 KYTHEIVTLWYRAP  169 (288)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccccccccccccCc
Confidence            22445789999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=3.7e-29  Score=254.59  Aligned_cols=167  Identities=26%  Similarity=0.402  Sum_probs=135.2

Q ss_pred             hCCCCcCceecccccceEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARI----QDGIEVAVKVFDLQY----EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|+.    .+|+.||+|+++...    ......+..|++++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788999999999999999987    478999999997542    2344568889999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987644 4788889999999999999999   889999999999999999999999999999854


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....  ......||+.||||
T Consensus       172 ~~~~~--~~~~~~gt~~y~aP  190 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAP  190 (327)
T ss_dssp             ---------CTTSSCCTTSCH
T ss_pred             ccCCc--cccccCCCcCccCH
Confidence            32221  23456799999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=3e-29  Score=257.04  Aligned_cols=171  Identities=27%  Similarity=0.438  Sum_probs=146.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ..++|...+.||+|+||.||+|+..      +++.||||+++... ....+.|.+|++++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3568999999999999999999875      34889999997553 3345789999999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  555 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  555 (599)
                      .++||||+++|+|.+++....                       ..+++..+..++.||++||.|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999997632                       45889999999999999999999   8899999999


Q ss_pred             CCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          556 PNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       556 ~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+||+++.++.+||+|||+++...............+|+.|+||
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            99999999999999999999866443332333456789999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=2.2e-29  Score=252.38  Aligned_cols=169  Identities=27%  Similarity=0.442  Sum_probs=141.9

Q ss_pred             CCCCcCceecccccceEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Ceee
Q 042902          428 NGFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  500 (599)
                      ++|+..+.||+|+||.||+|++     .+++.||||++........+.|.+|++++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5688889999999999999984     26889999999866666677899999999999999999999998654  4689


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999999999887667899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCc-eeeecccCCccccCC
Q 042902          581 EDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-~~~~~~~gt~~y~AP  599 (599)
                      .... .......+|+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~y~aP  186 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAP  186 (295)
T ss_dssp             ---------CTTCGGGGCCH
T ss_pred             CcceeeeccCCCCccceeCc
Confidence            3221 222345578889998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.96  E-value=2.5e-28  Score=242.23  Aligned_cols=209  Identities=25%  Similarity=0.274  Sum_probs=120.6

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecC
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLG  202 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  202 (599)
                      +|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34455555555544444444455555555555555544444445555555555555555554444455555555555555


Q ss_pred             CCCCCCCCc-cccCCCcccEEeecCCCcccc-CcccccccccccEEEccCCccCCCCCccccCccccc----cccccccc
Q 042902          203 SNQLTSIPS-TLWNLKYILYLNLSSNSFTGP-LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ----YLFLEYNR  276 (599)
Q Consensus       203 ~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~  276 (599)
                      +|.++.++. .+..+++|++|++++|.+++. .|..|.++++|+.|+|++|.+++..+..+..+.+|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            555554433 344555555555555555543 355555566666666666666655555555555555    56667777


Q ss_pred             ccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCC
Q 042902          277 LQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPRE  332 (599)
Q Consensus       277 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  332 (599)
                      +++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|+++|.+|..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            76555544443 36777777777777666666777888888888888888777643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=9.6e-29  Score=266.53  Aligned_cols=167  Identities=26%  Similarity=0.400  Sum_probs=146.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...   .......+.+|++++++++|||||++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999976 6999999999653   233456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          503 LEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |||++||+|.+++..... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999876543 4899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .   .....+||+.||||
T Consensus       340 ~---~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAP  354 (576)
T ss_dssp             C---CEECCCSCGGGCCH
T ss_pred             c---cccccCCCccccCH
Confidence            2   23446899999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=6.7e-29  Score=258.34  Aligned_cols=170  Identities=28%  Similarity=0.434  Sum_probs=146.7

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|++.        ++..||||+++... ....+++.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888899999999999999853        34679999997553 33457899999999999 899999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++||||+++|+|.+++....               ..+++..+..++.||++||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997653               34899999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+|+...............+|+.|+||
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            99999999999999876544333344556788999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.2e-28  Score=248.71  Aligned_cols=165  Identities=26%  Similarity=0.392  Sum_probs=144.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      +.|...+.||+|+||.||+|... +|+.||||++.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45888899999999999999976 689999999865422      24678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla~  576 (599)
                      +||||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++    .+||+|||+|+
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999987643 5889999999999999999999   88999999999999999887    89999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.||||
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAP  186 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCH
T ss_pred             ECCCCC---ccccccCCcCcCCc
Confidence            764332   22346799999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=1e-28  Score=249.80  Aligned_cols=170  Identities=25%  Similarity=0.428  Sum_probs=146.7

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .++|...+.||+|+||.||+|..      .+++.||||+++... ....+++.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            45688889999999999999986      245889999997543 34457899999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCC-----------------------cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNY-----------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP  556 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~  556 (599)
                      ++||||+++|+|.+++.....                       .+++..+..++.||++||.|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999976432                       3788899999999999999999   88999999999


Q ss_pred             CCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          557 NNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       557 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +||+++.++.+||+|||+|+...............+|+.|+||
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            9999999999999999999876544433334455678899998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=8.5e-29  Score=254.42  Aligned_cols=167  Identities=25%  Similarity=0.389  Sum_probs=142.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      +.|+..+.||+|+||.||+|... +|+.||||++....     ....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46888999999999999999875 68999999986431     2246789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc---EEEccccCC
Q 042902          502 VLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMA  575 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DFGla  575 (599)
                      ||||+++|+|.+.+...   ...+++..+..++.||++||+|||   +.+|+||||||+||+++.++.   +||+|||+|
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877542   234788999999999999999999   889999999999999986654   999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +......  .......||+.||||
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAP  202 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCH
T ss_pred             eEecCCC--eeecCCcCCcCccCH
Confidence            8764332  223456799999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=8.6e-29  Score=252.13  Aligned_cols=164  Identities=25%  Similarity=0.397  Sum_probs=143.3

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|.+ .+|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999997 478999999986432   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+ +|+|.+++...+ .+++..+..++.||++||.|||   +.+|+||||||+||++++++.+||+|||+|+.......
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            999 789988887644 4889999999999999999999   88999999999999999999999999999986543322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         ....+||+.|+||
T Consensus       164 ---~~~~~gt~~y~aP  176 (336)
T 3h4j_B          164 ---LKTSCGSPNYAAP  176 (336)
T ss_dssp             ---TCCCTTSTTTSCG
T ss_pred             ---cccccCCcCcCCH
Confidence               2345799999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=1.1e-28  Score=260.80  Aligned_cols=168  Identities=21%  Similarity=0.356  Sum_probs=144.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..++|...+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3457889999999999999999865 68999999997543  23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCCccCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla~~~~  579 (599)
                      |||+++|+|.+.+...+ .+++..+..++.||++||.|||   +.+|+||||||+|||++   .++.+||+|||+|+...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999888754 4889999999999999999999   88999999999999998   46789999999998664


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ......||+.||||
T Consensus       165 ~~~~--~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSP  182 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCH
T ss_pred             CCCc--eeecccCCcccCCH
Confidence            3322  23456899999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=1.3e-28  Score=253.87  Aligned_cols=166  Identities=22%  Similarity=0.464  Sum_probs=144.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457889999999999999999876 68999999997543  334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++   .+||+|||+|+....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999887654 4889999999999999999999   88999999999999998654   599999999986643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......||+.||||
T Consensus       184 ~~---~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSP  199 (362)
T ss_dssp             CC---SCCCSCSCTTTCCH
T ss_pred             Cc---ccccCCCCccccCH
Confidence            22   22346799999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=9.1e-29  Score=253.60  Aligned_cols=171  Identities=25%  Similarity=0.420  Sum_probs=145.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  497 (599)
                      ..++|...+.||+|+||.||+|.+.      +++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4567888999999999999999862      46689999997542 33457899999999999 8999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcCCC----------------------cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNY----------------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  555 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  555 (599)
                      ..++||||+++|+|.+++.....                      .+++..+..++.||++||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976542                      3788899999999999999999   8899999999


Q ss_pred             CCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          556 PNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       556 ~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+||+++.++.+||+|||+|+...............||+.|+||
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            99999999999999999999876544443444556688999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=1.4e-28  Score=249.19  Aligned_cols=167  Identities=28%  Similarity=0.433  Sum_probs=130.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457899999999999999999865 68999999997543 3345778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          505 YMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |++ |+|.+++....     ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59998886432     34788899999999999999999   8899999999999999999999999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....  ......||+.|+||
T Consensus       160 ~~~~--~~~~~~~t~~y~aP  177 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAP  177 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCH
T ss_pred             CCcc--cCCCCcccccccCc
Confidence            3221  23445789999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=2.2e-29  Score=260.36  Aligned_cols=169  Identities=24%  Similarity=0.394  Sum_probs=143.1

Q ss_pred             CCCCcCceecccccceEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|...+.||+|+||.||+|++.      +++.||||+++.. ......++..|+.++++++|||||++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            46888899999999999999853      4678999999654 3344567999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEcc
Q 042902          501 LVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSD  571 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~D  571 (599)
                      +||||+++|+|.+++....      ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997543      35889999999999999999999   88999999999999999555   599999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|+.+.............||+.||||
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             CccccccccccccccCCCcCCcccEECH
Confidence            9999865333322233456789999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=6.7e-29  Score=247.30  Aligned_cols=168  Identities=24%  Similarity=0.388  Sum_probs=144.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|+..+.||+|+||.||+|++.++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            456888899999999999999999888999999975432 3477999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999875556899999999999999999999   8899999999999999999999999999998654322 122


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....+|+.|+||
T Consensus       178 ~~~~~~~~~y~aP  190 (283)
T 3gen_A          178 SVGSKFPVRWSPP  190 (283)
T ss_dssp             TTSTTSCGGGCCH
T ss_pred             ccCCccCcccCCH
Confidence            2345578889998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=7.4e-28  Score=238.90  Aligned_cols=207  Identities=21%  Similarity=0.213  Sum_probs=170.1

Q ss_pred             cceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEee
Q 042902           99 SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG  178 (599)
Q Consensus        99 ~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  178 (599)
                      .++.|++++|++++..+..|.++++|++|+|++|.++++.+.+|..+++|++|+|++|.+++..+..|..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            35555555555555555667778888888888888887777788888888888888888887777888888888888888


Q ss_pred             CCccCCCCCcccCCCCCCcEeecCCCCCCC--CCccccCCCcccEEeecCCCccccCccccccccccc----EEEccCCc
Q 042902          179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTS--IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV----QIDLSMNN  252 (599)
Q Consensus       179 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  252 (599)
                      +|.+++..+..|..+++|++|++++|.++.  +|..+..+++|++|++++|++++..+..|..+++|+    .|++++|.
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            888888777778888899999999998886  577888889999999999999888888888777777    89999999


Q ss_pred             cCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCC
Q 042902          253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIP  306 (599)
Q Consensus       253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  306 (599)
                      +++..+..+.. .+|++|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            99776666654 489999999999998877888999999999999999986554

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=7.2e-29  Score=256.32  Aligned_cols=166  Identities=31%  Similarity=0.396  Sum_probs=134.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHH-HhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDM-MKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            46888999999999999999976 58899999997543   2234556777776 5778999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus       118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999987643 4788888999999999999999   8999999999999999999999999999998643222


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                        ......+||+.||||
T Consensus       194 --~~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          194 --STTSTFCGTPEYLAP  208 (373)
T ss_dssp             --CCCCSBSCCCCCCCH
T ss_pred             --CccccccCCccccCH
Confidence              123456899999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=1.9e-28  Score=263.64  Aligned_cols=167  Identities=26%  Similarity=0.405  Sum_probs=146.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+..|++++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999976 69999999996542   234578899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||++||+|.+++....   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999987543   35889999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  .....+||+.||||
T Consensus       342 ~~~--~~~~~~GT~~Y~AP  358 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAP  358 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCH
T ss_pred             CCc--ccccccCCccccCh
Confidence            322  22345899999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=4.3e-29  Score=265.22  Aligned_cols=167  Identities=26%  Similarity=0.344  Sum_probs=135.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++..   .......+..|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999865 6899999999653   233456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||++|+|.+++.... .+++..+..++.||++||+|||   + .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999887644 4889999999999999999999   7 89999999999999999999999999999864332


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......+||+.||||
T Consensus       303 ~--~~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAP  318 (446)
T ss_dssp             ------CCSSSCGGGCCH
T ss_pred             C--cccccccCCccccCH
Confidence            2  223457899999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=2.5e-28  Score=259.72  Aligned_cols=165  Identities=27%  Similarity=0.414  Sum_probs=146.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888899999999999999976 79999999996442   234568899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence            9999999999997644 4899999999999999999999   8999999999999999999999999999998764332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.|+||
T Consensus       171 --~~~~~~gt~~y~aP  184 (476)
T 2y94_A          171 --FLRTSCGSPNYAAP  184 (476)
T ss_dssp             --CBCCCCSCSTTCCH
T ss_pred             --cccccCCCcCeECh
Confidence              22345799999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=248.26  Aligned_cols=166  Identities=27%  Similarity=0.445  Sum_probs=143.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--eeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--FKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46888899999999999999976 58999999997543 344677899999999999999999999988665  779999


Q ss_pred             EccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----cCCCcEEEccccCCcc
Q 042902          504 EYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKP  577 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DFGla~~  577 (599)
                      ||+++|+|.+++.....  .+++..+..++.||++||+|||   +.+|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976443  3899999999999999999999   8899999999999999    7888899999999987


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   .....||+.|+||
T Consensus       166 ~~~~~~---~~~~~gt~~y~aP  184 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHP  184 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCH
T ss_pred             cCCCCc---eeecccCCCccCH
Confidence            644322   2345799999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=248.97  Aligned_cols=165  Identities=24%  Similarity=0.268  Sum_probs=138.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||++....  ......+..|+..+.++ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888999999999999999976 79999999986542  22334556666666555 8999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+ +|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 77999988876667999999999999999999999   8899999999999999999999999999998654322 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||++|+||
T Consensus       212 --~~~~~~gt~~y~aP  225 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAP  225 (311)
T ss_dssp             -----CCCCCGGGCCG
T ss_pred             --CCcccCCCccccCH
Confidence              23445699999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=2.1e-28  Score=249.89  Aligned_cols=170  Identities=28%  Similarity=0.457  Sum_probs=145.6

Q ss_pred             hCCCCcCceecccccceEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|++.        +++.||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467888999999999999999863        46789999997543 34457799999999999 899999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCC---------------cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNY---------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++||||+++|+|.+++.....               .+++..+..++.||++||.|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976432               3788999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+|+...............+|+.|+||
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            99999999999999876544433334455678899998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=1.8e-28  Score=249.94  Aligned_cols=166  Identities=23%  Similarity=0.322  Sum_probs=143.7

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|+. .+|+.||||++.....  .+.+..|+++++++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            5788899999999999999996 4789999999865432  34688999999999 999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc-----EEEccccCCccCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-----AHLSDFGMAKPLLK  580 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DFGla~~~~~  580 (599)
                      + +|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.     +||+|||+|+.+..
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9 99999999876567999999999999999999999   889999999999999998887     99999999987644


Q ss_pred             CCCce-----eeecccCCccccCC
Q 042902          581 EDQSL-----TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-----~~~~~~gt~~y~AP  599 (599)
                      .....     ......||+.||||
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             CCCCccccccccCCcCCCccccCh
Confidence            32211     12456899999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=7e-29  Score=252.58  Aligned_cols=168  Identities=24%  Similarity=0.375  Sum_probs=136.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcE----EEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIE----VAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.++.. .....++|.+|++++++++||||++++++|.+.+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46888899999999999999864 3443    688887543 2345678999999999999999999999998765 789


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |+||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999887777999999999999999999999   889999999999999999999999999999876544


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........+|+.|+||
T Consensus       171 ~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             CC-------CCCGGGSCH
T ss_pred             cccccccCCCccccccCh
Confidence            443344556678899998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=1.3e-28  Score=248.78  Aligned_cols=170  Identities=24%  Similarity=0.397  Sum_probs=147.1

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQYE-GAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      .++|...+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788889999999999999985      2578999999975532 3457899999999999 89999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCC-----------------cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          499 KALVLEYMPHGSLEKCLYSSNY-----------------ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      .++||||+++|+|.+++.....                 .+++..+..++.||++||.|||   +.+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976542                 3789999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+|+...............+|+.|+||
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            99999999999999876554433334455678899998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=2.1e-28  Score=252.32  Aligned_cols=165  Identities=24%  Similarity=0.311  Sum_probs=136.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999976 789999999965432 346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc--EEEccccCCccCCcCCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DFGla~~~~~~~~  583 (599)
                      +++|+|.+++...+ .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999987644 4889999999999999999999   899999999999999987765  9999999998433221 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       173 --~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAP  186 (361)
T ss_dssp             ----------CTTSCH
T ss_pred             --CCCCCcCCCCcCCh
Confidence              22445799999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=4e-28  Score=240.88  Aligned_cols=166  Identities=27%  Similarity=0.385  Sum_probs=146.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|+..+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356888999999999999999976 4789999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +++++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||++   +.++.+||+|||+|+.+....
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887644 4789999999999999999999   8899999999999999   788899999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       164 ---~~~~~~~t~~y~aP  177 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSP  177 (277)
T ss_dssp             ---CBCCCCSCTTTCCH
T ss_pred             ---chhccCCCCCccCh
Confidence               22345799999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=1.2e-28  Score=246.09  Aligned_cols=163  Identities=26%  Similarity=0.421  Sum_probs=144.3

Q ss_pred             CCCCcCceecccccceEEEEEecC-C-------cEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-G-------IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      ++|...+.||+|+||.||+|.... +       ..||+|++........+.+.+|++++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            468888999999999999998653 3       57999999776666778899999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc--------EEEcc
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--------AHLSD  571 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~D  571 (599)
                      ++||||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.++.        +||+|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999887666899999999999999999999   889999999999999998876        99999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+++.....      ....||+.|+||
T Consensus       165 fg~~~~~~~~------~~~~~~~~y~aP  186 (289)
T 4fvq_A          165 PGISITVLPK------DILQERIPWVPP  186 (289)
T ss_dssp             CCSCTTTSCH------HHHHHTTTTSCH
T ss_pred             CcccccccCc------cccCCcCcccCH
Confidence            9999754321      234578899998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=6.3e-29  Score=251.12  Aligned_cols=169  Identities=22%  Similarity=0.424  Sum_probs=135.8

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe----
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF----  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  498 (599)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++...   ......|.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35788999999999999999996 478999999997543   2334678999999999999999999999876543    


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||+++|+|.+++...+ .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 4889999999999999999999   889999999999999999999999999999866


Q ss_pred             CcCCCc-eeeecccCCccccCC
Q 042902          579 LKEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      ...... .......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             ---------------CCTTCCH
T ss_pred             cccccccccccccCcCcccCCH
Confidence            433222 222345789999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.8e-28  Score=261.43  Aligned_cols=168  Identities=24%  Similarity=0.358  Sum_probs=130.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Ce
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  498 (599)
                      .++|...+.||+|+||.||+|++. +|+.||||++....  ....+++.+|++++++++|||||++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999866 68999999986532  33457899999999999999999999998543     56


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 579999887653 5899999999999999999999   889999999999999999999999999999876


Q ss_pred             CcCCCc-------------------------eeeecccCCccccCC
Q 042902          579 LKEDQS-------------------------LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~-------------------------~~~~~~~gt~~y~AP  599 (599)
                      ......                         ...+..+||++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  252 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP  252 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence            422110                         123456889999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=2.1e-28  Score=262.86  Aligned_cols=168  Identities=24%  Similarity=0.423  Sum_probs=146.0

Q ss_pred             hCCCCcCceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..+|...+.||+|+||.||+|.+.. ++.||||.++... ...++|.+|+++|++++|||||+++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4567888999999999999999874 8899999997543 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++|+|.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence            99999999998643 35889999999999999999999   889999999999999999999999999999866432 22


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+|+.||||
T Consensus       374 ~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          374 TAHAGAKFPIKWTAP  388 (495)
T ss_dssp             ECCTTCCCCGGGCCH
T ss_pred             eecCCCcCCcceeCH
Confidence            233445677899998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=3.7e-28  Score=241.25  Aligned_cols=168  Identities=27%  Similarity=0.476  Sum_probs=136.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            356888999999999999999874 79999999996442   23457899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999877667899999999999999999999   8899999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......||+.|+||
T Consensus       167 ~--~~~~~~~~~~y~aP  181 (278)
T 3cok_A          167 E--KHYTLCGTPNYISP  181 (278)
T ss_dssp             -----------------
T ss_pred             C--cceeccCCCCcCCc
Confidence            1  22345789999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=1e-28  Score=251.19  Aligned_cols=168  Identities=24%  Similarity=0.379  Sum_probs=139.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcE----EEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIE----VAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ++|...+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46888899999999999999865 4443    7888775432 333456788999999999999999999986 456889


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999876667888999999999999999999   889999999999999999999999999999977555


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........||+.|+||
T Consensus       169 ~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             TTCCC-----CCTTTSCH
T ss_pred             cccccccCCCCcccccCh
Confidence            444444556788899998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=3.2e-28  Score=244.67  Aligned_cols=169  Identities=23%  Similarity=0.437  Sum_probs=143.2

Q ss_pred             CCCCcCceecccccceEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--Cee
Q 042902          428 NGFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFK  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  499 (599)
                      ..|+..+.||+|+||.||+|++     .+++.||||+++... ....+.+.+|++++++++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3477889999999999999984     368999999997543 34567899999999999999999999999876  568


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999766666899999999999999999999   8899999999999999999999999999998765


Q ss_pred             cCCCc-eeeecccCCccccCC
Q 042902          580 KEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      ..... .......||+.|+||
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCH
T ss_pred             CCCcceeccCCCCCCccccCC
Confidence            43322 223456688889998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=4.1e-28  Score=253.14  Aligned_cols=170  Identities=19%  Similarity=0.274  Sum_probs=145.7

Q ss_pred             hCCCCcCceeccc--ccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRG--GVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|  +||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568889999999  99999999976 69999999997553  3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          502 VLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      |||||++|+|.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999987652 35889999999999999999999   88999999999999999999999999999875533


Q ss_pred             CCCc-----eeeecccCCccccCC
Q 042902          581 EDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      ....     .......||+.|+||
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             ccccccccccccccccccccccCH
Confidence            2211     111234789999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=1.6e-28  Score=249.42  Aligned_cols=170  Identities=26%  Similarity=0.476  Sum_probs=128.2

Q ss_pred             hCCCCcCceecccccceEEEEEecC-C---cEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee-
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD-G---IEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK-  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-  499 (599)
                      .++|...+.||+|+||.||+|++.. +   ..||||+++..  .....+++.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999998764 3   27999999754  344567899999999999999999999999877655 


Q ss_pred             -----eEEEEccCCCChhhhhhcCC-----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          500 -----ALVLEYMPHGSLEKCLYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       500 -----~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                           ++||||+++|+|.+++....     ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999885422     24889999999999999999999   889999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+|+...............+|+.|+||
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             CCCCC-----------------CCGGGCCH
T ss_pred             eeccccccccccccccccccccCcccccCc
Confidence            999999876544433334455678899998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=2.5e-28  Score=250.22  Aligned_cols=167  Identities=23%  Similarity=0.407  Sum_probs=139.2

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCC--CcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRH--RNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  502 (599)
                      .+.|+..+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++.+++|  |||+++++++.+++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            34688899999999999999999889999999986543  3345789999999999986  9999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||| .+|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++ ++.+||+|||+|+.+....
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5889999998754 4888999999999999999999   88999999999999997 5789999999998765443


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .........||+.|+||
T Consensus       162 ~~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             --------CCCCSSCCH
T ss_pred             ccccCCCCcCCcCcCCH
Confidence            33334456899999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=5.2e-28  Score=239.78  Aligned_cols=169  Identities=24%  Similarity=0.354  Sum_probs=147.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356888999999999999999976 68999999996543 3445789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++|+|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||.++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999987543 4889999999999999999999   889999999999999999999999999999865433322


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       162 ~~~~~~~~~~~y~aP  176 (276)
T 2yex_A          162 RLLNKMCGTLPYVAP  176 (276)
T ss_dssp             CCBCCCCSCGGGCCG
T ss_pred             hcccCCccccCccCh
Confidence            233456789999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=7e-29  Score=251.98  Aligned_cols=175  Identities=20%  Similarity=0.356  Sum_probs=147.2

Q ss_pred             HHHHHhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 042902          422 ELFQATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCS  494 (599)
Q Consensus       422 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  494 (599)
                      ++....++|+..+.||+|+||.||+|.+.      +++.||||.+.... ......|.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999864      37889999997543 234567999999999999999999999999


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcCC---------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM  565 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~  565 (599)
                      +.+..++||||+++|+|.+++....         ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999987532         24688899999999999999999   88999999999999999999


Q ss_pred             cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+||+|||+++...............+|+.|+||
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccCh
Confidence            9999999999866443322233345678899998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=1.4e-28  Score=261.65  Aligned_cols=168  Identities=22%  Similarity=0.390  Sum_probs=144.2

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|||||++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            456788889999999999999999889999999997543 35688999999999999999999999986 5678999999


Q ss_pred             cCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++|+|.++++... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            99999999997543 25788889999999999999999   8899999999999999999999999999998654221 1


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+|+.|+||
T Consensus       340 ~~~~~~~~~~~y~aP  354 (454)
T 1qcf_A          340 TAREGAKFPIKWTAP  354 (454)
T ss_dssp             HTTCSSSSCGGGSCH
T ss_pred             eccCCCcccccccCH
Confidence            122344578899998

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=1.8e-27  Score=237.48  Aligned_cols=207  Identities=24%  Similarity=0.225  Sum_probs=184.0

Q ss_pred             cccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCC
Q 042902          117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSL  196 (599)
Q Consensus       117 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  196 (599)
                      .+.++++++++++++|.++.+++ .+.  ++++.|+|++|.|++..+..|..+++|++|+|++|.++++.+.  +.+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~ip~-~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCCcCCC-CCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            36778899999999999986544 332  6899999999999988888999999999999999999876443  788999


Q ss_pred             cEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccc
Q 042902          197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       197 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  276 (599)
                      ++|++++|+|+.+|..+..+++|++|++++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            99999999999999988899999999999999998888899999999999999999998888889999999999999999


Q ss_pred             ccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccC
Q 042902          277 LQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       277 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  329 (599)
                      |++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.+++++|++.|..
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            99887788899999999999999999 67888888889999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=3.7e-28  Score=249.15  Aligned_cols=162  Identities=28%  Similarity=0.379  Sum_probs=141.7

Q ss_pred             CCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      +.|...+.||+|+||.||+|+. .+|+.||||++....   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3478889999999999999986 478999999996542   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||++ |++.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 6888888655556899999999999999999999   889999999999999999999999999999865322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                          ....||+.||||
T Consensus       208 ----~~~~gt~~y~aP  219 (348)
T 1u5q_A          208 ----NSFVGTPYWMAP  219 (348)
T ss_dssp             ----CCCCSCGGGCCH
T ss_pred             ----CcccCCcceeCH
Confidence                235799999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=4.1e-28  Score=246.91  Aligned_cols=169  Identities=25%  Similarity=0.364  Sum_probs=146.4

Q ss_pred             CCCCcCceecccccceEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEE--cCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS--NDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  ..+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688889999999999999984     368899999998766666678999999999999999999999887  445789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999875556899999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCCc-eeeecccCCccccCC
Q 042902          581 EDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-~~~~~~~gt~~y~AP  599 (599)
                      .... .......||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCH
T ss_pred             CCccceeeccCCccccccCH
Confidence            3322 222345688899998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=4e-28  Score=256.51  Aligned_cols=168  Identities=27%  Similarity=0.358  Sum_probs=140.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Ce
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  498 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999875 5889999999654  233457899999999999999999999998766     57


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||++ |+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 59999987653 4899999999999999999999   889999999999999999999999999999876


Q ss_pred             CcCCCc--------------------eeeecccCCccccCC
Q 042902          579 LKEDQS--------------------LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~--------------------~~~~~~~gt~~y~AP  599 (599)
                      ......                    ...+..+||++|+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             -------------------------------CCCCCTTCCH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            433211                    123567899999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=2.6e-28  Score=242.77  Aligned_cols=168  Identities=23%  Similarity=0.366  Sum_probs=132.6

Q ss_pred             hCCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|.+..    +..||+|..+... ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3568888999999999999998742    5679999986543 334567999999999999999999999984 567899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999866433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .. .......+|+.|+||
T Consensus       170 ~~-~~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAP  186 (281)
T ss_dssp             ----------CCGGGCCH
T ss_pred             cc-cccccCCCcccccCh
Confidence            21 222345678899998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.95  E-value=6e-28  Score=242.53  Aligned_cols=167  Identities=29%  Similarity=0.426  Sum_probs=137.3

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCcceeEEEEEEcC----Ceee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR--IRHRNLIKIISSCSND----DFKA  500 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~  500 (599)
                      .++|+..+.||+|+||.||+|++ +|+.||||++...   ....+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            45788999999999999999988 5899999998644   23456667766665  7999999999986543    4689


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      +||||+++|+|.++++..  .+++..+..++.||++||+|||...     +.+|+||||||+|||++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  4899999999999999999999432     578999999999999999999999999999


Q ss_pred             ccCCcCCCce--eeecccCCccccCC
Q 042902          576 KPLLKEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      +.........  ......||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred             eecccccccccccccccccccceeCh
Confidence            8654332221  12345799999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=2.8e-29  Score=256.64  Aligned_cols=161  Identities=20%  Similarity=0.217  Sum_probs=132.7

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---------CCcceeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--------EGAFKSFDIECDMMKRIR---------HRNLIKI  489 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  489 (599)
                      .++|...+.||+|+||.||+|+. +|+.||||+++...        ....+.+.+|+++++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35678889999999999999998 68999999997542        223478899999998885         7777777


Q ss_pred             EEEEE------------------------------cCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHH
Q 042902          490 ISSCS------------------------------NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE  539 (599)
Q Consensus       490 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  539 (599)
                      .+.+.                              +.+..|+||||+++|++.+.+..  ..+++..+..|+.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            76542                              26789999999999977666644  34789999999999999999


Q ss_pred             HHhcCCCCCeEEccCCCCCeeecCCC--------------------cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          540 YLHFGYSVPIIHCDLKPNNVLLDDNM--------------------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       540 ~lH~~~~~~iiH~dlk~~Nill~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+|+....       ...+||+.||||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9992  25899999999999999887                    899999999986532       134799999999

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=2.6e-28  Score=240.78  Aligned_cols=167  Identities=26%  Similarity=0.391  Sum_probs=146.6

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56888899999999999999998899999999975533 34789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~  162 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  162 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence            99999999877667899999999999999999999   8899999999999999999999999999998653221 1122


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....+|+.|+||
T Consensus       163 ~~~~~~~~y~aP  174 (267)
T 3t9t_A          163 TGTKFPVKWASP  174 (267)
T ss_dssp             TSTTCCGGGCCH
T ss_pred             ccccccccccCh
Confidence            345678889998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=3.3e-28  Score=243.12  Aligned_cols=167  Identities=27%  Similarity=0.435  Sum_probs=132.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|++.  ..||||+++...  ....+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467899999999999999999865  469999997543  33457899999999999999999999965 4556899999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++++|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877777999999999999999999999   889999999999999999999999999999865433333


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       177 ~~~~~~~gt~~y~aP  191 (289)
T 3og7_A          177 HQFEQLSGSILWMAP  191 (289)
T ss_dssp             -------CCCTTCCH
T ss_pred             ccccccCCCccccCc
Confidence            333456799999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=4.9e-28  Score=252.23  Aligned_cols=166  Identities=23%  Similarity=0.404  Sum_probs=140.0

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCC--CCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR--HRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ..|...+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            3488899999999999999998889999999986543  334578999999999996  599999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      | +.+|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999998765 5788889999999999999999   89999999999999995 57999999999987654333


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      .......+||+.||||
T Consensus       210 ~~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPP  225 (390)
T ss_dssp             ----CCSCCCGGGCCH
T ss_pred             cccCCCCCcCCCccCh
Confidence            3333456799999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=3.1e-28  Score=248.49  Aligned_cols=167  Identities=28%  Similarity=0.367  Sum_probs=144.3

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--------GAFKSFDIECDMMKRIRHRNLIKIISSCSND  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  496 (599)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++....        ...+.+..|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3567999999999999999999865 689999999965421        1334678899999999999999999999999


Q ss_pred             CeeeEEEEccCCC-ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          497 DFKALVLEYMPHG-SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       497 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      +..++||||+.+| +|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887654 4899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCcCCCceeeecccCCccccCC
Q 042902          576 KPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.......   .....||+.|+||
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aP  198 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAP  198 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCH
T ss_pred             eECCCCCc---eeccCCCccccCh
Confidence            87643322   2345799999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=6.8e-28  Score=251.34  Aligned_cols=168  Identities=24%  Similarity=0.384  Sum_probs=132.7

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCC--ee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDD--FK  499 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  499 (599)
                      ..++|+..+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999865 6899999998543  2344567889999999997 999999999997654  68


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |+|||||+ |+|.+++...  .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5999988764  4888899999999999999999   8899999999999999999999999999998653


Q ss_pred             cCC-------------------CceeeecccCCccccCC
Q 042902          580 KED-------------------QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~-------------------~~~~~~~~~gt~~y~AP  599 (599)
                      ...                   .....+..+||++||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            211                   11123456899999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=1e-27  Score=242.75  Aligned_cols=168  Identities=26%  Similarity=0.361  Sum_probs=138.6

Q ss_pred             CCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.|... +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457663 78999999999999865 6999999999766656678899999999985 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc---EEEccccCCccCCcC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMAKPLLKE  581 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DFGla~~~~~~  581 (599)
                      |+++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.   +||+|||+++.....
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999997653 4788999999999999999999   889999999999999998775   999999999865422


Q ss_pred             CC-----ceeeecccCCccccCC
Q 042902          582 DQ-----SLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~-----~~~~~~~~gt~~y~AP  599 (599)
                      ..     ........||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             --------------CCSGGGCCH
T ss_pred             CccccccccccccccCCcCccCh
Confidence            11     1112345699999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=1.3e-27  Score=242.86  Aligned_cols=158  Identities=25%  Similarity=0.346  Sum_probs=125.6

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      .+.||+|+||.||+|... +|+.||||++...   ....+..|+.+++.+. ||||+++++++.+++..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999976 6899999999643   3467788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEEccccCCccCCcCCCceee
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      |.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++   .+||+|||+|+.......  ..
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            999998754 5899999999999999999999   88999999999999998665   899999999986543322  23


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||+.|+||
T Consensus       167 ~~~~~t~~y~aP  178 (325)
T 3kn6_A          167 KTPCFTLHYAAP  178 (325)
T ss_dssp             ------------
T ss_pred             cccCCCcCccCH
Confidence            456789999999

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=5.9e-27  Score=231.55  Aligned_cols=206  Identities=25%  Similarity=0.333  Sum_probs=162.4

Q ss_pred             CCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      .+.+++++++|.++. +|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|+++.+.+..|..+++|++|++
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            346777888887774 343332  56788888888887766667778888888888888887777777777888888888


Q ss_pred             CCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccccc
Q 042902          202 GSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       202 ~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      ++|.++.+|. .+..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            8888887765 456778888888888888877777788888888888888888877777788888888888888888877


Q ss_pred             CcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          281 IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       281 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      .+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.|..+
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            77778888888888888888887777778888888888888888887765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=4.8e-28  Score=248.32  Aligned_cols=175  Identities=26%  Similarity=0.384  Sum_probs=141.9

Q ss_pred             HHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc
Q 042902          422 ELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-----YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN  495 (599)
Q Consensus       422 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  495 (599)
                      ++....++|...+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34456678999999999999999999875 6889999998643     23456789999999999999999999999999


Q ss_pred             CCeeeEEEEccCCCChhhhhhcC---------------------------------------CCcCCHHHHHHHHHHHHH
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSS---------------------------------------NYILDIFQRLNIMIDVAS  536 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~  536 (599)
                      .+..++||||+++|+|.+++...                                       ...+++..+..++.||++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988521                                       112356667889999999


Q ss_pred             HHHHHhcCCCCCeEEccCCCCCeeecCCC--cEEEccccCCccCCcCCC--ceeeecccCCccccCC
Q 042902          537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNM--VAHLSDFGMAKPLLKEDQ--SLTQTQTLATIGYMAP  599 (599)
Q Consensus       537 ~l~~lH~~~~~~iiH~dlk~~Nill~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||   +.+|+||||||+||+++.++  .+||+|||+|+.+.....  ........||+.|+||
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            999999   88999999999999998776  899999999986543221  1223456799999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=7.2e-28  Score=243.26  Aligned_cols=166  Identities=27%  Similarity=0.348  Sum_probs=138.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999976 589999999865432  235678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+....... 
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999998876543 4889999999999999999999   88999999999999999999999999999986643222 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.|+||
T Consensus       158 -~~~~~~~~~~y~aP  171 (311)
T 4agu_A          158 -YYDDEVATRWYRSP  171 (311)
T ss_dssp             ---------GGGCCH
T ss_pred             -ccCCCcCCccccCh
Confidence             22445789999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=4.2e-28  Score=248.98  Aligned_cols=164  Identities=26%  Similarity=0.388  Sum_probs=128.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .+.|...+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            457888999999999999999986 58899999997543  346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~~~~~~~  582 (599)
                      +++|+|.+++...+ .+++..+..++.||++||.|||   +.+|+||||||+||+++.   ++.+||+|||+|+......
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999987654 4889999999999999999999   889999999999999975   8899999999998653221


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       206 ---~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          206 ---LMKTVCGTPGYCAP  219 (349)
T ss_dssp             ----------CGGGSCH
T ss_pred             ---ccccccCCCCccCH
Confidence               22346799999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=7e-28  Score=255.94  Aligned_cols=162  Identities=30%  Similarity=0.437  Sum_probs=139.6

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC-eeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD-FKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  505 (599)
                      .++|...+.||+|+||.||+|.+. |+.||||+++...  ..++|.+|+++|++++|||||++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            456888899999999999999986 8899999997543  4578999999999999999999999987665 78999999


Q ss_pred             cCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++|+|.+++...+. .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999986543 4688899999999999999999   889999999999999999999999999999854221   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....+|+.||||
T Consensus       343 --~~~~~~~~~y~aP  355 (450)
T 1k9a_A          343 --QDTGKLPVKWTAP  355 (450)
T ss_dssp             ------CCCTTTSCH
T ss_pred             --ccCCCCCcceeCH
Confidence              1223678899998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=2.6e-28  Score=246.97  Aligned_cols=179  Identities=23%  Similarity=0.392  Sum_probs=149.9

Q ss_pred             ccHHHHHHHhCCCCcCceecccccceEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeE
Q 042902          418 FTHLELFQATNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKI  489 (599)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l  489 (599)
                      +...++....++|...+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34444445567899999999999999999984      256899999997553 33456799999999999 69999999


Q ss_pred             EEEEEcCC-eeeEEEEccCCCChhhhhhcCCCc---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 042902          490 ISSCSNDD-FKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQRLNIMIDVASALEYLHFGYSVPIIHCD  553 (599)
Q Consensus       490 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d  553 (599)
                      ++++...+ ..++||||+++|+|.+++......               +++..+..++.|+++||.|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987654 589999999999999999865432               788899999999999999999   88999999


Q ss_pred             CCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          554 LKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       554 lk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+||+++.++.+||+|||+|+.+.............||+.|+||
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            9999999999999999999999876544443444556789999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=6e-28  Score=252.34  Aligned_cols=166  Identities=27%  Similarity=0.439  Sum_probs=143.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--eeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--FKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46888899999999999999976 58999999997543 344677889999999999999999999998765  779999


Q ss_pred             EccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----cCCCcEEEccccCCcc
Q 042902          504 EYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSDFGMAKP  577 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----~~~~~~kl~DFGla~~  577 (599)
                      ||+++|+|.+++.....  .+++..+..++.||++||+|||   +.+|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976433  3899999999999999999999   8899999999999999    7788899999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....   ......||+.|+||
T Consensus       166 ~~~~~---~~~~~~gt~~y~aP  184 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHP  184 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCH
T ss_pred             ccCCC---ccccccCCccccCH
Confidence            64332   22346799999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.7e-28  Score=252.55  Aligned_cols=167  Identities=26%  Similarity=0.358  Sum_probs=144.2

Q ss_pred             CCCCcCceecccccceEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          428 NGFSENNLIGRGGVASVYKARI----QDGIEVAVKVFDLQY----EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      ++|...+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+..|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5688899999999999999987    368999999986432    23345678899999999 69999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999997654 4888999999999999999999   889999999999999999999999999999866


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... .......||+.||||
T Consensus       210 ~~~~~-~~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          210 VADET-ERAYDFCGTIEYMAP  229 (355)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCH
T ss_pred             ccCCC-CcccCcccCcCccCh
Confidence            43322 223456799999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=1.7e-27  Score=237.65  Aligned_cols=163  Identities=29%  Similarity=0.492  Sum_probs=140.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEG-------AFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|++. +++.||||++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            357888999999999999999975 7899999998644221       1267999999999999999999999986654 


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeecCCCc-----EEEcc
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMV-----AHLSD  571 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~~~~~-----~kl~D  571 (599)
                       ++||||+++|+|.+.+......+++..+..++.|+++||+|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999999999877777999999999999999999999   778  999999999999987776     99999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|+....     ......||+.|+||
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAP  195 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCG
T ss_pred             CCccccccc-----cccccCCCccccCc
Confidence            999985422     23446799999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=8.5e-28  Score=266.88  Aligned_cols=168  Identities=23%  Similarity=0.272  Sum_probs=146.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  500 (599)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3567999999999999999999976 5889999999743   234557788999999987 6999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++...+ .+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998654 4889999999999999999999   88999999999999999999999999999986433


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  .....+||+.||||
T Consensus       495 ~~~--~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAP  511 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCH
T ss_pred             CCc--ccccccCCCcccCH
Confidence            322  23457899999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=7.7e-28  Score=239.11  Aligned_cols=165  Identities=27%  Similarity=0.435  Sum_probs=140.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..+.||+|+||.||+|... +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            456888999999999999999876 57899999985432   23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999987643 4788999999999999999999   899999999999999999999999999998754322 


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       163 ---~~~~~~~~~~y~aP  176 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPP  176 (279)
T ss_dssp             --------CCCCTTCCH
T ss_pred             ---cccccCCCCCccCH
Confidence               22345789999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=3.3e-28  Score=258.64  Aligned_cols=168  Identities=24%  Similarity=0.421  Sum_probs=138.6

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            345688889999999999999999888899999997543 345789999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++|+|.+++... ...+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            9999999999753 234889999999999999999999   8899999999999999999999999999998654322 2


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+|+.||||
T Consensus       336 ~~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          336 TARQGAKFPIKWTAP  350 (452)
T ss_dssp             -------CCGGGSCH
T ss_pred             ecccCCcccccccCH
Confidence            223345678899998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=1.2e-27  Score=242.96  Aligned_cols=165  Identities=25%  Similarity=0.384  Sum_probs=144.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      +.|...+.||+|+||.||+|+.. +|+.||||++.....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46888999999999999999976 689999999865422      13678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla~  576 (599)
                      +||||+++|+|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            9999999999999997644 4788999999999999999999   88999999999999999887    79999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.|+||
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          168 EIEDGV---EFKNIFGTPEFVAP  187 (321)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCH
T ss_pred             ecCccc---cccccCCCCCccCc
Confidence            664332   22345799999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=6.8e-28  Score=240.35  Aligned_cols=166  Identities=26%  Similarity=0.399  Sum_probs=139.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888899999999999999875 68999999986553 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCC
Q 042902          506 MPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       506 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~  579 (599)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||   +.+|+||||||+||++   +.++.+||+|||+|+.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988542   245889999999999999999999   8899999999999999   456789999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...   ......||+.|+||
T Consensus       179 ~~~---~~~~~~~t~~y~aP  195 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAP  195 (285)
T ss_dssp             -----------CTTGGGCCH
T ss_pred             Ccc---cCcCcccccCcCCh
Confidence            322   23446799999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=5.1e-28  Score=248.26  Aligned_cols=169  Identities=31%  Similarity=0.479  Sum_probs=139.6

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-----ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-----GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++.....     ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 589999999864321     123468899999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999976 899888877667888889999999999999999   889999999999999999999999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....  ......||+.|+||
T Consensus       163 ~~~~~--~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAP  181 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCH
T ss_pred             cCCcc--cCCcccccccccCc
Confidence            43322  23456789999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.4e-28  Score=248.26  Aligned_cols=166  Identities=25%  Similarity=0.412  Sum_probs=136.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEG-AFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999976 6899999998654322 222456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++ |+|.+++......+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999998877777899999999999999999999   8899999999999999999999999999998553222  2


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (324)
T 3mtl_A          156 TYDNEVVTLWYRPP  169 (324)
T ss_dssp             -------CGGGCCH
T ss_pred             ccccccCcccccCh
Confidence            23445789999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=243.57  Aligned_cols=169  Identities=27%  Similarity=0.449  Sum_probs=145.3

Q ss_pred             CCCCcCceecccccceEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--eee
Q 042902          428 NGFSENNLIGRGGVASVYKARI-----QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--FKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~  500 (599)
                      ++|...+.||+|+||.||+|++     .+|+.||||++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4578889999999999999984     368999999998766666788999999999999999999999987654  789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999887667899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCce-eeecccCCccccCC
Q 042902          581 EDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ..... ......+|+.|+||
T Consensus       198 ~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCH
T ss_pred             cccccccccCCCCceeEECc
Confidence            33221 12334577889998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.95  E-value=3.3e-27  Score=233.64  Aligned_cols=222  Identities=27%  Similarity=0.322  Sum_probs=117.8

Q ss_pred             CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccce
Q 042902           22 LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME  101 (599)
Q Consensus        22 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~  101 (599)
                      +..+++.++.+.+.  ..+..+++|+.|++++|.++.++       .+..+++|++|+|++|.+++.             
T Consensus        21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~-------~l~~l~~L~~L~l~~n~l~~~-------------   78 (272)
T 3rfs_A           21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQ-------GIQYLPNVRYLALGGNKLHDI-------------   78 (272)
T ss_dssp             HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCCT-------TGGGCTTCCEEECTTSCCCCC-------------
T ss_pred             HHHHHhcCcccccc--cccccccceeeeeeCCCCccccc-------ccccCCCCcEEECCCCCCCCc-------------
Confidence            34444555555443  22445555666666666555433       245555555555555555421             


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                                    ..+.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus        79 --------------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  144 (272)
T 3rfs_A           79 --------------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ  144 (272)
T ss_dssp             --------------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             --------------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc
Confidence                          134455666666666666665555556666666666666666665555555556666666666666


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCcc
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT  260 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  260 (599)
                      +++..+..|..+++|++|++++|+++.+|.. +..+++|++|++++|++++..+..|..+++|+.|+|++|.+.+.    
T Consensus       145 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~----  220 (272)
T 3rfs_A          145 LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT----  220 (272)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC----
T ss_pred             cCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc----
Confidence            6655555555555566666555555555432 34455555555555555544444445555555555555544422    


Q ss_pred             ccCcccccccccccccccccCccccc
Q 042902          261 IGDLKDLQYLFLEYNRLQGSIPDSIG  286 (599)
Q Consensus       261 ~~~l~~L~~L~L~~N~l~~~~~~~~~  286 (599)
                         +++|+.|+++.|.++|.+|..++
T Consensus       221 ---~~~l~~l~~~~n~~~g~ip~~~~  243 (272)
T 3rfs_A          221 ---CPGIRYLSEWINKHSGVVRNSAG  243 (272)
T ss_dssp             ---TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred             ---CcHHHHHHHHHHhCCCcccCccc
Confidence               22344444444444444444333

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=5.3e-28  Score=249.94  Aligned_cols=170  Identities=20%  Similarity=0.264  Sum_probs=138.3

Q ss_pred             HhCCCCcCceecccccceEEEEEecC------CcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCCccee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQYEG-----------AFKSFDIECDMMKRIRHRNLIK  488 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~  488 (599)
                      ..++|...+.||+|+||.||+|.+..      ++.||||++......           ....+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578999999999999999998764      478999998654311           1123445666778889999999


Q ss_pred             EEEEEEcC----CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec--
Q 042902          489 IISSCSND----DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--  562 (599)
Q Consensus       489 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~--  562 (599)
                      +++++...    ...++||||+ +|+|.+++......+++..+..|+.||++||+|||   +.+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998764    4589999999 99999999887667999999999999999999999   88999999999999999  


Q ss_pred             CCCcEEEccccCCccCCcCCCce-----eeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSL-----TQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~AP  599 (599)
                      .++.+||+|||+|+.+.......     ......||+.||||
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence            88999999999998765332211     11345699999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=1.8e-27  Score=238.30  Aligned_cols=167  Identities=20%  Similarity=0.342  Sum_probs=145.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|... +++.||+|++....   ....+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888899999999999999976 58899999986542   23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887543 4889999999999999999999   8899999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......||+.|+||
T Consensus       170 ~--~~~~~~~~~~y~aP  184 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAP  184 (294)
T ss_dssp             C--CBCCCCSCCSSCCH
T ss_pred             c--ccccccCCCCcCCc
Confidence            2  22346789999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.4e-28  Score=250.80  Aligned_cols=168  Identities=27%  Similarity=0.457  Sum_probs=131.5

Q ss_pred             CCCcCceecccccceEEEEEec--CC--cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCeeeEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ--DG--IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDFKALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  502 (599)
                      .|...+.||+|+||.||+|++.  ++  ..||||.++.. .....++|.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556689999999999999864  22  46899998654 33456789999999999999999999998764 4578999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877767889999999999999999999   8899999999999999999999999999998664332


Q ss_pred             Cc--eeeecccCCccccCC
Q 042902          583 QS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~--~~~~~~~gt~~y~AP  599 (599)
                      ..  .......+|+.||||
T Consensus       247 ~~~~~~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMAL  265 (373)
T ss_dssp             -----------CCGGGSCH
T ss_pred             cccccccCCCCCcccccCh
Confidence            11  122445678899998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=5e-28  Score=240.39  Aligned_cols=167  Identities=23%  Similarity=0.401  Sum_probs=143.2

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|...+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            45788899999999999999999888899999996543 34578999999999999999999999986 45689999999


Q ss_pred             CCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++..... .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...... ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            99999999875432 5889999999999999999999   8899999999999999999999999999998764332 22


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......+|+.|+||
T Consensus       166 ~~~~~~~~~~y~aP  179 (279)
T 1qpc_A          166 AREGAKFPIKWTAP  179 (279)
T ss_dssp             CCTTCCCCTTTSCH
T ss_pred             cccCCCCccCccCh
Confidence            22345678899998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=5e-28  Score=246.91  Aligned_cols=171  Identities=24%  Similarity=0.406  Sum_probs=145.7

Q ss_pred             HhCCCCcCceecccccceEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDD  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  497 (599)
                      ..++|...+.||+|+||.||+|....      ++.||||.+.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45678899999999999999998642      2479999997553 33457799999999999 8999999999999999


Q ss_pred             eeeEEEEccCCCChhhhhhcC-------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC
Q 042902          498 FKALVLEYMPHGSLEKCLYSS-------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~  564 (599)
                      ..++||||+++|+|.+++...             ...+++..+..++.||++||.|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998653             224788899999999999999999   8899999999999999999


Q ss_pred             CcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          565 MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       565 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.+||+|||+|+...............+|+.|+||
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP  235 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCH
Confidence            99999999999876544433333455678899998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=2e-27  Score=236.73  Aligned_cols=166  Identities=22%  Similarity=0.460  Sum_probs=143.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999876 58999999996543  334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc---EEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+.+.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887653 4889999999999999999999   889999999999999986655   99999999986543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......||+.|+||
T Consensus       161 ~~---~~~~~~~~~~y~aP  176 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSP  176 (284)
T ss_dssp             SC---BCCCSCSCGGGCCH
T ss_pred             Cc---cccCCCCCcCCcCc
Confidence            22   22346799999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=9.5e-28  Score=240.81  Aligned_cols=169  Identities=27%  Similarity=0.440  Sum_probs=140.6

Q ss_pred             CCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEE-cCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCS-NDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l  501 (599)
                      ..|...+.||+|+||.||+|.+.+    +..||+|.+.... ....+.+.+|++++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778999999999999998642    3368999987543 344578999999999999999999999865 4567899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999866433


Q ss_pred             CC--ceeeecccCCccccCC
Q 042902          582 DQ--SLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~--~~~~~~~~gt~~y~AP  599 (599)
                      ..  ........+|+.|+||
T Consensus       182 ~~~~~~~~~~~~~~~~y~aP  201 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMAL  201 (298)
T ss_dssp             GGCBC-----CCBCGGGSCH
T ss_pred             chhccccccCCCCCccccCh
Confidence            21  1223455678899998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=9.9e-28  Score=252.35  Aligned_cols=166  Identities=26%  Similarity=0.344  Sum_probs=133.5

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--------EGAFKSFDIECDMMKRIRHRNLIKIISSCSND  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  496 (599)
                      ..++|...+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999875 58999999986532        1122358899999999999999999999854 


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC---CcEEEcccc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFG  573 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DFG  573 (599)
                      +..++||||+++|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+|||++.+   +.+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            45799999999999999887654 4889999999999999999999   8899999999999999754   459999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|+.....   .......||+.||||
T Consensus       288 ~a~~~~~~---~~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          288 HSKILGET---SLMRTLCGTPTYLAP  310 (419)
T ss_dssp             TTTSCC--------------CTTCCT
T ss_pred             cceecCCC---ccccccCCCCCccCc
Confidence            99865432   223456799999999

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=2.5e-27  Score=237.68  Aligned_cols=167  Identities=17%  Similarity=0.189  Sum_probs=144.1

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|...+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+++++++ +|+|++++++++.+.+..++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35688999999999999999996 479999999986442  234678899999999 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc-----EEEccccCCccCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-----AHLSDFGMAKPLL  579 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~DFGla~~~~  579 (599)
                      |+ +|+|.+++...+..+++..+..++.||++||+|||   +.+|+||||||+||+++.++.     +||+|||+|+...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999876666899999999999999999999   899999999999999987775     9999999998765


Q ss_pred             cCCCc-----eeeecccCCccccCC
Q 042902          580 KEDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      .....     .......||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccccccccccCccCCCCCcccCCc
Confidence            43221     123456799999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=1.8e-27  Score=244.69  Aligned_cols=168  Identities=27%  Similarity=0.416  Sum_probs=142.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc--------C
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN--------D  496 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  496 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57889999999999999999974 78999999986443  3335678899999999999999999999876        3


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      +..++||||+++ ++.+.+......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 888888776667899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCcCC--CceeeecccCCccccCC
Q 042902          577 PLLKED--QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~--~~~~~~~~~gt~~y~AP  599 (599)
                      .+....  .........||+.|+||
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             cccccccccccccCCcccccCccCc
Confidence            664222  12223456789999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.8e-27  Score=241.68  Aligned_cols=165  Identities=28%  Similarity=0.412  Sum_probs=136.5

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC--CCCcceeEEEEEEcC----Cee
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI--RHRNLIKIISSCSND----DFK  499 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~  499 (599)
                      ..++|...+.||+|+||.||+|++. |+.||||++....   ...+..|.+++...  +||||+++++++...    +..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            4467999999999999999999986 8999999985432   24455566665554  899999999999877    688


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEEccCCCCCeeecCCCcEEEcc
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV--------PIIHCDLKPNNVLLDDNMVAHLSD  571 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~--------~iiH~dlk~~Nill~~~~~~kl~D  571 (599)
                      ++||||+++|+|.++++...  +++..+..++.|++.||.|||   +.        +|+||||||+||+++.++.+||+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            99999999999999997653  889999999999999999999   66        999999999999999999999999


Q ss_pred             ccCCccCCcCCCce--eeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      ||+|+.+.......  ......||+.|+||
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCH
T ss_pred             CCCceeeccccccccCCCCCCccCcceeCh
Confidence            99998664332211  12345799999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.95  E-value=6.6e-28  Score=245.33  Aligned_cols=169  Identities=24%  Similarity=0.373  Sum_probs=135.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcE----EEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIE----VAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      .++|...+.||+|+||.||+|.+. +++.    ||+|.+... .....+.+.+|++++++++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357888999999999999999865 4544    577776543 3445678999999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +|+||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...........+|+.|+||
T Consensus       170 ~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             ccccccccCCCccccccCH
Confidence            4433344456678899998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=3.4e-27  Score=236.33  Aligned_cols=167  Identities=26%  Similarity=0.385  Sum_probs=140.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34556679999999999999964 68899999997766566688999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCccCCcCCC
Q 042902          507 PHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       507 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~~~~~~~~  583 (599)
                      ++|+|.+++.....  ..++..+..++.|+++||.|||   +.+|+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976532  4568888899999999999999   889999999999999987 8999999999998654322 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                       .......||+.|+||
T Consensus       178 -~~~~~~~~~~~y~aP  192 (295)
T 2clq_A          178 -PCTETFTGTLQYMAP  192 (295)
T ss_dssp             ----CCCCCCGGGCCH
T ss_pred             -CcccccCCCccccCh
Confidence             122345789999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=1.9e-27  Score=242.90  Aligned_cols=167  Identities=20%  Similarity=0.342  Sum_probs=145.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..+|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            356888899999999999999976 58899999986542   23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887643 4889999999999999999999   8899999999999999999999999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .  ......||+.|+||
T Consensus       196 ~--~~~~~~gt~~y~aP  210 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAP  210 (335)
T ss_dssp             C--CBCCCCSCCSSCCH
T ss_pred             c--cccccCCCccccCH
Confidence            2  22446799999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=1.6e-27  Score=237.56  Aligned_cols=164  Identities=22%  Similarity=0.357  Sum_probs=141.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|... +++.||||++....  .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888999999999999999976 79999999987542  33456788999999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC---------------
Q 042902          503 LEYMPHGSLEKCLYSSN---YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---------------  564 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~---------------  564 (599)
                      |||+++|+|.+++....   ..+++..+..++.||++||.|||   +.+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999987532   34789999999999999999999   8899999999999999844               


Q ss_pred             ----CcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          565 ----MVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       565 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                          ..+||+|||.++......      ...||+.|+||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aP  199 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLAN  199 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCH
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccCh
Confidence                479999999998654321      23589999998

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=1.6e-26  Score=228.38  Aligned_cols=204  Identities=25%  Similarity=0.346  Sum_probs=174.1

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      .+.+.+++++++++.+ |..+.  ++|++|+|++|+++.+++.     .|.++++|++|+|++|.|+.+.+..|..++ .
T Consensus        16 ~~~~~l~~~~~~l~~i-p~~~~--~~l~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~-~   86 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTAI-PSNIP--ADTKKLDLQSNKLSSLPSK-----AFHRLTKLRLLYLNDNKLQTLPAGIFKELK-N   86 (270)
T ss_dssp             TTTTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCSCCCTT-----SSSSCTTCCEEECCSSCCSCCCTTTTSSCT-T
T ss_pred             CCCCEEEccCCCCCcc-CCCCC--CCCCEEECcCCCCCeeCHH-----HhcCCCCCCEEECCCCccCeeChhhhcCCC-C
Confidence            3577888888888864 44443  5788888888888887764     578888888888888888877777777776 4


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |+.|++++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++
T Consensus        87 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  166 (270)
T 2o6q_A           87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYN  166 (270)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecC
Confidence            88888888888888888889999999999999999988888899999999999999999987777789999999999999


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCcccc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGP  232 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~  232 (599)
                      |+++++.+..|..+++|++|+|++|+++.+|. .+..+++|+.|++++|.+...
T Consensus       167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            99998888889999999999999999999876 467789999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.6e-27  Score=237.82  Aligned_cols=168  Identities=24%  Similarity=0.393  Sum_probs=142.1

Q ss_pred             CCCCcCc-eecccccceEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENN-LIGRGGVASVYKARIQ---DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+ .||+|+||.||+|.+.   +++.||||+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3455555 8999999999999854   57889999997643 34567899999999999999999999999 45668999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999876667899999999999999999999   8899999999999999999999999999998764333


Q ss_pred             Cc-eeeecccCCccccCC
Q 042902          583 QS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~-~~~~~~~gt~~y~AP  599 (599)
                      .. .......+|+.|+||
T Consensus       165 ~~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             CEECCCCSSCCCGGGCCH
T ss_pred             ceeeccccccccccccCH
Confidence            22 122344578999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=3.8e-28  Score=244.18  Aligned_cols=168  Identities=26%  Similarity=0.388  Sum_probs=141.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|++........+++..|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            457888999999999999999986 5899999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999998765556899999999999999999999   889999999999999999999999999997643211  11


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.|+||
T Consensus       173 ~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          173 KRDSFIGTPYWMAP  186 (302)
T ss_dssp             C-----CCGGGCCH
T ss_pred             ccccccCChhhcCC
Confidence            12345689999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.2e-27  Score=244.20  Aligned_cols=169  Identities=27%  Similarity=0.485  Sum_probs=137.3

Q ss_pred             CCCCcCceecccccceEEEEEecC-----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD-----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..|+..+.||+|+||.||+|.+..     +..||||+++... ......+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999998653     2469999997543 3345679999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCc-eeeecccCCccccCC
Q 042902          582 DQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~-~~~~~~~gt~~y~AP  599 (599)
                      ... .......+|+.|+||
T Consensus       201 ~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             cccccccCCCCccccccCc
Confidence            211 122334568899998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=2.1e-27  Score=245.39  Aligned_cols=168  Identities=32%  Similarity=0.495  Sum_probs=146.2

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--------ccHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--------GAFKSFDIECDMMKRI-RHRNLIKIISSCS  494 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  494 (599)
                      ...++|...+.||+|+||.||+|++. +|+.||||+++....        ...+.+..|+++++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34567999999999999999999986 799999999865431        1245688999999999 7999999999999


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ..+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            9999999999999999999987643 4889999999999999999999   88999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +..+....   ......||+.|+||
T Consensus       247 ~~~~~~~~---~~~~~~gt~~y~aP  268 (365)
T 2y7j_A          247 SCHLEPGE---KLRELCGTPGYLAP  268 (365)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCH
T ss_pred             ccccCCCc---ccccCCCCCCccCh
Confidence            98765332   22446799999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=1.9e-27  Score=243.16  Aligned_cols=163  Identities=26%  Similarity=0.427  Sum_probs=138.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|... +|+.||||+++.....    +..|++++.++ +||||+++++++.+++..|+|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457889999999999999999976 6899999999755332    34688888887 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC----CcEEEccccCCccCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKPLLK  580 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~----~~~kl~DFGla~~~~~  580 (599)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||++.++    +.+||+|||+|+....
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999987654 4899999999999999999999   8899999999999998533    3599999999987643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  .....+||+.||||
T Consensus       173 ~~~--~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          173 ENG--LLMTPCYTANFVAP  189 (342)
T ss_dssp             TTC--CBCCSSCCSSCCCH
T ss_pred             CCC--ceeccCCCccccCH
Confidence            322  22346789999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.95  E-value=1.3e-27  Score=240.03  Aligned_cols=169  Identities=26%  Similarity=0.388  Sum_probs=138.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc----------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN----------  495 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  495 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            456888999999999999999975 7999999999643 3345788999999999999999999998865          


Q ss_pred             ---CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          496 ---DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       496 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                         .+..++||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               34679999999999999999876667888899999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCC------------ceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQ------------SLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~------------~~~~~~~~gt~~y~AP  599 (599)
                      |+++.......            ........||+.|+||
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            99986542210            1122345789999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=1.2e-27  Score=236.25  Aligned_cols=161  Identities=22%  Similarity=0.431  Sum_probs=141.4

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|++. ++.||||+++...  ....+.|.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888899999999999999985 8999999997553  33456799999999999999999999999877  6889999


Q ss_pred             EccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++..... .+++..+..++.|+++||.|||   +.+  |+||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999987654 5899999999999999999999   777  99999999999999999999999998764321


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                             ....||+.|+||
T Consensus       166 -------~~~~~t~~y~aP  177 (271)
T 3kmu_A          166 -------PGRMYAPAWVAP  177 (271)
T ss_dssp             -------TTCBSCGGGSCH
T ss_pred             -------cCccCCccccCh
Confidence                   234689999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=1.5e-27  Score=244.95  Aligned_cols=165  Identities=23%  Similarity=0.354  Sum_probs=144.7

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccc-----------------cHHHHHHHHHHHhcCCCCcceeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEG-----------------AFKSFDIECDMMKRIRHRNLIKI  489 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~l  489 (599)
                      .++|...+.||+|+||.||+|.. +|+.||||++......                 ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35789999999999999999999 8999999998644211                 11789999999999999999999


Q ss_pred             EEEEEcCCeeeEEEEccCCCChhhh------hhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeee
Q 042902          490 ISSCSNDDFKALVLEYMPHGSLEKC------LYSS-NYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLL  561 (599)
Q Consensus       490 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill  561 (599)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|+++||.|||   + .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 346899999999999999999999   7 899999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+++.....    ......||+.|+||
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aP  219 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPP  219 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCG
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCc
Confidence            99999999999999865332    33456799999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=1.3e-27  Score=236.30  Aligned_cols=163  Identities=28%  Similarity=0.465  Sum_probs=130.4

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY----EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|+..+.||+|+||.||+|.+. |+.||||+++...    ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888899999999999999975 8999999986542    23457899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEEccCCCCCeeecC--------CCcEEEcc
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP---IIHCDLKPNNVLLDD--------NMVAHLSD  571 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iiH~dlk~~Nill~~--------~~~~kl~D  571 (599)
                      |||+++|+|.+++...  .+++..+..++.|+++||.|||   +.+   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998654  4889999999999999999999   666   999999999999986        67899999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|+......    .....||+.|+||
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aP  183 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAP  183 (271)
T ss_dssp             CCC-----------------CCGGGSCH
T ss_pred             CCccccccccc----ccCCCCccceeCH
Confidence            99998654322    2345789999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.4e-27  Score=262.70  Aligned_cols=161  Identities=24%  Similarity=0.401  Sum_probs=134.4

Q ss_pred             eecccccceEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          435 LIGRGGVASVYKARIQ---DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      .||+|+||.||+|.+.   ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++|||||++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   46789999997653 3456889999999999999999999999976 56899999999999


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc-eeeec
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS-LTQTQ  589 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~  589 (599)
                      |.+++......+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...... .....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877667999999999999999999999   889999999999999999999999999999876433221 12233


Q ss_pred             ccCCccccCC
Q 042902          590 TLATIGYMAP  599 (599)
Q Consensus       590 ~~gt~~y~AP  599 (599)
                      ..+|+.||||
T Consensus       499 ~~~~~~y~AP  508 (613)
T 2ozo_A          499 GKWPLKWYAP  508 (613)
T ss_dssp             ---CCTTSCH
T ss_pred             CCCccceeCH
Confidence            4567899998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=3.3e-27  Score=238.07  Aligned_cols=167  Identities=29%  Similarity=0.412  Sum_probs=138.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCC---CCcceeEEEEEEcC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIR---HRNLIKIISSCSND  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  496 (599)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++....     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999964 68999999986432     122356777888777765   99999999999876


Q ss_pred             C-----eeeEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc
Q 042902          497 D-----FKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       497 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                      .     ..++||||++ |+|.+++..... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999996 599999876543 4899999999999999999999   8899999999999999999999999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+|+......   ......||+.||||
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aP  188 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAP  188 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCH
T ss_pred             eCccccccCCCc---ccCCccccccccCc
Confidence            999998654322   23456799999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=1.7e-27  Score=256.15  Aligned_cols=165  Identities=24%  Similarity=0.372  Sum_probs=139.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.|...+.||+|+||.||+|+.. +++.||||++....  ......+.+|+++++.++|||||++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999976 68999999997542  3345788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC---CcEEEccccCCccCCcC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DFGla~~~~~~  581 (599)
                      |+++|+|.+.+.... .+++..+..++.||++||.|||   +.+|+||||||+|||++..   +.+||+|||+|+.+...
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999998886643 4788999999999999999999   8899999999999999764   45999999999876433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .   ......||+.|+||
T Consensus       193 ~---~~~~~~gt~~y~aP  207 (494)
T 3lij_A          193 K---KMKERLGTAYYIAP  207 (494)
T ss_dssp             B---CBCCCCSCTTTCCH
T ss_pred             c---cccccCCCcCeeCH
Confidence            2   23456799999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=3.9e-27  Score=236.98  Aligned_cols=166  Identities=29%  Similarity=0.401  Sum_probs=145.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .+.|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888899999999999999865 68999999997553 3456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++++|.+++...  .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999998653  4889999999999999999999   8899999999999999999999999999998664322  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       174 ~~~~~~~~~~~y~aP  188 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAP  188 (303)
T ss_dssp             CCBCCCCSCGGGCCH
T ss_pred             cccCccCCCcCccCH
Confidence            123446789999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=1.4e-27  Score=246.58  Aligned_cols=173  Identities=23%  Similarity=0.287  Sum_probs=140.3

Q ss_pred             HHHHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEeccccc-----------ccHHHHHHHHHHHhcCCCCccee
Q 042902          420 HLELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE-----------GAFKSFDIECDMMKRIRHRNLIK  488 (599)
Q Consensus       420 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~  488 (599)
                      ..++....++|...+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4566777899999999999999999999988899999999854321           12378999999999999999999


Q ss_pred             EEEEEEc-----CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC
Q 042902          489 IISSCSN-----DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD  563 (599)
Q Consensus       489 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~  563 (599)
                      +++++..     ....++||||++ |+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||+++.
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD  169 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence            9999854     236799999997 6898888877667899999999999999999999   889999999999999999


Q ss_pred             CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++.+||+|||+|+......   ......||+.|+||
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAP  202 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCH
T ss_pred             CCCEEEEecCccccccccc---ccceecccceecCc
Confidence            9999999999998543222   23446789999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=3.8e-27  Score=238.77  Aligned_cols=165  Identities=27%  Similarity=0.424  Sum_probs=140.7

Q ss_pred             CCcCceecccccceEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC--CeeeE
Q 042902          430 FSENNLIGRGGVASVYKARIQ-----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND--DFKAL  501 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  501 (599)
                      |...+.||+|+||.||+|.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999998753     68899999997553 33457799999999999999999999999874  57899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++....  +++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997754  889999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCc-eeeecccCCccccCC
Q 042902          582 DQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~-~~~~~~~gt~~y~AP  599 (599)
                      ... .......+|+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             CSEEEC---CCCCGGGCCH
T ss_pred             ccccccccCCCCCceeeCh
Confidence            322 223445688899998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=1.2e-27  Score=238.72  Aligned_cols=169  Identities=25%  Similarity=0.419  Sum_probs=147.1

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..++|+..+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567888899999999999999977 48899999996543 345789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999997643 35889999999999999999999   8899999999999999999999999999998664332 


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      ........+|+.|+||
T Consensus       166 ~~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAP  181 (288)
T ss_dssp             SEEETTEEECGGGCCH
T ss_pred             cccccCCccccCcCCh
Confidence            2334455678899998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.94  E-value=1.6e-27  Score=243.46  Aligned_cols=164  Identities=33%  Similarity=0.474  Sum_probs=132.7

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHH--HhcCCCCcceeEEEEEEc-----CCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDM--MKRIRHRNLIKIISSCSN-----DDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~  499 (599)
                      .++|...+.||+|+||.||+|+. +++.||||+++...   ...+..|.++  +..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46788899999999999999987 58999999996443   2344445444  455899999999986532     2366


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEEccCCCCCeeecCCCcEEEc
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV---------PIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~---------~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                      ++||||+++|+|.+++....  .++..+..++.||++||.|||   +.         +|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997765  588889999999999999999   77         99999999999999999999999


Q ss_pred             cccCCccCCcCCC------ceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQ------SLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~------~~~~~~~~gt~~y~AP  599 (599)
                      |||+|+.+.....      ........||+.|+||
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             eccceeecccccccCccccccccccCCCccceeCc
Confidence            9999987643221      1222345799999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.94  E-value=1.7e-27  Score=240.79  Aligned_cols=171  Identities=25%  Similarity=0.433  Sum_probs=131.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec----CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC--
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD--  497 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  497 (599)
                      ..++|...+.||+|+||.||+|.+.    +++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3457888899999999999999864    34589999987542  334567999999999999999999999998765  


Q ss_pred             ---eeeEEEEccCCCChhhhhhc-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEE
Q 042902          498 ---FKALVLEYMPHGSLEKCLYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHL  569 (599)
Q Consensus       498 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl  569 (599)
                         ..++||||+++|+|.+++..     ....+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               34999999999999999842     2345899999999999999999999   899999999999999999999999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+++.+.............+++.|+||
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             CSCSCC----------------CCGGGSCH
T ss_pred             eecCcceecccccccCcccccCCCccccCc
Confidence            999999876544333333445678899998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=3.5e-27  Score=254.48  Aligned_cols=166  Identities=26%  Similarity=0.402  Sum_probs=141.8

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc-------------ccHHHHHHHHHHHhcCCCCcceeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-------------GAFKSFDIECDMMKRIRHRNLIKIISS  492 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~  492 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467899999999999999999976 588999999864321             335679999999999999999999999


Q ss_pred             EEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC---cEEE
Q 042902          493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM---VAHL  569 (599)
Q Consensus       493 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~---~~kl  569 (599)
                      +.+.+..++|||||++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999887643 4899999999999999999999   88999999999999998775   6999


Q ss_pred             ccccCCccCCcCCCceeeecccCCccccCC
Q 042902          570 SDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       570 ~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|||+|+.+....   ......||+.|+||
T Consensus       191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  217 (504)
T 3q5i_A          191 VDFGLSSFFSKDY---KLRDRLGTAYYIAP  217 (504)
T ss_dssp             CCCTTCEECCTTS---CBCCCCSCTTTCCH
T ss_pred             EECCCCEEcCCCC---ccccccCCcCCCCH
Confidence            9999998664332   23456799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1.8e-27  Score=255.52  Aligned_cols=166  Identities=23%  Similarity=0.389  Sum_probs=143.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356889999999999999999976 6899999998643  2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+.+.... .+++..+..++.||++||.|||   +.+|+||||||+||+++   .++.+||+|||+|+.+..
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999998886654 4889999999999999999999   88999999999999995   456799999999986543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......||+.||||
T Consensus       177 ~~---~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAP  192 (486)
T ss_dssp             C-------CCTTGGGGCCG
T ss_pred             CC---ccCCCcCCCCCCCH
Confidence            22   23456799999999

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-27  Score=239.27  Aligned_cols=168  Identities=23%  Similarity=0.377  Sum_probs=141.1

Q ss_pred             CCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee-eEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK-ALV  502 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  502 (599)
                      .|...+.||+|+||.||+|.+.+    +..||+|.+.... ....+.|.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            34556899999999999998542    2379999997543 34567899999999999999999999999876654 999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8899999999999999999999999999998654332


Q ss_pred             C--ceeeecccCCccccCC
Q 042902          583 Q--SLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~--~~~~~~~~gt~~y~AP  599 (599)
                      .  ........+|+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~y~aP  197 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTAL  197 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCH
T ss_pred             ccccccCcCCCCCccccCh
Confidence            1  1222345678899998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=1.5e-27  Score=246.19  Aligned_cols=173  Identities=29%  Similarity=0.356  Sum_probs=146.0

Q ss_pred             cccHHHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----CCcceeEE
Q 042902          417 RFTHLELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-----HRNLIKII  490 (599)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~  490 (599)
                      .++..+.....++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+..|+++++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3333333445678999999999999999999975 6899999999643 234466788999999886     99999999


Q ss_pred             EEEEcCCeeeEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC------
Q 042902          491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD------  563 (599)
Q Consensus       491 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~------  563 (599)
                      +++...+..++||||+ +++|.+++..... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 9999999976543 5889999999999999999999   899999999999999975      


Q ss_pred             -------------------CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 -------------------NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                                         ++.+||+|||+|+.....     .....||+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aP  228 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAP  228 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCc
Confidence                               789999999999854322     2345789999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=3.4e-27  Score=234.90  Aligned_cols=165  Identities=27%  Similarity=0.403  Sum_probs=141.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++...      ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45888899999999999999976 68999999986542      124678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla~  576 (599)
                      +||||+++++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999987643 4889999999999999999999   88999999999999998877    89999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.|+||
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAP  180 (283)
T ss_dssp             ECC-----------CCCGGGCCH
T ss_pred             eccCCC---cccccCCCcCccCc
Confidence            654322   22345689999998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=3.3e-27  Score=233.59  Aligned_cols=221  Identities=25%  Similarity=0.314  Sum_probs=145.0

Q ss_pred             cCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEccc
Q 042902            3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSN   82 (599)
Q Consensus         3 L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~   82 (599)
                      +.++.+.+.  ..+..+++|+.|++++|.++.+  ..+..+++|++|+|++|.++.++       .+..+++|++|+|++
T Consensus        26 l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~L~~   94 (272)
T 3rfs_A           26 LKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDIS-------ALKELTNLTYLILTG   94 (272)
T ss_dssp             HTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCG-------GGTTCTTCCEEECTT
T ss_pred             hcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCch-------hhcCCCCCCEEECCC
Confidence            445555544  3366789999999999999874  35899999999999999998753       488999999999999


Q ss_pred             CcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccC
Q 042902           83 NSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSI  162 (599)
Q Consensus        83 N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  162 (599)
                      |.|+++.+..|..                         +++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus        95 n~l~~~~~~~~~~-------------------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  149 (272)
T 3rfs_A           95 NQLQSLPNGVFDK-------------------------LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP  149 (272)
T ss_dssp             SCCCCCCTTTTTT-------------------------CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CccCccChhHhcC-------------------------CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccC
Confidence            9998665544444                         455555555555555555555555555555555555555544


Q ss_pred             ChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccc
Q 042902          163 PDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLR  241 (599)
Q Consensus       163 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  241 (599)
                      +..|..+++|+.|++++|++++..+..|..+++|++|++++|+++.+|. .+..+++|+.|++++|.+.+.       ++
T Consensus       150 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~  222 (272)
T 3rfs_A          150 KGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CP  222 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TT
T ss_pred             HHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------Cc
Confidence            4445555555555555555555555555555666666666666665543 345556666666666665532       33


Q ss_pred             cccEEEccCCccCCCCCccccCccc
Q 042902          242 VLVQIDLSMNNFSGFIPTTIGDLKD  266 (599)
Q Consensus       242 ~L~~L~Ls~N~l~~~~~~~~~~l~~  266 (599)
                      +|+.|+++.|.++|.+|..++.+..
T Consensus       223 ~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          223 GIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHHHHHHHhCCCcccCcccccCC
Confidence            5666667777777766766665544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=2.1e-27  Score=242.05  Aligned_cols=167  Identities=29%  Similarity=0.433  Sum_probs=138.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            356888899999999999999976 589999999865432  23456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||++++++.++..... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999988765543 4889999999999999999999   88999999999999999999999999999986543222


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       180 --~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          180 --VYDDEVATRWYRAP  193 (331)
T ss_dssp             ------CCCCCTTCCH
T ss_pred             --ccCCCcCCccccCc
Confidence              23445789999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2e-27  Score=245.57  Aligned_cols=162  Identities=27%  Similarity=0.352  Sum_probs=134.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++...  .....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467889999999999999999975 6999999998543  2334567899999999999999999999997653      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..|+||||+ +++|.+++...  .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999998764  3788899999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....     .....||+.|+||
T Consensus       178 ~~~~-----~~~~~~t~~y~aP  194 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAP  194 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cccc-----cCcCcCCCCcCCH
Confidence            5322     2446789999999

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=3.2e-27  Score=238.29  Aligned_cols=168  Identities=25%  Similarity=0.314  Sum_probs=138.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999976 689999999975432   2346789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999987643 4889999999999999999999   8899999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                       ........||+.|+||
T Consensus       189 -~~~~~~~~~~~~y~aP  204 (309)
T 2h34_A          189 -LTQLGNTVGTLYYMAP  204 (309)
T ss_dssp             ---------CCGGGCCG
T ss_pred             -cccccccCCCcCccCH
Confidence             1223456789999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=241.75  Aligned_cols=170  Identities=24%  Similarity=0.306  Sum_probs=141.8

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEE----cCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS----NDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l  501 (599)
                      .++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.    ..+..++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            35688899999999999999997 479999999987665566778999999999999999999999986    2347899


Q ss_pred             EEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          502 VLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||||+++|+|.+++..   ....+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999998875   3456899999999999999999999   889999999999999999999999999998865


Q ss_pred             CcCCCc-------eeeecccCCccccCC
Q 042902          579 LKEDQS-------LTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~-------~~~~~~~gt~~y~AP  599 (599)
                      ......       .......||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  212 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAP  212 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred             ccccccccccccccccccccCCcccCCH
Confidence            321110       001234579999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=3.4e-27  Score=235.08  Aligned_cols=164  Identities=27%  Similarity=0.434  Sum_probs=143.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999976 57899999986432   234567999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            9999999999987654 4788999999999999999999   899999999999999999999999999999755322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       168 --~~~~~~~~~~y~aP  181 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPP  181 (284)
T ss_dssp             --CBCCCCSCGGGCCH
T ss_pred             --ccccccCCCCcCCH
Confidence              12345789999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=1.6e-27  Score=253.63  Aligned_cols=163  Identities=26%  Similarity=0.319  Sum_probs=133.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|+..+.||+|+||.||+|... +|+.||||++...  .....+++.+|+++++.++|||||++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999865 6899999999654  3344677899999999999999999999996553      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..|+|||||++ ++.+.+..   .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999976 46666543   3788899999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....   ......+||++|+||
T Consensus       214 ~~~~---~~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAP  232 (464)
T ss_dssp             ---C---CCC----CCCTTCCH
T ss_pred             cCCC---cccCCCcccccccCH
Confidence            5332   223456899999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=4.7e-27  Score=237.62  Aligned_cols=167  Identities=28%  Similarity=0.361  Sum_probs=141.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..+.|+..+.||+|+||.||+|... +|+.||||.+....  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567899999999999999999876 58999999996543  34678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999755556899999999999999999999   8899999999999999999999999999998654322  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       180 ~~~~~~~~~~~y~aP  194 (314)
T 3com_A          180 AKRNTVIGTPFWMAP  194 (314)
T ss_dssp             SCBCCCCSCGGGCCH
T ss_pred             cccCccCCCCCccCh
Confidence            122345789999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=1.2e-27  Score=243.58  Aligned_cols=170  Identities=24%  Similarity=0.395  Sum_probs=139.1

Q ss_pred             hCCCCcCceecccccceEEEEEe------cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARI------QDGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .++|...+.||+|+||.||+|++      .+++.||||.+... ......++..|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35788999999999999999984      25778999999644 334456799999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLS  570 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~  570 (599)
                      ++||||+++|+|.+++....      ..+++..+..++.||++||.|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998653      34888999999999999999999   889999999999999984   4469999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++...............||+.|+||
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             ccccccccccccccccCCCcCCCcceeCH
Confidence            99999855433322233456789999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=3.3e-27  Score=234.03  Aligned_cols=166  Identities=27%  Similarity=0.409  Sum_probs=137.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888999999999999999976 79999999986442   33456899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 4788999999999999999999   8899999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       166 ---~~~~~~~~~~y~aP  179 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAP  179 (276)
T ss_dssp             --------------CCT
T ss_pred             ---ceecccCCccccCH
Confidence               22345689999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=6.5e-27  Score=235.46  Aligned_cols=169  Identities=24%  Similarity=0.360  Sum_probs=140.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCcceeEEEEEE--cCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY----EGAFKSFDIECDMMKRIRHRNLIKIISSCS--NDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  499 (599)
                      .++|...+.||+|+||.||+|... +++.||||+++...    ....+.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467999999999999999999975 68999999996542    234578999999999999999999999984  44578


Q ss_pred             eEEEEccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          500 ALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ++||||+++| +.+++... ...+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 66666543 346889999999999999999999   889999999999999999999999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .............||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCH
T ss_pred             CccccccccccCCCCCCCcCh
Confidence            543333334456799999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=5.5e-27  Score=235.18  Aligned_cols=167  Identities=28%  Similarity=0.432  Sum_probs=145.2

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---------cccHHHHHHHHHHHhcCC-CCcceeEEEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---------EGAFKSFDIECDMMKRIR-HRNLIKIISSCS  494 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  494 (599)
                      ..++|...+.||+|+||.||+|... +|+.||||+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3568899999999999999999976 68999999986442         123467889999999996 999999999999


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      ..+..++||||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999997643 4889999999999999999999   88999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++......   ......||+.|+||
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aP  192 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAP  192 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCH
T ss_pred             hhhcCCCc---ccccccCCccccCH
Confidence            98664332   22345789999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=7.9e-28  Score=260.82  Aligned_cols=168  Identities=24%  Similarity=0.419  Sum_probs=143.6

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            345688889999999999999999888899999997543 345789999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |++|+|.+++... ...+++..+..|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+... ..
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HH
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ce
Confidence            9999999999753 234889999999999999999999   889999999999999999999999999999865422 11


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......+|+.||||
T Consensus       419 ~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          419 TARQGAKFPIKWTAP  433 (535)
T ss_dssp             HTTCSTTSCGGGSCH
T ss_pred             ecccCCcCcccccCH
Confidence            122344578899998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.94  E-value=2.9e-27  Score=238.41  Aligned_cols=162  Identities=28%  Similarity=0.458  Sum_probs=132.0

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|++. ++.||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46778899999999999999985 789999998643  345789999999999999999999998863  4899999999


Q ss_pred             CCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc-EEEccccCCccCCcCCCc
Q 042902          508 HGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV-AHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       508 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~-~kl~DFGla~~~~~~~~~  584 (599)
                      +|+|.+++.....  .+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+|+.....   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986553  4688889999999999999999332289999999999999998876 899999999855322   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....||+.|+||
T Consensus       160 --~~~~~gt~~y~aP  172 (307)
T 2eva_A          160 --MTNNKGSAAWMAP  172 (307)
T ss_dssp             -------CCTTSSCH
T ss_pred             --cccCCCCCceECh
Confidence              2334689999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=1.8e-27  Score=255.66  Aligned_cols=165  Identities=25%  Similarity=0.417  Sum_probs=145.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999976 79999999986442   345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||++   +.++.+||+|||+|+.+..
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999887654 4889999999999999999999   8899999999999999   4678999999999986643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......||+.||||
T Consensus       182 ~~---~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAP  197 (484)
T ss_dssp             CC---SHHHHTTGGGTCCH
T ss_pred             cc---ccccCCCCccccCc
Confidence            32   23446799999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=1.4e-27  Score=243.30  Aligned_cols=167  Identities=26%  Similarity=0.393  Sum_probs=134.3

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3567999999999999999999865 68999999996543  22345788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-----CCCcEEEccccCCcc
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-----DNMVAHLSDFGMAKP  577 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-----~~~~~kl~DFGla~~  577 (599)
                      |||++ |+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++     .++.+||+|||+|+.
T Consensus       112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99997 59999987654 3889999999999999999999   88999999999999994     555699999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....  .......||+.|+||
T Consensus       187 ~~~~~--~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          187 FGIPI--RQFTHEIITLWYRPP  206 (329)
T ss_dssp             HC-------------CCTTCCH
T ss_pred             cCCcc--cccCCCcCCccccCH
Confidence            53222  223445789999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=3.1e-27  Score=246.90  Aligned_cols=161  Identities=24%  Similarity=0.351  Sum_probs=128.9

Q ss_pred             CCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHh-cCCCCcceeEEEEEEc----CCeee
Q 042902          428 NGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMK-RIRHRNLIKIISSCSN----DDFKA  500 (599)
Q Consensus       428 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~  500 (599)
                      ++|... +.||+|+||+||+|... +|+.||||+++..     ..+.+|++++. ..+||||+++++++..    .+..|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345554 68999999999999876 6899999998532     45677888774 4589999999998865    55789


Q ss_pred             EEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~  576 (599)
                      +|||||++|+|.+++.... ..+++..+..|+.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+|+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998754 35899999999999999999999   889999999999999997   7899999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   .....+||+.||||
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aP  232 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAP  232 (400)
T ss_dssp             ECC--------------CTTCCG
T ss_pred             ccCCCC---ccccCCCCCCccCH
Confidence            654322   23456789999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=2.4e-27  Score=238.59  Aligned_cols=165  Identities=25%  Similarity=0.391  Sum_probs=140.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356888999999999999999976 6999999999765544556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~~~  582 (599)
                      +++|+|.+++...+ .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999887544 4788999999999999999999   8899999999999999   77889999999999754322 


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       163 ---~~~~~~~~~~y~aP  176 (304)
T 2jam_A          163 ---IMSTACGTPGYVAP  176 (304)
T ss_dssp             ---TTHHHHSCCCBCCT
T ss_pred             ---ccccccCCCCccCh
Confidence               12345689999999

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=4.4e-27  Score=239.33  Aligned_cols=166  Identities=31%  Similarity=0.528  Sum_probs=137.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcE--EEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIE--VAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+.||+|+||.||+|+.. +|..  ||||.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888899999999999999865 5664  499988643 233456799999999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          503 LEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      |||+++|+|.+++....               ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997654               35889999999999999999999   8999999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||+++.....   .......+|+.|+||
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAI  210 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCH
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccCh
Confidence            99999999743221   122334578899998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=1.5e-27  Score=246.20  Aligned_cols=164  Identities=23%  Similarity=0.372  Sum_probs=142.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888999999999999999976 68999999997553 33457799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++.... .+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+|+.....   
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999997654 4788899999999999999999   64 8999999999999999999999999999754321   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.|+||
T Consensus       186 -~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          186 -MANSFVGTRSYMSP  199 (360)
T ss_dssp             -C----CCCCTTCCH
T ss_pred             -cccCCCCCCCeECH
Confidence             22345799999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=2.5e-27  Score=235.72  Aligned_cols=168  Identities=24%  Similarity=0.408  Sum_probs=139.8

Q ss_pred             hCCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|...+.||+|+||.||+|.+..    +..||||.+.... ....+.|.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4578888999999999999998643    3469999987553 3456789999999999999999999999865 45689


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999876666899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .. .......+|+.|+||
T Consensus       167 ~~-~~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSP  183 (281)
T ss_dssp             -------CCCCCGGGCCH
T ss_pred             cc-cccccCCCCcceeCc
Confidence            21 223345678899998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=1.2e-27  Score=240.49  Aligned_cols=172  Identities=26%  Similarity=0.357  Sum_probs=127.5

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999865 68999999986543 33456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhc-------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          503 LEYMPHGSLEKCLYS-------SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      |||+++|+|.+++..       ....+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999864       2345899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCcCCC---ceeeecccCCccccCC
Q 042902          576 KPLLKEDQ---SLTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~---~~~~~~~~gt~~y~AP  599 (599)
                      +.......   ........||+.|+||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             HHCC---------------CCCTTCCH
T ss_pred             heeccCCCccchhhhcccCCCccccCH
Confidence            86543221   1112345789999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=2.9e-27  Score=235.33  Aligned_cols=163  Identities=26%  Similarity=0.495  Sum_probs=140.4

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc----------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN----------  495 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------  495 (599)
                      ..+|+..+.||+|+||.||+|.+. +|+.||||+++...    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            346888999999999999999986 79999999996543    356789999999999999999998854          


Q ss_pred             ------CCeeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEE
Q 042902          496 ------DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAH  568 (599)
Q Consensus       496 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~k  568 (599)
                            ....++||||+++|+|.+++.... ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  345799999999999999997542 35889999999999999999999   88999999999999999999999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+++.......   .....||+.|+||
T Consensus       163 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aP  190 (284)
T 2a19_B          163 IGDFGLVTSLKNDGK---RTRSKGTLRYMSP  190 (284)
T ss_dssp             ECCCTTCEESSCCSC---CCCCCSCCTTSCH
T ss_pred             ECcchhheecccccc---ccccCCcccccCh
Confidence            999999987644322   2345699999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=5.7e-27  Score=236.57  Aligned_cols=167  Identities=29%  Similarity=0.435  Sum_probs=132.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|... +|+.||||+++..   .....+++.+|++++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888999999999999999864 7999999999753   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+++|+|.+++..   ....+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998864   3345889999999999999999999   88999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...  ......||+.|+||
T Consensus       189 ~~~--~~~~~~~~~~y~aP  205 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSP  205 (310)
T ss_dssp             ------------CCSSCCH
T ss_pred             CCc--cccccCCCeeEeCh
Confidence            221  22345789999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=8.5e-27  Score=232.94  Aligned_cols=163  Identities=26%  Similarity=0.370  Sum_probs=138.5

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc----CCeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN----DDFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  501 (599)
                      .|...+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3666788999999999999875 68899999986542  3345779999999999999999999998865    346899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeec-CCCcEEEccccCCccC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPL  578 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~DFGla~~~  578 (599)
                      ||||+++|+|.+++.... .+++..+..++.|+++||.|||   +.+  |+||||||+||+++ +++.+||+|||+|+..
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997643 4788999999999999999999   777  99999999999998 7899999999999754


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...    ......||+.|+||
T Consensus       183 ~~~----~~~~~~~t~~y~aP  199 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             CTT----SBEESCSSCCCCCG
T ss_pred             ccc----ccccccCCcCcCCH
Confidence            322    22345799999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=8.5e-28  Score=249.58  Aligned_cols=163  Identities=17%  Similarity=0.227  Sum_probs=132.9

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHH---HHHhcCCCCcceeEE-------EE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQ---YEGAFKSFDIEC---DMMKRIRHRNLIKII-------SS  492 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  492 (599)
                      .++|...+.||+|+||.||+|++ .+|+.||||++...   .....+.|.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678889999999999999996 46999999999743   334567899999   555666899999998       66


Q ss_pred             EEcCC-----------------eeeEEEEccCCCChhhhhhcCCC------cCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 042902          493 CSNDD-----------------FKALVLEYMPHGSLEKCLYSSNY------ILDIFQRLNIMIDVASALEYLHFGYSVPI  549 (599)
Q Consensus       493 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  549 (599)
                      +.+.+                 ..++||||+ +|+|.+++...+.      .+++..+..|+.||++||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65553                 278999999 6899999875432      2335778889999999999999   8899


Q ss_pred             EEccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       550 iH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +||||||+|||++.++.+||+|||+|+....     ......| +.||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  271 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPP  271 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccCh
Confidence            9999999999999999999999999985321     2345567 999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=8.1e-27  Score=242.74  Aligned_cols=164  Identities=26%  Similarity=0.400  Sum_probs=134.6

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-------
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND-------  496 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  496 (599)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++.....    ...+|+++++.++|||||++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999864 799999999864432    223699999999999999999998442       


Q ss_pred             -------------------------------CeeeEEEEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHh
Q 042902          497 -------------------------------DFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLH  542 (599)
Q Consensus       497 -------------------------------~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH  542 (599)
                                                     ...++||||++ |+|.+.+..   ....+++..+..++.||++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           34889999998 587777653   3446899999999999999999999


Q ss_pred             cCCCCCeEEccCCCCCeeec-CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          543 FGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       543 ~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                         +.+|+||||||+||+++ .++.+||+|||+|+.+....   ......||+.|+||
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAP  210 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCH
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCH
Confidence               89999999999999998 68899999999998764333   22346789999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=3.4e-27  Score=236.00  Aligned_cols=168  Identities=24%  Similarity=0.371  Sum_probs=138.4

Q ss_pred             hCCCCcCc-eecccccceEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          427 TNGFSENN-LIGRGGVASVYKARIQ---DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       427 ~~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ..+|...+ .||+|+||.||+|.+.   +++.||||+++...  ....+++.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34677777 9999999999999643   46889999997543  23357899999999999999999999999 556789


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998754 4889999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCce-eeecccCCccccCC
Q 042902          581 EDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ..... ......+|+.|+||
T Consensus       170 ~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TCSEEEC----CCCGGGCCH
T ss_pred             CCCcccccccCCCCceeeCh
Confidence            33221 22334567899998

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=4.4e-26  Score=227.43  Aligned_cols=202  Identities=24%  Similarity=0.268  Sum_probs=125.2

Q ss_pred             CcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhc
Q 042902           16 IFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN   95 (599)
Q Consensus        16 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~   95 (599)
                      +.++++++++++++|+++.+.+ .+.  ++|++|+|++|+|+.+++.     .|.++++|++|+|++|.|+++.+     
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~-~~~--~~l~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~-----   72 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPP-DLP--KDTTILHLSENLLYTFSLA-----TLMPYTRLTQLNLDRAELTKLQV-----   72 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCS-CCC--TTCCEEECTTSCCSEEEGG-----GGTTCTTCCEEECTTSCCCEEEC-----
T ss_pred             ccccCCccEEECCCCCCCcCCC-CCC--CCCCEEEcCCCcCCccCHH-----HhhcCCCCCEEECCCCccCcccC-----
Confidence            4455666666666666665332 222  4566666666666655443     45666666666666666654322     


Q ss_pred             ccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEE
Q 042902           96 LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLL  175 (599)
Q Consensus        96 l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  175 (599)
                                          .  ..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|++|
T Consensus        73 --------------------~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L  129 (290)
T 1p9a_G           73 --------------------D--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL  129 (290)
T ss_dssp             --------------------C--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred             --------------------C--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence                                1  45566666666666666 344556666666666666666666656666666666667


Q ss_pred             EeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          176 DLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       176 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +|++|+++++.+..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus       130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            7766666666666666666777777777777766653 345666777777777776 44555555667777777777665

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=1.9e-26  Score=236.01  Aligned_cols=169  Identities=28%  Similarity=0.437  Sum_probs=142.8

Q ss_pred             HHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCcceeEEEEEEcCC----e
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKR--IRHRNLIKIISSCSNDD----F  498 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~  498 (599)
                      ...++|...+.||+|+||.||+|++ +|+.||||+++..   ....+..|++++..  ++||||+++++++...+    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3456799999999999999999998 4999999998643   34567888888887  78999999999998776    7


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCeeecCCCcEEEcccc
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SVPIIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      .++||||+++|+|.+++...  .+++..+..++.|+++||.|||...     +.+|+||||||+||+++.++.+||+|||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            89999999999999999765  3889999999999999999999321     4689999999999999999999999999


Q ss_pred             CCccCCcCCCce--eeecccCCccccCC
Q 042902          574 MAKPLLKEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      +|+.........  ......||+.|+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred             CceeccccccccccccccCCcCcccCCH
Confidence            998654333221  22445799999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=3.3e-27  Score=242.11  Aligned_cols=167  Identities=21%  Similarity=0.217  Sum_probs=134.4

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCCcceeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQYEG-----------AFKSFDIECDMMKRIRHRNLIKIISS  492 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~  492 (599)
                      ++|...+.||+|+||.||+|...    ++..||||+.......           ..+.+..|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888999999999999999975    5788999998654321           22347788899999999999999999


Q ss_pred             EEc----CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC--c
Q 042902          493 CSN----DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM--V  566 (599)
Q Consensus       493 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~--~  566 (599)
                      +..    .+..++||||+ +|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            987    67899999999 999999987654 5899999999999999999999   88999999999999999877  9


Q ss_pred             EEEccccCCccCCcCCCc-----eeeecccCCccccCC
Q 042902          567 AHLSDFGMAKPLLKEDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       567 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      +||+|||+|+.+......     .......||+.|+||
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence            999999999876433211     111345799999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=8.2e-27  Score=240.98  Aligned_cols=167  Identities=26%  Similarity=0.325  Sum_probs=142.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Cee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  499 (599)
                      .++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999875 68899999997543 33457799999999999999999999998654     368


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||++ |+|.+++....  +++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 59999887653  889999999999999999999   8899999999999999999999999999998664


Q ss_pred             cCCCce-eeecccCCccccCC
Q 042902          580 KEDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ...... ......||+.|+||
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCCccccccccccccCCCCC
Confidence            332211 12445799999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.94  E-value=6.7e-27  Score=234.68  Aligned_cols=166  Identities=29%  Similarity=0.442  Sum_probs=140.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57888999999999999999976 68999999986543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |++ |+|.+++.... ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  158 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  158 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCcc
Confidence            997 69999887653 35788899999999999999999   88999999999999999999999999999986532221


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (299)
T 2r3i_A          159 --TYTHEVVTLWYRAP  172 (299)
T ss_dssp             --CTTSCBCCCTTCCH
T ss_pred             --ccCcccccccccCc
Confidence              22345689999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.6e-27  Score=259.15  Aligned_cols=156  Identities=19%  Similarity=0.163  Sum_probs=122.7

Q ss_pred             eecccccceEEEEE-ecCCcEEEEEEecccc----------cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY----------EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       435 ~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ..+.|++|.++.++ ...|+.||||++....          +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34566676666654 3358999999996431          23456799999999999 699999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||++||+|.+++...+. ++.   .+|+.||++||+|+|   +.|||||||||+|||++++|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~~-l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE-IDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC-CCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCCC-CCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999987653 554   358999999999999   9999999999999999999999999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                        ......+||++||||
T Consensus       394 --~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             --CCSHHHHHHHHHHHH
T ss_pred             --ccccCceechhhccH
Confidence              233457899999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=1.9e-26  Score=234.93  Aligned_cols=159  Identities=24%  Similarity=0.382  Sum_probs=138.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEc--CCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSN--DDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            56888999999999999999864 6899999998643   3467899999999997 9999999999987  56789999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~  582 (599)
                      ||+++++|.+++..    +++..+..++.||++||+|||   +.+|+||||||+|||++.++ .+||+|||+|+......
T Consensus       113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999998854    788889999999999999999   88999999999999999776 89999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                      .   .....||+.|+||
T Consensus       186 ~---~~~~~~~~~y~aP  199 (330)
T 3nsz_A          186 E---YNVRVASRYFKGP  199 (330)
T ss_dssp             C---CCSCCSCGGGCCH
T ss_pred             c---cccccccccccCh
Confidence            2   2345789999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=5.5e-27  Score=258.59  Aligned_cols=161  Identities=25%  Similarity=0.383  Sum_probs=132.4

Q ss_pred             ceecccccceEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQ---DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....++|.+|++++++++|||||++++++.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999754   46789999997543  3346789999999999999999999999965 457899999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC-ceee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ-SLTQ  587 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~  587 (599)
                      |+|.+++.... .+++..+..|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..... ....
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 4889999999999999999999   88999999999999999999999999999987654332 1223


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....+|+.||||
T Consensus       530 ~~~~~t~~y~AP  541 (635)
T 4fl3_A          530 THGKWPVKWYAP  541 (635)
T ss_dssp             -----CGGGSCH
T ss_pred             cCCCCceeeeCh
Confidence            445678899998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=6e-27  Score=237.77  Aligned_cols=165  Identities=27%  Similarity=0.364  Sum_probs=137.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  497 (599)
                      .++|...+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            356889999999999999999875 58999999986432        122345889999999999999999999987665


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc---EEEccccC
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFGM  574 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DFGl  574 (599)
                       .++||||+++|+|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999999887544 5889999999999999999999   889999999999999987654   99999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++......   ......||+.|+||
T Consensus       164 ~~~~~~~~---~~~~~~gt~~y~aP  185 (322)
T 2ycf_A          164 SKILGETS---LMRTLCGTPTYLAP  185 (322)
T ss_dssp             CEECCCCH---HHHHHHSCCTTCCH
T ss_pred             ceeccccc---ccccccCCcCccCc
Confidence            98653221   12345689999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=235.15  Aligned_cols=167  Identities=25%  Similarity=0.361  Sum_probs=134.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEE-----------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCS-----------  494 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  494 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888999999999999999976 48999999997666666788999999999999999999999874           


Q ss_pred             ---cCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEc
Q 042902          495 ---NDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLS  570 (599)
Q Consensus       495 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~  570 (599)
                         +.+..++||||++ |+|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 6999998653  4788899999999999999999   88999999999999997 56799999


Q ss_pred             cccCCccCCcCCC-ceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~-~~~~~~~~gt~~y~AP  599 (599)
                      |||+++....... ........+|+.|+||
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSP  193 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred             cCccccccCCCcccccccccccccccccCc
Confidence            9999986543211 1122345679999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=1.5e-26  Score=235.40  Aligned_cols=167  Identities=23%  Similarity=0.326  Sum_probs=139.6

Q ss_pred             hCCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  501 (599)
                      .+.|... +.||+|+||.||+|... +|+.||||++....  ......+.+|+.++..+. ||||+++++++.+.+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3456665 78999999999999876 68999999987543  334678999999999995 6999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCcc
Q 042902          502 VLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAKP  577 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~~  577 (599)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+|+.
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            99999999999998653 346899999999999999999999   889999999999999987   78999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....   ......||+.|+||
T Consensus       184 ~~~~~---~~~~~~gt~~y~aP  202 (327)
T 3lm5_A          184 IGHAC---ELREIMGTPEYLAP  202 (327)
T ss_dssp             C------------CCCGGGCCH
T ss_pred             cCCcc---ccccccCCcCccCC
Confidence            64322   22346799999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.4e-27  Score=239.94  Aligned_cols=170  Identities=29%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             HHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEc------
Q 042902          424 FQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSN------  495 (599)
Q Consensus       424 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------  495 (599)
                      ....++|...+.||+|+||.||+|++. +|+.||||++.... ...+.+..|+.+++++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            345678999999999999999999974 68999999986543 2347889999999999 79999999999976      


Q ss_pred             CCeeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                      .+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            467899999999999999997643 35888899999999999999999   88999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++......  .......||+.|+||
T Consensus       176 ~~~~~~~~--~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          176 SAQLDRTV--GRRNTFIGTPYWMAP  198 (326)
T ss_dssp             TC---------------CCGGGCCH
T ss_pred             ceecCcCc--cccccccCCccccCh
Confidence            98653221  122345789999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.94  E-value=6.7e-27  Score=233.65  Aligned_cols=168  Identities=26%  Similarity=0.372  Sum_probs=133.2

Q ss_pred             CCCCcCceecccccceEEEEEec--CCc--EEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ--DGI--EVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|++.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++.+.+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46888899999999999999864  233  6999998654   2345678999999999999999999999998765 88


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999876566899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCce-eeecccCCccccCC
Q 042902          581 EDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ..... ......+|+.|+||
T Consensus       174 ~~~~~~~~~~~~~~~~y~aP  193 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAP  193 (291)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             cccchhhhccCCCCceeeCc
Confidence            33221 22345678899998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=6.7e-27  Score=233.52  Aligned_cols=166  Identities=23%  Similarity=0.254  Sum_probs=128.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++....  ...+.+..+...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            357888999999999999999974 789999999965422  22334555556688899999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          504 EYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       504 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ||++ |+|.+++..   ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+|+...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588777653   3456899999999999999999999   76 99999999999999999999999999998654


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...   ......||+.|+||
T Consensus       162 ~~~---~~~~~~~t~~y~aP  178 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAP  178 (290)
T ss_dssp             -----------CCCCCCSCH
T ss_pred             ccc---cccccCCCccccCh
Confidence            322   22334799999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=5.1e-27  Score=242.38  Aligned_cols=162  Identities=27%  Similarity=0.366  Sum_probs=123.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------C
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND------D  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  497 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            467999999999999999999864 68999999986532  33456788999999999999999999998654      5


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..++||||+ +++|.+++...  .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 78999988763  4889999999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....     .....||+.|+||
T Consensus       182 ~~~~-----~~~~~~t~~y~aP  198 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAP  198 (367)
T ss_dssp             --------------CCCTTCCH
T ss_pred             cccc-----CCCcCcCcCccCh
Confidence            4321     2446799999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=2.6e-27  Score=235.17  Aligned_cols=168  Identities=26%  Similarity=0.392  Sum_probs=140.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEE--cCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCS--NDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  501 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|.+....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888999999999999999976 68999999997542  334567999999999999999999999875  3568899


Q ss_pred             EEEccCCCChhhhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEccCCCCCeeecCCCcEEEcccc
Q 042902          502 VLEYMPHGSLEKCLYSS---NYILDIFQRLNIMIDVASALEYLHFGYSVP-----IIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      ||||+++|+|.+++...   ...+++..+..++.|+++||.|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   234889999999999999999999   666     9999999999999999999999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +++.......  ......||+.|+||
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSP  185 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCH
T ss_pred             hheeeccccc--cccccCCCccccCh
Confidence            9986543221  12345689999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=237.00  Aligned_cols=168  Identities=27%  Similarity=0.311  Sum_probs=130.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEE--------cCC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCS--------NDD  497 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~~  497 (599)
                      .+|...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++.++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            46888899999999999999975 68999999987665556678999999999996 999999999984        233


Q ss_pred             eeeEEEEccCCCChhhhhhc--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeecCCCcEEEcccc
Q 042902          498 FKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      ..++||||++ |+|.+++..  ....+++..+..++.||+.||.|||   +.+  |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            5799999995 799888864  3345899999999999999999999   777  9999999999999999999999999


Q ss_pred             CCccCCcCCCce----------eeecccCCccccCC
Q 042902          574 MAKPLLKEDQSL----------TQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~----------~~~~~~gt~~y~AP  599 (599)
                      +++.........          ......||+.|+||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             TCBCCSSCC---------------------------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            998764322111          11245689999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=1.3e-26  Score=239.95  Aligned_cols=163  Identities=25%  Similarity=0.326  Sum_probs=130.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357889999999999999999865 68999999996532  334567899999999999999999999997665      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..++||||+++ +|.+.+..   .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78887753   3788899999999999999999   88999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....   .......||+.|+||
T Consensus       177 ~~~~---~~~~~~~gt~~y~aP  195 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAP  195 (371)
T ss_dssp             ----------------CTTCCH
T ss_pred             cccc---cccCCceecCCccCH
Confidence            5322   123456799999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=1e-26  Score=259.70  Aligned_cols=159  Identities=24%  Similarity=0.371  Sum_probs=136.6

Q ss_pred             CCCCcCceecccccceEEEEEec--CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe-----e
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ--DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF-----K  499 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~  499 (599)
                      ++|...+.||+|+||.||+|.+.  +|+.||||++.... ....+.|..|++++++++|||||++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999975  58999999986443 3345678999999999999999999999987655     6


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |+||||++|++|.+++..   .+++..+..|+.||++||.|+|   +.+|+||||||+|||++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987755   4899999999999999999999   8899999999999999986 99999999998653


Q ss_pred             cCCCceeeecccCCccccCC
Q 042902          580 KEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..      ....||++||||
T Consensus       233 ~~------~~~~gt~~y~aP  246 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAP  246 (681)
T ss_dssp             CC------SCCCCCTTTSCT
T ss_pred             cC------CccCCCccccCH
Confidence            32      345799999999

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.94  E-value=4.2e-26  Score=221.18  Aligned_cols=195  Identities=22%  Similarity=0.238  Sum_probs=104.1

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCcc-CcccCCCcccccccCCCCCCcEEEccc-CcccccCChhhhcccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNY-LTSSTPKLNFLSSLSNCKYLKYLSFSN-NSLDGILPRAIGNLSQ   98 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~   98 (599)
                      +|++|+|++|+|+++.+.+|.++++|++|+|++|+ ++.+++.     .|.++++|++|++++ |+|+++.+.+      
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~-----~f~~l~~L~~L~l~~~n~l~~i~~~~------  100 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH-----SFYNLSKVTHIEIRNTRNLTYIDPDA------  100 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTT-----TEESCTTCCEEEEEEETTCCEECTTS------
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHh-----HcCCCcCCcEEECCCCCCeeEcCHHH------
Confidence            56666666666666666566666666666666665 6655543     356666666666666 6665544444      


Q ss_pred             cceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCC---EEEcccc-cccccCChhhhcCCCCc-
Q 042902           99 SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQ---LLSLEDN-QLEGSIPDDLCRLAALF-  173 (599)
Q Consensus        99 ~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-  173 (599)
                                         |.++++|++|+|++|.+++ +|. |..+++|+   +|++++| .++++.+..|..+++|+ 
T Consensus       101 -------------------f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~  159 (239)
T 2xwt_C          101 -------------------LKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL  159 (239)
T ss_dssp             -------------------EECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEE
T ss_pred             -------------------hCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhccee
Confidence                               4444555555555555543 222 44444444   5555555 55544444455555555 


Q ss_pred             EEEeeCCccCCCCCcccCCCCCCcEeecCCCC-CCCCCc-cccCC-CcccEEeecCCCccccCcccccccccccEEEccC
Q 042902          174 LLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQ-LTSIPS-TLWNL-KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM  250 (599)
Q Consensus       174 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~ip~-~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  250 (599)
                      .|++++|+++.+.+..|.. ++|++|++++|+ ++.+|. .+..+ ++|+.|++++|++++..+.   .+++|+.|++++
T Consensus       160 ~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~  235 (239)
T 2xwt_C          160 TLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARN  235 (239)
T ss_dssp             EEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTT
T ss_pred             EEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccC
Confidence            5555555555444444443 455555555553 555533 34444 5555555555555533322   344555555554


Q ss_pred             C
Q 042902          251 N  251 (599)
Q Consensus       251 N  251 (599)
                      +
T Consensus       236 ~  236 (239)
T 2xwt_C          236 T  236 (239)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.94  E-value=1.6e-26  Score=237.73  Aligned_cols=167  Identities=25%  Similarity=0.331  Sum_probs=139.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Cee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  499 (599)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.... .....++.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467889999999999999999976 68999999996443 33456788999999999999999999988754     678


Q ss_pred             eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          500 ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ++||||++ |+|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 6999988764  4889999999999999999999   8899999999999999999999999999998664


Q ss_pred             cCCCce--------eeecccCCccccCC
Q 042902          580 KEDQSL--------TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~--------~~~~~~gt~~y~AP  599 (599)
                      ......        ......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             ----------------CCCCCCGGGCCH
T ss_pred             cccccccCccccccchhhccccccccCC
Confidence            322111        12235789999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=1.2e-26  Score=256.94  Aligned_cols=168  Identities=23%  Similarity=0.357  Sum_probs=139.2

Q ss_pred             hCCCCcCceecccccceEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|...+.||+|+||.||+|.+.    .+..||||.++... ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            356777889999999999999874    25679999986543 334578999999999999999999999985 456899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      . ........+|+.||||
T Consensus       545 ~-~~~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAP  561 (656)
T ss_dssp             ----------CCGGGCCH
T ss_pred             c-ceeccCCCCCcceeCH
Confidence            2 2223345678899998

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=3.1e-26  Score=222.12  Aligned_cols=196  Identities=18%  Similarity=0.183  Sum_probs=123.6

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEccccc-ccccCChhhhcCCCCcEEEeeC-CccCCCCCcccCCCCCCcEee
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQ-LEGSIPDDLCRLAALFLLDLGG-NKLSGFVPACFGNLTSLRNLY  200 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~  200 (599)
                      +|++|+|++|+++++.+.+|.++++|++|++++|. ++.+.+..|..+++|++|++++ |+++++.+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            55666666666665555556666666666666664 5555555566666666666665 666655555666666666666


Q ss_pred             cCCCCCCCCCccccCCCccc---EEeecCC-CccccCccccccccccc-EEEccCCccCCCCCccccCcccccccccccc
Q 042902          201 LGSNQLTSIPSTLWNLKYIL---YLNLSSN-SFTGPLPLEIGNLRVLV-QIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       201 L~~N~l~~ip~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      +++|.++.+|. +..+++|+   +|++++| .+++..+..|.++++|+ .|++++|.++.+.+..|.. ++|++|+|++|
T Consensus       112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence            66666666655 55555555   6777776 66666666667777777 7777777776444444444 67777777777


Q ss_pred             c-ccccCcccccCC-CCcccccCCCCcccccCCchhhccccceEEEcccc
Q 042902          276 R-LQGSIPDSIGGL-IDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFN  323 (599)
Q Consensus       276 ~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  323 (599)
                      + +++..+..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++
T Consensus       190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             TTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            4 776666667777 7777777777777743333   4556667776655

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=6.5e-27  Score=232.28  Aligned_cols=162  Identities=30%  Similarity=0.442  Sum_probs=132.6

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-CeeeEEEEc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND-DFKALVLEY  505 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  505 (599)
                      .++|+..+.||+|+||.||+|+.. |+.||||+++..  ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            356888899999999999999875 899999998644  3457899999999999999999999997654 478999999


Q ss_pred             cCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          506 MPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +++|+|.+++..... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999876432 3788889999999999999999   889999999999999999999999999999854322   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                        .....+++.|+||
T Consensus       171 --~~~~~~~~~y~aP  183 (278)
T 1byg_A          171 --QDTGKLPVKWTAP  183 (278)
T ss_dssp             -------CCTTTSCH
T ss_pred             --ccCCCccccccCH
Confidence              1234578899998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.93  E-value=2.4e-26  Score=230.13  Aligned_cols=168  Identities=25%  Similarity=0.372  Sum_probs=137.9

Q ss_pred             HhCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEE-EcCCeeeEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC-SNDDFKALVL  503 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  503 (599)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++.....  ..++..|+++++.++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 4789999998754432  23578899999999988877777665 5677889999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~  580 (599)
                      ||+ +|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+||++   +.++.+||+|||+|+....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999999866667899999999999999999999   8899999999999999   7889999999999987654


Q ss_pred             CCCc-----eeeecccCCccccCC
Q 042902          581 EDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      ....     .......||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred             cccCccCCCCcccccCCCccccch
Confidence            3221     122356799999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.93  E-value=4.3e-27  Score=241.95  Aligned_cols=163  Identities=17%  Similarity=0.256  Sum_probs=137.7

Q ss_pred             CCCCcCceecccccceEEEEEecC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCccee----------
Q 042902          428 NGFSENNLIGRGGVASVYKARIQD---------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK----------  488 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  488 (599)
                      ++|...+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999998763         789999998643     46788999999999999998          


Q ss_pred             -----EEEEEEc-CCeeeEEEEccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          489 -----IISSCSN-DDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       489 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                           +++++.. ++..++||||+ +|+|.+++... ...+++..+..++.||++||.|||   +.+|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 6777765 67899999999 99999999865 346899999999999999999999   8899999999999999


Q ss_pred             cCCC--cEEEccccCCccCCcCCCce-----eeecccCCccccCC
Q 042902          562 DDNM--VAHLSDFGMAKPLLKEDQSL-----TQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~AP  599 (599)
                      +.++  .+||+|||+|+.+.......     ......||+.|+||
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM  237 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence            9998  99999999998765332211     12345799999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.93  E-value=3.7e-27  Score=238.29  Aligned_cols=168  Identities=24%  Similarity=0.405  Sum_probs=138.0

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCC--CCcceeEEEEEEcCCeeeE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIR--HRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l  501 (599)
                      ..++|...+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++.+++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            456788999999999999999999889999999996543  334578999999999997  5999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||| +.+|+|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||++++ +.+||+|||+++.+...
T Consensus       106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            999 55889999998754 4788899999999999999999   889999999999999965 89999999999876543


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........||+.|+||
T Consensus       180 ~~~~~~~~~~gt~~y~aP  197 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPP  197 (313)
T ss_dssp             ----------CCGGGCCH
T ss_pred             cccccccCCCCCCCcCCH
Confidence            332233456799999998

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=1.2e-27  Score=246.86  Aligned_cols=255  Identities=20%  Similarity=0.224  Sum_probs=138.5

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCC----ccccCCC-CCCEEeccCccCcccCCCcccccccCCC----
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIP----NTFGNLR-NLKRLSLNYNYLTSSTPKLNFLSSLSNC----   72 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~l----   72 (599)
                      +|++|++++.+|..+...++|++|+|++|+|++..+    .+|.+++ +|++|+|++|+|+...+.     .+..+    
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-----~l~~~l~~~   78 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD-----ELVQILAAI   78 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH-----HHHHHHHTS
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH-----HHHHHHhcc
Confidence            567777777777766666668888888887777666    6677777 777777777777765443     23332    


Q ss_pred             -CCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCC-CCCCEEEccCCcCCcccCccc----cC-C
Q 042902           73 -KYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNL-TNLTTIYLGGNKLNGSIPIAL----DK-L  145 (599)
Q Consensus        73 -~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~----~~-l  145 (599)
                       ++|++|+|++|.|++..+..+...                     +..+ ++|++|+|++|.+++..+..+    .. .
T Consensus        79 ~~~L~~L~Ls~n~l~~~~~~~l~~~---------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~  137 (362)
T 3goz_A           79 PANVTSLNLSGNFLSYKSSDELVKT---------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP  137 (362)
T ss_dssp             CTTCCEEECCSSCGGGSCHHHHHHH---------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSC
T ss_pred             CCCccEEECcCCcCChHHHHHHHHH---------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCC
Confidence             677777777777776655544332                     1222 445555555555544333222    12 1


Q ss_pred             CCCCEEEcccccccccCCh----hhhcCC-CCcEEEeeCCccCCCCCcccC----CC-CCCcEeecCCCCCCC-----CC
Q 042902          146 QKLQLLSLEDNQLEGSIPD----DLCRLA-ALFLLDLGGNKLSGFVPACFG----NL-TSLRNLYLGSNQLTS-----IP  210 (599)
Q Consensus       146 ~~L~~L~L~~N~l~~~~~~----~~~~l~-~L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~-----ip  210 (599)
                      ++|++|+|++|.+++..+.    .+..++ +|++|+|++|++++..+..+.    .. ++|++|+|++|.|+.     ++
T Consensus       138 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~  217 (362)
T 3goz_A          138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA  217 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHH
Confidence            3555555555555432222    223333 555555555555544433222    22 355555555555554     33


Q ss_pred             ccccC-CCcccEEeecCCCccccCc----ccccccccccEEEccCCccCCCC-------CccccCccccccccccccccc
Q 042902          211 STLWN-LKYILYLNLSSNSFTGPLP----LEIGNLRVLVQIDLSMNNFSGFI-------PTTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       211 ~~~~~-l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l~  278 (599)
                      ..+.. .++|++|+|++|.+++..+    ..+..+++|+.|+|++|.+.+..       +..+..+++|+.|++++|++.
T Consensus       218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~  297 (362)
T 3goz_A          218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH  297 (362)
T ss_dssp             HHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred             HHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence            33333 2355566666665554433    22344555666666666543322       224455566666666666665


Q ss_pred             ccCc
Q 042902          279 GSIP  282 (599)
Q Consensus       279 ~~~~  282 (599)
                      +..+
T Consensus       298 ~~~~  301 (362)
T 3goz_A          298 PSHS  301 (362)
T ss_dssp             GGGC
T ss_pred             Ccch
Confidence            4433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.93  E-value=1.1e-26  Score=240.70  Aligned_cols=163  Identities=12%  Similarity=0.111  Sum_probs=121.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcC--CCCcceeEE-------EEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRI--RHRNLIKII-------SSCS  494 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  494 (599)
                      ..|...+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888899999999999999975 789999999976532   3455677885444444  699988865       4443


Q ss_pred             cC-----------------CeeeEEEEccCCCChhhhhhcCCCcCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEE
Q 042902          495 ND-----------------DFKALVLEYMPHGSLEKCLYSSNYILDIFQR------LNIMIDVASALEYLHFGYSVPIIH  551 (599)
Q Consensus       495 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~~~iiH  551 (599)
                      ..                 ...++|||||+ |+|.+++...+..+++..+      ..++.||++||+|||   +.+|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            32                 23799999998 8999999865444455555      678899999999999   889999


Q ss_pred             ccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       552 ~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||||+|||++.++.+||+|||+|+....     ......+|+.||||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aP  260 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR  260 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCH
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcCh
Confidence            99999999999999999999999986531     12245677999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.93  E-value=4.2e-26  Score=228.47  Aligned_cols=167  Identities=25%  Similarity=0.374  Sum_probs=140.8

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEE-EcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC-SNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++.....  .+++..|+++++.++|++++..++++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46789999999999999999996 4799999999865432  24688999999999998877766655 56678899999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCcC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~~  581 (599)
                      |+ +|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+||++   +.++.+||+|||+|+.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 99999999866667899999999999999999999   8899999999999999   48889999999999876543


Q ss_pred             CCc-----eeeecccCCccccCC
Q 042902          582 DQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~-----~~~~~~~gt~~y~AP  599 (599)
                      ...     .......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccccCCh
Confidence            221     112456799999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=3.4e-26  Score=240.67  Aligned_cols=161  Identities=29%  Similarity=0.486  Sum_probs=131.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC----C--eee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND----D--FKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~  500 (599)
                      .+|+..+.||+|+||.||+|++. +|+.||||++.....    .+.+|++++++++|||||++++++...    +  +.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999986 599999999864322    234699999999999999999988532    2  467


Q ss_pred             EEEEccCCCChhhhhh---cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-CcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-MVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-~~~kl~DFGla~  576 (599)
                      +||||+++ ++.+.+.   .....+++..+..++.||++||.|||   +.+|+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 6665543   23446899999999999999999999   8999999999999999955 678999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+.....   .....||+.||||
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aP  225 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAP  225 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCH
T ss_pred             hcccCCC---ceeeeeCCCcCCH
Confidence            7643322   2346789999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.93  E-value=2.7e-26  Score=239.50  Aligned_cols=162  Identities=28%  Similarity=0.432  Sum_probs=131.9

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------eeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------FKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  501 (599)
                      .+|...+.||+|+||.||+|++..+..||+|++......    ..+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            458889999999999999999987777999988543221    236999999999999999999985443      3789


Q ss_pred             EEEccCCCChhhhhh--cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccCCccC
Q 042902          502 VLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPL  578 (599)
Q Consensus       502 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGla~~~  578 (599)
                      ||||++++.+.....  .....+++..+..++.||++||+|||   +.+|+||||||+|||++ .++.+||+|||+|+.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998754433221  22345889999999999999999999   88999999999999999 7999999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....   ......||+.|+||
T Consensus       193 ~~~~---~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAP  210 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCH
T ss_pred             cCCC---CCcccccCcCccCH
Confidence            4332   22356789999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.93  E-value=6.5e-26  Score=241.50  Aligned_cols=167  Identities=22%  Similarity=0.321  Sum_probs=140.4

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-RNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|...+.||+|+||.||+|++ .+++.||||++.....  ..++..|+++++.++| ++++.+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            35789999999999999999996 4699999999865432  2457889999999987 556666667778889999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee---cCCCcEEEccccCCccCCcC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL---DDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill---~~~~~~kl~DFGla~~~~~~  581 (599)
                      |+ +++|.+++......+++..++.|+.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 99999999866667999999999999999999999   8899999999999999   68889999999999876543


Q ss_pred             CCc-----eeeecccCCccccCC
Q 042902          582 DQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~-----~~~~~~~gt~~y~AP  599 (599)
                      ...     .......||+.||||
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccccccccccccccCCCccccCH
Confidence            321     122356799999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.93  E-value=3e-26  Score=237.29  Aligned_cols=161  Identities=25%  Similarity=0.353  Sum_probs=135.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee----
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK----  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  499 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            457888999999999999999865 68999999997542  33457789999999999999999999999877654    


Q ss_pred             --eEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          500 --ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       500 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                        ++||||++ |+|.+.+..   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 688887743   3889999999999999999999   88999999999999999999999999999985


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...     ......||+.|+||
T Consensus       194 ~~~-----~~~~~~~t~~y~aP  210 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAP  210 (371)
T ss_dssp             -----------CTTCCCTTSCH
T ss_pred             ccc-----CcCCcccCccccCH
Confidence            432     22446789999998

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.93  E-value=2.4e-25  Score=228.54  Aligned_cols=218  Identities=18%  Similarity=0.162  Sum_probs=122.7

Q ss_pred             CEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccccc-CChhhhcccccce
Q 042902           23 SRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGI-LPRAIGNLSQSME  101 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~~l~  101 (599)
                      ++++.++++++.+ |..+  .+++++|+|++|+|+.+++.     +|+++++|++|+|++|+|.+. .+.+|.++++.++
T Consensus        12 ~~v~C~~~~Lt~i-P~~l--~~~l~~L~Ls~N~i~~i~~~-----~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~   83 (350)
T 4ay9_X           12 RVFLCQESKVTEI-PSDL--PRNAIELRFVLTKLRVIQKG-----AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE   83 (350)
T ss_dssp             TEEEEESTTCCSC-CTTC--CTTCSEEEEESCCCSEECTT-----SSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE
T ss_pred             CEEEecCCCCCcc-CcCc--CCCCCEEEccCCcCCCcCHH-----HHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh
Confidence            5677788888864 4444  35788888888888888765     578888888888888887543 3345555554444


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      .+.+.+|+++.+.|+.|.++++|++|++++|+|+...+..+....++..|++.+                       .|+
T Consensus        84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~-----------------------~~~  140 (350)
T 4ay9_X           84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD-----------------------NIN  140 (350)
T ss_dssp             EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES-----------------------CTT
T ss_pred             hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc-----------------------ccc
Confidence            455555555555555555555555555555555544444444444444444432                       133


Q ss_pred             cCCCCCcccCCCC-CCcEeecCCCCCCCCCccccCCCcccEEeecC-CCccccCcccccccccccEEEccCCccCCCCCc
Q 042902          182 LSGFVPACFGNLT-SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS-NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT  259 (599)
Q Consensus       182 l~~~~~~~~~~l~-~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  259 (599)
                      +..+.+..|..+. .++.|+|++|+|+.+|...+...+|+.|++++ |.++.+.+..|.++++|+.|||++|+|+.+.+.
T Consensus       141 i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~  220 (350)
T 4ay9_X          141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY  220 (350)
T ss_dssp             CCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred             cccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh
Confidence            4444444444443 35555555555555555544445555555543 444444444455555555555555555544444


Q ss_pred             cccCcccccccc
Q 042902          260 TIGDLKDLQYLF  271 (599)
Q Consensus       260 ~~~~l~~L~~L~  271 (599)
                      .|.++++|+.++
T Consensus       221 ~~~~L~~L~~l~  232 (350)
T 4ay9_X          221 GLENLKKLRARS  232 (350)
T ss_dssp             SCTTCCEEECTT
T ss_pred             hhccchHhhhcc
Confidence            444444444443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.93  E-value=3.8e-28  Score=253.07  Aligned_cols=265  Identities=20%  Similarity=0.214  Sum_probs=183.7

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc---ccCChhhhccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD---GILPRAIGNLS   97 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~---~~~~~~~~~l~   97 (599)
                      .|+...++...+.. ++..+..+++|++|+|++|.|+...+. .+...+..+++|++|+|++|.+.   +..|..+..+.
T Consensus        10 ~L~~~~l~~~~~~~-l~~~l~~~~~L~~L~L~~n~i~~~~~~-~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~   87 (386)
T 2ca6_A           10 SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL   87 (386)
T ss_dssp             CCEESSCCSHHHHT-TSHHHHHCSCCCEEECTTSEECHHHHH-HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH
T ss_pred             ccccCCCCHHHHHH-HHHHHhcCCCccEEECCCCCCCHHHHH-HHHHHHHhCCCccEEeCcccccCccccchhHHHHHHH
Confidence            34444444455554 567788889999999999988765332 11124778899999999986543   34444443332


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCc----ccCccccCCCCCCEEEcccccccccCChhhhc----C
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNG----SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR----L  169 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l  169 (599)
                                        ..|..+++|++|+|++|.++.    .++..+..+++|++|+|++|.+....+..+..    +
T Consensus        88 ------------------~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l  149 (386)
T 2ca6_A           88 ------------------QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL  149 (386)
T ss_dssp             ------------------HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH
T ss_pred             ------------------HHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH
Confidence                              456778999999999999987    46677888899999999999987554444443    3


Q ss_pred             ---------CCCcEEEeeCCccCC-CCC---cccCCCCCCcEeecCCCCCC------CCCccccCCCcccEEeecCCCcc
Q 042902          170 ---------AALFLLDLGGNKLSG-FVP---ACFGNLTSLRNLYLGSNQLT------SIPSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       170 ---------~~L~~L~Ls~N~l~~-~~~---~~~~~l~~L~~L~L~~N~l~------~ip~~~~~l~~L~~L~Ls~N~l~  230 (599)
                               ++|++|+|++|+++. ..+   ..+..+++|++|+|++|.++      -+|..+..+++|+.|+|++|.++
T Consensus       150 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~  229 (386)
T 2ca6_A          150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  229 (386)
T ss_dssp             HHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             hhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence                     788888888888862 233   35567778888888888887      23446677778888888888875


Q ss_pred             ----ccCcccccccccccEEEccCCccCCC----CCccc--cCcccccccccccccccc----cCcccc-cCCCCccccc
Q 042902          231 ----GPLPLEIGNLRVLVQIDLSMNNFSGF----IPTTI--GDLKDLQYLFLEYNRLQG----SIPDSI-GGLIDLKSLD  295 (599)
Q Consensus       231 ----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~  295 (599)
                          ..+|..+..+++|+.|+|++|.+++.    ++..+  +.+++|++|+|++|.+++    .+|..+ ..+++|+.|+
T Consensus       230 ~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~  309 (386)
T 2ca6_A          230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE  309 (386)
T ss_dssp             HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred             cHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEE
Confidence                45566777777888888888877754    34444  236777777777777775    355555 4567777777


Q ss_pred             CCCCcccccC
Q 042902          296 LSNNNISGAI  305 (599)
Q Consensus       296 L~~N~l~~~~  305 (599)
                      |++|++++..
T Consensus       310 l~~N~l~~~~  319 (386)
T 2ca6_A          310 LNGNRFSEED  319 (386)
T ss_dssp             CTTSBSCTTS
T ss_pred             ccCCcCCcch
Confidence            7777777555

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=4.1e-26  Score=227.60  Aligned_cols=166  Identities=23%  Similarity=0.386  Sum_probs=143.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            467999999999999999999976 68999999986542  345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC---CcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN---MVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~---~~~kl~DFGla~~~~~  580 (599)
                      ||+++++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++.+   +.+||+|||+++....
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999998886543 4889999999999999999999   8899999999999999754   4799999999986543


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..   ......||+.|+||
T Consensus       177 ~~---~~~~~~~~~~y~aP  192 (287)
T 2wei_A          177 NT---KMKDRIGTAYYIAP  192 (287)
T ss_dssp             CS---SCSCHHHHHTTCCH
T ss_pred             CC---ccccccCcccccCh
Confidence            22   12334688999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=3.8e-26  Score=239.47  Aligned_cols=164  Identities=23%  Similarity=0.315  Sum_probs=122.4

Q ss_pred             CCc-CceecccccceEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEEE
Q 042902          430 FSE-NNLIGRGGVASVYKARIQ---DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALVL  503 (599)
Q Consensus       430 ~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  503 (599)
                      |.. .++||+|+||.||+|++.   +++.||||++....  ....+.+|++++++++|||||++++++..  ....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            444 458999999999999965   57899999996442  33578899999999999999999999954  66899999


Q ss_pred             EccCCCChhhhhhcC--------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----cCCCcEEEcc
Q 042902          504 EYMPHGSLEKCLYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----DDNMVAHLSD  571 (599)
Q Consensus       504 e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----~~~~~~kl~D  571 (599)
                      ||++ |+|.+++...        ...+++..+..|+.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9996 4887776521        124888999999999999999999   8899999999999999    6778999999


Q ss_pred             ccCCccCCcCCCc-eeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~-~~~~~~~gt~~y~AP  599 (599)
                      ||+|+.+...... .......||+.|+||
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             TTCCC----------------CCCTTCCH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCc
Confidence            9999876432211 223456899999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.93  E-value=3.4e-26  Score=232.53  Aligned_cols=167  Identities=28%  Similarity=0.401  Sum_probs=138.8

Q ss_pred             HhCCCCcCceecccccceEEEEEe--cCCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCcceeEEEEEE----
Q 042902          426 ATNGFSENNLIGRGGVASVYKARI--QDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNLIKIISSCS----  494 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  494 (599)
                      +.++|+..+.||+|+||.||+|+.  .+|+.||||+++...  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999997  368899999986442  22234566777777666   8999999999987    


Q ss_pred             -cCCeeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          495 -NDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       495 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                       .....++||||++ |+|.+++.... ..+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999997 69999987654 34889999999999999999999   889999999999999999999999999


Q ss_pred             cCCccCCcCCCceeeecccCCccccCC
Q 042902          573 GMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       573 Gla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+++......   ......||+.|+||
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aP  188 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAP  188 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred             cccccccCCC---CccccccccceeCH
Confidence            9998654322   23446789999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.93  E-value=8.1e-26  Score=238.40  Aligned_cols=163  Identities=21%  Similarity=0.289  Sum_probs=138.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC------CCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRI------RHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  499 (599)
                      ..+|+..+.||+|+||.||+|... +++.||||+++.. ....+++..|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            356889999999999999999866 5899999999643 23346678888888877      577999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc--EEEccccCCc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAK  576 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~--~kl~DFGla~  576 (599)
                      ++||||++ |+|.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+|||++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 69998887654 35899999999999999999999   889999999999999999887  9999999997


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....     .....||+.||||
T Consensus       251 ~~~~~-----~~~~~gt~~y~aP  268 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAP  268 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCH
T ss_pred             ecCCc-----ccccCCCCCccCh
Confidence            54321     2345799999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=5e-26  Score=234.11  Aligned_cols=161  Identities=25%  Similarity=0.358  Sum_probs=135.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe-----
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF-----  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  498 (599)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357888999999999999999975 68999999996542  2335678999999999999999999999987654     


Q ss_pred             -eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          499 -KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       499 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                       .++||||++ |+|.+++..   .+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 688887753   3889999999999999999999   88999999999999999999999999999985


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....     .....||+.|+||
T Consensus       176 ~~~~-----~~~~~~t~~y~aP  192 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAP  192 (353)
T ss_dssp             -------------CCSBCCSCH
T ss_pred             CCCC-----ccccccCcCcCCH
Confidence            4321     2345789999998

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=3.3e-27  Score=243.73  Aligned_cols=255  Identities=20%  Similarity=0.216  Sum_probs=148.5

Q ss_pred             EEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCC----hhhhcccccceEEEccCCcccccCCccccCC--
Q 042902           48 RLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILP----RAIGNLSQSMEVFFMFNCNISGSIPEEISNL--  121 (599)
Q Consensus        48 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l--  121 (599)
                      .++|++|.+++..+.     .+...++|++|||++|.|++..+    .+|..++..++.|++++|.+++..+..|..+  
T Consensus         2 ~~~ls~n~~~~~~~~-----~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~   76 (362)
T 3goz_A            2 NYKLTLHPGSNPVEE-----FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA   76 (362)
T ss_dssp             EEECCCCTTCCHHHH-----HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHH
T ss_pred             ccccccccchHHHHH-----HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHh
Confidence            456777777765543     24444558888888888877666    5566665457777777777776666666554  


Q ss_pred             ---CCCCEEEccCCcCCcccCcc----ccCC-CCCCEEEcccccccccCChhhhc-----CCCCcEEEeeCCccCCCCCc
Q 042902          122 ---TNLTTIYLGGNKLNGSIPIA----LDKL-QKLQLLSLEDNQLEGSIPDDLCR-----LAALFLLDLGGNKLSGFVPA  188 (599)
Q Consensus       122 ---~~L~~L~L~~N~l~~~~~~~----~~~l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~~~  188 (599)
                         ++|++|+|++|.+++..+..    +..+ ++|++|+|++|++++..+..+..     .++|++|+|++|++++....
T Consensus        77 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  156 (362)
T 3goz_A           77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD  156 (362)
T ss_dssp             TSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH
T ss_pred             ccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH
Confidence               67777777777776555543    3333 67777777777776555544433     24677777777776643332


Q ss_pred             c----cCCCC-CCcEeecCCCCCCCCCc-----cccCC-CcccEEeecCCCccccC----cccccc-cccccEEEccCCc
Q 042902          189 C----FGNLT-SLRNLYLGSNQLTSIPS-----TLWNL-KYILYLNLSSNSFTGPL----PLEIGN-LRVLVQIDLSMNN  252 (599)
Q Consensus       189 ~----~~~l~-~L~~L~L~~N~l~~ip~-----~~~~l-~~L~~L~Ls~N~l~~~~----~~~~~~-l~~L~~L~Ls~N~  252 (599)
                      .    +..++ +|++|+|++|+++..+.     .+... ++|++|+|++|.+++..    +..+.. .++|+.|+|++|.
T Consensus       157 ~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  236 (362)
T 3goz_A          157 ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC  236 (362)
T ss_dssp             HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred             HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence            2    23333 66777777776664432     22233 36666666666666532    223333 2366666666666


Q ss_pred             cCCCCC----ccccCcccccccccccccccccCc-------ccccCCCCcccccCCCCcccccCCc
Q 042902          253 FSGFIP----TTIGDLKDLQYLFLEYNRLQGSIP-------DSIGGLIDLKSLDLSNNNISGAIPI  307 (599)
Q Consensus       253 l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~L~~N~l~~~~p~  307 (599)
                      +++..+    ..+..+++|++|+|++|.+.+..+       ..+..+++|+.||+++|++....+.
T Consensus       237 l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             CCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             CCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence            665433    223455666666666666443322       2344455555555555555544333

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=4.3e-26  Score=238.33  Aligned_cols=162  Identities=25%  Similarity=0.303  Sum_probs=135.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC--------CCcceeEEEEEE----
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR--------HRNLIKIISSCS----  494 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----  494 (599)
                      ++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++        ||||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            57889999999999999999865 6889999999643 234567889999999985        788999999987    


Q ss_pred             cCCeeeEEEEccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCC-------
Q 042902          495 NDDFKALVLEYMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNM-------  565 (599)
Q Consensus       495 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~-------  565 (599)
                      .....++||||+ +|++.+.+... ...+++..+..|+.||++||+|||   +. +|+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            456889999999 55666555443 346899999999999999999999   77 999999999999999775       


Q ss_pred             ------------------------------------------cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 ------------------------------------------VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                                                                .+||+|||+|+.....     .....||+.||||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                      7999999999865322     2345789999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=9.4e-27  Score=235.89  Aligned_cols=168  Identities=24%  Similarity=0.401  Sum_probs=138.7

Q ss_pred             HhCCCCcCceecccccceEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ..++|+..+.||+|+||.||+|++.+  .||+|+++...  ....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35678899999999999999998753  59999986542  233456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC-
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED-  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~-  582 (599)
                      ||+++++|.+++...+..+++..+..++.||++||+|||   +.+|+||||||+||+++ ++.+||+|||+|+...... 
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            999999999999877667889999999999999999999   88999999999999998 6799999999987543211 


Q ss_pred             --CceeeecccCCccccCC
Q 042902          583 --QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 --~~~~~~~~~gt~~y~AP  599 (599)
                        .........||+.|+||
T Consensus       185 ~~~~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCH
T ss_pred             cccccccccCCCcccccCh
Confidence              11122345689999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=3.8e-26  Score=240.80  Aligned_cols=165  Identities=25%  Similarity=0.420  Sum_probs=130.9

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+|...+.||+|+||+||.....+|+.||||++......   .+.+|+++++++ +|||||++++++.+.+..|+|||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            457788999999999976555567999999998654322   356799999999 7999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-----CCcEEEccccCCccCCcC
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-----NMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DFGla~~~~~~  581 (599)
                      + |+|.+++........+..+..++.||++||.|||   +.+|+||||||+||+++.     ...+||+|||+|+.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 5999999876654555566789999999999999   889999999999999953     236889999999876433


Q ss_pred             CCc-eeeecccCCccccCC
Q 042902          582 DQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~-~~~~~~~gt~~y~AP  599 (599)
                      ... .......||++||||
T Consensus       177 ~~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             ---------CCSCTTSCCG
T ss_pred             CcceeeccccCCCcCccCh
Confidence            211 223456799999999

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.7e-26  Score=231.81  Aligned_cols=167  Identities=25%  Similarity=0.333  Sum_probs=134.6

Q ss_pred             HHhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcC----CCCcceeEEEEE
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRI----RHRNLIKIISSC  493 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~~~  493 (599)
                      ...++|...+.||+|+||.||+|+.. +++.||||+++....      .....+..|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999864 689999999965432      1223466799999888    899999999999


Q ss_pred             EcCCeeeEEEEc-cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEcc
Q 042902          494 SNDDFKALVLEY-MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSD  571 (599)
Q Consensus       494 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~D  571 (599)
                      ...+..++|||| +++++|.+++.... .+++..+..++.||++||.|||   +.+|+||||||+||+++ .++.+||+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            999999999999 89999999997644 4889999999999999999999   88999999999999999 889999999


Q ss_pred             ccCCccCCcCCCceeeecccCCccccCC
Q 042902          572 FGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       572 FGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+++......    .....||+.|+||
T Consensus       184 fg~~~~~~~~~----~~~~~~~~~y~aP  207 (312)
T 2iwi_A          184 FGSGALLHDEP----YTDFDGTRVYSPP  207 (312)
T ss_dssp             CSSCEECCSSC----BCCCCSCTTTSCH
T ss_pred             cchhhhcccCc----ccccCCcccccCc
Confidence            99998664322    2345689999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=1.1e-25  Score=229.05  Aligned_cols=166  Identities=26%  Similarity=0.325  Sum_probs=125.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHH-HHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECD-MMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|...+.||+|+||.||+|... +|+.||||+++... .....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            357888899999999999999975 68999999997553 233445666665 777889999999999999999999999


Q ss_pred             EccCCCChhhhhhc----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          504 EYMPHGSLEKCLYS----SNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       504 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      ||+++ +|.+++..    ....+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88777652    2345889999999999999999999   77 9999999999999999999999999999865


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....   ......||+.|+||
T Consensus       177 ~~~~---~~~~~~gt~~y~aP  194 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAP  194 (327)
T ss_dssp             ---------------------
T ss_pred             cccc---ccccCCCCccccCc
Confidence            4322   22334789999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.93  E-value=1.5e-25  Score=230.99  Aligned_cols=173  Identities=22%  Similarity=0.307  Sum_probs=129.5

Q ss_pred             HHHHHHhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe-
Q 042902          421 LELFQATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF-  498 (599)
Q Consensus       421 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  498 (599)
                      .+.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+..|++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999975 68999999985442 233466778888999999999999999865432 


Q ss_pred             ------eeEEEEccCCCChhhhhh---cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEE
Q 042902          499 ------KALVLEYMPHGSLEKCLY---SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAH  568 (599)
Q Consensus       499 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~k  568 (599)
                            .++||||+++ ++.+.+.   .....+++..+..++.|++.||.|+|. .+.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999986 5544433   234457888899999999999999993 3678999999999999996 89999


Q ss_pred             EccccCCccCCcCCCceeeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+|+.+....   ......||+.|+||
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAP  200 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCH
Confidence            99999998764332   22346789999998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=7.2e-26  Score=228.49  Aligned_cols=201  Identities=19%  Similarity=0.211  Sum_probs=139.7

Q ss_pred             CCCCEEEccCCcCCcccCccc--cCCCCCCEEEcccccccccCC----hhhhcCCCCcEEEeeCCccCCCCCcccCCCCC
Q 042902          122 TNLTTIYLGGNKLNGSIPIAL--DKLQKLQLLSLEDNQLEGSIP----DDLCRLAALFLLDLGGNKLSGFVPACFGNLTS  195 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  195 (599)
                      ++|++|+|++|.+.+..|..+  ..+++|++|+|++|.+.+..+    ..+..+++|++|+|++|++++..+..|+.+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            457777777777776666666  667777777777777765444    33456777777777777777777777777777


Q ss_pred             CcEeecCCCCCCC---CCc--cccCCCcccEEeecCCCccccCcc---cccccccccEEEccCCccCCCCCccccCc---
Q 042902          196 LRNLYLGSNQLTS---IPS--TLWNLKYILYLNLSSNSFTGPLPL---EIGNLRVLVQIDLSMNNFSGFIPTTIGDL---  264 (599)
Q Consensus       196 L~~L~L~~N~l~~---ip~--~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---  264 (599)
                      |++|+|++|++..   ++.  .+..+++|++|+|++|+++...+.   .+..+++|++|||++|.+++..|..+..+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            7777777777653   322  235677777777777777632211   24667788888888888887767666665   


Q ss_pred             ccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcc
Q 042902          265 KDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      ++|++|+|++|+++ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|+++.
T Consensus       251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            58888888888888 4555553  6888888888888854 33 5677888888888888763

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=6e-26  Score=230.16  Aligned_cols=166  Identities=23%  Similarity=0.293  Sum_probs=141.7

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCC--CCcceeEEEEEEcC
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRIR--HRNLIKIISSCSND  496 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  496 (599)
                      ..++|+..+.||+|+||.||+|... +++.||||++.....      ...+.+..|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4567999999999999999999864 689999999965421      12245778999999996  59999999999999


Q ss_pred             CeeeEEEEccCC-CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec-CCCcEEEccccC
Q 042902          497 DFKALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGM  574 (599)
Q Consensus       497 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~-~~~~~kl~DFGl  574 (599)
                      +..++||||+++ ++|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+||+++ +++.+||+|||+
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999986 89999987643 4788999999999999999999   88999999999999999 789999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++.....    ......||+.|+||
T Consensus       197 ~~~~~~~----~~~~~~gt~~y~aP  217 (320)
T 3a99_A          197 GALLKDT----VYTDFDGTRVYSPP  217 (320)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCH
T ss_pred             ccccccc----cccCCCCCccCCCh
Confidence            9866432    22345799999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=1.7e-25  Score=228.41  Aligned_cols=163  Identities=19%  Similarity=0.309  Sum_probs=139.3

Q ss_pred             hCCCCcCceecccccceEEEEEe-c-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCc------ceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-Q-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN------LIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|.. . +++.||||+++.. ....+.+..|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788999999999999999986 3 6889999999643 234567889999999887654      9999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC--------------
Q 042902          499 KALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD--------------  563 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~--------------  563 (599)
                      .++||||+ +++|.+++..... .+++..+..++.||++||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 8899999876543 5788999999999999999999   889999999999999987              


Q ss_pred             -----CCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          564 -----NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       564 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                           ++.+||+|||+|+.....     .....||+.|+||
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  203 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAP  203 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccCh
Confidence                 668999999999864322     2345789999998

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.9e-25  Score=225.42  Aligned_cols=225  Identities=19%  Similarity=0.208  Sum_probs=187.9

Q ss_pred             CCCcEEEcccCcccccCChh---hhcccccceEEEccCCcccccCCccc--cCCCCCCEEEccCCcCCcccC----cccc
Q 042902           73 KYLKYLSFSNNSLDGILPRA---IGNLSQSMEVFFMFNCNISGSIPEEI--SNLTNLTTIYLGGNKLNGSIP----IALD  143 (599)
Q Consensus        73 ~~L~~L~Ls~N~i~~~~~~~---~~~l~~~l~~l~l~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~  143 (599)
                      ..++.|.++++.++...-..   +..++ .++.|++++|.+.+..|..+  ..+++|++|+|++|.+++..+    ..+.
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYS-RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHS-CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccC-ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            45788999888876321111   12233 49999999999999999998  899999999999999997555    3456


Q ss_pred             CCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCC---CC-CcccCCCCCCcEeecCCCCCCCCCcc----ccC
Q 042902          144 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSG---FV-PACFGNLTSLRNLYLGSNQLTSIPST----LWN  215 (599)
Q Consensus       144 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~-~~~~~~l~~L~~L~L~~N~l~~ip~~----~~~  215 (599)
                      .+++|++|+|++|++.+..+..|..+++|++|+|++|++.+   .. +..+..+++|++|+|++|+++.+|..    +..
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~  222 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA  222 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence            79999999999999998888999999999999999999865   22 23457899999999999999977653    467


Q ss_pred             CCcccEEeecCCCccccCccccccc---ccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcc
Q 042902          216 LKYILYLNLSSNSFTGPLPLEIGNL---RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK  292 (599)
Q Consensus       216 l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  292 (599)
                      +++|++|+|++|++++..|..+..+   ++|++|+|++|+|+. +|..+.  ++|++|+|++|+|++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            8999999999999999888877776   699999999999994 566664  8999999999999965 33 68889999


Q ss_pred             cccCCCCcccc
Q 042902          293 SLDLSNNNISG  303 (599)
Q Consensus       293 ~L~L~~N~l~~  303 (599)
                      .|+|++|+++.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            99999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.92  E-value=1.5e-25  Score=236.88  Aligned_cols=164  Identities=27%  Similarity=0.375  Sum_probs=126.1

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+..|++++.++ +|||||++++++.+++..++|||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34456889999999998776668999999998643   235678899999876 89999999999999999999999995


Q ss_pred             CCChhhhhhcCCCcC------CHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC-------------CcEE
Q 042902          508 HGSLEKCLYSSNYIL------DIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN-------------MVAH  568 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~------~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~-------------~~~k  568 (599)
                       |+|.+++.......      ++..+..++.||++||+|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999997654311      22235679999999999999   8899999999999999754             4899


Q ss_pred             EccccCCccCCcCCCce--eeecccCCccccCC
Q 042902          569 LSDFGMAKPLLKEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       569 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      |+|||+|+.+.......  ......||++||||
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCH
Confidence            99999998765432211  12346799999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=2.5e-25  Score=227.15  Aligned_cols=162  Identities=24%  Similarity=0.329  Sum_probs=119.9

Q ss_pred             hCCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc----CCeee
Q 042902          427 TNGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN----DDFKA  500 (599)
Q Consensus       427 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  500 (599)
                      .++|... +.||+|+||.||+|... +|+.||||++....    .........++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4567774 46999999999999976 69999999986432    122223334566799999999999875    44589


Q ss_pred             EEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~  576 (599)
                      +||||+++|+|.+++.... ..+++..+..++.||++||.|||   +.+|+||||||+||+++.   ++.+||+|||+|+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998754 35899999999999999999999   889999999999999986   4559999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....    ......||+.|+||
T Consensus       180 ~~~~~----~~~~~~~t~~y~aP  198 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAP  198 (336)
T ss_dssp             EC---------------------
T ss_pred             ecccc----ccccCCCCcCccCh
Confidence            65322    22345789999998

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=4.8e-25  Score=222.04  Aligned_cols=196  Identities=27%  Similarity=0.384  Sum_probs=152.8

Q ss_pred             ccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                      +..+++|++|++++|.++.. + .+..+++|++|+|++|.+.+..+  +..+++|++|+|++|++++.  ..+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence            44567788888888888754 3 57778888888888888875544  77888888888888888764  3577888888


Q ss_pred             EeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccc
Q 042902          198 NLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRL  277 (599)
Q Consensus       198 ~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  277 (599)
                      +|++++|.++.+|. +..+++|++|++++|.+++..+  +..+++|+.|+|++|.+++..+  +..+++|+.|++++|++
T Consensus       111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            88888888887764 7778888888888888876544  7788888888888888886544  78888888888888888


Q ss_pred             cccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCccc
Q 042902          278 QGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGE  328 (599)
Q Consensus       278 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  328 (599)
                      ++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            86544  7888888888888888886553  77888888888888888753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=226.45  Aligned_cols=166  Identities=22%  Similarity=0.295  Sum_probs=123.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE--GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      .++|+..+.||+|+||.||+|++. +|+.||||++.....  ...+.+..+..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888899999999999999976 689999999975432  22234455556788889999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||+ ++.+..+.......+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+++......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666655544456899999999999999999999   74 99999999999999999999999999998654322


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......||+.|+||
T Consensus       180 ---~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAP  193 (318)
T ss_dssp             ----------CCTTCCH
T ss_pred             ---cccccCCCccccCh
Confidence               22345689999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=8.6e-26  Score=245.98  Aligned_cols=167  Identities=29%  Similarity=0.422  Sum_probs=140.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc------CCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN------DDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  498 (599)
                      .++|...+.||+|+||.||+|.+. +|+.||||+++.. .....+.+..|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999875 6899999998654 33445779999999999999999999998765      667


Q ss_pred             eeEEEEccCCCChhhhhhcCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCc---EEEcccc
Q 042902          499 KALVLEYMPHGSLEKCLYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMV---AHLSDFG  573 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~---~kl~DFG  573 (599)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999986442  5788889999999999999999   889999999999999997664   9999999


Q ss_pred             CCccCCcCCCceeeecccCCccccCC
Q 042902          574 MAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       574 la~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +|+......   ......||+.|+||
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAP  192 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSS
T ss_pred             ccccccccc---ccccccCCcccCCh
Confidence            998664332   22446799999999

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=1e-24  Score=219.69  Aligned_cols=209  Identities=24%  Similarity=0.364  Sum_probs=111.3

Q ss_pred             EEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEE
Q 042902           24 RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVF  103 (599)
Q Consensus        24 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l  103 (599)
                      .+.+..+.++++.  .+..+++|++|++++|.++.++       .+..+++|++|+|++|.|+++.+             
T Consensus        23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l~-------~~~~l~~L~~L~L~~n~i~~~~~-------------   80 (308)
T 1h6u_A           23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-------GVQYLNNLIGLELKDNQITDLAP-------------   80 (308)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG-------------
T ss_pred             HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCch-------hhhccCCCCEEEccCCcCCCChh-------------
Confidence            3344555555432  2445666666666666666543       25556666666666666653322             


Q ss_pred             EccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccC
Q 042902          104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS  183 (599)
Q Consensus       104 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  183 (599)
                                    +.++++|++|+|++|.+++.  ..+..+++|++|+|++|++++. + .+..+++|++|++++|+++
T Consensus        81 --------------~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~  142 (308)
T 1h6u_A           81 --------------LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQIT  142 (308)
T ss_dssp             --------------GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             --------------HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccC
Confidence                          33444455555555554432  1344455555555555555432 1 2445555555555555555


Q ss_pred             CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccC
Q 042902          184 GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD  263 (599)
Q Consensus       184 ~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  263 (599)
                      +..+  +..+++|++|++++|.++.++. +..+++|+.|++++|.+++..+  +..+++|+.|+|++|++++..+  +..
T Consensus       143 ~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~  215 (308)
T 1h6u_A          143 NISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN  215 (308)
T ss_dssp             CCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTT
T ss_pred             cCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccC
Confidence            4322  4455555555555555555544 4555555555555555554332  5556666666666666665432  566


Q ss_pred             cccccccccccccccc
Q 042902          264 LKDLQYLFLEYNRLQG  279 (599)
Q Consensus       264 l~~L~~L~L~~N~l~~  279 (599)
                      +++|+.|+|++|++++
T Consensus       216 l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          216 TSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CTTCCEEEEEEEEEEC
T ss_pred             CCCCCEEEccCCeeec
Confidence            6666666666666653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.92  E-value=7.2e-25  Score=227.89  Aligned_cols=165  Identities=24%  Similarity=0.360  Sum_probs=138.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CC-----cceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HR-----NLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~  499 (599)
                      .++|...+.||+|+||.||+|... +++.||||+++.. .....++..|+++++.++ |+     +|+++++++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            568999999999999999999876 6889999999643 233567788888888875 44     499999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec--CCCcEEEccccCCc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAK  576 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DFGla~  576 (599)
                      ++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+|+
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            99999996 59999987654 3588999999999999999999932 46899999999999995  57789999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....     .....||+.||||
T Consensus       210 ~~~~~-----~~~~~~t~~y~aP  227 (382)
T 2vx3_A          210 QLGQR-----IYQYIQSRFYRSP  227 (382)
T ss_dssp             ETTCC-----CCSSCSCGGGCCH
T ss_pred             ecccc-----cccccCCccccCh
Confidence            65322     2346799999998

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=7.7e-26  Score=230.97  Aligned_cols=254  Identities=15%  Similarity=0.188  Sum_probs=134.5

Q ss_pred             CCCEEEccCccccccCCccccCC--CCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccccc-CChhhhccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNL--RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGI-LPRAIGNLS   97 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~   97 (599)
                      .++.|++++|.+.   +..+..+  ++++.|++++|.++...+.      +..+++|++|+|++|.+++. .+..+..++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~------~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~  118 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE------HFSPFRVQHMDLSNSVIEVSTLHGILSQCS  118 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS------CCCCBCCCEEECTTCEECHHHHHHHHTTBC
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh------hccCCCCCEEEccCCCcCHHHHHHHHhhCC
Confidence            4677888877776   3556666  7788888888887776553      45677788888888777643 444444443


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCC-cCCcc-cCccccCCCCCCEEEcccc-ccccc-CChhhhcCC-CC
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGN-KLNGS-IPIALDKLQKLQLLSLEDN-QLEGS-IPDDLCRLA-AL  172 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L  172 (599)
                       .|+.|++++|.+++..+..+..+++|++|+|++| .+++. .+..+..+++|++|++++| .+++. ++..+..++ +|
T Consensus       119 -~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L  197 (336)
T 2ast_B          119 -KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  197 (336)
T ss_dssp             -CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             -CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence             3555555555555444455555555555555555 34431 3333444555555555555 44432 233344444 44


Q ss_pred             cEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCC--CCCccccCCCcccEEeecCCC-ccccCcccccccccccEEEcc
Q 042902          173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT--SIPSTLWNLKYILYLNLSSNS-FTGPLPLEIGNLRVLVQIDLS  249 (599)
Q Consensus       173 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~ip~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls  249 (599)
                      ++|++++|.+                      .++  .+|..+..+++|++|++++|. +++..+..+..+++|+.|+++
T Consensus       198 ~~L~l~~~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~  255 (336)
T 2ast_B          198 TQLNLSGYRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS  255 (336)
T ss_dssp             CEEECCSCGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred             CEEEeCCCcc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCC
Confidence            4554444421                      222  233334445555555555555 444444455555555555555


Q ss_pred             CCc-cCCCCCccccCcccccccccccccccccCcccccCC-CCcccccCCCCcccccCCchhh
Q 042902          250 MNN-FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGL-IDLKSLDLSNNNISGAIPISLE  310 (599)
Q Consensus       250 ~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~  310 (599)
                      +|. +.......++.+++|++|++++| ++.   ..+..+ ..++.|++++|++++..|..+.
T Consensus       256 ~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          256 RCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             TCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence            553 22111123555556666666655 221   222222 2355555666666666655544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=6.3e-25  Score=225.73  Aligned_cols=163  Identities=21%  Similarity=0.304  Sum_probs=137.0

Q ss_pred             hCCCCcCceecccccceEEEEEec-CC-cEEEEEEecccccccHHHHHHHHHHHhcCCCCc------ceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DG-IEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN------LIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  498 (599)
                      .++|...+.||+|+||.||+|... ++ +.||||+++.. ....+.+..|++++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            357899999999999999999875 34 78999999643 234567888999999997766      9999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee----------------
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL----------------  561 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill----------------  561 (599)
                      .++||||+ +|++.+++.... ..+++..+..++.||++||+|||   +.+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567766665543 46899999999999999999999   8999999999999999                


Q ss_pred             ---cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 ---DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                         +.++.+||+|||+|+.....     .....||+.|+||
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  208 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPP  208 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCC
Confidence               56789999999999864322     2345799999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=7.6e-25  Score=218.15  Aligned_cols=143  Identities=15%  Similarity=0.073  Sum_probs=127.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|...+.||+|+||.||+|++. +|+.||||++.....   ...+.|.+|++++++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56889999999999999999976 489999999975532   33478999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      ||++|++|.+++...   ....++.+|+.|+++||+|||   +.+|+||||||+||+++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999998653   355578899999999999999   8899999999999999999999999887654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.7e-25  Score=241.80  Aligned_cols=154  Identities=18%  Similarity=0.182  Sum_probs=119.9

Q ss_pred             CcCceecccccceEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          431 SENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE--------GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ...+.||+|+||.||+|.. .++.+|+|+......        ...++|.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999955 478899998643311        1245689999999999999999777777777888999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      |||+++|+|.+++..         +..++.|+++||.|||   +.+|+||||||+|||++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999876         4579999999999999   899999999999999999  99999999999764322


Q ss_pred             Cce-----eeecccCCccccCC
Q 042902          583 QSL-----TQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~-----~~~~~~gt~~y~AP  599 (599)
                      ...     ......||+.||||
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHH
T ss_pred             ccccchhhhhhhhcCCCCcCCH
Confidence            111     12356799999998

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=9.3e-27  Score=242.58  Aligned_cols=241  Identities=24%  Similarity=0.273  Sum_probs=192.2

Q ss_pred             ccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcC---CcccCccc--
Q 042902           68 SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL---NGSIPIAL--  142 (599)
Q Consensus        68 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l---~~~~~~~~--  142 (599)
                      .+..+++|++|+|++|.|+...+.++                     +..|..+++|++|+|++|.+   ++.+|..+  
T Consensus        27 ~l~~~~~L~~L~L~~n~i~~~~~~~l---------------------~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~   85 (386)
T 2ca6_A           27 VLLEDDSVKEIVLSGNTIGTEAARWL---------------------SENIASKKDLEIAEFSDIFTGRVKDEIPEALRL   85 (386)
T ss_dssp             HHHHCSCCCEEECTTSEECHHHHHHH---------------------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH
T ss_pred             HHhcCCCccEEECCCCCCCHHHHHHH---------------------HHHHHhCCCccEEeCcccccCccccchhHHHHH
Confidence            45566677777777777664332222                     23466789999999999654   44445444  


Q ss_pred             -----cCCCCCCEEEcccccccc----cCChhhhcCCCCcEEEeeCCccCCCCCcccCC----C---------CCCcEee
Q 042902          143 -----DKLQKLQLLSLEDNQLEG----SIPDDLCRLAALFLLDLGGNKLSGFVPACFGN----L---------TSLRNLY  200 (599)
Q Consensus       143 -----~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----l---------~~L~~L~  200 (599)
                           ..+++|++|+|++|.+.+    .+|..+..+++|++|+|++|.+++..+..+..    +         ++|++|+
T Consensus        86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~  165 (386)
T 2ca6_A           86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII  165 (386)
T ss_dssp             HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred             HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence                 789999999999999997    47778899999999999999997554444433    3         8999999


Q ss_pred             cCCCCCC--CCC---ccccCCCcccEEeecCCCccc-----cCcccccccccccEEEccCCccC----CCCCccccCccc
Q 042902          201 LGSNQLT--SIP---STLWNLKYILYLNLSSNSFTG-----PLPLEIGNLRVLVQIDLSMNNFS----GFIPTTIGDLKD  266 (599)
Q Consensus       201 L~~N~l~--~ip---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~  266 (599)
                      |++|+++  .+|   ..+..+++|++|++++|.++.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            9999997  445   456678999999999999983     34457889999999999999996    567788999999


Q ss_pred             cccccccccccccc----Cccccc--CCCCcccccCCCCcccc----cCCchh-hccccceEEEcccccCcccC
Q 042902          267 LQYLFLEYNRLQGS----IPDSIG--GLIDLKSLDLSNNNISG----AIPISL-EKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       267 L~~L~L~~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~l~l~~N~l~~~~  329 (599)
                      |++|+|++|++++.    ++..+.  .+++|+.|+|++|.+++    .+|..+ .++++|++|++++|++++..
T Consensus       246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            99999999999876    566663  48999999999999997    477777 66899999999999998654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=2.9e-24  Score=220.47  Aligned_cols=236  Identities=17%  Similarity=0.161  Sum_probs=190.5

Q ss_pred             cCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcc-cCCCcccccccCCCCCCcE-EEc
Q 042902            3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTS-STPKLNFLSSLSNCKYLKY-LSF   80 (599)
Q Consensus         3 L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~~~l~~L~~-L~L   80 (599)
                      -++|+++ .+|..+.  +++++|+|++|+|+.+.+++|+++++|++|+|++|++.+ +++.     +|.++++|++ +++
T Consensus        16 C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~-----~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           16 CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD-----VFSNLPKLHEIRIE   87 (350)
T ss_dssp             EESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT-----SBCSCTTCCEEEEE
T ss_pred             ecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh-----Hhhcchhhhhhhcc
Confidence            4678888 6788774  689999999999999888999999999999999999865 4543     6899998775 677


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccC-CcCCcccCccccCCC-CCCEEEcccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG-NKLNGSIPIALDKLQ-KLQLLSLEDNQL  158 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l  158 (599)
                      ++|+|+.+.|++|..++ .|+.|++++|++....+..+....++..|++.+ |++..+.+.+|..+. .++.|+|++|+|
T Consensus        88 ~~N~l~~l~~~~f~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EETTCCEECTTSBCCCT-TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             cCCcccccCchhhhhcc-ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            78999999999999997 599999999999988888888888999999976 678888888888875 689999999999


Q ss_pred             cccCChhhhcCCCCcEEEee-CCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccc
Q 042902          159 EGSIPDDLCRLAALFLLDLG-GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI  237 (599)
Q Consensus       159 ~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~  237 (599)
                      +.+.+..| ...+|+.|+++ +|.++.+.+++|+++++|++|+|++|+|+.+|...  +.+|+.|.+.++.--...| .+
T Consensus       167 ~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP-~l  242 (350)
T 4ay9_X          167 QEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLP-TL  242 (350)
T ss_dssp             CEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCC-CT
T ss_pred             cCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCC-Cc
Confidence            96655555 45689999997 47888777788999999999999999999998642  3455555554443222444 46


Q ss_pred             cccccccEEEccCC
Q 042902          238 GNLRVLVQIDLSMN  251 (599)
Q Consensus       238 ~~l~~L~~L~Ls~N  251 (599)
                      .++++|+.++++++
T Consensus       243 ~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          243 EKLVALMEASLTYP  256 (350)
T ss_dssp             TTCCSCCEEECSCH
T ss_pred             hhCcChhhCcCCCC
Confidence            67777787777654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=4.1e-24  Score=208.68  Aligned_cols=180  Identities=24%  Similarity=0.285  Sum_probs=132.9

Q ss_pred             CCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      .+.++++++++.++.+ |..+.  ++|+.|+|++|.+.+..+..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~~~-p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLDSV-PSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCSSC-CSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcccc-CCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            4567888888888854 43333  57888888888888777778888888888888888888877777888888888888


Q ss_pred             CCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccccc
Q 042902          202 GSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       202 ~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      ++|+++.+|. .+..+++|++|+|++|++++..+..|..+++|+.|+|++|.|++..+..|+.+++|++|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            8888887764 456677777777777777766666677777777777777777766666677777777777777777766


Q ss_pred             CcccccCCCCcccccCCCCccccc
Q 042902          281 IPDSIGGLIDLKSLDLSNNNISGA  304 (599)
Q Consensus       281 ~~~~~~~l~~L~~L~L~~N~l~~~  304 (599)
                      .+..|..+++|+.|+|++|++++.
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCC
Confidence            666666666666666666666644

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.91  E-value=5e-25  Score=228.30  Aligned_cols=163  Identities=20%  Similarity=0.316  Sum_probs=137.1

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCcceeEEEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-----------HRNLIKIISSCS  494 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  494 (599)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+..|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357889999999999999999964 68999999996432 33567888999999886           899999999987


Q ss_pred             cCC----eeeEEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCeeec------
Q 042902          495 NDD----FKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV-PIIHCDLKPNNVLLD------  562 (599)
Q Consensus       495 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlk~~Nill~------  562 (599)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   +. +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 899999987643 35889999999999999999999   77 999999999999994      


Q ss_pred             CCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          563 DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       563 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..+.+||+|||+|+.....     .....||+.||||
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP  204 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSP  204 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCc
Confidence            4458999999999865322     2345789999998

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=7.2e-26  Score=231.16  Aligned_cols=251  Identities=22%  Similarity=0.227  Sum_probs=198.9

Q ss_pred             CCcEEEcccCcccccCChhhhcc-cccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcc-cCccccCCCCCCEE
Q 042902           74 YLKYLSFSNNSLDGILPRAIGNL-SQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS-IPIALDKLQKLQLL  151 (599)
Q Consensus        74 ~L~~L~Ls~N~i~~~~~~~~~~l-~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L  151 (599)
                      .++.+|+++|.+.   +..+..+ ...++.+++.+|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            3677777777765   4455544 13577788888887776655 45789999999999998865 77778899999999


Q ss_pred             EcccccccccCChhhhcCCCCcEEEeeCC-ccCCC-CCcccCCCCCCcEeecCCC-CCCC--CCccccCCC-cccEEeec
Q 042902          152 SLEDNQLEGSIPDDLCRLAALFLLDLGGN-KLSGF-VPACFGNLTSLRNLYLGSN-QLTS--IPSTLWNLK-YILYLNLS  225 (599)
Q Consensus       152 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~--ip~~~~~l~-~L~~L~Ls  225 (599)
                      +|++|.+.+..+..+..+++|++|++++| .+++. .+..+..+++|++|++++| .++.  ++..+..++ +|++|+++
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            99999998888888999999999999999 67652 4566788999999999999 8884  677778899 99999999


Q ss_pred             CC--Ccc-ccCcccccccccccEEEccCCc-cCCCCCccccCccccccccccccc-ccccCcccccCCCCcccccCCCCc
Q 042902          226 SN--SFT-GPLPLEIGNLRVLVQIDLSMNN-FSGFIPTTIGDLKDLQYLFLEYNR-LQGSIPDSIGGLIDLKSLDLSNNN  300 (599)
Q Consensus       226 ~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~  300 (599)
                      +|  .++ +..+..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++| 
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            99  455 3456677889999999999999 777778889999999999999995 33222336888999999999999 


Q ss_pred             ccccCCchhhccc-cceEEEcccccCcccCCCC
Q 042902          301 ISGAIPISLEKLL-DLKYINVSFNKLEGEIPRE  332 (599)
Q Consensus       301 l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~p~~  332 (599)
                      ++   ...+..+. .++.|++++|++++..|..
T Consensus       283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          283 VP---DGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence            44   23344442 3667779999999888753

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=8e-24  Score=206.64  Aligned_cols=178  Identities=26%  Similarity=0.294  Sum_probs=117.5

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      .+.++++++.++. +|..+.  ++|++|+|++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus        16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            4556666666663 333332  4666777777777666666666677777777777777666666666667777777777


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      |+++++.+..|..+++|++|+|++|+|+.+|.. +..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            777666666666667777777777777666553 4556667777777777766666566666777777777777766666


Q ss_pred             ccccCccccccccccccccccc
Q 042902          259 TTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      ..|..+++|++|+|++|+++..
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHhCCCCCCEEEeeCCceeCC
Confidence            6666667777777777766543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=1.2e-26  Score=255.65  Aligned_cols=228  Identities=16%  Similarity=0.137  Sum_probs=125.5

Q ss_pred             cCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChh
Q 042902           17 FNASKLSRLELEMNSFYGF----IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRA   92 (599)
Q Consensus        17 ~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~   92 (599)
                      .++++|++|+|++|.+++.    ++..+..+++|++|+|++|.++.+... .+...+.++++|++|++++|.+.+ .|..
T Consensus       161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~~~~-l~~~  238 (592)
T 3ogk_B          161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPK-DLETIARNCRSLVSVKVGDFEILE-LVGF  238 (592)
T ss_dssp             HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHH-HHHHHHHHCTTCCEEECSSCBGGG-GHHH
T ss_pred             hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHH-HHHHHHhhCCCCcEEeccCccHHH-HHHH
Confidence            4678999999999998775    333456789999999999988744321 112245678899999999999886 5577


Q ss_pred             hhcccccceEEEccCCccc---ccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCC-hhhhc
Q 042902           93 IGNLSQSMEVFFMFNCNIS---GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP-DDLCR  168 (599)
Q Consensus        93 ~~~l~~~l~~l~l~~n~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~  168 (599)
                      +..++ .|+.+.++.+...   ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+.+... ..+..
T Consensus       239 ~~~~~-~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~  316 (592)
T 3ogk_B          239 FKAAA-NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQK  316 (592)
T ss_dssp             HHHCT-TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTT
T ss_pred             Hhhhh-HHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHh
Confidence            77775 4888888653322   222334455555555555554322 334445555555555555555443222 22344


Q ss_pred             CCCCcEEEeeCCccCC-CCCcccCCCCCCcEeecCC-----------CCCCC--CCccccCCCcccEEeecCCCccccCc
Q 042902          169 LAALFLLDLGGNKLSG-FVPACFGNLTSLRNLYLGS-----------NQLTS--IPSTLWNLKYILYLNLSSNSFTGPLP  234 (599)
Q Consensus       169 l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~-----------N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~~~~  234 (599)
                      +++|+.|+++ |.+.+ ..+..+..+++|++|++++           |.++.  ++.....+++|++|+++.|.+++..+
T Consensus       317 ~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~  395 (592)
T 3ogk_B          317 CPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL  395 (592)
T ss_dssp             CTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHH
T ss_pred             CcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHH
Confidence            5555555555 22221 1122223345555555552           33331  11112234455555555555544333


Q ss_pred             ccccc-cccccEEEcc
Q 042902          235 LEIGN-LRVLVQIDLS  249 (599)
Q Consensus       235 ~~~~~-l~~L~~L~Ls  249 (599)
                      ..+.. +++|+.|+++
T Consensus       396 ~~l~~~~~~L~~L~l~  411 (592)
T 3ogk_B          396 ESIGTYLKNLCDFRLV  411 (592)
T ss_dssp             HHHHHHCCSCCEEEEE
T ss_pred             HHHHhhCCCCcEEEEe
Confidence            33332 4445555553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=5.2e-24  Score=213.68  Aligned_cols=144  Identities=23%  Similarity=0.371  Sum_probs=125.6

Q ss_pred             CCCCcC-ceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHH-hcCCCCcceeEEEEEEc----CCeee
Q 042902          428 NGFSEN-NLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMM-KRIRHRNLIKIISSCSN----DDFKA  500 (599)
Q Consensus       428 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~  500 (599)
                      ++|... +.||+|+||.||+|... +++.||||+++.     ...+.+|++++ +..+||||+++++++..    .+..+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 78999999999999874 689999999853     24567888887 55689999999999876    66789


Q ss_pred             EEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~  576 (599)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+|+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998754 35899999999999999999999   889999999999999997   7899999999998


Q ss_pred             cCC
Q 042902          577 PLL  579 (599)
Q Consensus       577 ~~~  579 (599)
                      ...
T Consensus       169 ~~~  171 (299)
T 3m2w_A          169 ETT  171 (299)
T ss_dssp             ECT
T ss_pred             ccc
Confidence            654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.90  E-value=1.1e-25  Score=248.00  Aligned_cols=321  Identities=15%  Similarity=0.065  Sum_probs=195.8

Q ss_pred             CccCCCcCccCCCCCCcCC--CCCCEEEccCcc-cccc-CCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCc
Q 042902            1 LLLWGNNFSGTIPSFIFNA--SKLSRLELEMNS-FYGF-IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLK   76 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l--~~L~~L~L~~n~-i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~   76 (599)
                      |+|++|.+++..+..+...  .+|++|+|++|. ++.. .+..+.++++|++|+|++|.+++....+ ....+..+++|+
T Consensus       117 L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~-l~~~~~~~~~L~  195 (592)
T 3ogk_B          117 VHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW-LHELAQHNTSLE  195 (592)
T ss_dssp             EEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH-HHHHHHHCCCCC
T ss_pred             EEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH-HHHHHhcCCCcc
Confidence            4567777766655555553  348888888776 2211 1222347788888888888776543210 111345677888


Q ss_pred             EEEcccCcccccC----ChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCC---cccCccccCCCCCC
Q 042902           77 YLSFSNNSLDGIL----PRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN---GSIPIALDKLQKLQ  149 (599)
Q Consensus        77 ~L~Ls~N~i~~~~----~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~  149 (599)
                      +|+|++|.+++..    +..+.+++ .|+.|++++|.+.+ .+..+.++++|++|+++++...   ...+..+..+++|+
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~-~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~  273 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCR-SLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC  273 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCT-TCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCC
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCC-CCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccc
Confidence            8888888886333    33334444 58888888888775 5577788888888888754322   22334566778888


Q ss_pred             EEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCC-cccCCCCCCcEeecCCCCCC--CCCccccCCCcccEEeec-
Q 042902          150 LLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVP-ACFGNLTSLRNLYLGSNQLT--SIPSTLWNLKYILYLNLS-  225 (599)
Q Consensus       150 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~--~ip~~~~~l~~L~~L~Ls-  225 (599)
                      .|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ +.+.  .++.....+++|++|+++ 
T Consensus       274 ~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~  351 (592)
T 3ogk_B          274 RLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER  351 (592)
T ss_dssp             EEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred             ccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeec
Confidence            8888876443 566677778888888888888654332 335778888888888 4444  233334457778888888 


Q ss_pred             ----------CCCccccCccc-ccccccccEEEccCCccCCCCCccccC-cccccccccc----ccccccc-----Cccc
Q 042902          226 ----------SNSFTGPLPLE-IGNLRVLVQIDLSMNNFSGFIPTTIGD-LKDLQYLFLE----YNRLQGS-----IPDS  284 (599)
Q Consensus       226 ----------~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~  284 (599)
                                .|.+++..... +..+++|+.|+++.|.+++..+..++. +++|+.|+++    .|.+++.     ++..
T Consensus       352 g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~  431 (592)
T 3ogk_B          352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL  431 (592)
T ss_dssp             CCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHH
T ss_pred             CccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHH
Confidence                      35665432222 345778888888888877655555554 6677777775    4556543     2222


Q ss_pred             ccCCCCcccccCCCC--cccccCCchhhc-cccceEEEcccccCc
Q 042902          285 IGGLIDLKSLDLSNN--NISGAIPISLEK-LLDLKYINVSFNKLE  326 (599)
Q Consensus       285 ~~~l~~L~~L~L~~N--~l~~~~p~~~~~-l~~L~~l~l~~N~l~  326 (599)
                      +..+++|+.|++++|  .+++..+..+.. +++|++|++++|+++
T Consensus       432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~  476 (592)
T 3ogk_B          432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES  476 (592)
T ss_dssp             HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSS
T ss_pred             HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCC
Confidence            444555555555432  233333333322 444555555555544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.7e-23  Score=207.50  Aligned_cols=141  Identities=16%  Similarity=0.178  Sum_probs=113.7

Q ss_pred             HHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEeccccc------------------ccHHHHHHHHHHHhcCCCC
Q 042902          423 LFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE------------------GAFKSFDIECDMMKRIRHR  484 (599)
Q Consensus       423 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  484 (599)
                      +......|...+.||+|+||.||+|.+.+|+.||||+++....                  ....++.+|++++++++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3344556667799999999999999997799999999864321                  134678999999999994 


Q ss_pred             cceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC
Q 042902          485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN  564 (599)
Q Consensus       485 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~  564 (599)
                        +++.+++.. +..++||||++||+|.+ +...       ....++.|+++||.|+|   +.+|+||||||+|||++ +
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~-------~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE-------NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS-------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cchh-------hHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence              555554433 55699999999999998 4221       23469999999999999   89999999999999999 9


Q ss_pred             CcEEEccccCCccCC
Q 042902          565 MVAHLSDFGMAKPLL  579 (599)
Q Consensus       565 ~~~kl~DFGla~~~~  579 (599)
                      +.+||+|||+|+...
T Consensus       229 ~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          229 EGIWIIDFPQSVEVG  243 (282)
T ss_dssp             TEEEECCCTTCEETT
T ss_pred             CcEEEEECCCCeECC
Confidence            999999999998553

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.89  E-value=9.9e-24  Score=221.37  Aligned_cols=162  Identities=20%  Similarity=0.229  Sum_probs=122.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCC-Ccce---------------
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRH-RNLI---------------  487 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv---------------  487 (599)
                      ..|...+.||+|+||.||+|++. +|+.||||++....   ....+.|.+|+.+++.++| +|..               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34667789999999999999955 69999999987432   2336789999999999987 2111               


Q ss_pred             ------eEEEEEEc-----CCeeeEEEEccCCCChhhhhh------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 042902          488 ------KIISSCSN-----DDFKALVLEYMPHGSLEKCLY------SSNYILDIFQRLNIMIDVASALEYLHFGYSVPII  550 (599)
Q Consensus       488 ------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ii  550 (599)
                            .+..++..     ....+++|+++ +|+|.+++.      .....+++..+..++.||++||+|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                  11111111     12456777776 679998884      22345778889999999999999999   89999


Q ss_pred             EccCCCCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       551 H~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||||||+|||++.++.+||+|||+|+.....     .....| +.||||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aP  276 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPP  276 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCc
Confidence            9999999999999999999999999864321     344567 999998

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=4.1e-22  Score=188.66  Aligned_cols=161  Identities=27%  Similarity=0.299  Sum_probs=98.5

Q ss_pred             CCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      ++|++|+|++|.++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            45666666666666555555666666666666666666555555566666666666666666555555666666666666


Q ss_pred             CCCCCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccccc
Q 042902          202 GSNQLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       202 ~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      ++|+|+.+|.. +..+++|++|++++|.+++..+..|..+++|+.|+|++|.+.+       .+++|++|+++.|+++|.
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~  180 (208)
T 2o6s_A          108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV  180 (208)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred             CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence            66666665543 4556666666666666665555556666666666666665543       234566666666666666


Q ss_pred             CcccccCCC
Q 042902          281 IPDSIGGLI  289 (599)
Q Consensus       281 ~~~~~~~l~  289 (599)
                      +|..++.++
T Consensus       181 ip~~~~~l~  189 (208)
T 2o6s_A          181 VRNSAGSVA  189 (208)
T ss_dssp             BBCTTSSBC
T ss_pred             eeccCcccc
Confidence            666655543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=3.9e-22  Score=188.80  Aligned_cols=160  Identities=28%  Similarity=0.354  Sum_probs=115.9

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      ++.|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  109 (208)
T 2o6s_A           30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT  109 (208)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence            33333444444434445566677777777777777776666677777788888888877766666677778888888888


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCC
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      |+++++.+..|..+++|++|++++|+++.+|.. +..+++|+.|++++|.+.+       .+++|+.|+++.|.++|.+|
T Consensus       110 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip  182 (208)
T 2o6s_A          110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVR  182 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBB
T ss_pred             CcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceee
Confidence            888777777777788888888888888877654 5667888888888887764       34578888888888888888


Q ss_pred             ccccCccc
Q 042902          259 TTIGDLKD  266 (599)
Q Consensus       259 ~~~~~l~~  266 (599)
                      ..++.++.
T Consensus       183 ~~~~~l~~  190 (208)
T 2o6s_A          183 NSAGSVAP  190 (208)
T ss_dssp             CTTSSBCT
T ss_pred             ccCccccC
Confidence            88776654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=2.3e-22  Score=217.35  Aligned_cols=145  Identities=24%  Similarity=0.331  Sum_probs=71.1

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |+.|++++|+|++ +|. +.+  +|++|+|++|.|+++ |.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++
T Consensus       102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A          102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTML-PE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCC-CC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence            4444444444443 222 332  555555555555542 22   34555555555555553 232   344555555555


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcc-------cEEeecCCCccccCcccccccccccEEEccCCc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYI-------LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN  252 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  252 (599)
                      |+|++ +|. |.  ++|+.|+|++|+|+.+|. +..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus       170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~  241 (571)
T 3cvr_A          170 NQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP  241 (571)
T ss_dssp             SCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSS
T ss_pred             CCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCc
Confidence            55554 222 33  555555555555555555 332  44       55555555555 244444445555555555555


Q ss_pred             cCCCCCccccCc
Q 042902          253 FSGFIPTTIGDL  264 (599)
Q Consensus       253 l~~~~~~~~~~l  264 (599)
                      +++.+|..+..+
T Consensus       242 l~~~~p~~l~~l  253 (571)
T 3cvr_A          242 LSSRIRESLSQQ  253 (571)
T ss_dssp             CCHHHHHHHHHH
T ss_pred             CCCcCHHHHHHh
Confidence            555555554443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.88  E-value=8.4e-25  Score=241.01  Aligned_cols=342  Identities=14%  Similarity=0.079  Sum_probs=199.9

Q ss_pred             CccCCCcCccCCCCCCc-CCCCCCEEEccCc-ccccc-CCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcE
Q 042902            1 LLLWGNNFSGTIPSFIF-NASKLSRLELEMN-SFYGF-IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY   77 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~-~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~   77 (599)
                      |+|++|.+++..+..+. .+++|++|+|++| .+++. .+..+.++++|++|+|++|.++...... +......+++|++
T Consensus       110 L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~-l~~~~~~~~~L~~  188 (594)
T 2p1m_B          110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHW-LSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGG-GGGSCTTCCCCCE
T ss_pred             EEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHH-HHHHhhcCCcCcE
Confidence            35566666655555554 4667777777776 44432 2333346777777777777766543321 1112335667777


Q ss_pred             EEcccCcccccCChhhhcc---cccceEEEccCC-cccccCCccccCCCCCCEEEccCCc--------------------
Q 042902           78 LSFSNNSLDGILPRAIGNL---SQSMEVFFMFNC-NISGSIPEEISNLTNLTTIYLGGNK--------------------  133 (599)
Q Consensus        78 L~Ls~N~i~~~~~~~~~~l---~~~l~~l~l~~n-~i~~~~~~~~~~l~~L~~L~L~~N~--------------------  133 (599)
                      |++++|. ..+.+..+..+   .+.|+.|++++| .+.+ .+..+.++++|++|+++.+.                    
T Consensus       189 L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~  266 (594)
T 2p1m_B          189 LNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE  266 (594)
T ss_dssp             EECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTT
T ss_pred             EEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCC
Confidence            7777775 21222222222   135777777777 3333 45555566666666654431                    


Q ss_pred             ------CCc----ccCccccCCCCCCEEEcccccccccCCh-hhhcCCCCcEEEeeCCccCCC-CCcccCCCCCCcEeec
Q 042902          134 ------LNG----SIPIALDKLQKLQLLSLEDNQLEGSIPD-DLCRLAALFLLDLGGNKLSGF-VPACFGNLTSLRNLYL  201 (599)
Q Consensus       134 ------l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L  201 (599)
                            +..    .++..+..+++|++|+|++|.+.+.... .+..+++|+.|++++| +.+. .+.....+++|++|++
T Consensus       267 L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L  345 (594)
T 2p1m_B          267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRV  345 (594)
T ss_dssp             CCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEE
T ss_pred             cccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEE
Confidence                  111    1222233568899999999887643222 3557888999999888 4322 1222235788888888


Q ss_pred             CC---------CCCCCC-Cccc-cCCCcccEEeecCCCccccCccccc-ccccccEEEcc--C----CccCCCC-----C
Q 042902          202 GS---------NQLTSI-PSTL-WNLKYILYLNLSSNSFTGPLPLEIG-NLRVLVQIDLS--M----NNFSGFI-----P  258 (599)
Q Consensus       202 ~~---------N~l~~i-p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~-----~  258 (599)
                      ++         +.++.. ...+ ..+++|+.|.++.|.+++.....+. .+++|+.|+|+  +    |.+++..     +
T Consensus       346 ~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~  425 (594)
T 2p1m_B          346 FPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFG  425 (594)
T ss_dssp             ECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHH
T ss_pred             ecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHH
Confidence            33         344421 1112 2367888888888888765555554 47788888888  3    4555321     1


Q ss_pred             ccccCcccccccccccccccccCcccccC-CCCcccccCCCCcccccCCchh-hccccceEEEcccccCcccCCC--CCC
Q 042902          259 TTIGDLKDLQYLFLEYNRLQGSIPDSIGG-LIDLKSLDLSNNNISGAIPISL-EKLLDLKYINVSFNKLEGEIPR--EGP  334 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~~~~p~--~~~  334 (599)
                      ..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+.  ...
T Consensus       426 ~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~  504 (594)
T 2p1m_B          426 AIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASK  504 (594)
T ss_dssp             HHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGG
T ss_pred             HHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHh
Confidence            1255677888888876 566555555554 7778888888888766555444 5677888888888887543221  122


Q ss_pred             CCCcccccccCCC
Q 042902          335 FRNFSAESFKGNE  347 (599)
Q Consensus       335 ~~~~~~~~~~~n~  347 (599)
                      +.++...++.+|+
T Consensus       505 l~~L~~L~l~~~~  517 (594)
T 2p1m_B          505 LETMRSLWMSSCS  517 (594)
T ss_dssp             GGGSSEEEEESSC
T ss_pred             CCCCCEEeeeCCC
Confidence            3455555555543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=3.1e-22  Score=216.29  Aligned_cols=147  Identities=28%  Similarity=0.354  Sum_probs=65.5

Q ss_pred             CCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeec
Q 042902          146 QKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS  225 (599)
Q Consensus       146 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls  225 (599)
                      ++|++|+|++|+|++ +|. +..  +|++|+|++|+|+++ |.   .+++|+.|+|++|.|+.+|.   .+++|+.|+|+
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls  168 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTML-PE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVR  168 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCC-CC---cCccccEEeCCCCccCcCCC---cCCCcCEEECC
Confidence            444444444444443 222 222  444444444444432 22   23444444444444444443   23444444444


Q ss_pred             CCCccccCcccccccccccEEEccCCccCCCCCccccCcccc-------cccccccccccccCcccccCCCCcccccCCC
Q 042902          226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDL-------QYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN  298 (599)
Q Consensus       226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  298 (599)
                      +|.|++ +|. |.  ++|+.|+|++|.|+. +|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus       169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~  239 (571)
T 3cvr_A          169 NNQLTF-LPE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED  239 (571)
T ss_dssp             SSCCSC-CCC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS
T ss_pred             CCCCCC-cch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC
Confidence            444443 222 32  444555555555442 222 332  34       55555555555 3444444455555555555


Q ss_pred             CcccccCCchhhcc
Q 042902          299 NNISGAIPISLEKL  312 (599)
Q Consensus       299 N~l~~~~p~~~~~l  312 (599)
                      |++++.+|..+..+
T Consensus       240 N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          240 NPLSSRIRESLSQQ  253 (571)
T ss_dssp             SSCCHHHHHHHHHH
T ss_pred             CcCCCcCHHHHHHh
Confidence            55555555555444

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.87  E-value=3.2e-22  Score=199.59  Aligned_cols=189  Identities=28%  Similarity=0.356  Sum_probs=93.2

Q ss_pred             CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccce
Q 042902           22 LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME  101 (599)
Q Consensus        22 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~  101 (599)
                      +..+.+..+.++++.  .+..+++|++|++++|.++.++       .+..+++|++|+|++|+|+++.+  +        
T Consensus        26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~~-------~~~~l~~L~~L~L~~n~l~~~~~--l--------   86 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP--L--------   86 (291)
T ss_dssp             HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG--G--------
T ss_pred             HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccCh-------hHhcCCCCCEEEccCCccCCCcc--c--------
Confidence            334455555555432  2455666666666666666553       25556666666666666664322  3        


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                                       .++++|++|+|++|.+++.  ..+..+++|++|+|++|++++.  ..+..+++|+.|++++|+
T Consensus        87 -----------------~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~  145 (291)
T 1h6t_A           87 -----------------ANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNK  145 (291)
T ss_dssp             -----------------TTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSC
T ss_pred             -----------------ccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCc
Confidence                             3344444444444444432  1244444444444444444432  234444444444444444


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCC
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      +++.  ..+..+++|++|++++|+++.++. +..+++|+.|++++|.+++. + .+..+++|+.|++++|+++.
T Consensus       146 l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          146 ITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            4433  334444455555555555544433 44445555555555555432 1 24455555555555555543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=8.1e-22  Score=196.68  Aligned_cols=172  Identities=27%  Similarity=0.362  Sum_probs=88.3

Q ss_pred             cCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcE
Q 042902          119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRN  198 (599)
Q Consensus       119 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  198 (599)
                      ..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|++++|++++.  ..+..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCE
Confidence            3455566666666665543 2 25555566666666666554332  55555555555555555542  22555555555


Q ss_pred             eecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccc
Q 042902          199 LYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       199 L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  278 (599)
                      |++++|+++.++ .+..+++|+.|++++|.+++.  ..                        +..+++|++|++++|+++
T Consensus       117 L~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~------------------------l~~l~~L~~L~L~~N~l~  169 (291)
T 1h6t_A          117 LSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TV------------------------LSRLTKLDTLSLEDNQIS  169 (291)
T ss_dssp             EECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GG------------------------GGGCTTCSEEECCSSCCC
T ss_pred             EECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hh------------------------hccCCCCCEEEccCCccc
Confidence            555555555542 344444555555555555433  33                        444455555555555554


Q ss_pred             ccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcc
Q 042902          279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       279 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      +..+  +..+++|+.|++++|.+++. | .+..+++|+.|++++|+++.
T Consensus       170 ~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          170 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            4333  44555555555555555532 2 25555555555555555543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.86  E-value=1.4e-21  Score=213.41  Aligned_cols=191  Identities=25%  Similarity=0.351  Sum_probs=108.0

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccccc
Q 042902           20 SKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS   99 (599)
Q Consensus        20 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~   99 (599)
                      ..+..+.|..+.+.++.+  +..|++|+.|+|++|.|+.++       .+..+++|+.|+|++|.|+++.|  +..++ .
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-------~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~-~   88 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP--LTNLK-N   88 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-------TGGGCTTCCEEECTTSCCCCCGG--GGGCT-T
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-------HHccCCCCCEEEeeCCCCCCChh--hccCC-C
Confidence            345666777777776543  567788888888888887764       26777888888888888775543  44443 2


Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      |+.|++++|.+.+.  ..+..+++|++|+|++|.|+++  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++
T Consensus        89 L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~  162 (605)
T 1m9s_A           89 LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED  162 (605)
T ss_dssp             CCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred             CCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence            45555555544432  2455555555555555555542  2355555555555555555543  3455555555555555


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTG  231 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~  231 (599)
                      |+|++..|  +..+++|+.|+|++|+|+.+| .+..+++|+.|+|++|++++
T Consensus       163 N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          163 NQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             SCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEEC
T ss_pred             CcCCCchh--hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcC
Confidence            55554433  445555555555555555443 24444445555555554443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=3.9e-22  Score=190.42  Aligned_cols=155  Identities=23%  Similarity=0.253  Sum_probs=110.0

Q ss_pred             cEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc--cccCCCcccEEeecCCCccccCcccccccccccEEEccC
Q 042902          173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS--TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM  250 (599)
Q Consensus       173 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  250 (599)
                      +.+++++|.++.+ |..+.  +.+++|+|++|+|+.++.  .+..+++|++|+|++|.|+++.+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~~i-P~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNKI-PEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcccC-ccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            3566666666643 33332  345677777777776632  356677777777777777766666777777777777777


Q ss_pred             CccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      |.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++.|.++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            77777777777777777777777777777777777777778888888888877777777778888888888888877665

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.86  E-value=2.3e-21  Score=211.86  Aligned_cols=188  Identities=27%  Similarity=0.378  Sum_probs=164.7

Q ss_pred             ccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc
Q 042902            2 LLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS   81 (599)
Q Consensus         2 ~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls   81 (599)
                      .|..+.++..++  +..+++|+.|+|++|.|..+ + .|..+++|+.|+|++|+|+.+++       +..+++|+.|+|+
T Consensus        27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~-------l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-------LTNLKNLGWLFLD   95 (605)
T ss_dssp             HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG-------GGGCTTCCEEECC
T ss_pred             hccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh-------hccCCCCCEEECc
Confidence            456666765544  56789999999999999985 3 59999999999999999998764       7899999999999


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS  161 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  161 (599)
                      +|.|+++  ..+..++ .|+.|++++|.+.+.  ..+..+++|+.|+|++|.|+++  ..+..+++|+.|+|++|+|.+.
T Consensus        96 ~N~l~~l--~~l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A           96 ENKIKDL--SSLKDLK-KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             SSCCCCC--TTSTTCT-TCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             CCCCCCC--hhhccCC-CCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence            9999864  3677776 599999999999974  5699999999999999999976  6789999999999999999977


Q ss_pred             CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc
Q 042902          162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS  211 (599)
Q Consensus       162 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~  211 (599)
                      .|  +..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|.+...|.
T Consensus       169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            66  99999999999999999975  468999999999999999998764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.9e-21  Score=200.31  Aligned_cols=155  Identities=26%  Similarity=0.274  Sum_probs=105.4

Q ss_pred             ceEEEccCCcccccCCcccc-CCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEee
Q 042902          100 MEVFFMFNCNISGSIPEEIS-NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLG  178 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  178 (599)
                      ++.|++++|+|++..+..|. ++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.+..|..+++|++|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44555555555555555565 67777777777777777777777777777777777777777766677777777777777


Q ss_pred             CCccCCCCCcccCCCCCCcEeecCCCCCCCCCccc----cCCCcccEEeecCCCccccCccccccccc--ccEEEccCCc
Q 042902          179 GNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTL----WNLKYILYLNLSSNSFTGPLPLEIGNLRV--LVQIDLSMNN  252 (599)
Q Consensus       179 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~Ls~N~  252 (599)
                      +|+|+++.+..|.++++|++|+|++|+|+.+|..+    ..+++|+.|+|++|+|++..+..|..++.  ++.|+|++|.
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence            77777777777777777888888777777777644    34566666666666666555455555554  2555555555


Q ss_pred             cC
Q 042902          253 FS  254 (599)
Q Consensus       253 l~  254 (599)
                      +.
T Consensus       201 ~~  202 (361)
T 2xot_A          201 LE  202 (361)
T ss_dssp             EE
T ss_pred             cc
Confidence            54

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=7.7e-22  Score=188.35  Aligned_cols=153  Identities=21%  Similarity=0.297  Sum_probs=90.5

Q ss_pred             EEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCc
Q 042902          174 LLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN  252 (599)
Q Consensus       174 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  252 (599)
                      .+++++|.++.+ |..+.  ++|+.|++++|.|+.+|. .+..+++|++|+|++|.+++..|..|.++++|++|+|++|.
T Consensus        15 ~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            444555555432 22221  345555555555555543 44555556666666666655555666666666666666666


Q ss_pred             cCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccC
Q 042902          253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  329 (599)
                      |+.+.+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|..
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            66555555666666666666666666666666666666666666666666665556666666666666666666544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=2.9e-21  Score=198.95  Aligned_cols=177  Identities=23%  Similarity=0.219  Sum_probs=146.6

Q ss_pred             CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccC-CCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           22 LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS-NCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        22 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      -+.+++++|+++.+ |..+.  ..++.|+|++|+|+.+++.     .|. ++++|++|+|++|+|+++.+.+|..++ .|
T Consensus        20 ~~~l~c~~~~l~~i-P~~~~--~~l~~L~Ls~N~l~~l~~~-----~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~-~L   90 (361)
T 2xot_A           20 SNILSCSKQQLPNV-PQSLP--SYTALLDLSHNNLSRLRAE-----WTPTRLTNLHSLLLSHNHLNFISSEAFVPVP-NL   90 (361)
T ss_dssp             TTEEECCSSCCSSC-CSSCC--TTCSEEECCSSCCCEECTT-----SSSSCCTTCCEEECCSSCCCEECTTTTTTCT-TC
T ss_pred             CCEEEeCCCCcCcc-CccCC--CCCCEEECCCCCCCccChh-----hhhhcccccCEEECCCCcCCccChhhccCCC-CC
Confidence            36788888888874 44443  4578888888888888765     466 788888888888888888888888886 48


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhh---hcCCCCcEEEe
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL---CRLAALFLLDL  177 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L  177 (599)
                      +.|++++|+|+.+.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|   ..+++|+.|+|
T Consensus        91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L  170 (361)
T 2xot_A           91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDL  170 (361)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEEC
T ss_pred             CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEEC
Confidence            888888888888888889999999999999999998888999999999999999999997665556   56899999999


Q ss_pred             eCCccCCCCCcccCCCCC--CcEeecCCCCCC
Q 042902          178 GGNKLSGFVPACFGNLTS--LRNLYLGSNQLT  207 (599)
Q Consensus       178 s~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~  207 (599)
                      ++|+|+++.+..|..++.  |+.|+|++|.+.
T Consensus       171 ~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            999999887788888887  488999999886

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.85  E-value=3.1e-23  Score=228.46  Aligned_cols=321  Identities=16%  Similarity=0.118  Sum_probs=220.5

Q ss_pred             CccCCC-cCccC-CCCCCcCCCCCCEEEccCccccccCCcccc----CCCCCCEEeccCccCcccCCCcccccccCCCCC
Q 042902            1 LLLWGN-NFSGT-IPSFIFNASKLSRLELEMNSFYGFIPNTFG----NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKY   74 (599)
Q Consensus         1 L~L~~n-~~~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~   74 (599)
                      |+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|+|++|. ..+... .+......+++
T Consensus       135 L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~-~l~~l~~~~~~  212 (594)
T 2p1m_B          135 LVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFS-ALERLVTRCPN  212 (594)
T ss_dssp             EEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHH-HHHHHHHHCTT
T ss_pred             EeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHH-HHHHHHHhCCC
Confidence            456666 44432 344445789999999999998876555554    66799999999987 222211 01112345789


Q ss_pred             CcEEEcccC-cccccCChhhhcccccceEEEccCCc--------------------------cc----ccCCccccCCCC
Q 042902           75 LKYLSFSNN-SLDGILPRAIGNLSQSMEVFFMFNCN--------------------------IS----GSIPEEISNLTN  123 (599)
Q Consensus        75 L~~L~Ls~N-~i~~~~~~~~~~l~~~l~~l~l~~n~--------------------------i~----~~~~~~~~~l~~  123 (599)
                      |++|++++| .+++ ++..+..++ .|+.|.+..+.                          +.    ...+..+..+++
T Consensus       213 L~~L~L~~~~~~~~-l~~~~~~~~-~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~  290 (594)
T 2p1m_B          213 LKSLKLNRAVPLEK-LATLLQRAP-QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR  290 (594)
T ss_dssp             CCEEECCTTSCHHH-HHHHHHHCT-TCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTT
T ss_pred             CcEEecCCCCcHHH-HHHHHhcCC-cceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCC
Confidence            999999988 4443 556666665 47777654431                          11    123333346799


Q ss_pred             CCEEEccCCcCCcccC-ccccCCCCCCEEEccccccccc-CChhhhcCCCCcEEEeeC---------CccCCCCCccc-C
Q 042902          124 LTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGS-IPDDLCRLAALFLLDLGG---------NKLSGFVPACF-G  191 (599)
Q Consensus       124 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~---------N~l~~~~~~~~-~  191 (599)
                      |++|+|++|.++.... ..+..+++|++|++++| +.+. .+.....+++|+.|++++         +.+++.....+ .
T Consensus       291 L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~  369 (594)
T 2p1m_B          291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM  369 (594)
T ss_dssp             CCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHH
T ss_pred             CCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHH
Confidence            9999999999774332 23568899999999998 5432 222334589999999954         44543322223 2


Q ss_pred             CCCCCcEeecCCCCCCCC-Ccccc-CCCcccEEeec--C----CCccccC-----cccccccccccEEEccCCccCCCCC
Q 042902          192 NLTSLRNLYLGSNQLTSI-PSTLW-NLKYILYLNLS--S----NSFTGPL-----PLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       192 ~l~~L~~L~L~~N~l~~i-p~~~~-~l~~L~~L~Ls--~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      .+++|++|.++.|.++.. +..+. .+++|+.|+++  +    |.+++..     +..+..+++|+.|+|++ .+++..+
T Consensus       370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~  448 (594)
T 2p1m_B          370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF  448 (594)
T ss_dssp             HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred             hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence            478999999999998843 22333 57899999999  4    5666322     12256788999999987 6766555


Q ss_pred             ccccC-cccccccccccccccccCcccc-cCCCCcccccCCCCcccccCCc-hhhccccceEEEcccccCcc
Q 042902          259 TTIGD-LKDLQYLFLEYNRLQGSIPDSI-GGLIDLKSLDLSNNNISGAIPI-SLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       259 ~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~  327 (599)
                      ..++. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. ....+++|+.|++++|+++.
T Consensus       449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            55655 8899999999999977655555 6789999999999999755444 33458999999999999853

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=2.2e-20  Score=178.17  Aligned_cols=129  Identities=27%  Similarity=0.285  Sum_probs=72.8

Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      .|++++|+|+++.+..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|+
T Consensus        36 ~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~  115 (220)
T 2v9t_B           36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK  115 (220)
T ss_dssp             EEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCC
Confidence            33333333333334445555555555555555555555555555555555555555554444445555666666666666


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCcc
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~  230 (599)
                      |+++.+..|..+++|++|+|++|+|+.++. .+..+++|+.|+|++|.+.
T Consensus       116 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          116 INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            665555566666666666666666665544 3555666666666666665

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=2.9e-20  Score=177.38  Aligned_cols=113  Identities=27%  Similarity=0.317  Sum_probs=57.1

Q ss_pred             ccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                      |.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|..+++|+
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            44555555555555555555555555555555555555555544444455555555555555555554444555555555


Q ss_pred             EeecCCCCCCCC-CccccCCCcccEEeecCCCcc
Q 042902          198 NLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       198 ~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      +|+|++|+|+.+ |..+..+++|+.|+|++|.+.
T Consensus       133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A          133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            555555444444 233444444444444444443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.83  E-value=6.8e-21  Score=186.96  Aligned_cols=167  Identities=19%  Similarity=0.253  Sum_probs=101.4

Q ss_pred             ceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeC
Q 042902          100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG  179 (599)
Q Consensus       100 l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  179 (599)
                      +..+.+.+|.+++..  .+..+++|++|++++|.++.+ + .+..+++|++|+|++|+|++..+  +..+++|+.|+|++
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            334455555555332  355566666666666666643 2 46666666666666666665433  66666666666666


Q ss_pred             CccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCc
Q 042902          180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPT  259 (599)
Q Consensus       180 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  259 (599)
                      |+++++.+  +.. ++|++|++++|+++.++ .+..+++|+.|++++|++++. + .+..+++|+.|+|++|.+++.  .
T Consensus        95 N~l~~l~~--~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~  166 (263)
T 1xeu_A           95 NRLKNLNG--IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G  166 (263)
T ss_dssp             SCCSCCTT--CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred             CccCCcCc--ccc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence            66665432  222 66666666666666654 355666666666666666654 2 466666666666666666654  4


Q ss_pred             cccCccccccccccccccccc
Q 042902          260 TIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       260 ~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      .+..+++|+.|++++|++++.
T Consensus       167 ~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          167 GLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TSTTCCCCCEEEEEEEEEECC
T ss_pred             HhccCCCCCEEeCCCCcccCC
Confidence            566666666666666666644

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=5.2e-20  Score=176.80  Aligned_cols=133  Identities=29%  Similarity=0.360  Sum_probs=83.4

Q ss_pred             CCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      ++|++|+|++|.|+++.|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            55666666666666666666666666666666666666555555666666666666666666665566666666666666


Q ss_pred             CCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          202 GSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       202 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      ++|+|+.+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       120 s~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          120 CCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             CSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             cCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            66666666666666666666666666666555555555555555555555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.83  E-value=2.4e-21  Score=190.16  Aligned_cols=170  Identities=19%  Similarity=0.277  Sum_probs=118.7

Q ss_pred             CCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEe
Q 042902          120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL  199 (599)
Q Consensus       120 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  199 (599)
                      ++.+++.+++++|.++++.  .+..+++|++|++++|.|+.. + .+..+++|+.|+|++|++++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4566778888888888654  577888888888888888743 4 67888888888888888887654  7888888888


Q ss_pred             ecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccc
Q 042902          200 YLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG  279 (599)
Q Consensus       200 ~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  279 (599)
                      +|++|+++.+|....  ++|++|++++|++++.  ..+..+++|+.|+|++|++++. + .++.+++|++|+|++|++++
T Consensus        91 ~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           91 SVNRNRLKNLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             ECCSSCCSCCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             ECCCCccCCcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            888888888765333  6777777777777753  2466667777777777776654 2 45566666666666666654


Q ss_pred             cCcccccCCCCcccccCCCCcccc
Q 042902          280 SIPDSIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       280 ~~~~~~~~l~~L~~L~L~~N~l~~  303 (599)
                      .  ..+..+++|+.|++++|.+++
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             h--HHhccCCCCCEEeCCCCcccC
Confidence            4  445555555555555555553

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.82  E-value=4.7e-21  Score=214.51  Aligned_cols=143  Identities=22%  Similarity=0.261  Sum_probs=74.9

Q ss_pred             cCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCC
Q 042902          113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGN  192 (599)
Q Consensus       113 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  192 (599)
                      ..++.|..+++|+.|+|++|.+.. +|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|..
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  291 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS  291 (727)
T ss_dssp             -------CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred             cChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence            445556666666666666666663 3333445666666666666666 45555666666666666666665 33555555


Q ss_pred             CCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccccc-ccEEEccCCccCCCCC
Q 042902          193 LTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV-LVQIDLSMNNFSGFIP  258 (599)
Q Consensus       193 l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~  258 (599)
                      +++|++|+|++|.|+.+|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus       292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          292 CFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             GTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             CCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence            66666666666666555555555555555555555555555544433211 1223444444444433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=5.4e-23  Score=223.38  Aligned_cols=217  Identities=22%  Similarity=0.153  Sum_probs=110.6

Q ss_pred             CCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCC
Q 042902           70 SNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQ  149 (599)
Q Consensus        70 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  149 (599)
                      ..+++|+.|+|++|.|+ .+|..++.+++ |+.|++++|......|..           +..+.+.+..|..+..+++|+
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~-L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKE-LQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHH-HHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHH-HHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcc
Confidence            45667777777777776 45667776653 666666554311111100           001112334445555555555


Q ss_pred             EEE-cccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCC
Q 042902          150 LLS-LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNS  228 (599)
Q Consensus       150 ~L~-L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~  228 (599)
                      .|+ ++.|.+.           +|..+.+++|.++.+.+      ..|+.|+|++|.|+.+|. +..+++|+.|+|++|.
T Consensus       413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          413 AVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSC
T ss_pred             cCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC-ccccccCcEeecCccc
Confidence            555 4444332           12222333344332211      124555555555555554 4555555555555555


Q ss_pred             ccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccC-cccccCCCCcccccCCCCcccccCCc
Q 042902          229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI-PDSIGGLIDLKSLDLSNNNISGAIPI  307 (599)
Q Consensus       229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~  307 (599)
                      |+ .+|..|+++++|+.|+|++|.|++ +| .++.+++|++|+|++|+|++.. |..++.+++|+.|+|++|++++.+|.
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            55 344455555555555555555554 23 4555556666666666665554 55566666666666666666654432


Q ss_pred             h---hhccccceEEEc
Q 042902          308 S---LEKLLDLKYINV  320 (599)
Q Consensus       308 ~---~~~l~~L~~l~l  320 (599)
                      .   +..+++|+.|++
T Consensus       552 ~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          552 QERLAEMLPSVSSILT  567 (567)
T ss_dssp             TTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHCcccCccCC
Confidence            1   233566666653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.82  E-value=3.6e-21  Score=215.48  Aligned_cols=227  Identities=22%  Similarity=0.222  Sum_probs=124.3

Q ss_pred             CCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEE
Q 042902           73 KYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLS  152 (599)
Q Consensus        73 ~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  152 (599)
                      +.++.|+|++|.+... +..      .++.+.|++|.|.              .++++.|++. ..+..|..+++|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~~------~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQA------LLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCcc-hhh------HhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEE
Confidence            4567777777777643 211      2444555554443              3456667776 6778899999999999


Q ss_pred             cccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCcccc
Q 042902          153 LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGP  232 (599)
Q Consensus       153 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~  232 (599)
                      |++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+.+|..+..+++|++|+|++|.|+ .
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~  307 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-T  307 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-c
Confidence            9999998 56777779999999999999999 6678889999999999999999999999999999999999999998 5


Q ss_pred             CcccccccccccEEEccCCccCCCCCccccCccc-ccccccccccccccCcccccCCCCcccccCCCC--------cccc
Q 042902          233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKD-LQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNN--------NISG  303 (599)
Q Consensus       233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~~  303 (599)
                      +|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|+++.|        .+.+
T Consensus       308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~  381 (727)
T 4b8c_D          308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQ  381 (727)
T ss_dssp             CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------------------
T ss_pred             cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccc
Confidence            6777999999999999999999888888766533 34588999999988876      4556667766        4555


Q ss_pred             cCCchhhccccceEEEcccccCcccCC
Q 042902          304 AIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       304 ~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      ..+..+..+..+....+++|-+.+...
T Consensus       382 ~~~~~~~~l~~~~~~~ls~Nil~~~~~  408 (727)
T 4b8c_D          382 STEHLATDLAKRTFTVLSYNTLCQHYA  408 (727)
T ss_dssp             --------------------CCCGGGC
T ss_pred             cccchhhcccccceeeeeccccccccC
Confidence            555556667777788888888865443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=6.5e-20  Score=176.14  Aligned_cols=152  Identities=24%  Similarity=0.325  Sum_probs=92.1

Q ss_pred             CCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecC
Q 042902          148 LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSS  226 (599)
Q Consensus       148 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~  226 (599)
                      -+.++.+++.+.. +|..+.  ++|++|+|++|.++++.|..|..+++|++|+|++|+|+.+|. .+..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            4567777777763 343332  667777777777776666667777777777777777766654 345566666666666


Q ss_pred             CCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccc
Q 042902          227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       227 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  303 (599)
                      |+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            6666555555566666666666666665 345555555555555555555554444455555555555555555543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.82  E-value=5.8e-21  Score=194.17  Aligned_cols=103  Identities=15%  Similarity=0.097  Sum_probs=82.6

Q ss_pred             CCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccc-ccccccccccccCcccccCCCCcccc
Q 042902          216 LKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ-YLFLEYNRLQGSIPDSIGGLIDLKSL  294 (599)
Q Consensus       216 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L  294 (599)
                      +++|+.|+|++|+++.+.+.+|.++.+|+.|+|++| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            677888888888888777778888888888888887 7777777888888888 888877 6776777888888888888


Q ss_pred             cCCCCcccccCCchhhccccceEEEc
Q 042902          295 DLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       295 ~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                      ++++|+++.+.+..|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            88888888777778888888887753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.82  E-value=1e-20  Score=192.40  Aligned_cols=261  Identities=15%  Similarity=0.147  Sum_probs=184.6

Q ss_pred             CCCCCEEEccCccccccCCccccC-CCCCCEEeccCccCc--ccCCCcccccccCCCCCCcEEEcccCcccccCChhhhc
Q 042902           19 ASKLSRLELEMNSFYGFIPNTFGN-LRNLKRLSLNYNYLT--SSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN   95 (599)
Q Consensus        19 l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~N~l~--~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~   95 (599)
                      +.+++.|.++++ +.......+.. +++|++|||++|+|+  ....        +.++.++.+++..|.   +.+.+|.+
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~--------~~~~~~~~~~~~~~~---I~~~aF~~   91 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA--------GTYPNGKFYIYMANF---VPAYAFSN   91 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS--------SSSGGGCCEEECTTE---ECTTTTEE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc--------ccccccccccccccc---cCHHHhcc
Confidence            567889998865 32222233444 788999999999988  2222        122224556666663   44566766


Q ss_pred             --------ccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccc----cccCC
Q 042902           96 --------LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL----EGSIP  163 (599)
Q Consensus        96 --------l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~~  163 (599)
                              ++ .|+.+.+.+ +++.+.+.+|.++++|++|+|++|.+..+.+.+|.++.++..+.+..+..    ..+..
T Consensus        92 ~~~~~~~g~~-~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~  169 (329)
T 3sb4_A           92 VVNGVTKGKQ-TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH  169 (329)
T ss_dssp             EETTEEEECT-TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT
T ss_pred             cccccccccC-CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc
Confidence                    65 478888877 77777778888888888888888888777777888877777777665322    22233


Q ss_pred             hhhhcCCCCc--------------------------EEEeeCCccCCCCCccc-CCCCCCcEeecCCCCCCCCCc-cccC
Q 042902          164 DDLCRLAALF--------------------------LLDLGGNKLSGFVPACF-GNLTSLRNLYLGSNQLTSIPS-TLWN  215 (599)
Q Consensus       164 ~~~~~l~~L~--------------------------~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~ip~-~~~~  215 (599)
                      .+|..+..|+                          .+.+.++-.. .....+ ..+++|+.|+|++|+++.||. .|.+
T Consensus       170 ~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~  248 (329)
T 3sb4_A          170 FAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ  248 (329)
T ss_dssp             SCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred             cccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence            3444444444                          3334333111 111111 136889999999999999986 6778


Q ss_pred             CCcccEEeecCCCccccCccccccccccc-EEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccc
Q 042902          216 LKYILYLNLSSNSFTGPLPLEIGNLRVLV-QIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSL  294 (599)
Q Consensus       216 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  294 (599)
                      +++|+.|++++| ++.+.+.+|.++.+|+ .+++++ .++.+.+.+|.++++|+.+++++|+++.+.+.+|.++++|+.+
T Consensus       249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            899999999988 8878888999999999 999988 7887888999999999999999999998888899999999987


Q ss_pred             cC
Q 042902          295 DL  296 (599)
Q Consensus       295 ~L  296 (599)
                      +.
T Consensus       327 y~  328 (329)
T 3sb4_A          327 YK  328 (329)
T ss_dssp             EC
T ss_pred             cc
Confidence            63

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.81  E-value=8.4e-20  Score=171.09  Aligned_cols=153  Identities=19%  Similarity=0.228  Sum_probs=95.4

Q ss_pred             cCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccC
Q 042902           41 GNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN  120 (599)
Q Consensus        41 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~  120 (599)
                      ..+++|++|++++|.++.++.       +..+++|++|++++|.++.                           +..+..
T Consensus        41 ~~l~~L~~L~l~~n~i~~l~~-------l~~l~~L~~L~l~~n~~~~---------------------------~~~l~~   86 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTDLTG-------IEYAHNIKDLTINNIHATN---------------------------YNPISG   86 (197)
T ss_dssp             HHHHTCCEEEEESSCCSCCTT-------GGGCTTCSEEEEESCCCSC---------------------------CGGGTT
T ss_pred             hhcCCccEEeccCCCccChHH-------HhcCCCCCEEEccCCCCCc---------------------------chhhhc
Confidence            445555555565555554431       4455555555555554431                           124556


Q ss_pred             CCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc-cCCCCCcccCCCCCCcEe
Q 042902          121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK-LSGFVPACFGNLTSLRNL  199 (599)
Q Consensus       121 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L  199 (599)
                      +++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|+ ++.+ + .+..+++|++|
T Consensus        87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L  164 (197)
T 4ezg_A           87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSL  164 (197)
T ss_dssp             CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEE
T ss_pred             CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEE
Confidence            6777777777777776666667777777777777777776666667777777777777776 5543 3 46667777777


Q ss_pred             ecCCCCCCCCCccccCCCcccEEeecCCCcc
Q 042902          200 YLGSNQLTSIPSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       200 ~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      ++++|+++.++ .+..+++|++|++++|++.
T Consensus       165 ~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          165 NIQFDGVHDYR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             ECTTBCCCCCT-TGGGCSSCCEEEECBC---
T ss_pred             ECCCCCCcChH-HhccCCCCCEEEeeCcccC
Confidence            77777777665 5566666666666666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.81  E-value=8.9e-19  Score=182.07  Aligned_cols=262  Identities=13%  Similarity=0.129  Sum_probs=121.8

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      .++.+.+. |.++.+...+|.+. +|+.+.|..| ++.+...     +|.++ +|+.+++.+ .++.+.+.+|.++. .|
T Consensus       114 ~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~-----aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~-~L  182 (401)
T 4fdw_A          114 GYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDM-----AFFNS-TVQEIVFPS-TLEQLKEDIFYYCY-NL  182 (401)
T ss_dssp             SCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTT-----TTTTC-CCCEEECCT-TCCEECSSTTTTCT-TC
T ss_pred             CccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHH-----hcCCC-CceEEEeCC-CccEehHHHhhCcc-cC
Confidence            34444443 23444444444442 3444444433 4444332     33332 344444443 34444444444443 24


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCC
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN  180 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  180 (599)
                      +.+.+.+|+++.+...+|. .++|+.+.|..+ ++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+. |
T Consensus       183 ~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~  257 (401)
T 4fdw_A          183 KKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-N  257 (401)
T ss_dssp             CEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-T
T ss_pred             CeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-C
Confidence            4444444444444444444 244455544422 44444444555555555555443 33344444444 445555552 2


Q ss_pred             ccCCCCCcccCCCCCCcEeecCCCCCC-----CCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          181 KLSGFVPACFGNLTSLRNLYLGSNQLT-----SIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       181 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      .++.+...+|.++++|+.+.+.+|.+.     .++. .|.++++|+.+++. +.++.+...+|.++.+|+.++|..| ++
T Consensus       258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~  335 (401)
T 4fdw_A          258 GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT  335 (401)
T ss_dssp             TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred             CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc
Confidence            344444445555555555555444443     3332 44455555555555 3344444555555555555555333 44


Q ss_pred             CCCCccccCcccccccccccccccccCcccccCCC-CcccccCCCCcc
Q 042902          255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI-DLKSLDLSNNNI  301 (599)
Q Consensus       255 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l  301 (599)
                      .+.+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+
T Consensus       336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            4455555555 566666655555544555555553 455555555544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=1.3e-20  Score=184.52  Aligned_cols=138  Identities=22%  Similarity=0.270  Sum_probs=105.7

Q ss_pred             CCcCceecccccceEEEEEe-cCCcE--EEEEEecccccc------------------------cHHHHHHHHHHHhcCC
Q 042902          430 FSENNLIGRGGVASVYKARI-QDGIE--VAVKVFDLQYEG------------------------AFKSFDIECDMMKRIR  482 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  482 (599)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+..|++++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999998 68999  999987543111                        1136888999999998


Q ss_pred             CCcc--eeEEEEEEcCCeeeEEEEccCC-C----ChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 042902          483 HRNL--IKIISSCSNDDFKALVLEYMPH-G----SLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  555 (599)
Q Consensus       483 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  555 (599)
                      |+++  +.++++    +..++||||+.+ |    +|.++...    .++..+..++.|+++||.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8754  444432    356899999942 4    56655432    1233567899999999999993  3589999999


Q ss_pred             CCCeeecCCCcEEEccccCCccCC
Q 042902          556 PNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       556 ~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      |+|||+++  .++|+|||+|....
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHEEEcC--cEEEEECcccccCC
Confidence            99999998  99999999998653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=1.3e-22  Score=220.26  Aligned_cols=120  Identities=22%  Similarity=0.233  Sum_probs=73.1

Q ss_pred             CCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCC
Q 042902          148 LQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN  227 (599)
Q Consensus       148 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N  227 (599)
                      |+.|+|++|.|++ +|. |..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|+.+| .+..+++|+.|+|++|
T Consensus       443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N  518 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNN  518 (567)
T ss_dssp             CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSS
T ss_pred             ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCC
Confidence            5666666666654 343 666666666666666666 34555666666666666666666665 5666666666666666


Q ss_pred             CccccC-cccccccccccEEEccCCccCCCCCcc---ccCcccccccc
Q 042902          228 SFTGPL-PLEIGNLRVLVQIDLSMNNFSGFIPTT---IGDLKDLQYLF  271 (599)
Q Consensus       228 ~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~  271 (599)
                      +|++.. |..|..+++|+.|+|++|++++.+|..   +..+++|+.|+
T Consensus       519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            666655 666666666666666666666554321   22356666664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.81  E-value=1.8e-20  Score=174.84  Aligned_cols=130  Identities=25%  Similarity=0.291  Sum_probs=76.2

Q ss_pred             cEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCcc--ccCCCcccEEeecCCCccccCcccccccccccEEEccC
Q 042902          173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST--LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSM  250 (599)
Q Consensus       173 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  250 (599)
                      +.+++++|.++.+ |..+.  .+|++|++++|+|+.++..  +..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~i-p~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCcC-ccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            4566666666543 33222  2566666666666655542  55566666666666666655566666666666666666


Q ss_pred             CccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccC
Q 042902          251 NNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      |+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            6666555555666666666666666666555555666666666666666665443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.81  E-value=7.5e-20  Score=171.41  Aligned_cols=151  Identities=17%  Similarity=0.252  Sum_probs=76.6

Q ss_pred             CCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEc
Q 042902          169 LAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDL  248 (599)
Q Consensus       169 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  248 (599)
                      +++|+.|++++|.++.+ | .+..+++|++|++++|.++.++ .+..+++|++|++++|.+++..+..+..+++|++|+|
T Consensus        43 l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  119 (197)
T 4ezg_A           43 MNSLTYITLANINVTDL-T-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI  119 (197)
T ss_dssp             HHTCCEEEEESSCCSCC-T-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred             cCCccEEeccCCCccCh-H-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence            33444444444444422 1 2344444444444444443332 3444455555555555555444455555555555555


Q ss_pred             cCCccCCCCCccccCccccccccccccc-ccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCc
Q 042902          249 SMNNFSGFIPTTIGDLKDLQYLFLEYNR-LQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLE  326 (599)
Q Consensus       249 s~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  326 (599)
                      ++|.+++..|..++.+++|++|++++|+ ++ .+| .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|++.
T Consensus       120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            5555555445555555555555555555 43 233 45566666666666666664 22 5566666666666666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.80  E-value=1.1e-18  Score=181.27  Aligned_cols=268  Identities=13%  Similarity=0.130  Sum_probs=193.9

Q ss_pred             ccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCcccc
Q 042902           40 FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEIS  119 (599)
Q Consensus        40 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~  119 (599)
                      +.....++.+.+.+ .++.++..     +|.++ +|+.++|.+| ++.+...+|.+.  .|+.+.+.+ .+..+.+.+|.
T Consensus       109 ~~~~~~l~~i~ip~-~i~~I~~~-----aF~~~-~L~~i~l~~~-i~~I~~~aF~~~--~L~~i~lp~-~l~~I~~~aF~  177 (401)
T 4fdw_A          109 TEILKGYNEIILPN-SVKSIPKD-----AFRNS-QIAKVVLNEG-LKSIGDMAFFNS--TVQEIVFPS-TLEQLKEDIFY  177 (401)
T ss_dssp             EEECSSCSEEECCT-TCCEECTT-----TTTTC-CCSEEECCTT-CCEECTTTTTTC--CCCEEECCT-TCCEECSSTTT
T ss_pred             EEecCCccEEEECC-ccCEehHh-----hcccC-CccEEEeCCC-ccEECHHhcCCC--CceEEEeCC-CccEehHHHhh
Confidence            34456777887764 47777664     57774 6888888766 777777888774  477777775 67777778888


Q ss_pred             CCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEe
Q 042902          120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL  199 (599)
Q Consensus       120 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  199 (599)
                      ++++|+.++|++|.++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+
T Consensus       178 ~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i  253 (401)
T 4fdw_A          178 YCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTV  253 (401)
T ss_dssp             TCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEE
T ss_pred             CcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEE
Confidence            888888888888888877777776 478888888744 66677778888888888888765 56667777777 678888


Q ss_pred             ecCCCCCCCCCc-cccCCCcccEEeecCCCcc-----ccCcccccccccccEEEccCCccCCCCCccccCcccccccccc
Q 042902          200 YLGSNQLTSIPS-TLWNLKYILYLNLSSNSFT-----GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE  273 (599)
Q Consensus       200 ~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  273 (599)
                      .+ .+.++.|+. .|.++++|+.+++.+|.+.     .+.+.+|.++++|+.++|. +.++.+...+|.++.+|+.+.|.
T Consensus       254 ~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          254 KL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             EE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred             Ee-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence            88 455677754 6667788888888777665     4566677777788888777 44766667777777778877775


Q ss_pred             cccccccCcccccCCCCcccccCCCCcccccCCchhhccc-cceEEEcccccCc
Q 042902          274 YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL-DLKYINVSFNKLE  326 (599)
Q Consensus       274 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~  326 (599)
                      .| ++.+...+|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       332 ~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          332 AN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             cc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            44 665666777777 777777777777766666676664 5667777666543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=5.1e-19  Score=164.96  Aligned_cols=132  Identities=26%  Similarity=0.296  Sum_probs=84.8

Q ss_pred             cEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcc-cccccccccEEEccCCccCCCCCccccCcccccccccccc
Q 042902          197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPL-EIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       197 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      +.+++++|.++.+|..+..  +|++|++++|.+++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            5566666666666654433  566666666666655543 3666666666666666666666666666666666666666


Q ss_pred             cccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          276 RLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       276 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      +|++..+..|..+++|++|+|++|++++..|..|..+++|++|++++|+++|.++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            6666666666666666666666666666666666666666666666666666554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.76  E-value=5.4e-19  Score=164.79  Aligned_cols=131  Identities=28%  Similarity=0.375  Sum_probs=85.6

Q ss_pred             cEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccc
Q 042902          197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       197 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  276 (599)
                      +.+++++|.++.+|..+.  ++|++|++++|.|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            455666666666665442  35666666666665 344566666666666666666666666666666666666676676


Q ss_pred             ccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          277 LQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       277 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      |++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|++.|...
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            666666667777777777777777776555567777777777777777776543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.73  E-value=5.8e-18  Score=154.18  Aligned_cols=107  Identities=27%  Similarity=0.316  Sum_probs=46.6

Q ss_pred             CCCCEEEccCCcCC-cccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEee
Q 042902          122 TNLTTIYLGGNKLN-GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLY  200 (599)
Q Consensus       122 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  200 (599)
                      ++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++..|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555544 33344444444444444444444433  3344444444444444444443333333344444444


Q ss_pred             cCCCCCCCCC--ccccCCCcccEEeecCCCcc
Q 042902          201 LGSNQLTSIP--STLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       201 L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      +++|.++.+|  ..+..+++|+.|++++|.++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            4444444433  23333333333333333333

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.73  E-value=1.1e-17  Score=152.20  Aligned_cols=95  Identities=24%  Similarity=0.319  Sum_probs=51.7

Q ss_pred             cccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCC-hhhhcCCCCcEEEeeCCccCCCCC---cccCC
Q 042902          117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFLLDLGGNKLSGFVP---ACFGN  192 (599)
Q Consensus       117 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~  192 (599)
                      .+..+++|++|+|++|++++.+|..+..+++|++|+|++|.|++..+ ..+..+++|+.|++++|.+++..+   ..|..
T Consensus        66 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  145 (168)
T 2ell_A           66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKL  145 (168)
T ss_dssp             SCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTT
T ss_pred             hhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHh
Confidence            34455555666666666555455555555555555555555554321 445555555555555555554443   34555


Q ss_pred             CCCCcEeecCCCCCCCCCc
Q 042902          193 LTSLRNLYLGSNQLTSIPS  211 (599)
Q Consensus       193 l~~L~~L~L~~N~l~~ip~  211 (599)
                      +++|++|++++|.+.++|.
T Consensus       146 l~~L~~L~l~~n~~~~~~~  164 (168)
T 2ell_A          146 LPQLTYLDGYDREDQEAPD  164 (168)
T ss_dssp             CSSCCEETTEETTSCBCCS
T ss_pred             CccCcEecCCCCChhhccc
Confidence            5555555555555555554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.73  E-value=1.1e-17  Score=153.80  Aligned_cols=133  Identities=24%  Similarity=0.271  Sum_probs=91.1

Q ss_pred             CcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccc
Q 042902          196 LRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       196 L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      .+.+++++|.++.+|..+.  ++|+.|++++|.+++..+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4556666666666665432  46667777777766665556666777777777777777666666677777777777777


Q ss_pred             cccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCC
Q 042902          276 RLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIP  330 (599)
Q Consensus       276 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  330 (599)
                      ++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|++.|.+|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            7776666666777777777777777776555556677777777777777776655

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=1.8e-18  Score=175.74  Aligned_cols=137  Identities=15%  Similarity=0.152  Sum_probs=99.5

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEeccccc--------------ccHHH--------HHHHHHHHhcCCCCcc
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYE--------------GAFKS--------FDIECDMMKRIRHRNL  486 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~ni  486 (599)
                      -|...+.||+|+||.||+|...+|+.||||+++....              .....        ...|...|.++.+..+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4888899999999999999999999999998753210              01111        2345666666654443


Q ss_pred             eeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-
Q 042902          487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-  565 (599)
Q Consensus       487 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-  565 (599)
                      .-..-+...  ..+|||||++|+++.++....       ....++.|++.||.|+|   +.+||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            211111111  247999999999987654321       23568899999999999   88999999999999998776 


Q ss_pred             ---------cEEEccccCCcc
Q 042902          566 ---------VAHLSDFGMAKP  577 (599)
Q Consensus       566 ---------~~kl~DFGla~~  577 (599)
                               .+.|+||+-|..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999998764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=2.9e-17  Score=152.99  Aligned_cols=129  Identities=25%  Similarity=0.322  Sum_probs=107.9

Q ss_pred             cEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCc
Q 042902          173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN  252 (599)
Q Consensus       173 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  252 (599)
                      +.+++++|.++.+ |..+  .++|++|+|++|+|+.+|..+.++++|+.|+|++|.|++..+..|.++++|+.|+|++|.
T Consensus        13 ~~l~~~~~~l~~i-p~~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVL-PKGI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSC-CSCC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcC-CCCC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4677777777754 3333  257888888888888888888888888999999999888888888899999999999999


Q ss_pred             cCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCccccc
Q 042902          253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGA  304 (599)
Q Consensus       253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  304 (599)
                      |+++.|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|++...
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            9988888899999999999999999977777888999999999999998753

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=1.3e-17  Score=148.52  Aligned_cols=125  Identities=22%  Similarity=0.268  Sum_probs=56.3

Q ss_pred             CCCCEEEccCCcCC-cccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEee
Q 042902          122 TNLTTIYLGGNKLN-GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLY  200 (599)
Q Consensus       122 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  200 (599)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|++++..|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555554 34444444555555555555555433  3344444444444444444443444444444444444


Q ss_pred             cCCCCCCCCC--ccccCCCcccEEeecCCCccccCc---ccccccccccEEEc
Q 042902          201 LGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPLP---LEIGNLRVLVQIDL  248 (599)
Q Consensus       201 L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L  248 (599)
                      +++|.++.+|  ..+..+++|++|++++|.+++..+   ..+..+++|+.||+
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  147 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG  147 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence            4444444432  333444444444444444443322   23344444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=2e-17  Score=147.32  Aligned_cols=125  Identities=23%  Similarity=0.181  Sum_probs=55.4

Q ss_pred             CCcEEEeeCCccC-CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEcc
Q 042902          171 ALFLLDLGGNKLS-GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLS  249 (599)
Q Consensus       171 ~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  249 (599)
                      +|+.|++++|.++ +..|..+..+++|++|++++|.++.+ ..+..+++|++|++++|.+++.+|..+..+++|++|+++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            3444444444444 33344444444444444444444444 334444444444444444444344444444444444454


Q ss_pred             CCccCCC-CCccccCcccccccccccccccccCc---ccccCCCCcccccC
Q 042902          250 MNNFSGF-IPTTIGDLKDLQYLFLEYNRLQGSIP---DSIGGLIDLKSLDL  296 (599)
Q Consensus       250 ~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L  296 (599)
                      +|.+++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|++
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  147 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG  147 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence            4444432 12334444444444444444443333   23444444444444

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.69  E-value=3.3e-16  Score=163.07  Aligned_cols=297  Identities=13%  Similarity=0.067  Sum_probs=194.7

Q ss_pred             CccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccc
Q 042902            8 FSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG   87 (599)
Q Consensus         8 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~   87 (599)
                      ++..-..+|.++++|+.+.|. +.++.+...+|.++++|+.++|.++ ++.+...     +|.++++|+.+.+..+ +..
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp-~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~-----aF~~c~~L~~i~~p~~-l~~  130 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIP-STVREIGEFAFENCSKLEIINIPDS-VKMIGRC-----TFSGCYALKSILLPLM-LKS  130 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECC-TTCCEECTTTTTTCTTCCEECCCTT-CCEECTT-----TTTTCTTCCCCCCCTT-CCE
T ss_pred             EeEhHHHHhhCCCCceEEEeC-CCccCcchhHhhCCCCCcEEEeCCC-ceEccch-----hhcccccchhhcccCc-eee
Confidence            444455678899999999997 4588888999999999999999765 7777764     6899999998888655 555


Q ss_pred             cCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhh
Q 042902           88 ILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLC  167 (599)
Q Consensus        88 ~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  167 (599)
                      +...+|.+.. .++...  ...+..+...+|.++++|+.+.+.++. ..+...+|.++.+|+.+++..| ++.+...+|.
T Consensus       131 i~~~aF~~~~-~~~~~~--~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~  205 (394)
T 4fs7_A          131 IGVEAFKGCD-FKEITI--PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFA  205 (394)
T ss_dssp             ECTTTTTTCC-CSEEEC--CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTT
T ss_pred             ecceeeeccc-cccccc--CccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhc
Confidence            7777777664 232222  223344556778888888888887654 4466778888888888888776 5556666777


Q ss_pred             cCCCCcEEEeeCCccC---------------------CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecC
Q 042902          168 RLAALFLLDLGGNKLS---------------------GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS  226 (599)
Q Consensus       168 ~l~~L~~L~Ls~N~l~---------------------~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~  226 (599)
                      ++..|+.+.+..+...                     .+...+|.++..|+.+.+..+...--...+..+..++.+....
T Consensus       206 ~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~  285 (394)
T 4fs7_A          206 ECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGS  285 (394)
T ss_dssp             TCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECS
T ss_pred             cccccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCc
Confidence            7777766665554322                     1223344444555555554443222222444455555555444


Q ss_pred             CCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCC
Q 042902          227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIP  306 (599)
Q Consensus       227 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  306 (599)
                      +.+   ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.+..
T Consensus       286 ~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~  359 (394)
T 4fs7_A          286 VIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGA  359 (394)
T ss_dssp             SEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT
T ss_pred             eee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehH
Confidence            332   2345666667777777654 55555666777777777777543 55566667777777777777665 665666


Q ss_pred             chhhccccceEEEcccc
Q 042902          307 ISLEKLLDLKYINVSFN  323 (599)
Q Consensus       307 ~~~~~l~~L~~l~l~~N  323 (599)
                      .+|.++.+|+.+++..+
T Consensus       360 ~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          360 NAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TTBTTCTTCCEEEEEGG
T ss_pred             HHhhCCCCCCEEEECCC
Confidence            67777777777776543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.67  E-value=4.7e-17  Score=149.32  Aligned_cols=110  Identities=23%  Similarity=0.242  Sum_probs=55.6

Q ss_pred             ccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                      +.++++|++|+|++|.++.+ |......++|++|+|++|.|++.  ..|..+++|++|+|++|+++++.+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            44556666666666666643 32222223566666666665543  3445555555555555555544444444555555


Q ss_pred             EeecCCCCCCCCCc--cccCCCcccEEeecCCCcc
Q 042902          198 NLYLGSNQLTSIPS--TLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       198 ~L~L~~N~l~~ip~--~~~~l~~L~~L~Ls~N~l~  230 (599)
                      +|++++|+|+.+|.  .+..+++|+.|++++|.++
T Consensus        92 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           92 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             EEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            55555555554443  3444444444444444444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=5.5e-16  Score=142.31  Aligned_cols=127  Identities=26%  Similarity=0.294  Sum_probs=59.6

Q ss_pred             CEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCC
Q 042902          125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSN  204 (599)
Q Consensus       125 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  204 (599)
                      +.+++++|.++.++. .+  .++|++|++++|++++..+..|..+++|++|++++|+++++.+..|..+++|++|++++|
T Consensus        10 ~~l~~~~~~l~~~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLTSVPT-GI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCSSCCT-TC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCccCCC-CC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            445555555553321 11  134555555555555444444445555555555555555444444455555555555555


Q ss_pred             CCCCCCcc-ccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          205 QLTSIPST-LWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       205 ~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +|+.+|.. +..+++|++|++++|.+++..+..|..+++|+.|+|++|++.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            55544432 334444444444444444333333444444444444444444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.65  E-value=1.2e-16  Score=146.58  Aligned_cols=133  Identities=20%  Similarity=0.175  Sum_probs=83.5

Q ss_pred             cCCCCCCcEeecCCCCCCCCCccccCC-CcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccc
Q 042902          190 FGNLTSLRNLYLGSNQLTSIPSTLWNL-KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQ  268 (599)
Q Consensus       190 ~~~l~~L~~L~L~~N~l~~ip~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  268 (599)
                      +.++++|++|++++|+++.+|. +..+ ++|++|++++|.+++.  ..|..+++|+.|+|++|.|++..+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            4445556666666666665543 3333 3666666666666654  4566666666666666666655445556666777


Q ss_pred             ccccccccccccCcc--cccCCCCcccccCCCCcccccCCc----hhhccccceEEEcccccCcc
Q 042902          269 YLFLEYNRLQGSIPD--SIGGLIDLKSLDLSNNNISGAIPI----SLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       269 ~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~~  327 (599)
                      +|+|++|+++. +|.  .+..+++|+.|++++|+++ .+|.    .+..+++|+.||+++|....
T Consensus        92 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            77777777653 333  5667777777777777776 3444    36777777777777777653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.65  E-value=1.3e-18  Score=163.00  Aligned_cols=132  Identities=24%  Similarity=0.258  Sum_probs=66.4

Q ss_pred             CCCCCEEEcccccccccCCh------hhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCc
Q 042902          145 LQKLQLLSLEDNQLEGSIPD------DLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKY  218 (599)
Q Consensus       145 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~  218 (599)
                      ...++.++++.|.+.+..|.      .+..+++|++|+|++|++++ +| .+..+++|+.|++++|.++.+|..+..+++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~   94 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADT   94 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCc
Confidence            33444444444444443333      55555555666665555554 23 455555555555555555555554444455


Q ss_pred             ccEEeecCCCccccCcccccccccccEEEccCCccCCCCC-ccccCccccccccccccccccc
Q 042902          219 ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP-TTIGDLKDLQYLFLEYNRLQGS  280 (599)
Q Consensus       219 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  280 (599)
                      |++|++++|++++. | .+..+++|+.|++++|.+++..+ ..+..+++|++|++++|++++.
T Consensus        95 L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~  155 (198)
T 1ds9_A           95 LEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             CSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred             CCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence            55555555555542 2 34455555555555555553222 2344444555555555544433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.64  E-value=2.1e-18  Score=161.69  Aligned_cols=156  Identities=19%  Similarity=0.273  Sum_probs=133.2

Q ss_pred             hhhcCCCCcEEEeeCCccCCCCCc------ccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccc
Q 042902          165 DLCRLAALFLLDLGGNKLSGFVPA------CFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG  238 (599)
Q Consensus       165 ~~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  238 (599)
                      .+.....++.++++.|.+++..|.      .|..+++|++|++++|.++.+| .+..+++|++|++++|.++ .+|..+.
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            356677888888888888887776      8889999999999999999998 8888999999999999998 5677778


Q ss_pred             ccccccEEEccCCccCCCCCccccCcccccccccccccccccCc-ccccCCCCcccccCCCCcccccCCch---------
Q 042902          239 NLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNNNISGAIPIS---------  308 (599)
Q Consensus       239 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~---------  308 (599)
                      .+++|+.|+|++|.+++. | .+..+++|++|++++|++++..+ ..+..+++|+.|++++|++++.+|..         
T Consensus        91 ~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            889999999999999974 4 68899999999999999986543 57889999999999999998776653         


Q ss_pred             -hhccccceEEEcccccCc
Q 042902          309 -LEKLLDLKYINVSFNKLE  326 (599)
Q Consensus       309 -~~~l~~L~~l~l~~N~l~  326 (599)
                       +..+++|+.||  +|+++
T Consensus       169 ~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGT
T ss_pred             HHHhCCCcEEEC--CcccC
Confidence             77889999886  66665

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.61  E-value=1.3e-14  Score=151.08  Aligned_cols=297  Identities=14%  Similarity=0.107  Sum_probs=217.8

Q ss_pred             CcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCc-----------------ccccc
Q 042902            6 NNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL-----------------NFLSS   68 (599)
Q Consensus         6 n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----------------~~~~~   68 (599)
                      ++++..-..+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ ++.+....                 -...+
T Consensus        80 ~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~~~i~~~a  157 (394)
T 4fs7_A           80 STVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGVTVIGDEA  157 (394)
T ss_dssp             TTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTCCEECTTT
T ss_pred             CCccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCccccccchhh
Confidence            4466566678999999999999754 88888899999999999887654 33332210                 00125


Q ss_pred             cCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCC
Q 042902           69 LSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKL  148 (599)
Q Consensus        69 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  148 (599)
                      |.++++|+.+.+.++. ..+...+|.+.. .|+.+.+..+ ++.+...+|.+++.|+.+.+..+... + ...+....+|
T Consensus       158 F~~c~~L~~i~l~~~~-~~I~~~~F~~c~-~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l  232 (394)
T 4fs7_A          158 FATCESLEYVSLPDSM-ETLHNGLFSGCG-KLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGV  232 (394)
T ss_dssp             TTTCTTCCEEECCTTC-CEECTTTTTTCT-TCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCC
T ss_pred             hcccCCCcEEecCCcc-ceeccccccCCC-CceEEEcCCC-ceEeCchhhccccccceeecCCCceE-e-ehhhcccCCC
Confidence            6667777777776543 346666666665 3666666554 55566667777777777776655432 2 2233444677


Q ss_pred             CEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCC
Q 042902          149 QLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNS  228 (599)
Q Consensus       149 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~  228 (599)
                      +.+.+..+ ++.+....|..+..|+.+.+..+... +....|..+..++.+....+.+..  ..+..+.+|+.+.+..+ 
T Consensus       233 ~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-  307 (394)
T 4fs7_A          233 KNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-  307 (394)
T ss_dssp             CEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-
T ss_pred             ceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--ccccccccccccccccc-
Confidence            77777544 34466678888999999999887554 677889999999999887765322  36778899999999865 


Q ss_pred             ccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCch
Q 042902          229 FTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS  308 (599)
Q Consensus       229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  308 (599)
                      ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..| ++.+...+|.++++|+.+++..+ ++ .+...
T Consensus       308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~  383 (394)
T 4fs7_A          308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYD  383 (394)
T ss_dssp             CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGG
T ss_pred             cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhhe
Confidence            77677889999999999999754 77778889999999999999877 77788889999999999999765 44 34567


Q ss_pred             hhccccceEE
Q 042902          309 LEKLLDLKYI  318 (599)
Q Consensus       309 ~~~l~~L~~l  318 (599)
                      |.+.++|+.+
T Consensus       384 F~~c~~L~~I  393 (394)
T 4fs7_A          384 FEDTTKFKWI  393 (394)
T ss_dssp             BCTTCEEEEE
T ss_pred             ecCCCCCcEE
Confidence            8888888865

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.58  E-value=5.4e-14  Score=146.30  Aligned_cols=296  Identities=12%  Similarity=0.133  Sum_probs=182.5

Q ss_pred             CCCCcCCC-CCCEEEccCccccccCCccccCCCCCCEEeccCcc---CcccCCCcccccccCCCCCCcEEEcccCccccc
Q 042902           13 PSFIFNAS-KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNY---LTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGI   88 (599)
Q Consensus        13 ~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~   88 (599)
                      ..+|.+.. .|+.+.+-. .++.|...+|.++.+|+.+.+..|.   ++.+...     +|.++.+|+.+.+..+ ++.+
T Consensus        56 ~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~-----aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQ-----AFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             TTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTT-----TTTTCTTCCBCGGGTT-CSEE
T ss_pred             HhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechh-----hchhcccceeeccCCc-ccee
Confidence            34565553 477777753 4677777777777777777777654   5555543     5777777777666544 4446


Q ss_pred             CChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhc
Q 042902           89 LPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR  168 (599)
Q Consensus        89 ~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  168 (599)
                      ...+|.... .|+.+.+.+ .+..+...+|.++.+|+.+.+..+ +..+...+|.. .+|+.+.+..+-.. +...+|..
T Consensus       129 ~~~aF~~c~-~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~  203 (394)
T 4gt6_A          129 DSEAFHHCE-ELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE  203 (394)
T ss_dssp             CTTTTTTCT-TCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred             hhhhhhhhc-ccccccccc-eeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence            666666665 366666654 344456666777777777777654 44455555654 45777776654433 55566666


Q ss_pred             CCCCcEEEeeCCccCCCCCcccC-------------CCCCCcEeecCCCCCCCCC-ccccCCCcccEEeecCCCccccCc
Q 042902          169 LAALFLLDLGGNKLSGFVPACFG-------------NLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLP  234 (599)
Q Consensus       169 l~~L~~L~Ls~N~l~~~~~~~~~-------------~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~~~~~  234 (599)
                      +.++.......+.........+.             ....+..+.+. +.++.+. ..|.++..|+.+.+..+..+ +..
T Consensus       204 c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~  281 (394)
T 4gt6_A          204 CFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGT  281 (394)
T ss_dssp             CTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECT
T ss_pred             ccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecC
Confidence            66666666554443321111111             11122222222 1222332 24566777888887765543 666


Q ss_pred             ccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhcccc
Q 042902          235 LEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD  314 (599)
Q Consensus       235 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  314 (599)
                      .+|.++.+|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+
T Consensus       282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence            777778888888875 4566566677888888888888654 65566677888888888888544 66566777888888


Q ss_pred             ceEEEcccccC
Q 042902          315 LKYINVSFNKL  325 (599)
Q Consensus       315 L~~l~l~~N~l  325 (599)
                      |+.+++.+|..
T Consensus       359 L~~i~~~~~~~  369 (394)
T 4gt6_A          359 LNNIEYSGSRS  369 (394)
T ss_dssp             CCEEEESSCHH
T ss_pred             CCEEEECCcee
Confidence            88888877654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.58  E-value=4.2e-15  Score=135.31  Aligned_cols=106  Identities=23%  Similarity=0.209  Sum_probs=73.0

Q ss_pred             CcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccc
Q 042902          196 LRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       196 L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      .+.+++++|.++.+|..+.  ++|++|+|++|.|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            4667777777777776553  56777777777777666667777777777777777777666666666777777777777


Q ss_pred             cccccCcccccCCCCcccccCCCCcccc
Q 042902          276 RLQGSIPDSIGGLIDLKSLDLSNNNISG  303 (599)
Q Consensus       276 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~  303 (599)
                      +|++..+..|..+++|+.|+|++|+++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            7666555566666666666666666664

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.56  E-value=6.6e-15  Score=134.55  Aligned_cols=104  Identities=22%  Similarity=0.185  Sum_probs=74.2

Q ss_pred             cEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccc
Q 042902          197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       197 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  276 (599)
                      +.+++++|.++.+|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            567777777777776553  567777777777777667777777777777777777776666666777777777777777


Q ss_pred             ccccCcccccCCCCcccccCCCCccc
Q 042902          277 LQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       277 l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      |++..+..|..+++|+.|+|++|++.
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcc
Confidence            77655555777777777777777776

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=6.7e-15  Score=134.01  Aligned_cols=111  Identities=20%  Similarity=0.181  Sum_probs=101.2

Q ss_pred             cccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCC
Q 042902          218 YILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS  297 (599)
Q Consensus       218 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  297 (599)
                      ..+.+++++|.++. +|..+  .++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            35789999999995 55554  3789999999999999999999999999999999999998888889999999999999


Q ss_pred             CCcccccCCchhhccccceEEEcccccCcccCCC
Q 042902          298 NNNISGAIPISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       298 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      +|+|++..+..|..+++|+.|+|++|+++|.++.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            9999988888899999999999999999988763

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.53  E-value=3e-13  Score=140.66  Aligned_cols=300  Identities=11%  Similarity=0.112  Sum_probs=218.9

Q ss_pred             cCccCCCCCCcCCCCCCEEEccCcc---ccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccC
Q 042902            7 NFSGTIPSFIFNASKLSRLELEMNS---FYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN   83 (599)
Q Consensus         7 ~~~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N   83 (599)
                      .++..-..+|.++++|+.+.+..|.   ++.+...+|.++.+|+.+.+..+ ++.+...     +|.++.+|+.+.+..+
T Consensus        74 svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~-----aF~~c~~L~~i~lp~~  147 (394)
T 4gt6_A           74 TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE-----AFHHCEELDTVTIPEG  147 (394)
T ss_dssp             TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT-----TTTTCTTCCEEECCTT
T ss_pred             CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh-----hhhhhcccccccccce
Confidence            3555556789999999999998774   88888999999999999998765 7777764     6999999999999755


Q ss_pred             cccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCC
Q 042902           84 SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP  163 (599)
Q Consensus        84 ~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  163 (599)
                       +..+...+|.... .|+.+.+.+ .+..+...+|.+ .+|+.+.+..+-. .+...+|..+.+|+......+.......
T Consensus       148 -~~~I~~~~F~~c~-~L~~i~~~~-~~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~  222 (394)
T 4gt6_A          148 -VTSVADGMFSYCY-SLHTVTLPD-SVTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDN  222 (394)
T ss_dssp             -CCEECTTTTTTCT-TCCEEECCT-TCCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSS
T ss_pred             -eeeecccceeccc-ccccccccc-eeeEeccccccc-cceeEEEECCccc-ccccchhhhccccceecccccccccccc
Confidence             5557788888876 488888866 466677778865 6799999987543 4667789999999998887766542211


Q ss_pred             hhhh-------------cCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCC-ccccCCCcccEEeecCCCc
Q 042902          164 DDLC-------------RLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSF  229 (599)
Q Consensus       164 ~~~~-------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l  229 (599)
                      ..+.             ....+..+.+. +.++.+...+|.++..|+.+.+.++.. .+. ..|.++++|+.+.+. +.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i  299 (394)
T 4gt6_A          223 VLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRI  299 (394)
T ss_dssp             CEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTC
T ss_pred             eeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-Ccc
Confidence            1111             12233444443 234445667889999999999876544 444 477788999999996 556


Q ss_pred             cccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchh
Q 042902          230 TGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISL  309 (599)
Q Consensus       230 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  309 (599)
                      +.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|....   ..+
T Consensus       300 ~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~  374 (394)
T 4gt6_A          300 TELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAI  374 (394)
T ss_dssp             CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTC
T ss_pred             cccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhh
Confidence            6677888999999999999864 77677788999999999999654 776778889999999999999887542   456


Q ss_pred             hccccceEEEcccccC
Q 042902          310 EKLLDLKYINVSFNKL  325 (599)
Q Consensus       310 ~~l~~L~~l~l~~N~l  325 (599)
                      .....|+.+.+..|.+
T Consensus       375 ~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          375 STDSGLQNLPVAPGSI  390 (394)
T ss_dssp             BCCCCC----------
T ss_pred             hccCCCCEEEeCCCCE
Confidence            6677888888776654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=1.7e-14  Score=131.73  Aligned_cols=110  Identities=21%  Similarity=0.257  Sum_probs=99.3

Q ss_pred             ccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCC
Q 042902          219 ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSN  298 (599)
Q Consensus       219 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  298 (599)
                      -+.+++++|.++ .+|..+.  ++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478999999998 4565553  8999999999999999999999999999999999999988888889999999999999


Q ss_pred             CcccccCCchhhccccceEEEcccccCcccCCC
Q 042902          299 NNISGAIPISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       299 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      |+|++..+..|..+++|+.|++++|++.+.++.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            999987777799999999999999999987653

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.47  E-value=5.9e-16  Score=159.21  Aligned_cols=185  Identities=17%  Similarity=0.122  Sum_probs=88.6

Q ss_pred             CCCCEEEccCCcCCcccCccccC-----CCCCCEEEcccccccccCChhhh-cCCCCcEEEeeCCccCCCCCccc-----
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDK-----LQKLQLLSLEDNQLEGSIPDDLC-RLAALFLLDLGGNKLSGFVPACF-----  190 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-----  190 (599)
                      ++|++|+|++|.|+......+..     .++|++|+|++|.|.+.....+. .+++|+.|+|++|.+++.....+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            56677777777776433333322     25677777777776543322222 34566666666666654332322     


Q ss_pred             CCCCCCcEeecCCCCCCC-----CCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcc
Q 042902          191 GNLTSLRNLYLGSNQLTS-----IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLK  265 (599)
Q Consensus       191 ~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  265 (599)
                      ...++|++|+|++|.|+.     ++..+...++|++|+|++|.|++....                    .++..+...+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~~  211 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRNR  211 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGCS
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcCC
Confidence            234556666666665543     222333444555555555555432110                    0122233344


Q ss_pred             ccccccccccccccc----CcccccCCCCcccccCCCCcccccCCchhhcccc-----ceEEE--cccccCc
Q 042902          266 DLQYLFLEYNRLQGS----IPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD-----LKYIN--VSFNKLE  326 (599)
Q Consensus       266 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-----L~~l~--l~~N~l~  326 (599)
                      +|++|+|++|.|++.    ++..+...++|++|+|++|.|+......+..+..     |+.+.  +..|.++
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            444445555444432    2223334456666666666665544444433311     45554  4455443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=7.1e-14  Score=142.81  Aligned_cols=132  Identities=18%  Similarity=0.138  Sum_probs=83.3

Q ss_pred             EeecCCC-CCCCCCccccCCCcccEEeecC-CCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccc
Q 042902          198 NLYLGSN-QLTSIPSTLWNLKYILYLNLSS-NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYN  275 (599)
Q Consensus       198 ~L~L~~N-~l~~ip~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  275 (599)
                      .++++++ .|+.+|. +..+++|+.|+|++ |.|+++.+..|.++++|+.|+|++|+|+++.|..|.++++|++|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            4566666 6667766 66666777777774 7777666666777777777777777777766667777777777777777


Q ss_pred             cccccCcccccCCCCcccccCCCCcccccCC-chhhccccceEEEcccccCcccCCC
Q 042902          276 RLQGSIPDSIGGLIDLKSLDLSNNNISGAIP-ISLEKLLDLKYINVSFNKLEGEIPR  331 (599)
Q Consensus       276 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~  331 (599)
                      +|++..+..|..++ |+.|+|++|.+..... ..|..+.......+..+.++|..|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            77766655565554 7777777777763322 2233332223333445566665554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=3.9e-13  Score=131.54  Aligned_cols=145  Identities=18%  Similarity=0.164  Sum_probs=114.7

Q ss_pred             HHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEE
Q 042902          425 QATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       425 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ....+|+.....+.|+.+.||++... ++.+++|+...........+..|+++++.+. |..+.++++++.+.+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            44567888888888899999999764 7899999987543233346888999999884 678889999999888999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG---------------------------------------  544 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------------------------------------  544 (599)
                      ||++|.++.+.+..      ......++.++++++..||..                                       
T Consensus        90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999875321      112346888999999999951                                       


Q ss_pred             -----------------CCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          545 -----------------YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       545 -----------------~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                                       ....++|+|++|.||+++++..+.|+||+.|.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             01459999999999999876667899999875

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=1.7e-15  Score=155.78  Aligned_cols=187  Identities=18%  Similarity=0.097  Sum_probs=116.4

Q ss_pred             CCCCCEEeccCccCcccCCCcccccccC-CCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccc---
Q 042902           43 LRNLKRLSLNYNYLTSSTPKLNFLSSLS-NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEI---  118 (599)
Q Consensus        43 l~~L~~L~L~~N~l~~~~~~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~---  118 (599)
                      ++.|++|+|++|.|+..... .+...+. ..++|++|+|++|.|+......+...-..++.|++++|.++......+   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~  149 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL  149 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHH
Confidence            35677777777777653321 0111122 225777777777777644333333322347777777777765544444   


Q ss_pred             --cCCCCCCEEEccCCcCCcc----cCccccCCCCCCEEEcccccccccC----ChhhhcCCCCcEEEeeCCccCCCC--
Q 042902          119 --SNLTNLTTIYLGGNKLNGS----IPIALDKLQKLQLLSLEDNQLEGSI----PDDLCRLAALFLLDLGGNKLSGFV--  186 (599)
Q Consensus       119 --~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~--  186 (599)
                        ...++|++|+|++|.|+..    ++.++..+++|++|+|++|.|.+..    +..+...++|+.|+|++|.|++..  
T Consensus       150 L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~  229 (372)
T 3un9_A          150 LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL  229 (372)
T ss_dssp             HHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred             HHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence              3467899999999988642    3344577888999999999987532    455677788999999999987542  


Q ss_pred             --CcccCCCCCCcEeecCCCCCCCCC-ccccC---CC--cccEEe--ecCCCcc
Q 042902          187 --PACFGNLTSLRNLYLGSNQLTSIP-STLWN---LK--YILYLN--LSSNSFT  230 (599)
Q Consensus       187 --~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~---l~--~L~~L~--Ls~N~l~  230 (599)
                        ...+...++|++|+|++|.|+... ..+..   ..  .|+.+.  +..|.++
T Consensus       230 ~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          230 ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence              233445688999999999988432 12221   12  166666  6666665

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.40  E-value=2.5e-11  Score=125.42  Aligned_cols=288  Identities=10%  Similarity=0.088  Sum_probs=178.3

Q ss_pred             CcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhc
Q 042902           16 IFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN   95 (599)
Q Consensus        16 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~   95 (599)
                      +....+|+.+.+. ..++.|...+|.++.+|+.+.|..+ ++.+...     +|.++ +|+.+.+..+ ++.+...+|..
T Consensus        42 ~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~-----aF~~c-~l~~i~~~~~-l~~I~~~aF~~  112 (379)
T 4h09_A           42 YKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDG-----AFADT-KLQSYTGMER-VKKFGDYVFQG  112 (379)
T ss_dssp             GGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTT-----TTTTC-CCCEEEECTT-CCEECTTTTTT
T ss_pred             cccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechh-----hhcCC-CCceEECCce-eeEeccceecc
Confidence            4455778888885 5688888888888888999888654 7777664     67776 5777777644 66666777765


Q ss_pred             ccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc------------CC
Q 042902           96 LSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS------------IP  163 (599)
Q Consensus        96 l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------~~  163 (599)
                      .  .|+.+.+.++ +..+...+|.+. +|+.+.+..+ ++.+...+|....+++.+.+..+.....            ..
T Consensus       113 ~--~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (379)
T 4h09_A          113 T--DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTIL  187 (379)
T ss_dssp             C--CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEE
T ss_pred             C--CcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceeccccccee
Confidence            4  4777777653 444555566554 5666666543 4445566777777777777665543211            11


Q ss_pred             hhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCC-ccccCCCcccEEeecCCCccccCccccccccc
Q 042902          164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRV  242 (599)
Q Consensus       164 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  242 (599)
                      ..+.....+..+.+..+. .......|....+|+.+.+..+ ++.++ ..+.++..|+.+.+..+ ++.+...+|.++.+
T Consensus       188 ~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~  264 (379)
T 4h09_A          188 ESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA  264 (379)
T ss_dssp             EECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT
T ss_pred             ccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh
Confidence            122333344444443322 2234455566666666666544 44443 35556666777777655 55455666666677


Q ss_pred             ccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEccc
Q 042902          243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSF  322 (599)
Q Consensus       243 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~  322 (599)
                      |+.+.+..+ ++.+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|.++ ++.+...+|.++.+|+.+.+..
T Consensus       265 l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          265 LKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             CCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             hcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            777766543 44455566677777777777766666666666777777777777543 5555566677777776665543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.35  E-value=1.6e-12  Score=132.75  Aligned_cols=89  Identities=26%  Similarity=0.193  Sum_probs=40.7

Q ss_pred             ccCCCCCCEEEccc-ccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCccc
Q 042902          142 LDKLQKLQLLSLED-NQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYIL  220 (599)
Q Consensus       142 ~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~  220 (599)
                      +..+++|++|+|++ |+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|+.+|..++....|+
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~  106 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQ  106 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCce
Confidence            44444444444443 44444444444444444444444444444444444444444444444444444443332222244


Q ss_pred             EEeecCCCcc
Q 042902          221 YLNLSSNSFT  230 (599)
Q Consensus       221 ~L~Ls~N~l~  230 (599)
                      .|+|++|.+.
T Consensus       107 ~l~l~~N~~~  116 (347)
T 2ifg_A          107 ELVLSGNPLH  116 (347)
T ss_dssp             EEECCSSCCC
T ss_pred             EEEeeCCCcc
Confidence            4445444444

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.32  E-value=6.9e-11  Score=122.08  Aligned_cols=286  Identities=12%  Similarity=0.060  Sum_probs=161.6

Q ss_pred             CccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccc
Q 042902            8 FSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG   87 (599)
Q Consensus         8 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~   87 (599)
                      ++..-..+|.++.+|+.++|.. .++.+...+|.+. +|+.+.+..+ ++.+...     +|... +|+.+++..+ +..
T Consensus        57 vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~-----aF~~~-~L~~i~lp~~-~~~  126 (379)
T 4h09_A           57 ITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDY-----VFQGT-DLDDFEFPGA-TTE  126 (379)
T ss_dssp             EEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTT-----TTTTC-CCSEEECCTT-CCE
T ss_pred             ccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccc-----eeccC-CcccccCCCc-ccc
Confidence            3333345666667777777753 3666666677665 5666666533 5555443     35443 5777776554 333


Q ss_pred             cCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCc------------ccCccccCCCCCCEEEccc
Q 042902           88 ILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNG------------SIPIALDKLQKLQLLSLED  155 (599)
Q Consensus        88 ~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~~~~~~~l~~L~~L~L~~  155 (599)
                      +...+|.+.  .++...+.. .++.+...+|.++.+++.+.+..+....            .....+.....+..+.+..
T Consensus       127 i~~~~F~~~--~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (379)
T 4h09_A          127 IGNYIFYNS--SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPS  203 (379)
T ss_dssp             ECTTTTTTC--CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCT
T ss_pred             ccccccccc--eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccccccccccccc
Confidence            445555543  233333332 3444555666666666666665443221            1122334444555555544


Q ss_pred             ccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCc
Q 042902          156 NQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLP  234 (599)
Q Consensus       156 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~  234 (599)
                      +.-. .....+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+.. .+.++.+|+.+.+..+ ++.+..
T Consensus       204 ~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~  279 (379)
T 4h09_A          204 TVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPY  279 (379)
T ss_dssp             TCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECT
T ss_pred             ceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccc
Confidence            3322 44555666666666666544 44455566666677777776654 555543 4555666777766543 444555


Q ss_pred             ccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhcc
Q 042902          235 LEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKL  312 (599)
Q Consensus       235 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  312 (599)
                      .+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+.
T Consensus       280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             TTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             cccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            66667777777777666666666666777777777777543 55455566777777777766544 544445555443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=5.5e-12  Score=123.02  Aligned_cols=131  Identities=16%  Similarity=0.112  Sum_probs=99.6

Q ss_pred             eec-ccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCc--ceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          435 LIG-RGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN--LIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       435 ~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      .++ .|..+.||++...+|..+++|+....   ....+..|+++++.+.+.+  +.+++++...++..++||||++|.++
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            344 55569999998877889999997543   2245778999998886544  56688888887889999999999888


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY----------------------------------------------  545 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------------------------------------------  545 (599)
                      .  ...    .+   ...++.++++++..+|...                                              
T Consensus       103 ~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          103 L--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             T--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             C--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            4  211    12   2357888889999998421                                              


Q ss_pred             ---------CCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          546 ---------SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       546 ---------~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                               ...++|+|++|.||++++++.++|+|||.|..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11299999999999998876778999999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=9.2e-11  Score=120.19  Aligned_cols=142  Identities=12%  Similarity=0.158  Sum_probs=106.4

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEec--ccc-cccHHHHHHHHHHHhcCC--CCcceeEEEEEEcC---CeeeEEE
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFD--LQY-EGAFKSFDIECDMMKRIR--HRNLIKIISSCSND---DFKALVL  503 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  503 (599)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+..|+++++.+.  +..++++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567899999999999876 4678888875  322 122356788999999887  45688999988776   4589999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY--------------------------------------  545 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------  545 (599)
                      ||++|..+.+...   ..++..++..++.+++++|..||...                                      
T Consensus       121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999988754221   12567778889999999999999520                                      


Q ss_pred             -----------------CCCeEEccCCCCCeeecCCCc--EEEccccCCcc
Q 042902          546 -----------------SVPIIHCDLKPNNVLLDDNMV--AHLSDFGMAKP  577 (599)
Q Consensus       546 -----------------~~~iiH~dlk~~Nill~~~~~--~kl~DFGla~~  577 (599)
                                       ...++|+|+++.||++++++.  +.|+||+.|..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             257999999999999997753  68999999863

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.05  E-value=4.1e-11  Score=122.12  Aligned_cols=84  Identities=18%  Similarity=0.158  Sum_probs=51.4

Q ss_pred             cccccEEEccCCccCCCCCccc---cCcccccccccccccccccC----cccccCCCCcccccCCCCcccccCCchhhcc
Q 042902          240 LRVLVQIDLSMNNFSGFIPTTI---GDLKDLQYLFLEYNRLQGSI----PDSIGGLIDLKSLDLSNNNISGAIPISLEKL  312 (599)
Q Consensus       240 l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  312 (599)
                      +++|+.|+|++|.+.+..+..+   ..+++|++|+|+.|.+++..    +..+..+++|+.|+|++|.|+...-..+...
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            5666777776666653222222   24677777777777776532    3333456788888888888775444444431


Q ss_pred             ccceEEEccccc
Q 042902          313 LDLKYINVSFNK  324 (599)
Q Consensus       313 ~~L~~l~l~~N~  324 (599)
                      - ...+++++|+
T Consensus       331 l-g~~~~~~~~~  341 (362)
T 2ra8_A          331 L-PMKIDVSDSQ  341 (362)
T ss_dssp             C-CSEEECCSBC
T ss_pred             c-CCEEEecCCc
Confidence            1 3457888877

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.99  E-value=2e-10  Score=116.95  Aligned_cols=135  Identities=19%  Similarity=0.211  Sum_probs=82.0

Q ss_pred             CCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccc--ccccccEEEccC--CccCCC-----CCccc
Q 042902          191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG--NLRVLVQIDLSM--NNFSGF-----IPTTI  261 (599)
Q Consensus       191 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~~~~~  261 (599)
                      ..+|+|+.|+|++|.-..++. + .+++|+.|++..|.++......+.  .+++|+.|+|+.  |...+.     +...+
T Consensus       169 ~~~P~L~~L~L~g~~~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l  246 (362)
T 2ra8_A          169 DAMPLLNNLKIKGTNNLSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF  246 (362)
T ss_dssp             HTCTTCCEEEEECCBTCBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred             hcCCCCcEEEEeCCCCceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence            344555555555442112222 2 245666666666655433222332  566677776642  221111     01112


Q ss_pred             --cCcccccccccccccccccCccccc---CCCCcccccCCCCcccccC----CchhhccccceEEEcccccCcc
Q 042902          262 --GDLKDLQYLFLEYNRLQGSIPDSIG---GLIDLKSLDLSNNNISGAI----PISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       262 --~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                        ..+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+++..    +..+..+++|+.|++++|.++.
T Consensus       247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence              3578999999999998764444443   5789999999999998643    3444568999999999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.72  E-value=2.9e-08  Score=98.89  Aligned_cols=136  Identities=20%  Similarity=0.229  Sum_probs=99.3

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCc--ceeEEEEEEcCC---eeeEEEEcc
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRN--LIKIISSCSNDD---FKALVLEYM  506 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  506 (599)
                      .+.++.|.+..||++.    ..+++|+....  .....+..|+++++.+. +..  +.++++++...+   ..|+||||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4578999999999863    56888986432  34567889999998873 322  445555544333   458999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------  544 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------------  544 (599)
                      +|.++.+....   .++..++..++.++++.+..+|..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888653322   256667778888888888888841                                          


Q ss_pred             -------------CCCCeEEccCCCCCeeecC--CCcEEEccccCCcc
Q 042902          545 -------------YSVPIIHCDLKPNNVLLDD--NMVAHLSDFGMAKP  577 (599)
Q Consensus       545 -------------~~~~iiH~dlk~~Nill~~--~~~~kl~DFGla~~  577 (599)
                                   ....++|+|++|.||++++  ...+.|+||+.|..
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                         1245899999999999998  45688999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=1.8e-07  Score=93.24  Aligned_cols=136  Identities=15%  Similarity=0.118  Sum_probs=95.1

Q ss_pred             CceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC---cceeEEEEEE-cCCeeeEEEEccCC
Q 042902          433 NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHR---NLIKIISSCS-NDDFKALVLEYMPH  508 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  508 (599)
                      .+.++.|....||+.    |..+++|+..  .......+..|.++|..+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899987    5778888853  223456789999999998752   3667777774 45567899999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  544 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------  544 (599)
                      .++.+....   .++..++..++.++++.|..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888653211   123344445555555555555521                                            


Q ss_pred             -------------CCCCeEEccCCCCCeeecC---CCc-EEEccccCCcc
Q 042902          545 -------------YSVPIIHCDLKPNNVLLDD---NMV-AHLSDFGMAKP  577 (599)
Q Consensus       545 -------------~~~~iiH~dlk~~Nill~~---~~~-~kl~DFGla~~  577 (599)
                                   ....++|+|+++.||++++   ++. +.|+||+.|..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2346799999999999987   455 58999998863

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.61  E-value=5.7e-09  Score=95.86  Aligned_cols=93  Identities=19%  Similarity=0.138  Sum_probs=52.3

Q ss_pred             CccccCCCCCCEEEccCC-cCCcc----cCccccCCCCCCEEEcccccccccC----ChhhhcCCCCcEEEeeCCccCCC
Q 042902          115 PEEISNLTNLTTIYLGGN-KLNGS----IPIALDKLQKLQLLSLEDNQLEGSI----PDDLCRLAALFLLDLGGNKLSGF  185 (599)
Q Consensus       115 ~~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~  185 (599)
                      ...+...++|++|+|++| .|...    +...+...++|++|+|++|.|.+..    ...+...++|++|+|++|.|.+.
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            345566778888888887 77632    2334556677777777777776422    23344445666666666666532


Q ss_pred             C----CcccCCCCCCcEeec--CCCCCC
Q 042902          186 V----PACFGNLTSLRNLYL--GSNQLT  207 (599)
Q Consensus       186 ~----~~~~~~l~~L~~L~L--~~N~l~  207 (599)
                      .    ...+...++|++|+|  ++|.|+
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            1    223333344444444  444444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.60  E-value=5.7e-09  Score=95.88  Aligned_cols=124  Identities=19%  Similarity=0.206  Sum_probs=58.8

Q ss_pred             CccccCCCCCCEEeccCc-cCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCC
Q 042902           37 PNTFGNLRNLKRLSLNYN-YLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIP  115 (599)
Q Consensus        37 ~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~  115 (599)
                      ...+...+.|++|+|++| .|...... .+...+...++|++|+|++|.|...-..+++                     
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~-~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~---------------------   86 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLK-ACAEALKTNTYVKKFSIVGTRSNDPVAFALA---------------------   86 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHH-HHHHHHTTCCSCCEEECTTSCCCHHHHHHHH---------------------
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHH-HHHHHHHhCCCcCEEECcCCCCChHHHHHHH---------------------
Confidence            344555666666666666 66542211 1112345556666666666666532111111                     


Q ss_pred             ccccCCCCCCEEEccCCcCCcc----cCccccCCCCCCEEEc--ccccccccC----ChhhhcCCCCcEEEeeCCcc
Q 042902          116 EEISNLTNLTTIYLGGNKLNGS----IPIALDKLQKLQLLSL--EDNQLEGSI----PDDLCRLAALFLLDLGGNKL  182 (599)
Q Consensus       116 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l  182 (599)
                      +.+...++|++|+|++|.|+..    +..++...++|++|+|  ++|.|....    ...+...++|+.|+|++|.+
T Consensus        87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A           87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence            1222334555666666655532    2233444555555555  555554321    22233334555555555544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=3.8e-07  Score=89.08  Aligned_cols=136  Identities=17%  Similarity=0.078  Sum_probs=98.3

Q ss_pred             ceecccccc-eEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          434 NLIGRGGVA-SVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       434 ~~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      +.+..|..| .||+.... ++..+++|+....   ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345566665 69988765 4678999986533   3456788999888774 3347788999999999999999999988


Q ss_pred             hhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 042902          511 LEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG----------------------------------------------  544 (599)
Q Consensus       511 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------------------------------------------  544 (599)
                      +.+......     .....++.++++.+.-||..                                              
T Consensus       107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            876543321     12234666777777777721                                              


Q ss_pred             ---------CCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          545 ---------YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       545 ---------~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                               ....++|+|+.+.||++++++.+-|+||+.|..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     012379999999999999887778999998863

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.55  E-value=7.5e-09  Score=100.02  Aligned_cols=78  Identities=19%  Similarity=0.290  Sum_probs=36.7

Q ss_pred             cccccEEEccCCccCCC--CCccccCcccccccccccccccccCcccccCCC--CcccccCCCCcccccCCc-------h
Q 042902          240 LRVLVQIDLSMNNFSGF--IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLI--DLKSLDLSNNNISGAIPI-------S  308 (599)
Q Consensus       240 l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~-------~  308 (599)
                      +++|+.|+|++|+|+++  +|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|++++..|.       .
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i  246 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI  246 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence            44444444444444442  223334445555555555555433  1122222  566666666666554442       2


Q ss_pred             hhccccceEEE
Q 042902          309 LEKLLDLKYIN  319 (599)
Q Consensus       309 ~~~l~~L~~l~  319 (599)
                      +..+++|+.||
T Consensus       247 l~~~P~L~~LD  257 (267)
T 3rw6_A          247 RERFPKLLRLD  257 (267)
T ss_dssp             HHHCTTCCEES
T ss_pred             HHHCcccCeEC
Confidence            44556666543

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=1.6e-08  Score=97.67  Aligned_cols=63  Identities=27%  Similarity=0.309  Sum_probs=29.7

Q ss_pred             cCCCCcEEEeeCCccCCCC--CcccCCCCCCcEeecCCCCCCCCCccccCCC--cccEEeecCCCccc
Q 042902          168 RLAALFLLDLGGNKLSGFV--PACFGNLTSLRNLYLGSNQLTSIPSTLWNLK--YILYLNLSSNSFTG  231 (599)
Q Consensus       168 ~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~--~L~~L~Ls~N~l~~  231 (599)
                      .+++|+.|+|++|+|+++.  +..+..+++|+.|+|++|+|+.+. .+..+.  +|++|+|++|.+.+
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~-~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER-ELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG-GGGGGTTSCCSEEECTTSTTGG
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch-hhhhcccCCcceEEccCCcCcc
Confidence            3455555555555555422  233444555555555555555441 122222  45555555555543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.48  E-value=2.3e-07  Score=94.61  Aligned_cols=81  Identities=5%  Similarity=-0.011  Sum_probs=57.0

Q ss_pred             Ccee-cccccceEEEEEec-------CCcEEEEEEecccc---cccHHHHHHHHHHHhcCC-C--CcceeEEEEEEcC--
Q 042902          433 NNLI-GRGGVASVYKARIQ-------DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIR-H--RNLIKIISSCSND--  496 (599)
Q Consensus       433 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--  496 (599)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+..|+++++.+. +  -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998764       26788999875432   111245677888888774 2  3577888887655  


Q ss_pred             -CeeeEEEEccCCCChhh
Q 042902          497 -DFKALVLEYMPHGSLEK  513 (599)
Q Consensus       497 -~~~~lv~e~~~~g~L~~  513 (599)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35789999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=3.9e-06  Score=86.81  Aligned_cols=75  Identities=17%  Similarity=0.164  Sum_probs=50.2

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEeccccc-------ccHHHHHHHHHHHhcCCC--C-cceeEEEEEEcCCeeeE
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-------GAFKSFDIECDMMKRIRH--R-NLIKIISSCSNDDFKAL  501 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l  501 (599)
                      .+.+|.|.++.||++... +++.|+||.......       ....++..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999764 478899998643211       123456778888887742  3 34455544  3445689


Q ss_pred             EEEccCCC
Q 042902          502 VLEYMPHG  509 (599)
Q Consensus       502 v~e~~~~g  509 (599)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=8.5e-06  Score=82.22  Aligned_cols=138  Identities=17%  Similarity=0.142  Sum_probs=79.4

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCcceeEEE------EEEcCCeeeEEEEc
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR--HRNLIKIIS------SCSNDDFKALVLEY  505 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~  505 (599)
                      +.++.|..+.||++...+| .+++|+....    ......|..++..+.  .-.+++++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987654 5899998642    123334455444442  112333332      12345678999999


Q ss_pred             cCCCChh-----h---------hhhc----C--C-------CcCCHHHHH------------------------------
Q 042902          506 MPHGSLE-----K---------CLYS----S--N-------YILDIFQRL------------------------------  528 (599)
Q Consensus       506 ~~~g~L~-----~---------~l~~----~--~-------~~~~~~~~~------------------------------  528 (599)
                      ++|.++.     .         .+|.    .  .       ....|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987542     0         1111    0  0       011232110                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          529 -NIMIDVASALEYLHF----------GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       529 -~i~~~i~~~l~~lH~----------~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                       .+...+.+++.+++.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111223445666652          125789999999999999888899999999885

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.09  E-value=2.3e-05  Score=77.79  Aligned_cols=137  Identities=14%  Similarity=0.096  Sum_probs=93.3

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR---HRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      ..+.|+.|.+..+|+... ++..+++|+....   ....|..|.+.|+.+.   ...++++++++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999886 4678889987532   3567888999888874   36788899998888889999999999


Q ss_pred             CChhh-----------hhhcCCC---------------------cCCHHHHH---HHHH----------------HHHH-
Q 042902          509 GSLEK-----------CLYSSNY---------------------ILDIFQRL---NIMI----------------DVAS-  536 (599)
Q Consensus       509 g~L~~-----------~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~-  536 (599)
                      ..+..           .+|....                     .-+|....   ++..                .+++ 
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86521           1222110                     12454321   1111                1111 


Q ss_pred             HHHHHh-cCCCCCeEEccCCCCCeeecCCCcEEEcccc
Q 042902          537 ALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFG  573 (599)
Q Consensus       537 ~l~~lH-~~~~~~iiH~dlk~~Nill~~~~~~kl~DFG  573 (599)
                      ....+. ....+.++|+|+.+.|++++.++ +.|.||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            122332 12357899999999999999887 8899984

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.00  E-value=2.1e-06  Score=76.92  Aligned_cols=82  Identities=12%  Similarity=0.147  Sum_probs=36.5

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEccccc-ccccCChhhhcC----CCCcEEEeeCCc-cCCCCCcccCCCCCC
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQ-LEGSIPDDLCRL----AALFLLDLGGNK-LSGFVPACFGNLTSL  196 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  196 (599)
                      +|+.|||+++.|+..--..+.++++|++|+|++|. |++..-..+..+    ++|++|+|++|. +++..-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555543333344455555555555553 443222223332    235555555542 443322333444444


Q ss_pred             cEeecCCC
Q 042902          197 RNLYLGSN  204 (599)
Q Consensus       197 ~~L~L~~N  204 (599)
                      ++|+++++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            44444444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.98  E-value=1.6e-06  Score=77.66  Aligned_cols=84  Identities=13%  Similarity=0.015  Sum_probs=50.6

Q ss_pred             CcccEEeecCCCccccCcccccccccccEEEccCCc-cCCCCCccccCc----cccccccccccc-ccccCcccccCCCC
Q 042902          217 KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNN-FSGFIPTTIGDL----KDLQYLFLEYNR-LQGSIPDSIGGLID  290 (599)
Q Consensus       217 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~  290 (599)
                      ..|+.||++++.++...-..+.++++|+.|+|++|. |++..-..++.+    ++|++|+|++|. +++..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356677777766665555556666777777777764 554333334443    357777777763 66544445566667


Q ss_pred             cccccCCCCc
Q 042902          291 LKSLDLSNNN  300 (599)
Q Consensus       291 L~~L~L~~N~  300 (599)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777776664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=3.7e-05  Score=75.56  Aligned_cols=78  Identities=13%  Similarity=0.117  Sum_probs=57.5

Q ss_pred             CCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC---CcceeEEEEEEcCCeeeEEEEcc
Q 042902          430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH---RNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       430 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ....+.+|.|..+.||+.+..||+.|.+|+...........|..|++.|+.+.-   --+++++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            445578899999999999999999999998764443334568889998887742   2345555542    347999999


Q ss_pred             CCCCh
Q 042902          507 PHGSL  511 (599)
Q Consensus       507 ~~g~L  511 (599)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            88754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=4.9e-05  Score=79.08  Aligned_cols=74  Identities=9%  Similarity=0.057  Sum_probs=47.3

Q ss_pred             cCceecccccceEEEEEecCCcEEEEEEeccc-----c--c--ccHHHHHHHHHHHh-cCCCCcceeEEEEEEcCCeeeE
Q 042902          432 ENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ-----Y--E--GAFKSFDIECDMMK-RIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--~--~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      ..+.+|.|..+.||++.. +++.++||.....     .  .  .....+..|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            346789999999999965 4778999953221     0  1  12234444544332 22334667777765  466799


Q ss_pred             EEEcc-CC
Q 042902          502 VLEYM-PH  508 (599)
Q Consensus       502 v~e~~-~~  508 (599)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.58  E-value=0.00043  Score=69.38  Aligned_cols=139  Identities=12%  Similarity=0.093  Sum_probs=72.2

Q ss_pred             ceecccccce-EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCcceeEEEEEEcCCeeeEEEEccCCCC
Q 042902          434 NLIGRGGVAS-VYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR--HRNLIKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       434 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      +.++.|+... +|+....+|..+++|.......   ..+..|+.++..+.  .-.+.+++.+....+  ++|||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565565544 6777654477788887543321   22334555555553  123566776643333  78999997766


Q ss_pred             hhhhhhcCC-------------------------CcCCHHHHH--------------------HHHHHHHHHHHHHh---
Q 042902          511 LEKCLYSSN-------------------------YILDIFQRL--------------------NIMIDVASALEYLH---  542 (599)
Q Consensus       511 L~~~l~~~~-------------------------~~~~~~~~~--------------------~i~~~i~~~l~~lH---  542 (599)
                      +.+++....                         ..++.....                    .....+.+.+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543332110                         011111000                    00001112222221   


Q ss_pred             cCCCCCeEEccCCCCCeeecCC----CcEEEccccCCcc
Q 042902          543 FGYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAKP  577 (599)
Q Consensus       543 ~~~~~~iiH~dlk~~Nill~~~----~~~kl~DFGla~~  577 (599)
                      ......++|+|+.+.||+++.+    +.+.|+||+.|..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125679999999999999875    6899999998863

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.00061  Score=67.86  Aligned_cols=155  Identities=14%  Similarity=0.161  Sum_probs=85.3

Q ss_pred             cHHHHHHHhCCCCc-----CceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCc--ceeEEE
Q 042902          419 THLELFQATNGFSE-----NNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN--LIKIIS  491 (599)
Q Consensus       419 ~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~  491 (599)
                      +..++......|..     .+.|+.|....+|+....+| .+++|+.....  ..+.+..|+.++..+....  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            33444444444543     34567788889999987655 68889886531  1234455676666553111  333332


Q ss_pred             E------EEcCCeeeEEEEccCCCChhh--------------hhhcC----CC-------cCCHHHHHH-----------
Q 042902          492 S------CSNDDFKALVLEYMPHGSLEK--------------CLYSS----NY-------ILDIFQRLN-----------  529 (599)
Q Consensus       492 ~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~-------~~~~~~~~~-----------  529 (599)
                      .      ....+..+++|||++|..+..              .+|..    ..       ...|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      123456789999999865421              01110    00       011222100           


Q ss_pred             -HHHHHHHHHHHHhcC----CCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          530 -IMIDVASALEYLHFG----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       530 -i~~~i~~~l~~lH~~----~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                       +...+.+.+++++..    ...+++|+|+++.||+++++..+.++||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             011244455555422    24579999999999999987666899999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.49  E-value=3e-05  Score=70.77  Aligned_cols=88  Identities=14%  Similarity=0.087  Sum_probs=50.5

Q ss_pred             cccCCCCCCEEEccCC-cCCc----ccCccccCCCCCCEEEcccccccccC----ChhhhcCCCCcEEEeeCCccCCCCC
Q 042902          117 EISNLTNLTTIYLGGN-KLNG----SIPIALDKLQKLQLLSLEDNQLEGSI----PDDLCRLAALFLLDLGGNKLSGFVP  187 (599)
Q Consensus       117 ~~~~l~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~  187 (599)
                      .+.+-+.|++|+|++| .|..    .+..++..-+.|++|+|++|+|.+..    .+.+..-+.|+.|+|++|.|.+..-
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3445567888888875 6653    12344566677888888888776432    2334455667777777777654211


Q ss_pred             ----cccCCCCCCcEeecCCC
Q 042902          188 ----ACFGNLTSLRNLYLGSN  204 (599)
Q Consensus       188 ----~~~~~l~~L~~L~L~~N  204 (599)
                          +++..-+.|++|+|++|
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHHhhCCceeEEECCCC
Confidence                22333344555555543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.48  E-value=0.00033  Score=69.17  Aligned_cols=128  Identities=14%  Similarity=0.115  Sum_probs=75.3

Q ss_pred             CcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcc-eeEEEEEEcCCeeeEEEEcc-CC
Q 042902          431 SENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL-IKIISSCSNDDFKALVLEYM-PH  508 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~  508 (599)
                      ...+.++.|....+|++     ..+++|+........ .....|+.+++.+....+ .++++++  .+.-++|+||+ +|
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            33678999999999998     568888875432211 122457777766642222 4555543  33457899999 65


Q ss_pred             CChhhh-hhcCCCcCCHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 042902          509 GSLEKC-LYSSNYILDIFQRLNIMIDVASALEYLHF--------------------------------------------  543 (599)
Q Consensus       509 g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------------------------------------------  543 (599)
                      .++... +..         +..++.++++.|+-+|.                                            
T Consensus        93 ~~l~~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A           93 QTMSPEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             EECCHHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred             ccCCHhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence            544310 000         00122222222222221                                            


Q ss_pred             ------CCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          544 ------GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       544 ------~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                            .....++|+|+.+.||+ ..++.+.++||..|.
T Consensus       164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence                  12345899999999999 566678999999876

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.47  E-value=2.6e-05  Score=71.18  Aligned_cols=44  Identities=16%  Similarity=0.334  Sum_probs=18.8

Q ss_pred             CCCCCCEEeccCc-cCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902           42 NLRNLKRLSLNYN-YLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        42 ~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      +-+.|++|+|++| +|...... .+..++..-+.|+.|+|++|.|.
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~-~la~aL~~N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIR-SLIEAACNSKHIEKFSLANTAIS   83 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHH-HHHHHHTTCSCCCEEECTTSCCB
T ss_pred             cCCCccEEECCCCCCCCHHHHH-HHHHHHhhCCCcCEEEccCCCCC
Confidence            3344555555553 44322110 11123344445555555555554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.46  E-value=0.00017  Score=75.00  Aligned_cols=73  Identities=18%  Similarity=0.206  Sum_probs=50.0

Q ss_pred             CceecccccceEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCc-ceeEEEEEEcCCeeeEEE
Q 042902          433 NNLIGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN-LIKIISSCSNDDFKALVL  503 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  503 (599)
                      .+.|+.|....||++...+        +..+++|+....  .....+..|..+++.+...+ .+++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578888889999998753        578999998432  11245567888888774223 3567766532    3899


Q ss_pred             EccCCCCh
Q 042902          504 EYMPHGSL  511 (599)
Q Consensus       504 e~~~~g~L  511 (599)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.41  E-value=0.00054  Score=69.73  Aligned_cols=138  Identities=14%  Similarity=0.170  Sum_probs=81.8

Q ss_pred             ceecccccceEEEEEec--------CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEE
Q 042902          434 NLIGRGGVASVYKARIQ--------DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.+..|-...+|++...        +++.+.+|+..... .......+|.++++.+. +.-..++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888899999875        25789999864322 23456678999888774 3334566766543    39999


Q ss_pred             ccCCCChhhh-----------------hhcCC----CcCC--HHHHHHHHHHHH-------------------HHHHHHh
Q 042902          505 YMPHGSLEKC-----------------LYSSN----YILD--IFQRLNIMIDVA-------------------SALEYLH  542 (599)
Q Consensus       505 ~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~-------------------~~l~~lH  542 (599)
                      |++|.++..-                 +|...    ....  +.+..++..++.                   +.+.++.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311                 12111    1122  223333333321                   1223332


Q ss_pred             ----c-CCCCCeEEccCCCCCeeecCC----CcEEEccccCCc
Q 042902          543 ----F-GYSVPIIHCDLKPNNVLLDDN----MVAHLSDFGMAK  576 (599)
Q Consensus       543 ----~-~~~~~iiH~dlk~~Nill~~~----~~~kl~DFGla~  576 (599)
                          . .....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                1 124578999999999999876    789999999886

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.00072  Score=67.52  Aligned_cols=139  Identities=12%  Similarity=0.127  Sum_probs=81.6

Q ss_pred             ceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--cceeEEEE-----EEcCCeeeEEEEcc
Q 042902          434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHR--NLIKIISS-----CSNDDFKALVLEYM  506 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  506 (599)
                      ..++ |....||++...+|+.+++|+..... .....+..|..++..+...  .+++++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889999887778889999986432 1345666788777766421  24444442     12245668899999


Q ss_pred             CCCChhh-----h---------hhc----C----CCcCCHHHH----HHH---------------HHHHHHHHHHHhc--
Q 042902          507 PHGSLEK-----C---------LYS----S----NYILDIFQR----LNI---------------MIDVASALEYLHF--  543 (599)
Q Consensus       507 ~~g~L~~-----~---------l~~----~----~~~~~~~~~----~~i---------------~~~i~~~l~~lH~--  543 (599)
                      +|..+..     .         +|.    .    ....++...    ..+               ...+.+.++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8854421     0         111    0    011222110    000               1111122333321  


Q ss_pred             --CCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          544 --GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       544 --~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                        .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              1245689999999999999 4 89999998876

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.23  E-value=0.00049  Score=58.50  Aligned_cols=54  Identities=26%  Similarity=0.249  Sum_probs=29.3

Q ss_pred             EeecCCCCCC--CCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCcc
Q 042902          198 NLYLGSNQLT--SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF  253 (599)
Q Consensus       198 ~L~L~~N~l~--~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  253 (599)
                      .++.+++.++  .+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            5556666665  5654332  2455555555555555455555555555555555544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.17  E-value=0.00043  Score=58.89  Aligned_cols=56  Identities=20%  Similarity=0.250  Sum_probs=41.8

Q ss_pred             CEEEccCcccc--ccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902           23 SRLELEMNSFY--GFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        23 ~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      +.++.+++.++  . +|..+.  .+|++|+|++|+|+.++..     .|..+++|++|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~-vP~~lp--~~l~~L~Ls~N~l~~l~~~-----~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWAS-LPTAFP--VDTTELVLTGNNLTALPPG-----LLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTT-SCSCCC--TTCSEEECTTSCCSSCCTT-----TGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCcccc-CCCCCC--cCCCEEECCCCcCCccChh-----hhhhccccCEEEecCCCee
Confidence            46788888887  5 443332  3588888888888888875     5788888888888888775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.16  E-value=0.0011  Score=69.20  Aligned_cols=74  Identities=14%  Similarity=0.153  Sum_probs=47.7

Q ss_pred             CceecccccceEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCcc-eeEEEEEEcCCeeeEEEEccCCCC
Q 042902          433 NNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL-IKIISSCSNDDFKALVLEYMPHGS  510 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  510 (599)
                      .+.|+.|-...+|++...+ +..+++|+........ -+-..|..+++.+...++ .++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578888889999998865 5788999875432211 111468888887764334 56777662  2  35999998755


Q ss_pred             h
Q 042902          511 L  511 (599)
Q Consensus       511 L  511 (599)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0011  Score=67.58  Aligned_cols=73  Identities=10%  Similarity=0.215  Sum_probs=43.9

Q ss_pred             ceecccccceEEEEEecC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCc-ceeEEEEEEcCCeeeEEE
Q 042902          434 NLIGRGGVASVYKARIQD---------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRN-LIKIISSCSNDDFKALVL  503 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  503 (599)
                      +.++.|....+|++...+         +..+++|+....... ......|.++++.+.... +.++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467788888999998754         268899987543221 112356777777764223 44666544  2  37899


Q ss_pred             EccCCCCh
Q 042902          504 EYMPHGSL  511 (599)
Q Consensus       504 e~~~~g~L  511 (599)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.87  E-value=0.0055  Score=61.44  Aligned_cols=32  Identities=19%  Similarity=0.293  Sum_probs=28.2

Q ss_pred             CCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       546 ~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.11  E-value=0.0059  Score=62.94  Aligned_cols=73  Identities=14%  Similarity=0.225  Sum_probs=47.4

Q ss_pred             ceecccccceEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEE
Q 042902          434 NLIGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.+..|-...+|++...+        ++.+++|+....... .-+-.+|.++++.+. +.-..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            567778888999998763        578999987543221 112245777777664 333456665432    378999


Q ss_pred             ccCCCCh
Q 042902          505 YMPHGSL  511 (599)
Q Consensus       505 ~~~~g~L  511 (599)
                      |++|.++
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.25  E-value=0.092  Score=53.76  Aligned_cols=29  Identities=28%  Similarity=0.400  Sum_probs=24.7

Q ss_pred             CeEEccCCCCCeee------cCCCcEEEccccCCc
Q 042902          548 PIIHCDLKPNNVLL------DDNMVAHLSDFGMAK  576 (599)
Q Consensus       548 ~iiH~dlk~~Nill------~~~~~~kl~DFGla~  576 (599)
                      .++|+|+.+.||++      +++..++++||-.|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35799999999999      345679999999886

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.26  E-value=0.36  Score=31.53  Aligned_cols=22  Identities=18%  Similarity=0.262  Sum_probs=8.2

Q ss_pred             ehhhhhHHHHHHHHHHhhhhhh
Q 042902          377 IVLPLSTIFMMAVILLILRYRK  398 (599)
Q Consensus       377 ~~i~~~~~~~~~~~~~~~~~r~  398 (599)
                      ++.++++++++++.++++.+||
T Consensus        17 VVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           17 MVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHHHHhhhh
Confidence            3333433333333333333333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.89  E-value=1.7  Score=39.55  Aligned_cols=89  Identities=8%  Similarity=0.057  Sum_probs=62.7

Q ss_pred             CCCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCee
Q 042902          481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVL  560 (599)
Q Consensus       481 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nil  560 (599)
                      -.||+.+.. ..-.+++...+.|+--+.+-=...++    ..+...+++++..|+....+++   .+  +|--+.|+|++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~---~r--~tf~L~P~NL~  111 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNR---TR--YTFVLAPDELF  111 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGG---SS--EECCCSGGGEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhc---Cc--eEEEEecceEE
Confidence            358888866 45555666555555443221122232    2677889999999999887766   32  68889999999


Q ss_pred             ecCCCcEEEccccCCccCC
Q 042902          561 LDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       561 l~~~~~~kl~DFGla~~~~  579 (599)
                      ++.++.+++.-.|+...+.
T Consensus       112 f~~~~~p~i~~RGik~~l~  130 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVD  130 (215)
T ss_dssp             ECTTSCEEESCCEETTTBS
T ss_pred             EcCCCCEEEEEccCccCCC
Confidence            9999999999999865443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.80  E-value=2.9  Score=38.19  Aligned_cols=87  Identities=10%  Similarity=0.115  Sum_probs=62.3

Q ss_pred             CCCcceeEEEEEEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEEccCCCCCee
Q 042902          482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE-YLHFGYSVPIIHCDLKPNNVL  560 (599)
Q Consensus       482 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~iiH~dlk~~Nil  560 (599)
                      .||++  -...-.+++...+.++--+++-=...++.    .+...+++++..|+.... +++     .-+|--+.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            58887  33344666777776766544333333332    677888999999888877 665     3368889999999


Q ss_pred             ecCCCcEEEccccCCccCC
Q 042902          561 LDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       561 l~~~~~~kl~DFGla~~~~  579 (599)
                      +|.++.+++.-.|+-..+.
T Consensus       117 f~~~~~p~i~hRGi~~~lp  135 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESLP  135 (219)
T ss_dssp             ECTTCCEEESCCEETTTBS
T ss_pred             EeCCCcEEEEEcCCcccCC
Confidence            9999999999999866553

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.56  E-value=0.1  Score=54.51  Aligned_cols=60  Identities=10%  Similarity=0.011  Sum_probs=17.6

Q ss_pred             cCceecccccceEEEEEecC-CcEEEE------EEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 042902          432 ENNLIGRGGVASVYKARIQD-GIEVAV------KVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCS  494 (599)
Q Consensus       432 ~~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  494 (599)
                      ..+.+|   ||.||+|.+.. ..+|||      |..+..  .......|..|..++...+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345566   99999999864 467898      665432  2233457888999999999999999988764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=82.48  E-value=0.6  Score=30.40  Aligned_cols=27  Identities=19%  Similarity=0.394  Sum_probs=12.8

Q ss_pred             eeeehhhhhHHHHHHHHHHhhhhhhcC
Q 042902          374 LLGIVLPLSTIFMMAVILLILRYRKRG  400 (599)
Q Consensus       374 ~~~~~i~~~~~~~~~~~~~~~~~r~r~  400 (599)
                      ++++++++...+++++.++++.+||+.
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            445555544444444444455444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=81.82  E-value=0.67  Score=30.20  Aligned_cols=18  Identities=17%  Similarity=0.322  Sum_probs=6.6

Q ss_pred             hhHHHHHHHHHHhhhhhh
Q 042902          381 LSTIFMMAVILLILRYRK  398 (599)
Q Consensus       381 ~~~~~~~~~~~~~~~~r~  398 (599)
                      ++.++++++..+++++||
T Consensus        20 v~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhhhh
Confidence            333333333333333333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	599
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-25
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-04
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-05
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-18
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-42
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 8/168 (4%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
             IG G   +VYK +     +VAVK+ ++        ++F  E  ++++ RH N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             +     A+V ++    SL   L+      ++ + ++I    A  ++YLH      IIH
Sbjct: 72  YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLK NN+ L +++   + DFG+A    +   S    Q   +I +MAP
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 9e-42
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 20/199 (10%)

Query: 418 FTHLELFQATNGFSEN---------NLIGRGGVASVYKARI----QDGIEVAVKVFDLQY 464
           FT  +  +A   F++           +IG G    V    +    +  I VA+K     Y
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 465 -EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILD 523
            E   + F  E  +M +  H N+I +    +      ++ E+M +GSL+  L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 524 IFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ 583
           + Q + ++  +A+ ++YL     +  +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 584 SLTQTQTL---ATIGYMAP 599
             T T  L     I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 7/171 (4%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
                 +G G    V+        +VAVK           +F  E ++MK+++H+ L+++
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL 73

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSVP 548
            +  + +    ++ EYM +GSL   L + + I L I + L++   +A  + ++       
Sbjct: 74  YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            IH DL+  N+L+ D +   ++DFG+A+ L+++++   +      I + AP
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 2e-39
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 6/167 (3%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
             +G G    VYKA+  +  +  A KV D + E   + + +E D++    H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
              ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           DLK  N+L   +    L+DFG++    +  Q         T  +MAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-39
 Identities = 41/181 (22%), Positives = 81/181 (44%), Gaps = 11/181 (6%)

Query: 421 LELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKS-FDIECDMM 478
           +EL    + F + + +G G    V+K      G+ +A K+  L+ + A ++    E  ++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 479 KRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
                  ++    +  +D   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
            YL   +   I+H D+KP+N+L++      L DFG++  L+           + T  YM+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171

Query: 599 P 599
           P
Sbjct: 172 P 172

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 5e-39
 Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 10/184 (5%)

Query: 422 ELFQATNGFS-ENNLIGRGGVASVYKARIQ---DGIEVAVKVFDLQY-EGAFKSFDIECD 476
           +LF   +     +  +G G   SV +   +     I+VA+KV      +   +    E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 477 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVAS 536
           +M ++ +  ++++I  C  +    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 537 ALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIG 595
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 596 YMAP 599
           + AP
Sbjct: 178 WYAP 181

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 8e-39
 Identities = 39/170 (22%), Positives = 72/170 (42%), Gaps = 5/170 (2%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
            +    +G G    V   + +   +VA+K+           F  E  +M  + H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
              C+      ++ EYM +G L   L    +     Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  P
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPP 170

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 14/174 (8%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL---QYEGAFKSFDIECDMMKRIRHRN 485
           FS+   IG G   +VY AR +++   VA+K       Q    ++    E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            I+       +    LV+EY    + +         L   +   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S  +IH D+K  N+LL +  +  L DFG A  +            + T  +MAP
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAP 180

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 41/171 (23%), Positives = 80/171 (46%), Gaps = 7/171 (4%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
                 +G+G    V+         VA+K          ++F  E  +MK++RH  L+++
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQL 77

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIF-QRLNIMIDVASALEYLHFGYSVP 548
            +  S +    +V EYM  GSL   L           Q +++   +AS + Y+     + 
Sbjct: 78  YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            +H DL+  N+L+ +N+V  ++DFG+A+ L+++++   +      I + AP
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 183

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 5/170 (2%)

Query: 430 FSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI 489
            +    IG G    V+     +  +VA+K          + F  E ++M ++ H  L+++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
              C       LV E+M HG L   L +   +      L + +DV   + YL       +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +P
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASP 171

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-37
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 10/176 (5%)

Query: 430 FSEN----NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRH 483
           F E+      +G G    V  A        VAVK+ D++      ++   E  + K + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N++K        + + L LEY   G L   +   +  +           + + + YLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 7/172 (4%)

Query: 430 FSENNLIGRGGVASVYKARIQD-GIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
            +  + +G G    VY+   +   + VAVK          + F  E  +MK I+H NL++
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSV 547
           ++  C+ +    ++ E+M +G+L   L   N   +     L +   ++SA+EYL      
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 11/174 (6%)

Query: 432 ENNLIGRGGVASVYKARIQD---GIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNL 486
           E+  +G G   +V K   Q       VAVK+   +            E ++M+++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +++I  C  + +  LV+E    G L K L  + + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
              +H DL   NVLL     A +SDFG++K L  ++            + + AP
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 33/195 (16%)

Query: 435 LIGRGGVASVYKA------RIQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNL 486
           ++G G    V  A      +    I+VAVK+   +      ++   E  MM ++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSN----------------------YILDI 524
           + ++ +C+      L+ EY  +G L   L S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
              L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 585 LTQTQTLATIGYMAP 599
           + +      + +MAP
Sbjct: 221 VVRGNARLPVKWMAP 235

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 10/177 (5%)

Query: 430 FSENNLIGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRH 483
            +   +IG G    VYK  ++       + VA+K     Y E     F  E  +M +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
            N+I++    S      ++ EYM +G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE-DQSLTQTQTLATIGYMAP 599
             ++  +H DL   N+L++ N+V  +SDFG+++ L  + + + T +     I + AP
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-35
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 8/174 (4%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRN 485
           F    ++G G  ++V  AR +    E A+K+ + ++   E        E D+M R+ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
            +K+  +  +D+     L Y  +G L K +       D         ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH--- 125

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
              IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
             IG+G    V       G +VAVK   ++ +   ++F  E  +M ++RH NL++++   
Sbjct: 13  QTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 494 SNDDFK-ALVLEYMPHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
             +     +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 169

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-35
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFD---LQYEGAFKSFDIECDMMKRIRHRNLIKI 489
             +G+G   +VY AR  Q    +A+KV     L+  G       E ++   +RH N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
                +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  +
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 173

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  133 bits (336), Expect = 4e-35
 Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 9/168 (5%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            +G G    V++      G   A K     +E   ++   E   M  +RH  L+ +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +D+   ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 554 LKPNNVLL--DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           LKP N++     +    L DFG+   L  +      T T     + AP
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 5e-35
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 12/176 (6%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKII 490
             IG G      K R   DG  +  K  D     E   +    E ++++ ++H N+++  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 491 SSC--SNDDFKALVLEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLH--F 543
                  +    +V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                ++H DLKP NV LD      L DFG+A+ +L  D S  +     T  YM+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFV-GTPYYMSP 183

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-35
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 15/175 (8%)

Query: 436 IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN 495
           IG+G    V++ +   G EVAVK+F  + E ++   + E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 496 DDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH-----FGYS 546
           D+       LV +Y  HGSL   L  + Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT--QTQTLATIGYMAP 599
             I H DLK  N+L+  N    ++D G+A        ++       + T  YMAP
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-35
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 8/167 (4%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISS 492
             IG+G   +VY A  +  G EVA++  +LQ +   +    E  +M+  ++ N++  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHC 552
               D   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH   S  +IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 553 DLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           D+K +N+LL  +    L+DFG    +  E    +      T  +MAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAP 185

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 3e-34
 Identities = 47/202 (23%), Positives = 77/202 (38%), Gaps = 33/202 (16%)

Query: 428 NGFSENNLIGRGGVASVYKAR------IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKR 480
           N       IG G    V++AR       +    VAVK+   +        F  E  +M  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNY-------------------- 520
             + N++K++  C+      L+ EYM +G L + L S +                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 521 ---ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP 577
               L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 578 LLKEDQSLTQTQTLATIGYMAP 599
           +   D           I +M P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPP 211

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 9/168 (5%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            +G G    V++      G     K  +  Y     +   E  +M ++ H  LI +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            +     L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 554 LKPNNVLLD--DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +KP N++ +        + DFG+A  L   +       T AT  + AP
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAP 197

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-34
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 14/175 (8%)

Query: 433 NNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKI 489
           +  IGRG   +VYK    +  +EVA      +   +   + F  E +M+K ++H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 490 ISSC----SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             S            LV E M  G+L+  L     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 546 SVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           + PIIH DLK +N+ +        + D G+A        S  +   + T  +MAP
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAP 182

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 39/195 (20%), Positives = 73/195 (37%), Gaps = 28/195 (14%)

Query: 430 FSENNLIGRGGVASVYKARI------QDGIEVAVKVFDL-QYEGAFKSFDIECDMMKRI- 481
            S    +G G    V +A           + VAVK+     +    ++   E  ++  + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 482 RHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSS-----------------NYILDI 524
            H N++ ++ +C+      ++ EY  +G L   L                       LD+
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
              L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 585 LTQTQTLATIGYMAP 599
           + +      + +MAP
Sbjct: 202 VVKGNARLPVKWMAP 216

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-33
 Identities = 43/185 (23%), Positives = 78/185 (42%), Gaps = 11/185 (5%)

Query: 421 LELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKV-----FDLQYEGAFKSFDIE 474
           L + + T  F +  ++G G   +VYK   I +G +V + V      +     A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 475 CDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
             +M  + + ++ +++  C     + L+ + MP G L   +      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 595 GYMAP 599
            +MA 
Sbjct: 178 KWMAL 182

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 9e-33
 Identities = 44/172 (25%), Positives = 64/172 (37%), Gaps = 12/172 (6%)

Query: 436 IGRGGVASVYKARI----QDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIK 488
           +G G    V +          + VAVK           A   F  E + M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 489 IISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP 548
           +         K +V E  P GSL   L        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 549 IIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGYMAP 599
            IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-32
 Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 10/169 (5%)

Query: 435 LIGRGGVASVYKARI----QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKI 489
            IG G    V++          + VA+K       +   + F  E   M++  H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
           I   + ++   +++E    G L   L    Y LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H D+   NVL+  N    L DFG+++  +++      ++    I +MA
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMA 177

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-32
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 11/175 (6%)

Query: 433 NNLIGRGGVASVYKARIQD----GIEVAVKVFD-LQYEGAFKSFDIECDMMKRIRHRNLI 487
           N +IGRG    VY   + D     I  AVK  + +   G    F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 488 KIISSCSNDDFKA-LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            ++  C   +    +VL YM HG L   + +  +   +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 149

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED--QSLTQTQTLATIGYMAP 599
              +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-32
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 26/192 (13%)

Query: 428 NGFSENNLIGRGGVASVYKARIQDG---IEVAVKVFDLQY-EGAFKSFDIECDMMKRI-R 482
           N     ++IG G    V KARI+     ++ A+K       +   + F  E +++ ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------------LDIFQR 527
           H N+I ++ +C +  +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 528 LNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ 587
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 588 TQTLATIGYMAP 599
           T     + +MA 
Sbjct: 184 TMGRLPVRWMAI 195

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 5e-31
 Identities = 33/186 (17%), Positives = 75/186 (40%), Gaps = 19/186 (10%)

Query: 430 FSENNLIGRGGVASVYKA------RIQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR 482
            + +  +G+G    VY+       + +    VA+K  +          F  E  +MK   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 483 HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYI---------LDIFQRLNIMID 533
             ++++++   S      +++E M  G L+  L S               + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 534 VASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLAT 593
           +A  + YL+   +   +H DL   N ++ ++    + DFGM + + + D      + L  
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 594 IGYMAP 599
           + +M+P
Sbjct: 199 VRWMSP 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  119 bits (300), Expect = 6e-31
 Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 13/174 (7%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKII 490
           ++G GG++ V+ AR ++   +VAVKV           +  F  E      + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 491 SSCSNDDFKA----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
            +   +        +V+EY+   +L   +++    +   + + ++ D   AL + H    
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLA-TIGYMAP 599
             IIH D+KP N+++       + DFG+A+ +     S+TQT  +  T  Y++P
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 15/178 (8%)

Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDL------QYEGAFKSFDIECDMMKR 480
           N FS + +IGRGG   VY  R    G   A+K  D       Q E    +  I   ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 481 IRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEY 540
                ++ +  +    D  + +L+ M  G L   L S + +           ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 541 LHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           +H   +  +++ DLKP N+LLD++    +SD G+A    K+        ++ T GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMA 173

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (295), Expect = 6e-30
 Identities = 37/168 (22%), Positives = 70/168 (41%), Gaps = 6/168 (3%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +++G G  + V  A   +    VA+K    +  EG   S + E  ++ +I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
              +     L+++ +  G L   +    +         ++  V  A++YLH    V    
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
                    LD++    +SDFG++K    ED     +    T GY+AP
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 178

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 22/185 (11%)

Query: 430 FSEN----NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDI---------EC 475
           F EN     ++GRG  + V +        E AVK+ D+   G+F + ++         E 
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 476 DMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDV 534
           D+++++  H N+I++  +   + F  LV + M  G L   L +    L   +   IM  +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119

Query: 535 ASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATI 594
              +  LH    + I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173

Query: 595 GYMAP 599
            Y+AP
Sbjct: 174 SYLAP 178

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 12/172 (6%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY-----EGAFKSFDIECDMMKRIRHRNLI 487
           + +G G  A+VYKAR       VA+K   L +     +G  ++   E  +++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            ++ +  +    +LV ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 548 PIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I+H DLKPNN+LLD+N V  L+DFG+AK       +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-29
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 8/183 (4%)

Query: 422 ELFQATNGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFD-LQYEGAFKSFDIECDMMK 479
           ++F     ++  + IG G    V  A    + + VA+K     +++   +    E  ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 480 RIRHRNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYS--SNYILDIFQRLNIMIDVASA 537
           R RH N+I I         + +   Y+    +   LY       L        +  +   
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 538 LEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK-EDQSLTQTQTLATIGY 596
           L+Y+H   S  ++H DLKP+N+LL+      + DFG+A+      D +   T+ +AT  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 597 MAP 599
            AP
Sbjct: 179 RAP 181

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 13/170 (7%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKI 489
             +G G    V+  R   +G   A+KV   +        +  + E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 490 ISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
             +  +     ++++Y+  G L   L  S              +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 550 IHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           I+ DLKP N+LLD N    ++DFG AK +     +L       T  Y+AP
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAP 170

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 9e-29
 Identities = 30/159 (18%), Positives = 66/159 (41%), Gaps = 7/159 (4%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            +GRG    V++            K   ++          E  ++   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
            + +   ++ E++    + + + +S + L+  + ++ +  V  AL++LH   S  I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 554 LKPNNVLLD--DNMVAHLSDFGMAKPLLKEDQSLTQTQT 590
           ++P N++     +    + +FG A+ L   D        
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  113 bits (284), Expect = 1e-28
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 8/168 (4%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDL--QYEGAFKSFDIECDMMKRIRHRNLIKIIS 491
             IG G    VYKA+   G   A+K   L  + EG   +   E  ++K ++H N++K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
                    LV E++    L+K L      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAP 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 28/191 (14%)

Query: 434 NLIGRGGVASVYKAR--------IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RH 483
             +G G    V  A              +VAVK+      E        E +MMK I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCL---------------YSSNYILDIFQRL 528
           +N+I ++ +C+ D    +++EY   G+L + L               ++    L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 529 NIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQT 588
           +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 589 QTLATIGYMAP 599
                + +MAP
Sbjct: 196 NGRLPVKWMAP 206

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 8/173 (4%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKSFDIECDMMKRIRHRNL 486
           F +   IG G    VYKAR    G  VA+K    D + EG   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 487 IKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS 546
           +K++     ++   LV E++     +    S+   + +    + +  +   L + H   S
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120

Query: 547 VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-27
 Identities = 39/194 (20%), Positives = 69/194 (35%), Gaps = 27/194 (13%)

Query: 430 FSENNLIGRGGVASVYKAR------IQDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIR 482
                 +GRG    V +A             VAVK+          ++   E  ++  I 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 483 HRNLIKII--SSCSNDDFKALVLEYMPHGSLEKCLYSSNY---------------ILDIF 525
           H   +  +  +         +++E+   G+L   L S                   L + 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 526 QRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL 585
             +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + K+   +
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 586 TQTQTLATIGYMAP 599
            +      + +MAP
Sbjct: 192 RKGDARLPLKWMAP 205

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-27
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 20/180 (11%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIK 488
           +++  +IG G    VY+A+    G  VA+K          +  + E  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 489 IISSC------SNDDFKALVLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEY 540
           +           ++ +  LVL+Y+P        +   +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 541 LHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H   S  I H D+KP N+LLD D  V  L DFG AK L++ + +++    + +  Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 6e-27
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 11/175 (6%)

Query: 430 FSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECD-MMKRIRHR 484
           F  + ++G+G    V+ A   +     A+K         +   +   +E   +     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
            L  +  +    +    V+EY+  G L   + S +   D+ +      ++   L++LH  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            S  I++ DLK +N+LLD +    ++DFGM K  +  D          T  Y+AP
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAP 172

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 21/175 (12%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISS 492
           ++G G    V +    +   + A+K+              E ++  R  +  ++++I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 493 C----SNDDFKALVLEYMPHGSLEKCLYS-SNYILDIFQRLNIMIDVASALEYLHFGYSV 547
                +      +V+E +  G L   +    +      +   IM  +  A++YLH   S+
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 548 PIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I H D+KP N+L      N +  L+DFG AK     +   T      T  Y+AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 5e-26
 Identities = 38/175 (21%), Positives = 64/175 (36%), Gaps = 17/175 (9%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVF------DLQYEGAFKSFDIECDMMKRIR--HRN 485
           L+G GG  SVY    + D + VA+K        D           +E  ++K++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 486 LIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
           +I+++      D   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 546 SVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +  ++H D+K  N+L+D +     L DFG    L    +    T    T  Y  P
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPP 178

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 5e-26
 Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 18/176 (10%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRHRNLI 487
            +G G  A V K R    G++ A K    +         + +  + E  ++K I+H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 488 KIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSV 547
            +     N     L+LE +  G L     +    L   +    +  + + + YLH   S+
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 548 PIIHCDLKPNNVLLDDNMVA----HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            I H DLKP N++L D  V      + DFG+A  +   D          T  ++AP
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 185

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (264), Expect = 6e-26
 Identities = 39/174 (22%), Positives = 66/174 (37%), Gaps = 14/174 (8%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            IG G    +Y    I  G EVA+K+  +  +       IE  + K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
             +    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 554 LKPNNVL---LDDNMVAHLSDFGMAKPL-----LKEDQSLTQTQTLATIGYMAP 599
           +KP+N L        + ++ DFG+AK        +            T  Y + 
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 3e-25
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 9/169 (5%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKII 490
             IG G   +V+KA+  +    VA+K   L    EG   S   E  ++K ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 491 SSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPII 550
               +D    LV E+      +     +  + D     + +  +   L + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 551 HCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPP 170

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 3e-25
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 10/176 (5%)

Query: 428 NGFSENNLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRH 483
           N F    L+G+G    V   R    G   A+K+   +    +        E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 484 RNLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHF 543
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 544 GYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
             S  +++ D+K  N++LD +    ++DFG+ K  + +  ++       T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 8e-25
 Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 17/179 (9%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKII 490
             IG+G    V+KAR  + G +VA+K   ++   EG   +   E  +++ ++H N++ +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 491 SSCSNDDFKA--------LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLH 542
             C               LV ++  H               + +   +M  + + L Y+H
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134

Query: 543 FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL--LKEDQSLTQTQTLATIGYMAP 599
                 I+H D+K  NVL+  + V  L+DFG+A+     K  Q    T  + T+ Y  P
Sbjct: 135 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (253), Expect = 2e-24
 Identities = 65/299 (21%), Positives = 100/299 (33%), Gaps = 32/299 (10%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N  +        N   L  L L  N      P  F  L  L+RL L+ N L    
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFM-FNCNISGSIPEEIS 119
            K+         K L+ L    N +  +       L+Q + V         SG       
Sbjct: 96  EKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
            +  L+ I +    +  +IP  L     L  L L+ N++       L  L  L  L L  
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN 239
           N +S        N   LR L+L +N+L  +P  L + KYI  + L +N+ +         
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA-------- 256

Query: 240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS--IPDSIGGLIDLKSLDL 296
                   +  N+F    P           + L  N +Q     P +   +    ++ L
Sbjct: 257 --------IGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 59/268 (22%), Positives = 102/268 (38%), Gaps = 11/268 (4%)

Query: 75  LKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL 134
              L   NN +  I      NL   +    + N  IS   P   + L  L  +YL  N+L
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 135 NGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLT 194
                     LQ+L++   E  ++  S+ + L ++  + L      K SG     F  + 
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGMK 150

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS 254
            L  + +    +T+IP  L     +  L+L  N  T      +  L  L ++ LS N+ S
Sbjct: 151 KLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208

Query: 255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISG------AIPIS 308
                ++ +   L+ L L  N+L   +P  +     ++ + L NNNIS         P  
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267

Query: 309 LEKLLDLKYINVSFNKLEGEIPREGPFR 336
             K      +++  N ++    +   FR
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.7 bits (221), Expect = 2e-20
 Identities = 51/261 (19%), Positives = 88/261 (33%), Gaps = 5/261 (1%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
            +P+++    +   + L  NK+          L+ L  L L +N++    P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 173 FLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGP 232
             L L  N+L          L  LR       ++        N   ++ L  +    +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLK 292
                  ++ L  I ++  N +       G    L  L L+ N++      S+ GL +L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 293 SLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGT 352
            L LS N+IS     SL     L+ ++++ NKL          +         N +    
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258

Query: 353 PNLQVPPCRTRIHHTSRKNDL 373
            N   PP       +     L
Sbjct: 259 SNDFCPPGYNTKKASYSGVSL 279

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.6 bits (213), Expect = 3e-19
 Identities = 53/232 (22%), Positives = 84/232 (36%), Gaps = 6/232 (2%)

Query: 123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKL 182
           +L  +      L   +P  L       LL L++N++      D   L  L  L L  NK+
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 183 SGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV 242
           S   P  F  L  L  LYL  NQL  +P  +      L ++ +  +          N  +
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS 302
           +V++  +    SG        +K L Y+ +    +  +IP  +     L  L L  N I+
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184

Query: 303 GAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPN 354
                SL+ L +L  + +SFN +               E    N  L   P 
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 13/168 (7%)

Query: 436 IGRGGVASVYKAR-IQDGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIIS 491
           +G G    V   +  + G   A+K+ D Q        +    E  +++ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 492 SCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIH 551
           S  ++    +V+EY+  G +   L                  +    EYLH   S+ +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164

Query: 552 CDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
            DLKP N+L+D      ++DFG AK +     +L       T   +AP
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAP 207

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 5e-24
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 18/178 (10%)

Query: 434 NLIGRGGVASVYKAR--IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNL 486
             IG G    V+KAR     G  VA+K   +Q   EG   S   E  +++ +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 487 IKIISSCSNDDFKA-----LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYL 541
           +++   C+           LV E++               +      ++M  +   L++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 542 HFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           H   S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T+ Y AP
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 184

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 99.9 bits (248), Expect = 7e-24
 Identities = 30/176 (17%), Positives = 66/176 (37%), Gaps = 16/176 (9%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            IG G    +++   + +  +VA+K    + +        E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 494 SNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCD 553
             +    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 554 LKPNNVLLDDNMVAH-----LSDFGMAK----PLLKEDQSLTQTQTLA-TIGYMAP 599
           +KP+N L+      +     + DFGM K    P+ K+     + + L+ T  YM+ 
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 5e-23
 Identities = 43/195 (22%), Positives = 78/195 (40%), Gaps = 24/195 (12%)

Query: 418 FTHLELFQATNGFSEN----NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKS 470
           F   E+ +              +G G   +V  A   + G +VA+K     +  E   K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 471 FDIECDMMKRIRHRNLIKIISSCSNDDFKA------LVLEYMPHGSLEKCLYSSNYILDI 524
              E  ++K +RH N+I ++   + D+         LV+ +M     +      +  L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120

Query: 525 FQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS 584
            +   ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A+        
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----D 172

Query: 585 LTQTQTLATIGYMAP 599
              T  + T  Y AP
Sbjct: 173 SEMTGYVVTRWYRAP 187

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.4 bits (239), Expect = 2e-22
 Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 18/171 (10%)

Query: 434 NLIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIIS 491
             +GRG  + V++A  I +  +V VK+     +   K    E  +++ +R   N+I +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 97

Query: 492 SCSNDDFK--ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPI 549
              +   +  ALV E++ +   ++   +    L  +     M ++  AL+Y H   S+ I
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150

Query: 550 IHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           +H D+KP+NV++D ++    L D+G+A+              +A+  +  P
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGP 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.5 bits (236), Expect = 8e-22
 Identities = 77/333 (23%), Positives = 123/333 (36%), Gaps = 30/333 (9%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           +    N  +   P  + N +KL  + +  N      P           L  N        
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 61  PK----------LNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNI 110
                        N +S +S    L  L   +        + + NL+    +    N   
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 111 SGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLA 170
                  ++ LTNL ++    N+++   P+ +     L  LSL  NQL+      L  L 
Sbjct: 189 ---DISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLT 241

Query: 171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT 230
            L  LDL  N++S   P     LT L  L LG+NQ+++I   L  L  +  L L+ N   
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLE 298

Query: 231 GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID 290
              P  I NL+ L  + L  NN S   P  +  L  LQ LF   N++      S+  L +
Sbjct: 299 DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352

Query: 291 LKSLDLSNNNISGAIPISLEKLLDLKYINVSFN 323
           +  L   +N IS   P++   L  +  + ++  
Sbjct: 353 INWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 1e-06
 Identities = 55/306 (17%), Positives = 93/306 (30%), Gaps = 56/306 (18%)

Query: 42  NLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME 101
            L    +  L    +T          S ++   +  L      +  I             
Sbjct: 20  ALAEKMKTVLGKTNVTD-------TVSQTDLDQVTTLQADRLGIKSI------------- 59

Query: 102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIA-LDKLQKLQLLSLEDNQLEG 160
                         + +  L NLT I    N+L    P+  L KL  + + + +   +  
Sbjct: 60  --------------DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP 105

Query: 161 SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNL-------------YLGSNQLT 207
                      LF   +        +        S   +              L      
Sbjct: 106 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 165

Query: 208 SIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDL 267
           +    L NL  +  L++SSN  +      +  L  L  +  + N  S   P  I    +L
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGIL--TNL 221

Query: 268 QYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEG 327
             L L  N+L+     ++  L +L  LDL+NN IS   P+S   L  L  + +  N++  
Sbjct: 222 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 277

Query: 328 EIPREG 333
             P  G
Sbjct: 278 ISPLAG 283

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 23/92 (25%), Positives = 34/92 (36%), Gaps = 7/92 (7%)

Query: 162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILY 221
             D    LA      LG   ++  V     +L  +  L      + SI   +  L  +  
Sbjct: 16  FTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG-VEYLNNLTQ 70

Query: 222 LNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF 253
           +N S+N  T   PL   NL  LV I ++ N  
Sbjct: 71  INFSNNQLTDITPL--KNLTKLVDILMNNNQI 100

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 18/84 (21%), Positives = 33/84 (39%), Gaps = 7/84 (8%)

Query: 143 DKLQKLQLLSLEDNQLEGSIP-DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL 201
             L +     L    +  ++   DL ++  L    LG   + G        L +L  +  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINF 73

Query: 202 GSNQLTSIPSTLWNLKYILYLNLS 225
            +NQLT I   L NL  ++ + ++
Sbjct: 74  SNNQLTDITP-LKNLTKLVDILMN 96

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 1e-21
 Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 14/174 (8%)

Query: 434 NLIGRGGVASVYKAR----IQDGIEVAVKVFD----LQYEGAFKSFDIECDMMKRIRHR- 484
            ++G G    V+  R       G   A+KV      +Q     +    E  +++ IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 485 NLIKIISSCSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG 544
            L+ +  +   +    L+L+Y+  G L   L         F    + I V   +  L   
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 545 YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMA 598
           + + II+ D+K  N+LLD N    L+DFG++K  + ++          TI YMA
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.0 bits (224), Expect = 7e-21
 Identities = 51/254 (20%), Positives = 88/254 (34%), Gaps = 5/254 (1%)

Query: 75  LKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKL 134
            + +    N +  +   +         ++   N                         +L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 135 NGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLT 194
               P     L +L  L L+   L+   P     LAAL  L L  N L       F +L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 195 SLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF 253
           +L +L+L  N+++S+P      L  +  L L  N      P    +L  L+ + L  NN 
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
           S      +  L+ LQYL L  N        +      L+    S++ +  ++P   ++L 
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRLA 269

Query: 314 DLKYINVSFNKLEG 327
                 ++ N L+G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (208), Expect = 9e-19
 Identities = 52/255 (20%), Positives = 84/255 (32%), Gaps = 8/255 (3%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           + L GN  S    +       L+ L L  N         F  L  L++L L+ N    S 
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISN 120
               F         L  L          L   +     +++  ++ +  +     +   +
Sbjct: 97  DPATF----HGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 121 LTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN 180
           L NLT ++L GN+++     A   L  L  L L  N++    P     L  L  L L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNL 240
            LS         L +L+ L L  N             ++     SS+     LP  +   
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271

Query: 241 RVLVQIDLSMNNFSG 255
            +     L+ N+  G
Sbjct: 272 DLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (177), Expect = 8e-15
 Identities = 60/251 (23%), Positives = 89/251 (35%), Gaps = 6/251 (2%)

Query: 107 NCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD 164
           +C   G  ++P  I        I+L GN+++     +    + L +L L  N L      
Sbjct: 17  SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 165 DLCRLAALFLLDLGGNKLSGFV-PACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYL- 222
               LA L  LDL  N     V PA F  L  L  L+L    L  +   L+     L   
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 223 NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP 282
            L  N+          +L  L  + L  N  S         L  L  L L  NR+    P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 283 DSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAES 342
            +   L  L +L L  NN+S     +L  L  L+Y+ ++ N    +      +       
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 343 FKGNELLCGTP 353
              +E+ C  P
Sbjct: 255 GSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 3e-05
 Identities = 28/145 (19%), Positives = 44/145 (30%), Gaps = 3/145 (2%)

Query: 187 PACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQI 246
            AC                L ++P  +        + L  N  +          R L  +
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 247 DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI-PDSIGGLIDLKSLDLSNNNISGAI 305
            L  N  +         L  L+ L L  N    S+ P +  GL  L +L L    +    
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 306 PISLEKLLDLKYINVSFNKLEGEIP 330
           P     L  L+Y+ +  N L+    
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPD 146

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 7e-21
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 19/174 (10%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIIS 491
            IG G    V  A        VA+K     +  +   K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 492 SCSNDDFK------ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY 545
             +            LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 546 SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP 599
           S  IIH DLKP+N+++  +    + DFG+A+       S   T  + T  Y AP
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 91.4 bits (225), Expect = 9e-21
 Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 29/296 (9%)

Query: 67  SSLSNCKYLKYLSFSNNSLDGI--LPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNL 124
            + +    +  L  S  +L     +P ++ NL     ++     N+ G IP  I+ LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSG 184
             +Y+    ++G+IP  L +++ L  L    N L G++P  +  L  L  +   GN++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 185 FVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLV 244
            +P  +G+ + L      S    +           L     S +        +       
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 245 QIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGA 304
           Q      N   F    +G  K+L  L L  NR+ G++P  +  L  L SL++S NN+   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-- 281

Query: 305 IPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPC 360
                                 GEIP+ G  + F   ++  N+ LCG+P   +P C
Sbjct: 282 ----------------------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.9 bits (172), Expect = 6e-14
 Identities = 57/267 (21%), Positives = 102/267 (38%), Gaps = 8/267 (2%)

Query: 18  NASKLSRLELEMNSFYGF--IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYL 75
              +++ L+L   +      IP++  NL  L  L +                +++    L
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG----PIPPAIAKLTQL 103

Query: 76  KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN 135
            YL  ++ +          +  +++         +SG++P  IS+L NL  I   GN+++
Sbjct: 104 HYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 136 GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTS 195
           G+IP +     KL                       L  +DL  N L G     FG+  +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 196 LRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG 255
            + ++L  N L      +   K +  L+L +N   G LP  +  L+ L  +++S NN  G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282

Query: 256 FIPTTIGDLKDLQYLFLEYNRLQGSIP 282
            IP   G+L+         N+     P
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 5e-11
 Identities = 59/261 (22%), Positives = 90/261 (34%), Gaps = 32/261 (12%)

Query: 1   LLLWGNNFSG--TIPSFIFNASKLSRLELEMN-SFYGFIPNTFGNLRNLKRLSLNYNYLT 57
           L L G N      IPS + N   L+ L +    +  G IP     L  L  L + +  ++
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 58  SSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEE 117
            + P           K L  L FS N+L G LP +I +L   +         ISG+IP+ 
Sbjct: 115 GAIPDFLS-----QIKTLVTLDFSYNALSGTLPPSISSLPN-LVGITFDGNRISGAIPDS 168

Query: 118 ISNLTNLTT-IYLGGNKLNGSIPIALDKLQKLQLLSLED--------------------- 155
             + + L T + +  N+L G IP     L    +    +                     
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228

Query: 156 -NQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLW 214
                      +     L  LDL  N++ G +P     L  L +L +  N L        
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288

Query: 215 NLKYILYLNLSSNSFTGPLPL 235
           NL+       ++N      PL
Sbjct: 289 NLQRFDVSAYANNKCLCGSPL 309

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 2e-20
 Identities = 24/159 (15%), Positives = 53/159 (33%), Gaps = 26/159 (16%)

Query: 434 NLIGRGGVASVYKARIQDGIEVAVKVFDL----------QYEGAFKSFDIECDMMKRIRH 483
            L+G G  ++V+    +   E  VK   +          + +     F +      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 484 RNLIKIISSCSNDDF----KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALE 539
           R L K+        +     A+++E +    L +          +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 540 YLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL 578
             +      I+H DL   NVL+ +  +  + DF  +  +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 9e-20
 Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 20/193 (10%)

Query: 418 FTHLELFQATNGFSEN----NLIGRGGVASVYKAR-IQDGIEVAVKVF--DLQYEGAFKS 470
           F   EL +      E     + +G G   SV  A   + G+ VAVK      Q     K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 471 FDIECDMMKRIRHRNLIKIISSCSND----DFKALVLEYMPHGSLEKCLYSSNYILDIFQ 526
              E  ++K ++H N+I ++   +      +F  + L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 527 RLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT 586
              ++  +   L+Y+H   S  IIH DLKP+N+ ++++    + DFG+A+          
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDE 174

Query: 587 QTQTLATIGYMAP 599
            T  +AT  Y AP
Sbjct: 175 MTGYVATRWYRAP 187

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.2 bits (204), Expect = 7e-18
 Identities = 35/182 (19%), Positives = 71/182 (39%), Gaps = 20/182 (10%)

Query: 435 LIGRGGVASVYKAR-IQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSC 493
            +G G  ++V+ A+ + +   VA+K+     +   ++ + E  +++R+   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 494 SNDDFK---------------ALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASAL 538
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 539 EYLHFGYSVPIIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYM 597
           +Y+H      IIH D+KP NVL++  +   +L    +A            T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 598 AP 599
           +P
Sbjct: 197 SP 198

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.3 bits (160), Expect = 1e-12
 Identities = 49/209 (23%), Positives = 75/209 (35%), Gaps = 6/209 (2%)

Query: 117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
           E+S + +   +      L  ++P  L K     +L L +N L       L     L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLE 236
           L   +         G L  L  L L  NQL S+P     L  +  L++S N  T      
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 237 IGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDL 296
           +  L  L ++ L  N      P  +     L+ L L  N L       + GL +L +L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 297 SNNNISGAIPISLEKLLDLKYINVSFNKL 325
             N++   IP        L +  +  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (141), Expect = 3e-10
 Identities = 35/186 (18%), Positives = 65/186 (34%), Gaps = 9/186 (4%)

Query: 44  RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVF 103
           ++   L L+ N L + +      ++L     L  L+     L  +       +  ++++ 
Sbjct: 31  KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS 85

Query: 104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP 163
                ++        +      +      +L      AL  L +LQ L L+ N+L+   P
Sbjct: 86  HNQLQSLPLLGQTLPALTVLDVSFN----RLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLN 223
             L     L  L L  N L+         L +L  L L  N L +IP   +    + +  
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201

Query: 224 LSSNSF 229
           L  N +
Sbjct: 202 LHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 4e-09
 Identities = 39/211 (18%), Positives = 64/211 (30%), Gaps = 7/211 (3%)

Query: 68  SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTI 127
            +S       ++    +L  + P    +L +   +  +    +       +   T LT +
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPP----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 128 YLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVP 187
            L   +L          L  L  L L  NQL+          A   L        S  + 
Sbjct: 61  NLDRAELTKLQVD--GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 188 ACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQID 247
           A  G          G+   T  P  L     +  L+L++N+ T      +  L  L  + 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 248 LSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           L  N+    IP        L + FL  N   
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 5e-09
 Identities = 43/196 (21%), Positives = 63/196 (32%), Gaps = 12/196 (6%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            +P  +      + L L  N  Y F   T      L +L+L+     +       L  L 
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD-RAELTKLQVDGTLPVLG 80

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
                     S           +G    ++ V  +    ++      +  L  L  +YL 
Sbjct: 81  TLDLSHNQLQSLPL--------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132

Query: 131 GNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACF 190
           GN+L    P  L    KL+ LSL +N L       L  L  L  L L  N L   +P  F
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

Query: 191 GNLTSLRNLYLGSNQL 206
                L   +L  N  
Sbjct: 192 FGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 7e-04
 Identities = 17/83 (20%), Positives = 22/83 (26%), Gaps = 6/83 (7%)

Query: 4   WGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL 63
            GN      P  +    KL +L L  N+           L NL  L L  N L +     
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT----- 186

Query: 64  NFLSSLSNCKYLKYLSFSNNSLD 86
                      L +     N   
Sbjct: 187 -IPKGFFGSHLLPFAFLHGNPWL 208

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.7 bits (140), Expect = 8e-10
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 8/89 (8%)

Query: 180 NKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGN 239
           N  S  + +      SL  L + +N+L  +P+    L+    L  S N     +P    N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQN 325

Query: 240 LRVLVQIDLSMNNFSGFIPTTIGDLKDLQ 268
           L+ L    +  N      P     ++DL+
Sbjct: 326 LKQL---HVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 1e-06
 Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 9/98 (9%)

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLE 159
           +     +    S  I        +L  + +  NKL   +P    +L++   L    N L 
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA 317

Query: 160 GSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
             +P+    L     L +  N L  F P    ++  LR
Sbjct: 318 -EVPELPQNLK---QLHVEYNPLREF-PDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 4e-06
 Identities = 19/103 (18%), Positives = 36/103 (34%), Gaps = 9/103 (8%)

Query: 214 WNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE 273
             L  +       N+ +  +         L ++++S N     +P     L   + L   
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIAS 312

Query: 274 YNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLK 316
           +N L   +P+    L   K L +  N +    P   E + DL+
Sbjct: 313 FNHLA-EVPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 10/80 (12%)

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
               L+ L+ SNN L  + P     L    E       +++  +PE   NL  L   ++ 
Sbjct: 282 LPPSLEELNVSNNKLIEL-PALPPRL----ERLIASFNHLA-EVPELPQNLKQL---HVE 332

Query: 131 GNKLNGSIPIALDKLQKLQL 150
            N L    P   + ++ L++
Sbjct: 333 YNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 2e-05
 Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 9/83 (10%)

Query: 248 LSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPI 307
             +N  S  I +       L+ L +  N+L   +P     L   + L  S N+++  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPE 321

Query: 308 SLEKLLDLKYINVSFNKLEGEIP 330
             + L   K ++V +N L  E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 19/69 (27%), Positives = 28/69 (40%), Gaps = 4/69 (5%)

Query: 167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS 226
           C       L+L    LS  +P    +L SL       N LT +P    +LK +L  N + 
Sbjct: 35  CLDRQAHELELNNLGLSS-LPELPPHLESL---VASCNSLTELPELPQSLKSLLVDNNNL 90

Query: 227 NSFTGPLPL 235
            + +   PL
Sbjct: 91  KALSDLPPL 99

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (123), Expect = 8e-09
 Identities = 29/108 (26%), Positives = 41/108 (37%), Gaps = 5/108 (4%)

Query: 197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF 256
           R L+L    LT +   L  L  + +L+LS N      P  +  LR L  +  S N     
Sbjct: 1   RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 257 IPTTIGDLKDLQYLFLEYNRLQG-SIPDSIGGLIDLKSLDLSNNNISG 303
                     LQ L L  NRLQ  +    +     L  L+L  N++  
Sbjct: 59  DGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 23/118 (19%), Positives = 39/118 (33%), Gaps = 6/118 (5%)

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP 234
           L L    L+  V      L  + +L L  N+L ++P  L  L+ +  L  S N+      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 235 LEIGNLRVLVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDL 291
           +         ++ L  N          +     L  L L+ N L          L ++
Sbjct: 61  VANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.6 bits (115), Expect = 1e-07
 Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 4/109 (3%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAAL 172
           ++   +  L  +T + L  N+L    P AL  L+ L++L   DN       D +  L  L
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGVANLPRL 67

Query: 173 FLLDLGGNKLSGF-VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYIL 220
             L L  N+L          +   L  L L  N L         L  +L
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 2e-05
 Identities = 27/109 (24%), Positives = 43/109 (39%), Gaps = 6/109 (5%)

Query: 221 YLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGS 280
            L+L+    T    L    L ++  +DLS N      P  +  L+ L+ L  + +     
Sbjct: 2   VLHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALE 56

Query: 281 IPDSIGGLIDLKSLDLSNNNISGAIPI-SLEKLLDLKYINVSFNKLEGE 328
             D +  L  L+ L L NN +  +  I  L     L  +N+  N L  E
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 5e-05
 Identities = 26/121 (21%), Positives = 43/121 (35%), Gaps = 8/121 (6%)

Query: 126 TIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGF 185
            ++L    L  ++   L++L  +  L L  N+L    P  L  L  L +L    N L   
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 186 VPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL 243
                      + L L +N+L        L +   ++ LNL  NS           L  +
Sbjct: 59  DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

Query: 244 V 244
           +
Sbjct: 116 L 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 6e-05
 Identities = 19/113 (16%), Positives = 35/113 (30%), Gaps = 8/113 (7%)

Query: 40  FGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
              L  +  L L++N L +  P L  L  L   +       + + +  +       L   
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCN- 74

Query: 100 MEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLS 152
                  N     +  + + +   L  + L GN L     I     + L  +S
Sbjct: 75  -------NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 3e-08
 Identities = 34/221 (15%), Positives = 70/221 (31%), Gaps = 25/221 (11%)

Query: 18  NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY 77
             +   ++    ++    +  T  +L  +  LS     +T+       +  +     L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG------ 131
           L   +N +  + P         +E+      N+S     +     +LT+  +        
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 132 -------NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSG 184
                        I           L  L     + S    L  L+ L  L    NK+S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 185 FVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS 225
             P    +L +L  ++L +NQ++ +   L N   +  + L+
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 38/207 (18%), Positives = 68/207 (32%), Gaps = 23/207 (11%)

Query: 107 NCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL 166
             N++ ++ +  ++L  +TT+   G  +  +I   +  L  L  L L+DNQ+    P   
Sbjct: 28  KSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKN 83

Query: 167 CRLAALFLLDLGGNKLSGFVPACFGN---------------LTSLRNLYLGSNQLTSIPS 211
                   L     K    +                     L  L NL +    L  I +
Sbjct: 84  LTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN 143

Query: 212 TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLF 271
                       LS  +        + NL  L  +    N  S   P  +  L +L  + 
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201

Query: 272 LEYNRLQGSIPDSIGGLIDLKSLDLSN 298
           L+ N++    P  +    +L  + L+N
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 37/217 (17%), Positives = 71/217 (32%), Gaps = 23/217 (10%)

Query: 120 NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG 179
            L N   I  G + +  ++  A   L  +  LS     +     + +  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 180 NKLSGF-VPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIG 238
           N+++          +T L         +++I          L     ++         + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 239 NLRVLVQI--------------DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDS 284
            L + +                 LS+ N      T + +L  L  L  + N++    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 285 IGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVS 321
           +  L +L  + L NN IS   P  L    +L  + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 9/79 (11%)

Query: 4   WGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKL 63
              N   +  + + N SKL+ L+ + N      P    +L NL  + L  N ++      
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD----- 209

Query: 64  NFLSSLSNCKYLKYLSFSN 82
             +S L+N   L  ++ +N
Sbjct: 210 --VSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 4e-04
 Identities = 12/58 (20%), Positives = 27/58 (46%), Gaps = 4/58 (6%)

Query: 98  QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLED 155
             +      +  IS   P  +++L NL  ++L  N+++   P+A      L +++L +
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 51.7 bits (122), Expect = 3e-08
 Identities = 39/160 (24%), Positives = 60/160 (37%), Gaps = 3/160 (1%)

Query: 195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNNF 253
               +      L  IP  +    +   L L+ N         + G L  LV+++L  N  
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLL 313
           +G  P        +Q L L  N+++        GL  LK+L+L +N IS  +P S E L 
Sbjct: 67  TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126

Query: 314 DLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP 353
            L  +N++ N                 +S  G    CG P
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 51.3 bits (121), Expect = 5e-08
 Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 6/173 (3%)

Query: 81  SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPI 140
           +   L  I PR I   +   E+    N     S       L +L  + L  N+L G  P 
Sbjct: 16  TGRGLKEI-PRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72

Query: 141 ALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLY 200
           A +    +Q L L +N+++         L  L  L+L  N++S  +P  F +L SL +L 
Sbjct: 73  AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132

Query: 201 LGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF 253
           L SN         W  +++   +L+  +     P ++ ++++    DL  + F
Sbjct: 133 LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.7 bits (109), Expect = 2e-06
 Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 6/175 (3%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQK-LQLLSLEDNQLEGSIPDDLCRLAA 171
            IP +I    + T + L  N+L       L      L  L L+ NQL G  P+     + 
Sbjct: 22  EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTG 231
           +  L LG NK+       F  L  L+ L L  NQ++ +    +     L     +++   
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

Query: 232 PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
                      L +  L+        P+    ++D+Q   L ++  + S  +S G
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENSEG 191

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 7e-08
 Identities = 34/287 (11%), Positives = 81/287 (28%), Gaps = 25/287 (8%)

Query: 24  RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNN 83
            L+L   + +   P+  G L +   ++          P     S       ++++  SN+
Sbjct: 4   TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR----VQHMDLSNS 56

Query: 84  SLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALD 143
            ++      I +    ++   +    +S  I   ++  +NL  + L G        +   
Sbjct: 57  VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116

Query: 144 KLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS 203
                +L  L  +         +    A     +    LSG+      +           
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS----------- 165

Query: 204 NQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLS-MNNFSGFIPTTIG 262
                          +      S         E   L  L  + LS   +        +G
Sbjct: 166 ---DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222

Query: 263 DLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISL 309
           ++  L+ L +      G++         L  L ++ ++ +     ++
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEA---LPHLQINCSHFTTIARPTI 266

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 7e-07
 Identities = 50/261 (19%), Positives = 87/261 (33%), Gaps = 17/261 (6%)

Query: 78  LSFSNNSLDGILPRAIGNL-SQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNG 136
           L  +  +L    P   G L SQ +  F      +   + E  S    +  + L  + +  
Sbjct: 5   LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 137 -SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGG--NKLSGFVPACFGNL 193
            ++   L +  KLQ LSLE  +L   I + L + + L  L+L G        +     + 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 194 TSLRNLYLGSNQLTSIPSTLWNLKYILY-------LNLSSNSFTGPLPLEIGNLRVLVQI 246
           + L  L L      +       + ++              N     L   +     LV +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 247 DLSMN-NFSGFIPTTIGDLKDLQYLFLEY-NRLQGSIPDSIGGLIDLKSLDLSNNNISGA 304
           DLS +             L  LQ+L L     +       +G +  LK+L +      G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 305 IPISLEKLLDLKYINVSFNKL 325
           + +  E L  L+     F  +
Sbjct: 241 LQLLKEALPHLQINCSHFTTI 261

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 5e-07
 Identities = 42/209 (20%), Positives = 81/209 (38%), Gaps = 21/209 (10%)

Query: 18  NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY 77
             ++  +  L+  S    +      L ++ ++  N + + S       +  +     +  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS 137
           L  + N L     + + NL     +F   N     S  +++  L +L+  + G + +NG 
Sbjct: 73  LFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
           + +   +              + +    L RL  L  L L  N++S  VP     LT L+
Sbjct: 131 VHLPQLESLY-------LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181

Query: 198 NLYLGSNQLTSIPSTLWNLKYILYLNLSS 226
           NLYL  N ++ + + L  LK +  L L S
Sbjct: 182 NLYLSKNHISDLRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 2e-06
 Identities = 36/215 (16%), Positives = 67/215 (31%), Gaps = 21/215 (9%)

Query: 113 SIPEEIS------NLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDL 166
           ++P  I                L    +  ++    ++L  +  +   ++ ++      +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64

Query: 167 CRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSS 226
             L  +  L L GNKL+   P        L NL                        L S
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 227 NSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIG 286
            S       +I  L  L Q++      +     T+             +     I   + 
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LA 175

Query: 287 GLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVS 321
           GL  L++L LS N+IS  +  +L  L +L  + + 
Sbjct: 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 41/209 (19%), Positives = 68/209 (32%), Gaps = 16/209 (7%)

Query: 64  NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTN 123
             + S          +    S+   + +    L+ S++     N +I       I  L N
Sbjct: 15  KQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIKSVQG--IQYLPN 69

Query: 124 LTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS 183
           +T ++L GNKL    P+A  K      L     +   S+ D     +     +   +   
Sbjct: 70  VTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129

Query: 184 GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL 243
                   +L    N              L  L  +  L+L  N  +  +PL    L  L
Sbjct: 130 LVHLPQLESLYLGNNKITDITV-------LSRLTKLDTLSLEDNQISDIVPL--AGLTKL 180

Query: 244 VQIDLSMNNFSGFIPTTIGDLKDLQYLFL 272
             + LS N+ S      +  LK+L  L L
Sbjct: 181 QNLYLSKNHISDLRA--LAGLKNLDVLEL 207

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (109), Expect = 3e-06
 Identities = 25/219 (11%), Positives = 62/219 (28%), Gaps = 5/219 (2%)

Query: 11  TIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS 70
            IPS +        L   +          F    +L+++ ++ N +        F +   
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 71  NCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLG 130
             +     + +   ++    + + NL   +                 +  +       + 
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 131 GNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACF 190
            + +  +  +      +  +L L  N ++              L     N L       F
Sbjct: 140 IHTIERNSFV--GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF 197

Query: 191 GNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNS 228
              +    L +   ++ S+PS  L NLK +   +  +  
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 5e-05
 Identities = 36/226 (15%), Positives = 60/226 (26%), Gaps = 9/226 (3%)

Query: 106 FNCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIP 163
           F C  S    IP ++    N   +     KL      A      L+ + +  N +   I 
Sbjct: 13  FLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70

Query: 164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-----SIPSTLWNLKY 218
            D+                +                YL  +         +       K 
Sbjct: 71  ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130

Query: 219 ILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ 278
           +L +  + N  T      +G     V + L+ N             +  +    + N L+
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190

Query: 279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNK 324
               D   G      LD+S   I       LE L  L+  +    K
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 13/84 (15%), Positives = 20/84 (23%), Gaps = 5/84 (5%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSST 60
           L L  N                     + N+      + F        L ++   + S  
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 61  PKLNFLSSLSNCKYLKYLSFSNNS 84
                   L N K L+  S  N  
Sbjct: 218 S-----YGLENLKKLRARSTYNLK 236

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (105), Expect = 4e-06
 Identities = 24/133 (18%), Positives = 43/133 (32%), Gaps = 5/133 (3%)

Query: 153 LEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPST 212
           L+  Q+E  +   + +        L    L                L   S+   ++   
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRII 60

Query: 213 LWNLKYILYLNLSSNSFTG--PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYL 270
             N+  +L LNLS+N       +   +     L  ++LS N               L+ L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 271 FLEYNRLQGSIPD 283
           +L+ N L  +  D
Sbjct: 121 WLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 1e-04
 Identities = 25/155 (16%), Positives = 52/155 (33%), Gaps = 5/155 (3%)

Query: 201 LGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTT 260
           L   Q+  +   +          L           ++    + V ++   ++ +  +   
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRII 60

Query: 261 IGDLKDLQYLFLEYNRLQG--SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYI 318
             ++ +L  L L  NRL     +   +    +LK L+LS N +     +   K L L+ +
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 319 NVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTP 353
            +  N L      +  + +   E F     L G  
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 6/146 (4%)

Query: 137 SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSL 196
            + + + K       +L+   L      DL       +L+   + ++  +     N+  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67

Query: 197 RNLYLGSNQLTS---IPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNF 253
            +L L +N+L     + S +     +  LNLS N       L+      L ++ L  N+ 
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 254 SGFIPTTIGDLKDLQYLFLEYNRLQG 279
           S         +  ++  F +  RL G
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 3e-04
 Identities = 22/140 (15%), Positives = 46/140 (32%), Gaps = 11/140 (7%)

Query: 36  IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGN 95
           +        +  + +L+          L     L        L+  ++     L     N
Sbjct: 12  LKLIMSKRYDGSQQALDLK-------GLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEEN 63

Query: 96  LSQSMEVFFMFNCNISG--SIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSL 153
           + + +    + N  +     +   +    NL  + L GN+L     +   K  KL+ L L
Sbjct: 64  IPE-LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 154 EDNQLEGSIPDDLCRLAALF 173
           + N L  +  D    ++A+ 
Sbjct: 123 DGNSLSDTFRDQSTYISAIR 142

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 5e-06
 Identities = 40/204 (19%), Positives = 77/204 (37%), Gaps = 22/204 (10%)

Query: 18  NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKY 77
             ++  +  L   +    +  +  +L  +  L  +   + S       +  +     L  
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66

Query: 78  LSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS 137
           ++FSNN L       + NL++ +++    N     +    ++NLT LT            
Sbjct: 67  INFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN-------NQ 117

Query: 138 IPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR 197
           I           L  LE +    S    L  L +L  L+   N+++   P    NLT+L 
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLE 175

Query: 198 NLYLGSNQLTSIP--STLWNLKYI 219
            L + SN+++ I   + L NL+ +
Sbjct: 176 RLDISSNKVSDISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 3e-04
 Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 17/201 (8%)

Query: 119 SNLTNLTTIYLGGNKLNGSIPIA-LDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL 177
           + L       LG   +  ++    LD++  LQ   L    ++G     +  L  L  ++ 
Sbjct: 15  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 69

Query: 178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI 237
             N+L+        NLT L ++ + +NQ+  I               ++          +
Sbjct: 70  SNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127

Query: 238 GNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLS 297
            NL  L     ++++ S     T     +     +       +    +  L  L+ LD+S
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQV-------TDLKPLANLTTLERLDIS 180

Query: 298 NNNISGAIPISLEKLLDLKYI 318
           +N +S      L KL +L+ +
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 6e-06
 Identities = 25/134 (18%), Positives = 42/134 (31%), Gaps = 6/134 (4%)

Query: 190 FGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLS 249
           + N    R L L   ++  I +    L     ++ S N            LR L  + ++
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVN 71

Query: 250 MNNFSGFIPTTIGDLKDLQYLFLEYNRLQG-SIPDSIGGLIDLKSLDLSNNN---ISGAI 305
            N            L DL  L L  N L      D +  L  L  L +  N         
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 306 PISLEKLLDLKYIN 319
              + K+  ++ ++
Sbjct: 132 LYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 3e-04
 Identities = 24/143 (16%), Positives = 48/143 (33%), Gaps = 12/143 (8%)

Query: 12  IPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSN 71
              +  NA +   L+L        I N    L     +  + N        +  L     
Sbjct: 11  AAQYT-NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNE-------IRKLDGFPL 61

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
            + LK L  +NN +  I       L    E+    N  +     + +++L +LT + +  
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121

Query: 132 NK---LNGSIPIALDKLQKLQLL 151
           N            + K+ ++++L
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.001
 Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 6/127 (4%)

Query: 175 LDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLP 234
           LDL G K+   +      L     +    N++  +      L+ +  L +++N       
Sbjct: 23  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-PLLRRLKTLLVNNNRICRIGE 80

Query: 235 LEIGNLRVLVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLE---YNRLQGSIPDSIGGLID 290
                L  L ++ L+ N+         +  LK L YL +        +      I  +  
Sbjct: 81  GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQ 140

Query: 291 LKSLDLS 297
           ++ LD  
Sbjct: 141 VRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 28/138 (20%), Positives = 47/138 (34%), Gaps = 8/138 (5%)

Query: 117 EISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD 176
           + +N      + L G K+   I      L +   +   DN++     D    L  L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP--STLWNLKYILYLNLSSNSFT---G 231
           +  N++          L  L  L L +N L  +     L +LK + YL +  N  T    
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 232 PLPLEIGNLRVLVQIDLS 249
                I  +  +  +D  
Sbjct: 130 YRLYVIYKVPQVRVLDFQ 147

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.4 bits (108), Expect = 6e-06
 Identities = 50/333 (15%), Positives = 102/333 (30%), Gaps = 32/333 (9%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDG----ILPRAIGNLS--Q 98
           +++  SL  + +T+   K +  + L     +K +  S N++       L   I +    +
Sbjct: 4   SIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 99  SMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQL 158
             E   +F   +   IPE +  L          + +  S        Q+  +  L  +  
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 159 EGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKY 218
              +      L       +        V     N   LR++  G N+L +     W   +
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 219 ILYLNLSSNSFTGP--------------LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDL 264
             +  L +                    L        + +Q +   +  S  +   +   
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 265 KDLQYLFLEYNRLQGSIPDSIGGLID------LKSLDLSNNNISGAIPISL-----EKLL 313
            +L+ L L    L      ++           L++L L  N I      +L     EK+ 
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 314 DLKYINVSFNKLEGEIPREGPFRNFSAESFKGN 346
           DL ++ ++ N+   E       R   +   +G 
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 37/341 (10%), Positives = 95/341 (27%), Gaps = 40/341 (11%)

Query: 1   LLLWGNNFSGTIPSFIFNASKLSRLELEMNSF----YGFIPNTFGNLRNLKRLSLNYNYL 56
           L         ++ + +     +  + L  N+       ++     + ++L+    +  + 
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 57  TSSTPKL-----NFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNIS 111
                ++       L +L  C  L  +  S+N+        + +             + +
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 112 GSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAA 171
           G  P+  + +               ++         L+ +    N+L  +          
Sbjct: 132 GLGPQAGAKIAR--------ALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTF 182

Query: 172 LFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTG 231
                L   K+        G    L        +L  +        ++    L+    + 
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242

Query: 232 PLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD------LKDLQYLFLEYNRLQGSIPDSI 285
           P            ++ L+    S      + D         LQ L L+YN ++     ++
Sbjct: 243 PNL---------RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 286 -----GGLIDLKSLDLSNNNIS--GAIPISLEKLLDLKYIN 319
                  + DL  L+L+ N  S    +   + ++   +   
Sbjct: 294 KTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 2e-05
 Identities = 14/100 (14%), Positives = 24/100 (24%), Gaps = 4/100 (4%)

Query: 4   WGNNFSGTIPSFIFNASKLSRLELEMNSF----YGFIPNTFGNLRNLKRLSLNYNYLTSS 59
                           S L  L L            +  T     +L+ L L+ N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 60  TPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQS 99
                  S       L+ L   +      +   +  L + 
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 18/122 (14%), Positives = 35/122 (28%), Gaps = 25/122 (20%)

Query: 35  FIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIG 94
                      L+ L L    ++ S+   +  ++L     L+ L  SNN L       + 
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 95  NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQK----LQL 150
              +                         L  + L     +  +   L  L+K    L++
Sbjct: 419 ESVRQ--------------------PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

Query: 151 LS 152
           +S
Sbjct: 459 IS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 12/76 (15%), Positives = 26/76 (34%), Gaps = 5/76 (6%)

Query: 243 LVQIDLSMNNFSGF-IPTTIGDLKDLQYLFLEYNRLQG----SIPDSIGGLIDLKSLDLS 297
           +  +D+     S       +  L+  Q + L+   L       I  ++     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 298 NNNISGAIPISLEKLL 313
           +N +       + + L
Sbjct: 64  SNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 9/87 (10%)

Query: 239 NLRVLVQIDLSMNNFSG----FIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLID---- 290
              VL  + L+  + S      +  T+     L+ L L  N L  +    +   +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 291 -LKSLDLSNNNISGAIPISLEKLLDLK 316
            L+ L L +   S  +   L+ L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 10/89 (11%)

Query: 187 PACFGNLTSLRNLYLGSNQLT-----SIPSTLWNLKYILYLNLSSNSFTGPLPLEIG--- 238
                  + LR L+L    ++     S+ +TL     +  L+LS+N       L++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 239 --NLRVLVQIDLSMNNFSGFIPTTIGDLK 265
                +L Q+ L    +S  +   +  L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 10/93 (10%)

Query: 123 NLTTIYLGGNKLNGS-IPIALDKLQKLQLLSLEDNQLEG----SIPDDLCRLAALFLLDL 177
           ++ ++ +   +L+ +     L  LQ+ Q++ L+D  L       I   L    AL  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 178 GGNKLSG-----FVPACFGNLTSLRNLYLGSNQ 205
             N+L        +         ++ L L +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 10/116 (8%), Positives = 32/116 (27%), Gaps = 25/116 (21%)

Query: 45  NLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFF 104
           +++ L +    L+ +     +   L   +  + +   +  L     + I +         
Sbjct: 3   DIQSLDIQCEELSDA----RWAELLPLLQQCQVVRLDDCGLTEARCKDISSA-------- 50

Query: 105 MFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG 160
                        +     L  + L  N+L       + +  +     ++   L+ 
Sbjct: 51  -------------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 7e-05
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 9/75 (12%)

Query: 267 LQYLFLEYNRLQG----SIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLD-----LKY 317
           L+ L+L    +      S+  ++     L+ LDLSNN +  A  + L + +      L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 318 INVSFNKLEGEIPRE 332
           + +       E+   
Sbjct: 431 LVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 17/90 (18%), Positives = 26/90 (28%), Gaps = 11/90 (12%)

Query: 175 LDLGGNKLSGF-VPACFGNLTSLRNLYLGSNQLT-----SIPSTLWNLKYILYLNLSSNS 228
           LD+   +LS          L   + + L    LT      I S L     +  LNL SN 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 229 FTGPLPLEIG-----NLRVLVQIDLSMNNF 253
                   +          + ++ L     
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 9/88 (10%)

Query: 91  RAIGNLSQSMEVFFMFNCNISG----SIPEEISNLTNLTTIYLGGNKLNGSIPIAL---- 142
           + +G     + V ++ +C++S     S+   +    +L  + L  N L  +  + L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 143 -DKLQKLQLLSLEDNQLEGSIPDDLCRL 169
                 L+ L L D      + D L  L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 11/91 (12%), Positives = 27/91 (29%), Gaps = 6/91 (6%)

Query: 195 SLRNLYLGSNQLTS--IPSTLWNLKYILYLNLSSNSFTG----PLPLEIGNLRVLVQIDL 248
            +++L +   +L+       L  L+    + L     T      +   +     L +++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQG 279
             N         +          ++   LQ 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 13/82 (15%), Positives = 20/82 (24%), Gaps = 4/82 (4%)

Query: 113 SIPEEISNLTNLTTIYLGGNKLNG----SIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR 168
              E +  L     + L    L       I  AL     L  L+L  N+L       + +
Sbjct: 18  RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ 77

Query: 169 LAALFLLDLGGNKLSGFVPACF 190
                   +    L        
Sbjct: 78  GLQTPSCKIQKLSLQNCCLTGA 99

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (97), Expect = 4e-05
 Identities = 23/139 (16%), Positives = 43/139 (30%), Gaps = 3/139 (2%)

Query: 194 TSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEI-GNLRVLVQIDLSMNN 252
                L    +        L   + +  L + +      L L     L  L  + +  + 
Sbjct: 8   HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 253 FSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPIS-LEK 311
                P        L  L L +N L+ S+       + L+ L LS N +  +  +  L++
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 312 LLDLKYINVSFNKLEGEIP 330
             +     V   KL+    
Sbjct: 127 WEEEGLGGVPEQKLQCHGQ 145

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.001
 Identities = 20/132 (15%), Positives = 44/132 (33%), Gaps = 2/132 (1%)

Query: 243 LVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIP-DSIGGLIDLKSLDLSNNNI 301
              +  + +         +   ++L  L++E  +    +    + GL +L++L +  + +
Sbjct: 10  SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 302 SGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGTPNLQVPPCR 361
               P +      L  +N+SFN LE    +     +       GN L C      +    
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 362 TRIHHTSRKNDL 373
                   +  L
Sbjct: 129 EEGLGGVPEQKL 140

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 22/109 (20%), Positives = 33/109 (30%), Gaps = 2/109 (1%)

Query: 122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCR-LAALFLLDLGGN 180
              + +    +         L   + L  L +E+ Q    +     R L  L  L +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSF 229
            L    P  F     L  L L  N L S+         +  L LS N  
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.002
 Identities = 21/137 (15%), Positives = 40/137 (29%), Gaps = 3/137 (2%)

Query: 72  CKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGG 131
                 L  + +         +       E++     ++      ++  L  L  + +  
Sbjct: 7   PHGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 132 NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS-GFVPACF 190
           + L    P A     +L  L+L  N LE S+     +  +L  L L GN L         
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 191 GNLTSLRNLYLGSNQLT 207
                     +   +L 
Sbjct: 125 QRWEEEGLGGVPEQKLQ 141

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	599
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.98
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.98
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.98
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.98
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.88
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.86
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.84
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.83
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.82
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.77
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.65
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.64
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.62
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.62
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.61
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.49
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.48
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.72
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.71
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.28
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.93
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.91
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.78
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.44
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.3
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.72
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.51

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=304.60  Aligned_cols=168  Identities=24%  Similarity=0.356  Sum_probs=146.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56888999999999999999975 69999999997543 33456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      |++|+|.+++.... .+++..+..++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.......
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            99999999997644 5899999999999999999999   8899999999999999999999999999999765444333


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      .....+||+.||||
T Consensus       161 ~~~~~~GT~~Y~AP  174 (271)
T d1nvra_         161 LLNKMCGTLPYVAP  174 (271)
T ss_dssp             CBCCCCSCGGGSCT
T ss_pred             cccceeeCcCccCH
Confidence            44567899999999

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-36  Score=298.85  Aligned_cols=165  Identities=28%  Similarity=0.413  Sum_probs=148.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46999999999999999999864 69999999998766566788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +||+|.+++...  .+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            999999988764  3899999999999999999999   89999999999999999999999999999997654332  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+||+.||||
T Consensus       173 ~~~~~gt~~Y~aP  185 (293)
T d1yhwa1         173 RSTMVGTPYWMAP  185 (293)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCCCccCh
Confidence            3456899999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-37  Score=300.14  Aligned_cols=167  Identities=26%  Similarity=0.441  Sum_probs=141.0

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|...+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467889999999999999999875  46999999654  34456789999999999999999999998754 56899999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||++|+|.+++...+..+++..+..|+.|||+||+|||   +.+||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877667999999999999999999999   889999999999999999999999999999876544433


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.||||
T Consensus       161 ~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         161 HQFEQLSGSILWMAP  175 (276)
T ss_dssp             -----CCCCGGGCCH
T ss_pred             ccccccccCcccCCH
Confidence            444567899999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-36  Score=296.29  Aligned_cols=167  Identities=26%  Similarity=0.395  Sum_probs=139.4

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5688889999999999999999889999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|+|.+++......+++..+..|+.|||+||.|+|   +.+|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999887777899999999999999999999   88999999999999999999999999999987644332 223


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||+.||||
T Consensus       160 ~~~~gt~~y~aP  171 (263)
T d1sm2a_         160 TGTKFPVKWASP  171 (263)
T ss_dssp             -----CTTSCCH
T ss_pred             cceecCcccCCh
Confidence            446799999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=300.34  Aligned_cols=167  Identities=25%  Similarity=0.371  Sum_probs=148.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|+..+.||+|+||+||+|++. +|+.||||+++.......+.|.+|+++|++++|||||++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888899999999999999975 68999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      ++|+|.+++......+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            999999998766666899999999999999999999   8899999999999999999999999999998553221  12


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....||+.||||
T Consensus       167 ~~~~~Gt~~y~AP  179 (288)
T d2jfla1         167 RDSFIGTPYWMAP  179 (288)
T ss_dssp             HTCCCSCCTTCCH
T ss_pred             ccccccccccCCH
Confidence            2356799999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-36  Score=296.29  Aligned_cols=168  Identities=30%  Similarity=0.452  Sum_probs=144.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999975 6999999999643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||++|+|.+++...+ .+++..+..++.|++.||+|+|   +.+||||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 4889999999999999999999   89999999999999999999999999999997754444


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      .......+||+.||||
T Consensus       164 ~~~~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         164 QARANSFVGTAQYVSP  179 (288)
T ss_dssp             ------CCCCGGGCCH
T ss_pred             ccccccccCCccccCc
Confidence            3344567899999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-36  Score=299.11  Aligned_cols=169  Identities=24%  Similarity=0.412  Sum_probs=148.4

Q ss_pred             HhCCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ..++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3457888899999999999999976 58899999987543 346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSS-NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||++|+|.+++... ...+++..+..|+.|||+||+|||   +.+|+||||||+|||+++++.+||+|||+|+..... .
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            99999999998754 346899999999999999999999   889999999999999999999999999999976433 2


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                      ........||+.||||
T Consensus       170 ~~~~~~~~g~~~y~aP  185 (287)
T d1opja_         170 YTAHAGAKFPIKWTAP  185 (287)
T ss_dssp             SEEETTEEECGGGCCH
T ss_pred             ceeeccccccccccCh
Confidence            3344556789999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-36  Score=295.32  Aligned_cols=167  Identities=23%  Similarity=0.398  Sum_probs=145.1

Q ss_pred             hCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .++|+..+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45688889999999999999999988999999997543 345789999999999999999999998854 5679999999


Q ss_pred             CCCChhhhhhcCCC-cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++..... .+++..+++|+.||++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+... ...
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            99999987765433 5899999999999999999999   899999999999999999999999999999976533 223


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......||+.||||
T Consensus       166 ~~~~~~gt~~y~AP  179 (272)
T d1qpca_         166 AREGAKFPIKWTAP  179 (272)
T ss_dssp             CCTTCCCCTTTSCH
T ss_pred             cccccCCcccccCh
Confidence            34556799999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-36  Score=290.07  Aligned_cols=164  Identities=27%  Similarity=0.437  Sum_probs=145.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888899999999999999976 6899999998643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||++|+|.+++.... .+++..+..|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999987644 4899999999999999999999   899999999999999999999999999999865432  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        ......||+.||||
T Consensus       160 --~~~~~~Gt~~Y~AP  173 (263)
T d2j4za1         160 --RRTTLCGTLDYLPP  173 (263)
T ss_dssp             --CCEETTEEGGGCCH
T ss_pred             --cccccCCCCcccCH
Confidence              22456799999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-36  Score=297.99  Aligned_cols=169  Identities=24%  Similarity=0.428  Sum_probs=133.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CC---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DG---IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      +.|+..+.||+|+||+||+|+++ ++   ..||||.+... .....++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34566789999999999999875 23   36899998654 344567899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||||++|+|.+++......+++.++..|+.|||+||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999998887777999999999999999999999   8899999999999999999999999999998765433


Q ss_pred             Cce---eeecccCCccccCC
Q 042902          583 QSL---TQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~---~~~~~~gt~~y~AP  599 (599)
                      ...   ......||+.||||
T Consensus       183 ~~~~~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAP  202 (299)
T ss_dssp             -------------CGGGSCH
T ss_pred             CcceeeecccccCCccccCH
Confidence            221   12335679999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-35  Score=285.43  Aligned_cols=167  Identities=24%  Similarity=0.391  Sum_probs=150.2

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999999899999999975433 45789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCceee
Q 042902          508 HGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQ  587 (599)
Q Consensus       508 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  587 (599)
                      +|++.+++......+++..+.+++.|||+||+|||   +.+|+||||||+||++++++.+||+|||+|+.+..... ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence            99999998877777899999999999999999999   89999999999999999999999999999987654332 233


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||+.||||
T Consensus       159 ~~~~~t~~y~aP  170 (258)
T d1k2pa_         159 VGSKFPVRWSPP  170 (258)
T ss_dssp             CCSCCCGGGCCH
T ss_pred             cccCCCCCcCCc
Confidence            456799999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-35  Score=288.95  Aligned_cols=168  Identities=24%  Similarity=0.392  Sum_probs=142.8

Q ss_pred             CCCCcCc-eecccccceEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENN-LIGRGGVASVYKARIQ---DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+ .||+|+||+||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455555 4999999999999864   35689999997553 3456789999999999999999999999875 467899


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||||++|+|.+++......+++..+..|+.|||+||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998776667999999999999999999999   8999999999999999999999999999999775443


Q ss_pred             Cc-eeeecccCCccccCC
Q 042902          583 QS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~-~~~~~~~gt~~y~AP  599 (599)
                      .. .......||+.||||
T Consensus       164 ~~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             CEECCCCSSCCCGGGCCH
T ss_pred             cccccccccccCccccCh
Confidence            22 222345789999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-36  Score=299.71  Aligned_cols=165  Identities=23%  Similarity=0.369  Sum_probs=144.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+++|++++|||||++++++.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467899999999999999999975 68999999997553 3445689999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+||+|.+++...+ .+++..+..++.|+++||.|||   + .+|+||||||+|||+++++.+||+|||+|+.+...  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 4889999999999999999999   6 48999999999999999999999999999865322  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.||||
T Consensus       159 --~~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         159 --MANSFVGTRSYMSP  172 (322)
T ss_dssp             --TC---CCSSCCCCH
T ss_pred             --ccccccCCccccCc
Confidence              12346899999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.2e-35  Score=295.63  Aligned_cols=166  Identities=22%  Similarity=0.332  Sum_probs=148.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999975 69999999997666556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec--CCCcEEEccccCCccCCcCCCc
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +||+|.+++......+++..+..|+.||+.||.|||   +.+||||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            999999999776667999999999999999999999   89999999999999996  45789999999998764332  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.||||
T Consensus       181 -~~~~~~gT~~Y~aP  194 (350)
T d1koaa2         181 -SVKVTTGTAEFAAP  194 (350)
T ss_dssp             -CEEEECSCTTTCCH
T ss_pred             -ccceecCcccccCH
Confidence             23456799999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-35  Score=292.51  Aligned_cols=161  Identities=27%  Similarity=0.350  Sum_probs=142.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .|+..+.||+|+||+||+|+.. +|+.||||+++...   ....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999865 68999999987543   2345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      ||++|++..++...+ .+++..+..|+.||++||.|||   +.+||||||||+|||++.++.+||+|||+|+.....   
T Consensus        96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            999999987665543 5899999999999999999999   899999999999999999999999999999865321   


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                         ....||+.||||
T Consensus       169 ---~~~~GT~~Y~AP  180 (309)
T d1u5ra_         169 ---NSFVGTPYWMAP  180 (309)
T ss_dssp             ---CCCCSCGGGCCH
T ss_pred             ---CccccCccccCH
Confidence               345799999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=289.46  Aligned_cols=170  Identities=26%  Similarity=0.377  Sum_probs=131.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc--CCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN--DDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  502 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||.++...  +...+.|.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56889999999999999999875 68999999986543  3345679999999999999999999999865  4568999


Q ss_pred             EEccCCCChhhhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          503 LEYMPHGSLEKCLYS---SNYILDIFQRLNIMIDVASALEYLHFGY--SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ||||++|+|.+++..   ....+++..+..++.||++||.|||+..  ..+||||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999998864   2345899999999999999999999421  23599999999999999999999999999987


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.....  ......||+.||||
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~AP  183 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSP  183 (269)
T ss_dssp             C-------------CCCSCCCH
T ss_pred             cccCCC--ccccCCCCcccCCH
Confidence            643322  23457899999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-34  Score=293.56  Aligned_cols=166  Identities=22%  Similarity=0.371  Sum_probs=148.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      +.|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46899999999999999999975 79999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec--CCCcEEEccccCCccCCcCCCc
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD--DNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~--~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      +||+|.+++......+++..+..|+.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999988776667999999999999999999999   89999999999999998  67899999999999765432  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.||||
T Consensus       184 -~~~~~~gt~~y~aP  197 (352)
T d1koba_         184 -IVKVTTATAEFAAP  197 (352)
T ss_dssp             -CEEEECSSGGGCCH
T ss_pred             -ceeeccCcccccCH
Confidence             23446799999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-35  Score=288.46  Aligned_cols=169  Identities=27%  Similarity=0.488  Sum_probs=139.0

Q ss_pred             CCCCcCceecccccceEEEEEecCC-----cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDG-----IEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      +.|+..+.||+|+||.||+|.++++     ..||||+++... .....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999987642     479999996543 3345679999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      |||||++|++.+++......+++..+.+++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999988877777999999999999999999999   899999999999999999999999999999876443


Q ss_pred             CC-ceeeecccCCccccCC
Q 042902          582 DQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~-~~~~~~~~gt~~y~AP  599 (599)
                      .. ........||+.||||
T Consensus       164 ~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             CccceEeccCCCCccccCH
Confidence            22 2233456789999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-35  Score=292.62  Aligned_cols=170  Identities=25%  Similarity=0.429  Sum_probs=144.1

Q ss_pred             hCCCCcCceecccccceEEEEEecC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD------GIEVAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||+||+|++..      ...||||.+... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578888999999999999998652      236999998654 334456899999999998 89999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC----------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 042902          499 KALVLEYMPHGSLEKCLYSSN----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKP  556 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~  556 (599)
                      .++|||||++|+|.++++...                      ..+++..++.|+.||++||+|||   +.+||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997643                      24788899999999999999999   88999999999


Q ss_pred             CCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          557 NNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       557 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +||+++.++.+||+|||+|+...............||+.||||
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            9999999999999999999976655444444566789999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=282.22  Aligned_cols=161  Identities=26%  Similarity=0.381  Sum_probs=136.9

Q ss_pred             CcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEc----CCeeeEEE
Q 042902          431 SENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSN----DDFKALVL  503 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  503 (599)
                      ...+.||+|+||+||+|.+. +++.||+|.+....  ....+.|.+|+++|++++|||||++++++.+    .+..|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999976 68899999986542  3345679999999999999999999999864    34679999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCeeec-CCCcEEEccccCCccCCc
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVP--IIHCDLKPNNVLLD-DNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~DFGla~~~~~  580 (599)
                      |||++|+|.+++.... .+++..+..++.||++||+|||   +.+  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997644 4889999999999999999999   666  99999999999996 578999999999985432


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      .    .....+||+.||||
T Consensus       168 ~----~~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAP  182 (270)
T ss_dssp             T----SBEESCSSCCCCCG
T ss_pred             C----ccCCcccCccccCH
Confidence            2    22356899999999

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=291.77  Aligned_cols=166  Identities=26%  Similarity=0.354  Sum_probs=147.2

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46889999999999999999975 7999999999754   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||+||+|.+++...+ .+++..+..++.||+.||+|+|   +.+|+||||||+|||++.+|.+||+|||+|+.......
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999987654 4788889999999999999999   89999999999999999999999999999986643322


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                        .....+||+.||||
T Consensus       161 --~~~~~~GT~~Y~aP  174 (337)
T d1o6la_         161 --TMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CBCCCEECGGGCCG
T ss_pred             --ccccceeCHHHhhh
Confidence              33457899999999

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=283.92  Aligned_cols=161  Identities=25%  Similarity=0.382  Sum_probs=135.0

Q ss_pred             ceecccccceEEEEEecC---CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccCC
Q 042902          434 NLIGRGGVASVYKARIQD---GIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMPH  508 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  508 (599)
                      +.||+|+||+||+|.+++   ++.||||+++...  ....++|.+|+++|++++|||||+++|+|.++ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998653   5689999996442  33456899999999999999999999999654 57899999999


Q ss_pred             CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc-eee
Q 042902          509 GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS-LTQ  587 (599)
Q Consensus       509 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~  587 (599)
                      |+|.++++... .+++..+..|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999988654 4899999999999999999999   889999999999999999999999999999876544332 223


Q ss_pred             ecccCCccccCC
Q 042902          588 TQTLATIGYMAP  599 (599)
Q Consensus       588 ~~~~gt~~y~AP  599 (599)
                      ....||++||||
T Consensus       168 ~~~~gt~~y~AP  179 (277)
T d1xbba_         168 THGKWPVKWYAP  179 (277)
T ss_dssp             ---CCCGGGCCH
T ss_pred             cccCCCceecCc
Confidence            456799999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-34  Score=287.34  Aligned_cols=163  Identities=28%  Similarity=0.349  Sum_probs=144.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            45888999999999999999975 6999999999643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      |||+||++..++.... ..++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999887655 3678888889999999999999   999999999999999999999999999999876432  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         ....+||+.||||
T Consensus       158 ---~~~~~Gt~~Y~AP  170 (316)
T d1fota_         158 ---TYTLCGTPDYIAP  170 (316)
T ss_dssp             ---BCCCCSCTTTCCH
T ss_pred             ---cccccCcccccCH
Confidence               2346899999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-34  Score=288.24  Aligned_cols=166  Identities=24%  Similarity=0.384  Sum_probs=129.5

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356889999999999999999975 68999999997553 3334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCCccCCcC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla~~~~~~  581 (599)
                      ||+||+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997654 5899999999999999999999   89999999999999995   5789999999999865332


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      .   .....+||+.||||
T Consensus       164 ~---~~~~~~GT~~y~AP  178 (307)
T d1a06a_         164 S---VLSTACGTPGYVAP  178 (307)
T ss_dssp             ------------CTTSCH
T ss_pred             C---eeeeeeeCccccCc
Confidence            2   23456799999999

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=284.10  Aligned_cols=166  Identities=25%  Similarity=0.426  Sum_probs=138.3

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEccC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  507 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  507 (599)
                      ++|+..+.||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5688899999999999999999988899999996543 345789999999999999999999999854 56899999999


Q ss_pred             CCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          508 HGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       508 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +|++.+++.... ..++|..++.|+.||++||+|||   +.+|+||||||+|||+|+++.+||+|||+|+.+.... ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence            999998887532 35899999999999999999999   8899999999999999999999999999998664332 223


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      .....||+.||||
T Consensus       171 ~~~~~gt~~y~aP  183 (285)
T d1fmka3         171 RQGAKFPIKWTAP  183 (285)
T ss_dssp             -----CCGGGSCH
T ss_pred             eccccccccccCh
Confidence            3456799999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.5e-33  Score=281.31  Aligned_cols=257  Identities=34%  Similarity=0.585  Sum_probs=227.3

Q ss_pred             ceEEEccCCcccc--cCCccccCCCCCCEEEccC-CcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEE
Q 042902          100 MEVFFMFNCNISG--SIPEEISNLTNLTTIYLGG-NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLD  176 (599)
Q Consensus       100 l~~l~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  176 (599)
                      ++.|++++|++.+  .+|..++++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++.+..+..+..+.+|+.++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            4555555555554  4678888999999999986 888888898999999999999999999988888899999999999


Q ss_pred             eeCCccCCCCCcccCCCCCCcEeecCCCCCC-CCCccccCCCcc-cEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLT-SIPSTLWNLKYI-LYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       177 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      +++|.+.+..|..+..++.|+.+++++|.++ .+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            9999999888999999999999999999998 678888887775 889999999999999888887655 7999999999


Q ss_pred             CCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCC
Q 042902          255 GFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGP  334 (599)
Q Consensus       255 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~  334 (599)
                      +.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|.++++|++|+|++|+|+|.+|..+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence            9999999999999999999999987655 688899999999999999999999999999999999999999999998888


Q ss_pred             CCCcccccccCCCCCcCCCCCCCCCCc
Q 042902          335 FRNFSAESFKGNELLCGTPNLQVPPCR  361 (599)
Q Consensus       335 ~~~~~~~~~~~n~~~c~~~~~~~~~~~  361 (599)
                      +..+...++.+|+.+|+.|   .|+|.
T Consensus       290 L~~L~~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred             CCCCCHHHhCCCccccCCC---CCCCC
Confidence            8999999999999999987   56773

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=279.63  Aligned_cols=165  Identities=26%  Similarity=0.391  Sum_probs=145.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY------EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++...      ....+.|.+|+++|++++|||||++++++.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999975 69999999986432      224678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC----cEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM----VAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~----~~kl~DFGla~  576 (599)
                      +|||||++|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+||+++.++    .+|++|||+|+
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999997654 4899999999999999999999   89999999999999998776    49999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.||||
T Consensus       166 ~~~~~~---~~~~~~~t~~y~AP  185 (293)
T d1jksa_         166 KIDFGN---EFKNIFGTPEFVAP  185 (293)
T ss_dssp             ECTTSC---BCSCCCCCGGGCCH
T ss_pred             hcCCCc---cccccCCCCcccCH
Confidence            764332   23446799999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-33  Score=275.87  Aligned_cols=165  Identities=28%  Similarity=0.440  Sum_probs=145.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc---------ccHHHHHHHHHHHhcCC-CCcceeEEEEEEcC
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE---------GAFKSFDIECDMMKRIR-HRNLIKIISSCSND  496 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  496 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++....         ...+++.+|++++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57889999999999999999974 799999999865421         12346889999999997 99999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                      +..|+|||||++|+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 5899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+....   ......||+.|+||
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~P  178 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAP  178 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCH
T ss_pred             EccCCC---ceeeeeccCCCCCH
Confidence            764432   23456799999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-34  Score=284.54  Aligned_cols=171  Identities=27%  Similarity=0.438  Sum_probs=146.7

Q ss_pred             HhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCe
Q 042902          426 ATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDF  498 (599)
Q Consensus       426 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  498 (599)
                      ..++|+..+.||+|+||+||+|++.      +++.||||+++... ....++|.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4567999999999999999999864      35789999997553 3345789999999999999999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLK  555 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  555 (599)
                      .++||||+++|+|.++++...                       ..+++..+..|+.|+++||+|+|   +.+|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999986432                       24788899999999999999999   8999999999


Q ss_pred             CCCeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          556 PNNVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       556 ~~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |+|||+|.++.+||+|||+|+.+.............||+.||||
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            99999999999999999999876554444444567789999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-33  Score=284.68  Aligned_cols=163  Identities=24%  Similarity=0.321  Sum_probs=145.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  503 (599)
                      ++|+..+.||+|+||.||+|++. +|+.||||+++..   .....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46889999999999999999975 6999999998643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQ  583 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~  583 (599)
                      ||+++|+|.+++...+ .+++..+..|+.||+.||.|||   +.+||||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987654 4889999999999999999999   899999999999999999999999999999976432  


Q ss_pred             ceeeecccCCccccCC
Q 042902          584 SLTQTQTLATIGYMAP  599 (599)
Q Consensus       584 ~~~~~~~~gt~~y~AP  599 (599)
                         .....||+.||||
T Consensus       195 ---~~~~~Gt~~Y~AP  207 (350)
T d1rdqe_         195 ---TWTLCGTPEALAP  207 (350)
T ss_dssp             ---BCCCEECGGGCCH
T ss_pred             ---cccccCccccCCH
Confidence               2346799999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=282.37  Aligned_cols=168  Identities=24%  Similarity=0.368  Sum_probs=139.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI----EVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .+|+..+.||+|+||+||+|.+. +|+    .||||.++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35888999999999999999865 444    5889988644 344567899999999999999999999999865 5678


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      +|||+++|+|.+++......+++..+.+|+.|||+||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999998887778999999999999999999999   889999999999999999999999999999977655


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      ..........||+.||||
T Consensus       165 ~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             CC--------CCTTTSCH
T ss_pred             cccccccccccCccccCh
Confidence            444444556799999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-33  Score=278.87  Aligned_cols=165  Identities=20%  Similarity=0.312  Sum_probs=145.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      ++|...+.||+|+||+||+|.+. +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            57889999999999999999976 688999999976533 3456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCC--CcEEEccccCCccCCcCCCc
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDN--MVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~--~~~kl~DFGla~~~~~~~~~  584 (599)
                      +||+|.+++...+..+++.++..|+.||++||+|||   +.+|+||||||+|||++.+  ..+||+|||+|+......  
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--  158 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence            999999999877667899999999999999999999   8999999999999999854  589999999998764332  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......||+.||||
T Consensus       159 -~~~~~~~t~~y~ap  172 (321)
T d1tkia_         159 -NFRLLFTAPEYYAP  172 (321)
T ss_dssp             -EEEEEESCGGGSCH
T ss_pred             -cccccccccccccc
Confidence             23446789999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-33  Score=285.08  Aligned_cols=164  Identities=26%  Similarity=0.359  Sum_probs=140.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHH---HHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDI---ECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+.+   |+++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999975 69999999986432   222233444   467778889999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +|||||+||+|.+++.... .+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999997654 4788899999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCceeeecccCCccccCC
Q 042902          581 EDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..    .....||+.||||
T Consensus       160 ~~----~~~~~GT~~y~AP  174 (364)
T d1omwa3         160 KK----PHASVGTHGYMAP  174 (364)
T ss_dssp             SC----CCSCCSCGGGCCH
T ss_pred             Cc----ccccccccccchh
Confidence            32    2346799999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=281.46  Aligned_cols=175  Identities=23%  Similarity=0.396  Sum_probs=137.5

Q ss_pred             HHHHHhCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEE
Q 042902          422 ELFQATNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSC  493 (599)
Q Consensus       422 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  493 (599)
                      ++....++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.+..|..++.++ +|||||.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33334567899999999999999999864      34689999997543 33456788888888777 689999999998


Q ss_pred             EcC-CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 042902          494 SND-DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPN  557 (599)
Q Consensus       494 ~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~  557 (599)
                      ..+ +..++|||||++|+|.++++...               ..+++..+..|+.||++||.|||   +.+||||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcc
Confidence            765 46899999999999999987542               24789999999999999999999   899999999999


Q ss_pred             CeeecCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          558 NVLLDDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       558 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+++++.+||+|||+|+...............||+.||||
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            999999999999999999876544444444567899999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.2e-33  Score=277.68  Aligned_cols=166  Identities=23%  Similarity=0.377  Sum_probs=143.9

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHh-cCCCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ---YEGAFKSFDIECDMMK-RIRHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|...+.||+|+||+||+|+.. +|+.||||++++.   .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888999999999999999976 6999999999653   2344566777777765 68999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCC
Q 042902          503 LEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~  582 (599)
                      ||||++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997654 4788899999999999999999   8899999999999999999999999999998654332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                        .......||+.||||
T Consensus       158 --~~~~~~~gt~~y~aP  172 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAP  172 (320)
T ss_dssp             --CCBCCCCSCGGGCCH
T ss_pred             --ccccccCCCCCcCCH
Confidence              233456899999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3e-33  Score=274.51  Aligned_cols=168  Identities=23%  Similarity=0.366  Sum_probs=133.3

Q ss_pred             hCCCCcCceecccccceEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeE
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD----GIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  501 (599)
                      .++|...+.||+|+||.||+|++..    +..||||.++... ....+.|.+|++++++++|||||+++|++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3568888999999999999998652    4578999986543 334567999999999999999999999985 467899


Q ss_pred             EEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcC
Q 042902          502 VLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKE  581 (599)
Q Consensus       502 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~  581 (599)
                      ||||+++|++.+++......+++..+..++.||++||.|+|   +.+|+||||||+||++++++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999988877777899999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCceeeecccCCccccCC
Q 042902          582 DQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       582 ~~~~~~~~~~gt~~y~AP  599 (599)
                      . ........||+.||||
T Consensus       162 ~-~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAP  178 (273)
T ss_dssp             ----------CCGGGCCH
T ss_pred             c-ceeccceecCcccchh
Confidence            2 2233456789999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=9.2e-33  Score=274.77  Aligned_cols=167  Identities=28%  Similarity=0.391  Sum_probs=134.5

Q ss_pred             CCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC----eeeEEEE
Q 042902          429 GFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD----FKALVLE  504 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  504 (599)
                      +|...+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+..++|||||+++++|.+.+    ..|+|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            456678999999999999997 589999999964432 1122334555556789999999999997654    5789999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEccCCCCCeeecCCCcEEEccccCCccCC
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLL  579 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~  579 (599)
                      ||++|+|.+++++..  ++|..+.+++.|+|.||+|+|+.     ..++||||||||+|||+++++.+||+|||+|+...
T Consensus        82 y~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          82 YHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            999999999998754  89999999999999999999943     24799999999999999999999999999998764


Q ss_pred             cCCCce--eeecccCCccccCC
Q 042902          580 KEDQSL--TQTQTLATIGYMAP  599 (599)
Q Consensus       580 ~~~~~~--~~~~~~gt~~y~AP  599 (599)
                      ......  ......||++||||
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCH
T ss_pred             CCCcceeccccceecccCcCCh
Confidence            433221  23456899999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.3e-33  Score=278.84  Aligned_cols=170  Identities=19%  Similarity=0.366  Sum_probs=146.9

Q ss_pred             hCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCee
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFK  499 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  499 (599)
                      .++|...+.||+|+||.||+|.+.      +++.||||+++... ......|.+|++++++++|||||+++|+|..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888899999999999999864      35789999997543 33456799999999999999999999999999999


Q ss_pred             eEEEEccCCCChhhhhhcCC---------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEc
Q 042902          500 ALVLEYMPHGSLEKCLYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLS  570 (599)
Q Consensus       500 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~  570 (599)
                      ++|||||++|+|.+++....         ..+++..+.+|+.|+|+||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886421         24688899999999999999999   8899999999999999999999999


Q ss_pred             cccCCccCCcCCCceeeecccCCccccCC
Q 042902          571 DFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       571 DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      |||+|+.+.............||+.||||
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             ecccceeccCCcceeeccceecccccCCH
Confidence            99999977555444444556789999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.5e-33  Score=276.22  Aligned_cols=167  Identities=28%  Similarity=0.388  Sum_probs=141.5

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++...  +...+++.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57889999999999999999974 79999999996542  3346789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+.++.+..........+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99765554444444556899999999999999999999   8999999999999999999999999999998654332  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.|+||
T Consensus       157 ~~~~~~~gt~~y~ap  171 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAP  171 (298)
T ss_dssp             BCTTCCBCCCTTCCH
T ss_pred             ccceeecccceeeeh
Confidence            223446799999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-32  Score=273.03  Aligned_cols=164  Identities=27%  Similarity=0.472  Sum_probs=140.5

Q ss_pred             CceecccccceEEEEEecCC----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCeeeEEEEcc
Q 042902          433 NNLIGRGGVASVYKARIQDG----IEVAVKVFDLQ-YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDFKALVLEYM  506 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  506 (599)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999997532    36999998643 34456789999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc--
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS--  584 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~--  584 (599)
                      ++|+|.++++......++..+++++.|+++||.|+|   +.+|+||||||+|||+++++.+||+|||+|+........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   899999999999999999999999999999876543322  


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                      .......||+.||||
T Consensus       189 ~~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         189 HNKTGAKLPVKWMAL  203 (311)
T ss_dssp             TCTTCSSCCGGGSCH
T ss_pred             eecccccccccccCh
Confidence            122346789999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.1e-33  Score=270.74  Aligned_cols=168  Identities=26%  Similarity=0.376  Sum_probs=133.6

Q ss_pred             CCCCcCceecccccceEEEEEec--CC--cEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeee
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ--DG--IEVAVKVFDLQ---YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  500 (599)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||+++..   .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45888899999999999999864  23  47899998654   23446789999999999999999999999965 4678


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +||||+++|++.+++......+++..++.++.|||+||.|||   +++|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988776667999999999999999999999   89999999999999999999999999999997754


Q ss_pred             CCCce-eeecccCCccccCC
Q 042902          581 EDQSL-TQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~~-~~~~~~gt~~y~AP  599 (599)
                      ..... ......||+.||||
T Consensus       164 ~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             CCCcceecCccccCcccCCH
Confidence            43322 22345678899998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=275.66  Aligned_cols=170  Identities=24%  Similarity=0.391  Sum_probs=148.9

Q ss_pred             hCCCCcCceecccccceEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCe
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ------DGIEVAVKVFDLQY-EGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  498 (599)
                      .++|+..+.||+|+||.||+|++.      +++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            457888899999999999999852      46789999997553 34456799999999999 69999999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCC-----------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          499 KALVLEYMPHGSLEKCLYSSN-----------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      .++|||||++|+|.++++...                 ..+++..+..|+.||++||+|||   +.+||||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 24888999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+|++|||.|+...............||+.||||
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            99999999999999987655555555667899999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=1.4e-32  Score=270.41  Aligned_cols=169  Identities=21%  Similarity=0.406  Sum_probs=136.9

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC----e
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY---EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD----F  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  498 (599)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++...   ....+.|.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999864 79999999997543   234567999999999999999999999987654    4


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+||||++||+|.+++...+ .+++..+..++.||++||+|||   +.+|+||||||+|||++.++..+++|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 4889999999999999999999   899999999999999999999999999998765


Q ss_pred             CcCCC-ceeeecccCCccccCC
Q 042902          579 LKEDQ-SLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~-~~~~~~~~gt~~y~AP  599 (599)
                      ..... .......+||+.||||
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             C----------------TTCCH
T ss_pred             ccccccccccccccCcccccCH
Confidence            43322 2233556899999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=274.38  Aligned_cols=161  Identities=32%  Similarity=0.445  Sum_probs=135.1

Q ss_pred             CceecccccceEEEEEec-CCcEEEEEEeccccc-----ccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEcc
Q 042902          433 NNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE-----GAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEYM  506 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  506 (599)
                      .+.||+|+||+||+|++. +|+.||||+++....     ...+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999975 699999999864422     12356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCcee
Q 042902          507 PHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSLT  586 (599)
Q Consensus       507 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~~  586 (599)
                      +++++..+... ...+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......  .
T Consensus        83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             cchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            98877665543 445788888999999999999999   89999999999999999999999999999986644322  2


Q ss_pred             eecccCCccccCC
Q 042902          587 QTQTLATIGYMAP  599 (599)
Q Consensus       587 ~~~~~gt~~y~AP  599 (599)
                      ....+||+.||||
T Consensus       157 ~~~~~gt~~y~aP  169 (299)
T d1ua2a_         157 YTHQVVTRWYRAP  169 (299)
T ss_dssp             CCCSCCCCTTCCH
T ss_pred             ccceecChhhccH
Confidence            3446799999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-32  Score=272.40  Aligned_cols=166  Identities=31%  Similarity=0.522  Sum_probs=138.4

Q ss_pred             CCCCcCceecccccceEEEEEec-CCc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCcceeEEEEEEcCCeeeEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGI--EVAVKVFDLQ-YEGAFKSFDIECDMMKRI-RHRNLIKIISSCSNDDFKALV  502 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  502 (599)
                      ++|+..+.||+|+||+||+|++. +|.  .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999976 344  5788887543 344566899999999998 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcC---------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcE
Q 042902          503 LEYMPHGSLEKCLYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVA  567 (599)
Q Consensus       503 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~  567 (599)
                      |||+++|+|.++++..               ...+++..+.+++.|||+||.|+|   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998754               246899999999999999999999   8899999999999999999999


Q ss_pred             EEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          568 HLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       568 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ||+|||+|+......   ......||+.|+||
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP  195 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAI  195 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCH
T ss_pred             EEccccccccccccc---cccceecCCcccch
Confidence            999999998653322   22345689999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=8.5e-31  Score=270.13  Aligned_cols=191  Identities=32%  Similarity=0.483  Sum_probs=87.4

Q ss_pred             ccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCc
Q 042902          118 ISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLR  197 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  197 (599)
                      +..+++++.+++++|.+++..|  +...++|++|++++|++++.  +.+..+++|+.|++++|++++..+  +..+++|+
T Consensus       193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~  266 (384)
T d2omza2         193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT  266 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             cccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCC
Confidence            3344444555555554444322  23344455555555544421  234444555555555555443321  44444555


Q ss_pred             EeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccc
Q 042902          198 NLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRL  277 (599)
Q Consensus       198 ~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  277 (599)
                      +|++++|.++.+++ +..++.++.++++.|.+++.  ..+..+++++.|++++|++++..  .+..+++|++|++++|+|
T Consensus       267 ~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         267 ELKLGANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             EEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred             EeeccCcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence            55555555444432 33444445555555544432  22444445555555555554432  144445555555555554


Q ss_pred             cccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccc
Q 042902          278 QGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFN  323 (599)
Q Consensus       278 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  323 (599)
                      ++ ++ .++.+++|++|++++|++++..|  +.++++|+.|++++|
T Consensus       342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         342 SD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            42 12 34445555555555555543332  444455555555444

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=267.51  Aligned_cols=161  Identities=30%  Similarity=0.441  Sum_probs=132.5

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEc-CCeeeEEEEcc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSN-DDFKALVLEYM  506 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  506 (599)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++..  ...++|.+|++++++++|||||+++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45777889999999999999985 889999999643  345789999999999999999999999865 45689999999


Q ss_pred             CCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          507 PHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       507 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      ++|+|.+++.... ..+++..+++|+.||+.||.|||   +.+|+||||||+||+++.++.+|++|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999997543 25899999999999999999999   899999999999999999999999999999864322    


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                       .....+|+.||||
T Consensus       157 -~~~~~~~~~y~aP  169 (262)
T d1byga_         157 -QDTGKLPVKWTAP  169 (262)
T ss_dssp             ------CCTTTSCH
T ss_pred             -CccccccccCCCh
Confidence             2334688999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-32  Score=271.20  Aligned_cols=170  Identities=28%  Similarity=0.428  Sum_probs=142.2

Q ss_pred             hCCCCcCceecccccceEEEEEecC--------CcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCcceeEEEEEEcC
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQD--------GIEVAVKVFDLQYE-GAFKSFDIECDMMKRI-RHRNLIKIISSCSND  496 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  496 (599)
                      .++|...+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4578888999999999999998532        35799999976543 3457889999999888 899999999999999


Q ss_pred             CeeeEEEEccCCCChhhhhhcCC---------------CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeee
Q 042902          497 DFKALVLEYMPHGSLEKCLYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLL  561 (599)
Q Consensus       497 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill  561 (599)
                      +..++|||||++|+|.+++....               ..+++..++.++.||++||+|||   +.+||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997543               24799999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          562 DDNMVAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       562 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      +.++.+||+|||+++...............||+.||||
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            99999999999999977655444445567899999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7e-32  Score=271.78  Aligned_cols=161  Identities=24%  Similarity=0.367  Sum_probs=136.3

Q ss_pred             CCCCcC-ceecccccceEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCcceeEEEEEEc----CCeee
Q 042902          428 NGFSEN-NLIGRGGVASVYKARI-QDGIEVAVKVFDLQYEGAFKSFDIECDMMKRI-RHRNLIKIISSCSN----DDFKA  500 (599)
Q Consensus       428 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~  500 (599)
                      ++|... +.||+|+||+||+|++ .+|+.||||+++.     ...+.+|++++.++ +|||||++++++.+    ....|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            467776 4699999999999987 4799999999853     24577899887655 89999999999865    35789


Q ss_pred             EEEEccCCCChhhhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC---CCcEEEccccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSN-YILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD---NMVAHLSDFGMAK  576 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~---~~~~kl~DFGla~  576 (599)
                      +|||||+||+|.+++...+ ..+++..+..|+.||+.||+|||   +.+|+||||||+|||+++   ++.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceee
Confidence            9999999999999998653 36899999999999999999999   899999999999999985   4579999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ......   ......||+.||||
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aP  182 (335)
T d2ozaa1         163 ETTSHN---SLTTPCYTPYYVAP  182 (335)
T ss_dssp             ECCCCC---CCCCCSCCCSSCCC
T ss_pred             eccCCC---ccccccCCcccCCc
Confidence            765432   23456799999999

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=3e-31  Score=266.03  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=138.8

Q ss_pred             CCCEEEccCcccccc--CCccccCCCCCCEEeccC-ccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccc
Q 042902           21 KLSRLELEMNSFYGF--IPNTFGNLRNLKRLSLNY-NYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS   97 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~   97 (599)
                      +++.|+|++|.+++.  +|.+|++|++|++|+|++ |++++..|.     .++++++|++|+|++|+|.+..+..+..+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~-----~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~  125 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP-----AIAKLTQLHYLYITHTNVSGAIPDFLSQIK  125 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCG-----GGGGCTTCSEEEEEEECCEEECCGGGGGCT
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccc-----ccccccccchhhhccccccccccccccchh
Confidence            466666666666652  456666666666666664 555532221     466666666666666666666665555554


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCC-CEEEcccccccccCChhhhcCCCCcEEE
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKL-QLLSLEDNQLEGSIPDDLCRLAALFLLD  176 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~  176 (599)
                       .|+.+++++|++.+..|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .++
T Consensus       126 -~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~  203 (313)
T d1ogqa_         126 -TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVD  203 (313)
T ss_dssp             -TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEE
T ss_pred             -hhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccc
Confidence             35566666666665566666666666666666666655555555555554 555666666665555555554333 455


Q ss_pred             eeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCC
Q 042902          177 LGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGF  256 (599)
Q Consensus       177 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  256 (599)
                      +++|...+..|..+..+++|+.+++++|.+...+..+..+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.
T Consensus       204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~  283 (313)
T d1ogqa_         204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccccc
Confidence            55555555555555555555555555555554444444455555555555555555555555555555555555555544


Q ss_pred             CCccccCccccccccccccc
Q 042902          257 IPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       257 ~~~~~~~l~~L~~L~L~~N~  276 (599)
                      +|. ++.+++|+.+++++|+
T Consensus       284 iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         284 IPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCC-STTGGGSCGGGTCSSS
T ss_pred             CCC-cccCCCCCHHHhCCCc
Confidence            442 3444444444444443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=4.2e-32  Score=268.42  Aligned_cols=166  Identities=24%  Similarity=0.360  Sum_probs=140.8

Q ss_pred             CCCCcCceecccccceEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||+||+|++++|+.||||+++..  .+...+++.+|+.+|++++|||||++++++.+++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578899999999999999999999999999999654  233467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCce
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQSL  585 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~~  585 (599)
                      +.++.+..+... ...+++..+..++.||++||+|||   +.+||||||||+|||++.++.+|++|||.|........  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            988766665544 446899999999999999999999   88999999999999999999999999999986543322  


Q ss_pred             eeecccCCccccCC
Q 042902          586 TQTQTLATIGYMAP  599 (599)
Q Consensus       586 ~~~~~~gt~~y~AP  599 (599)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~y~~p  169 (286)
T d1ob3a_         156 KYTHEIVTLWYRAP  169 (286)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccceecccchhhhH
Confidence            23445789999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.9e-32  Score=264.10  Aligned_cols=164  Identities=23%  Similarity=0.287  Sum_probs=138.8

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCC--CCcceeEEEEEEcCCe
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYE------GAFKSFDIECDMMKRIR--HRNLIKIISSCSNDDF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  498 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++....      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57889999999999999999975 799999999864321      12234678999999986  9999999999999999


Q ss_pred             eeEEEEccCC-CChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-CCcEEEccccCCc
Q 042902          499 KALVLEYMPH-GSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-NMVAHLSDFGMAK  576 (599)
Q Consensus       499 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-~~~~kl~DFGla~  576 (599)
                      .++||||+++ +++.+++.... .+++..+..++.||++||+|||   +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999986 57777776543 4889999999999999999999   899999999999999985 5799999999998


Q ss_pred             cCCcCCCceeeecccCCccccCC
Q 042902          577 PLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       577 ~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .....    ......||+.||||
T Consensus       160 ~~~~~----~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPP  178 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCH
T ss_pred             ecccc----cccccccCCCcCCH
Confidence            65322    23456799999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1e-29  Score=262.01  Aligned_cols=314  Identities=27%  Similarity=0.423  Sum_probs=233.1

Q ss_pred             cCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEccc
Q 042902            3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSN   82 (599)
Q Consensus         3 L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~   82 (599)
                      ++.+++++.++  ...+.+|++|++++|.|+++  ..+..|++|++|+|++|+|+++++       ++++++|++|++++
T Consensus        29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~-------l~~L~~L~~L~L~~   97 (384)
T d2omza2          29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-------LKNLTKLVDILMNN   97 (384)
T ss_dssp             TTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEECCS
T ss_pred             hCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc-------ccCCcccccccccc
Confidence            34455555443  23456677777777777764  346677777777777777776542       66777777777777


Q ss_pred             CcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCC---------------------------
Q 042902           83 NSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN---------------------------  135 (599)
Q Consensus        83 N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~---------------------------  135 (599)
                      |+|.++.+  ++.++ .|+.+++.+|.+++..+  ......+..+....|.+.                           
T Consensus        98 n~i~~i~~--l~~l~-~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (384)
T d2omza2          98 NQIADITP--LANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA  172 (384)
T ss_dssp             SCCCCCGG--GTTCT-TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGT
T ss_pred             cccccccc--ccccc-ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhc
Confidence            77765432  55665 37777777776664332  222333333333332221                           


Q ss_pred             --------------cccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          136 --------------GSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       136 --------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                                    ......+..+++++.+++++|.+++..|  +...++|+.|++++|++++.  +.+..+++|+.|++
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l  248 (384)
T d2omza2         173 NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDL  248 (384)
T ss_dssp             TCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred             cccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhcc
Confidence                          1123456788999999999999997654  56778999999999999864  46888999999999


Q ss_pred             CCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccC
Q 042902          202 GSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSI  281 (599)
Q Consensus       202 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  281 (599)
                      ++|.++.++. +..+++|+.|++++|.+++..  .+..++.++.++++.|.+++.  ..+..+++++.|++++|++++..
T Consensus       249 ~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~  323 (384)
T d2omza2         249 ANNQISNLAP-LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS  323 (384)
T ss_dssp             CSSCCCCCGG-GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG
T ss_pred             ccCccCCCCc-ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc
Confidence            9999998864 778899999999999998654  477889999999999999864  45888999999999999999764


Q ss_pred             cccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCC
Q 042902          282 PDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGN  346 (599)
Q Consensus       282 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n  346 (599)
                      +  +..+++|++|++++|+|++ ++ .+..+++|++|++++|++++.+| ...+..+....+.+|
T Consensus       324 ~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         324 P--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             G--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             c--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            3  8899999999999999985 44 68999999999999999997765 344556666665554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=264.80  Aligned_cols=168  Identities=24%  Similarity=0.298  Sum_probs=138.0

Q ss_pred             hCCCCcCceecccccceEEEEEe-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC----eee
Q 042902          427 TNGFSENNLIGRGGVASVYKARI-QDGIEVAVKVFDLQY-EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD----FKA  500 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  500 (599)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35688999999999999999986 479999999997543 344568999999999999999999999987543    234


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCc
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~  580 (599)
                      +++||+.+|+|.+++...  .+++..+..++.||++||+|||   +.+||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            556667799999999765  3899999999999999999999   89999999999999999999999999999986644


Q ss_pred             CCCc-eeeecccCCccccCC
Q 042902          581 EDQS-LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-~~~~~~~gt~~y~AP  599 (599)
                      .... ......+||+.|+||
T Consensus       162 ~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCG
T ss_pred             CCccceeeccccccceechH
Confidence            3221 123456799999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=4e-30  Score=254.51  Aligned_cols=166  Identities=17%  Similarity=0.206  Sum_probs=141.3

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CcceeEEEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRH-RNLIKIISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  505 (599)
                      ++|...+.||+|+||+||+|++. +|+.||||+++....  ...+..|++.++.++| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57889999999999999999965 689999999865432  2356778888988875 8999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecC-----CCcEEEccccCCccCCc
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDD-----NMVAHLSDFGMAKPLLK  580 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~DFGla~~~~~  580 (599)
                      + +|+|.+++......+++..+..++.|++.||+|+|   +.+|+||||||+|||++.     ++.+||+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 78999999877777999999999999999999999   999999999999999974     56899999999987653


Q ss_pred             CCCc-----eeeecccCCccccCC
Q 042902          581 EDQS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       581 ~~~~-----~~~~~~~gt~~y~AP  599 (599)
                      ....     ......+||+.||||
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             CccccceeecccCceEEchhhcCH
Confidence            3211     123356799999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-30  Score=262.24  Aligned_cols=162  Identities=27%  Similarity=0.352  Sum_probs=134.6

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEcCC------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSNDD------  497 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  497 (599)
                      .++|+..+.||+|+||+||+|... +|+.||||+++..  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999975 6999999999754  2334567899999999999999999999997654      


Q ss_pred             eeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          498 FKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       498 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ..|+||||+ ++++..+.+..  .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 66888777654  3899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCcCCCceeeecccCCccccCC
Q 042902          578 LLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       578 ~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....     .+...||+.||||
T Consensus       171 ~~~~-----~~~~~~t~~y~aP  187 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAP  187 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cCCc-----cccccccccccCH
Confidence            5322     2456799999999

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-30  Score=261.58  Aligned_cols=161  Identities=28%  Similarity=0.460  Sum_probs=132.3

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------CeeeE
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKIISSCSND------DFKAL  501 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  501 (599)
                      .|+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+++|++++|||||++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999975 699999999965432    234699999999999999999998543      25789


Q ss_pred             EEEccCCCChhhhhh--cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccC
Q 042902          502 VLEYMPHGSLEKCLY--SSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPL  578 (599)
Q Consensus       502 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~  578 (599)
                      |||||++|.......  .....+++..+..++.||++||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764443332  23446899999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ....   ......||+.|+||
T Consensus       174 ~~~~---~~~~~~gt~~y~aP  191 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAP  191 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCH
T ss_pred             cCCc---ccccccccccccCh
Confidence            4433   22346799999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-30  Score=259.39  Aligned_cols=167  Identities=26%  Similarity=0.374  Sum_probs=137.3

Q ss_pred             hCCCCcCceecccccceEEEEEec-C-CcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCcceeEEEEEEc----
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-D-GIEVAVKVFDLQY--EGAFKSFDIECDMMKRI---RHRNLIKIISSCSN----  495 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  495 (599)
                      .++|+..+.||+|+||+||+|++. + ++.||||+++...  .....++.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 6679999986542  22334566777776655   79999999998853    


Q ss_pred             -CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccC
Q 042902          496 -DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGM  574 (599)
Q Consensus       496 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGl  574 (599)
                       ....+++|||+++|++..........+++..+..++.||++||+|||   +.+||||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             24679999999998877666666667899999999999999999999   89999999999999999999999999999


Q ss_pred             CccCCcCCCceeeecccCCccccCC
Q 042902          575 AKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       575 a~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ++.....   .......||+.||||
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~AP  184 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAP  184 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCH
T ss_pred             hhhhccc---ccCCCcccChhhcCc
Confidence            9855322   233457899999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.6e-30  Score=258.48  Aligned_cols=169  Identities=25%  Similarity=0.380  Sum_probs=137.2

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCcceeEEEEEEc--------
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQ--YEGAFKSFDIECDMMKRIRHRNLIKIISSCSN--------  495 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  495 (599)
                      .++|+..+.||+|+||+||+|++. +|+.||||++...  .+...+++.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367889999999999999999975 7999999998644  33456788999999999999999999998855        


Q ss_pred             CCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCC
Q 042902          496 DDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMA  575 (599)
Q Consensus       496 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla  575 (599)
                      .+..|+||||++++.+..... ....++...+..++.||++||.|||   +.+|+||||||+|||++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            345799999998877665443 3345788889999999999999999   899999999999999999999999999999


Q ss_pred             ccCCcCCCc--eeeecccCCccccCC
Q 042902          576 KPLLKEDQS--LTQTQTLATIGYMAP  599 (599)
Q Consensus       576 ~~~~~~~~~--~~~~~~~gt~~y~AP  599 (599)
                      +.+......  ......+||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCH
T ss_pred             eecccccccccccccceecCHHHhhH
Confidence            866533221  122345799999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=5.7e-30  Score=258.16  Aligned_cols=159  Identities=24%  Similarity=0.372  Sum_probs=136.6

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcC--CeeeEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSND--DFKALVL  503 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  503 (599)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..   ..+++.+|+++|+++. ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            46889999999999999999974 6999999998643   3467889999999995 99999999998744  4689999


Q ss_pred             EccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCC-cEEEccccCCccCCcCC
Q 042902          504 EYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNM-VAHLSDFGMAKPLLKED  582 (599)
Q Consensus       504 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~-~~kl~DFGla~~~~~~~  582 (599)
                      |||++|+|..+.+    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999987643    3888999999999999999999   89999999999999998655 69999999998664332


Q ss_pred             CceeeecccCCccccCC
Q 042902          583 QSLTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~~~~~~~~gt~~y~AP  599 (599)
                         ......+|+.|+||
T Consensus       185 ---~~~~~~~t~~y~aP  198 (328)
T d3bqca1         185 ---EYNVRVASRYFKGP  198 (328)
T ss_dssp             ---CCCSCCSCGGGCCH
T ss_pred             ---cccccccCccccCc
Confidence               23456789999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.7e-30  Score=252.97  Aligned_cols=166  Identities=25%  Similarity=0.351  Sum_probs=143.0

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcCCeeeEEEE
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47889999999999999999975 78999999986543  3456789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccCCcCCCc
Q 042902          505 YMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPLLKEDQS  584 (599)
Q Consensus       505 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~~~~~~~  584 (599)
                      |+.++++..++...+ .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999999888776543 5788899999999999999999   88999999999999999999999999999987654332 


Q ss_pred             eeeecccCCccccCC
Q 042902          585 LTQTQTLATIGYMAP  599 (599)
Q Consensus       585 ~~~~~~~gt~~y~AP  599 (599)
                       ......+++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (292)
T d1unla_         157 -CYSAEVVTLWYRPP  170 (292)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -cceeeccccchhhh
Confidence             22334567777776

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.7e-28  Score=244.88  Aligned_cols=277  Identities=21%  Similarity=0.284  Sum_probs=145.2

Q ss_pred             CCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCc
Q 042902            5 GNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNS   84 (599)
Q Consensus         5 ~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~   84 (599)
                      +++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.++.+++.     .|.++++|++|++++|+
T Consensus        19 ~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~-----~f~~l~~L~~L~l~~n~   90 (305)
T d1xkua_          19 DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFAPLVKLERLYLSKNQ   90 (305)
T ss_dssp             TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEECCSSC
T ss_pred             CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh-----hhhCCCccCEecccCCc
Confidence            34455 4566553  4677777777777776666777777777777777777776654     46777777777777777


Q ss_pred             ccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCC--cccCccccCCCCCCEEEcccccccccC
Q 042902           85 LDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLN--GSIPIALDKLQKLQLLSLEDNQLEGSI  162 (599)
Q Consensus        85 i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~  162 (599)
                      |+.+....+    ..+..+.+.+|.+.++.+..+.....++.++...|...  ...+..|..+++|+++++++|.+.. +
T Consensus        91 l~~l~~~~~----~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l  165 (305)
T d1xkua_          91 LKELPEKMP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-I  165 (305)
T ss_dssp             CSBCCSSCC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-C
T ss_pred             cCcCccchh----hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-c
Confidence            764432211    13445555555555555555555555555555555432  2223344555555555555555542 2


Q ss_pred             ChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCC-ccccCCCcccEEeecCCCccccCcccccccc
Q 042902          163 PDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLR  241 (599)
Q Consensus       163 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  241 (599)
                      |..+  +++|+.|++++|..+...+..|.+++.++.|++++|.++.++ ..+.++++|++|+|++|+|+. +|.+|..++
T Consensus       166 ~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~  242 (305)
T d1xkua_         166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHK  242 (305)
T ss_dssp             CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCS
T ss_pred             Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-ccccccccc
Confidence            2221  344555555555555444445555555555555555555442 233444445555555554442 233444444


Q ss_pred             cccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCccc--ccCCchhhccccc
Q 042902          242 VLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS--GAIPISLEKLLDL  315 (599)
Q Consensus       242 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L  315 (599)
                      +|++|+|++|+|+.+....|..                  +..+..+.+|+.|+|++|+++  ...|..|..+...
T Consensus       243 ~L~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~  300 (305)
T d1xkua_         243 YIQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR  300 (305)
T ss_dssp             SCCEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred             CCCEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCccCcCCHhHhcccccC
Confidence            4555555444444332222211                  112233456666666666654  2444455444333

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=2.9e-28  Score=243.06  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=181.6

Q ss_pred             CcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcc
Q 042902           75 LKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLE  154 (599)
Q Consensus        75 L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  154 (599)
                      +++|+|++|+|+.+.+.+|.+++ .|+.+++++|.+..+.|..|.++++|++|++++|+++.+...   ....++.|++.
T Consensus        33 l~~L~Ls~N~i~~l~~~~f~~l~-~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~  108 (305)
T d1xkua_          33 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVH  108 (305)
T ss_dssp             CCEEECCSSCCCCBCTTTTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECC
T ss_pred             CCEEECcCCcCCCcChhHhhccc-cccccccccccccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhhhcc
Confidence            44444444444433333444443 244444444444445556667777788888888877754332   23567778888


Q ss_pred             cccccccCChhhhcCCCCcEEEeeCCccC--CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCcccc
Q 042902          155 DNQLEGSIPDDLCRLAALFLLDLGGNKLS--GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGP  232 (599)
Q Consensus       155 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~  232 (599)
                      +|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.++.+|..+  .++|+.|++++|.+++.
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~  186 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKV  186 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEE
T ss_pred             ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCC
Confidence            88887766666777777778887777543  334556788888999999999988887654  57889999999999888


Q ss_pred             CcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCchh---
Q 042902          233 LPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISL---  309 (599)
Q Consensus       233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~---  309 (599)
                      .+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......|   
T Consensus       187 ~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~  265 (305)
T d1xkua_         187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP  265 (305)
T ss_dssp             CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred             ChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCc
Confidence            8888999999999999999999888888999999999999999998 457789999999999999999986544443   


Q ss_pred             ---hccccceEEEcccccCcc
Q 042902          310 ---EKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       310 ---~~l~~L~~l~l~~N~l~~  327 (599)
                         ..+.+|+.|++++|++..
T Consensus       266 ~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         266 GYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             SCCTTSCCCSEEECCSSSSCG
T ss_pred             chhcccCCCCEEECCCCcCcc
Confidence               456789999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.9e-29  Score=249.54  Aligned_cols=166  Identities=24%  Similarity=0.335  Sum_probs=135.7

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcceeE-EEEEEcCCeeeEEEEc
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNLIKI-ISSCSNDDFKALVLEY  505 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~  505 (599)
                      ++|+..+.||+|+||+||+|++. +|+.||||++.....  .+++..|+++++.++|+++|.. .+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46889999999999999999874 689999999865432  2457889999999987776555 4555677889999999


Q ss_pred             cCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeec---CCCcEEEccccCCccCCcCC
Q 042902          506 MPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLD---DNMVAHLSDFGMAKPLLKED  582 (599)
Q Consensus       506 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~---~~~~~kl~DFGla~~~~~~~  582 (599)
                      + +|++.+.+......+++..+..++.|+++||+|||   +.+|+||||||+|||++   .+..+|++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 56777777666667999999999999999999999   89999999999999986   44579999999999765433


Q ss_pred             Cc-----eeeecccCCccccCC
Q 042902          583 QS-----LTQTQTLATIGYMAP  599 (599)
Q Consensus       583 ~~-----~~~~~~~gt~~y~AP  599 (599)
                      ..     .......||+.||||
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCH
T ss_pred             cccceeccccCCcCCCccccCH
Confidence            21     123456799999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.5e-30  Score=257.19  Aligned_cols=167  Identities=26%  Similarity=0.363  Sum_probs=143.2

Q ss_pred             CCCCcCceecccccceEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCC-CcceeEEEEEEcCCe
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ----DGIEVAVKVFDLQY----EGAFKSFDIECDMMKRIRH-RNLIKIISSCSNDDF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  498 (599)
                      ++|+..+.||+|+||+||+|+..    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999852    58999999986432    2345678899999999977 899999999999999


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+++|+|.+++...+. .....+..++.||+.|++|+|   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999876554 567788889999999999999   889999999999999999999999999999876


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ..... .......||+.|+||
T Consensus       180 ~~~~~-~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         180 VADET-ERAYDFCGTIEYMAP  199 (322)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCH
T ss_pred             ccccc-ccccccccccccchh
Confidence            43322 223456799999997

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.4e-28  Score=240.00  Aligned_cols=253  Identities=23%  Similarity=0.241  Sum_probs=162.8

Q ss_pred             EEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceEE
Q 042902           24 RLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVF  103 (599)
Q Consensus        24 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l  103 (599)
                      .++.++++++.+ |..+.  +++++|+|++|+|+.+++.     +|.++++|++|++++|+|..+.+..+.......+..
T Consensus        15 ~v~c~~~~L~~i-P~~ip--~~~~~L~Ls~N~i~~i~~~-----~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~   86 (284)
T d1ozna_          15 TTSCPQQGLQAV-PVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD   86 (284)
T ss_dssp             EEECCSSCCSSC-CTTCC--TTCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             EEEcCCCCCCcc-CCCCC--CCCCEEECcCCcCCCCCHH-----Hhhccccccccccccccccccccccccccccccccc
Confidence            455666667653 44332  4567777777777777664     577777777777777777777666666665433333


Q ss_pred             EccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccC
Q 042902          104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS  183 (599)
Q Consensus       104 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  183 (599)
                      ....+.++.+.+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+++
T Consensus        87 ~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~  166 (284)
T d1ozna_          87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS  166 (284)
T ss_dssp             CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc
Confidence            44556666666777777777777777777777666666777777777777777777666666767777777777777777


Q ss_pred             CCCCcccCCCCCCcEeecCCCCCCCC-CccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCcccc
Q 042902          184 GFVPACFGNLTSLRNLYLGSNQLTSI-PSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIG  262 (599)
Q Consensus       184 ~~~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  262 (599)
                      ++.+.+|.++++|+.+++++|+++.+ |..|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+...-+ .-.
T Consensus       167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~  245 (284)
T d1ozna_         167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARP  245 (284)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHH
T ss_pred             ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chH
Confidence            66666777777777777777777655 4566666667777777777766666666666667777777666653211 101


Q ss_pred             CcccccccccccccccccCcccc
Q 042902          263 DLKDLQYLFLEYNRLQGSIPDSI  285 (599)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~~  285 (599)
                      -...++.+....+++....|..+
T Consensus       246 l~~~l~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         246 LWAWLQKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             HHHHHHHCCSEECCCBEEESGGG
T ss_pred             HHHHHHhCcCCCCceEeCCchHH
Confidence            11234444555555544444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.7e-28  Score=237.40  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=225.3

Q ss_pred             cCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcc-
Q 042902            3 LWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFS-   81 (599)
Q Consensus         3 L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls-   81 (599)
                      .++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|+|..++..     .+.+++.++.++.+ 
T Consensus        18 c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~-----~~~~~~~~~~l~~~~   89 (284)
T d1ozna_          18 CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-----AFTGLALLEQLDLSD   89 (284)
T ss_dssp             CCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCCEEECCS
T ss_pred             cCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccc-----ccccccccccccccc
Confidence            4556666 6787765  5799999999999999989999999999999999999998876     58889999999875 


Q ss_pred             cCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEccccccccc
Q 042902           82 NNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGS  161 (599)
Q Consensus        82 ~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  161 (599)
                      .|.++.+.+.+|.+++ .|+.|++++|.+....+..+...++|+.+++++|.|+++.+.+|..+++|++|++++|+++++
T Consensus        90 ~~~~~~l~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l  168 (284)
T d1ozna_          90 NAQLRSVDPATFHGLG-RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (284)
T ss_dssp             CTTCCCCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             ccccccccchhhcccc-cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence            6788888899999997 499999999999988888999999999999999999998889999999999999999999999


Q ss_pred             CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCc-cccCCCcccEEeecCCCccccCccccccc
Q 042902          162 IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNL  240 (599)
Q Consensus       162 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  240 (599)
                      .+..|.++++|+.+++++|+++++.|..|.++++|++|++++|.+..++. .+..+++|++|++++|.+....+.. .-.
T Consensus       169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~  247 (284)
T d1ozna_         169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW  247 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred             chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-HHH
Confidence            99999999999999999999999999999999999999999999999875 6778999999999999998643321 112


Q ss_pred             ccccEEEccCCccCCCCCccccCccccccccccccccc
Q 042902          241 RVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  278 (599)
                      ..++.+....+++....|..+.+   ....+++.+.|+
T Consensus       248 ~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         248 AWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             HHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             HHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            34666677777777666776654   344455555554

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.3e-29  Score=254.76  Aligned_cols=163  Identities=25%  Similarity=0.338  Sum_probs=135.7

Q ss_pred             hCCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC-----Ce
Q 042902          427 TNGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND-----DF  498 (599)
Q Consensus       427 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  498 (599)
                      .++|+..+.||+|+||+||+|+.. +|+.||||+++...  ....+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999864 79999999997543  23456789999999999999999999998643     34


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .++||||+.+|+|.+++..+  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            56778888899999998654  4899999999999999999999   899999999999999999999999999999754


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...     .....||+.||||
T Consensus       172 ~~~-----~~~~~g~~~y~ap  187 (348)
T d2gfsa1         172 DDE-----MTGYVATRWYRAP  187 (348)
T ss_dssp             TGG-----GSSSCHHHHTSCH
T ss_pred             Ccc-----cccccccccccCc
Confidence            322     2345789999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=250.93  Aligned_cols=162  Identities=25%  Similarity=0.328  Sum_probs=127.1

Q ss_pred             CCCCcCceecccccceEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCcceeEEEEEEcC------Ce
Q 042902          428 NGFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQY--EGAFKSFDIECDMMKRIRHRNLIKIISSCSND------DF  498 (599)
Q Consensus       428 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  498 (599)
                      ++|...+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57889999999999999999976 69999999996542  33456789999999999999999999998643      57


Q ss_pred             eeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccccCCccC
Q 042902          499 KALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKPL  578 (599)
Q Consensus       499 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~~  578 (599)
                      .|+|||||.++.+. .+..   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~-~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHH-HHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHH-hhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765554 4432   3788999999999999999999   899999999999999999999999999998865


Q ss_pred             CcCCCceeeecccCCccccCC
Q 042902          579 LKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       579 ~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      ...   .......||+.|+||
T Consensus       170 ~~~---~~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAP  187 (355)
T ss_dssp             --------------CCTTCCH
T ss_pred             ccc---cccccccccccccCh
Confidence            332   233456799999998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.6e-26  Score=222.88  Aligned_cols=201  Identities=21%  Similarity=0.257  Sum_probs=117.6

Q ss_pred             CCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccc
Q 042902           18 NASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS   97 (599)
Q Consensus        18 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~   97 (599)
                      +.+.+.+.+.++++++.+ |..+.  ++|++|+|++|+|+.+++.     +|.++++|++|+|++|+|+.+.+  ++.++
T Consensus         8 ~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~l~~~-----~f~~l~~L~~L~L~~N~l~~l~~--~~~l~   77 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLA-----TLMPYTRLTQLNLDRAELTKLQV--DGTLP   77 (266)
T ss_dssp             CSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGG-----GGTTCTTCCEEECTTSCCCEEEC--CSCCT
T ss_pred             ccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCCcCHH-----Hhhcccccccccccccccccccc--ccccc
Confidence            344455556666666653 43332  3566666666666665543     45666666666666666653311  22222


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEe
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDL  177 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  177 (599)
                       .|+.|++++|+++. .+..+.++++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++
T Consensus        78 -~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l  155 (266)
T d1p9ag_          78 -VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (266)
T ss_dssp             -TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             -cccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence             23333333333332 2344556666666666666666666666666666666666666666655566666666666666


Q ss_pred             eCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCcc
Q 042902          178 GGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       178 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      ++|+++++.+..|..+++|++|+|++|+|+++|..++.+++|+.|+|++|.+.
T Consensus       156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         156 ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence            66666666666666666666666666666666666666666666666665543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-26  Score=223.64  Aligned_cols=205  Identities=23%  Similarity=0.212  Sum_probs=160.8

Q ss_pred             cCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcE
Q 042902          119 SNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRN  198 (599)
Q Consensus       119 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  198 (599)
                      .+...+.+++.+++.|+.+ |..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.  .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence            3455666677777777743 43332  46777888888777666677777778888888888777542  3567788888


Q ss_pred             eecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccccc
Q 042902          199 LYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       199 L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  278 (599)
                      |+|++|+++.++..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+++
T Consensus        82 L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            88888888888777778888888888888888777778888888888888888888877788888888888888888888


Q ss_pred             ccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccC
Q 042902          279 GSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEI  329 (599)
Q Consensus       279 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  329 (599)
                      +..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.|..
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            888888888888888888888888 67777778888888888888887754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.2e-23  Score=192.26  Aligned_cols=133  Identities=17%  Similarity=0.201  Sum_probs=105.8

Q ss_pred             CcCceecccccceEEEEEecCCcEEEEEEecccc------------------cccHHHHHHHHHHHhcCCCCcceeEEEE
Q 042902          431 SENNLIGRGGVASVYKARIQDGIEVAVKVFDLQY------------------EGAFKSFDIECDMMKRIRHRNLIKIISS  492 (599)
Q Consensus       431 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~~  492 (599)
                      ...+.||+|+||+||+|...+|+.||||+++...                  .........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467999999999999998899999999875321                  0112345668889999999999988766


Q ss_pred             EEcCCeeeEEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeeecCCCcEEEccc
Q 042902          493 CSNDDFKALVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGYSVPIIHCDLKPNNVLLDDNMVAHLSDF  572 (599)
Q Consensus       493 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk~~Nill~~~~~~kl~DF  572 (599)
                      ..    .+++|||++++...+.        +......++.|+++|+.|||   +.+|+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    3799999988765432        22334679999999999999   8999999999999999965 5899999


Q ss_pred             cCCccCC
Q 042902          573 GMAKPLL  579 (599)
Q Consensus       573 Gla~~~~  579 (599)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.88  E-value=9.8e-24  Score=215.24  Aligned_cols=162  Identities=20%  Similarity=0.268  Sum_probs=127.2

Q ss_pred             CCCcCceecccccceEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCcceeEEEEEEc-
Q 042902          429 GFSENNLIGRGGVASVYKARIQ-DGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-----------HRNLIKIISSCSN-  495 (599)
Q Consensus       429 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~-  495 (599)
                      +|+..+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++           |+|||++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4889999999999999999974 79999999997543 23467788999888775           5789999988754 


Q ss_pred             -CCeeeEEEEccCCCChhhh--hhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCeeecCCC------
Q 042902          496 -DDFKALVLEYMPHGSLEKC--LYSSNYILDIFQRLNIMIDVASALEYLHFGYS-VPIIHCDLKPNNVLLDDNM------  565 (599)
Q Consensus       496 -~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlk~~Nill~~~~------  565 (599)
                       ....+++|+++..+.....  .......+++..+..++.||+.||+|||   + .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccc
Confidence             3566777777655543222  2233346788889999999999999999   5 7899999999999998654      


Q ss_pred             cEEEccccCCccCCcCCCceeeecccCCccccCC
Q 042902          566 VAHLSDFGMAKPLLKEDQSLTQTQTLATIGYMAP  599 (599)
Q Consensus       566 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  599 (599)
                      .+|++|||.|+.....     ....+||+.||||
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aP  198 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSP  198 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred             eeeEeecccccccccc-----cccccccccccCh
Confidence            4999999999854322     2346799999998

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=2.9e-21  Score=184.96  Aligned_cols=219  Identities=18%  Similarity=0.137  Sum_probs=133.4

Q ss_pred             CEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccceE
Q 042902           23 SRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEV  102 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~  102 (599)
                      +.++.+++.++.+ |+.+-  +++++|+|++|+|+.++..     +|.++++|++|++++|.+...              
T Consensus        11 ~~i~c~~~~l~~i-P~~l~--~~l~~L~Ls~n~i~~l~~~-----~f~~l~~L~~L~ls~n~~~~~--------------   68 (242)
T d1xwdc1          11 RVFLCQESKVTEI-PSDLP--RNAIELRFVLTKLRVIQKG-----AFSGFGDLEKIEISQNDVLEV--------------   68 (242)
T ss_dssp             SEEEEESCSCSSC-CSCSC--SCCSEEEEESCCCCEECTT-----TTTTCTTCCEEEEESCTTCCE--------------
T ss_pred             CEEEEeCCCCCCc-CCCCC--CCCCEEECcCCcCCccChh-----Hhhccchhhhhhhccccccce--------------
Confidence            4566666666653 33321  4567777777777666654     466677777777777766532              


Q ss_pred             EEccCCcccccCCccccCCCCCCEEEccC-CcCCcccCccccCCCCCCEEEcccccccccCCh-hhhcCCCCcEEEeeCC
Q 042902          103 FFMFNCNISGSIPEEISNLTNLTTIYLGG-NKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPD-DLCRLAALFLLDLGGN  180 (599)
Q Consensus       103 l~l~~n~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N  180 (599)
                                +.+.+|.+++++++|.+.. |.+....+..|.++++|++|++++|.+....+. .+..+..+..+..+++
T Consensus        69 ----------i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~  138 (242)
T d1xwdc1          69 ----------IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI  138 (242)
T ss_dssp             ----------ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCT
T ss_pred             ----------eeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccc
Confidence                      1233455555566655543 455555555566666666666666665533222 2333445555556666


Q ss_pred             ccCCCCCcccCCCC-CCcEeecCCCCCCCCCccccCCCcccEE-eecCCCccccCcccccccccccEEEccCCccCCCCC
Q 042902          181 KLSGFVPACFGNLT-SLRNLYLGSNQLTSIPSTLWNLKYILYL-NLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIP  258 (599)
Q Consensus       181 ~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ip~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  258 (599)
                      .+..+.+..|.+++ .++.|++++|+++.++...+..++++++ ++++|+++.+.+..|.++++|++|+|++|+|+.+.+
T Consensus       139 ~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~  218 (242)
T d1xwdc1         139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS  218 (242)
T ss_dssp             TCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred             ccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence            66666666666554 6777777777777776665555555444 456667776556667777777777777777776666


Q ss_pred             ccccCcccccccccc
Q 042902          259 TTIGDLKDLQYLFLE  273 (599)
Q Consensus       259 ~~~~~l~~L~~L~L~  273 (599)
                      ..|.++++|+.+++.
T Consensus       219 ~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         219 YGLENLKKLRARSTY  233 (242)
T ss_dssp             SSCTTCCEEESSSEE
T ss_pred             HHHcCCcccccCcCC
Confidence            667777777776664

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=5.9e-20  Score=185.55  Aligned_cols=262  Identities=24%  Similarity=0.260  Sum_probs=141.1

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      ++++|||++|.++. +|+.   +++|++|+|++|+|++++..         +.+|+.|++++|+++.+     ..+++.|
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~lp~~---------~~~L~~L~l~~n~l~~l-----~~lp~~L  100 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTELPEL---------PQSLKSLLVDNNNLKAL-----SDLPPLL  100 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSCCCC---------CTTCCEEECCSSCCSCC-----CSCCTTC
T ss_pred             CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCcccccc---------hhhhhhhhhhhcccchh-----hhhcccc
Confidence            46666666666664 3432   34566666666666655431         23566666666666532     1234456


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCC
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN  180 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  180 (599)
                      +.|++++|.+... | .++.+++|++|++++|.+.....    ....+..+.+..+....  ...+..++.++.+++++|
T Consensus       101 ~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n  172 (353)
T d1jl5a_         101 EYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNN  172 (353)
T ss_dssp             CEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSS
T ss_pred             ccccccccccccc-c-chhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceecccccc
Confidence            6666666666533 3 24556666666666666553221    12333444444333321  122333444444444444


Q ss_pred             ccCCCC------------------CcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCccccccccc
Q 042902          181 KLSGFV------------------PACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRV  242 (599)
Q Consensus       181 ~l~~~~------------------~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  242 (599)
                      .+....                  ...+..++.|+.+++++|....+|...   .++..+.+.+|.+.... ..   ...
T Consensus       173 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~---~~l~~~~~~~~~~~~~~-~~---~~~  245 (353)
T d1jl5a_         173 SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLP-EL---PQS  245 (353)
T ss_dssp             CCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCC---TTCCEEECCSSCCSCCC-CC---CTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-cc---ccc
Confidence            433211                  122455677777777777777665432   34556666666655321 11   122


Q ss_pred             ccEE--------------------EccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCccc
Q 042902          243 LVQI--------------------DLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       243 L~~L--------------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      +...                    ++..|.+.+.    ...+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+
T Consensus       246 l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~  317 (353)
T d1jl5a_         246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA  317 (353)
T ss_dssp             CCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS
T ss_pred             ccccccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC
Confidence            2333                    3333333321    233567888888888887 4443   3567888888888887


Q ss_pred             ccCCchhhccccceEEEcccccCcc
Q 042902          303 GAIPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       303 ~~~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                       .+|..   +++|+.|++++|+++.
T Consensus       318 -~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         318 -EVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             -CCCCC---CTTCCEEECCSSCCSS
T ss_pred             -ccccc---cCCCCEEECcCCcCCC
Confidence             45543   4578888888888874

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.86  E-value=2.5e-21  Score=183.53  Aligned_cols=206  Identities=20%  Similarity=0.297  Sum_probs=107.8

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      ++..++++.+++++..  .++.+.+|+.|++++|.|+++.       .+..+++|++|++++|.|+++.|  +..++ .+
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~-------~l~~l~~L~~L~ls~n~i~~~~~--l~~l~-~l   87 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-------GVQYLNNLIGLELKDNQITDLAP--LKNLT-KI   87 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG--GTTCC-SC
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcch-------hHhcCCCCcEeecCCceeecccc--ccccc-cc
Confidence            3445566777777643  4567777788888877777653       26677777788887777764422  33333 24


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCC
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN  180 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  180 (599)
                      +.+.+++|.++.+  ..+.++++|+++++++|...+.  ..+...+.++.+.++++.+...  ..+..+++|+.|++++|
T Consensus        88 ~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n  161 (227)
T d1h6ua2          88 TELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNA  161 (227)
T ss_dssp             CEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccc
Confidence            4444444444322  2345555556666655555433  2244455555555555555422  22444555555555555


Q ss_pred             ccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEcc
Q 042902          181 KLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLS  249 (599)
Q Consensus       181 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  249 (599)
                      .+++.  ..++++++|++|+|++|+++.++. +.++++|++|+|++|+++++.  .+.++++|+.|+++
T Consensus       162 ~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         162 QVSDL--TPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             CCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             ccccc--hhhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            55432  124445555555555555554432 344444444444444444322  13444444444443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=4.3e-21  Score=183.82  Aligned_cols=216  Identities=13%  Similarity=0.095  Sum_probs=106.9

Q ss_pred             cEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcc-cCccccCCCCCCEEEcc
Q 042902           76 KYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS-IPIALDKLQKLQLLSLE  154 (599)
Q Consensus        76 ~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~  154 (599)
                      +.++.++++++.+ |..+   +..++.|++++|+|+.+.+.+|.++++|++|+|++|.+... .+.+|.++++++++.+.
T Consensus        11 ~~i~c~~~~l~~i-P~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVTEI-PSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCSSC-CSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCCCc-CCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            5677777777633 3222   23456666666666655555666666666666666665542 33456666666666554


Q ss_pred             c-ccccccCChhhhcCCCCcEEEeeCCccCCCCCc-ccCCCCCCcEeecCCCCCCCCCc-cccCCC-cccEEeecCCCcc
Q 042902          155 D-NQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPA-CFGNLTSLRNLYLGSNQLTSIPS-TLWNLK-YILYLNLSSNSFT  230 (599)
Q Consensus       155 ~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~-~L~~L~Ls~N~l~  230 (599)
                      . |.+....+..|.++++|+.|++++|++....+. .+..+..+..+..+++.+..++. .+..++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            3 455555555566666666666666665543221 12233344444445555554432 222222 4445555555554


Q ss_pred             ccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCccccc
Q 042902          231 GPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLD  295 (599)
Q Consensus       231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  295 (599)
                      .+.+..|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+.|+
T Consensus       167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~  231 (242)
T d1xwdc1         167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS  231 (242)
T ss_dssp             EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred             ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence            43333332222222223444444443333444444444444444444433333344444444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=1.4e-19  Score=182.87  Aligned_cols=274  Identities=26%  Similarity=0.318  Sum_probs=186.2

Q ss_pred             CccCCCcCccCCCCCCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEc
Q 042902            1 LLLWGNNFSGTIPSFIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSF   80 (599)
Q Consensus         1 L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L   80 (599)
                      |||++|+++ .+|+.   .++|++|+|++|+|+.+ |+.   +.+|+.|++++|+++.++.       +  .+.|++|++
T Consensus        43 LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~l~~n~l~~l~~-------l--p~~L~~L~L  105 (353)
T d1jl5a_          43 LELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL---PQSLKSLLVDNNNLKALSD-------L--PPLLEYLGV  105 (353)
T ss_dssp             EECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSCCCS-------C--CTTCCEEEC
T ss_pred             EEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc---hhhhhhhhhhhcccchhhh-------h--ccccccccc
Confidence            689999998 56764   46899999999999974 654   4689999999999987653       1  146999999


Q ss_pred             ccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccc
Q 042902           81 SNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG  160 (599)
Q Consensus        81 s~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  160 (599)
                      ++|.|..+ |. ++.++ .|+.+++++|.+.....    ....+..+.+..+....  ...+..++.++.|++++|.+..
T Consensus       106 ~~n~l~~l-p~-~~~l~-~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~  176 (353)
T d1jl5a_         106 SNNQLEKL-PE-LQNSS-FLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK  176 (353)
T ss_dssp             CSSCCSSC-CC-CTTCT-TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSS
T ss_pred             cccccccc-cc-hhhhc-cceeecccccccccccc----ccccccchhhccccccc--cccccccccceecccccccccc
Confidence            99999865 43 45665 59999999998874322    23455556665554432  2345556666666666665442


Q ss_pred             c------------------CChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCC------
Q 042902          161 S------------------IPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNL------  216 (599)
Q Consensus       161 ~------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l------  216 (599)
                      .                  ....+..++.|+.+++++|..... +.   ...++..+.+.+|.+...+.....+      
T Consensus       177 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~~---~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~  252 (353)
T d1jl5a_         177 LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVS  252 (353)
T ss_dssp             CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCCCCCCTTCCEEECC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc-cc---ccccccccccccccccccccccccccccccc
Confidence            1                  112345678899999999987743 22   3456788888888877654332111      


Q ss_pred             -----------CcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccc
Q 042902          217 -----------KYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSI  285 (599)
Q Consensus       217 -----------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  285 (599)
                                 ......++..|.+.+    ....+++|++|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|.. 
T Consensus       253 ~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~-  322 (353)
T d1jl5a_         253 ENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL-  322 (353)
T ss_dssp             SSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC-
T ss_pred             cccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc-
Confidence                       112233344444332    22346789999999999995 454   3678999999999998 45543 


Q ss_pred             cCCCCcccccCCCCcccccCCchhhccccceEEEc
Q 042902          286 GGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINV  320 (599)
Q Consensus       286 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  320 (599)
                        +++|++|+|++|+|+ .+|....   .|+.|.+
T Consensus       323 --~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~  351 (353)
T d1jl5a_         323 --PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM  351 (353)
T ss_dssp             --CTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred             --cCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence              568999999999998 5665433   4555544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.84  E-value=1.2e-20  Score=178.89  Aligned_cols=202  Identities=24%  Similarity=0.313  Sum_probs=145.5

Q ss_pred             EccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccC
Q 042902          104 FMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLS  183 (599)
Q Consensus       104 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  183 (599)
                      .+..+++++..  .+..+.+|++|++++|.|+.+ + .+..+++|++|++++|++.+..  .+..+++|+++++++|.++
T Consensus        25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~   98 (227)
T d1h6ua2          25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK   98 (227)
T ss_dssp             HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS
T ss_pred             HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc
Confidence            44445555432  345567778888888877754 2 4777888888888888777543  3777788888888888777


Q ss_pred             CCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccC
Q 042902          184 GFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGD  263 (599)
Q Consensus       184 ~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  263 (599)
                      .+  ..+..+++|+.+++++|....++ .+...+.+..+.++.+.+...  ..+.+.++|+.|++++|.+++..  .+++
T Consensus        99 ~i--~~l~~l~~L~~l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~  171 (227)
T d1h6ua2          99 NV--SAIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLAN  171 (227)
T ss_dssp             CC--GGGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTT
T ss_pred             cc--ccccccccccccccccccccccc-hhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcc
Confidence            53  34677788888888888777654 345567778888888877643  34667778888888888887543  3778


Q ss_pred             cccccccccccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEccc
Q 042902          264 LKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSF  322 (599)
Q Consensus       264 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~  322 (599)
                      +++|++|+|++|++++. + .++.+++|++|+|++|++++..  .+.++++|++|++++
T Consensus       172 l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         172 LSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN  226 (227)
T ss_dssp             CTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred             cccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence            88888888888888754 2 3788888888888888888543  377888888888873

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=1.7e-20  Score=175.32  Aligned_cols=182  Identities=25%  Similarity=0.350  Sum_probs=89.5

Q ss_pred             CCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccce
Q 042902           22 LSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSME  101 (599)
Q Consensus        22 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~  101 (599)
                      +...++..+.+++.++.  ..+.+|++|++++|.++.+..       +..+++|++|+|++|+|+++.+  +..++ .|+
T Consensus        26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~-------l~~l~~L~~L~L~~n~i~~l~~--~~~l~-~L~   93 (210)
T d1h6ta2          26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG-------IQYLPNVTKLFLNGNKLTDIKP--LANLK-NLG   93 (210)
T ss_dssp             HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT-------GGGCTTCCEEECCSSCCCCCGG--GTTCT-TCC
T ss_pred             HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCchh-------HhhCCCCCEEeCCCccccCccc--cccCc-ccc
Confidence            33445666777665432  456777888888888776543       5677778888888887764321  22222 233


Q ss_pred             EEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCc
Q 042902          102 VFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNK  181 (599)
Q Consensus       102 ~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  181 (599)
                      .|++++|+|+++ + .+.++++|+.|++++|.+...  ..+..+++|+.+++++|.+++  +..+..+++|+++++++|+
T Consensus        94 ~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~  167 (210)
T d1h6ta2          94 WLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ  167 (210)
T ss_dssp             EEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred             cccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccccccccccccccc
Confidence            333333333321 1 244444455555554444321  234444444444444444432  1233344444444444444


Q ss_pred             cCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEee
Q 042902          182 LSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNL  224 (599)
Q Consensus       182 l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  224 (599)
                      ++++.  .++++++|++|+|++|+|+++| .+.++++|++|+|
T Consensus       168 l~~i~--~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L  207 (210)
T d1h6ta2         168 ISDIV--PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLEL  207 (210)
T ss_dssp             CCCCG--GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEE
T ss_pred             ccccc--cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEc
Confidence            44321  1444444444444444444443 2344444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=1.1e-20  Score=175.16  Aligned_cols=124  Identities=35%  Similarity=0.438  Sum_probs=50.3

Q ss_pred             CCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          122 TNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       122 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      ++|++|+|++|++++..+  +.++++|++|++++|.+... + .+..+++|+.|++++|.+...  ..+..+++|+.|++
T Consensus        62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l  135 (199)
T d2omxa2          62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL  135 (199)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred             CCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhh
Confidence            344444444444433221  33444444444444443321 1 233444444444444444322  12334444444444


Q ss_pred             CCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccC
Q 042902          202 GSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFS  254 (599)
Q Consensus       202 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  254 (599)
                      ++|++..++ .+..+++|++|++++|++++..  .++++++|+.|++++|+++
T Consensus       136 ~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         136 SSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             hhhhhcccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            444444332 2334444444444444444321  2344444444444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=8.5e-20  Score=168.99  Aligned_cols=169  Identities=26%  Similarity=0.346  Sum_probs=84.9

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           21 KLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        21 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      ++..+.++.+++++..+  ...+.+|++|++++|.|+++.       .++.+++|++|++++|+|+++.|  +.+++ .|
T Consensus        19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~-------~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~-~L   86 (199)
T d2omxa2          19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID-------GVEYLNNLTQINFSNNQLTDITP--LKNLT-KL   86 (199)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG--GTTCT-TC
T ss_pred             HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCcc-------ccccCCCcCcCccccccccCccc--ccCCc-cc
Confidence            34455667777776432  356777888888888777654       25667778888888887764322  33332 23


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccccccccCChhhhcCCCCcEEEeeCC
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGN  180 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  180 (599)
                      +.|++++|.+....  .+.++++|++|++++|.+...  ..+..+++|+.|++++|++...  +.+..+++|+.|++++|
T Consensus        87 ~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n  160 (199)
T d2omxa2          87 VDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSN  160 (199)
T ss_dssp             CEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSS
T ss_pred             cccccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccc
Confidence            33333333333211  244444455555554444432  1244444444444444444321  23444444444444444


Q ss_pred             ccCCCCCcccCCCCCCcEeecCCCCCCCC
Q 042902          181 KLSGFVPACFGNLTSLRNLYLGSNQLTSI  209 (599)
Q Consensus       181 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~i  209 (599)
                      +++++.  .|+++++|++|++++|+++++
T Consensus       161 ~l~~l~--~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         161 QVTDLK--PLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             CCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred             cccCCc--cccCCCCCCEEECCCCCCCCC
Confidence            444321  244444444444444444443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=5.3e-20  Score=169.40  Aligned_cols=156  Identities=20%  Similarity=0.236  Sum_probs=77.7

Q ss_pred             CCcEeecCCCCCCC-CC-ccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccc
Q 042902          195 SLRNLYLGSNQLTS-IP-STLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFL  272 (599)
Q Consensus       195 ~L~~L~L~~N~l~~-ip-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  272 (599)
                      ++++|+|++|+|+. ++ ..|.++++|+.|+|++|.+....+..|..+++|+.|+|++|+|+.+.+..|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            44455555555542 22 23344555555555555555555555555555555555555555555555555555555555


Q ss_pred             ccccccccCcccccCCCCcccccCCCCcccccCCchhhccccceEEEcccccCcccCCCCCCCCCcccccccCCCCCcCC
Q 042902          273 EYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPISLEKLLDLKYINVSFNKLEGEIPREGPFRNFSAESFKGNELLCGT  352 (599)
Q Consensus       273 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  352 (599)
                      ++|+|+++.++.|..+++|++|+|++|++....+..+ -...++.+.+..|.++|..|.  .++.....++..|...|.+
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~  186 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCC
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCC
Confidence            5555555555555555555555555555543222111 112344445555555555553  2344444555555555654


Q ss_pred             C
Q 042902          353 P  353 (599)
Q Consensus       353 ~  353 (599)
                      +
T Consensus       187 ~  187 (192)
T d1w8aa_         187 E  187 (192)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=9.3e-20  Score=170.21  Aligned_cols=164  Identities=26%  Similarity=0.363  Sum_probs=78.8

Q ss_pred             CCCCEEEcccccccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeec
Q 042902          146 QKLQLLSLEDNQLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLS  225 (599)
Q Consensus       146 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls  225 (599)
                      .+|++|++++|.++...  .+..+++|++|+|++|+++++.  .++.+++|+.|++++|+|+.+| .+..+++|+.|+++
T Consensus        46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECT
T ss_pred             cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-cccccccccccccc
Confidence            33444444444443221  2334444444444444444322  1334444444444444444443 24444445555555


Q ss_pred             CCCccccCcccccccccccEEEccCCccCCCCCccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccC
Q 042902          226 SNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAI  305 (599)
Q Consensus       226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  305 (599)
                      +|.+...  ..+..++.++.+++++|.+++.  ..+..+++|+++++++|++++..  .++.+++|+.|+|++|+|+. +
T Consensus       121 ~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l  193 (210)
T d1h6ta2         121 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-L  193 (210)
T ss_dssp             TSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-C
T ss_pred             ccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-C
Confidence            5544321  2344455555555555555432  23445555555556555555332  25556666666666666653 3


Q ss_pred             CchhhccccceEEEccc
Q 042902          306 PISLEKLLDLKYINVSF  322 (599)
Q Consensus       306 p~~~~~l~~L~~l~l~~  322 (599)
                      | .+.++++|++|+|++
T Consensus       194 ~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         194 R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             G-GGTTCTTCSEEEEEE
T ss_pred             h-hhcCCCCCCEEEccC
Confidence            3 356666666666653

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=2.2e-19  Score=165.16  Aligned_cols=128  Identities=29%  Similarity=0.412  Sum_probs=76.8

Q ss_pred             CEEEccCCcCCcccCccccCCCCCCEEEcccccccc-cCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCC
Q 042902          125 TTIYLGGNKLNGSIPIALDKLQKLQLLSLEDNQLEG-SIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGS  203 (599)
Q Consensus       125 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  203 (599)
                      ++++.++|+++.+ |..+.  +++++|+|++|+|+. ..+..|..+++|+.|+|++|.+..+.+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcCcc-CCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            4566666666633 32221  456666666666654 3344556666666666666666666666666666666666666


Q ss_pred             CCCCCCCc-cccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCC
Q 042902          204 NQLTSIPS-TLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSG  255 (599)
Q Consensus       204 N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  255 (599)
                      |+|+.+|. .|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+..
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            66666543 44556666666666666665555666666666666666666553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.8e-21  Score=204.06  Aligned_cols=162  Identities=21%  Similarity=0.206  Sum_probs=110.2

Q ss_pred             hhcCCCCcEEEeeCCccCC-----CCCcccCCCCCCcEeecCCCCCCCCC-----ccccCCCcccEEeecCCCccccCcc
Q 042902          166 LCRLAALFLLDLGGNKLSG-----FVPACFGNLTSLRNLYLGSNQLTSIP-----STLWNLKYILYLNLSSNSFTGPLPL  235 (599)
Q Consensus       166 ~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~ip-----~~~~~l~~L~~L~Ls~N~l~~~~~~  235 (599)
                      +...+.++.+++++|++..     .....+.....++.+++++|.+...+     ..+...+.++.+++++|.++.....
T Consensus       222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~  301 (460)
T d1z7xw1         222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  301 (460)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3456778888888887542     12233455678888999988887432     2345577888899999988643322


Q ss_pred             cc-----cccccccEEEccCCccCCCCCccc----cCccccccccccccccccc----Cccccc-CCCCcccccCCCCcc
Q 042902          236 EI-----GNLRVLVQIDLSMNNFSGFIPTTI----GDLKDLQYLFLEYNRLQGS----IPDSIG-GLIDLKSLDLSNNNI  301 (599)
Q Consensus       236 ~~-----~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l  301 (599)
                      .+     .....|+.+++++|.++......+    ...++|++|+|++|++++.    ++..+. ..+.|++|+|++|+|
T Consensus       302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i  381 (460)
T d1z7xw1         302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  381 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence            22     234578899999998875533333    3456799999999988653    233332 456799999999998


Q ss_pred             ccc----CCchhhccccceEEEcccccCcc
Q 042902          302 SGA----IPISLEKLLDLKYINVSFNKLEG  327 (599)
Q Consensus       302 ~~~----~p~~~~~l~~L~~l~l~~N~l~~  327 (599)
                      +..    ++..+...++|++|++++|+++.
T Consensus       382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         382 SDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             ChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            753    34456667889999999998864

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=4.2e-21  Score=201.23  Aligned_cols=326  Identities=19%  Similarity=0.133  Sum_probs=210.5

Q ss_pred             CccCCCcCccCC-CCCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEeccCccCcccCCCcccccccC-CCCC
Q 042902            1 LLLWGNNFSGTI-PSFIFNASKLSRLELEMNSFYGF----IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLS-NCKY   74 (599)
Q Consensus         1 L~L~~n~~~~~~-~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~-~l~~   74 (599)
                      |||++|++++.. .+-+..++++++|+|++|+|+..    ++.++..+++|++|+|++|.|+..... .....+. ...+
T Consensus         7 ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~-~l~~~l~~~~~~   85 (460)
T d1z7xw1           7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-CVLQGLQTPSCK   85 (460)
T ss_dssp             EEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH-HHHHTTCSTTCC
T ss_pred             EEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHH-HHHHHHhcCCCC
Confidence            577788887542 23355577888888888887742    344567778888888888887642211 0011222 2346


Q ss_pred             CcEEEcccCcccccC----ChhhhcccccceEEEccCCcccccCCc---------------------------------c
Q 042902           75 LKYLSFSNNSLDGIL----PRAIGNLSQSMEVFFMFNCNISGSIPE---------------------------------E  117 (599)
Q Consensus        75 L~~L~Ls~N~i~~~~----~~~~~~l~~~l~~l~l~~n~i~~~~~~---------------------------------~  117 (599)
                      |++|+|++|.|+...    +.++...+ .|+.|++++|.+......                                 .
T Consensus        86 L~~L~L~~n~it~~~~~~l~~~l~~~~-~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (460)
T d1z7xw1          86 IQKLSLQNCCLTGAGCGVLSSTLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV  164 (460)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             CCEEECCCCCccccccccccchhhccc-cccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccc
Confidence            888888888876432    33444443 578888888776532110                                 0


Q ss_pred             ccCCCCCCEEEccCCcCC-----------------------------cc----cCccccCCCCCCEEEccccccccc---
Q 042902          118 ISNLTNLTTIYLGGNKLN-----------------------------GS----IPIALDKLQKLQLLSLEDNQLEGS---  161 (599)
Q Consensus       118 ~~~l~~L~~L~L~~N~l~-----------------------------~~----~~~~~~~l~~L~~L~L~~N~l~~~---  161 (599)
                      +.....++.++++++.+.                             ..    ....+...+.++.+++++|.+...   
T Consensus       165 l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~  244 (460)
T d1z7xw1         165 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA  244 (460)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccc
Confidence            112234555555544322                             10    001233467788888888876532   


Q ss_pred             --CChhhhcCCCCcEEEeeCCccCCCC----CcccCCCCCCcEeecCCCCCCCC-----Cccc-cCCCcccEEeecCCCc
Q 042902          162 --IPDDLCRLAALFLLDLGGNKLSGFV----PACFGNLTSLRNLYLGSNQLTSI-----PSTL-WNLKYILYLNLSSNSF  229 (599)
Q Consensus       162 --~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~i-----p~~~-~~l~~L~~L~Ls~N~l  229 (599)
                        .+........++.+++++|.+....    ...+...+.++.+++++|.++..     ...+ .....|+.+++++|.+
T Consensus       245 ~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l  324 (460)
T d1z7xw1         245 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF  324 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             hhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccch
Confidence              2233445678999999999886432    22345678899999999998731     1112 2345799999999999


Q ss_pred             cccCcccc----cccccccEEEccCCccCCCC----Ccccc-Cccccccccccccccccc----CcccccCCCCcccccC
Q 042902          230 TGPLPLEI----GNLRVLVQIDLSMNNFSGFI----PTTIG-DLKDLQYLFLEYNRLQGS----IPDSIGGLIDLKSLDL  296 (599)
Q Consensus       230 ~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L  296 (599)
                      +......+    ...++|++|+|++|++++..    +..+. ..+.|++|+|++|.|++.    ++..+..+++|++|+|
T Consensus       325 ~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~L  404 (460)
T d1z7xw1         325 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL  404 (460)
T ss_dssp             BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred             hhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEEC
Confidence            86544433    45568999999999997532    22332 467799999999999753    4455677899999999


Q ss_pred             CCCcccccCCchhh-----ccccceEEEcccccCccc
Q 042902          297 SNNNISGAIPISLE-----KLLDLKYINVSFNKLEGE  328 (599)
Q Consensus       297 ~~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~~~  328 (599)
                      ++|+|+......+.     +...|+.|++.+|.+...
T Consensus       405 s~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             CSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             CCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            99999865444442     234699999999998753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=1e-16  Score=142.25  Aligned_cols=129  Identities=20%  Similarity=0.147  Sum_probs=83.9

Q ss_pred             CCcCCCCCCEEEccCccccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhh
Q 042902           15 FIFNASKLSRLELEMNSFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIG   94 (599)
Q Consensus        15 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~   94 (599)
                      .|.+..++++|+|++|+|+.+ ++.+..+++|+.|+|++|+|++++       .|..+++|++|++++|+|+.+.+..+.
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~-------~~~~l~~L~~L~ls~N~i~~l~~~~~~   84 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD-------GFPLLRRLKTLLVNNNRICRIGEGLDQ   84 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC-------CCCCCSSCCEEECCSSCCCEECSCHHH
T ss_pred             hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC-------CcccCcchhhhhcccccccCCCccccc
Confidence            366777888888888888875 566788888888888888888764       267788888888888888765544444


Q ss_pred             cccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-ccccCCCCCCEEEcccccccccC---ChhhhcCC
Q 042902           95 NLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGSI---PDDLCRLA  170 (599)
Q Consensus        95 ~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~  170 (599)
                      .                         +++|++|+|++|+|+.... ..+..+++|++|++++|.++...   +..+..++
T Consensus        85 ~-------------------------l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp  139 (162)
T d1a9na_          85 A-------------------------LPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP  139 (162)
T ss_dssp             H-------------------------CTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCT
T ss_pred             c-------------------------ccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCC
Confidence            4                         4455555555555543321 23455555555555555554321   12355556


Q ss_pred             CCcEEE
Q 042902          171 ALFLLD  176 (599)
Q Consensus       171 ~L~~L~  176 (599)
                      +|++||
T Consensus       140 ~L~~LD  145 (162)
T d1a9na_         140 QVRVLD  145 (162)
T ss_dssp             TCSEET
T ss_pred             CcCeeC
Confidence            666554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.64  E-value=4e-18  Score=171.87  Aligned_cols=200  Identities=19%  Similarity=0.182  Sum_probs=105.6

Q ss_pred             CccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccC---ChhhhcccccceEEEccCCccccc
Q 042902           37 PNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGIL---PRAIGNLSQSMEVFFMFNCNISGS  113 (599)
Q Consensus        37 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~---~~~~~~l~~~l~~l~l~~n~i~~~  113 (599)
                      ..++.+...|+.|+|++|.|...... .+...+...++|+.|+++++.+....   +..+..                  
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~-~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~------------------   84 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL------------------   84 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHH-HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH------------------
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHH-HHHHHHHhCCCCCEEECCCCcccccccccchHHHH------------------
Confidence            45566677788888888877543211 11124666777888888776554221   111111                  


Q ss_pred             CCccccCCCCCCEEEccCCcCCcc----cCccccCCCCCCEEEcccccccccCChhh-------------hcCCCCcEEE
Q 042902          114 IPEEISNLTNLTTIYLGGNKLNGS----IPIALDKLQKLQLLSLEDNQLEGSIPDDL-------------CRLAALFLLD  176 (599)
Q Consensus       114 ~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~  176 (599)
                      +...+...++|++|+|++|.++..    +...+...++|++|++++|.+.......+             ...+.|+.++
T Consensus        85 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~  164 (344)
T d2ca6a1          85 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII  164 (344)
T ss_dssp             HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred             HHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceee
Confidence            123455567777777777777643    22234456777777777777642211111             2345566666


Q ss_pred             eeCCccCCCCC----cccCCCCCCcEeecCCCCCCC------CCccccCCCcccEEeecCCCcccc----Cccccccccc
Q 042902          177 LGGNKLSGFVP----ACFGNLTSLRNLYLGSNQLTS------IPSTLWNLKYILYLNLSSNSFTGP----LPLEIGNLRV  242 (599)
Q Consensus       177 Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~------ip~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~  242 (599)
                      +++|.++....    ..+...+.|++|+|++|+|+.      +...+...++|+.|+|++|.++..    +...+...++
T Consensus       165 l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~  244 (344)
T d2ca6a1         165 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  244 (344)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             cccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence            66666543211    123344556666666666552      122334455555666665555432    1223344455


Q ss_pred             ccEEEccCCccCC
Q 042902          243 LVQIDLSMNNFSG  255 (599)
Q Consensus       243 L~~L~Ls~N~l~~  255 (599)
                      |++|+|++|.|++
T Consensus       245 L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         245 LRELGLNDCLLSA  257 (344)
T ss_dssp             CCEEECTTCCCCH
T ss_pred             chhhhhhcCccCc
Confidence            5555555555543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=2.4e-17  Score=161.10  Aligned_cols=125  Identities=17%  Similarity=0.146  Sum_probs=65.2

Q ss_pred             CEEEccCccccccCCccccCC--CCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhcccccc
Q 042902           23 SRLELEMNSFYGFIPNTFGNL--RNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSM  100 (599)
Q Consensus        23 ~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l  100 (599)
                      ++|||+++.+..   +.+..+  ..+..+.+++..+.....      ......+|++|||++|.++....          
T Consensus         3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~~------~~~~~~~L~~LdLs~~~i~~~~l----------   63 (284)
T d2astb2           3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLA------EHFSPFRVQHMDLSNSVIEVSTL----------   63 (284)
T ss_dssp             SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCCC------SCCCCBCCCEEECTTCEECHHHH----------
T ss_pred             CEEECCCCCCCc---hHHHHHHhccceEeeccccccccchh------hhccCCCCCEEECCCCccCHHHH----------
Confidence            478888777642   222222  235566666665543322      13344578888888887753211          


Q ss_pred             eEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccCccccCCCCCCEEEcccc-cccccC-ChhhhcCCCCcEEEee
Q 042902          101 EVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDN-QLEGSI-PDDLCRLAALFLLDLG  178 (599)
Q Consensus       101 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~Ls  178 (599)
                                    +..+.++++|++|+|++|.+++..+..+..+++|++|+++++ .+++.. ...+..+++|++|+++
T Consensus        64 --------------~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls  129 (284)
T d2astb2          64 --------------HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS  129 (284)
T ss_dssp             --------------HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECC
T ss_pred             --------------HHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccc
Confidence                          122344556666666666655544455555566666666653 343211 1122345555666555


Q ss_pred             CC
Q 042902          179 GN  180 (599)
Q Consensus       179 ~N  180 (599)
                      ++
T Consensus       130 ~c  131 (284)
T d2astb2         130 WC  131 (284)
T ss_dssp             CC
T ss_pred             cc
Confidence            53

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1e-16  Score=142.31  Aligned_cols=111  Identities=18%  Similarity=0.138  Sum_probs=52.8

Q ss_pred             hhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccE
Q 042902          166 LCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQ  245 (599)
Q Consensus       166 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  245 (599)
                      |.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|++++ .+..+++|++|++++|+++...+..+..+++|+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence            33444555555555555543 334444555555555555555553 2444555555555555555444434444555555


Q ss_pred             EEccCCccCCCCC-ccccCccccccccccccccc
Q 042902          246 IDLSMNNFSGFIP-TTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       246 L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  278 (599)
                      |++++|+|+.... ..+..+++|++|++++|+++
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ceeccccccccccccccccccccchhhcCCCccc
Confidence            5555555443211 23334444444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=6.9e-17  Score=157.80  Aligned_cols=245  Identities=22%  Similarity=0.225  Sum_probs=166.2

Q ss_pred             cEEEcccCcccccCChhhhccc-ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcc-cCccccCCCCCCEEEc
Q 042902           76 KYLSFSNNSLDGILPRAIGNLS-QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS-IPIALDKLQKLQLLSL  153 (599)
Q Consensus        76 ~~L~Ls~N~i~~~~~~~~~~l~-~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L  153 (599)
                      +.|||+++.+.   |+.+..+. .....+.+....+...... .....+|++|+|++|.++.. +...+..+++|++|+|
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L   78 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL   78 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence            46788877764   33333322 1244555555544433222 33557899999999988743 3445788999999999


Q ss_pred             ccccccccCChhhhcCCCCcEEEeeCC-ccCCCC-CcccCCCCCCcEeecCCC-CCCC--CCccccC-CCcccEEeecCC
Q 042902          154 EDNQLEGSIPDDLCRLAALFLLDLGGN-KLSGFV-PACFGNLTSLRNLYLGSN-QLTS--IPSTLWN-LKYILYLNLSSN  227 (599)
Q Consensus       154 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~-~~~~~~l~~L~~L~L~~N-~l~~--ip~~~~~-l~~L~~L~Ls~N  227 (599)
                      +++.+.+..+..+..+++|++|+++++ .+++.. ...+.++++|++|+++++ .++.  ++..+.. .++|+.|+++++
T Consensus        79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~  158 (284)
T d2astb2          79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  158 (284)
T ss_dssp             TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence            999998877888889999999999995 565321 122456899999999986 4542  2222333 468999999875


Q ss_pred             --CccccC-cccccccccccEEEccCC-ccCCCCCccccCcccccccccccc-cccccCcccccCCCCcccccCCCCccc
Q 042902          228 --SFTGPL-PLEIGNLRVLVQIDLSMN-NFSGFIPTTIGDLKDLQYLFLEYN-RLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       228 --~l~~~~-~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                        .++... ...+.++++|++|++++| .+++.....+..+++|++|+|++| .+++.....++.+++|+.|+++++ ++
T Consensus       159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~  237 (284)
T d2astb2         159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP  237 (284)
T ss_dssp             GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC
T ss_pred             ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC
Confidence              344322 223356789999999986 477777778888999999999995 677766777888899999999887 33


Q ss_pred             c-cCCchhhccccceEEEcccccCccc
Q 042902          303 G-AIPISLEKLLDLKYINVSFNKLEGE  328 (599)
Q Consensus       303 ~-~~p~~~~~l~~L~~l~l~~N~l~~~  328 (599)
                      . ..+.....+++|+   +..++++..
T Consensus       238 d~~l~~l~~~lp~L~---i~~~~ls~~  261 (284)
T d2astb2         238 DGTLQLLKEALPHLQ---INCSHFTTI  261 (284)
T ss_dssp             TTCHHHHHHHSTTSE---ESCCCSCCT
T ss_pred             HHHHHHHHHhCcccc---ccCccCCCC
Confidence            2 2222234466655   466666644

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.62  E-value=1.8e-17  Score=166.89  Aligned_cols=239  Identities=22%  Similarity=0.223  Sum_probs=171.5

Q ss_pred             ccCCCCCCcEEEcccCcccccCChhhhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCccc---------
Q 042902           68 SLSNCKYLKYLSFSNNSLDGILPRAIGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSI---------  138 (599)
Q Consensus        68 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------  138 (599)
                      ++...++|++|+|++|.|.......++                     ..+...++|+.|+++++......         
T Consensus        26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~---------------------~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~   84 (344)
T d2ca6a1          26 VLLEDDSVKEIVLSGNTIGTEAARWLS---------------------ENIASKKDLEIAEFSDIFTGRVKDEIPEALRL   84 (344)
T ss_dssp             HHHHCSCCCEEECTTSEECHHHHHHHH---------------------HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH
T ss_pred             HHhhCCCCCEEECcCCcCCHHHHHHHH---------------------HHHHhCCCCCEEECCCCcccccccccchHHHH
Confidence            466677888888888887633222221                     34556788899999887654221         


Q ss_pred             -CccccCCCCCCEEEccccccccc----CChhhhcCCCCcEEEeeCCccCCCCCcc-------------cCCCCCCcEee
Q 042902          139 -PIALDKLQKLQLLSLEDNQLEGS----IPDDLCRLAALFLLDLGGNKLSGFVPAC-------------FGNLTSLRNLY  200 (599)
Q Consensus       139 -~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~  200 (599)
                       ...+...++|++|+|++|.+...    +...+...++|+.|++++|.+.......             ....+.|+.+.
T Consensus        85 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~  164 (344)
T d2ca6a1          85 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII  164 (344)
T ss_dssp             HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred             HHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceee
Confidence             23356788999999999999754    3344567899999999999875321111             13467899999


Q ss_pred             cCCCCCCC-----CCccccCCCcccEEeecCCCcccc-----CcccccccccccEEEccCCccCCC----CCccccCccc
Q 042902          201 LGSNQLTS-----IPSTLWNLKYILYLNLSSNSFTGP-----LPLEIGNLRVLVQIDLSMNNFSGF----IPTTIGDLKD  266 (599)
Q Consensus       201 L~~N~l~~-----ip~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~  266 (599)
                      +++|.++.     +...+...+.|+.|+|++|.++..     ....+...++|+.|+|++|.++..    +...+..+++
T Consensus       165 l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~  244 (344)
T d2ca6a1         165 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  244 (344)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             cccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence            99999873     233455678899999999998742     234567789999999999998643    3355678899


Q ss_pred             ccccccccccccccCcccc----c--CCCCcccccCCCCcccccC----Cchhh-ccccceEEEcccccCcc
Q 042902          267 LQYLFLEYNRLQGSIPDSI----G--GLIDLKSLDLSNNNISGAI----PISLE-KLLDLKYINVSFNKLEG  327 (599)
Q Consensus       267 L~~L~L~~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~l~l~~N~l~~  327 (599)
                      |++|+|++|.|++.....+    .  ..+.|++|++++|+|+...    ...+. +.++|+.|++++|++..
T Consensus       245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            9999999999986533333    2  2467999999999987532    23332 56789999999999864

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.61  E-value=9.1e-16  Score=129.42  Aligned_cols=40  Identities=28%  Similarity=0.405  Sum_probs=15.9

Q ss_pred             CCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCcc
Q 042902          191 GNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       191 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      ..+++|++|++++|+|+++|..+..+++|+.|++++|.|+
T Consensus        17 ~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~   56 (124)
T d1dcea3          17 EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE   56 (124)
T ss_dssp             GGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             ccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc
Confidence            3333444444444444444333333333444444444333

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1.6e-15  Score=127.95  Aligned_cols=118  Identities=30%  Similarity=0.316  Sum_probs=86.5

Q ss_pred             cEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccccEEEccCCccCCCCCccccCccccccccccccc
Q 042902          197 RNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLEYNR  276 (599)
Q Consensus       197 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  276 (599)
                      +.|+|++|+|+.++. +..+++|++|++++|+|+. +|..|+.+++|+.|++++|.|++. | .++.+++|++|++++|+
T Consensus         1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCCCCcc-cccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence            568888888888864 7788888888888888874 566788888888888888888854 3 47788888888888888


Q ss_pred             ccccCc-ccccCCCCcccccCCCCcccccC---CchhhccccceEE
Q 042902          277 LQGSIP-DSIGGLIDLKSLDLSNNNISGAI---PISLEKLLDLKYI  318 (599)
Q Consensus       277 l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~l  318 (599)
                      +++... ..+..+++|+.|++++|+++...   ......+|+|+.|
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            875442 56777788888888888876432   2223345666554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.52  E-value=1.7e-16  Score=145.89  Aligned_cols=111  Identities=24%  Similarity=0.229  Sum_probs=56.0

Q ss_pred             hhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccCcccccccccc
Q 042902          164 DDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPLPLEIGNLRVL  243 (599)
Q Consensus       164 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  243 (599)
                      ..+..+++|++|+|++|+|+.+ + .+.++++|++|+|++|+|+++|.....+++|++|++++|+++..  ..+..+++|
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             hHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccccccccccc--ccccccccc
Confidence            4455555555555555555543 1 24555555555555555555554333344555555555555532  234455555


Q ss_pred             cEEEccCCccCCCCC-ccccCccccccccccccccc
Q 042902          244 VQIDLSMNNFSGFIP-TTIGDLKDLQYLFLEYNRLQ  278 (599)
Q Consensus       244 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  278 (599)
                      +.|+|++|+|+.... ..+..+++|++|+|++|++.
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555553321 23445555555555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.49  E-value=6.4e-16  Score=141.98  Aligned_cols=130  Identities=25%  Similarity=0.318  Sum_probs=90.4

Q ss_pred             CCCCEEEccCc--cccccCCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChhhhccc
Q 042902           20 SKLSRLELEMN--SFYGFIPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRAIGNLS   97 (599)
Q Consensus        20 ~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~   97 (599)
                      ..++.+++.++  .++. .+.+|..|++|++|+|++|+|+.++       .+.++++|++|+|++|.|+.+ |..+..+ 
T Consensus        23 ~~~~~~~l~~~~~~i~~-l~~sl~~L~~L~~L~Ls~n~I~~i~-------~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~-   92 (198)
T d1m9la_          23 TEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKIS-------SLSGMENLRILSLGRNLIKKI-ENLDAVA-   92 (198)
T ss_dssp             TTCSCEECCBCCTTCCC-CHHHHHHTTTCCEEECSEEEESCCC-------CHHHHTTCCEEECCEEEECSC-SSHHHHH-
T ss_pred             cccceeeeecccCchhh-hhhHHhcccccceeECcccCCCCcc-------cccCCccccChhhcccccccc-ccccccc-
Confidence            44666777654  3443 4567889999999999999998764       277888999999999998854 4333333 


Q ss_pred             ccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcccC-ccccCCCCCCEEEccccccccc
Q 042902           98 QSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGSIP-IALDKLQKLQLLSLEDNQLEGS  161 (599)
Q Consensus        98 ~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  161 (599)
                      +.|+.|++++|+|+.+  ..+.++++|++|+|++|+|+.... ..+..+++|++|+|++|.+...
T Consensus        93 ~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_          93 DTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             cccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            3477777777777654  346667777777777777765432 3566777777777777776543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=5.7e-14  Score=123.38  Aligned_cols=107  Identities=21%  Similarity=0.118  Sum_probs=69.8

Q ss_pred             CCCEEEccCCcCCcccCccccCCCCCCEEEcccc-cccccCChhhhcCCCCcEEEeeCCccCCCCCcccCCCCCCcEeec
Q 042902          123 NLTTIYLGGNKLNGSIPIALDKLQKLQLLSLEDN-QLEGSIPDDLCRLAALFLLDLGGNKLSGFVPACFGNLTSLRNLYL  201 (599)
Q Consensus       123 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  201 (599)
                      ..+.++.+++.+.. .|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            34456666666653 3455666667777777554 366666666777777777777777777666667777777777777


Q ss_pred             CCCCCCCCCccccCCCcccEEeecCCCcc
Q 042902          202 GSNQLTSIPSTLWNLKYILYLNLSSNSFT  230 (599)
Q Consensus       202 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~  230 (599)
                      ++|+|+++|...+...+|+.|+|++|.+.
T Consensus        88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhccccccccccCCCccc
Confidence            77777777665555455667777777664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=7.6e-14  Score=122.55  Aligned_cols=107  Identities=17%  Similarity=0.141  Sum_probs=63.6

Q ss_pred             CCcEeecCCCCCCCCCccccCCCcccEEeecCC-CccccCcccccccccccEEEccCCccCCCCCccccCcccccccccc
Q 042902          195 SLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSN-SFTGPLPLEIGNLRVLVQIDLSMNNFSGFIPTTIGDLKDLQYLFLE  273 (599)
Q Consensus       195 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  273 (599)
                      ..+.++.+++.+.++|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus         9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3           9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            344566666666666666666666666666544 3665555566666666666666666666556666666666666666


Q ss_pred             cccccccCcccccCCCCcccccCCCCccc
Q 042902          274 YNRLQGSIPDSIGGLIDLKSLDLSNNNIS  302 (599)
Q Consensus       274 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  302 (599)
                      +|+|+...+..|..+ +|+.|+|++|++.
T Consensus        89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          89 FNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCCCcccChhhhccc-cccccccCCCccc
Confidence            666664444444333 4555555555553

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=2.6e-10  Score=100.21  Aligned_cols=83  Identities=20%  Similarity=0.184  Sum_probs=45.3

Q ss_pred             ccccccccEEEccCCccCCCC--CccccCcccccccccccccccccCcccccCCCCcccccCCCCcccccCCc-------
Q 042902          237 IGNLRVLVQIDLSMNNFSGFI--PTTIGDLKDLQYLFLEYNRLQGSIPDSIGGLIDLKSLDLSNNNISGAIPI-------  307 (599)
Q Consensus       237 ~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-------  307 (599)
                      +..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|+++.....       
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence            344555555555555555432  23345566666666666666644433333444566777777766644332       


Q ss_pred             hhhccccceEEE
Q 042902          308 SLEKLLDLKYIN  319 (599)
Q Consensus       308 ~~~~l~~L~~l~  319 (599)
                      .+..+|+|+.||
T Consensus       141 i~~~~P~L~~LD  152 (162)
T d1koha1         141 IRERFPKLLRLD  152 (162)
T ss_dssp             HHTTSTTCCEET
T ss_pred             HHHHCCCCCEEC
Confidence            244566777654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=8.4e-10  Score=96.89  Aligned_cols=125  Identities=21%  Similarity=0.101  Sum_probs=77.5

Q ss_pred             CCcEEEeeCCccCCCCCcccCCCCCCcEeecCCCCCCCCCccccCCCcccEEeecCCCccccC--cccccccccccEEEc
Q 042902          171 ALFLLDLGGNKLSGFVPACFGNLTSLRNLYLGSNQLTSIPSTLWNLKYILYLNLSSNSFTGPL--PLEIGNLRVLVQIDL  248 (599)
Q Consensus       171 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L  248 (599)
                      ..+.|+++++...    ..+..+..+..+...++....++.....+++|++|+|++|+|+...  +..+..+++|+.|+|
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L   98 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL   98 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence            4455666655432    1233444445555555444444444456778888888888887653  344667788888888


Q ss_pred             cCCccCCCCCccccCcccccccccccccccccCcc-------cccCCCCcccccCCCCcc
Q 042902          249 SMNNFSGFIPTTIGDLKDLQYLFLEYNRLQGSIPD-------SIGGLIDLKSLDLSNNNI  301 (599)
Q Consensus       249 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~L~~N~l  301 (599)
                      ++|.|+...+-.+....+|+.|++++|++......       .+..+|+|+.||  ++.+
T Consensus        99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            88888865544444455688888888888755432       255677888776  4444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=6.9e-08  Score=91.51  Aligned_cols=149  Identities=19%  Similarity=0.183  Sum_probs=102.2

Q ss_pred             HHHHHhCCCCcCceecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeee
Q 042902          422 ELFQATNGFSENNLIGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKA  500 (599)
Q Consensus       422 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  500 (599)
                      ++...-..|...+..+-++.+.||+... +++.+.+|+...........+..|..++..+. +--+.+++.++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4444455666554433344568999865 46778889886554444456777888877663 434678888888888999


Q ss_pred             EEEEccCCCChhhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 042902          501 LVLEYMPHGSLEKCLYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------  545 (599)
Q Consensus       501 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----------------------------------  545 (599)
                      +|||+++|.++.+......      ....++.++++.++.+|...                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988865432211      12335666667777776210                                   


Q ss_pred             ---------------------CCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          546 ---------------------SVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       546 ---------------------~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                                           ...++|+|+.|.||++++++.+-|+||+.|..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 12379999999999999877778999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.28  E-value=1.6e-06  Score=81.34  Aligned_cols=131  Identities=16%  Similarity=0.109  Sum_probs=87.6

Q ss_pred             eeccccc-ceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCcceeEEEEEEcCCeeeEEEEccCCCCh
Q 042902          435 LIGRGGV-ASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR--HRNLIKIISSCSNDDFKALVLEYMPHGSL  511 (599)
Q Consensus       435 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  511 (599)
                      .+..|.. +.||+...+++..+++|.......   ..+..|+..++.+.  .--+.++++++.+++..++||||++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 679999988888899998754432   23556777776553  33467788888888889999999998766


Q ss_pred             hhhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 042902          512 EKCLYSSNYILDIFQRLNIMIDVASALEYLHF------------------------------------------------  543 (599)
Q Consensus       512 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~------------------------------------------------  543 (599)
                      .+..      ..   ....+.++++.|+-||.                                                
T Consensus        94 ~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      11   01122333344444441                                                


Q ss_pred             ---C----CCCCeEEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          544 ---G----YSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       544 ---~----~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                         .    ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               0    123479999999999999887788999998763

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.93  E-value=1.2e-06  Score=76.60  Aligned_cols=18  Identities=22%  Similarity=0.403  Sum_probs=8.6

Q ss_pred             cCCCCCCcEEEcccCccc
Q 042902           69 LSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        69 ~~~l~~L~~L~Ls~N~i~   86 (599)
                      +...++|++|+|++|.|.
T Consensus        40 L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             HTTCSCCCEEECTTSCCB
T ss_pred             HhhCCccceeeccccccc
Confidence            444444555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.91  E-value=1.3e-06  Score=76.22  Aligned_cols=119  Identities=10%  Similarity=0.160  Sum_probs=77.7

Q ss_pred             CCCCCCEEEccCc-ccccc----CCccccCCCCCCEEeccCccCcccCCCcccccccCCCCCCcEEEcccCcccccCChh
Q 042902           18 NASKLSRLELEMN-SFYGF----IPNTFGNLRNLKRLSLNYNYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLDGILPRA   92 (599)
Q Consensus        18 ~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~   92 (599)
                      +.++|++|+|+++ .|+..    +..++...+.|++|+|++|.++..... .+...+...+.|++|+|++|.|+..   .
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~-~la~~L~~n~~L~~L~L~~n~i~~~---g   88 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR-GLIELIETSPSLRVLNVESNFLTPE---L   88 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT-THHHHHHHCSSCCEEECCSSBCCHH---H
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHH-HHhhhhhhcccccceeeehhhcchH---H
Confidence            4578999999974 56542    334567788999999999999754322 1223466678899999999988743   2


Q ss_pred             hhcccccceEEEccCCcccccCCccccCCCCCCEEEccCCcCCcc-------cCccccCCCCCCEEEcccccc
Q 042902           93 IGNLSQSMEVFFMFNCNISGSIPEEISNLTNLTTIYLGGNKLNGS-------IPIALDKLQKLQLLSLEDNQL  158 (599)
Q Consensus        93 ~~~l~~~l~~l~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l  158 (599)
                      +..+.                  .++...++|++|+|++|++...       +...+...+.|+.|+++.+..
T Consensus        89 ~~~l~------------------~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          89 LARLL------------------RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHH------------------HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHH------------------HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            22221                  2344557788888888876532       223344456677776665543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.78  E-value=4e-05  Score=76.42  Aligned_cols=77  Identities=17%  Similarity=0.202  Sum_probs=49.4

Q ss_pred             CceecccccceEEEEEecC-CcEEEEEEeccc-------ccccHHHHHHHHHHHhcCC---CCcceeEEEEEEcCCeeeE
Q 042902          433 NNLIGRGGVASVYKARIQD-GIEVAVKVFDLQ-------YEGAFKSFDIECDMMKRIR---HRNLIKIISSCSNDDFKAL  501 (599)
Q Consensus       433 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  501 (599)
                      .+.||.|....||++...+ ++.|+||.....       ......+...|.+.++.+.   ...+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999998764 678999975421       1112334456777776552   2346666655  3455689


Q ss_pred             EEEccCCCCh
Q 042902          502 VLEYMPHGSL  511 (599)
Q Consensus       502 v~e~~~~g~L  511 (599)
                      ||||+++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.44  E-value=5.7e-06  Score=71.96  Aligned_cols=45  Identities=20%  Similarity=0.228  Sum_probs=22.7

Q ss_pred             cCCCCCCEEeccC-ccCcccCCCcccccccCCCCCCcEEEcccCccc
Q 042902           41 GNLRNLKRLSLNY-NYLTSSTPKLNFLSSLSNCKYLKYLSFSNNSLD   86 (599)
Q Consensus        41 ~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~i~   86 (599)
                      .+.++|++|+|++ +.|+.... ..+..++...++|++|+|++|.++
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~-~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTL-KACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHH-HHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHH-HHHHHHHhcCCccCeeeccCCccc
Confidence            4455666666665 33432211 112234455566666666666654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.39  E-value=9.2e-06  Score=70.61  Aligned_cols=66  Identities=17%  Similarity=0.135  Sum_probs=39.2

Q ss_pred             ccCCCCCCEEEccC-CcCCcc----cCccccCCCCCCEEEcccccccccCC----hhhhcCCCCcEEEeeCCccC
Q 042902          118 ISNLTNLTTIYLGG-NKLNGS----IPIALDKLQKLQLLSLEDNQLEGSIP----DDLCRLAALFLLDLGGNKLS  183 (599)
Q Consensus       118 ~~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~  183 (599)
                      ..+.++|++|+|++ +.++..    +-.++...++|++|+|++|.+.....    ..+...++++.+++++|.+.
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            34567788888876 445421    22334567777777777777754322    23344556666666666654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.30  E-value=0.00023  Score=68.72  Aligned_cols=133  Identities=13%  Similarity=0.156  Sum_probs=78.3

Q ss_pred             ceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCcc--eeEEE-----EEEcCCeeeEEEEccCCCChhh-
Q 042902          442 ASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIRHRNL--IKIIS-----SCSNDDFKALVLEYMPHGSLEK-  513 (599)
Q Consensus       442 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~~-  513 (599)
                      -.||+++.++|+.|++|+.+.... ..+++..|...+..+....+  +..+.     .....+..+.+++|++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            479999999999999999875533 34677888888877642211  11111     2244567889999998754321 


Q ss_pred             ----h---------hh----cC----CCcCCHH-------------------HHHHHHHHHHHHHHHHh----cCCCCCe
Q 042902          514 ----C---------LY----SS----NYILDIF-------------------QRLNIMIDVASALEYLH----FGYSVPI  549 (599)
Q Consensus       514 ----~---------l~----~~----~~~~~~~-------------------~~~~i~~~i~~~l~~lH----~~~~~~i  549 (599)
                          +         ++    ..    ....++.                   .+..+...+.+.+..+.    .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0         00    00    0011111                   11112222233333332    2234678


Q ss_pred             EEccCCCCCeeecCCCcEEEccccCCcc
Q 042902          550 IHCDLKPNNVLLDDNMVAHLSDFGMAKP  577 (599)
Q Consensus       550 iH~dlk~~Nill~~~~~~kl~DFGla~~  577 (599)
                      ||+|+.+.|||++++  ..++||+-|..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999744  45899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.72  E-value=0.0021  Score=63.59  Aligned_cols=72  Identities=18%  Similarity=0.208  Sum_probs=48.8

Q ss_pred             ceecccccceEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCC-CCcceeEEEEEEcCCeeeEEEE
Q 042902          434 NLIGRGGVASVYKARIQD--------GIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-HRNLIKIISSCSNDDFKALVLE  504 (599)
Q Consensus       434 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  504 (599)
                      +.|+.|-.-.+|++...+        .+.|.+++.. ... ....-.+|..+++.+. +.-..++++++..    .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578888888999998653        3567777765 222 2234457888888774 4444577777643    68999


Q ss_pred             ccCCCCh
Q 042902          505 YMPHGSL  511 (599)
Q Consensus       505 ~~~~g~L  511 (599)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.51  E-value=0.01  Score=56.29  Aligned_cols=156  Identities=15%  Similarity=0.119  Sum_probs=81.8

Q ss_pred             ccHHHHHHHhCCCCcCce-----ecccccceEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-----CCcce
Q 042902          418 FTHLELFQATNGFSENNL-----IGRGGVASVYKARIQDGIEVAVKVFDLQYEGAFKSFDIECDMMKRIR-----HRNLI  487 (599)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  487 (599)
                      .+..++.....+|...+.     |..|---+.|+.+..+| .+++|+.......  ++...|++++..+.     -|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccc
Confidence            455666666777766443     33455567899887765 4889998654222  23333555555543     22222


Q ss_pred             eEE-E--EEEcCCeeeEEEEccCCCChhhh--------------hh----cC--C--CcCCHH-----------------
Q 042902          488 KII-S--SCSNDDFKALVLEYMPHGSLEKC--------------LY----SS--N--YILDIF-----------------  525 (599)
Q Consensus       488 ~l~-~--~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~--~--~~~~~~-----------------  525 (599)
                      .-. |  +.........++.++++......              ++    ..  .  ......                 
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            211 0  12234566778888877543211              00    00  0  000000                 


Q ss_pred             -HHHHHHHHHHHHHHHHh-cCCCCCeEEccCCCCCeeecCCCcEEEccccCCc
Q 042902          526 -QRLNIMIDVASALEYLH-FGYSVPIIHCDLKPNNVLLDDNMVAHLSDFGMAK  576 (599)
Q Consensus       526 -~~~~i~~~i~~~l~~lH-~~~~~~iiH~dlk~~Nill~~~~~~kl~DFGla~  576 (599)
                       .....+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.|.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             01111222222222222 1235789999999999999998777899999875